Citrus Sinensis ID: 039344

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870---
Protein Sequence
LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEccccEEEEccccccccccccccccccccccEEcccccccccccccEEEccccEEEEEccccccccccccEEEccccEEcEEccccccccccccEEEccccccEEEccccccccccccEEEccccEEEEccccccccccccEEEcccccccccccHHHcccccccEEEccccEEcccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHccccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccHHHHcccccccccccHHHHHHHHHHHHHHHcccccccccccEEccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccHHHcccccccccccccccccccHHHHHHHHHHHHHHccccccccccccHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccEccccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEEccccccccccccccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEcEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEEcccccccccccHHHHccccccEEEcccccccccccHHHccccccEEEEEcccccccccccccccccccHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEHccccccccHHHHHHHHHccccccEEEccccEEEEEEEcccccEEEEEEcccccccccccccHHHHHHHHHHHHHHHHHHHHHEEccccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEEccccHHHHHHHcHHEEEccccccccEEEcccccccccHEEEEEEcccccHHHHHHHHHHHHcccccccccccEEEEEEcccccHHHHcccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
lpciynnslydsipselrnlkslsdlelgnnklsgsiphslgnltNLATLYIHTnslsgsipgeignfrffsdlelsnnklsgsippslgnlsnLATLYldtnslsnsipselgnlrslsnlqlnnnilsgsiphslgnltnLATLYIYSNSLSASILGkignlkslsnlqlsennfngsippslgnlsnlatlyldtnslsysipselgnlrslsnlslgynklsgsipismgnlsnltyLNLFENslsgaipyeYRNLVKLTILLLghnqfrgpipilrnltslerVRLDrnyltgnisesfyiypnltyidlsqnnfygeissdwgrcpklstldfsinnitgnvppeighssqlgvldlssnhivgeipielgKLNFFIKLVLAHNqlsgqlspklgslvqlehldlssnrlsnsipkslgnlelihlsELDLSRNFLREAIPSQICIMQSLEklnlshnslsglipsCFEKMNGLLHIDISynelrgsipnsttfkdapiealqgnkglygdvKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKfqrrkndsqtqqsspgnsrgllSVLTFEGKIIYEEIIRAtndfddehcigkggqgsvYMSKLASGEIIAvkkfhsplpgemtFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSymhndcfppivhrdissknvlldfeneahvsdfgiakflkpdssnwtelagtygyvapelAYTMKvtekcdvySFGVLALEVIkgkhprdfissmsfSSLNLNIAldemldprlptpsrnvhdKLISIVEVTIScvdenpesrptMQKVCQLLKI
Flexible Loop (DISEMBL)
lpciynnslydsiPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHnqfrgpipilrnltslerVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNdsqtqqsspgnsrgllSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTIScvdenpesrptmqkvcqllki
Low Complexity Region (SEG)
LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSElgnlrslsnlqlnnnilsgsiPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPselgnlrslsnlslgYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI
Disordered region (IsUnstruct)
****Y***LY**************************IPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELS***********LGNLSNLATLYLDTN************LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLS**NFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLD***********KSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQ******************LLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD*******RNVHDKLISIVEVTISCV*******************
Disordered Region (DISOPRED)
LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDV*********************VVVFPLLGFVALLISLIGLFFKF*********************SVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG*****QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI
Disordered Region (DISEMBL)
LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQR**************SRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI
Disordered Region (DISPRO)
LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSC*******QALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKN************RGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	873	2.2.26 [Sep-21-2011]
Q9LP24	1120	Probable leucine-rich rep	yes	no	0.980	0.764	0.481	0.0
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.957	0.8	0.456	0.0
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.973	0.772	0.367	1e-145
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.975	0.773	0.362	1e-143
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.980	0.685	0.363	1e-139
O49318	1124	Probable leucine-rich rep	no	no	0.975	0.758	0.351	1e-138
Q9LHP4	1141	Receptor-like protein kin	no	no	0.985	0.753	0.358	1e-137
C0LGV1	1135	LRR receptor-like serine/	no	no	0.983	0.756	0.356	1e-133
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.975	0.680	0.348	1e-129
C0LGF5	1072	Probable LRR receptor-lik	no	no	0.981	0.799	0.360	1e-123

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  756 bits (1953), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/913 (48%), Positives = 581/913 (63%), Gaps = 57/913 (6%)

Query: 4    IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
            +Y N L   IP EL N++S++DL L  NKL+GSIP +LGNL NL  LY++ N L+G IP 
Sbjct: 205  LYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPP 264

Query: 64   EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            EIGN    ++L LS NKL+GSIP SLGNL NL  L L  N L+  IP +LGN+ S+ +L+
Sbjct: 265  EIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLE 324

Query: 124  LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            L+NN L+GSIP SLGNL NL  LY+Y N L+  I  ++GN++S+ +LQL+ N   GSIP 
Sbjct: 325  LSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPS 384

Query: 184  SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            S GNL NL  LYL  N L+  IP ELGN+ S+ NL L  NKL+GS+P S GN + L  L 
Sbjct: 385  SFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLY 444

Query: 244  LFENSLSGAIPYEYRNLVKLTILLLGHNQF------------------------RGPIPI 279
            L  N LSGAIP    N   LT L+L  N F                         GPIP 
Sbjct: 445  LRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPK 504

Query: 280  -LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD 338
             LR+  SL R R   N  TG+I E+F IYP+L +ID S N F+GEISS+W + PKL  L 
Sbjct: 505  SLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALI 564

Query: 339  FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
             S NNITG +P EI + +QL  LDLS+N++ GE+P  +G L    +L L  NQLSG++  
Sbjct: 565  MSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPA 624

Query: 399  KLGSLVQLEHLDLSSNRLSNSIPKSLGNL---------------------ELIHLSELDL 437
             L  L  LE LDLSSN  S+ IP++  +                      +L  L++LDL
Sbjct: 625  GLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDL 684

Query: 438  SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            S N L   IPSQ+  +QSL+KL+LSHN+LSGLIP+ FE M  L ++DIS N+L G +P++
Sbjct: 685  SHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDT 744

Query: 498  TTFKDAPIEALQGNKGLYGDV--KGLLSCKALKS-NKQALRTIWVVVVFPLLGFVALLIS 554
             TF+ A  +AL+ N GL  ++  + L  C+ LK   K     +W++V  P+LG V +++S
Sbjct: 745  PTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILG-VLVILS 801

Query: 555  LIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGG 614
            +    F +  RK   Q  +++   +   +S+ + +GK  Y++II +TN+FD  H IG GG
Sbjct: 802  ICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGG 861

Query: 615  QGSVYMSKLASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIWHRNIVKVYGFCL 671
               VY + L    IIAVK+ H  +  E++    +QEFLNEVKALTEI HRN+VK++GFC 
Sbjct: 862  YSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCS 920

Query: 672  HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHR 731
            H RH F++YEY +  SL  +L+ND  AK L WT+R+N++KG+  ALSYMH+D   PIVHR
Sbjct: 921  HRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHR 980

Query: 732  DISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 791
            DISS N+LLD +  A +SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVY
Sbjct: 981  DISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVY 1040

Query: 792  SFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTI 851
            SFGVL LE+I GKHP D +SS+S SS    ++L  + D R+  P     +KL+ +VE+ +
Sbjct: 1041 SFGVLILELIIGKHPGDLVSSLS-SSPGEALSLRSISDERVLEPRGQNREKLLKMVEMAL 1099

Query: 852  SCVDENPESRPTM 864
             C+  NPESRPTM
Sbjct: 1100 LCLQANPESRPTM 1112

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  736 bits (1901), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/894 (45%), Positives = 563/894 (62%), Gaps = 58/894 (6%)

Query: 26   LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
             +L  N+L G IP  LG+L+NL TL++  N L+GSIP EIG     +++ + +N L+G I
Sbjct: 147  FDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPI 206

Query: 86   PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLAT 145
            P S GNL+ L  LYL  NSLS SIPSE+GNL +L  L L+ N L+G IP S GNL N+  
Sbjct: 207  PSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTL 266

Query: 146  LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSI 205
            L ++ N LS  I  +IGN+ +L  L L  N   G IP +LGN+  LA L+L  N L+ SI
Sbjct: 267  LNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSI 326

Query: 206  PSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTI 265
            P ELG + S+ +L +  NKL+G +P S G L+ L +L L +N LSG IP    N  +LT+
Sbjct: 327  PPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTV 386

Query: 266  L------------------------LLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNI 300
            L                         L  N F GP+P  LR+  SL RVR   N  +G+I
Sbjct: 387  LQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDI 446

Query: 301  SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGV 360
            SE+F +YP L +IDLS NNF+G++S++W +  KL     S N+ITG +PPEI + +QL  
Sbjct: 447  SEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQ 506

Query: 361  LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
            LDLSSN I GE+P  +  +N   KL L  N+LSG++   +  L  LE+LDLSSNR S+ I
Sbjct: 507  LDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEI 566

Query: 421  PKSLGNL----------------------ELIHLSELDLSRNFLREAIPSQICIMQSLEK 458
            P +L NL                      +L  L  LDLS N L   I SQ   +Q+LE+
Sbjct: 567  PPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLER 626

Query: 459  LNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDV 518
            L+LSHN+LSG IP  F+ M  L H+D+S+N L+G IP++  F++AP +A +GNK L G V
Sbjct: 627  LDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSV 686

Query: 519  ---KGLLSCKALKSNK-QALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQS 574
               +GL  C    S K    R + + ++ P++G + +L    G+F  F++R    Q ++ 
Sbjct: 687  NTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTK--QIEEH 744

Query: 575  SPGNSRG-LLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKK 633
            +   S G  LS+ +F+GK+ Y+EII+AT +FD ++ IG GG G VY +KL +  I+AVKK
Sbjct: 745  TDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKK 803

Query: 634  FHSPLPGEMT---FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAV 690
             +      ++    +QEFLNE++ALTEI HRN+VK++GFC H R+ F+VYEY +  SL  
Sbjct: 804  LNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRK 863

Query: 691  ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD 750
            +L ND  AK L W +R+N++KG+  ALSYMH+D  P IVHRDISS N+LL  + EA +SD
Sbjct: 864  VLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISD 923

Query: 751  FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 810
            FG AK LKPDSSNW+ +AGTYGYVAPELAY MKVTEKCDVYSFGVL LEVIKG+HP D +
Sbjct: 924  FGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLV 983

Query: 811  SSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTM 864
            S++S S  +  ++L  + D RLP P+  + ++++ I++V + C+  +P++RPTM
Sbjct: 984  STLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  517 bits (1331), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 345/939 (36%), Positives = 491/939 (52%), Gaps = 89/939 (9%)

Query: 7    NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
            N L+ SIP ++ NL SL +L + +N L+G IP S+  L  L  +    N  SG IP EI 
Sbjct: 149  NYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEIS 208

Query: 67   NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
                   L L+ N L GS+P  L  L NL  L L  N LS  IP  +GN+  L  L L+ 
Sbjct: 209  GCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHE 268

Query: 127  NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
            N  +GSIP  +G LT +  LY+Y+N L+  I  +IGNL   + +  SEN   G IP   G
Sbjct: 269  NYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFG 328

Query: 187  NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM------------- 233
            ++ NL  L+L  N L   IP ELG L  L  L L  N+L+G+IP  +             
Sbjct: 329  HILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFD 388

Query: 234  -----------GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LR 281
                       G  SN + L++  NSLSG IP  +     L +L LG N+  G IP  L+
Sbjct: 389  NQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLK 448

Query: 282  NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
               SL ++ L  N LTG++    +   NLT ++L QN   G IS+D G+   L  L  + 
Sbjct: 449  TCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLAN 508

Query: 342  NNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
            NN TG +PPEIG+ +++   ++SSN + G IP ELG      +L L+ N+ SG ++ +LG
Sbjct: 509  NNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELG 568

Query: 402  SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLE-KLN 460
             LV LE L LS NRL+  IP S G  +L  L EL L  N L E IP ++  + SL+  LN
Sbjct: 569  QLVYLEILRLSDNRLTGEIPHSFG--DLTRLMELQLGGNLLSENIPVELGKLTSLQISLN 626

Query: 461  LSHNSLSGLIPSCF-------------EKMNG-----------LLHIDISYNELRGSIPN 496
            +SHN+LSG IP                 K++G           LL  +IS N L G++P+
Sbjct: 627  ISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPD 686

Query: 497  STTFKDAPIEALQGNKGLYGDVKGLLSCKAL-------------KSNKQALRTIWVVVVF 543
            +  F+        GN GL    +    C+ L              S +Q + TI  +V+ 
Sbjct: 687  TAVFQRMDSSNFAGNHGLCNSQRS--HCQPLVPHSDSKLNWLINGSQRQKILTITCIVI- 743

Query: 544  PLLGFVALLISLIGLFFKFQRRKND--SQTQQSSPGNSRGLLSVLTFEGK-IIYEEIIRA 600
               G V  LI+ +GL +  +RR+    +   Q+ P     ++    F  K   Y+ ++ A
Sbjct: 744  ---GSV-FLITFLGLCWTIKRREPAFVALEDQTKPD----VMDSYYFPKKGFTYQGLVDA 795

Query: 601  TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            T +F ++  +G+G  G+VY ++++ GE+IAVKK +S   G  +    F  E+  L +I H
Sbjct: 796  TRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS-DNSFRAEISTLGKIRH 854

Query: 661  RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            RNIVK+YGFC H     ++YEY    SL   L        L W  R  +  G  + L Y+
Sbjct: 855  RNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYL 914

Query: 721  HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGTYGYVAPELA 779
            H+DC P IVHRDI S N+LLD   +AHV DFG+AK +    S + + +AG+YGY+APE A
Sbjct: 915  HHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYA 974

Query: 780  YTMKVTEKCDVYSFGVLALEVIKGKHP-------RDFISSMSFSSLNLNIALDEMLDPRL 832
            YTMKVTEKCD+YSFGV+ LE+I GK P        D ++ +  S  N+ I   EM D RL
Sbjct: 975  YTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNM-IPTIEMFDARL 1033

Query: 833  PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             T  +    ++  ++++ + C   +P SRPTM++V  ++
Sbjct: 1034 DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  509 bits (1310), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 342/943 (36%), Positives = 485/943 (51%), Gaps = 91/943 (9%)

Query: 4    IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
            IYNN +  S+P E+ NL SLS L   +N +SG +P S+GNL  L +     N +SGS+P 
Sbjct: 152  IYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPS 211

Query: 64   EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            EIG       L L+ N+LSG +P  +G L  L+ + L  N  S  IP E+ N  SL  L 
Sbjct: 212  EIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLA 271

Query: 124  LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            L  N L G IP  LG+L +L  LY+Y N L+ +I  +IGNL     +  SEN   G IP 
Sbjct: 272  LYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPL 331

Query: 184  SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
             LGN+  L  LYL  N L+ +IP EL  L++LS L L  N L+G IP+    L  L  L 
Sbjct: 332  ELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQ 391

Query: 244  LFENSLSGAIPYE---YRNLVKL---------------------TILLLGHNQFRGPIPI 279
            LF+NSLSG IP +   Y +L  L                      IL LG N   G IP 
Sbjct: 392  LFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPT 451

Query: 280  -LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD 338
             +    +L ++RL RN L G    +     N+T I+L QN F G I  + G C  L  L 
Sbjct: 452  GITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQ 511

Query: 339  FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
             + N  TG +P EIG  SQLG L++SSN + GE+P E+       +L +  N  SG L  
Sbjct: 512  LADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPS 571

Query: 399  KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLE- 457
            ++GSL QLE L LS+N LS +IP +LGNL    L+EL +  N    +IP ++  +  L+ 
Sbjct: 572  EVGSLYQLELLKLSNNNLSGTIPVALGNLS--RLTELQMGGNLFNGSIPRELGSLTGLQI 629

Query: 458  KLNLSHNSL------------------------SGLIPSCFEKMNGLLHIDISYNELRGS 493
             LNLS+N L                        SG IPS F  ++ LL  + SYN L G 
Sbjct: 630  ALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGP 689

Query: 494  IPNSTTFKDAPIEALQGNKGLYG-------DVKGLLSCKALKSNKQALRTIWVVVVFPLL 546
            IP     ++  + +  GN+GL G         +     ++         +  + +   ++
Sbjct: 690  IP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVI 746

Query: 547  GFVAL-LISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFD 605
            G V+L LI+LI    +   R   S  Q   P      +     EG   +++++ AT++FD
Sbjct: 747  GGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDLVAATDNFD 805

Query: 606  DEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIWHRNI 663
            +   +G+G  G+VY + L +G  +AVKK  S   G         F  E+  L  I HRNI
Sbjct: 806  ESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNI 865

Query: 664  VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
            VK++GFC H     ++YEY    SL  IL + +   NL W++R  +  G    L+Y+H+D
Sbjct: 866  VKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHD 923

Query: 724  CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTM 782
            C P I HRDI S N+LLD + EAHV DFG+AK +  P S + + +AG+YGY+APE AYTM
Sbjct: 924  CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTM 983

Query: 783  KVTEKCDVYSFGVLALEVIKGKHP--------------RDFISSMSFSSLNLNIALDEML 828
            KVTEK D+YS+GV+ LE++ GK P              R +I   + SS         +L
Sbjct: 984  KVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSS--------GVL 1035

Query: 829  DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            D RL      +   +++++++ + C   +P +RP+M++V  +L
Sbjct: 1036 DARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  495 bits (1274), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 345/948 (36%), Positives = 485/948 (51%), Gaps = 92/948 (9%)

Query: 7    NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPGEI 65
            N+L   IP E  N+  L DL L NN LSGS+P S+  N TNL  L +    LSG IP E+
Sbjct: 297  NNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVEL 356

Query: 66   GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN 125
               +    L+LSNN L+GSIP +L  L  L  LYL  N+L  ++   + NL +L  L L 
Sbjct: 357  SKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLY 416

Query: 126  NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL 185
            +N L G +P  +  L  L  L++Y N  S  I  +IGN  SL  + +  N+F G IPPS+
Sbjct: 417  HNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSI 476

Query: 186  GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLF 245
            G L  L  L+L  N L   +P+ LGN   L+ L L  N+LSGSIP S G L  L  L L+
Sbjct: 477  GRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLY 536

Query: 246  ENSLSGAIPYEYRNLVKLTILLLGHNQ-----------------------FRGPIPI-LR 281
             NSL G +P    +L  LT + L HN+                       F   IP+ L 
Sbjct: 537  NNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELG 596

Query: 282  NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
            N  +L+R+RL +N LTG I  +      L+ +D+S N   G I      C KL+ +D + 
Sbjct: 597  NSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNN 656

Query: 342  NNITGNVPPEIGHSSQLGVLDLSSNHIV------------------------GEIPIELG 377
            N ++G +PP +G  SQLG L LSSN  V                        G IP E+G
Sbjct: 657  NFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIG 716

Query: 378  KLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL 437
             L     L L  NQ SG L   +G L +L  L LS N L+  IP  +G L+ +  S LDL
Sbjct: 717  NLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQ-SALDL 775

Query: 438  SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            S N     IPS I  +  LE L+LSHN L+G +P     M  L ++++S+N L G +   
Sbjct: 776  SYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--K 833

Query: 498  TTFKDAPIEALQGNKGLYGDVKGLLSCKALKSN--KQAL--RTIWVVVVFPLLGFVALLI 553
              F   P ++  GN GL G    L  C  ++SN  +Q L  R++ ++     L  + L+I
Sbjct: 834  KQFSRWPADSFLGNTGLCGSP--LSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMI 891

Query: 554  SLIGLFFK-----FQRRKNDSQTQQSSPGNSRGLLSVLTFEG----KIIYEEIIRATNDF 604
             +I LFFK     F++  + S    SS  +S+     L   G     I +E+I+ AT++ 
Sbjct: 892  LVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNL 951

Query: 605  DDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
             +E  IG GG G VY ++L +GE +AVKK       ++   + F  EVK L  I HR++V
Sbjct: 952  SEEFMIGSGGSGKVYKAELENGETVAVKKIL--WKDDLMSNKSFSREVKTLGRIRHRHLV 1009

Query: 665  KVYGFCLHVRHL--FIVYEYFKMCSLAVILSNDAAA-----KNLGWTRRMNMIKGIVDAL 717
            K+ G+C         ++YEY K  S+   L  D        K L W  R+ +  G+   +
Sbjct: 1010 KLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGV 1069

Query: 718  SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP------DSSNWTELAGTY 771
             Y+H+DC PPIVHRDI S NVLLD   EAH+ DFG+AK L        DS+ W   A +Y
Sbjct: 1070 EYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW--FACSY 1127

Query: 772  GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD--FISSMS---FSSLNLNI---A 823
            GY+APE AY++K TEK DVYS G++ +E++ GK P D  F + M    +   +L +   A
Sbjct: 1128 GYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSA 1187

Query: 824  LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             D+++DP+L        D    ++E+ + C   +P+ RP+ ++ C  L
Sbjct: 1188 RDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  491 bits (1265), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 342/972 (35%), Positives = 483/972 (49%), Gaps = 120/972 (12%)

Query: 6    NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
            NN    SIP E+  L  L    + NNKLSG +P  +G+L NL  L  +TN+L+G +P  +
Sbjct: 142  NNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSL 201

Query: 66   GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN 125
            GN    +      N  SG+IP  +G   NL  L L  N +S  +P E+G L  L  + L 
Sbjct: 202  GNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILW 261

Query: 126  NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL 185
             N  SG IP  +GNLT+L TL +Y NSL   I  +IGN+KSL  L L +N  NG+IP  L
Sbjct: 262  QNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKEL 321

Query: 186  GNLSN------------------------LATLYLDTNSLSYSIPSELGNLRSLSNLSLG 221
            G LS                         L  LYL  N L+  IP+EL  LR+L+ L L 
Sbjct: 322  GKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLS 381

Query: 222  YNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP--- 278
             N L+G IP    NL+++  L LF NSLSG IP        L ++    NQ  G IP   
Sbjct: 382  INSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFI 441

Query: 279  ------ILRNL----------------TSLERVRLDRNYLTGNISESFYIYPNLTYIDLS 316
                  IL NL                 SL ++R+  N LTG          NL+ I+L 
Sbjct: 442  CQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELD 501

Query: 317  QNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIEL 376
            QN F G +  + G C KL  L  + N  + N+P EI   S L   ++SSN + G IP E+
Sbjct: 502  QNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEI 561

Query: 377  GKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELD 436
                   +L L+ N   G L P+LGSL QLE L LS NR S +IP ++GN  L HL+EL 
Sbjct: 562  ANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGN--LTHLTELQ 619

Query: 437  LSRNFLREAIPSQICIMQSLE-KLNLSHNS------------------------LSGLIP 471
            +  N    +IP Q+ ++ SL+  +NLS+N                         LSG IP
Sbjct: 620  MGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIP 679

Query: 472  SCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCK------ 525
            + FE ++ LL  + SYN L G +P++  F++  + +  GNKGL G    L SC       
Sbjct: 680  TTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG--HLRSCDPSHSSW 737

Query: 526  ----ALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRG 581
                +LK+       I ++V   + G   LLI+++  F +              P     
Sbjct: 738  PHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQES 797

Query: 582  LLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFH----SP 637
             +  +  E +   ++I+ AT  F D + +G+G  G+VY + + SG+ IAVKK        
Sbjct: 798  DIYFVPKE-RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGN 856

Query: 638  LPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSND 695
                      F  E+  L +I HRNIV++Y FC H       ++YEY    SL  +L + 
Sbjct: 857  NNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELL-HG 915

Query: 696  AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK 755
              + ++ W  R  +  G  + L+Y+H+DC P I+HRDI S N+L+D   EAHV DFG+AK
Sbjct: 916  GKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAK 975

Query: 756  FLK-PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-------- 806
             +  P S + + +AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE++ GK P        
Sbjct: 976  VIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG 1035

Query: 807  ------RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV-HDKLISIVEVTISCVDENPE 859
                  R+ I   S +S        E+LDP L     +V  + +I++ ++ + C   +P 
Sbjct: 1036 DLATWTRNHIRDHSLTS--------EILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPS 1087

Query: 860  SRPTMQKVCQLL 871
             RPTM++V  +L
Sbjct: 1088 DRPTMREVVLML 1099

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  488 bits (1257), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 319/890 (35%), Positives = 476/890 (53%), Gaps = 30/890 (3%)

Query: 4    IYNNSLYDSIPSELRNLKSLSDLELGNNK-LSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
            +++N L  SIP+EL  L  L  + +G NK +SG IP  +G+ +NL  L +   S+SG++P
Sbjct: 184  LFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLP 243

Query: 63   GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
              +G  +    L +    +SG IP  LGN S L  L+L  NSLS SIP E+G L  L  L
Sbjct: 244  SSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQL 303

Query: 123  QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
             L  N L G IP  +GN +NL  + +  N LS SI   IG L  L    +S+N F+GSIP
Sbjct: 304  FLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIP 363

Query: 183  PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
             ++ N S+L  L LD N +S  IPSELG L  L+      N+L GSIP  + + ++L  L
Sbjct: 364  TTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQAL 423

Query: 243  NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNIS 301
            +L  NSL+G IP     L  LT LLL  N   G IP  + N +SL R+RL  N +TG I 
Sbjct: 424  DLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIP 483

Query: 302  ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVL 361
                    + ++D S N  +G++  + G C +L  +D S N++ G++P  +   S L VL
Sbjct: 484  SGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVL 543

Query: 362  DLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIP 421
            D+S+N   G+IP  LG+L    KL+L+ N  SG +   LG    L+ LDL SN LS  IP
Sbjct: 544  DVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIP 603

Query: 422  KSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSG-LIPSCFEKMNGL 480
              LG++E + ++ L+LS N L   IPS+I  +  L  L+LSHN L G L P     +  L
Sbjct: 604  SELGDIENLEIA-LNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP--LANIENL 660

Query: 481  LHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSC-------KALKSNKQA 533
            + ++ISYN   G +P++  F+    + L+GNK L    +   SC         L  +  A
Sbjct: 661  VSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQD--SCFLTYRKGNGLGDDGDA 718

Query: 534  LRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKII 593
             RT  + +   LL  + +++ ++G     + R+N    + S  G +         +    
Sbjct: 719  SRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFS 778

Query: 594  YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPL------PGEMTFQQE 647
             ++IIR      + + IGKG  G VY + + +GE+IAVKK    +            +  
Sbjct: 779  VDQIIRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDS 835

Query: 648  FLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM 707
            F  EVK L  I H+NIV+  G C +     ++Y+Y    SL  +L ++    +L W  R 
Sbjct: 836  FSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRY 894

Query: 708  NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE- 766
             ++ G    L+Y+H+DC PPIVHRDI + N+L+  + E +++DFG+AK +          
Sbjct: 895  RILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSN 954

Query: 767  -LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL---NI 822
             +AG+YGY+APE  Y+MK+TEK DVYS+GV+ LEV+ GK P D         ++    N 
Sbjct: 955  TVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNR 1014

Query: 823  ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               E+LD  L + +    D+++ ++   + CV+ +P+ RPTM+ V  +LK
Sbjct: 1015 GSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  476 bits (1224), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 326/914 (35%), Positives = 493/914 (53%), Gaps = 55/914 (6%)

Query: 3    CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNS-LSGSI 61
            C+ +N L   IP EL +  SL +LE+ +N LS ++P  LG ++ L ++    NS LSG I
Sbjct: 160  CLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKI 219

Query: 62   PGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN 121
            P EIGN R    L L+  K+SGS+P SLG LS L +L + +  LS  IP ELGN   L N
Sbjct: 220  PEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELIN 279

Query: 122  LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL-------------- 167
            L L +N LSG++P  LG L NL  + ++ N+L   I  +IG +KSL              
Sbjct: 280  LFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTI 339

Query: 168  -------SNLQ---LSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSN 217
                   SNLQ   LS NN  GSIP  L N + L    +D N +S  IP E+G L+ L N
Sbjct: 340  PKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKEL-N 398

Query: 218  LSLGY-NKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP 276
            + LG+ NKL G+IP  +    NL  L+L +N L+G++P     L  LT LLL  N   G 
Sbjct: 399  IFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGV 458

Query: 277  IPI-LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS 335
            IP+ + N TSL R+RL  N +TG I +      NL+++DLS+NN  G +  +   C +L 
Sbjct: 459  IPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQ 518

Query: 336  TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQ 395
             L+ S N + G +P  +   ++L VLD+SSN + G+IP  LG L    +L+L+ N  +G+
Sbjct: 519  MLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGE 578

Query: 396  LSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQS 455
            +   LG    L+ LDLSSN +S +IP+ L +++ + ++ L+LS N L   IP +I  +  
Sbjct: 579  IPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIA-LNLSWNSLDGFIPERISALNR 637

Query: 456  LEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLY 515
            L  L++SHN LSG + S    +  L+ ++IS+N   G +P+S  F+      ++GN GL 
Sbjct: 638  LSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLC 696

Query: 516  GDVKGLLSCKALKSN----KQALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQT 571
               KG  SC    S+    ++ + +  + +   LL  V  +++++G+    + ++     
Sbjct: 697  S--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDD 754

Query: 572  QQSSPGNSRGLLSVLTFEG-KIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIA 630
              S  G +        F+      E +++      + + IGKG  G VY +++ + E+IA
Sbjct: 755  NDSETGENLWTWQFTPFQKLNFTVEHVLKC---LVEGNVIGKGCSGIVYKAEMPNREVIA 811

Query: 631  VKKFHS---PLPGEMT----FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF 683
            VKK      P   E T     +  F  EVK L  I H+NIV+  G C +     ++Y+Y 
Sbjct: 812  VKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYM 871

Query: 684  KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE 743
               SL  +L   +   +LGW  R  +I G    L+Y+H+DC PPIVHRDI + N+L+  +
Sbjct: 872  SNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPD 931

Query: 744  NEAHVSDFGIAKFLK----PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 799
             E ++ DFG+AK +       SSN   +AG+YGY+APE  Y+MK+TEK DVYS+GV+ LE
Sbjct: 932  FEPYIGDFGLAKLVDDGDFARSSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLE 989

Query: 800  VIKGKHPRD--FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDEN 857
            V+ GK P D      +        I   +++D  L     +  ++++  + V + C++  
Sbjct: 990  VLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPI 1049

Query: 858  PESRPTMQKVCQLL 871
            PE RPTM+ V  +L
Sbjct: 1050 PEDRPTMKDVAAML 1063

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  463 bits (1192), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 330/948 (34%), Positives = 480/948 (50%), Gaps = 96/948 (10%)

Query: 7    NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPGEI 65
            N+L   I  E   +  L  L L  N+LSGS+P ++  N T+L  L++    LSG IP EI
Sbjct: 298  NNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEI 357

Query: 66   GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN 125
             N +    L+LSNN L+G IP SL  L  L  LYL+ NSL  ++ S + NL +L    L 
Sbjct: 358  SNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLY 417

Query: 126  NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL 185
            +N L G +P  +G L  L  +Y+Y N  S  +  +IGN   L  +    N  +G IP S+
Sbjct: 418  HNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSI 477

Query: 186  GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLF 245
            G L +L  L+L  N L  +IP+ LGN   ++ + L  N+LSGSIP S G L+ L    ++
Sbjct: 478  GRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIY 537

Query: 246  ENSLSGAIPYEYRNLVKLTIL-------------LLG----------HNQFRGPIPI-LR 281
             NSL G +P    NL  LT +             L G           N F G IP+ L 
Sbjct: 538  NNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELG 597

Query: 282  NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
              T+L+R+RL +N  TG I  +F     L+ +D+S+N+  G I  + G C KL+ +D + 
Sbjct: 598  KSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNN 657

Query: 342  NNITGNVPPEIGHSSQLGVLDLSSNHIV------------------------GEIPIELG 377
            N ++G +P  +G    LG L LSSN  V                        G IP E+G
Sbjct: 658  NYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIG 717

Query: 378  KLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL 437
             L     L L  NQLSG L   +G L +L  L LS N L+  IP  +G L+ +  S LDL
Sbjct: 718  NLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQ-SALDL 776

Query: 438  SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            S N     IPS I  +  LE L+LSHN L G +P     M  L ++++SYN L G +   
Sbjct: 777  SYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ 836

Query: 498  TTFKDAPIEALQGNKGLYGDVKGLLSC-KALKSNKQAL--RTIWVVVVFPLLGFVALLIS 554
              F     +A  GN GL G    L  C +A   N+++L  +T+ ++     L  +AL++ 
Sbjct: 837  --FSRWQADAFVGNAGLCGSP--LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVL 892

Query: 555  LIGLFFK-----FQRRKNDSQTQQSSPGNSRG-LLSVLTFEGKIIYEEIIRATNDFDDEH 608
            +I LFFK     F++ +  +    S+  +S+  L S    +  I +++I+ AT+  ++E 
Sbjct: 893  VIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEF 952

Query: 609  CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
             IG GG G VY ++L +GE IAVKK       ++   + F  EVK L  I HR++VK+ G
Sbjct: 953  MIGSGGSGKVYKAELKNGETIAVKKIL--WKDDLMSNKSFNREVKTLGTIRHRHLVKLMG 1010

Query: 669  FCLHVRHL--FIVYEYFKMCSLAVIL---SNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
            +C         ++YEY    S+   L    N    + LGW  R+ +  G+   + Y+H D
Sbjct: 1011 YCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYD 1070

Query: 724  CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE----LAGTYGYVAPELA 779
            C PPIVHRDI S NVLLD   EAH+ DFG+AK L  +    TE     AG+YGY+APE A
Sbjct: 1071 CVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYA 1130

Query: 780  YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
            Y++K TEK DVYS G++ +E++ GK P +   +M     ++   ++ +LD     P    
Sbjct: 1131 YSLKATEKSDVYSMGIVLMEIVTGKMPTE---AMFDEETDMVRWVETVLD---TPPGSEA 1184

Query: 840  HDKLI----------------SIVEVTISCVDENPESRPTMQKVCQLL 871
             +KLI                 ++E+ + C    P+ RP+ ++  + L
Sbjct: 1185 REKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2

 Score =  442 bits (1138), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 322/893 (36%), Positives = 479/893 (53%), Gaps = 36/893 (4%)

Query: 3    CIYNNSLYDSIPSELRNLKSLSDLELG-NNKLSGSIPHSLGNLTNLATLYIHTNSLSGSI 61
            C+ +N L  SIPS   +L SL    LG N  L G IP  LG L NL TL    + LSGSI
Sbjct: 169  CLQDNLLNGSIPSSFGSLVSLQQFRLGGNTNLGGPIPAQLGFLKNLTTLGFAASGLSGSI 228

Query: 62   PGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN 121
            P   GN      L L + ++SG+IPP LG  S L  LYL  N L+ SIP ELG L+ +++
Sbjct: 229  PSTFGNLVNLQTLALYDTEISGTIPPQLGLCSELRNLYLHMNKLTGSIPKELGKLQKITS 288

Query: 122  LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI 181
            L L  N LSG IP  + N ++L    + +N L+  I G +G L  L  LQLS+N F G I
Sbjct: 289  LLLWGNSLSGVIPPEISNCSSLVVFDVSANDLTGDIPGDLGKLVWLEQLQLSDNMFTGQI 348

Query: 182  PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY 241
            P  L N S+L  L LD N LS SIPS++GNL+SL +  L  N +SG+IP S GN ++L  
Sbjct: 349  PWELSNCSSLIALQLDKNKLSGSIPSQIGNLKSLQSFFLWENSISGTIPSSFGNCTDLVA 408

Query: 242  LNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNI 300
            L+L  N L+G IP E  +L +L+ LLL  N   G +P  +    SL R+R+  N L+G I
Sbjct: 409  LDLSRNKLTGRIPEELFSLKRLSKLLLLGNSLSGGLPKSVAKCQSLVRLRVGENQLSGQI 468

Query: 301  SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGV 360
             +      NL ++DL  N+F G +  +      L  LD   N ITG++P ++G+   L  
Sbjct: 469  PKEIGELQNLVFLDLYMNHFSGGLPYEISNITVLELLDVHNNYITGDIPAQLGNLVNLEQ 528

Query: 361  LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
            LDLS N   G IP+  G L++  KL+L +N L+GQ+   + +L +L  LDLS N LS  I
Sbjct: 529  LDLSRNSFTGNIPLSFGNLSYLNKLILNNNLLTGQIPKSIKNLQKLTLLDLSYNSLSGEI 588

Query: 421  PKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGL 480
            P+ LG +  + ++ LDLS N     IP     +  L+ L+LS NSL G I      +  L
Sbjct: 589  PQELGQVTSLTIN-LDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDI-KVLGSLTSL 646

Query: 481  LHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVV 540
              ++IS N   G IP++  FK     +   N  L   + G ++C +       +++  +V
Sbjct: 647  ASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCHSLDG-ITCSSHTGQNNGVKSPKIV 705

Query: 541  VVFPLLGFVALLISLIGLFFKFQRRKNDSQT---QQSSPGNSRGLLSVLTFEGKIIYEEI 597
             +  ++   ++ I+++  +    R  +  +T     SSP  +       TF   I ++++
Sbjct: 706  ALTAVI-LASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDFSYPWTF---IPFQKL 761

Query: 598  IRATND----FDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPL----PGEMTFQQEFL 649
                N+      DE+ IGKG  G VY +++ +G+I+AVKK          GE T    F 
Sbjct: 762  GITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNNEEGESTI-DSFA 820

Query: 650  NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM 709
             E++ L  I HRNIVK+ G+C +     ++Y YF   +L  +L  +   +NL W  R  +
Sbjct: 821  AEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGN---RNLDWETRYKI 877

Query: 710  IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSN-WTE 766
              G    L+Y+H+DC P I+HRD+   N+LLD + EA ++DFG+AK +   P+  N  + 
Sbjct: 878  AIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMNSPNYHNAMSR 937

Query: 767  LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD--------FISSMSFSSL 818
            +AG+YGY+APE  YTM +TEK DVYS+GV+ LE++ G+   +         +  +     
Sbjct: 938  VAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDGLHIVEWVKKKMG 997

Query: 819  NLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                AL  +LD +L      +  +++  + + + CV+ +P  RPTM++V  LL
Sbjct: 998  TFEPAL-SVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKEVVTLL 1049

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	873
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.987	0.835	0.526	0.0
359491509	1032	PREDICTED: probable LRR receptor-like se	0.987	0.835	0.523	0.0
147772402	996	hypothetical protein VITISV_022117 [Viti	0.991	0.869	0.515	0.0
225456159	1038	PREDICTED: probable LRR receptor-like se	0.986	0.829	0.515	0.0
359484864	1091	PREDICTED: probable LRR receptor-like se	0.983	0.787	0.498	0.0
225456161	1037	PREDICTED: probable LRR receptor-like se	0.985	0.829	0.503	0.0
359491512	1078	PREDICTED: probable LRR receptor-like se	0.985	0.797	0.508	0.0
359484867	1217	PREDICTED: probable leucine-rich repeat	0.990	0.710	0.478	0.0
297846638	1123	hypothetical protein ARALYDRAFT_473694 [	0.978	0.760	0.486	0.0
255545702	1008	receptor protein kinase, putative [Ricin	0.967	0.838	0.488	0.0

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  871 bits (2251), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 480/912 (52%), Positives = 609/912 (66%), Gaps = 50/912 (5%)

Query: 7    NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
            N L   IP ++  L  L  L+L  N+ SG IP  +G LTNL  L++  N L+GSIP EIG
Sbjct: 120  NKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIG 179

Query: 67   NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
              +   DL L  NKL GSIP SLGNLSNL  LYLD N LS  IP E+GNL  L  L LN 
Sbjct: 180  QLKSLCDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNA 239

Query: 127  NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
            N L+G IP +LGNL +L  L +Y+N LS  I  +IGNLK L NL LS N  +G IP SLG
Sbjct: 240  NNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLG 299

Query: 187  NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE 246
            +LS L +L L  N LS  IP E+GNLRSL +L +  N+L+GSIP S+GNL NL  L L +
Sbjct: 300  DLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRD 359

Query: 247  NSLSGAIPYEYRNLVKLTILLLGHNQFRG------------------------PIP-ILR 281
            N LS +IP E   L KL  L +  NQ  G                        PIP  L+
Sbjct: 360  NKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLK 419

Query: 282  NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
            N  SL R RL RN LTGNISE+F + PNL +I+LS N FYGE+S +WGRC KL  LD + 
Sbjct: 420  NCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAG 479

Query: 342  NNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
            NNITG++P + G S+QL VL+LSSNH+VGEIP +LG ++   KL+L  N+LSG + P+LG
Sbjct: 480  NNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELG 539

Query: 402  SLVQLEHLDLSSNRLSNSIPKSLGN---LELIHLSELDLSR------------------- 439
            SL  L +LDLS NRL+ SIP+ LGN   L  ++LS   LS                    
Sbjct: 540  SLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSH 599

Query: 440  NFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTT 499
            N L   IPSQI  +QSLEKLNLSHN+LSG+IP  FE M+GL  +DISYN+L+GSIPNS  
Sbjct: 600  NLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEA 659

Query: 500  FKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLF 559
            F++  IE LQGNKGL G VKGL  C+   + K   + +++++ F LLG + +L + IG+ 
Sbjct: 660  FQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII-FSLLGALLILSAFIGIS 718

Query: 560  FKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVY 619
               Q R+N ++ +++    +  L S+ TF+G+  YE II AT DFD  +CIG+GG GSVY
Sbjct: 719  LISQGRRN-AKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVY 777

Query: 620  MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV 679
             ++L SG I+AVKK H     +M  Q++F+NE++ALTEI HRNIVK+ GFC H RH F+V
Sbjct: 778  KAELPSGNIVAVKKLHR-FDIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLV 836

Query: 680  YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVL 739
            YEY +  SL  ILS +  AK +GW  R+N+IKG+  ALSY+H+DC PPIVHRDISS NVL
Sbjct: 837  YEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVL 896

Query: 740  LDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 799
            LD + EAHVSDFG AKFLK DSSNW+ LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE
Sbjct: 897  LDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 956

Query: 800  VIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPE 859
            V++G+HP D ISS+S S    N+ L ++LDPRLP P+     +++S++++  +C++ +P+
Sbjct: 957  VMRGRHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQ 1016

Query: 860  SRPTMQKVCQLL 871
            SRPTMQ V Q+L
Sbjct: 1017 SRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  862 bits (2227), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 477/912 (52%), Positives = 606/912 (66%), Gaps = 50/912 (5%)

Query: 7    NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
            N L   IP ++  L  L  L+L  N+ SG IP  +G LTNL  L++  N L+GSIP EIG
Sbjct: 120  NKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIG 179

Query: 67   NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
              +   DL L  NKL G+IP SLGNLSNL  LYLD N LS  IP E+GNL  L  L LN 
Sbjct: 180  QLKSLCDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNA 239

Query: 127  NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
            N L+G IP +LGNL +L  L +Y+N LS  I  +IGNLK L NL LS N  +G IP SLG
Sbjct: 240  NNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLG 299

Query: 187  NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE 246
            +LS L +L L  N LS  IP E+GNLRSL +L +  N+L+GSIP  +GNL NL  L L +
Sbjct: 300  DLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRD 359

Query: 247  NSLSGAIPYEYRNLVKLTILLLGHNQFRG------------------------PIP-ILR 281
            N LS +IP E   L KL  L +  NQ  G                        PIP  L+
Sbjct: 360  NKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLK 419

Query: 282  NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
            N  SL R RL  N LTGNISE+F + PNL +I+LS N FYGE+S +WGRC KL  LD + 
Sbjct: 420  NCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAG 479

Query: 342  NNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
            NNITG++P + G S+QL VL+LSSNH+VGEIP +LG ++   KL+L  N+LSG + P+LG
Sbjct: 480  NNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELG 539

Query: 402  SLVQLEHLDLSSNRLSNSIPKSLGN---LELIHLSELDLSR------------------- 439
            SL  L +LDLS NRL+ SIP+ LGN   L  ++LS   LS                    
Sbjct: 540  SLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSH 599

Query: 440  NFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTT 499
            N L   IPSQI  +QSLEKLNLSHN+LSG+IP  FE M+GL  +DISYN+L+GSIPNS  
Sbjct: 600  NLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEA 659

Query: 500  FKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLF 559
            F++  IE LQGNKGL G VKGL  C+   + K   + +++++ F LLG + +L + IG+ 
Sbjct: 660  FQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII-FSLLGALLILSAFIGIS 718

Query: 560  FKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVY 619
               Q R+N ++ +++    +  L S+ TF+G+  YE II AT DFD  +CIG+GG GSVY
Sbjct: 719  LISQGRRN-AKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVY 777

Query: 620  MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV 679
             ++L SG I+AVKK H     +M  Q++F+NE++ALTEI HRNIVK+ GFC H RH F+V
Sbjct: 778  KAELPSGNIVAVKKLHR-FDIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLV 836

Query: 680  YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVL 739
            YEY +  SL  ILS +  AK +GW  R+N+IKG+  ALSY+H+DC PPIVHRDISS NVL
Sbjct: 837  YEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVL 896

Query: 740  LDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 799
            LD + EAHVSDFG AKFLK DSSNW+ LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE
Sbjct: 897  LDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 956

Query: 800  VIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPE 859
            V++G+HP D ISS+S S    N+ L ++LDPRLP P+     ++ S++++  +C++ +P+
Sbjct: 957  VMRGRHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQ 1016

Query: 860  SRPTMQKVCQLL 871
            SRPTMQ V Q+L
Sbjct: 1017 SRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  851 bits (2198), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 475/921 (51%), Positives = 606/921 (65%), Gaps = 55/921 (5%)

Query: 2   PCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSI 61
           PC   N+L   IP ++  L  L  L+L  N+ SG IP  +G LTNL  L++  N L+GSI
Sbjct: 76  PCKCMNNLSGPIPPQIGLLSELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSI 135

Query: 62  PGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN 121
           P EIG      +L L  N+L GSIP SLGNLSNLA LYL  N LS+SIP E+GNL +L  
Sbjct: 136 PHEIGQLASLYELALYTNQLEGSIPASLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVE 195

Query: 122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI 181
           +  + N L G IP + GNL  L  LY+++N LS  I  +IGNLKSL  L L ENN +G I
Sbjct: 196 IYSDTNNLIGPIPSTFGNLKRLTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPI 255

Query: 182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY 241
           P SLG+LS L  L+L  N LS  IP E+GNL+SL +L L  N+L+GSIP S+GNL+NL  
Sbjct: 256 PASLGDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLET 315

Query: 242 LNLFENSLSGAIPYEYRNLVKLTILLLGHNQ------------------------FRGPI 277
           L L +N LSG IP E   L KL +L +  NQ                          GPI
Sbjct: 316 LFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPI 375

Query: 278 PI-LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLST 336
           P  L+N  +L R     N LTGNISE     PNL YI++S N+F+GE+S +WGR P+L  
Sbjct: 376 PKSLKNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQR 435

Query: 337 LDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQL 396
           L+ + NNITG++P + G S+ L +LDLSSNH+ GEIP ++G +    KL+L  NQLSG +
Sbjct: 436 LEMAWNNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNI 495

Query: 397 SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL----------------------ELIHLSE 434
            P+LGSL  L +LDLS+NRL+ SIP+ LG+                       +L HLS+
Sbjct: 496 PPELGSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQ 555

Query: 435 LDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSI 494
           LDLS N L   IP QI  +QSLE LNLSHN+LSG IP  FE+M GL  +DISYN+L+G I
Sbjct: 556 LDLSHNLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPI 615

Query: 495 PNSTTFKDAPIEALQGNKGLYGDVKGLLSCK-ALKSNKQALR---TIWVVVVFPLLGFVA 550
           PNS  F+DA IEAL+GNKGL G+VK L  CK     ++Q ++    +  +++FPLLG + 
Sbjct: 616 PNSKAFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALV 675

Query: 551 LLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCI 610
           LL + IG+F    RR+   + ++    N   L S+ TF+G+ +YEEII+AT DFD  +CI
Sbjct: 676 LLFAFIGIFLIAARRERTPEIKEGEVQND--LFSISTFDGRTMYEEIIKATKDFDPMYCI 733

Query: 611 GKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFC 670
           GKGG GSVY ++L S  I+AVKK H P   EM  Q++FLNE++ALTEI HRNIVK+ GFC
Sbjct: 734 GKGGHGSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFC 792

Query: 671 LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVH 730
            H RH F+VYEY +  SLA ILS +  AK LGW  R+N+IKG+  AL+YMH+DC PPIVH
Sbjct: 793 SHPRHKFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVH 851

Query: 731 RDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDV 790
           RDISS N+LLD + EAH+SDFG AK LK DSSN + LAGT+GY+APELAYTMKVTEK DV
Sbjct: 852 RDISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDV 911

Query: 791 YSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVT 850
           +SFGV+ALEVIKG+HP D I S+S S    NIAL++MLDPRLP  +     ++I+I++  
Sbjct: 912 FSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQA 971

Query: 851 ISCVDENPESRPTMQKVCQLL 871
             C+  NP+SRPTMQ V Q+L
Sbjct: 972 TECLKANPQSRPTMQTVSQML 992

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  850 bits (2195), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 472/916 (51%), Positives = 606/916 (66%), Gaps = 55/916 (6%)

Query: 7    NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
            N+L   IP ++  L  L  L+L  N+ SG IP  +G LTNL  L++  N L+GSIP EIG
Sbjct: 123  NNLSGPIPPQIGLLFELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIG 182

Query: 67   NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
                  +L L  N+L GSIP SLGNLSNLA+LYL  N LS SIP E+GNL +L  +  NN
Sbjct: 183  QLASLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNN 242

Query: 127  NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
            N L+G IP + GNL  L  LY+++NSLS  I  +IGNLKSL  L L ENN +G IP SL 
Sbjct: 243  NNLTGPIPSTFGNLKRLTVLYLFNNSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLC 302

Query: 187  NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE 246
            +LS L  L+L  N LS  IP E+GNL+SL +L L  N+L+GSIP S+GNL+NL  L L +
Sbjct: 303  DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 362

Query: 247  NSLSGAIPYEYRNLVKLTILLLGHNQ------------------------FRGPIPI-LR 281
            N LSG IP E   L KL +L +  NQ                          GPIP  L+
Sbjct: 363  NQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLK 422

Query: 282  NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
            N  +L R     N LTGNISE     PNL +IDLS N F+GE+S +WGRCP+L  L+ + 
Sbjct: 423  NCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAG 482

Query: 342  NNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
            NNITG++P + G S+ L +LDLSSNH+VGEIP ++G L   + L+L  NQLSG + P+LG
Sbjct: 483  NNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELG 542

Query: 402  SLVQLEHLDLSSNRLSNSIPKSLGNL----------------------ELIHLSELDLSR 439
            SL  LE+LDLS+NRL+ SIP+ LG+                       +L HLS+LDLS 
Sbjct: 543  SLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSH 602

Query: 440  NFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTT 499
            N L   IP QI  +QSLE L+LSHN+L G IP  FE M  L ++DISYN+L+G IP+S  
Sbjct: 603  NLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNA 662

Query: 500  FKDAPIEALQGNKGLYGDVKGLLSCK-ALKSNKQALR---TIWVVVVFPLLGFVALLISL 555
            F++A IE L+GNK L G+VKGL  CK     ++Q ++    +  +++FPLLG + LL + 
Sbjct: 663  FRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAF 722

Query: 556  IGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQ 615
            IG+F   +RR+   + ++    N   L S+  F+G+ +YEEII+AT DFD  +CIGKGG 
Sbjct: 723  IGIFLIAERRERTPEIEEGDVQND--LFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGH 780

Query: 616  GSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH 675
            GSVY ++L S  I+AVKK H P   EM  Q++FLNE++ALTEI HRNIVK+ GFC H RH
Sbjct: 781  GSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRH 839

Query: 676  LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS 735
             F+VYEY +  SLA ILS +  AK LGW  R+N+IKG+  AL+YMH+DC PPIVHRD+SS
Sbjct: 840  KFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSS 898

Query: 736  KNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 795
             N+LLD + EAH+SDFG AK LK DSSN + LAGT+GY+APELAYTMKVTEK DV+SFGV
Sbjct: 899  NNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGV 958

Query: 796  LALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVD 855
            +ALEVIKG+HP D I S+S S    NIAL++MLDPRLP  +     ++I+I++  I C+ 
Sbjct: 959  IALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLK 1018

Query: 856  ENPESRPTMQKVCQLL 871
             NP+SRPTMQ V Q+L
Sbjct: 1019 ANPQSRPTMQTVSQML 1034

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484864|ref|XP_002273966.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  827 bits (2137), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 474/950 (49%), Positives = 605/950 (63%), Gaps = 91/950 (9%)

Query: 4    IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
            +YNNSL  SIP E+  L+SL++L+L  N LSG IP S+GNL NL TLY+HTN LSGSIP 
Sbjct: 129  LYNNSLSGSIPQEIGLLRSLNNLKLSTNNLSGPIPPSIGNLRNLTTLYLHTNKLSGSIPQ 188

Query: 64   EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            EIG  R  +DLELS N LSG IPPS+GNL NL TLYL TN LS SIP E+G LRSL++L+
Sbjct: 189  EIGLLRSLNDLELSANNLSGPIPPSIGNLRNLTTLYLHTNKLSGSIPQEIGLLRSLNDLE 248

Query: 124  LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            L+ N L+G IP S+GNL NL TLY+++N LS SI  +IG L+SL++L+LS NN NG IPP
Sbjct: 249  LSTNNLNGPIPPSIGNLRNLTTLYLHTNKLSGSIPKEIGMLRSLNDLELSTNNLNGPIPP 308

Query: 184  SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLT--Y 241
            S+G L NL TLYL  N LS SIP E+G LRSL NLSL  N LSG IP  +GNL NLT  Y
Sbjct: 309  SIGKLRNLTTLYLHNNKLSGSIPLEIGLLRSLFNLSLSTNNLSGPIPPFIGNLRNLTKLY 368

Query: 242  LN----------------------LFENSLSGAIPYEYRNLVKLTILLL------GH--- 270
            L+                      L  N LSG IP E  NL+ L  L L      GH   
Sbjct: 369  LDNNRFSGSIPREIGLLRSLHDLALATNKLSGPIPQEIDNLIHLKSLHLEENNFTGHLPQ 428

Query: 271  ---------------NQFRGPIPI-LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYID 314
                           N F GPIP+ LRN TSL RVRL+RN L GNI+E F +YPNL ++D
Sbjct: 429  QMCLGGALENFTAMGNHFTGPIPMSLRNCTSLFRVRLERNQLEGNITEVFGVYPNLNFMD 488

Query: 315  LSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI 374
            LS NN YGE+S  WG+C  L++L+ S NN++G +PP++G + QL  LDLSSNH++G+IP 
Sbjct: 489  LSSNNLYGELSHKWGQCGSLTSLNISHNNLSGIIPPQLGEAIQLHRLDLSSNHLLGKIPR 548

Query: 375  ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE------ 428
            ELGKL     LVL++NQLSG +  ++G+L  LEHL L+SN LS SIPK LG L       
Sbjct: 549  ELGKLTSMFHLVLSNNQLSGNIPLEVGNLFNLEHLSLTSNNLSGSIPKQLGMLSKLFFLN 608

Query: 429  ----------------LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS 472
                            +  L  LDLS+N L   IP Q+  +Q LE LNLSHN LSG IPS
Sbjct: 609  LSKNKFGESIPDEIGNMHSLQNLDLSQNMLNGKIPQQLGELQRLETLNLSHNELSGSIPS 668

Query: 473  CFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKAL--KSN 530
             FE M  L  +DIS N+L G +P+   F++AP EA   N GL G+  GL  C     K N
Sbjct: 669  TFEDMLSLTSVDISSNQLEGPLPDIKAFQEAPFEAFMSNGGLCGNATGLKPCIPFTQKKN 728

Query: 531  KQALRTIWVVVVFPLLGFVALLISLIGLFFK-FQRRKNDSQTQQSSPGNSRGLLSVLTFE 589
            K+++  I    VF       LL   +G++F  + R +N       +P     L ++   +
Sbjct: 729  KRSMILIISSTVF-------LLCISMGIYFTLYWRARNRKGKSSETP--CEDLFAIWDHD 779

Query: 590  GKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFL 649
            G I+Y++II  T +F+ ++CIG GGQG+VY ++L +G ++AVKK H P  GEM+  + F 
Sbjct: 780  GGILYQDIIEVTEEFNSKYCIGSGGQGTVYKAELPTGRVVAVKKLHPPQDGEMSSLKAFT 839

Query: 650  NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM 709
            +E++ALTEI HRNIVK YG+C H RH F+VY+  +  SL  ILSN+  A  L W RR+N+
Sbjct: 840  SEIRALTEIRHRNIVKFYGYCSHARHSFLVYKLMEKGSLRNILSNEEEAIGLDWIRRLNI 899

Query: 710  IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELA 768
            +KG+ +ALSYMH+DC PPI+HRDISS NVLLD E EAHVSDFG A+ LKPD SSNWT  A
Sbjct: 900  VKGVAEALSYMHHDCSPPIIHRDISSNNVLLDSEYEAHVSDFGTARLLKPDSSSNWTSFA 959

Query: 769  GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI-------SSMSFSSLNLN 821
            GT+GY APELAYT +V  K DVYS+GV+ LEVI GKHP D I       SS S +++  +
Sbjct: 960  GTFGYSAPELAYTTQVNNKTDVYSYGVVTLEVIMGKHPGDLISSLSSASSSSSVTAVADS 1019

Query: 822  IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            + L + +D RL  P   + +++   V++  +C   NP  RPTM++V Q L
Sbjct: 1020 LLLKDAIDQRLSPPIHQISEEVAFAVKLAFACQHVNPHCRPTMRQVSQAL 1069

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  827 bits (2137), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 461/916 (50%), Positives = 606/916 (66%), Gaps = 56/916 (6%)

Query: 7    NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
            N+L   IP ++  L  L  L+L  N+ SG IP  +G LTNL  L++  N L+GSIP EIG
Sbjct: 123  NNLSGPIPPQIGLLSKLKYLDLSINQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIG 182

Query: 67   NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
                  +L L  N+L GSIP SLGNLSNLA+LYL  N LS SIP E+GNL +L  L  + 
Sbjct: 183  QLTSLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDT 242

Query: 127  NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
            N L+G IP + GNL +L  LY+++NSLS  I  +IGNLKSL  L L  NN +G IP SL 
Sbjct: 243  NNLTGPIPSTFGNLKHLTVLYLFNNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLC 302

Query: 187  NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE 246
            +LS L  L+L  N LS  IP E+GNL+SL +L L  N+L+GSIP S+GNL+NL  L L +
Sbjct: 303  DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 362

Query: 247  NSLSGAIPYEYRNLVKLTILLLGHNQ------------------------FRGPIPI-LR 281
            N LSG  P E   L KL +L +  NQ                          GPIP  L+
Sbjct: 363  NRLSGYFPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLK 422

Query: 282  NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
            N  +L R     N LTGN+SE     PNL +IDLS N F+GE+S +WGRCP+L  L+ + 
Sbjct: 423  NCRNLTRALFQGNRLTGNVSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAG 482

Query: 342  NNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
            NNITG++P + G S+ L +LDLSSNH+VGEIP ++G L   + L+L  NQLSG + P+LG
Sbjct: 483  NNITGSIPEDFGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELG 542

Query: 402  SLVQLEHLDLSSNRLSNSIPKSLGNL----------------------ELIHLSELDLSR 439
            SL  LE+LDLS+NRL+ SIP+ LG+                       +L HLS+LDLS 
Sbjct: 543  SLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSH 602

Query: 440  NFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTT 499
            N L   IP+QI  ++SLE L+LSHN+L G IP  FE M  L ++DISYN+L+G IP+S  
Sbjct: 603  NLLTGGIPAQIQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNA 662

Query: 500  FKDAPIEALQGNKGLYGDVKGLLSCK-ALKSNKQALR---TIWVVVVFPLLGFVALLISL 555
            F++A IE L+GNK L G+VKGL  CK     ++Q ++    +  +++FPLLG + LL + 
Sbjct: 663  FRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAF 722

Query: 556  IGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQ 615
            IG+F   +RR+   + ++    N+  LLS+ TF+G+ +YEEII+AT DFD  +CIGKGG 
Sbjct: 723  IGIFLIAERRERTPEIEEGDVQNN--LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGH 780

Query: 616  GSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH 675
            GSVY ++L SG I+AVKK H P   +M  Q++FLN+V+A+TEI HRNIV++ GFC + RH
Sbjct: 781  GSVYKAELPSGNIVAVKKLH-PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRH 839

Query: 676  LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS 735
             F+VYEY +  SLA ILS +  AK LGW  R+ +IKG+  ALSYMH+DC PPIVHRDISS
Sbjct: 840  SFLVYEYLERGSLATILSRE-EAKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISS 898

Query: 736  KNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 795
             N+LLD + EAH+S+ G AK LK DSSN ++LAGT GYVAPE AYTMKVTEK DVYSFGV
Sbjct: 899  NNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGV 958

Query: 796  LALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVD 855
            +ALEVIKG+HP D I S+S S    NI L +MLDPRLP  +     ++++I+++  +C++
Sbjct: 959  IALEVIKGRHPGDQILSISVSP-EKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLN 1017

Query: 856  ENPESRPTMQKVCQLL 871
             NP+SRPTM+ + Q+L
Sbjct: 1018 ANPQSRPTMEIISQML 1033

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  815 bits (2105), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 459/902 (50%), Positives = 594/902 (65%), Gaps = 42/902 (4%)

Query: 3    CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLY---IHTNSLSG 59
            CI  N+L   IP ++  L  L  L+L  N+ SG IP  +G LTNL  L+   ++TN L G
Sbjct: 149  CI--NNLSGPIPPQIGLLSKLKYLDLSTNQFSGGIPPEIGLLTNLEVLHLLALYTNQLEG 206

Query: 60   SIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
            SIP  +GN    + L L  N+LSGSIPP +GNL+NL  +Y DTN+L+  IPS  GNL+ L
Sbjct: 207  SIPASLGNLSNLASLYLYENQLSGSIPPEMGNLANLVEIYSDTNNLTGLIPSTFGNLKRL 266

Query: 120  SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
            + L L NN LSG IP  +GNLT+L  + +Y+N+LS  I   +G+L  L+ L L  N  +G
Sbjct: 267  TTLYLFNNQLSGHIPPEIGNLTSLQGISLYANNLSGPIPASLGDLSGLTLLHLYANQLSG 326

Query: 180  SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
             IPP +GNL +L  L L  N L+ SIP+ LGNL +L  L L  N LSG  P  +G L  L
Sbjct: 327  PIPPEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKL 386

Query: 240  TYLNLFENSLSGAIPY---EYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNY 295
              L +  N LSG++P    +  +LV+ T+     N   GPIP  ++N  +L R     N 
Sbjct: 387  VVLEIDTNRLSGSLPEGICQGGSLVRFTV---SDNLLSGPIPKSMKNCRNLTRALFGGNQ 443

Query: 296  LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
            LTGNISE     PNL YIDLS N F+GE+S +WGRCP+L  L+ + N+ITG++P + G S
Sbjct: 444  LTGNISEVVGDCPNLEYIDLSYNRFHGELSHNWGRCPQLQRLEMAGNDITGSIPEDFGIS 503

Query: 356  SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNR 415
            + L +LDLSSNH+VGEIP ++G L   ++L L  NQLSG + P+LGSL  L HLDLS+NR
Sbjct: 504  TNLTLLDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSANR 563

Query: 416  LSNSIPKSLG---NL-------------------ELIHLSELDLSRNFLREAIPSQICIM 453
            L+ SI ++LG   NL                   +L HLS+LDLS N L   IP QI  +
Sbjct: 564  LNGSITENLGACLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGL 623

Query: 454  QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKG 513
            +SLE LNLSHN+LSG IP  FE+M GL  IDISYN+L+G IPNS  F+DA IE L+GNK 
Sbjct: 624  ESLENLNLSHNNLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNKD 683

Query: 514  LYGDVKGLLSCK----ALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDS 569
            L G+VKGL  CK    A +   +    I  ++VFPLLG + LL + IG+F   +R K   
Sbjct: 684  LCGNVKGLQPCKNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRTP 743

Query: 570  QTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEII 629
            + ++    N   L S+ TF+G+ +YEEII+AT DFD  +CIGKGG GSVY ++L+SG I+
Sbjct: 744  EIEEGDVQND--LFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIV 801

Query: 630  AVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLA 689
            AVKK ++    +M  Q++F NEV+ALTEI HRNIVK+ GFC H RH F+VYEY +  SLA
Sbjct: 802  AVKKLYAS-DIDMANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLA 860

Query: 690  VILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVS 749
             +LS +  AK LGW  R+N+IKG+  ALSYMH+DC PPIVHRDISS N+LLD + E H+S
Sbjct: 861  AMLSRE-EAKKLGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHIS 919

Query: 750  DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 809
            DFG AK LK DSSN + LAGT+GYVAPE AYTMKVTEK DVYSFGV+ LEVIKG+HP D 
Sbjct: 920  DFGTAKLLKLDSSNQSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQ 979

Query: 810  ISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            I S+S S    NI L++MLDPRLP  +     ++ISI+ +  +C+  NPESRPTM+ + Q
Sbjct: 980  ILSLSVSPEKENIVLEDMLDPRLPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQ 1039

Query: 870  LL 871
            +L
Sbjct: 1040 ML 1041

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484867|ref|XP_002273645.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  804 bits (2077), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 456/953 (47%), Positives = 602/953 (63%), Gaps = 88/953 (9%)

Query: 4    IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
            +++NS    IP ++  L SL+ L L +N L G IP ++GNL NL TLY+  N L GSIP 
Sbjct: 250  VHSNSFSGLIPYQVGLLTSLTFLALTSNHLRGPIPPTIGNLRNLTTLYLDENKLFGSIPH 309

Query: 64   EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            EIG+ R  +DLELS N LSG IPPS+GNL NL TLYL  N LS SIP E+G LRSL++L+
Sbjct: 310  EIGSLRSLNDLELSTNNLSGPIPPSIGNLRNLTTLYLYENKLSGSIPHEIGLLRSLNDLE 369

Query: 124  LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            L+ N LSG IP S+GNL NL TLY+Y N LS SI  +IG+L+SL++L LS NN +G IPP
Sbjct: 370  LSTNNLSGPIPPSIGNLRNLTTLYLYENKLSGSIPHEIGSLRSLNDLVLSTNNLSGPIPP 429

Query: 184  SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            S+GNL NL TLYL  N LS SIP E+G+LRSL++L L  N LSG IP S+GNL NLT L 
Sbjct: 430  SIGNLRNLTTLYLYENKLSGSIPHEIGSLRSLNDLVLSTNNLSGPIPPSIGNLRNLTTLY 489

Query: 244  LFENSLS------------------------GAIPYEYRNLVKLTILLL------GH--- 270
            L+EN LS                        G IP E  NL+ L  L L      GH   
Sbjct: 490  LYENKLSGFIPQEIGLLSNLTHLLLHYNQLNGPIPQEIDNLIHLKSLHLDENNFTGHLPQ 549

Query: 271  ---------------NQFRGPIPI-LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYID 314
                           N F GPIP+ LRN TSL RVRL+RN L GNI+E F +YPNL ++D
Sbjct: 550  QMCLGGALENFTAMGNNFTGPIPMSLRNCTSLFRVRLNRNQLKGNITEGFGVYPNLNFMD 609

Query: 315  LSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI 374
            LS NN YGE+S  WG+C  L++L+ S NN++G +PP++G + QL  LDLSSNH++G+IP 
Sbjct: 610  LSSNNLYGELSQKWGQCRSLTSLNISHNNLSGIIPPQLGEAIQLHQLDLSSNHLLGKIPR 669

Query: 375  ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE------ 428
            ELG+L     L+L++NQLSG +  ++G+L  LEHL L+SN LS SIPK LG L       
Sbjct: 670  ELGRLTSMFNLLLSNNQLSGNIPWEVGNLFNLEHLILASNNLSGSIPKQLGMLSKLSFLN 729

Query: 429  ----------------LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS 472
                            L  L  LDLS+N L   IP ++  +Q LE LNLSHN LSG IPS
Sbjct: 730  LSKNEFVESIPDEIGNLHSLQSLDLSQNMLNGKIPQELGELQRLEALNLSHNELSGSIPS 789

Query: 473  CFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQ 532
             F  M  L  +DIS N+L G +P+   F++AP EA   N GL G+V GL  C  L   K 
Sbjct: 790  TFADMLSLTSVDISSNQLEGPLPDIKAFQEAPFEAFINNHGLCGNVTGLKPCIPLTQKKN 849

Query: 533  ALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKI 592
                  ++++     F  LL   +G++F    R  + + ++SS      L ++ + +G+I
Sbjct: 850  --NRFMMIMIISSTSF--LLCIFMGIYFTLHWRARN-RKRKSSETPCEDLFAIWSHDGEI 904

Query: 593  IYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEV 652
            +Y++II  T DF+ ++CIG GGQG+VY ++L +G ++AVKK H P  GEM+  + F +E+
Sbjct: 905  LYQDIIEVTEDFNSKYCIGSGGQGTVYKAELPTGRVVAVKKLHPPQDGEMSHLKAFTSEI 964

Query: 653  KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
            +ALTEI HRNIVK+YG+C H RH F+VY+  +  SL  ILS +  A  L W RR+N++KG
Sbjct: 965  RALTEIRHRNIVKLYGYCSHARHSFLVYKLMEKGSLRNILSKEEEAIGLDWNRRLNIVKG 1024

Query: 713  IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
            +  ALSYMH+DC  PI+HRDISS NVLLD E EAHVSD G A+ LKPDSSNWT   GT+G
Sbjct: 1025 VAAALSYMHHDCSAPIIHRDISSNNVLLDSEYEAHVSDLGTARLLKPDSSNWTSFVGTFG 1084

Query: 773  YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL------------ 820
            Y APELAYT +V  K DVYSFGV+ALEV+ G+HP D I S++ SS +             
Sbjct: 1085 YSAPELAYTTQVNNKTDVYSFGVVALEVVIGRHPGDLILSLTSSSGSASSSSSSVTAVAD 1144

Query: 821  NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
            ++ L +++D R+  P+  + ++++  V++  +C   NP+ RPTM++V Q L I
Sbjct: 1145 SLLLKDVIDQRISPPTDQISEEVVFAVKLAFACQHVNPQCRPTMRQVSQALSI 1197

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata]

 Score =  790 bits (2039), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 445/915 (48%), Positives = 586/915 (64%), Gaps = 61/915 (6%)

Query: 4    IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
            +Y N L   IP EL N++S+ DLEL  NKL+GSIP SLGNL NL  LY+H N L+G IP 
Sbjct: 208  LYQNYLTGVIPPELGNMESMIDLELSTNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPP 267

Query: 64   EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            E+GN     DLELS+NKL+GSIP SLGNL NL  LYL  N L+  IP ELGN+ S++ L 
Sbjct: 268  ELGNMESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLYKNYLTGVIPPELGNMESMTYLD 327

Query: 124  LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            L+ N L+GSIP SLGNL NL  LY++ N L+  I  ++GNL+S+ +L+LS+N   GSIP 
Sbjct: 328  LSENKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNLESMIDLELSDNKLTGSIPS 387

Query: 184  SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            SLGNL NL  LYL  N L+  IP ELGN+ S+ +L+L  N L+GSIP S GN + L  L 
Sbjct: 388  SLGNLKNLTVLYLHHNYLTGVIPPELGNMESMIDLALSQNNLTGSIPSSFGNFTKLESLY 447

Query: 244  LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP------------------------- 278
            L +N LSG IP    N  +LT LLL  N F G +P                         
Sbjct: 448  LRDNHLSGTIPRGVANSSELTELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPK 507

Query: 279  ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD 338
             LR+  SL R +   N   GNISE+F +YP+L +IDLS N F GEISS+W + PKL  L 
Sbjct: 508  SLRDCKSLIRAKFVGNKFIGNISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALI 567

Query: 339  FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
             S NNITG +PPEI +  QLG LDLS+N++ GE+P  +G L    KL+L  N+LSG++  
Sbjct: 568  MSNNNITGAIPPEIWNMKQLGELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPT 627

Query: 399  KLGSLVQLEHLDLSSNRLSNSIPKSL---------------------GNLELIHLSELDL 437
             L  L  LE LDLSSNR S+ IP++                      G  +L  L+ LDL
Sbjct: 628  GLSFLTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLSKNNFDGRIPGLTKLTQLTHLDL 687

Query: 438  SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            S N L   IPSQ+  +QSL+KLNLSHN+LSG IP+ FE M  L  IDIS N+L G +P++
Sbjct: 688  SHNQLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDN 747

Query: 498  TTFKDAPIEALQGNKGLYGDV--KGLLSCKAL-KSNKQALRTIWVVVVFPLLGFVALLIS 554
              F++A  +AL+GN+GL  ++  + L SC+   K  K     +W++V  P+LG + +L  
Sbjct: 748  PAFQNATSDALEGNRGLCSNIPKQRLKSCRGFQKPKKNGNLLVWILV--PILGALVILSI 805

Query: 555  LIGLFFKF--QRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGK 612
              G F  +  +R+ ++ +   S  G +   +S+ + +GK  Y++II +TN+FD  + IG 
Sbjct: 806  CAGAFTYYIRKRKPHNGRNTDSETGEN---MSIFSVDGKFKYQDIIESTNEFDQRYLIGS 862

Query: 613  GGQGSVYMSKLASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIWHRNIVKVYGF 669
            GG   VY + L    I+AVK+ H  +  E++    +QEFLNEV+ALTEI HRN+VK++GF
Sbjct: 863  GGYSKVYKANLPDA-IVAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGF 921

Query: 670  CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            C H RH F++YEY +  SL  +L+N+  AK L WT+R+N++KG+  ALSYMH+D   PIV
Sbjct: 922  CSHRRHTFLIYEYMEKGSLNKLLANEEEAKRLTWTKRINIVKGVAHALSYMHHDRSTPIV 981

Query: 730  HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCD 789
            HRDISS N+LLD +  A +SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCD
Sbjct: 982  HRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCD 1041

Query: 790  VYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEV 849
            VYSFGVL LEVI GKHP D ++S+S SS    ++L  + D R+  P     +KLI +VEV
Sbjct: 1042 VYSFGVLILEVIMGKHPGDLVASLS-SSPGETLSLRSISDERILEPRGQNREKLIKMVEV 1100

Query: 850  TISCVDENPESRPTM 864
             +SC+  +P+SRPTM
Sbjct: 1101 ALSCLQADPQSRPTM 1115

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis]

 Score =  780 bits (2014), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/897 (48%), Positives = 592/897 (65%), Gaps = 52/897 (5%)

Query: 26   LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
            L+L  N LS +IP  +  L  L  L + +N LSG IP +IG     + L LS N+L GSI
Sbjct: 113  LDLSCNSLSSTIPLEITQLPKLIFLDLSSNQLSGVIPPDIGLLTNLNTLRLSANRLDGSI 172

Query: 86   PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLAT 145
            P S+GNL+ LA L+L  N  S SIPSE+GNL++L  L ++ N+L+GSIP + G+LT L  
Sbjct: 173  PSSVGNLTELAWLHLYDNRFSGSIPSEMGNLKNLVELFMDTNLLTGSIPSTFGSLTKLVQ 232

Query: 146  LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSI 205
            L++Y+N LS  I  ++G+LKSL++L L  NN +G IP SLG L++L  L+L  N LS +I
Sbjct: 233  LFLYNNQLSGHIPQELGDLKSLTSLSLFGNNLSGPIPASLGGLTSLTILHLYQNQLSGTI 292

Query: 206  PSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIP----------- 254
            P ELGNL SLSNL L  NKL+GSIP S+GNLS L  L L  N LSG IP           
Sbjct: 293  PKELGNLNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSKLSL 352

Query: 255  ----------YEYRNLVKLTILL---LGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNI 300
                      Y  +N+ +  +L    +  N+  GPIP  +R+  SL R+ L+ N   GNI
Sbjct: 353  LQLQSNQLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFIGNI 412

Query: 301  SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGV 360
            SE F +YP L ++D+  N F+GEISS WG CP L TL  S NNI+G +PPEIG++++L  
Sbjct: 413  SEDFGVYPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAARLQG 472

Query: 361  LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
            LD SSN +VG IP ELGKL   +++ L  NQLS  +  + GSL  LE LDLS+NR + SI
Sbjct: 473  LDFSSNQLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFNQSI 532

Query: 421  PKSLGNL----------------------ELIHLSELDLSRNFLREAIPSQICIMQSLEK 458
            P ++GNL                      +L+HLS+LDLS+NFL   IPS++  MQSLE 
Sbjct: 533  PGNIGNLVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQSLEV 592

Query: 459  LNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDV 518
            LNLS N+LSG IP   ++M+GL  IDISYN+L G +P++  F+++ IEA QGNKGL G V
Sbjct: 593  LNLSRNNLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHV 652

Query: 519  KGLLSCKALKSNK----QALRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQS 574
            +GL  CK   + +    +  + +++V+  PL G   L++S +G+ F   +R  ++   + 
Sbjct: 653  QGLQPCKPSSTEQGSSIKFHKRLFLVISLPLFG-AFLILSFLGVLFFQSKRSKEALEAEK 711

Query: 575  SPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKF 634
            S   S  +L + +F+GK +++EII AT+ F+D +CIGKGG GSVY +KL+SG  +AVKK 
Sbjct: 712  SSQESEEILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKL 771

Query: 635  HSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN 694
            H        +Q+EF +E++ALTEI HRNIVK YGFC +  + F+VYE  +  SLA IL +
Sbjct: 772  HQSHDAWKPYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRD 831

Query: 695  DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA 754
            + AAK L W +R N+IKG+ +ALSYMH+DC PPIVHRDISSKN+LLD ENEA VSDFGIA
Sbjct: 832  NEAAKELEWFKRANIIKGVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIA 891

Query: 755  KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS 814
            + L  DSS+ T LAGT+GY+APELAY++ VTEKCDVYSFGVLALEVI GKHP + ISS+S
Sbjct: 892  RILNLDSSHRTALAGTFGYMAPELAYSIVVTEKCDVYSFGVLALEVINGKHPGEIISSIS 951

Query: 815  FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             SS    + L+ ++D RLP PS  V  +L++I+ +  +C++ NP+ RPTM+ +C +L
Sbjct: 952  SSSSTRKMLLENIVDLRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTMEMICHML 1008

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	873
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.979	0.763	0.433	1.1e-174
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.980	0.819	0.412	7.2e-171
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.977	0.774	0.362	1.2e-131
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.982	0.751	0.346	1.6e-127
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.979	0.684	0.343	4e-122
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.983	0.756	0.331	4e-122
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.982	0.778	0.345	3.6e-121
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.983	0.764	0.334	7.4e-121
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.979	0.682	0.340	5.2e-120
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.972	0.849	0.346	7.3e-114

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 1697 (602.4 bits), Expect = 1.1e-174, P = 1.1e-174
 Identities = 378/872 (43%), Positives = 517/872 (59%)

Query:     4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
             +Y N L   IP E+ N++S+++L L  NKL+GSIP SLGNL NL  L +  N L+G IP 
Sbjct:   253 LYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPP 312

Query:    64 EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXX 123
             ++GN     DLELSNNKL+GSIP SLGNL NL  LYL  N L+  IP E           
Sbjct:   313 KLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQ 372

Query:   124 XXXXXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
                       P S GNL NL  LY+Y N L+  I  ++GN++S+ NL LS+N   GS+P 
Sbjct:   373 LNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPD 432

Query:   184 SLGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLN 243
             S GN + L +LYL  N LS +IP                N  +G  P ++     L  ++
Sbjct:   433 SFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNIS 492

Query:   244 LFENSLSGAIPYEYRNLVKLT-ILLLGHNQFRGPI-PILRNLTSLERVRLDRNYLTGNIS 301
             L  N L G IP   R+   L     LG N+F G I         L  +    N   G IS
Sbjct:   493 LDYNHLEGPIPKSLRDCKSLIRARFLG-NKFTGDIFEAFGIYPDLNFIDFSHNKFHGEIS 551

Query:   302 ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVL 361
              ++   P L  + +S NN  G I ++     +L  LD S NN+ G +P  IG+ + L  L
Sbjct:   552 SNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRL 611

Query:   362 DLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIP 421
              L+ N + G +P  L  L     L L+ N  S ++     S ++L  ++LS N+   SIP
Sbjct:   612 RLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP 671

Query:   422 KSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLL 481
             + L   +L  L++LDLS N L   IPSQ+  +QSL+KL+LSHN+LSGLIP+ FE M  L 
Sbjct:   672 R-LS--KLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALT 728

Query:   482 HIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDV--KGLLSCKALKS-NKQALRTIW 538
             ++DIS N+L G +P++ TF+ A  +AL+ N GL  ++  + L  C+ LK   K     +W
Sbjct:   729 NVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVW 788

Query:   539 VVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEII 598
             ++V  P+LG V +++S+    F +  RK   Q  +++   +   +S+ + +GK  Y++II
Sbjct:   789 ILV--PILG-VLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDII 845

Query:   599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKAL 655
              +TN+FD  H IG GG   VY + L    IIAVK+ H  +  E++    +QEFLNEVKAL
Sbjct:   846 ESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKAL 904

Query:   656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
             TEI HRN+VK++GFC H RH F++YEY +  SL  +L+ND  AK L WT+R+N++KG+  
Sbjct:   905 TEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAH 964

Query:   716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
             ALSYMH+D   PIVHRDISS N+LLD +  A +SDFG AK LK DSSNW+ +AGTYGYVA
Sbjct:   965 ALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVA 1024

Query:   776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
             PE AYTMKVTEKCDVYSFGVL LE+I GKHP D +SS+S SS    ++L  + D R+  P
Sbjct:  1025 PEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLS-SSPGEALSLRSISDERVLEP 1083

Query:   836 SRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                  +KL+ +VE+ + C+  NPESRPTM  +
Sbjct:  1084 RGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1661 (589.8 bits), Expect = 7.2e-171, P = 7.2e-171
 Identities = 361/876 (41%), Positives = 517/876 (59%)

Query:     4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
             +  N L  SIPSE+  L  ++++ + +N L+G IP S GNLT L  LY+  NSLSGSIP 
Sbjct:   173 LVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPS 232

Query:    64 EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXX 123
             EIGN     +L L  N L+G IP S GNL N+  L +  N LS  IP E           
Sbjct:   233 EIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLS 292

Query:   124 XXXXXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
                       P +LGN+  LA L++Y N L+ SI  ++G ++S+ +L++SEN   G +P 
Sbjct:   293 LHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPD 352

Query:   184 SLGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISM---GNLSNLT 240
             S G L+ L  L+L  N LS  IP                N  +G +P ++   G L NLT
Sbjct:   353 SFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLT 412

Query:   241 YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL-TSLERVRLDRNYLTGN 299
                L +N   G +P   R+   L  +    N F G I     +  +L  + L  N   G 
Sbjct:   413 ---LDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQ 469

Query:   300 ISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLG 359
             +S ++     L    LS N+  G I  +     +LS LD S N ITG +P  I + +++ 
Sbjct:   470 LSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRIS 529

Query:   360 VLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNS 419
              L L+ N + G+IP  +  L     L L+ N+ S ++ P L +L +L +++LS N L  +
Sbjct:   530 KLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQT 589

Query:   420 IPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNG 479
             IP+ L  L  + +  LDLS N L   I SQ   +Q+LE+L+LSHN+LSG IP  F+ M  
Sbjct:   590 IPEGLTKLSQLQM--LDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLA 647

Query:   480 LLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDV---KGLLSCKALKSNKQAL-R 535
             L H+D+S+N L+G IP++  F++AP +A +GNK L G V   +GL  C    S K    R
Sbjct:   648 LTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDR 707

Query:   536 TIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRG-LLSVLTFEGKIIY 594
              + + ++ P++G + +L    G+F  F  RK   Q ++ +   S G  LS+ +F+GK+ Y
Sbjct:   708 NLIIYILVPIIGAIIILSVCAGIFICF--RKRTKQIEEHTDSESGGETLSIFSFDGKVRY 765

Query:   595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT---FQQEFLNE 651
             +EII+AT +FD ++ IG GG G VY +KL +  I+AVKK +      ++    +QEFLNE
Sbjct:   766 QEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNE 824

Query:   652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
             ++ALTEI HRN+VK++GFC H R+ F+VYEY +  SL  +L ND  AK L W +R+N++K
Sbjct:   825 IRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVK 884

Query:   712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
             G+  ALSYMH+D  P IVHRDISS N+LL  + EA +SDFG AK LKPDSSNW+ +AGTY
Sbjct:   885 GVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTY 944

Query:   772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
             GYVAPELAY MKVTEKCDVYSFGVL LEVIKG+HP D +S++S S  +  ++L  + D R
Sbjct:   945 GYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHR 1004

Query:   832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
             LP P+  + ++++ I++V + C+  +P++RPTM  +
Sbjct:  1005 LPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1291 (459.5 bits), Expect = 1.2e-131, P = 1.2e-131
 Identities = 322/888 (36%), Positives = 456/888 (51%)

Query:     7 NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
             N     IPSE+   +SL  L L  N L GS+P  L  L NL  L +  N LSG IP  +G
Sbjct:   197 NGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVG 256

Query:    67 NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXX 126
             N      L L  N  +GSIP  +G L+ +  LYL TN L+  IP E              
Sbjct:   257 NISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSE 316

Query:   127 XXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
                    P   G++ NL  L+++ N L   I  ++G L  L  L LS N  NG+IP  L 
Sbjct:   317 NQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQ 376

Query:   187 NLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFE 246
              L  L  L L  N L   IP                N LSG IP        L  L+L  
Sbjct:   377 FLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGS 436

Query:   247 NSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNISESFY 305
             N LSG IP + +    LT L+LG NQ  G +PI L NL +L  + L +N+L+GNIS    
Sbjct:   437 NKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLG 496

Query:   306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
                NL  + L+ NNF GEI  + G   K+   + S N +TG++P E+G    +  LDLS 
Sbjct:   497 KLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSG 556

Query:   366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
             N   G I  ELG+L +   L L+ N+L+G++    G L +L  L L  N LS +IP  LG
Sbjct:   557 NKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELG 616

Query:   426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDI 485
              L  + +S L++S N L   IP  +  +Q LE L L+ N LSG IP+    +  LL  +I
Sbjct:   617 KLTSLQIS-LNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNI 675

Query:   486 SYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVV----- 540
             S N L G++P++  F+        GN GL    +    C+ L  +  + +  W++     
Sbjct:   676 SNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRS--HCQPLVPHSDS-KLNWLINGSQR 732

Query:   541 -----VVFPLLGFVALLISLIGLFFKFQRRKND--SQTQQSSPGNSRGLLSVLTFEGK-I 592
                  +   ++G V  LI+ +GL +  +RR+    +   Q+ P     ++    F  K  
Sbjct:   733 QKILTITCIVIGSV-FLITFLGLCWTIKRREPAFVALEDQTKPD----VMDSYYFPKKGF 787

Query:   593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEV 652
              Y+ ++ AT +F ++  +G+G  G+VY ++++ GE+IAVKK +S   G  +    F  E+
Sbjct:   788 TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS-DNSFRAEI 846

Query:   653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
               L +I HRNIVK+YGFC H     ++YEY    SL   L        L W  R  +  G
Sbjct:   847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALG 906

Query:   713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGTY 771
               + L Y+H+DC P IVHRDI S N+LLD   +AHV DFG+AK +    S + + +AG+Y
Sbjct:   907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSY 966

Query:   772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-------RDFISSMSFSSLNLNIAL 824
             GY+APE AYTMKVTEKCD+YSFGV+ LE+I GK P        D ++ +  S  N+ I  
Sbjct:   967 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNM-IPT 1025

Query:   825 DEMLDPRLPT-PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
              EM D RL T   R VH+  + ++++ + C   +P SRPTM++V  ++
Sbjct:  1026 IEMFDARLDTNDKRTVHEMSL-VLKIALFCTSNSPASRPTMREVVAMI 1072

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 1252 (445.8 bits), Expect = 1.6e-127, P = 1.6e-127
 Identities = 309/892 (34%), Positives = 468/892 (52%)

Query:     4 IYNNSLYDSIPSELRNLKSLSDLELGNNK-LSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
             +++N L  SIP+EL  L  L  + +G NK +SG IP  +G+ +NL  L +   S+SG++P
Sbjct:   184 LFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLP 243

Query:    63 GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXX 122
               +G  +    L +    +SG IP  LGN S L  L+L  NSLS SIP E          
Sbjct:   244 SSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQL 303

Query:   123 XXXXXXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
                        P  +GN +NL  + +  N LS SI   IG L  L    +S+N F+GSIP
Sbjct:   304 FLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIP 363

Query:   183 PSLGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYL 242
              ++ N S+L  L LD N +S  IP                N+L GSIP  + + ++L  L
Sbjct:   364 TTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQAL 423

Query:   243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNIS 301
             +L  NSL+G IP     L  LT LLL  N   G IP  + N +SL R+RL  N +TG I 
Sbjct:   424 DLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIP 483

Query:   302 ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVL 361
                     + ++D S N  +G++  + G C +L  +D S N++ G++P  +   S L VL
Sbjct:   484 SGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVL 543

Query:   362 DLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIP 421
             D+S+N   G+IP  LG+L    KL+L+ N  SG +   LG    L+ LDL SN LS  IP
Sbjct:   544 DVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIP 603

Query:   422 KSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSG-LIPSCFEKMNGL 480
               LG++E + ++ L+LS N L   IPS+I  +  L  L+LSHN L G L P     +  L
Sbjct:   604 SELGDIENLEIA-LNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP--LANIENL 660

Query:   481 LHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSC-------KALKSNKQA 533
             + ++ISYN   G +P++  F+    + L+GNK L    +   SC         L  +  A
Sbjct:   661 VSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQD--SCFLTYRKGNGLGDDGDA 718

Query:   534 LRTIWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKII 593
              RT  + +   LL  + +++ ++G     + R+N    + S  G +        F+ K+ 
Sbjct:   719 SRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKW-QFTPFQ-KLN 776

Query:   594 Y--EEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG----EMT--FQ 645
             +  ++IIR      + + IGKG  G VY + + +GE+IAVKK    +      E T   +
Sbjct:   777 FSVDQIIRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVR 833

Query:   646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
               F  EVK L  I H+NIV+  G C +     ++Y+Y    SL  +L ++    +L W  
Sbjct:   834 DSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDL 892

Query:   706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL-KPDSSNW 764
             R  ++ G    L+Y+H+DC PPIVHRDI + N+L+  + E +++DFG+AK + + D    
Sbjct:   893 RYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRC 952

Query:   765 TE-LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL--- 820
             +  +AG+YGY+APE  Y+MK+TEK DVYS+GV+ LEV+ GK P D         ++    
Sbjct:   953 SNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQ 1012

Query:   821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             N    E+LD  L + +    D+++ ++   + CV+ +P+ RPTM+ V  +LK
Sbjct:  1013 NRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
 Identities = 308/896 (34%), Positives = 444/896 (49%)

Query:     9 LYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNF 68
             L   IP EL   +SL  L+L NN L+GSIP +L  L  L  LY+H N+L G++   I N 
Sbjct:   348 LSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNL 407

Query:    69 RFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXXXX 128
                  L L +N L G +P  +  L  L  L+L  N  S  IP E                
Sbjct:   408 TNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNH 467

Query:   129 XXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNL 188
                  P S+G L  L  L++  N L   +   +GN   L+ L L++N  +GSIP S G L
Sbjct:   468 FEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFL 527

Query:   189 SNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFENS 248
               L  L L  NSL  ++P               +N+L+G+I    G+ S L++ ++  N 
Sbjct:   528 KGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSF-DVTNNG 586

Query:   249 LSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIY 307
                 IP E  N   L  L LG NQ  G IP  L  +  L  + +  N LTG I     + 
Sbjct:   587 FEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLC 646

Query:   308 PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH 367
               LT+IDL+ N   G I    G+  +L  L  S N    ++P E+ + ++L VL L  N 
Sbjct:   647 KKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNS 706

Query:   368 IVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL 427
             + G IP E+G L     L L  NQ SG L   +G L +L  L LS N L+  IP  +G L
Sbjct:   707 LNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQL 766

Query:   428 ELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISY 487
             + +  S LDLS N     IPS I  +  LE L+LSHN L+G +P     M  L ++++S+
Sbjct:   767 QDLQ-SALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSF 825

Query:   488 NELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQAL--RTIWVVVVFPL 545
             N L G +     F   P ++  GN GL G      +     + +Q L  R++ ++     
Sbjct:   826 NNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISA 883

Query:   546 LGFVALLISLIGLFFK-----FQRRKNDSQTQQSSPGNSRGLLSVLTFEGK----IIYEE 596
             L  + L+I +I LFFK     F++  + S    SS  +S+     L   G     I +E+
Sbjct:   884 LTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWED 943

Query:   597 IIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
             I+ AT++  +E  IG GG G VY ++L +GE +AVKK       ++   + F  EVK L 
Sbjct:   944 IMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKIL--WKDDLMSNKSFSREVKTLG 1001

Query:   657 EIWHRNIVKVYGFCLHVRH-L-FIVYEYFKMCSLAVILSNDAAA-----KNLGWTRRMNM 709
              I HR++VK+ G+C      L  ++YEY K  S+   L  D        K L W  R+ +
Sbjct:  1002 RIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRI 1061

Query:   710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL------KPDSSN 763
               G+   + Y+H+DC PPIVHRDI S NVLLD   EAH+ DFG+AK L        DS+ 
Sbjct:  1062 AVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNT 1121

Query:   764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD--FISSMS---FSSL 818
             W   A +YGY+APE AY++K TEK DVYS G++ +E++ GK P D  F + M    +   
Sbjct:  1122 W--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179

Query:   819 NLNIA---LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             +L +A    D+++DP+L        D    ++E+ + C   +P+ RP+ ++ C  L
Sbjct:  1180 HLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
 Identities = 294/888 (33%), Positives = 457/888 (51%)

Query:     4 IYNNSLYDSIPSELRNLKSLSDLELG-NNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
             I++N L +++P EL  + +L  +  G N++LSG IP  +GN  NL  L +    +SGS+P
Sbjct:   185 IFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLP 244

Query:    63 GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXX 122
               +G       L + +  LSG IP  LGN S L  L+L  N LS ++P E          
Sbjct:   245 VSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKM 304

Query:   123 XXXXXXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
                        P  +G + +L  + +  N  S +I    GNL +L  L LS NN  GSIP
Sbjct:   305 LLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIP 364

Query:   183 PSLGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYL 242
               L N + L    +D N +S  IP                NKL G+IP  +    NL  L
Sbjct:   365 SILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQAL 424

Query:   243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNIS 301
             +L +N L+G++P     L  LT LLL  N   G IP+ + N TSL R+RL  N +TG I 
Sbjct:   425 DLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIP 484

Query:   302 ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVL 361
             +      NL+++DLS+NN  G +  +   C +L  L+ S N + G +P  +   ++L VL
Sbjct:   485 KGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVL 544

Query:   362 DLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIP 421
             D+SSN + G+IP  LG L    +L+L+ N  +G++   LG    L+ LDLSSN +S +IP
Sbjct:   545 DVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIP 604

Query:   422 KSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLL 481
             + L +++ + ++ L+LS N L   IP +I  +  L  L++SHN LSG + S    +  L+
Sbjct:   605 EELFDIQDLDIA-LNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL-SALSGLENLV 662

Query:   482 HIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNK----QALRTI 537
              ++IS+N   G +P+S  F+      ++GN GL    KG  SC    S++    + + + 
Sbjct:   663 SLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS--KGFRSCFVSNSSQLTTQRGVHSH 720

Query:   538 WVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEG-KIIYEE 596
              + +   LL  V  +++++G+    + ++       S  G +        F+      E 
Sbjct:   721 RLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEH 780

Query:   597 IIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHS---PLPGEMT----FQQEFL 649
             +++      + + IGKG  G VY +++ + E+IAVKK      P   E T     +  F 
Sbjct:   781 VLKC---LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFS 837

Query:   650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM 709
              EVK L  I H+NIV+  G C +     ++Y+Y    SL  +L   +   +LGW  R  +
Sbjct:   838 AEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKI 897

Query:   710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSNWT 765
             I G    L+Y+H+DC PPIVHRDI + N+L+  + E ++ DFG+AK +       SSN  
Sbjct:   898 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSN-- 955

Query:   766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD--FISSMSFSSLNLNIA 823
              +AG+YGY+APE  Y+MK+TEK DVYS+GV+ LEV+ GK P D      +        I 
Sbjct:   956 TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIR 1015

Query:   824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
               +++D  L     +  ++++  + V + C++  PE RPTM+ V  +L
Sbjct:  1016 DIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAML 1063

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1192 (424.7 bits), Expect = 3.6e-121, P = 3.6e-121
 Identities = 305/883 (34%), Positives = 454/883 (51%)

Query:     7 NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
             N +  S+PSE+   +SL  L L  N+LSG +P  +G L  L+ + +  N  SG IP EI 
Sbjct:   203 NMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREIS 262

Query:    67 NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXX 126
             N      L L  N+L G IP  LG+L +L  LYL  N L+ +IP E              
Sbjct:   263 NCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSE 322

Query:   127 XXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
                    P  LGN+  L  LY++ N L+ +I  ++  LK+LS L LS N   G IP    
Sbjct:   323 NALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQ 382

Query:   187 NLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFE 246
              L  L  L L  NSLS +IP                N LSG IP  +   SN+  LNL  
Sbjct:   383 YLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGT 442

Query:   247 NSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNISESFY 305
             N+LSG IP        L  L L  N   G  P  L    ++  + L +N   G+I     
Sbjct:   443 NNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVG 502

Query:   306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
                 L  + L+ N F GE+  + G   +L TL+ S N +TG VP EI +   L  LD+  
Sbjct:   503 NCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCC 562

Query:   366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
             N+  G +P E+G L     L L++N LSG +   LG+L +L  L +  N  + SIP+ LG
Sbjct:   563 NNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELG 622

Query:   426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDI 485
             +L  + ++ L+LS N L   IP ++  +  LE L L++N+LSG IPS F  ++ LL  + 
Sbjct:   623 SLTGLQIA-LNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNF 681

Query:   486 SYNELRGSIPNSTTFKDAPIEALQGNKGLYGD-VKGLLSCKALKSNKQA-----LRTIWV 539
             SYN L G IP     ++  + +  GN+GL G  +   +  +    ++       +R+  +
Sbjct:   682 SYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI 738

Query:   540 VVVFP-LLGFVAL-LISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEI 597
             + +   ++G V+L LI+LI    +   R   S  Q   P      +     EG   ++++
Sbjct:   739 IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDL 797

Query:   598 IRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKAL 655
             + AT++FD+   +G+G  G+VY + L +G  +AVKK  S   G         F  E+  L
Sbjct:   798 VAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTL 857

Query:   656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
               I HRNIVK++GFC H     ++YEY    SL  IL + +   NL W++R  +  G   
Sbjct:   858 GNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQ 915

Query:   716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTELAGTYGYV 774
              L+Y+H+DC P I HRDI S N+LLD + EAHV DFG+AK +  P S + + +AG+YGY+
Sbjct:   916 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYI 975

Query:   775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS----MSF--SSLNLNIALDEML 828
             APE AYTMKVTEK D+YS+GV+ LE++ GK P   I      +++  S +  +     +L
Sbjct:   976 APEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVL 1035

Query:   829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             D RL      +   +++++++ + C   +P +RP+M++V  +L
Sbjct:  1036 DARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
 Identities = 298/891 (33%), Positives = 450/891 (50%)

Query:     7 NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
             N    +IP+E+    +L  L L  N +SG +P  +G L  L  + +  N  SG IP +IG
Sbjct:   215 NDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIG 274

Query:    67 NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXX 126
             N      L L  N L G IP  +GN+ +L  LYL  N L+ +IP E              
Sbjct:   275 NLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSE 334

Query:   127 XXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
                    P  L  ++ L  LY++ N L+  I  ++  L++L+ L LS N+  G IPP   
Sbjct:   335 NLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQ 394

Query:   187 NLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFE 246
             NL+++  L L  NSLS  IP                N+LSG IP  +   SNL  LNL  
Sbjct:   395 NLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGS 454

Query:   247 NSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNISESFY 305
             N + G IP        L  L +  N+  G  P  L  L +L  + LD+N  +G +     
Sbjct:   455 NRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIG 514

Query:   306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
                 L  + L+ N F   + ++  +   L T + S N++TG +P EI +   L  LDLS 
Sbjct:   515 TCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSR 574

Query:   366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
             N  +G +P ELG L+    L L+ N+ SG +   +G+L  L  L +  N  S SIP  LG
Sbjct:   575 NSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLG 634

Query:   426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDI 485
              L  + ++ ++LS N     IP +I  +  L  L+L++N LSG IP+ FE ++ LL  + 
Sbjct:   635 LLSSLQIA-MNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNF 693

Query:   486 SYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSC----------KALKSNKQALR 535
             SYN L G +P++  F++  + +  GNKGL G    L SC           +LK+   A R
Sbjct:   694 SYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG--HLRSCDPSHSSWPHISSLKAGS-ARR 750

Query:   536 TIWVVVVFPLLGFVALL-ISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIY 594
                +++V  ++G ++LL I+++  F +              P      +  +  E +   
Sbjct:   751 GRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE-RFTV 809

Query:   595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT----FQQEFLN 650
             ++I+ AT  F D + +G+G  G+VY + + SG+ IAVKK  S   G           F  
Sbjct:   810 KDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRA 869

Query:   651 EVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
             E+  L +I HRNIV++Y FC H       ++YEY    SL  +L +   + ++ W  R  
Sbjct:   870 EILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPTRFA 928

Query:   709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTEL 767
             +  G  + L+Y+H+DC P I+HRDI S N+L+D   EAHV DFG+AK +  P S + + +
Sbjct:   929 IALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAV 988

Query:   768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALD- 825
             AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE++ GK P +        ++   N   D 
Sbjct:   989 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDH 1048

Query:   826 ----EMLDPRLPTPSRNVH-DKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                 E+LDP L     +V  + +I++ ++ + C   +P  RPTM++V  +L
Sbjct:  1049 SLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1181 (420.8 bits), Expect = 5.2e-120, P = 5.2e-120
 Identities = 304/892 (34%), Positives = 447/892 (50%)

Query:     9 LYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNF 68
             L   IP+E+ N +SL  L+L NN L+G IP SL  L  L  LY++ NSL G++   I N 
Sbjct:   349 LSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNL 408

Query:    69 RFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXXXX 128
                 +  L +N L G +P  +G L  L  +YL  N  S  +P E                
Sbjct:   409 TNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNR 468

Query:   129 XXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNL 188
                  P S+G L +L  L++  N L  +I   +GN   ++ + L++N  +GSIP S G L
Sbjct:   469 LSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFL 528

Query:   189 SNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFENS 248
             + L    +  NSL  ++P                NK +GSI    G+ S L++ ++ EN 
Sbjct:   529 TALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSF-DVTENG 587

Query:   249 LSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIY 307
               G IP E      L  L LG NQF G IP     ++ L  + + RN L+G I     + 
Sbjct:   588 FEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLC 647

Query:   308 PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH 367
               LT+IDL+ N   G I +  G+ P L  L  S N   G++P EI   + +  L L  N 
Sbjct:   648 KKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNS 707

Query:   368 IVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL 427
             + G IP E+G L     L L  NQLSG L   +G L +L  L LS N L+  IP  +G L
Sbjct:   708 LNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQL 767

Query:   428 ELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISY 487
             + +  S LDLS N     IPS I  +  LE L+LSHN L G +P     M  L ++++SY
Sbjct:   768 QDLQ-SALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSY 826

Query:   488 NELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSC-KALKSNKQAL--RTIWVVVVFP 544
             N L G +     F     +A  GN GL G    L  C +A   N+++L  +T+ ++    
Sbjct:   827 NNLEGKLKKQ--FSRWQADAFVGNAGLCGSP--LSHCNRAGSKNQRSLSPKTVVIISAIS 882

Query:   545 LLGFVALLISLIGLFFK-----FQR-RKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEII 598
              L  +AL++ +I LFFK     F++ R  +S    +S  +   L S    +  I +++I+
Sbjct:   883 SLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIM 942

Query:   599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
              AT+  ++E  IG GG G VY ++L +GE IAVKK       ++   + F  EVK L  I
Sbjct:   943 EATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL--WKDDLMSNKSFNREVKTLGTI 1000

Query:   659 WHRNIVKVYGFCLHVRH-L-FIVYEYFKMCSLAVIL-SNDAAAKN--LGWTRRMNMIKGI 713
              HR++VK+ G+C      L  ++YEY    S+   L +N+   K   LGW  R+ +  G+
Sbjct:  1001 RHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGL 1060

Query:   714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE----LAG 769
                + Y+H DC PPIVHRDI S NVLLD   EAH+ DFG+AK L  +    TE     AG
Sbjct:  1061 AQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAG 1120

Query:   770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-LNIALD--- 825
             +YGY+APE AY++K TEK DVYS G++ +E++ GK P + +       +  +   LD   
Sbjct:  1121 SYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPP 1180

Query:   826 ------EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                   +++D  L +      +    ++E+ + C    P+ RP+ ++  + L
Sbjct:  1181 GSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1123 (400.4 bits), Expect = 7.3e-114, P = 7.3e-114
 Identities = 308/890 (34%), Positives = 456/890 (51%)

Query:     4 IYNNSLYDSIPSE-LRNLKSLSDLELGNNKLSGSIPHSLG-NLTNLATLYIHTNSLSGSI 61
             +YNNS+  S+ ++      +L  L+L  N L GSIP SL  NL NL  L I  N+LS +I
Sbjct:    96 LYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTI 155

Query:    62 PGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNS-IPSEXXXXXXXX 120
             P   G FR    L L+ N LSG+IP SLGN++ L  L L  N  S S IPS+        
Sbjct:   156 PSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQ 215

Query:   121 XXXXXXXXXXXXXPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
                          P SL  LT+L  L +  N L+ SI   I  LK++  ++L  N+F+G 
Sbjct:   216 VLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGE 275

Query:   181 IPPSLGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLT 240
             +P S+GN++ L       N L+  IP                N L G +P S+     L+
Sbjct:   276 LPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLNLFE-NMLEGPLPESITRSKTLS 334

Query:   241 YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGN 299
              L LF N L+G +P +      L  + L +N+F G IP  +     LE + L  N  +G 
Sbjct:   335 ELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGE 394

Query:   300 ISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSINNITGNVPPEIGHSSQL 358
             IS +     +LT + LS N   G+I    WG  P+LS L+ S N+ TG++P  I  +  L
Sbjct:   395 ISNNLGKCKSLTRVRLSNNKLSGQIPHGFWG-LPRLSLLELSDNSFTGSIPKTIIGAKNL 453

Query:   359 GVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN 418
               L +S N   G IP E+G LN  I++  A N  SG++   L  L QL  LDLS N+LS 
Sbjct:   454 SNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSG 513

Query:   419 SIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMN 478
              IP+ L   +  +L+EL+L+ N L   IP ++ I+  L  L+LS N  SG IP   E  N
Sbjct:   514 EIPRELRGWK--NLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIP--LELQN 569

Query:   479 GLLHI-DISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTI 537
               L++ ++SYN L G IP     K    + + GN GL  D+ GL  C+ +  +K  +  +
Sbjct:   570 LKLNVLNLSYNHLSGKIPPLYANKIYAHDFI-GNPGLCVDLDGL--CRKITRSKN-IGYV 625

Query:   538 WVVVVFPLLGFVALLISLIGLFFKFQR-RKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEE 596
             W+++   LL  +  ++ ++    K ++ R   S T  +S   S        F  K+ + E
Sbjct:   626 WILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWRS--------FH-KLHFSE 676

Query:   597 IIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG-EMTFQQEFLN----- 650
                  +  D+++ IG G  G VY  +L  GE++AVKK +  + G +  +  + LN     
Sbjct:   677 H-EIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFA 735

Query:   651 -EVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMN 708
              EV+ L  I H++IV+++  C       +VYEY    SLA +L  D      LGW  R+ 
Sbjct:   736 AEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLR 795

Query:   709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE-- 766
             +     + LSY+H+DC PPIVHRD+ S N+LLD +  A V+DFGIAK  +   S   E  
Sbjct:   796 IALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEAM 855

Query:   767 --LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL 824
               +AG+ GY+APE  YT++V EK D+YSFGV+ LE++ GK P D        +  +  AL
Sbjct:   856 SGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDKDMAKWVCTAL 915

Query:   825 DEM-LDPRL-PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             D+  L+P + P       +++  ++ + + C    P +RP+M+KV  +L+
Sbjct:   916 DKCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQ 965

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00017148001 SubName- Full=Chromosome chr11 scaffold_14, whole genome shotgun sequence; (1154 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	873
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-127
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-40
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-16
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-14
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  406 bits (1044), Expect = e-127
 Identities = 283/883 (32%), Positives = 442/883 (50%), Gaps = 76/883 (8%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           NN+   SIP    ++ +L  L+L NN LSG IP+ +G+ ++L  L +  N L G IP  +
Sbjct: 127 NNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN 125
            N      L L++N+L G IP  LG + +L  +YL  N+LS  IP E+G L SL++L L 
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244

Query: 126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL 185
            N L+G IP SLGNL NL  L++Y N LS  I   I +L+ L +L LS+N+ +G IP  +
Sbjct: 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304

Query: 186 GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLF 245
             L NL  L+L +N+ +  IP  L +L  L  L L  NK SG IP ++G  +NLT L+L 
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364

Query: 246 ENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESF 304
            N+L+G IP    +   L  L+L  N   G IP  L    SL RVRL  N  +G +   F
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424

Query: 305 YIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS 364
              P + ++D+S NN  G I+S     P L  L  + N   G +P   G S +L  LDLS
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLS 483

Query: 365 SNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSL 424
            N   G +P +LG L+  ++L L+ N+LSG++  +L S  +L  LDLS N+LS  IP S 
Sbjct: 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543

Query: 425 GNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHID 484
                                       M  L +L+LS N LSG IP     +  L+ ++
Sbjct: 544 SE--------------------------MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577

Query: 485 ISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVK--GLLSCKALKSNKQALRTIWVVVV 542
           IS+N L GS+P++  F      A+ GN  L G     GL  CK ++       + W  + 
Sbjct: 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTP----SWWFYIT 633

Query: 543 FPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGK----IIYEEII 598
             L  F+ L   L+   F F R +N+ + ++    N  G   +  F+ K    I   +I+
Sbjct: 634 CTLGAFLVLA--LVAFGFVFIRGRNNLELKRVE--NEDGTWELQFFDSKVSKSITINDIL 689

Query: 599 RATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFH--SPLPGEMTFQQEFLNEVKAL 655
            +     +E+ I +G +G+ Y  K     +   VK+ +  + +P          +E+  +
Sbjct: 690 SSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---------SSEIADM 737

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
            ++ H NIVK+ G C   +  ++++EY +  +L+ +L       NL W RR  +  GI  
Sbjct: 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAK 791

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           AL ++H  C P +V  ++S + +++D ++E H+    +   L  D+  +   A    YVA
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVA 846

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL------NIALDEMLD 829
           PE   T  +TEK D+Y FG++ +E++ GK P D    +  S +        +  LD  +D
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906

Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           P +        ++++ ++ + + C   +P +RP    V + L+
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  181 bits (461), Expect = 4e-47
 Identities = 122/347 (35%), Positives = 172/347 (49%), Gaps = 24/347 (6%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +Y N L   IP  + +L+ L  L+L +N LSG IP  +  L NL  L++ +N+ +G IP 
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            + +      L+L +NK SG IP +LG  +NL  L L TN+L+  IP  L +  +L  L 
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           L +N L G IP SLG   +L  + +  NS S  +  +   L  +  L +S NN  G I  
Sbjct: 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
              ++ +L  L L  N     +P   G+ R L NL L  N+ SG++P  +G+LS L  L 
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQLK 505

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
           L EN LSG IP E  +  KL  L L HNQ  G IP                        S
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP-----------------------AS 542

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPP 350
           F   P L+ +DLSQN   GEI  + G    L  ++ S N++ G++P 
Sbjct: 543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (394), Expect = 1e-42
 Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 20/271 (7%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           ++    +G G  G+VY +K   +G+I+AVK        +    Q    E++ L  + H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           IV++        HL++V EY +   L   LS       L       +   I+  L Y+H+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHS 116

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYT 781
           +    I+HRD+  +N+LLD      ++DFG+AK L   SS+ T   GT  Y+APE L   
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL---DEMLDPRLPTPSRN 838
                K DV+S GV+  E++ GK P        FS  N+   L     +L P L      
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP--------FSGENILDQLQLIRRILGPPLEFDEPK 225

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                    ++   C++++P  RPT +++ Q
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  151 bits (384), Expect = 1e-41
 Identities = 67/207 (32%), Positives = 115/207 (55%), Gaps = 13/207 (6%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+GG G+VY+++   +G+ +A+K          +  +E L E++ L ++ H NIVK+YG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                 HL++V EY +  SL  +L  +     L     + ++  I++ L Y+H++    I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 729 VHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 786
           +HRD+  +N+LLD +N +  ++DFG++K L  D S    + GT  Y+APE L      +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSM 813
           K D++S GV+  E+ + K   D I  M
Sbjct: 174 KSDIWSLGVILYELPELK---DLIRKM 197

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  149 bits (378), Expect = 2e-40
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 24/270 (8%)

Query: 604 FDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           ++    +G+G  G VY      +G+++A+K            ++  L E+K L ++ H N
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--KKKIKKDRERILREIKILKKLKHPN 58

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           IV++Y        L++V EY +   L  +L       +    R    ++ I+ AL Y+H+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFY--LRQILSALEYLHS 115

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                IVHRD+  +N+LLD +    ++DFG+A+ L P     T   GT  Y+APE+    
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGK 171

Query: 783 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-SLNLNIALDEMLDPRLPTPSR--NV 839
              +  D++S GV+  E++ GK P        F     L     ++  P+ P P    ++
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP--------FPGDDQLLELFKKIGKPKPPFPPPEWDI 223

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             +   ++      + ++PE R T ++  Q
Sbjct: 224 SPEAKDLIR---KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  149 bits (379), Expect = 5e-37
 Identities = 100/271 (36%), Positives = 141/271 (52%), Gaps = 6/271 (2%)

Query: 231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP--ILRNLTSLER 288
           I+  N S +  ++L   ++SG I      L  +  + L +NQ  GPIP  I    +SL  
Sbjct: 63  ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122

Query: 289 VRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNV 348
           + L  N  TG+I       PNL  +DLS N   GEI +D G    L  LD   N + G +
Sbjct: 123 LNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180

Query: 349 PPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEH 408
           P  + + + L  L L+SN +VG+IP ELG++     + L +N LSG++  ++G L  L H
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240

Query: 409 LDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSG 468
           LDL  N L+  IP SLGNL+  +L  L L +N L   IP  I  +Q L  L+LS NSLSG
Sbjct: 241 LDLVYNNLTGPIPSSLGNLK--NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298

Query: 469 LIPSCFEKMNGLLHIDISYNELRGSIPNSTT 499
            IP    ++  L  + +  N   G IP + T
Sbjct: 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALT 329

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  127 bits (321), Expect = 7e-33
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 40/280 (14%)

Query: 603 DFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            F+    IGKGG G VY      +G+ +A+K            +++ +NE++ L +  H 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE---SKEKKEKIINEIQILKKCKHP 57

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVD 715
           NIVK YG  L    L+IV E+    SL  +L +          + +       + K ++ 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELLK 109

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
            L Y+H++    I+HRDI + N+LL  + E  + DFG++  L  D+     + GT  ++A
Sbjct: 110 GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMA 165

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD---PRL 832
           PE+        K D++S G+ A+E+ +GK P   +  M         AL ++     P L
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------ALFKIATNGPPGL 217

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             P +          +    C+ +NPE RPT     QLLK
Sbjct: 218 RNPEKWS----DEFKDFLKKCLQKNPEKRPT---AEQLLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (318), Expect = 2e-32
 Identities = 76/280 (27%), Positives = 118/280 (42%), Gaps = 47/280 (16%)

Query: 610 IGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G+G  G VY  KL          +AVK        +    +EFL E + + ++ H N+V
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           K+ G C     L+IV EY +   L   L        L  +  ++    I   + Y+ +  
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN----------WTELAGTYGYV 774
               +HRD++++N L+       +SDFG+++ L  D             W          
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM--------- 170

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--R 831
           APE     K T K DV+SFGVL  E+   G+ P   +S         N  + E L    R
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---------NEEVLEYLKNGYR 221

Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           LP P  N   +L  ++     C  E+PE RPT  ++ ++L
Sbjct: 222 LPQPP-NCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  124 bits (315), Expect = 6e-32
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 48/282 (17%)

Query: 608 HCIGKGGQGSVY--MSKLASGEIIAVKKFHSPLPGEMTFQQEFL-NEVKALTEIWHRNIV 664
             +G+G  GSVY  + K  +GE++AVK     L G+   + E L  E++ L+ + H NIV
Sbjct: 6   ELLGRGSFGSVYLALDKD-TGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIV 62

Query: 665 KVYGFCLHV--RHLFIVYEYFKMCSLAVILS-----NDAAAKNLGWTRRMNMIKGIVDAL 717
           + YG         L I  EY    SL+ +L       +   +   +TR+      I++ L
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK--YTRQ------ILEGL 114

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVA 775
           +Y+H++    IVHRDI   N+L+D +    ++DFG AK L    +      + GT  ++A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL-----DEMLDP 830
           PE+    +     D++S G   +E+  GK P        +S L   +A           P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP--------WSELGNPMAALYKIGSSGEPP 223

Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            +P    ++ ++    +     C+  +P+ RPT     +LL+
Sbjct: 224 EIPE---HLSEEAKDFLR---KCLRRDPKKRPT---ADELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (311), Expect = 2e-31
 Identities = 75/283 (26%), Positives = 116/283 (40%), Gaps = 52/283 (18%)

Query: 610 IGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G+G  G VY   L          +AVK        +    +EFL E + + ++ H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           K+ G C     L IV EY     L   L      K L  +  ++    I   + Y+ +  
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN----------WTELAGTYGYV 774
               +HRD++++N L+       +SDFG+++ L  D             W          
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM--------- 171

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLD---- 829
           APE     K T K DV+SFGVL  E+   G+ P               ++  E+L+    
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP------------GMSNAEVLEYLKK 219

Query: 830 -PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             RLP P  N   +L  ++     C  E+PE RPT  ++ ++L
Sbjct: 220 GYRLPKPP-NCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (310), Expect = 3e-31
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 22/273 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +D +    +G+G  G VY  +   +G+I A+KK H  + G+  F+++ L E+K L     
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCES 58

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI--KGIVDALS 718
             +VK YG       + IV EY    SLA     D   K       +     + I+  L 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLA-----DLLKKVGKIPEPVLAYIARQILKGLD 113

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y+H      I+HRDI   N+L++ + E  ++DFGI+K L+          GT  Y++PE 
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER 171

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
                 +   D++S G+  LE   GK P       SF  L   I       P L  P+  
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSL--PAEE 227

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
              +    +    +C+ ++P+ RP+     +LL
Sbjct: 228 FSPEFRDFIS---ACLQKDPKKRPSAA---ELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  121 bits (306), Expect = 9e-31
 Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 48/281 (17%)

Query: 610 IGKGGQGSVYM-----SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G+G  G VY          +   +AVK        E   ++EFL E   + ++ H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLSHPNIV 64

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           ++ G C     L+IV EY     L   L      + L     + M   I   + Y+ +  
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEYLESKN 122

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV-----APELA 779
           F   VHRD++++N L+       +SDFG+++ +  D           G +     APE  
Sbjct: 123 F---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPESL 176

Query: 780 YTMKVTEKCDVYSFGVLALEVI-------KGKHPRDFISSMSFSSLNLNIALDEMLD--P 830
              K T K DV+SFGVL  E+         G    + +               E+L+   
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL---------------ELLEDGY 221

Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           RLP P  N  D+   + E+ + C   +PE RPT  ++ + L
Sbjct: 222 RLPRP-ENCPDE---LYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 3e-30
 Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 53/288 (18%)

Query: 610 IGKGGQGSVYM----SKLASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWHRNI 663
           +G+G  G VY      K      +AVK     L  + + ++  +FL E + + ++ H N+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKT----LKEDASEEERKDFLKEARVMKKLGHPNV 58

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSL------AVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
           V++ G C     L++V EY +   L      +  +        L     ++    I   +
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-----------WTE 766
            Y+ +      VHRD++++N L+  +    +SDFG+++ +  D              W  
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174

Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD 825
                   APE       T K DV+SFGVL  E+   G  P        +  L+    L+
Sbjct: 175 --------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------YPGLSNEEVLE 218

Query: 826 EMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            +    RLP P     D+L  ++    SC   +PE RPT  ++ + L+
Sbjct: 219 YLRKGYRLPKPE-YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 7e-27
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 26/266 (9%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V++ K      +A+K       G M+ + +F+ E K + ++ H N+V++YG 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIRE---GAMS-EDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FIV EY     L   L          W   ++M   + +A+ Y+ ++ F   +
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNGF---I 122

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L+  +N   VSDFG+A+++  D   +T   GT     +  PE+    + + 
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 787 KCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
           K DV+SFGVL  EV  +GK P +  S       N  +        RL  P          
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFS-------NSEVVESVSAGYRLYRP----KLAPTE 229

Query: 846 IVEVTISCVDENPESRPTMQKVCQLL 871
           +  +  SC  E PE RP  +K+   L
Sbjct: 230 VYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  108 bits (270), Expect = 5e-26
 Identities = 73/210 (34%), Positives = 110/210 (52%), Gaps = 19/210 (9%)

Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQE------FLNEVKALTEIWHRN 662
           IG G  GSVY+   A SGE++AVK+   P     +  ++         E+  L E+ H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           IV+  G  L   HL I  EY    S+A +L+N  A +    T   N ++ I+  L+Y+HN
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAP 776
                I+HRDI   N+L+D +    +SDFGI+K L+ +S +         L G+  ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           E+      T K D++S G L +E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (265), Expect = 5e-25
 Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 42/280 (15%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQE----FLNEVKALTEI 658
           + +   IG+G  G VY +   A+G+ +A+KK        M  +++     +NE+  + + 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKK--------MRLRKQNKELIINEILIMKDC 72

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKG 712
            H NIV  Y   L    L++V EY    SL  I++ +          RMN      + + 
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV--------RMNEPQIAYVCRE 124

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           ++  L Y+H+     ++HRDI S N+LL  +    ++DFG A  L  + S    + GT  
Sbjct: 125 VLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY 181

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           ++APE+        K D++S G++ +E+ +G+ P      +    L     +     P L
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY-----LREPPLRALFLITTKGIPPL 236

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             P +    +    +     C+ ++PE RP+ +   +LL+
Sbjct: 237 KNPEK-WSPEFKDFLN---KCLVKDPEKRPSAE---ELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 35/274 (12%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IGKG  G VY   L     +AVK   S LP ++  +++FL E + L +  H NIVK+ G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA---LSYMHNDCFP 726
           C+  + ++IV E     SL   L                +++  +DA   + Y+ +    
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNR-----LTVKKLLQMSLDAAAGMEYLESKN-- 113

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YGYVAPELAYTM 782
             +HRD++++N L+   N   +SDFG+++  + +   +T   G       + APE     
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 783 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNV 839
           + T + DV+S+G+L  E    G  P      MS      N    E ++   R+P P    
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTP---YPGMS------NQQTRERIESGYRMPAPQLCP 221

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
            +    I  + + C   +PE+RP+  ++   L+I
Sbjct: 222 EE----IYRLMLQCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 5e-24
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 38/273 (13%)

Query: 609 CIGKGGQGSVYMS-KLASGEIIAVKKF--HSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
            IG+G  G VY    L +G+ +A+K+          +   +  + E+  L  + H NIVK
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKHPNIVK 63

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
             G       L+I+ EY +  SL  I+           +     +  ++  L+Y+H    
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ-- 118

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             ++HRDI + N+L   +    ++DFG+A  L   S +   + GT  ++APE+      +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-----LNIALDEMLDPRLPTP-SRNV 839
              D++S G   +E++ G  P        +  LN       I  D+   P LP   S  +
Sbjct: 178 TASDIWSLGCTVIELLTGNPP--------YYDLNPMAALFRIVQDDH--PPLPEGISPEL 227

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            D L       + C  ++P  RPT +   QLLK
Sbjct: 228 KDFL-------MQCFQKDPNLRPTAK---QLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  101 bits (253), Expect = 7e-24
 Identities = 69/269 (25%), Positives = 132/269 (49%), Gaps = 32/269 (11%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V++ K  +   +A+K  +    G M+ +++F+ E K + ++ H  +V++YG 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE---GAMS-EEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR---MNMIKGIVDALSYMHNDCFP 726
           C   + L+IV E+ +   L   L      +  G   +   ++M + + + + Y+  + F 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLR-----QRQGKLSKDMLLSMCQDVCEGMEYLERNSF- 121

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
             +HRD++++N L+       VSDFG+ +++  D   +T  +G      +  PE+    K
Sbjct: 122 --IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVKWSPPEVFNFSK 177

Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK 842
            + K DV+SFGVL  EV  +GK P  F    ++  + +      +  P+L +        
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMP--FEKKSNYEVVEMISRGFRLYRPKLAS-------- 227

Query: 843 LISIVEVTISCVDENPESRPTMQKVCQLL 871
            +++ EV  SC  E PE RPT  ++ + +
Sbjct: 228 -MTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  101 bits (253), Expect = 1e-23
 Identities = 75/270 (27%), Positives = 122/270 (45%), Gaps = 17/270 (6%)

Query: 603 DFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            ++    IGKG  G VY + + + G++  +K+       E   +++ LNEVK L ++ H 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHP 59

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLA-VILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           NI+K Y        L IV EY     L+  I       K     + ++    +  AL Y+
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     I+HRDI  +N+ L       + DFGI+K L         + GT  Y++PEL  
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
                 K D++S G +  E+   KHP  F    +   L L I    +     P PS+   
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP--FEGE-NLLELALKI----LKGQYPPIPSQ-YS 228

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQL 870
            +L ++V    S + ++PE RP++ ++ Q 
Sbjct: 229 SELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (251), Expect = 2e-23
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 37/216 (17%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQ-------QEFLNEVKALTEIWHR 661
           IG G  G VY +  L +GE++AVK        E+  Q       +E  +E+K L  + H 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVK--------EIRIQDNDPKTIKEIADEMKVLELLKHP 59

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI----KGIVDAL 717
           N+VK YG  +H   ++I  EY    +L  +L +       G     ++I      +++ L
Sbjct: 60  NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-------GRILDEHVIRVYTLQLLEGL 112

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE----LAGTYGY 773
           +Y+H+     IVHRDI   N+ LD      + DFG A  LK +++   E    LAGT  Y
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169

Query: 774 VAPELAYTMKVTEK---CDVYSFGVLALEVIKGKHP 806
           +APE+    K        D++S G + LE+  GK P
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  102 bits (255), Expect = 2e-23
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 17/267 (6%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYG 668
           +G+G  G VY+++    +++A+K     L  +    + FL E++ L  +    NIVK+Y 
Sbjct: 8   LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      L++V EY    SL  +L        L  +  + ++  I+ AL Y+H+     I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122

Query: 729 VHRDISSKNVLLD-FENEAHVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELAYT 781
           +HRDI  +N+LLD       + DFG+AK L    S        +   GT GY+APE+   
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 782 M---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-NIALDEMLDPRLPTPSR 837
           +     +   D++S G+   E++ G  P +   + S +S  L  I          P    
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 838 NVHDKLISIVEVTISCVDENPESRPTM 864
           N      +  ++    + ++P++R + 
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 58/288 (20%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            +      IGKG  G V +     G+ +AVK     L  + T  Q FL E   +T + H 
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKC----LKDDSTAAQAFLAEASVMTTLRHP 60

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           N+V++ G  L    L+IV EY    SL   L S   A   L   +++     + + + Y+
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL--AQQLGFALDVCEGMEYL 118

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSS----NWTELAGTYGYV 774
               F   VHRD++++NVL+  +  A VSDFG+AK      DS      WT         
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVI---KGKHPRDFISSMSFSSLNLNIALDEMLDP- 830
           APE     K + K DV+SFG+L  E+    +  +PR              I L +++   
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IPLKDVVPHV 212

Query: 831 ----RLPTPS---RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
               R+  P      V+       +V   C + +P  RPT +++ + L
Sbjct: 213 EKGYRMEAPEGCPPEVY-------KVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 26/262 (9%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K + ++ H  +V++YG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R ++IV EY     L   L      K    ++ + M K + + ++Y+ +  F   +
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQF---I 122

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L+D +    VSDFG+++++  D   +T   G+     +  PE+    K + 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSS 180

Query: 787 KCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
           K DV++FGVL  EV   GK P +  +       N           RL  P    H     
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFN-------NSETVEKVSQGLRLYRP----HLASEK 229

Query: 846 IVEVTISCVDENPESRPTMQKV 867
           +  +  SC  E  E RPT Q++
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 65/272 (23%), Positives = 112/272 (41%), Gaps = 20/272 (7%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +D +    +G G  G V  +    +G+I+AVK     L      Q++ L E+  L +   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNS 58

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN---LGWTRRMNMIKGIVDAL 717
             IV  YG   +   + I  EY    SL  IL           LG      +   ++  L
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGL 113

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+H      I+HRD+   N+L++   +  + DFG++  L    +      GT  Y+APE
Sbjct: 114 TYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPE 169

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
                  + K D++S G+  +E+  G+ P    +        L   +     PRL  PS 
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--PSG 227

Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                    V +   C+ ++P  RP+ +++ +
Sbjct: 228 KFSPDFQDFVNL---CLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 66/269 (24%), Positives = 127/269 (47%), Gaps = 25/269 (9%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           R   +F  E  +G G  G V+     +   +A+K   S    ++  QQ+F  EV+AL  +
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRL 59

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H++++ ++  C     ++I+ E  +  SL   L      + L     ++M   + + ++
Sbjct: 60  RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMA 118

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD--SSNWTELAGTYGYVAP 776
           Y+        +HRD++++N+L+  +    V+DFG+A+ +K D   S+  ++   Y + AP
Sbjct: 119 YLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAP 173

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDE-MLDPRLPT 834
           E A     + K DV+SFG+L  E+   G+ P        +  +N +   D+     R+P 
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP--------YPGMNNHEVYDQITAGYRMPC 225

Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPT 863
           P++        I ++ + C    PE RP+
Sbjct: 226 PAKCPQ----EIYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKK----FHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           IG+G  G VY ++   +GEI+A+KK    F S         +  L E+K L E+ H NI+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-----GIPKTALREIKLLKELNHPNII 61

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           K+     H   L++V+E+     L  ++      + L  +   + +  ++  L++ H+  
Sbjct: 62  KLLDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APEL    K 
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 785 -TEKCDVYSFGVLALEVIKGK 804
            +   D++S G +  E++  +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 50/277 (18%)

Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWHRNIVK 665
            IGKG  G+V   +  + G+I+  K+      G MT +  Q+ ++EV  L E+ H NIV+
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 666 VYGFCLHVRH---LFIVYEYFKMCS---LAVILSNDAAAKNLGWTRRMN----------M 709
            Y   +  R    L+IV EY   C    LA ++            ++            +
Sbjct: 64  YYDR-IIDRSNQTLYIVMEY---CEGGDLAQLIQK---------CKKERKYIEEEFIWRI 110

Query: 710 IKGIVDALSYMHN--DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL 767
           +  ++ AL   HN  D    ++HRD+   N+ LD  N   + DFG+AK L  DSS     
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170

Query: 768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM 827
            GT  Y++PE    M   EK D++S G L  E+     P    ++ +   L   I   E 
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP---FTARNQLQLASKIK--EG 225

Query: 828 LDPRLPTP-SRNVHDKLISIVEVTISCVDENPESRPT 863
              R+P   S  ++ ++I       S ++ +P+ RP+
Sbjct: 226 KFRRIPYRYSSELN-EVIK------SMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 43/267 (16%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C     ++IV EY    SL   L +    K L   + ++M   I + ++Y+ +  +   +
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRNY---I 125

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN----------WTELAGTYGYVAPELA 779
           HRD++++N+L+       ++DFG+A+ ++ D             WT         APE A
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT---------APEAA 176

Query: 780 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPS 836
              + T K DV+SFG+L  E++  G+ P      M+      N  + E ++   R+P P 
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP---YPGMT------NREVLEQVERGYRMPRPP 227

Query: 837 RNVHDKLISIVEVTISCVDENPESRPT 863
            N  +    + ++ + C D++PE RPT
Sbjct: 228 -NCPE---ELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 41/280 (14%)

Query: 607 EHCIGKGGQGSVY--MSKLASGEII--AVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           E  IG G  G V     KL   + I  A+K   +    +   + +FL E   + +  H N
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ--RLDFLTEASIMGQFDHPN 66

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           I+++ G     R + I+ EY +  SL   L  ND         + + M++GI   + Y+ 
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLS 123

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG--YVAPE-L 778
              +   VHRD++++N+L++      VSDFG+++ L+   + +T   G     + APE +
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 779 AYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSMSFSSLNLNIALDEMLDPR 831
           AY  K T   DV+SFG++  EV+  G+ P      +D I ++                 R
Sbjct: 181 AYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-------------EDGYR 226

Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           LP P     D   ++ ++ + C  ++   RPT  ++   L
Sbjct: 227 LPPPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 90.2 bits (224), Expect = 6e-20
 Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 25/260 (9%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+     +   +AVK      PG M   ++FL E + + ++ H  ++++Y  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C     ++IV E  K  SL   L   A  + L   + ++M   +   ++Y+    +   +
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQNY---I 125

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD++++NVL+   N   V+DFG+A+ +K D     E A     + APE A   + + K 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 789 DVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLIS 845
           DV+SFG+L  E++  G+ P      M+      N  + + +D   R+P P      +L  
Sbjct: 186 DVWSFGILLTEIVTYGRMP---YPGMT------NAEVLQQVDQGYRMPCPP-GCPKELYD 235

Query: 846 IVEVTISCVDENPESRPTMQ 865
           I+   + C  E+P+ RPT +
Sbjct: 236 IM---LDCWKEDPDDRPTFE 252

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 31/268 (11%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWHRNIVKV 666
           +GKG  GSVY  K L+  +  A+K+      G M+ ++  + +NE++ L  + H NI+  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDL---GSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG-----WTRRMNMIKGIVDALSYMH 721
               L    L IV EY     L+  +S     + L      W   + +++G    L  +H
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALH 120

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
                 I+HRD+ S N+LL   +   + D GI+K LK + +  T++ GT  Y+APE+   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKG 175

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
              + K D++S G L  E+     P     + S   L   +          P P     D
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKV----QRGKYPPIPPIYSQD 228

Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQ 869
            L + +    S +   P+ RP   K+  
Sbjct: 229 -LQNFIR---SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 28/268 (10%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMS-PESFLEEAQIMKKLRHDKLVQLYA- 68

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  D   + L     ++M   +   ++Y+    +   +
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 124

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ S N+L+       ++DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 787 KCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTPSRNVHDKLI 844
           K DV+SFG+L  E++ KG+ P        +  +N    L+++    R+P P     D  I
Sbjct: 183 KSDVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP----QDCPI 230

Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
           S+ E+ + C  ++PE RPT + +   L+
Sbjct: 231 SLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 90.2 bits (223), Expect = 1e-19
 Identities = 73/273 (26%), Positives = 138/273 (50%), Gaps = 34/273 (12%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A++        +M  QQ+      +NE+  + E  + NI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 135

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 784 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL 843
              K D++S G++A+E+I+G+ P  +++     +L L IA +    P L  P     +KL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYL-IATNGT--PELQNP-----EKL 242

Query: 844 ISIVEVTIS-CVDENPESRPTMQKVC--QLLKI 873
            +I    ++ C+D + E R + +++   Q LKI
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 78/291 (26%), Positives = 120/291 (41%), Gaps = 49/291 (16%)

Query: 610 IGKGGQGSVYMSKL-----ASGEIIAVKKF-HSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V + +       +GE +AVK   HS   GE   + +F  E++ L  + H NI
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHENI 68

Query: 664 VKVYGFC--LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           VK  G C     R L ++ EY    SL   L       NL   R +     I   + Y+ 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLG 126

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV------- 774
           +      +HRD++++N+L++ E+   +SDFG+AK L  D          Y YV       
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--------YYYVKEPGESP 175

Query: 775 ----APELAYTMKVTEKCDVYSFGVLALEVI----KGKHPRDFISSMSFSSLNLNIALD- 825
               APE   T K +   DV+SFGV   E+       + P      M   +    I    
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 826 -EMLDP--RLPTPSRNVHDKLISIV-EVTISCVDENPESRPTMQKVCQLLK 872
            E+L    RLP P           V ++   C +  P+ RP+   +  ++ 
Sbjct: 236 LELLKEGERLPRP-----PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+ +K   +GE +A+KK       E     + L E+KAL    H  +VK+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR-MNMIKGIVDALSYMHNDCFPP 727
              H     +V EY     L+ +L ++         +  M M+   +  ++YMH +    
Sbjct: 67  VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRML---LKGVAYMHAN---G 119

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-WTELAGTYGYVAPELAY-TMKVT 785
           I+HRD+   N+L+  +    ++DFG+A+    +    ++    T  Y APEL Y   K  
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 786 EKCDVYSFGVLALEVIKG 803
              D+++ G +  E++ G
Sbjct: 180 PGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 27/272 (9%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLN---EVKALTEIWHRNIVKV 666
           +GKG  G+VY      G++IAVK+        +  ++E+     EV  L  + H NIV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
            G CL    + I  E+    S++ IL+         + +     K I+D ++Y+HN+C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE------LAGTYGYVAPELAY 780
            +VHRDI   NV+L       + DFG A+ L     + T       + GT  ++APE+  
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
                 K D++S G    E+  GK P   ++SM   +    I     L PRLP       
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLPDSFSA-- 236

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               + ++   SC+  +   RP+     QLL+
Sbjct: 237 ----AAIDFVTSCLTRDQHERPS---ALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.8 bits (220), Expect = 3e-19
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 21/203 (10%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A+K        +M  QQ+      +NE+  + E  H NI
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 134

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+     
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 784 VTEKCDVYSFGVLALEVIKGKHP 806
              K D++S G++A+E+++G+ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.9 bits (215), Expect = 6e-19
 Identities = 69/262 (26%), Positives = 123/262 (46%), Gaps = 34/262 (12%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G V++        +A+K       G M+ +++F+ E + + ++ H  +V++YG 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           C     + +V+E+ +   L+  L       + + L     + M   + + ++Y+ +    
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSNV- 121

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
             +HRD++++N L+       VSDFG+ +F+  D   +T   GT     + +PE+    K
Sbjct: 122 --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFIS-SMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            + K DV+SFGVL  EV  +GK P +  S S    ++N    L     PRL +       
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---YKPRLASQ------ 228

Query: 842 KLISIVEVTISCVDENPESRPT 863
              S+ E+   C  E PE RP+
Sbjct: 229 ---SVYELMQHCWKERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.8 bits (215), Expect = 7e-19
 Identities = 68/273 (24%), Positives = 126/273 (46%), Gaps = 25/273 (9%)

Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIWH 660
           DF+  + IGKG  G V+   + A   + A+K+   S +      ++E ++E + L ++  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE--REEAIDEARVLAKLDS 58

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAA---AKNLGWTRRMNMIKGIVDAL 717
             I++ Y   L    L IV EY +   L  +L         ++  W   + ++ G    L
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +++H+     I+HRDI S N+ LD  +   + D G+AK L  +++    + GT  Y++PE
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
           L       EK DV++ GV+  E   GKHP        F + N    + +++    P  S+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP--------FDANNQGALILKIIRGVFPPVSQ 223

Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQL 870
               +L  +++    C+ ++   RP   ++ + 
Sbjct: 224 MYSQQLAQLID---QCLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 35/268 (13%)

Query: 620 MSKLASGEIIAVKKFHSPLPGEMTFQ-------------QEFLNEVKALTEIWHRNIVKV 666
           + KL  GEII   +F + L GE T Q             Q FL E   +T++ H+N+V++
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
            G  LH   L+IV E     +L   L +   A  ++    + ++   + + + Y+ +   
Sbjct: 65  LGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK-- 119

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             +VHRD++++N+L+  +  A VSDFG+A+ +     + ++L     + APE     K +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFS 175

Query: 786 EKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
            K DV+S+GVL  EV   G+ P      MS   +   +     ++P    P+        
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAP---YPKMSLKEVKECVEKGYRMEPPEGCPA-------- 224

Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
            +  +  SC +  P+ RP+  K+ + L+
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 63/234 (26%), Positives = 118/234 (50%), Gaps = 26/234 (11%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A+K        +M  QQ+      +NE+  + E  + NI
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALDFLHSN 134

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+     
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 784 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
              K D++S G++A+E+++G+ P  +++     +L L IA +    P L  P R
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP--YLNENPLRALYL-IATNGT--PELQNPER 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 29/278 (10%)

Query: 607 EHCIGKGGQGSVY--MSKLASGEIIAVKK--FHSPLPGEMTFQQE-----FLNEVKALTE 657
           EH +G G  G VY    K     ++A+K+   H+P  G+   +++      ++EV  + E
Sbjct: 6   EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 658 -IWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLA-VILSNDAAAKNLGWTRRMNMIKGIVD 715
            + H NIV+ Y   L    L+IV +  +   L     S     +     R  N+   +V 
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           AL Y+H +    IVHRD++  N++L  +++  ++DFG+AK  K   S  T + GT  Y  
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSC 181

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
           PE+       EK DV++FG +  ++   + P  F S+ +  SL   I ++ + +P     
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYST-NMLSLATKI-VEAVYEP----- 232

Query: 836 SRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
              + + + S  + +V  SC+  + E+RP + +V  ++
Sbjct: 233 ---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 85.9 bits (212), Expect = 3e-18
 Identities = 53/198 (26%), Positives = 104/198 (52%), Gaps = 11/198 (5%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G+V+    +A+G+ +A+K+ +     +   ++  +NE+  + E+ + NIV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    LF+V EY    SL  +++     +     +   + +  + AL ++H +    +
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDE----AQIAAVCRECLQALEFLHAN---QV 136

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI S NVLL  +    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 789 DVYSFGVLALEVIKGKHP 806
           D++S G++A+E+++G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 24/271 (8%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G    VY +  L + E +A+K+    L    T   E   EV+A+++  H N+VK Y 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             +    L++V  Y    SL  I+ +      L       ++K ++  L Y+H++     
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW----TELAGTYGYVAPELAYTMK- 783
           +HRDI + N+LL  +    ++DFG++  L               GT  ++APE+   +  
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 784 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL 843
              K D++SFG+ A+E+  G  P      M    L L         P L T       K 
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-----PPSLET---GADYKK 235

Query: 844 ISIV--EVTISCVDENPESRPTMQKVCQLLK 872
            S    ++   C+ ++P  RPT ++   LLK
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEE---LLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 71/276 (25%), Positives = 113/276 (40%), Gaps = 38/276 (13%)

Query: 610 IGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEM-TFQQEFLNEVKALTEIWHRNIV 664
           +G G  GSV    Y+ K      +AVK         +   ++EFL E   + ++ H  IV
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           ++ G C     L +V E   +  L   L                +   +   ++Y+ +  
Sbjct: 60  RLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESKH 115

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELA 779
           F   VHRD++++NVLL   ++A +SDFG+++ L   S  +   A T G     + APE  
Sbjct: 116 F---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECI 170

Query: 780 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPS 836
              K + K DV+S+GV   E    G  P   +             +  ML+   RLP P 
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---------GAEVIAMLESGERLPRPE 221

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                    I  + +SC    PE RPT  ++    +
Sbjct: 222 ECP----QEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 34/262 (12%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH---RNIVK 665
           IG+G  G+VY  K + +G ++A+K  +   P +     +   EV  L+++      NI K
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV--SDIQREVALLSQLRQSQPPNITK 66

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI-KGIVDALSYMHNDC 724
            YG  L    L+I+ EY +  S+  ++     A+     + +++I + ++ AL Y+H   
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE-----KYISVIIREVLVALKYIHKV- 120

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 779
              ++HRDI + N+L+       + DFG+A  L  +SS  +   GT  ++APE+      
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
           Y  K     D++S G+   E+  G  P        +S ++   A+  +   + P    N 
Sbjct: 179 YDTKA----DIWSLGITIYEMATGNPP--------YSDVDAFRAMMLIPKSKPPRLEDNG 226

Query: 840 HDKLISIVEVTISCVDENPESR 861
           + KL+   E   +C+DE P+ R
Sbjct: 227 YSKLLR--EFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.5 bits (209), Expect = 6e-18
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 27/273 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVK--KFHSPLPGEM-TFQQEFLNEVKALTEIWHRNIVK 665
           +G G   S Y ++ + +G ++AVK   +      E     +    E++ +  + H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           + G      H  +  E+    S++ +LS   A K       +N  + ++  LSY+H +  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122

Query: 726 PPIVHRDISSKNVLLDFENE-AHVSDFGIAKFLKPDSSNWTE----LAGTYGYVAPELAY 780
             I+HRD+   N+L+D   +   ++DFG A  L    +   E    L GT  ++APE+  
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SRNV 839
             +    CDV+S G + +E+   K P +     +  +L   IA      P +P   S  +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-SATTAPSIPEHLSPGL 240

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            D       VT+ C++  PE RP      +LLK
Sbjct: 241 RD-------VTLRCLELQPEDRP---PSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 7e-18
 Identities = 74/275 (26%), Positives = 135/275 (49%), Gaps = 32/275 (11%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWH 660
           F D   IG G  G+VY ++ + + E++A+KK      G+ + +  Q+ + EV+ L ++ H
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMC--SLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            N ++  G  L     ++V EY   C  S + IL  +   K L       +  G +  L+
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEY---CLGSASDIL--EVHKKPLQEVEIAAICHGALQGLA 129

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y+H+      +HRDI + N+LL       ++DFG A  + P +S      GT  ++APE+
Sbjct: 130 YLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEV 182

Query: 779 AYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
              M   +   K DV+S G+  +E+ + K P   + +M+  S   +IA ++   P L + 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND--SPTLSSN 237

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL 870
             +  D   + V+   SC+ + P+ RP+ +++ + 
Sbjct: 238 DWS--DYFRNFVD---SCLQKIPQDRPSSEELLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV-Y 667
           IGKG  G V  + K  + ++ A+K  +     E    +  LNE + L E+ H  +V + Y
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSYMH 721
            F     ++++V +         +L  D    +L    + +       I  IV AL Y+H
Sbjct: 68  SFQ-DEENMYLVVDL--------LLGGDLRY-HLSQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           +     I+HRDI   N+LLD +   H++DF IA  + PD+   T  +GT GY+APE+   
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPGYMAPEVLCR 173

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS 814
              +   D +S GV A E ++GK P    S   
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 31/276 (11%)

Query: 602 NDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
             FD    +G+G  GSVY +    +G+++A+K    P+  ++   QE + E+  L +   
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDS 57

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND---AAAKNLGWTRRMNMIKGIVDAL 717
             IVK YG       L+IV EY   C    +  +D      K L       ++   +  L
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEY---CGAGSV--SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H++     +HRDI + N+LL+ E +A ++DFG++  L    +    + GT  ++APE
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS- 836
           +   +    K D++S G+ A+E+ +GK P   I  M         A+   + P  P P+ 
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AI--FMIPNKPPPTL 219

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            +         +    C+ ++PE RP+     QLL+
Sbjct: 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAI---QLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 29/214 (13%)

Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQ--EFL-NEVKALTEI 658
             D+   IG+G  G V ++   ++G  +AVKK       ++  QQ  E L NEV  + + 
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDY 73

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKG 712
            H NIV++Y   L    L++V E+ +  +L  I+++           RMN      +   
Sbjct: 74  QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH----------TRMNEEQIATVCLA 123

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           ++ ALS++H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  
Sbjct: 124 VLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 180

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           ++APE+   +    + D++S G++ +E++ G+ P
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 37/279 (13%)

Query: 602 NDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKF---HSPLPGEMTFQQE--FLNEVKAL 655
             F    CIGKG  G VY +    + +++A+K      +    E   QQE  FL++ ++ 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSP 59

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
                  I K YG  L    L+I+ EY    S   +L        L  T    +++ ++ 
Sbjct: 60  ------YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLL 109

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
            L Y+H +     +HRDI + N+LL  E +  ++DFG++  L    S      GT  ++A
Sbjct: 110 GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMA 166

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
           PE+       EK D++S G+ A+E+ KG+ P   +  M          L   L P+   P
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VL--FLIPKNNPP 216

Query: 836 S--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           S   N   K     +    C++++P+ RP+ +   +LLK
Sbjct: 217 SLEGNKFSKPFK--DFVSLCLNKDPKERPSAK---ELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 30/275 (10%)

Query: 607 EHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWHR 661
           +  IG G  G V+   L         +A+K      PG    Q Q+FL+E   + +  H 
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK---PGYTEKQRQDFLSEASIMGQFSHH 66

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           NI+++ G     +   I+ EY +  +L   L  +D    +    + + M++GI   + Y+
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL 123

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGTYG--YVAPE 777
            +  +   VHRD++++N+L++   E  VSDFG+++ L+ D    +T   G     + APE
Sbjct: 124 SDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                K T   DV+SFG++  EV+  G+ P         S+  +  A+++    RLP P 
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP-----YWDMSNHEVMKAINDGF--RLPAPM 233

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
               D   ++ ++ + C  ++   RP    +  LL
Sbjct: 234 ----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 20/222 (9%)

Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
            +E L+E   +  + H ++V++ G CL  +   I  +   +  L   + N     N+G  
Sbjct: 53  NKEILDEAYVMASVDHPHVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKD--NIGSQ 109

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
             +N    I   +SY+       +VHRD++++NVL+       ++DFG+AK L  D   +
Sbjct: 110 YLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY 166

Query: 765 TELAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLN 821
               G     ++A E       T K DV+S+GV   E++  G  P + I ++    L   
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226

Query: 822 IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
                    RLP P        I +  V + C   + ESRPT
Sbjct: 227 -------GERLPQPPICT----IDVYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 42/276 (15%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+  +L A    +AVK     LP ++  + +FL E + L +  H NIV++ G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
            C   + ++IV E  +       L  +     L     + M++     + Y+ +      
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----------YVAPE 777
           +HRD++++N L+  +N   +SDFG+++          E  G Y            + APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---------EEEDGVYASTGGMKQIPVKWTAPE 166

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTP 835
                + + + DV+SFG+L  E          + ++ +++L+ N    E ++   RLP P
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFS-------LGAVPYANLS-NQQTREAIEQGVRLPCP 218

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                D +  ++E    C + +P  RP+   V Q L
Sbjct: 219 E-LCPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 70/264 (26%), Positives = 119/264 (45%), Gaps = 21/264 (7%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M    +   +AVK      PG M+ Q  FL E   +  + H  +V++Y  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA-FLEEANLMKTLQHDKLVRLYAV 69

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY    SL   L +D   K +   + ++    I + ++Y+    +   +
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERKNY---I 125

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + NVL+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 789 DVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIV 847
           DV+SFG+L  E++  GK P   +S       N ++        R+P    N  D+L  I+
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMS-------NSDVMSALQRGYRMPRM-ENCPDELYDIM 237

Query: 848 EVTISCVDENPESRPTMQKVCQLL 871
           +   +C  E  E RPT   +  +L
Sbjct: 238 K---TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 38/274 (13%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWHRNIVKV 666
           +G G  GSVY    L  G+  AVK+      G+   +  ++   E+  L+++ H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN---LGWTRRMNMIKGIVDALSYMHND 723
            G      +L+I  E     SLA +L    +        +TR+      I+  L Y+H+ 
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHDR 121

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 778
                VHRDI   N+L+D      ++DFG+AK +  + S      G+  ++APE+     
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
            Y +      D++S G   LE+  GK P    S +   +    I   + L P     S  
Sbjct: 178 GYGLAA----DIWSLGCTVLEMATGKPP---WSQLEGVAAVFKIGRSKELPPIPDHLSDE 230

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             D +       + C+  +P  RPT     +LL+
Sbjct: 231 AKDFI-------LKCLQRDPSLRPT---AAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 607 EHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +H +G G  G VY          +AVK     L  +    +EFL E   + EI H N+V+
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           + G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+    F
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE-LAYT 781
              +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE LAY 
Sbjct: 126 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN 180

Query: 782 MKVTEKCDVYSFGVLALEV 800
            K + K DV++FGVL  E+
Sbjct: 181 -KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 74/278 (26%), Positives = 133/278 (47%), Gaps = 34/278 (12%)

Query: 607 EHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWH 660
           E  IG G  G V   +L      EI +A+K     L    T +Q  +FL+E   + +  H
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKT----LKSGYTEKQRRDFLSEASIMGQFDH 64

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-NDAAAKNLGWTRRMNMIKGIVDALSY 719
            NI+ + G     R + I+ E+ +  +L   L  ND         + + M++GI   + Y
Sbjct: 65  PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKY 121

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YV 774
           +    +   VHRD++++N+L++      VSDFG+++FL+ D+S+ T  +   G     + 
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           APE     K T   DV+S+G++  EV+  G+ P         S+ ++  A+++  D RLP
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQDVINAIEQ--DYRLP 231

Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            P     D   ++ ++ + C  ++  +RP   ++   L
Sbjct: 232 PPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 82.8 bits (204), Expect = 4e-17
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 26/264 (9%)

Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V +++   SG  +AVK        ++  QQ      NEV  + +  H+N+V+
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           +Y   L    L+++ E+ +  +L  I+S       L   +   + + ++ AL Y+H+   
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ-- 136

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             ++HRDI S ++LL  +    +SDFG    +  D      L GT  ++APE+       
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
            + D++S G++ +E++ G+ P  + S           A+  + D   P   +N H     
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP--YFSDSPVQ------AMKRLRDSPPPK-LKNAHKISPV 246

Query: 846 IVEVTISCVDENPESRPTMQKVCQ 869
           + +     +   P+ R T Q++  
Sbjct: 247 LRDFLERMLTREPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 20/210 (9%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N ++    +G+G  G V   +  A+GEI+A+KKF      E   ++  L EVK L ++ H
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV-KKTALREVKVLRQLRH 59

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIV +         L++V+EY +   L ++   +A+   L      + I  ++ A++Y 
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 721 H-NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPEL 778
           H ++    I+HRDI  +N+L+       + DFG A+ L+   +S  T+   T  Y APEL
Sbjct: 117 HSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Query: 779 -----AYTMKVTEKCDVYSFGVLALEVIKG 803
                 Y   V    DV++ G +  E++ G
Sbjct: 173 LVGDTNYGKPV----DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 42/275 (15%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIW------HR 661
           IGKG  G VY++  + +GE++AVK+   P            + VKAL +EI       H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDAL 717
           NIV+  GF     +L I  EY    S+   L      +         +++     +++ L
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEGL 121

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP--DSSNWTELAGTYGYVA 775
           +Y+H+     I+HRD+ + N+L+D +    +SDFGI+K      D+     + G+  ++A
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 776 PEL--AYTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSMSFSSLNLNIA--LDEML 828
           PE+  +Y+   + K D++S G + LE+  G+ P    + I++M F   N   A  +   +
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-FKLGNKRSAPPIPPDV 237

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
              L   + +  +          +C   NP++RPT
Sbjct: 238 SMNLSPVALDFLN----------ACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.0 bits (202), Expect = 7e-17
 Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 30/267 (11%)

Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWH 660
           F   H IG G  G+VY +  + + E++AVKK      G+ T +  Q+ + EVK L ++ H
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM--SYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N ++  G  L     ++V EY  + S + +L  +   K L       +  G +  L+Y+
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRDI + N+LL    +  ++DFG A    P +S      GT  ++APE+  
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVIL 190

Query: 781 TMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
            M   +   K DV+S G+  +E+ + K P   +++MS        AL  +     PT   
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNDSPTLQS 242

Query: 838 NV-HDKLISIVEVTISCVDENPESRPT 863
           N   D     V+    C+ + P+ RP 
Sbjct: 243 NEWTDSFRGFVDY---CLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.7 bits (201), Expect = 1e-16
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 26/269 (9%)

Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   IG G  G+VY ++   + E++A+KK            Q+ + EVK L  I H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
            ++  G  L     ++V EY  + S + +L  +   K L       +  G +  L+Y+H+
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                ++HRDI + N+LL    +  ++DFG A    P +S      GT  ++APE+   M
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAM 196

Query: 783 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT-PSRN 838
              +   K DV+S G+  +E+ + K P   +++MS        AL  +     PT  S  
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTLQSNE 248

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKV 867
             D   + V+   SC+ + P+ RPT +++
Sbjct: 249 WSDYFRNFVD---SCLQKIPQDRPTSEEL 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 29/219 (13%)

Query: 610 IGKGGQGSVYMSKLASG------EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++ +          E++AVK        +   +++F  E + LT   H NI
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA--RKDFEREAELLTNFQHENI 70

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVIL-----------SNDAAAKNLGWTRRMNMIKG 712
           VK YG C       +V+EY +   L   L           S D+    L  ++ + +   
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT-- 770
           I   + Y+ +  F   VHRD++++N L+ ++    + DFG+++ +   ++++  + G   
Sbjct: 131 IASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHTM 185

Query: 771 --YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
               ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.9 bits (199), Expect = 1e-16
 Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 24/264 (9%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G V+      + +++A+K     L       ++   E+  L++     + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L     A      +   M+K I+  L Y+H++     
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KK 122

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL  + +  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182

Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           D++S G+ A+E+ KG+ P   +  M              L P+   P+    +      E
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVL----------FLIPKNNPPTL-TGEFSKPFKE 231

Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
              +C++++P  RPT +   +LLK
Sbjct: 232 FIDACLNKDPSFRPTAK---ELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ + +SG+++AVKK       ++  QQ      NEV  + +  H N+V+
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSY 719
           +Y   L    L++V E+ +  +L  I+++           RMN      +   ++ ALS 
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLKALSV 131

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APEL 
Sbjct: 132 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             +    + D++S G++ +E++ G+ P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 42/294 (14%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-W 659
           +DF     IG+G   +V ++K   + +  A+K        +    +    E + LT +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 660 HRNIVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
           H  I+K+Y +       L+ V EY     L   +     + +   TR       I+ AL 
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTR--FYAAEILLALE 116

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---------- 768
           Y+H+     I+HRD+  +N+LLD +    ++DFG AK L P+SS  +             
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 769 ----------GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL 818
                     GT  YV+PEL       +  D+++ G +  +++ GK P  F  S  + + 
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP--FRGSNEYLTF 231

Query: 819 NLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              + L+    P  P  ++++ +KL+ +          +P+ R  + +    LK
Sbjct: 232 QKILKLEYSFPPNFPPDAKDLIEKLLVL----------DPQDRLGVNEGYDELK 275

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 78/285 (27%), Positives = 121/285 (42%), Gaps = 38/285 (13%)

Query: 604 FDDEHCI-----GKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           F++ H       GKG  GSV + +       +GE++AVKK            ++F  E++
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFEREIE 57

Query: 654 ALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
            L  + H NIVK  G C     R+L +V EY    SL   L        L   + +    
Sbjct: 58  ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYAS 115

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL---- 767
            I   + Y+ +  +   VHRD++++N+L++ EN   + DFG+ K L  D   +       
Sbjct: 116 QICKGMEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172

Query: 768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFISSMSFSSLNLNI 822
           +  + Y APE     K +   DV+SFGV+  E+     K   P  +F+  M        I
Sbjct: 173 SPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231

Query: 823 A--LDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
              L E+L    RLP P          I  +   C + +P  RP+
Sbjct: 232 VYHLIELLKNNGRLPAPP----GCPAEIYAIMKECWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 81.9 bits (202), Expect = 2e-16
 Identities = 88/245 (35%), Positives = 120/245 (48%), Gaps = 12/245 (4%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLT-NLATLYIHTNSLSGSIPGE 64
           N +   S  SEL  L +L+ L+L NN ++  IP  +G L  NL  L +  N +  S+P  
Sbjct: 101 NLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL 124
           + N     +L+LS N LS  +P  L NLSNL  L L  N +S  +P E+  L +L  L L
Sbjct: 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216

Query: 125 NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS 184
           +NN +   +  SL NL NL+ L + +N L       IGNL +L  L LS N    S   S
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNN--QISSISS 272

Query: 185 LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNL 244
           LG+L+NL  L L  NSLS ++P     L  L  L    N L     + +   S L   N+
Sbjct: 273 LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL---NLLLTLKALELKLNSILLNNNI 329

Query: 245 FENSL 249
             N  
Sbjct: 330 LSNGE 334

Length = 394

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 36/265 (13%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 68

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 124

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLDP-----RLPTPSRNVH 840
           K DV+SFG+L  E+  KG+ P   + +             E+LD      R+P P     
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNR------------EVLDQVERGYRMPCPPECPE 230

Query: 841 DKLISIVEVTISCVDENPESRPTMQ 865
               S+ ++   C  + PE RPT +
Sbjct: 231 ----SLHDLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 14/195 (7%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
              IGKG  G V +     G  +AVK   +         Q FL E   +T++ H N+V++
Sbjct: 11  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQL 64

Query: 667 YGFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
            G  +  +  L+IV EY    SL   L +   +  LG    +     + +A+ Y+  + F
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNF 123

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
              VHRD++++NVL+  +N A VSDFG+    K  SS          + APE     K +
Sbjct: 124 ---VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS 177

Query: 786 EKCDVYSFGVLALEV 800
            K DV+SFG+L  E+
Sbjct: 178 TKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 65/262 (24%), Positives = 118/262 (45%), Gaps = 28/262 (10%)

Query: 625 SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEY 682
           +GE++AVK        + T    +  E+  L  ++H NIVK  G C     + L ++ EY
Sbjct: 32  TGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89

Query: 683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
             + SL   L        L   + +   + I + ++Y+H+  +   +HRD++++NVLLD 
Sbjct: 90  VPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLLDN 142

Query: 743 ENEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLAL 798
           +    + DFG+AK + P+   +  +         + A E     K +   DV+SFGV   
Sbjct: 143 DRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201

Query: 799 EVI-----KGKHPRDFISSMSFSSLNLN-IALDEMLD--PRLPTPSRNVHDKLISIVEVT 850
           E++     K   P+ F   +      +  + L E+L+   RLP P     +    +  + 
Sbjct: 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK----NCPQEVYILM 257

Query: 851 ISCVDENPESRPTMQKVCQLLK 872
            +C +   + RPT + +  +LK
Sbjct: 258 KNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 30/269 (11%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M   + FL E + + ++ H  +V +Y  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMM-PEAFLQEAQIMKKLRHDKLVPLYA- 68

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV E+    SL   L  +   K L   + ++M   I D ++Y+    +   +
Sbjct: 69  VVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---I 124

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       ++DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 787 KCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKL 843
           K DV+SFG+L  E++ KG+ P   +         +N  + E ++   R+P P        
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGM---------VNREVLEQVERGYRMPCPQGCPE--- 230

Query: 844 ISIVEVTISCVDENPESRPTMQKVCQLLK 872
            S+ E+   C  ++P+ RPT + +   L+
Sbjct: 231 -SLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.7 bits (196), Expect = 4e-16
 Identities = 72/266 (27%), Positives = 130/266 (48%), Gaps = 28/266 (10%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWH 660
           F D   IG G  G+VY ++ + + E++A+KK      G+ + +  Q+ + EV+ L ++ H
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N ++  G  L     ++V EY  + S + +L  +   K L       +  G +  L+Y+
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+ + N+LL       + DFG A  + P +       GT  ++APE+  
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVIL 184

Query: 781 TMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
            M   +   K DV+S G+  +E+ + K P   + +M+  S   +IA +E   P L   S 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPAL--QSG 237

Query: 838 NVHDKLISIVEVTISCVDENPESRPT 863
           +  +   + V+   SC+ + P+ RPT
Sbjct: 238 HWSEYFRNFVD---SCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 81.8 bits (202), Expect = 6e-16
 Identities = 39/82 (47%), Positives = 50/82 (60%)

Query: 57  LSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNL 116
           L G IP +I   R    + LS N + G+IPPSLG++++L  L L  NS + SIP  LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 117 RSLSNLQLNNNILSGSIPHSLG 138
            SL  L LN N LSG +P +LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 25/224 (11%)

Query: 649 LNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAA----AKNLGWT 704
           LNE+  L+ + H NI+  Y   +    L I  EY    +L   +          + + W 
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW- 105

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
                +  IV A+SY+H      I+HRDI + N+ L       + DFGI+K L  + S  
Sbjct: 106 ----YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-LNIA 823
             + GT  Y++PEL   +K   K D+++ G +  E++  K         +F + N LN+ 
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR--------TFDATNPLNLV 210

Query: 824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           +  +     P  S     +LIS+V    S + ++PE RPT  +V
Sbjct: 211 VKIVQGNYTPVVSV-YSSELISLVH---SLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 25/280 (8%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKK---FHSPLPGEMT---FQQEFLNEVK 653
             +F  E  IGKG    VY +  L  G ++A+KK   F      EM     +Q+ L E+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF------EMMDAKARQDCLKEID 54

Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM-NMIKG 712
            L ++ H N++K     +    L IV E      L+ ++ +    K L   R +      
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           +  AL +MH+     I+HRDI   NV +       + D G+ +F    ++    L GT  
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           Y++PE  +      K D++S G L  E+   + P  +   M+  SL   I   +      
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEKCDY----P 226

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           P P+ +  ++L  +V     C++ +PE RP +  V Q+ K
Sbjct: 227 PLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 29/209 (13%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKG  G V +  K  +G++ A+K        +    +  L E   L+ I H  IVK++ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 669 FCLHV-RHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +       L++V EY      F   S     S +         R       IV AL Y+H
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-------RARFY--AAEIVLALEYLH 110

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--- 778
           +     I++RD+  +N+LLD +    ++DFG+AK L  + S      GT  Y+APE+   
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167

Query: 779 -AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             Y   V    D +S GVL  E++ GK P
Sbjct: 168 KGYGKAV----DWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.2 bits (192), Expect = 1e-15
 Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 17/201 (8%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V + ++  +G+ +AVKK       ++  QQ      NEV  + +  H N+V 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           +Y   L    L++V E+ +  +L  I+++    +    T  +++++    ALSY+HN   
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQ-- 137

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APE+   +   
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 786 EKCDVYSFGVLALEVIKGKHP 806
            + D++S G++ +E+I G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 31/264 (11%)

Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           IGKG  G V+        K+ + +II +++    +       ++   E+  L++     +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-------EDIQQEITVLSQCDSPYV 64

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
            K YG  L    L+I+ EY    S   +L        L  T+   +++ I+  L Y+H++
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE 120

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
                +HRDI + NVLL    E  ++DFG+A  L           GT  ++APE+     
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 784 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL 843
              K D++S G+ A+E+ KG+ P   +  M        + L    +P  PT   N    L
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIPKNNP--PTLEGNYSKPL 229

Query: 844 ISIVEVTISCVDENPESRPTMQKV 867
              VE   +C+++ P  RPT +++
Sbjct: 230 KEFVE---ACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 57/290 (19%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEF---LNEVKALTEI 658
           D++    IG G  G VY ++ +A+GE++A+K        ++    +F     E+  L E 
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI------KLEPGDDFEIIQQEISMLKEC 57

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVI-------LSNDAAAKNLGWTRRMNMIK 711
            H NIV  +G  L    L+IV EY    SL  I       LS    A    +  R   +K
Sbjct: 58  RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA----YVCR-ETLK 112

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           G    L+Y+H       +HRDI   N+LL  + +  ++DFG++  L    +      GT 
Sbjct: 113 G----LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP 165

Query: 772 GYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGK------HPRD---FISSMSFSSLN 819
            ++APE+A          KCD+++ G+ A+E+ + +      HP      IS  +F    
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-- 223

Query: 820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                     P+L    +         ++    C+ ++P+ RPT  K+ Q
Sbjct: 224 ----------PKLKDKEK-WSPVFHDFIKK---CLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 22/211 (10%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D +    +G G  G V++ +   S    A+K    P    +  +Q   NE + L E+ H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG------IVD 715
            I++++      R L+++ EY     L   L N         + R +   G      IV 
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASEIVC 112

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           AL Y+H+     IV+RD+  +N+LLD E    ++DFG AK L+     WT L GT  Y+A
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLA 166

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           PE+  +    +  D ++ G+L  E++ G  P
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 25/206 (12%)

Query: 609 CIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            +G+G  G VY      +GEI+A+KK       E       L E+  L E+ H NIVK+ 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-GIPSTALREISLLKELKHPNIVKLL 64

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV----DALSYMHND 723
                 R L++V+EY  M  L   L        L      N+IK I+      L+Y H+ 
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDK--RPGPL----SPNLIKSIMYQLLRGLAYCHSH 117

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 778
               I+HRD+  +N+L++ +    ++DFG+A+        +T    T  Y APE+     
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGK 804
            Y+  V    D++S G +  E+I GK
Sbjct: 175 HYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 56/226 (24%), Positives = 109/226 (48%), Gaps = 25/226 (11%)

Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           ++F+ E+  L+E  H NIV +Y    +   L+I+ E+    +L  I+      + L   +
Sbjct: 47  EDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQ 104

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
              + + +++AL+++H+     ++HRD+ + N+LL  + +  ++DFG++   K       
Sbjct: 105 IRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161

Query: 766 ELAGTYGYVAPELAY--TMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL 820
              GT  ++APE+    T K      K D++S G+  +E+ + + P      ++   + L
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH---HELNPMRVLL 218

Query: 821 NIALDEMLDPRLPTP---SRNVHDKLISIVEVTISCVDENPESRPT 863
            I   E   P L  P   S + +D L        SC+ ++P+ RPT
Sbjct: 219 KILKSE--PPTLDQPSKWSSSFNDFL-------KSCLVKDPDDRPT 255

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 31/265 (11%)

Query: 610 IGKGGQGSVYM--SKLASGEII--AVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +G G  G V       + G++I  AVK   S    ++    +FL E   +  + H N+++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           +YG  L    L +V E   + SL   L  DA    L  +   +    I + + Y+ +  F
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESKRF 118

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTM 782
              +HRD++++N+LL  +++  + DFG+ + L  +  ++     L   + + APE   T 
Sbjct: 119 ---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 783 KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN-LNI--ALDEMLDPRLPTPSRN 838
             +   DV+ FGV   E+   G+ P        ++ L+   I   +D+  + RL  P   
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP--------WAGLSGSQILKKIDKEGE-RLERPEAC 226

Query: 839 VHDKLISIVEVTISCVDENPESRPT 863
             D    I  V + C   NP  RPT
Sbjct: 227 PQD----IYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG G V + K+ S     A+K        E   Q+   +E + L E  H  IVK+Y 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILS-----NDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                ++++++ EY     L  IL      ++  A+          I  +V A  Y+HN 
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY--------IACVVLAFEYLHNR 112

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----A 779
               I++RD+  +N+LLD      + DFG AK LK     WT   GT  YVAPE+     
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKG 168

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y   V    D +S G+L  E++ G+ P
Sbjct: 169 YDFSV----DYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           I KG  G V+++ K ++G+I A+K  K    +  +    Q  L E   L++     +VK+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQ-VLTERDILSQAQSPYVVKL 58

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSN-----DAAAKNLGWTRRMNMIKGIVDALSYMH 721
           Y      ++L++V EY     LA +L N     +  A+          I  IV AL Y+H
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIY--------IAEIVLALEYLH 110

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKF--------LKPDSSNWTELAGTY 771
           ++    I+HRD+   N+L+D  +  H+  +DFG++K         L  D      + GT 
Sbjct: 111 SN---GIIHRDLKPDNILID--SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y+APE+      ++  D +S G +  E + G  P
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 78/278 (28%), Positives = 137/278 (49%), Gaps = 44/278 (15%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G VY +K   +G + A K   +    E+   ++++ E++ L    H  IVK+ G
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76

Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                  L+I+ E+    ++ A++L  D   + L   +   + + +++AL Y+H+     
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---K 130

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGI-AKFLKP----DSSNWTELAGTYGYVAPELAY-- 780
           I+HRD+ + NVLL  + +  ++DFG+ AK +K     DS       GT  ++APE+    
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-----FIGTPYWMAPEVVMCE 185

Query: 781 TMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
           TMK T    K D++S G+  +E+ + + P   ++ M    + L IA  E   P L  PS+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--PPTLSQPSK 240

Query: 838 ---NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                 D L        + +D++PE+RP+     QLL+
Sbjct: 241 WSMEFRDFL-------KTALDKHPETRPS---AAQLLE 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 32/221 (14%)

Query: 610 IGKGGQGSVYM------SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++      S      ++AVK    P    +  +++F  E + LT + H +I
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHI 69

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSL----------AVILSND---AAAKNLGWTRRMNMI 710
           VK YG C     L +V+EY K   L          A+IL +     A   LG ++ +++ 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG- 769
             I   + Y+ +  F   VHRD++++N L+       + DFG+++ +   S+++  + G 
Sbjct: 130 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 184

Query: 770 ---TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
                 ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 15/273 (5%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +F  E  IG+G    VY +  L  G  +A+KK       +   + + + E+  L ++ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM-NMIKGIVDALSYM 720
           N++K Y   +    L IV E      L+ ++ +    K L   + +      +  AL +M
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRDI   NV +       + D G+ +F    ++    L GT  Y++PE  +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRNV 839
                 K D++S G L  E+   + P  +   M+  SL   I   E  D P  P PS + 
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKI---EQCDYP--PLPSDHY 233

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            ++L  +V +   C++ +PE RP +  V  + K
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 26/265 (9%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G VY      + E++A+K     L       ++   E+  L++     I + YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L        L  T    +++ I+  L Y+H++     
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---RK 122

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL  + +  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS-RNVHDKLISIV 847
           D++S G+ A+E+ KG+ P   +  M              L P+   P+    + K     
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVL----------FLIPKNSPPTLEGQYSKPFK-- 230

Query: 848 EVTISCVDENPESRPTMQKVCQLLK 872
           E   +C++++P  RPT +   +LLK
Sbjct: 231 EFVEACLNKDPRFRPTAK---ELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 73/299 (24%), Positives = 124/299 (41%), Gaps = 57/299 (19%)

Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
            T  F+    IG+G  G VY ++   +G+++A+K        E   ++E  N ++  +  
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-YNILRKYSN- 61

Query: 659 WHRNIVKVYGFCLHVRH------LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM--NMI 710
            H NI   YG  +          L++V E    C    +   D         +R+    I
Sbjct: 62  -HPNIATFYGAFIKKNPPGNDDQLWLVMEL---CGGGSVT--DLVKGLRKKGKRLKEEWI 115

Query: 711 ----KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
               +  +  L+Y+H +    ++HRDI  +N+LL    E  + DFG++  L         
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 767 LAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN 821
             GT  ++APE+    +  +     + DV+S G+ A+E+  GK P           ++  
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP--------LCDMHPM 224

Query: 822 IALDEMLDPRLPTP--------SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            AL     PR P P        S+  +D  IS       C+ +N E RP M+   +LL+
Sbjct: 225 RAL--FKIPRNPPPTLKSPENWSKKFND-FIS------ECLIKNYEQRPFME---ELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 71/271 (26%), Positives = 118/271 (43%), Gaps = 42/271 (15%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +GKG  G V+   L     +AVK     LP E+  +  FL+E + L +  H NIVK+ G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIGV 60

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   + ++IV E   +      LS     K+   T++  ++K  +DA + M        +
Sbjct: 61  CTQRQPIYIVME---LVPGGDFLSFLRKKKDELKTKQ--LVKFALDAAAGMAYLESKNCI 115

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAK----------FLKPDSSNWTELAGTYGYVAPELA 779
           HRD++++N L+   N   +SDFG+++           LK     WT         APE  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT---------APEAL 166

Query: 780 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPS 836
              + + + DV+S+G+L  E    G  P   ++         N    E ++   R+  P 
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---------NQQAREQVEKGYRMSCPQ 217

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           +   D    + +V   C D  PE+RP   ++
Sbjct: 218 KCPDD----VYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 4e-14
 Identities = 65/296 (21%), Positives = 125/296 (42%), Gaps = 57/296 (19%)

Query: 609 CIGKGGQGSVYMSK-LASGEIIAVK----KFHSPLPGEMTFQQEFLN--EVKALTEI-WH 660
            +G G  GSVY+++   +GE++A+K    KF+S         +E +N  EVK+L ++  H
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--------EECMNLREVKSLRKLNEH 57

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L+ V+EY +     ++        +    R  ++I  I+  L+++
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR--SIIYQILQGLAHI 115

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 778
           H   F    HRD+  +N+L+       ++DFG+A+ ++     +T+   T  Y APE+  
Sbjct: 116 HKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEILL 171

Query: 779 ---AYTMKVTEKCDVYSFGVLALEVIKGK----------------------HPRDFISSM 813
              +Y+  V    D+++ G +  E+   +                        +D+    
Sbjct: 172 RSTSYSSPV----DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 814 SFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             +S  L     +     L     N   + I +++     +  +P+ RPT  +  Q
Sbjct: 228 KLAS-KLGFRFPQFAPTSLHQLIPNASPEAIDLIK---DMLRWDPKKRPTASQALQ 279

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 35/213 (16%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  GSV   +L +  +I   K  +  P     Q++ L E++         IVK YG 
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILRELEINKSCKSPYIVKYYGA 67

Query: 670 CL--HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI----------KGIVDAL 717
            L      + I  EY +  SL      D+  K +   ++              + ++  L
Sbjct: 68  FLDESSSSIGIAMEYCEGGSL------DSIYKKV---KKRGGRIGEKVLGKIAESVLKGL 118

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           SY+H+     I+HRDI   N+LL  + +  + DFG++  L   +S      GT  Y+APE
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPE 173

Query: 778 ----LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                 Y++      DV+S G+  LEV + + P
Sbjct: 174 RIQGKPYSI----TSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.4 bits (188), Expect = 4e-14
 Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 21/193 (10%)

Query: 625 SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY--GFCLHVRHLFIVYEY 682
           +G  +A+K   +  P E   +  F  E      ++H NIV +   G       LF V+EY
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60

Query: 683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL-- 740
               +L  +L+ D A    G T R+ M++ ++DAL+  HN     IVHRD+  +N+++  
Sbjct: 61  VPGRTLREVLAADGALPA-GETGRL-MLQ-VLDALACAHNQ---GIVHRDLKPQNIMVSQ 114

Query: 741 -DFENEAHVSDFGIAKFLKPDSSNW--------TELAGTYGYVAPELAYTMKVTEKCDVY 791
                 A V DFGI   L P   +         TE+ GT  Y APE      VT   D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 792 SFGVLALEVIKGK 804
           ++G++ LE + G+
Sbjct: 174 AWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 72/275 (26%), Positives = 131/275 (47%), Gaps = 30/275 (10%)

Query: 607 EHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQ-EFLNEVKALTEIWHR 661
           E  IG G  G V   +L      EI +A+K   +   G    Q+ +FL+E   + +  H 
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA---GYTEKQRRDFLSEASIMGQFDHP 65

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           NI+ + G     + + IV EY +  SL   L  +D         + + M++GI   + Y+
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYL 122

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGTYG--YVAPE 777
            +  +   VHRD++++N+L++      VSDFG+++ L+ D  + +T   G     + APE
Sbjct: 123 SDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                K T   DV+S+G++  EV+  G+ P         S+ ++  A++E    RLP P 
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWEMSNQDVIKAIEEGY--RLPAPM 232

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
               D   ++ ++ + C  ++   RP  +++  +L
Sbjct: 233 ----DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 74.2 bits (182), Expect = 6e-14
 Identities = 78/220 (35%), Positives = 115/220 (52%), Gaps = 8/220 (3%)

Query: 73  DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGS 132
            L+L+ N+L  +I   L  L+NL +L LD N++++  P       +L  L L++N +  S
Sbjct: 97  SLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-S 154

Query: 133 IPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLA 192
           +P  L NL NL  L +  N LS  +   + NL +L+NL LS N  +  +PP +  LS L 
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGA 252
            L L  NS+   + S L NL++LS L L  NKL   +P S+GNLSNL  L+L  N +S  
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-- 268

Query: 253 IPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLD 292
                 +L  L  L L  N     +P++  L  L  + L+
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN 308

Length = 394

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.7 bits (178), Expect = 8e-14
 Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 31/220 (14%)

Query: 610 IGKGGQGSVYMSKLAS------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++  +        ++AVK          + +Q+F  E + LT + H++I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSL----------AVIL--SNDAAAKNLGWTRRMNMIK 711
           V+ YG C   R L +V+EY +   L          A IL    D A   L   + + +  
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-- 769
            I   + Y+ +  F   VHRD++++N L+       + DFG+++ +   S+++  + G  
Sbjct: 130 QIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 184

Query: 770 --TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
                ++ PE     K T + D++SFGV+  E+   GK P
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 40/287 (13%)

Query: 596 EIIRAT--NDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEV 652
           +I+R    +D++    +G G  G VY +  L +GE+ AVK        + +  Q+   E+
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EI 57

Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             + E  H NIV  +G  L    L+I  EY    SL  I         L   +   + + 
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRE 114

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
            +  L+Y+H+      +HRDI   N+LL    +  ++DFG+A  +    +      GT  
Sbjct: 115 TLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 773 YVAPELAYTMK---VTEKCDVYSFGVLALEVIKGK------HPRDFISSMSFSSLNLNIA 823
           ++APE+A   K     + CD+++ G+ A+E+ + +      HP   +  MS S+      
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ---- 227

Query: 824 LDEMLDPRLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                 P+L      S   H+     V+++++   +NP+ RPT +++
Sbjct: 228 -----PPKLKDKTKWSSTFHN----FVKISLT---KNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 45/284 (15%)

Query: 610 IGKGGQGSVYMSKLASGE------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V+++K    E      ++ VK        +   Q EF  E+    ++ H+N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNV 70

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVIL------SNDAAAKNLGWTRRMNMIKGIVDAL 717
           V++ G C      +++ EY  +  L   L              L   +++ +   I   +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG---YV 774
            ++ N  F   VHRD++++N L+  + E  VS   ++K     +S + +L        ++
Sbjct: 131 DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWL 185

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEML----- 828
           APE       + K DV+SFGVL  EV  +G+ P        F  L+     +E+L     
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--------FYGLS----DEEVLNRLQA 233

Query: 829 -DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
               LP P      +L  ++     C   NP+ RP+  ++   L
Sbjct: 234 GKLELPVPE-GCPSRLYKLMT---RCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 2e-13
 Identities = 44/113 (38%), Positives = 60/113 (53%), Gaps = 24/113 (21%)

Query: 98  LYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASI 157
           L LD   L   IP+++  LR L ++ L+ N + G+IP SLG++T                
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT---------------- 466

Query: 158 LGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELG 210
                   SL  L LS N+FNGSIP SLG L++L  L L+ NSLS  +P+ LG
Sbjct: 467 --------SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 2e-13
 Identities = 37/92 (40%), Positives = 55/92 (59%)

Query: 23  LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLS 82
           +  L L N  L G IP+ +  L +L ++ +  NS+ G+IP  +G+      L+LS N  +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 83  GSIPPSLGNLSNLATLYLDTNSLSNSIPSELG 114
           GSIP SLG L++L  L L+ NSLS  +P+ LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 32/210 (15%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G VY ++   +GE++A+KK       +  F    + E+K L ++ H NIV++  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 669 FCLHVRH--LFIVYEYFKMCSLAVILSN------DAAAKNLGWTRRMNMIKGIVDALSYM 720
                    +++V+EY     L  +L +      ++  K          +K +++ L Y+
Sbjct: 66  IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--------MKQLLEGLQYL 116

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-NWTELAGTYGYVAPEL- 778
           H++    I+HRDI   N+L++ +    ++DFG+A+     +S ++T    T  Y  PEL 
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 779 ----AYTMKVTEKCDVYSFGVLALEVIKGK 804
                Y  +V    D++S G +  E+  GK
Sbjct: 174 LGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 65/257 (25%), Positives = 116/257 (45%), Gaps = 20/257 (7%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +A+K       G M+  + FL E   + ++ H  +V++Y  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMS-PEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L      K L   + ++M   I + ++++    +   +
Sbjct: 70  VTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY---I 124

Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   + R     M+   +  N  L+     R+P P  N  ++L    E
Sbjct: 185 DVWSFGILLTEIV--TYGRIPYPGMTNPEVIQN--LERGY--RMPRPD-NCPEEL---YE 234

Query: 849 VTISCVDENPESRPTMQ 865
           +   C  E PE RPT +
Sbjct: 235 LMRLCWKEKPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 71/268 (26%), Positives = 115/268 (42%), Gaps = 36/268 (13%)

Query: 609 CIGKGGQGSVYMS-KLASGEIIAVKKFH-SPLPGEMTFQQEFL-NEVKALTEIWHRNIVK 665
            +G+G  G VY+   + +G  +AVK+    P   E   +   L  E++ L  + H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 666 VYGFCLHVR-HLFIVYEYFKMCSLAV------ILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            YG CL     L I  EY    S+         L+     K   +TR+      I++ + 
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK---YTRQ------ILEGVE 118

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVA 775
           Y+H++    IVHRDI   N+L D      + DFG +K L+   S+ T +    GT  +++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
           PE+        K DV+S G   +E++  K P     +M   +    IA     +P+LP+ 
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPT-NPQLPSH 231

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPT 863
                   +           EN + RP+
Sbjct: 232 VSPDARNFLRR------TFVENAKKRPS 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 64/280 (22%), Positives = 124/280 (44%), Gaps = 26/280 (9%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           EI R +   + +  +G G  G V+M+       +AVK      PG M+ +  FL E   +
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA-FLAEANVM 55

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
             + H  +VK++        ++I+ E+    SL   L +D  +K     + ++    I +
Sbjct: 56  KTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAE 113

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYV 774
            ++++    +   +HRD+ + N+L+       ++DFG+A+ ++ +     E A     + 
Sbjct: 114 GMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS-FSSLNLNIALDEMLDPRL 832
           APE       T K DV+SFG+L +E++  G+ P   +S+     +L     +     PR 
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-----PRP 225

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                 +++       + + C    PE RPT + +  +L 
Sbjct: 226 ENCPEELYN-------IMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 4e-13
 Identities = 34/74 (45%), Positives = 48/74 (64%)

Query: 161 IGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL 220
           I  L+ L ++ LS N+  G+IPPSLG++++L  L L  NS + SIP  LG L SL  L+L
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497

Query: 221 GYNKLSGSIPISMG 234
             N LSG +P ++G
Sbjct: 498 NGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 33/272 (12%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV   K + +G ++A K  H  +  + + +++ L E++ + E     IV  YG
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM---NMIKGIVDALSYMHNDCF 725
             L+  ++ +  E+    SL      D   K  G         +   +V+ L+Y++N   
Sbjct: 71  AFLNENNICMCMEFMDCGSL------DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV-- 122

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             I+HRDI   N+L++   +  + DFG++  L    ++     GT  Y++PE     K T
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGKYT 180

Query: 786 EKCDVYSFGVLALEVIKGKHPRDF--------ISSMSFSSLNLNIALDEMLDPRLPTPSR 837
            K DV+S G+  +E+  GK P  F           M    L   I  +    PRLP+   
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPS--- 235

Query: 838 NVHDKLISIVEVTIS-CVDENPESRPTMQKVC 868
                    +   +  C+ ++P  RPT Q++C
Sbjct: 236 ---SDFPEDLRDFVDACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 49/229 (21%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQE-------FLN 650
           R+  +F+  + IG+G  G VY ++   SGEI+A+KK        +    E        L 
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKK--------VRMDNERDGIPISSLR 55

Query: 651 EVKALTEIWHRNIVKVYGFCLHV---RHL---FIVYEYFKMCS--LAVILSN------DA 696
           E+  L  + H NIV++      V   +HL   F+V EY   C   LA +L N      ++
Sbjct: 56  EITLLLNLRHPNIVEL----KEVVVGKHLDSIFLVMEY---CEQDLASLLDNMPTPFSES 108

Query: 697 AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF 756
             K L       M++ ++  L Y+H +    I+HRD+   N+LL  +    ++DFG+A+ 
Sbjct: 109 QVKCL-------MLQ-LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157

Query: 757 LKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGK 804
               +   T    T  Y APEL       T   D+++ G +  E++  K
Sbjct: 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 38/284 (13%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F+    +G G  G VY  + + +G++ A+K        E   +QE +N +K  +   HRN
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-INMLKKYSH--HRN 64

Query: 663 IVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
           I   YG  +          L++V E+    S+  ++ N      L       + + I+  
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRG 123

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           LS++H      ++HRDI  +NVLL    E  + DFG++  L           GT  ++AP
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 777 ELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
           E+    +  +     K D++S G+ A+E+ +G  P   +  M         AL   L PR
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------AL--FLIPR 230

Query: 832 LPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            P P   S+    K  S +E   SC+ +N   RPT +   QL+K
Sbjct: 231 NPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE---QLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKF----HSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           IG+G  G V+  +   +G+I+A+KKF      P+  ++      L E++ L ++ H N+V
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-----LREIRMLKQLKHPNLV 63

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH-ND 723
            +       R L +V+EY   C   V+   +   + +       +I   + A+++ H ++
Sbjct: 64  NLIEVFRRKRKLHLVFEY---CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 778
           C    +HRD+  +N+L+  + +  + DFG A+ L     ++T+   T  Y APEL     
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKG 803
            Y   V    DV++ G +  E++ G
Sbjct: 177 QYGPPV----DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 16/177 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEV---KALTEIWHRNIVK 665
           IG+G  G+VY ++ L +G  +A+KK   PL  E       L E+   K L    H NIV+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 666 VYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           +   C   R      L +V+E+     LA  LS       L      ++++ ++  + ++
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSK-CPKPGLPPETIKDLMRQLLRGVDFL 123

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           H+     IVHRD+  +N+L+  + +  ++DFG+A+    + +  T +  T  Y APE
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 40/271 (14%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG+G  G +Y++K  S     V K        +  ++    EV  L ++ H NIV  +  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 670 CLHVRHLFIVYEYFKMCSL--------AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
                 LFIV EY     L         V+ S D   + L W  ++++       L ++H
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED---QILSWFVQISL------GLKHIH 118

Query: 722 NDCFPPIVHRDISSKNVLLDFENE-AHVSDFGIAKFLKPDSSNWTELA----GTYGYVAP 776
           +     I+HRDI S+N+ L      A + DFGIA+ L    ++  ELA    GT  Y++P
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLSP 171

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           E+        K D++S G +  E+   KHP       +   L L I       P  P  S
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHP---FEGNNLHQLVLKIC-QGYFAPISPNFS 227

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           R++   +  + +V+       P  RP++  +
Sbjct: 228 RDLRSLISQLFKVS-------PRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 7e-13
 Identities = 37/88 (42%), Positives = 51/88 (57%)

Query: 167 LSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS 226
           +  L L      G IP  +  L +L ++ L  NS+  +IP  LG++ SL  L L YN  +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 227 GSIPISMGNLSNLTYLNLFENSLSGAIP 254
           GSIP S+G L++L  LNL  NSLSG +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 12/182 (6%)

Query: 625 SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEY 682
           +GE +AVK       G      +   E++ L  ++H NIVK  G C       + ++ E+
Sbjct: 32  TGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89

Query: 683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
               SL   L  +    NL   +++     I   + Y+ +  +   VHRD++++NVL++ 
Sbjct: 90  LPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVES 144

Query: 743 ENEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 799
           E++  + DFG+ K ++ D   +T   +L     + APE     K     DV+SFGV   E
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204

Query: 800 VI 801
           ++
Sbjct: 205 LL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGE-MTFQQEF--LNEVKALTEIWHRNIVK 665
           +G+G  G V++ +  A  +++ +K+    +P E MT  +     NE + L  + H NI++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
            Y   L  + L IV EY    +LA  +        L     ++    I+ AL ++H    
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121

Query: 726 PPIVHRDISSKNVLLD-FENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
             I+HRD+ ++N+LLD  +    + DFGI+K L   S  +T + GT  Y++PEL      
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPY 178

Query: 785 TEKCDVYSFGVLALEV 800
            +K D+++ G +  E+
Sbjct: 179 NQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 28/219 (12%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
            ++  +   +GKG  G VY ++  S ++ IA+K+       +  + Q    E+   + + 
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK 63

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           HRNIV+  G         I  E     SL+ +L +            +   K I++ L Y
Sbjct: 64  HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 720 MHNDCFPPIVHRDISSKNVLLD-FENEAHVSDFGIAKFL---KPDSSNWTELAGTYGYVA 775
           +H++    IVHRDI   NVL++ +     +SDFG +K L    P +  +T   GT  Y+A
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMA 177

Query: 776 PELAYTMKVTEK--------CDVYSFGVLALEVIKGKHP 806
           PE      V +K         D++S G   +E+  GK P
Sbjct: 178 PE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 40/281 (14%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGE--MTFQQEFLNEVKALTEIW 659
           DF+    IG G  G VY ++ + +GE+ A+K      PGE     QQE +     + +  
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEII----MMKDCK 64

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVI--LSNDAAAKNLGWTRRMNMIKGIVDAL 717
           H NIV  +G  L    L+I  E+    SL  I  ++   +   + +  R  +       L
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+      +HRDI   N+LL       ++DFG++  +    +      GT  ++APE
Sbjct: 120 YYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176

Query: 778 LAYTMK---VTEKCDVYSFGVLALEVIKGK------HPRDFISSMSFSSLNLNIALDEML 828
           +A   +     + CD+++ G+ A+E+ + +      HP   +  M+ S+       D+M 
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM- 235

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                  S + H      V++ ++   +NP+ RPT +K+ Q
Sbjct: 236 -----KWSNSFH----HFVKMALT---KNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.0 bits (174), Expect = 1e-12
 Identities = 38/93 (40%), Positives = 52/93 (55%)

Query: 70  FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNIL 129
           F   L L N  L G IP  +  L +L ++ L  NS+  +IP  LG++ SL  L L+ N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 130 SGSIPHSLGNLTNLATLYIYSNSLSASILGKIG 162
           +GSIP SLG LT+L  L +  NSLS  +   +G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G V  +    +GE +A+KK +      ++     L E+K L  + H +IV++  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
             L       + +++V+E  +     VI +ND    +L        +  ++ AL Y+H  
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT- 121

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAK--FLK-PDSSNWTELAGTYGYVAPEL-- 778
               + HRD+  KN+L + + +  + DFG+A+  F   P +  WT+   T  Y APEL  
Sbjct: 122 --ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGK 804
           ++  K T   D++S G +  EV+ GK
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 63/284 (22%), Positives = 128/284 (45%), Gaps = 40/284 (14%)

Query: 610 IGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++           ++AVK            +++F  E + LT + H +I
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 69

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSL----------AVILSNDAAAKNLGWTRRMNMIKGI 713
           VK YG C+    L +V+EY K   L          AV+++       L  ++ +++ + I
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG---- 769
              + Y+ +  F   VHRD++++N L+       + DFG+++ +   S+++  + G    
Sbjct: 130 AAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTML 184

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML 828
              ++ PE     K T + DV+S GV+  E+   GK P        +  L+ N  ++ + 
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------WYQLSNNEVIECIT 236

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             R+    R    +   + ++ + C    P  R  ++++  LL+
Sbjct: 237 QGRVLQRPRTCPKE---VYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 77/286 (26%), Positives = 113/286 (39%), Gaps = 43/286 (15%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           ND ++   IG G  G VY M    +G ++AVK+         T  +E    +    ++  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR------RTGNKEENKRILMDLDVVL 68

Query: 661 R-----NIVKVYGFCLHVRHLFIVYEYFKMC--SLAVILSNDAAAKNLGWTRRMNMIKGI 713
           +      IVK YG+ +    +FI  E    C   L   +        LG      M   I
Sbjct: 69  KSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAI 123

Query: 714 VDALSYM---HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
           V AL Y+   H      ++HRD+   N+LLD      + DFGI+  L  DS   T  AG 
Sbjct: 124 VKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGC 177

Query: 771 YGYVAPELAYTMKVTEK----CDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE 826
             Y+APE         K     DV+S G+  +E+  G+ P        F    L   L E
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK-NCKTEFEV--LTKILQE 234

Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             +P    P+        S V+    C+ ++   RP   K  +LL+
Sbjct: 235 --EPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP---KYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 15/273 (5%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +F  E  IG+G    VY +  L   + +A+KK       +   +Q+ + E+  L ++ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM-NMIKGIVDALSYM 720
           N++K     +    L IV E      L+ ++      K L   R +      +  A+ +M
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRDI   NV +       + D G+ +F    ++    L GT  Y++PE  +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRNV 839
                 K D++S G L  E+   + P  +   M+  SL   I   E  D P  P P+ + 
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKI---EQCDYP--PLPTEHY 233

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            +KL  +V +   C+  +P+ RP +  V Q+ K
Sbjct: 234 SEKLRELVSM---CIYPDPDQRPDIGYVHQIAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 34/210 (16%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-----NI 663
           I KG  GSVY++ K ++G+  A+K        +M  + +  N VKA   I         +
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTN-VKAERAIMMIQGESPYV 59

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG-----WTRRMNMIKGIVDALS 718
            K+Y       +L++V EY      A ++      K LG     W +    I  +V  + 
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGVE 111

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAP 776
            +H      I+HRDI  +N+L+D      ++DFG+++               GT  Y+AP
Sbjct: 112 DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAP 162

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           E    +   +  D +S G +  E + G  P
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 46/288 (15%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F+    +G G  G VY  + + +G++ A+K        E   + E +N +K  +   HRN
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-INMLKKYSH--HRN 74

Query: 663 IVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI----KG 712
           I   YG  +      H   L++V E+   C    +   D      G   + + I    + 
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEF---CGAGSV--TDLVKNTKGNALKEDWIAYICRE 129

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           I+  L+++H      ++HRDI  +NVLL    E  + DFG++  L           GT  
Sbjct: 130 ILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 773 YVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM 827
           ++APE+    +  +     + D++S G+ A+E+ +G  P   +  M         AL   
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--------AL--F 236

Query: 828 LDPRLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L PR P P   S+    K I  +E    C+ +N  SRP+ +   QLLK
Sbjct: 237 LIPRNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPSTE---QLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 25/265 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +G G  G+VY    +  GE + +    K  +   G      EF++E   +  + H ++V+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHLVR 73

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           + G CL      +       C L  +  +     N+G    +N    I   + Y+     
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER-- 128

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTMK 783
             +VHRD++++NVL+   N   ++DFG+A+ L+ D   +    G     ++A E  +  K
Sbjct: 129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 784 VTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK 842
            T + DV+S+GV   E++  G  P D I +     L     L++    RLP P       
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEK--GERLPQPPICT--- 237

Query: 843 LISIVEVTISCVDENPESRPTMQKV 867
            I +  V + C   + +SRP  +++
Sbjct: 238 -IDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 14/155 (9%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           I  AL Y+H      I+HRD+ ++NV L   N   V D GIA+ L+      + L GT  
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY 167

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           Y++PEL        K DV++ G    E+   KH        +F++ ++N  +  +++ +L
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKH--------AFNAKDMNSLVYRIIEGKL 219

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           P   ++   +L  ++   +S   + PE RP+++ +
Sbjct: 220 PPMPKDYSPELGELIATMLS---KRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.7 bits (168), Expect = 6e-12
 Identities = 33/85 (38%), Positives = 49/85 (57%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           N  L   IP+++  L+ L  + L  N + G+IP SLG++T+L  L +  NS +GSIP  +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLG 90
           G       L L+ N LSG +P +LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 66.8 bits (164), Expect = 7e-12
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 36/219 (16%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V + +   SG+  A+K        ++   +  LNE + L  I H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM-----NMIK---- 711
             +V +YG      +L++V EY        + S           R+       + +    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEY---VPGGELFS---------HLRKSGRFPEPVARFYAA 108

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            +V AL Y+H+     IV+RD+  +N+LLD +    ++DFG AK +K  +  +T L GT 
Sbjct: 109 QVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGTP 162

Query: 772 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y+APE+     Y   V    D ++ G+L  E++ G  P
Sbjct: 163 EYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 34/217 (15%)

Query: 603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIW 659
           DF+    +G G  G V ++K   +GE  A+K  K    L  +M   Q    E   L E+ 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELS 76

Query: 660 HRNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAA----AKNLGWTRRMNM 709
           H  IV +         ++ + E+      F     A    ND A    A+          
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE---------- 126

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
              +V A  Y+H+     I++RD+  +N+LLD +    V+DFG AK  K     +T L G
Sbjct: 127 ---LVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCG 177

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+  +    +  D ++ GVL  E I G  P
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 34/91 (37%), Positives = 47/91 (51%)

Query: 313 IDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEI 372
           + L      G I +D  +   L +++ S N+I GN+PP +G  + L VLDLS N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 373 PIELGKLNFFIKLVLAHNQLSGQLSPKLGSL 403
           P  LG+L     L L  N LSG++   LG  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 77/286 (26%), Positives = 112/286 (39%), Gaps = 55/286 (19%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            D  D   IG+G  G+V  M    SG I+AVK+  S +      Q+  L ++  +     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSD 61

Query: 661 -RNIVKVYG---------FCLHVRHL------FIVYEYFKMCSLAVILSNDAAAKNLGWT 704
              IVK YG          C+ +  +        VYE  K      IL   A A      
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA------ 115

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
                    V AL+Y+  +    I+HRD+   N+LLD      + DFGI+  L  DS   
Sbjct: 116 --------TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAK 164

Query: 765 TELAGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS 817
           T  AG   Y+APE         Y +    + DV+S G+   EV  GK P    +S+ F  
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFPYPKWNSV-FDQ 219

Query: 818 LNLNIALDEMLDPRL-PTPSRNVHDKLISIVEVTISCVDENPESRP 862
           L   +  D    P L  +  R      ++ +     C+ ++   RP
Sbjct: 220 LTQVVKGDP---PILSNSEEREFSPSFVNFIN---LCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 11/197 (5%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V   K   +G+I+A+KKF      +M  ++  + E++ L ++ H N+V +  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV-KKIAMREIRMLKQLRHENLVNLIE 67

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKGIVDALSYMHNDCFPP 727
                + L++V+E+        +L +     N L  +R    +  I+  + + H+     
Sbjct: 68  VFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTE 786
           I+HRDI  +N+L+       + DFG A+ L      +T+   T  Y APEL     K   
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180

Query: 787 KCDVYSFGVLALEVIKG 803
             D+++ G L  E++ G
Sbjct: 181 AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 61/276 (22%)

Query: 629 IAVKKFHSPLPGE-MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           +AVK      P      +++FL EVK L+ +   NI ++ G C     L ++ EY +   
Sbjct: 49  VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 688 L------AVILSNDAA--AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVL 739
           L       V  ++  A  +K+L ++  + M   I   + Y+ +  F   VHRD++++N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCL 162

Query: 740 LDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP------ELAYTMKVTEKCDVYSF 793
           +       ++DFG+++ L   SS++  + G      P      E     K T K DV++F
Sbjct: 163 VGKNYTIKIADFGMSRNLY--SSDYYRVQGR--APLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 794 GVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR-----------------LPTPS 836
           GV   E+            ++          + + D +                 LP P 
Sbjct: 219 GVTLWEI------------LTLCREQ---PYEHLTDQQVIENAGHFFRDDGRQIYLPRPP 263

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               D    I E+ + C   + E RPT +++   L+
Sbjct: 264 NCPKD----IYELMLECWRRDEEDRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 29/235 (12%)

Query: 640 GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK 699
           G  TFQ E  + + A+  + H  IV++ G C     L +V +   + SL   +       
Sbjct: 49  GRQTFQ-EITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRD-- 104

Query: 700 NLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP 759
           +L   R +N    I   + Y+       +VHR+++++N+LL  ++   ++DFG+A  L P
Sbjct: 105 SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161

Query: 760 DSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFS 816
           D     ++E      ++A E     + T + DV+S+GV   E++  G  P        ++
Sbjct: 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP--------YA 213

Query: 817 SLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISC--VDENPESRPTMQKV 867
            +  +   D +L+   RL  P        I +  V + C  +DEN   RPT +++
Sbjct: 214 GMRPHEVPD-LLEKGERLAQP----QICTIDVYMVMVKCWMIDEN--VRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 18/198 (9%)

Query: 610 IGKGGQGSV---YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +G G  G+V         S + +AVK   +    +   + E L E   + ++ +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
            G C       +V E  ++  L   L  +   K++       ++  +   + Y+    F 
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETNF- 116

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELAYT 781
             VHRD++++NVLL  ++ A +SDFG++K L  D + +   A T+G     + APE    
Sbjct: 117 --VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNY 172

Query: 782 MKVTEKCDVYSFGVLALE 799
            K + K DV+SFGVL  E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 10/200 (5%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV-Y 667
           +GKGG G V   ++ A+G++ A KK       +   +Q  LNE K L ++  R IV + Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 668 GFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
            F    +  L +V        L   + N          R +     I+  L ++H     
Sbjct: 61  AF--ETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
            IV+RD+  +NVLLD      +SD G+A  L          AGT GY+APE+        
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 787 KCDVYSFGVLALEVIKGKHP 806
             D ++ G    E+I G+ P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 28/279 (10%)

Query: 597 IIRATNDFDDEHCIGKGGQGSVYMSK-LASGEII----AVKKFHSPLPGEMTFQQEFLNE 651
           I++ T +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E
Sbjct: 3   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDE 59

Query: 652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              +  + + ++ ++ G CL      I       C L  +  +     N+G    +N   
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCV 116

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   ++Y+       +VHRD++++NVL+       ++DFG+AK L  D   +    G  
Sbjct: 117 QIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 772 --GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML 828
              ++A E       T + DV+S+GV   E++  G  P D I +   SS+          
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------- 226

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
             RLP P        I +  + + C   + +SRP  +++
Sbjct: 227 GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 16/206 (7%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFH-SPLPGEMTFQQEFLN-EVKALTEIWHRNIVKV 666
           +G+G  G VY+   + +G  +A K+    P   E + +   L  E++ L  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 667 YGFCLH---VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           YG CL     + L I  EY    S+   L    A      TR+    + I++ +SY+H++
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-SVTRKYT--RQILEGMSYLHSN 125

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAY 780
               IVHRDI   N+L D      + DFG +K L+    + T    + GT  +++PE+  
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
                 K DV+S G   +E++  K P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 64.5 bits (158), Expect = 4e-11
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 36/212 (16%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIWHRNI 663
           +G+G    VY ++   +G I+A+KK      GE    ++ +N     E+K L E+ H NI
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 664 VK---VYGFCLHVRHLFIVYEYFKMCS-LAVILSN------DAAAKNLGWTRRMNMIKGI 713
           +    V+G   H  ++ +V+E+  M + L  ++ +       A  K+      M M    
Sbjct: 65  IGLLDVFG---HKSNINLVFEF--METDLEKVIKDKSIVLTPADIKSY-----MLMT--- 111

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGY 773
           +  L Y+H+  +  I+HRD+   N+L+  +    ++DFG+A+     +   T    T  Y
Sbjct: 112 LRGLEYLHS-NW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168

Query: 774 VAPELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
            APEL +         D++S G +  E++   
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 66/275 (24%), Positives = 108/275 (39%), Gaps = 43/275 (15%)

Query: 602 NDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            DF     +G+GG G V+++ K  +GEI+A+K+    L  ++   +  L E   LT    
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 661 RNIVK-VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI--VDAL 717
             +VK +Y F     +L++  EY        +L+N           R  M +    VDAL
Sbjct: 61  EWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFEAVDAL 117

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA----GTYGY 773
             +        +HRD+  +N L+D      ++DFG+       S      A    G+  Y
Sbjct: 118 HELG------YIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDY 164

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD------EM 827
           +APE+          D +S G +  E + G  P        FS    N   +      E 
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP--------FSGSTPNETWENLKYWKET 216

Query: 828 LD-PRLPTPSRNVHDKLISIVEVTISCVDENPESR 861
           L  P    P  N+ D+   ++      +++ P  R
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLIT---KLIND-PSRR 247

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 16/206 (7%)

Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFH-SPLPGEMTFQQEFLN-EVKALTEIWHRNIVKV 666
           +G+G  G VY+   A +G  +AVK+    P   E + +   L  E++ L  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 667 YGFCLHV--RHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           YG       R L I  E+    S+   L S  A  +N+  TR+    + I++ +SY+H++
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV--TRKYT--RQILEGVSYLHSN 125

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP---DSSNWTELAGTYGYVAPELAY 780
               IVHRDI   N+L D      + DFG +K L+      +    + GT  +++PE+  
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
                 K D++S G   +E++  K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 58/299 (19%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKL---------ASGEIIAVKKFHSPLPGEMTFQQ 646
           EI  +   F +E  +G+G  G VY  +L          S  I  +K+   P       QQ
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQ 53

Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           EF  E + ++++ H NIV + G C   +   +++EY     L   L  ++   ++G    
Sbjct: 54  EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 707 MNMIKGIVDALSYM---------------HNDCFPPIVHRDISSKNVLLDFENEAHVSDF 751
              +K  +D   ++               H+      VHRD++++N L+       +SDF
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDF 168

Query: 752 GIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
           G+++ +   S+++  +         ++ PE     K T + D++SFGV+  E+   G  P
Sbjct: 169 GLSRDIY--SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Query: 807 RDFISSMSFSSLNLNIALDEMLDPR--LPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
                   FS    N  + EM+  R  LP P     D    +  + I C +E P  RP 
Sbjct: 227 Y-----YGFS----NQEVIEMIRSRQLLPCPE----DCPARVYALMIECWNEIPARRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 8/199 (4%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVY 667
           +GKG  G V++++L  + +  A+K     +       +  + E + L+  W H  +  +Y
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                  +LF V EY     L   + +  +       R       I+  L ++H+     
Sbjct: 63  CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---G 116

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           IV+RD+   N+LLD +    ++DFG+ K      +      GT  Y+APE+    K    
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 788 CDVYSFGVLALEVIKGKHP 806
            D +SFGVL  E++ G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 32/85 (37%), Positives = 49/85 (57%)

Query: 194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAI 253
           L LD   L   IP+++  LR L +++L  N + G+IP S+G++++L  L+L  NS +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 254 PYEYRNLVKLTILLLGHNQFRGPIP 278
           P     L  L IL L  N   G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           I +G  G VY ++   +GEI+A+K  K      G   F    L E+  L ++ H NIV V
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTV 69

Query: 667 YGFCL--HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
               +  ++  +++V EY +   L  ++      +    +    ++  ++  ++++H++ 
Sbjct: 70  KEVVVGSNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW 126

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMK 783
              I+HRD+ + N+LL+      + DFG+A+        +T+L  T  Y APEL     +
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 784 VTEKCDVYSFGVLALEVIKGK 804
            +   D++S G +  E++  K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 13/207 (6%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N F+    +G+G  G V   +   + EI+A+KKF      E   ++  L E+K L  +  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQ 59

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFK--MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            NIV++         L++V+EY +  M  L   + N    + +      + I  ++ A+ 
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-----RSYIYQLIKAIH 114

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS-SNWTELAGTYGYVAPE 777
           + H +    IVHRDI  +N+L+   +   + DFG A+ L   S +N+TE   T  Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGK 804
           L       +  D++S G +  E+  G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 61/266 (22%), Positives = 108/266 (40%), Gaps = 26/266 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  G+VY      +G + A+K  +     E T +++   E++ L ++ H N+VK + 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
              H   + ++ E+    SL      D            ++ + I+  ++Y+H      I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVARQILSGIAYLHRR---HI 189

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-----LAYTMK 783
           VHRDI   N+L++      ++DFG+++ L           GT  Y++PE     L +   
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249

Query: 784 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL 843
                D++S GV  LE   G+ P        ++SL   I    M  P  P        + 
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MSQP--PEAPATASREF 304

Query: 844 ISIVEVTISCVDENPESRPTMQKVCQ 869
              +     C+   P  R +  ++ Q
Sbjct: 305 RHFISC---CLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 49/282 (17%)

Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH-RNIVKVY 667
           +G+G  G V  M  + +G I+AVK+  + +      Q+  L ++            V  Y
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 668 G---------FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
           G          C+ V    +   Y K+    + +  D   K         +   IV AL 
Sbjct: 67  GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK---------IAVSIVKALE 117

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y+H+     ++HRD+   NVL++   +  + DFGI+ +L  DS   T  AG   Y+APE 
Sbjct: 118 YLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174

Query: 779 --------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
                    Y +    K DV+S G+  +E+  G+ P D   +  F  L   +   E   P
Sbjct: 175 INPELNQKGYDV----KSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVV---EEPSP 226

Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +LP    +         +    C+ +N + RP      +LL+
Sbjct: 227 QLPAEKFSP-----EFQDFVNKCLKKNYKERPNYP---ELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 61/213 (28%), Positives = 88/213 (41%), Gaps = 56/213 (26%)

Query: 361 LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
           L L +  + G IP ++ KL     + L+ N + G + P LGS+  LE LDLS N  + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 421 PKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGL 480
           P+SLG L                           SL  LNL+ NSLSG +P+    + G 
Sbjct: 483 PESLGQL--------------------------TSLRILNLNGNSLSGRVPAA---LGGR 513

Query: 481 LHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWVV 540
           L        L  +  N T            N GL G + GL +C    S    +      
Sbjct: 514 L--------LHRASFNFTD-----------NAGLCG-IPGLRACGPHLSVGAKIG----- 548

Query: 541 VVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQ 573
           + F +   VA L  +I     ++RR+N  + Q+
Sbjct: 549 IAFGVS--VAFLFLVICAMCWWKRRQNILRAQR 579

Length = 623

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 24/213 (11%)

Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F     +GKGG G V   ++ A+G++ A KK       +   +   LNE + L ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLGWT-----RRMNMIKGI 713
           +V           L   YE      L + L N    K    ++G       R +     I
Sbjct: 62  VVS----------LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGY 773
              L  +H +    IV+RD+  +N+LLD      +SD G+A  + P+        GT GY
Sbjct: 112 CCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGY 167

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +APE+    + T   D ++ G L  E+I G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 65/269 (24%), Positives = 122/269 (45%), Gaps = 29/269 (10%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G VY ++     ++A  K       E    ++++ E+  L    H NIVK+   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70

Query: 670 CLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             +  +L+I+ E+    ++ AV+L  +     L   +   + K  ++AL+Y+H +    I
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE-- 786
           +HRD+ + N+L   + +  ++DFG++              GT  ++APE+       +  
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 787 ---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR---NVH 840
              K DV+S G+  +E+ + + P   ++ M    + L IA  E   P L  PSR      
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--PPTLAQPSRWSSEFK 239

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQ 869
           D L         C+++N ++R T  ++ Q
Sbjct: 240 DFL-------KKCLEKNVDARWTTTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 63.6 bits (155), Expect = 3e-10
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKGG G VY++        +A+KK    L      ++ FL E K   ++ H  IV VY 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVD----ALSYM 720
            C     ++    Y +  +L  +L +    ++ +K L     +     I       + Y+
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD---------------SSNWT 765
           H+     ++HRD+   N+LL    E  + D+G A F K +                S+ T
Sbjct: 130 HSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186

Query: 766 ---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 796
              ++ GT  Y+APE    +  +E  D+Y+ GV+
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 4e-10
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 35/227 (15%)

Query: 604 FDDEHCIGKGGQGSVY---MSKLASGEIIAVKKFHSPLPGEMT-FQQEFLNEVKALTEIW 659
           ++ E CIG+G  G VY         G+  A+KKF      + T   Q    E+  L E+ 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-KEQYTGISQSACREIALLRELK 60

Query: 660 HRNIVKVYGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM--NMIKGIVD 715
           H N+V +    L    + ++++++Y +   L  I+     AK +     M  +++  I++
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAG-- 769
            + Y+H++    ++HRD+   N+L+  E        + D G+A+          +L    
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 770 -TYGYVAPELA-----YTMKVTEKCDVYSFG-----VLALEVI-KGK 804
            T  Y APEL      YT  +    D+++ G     +L LE I KG+
Sbjct: 177 VTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKF-HSPLPGEMTFQQEFLN-EVKALTEIWHRNIVKV 666
           +G+G  G VY+   A +G  +AVK+    P   E + +   L  E++ L  + H  IV+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 667 YGFCLH---VRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           YG CL     + L I  EY    S+   L +  A  +N+  TRR    + I+  +SY+H+
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV--TRRYT--RQILQGVSYLHS 124

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELA 779
           +    IVHRDI   N+L D      + DFG +K ++    + T    + GT  +++PE+ 
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  K DV+S     +E++  K P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 70/283 (24%), Positives = 112/283 (39%), Gaps = 39/283 (13%)

Query: 610 IGKGGQGSVYMSKLASGEIIA---VKKFH-SPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           IG G  G V + +   G   A   VK+   S  P E   Q  FL EV+   E+ H N+++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTR-RMNMIKGIVDALSYMHND 723
             G C+      +V E+  +  L   L SN      +        M   +   L ++H  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIA------KFLKPDSSNWTELAGTYGYVAPE 777
            F   +H D++ +N  L  +    + D+G+A       +      +   L     ++APE
Sbjct: 120 DF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPE 172

Query: 778 LA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
           L             T+K +++S GV   E+      P   +S        L   + E  D
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV----LKQVVREQ-D 227

Query: 830 PRLPTPSRNVHDKLIS-IVEVTISCVDENPESRPTMQKVCQLL 871
            +LP P   +  K      EV   C   +PE+RPT ++V +LL
Sbjct: 228 IKLPKP--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           I+  L ++H      I++RD+   NVLLD +    ++DFG+ K         +   GT  
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD 161

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+    K  E  D +SFGVL  E++ G+ P
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 39/213 (18%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQE-------FLNEVKALTEIWHR 661
           IG+G  G VY ++   + E IA+KK        +  +QE        + E+  L E+ H 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKK--------IRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDAL 717
           NIV++       + L++V+EY  +     + S+   AKN        +IK     I+  +
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP------RLIKTYLYQILRGI 115

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           +Y H+     ++HRD+  +N+L+D   N   ++DFG+A+        +T    T  Y AP
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query: 777 EL-----AYTMKVTEKCDVYSFGVLALEVIKGK 804
           E+      Y+  V    D++S G +  E++  K
Sbjct: 173 EILLGSRHYSTPV----DIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 39/283 (13%)

Query: 610 IGKGGQGSVYMSKL------ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G G  G VY           SG I +AVK        +   ++EFL E   ++   H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN----LGWTRRMNMIKGIVDALS 718
           IVK+ G CL     +I+ E  +   L   L +    +     L     +++   +     
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 719 YMHNDCFPPIVHRDISSKNVLL-----DFENEAHVSDFGIAKFLKPDSSNWTELAG---- 769
           Y+    F   +HRD++++N L+     D +    + DFG+A+ +    S++    G    
Sbjct: 121 YLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGLL 175

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML 828
              ++APE     K T + DV+SFGVL  E++  G+ P   ++       N  +      
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTA 228

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             RL  P  N  DK+  ++    +C  ++P  RPT  ++ ++L
Sbjct: 229 GGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 8/199 (4%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN-IVKVY 667
           +GKG  G V +++L   GE  AVK     +       +  + E + L   W    +  +Y
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                  HLF V E+     L   + +          R       IV  L ++H+     
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---G 116

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           I++RD+   NV+LD +    ++DFG+ K      +  +   GT  Y+APE+   +K T  
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176

Query: 788 CDVYSFGVLALEVIKGKHP 806
            D +SFGVL  E++ G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 34/223 (15%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +DF+    IG+G  G V + K+   E I   K  +        + E L   +       R
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN--------KWEMLKRAETACFREER 52

Query: 662 NIVKVYGFC-----LHV-----RHLFIVYEYFKMCSLAVILSN--DAAAKNLGWTRRMNM 709
           N++ V G C     LH       +L++V +Y+    L  +LS   D   +++       M
Sbjct: 53  NVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA- 768
           +  I  ++  +H       VHRDI   NVLLD      ++DFG    +  D +  + +A 
Sbjct: 112 VLAI-HSIHQLH------YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164

Query: 769 GTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 806
           GT  Y++PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F     +GKGG G V   ++ A+G++ A K+       +   +   LNE + L ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLG-----WTRRMNMIKGI 713
           +V          +L   YE      L + + N    K    N+G       R +     I
Sbjct: 62  VV----------NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI 111

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGY 773
           +  L  +H +     V+RD+  +N+LLD      +SD G+A  + P+  +     GT GY
Sbjct: 112 LCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGY 167

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +APE+    + T   D +  G L  E+I+G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 38/265 (14%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G+VY +  L +  I+AVK    PL   +  Q++ ++E++ L +     I+  YG
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 669 FCLHVRHLFIVYEYFKMCSLAV-------ILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
                  + I  E+    SL V       +L   A A              +V  L+Y+ 
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------------VVKGLTYLW 112

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           +     I+HRD+   N+L++   +  + DFG++  L   +S      GT  Y+APE    
Sbjct: 113 S---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISG 167

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD---PRLPTPSRN 838
            +     DV+S G+  +E+  G+ P   I     S + L + L  ++D   P LP     
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP----- 221

Query: 839 VHDKLISIVEVTISCVDENPESRPT 863
           V       V     C+ + P+ RP 
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 23/205 (11%)

Query: 609 CIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           C+ KG    VY  K+   +I +A+K   +    E + + E + E + + ++ +  IV++ 
Sbjct: 10  CVKKG----VY--KMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
           G C     L +V E      L   LS       +  +  + ++  +   + Y+    F  
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF-- 116

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELAYTM 782
            VHRD++++NVLL  ++ A +SDFG++K L  D S +   A + G     + APE     
Sbjct: 117 -VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFR 173

Query: 783 KVTEKCDVYSFGVLALEVIK-GKHP 806
           K + + DV+S+G+   E    G+ P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 39/275 (14%)

Query: 611 GKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYG 668
           GK  + + Y +SK  +   +AVK          + ++  ++E+K ++ +  H NIV + G
Sbjct: 49  GKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLG 106

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY-------MH 721
            C     + ++ EY     L   L            R+      + D LS+       M 
Sbjct: 107 ACTIGGPILVITEYCCYGDLLNFLR-----------RKRESFLTLEDLLSFSYQVAKGMA 155

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPEL 778
                  +HRD++++NVLL       + DFG+A+ +  D SN+           ++APE 
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWMAPES 214

Query: 779 AYTMKVTEKCDVYSFGVLALEVIK-GKHPR-DFISSMSFSSLNLNIALDEMLDPRLPTPS 836
            +    T + DV+S+G+L  E+   G +P         F  L        M  P      
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--RMAQPEHAPA- 271

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                    I ++  +C D +P  RPT +++ QL+
Sbjct: 272 --------EIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 29/230 (12%)

Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           ++E   EV  L+ + H NIV+         +L+IV +Y   C    +     A + + + 
Sbjct: 43  REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY---CEGGDLYKKINAQRGVLFP 99

Query: 705 RR--MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               ++    I  AL ++H+     I+HRDI S+N+ L  +    + DFGIA+ L    +
Sbjct: 100 EDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----N 152

Query: 763 NWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL 818
           +  ELA    GT  Y++PE+        K D+++ G +  E+   KH        +F + 
Sbjct: 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH--------AFEAG 204

Query: 819 NL-NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           N+ N+ L  +     P  S   +D L ++V         NP  RP++  +
Sbjct: 205 NMKNLVLKIIRGSYPPVSSHYSYD-LRNLVS---QLFKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 7/200 (3%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV-Y 667
           +GKGG G V   ++ A+G++ A KK +     +    +  + E + L ++  R IV + Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
            F      L +V        L   + N D         R       I+  L ++H     
Sbjct: 61  AFQTKT-DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
            I++RD+  +NVLLD +    +SD G+A  LK   S     AGT G++APEL    +   
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 787 KCDVYSFGVLALEVIKGKHP 806
             D ++ GV   E+I  + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.2 bits (147), Expect = 1e-09
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 50/228 (21%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEF-----LNEVKALTE 657
           ++    IG G  G V  +    +G  +A+KK          F         L E+K L  
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS------NVFDDLIDAKRILREIKLLRH 55

Query: 658 IWHRNIVKVYGFCLHV-----RHLFIVYEYFKMCSLAVI-----LSNDAAAKNLGWTRRM 707
           + H NI+ +              ++IV E  +     VI     L++D     L      
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL-----Y 110

Query: 708 NMIKGIVDALSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS--- 762
            +++G    L Y+H  N     ++HRD+   N+L++   +  + DFG+A+ + PD     
Sbjct: 111 QILRG----LKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 763 NWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKH 805
             TE   T  Y APEL      YT  +    D++S G +  E++  K 
Sbjct: 162 FLTEYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 604 FDDEHCIGKGGQGSV-YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           + D   +G G  G+V       +G  +A+KK + P   E+ F +    E++ L  + H N
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHEN 75

Query: 663 IVKVYGF-----CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
           ++ +         L   H F    Y  M  +   L      + L   R   ++  ++  L
Sbjct: 76  VIGLLDVFTPDLSLDRFHDF----YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG---TYGYV 774
            Y+H      I+HRD+   N+ ++ + E  + DFG+A+  + DS    E+ G   T  Y 
Sbjct: 132 KYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDS----EMTGYVVTRWYR 182

Query: 775 APELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
           APE+    M  T+  D++S G +  E++ GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 86/288 (29%), Positives = 124/288 (43%), Gaps = 35/288 (12%)

Query: 223 NKLSGSIPISMGNLSNLTYLNLFENSL--SGAIPYEYRNLVKLTILLLGHNQFRGPIPIL 280
           N  S ++ +   +LS L  L+L   S   S        NL+ L  L L  N+ R  I  L
Sbjct: 53  NLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISEL 112

Query: 281 RNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFS 340
             LT+L  + LD N +T        +  NL  +DLS N     + S     P L  LD S
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNLDLS 171

Query: 341 INNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL 400
            N+++ ++P  + + S L  LDLS N I                           L P++
Sbjct: 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKI-------------------------SDLPPEI 205

Query: 401 GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLN 460
             L  LE LDLS+N +   +  SL NL+   LS L+LS N L E +P  I  + +LE L+
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKN--LSGLELSNNKL-EDLPESIGNLSNLETLD 261

Query: 461 LSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEAL 508
           LS+N +S    S    +  L  +D+S N L  ++P            L
Sbjct: 262 LSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307

Length = 394

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 24/227 (10%)

Query: 595 EEIIRATNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           E +   T+ ++    IGKG  G VY ++    G + AVK        +   + E+ N ++
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY-NILQ 73

Query: 654 ALTEIWHRNIVKVYGFCLHVRH-----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
           +L    H N+VK YG            L++V E   +C+   +          G      
Sbjct: 74  SLPN--HPNVVKFYGMFYKADKLVGGQLWLVLE---LCNGGSVTELVKGLLICGQRLDEA 128

Query: 709 MIK----GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
           MI     G +  L ++HN+    I+HRD+   N+LL  E    + DFG++  L       
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 765 TELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
               GT  ++APE+      Y      +CDV+S G+ A+E+  G  P
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 31/198 (15%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
           R  + FD    IG+G  G VY ++   +GE++A+KK       E  F    + E+K L +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQ 62

Query: 658 IWHRNIVKVY----------GFCLHVRHLFIVYEYFK------MCSLAVILSNDAAAKNL 701
           + HRNIV +            F       ++V+EY        + S  V  S D      
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK--- 119

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
                 + +K +++ L+Y H   F   +HRDI   N+LL+ + +  ++DFG+A+    + 
Sbjct: 120 ------SFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 762 SN-WTELAGTYGYVAPEL 778
           S  +T    T  Y  PEL
Sbjct: 171 SRPYTNKVITLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.6 bits (147), Expect = 3e-09
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 1/87 (1%)

Query: 215 LSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR 274
           +  L L    L G IP  +  L +L  +NL  NS+ G IP    ++  L +L L +N F 
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 275 GPIP-ILRNLTSLERVRLDRNYLTGNI 300
           G IP  L  LTSL  + L+ N L+G +
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 3e-09
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 1/95 (1%)

Query: 346 GNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQ 405
           G +P +I     L  ++LS N I G IP  LG +     L L++N  +G +   LG L  
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 406 LEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN 440
           L  L+L+ N LS  +P +LG   L+H +  + + N
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR-LLHRASFNFTDN 525

Length = 623

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTE 657
           +DF+    IG+G  G V + K+  +G++ A+K  +     EM  + E   F  E   L  
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK---WEMLKRAETACFREERDVLVN 57

Query: 658 IWHRNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLGWTRRMNMIKGIV 714
              R I  + Y F     +L++V +Y+    L  +LS   D   +++       M+  I 
Sbjct: 58  GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI- 115

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGY 773
           D++  +        VHRDI   NVLLD      ++DFG    L  D +  + +A GT  Y
Sbjct: 116 DSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169

Query: 774 VAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 806
           ++PE+   M     +   +CD +S GV   E++ G+ P
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 38/214 (17%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE----FLNEVKALTEIW-HRNI 663
           +GKG  G V +++L  + E+ AVK     L  ++  Q +     + E + L     H  +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKV----LKKDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 664 VKVYGFCLHVR-HLFIVYEY-------FKMCSLAVILSNDA---AAKNLGWTRRMNMIKG 712
            +++  C   +  LF V EY       F +          A   AA+             
Sbjct: 59  TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE------------- 104

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV  L ++H      I++RD+   NVLLD E    ++DFG+ K         +   GT  
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD 161

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+          D ++ GVL  E++ G+ P
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 32/243 (13%)

Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL--SNDAAAKNLGW 703
           ++ L+E   L ++ H +++K+YG C     L ++ EY K  SL   L  S       LG 
Sbjct: 48  RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGS 107

Query: 704 TRRMNMIK---------GIVDALSYMHNDCFP-------PIVHRDISSKNVLLDFENEAH 747
               N             + D +S+               +VHRD++++NVL+    +  
Sbjct: 108 DGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMK 167

Query: 748 VSDFGIAKFLKPDSSNWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
           +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E++  G 
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227

Query: 805 HPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTM 864
           +P   I+     +L L          R+  P  N  +++ +++   ++C  + P+ RPT 
Sbjct: 228 NPYPGIAPERLFNL-LKTGY------RMERPE-NCSEEMYNLM---LTCWKQEPDKRPTF 276

Query: 865 QKV 867
             +
Sbjct: 277 ADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 16/198 (8%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H NIVK+  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDALSYMHNDC 724
                  L++V+E+     L   +  DA+  +      + +IK     ++  L++ H+  
Sbjct: 67  VIHTENKLYLVFEFLHQ-DLKKFM--DASPLS---GIPLPLIKSYLFQLLQGLAFCHSH- 119

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+    K 
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177

Query: 785 -TEKCDVYSFGVLALEVI 801
            +   D++S G +  E++
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.4 bits (144), Expect = 5e-09
 Identities = 26/66 (39%), Positives = 36/66 (54%)

Query: 432 LSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
           +  L L    LR  IP+ I  ++ L+ +NLS NS+ G IP     +  L  +D+SYN   
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 492 GSIPNS 497
           GSIP S
Sbjct: 480 GSIPES 485

Length = 623

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 11/200 (5%)

Query: 610 IGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G ++ +  + S +  A+K+    LP   +  ++   E   L ++ H NIV    
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM--NMIKGIVDALSYMHNDCFP 726
                 HL+IV EY   C    ++      +   +           +   + ++H     
Sbjct: 66  SFEADGHLYIVMEY---CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK--- 119

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
            ++HRDI SKN+ L    +  + DFG A+ L    +      GT  YV PE+   M    
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179

Query: 787 KCDVYSFGVLALEVIKGKHP 806
           K D++S G +  E+   KHP
Sbjct: 180 KSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 10/148 (6%)

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTYGYV 774
           AL+Y+H      I++RD+   NVLLD E    ++D+G+ K  L+P  +  +   GT  Y+
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYI 163

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE-MLDPRLP 833
           APE+          D ++ GVL  E++ G+ P D + S      N    L + +L+ ++ 
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 223

Query: 834 TPSRNVHDKLISIVEVTISCVDENPESR 861
            P R++  K  S+++   S ++++P+ R
Sbjct: 224 IP-RSLSVKAASVLK---SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 27/153 (17%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL   N   + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 787 KCDVYSFGVLALEVIK-GKHP-------RDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
           + DV+SFGVL  E+   G  P        +F   +   +         M  P   TP   
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------RMRAPEYATP--- 303

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                  I  + + C   NPE RPT  ++ ++L
Sbjct: 304 ------EIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 16/204 (7%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEV---KALTEIWHRNIVK 665
           IG G  G+VY ++   SG  +A+K        E       + EV   K L    H NIV+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQ-TNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 666 VYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           +   C   R      + +V+E+     L   L        L      ++++  +  L ++
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H +C   IVHRD+  +N+L+    +  ++DFG+A+      +  T +  T  Y APE+  
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLL 180

Query: 781 TMKVTEKCDVYSFGVLALEVIKGK 804
                   D++S G +  E+ + K
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 6e-09
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 38/228 (16%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGE-MTFQQEFLNEVKALTEIWH 660
            + +   IG+G  G V  +    +G  +A+KK     P E  TF Q  L E+K L    H
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS---PFEHQTFCQRTLREIKILRRFKH 62

Query: 661 RNIVKVY------GFCLHVRHLFIVYEYFKMCSLAVI----LSNDAAAKNLGWTRRMNMI 710
            NI+ +        F      ++IV E  +     +I    LSND              +
Sbjct: 63  ENIIGILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQY---------FL 112

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTEL 767
             I+  L Y+H+     ++HRD+   N+LL+   +  + DFG+A+   P+  +    TE 
Sbjct: 113 YQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 768 AGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIK------GKHPRD 808
             T  Y APE+    K  T+  D++S G +  E++       GK    
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 27/220 (12%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            DFD +  +G+G  G V + +  A+G+I A+K     +   +   QE ++  +   +I  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV----MKKSVLLAQETVSFFEEERDILS 56

Query: 661 RN----IVKV-YGFCLHVRHLFIVYEYFKMCSLAVILS--NDAAAKNLGWTRRMNMIKGI 713
            +    I ++ Y F     +L++V EY     L  +L+   D   +++    +  + + +
Sbjct: 57  ISNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA---QFYLAE-L 111

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL-AGTYG 772
           V A+  +H   +   VHRDI  +NVL+D      ++DFG A  L  +    ++L  GT  
Sbjct: 112 VLAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 773 YVAPELAYTMKVTEK------CDVYSFGVLALEVIKGKHP 806
           Y+APE+  TM    K      CD +S GV+A E+I G+ P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG G V   ++ A+G++ A KK       +   +   LNE + L ++  R +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS--- 64

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLG-----WTRRMNMIKGIVDALSY 719
                  L   YE      L + + N    K    N+G       R +     +   L  
Sbjct: 65  -------LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED 117

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +  +    IV+RD+  +N+LLD      +SD G+A  + P+        GT GY+APE+ 
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVI 173

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
              K T   D +  G L  E+I+G+ P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 61/267 (22%), Positives = 113/267 (42%), Gaps = 42/267 (15%)

Query: 628 IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           ++AVK   + +    T + +FL E+K ++ + + NI+++ G C+    L ++ EY +   
Sbjct: 46  LVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 688 LAVILSND------AAAKNLGWTRRMN---MIKGIVDALSYMHNDCFPPIVHRDISSKNV 738
           L   LS          A N+      N   M   I   + Y+ +  F   VHRD++++N 
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRNC 160

Query: 739 LLDFENEAHVSDFGIAKFLKPDSSNWTELAG----TYGYVAPELAYTMKVTEKCDVYSFG 794
           L+       ++DFG+++ L   S ++  + G       ++A E     K T   DV++FG
Sbjct: 161 LVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 795 VLALEVIK--GKHPRDFISSMS--------FSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           V   E+     + P   +S           F +    I L +   P  P+P         
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQT--PLCPSP--------- 267

Query: 845 SIVEVTISCVDENPESRPTMQKVCQLL 871
            + ++ + C   + + RPT  K+   L
Sbjct: 268 -VFKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG G V   ++ A+G++ A KK       +   +   LNE + L ++  R +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS--- 64

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLG-----WTRRMNMIKGIVDALSY 719
                  L   YE      L + L N    K    N+G       R +     I   L  
Sbjct: 65  -------LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H +    IV+RD+  +N+LLD      +SD G+A  + P+        GT GY+APE+ 
Sbjct: 118 LHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVV 173

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
              + T   D +  G L  E+I+GK P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 46/282 (16%)

Query: 609 CIGKGGQGSVYMS--KLASGEII--AVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           CIG+G  G VY         E I  AVK   +     +   ++FL E   + +  H +IV
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDHPHIV 70

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDALSYMH 721
           K+ G       ++IV E   +  L   L       N       ++I     +  AL+Y+ 
Sbjct: 71  KLIGVI-TENPVWIVMELAPLGELRSYLQ-----VNKYSLDLASLILYSYQLSTALAYLE 124

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELA 779
           +  F   VHRDI+++NVL+   +   + DFG++++L+ D S +    G     ++APE  
Sbjct: 125 SKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESI 180

Query: 780 YTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSMSFSSLNLNIALDEMLDPRL 832
              + T   DV+ FGV   E++  G  P       D I  +                 RL
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------------RL 227

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQK-VCQLLKI 873
           P P  N    L S++     C   +P  RP   +   QL  I
Sbjct: 228 PMPP-NCPPTLYSLMT---KCWAYDPSKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 8e-09
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 38/212 (17%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQE-------FLNEVKALTEIWHR 661
           IG+G  G VY ++   +GEI+A+KK        +  + E        + E+  L E+ H 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKK--------IRLETEDEGVPSTAIREISLLKELNHP 58

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDAL 717
           NIV++         L++V+E+  +  L   +    ++   G    +  IK     ++  +
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFLDL-DLKKYMD---SSPLTGLDPPL--IKSYLYQLLQGI 112

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y H+     ++HRD+  +N+L+D E    ++DFG+A+        +T    T  Y APE
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169

Query: 778 L-----AYTMKVTEKCDVYSFGVLALEVIKGK 804
           +      Y+  V    D++S G +  E++  +
Sbjct: 170 ILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 33/293 (11%)

Query: 592 IIYEEIIRATNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLN 650
           II++     ++ ++    IGKG  G V+ +    +G   AVK        +   + E+ N
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY-N 66

Query: 651 EVKALTEIWHRNIVKVYG--FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
            +KAL++  H N+VK YG  +   V++   ++   ++C+   +   D     L    RM 
Sbjct: 67  ILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV--TDLVKGFLKRGERME 122

Query: 709 --MIKGIVD----ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
             +I  I+      L ++H +     +HRD+   N+LL  E    + DFG++  L     
Sbjct: 123 EPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 763 NWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS 817
                 GT  ++APE+             +CDV+S G+ A+E+  G  P         + 
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP--------LAD 231

Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTIS-CVDENPESRPTMQKVCQ 869
           L+   AL ++  PR P P+ +  +   +     I  C+ ++ E RPT+  + Q
Sbjct: 232 LHPMRALFKI--PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 38/215 (17%)

Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +A+K  +      M  + EFLNE   + E    ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVIL----SNDAAAKNLG---WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L            LG     + + M   I D 
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------FLKPDSS-----NWT 765
           ++Y+    F   VHRD++++N ++  +    + DFG+ +      + +          W 
Sbjct: 132 MAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
                   +APE       T K DV+SFGV+  E+
Sbjct: 188 --------MAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.8 bits (139), Expect = 1e-08
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)

Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIW 659
           DF+    IG+G  G V + KL + + +   K  +    EM  + E   F  E   L    
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGD 59

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLGWTRRMNMIKGIVDAL 717
           ++ I  ++       +L++V +Y+    L  +LS   D   +++       M+  I D++
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSV 118

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAP 776
             +H       VHRDI   N+L+D      ++DFG    L  D +  + +A GT  Y++P
Sbjct: 119 HQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172

Query: 777 ELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 806
           E+   M     K   +CD +S GV   E++ G+ P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 52/227 (22%), Positives = 97/227 (42%), Gaps = 24/227 (10%)

Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           +E L+E   +  +    + ++ G CL      +       C L  +  N      +G   
Sbjct: 54  KEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVREN---KDRIGSQD 110

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
            +N    I   +SY+       +VHRD++++NVL+   N   ++DFG+A+ L  D + + 
Sbjct: 111 LLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 766 ELAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNI 822
              G     ++A E     + T + DV+S+GV   E++  G  P D I +          
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------- 219

Query: 823 ALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            + ++L+   RLP P        I +  + + C   + E RP  +++
Sbjct: 220 -IPDLLEKGERLPQPPICT----IDVYMIMVKCWMIDSECRPRFREL 261

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 19/204 (9%)

Query: 608 HCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI--- 663
             +G G  GSV  +    +GE +A+KK   P   E+ F +    E+  L  + H N+   
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGL 79

Query: 664 --VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
             V            F +   +    L  I+ +  +   + +     M+ G    L Y+H
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV-YQMLCG----LKYIH 134

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           +     I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+   
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPEVILN 188

Query: 782 -MKVTEKCDVYSFGVLALEVIKGK 804
            M   +  D++S G +  E++ GK
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 39/270 (14%)

Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKG  GSVY +    +G  +A+K+    L  E  F Q  + E+  L +     IV  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQ-IIMELDILHKAVSPYIVDFYG 66

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNL--GWTRRMN--MIKGIVDALSYMHNDC 724
                  +++  EY    SL  + +   A + +     RR+   ++KG+   L   HN  
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL-KFLKEEHN-- 123

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE------- 777
              I+HRD+   NVL++   +  + DFG++  L    +  T + G   Y+APE       
Sbjct: 124 ---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-TNI-GCQSYMAPERIKSGGP 178

Query: 778 ---LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-FSSLNLNIALDEMLDPRLP 833
                YT+    + DV+S G+  LE+  G++P    +  + F+ L+   A+ +   P LP
Sbjct: 179 NQNPTYTV----QSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AIVDGDPPTLP 231

Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPT 863
           +   +     ++       C+++ P  RPT
Sbjct: 232 SGYSDDAQDFVA------KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 25/154 (16%)

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA 768
           + K I++ L Y+H      I+HRD+ ++N+ ++  ++  + D G A+F    +  +  LA
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA 217

Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML 828
           GT    APE+    K   K D++S G++  E++                      + E  
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS-----------------TIFEDP 260

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
                   ++ H  L+ I    IS +  +PE  P
Sbjct: 261 PSTPEEYVKSCHSHLLKI----ISTLKVHPEEFP 290

Length = 357

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 75/270 (27%), Positives = 118/270 (43%), Gaps = 40/270 (14%)

Query: 610 IGKGGQGSVYMSKLASGEII----AVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           IGKG  G VY   L   +      AVK  +     ++   ++FL E   + +  H N++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 666 VYGFCLHVRHL-FIVYEYFKMCSLAVIL---SNDAAAKNL-GWTRRMNMIKGIVDALSYM 720
           + G CL       +V  Y K   L   +   +++   K+L G+   + + KG    + Y+
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--LQVAKG----MEYL 114

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------FLKPDSSNWTELAGTYGYV 774
            +  F   VHRD++++N +LD      V+DFG+A+      +    +    +L     ++
Sbjct: 115 ASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKWM 169

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           A E   T K T K DV+SFGVL  E++ +G  P   + S   +   L          RL 
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-------GRRLL 222

Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPT 863
            P     D L    EV +SC    PE RPT
Sbjct: 223 QP-EYCPDPL---YEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 8/199 (4%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV-Y 667
           +GKG  G V + K  A+G   A+K     +          L E + L    H  +  + Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            F  H R  F++ EY     L   LS +   +     R       IV AL Y+H++    
Sbjct: 63  SFQTHDRLCFVM-EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE--KN 116

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           +V+RD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+         
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 788 CDVYSFGVLALEVIKGKHP 806
            D +  GV+  E++ G+ P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 53/230 (23%), Positives = 101/230 (43%), Gaps = 40/230 (17%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK---LASGE---IIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           N+ +    IG+G  G V+ ++   L   E   ++AVK        +M  Q +F  E   +
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 62

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFK---------------MCSLAVILSNDAAAK- 699
            E  H NIVK+ G C   + + +++EY                  CSL+   S+      
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 700 ---NLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI--- 753
               L  T ++ + K +   ++Y+    F   VHRD++++N L+       ++DFG+   
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 754 ---AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
              A + K   ++   +     ++ PE  +  + T + DV+++GV+  E+
Sbjct: 180 IYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 28/148 (18%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA---KFLKPDSSNWTELAG 769
           I+  L +MHN     +V+RD+   N+LLD      +SD G+A      KP +S      G
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 157

Query: 770 TYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP--------RDFISSMSFSSLNL 820
           T+GY+APE L   +      D +S G +  ++++G  P        +  I  M   +L +
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTM 214

Query: 821 NIALDEMLDPRLPTP-----SRNVHDKL 843
            + L +   P L +       R+V+ +L
Sbjct: 215 AVELPDSFSPELRSLLEGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           AL ++H+     I++RD+  +N+LLD E    ++DFG++K             GT  Y+A
Sbjct: 110 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           PE+      T+  D +SFGVL  E++ G  P
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 2/101 (1%)

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           IV+RD+  +NVLLD +    +SD G+A  L  D    T+ AGT GY+APE+      +  
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 788 CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEM 827
            D ++ G    E++ G+ P +D    ++   L      DE+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 16/208 (7%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG+G    V + +L   + I   K    +  E+    E ++ V+    ++ +     +  
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKV---VKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59

Query: 670 CLH-----VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
            LH        LF+V EY     L   +      + L           I  AL+++H   
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER- 115

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMK 783
              I++RD+   NVLLD +    ++D+G+ K  L P  +  T   GT  Y+APE+    +
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEE 172

Query: 784 VTEKCDVYSFGVLALEVIKGKHPRDFIS 811
                D ++ GVL  E++ G+ P D I+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIIT 200

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 27/81 (33%), Positives = 43/81 (53%)

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           I++RD+   NV+LD E    ++DFG+ K    D        GT  Y+APE+       + 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 788 CDVYSFGVLALEVIKGKHPRD 808
            D +++GVL  E++ G+ P D
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 5e-08
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 32/232 (13%)

Query: 594 YEEIIR-------ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVK---KFHSPLPGEM 642
           YE+I+R          D+D    IG+G  G V + +  +S ++ A+K   KF      + 
Sbjct: 28  YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNL 701
            F  E  + +      W   +V+++      ++L++V EY     L  ++SN D   K  
Sbjct: 88  AFFWEERDIMAFANSPW---VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-- 142

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
            W +       +V AL  +H+     ++HRD+   N+LLD      ++DFG    +K D 
Sbjct: 143 -WAKFYT--AEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDE 194

Query: 762 SNWTEL---AGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 806
           +         GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 15/201 (7%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G VY  +   +G+I+A+KK       E       + E+  L E+ H NIV +  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQD 66

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             +    L++++E+  M  L   L +    + +      + +  I+  + + H+     +
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMK 783
           +HRD+  +N+L+D +    ++DFG+A+        +T    T  Y APE+      Y+  
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182

Query: 784 VTEKCDVYSFGVLALEVIKGK 804
           V    D++S G +  E+   K
Sbjct: 183 V----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 9/199 (4%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV-Y 667
           +GKG  G V + +  ASG+  A+K     +          L E + L    H  +  + Y
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            F    R  F++ EY     L   LS +   +     R       IV AL Y+H+     
Sbjct: 63  SFQTKDRLCFVM-EYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---K 115

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           IV+RD+  +N++LD +    ++DFG+ K    D++      GT  Y+APE+         
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 788 CDVYSFGVLALEVIKGKHP 806
            D +  GV+  E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 30/210 (14%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE----FLNEVKALT-EIWHRNI 663
           +GKG  G V +++L  SG + AVK     L  ++  Q +     + E + L+    H  +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKV----LKKDVILQDDDVECTMTEKRILSLARNHPFL 58

Query: 664 VKVYGFCLHV-RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG------IVDA 716
            ++Y  C      LF V E+     L   +           +RR +  +       I  A
Sbjct: 59  TQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQK---------SRRFDEARARFYAAEITSA 108

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           L ++H+     I++RD+   NVLLD E    ++DFG+ K    +    +   GT  Y+AP
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAP 165

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           E+   M      D ++ GVL  E++ G  P
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 39/285 (13%)

Query: 603 DFDDEHCIGKGGQGSVY--MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-W 659
           D   E  IG+G  G V   M K    ++ A  K       E    ++F  E++ L ++  
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-HRDFAGELEVLCKLGH 61

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSL-------AVILSNDAAAKNLGWTRRMN---M 709
           H NI+ + G C +  +L+I  EY    +L        V+ ++ A AK  G    +    +
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
           ++   D  + M        +HRD++++NVL+     + ++DFG+++           +  
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKK 175

Query: 770 TYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNI 822
           T G     ++A E L Y++  T K DV+SFGVL  E++  G  P      M+ + L   +
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTP---YCGMTCAELYEKL 231

Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                   R+  P RN  D+   + E+   C  + P  RP   ++
Sbjct: 232 PQGY----RMEKP-RNCDDE---VYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.8 bits (132), Expect = 9e-08
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 15/215 (6%)

Query: 593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNE 651
           I+  +   TN + D   +G G  G V  ++   +G+ +A+KK   P    +  ++ +  E
Sbjct: 1   IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RE 59

Query: 652 VKALTEIWHRNIVKVYG-FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
           +K L  + H NI+ +   F   +  ++ V E      L  +L++    K         ++
Sbjct: 60  LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL 118

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
           +G    L Y+H+     +VHRD+   N+L++   +  + DFG+A   +      T    T
Sbjct: 119 RG----LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVST 168

Query: 771 YGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
             Y APE+  T  K   + D++S G +  E+++GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 6/123 (4%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV AL Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           Y+APE+          D +  GV+  E++ G+ P     +     L   I ++E+  PR 
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRT 217

Query: 833 PTP 835
            +P
Sbjct: 218 LSP 220

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 23/134 (17%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA---KFLKPDSSNWTELAG 769
           I+  L +MHN     +V+RD+   N+LLD      +SD G+A      KP +S      G
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 157

Query: 770 TYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP--------RDFISSMSFSSLNL 820
           T+GY+APE L          D +S G +  ++++G  P        +  I  M   +L +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTV 214

Query: 821 NIALDEMLDPRLPT 834
           N+ L +   P L +
Sbjct: 215 NVELPDSFSPELKS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 65/290 (22%), Positives = 125/290 (43%), Gaps = 47/290 (16%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           ND   +  IG+G  G V  +++    +    A+K+            ++F  E++ L ++
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKL 64

Query: 659 W-HRNIVKVYGFCLHVRHLFIVYEYFKMCSL------AVILSNDAA-------AKNLGWT 704
             H NI+ + G C H  +L++  EY    +L      + +L  D A       A  L   
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
           + ++    +   + Y+    F   +HRD++++N+L+     A ++DFG+++         
Sbjct: 125 QLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQE 175

Query: 765 TELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSS 817
             +  T G     ++A E L Y++  T   DV+S+GVL  E++  G  P      M+ + 
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP---YCGMTCAE 231

Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           L   +     L+  L     N  D++  ++     C  E P  RP+  ++
Sbjct: 232 LYEKLPQGYRLEKPL-----NCDDEVYDLMR---QCWREKPYERPSFAQI 273

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 27/81 (33%), Positives = 43/81 (53%)

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           I++RD+   NV+LD E    ++DFG+ K    D        GT  Y+APE+       + 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181

Query: 788 CDVYSFGVLALEVIKGKHPRD 808
            D ++FGVL  E++ G+ P +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 5/97 (5%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I   L ++H+     I++RD+   NV+LD E    ++DFG+ K  +    +  T   GT 
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 808
            Y+APE+       +  D ++FGVL  E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 30/211 (14%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP------GEMTFQQ---EFLNEVKALTEIWH 660
           +G G  G VY      G           L        E   +Q   +FL E   +++  H
Sbjct: 14  LGHGAFGEVYE-----GLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM----NMIKGIVDA 716
           +NIV++ G        FI+ E      L   L  +        +  M       + +   
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT--- 770
             Y+  + F   +HRDI+++N LL  +     A ++DFG+A+ +    +++    G    
Sbjct: 129 CKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAML 183

Query: 771 -YGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
              ++ PE       T K DV+SFGVL  E+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 18/220 (8%)

Query: 589 EGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI--IAVKKFHSPLPGEMTFQQ 646
           + K+ YE       DF+    +G G  G V ++   + +   +A+K+F      +     
Sbjct: 24  KNKMKYE-------DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
              +E K L  I H   V +YG      +L++V E+         L  +    N      
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY 136

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
              I  I + L  ++      IV+RD+  +N+LLD +    ++DFG AK +  D+  +T 
Sbjct: 137 AAQIVLIFEYLQSLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT- 187

Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           L GT  Y+APE+   +   +  D ++ G+   E++ G  P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 53/265 (20%), Positives = 108/265 (40%), Gaps = 27/265 (10%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           I +  Q S+Y     + + + ++ F     G         NE+K L  I   NI+K+YGF
Sbjct: 28  IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86

Query: 670 CLHVR----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
            + +      L ++ EY     L  +L  +   K+L +  +++M       L  ++    
Sbjct: 87  IIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN 143

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTM-- 782
            P  +++++S + L+    +  +   G+ K L  P   N   +     Y + ++   +  
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFS 197

Query: 783 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK 842
           + T K D+YS GV+  E+  GK P + +++     L +N      L    P   + + + 
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257

Query: 843 LISIVEVTISCVDENPESRPTMQKV 867
                     C   +   RP ++++
Sbjct: 258 ----------CTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 5/108 (4%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I  AL+++H      I++RD+   NVLLD E    ++D+G+ K  ++P  +  T   GT 
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTP 160

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN 819
            Y+APE+          D ++ GVL  E++ G+ P D +        N
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG I+A K  H  L  +   + + + E++ L E   
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL--SNDAAAKNLGWTRRMNMIKGIVDALS 718
             IV  YG       + I  E+    SL  +L  +     + LG    + +IKG    L+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----LT 117

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE 
Sbjct: 118 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                 + + D++S G+  +E+  G++P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 27/268 (10%)

Query: 610 IGKGGQGSVYM---SKLASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKA--LTEIWHRNI 663
           +GKG  G+VY+    K  + E + V K    +P GE+   +      +A  L+++ H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLK---EIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           VK +   L      I+ EY +   L   L       K L   +       ++  + YMH 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                I+HRD+ +KN+ L   N   + DFG+++ L       T   GT  Y++PE     
Sbjct: 125 R---RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 783 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP-TPSRNVHD 841
               K D++S G +  E+    H   F    +F S+ L I   E   P LP T SR    
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHA--FEGQ-NFLSVVLRIV--EGPTPSLPETYSR---- 231

Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQ 869
           +L SI++   S ++++P  RP+  ++ +
Sbjct: 232 QLNSIMQ---SMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 26/79 (32%), Positives = 42/79 (53%)

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           +++RD+  +N+LLD++    + DFG+ K    D        GT  Y+APEL      T+ 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 788 CDVYSFGVLALEVIKGKHP 806
            D ++ GVL  E++ G  P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 17/148 (11%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL   N   + DFG+A+  +  PD            ++APE  +    T 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 787 KCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
           + DV+SFGVL  E+   G  P               + ++E    RL   +R    +  +
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYP------------GVQINEEFCQRLKDGTRMRAPENAT 303

Query: 846 --IVEVTISCVDENPESRPTMQKVCQLL 871
             I  + ++C   +P+ RPT   + ++L
Sbjct: 304 PEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 29/89 (32%), Positives = 43/89 (48%)

Query: 289 VRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNV 348
           + LD   L G I        +L  I+LS N+  G I    G    L  LD S N+  G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 349 PPEIGHSSQLGVLDLSSNHIVGEIPIELG 377
           P  +G  + L +L+L+ N + G +P  LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           +  AL ++H      +++RD+   N+LLD E    ++DFG+ K    +    T   GT  
Sbjct: 105 VTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+   ++     D ++ GVL  E++ G+ P
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 40/235 (17%)

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L                   + L +   
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 707 MNMIKGIVDALSYMHND-CFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------FLKP 759
           ++    +   + Y+ +  C    +HRD++++NVL+  +N   ++DFG+A+      + K 
Sbjct: 137 VSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSL 818
            S+    +     ++APE  +    T + DV+SFG+L  E+   G  P   I       L
Sbjct: 193 TSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248

Query: 819 NLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
                L E    R+  PS   H+  + + E    C    P  RPT +++ + L  
Sbjct: 249 -----LRE--GHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALDK 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 40/225 (17%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFH-SPLPGEMTFQQEF----------LNEVKALTE 657
           +G+G  G V  +    +G+I+A+KK     +  ++T  ++           L E+K + E
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 658 IWHRNIVKVYGFCLHVRHLFI--VYEYFKMCS-LAVILSNDAAAKNLGWTRRMNMIKGIV 714
           I H NI+ +    ++V   FI  V +   M S L  ++        L  ++   ++  I+
Sbjct: 77  IKHENIMGLVD--VYVEGDFINLVMDI--MASDLKKVVDRKI---RLTESQVKCILLQIL 129

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA-KFLKPDSS----------- 762
           + L+ +H   +   +HRD+S  N+ ++ +    ++DFG+A ++  P  S           
Sbjct: 130 NGLNVLHK-WY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 763 --NWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
               T    T  Y APEL     K     D++S G +  E++ GK
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 18/181 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+ ++   + +I+A+KK       E  F    L E+K L  + H N+V +  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 78

Query: 669 FC-----LHVRHLFIVYEYFKMCS--LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            C      + R+    Y  F+ C   LA +LSN      L   +++  +K +++ L Y+H
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--MKMLLNGLYYIH 136

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL----KPDSSNWTELAGTYGYVAPE 777
                 I+HRD+ + N+L+  +    ++DFG+A+          + +T    T  Y  PE
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 778 L 778
           L
Sbjct: 194 L 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 5/96 (5%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I+ AL ++H      IV+RDI  +N+LLD E    ++DFG++K FL  +        GT 
Sbjct: 114 IILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 772 GYVAPELAYTMKVTEKC-DVYSFGVLALEVIKGKHP 806
            Y+APE+        K  D +S G+L  E++ G  P
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 20/151 (13%)

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVT 785
           ++HRDI S N+LL       + DFG +K      S+       GT  YVAPE+      +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL-PTPSRNVHDKLI 844
           +K D++S GVL  E++  K P        F   N+   + + L  R  P P  ++  ++ 
Sbjct: 224 KKADMFSLGVLLYELLTLKRP--------FDGENMEEVMHKTLAGRYDPLPP-SISPEMQ 274

Query: 845 SIVEVTISCVDENPESRPTMQK-----VCQL 870
            IV   +S    +P+ RP+  K     +C+L
Sbjct: 275 EIVTALLS---SDPKRRPSSSKLLNMPICKL 302

Length = 496

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 56/304 (18%)

Query: 603 DFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           DF+    +G G  G V  +    SG I+A K  H  L  +   + + + E+K L E    
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSP 59

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG-----IVDA 716
            IV  YG       + I  E+    SL      D   K  G  R    I G     ++  
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAG--RIPENILGKISIAVLRG 111

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           L+Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++P
Sbjct: 112 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSP 167

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFISSMSFSSLN 819
           E       T + D++S G+  +E+  G++P                  +  +  S   ++
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227

Query: 820 LN-------IALDEMLD-------PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
            +       +A+ E+LD       P+L  PS    D+    V+    C+ +NP+ R  ++
Sbjct: 228 GHPPDSPRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVD---KCLKKNPKERADLK 282

Query: 866 KVCQ 869
           ++ +
Sbjct: 283 ELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 10/206 (4%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V  +    SG I+A K  H  L  +   + + + E++ L E   
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             IV  YG       + I  E+    SL  +L     AK +       +   ++  L+Y+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYL 119

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
                  I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE   
Sbjct: 120 REK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQ 175

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
               + + D++S G+  +E+  G++P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 6/100 (6%)

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELA 768
           I  IV AL ++H      I++RDI  +N+LLD E    ++DFG++K FL  +        
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167

Query: 769 GTYGYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 806
           GT  Y+APE+         +  D +S GVL  E++ G  P
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 52.6 bits (127), Expect = 4e-07
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 63/227 (27%)

Query: 610 IGKGGQGSVY--MSKLASGEIIAVKK----FHSPLPGEMTFQQ-EFLNEVKALTEIWHRN 662
           +GKG  G V+  + +  + E++A+KK    F +    + TF++  FL E+       H N
Sbjct: 15  LGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD-----HPN 68

Query: 663 IVKVYGFCLHV------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI--- 713
           IVK+    L+V      + +++V+EY +    AVI              R N+++ +   
Sbjct: 69  IVKL----LNVIKAENDKDIYLVFEYMETDLHAVI--------------RANILEDVHKR 110

Query: 714 ------VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--- 764
                 + AL Y+H+     ++HRD+   N+LL+ +    ++DFG+A+ L     N    
Sbjct: 111 YIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 765 --TELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 804
             T+   T  Y APE+      YT  V    D++S G +  E++ GK
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 17/148 (11%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL   N   + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 787 KCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
           + DV+SFGVL  E+   G  P               + +DE    RL   +R       +
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYP------------GVKIDEEFCRRLKEGTRMRAPDYTT 308

Query: 846 --IVEVTISCVDENPESRPTMQKVCQLL 871
             + +  + C    P  RPT  ++ + L
Sbjct: 309 PEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 15/211 (7%)

Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           D++    IG+G  G V + +  S   +   K  S           F  E + +    +  
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 663 -IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYM 720
            +V+++      R+L++V EY     L  ++SN D   K   W R       +V AL  +
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYT--AEVVLALDAI 158

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAPELA 779
           H+  F   +HRD+   N+LLD      ++DFG    +  +     + A GT  Y++PE+ 
Sbjct: 159 HSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215

Query: 780 YTMK----VTEKCDVYSFGVLALEVIKGKHP 806
            +         +CD +S GV   E++ G  P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.4 bits (125), Expect = 7e-07
 Identities = 52/237 (21%), Positives = 94/237 (39%), Gaps = 50/237 (21%)

Query: 650 NEVKALTEIWHRNIVKV--------YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNL 701
           NE+ AL  + H NI+K+          + +  ++ F +Y +    +       D   + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA-KFLKPD 760
               R  M K ++ A+ Y+H+     ++HRDI  +N+ L+ + +  + DFG A  F K  
Sbjct: 266 LKQTRAIM-KQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-------------GKHPR 807
            +      GT    +PE+       E  D++S G++ L+++              GK   
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381

Query: 808 DFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTM 864
             I S+S            + D   P P   + D + S      + +D    S P +
Sbjct: 382 KIIDSLS------------VCDEEFPDPPCKLFDYIDS------AEIDHAGHSVPPL 420

Length = 501

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 37/282 (13%)

Query: 610 IGKGGQGSVYMSKLASG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           IG G  G V + ++ SG     + VK+        +  Q +FL E +    + H N+++ 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM--NMIKGIVDALSYMHNDC 724
            G C  V    +V E+  +  L   L +   A+ +         M   I   L ++H + 
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAK-------FLKPDSSNWTELAGTYGYVAPE 777
           F   +H D++ +N LL  +    + D+G++        ++ PD   W  L     ++APE
Sbjct: 121 F---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----WIAPE 172

Query: 778 LA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
           L          +  T++ +V+S GV   E+ + G  P   +S     +  +     ++  
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232

Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           PRL  P  +         EV   C  + PE RP+ ++V  LL
Sbjct: 233 PRLKLPLSD------RWYEVMQFCWLQ-PEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.4 bits (123), Expect = 8e-07
 Identities = 53/241 (21%), Positives = 105/241 (43%), Gaps = 23/241 (9%)

Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--------DA 696
           + +FL E+K ++ +   NI+++   C+    L ++ EY +   L   LS          A
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 697 AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF 756
               + ++  + M   I   + Y+ +  F   VHRD++++N L+       ++DFG+++ 
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCLVGKNYTIKIADFGMSRN 179

Query: 757 LKPDSSNWTELAG----TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFI 810
           L   S ++  + G       +++ E     K T   DV++FGV   E++    + P   +
Sbjct: 180 LY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237

Query: 811 SSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL 870
           S             D+     LP P+        S+ ++ +SC   N + RP+ Q++   
Sbjct: 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPD----SLYKLMLSCWRRNAKERPSFQEIHAT 293

Query: 871 L 871
           L
Sbjct: 294 L 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 21/151 (13%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKV 784
           +HRD++++NVLL     A + DFG+A+ +  DS N+  + G       ++APE  +    
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYV-VKGNARLPVKWMAPESIFDCVY 291

Query: 785 TEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD--EMLDPRLPTPSRNVHD 841
           T + DV+S+G+L  E+   GK P      +  +S    +     +M  P    P      
Sbjct: 292 TVQSDVWSYGILLWEIFSLGKSP---YPGILVNSKFYKMVKRGYQMSRPDFAPPE----- 343

Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               I  +   C +  P  RPT  ++ QL++
Sbjct: 344 ----IYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 41/229 (17%)

Query: 605 DDEHCIGKGGQGS---VYMS-KLASGEIIAVKKF--HSPLPGEMTFQQEFLNEVKALTEI 658
            D   +GK G+G+   VY + ++ +G ++A+KK   H+   G   F    L E+K L ++
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKL 64

Query: 659 WHRNIVKVYGFCL-----HVRHLFIVYEYFK-MCS-LAVILSNDAAAKNLGWTRRMNMIK 711
            H N+V +    +       R    VY     M   L+ +L N +    L  ++    + 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQIKCYML 122

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW------- 764
            +++ ++Y+H +    I+HRDI + N+L+D +    ++DFG+A+       N        
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 765 ----TELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGK 804
               T L  T  Y  PEL      YT  V    D++  G +  E+   +
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 38/230 (16%)

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL----------SNDAAA---KNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L          S D      + L +   
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+    D  N   
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDY 189

Query: 767 LAGTYG------YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN 819
              T        ++APE  +    T + DV+SFGVL  E+   G  P   I       L 
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL- 248

Query: 820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
               L E    R+  P+   H+  + + E    C    P  RPT +++ +
Sbjct: 249 ----LKE--GHRMDKPANCTHELYMIMRE----CWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 14/139 (10%)

Query: 674 RHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRD 732
           ++L++V EY     L  ++SN D   K   W R       +V AL  +H+  F   +HRD
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYDIPEK---WARFYTA--EVVLALDAIHSMGF---IHRD 167

Query: 733 ISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAPELAYTMKVT----EK 787
           +   N+LLD      ++DFG    +  +     + A GT  Y++PE+  +         +
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 788 CDVYSFGVLALEVIKGKHP 806
           CD +S GV   E++ G  P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 35/150 (23%), Positives = 69/150 (46%), Gaps = 19/150 (12%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVT 785
           VHRD++++NVLL       + DFG+A+ +  D SN+     T+    ++APE  +    T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYT 317

Query: 786 EKCDVYSFGVLALEVIK---GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK 842
              DV+S+G+L  E+       +P   + S  ++ +            R+  P     + 
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY--------RMAKPDHATQE- 368

Query: 843 LISIVEVTISCVDENPESRPTMQKVCQLLK 872
              + ++ + C +  PE RP+   +  +++
Sbjct: 369 ---VYDIMVKCWNSEPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 56/248 (22%)

Query: 602 NDFDDEHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 658
           +DF+    IG+G  G V +  K  +G I A+K        +M  ++E +  ++A  +I  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK---ADM-LEKEQVAHIRAERDILV 56

Query: 659 -----WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI 713
                W   +VK++      R+L+++ E+     +  +L        L        I   
Sbjct: 57  EADGAW---VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAET 110

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK--------------P 759
           V A+  +H   F   +HRDI   N+LLD +    +SDFG+   LK              P
Sbjct: 111 VLAIDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167

Query: 760 DS-----------------SNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLAL 798
            S                  N  +LA    GT  Y+APE+       + CD +S GV+  
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 799 EVIKGKHP 806
           E++ G  P
Sbjct: 228 EMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 18/201 (8%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +     G  +AVKK   P   + T  +    E+  L  + H+NI+ +  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLN 87

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +    +     L   R   ++  ++  + ++H+  
Sbjct: 88  VFTPQKSL----EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS-- 141

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTM 782
              I+HRD+   N+++  +    + DFG+A+      +N+  T    T  Y APE+   M
Sbjct: 142 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 783 KVTEKCDVYSFGVLALEVIKG 803
              E  D++S G +  E++KG
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 59/280 (21%), Positives = 116/280 (41%), Gaps = 34/280 (12%)

Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 71

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVIL------SNDAAAKNLGWTRRM-NMIKGIVDA 716
           V++ G     +   +V E      L   L      + +   +     + M  M   I D 
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YG 772
           ++Y++   F   VHRD++++N ++  +    + DFG+ + +    +++    G       
Sbjct: 132 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 186

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           ++APE       T   D++SFGV+  E+         ++   +  L+    L  ++D   
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGY 239

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                N  +++  ++ +   C   NP+ RPT  ++  LLK
Sbjct: 240 LDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 74/307 (24%), Positives = 121/307 (39%), Gaps = 76/307 (24%)

Query: 602 NDFDDEHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 658
            DF     IGKG  G V +  K  +G+I A+K   + L  EM F+++ L  VKA  ++  
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEM-FKKDQLAHVKAERDVLA 56

Query: 659 -----WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKG 712
                W   +V +Y      ++L+++ E+     L  +L   D  ++++  TR    +  
Sbjct: 57  ESDSPW---VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV--TRFY--MAE 109

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSN-WTEL--- 767
            V A+  +H   F   +HRDI   N+L+D      +SDFG++  F K   S  + +L   
Sbjct: 110 CVLAIEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166

Query: 768 ------------------------------------------AGTYGYVAPELAYTMKVT 785
                                                      GT  Y+APE+       
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML----DPRLPTPSRNVHD 841
           ++CD +S G +  E + G  P  F S  S  +    I   E L    D  L   + ++  
Sbjct: 227 QECDWWSLGAIMFECLIGWPP--FCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIR 284

Query: 842 KLISIVE 848
           +LI+  E
Sbjct: 285 RLITNAE 291

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 4/98 (4%)

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
           I  +V AL ++H      IV+RD+  +N+LLD      + DFG++K    D+       G
Sbjct: 102 IAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158

Query: 770 TYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+    K  T+  D +S GVL  E+  G  P
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV AL Y+H+     +V+RD+  +N++LD +    ++DFG+ K    D +      GT  
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 57/244 (23%), Positives = 108/244 (44%), Gaps = 42/244 (17%)

Query: 645 QQEFLNEVKALTEIWHR-NIVKVYGFCLHVRHLFIVYEYFKMCSL------AVILSNDAA 697
            ++F  E++ L ++ H  NI+ + G C H  +L++  EY    +L      + +L  D A
Sbjct: 39  HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 98

Query: 698 -------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD 750
                  A  L   + ++    +   + Y+    F   +HRD++++N+L+     A ++D
Sbjct: 99  FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIAD 155

Query: 751 FGIAKFLKPDSSNWTELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-G 803
           FG+++           +  T G     ++A E L Y++  T   DV+S+GVL  E++  G
Sbjct: 156 FGLSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLG 208

Query: 804 KHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
             P      M+ + L   +        RL  P  N  D+   + ++   C  E P  RP+
Sbjct: 209 GTP---YCGMTCAELYEKLPQGY----RLEKP-LNCDDE---VYDLMRQCWREKPYERPS 257

Query: 864 MQKV 867
             ++
Sbjct: 258 FAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 30/166 (18%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW---TELAG 769
           IV AL  +H+     ++HRD+ S N+ L       + DFG +K    DS +    +   G
Sbjct: 178 IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCG 233

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI------KGKHPRDFISSMSFSSLNLNIA 823
           T  Y+APEL    + ++K D++S GV+  E++      KG   R+ +  + +        
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK------ 287

Query: 824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                DP  P P   V   + ++++  +S   +NP  RPT Q++  
Sbjct: 288 ----YDP-FPCP---VSSGMKALLDPLLS---KNPALRPTTQQLLH 322

Length = 478

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 50/247 (20%)

Query: 602 NDFDDEHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    IG+G  G V++     +G++ A+K        +         E   L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 661 RNIVKVYGFCLHVRHLFIVYEYF---KMCSLAV---ILSNDAAAKNLGWTRRMNMIKGIV 714
             IVK+Y       HL++V EY     + +L +   +   +         R    I  +V
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-------TARFY--IAELV 111

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------------------- 755
            AL  +H   F   +HRDI   N+L+D +    ++DFG+ K                   
Sbjct: 112 LALDSVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 756 FLKPDSSNWTEL----------AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 805
           F         +            GT  Y+APE+        +CD +S GV+  E++ G  
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Query: 806 PRDFISS 812
           P  F S 
Sbjct: 229 P--FYSD 233

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           IV AL ++H      I++RDI  +N+LLD      ++DFG++K F + +        GT 
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170

Query: 772 GYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 806
            Y+AP++         +  D +S GVL  E++ G  P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 35/282 (12%)

Query: 610 IGKGGQGSVYMSKLASGEII---AVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +G+G  GSV   +L   + I   AVK     +    +  ++FL+E   + E  H N++++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRL 65

Query: 667 YGFCLHVRHL------FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            G CL            ++  + K   L   L          +     ++K + D  S M
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA-KFLKPDSSNWTELAGT-YGYVAPEL 778
                   +HRD++++N +L+      V+DFG++ K    D      +A     ++A E 
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185

Query: 779 AYTMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-----PRL 832
                 T K DV+SFGV   E+  +G+ P   + +             E+ D      RL
Sbjct: 186 LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------------SEIYDYLRQGNRL 233

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV-CQLLKI 873
             P     D L  +  +  SC   NP+ RP+ + + C+L K 
Sbjct: 234 KQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 37/160 (23%), Positives = 70/160 (43%), Gaps = 26/160 (16%)

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L                   + + +   
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDY 192

Query: 767 LAGTYG------YVAPELAYTMKVTEKCDVYSFGVLALEV 800
              T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83

Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 140

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 197

Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 198 TVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 53/234 (22%), Positives = 97/234 (41%), Gaps = 32/234 (13%)

Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
           + + F      ++++ H+++V  YG C+      +V EY K  SL   L  +    N+ W
Sbjct: 42  YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW 101

Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH--------VSDFGIAK 755
             ++ + K +  AL ++ +     + H ++ +KNVLL  E +          +SD GI+ 
Sbjct: 102 --KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156

Query: 756 FLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS 814
            + P       L     +V PE +     ++   D +SFG    E+  G           
Sbjct: 157 TVLPKEI----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-------GDKP 205

Query: 815 FSSLNLNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            S+L+    L    D  +LP P      K   +  +   C+D  P+ RP+ + +
Sbjct: 206 LSALDSQKKLQFYEDRHQLPAP------KWTELANLINQCMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 57/281 (20%), Positives = 119/281 (42%), Gaps = 36/281 (12%)

Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 14  LGQGSFGMVY-EGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 70

Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+         + + M   I D
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 131 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 185

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  ++    L  +++  
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGMSNEQVLRFVMEGG 238

Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 239 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 68/259 (26%), Positives = 108/259 (41%), Gaps = 67/259 (25%)

Query: 602 NDFDDEHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA----LT 656
           +DF+    IG+G  G V +  K  +G I A+KK       EM  ++E +  V+A    L 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEM-LEKEQVAHVRAERDILA 56

Query: 657 EIWHRNIVKVYGFCLHVRHLFIVYEYF---KMCSLAV---ILSNDAAAKNLGWTRRMNMI 710
           E  +  +VK+Y       +L+++ EY     M +L +     + +          R  + 
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET--------RFYIA 108

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK------------ 758
           + I+ A+  +H   +   +HRDI   N+LLD +    +SDFG+   LK            
Sbjct: 109 ETIL-AIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164

Query: 759 -------------PDSS-----NWTE----LA----GTYGYVAPELAYTMKVTEKCDVYS 792
                        P SS      W      LA    GT  Y+APE+       ++CD +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224

Query: 793 FGVLALEVIKGKHPRDFIS 811
            GV+  E++ G  P  F S
Sbjct: 225 LGVIMYEMLVGYPP--FCS 241

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 70/300 (23%), Positives = 127/300 (42%), Gaps = 42/300 (14%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKL---ASGE---IIAVKKFHSPLPGEMTFQQEFL 649
           EI  +T  F +E  +G+   G VY   L   A GE    +A+K        E   ++EF 
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFK 56

Query: 650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM 709
           +E    + + H NIV + G     + L +++ Y     L   L   +   ++G T     
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 710 IKGIVDALSYMHNDC----------FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP 759
           +K  ++   ++H                +VH+D++++NVL+  +    +SD G+  F + 
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL--FREV 174

Query: 760 DSSNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS 814
            ++++ +L G       +++PE     K +   D++S+GV+  EV   G  P    S   
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--- 231

Query: 815 FSSLNLNIALDEMLDPR--LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                 N  + EM+  R  LP P     D    +  + + C +E P  RP  + +   L+
Sbjct: 232 ------NQDVIEMIRNRQVLPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.8 bits (107), Expect = 4e-06
 Identities = 20/60 (33%), Positives = 31/60 (51%)

Query: 431 HLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
           +L  LDLS N L          + +L+ L+LS N+L+ + P  F  +  L  +D+S N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)

Query: 610 IGKGGQGSV---YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +G G  GSV   Y ++L   + +AVKK   P    +  ++ +  E++ L  + H N++ +
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79

Query: 667 YGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
                    +    E + + +L    L+N    + L       +I  ++  L Y+H+   
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS--- 136

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKV 784
             I+HRD+   NV ++ + E  + DFG+A   +      T    T  Y APE+    M  
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIMLNWMHY 193

Query: 785 TEKCDVYSFGVLALEVIKGK 804
            +  D++S G +  E++KGK
Sbjct: 194 NQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 29/278 (10%)

Query: 610 IGKGGQGSVYMSKL----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +GKG  GSV  ++L     S + +AVK   + +      + EFL E   + E  H N++K
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVIK 65

Query: 666 VYGFCLHVRHL------FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           + G  L  R         ++  + K   L   L      +         +++ ++D  S 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YGYVA 775
           M        +HRD++++N +L+      V+DFG++K  K  S ++            ++A
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQGCASKLPVKWLA 183

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
            E       T   DV++FGV   E++ +G+ P   +        N  I    +   RL  
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-------NSEIYNYLIKGNRLKQ 236

Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           P     D L  + E+   C    P+ RP+ Q +   L+
Sbjct: 237 PP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 32/226 (14%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSP-LPGEMTFQQEFLNEVKALTEIW 659
            DF+    I  G  G+VY+ +   + +  A+KK +   L      QQ F+ E   LT   
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW----TRRMNMIKGIVD 715
           +  +V ++      RHL +V EY +    A +L      KN+G       RM   + ++ 
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETVL- 112

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF-LKPDSSNWTE-------- 766
           AL Y+HN     IVHRD+   N+L+       ++DFG++K  L   ++N  E        
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 767 ------LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                 + GT  Y+APE+       +  D ++ G++  E + G  P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 8/199 (4%)

Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IWHRNIVKVY 667
           IGKG  G V ++K    G+  AVK     +      Q+  + E   L + + H  +V ++
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                   L+ V ++     L   L  +   ++    R       I  AL Y+H+     
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS---IN 116

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           IV+RD+  +N+LLD +    ++DFG+ K     S   T   GT  Y+APE+         
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 788 CDVYSFGVLALEVIKGKHP 806
            D +  G +  E++ G  P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 5e-06
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 11/95 (11%)

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL-----KPDSSNWT 765
           + +++AL+Y+H      I+HRD+ ++N+ LD    A + DFG A  L      P    W 
Sbjct: 192 RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW- 247

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
             +GT    +PEL        K D++S G++  E+
Sbjct: 248 --SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 5e-06
 Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 19/150 (12%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVT 785
           +HRD++++N+LL       + DFG+A+ ++ D SN+           ++APE  +    T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESIFNCVYT 294

Query: 786 EKCDVYSFGVLALEVI---KGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK 842
            + DV+S+G+L  E+       +P   + S  +  +        ML P            
Sbjct: 295 FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY---RMLSPECAPS------- 344

Query: 843 LISIVEVTISCVDENPESRPTMQKVCQLLK 872
              + ++  SC D +P  RPT +++ QL++
Sbjct: 345 --EMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.3 bits (118), Expect = 5e-06
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IG+G  G V  +K   + E +A+KK  +     +  ++  L E+K L  + H N++ + 
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIK 70

Query: 668 GFCLHV-----RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                        ++IVYE        +I S+   + +        +++G    L Y+H+
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG----LKYIHS 126

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 778
                ++HRD+   N+LL+   +  + DFG+A+         TE   T  Y APEL    
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183

Query: 779 -AYTMKVTEKCDVYSFGVLALEVIKGK 804
             YT  +    DV+S G +  E++  K
Sbjct: 184 SEYTTAI----DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 61/284 (21%), Positives = 117/284 (41%), Gaps = 45/284 (15%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWHRNIV 664
           E   GK  +G +Y+  +   +++A+K     L      QQ  EF  E   + E+ H NIV
Sbjct: 15  ECAFGKIYKGHLYLPGMDHAQLVAIKT----LKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR--------------MNMI 710
            + G     + + +++EY     L   L   +   ++G +                +++ 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
             I   + Y+ +  F   VH+D++++N+L+  +    +SD G+++ +   S+++  +   
Sbjct: 131 IQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQPK 185

Query: 771 ----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++ PE     K +   D++SFGV+  E+   G  P        FS    N  + 
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-----YYGFS----NQEVI 236

Query: 826 EMLDPR--LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           EM+  R  LP       D    +  +   C  E P  RP  + +
Sbjct: 237 EMVRKRQLLPCS----EDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 42/184 (22%), Positives = 79/184 (42%), Gaps = 39/184 (21%)

Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN---------- 694
           + +FL EVK L+ +   NI+++ G C+    L ++ EY +   L   LS+          
Sbjct: 63  RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122

Query: 695 ------DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
                       + ++  +++   I   + Y+ +  F   VHRD++++N L+       +
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVGENLTIKI 179

Query: 749 SDFGIAKFLKPDSSNWTELAGTY-----------GYVAPELAYTMKVTEKCDVYSFGVLA 797
           +DFG+++ L          AG Y            ++A E     K T   DV++FGV  
Sbjct: 180 ADFGMSRNL---------YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230

Query: 798 LEVI 801
            E++
Sbjct: 231 WEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 28/110 (25%), Positives = 56/110 (50%), Gaps = 4/110 (3%)

Query: 696 AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK 755
           AA +N+     + + + ++ A+ Y+H +    I+HRDI ++N+ ++   +  + DFG A 
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230

Query: 756 F-LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
           F +  +++ +   AGT    APEL          D++S G++  E+    
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 24/232 (10%)

Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           ++ FL E   L +  H NIV++ G       + IV EY    +L   L        L   
Sbjct: 50  RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAG 107

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN- 763
           + M M+ G+   + Y+    +   VH+ +++  VL++ +    +S F     L+ D S  
Sbjct: 108 QLMGMLPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEA 161

Query: 764 -WTELAGTYG--YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN 819
            +T ++G     + APE       +   DV+SFG++  EV+  G+ P         S  +
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP-----YWDMSGQD 216

Query: 820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           +  A+++    RLP P RN  + L  ++   + C  +    RP   ++  +L
Sbjct: 217 VIKAVEDGF--RLPAP-RNCPNLLHQLM---LDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 35/157 (22%)

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT------YGYVAPELAYT 781
            +HRD++++NVL+  ++   ++DFG+A+    D  +      T        ++APE  + 
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTTNGRLPVKWMAPEALFD 208

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-SLNLNIALDEMLD-----PRLPTP 835
              T + DV+SFGVL  E+             +   S    I ++E+        R+  P
Sbjct: 209 RVYTHQSDVWSFGVLLWEI------------FTLGGSPYPGIPVEELFKLLKEGYRMEKP 256

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                +    +  +   C  E P  RPT     QL++
Sbjct: 257 QNCTQE----LYHLMRDCWHEVPSQRPTF---KQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 37/139 (26%), Positives = 66/139 (47%), Gaps = 19/139 (13%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I  AL Y+H+     IV+RD+  +N+LLD +    ++DFG+ K  ++ + +  T   GT 
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTP 160

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD-- 829
            Y+APE+ +        D +  G +  E++ G  P        F S N     D +L+  
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--------FYSRNTAEMYDNILNKP 212

Query: 830 ----PRLPTPSRNVHDKLI 844
               P +   +R++ + L+
Sbjct: 213 LQLKPNITNSARHLLEGLL 231

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 66/268 (24%), Positives = 98/268 (36%), Gaps = 49/268 (18%)

Query: 13  IPSELRNLKSLSDLELGNNKLS------GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
           + S LR   SL +L L  N+         S+   L     L  L +  N+L     G + 
Sbjct: 43  LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102

Query: 67  NFRFFSDLE---LSNNKLSGSIPPSLG-----NLSNLATLYLDTNSLSN----SIPSELG 114
           +    S L+   L+NN L       L          L  L L  N L      ++   L 
Sbjct: 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162

Query: 115 NLRSLSNLQL-NNNILSGSIPH---SLGNLTNLATLYIYSNSL----SASILGKIGNLKS 166
             R L  L L NN I    I      L    NL  L + +N L    ++++   + +LKS
Sbjct: 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222

Query: 167 LSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL- 225
           L  L L +N           NL++     L +  LS +I        SL  LSL  N + 
Sbjct: 223 LEVLNLGDN-----------NLTDAGAAALASALLSPNI--------SLLTLSLSCNDIT 263

Query: 226 -SGSIPIS--MGNLSNLTYLNLFENSLS 250
             G+  ++  +    +L  L+L  N   
Sbjct: 264 DDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G+V+ +K   + EI+A+K+       E       L E+  L E+ H+NIV++Y 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYD 66

Query: 669 FCLHVRHLFIVYE--------YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
                + L +V+E        YF  C       N      +  +    ++KG+  A  + 
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSC-------NGDIDPEIVKSFMFQLLKGL--AFCHS 117

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELA 779
           HN     ++HRD+  +N+L++   E  ++DFG+A+ F  P      E+  T  Y  P++ 
Sbjct: 118 HN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 171

Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHP 806
           +  K+ +   D++S G +  E+     P
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 604 FDDEHCIGKGGQGSVYMSKLAS--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           + D   +G G  G V+ S + S   + +AVKK     P  +   +  L E+K +  + H 
Sbjct: 7   YMDLRPLGCGSNGLVF-SAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIRRLDHD 62

Query: 662 NIVKVY--------------GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM 707
           NIVKVY              G    +  ++IV EY +   LA +L     ++        
Sbjct: 63  NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMY 121

Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSN--- 763
            +++G    L Y+H+     ++HRD+   NV ++ E+    + DFG+A+ + P  S+   
Sbjct: 122 QLLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 764 WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
            +E   T  Y +P L  +    T+  D+++ G +  E++ GK
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 36/160 (22%), Positives = 72/160 (45%), Gaps = 26/160 (16%)

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L                   + L +   
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------FLKPD 760
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+      + K  
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
           ++    +     ++APE  +    T + DV+SFGVL  E+
Sbjct: 200 TNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           +V  L Y+H +    IV+RD+   N+LLD E    ++DFG+ K  +       T   GT 
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTP 165

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            ++APE+      T   D +  GVL  E++ G+ P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 65/290 (22%), Positives = 120/290 (41%), Gaps = 63/290 (21%)

Query: 610 IGKGGQGSVYMSKLASGEI----IAVKKF------HSPLPGEMTFQQEFLNEVKALTEIW 659
           +G+G  GSV   +L+  +     +AVK        +S +       +EFL+E   + +  
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-------EEFLSEAACMKDFD 59

Query: 660 HRNIVKVYGFCLHVRHL------FIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKG 712
           H N++K+ G C     L       ++  + K   L + +L +           +  ++K 
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT-LLKF 118

Query: 713 IVD---ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
           +VD    + Y+ N  F   +HRD++++N +L  +    V+DFG++K            +G
Sbjct: 119 MVDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK---------KIYSG 166

Query: 770 TY-----------GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSS 817
            Y            ++A E       T K DV++FGV   E+  +G+ P   + +     
Sbjct: 167 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226

Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
              +         RL  P  +  D+L  ++    SC   +P+ RPT  K+
Sbjct: 227 YLRH-------GNRLKQPE-DCLDELYDLM---YSCWRADPKDRPTFTKL 265

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 54/206 (26%), Positives = 105/206 (50%), Gaps = 26/206 (12%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G   +VY  +   +GEI+A+K+ H  L  E       + E+  + E+ H NIV+++ 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 669 FCLHVRH-LFIVYEYFK------MCSLAVILSNDAA-AKNLGWTRRMNMIKGIVDALSYM 720
             +H  + L +V+EY        M +  V  + D    K+  +     ++KGI    ++ 
Sbjct: 66  -VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY----QLLKGI----AFC 116

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELA 779
           H +    ++HRD+  +N+L++   E  ++DFG+A+ F  P ++   E+  T  Y AP++ 
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172

Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGK 804
              +  +   D++S G +  E+I G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 18/229 (7%)

Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IWHRNIVKVY 667
           IGKG  G V ++K  S G   AVK        +   Q   + E   L + + H  +V ++
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                   L+ V +Y     L   L  +   +     R       +  A+ Y+H+     
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHS---LN 116

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           I++RD+  +N+LLD +    ++DFG+ K  ++P+ +  T   GT  Y+APE+        
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDR 175

Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
             D +  G +  E++ G  P        F S +++   D +L   L  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--------FYSRDVSQMYDNILHKPLQLP 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 610 IGKGGQGSVYMSKLAS---GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW------- 659
           +G+G  G V  ++ A     E +A+KK  +       F ++ L + +AL E+        
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITN------VFSKKILAK-RALRELKLLRHFRG 60

Query: 660 HRNIVKVYG----FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           H+NI  +Y     F  +   L++ YE      L  I+ +    + L      + I  I+ 
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSG---QPLTDAHFQSFIYQILC 116

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSNWTELAGTY 771
            L Y+H+     ++HRD+   N+L++ + E  + DFG+A+    +    +   TE   T 
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 772 GYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGK 804
            Y APE+  + +  T+  DV+S G +  E++  K
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 41/242 (16%)

Query: 610 IGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +GKGG G V+  +      +G+I A+K         +   Q+     KA      RNI++
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKK---ATIVRNQKDTAHTKA-----ERNILE 55

Query: 666 VYGFCLHVRHLFIV---YEYFKMCSLAVILSNDAAAKNLGWTRRMNM---------IKGI 713
                  V+H FIV   Y +     L +IL   +  +      R  +         +  I
Sbjct: 56  A------VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGY 773
             AL ++H      I++RD+  +N+LLD +    ++DFG+ K    + +      GT  Y
Sbjct: 110 SLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEY 166

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           +APE+       +  D +S G L  +++ G  P        F++ N    +D++L  +L 
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP--------FTAENRKKTIDKILKGKLN 218

Query: 834 TP 835
            P
Sbjct: 219 LP 220

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 31/206 (15%)

Query: 618 VYMSKLASGEIIAVKKFHSPLPGEMTFQQEF------------LNEVKALTEIWHRNIVK 665
           V + KL  G    V K  S L   +   +E             + EV  L  + H NIV 
Sbjct: 8   VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAA--KNLGWTRRMNMIK----GIVDALSY 719
           ++      R L +V+EY         L +D      N G    M+ +K     ++  LSY
Sbjct: 68  LHDIIHTERCLTLVFEY---------LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-L 778
            H      I+HRD+  +N+L++ + E  ++DFG+A+     +  ++    T  Y  P+ L
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGK 804
             + + +   D++  G +  E+  G+
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 58/246 (23%), Positives = 95/246 (38%), Gaps = 54/246 (21%)

Query: 603 DFDDEHCIGKGGQGSVYM-SKLASGEIIAVK------KFHSPLPGEMTFQQEFLNEVKAL 655
           DF+    IG+G  G V +  K  +G + A+K             G +  +++ L E  +L
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
              W   +VK++       +L+++ E+     +  +L        L        I   V 
Sbjct: 62  ---W---VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVL 112

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP---------------- 759
           A+  +H   F   +HRDI   N+LLD +    +SDFG+   LK                 
Sbjct: 113 AIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 760 -----------DSSNWT----ELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
                       +  W     +LA    GT  Y+APE+       + CD +S GV+  E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 801 IKGKHP 806
           + G  P
Sbjct: 230 LIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 46/198 (23%), Positives = 94/198 (47%), Gaps = 12/198 (6%)

Query: 610 IGKGGQGSVY--MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G+G   +VY  +S++ +G+++A+K         + F    + E   L  + H NIV ++
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTA--IREASLLKGLKHANIVLLH 69

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                   L  V+EY     LA  +       +  +  R+ M + ++  L+Y+H      
Sbjct: 70  DIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLH-PYNVRLFMFQ-LLRGLAYIHGQ---H 123

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 786
           I+HRD+  +N+L+ +  E  ++DFG+A+     S  ++    T  Y  P+ L      + 
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183

Query: 787 KCDVYSFGVLALEVIKGK 804
             D++  G + +E+++G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 5e-05
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 18/202 (8%)

Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90

Query: 669 FCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                      + ++IV E        VI         L   R   ++  ++  + ++H+
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS 144

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                I+HRD+   N+++  +    + DFG+A+           +   Y Y APE+   M
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGM 200

Query: 783 KVTEKCDVYSFGVLALEVIKGK 804
              E  D++S G +  E+IKG 
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.2 bits (110), Expect = 5e-05
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 40/214 (18%)

Query: 609 CIGKGGQGSV--YMSKLASGEIIAVKK----FHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
            IG G  G V   +    SG+ +A+KK    F  P     T  +  L E+K L    H N
Sbjct: 12  NIGSGAYGVVCSAIDTR-SGKKVAIKKIPHAFDVP-----TLAKRTLRELKILRHFKHDN 65

Query: 663 IVKVYGFCL----HVRHLFIVYEYFKMCSLAVI------LSNDAAAKNLGWTRRMNMIKG 712
           I+ +           + +++V +  +   L  I      L+ +     L    R      
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLR------ 118

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPD--SSNWTELA 768
               L Y+H+     ++HRD+   N+L++ + E  + DFG+A+ L   P       TE  
Sbjct: 119 ---GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 769 GTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVI 801
            T  Y APEL  ++ + T   D++S G +  E++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 9e-05
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 2/85 (2%)

Query: 271 NQ-FRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW 328
           NQ  RG IP  +  L  L+ + L  N + GNI  S     +L  +DLS N+F G I    
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 329 GRCPKLSTLDFSINNITGNVPPEIG 353
           G+   L  L+ + N+++G VP  +G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 45.4 bits (108), Expect = 9e-05
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKK----FHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G G  G V  +    +G  +A+KK    F S +  + T++     E++ L  + H N++
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-----ELRLLKHMDHENVI 77

Query: 665 ---KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
               V+     +     VY       +   L+N    + L       ++  I+  L Y+H
Sbjct: 78  GLLDVFTPASSLEDFQDVY--LVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           +     I+HRD+   N+ ++ + E  + DFG+A   +      T    T  Y APE+   
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLN 189

Query: 782 -MKVTEKCDVYSFGVLALEVIKGK 804
            M   +  D++S G +  E++ GK
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 56/291 (19%)

Query: 610 IGKGGQGSVYMSKLASGEIIA---VKKFH-SPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           IG G  G V +S++ +   +A   VK+   +    E   Q EFL +      + H NI++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNILQ 59

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR-------MNMIKGIVDALS 718
             G C+      +V+EY ++  L   LS +       W RR         M   I   ++
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVT 113

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA------KFLKPDSSNWTELAGTYG 772
           +MH   F   +H D++ +N  L  +    V D+GI        +++ +      L     
Sbjct: 114 HMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR---- 166

Query: 773 YVAPELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIAL 824
           ++APEL         T + T+  +V++ GV   E+ +    P   +S        LN  +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV----LNHVI 222

Query: 825 DE----MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            +    +  P+L  P            EV   C   +PE R T ++V +LL
Sbjct: 223 KDQQVKLFKPQLELPYSE------RWYEVLQFCW-LSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.8 bits (106), Expect = 9e-05
 Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 43/231 (18%)

Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
            F      ++++ H+++VK+YG C+   ++ +V EY K   L V L  +    +L W  +
Sbjct: 47  AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--K 103

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENE----AHVSDFGIAKFLKP 759
           +++ K +  AL Y+ +     +VH ++  KN+L+              +SD GI   +  
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160

Query: 760 DSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFS 816
                 E      ++APE        +T   D +SFG   LE+   G+ P         S
Sbjct: 161 RE----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP--------LS 208

Query: 817 SLNLNIALDEMLD-----PRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
           +L+ +    E         RLP P       LI+       C   +P  RP
Sbjct: 209 TLSSS----EKERFYQDQHRLPMPDCAELANLIN------QCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 24/62 (38%), Positives = 32/62 (51%), Gaps = 2/62 (3%)

Query: 405 QLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN 464
            L+ LDLS+NRL+     +   L   +L  LDLS N L    P     + SL  L+LS N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLP--NLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Query: 465 SL 466
           +L
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.1 bits (107), Expect = 1e-04
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 13/98 (13%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-NWTELAGTY 771
           I+  L Y+H+     I+HRDI   N+L++      + DFG+A+  +PD S + T+   T 
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 772 GYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGK 804
            Y APE+      YT  V    D++S G +  E++  +
Sbjct: 169 YYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 14/198 (7%)

Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G   +VY  K   +G+++A+K     L  E       + E   L  + H NIV ++ 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 669 FCLHVRHLFIVYEYF--KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
                  L +V+EY    +C        D     L        +  ++  LSY+H     
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYM-----DKHPGGLHPENVKLFLFQLLRGLSYIHQRY-- 123

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
            I+HRD+  +N+L+    E  ++DFG+A+     S  ++    T  Y  P++        
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 787 KC-DVYSFGVLALEVIKG 803
            C D++  G + +E+I+G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.5 bits (106), Expect = 1e-04
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 35/160 (21%)

Query: 660 HRNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGI 713
           + N +K+Y     ++   ++ +Y      F +      LS     K         +I+ +
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK---------IIRQL 118

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLD-FENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           V+AL+ +H      I+H DI  +NVL D  ++  ++ D+G+ K +   S       GT  
Sbjct: 119 VEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLD 171

Query: 773 YVAPELAYTMKVT-EKCDVYSF-----GVLALEVIKGKHP 806
           Y +PE     K+     D  SF     GVL  E++ GKHP
Sbjct: 172 YFSPE-----KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 56/241 (23%), Positives = 101/241 (41%), Gaps = 17/241 (7%)

Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 83

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +    +     L   R   ++  ++  + ++H+  
Sbjct: 84  VFTPQKSL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 137

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 138 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 842 K 842
           +
Sbjct: 256 R 256

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 23/151 (15%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVT 785
           VHRD++++NVL+       + DFG+A+ +  D SN+     T+    ++APE  +    T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWMAPESIFNNLYT 319

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP-----RLPTPSRNVH 840
              DV+SFG+L  E+         +    +  L +N   ++  +      R+  P+    
Sbjct: 320 TLSDVWSFGILLWEIFT-------LGGTPYPELPMN---EQFYNAIKRGYRMAKPAHASD 369

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           +    I E+   C +E  E RP   ++  L+
Sbjct: 370 E----IYEIMQKCWEEKFEIRPDFSQLVHLV 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 42/214 (19%)

Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +    +G+ +A+KK   P       ++ +  E+  +  + H+NI+ +  
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGL-- 80

Query: 669 FCLHV----------RHLFIVYEYFKMCSLAVI---LSNDAAAKNLGWTRRMN-----MI 710
             L+V          + +++V E        VI   L ++          RM+     M+
Sbjct: 81  --LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE----------RMSYLLYQML 128

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
            GI     ++H+     I+HRD+   N+++  +    + DFG+A+     S   T    T
Sbjct: 129 CGI----KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVT 180

Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
             Y APE+   M   E  D++S G +  E+I+G 
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 59/288 (20%), Positives = 93/288 (32%), Gaps = 64/288 (22%)

Query: 205 IPSELGNLRSLSNLSLGYNKLSGSIPI------SMGNLSNLTYLNLFENSLSGAIPYEYR 258
           + S L    SL  L L  N+              +     L  L+L +N+L         
Sbjct: 43  LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102

Query: 259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
           +L  L    L        + +  N      +RL    L           P L  + L +N
Sbjct: 103 SL--LRSSSLQE------LKLNNNGLGDRGLRLLAKGLKDL-------PPALEKLVLGRN 147

Query: 319 NFYGEISSDWGR----CPKLSTLDFSINNITGN----VPPEIGHSSQLGVLDLSSNHIVG 370
              G       +       L  L+ + N I       +   +  +  L VLDL++N +  
Sbjct: 148 RLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT- 206

Query: 371 EIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGN---L 427
               + G               +  L+  L SL  LE L+L  N L+++   +L +    
Sbjct: 207 ----DEG---------------ASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLS 247

Query: 428 ELIHLSELDLSRN--------FLREAIPSQICIMQSLEKLNLSHNSLS 467
             I L  L LS N         L E +       +SL +L+L  N   
Sbjct: 248 PNISLLTLSLSCNDITDDGAKDLAEVLAE----KESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 5/89 (5%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGT 770
           ++ A+ Y+H +    I+HRDI ++NVL++   +  + DFG A F +   S      +AGT
Sbjct: 269 LLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325

Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALE 799
               APE+      T   D++S G++  E
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 35/147 (23%), Positives = 55/147 (37%), Gaps = 13/147 (8%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HR   S N+LL ++    +   G   F  P+ S          ++APE+      TEK 
Sbjct: 33  LHRQAKSGNILLTWD--GLLKLDGSVAFKTPEQSR-----PDPYFMAPEVIQGQSYTEKA 85

Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISI 846
           D+YS G+   E +  + P +    +   S  L I L+ M   DPR  +    V     S 
Sbjct: 86  DIYSLGITLYEALDYELPYNEEREL---SAILEILLNGMPADDPRDRSNLEGVSAAR-SF 141

Query: 847 VEVTISCVDENPESRPTMQKVCQLLKI 873
            +    C    P+ R          + 
Sbjct: 142 EDFMRLCASRLPQRREAANHYLAHCRA 168

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 36/125 (28%), Positives = 55/125 (44%), Gaps = 15/125 (12%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           I  AL Y+H+     I++RD+  +N+LLD +    ++DFG+ K     S   +   GT  
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           Y+APE+          D +  G +  E++ G  P        F S +      EM D  L
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP--------FYSRDTA----EMYDNIL 209

Query: 833 PTPSR 837
             P R
Sbjct: 210 NKPLR 214

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 19/206 (9%)

Query: 610 IGKGGQGSVYMSK--LASGEIIAVKKFHSPLPGE-MTFQQEFLNEVKALTEIW---HRNI 663
           IG+G  G V+ ++     G  +A+K+       E M      + EV  L  +    H N+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNV 66

Query: 664 VKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
           V+++  C   R      L +V+E+     L   L +      +      +M+  ++  L 
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           ++H+     +VHRD+  +N+L+    +  ++DFG+A+      +  T +  T  Y APE+
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEV 180

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGK 804
                     D++S G +  E+ + K
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 35/140 (25%), Positives = 57/140 (40%), Gaps = 46/140 (32%)

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI---------AKFLKP- 759
           I  +  A+  +H   F   +HRDI   N+L+D +    ++DFG+         +K+ +  
Sbjct: 107 IAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163

Query: 760 -----DS----SNWTE------------------------LAGTYGYVAPELAYTMKVTE 786
                DS      W+E                        L GT  Y+APE+      T+
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223

Query: 787 KCDVYSFGVLALEVIKGKHP 806
            CD +S GV+  E++ G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 30/223 (13%)

Query: 607 EHCIGKGGQGSVYMSKLASGEII---AVKKFHS---------PLPGEMTFQQEFLNEVKA 654
           +  IG GG G VY ++ AS   I   AV K  +          L     +  + +   K 
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76

Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM--NMIKG 712
           +  I H  I K YG C   +   + Y +  +  L V  + +   +     +++  N++K 
Sbjct: 77  IHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKD 134

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---------KPDSSN 763
           ++  L Y+H      I H DI  +N+++D  N  ++ D+GIA              +  +
Sbjct: 135 MLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191

Query: 764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                GT  Y   +      VT + D+ S G   L+    K P
Sbjct: 192 LHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 46/198 (23%), Positives = 93/198 (46%), Gaps = 12/198 (6%)

Query: 610 IGKGGQGSVYM--SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G+G   +VY   SKL +  ++A+K+    L  E       + EV  L ++ H NIV ++
Sbjct: 14  LGEGTYATVYKGRSKL-TDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L +V+EY     L   L +   + N+   +    +  ++  L+Y H      
Sbjct: 71  DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---K 124

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 786
           ++HRD+  +N+L++   E  ++DFG+A+     +  ++    T  Y  P+ L  +   + 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 787 KCDVYSFGVLALEVIKGK 804
           + D++  G +  E+  G+
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 24/204 (11%)

Query: 610 IGKGGQGSVYM--SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G+G   +V+   SKL    ++A+K+    L  E       + EV  L ++ H NIV ++
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAA--KNLGWTRRMNMIK----GIVDALSYMH 721
                 + L +V+EY         L  D      + G    M+ +K     I+  L+Y H
Sbjct: 71  DIVHTDKSLTLVFEY---------LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAY 780
                 ++HRD+  +N+L++   E  ++DFG+A+     +  ++    T  Y  P+ L  
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 781 TMKVTEKCDVYSFGVLALEVIKGK 804
           + + + + D++  G +  E+  G+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 42.6 bits (100), Expect = 7e-04
 Identities = 55/179 (30%), Positives = 79/179 (44%), Gaps = 7/179 (3%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           +N+    + S L NLK+LS LEL NNKL   +P S+GNL+NL TL +  N +  S    +
Sbjct: 217 SNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSL 273

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN 125
           G+     +L+LS N LS ++P     L  L  L    N L      EL     L N  + 
Sbjct: 274 GSLTNLRELDLSGNSLSNALPLIALLLLLLELL---LNLLLTLKALELKLNSILLNNNIL 330

Query: 126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS 184
           +N    S P +L  L +L  L+   N+L  S L +       +   L +          
Sbjct: 331 SNGE-TSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLDLVKKHVNQLL 388

Length = 394

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 25/106 (23%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           +V AL  +H +    IV RD++  N+LLD      ++ F            W+E+  +  
Sbjct: 94  MVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS----------RWSEVEDSCD 140

Query: 773 -------YVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-----HP 806
                  Y APE+    + TE CD +S G +  E++ GK     HP
Sbjct: 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 13/43 (30%), Positives = 24/43 (55%)

Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
           +L+ L+LS+N L+ +    F+ +  L  +D+S N L    P +
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEA 43

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 18/60 (30%), Positives = 27/60 (45%)

Query: 214 SLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQF 273
           +L +L L  N+L+     +   L NL  L+L  N+L+   P  +  L  L  L L  N  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 29/125 (23%), Positives = 51/125 (40%), Gaps = 47/125 (37%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGI---------AKF------LKPDSSNWT-------- 765
           +HRDI   N+L+D +    ++DFG+         +K+      ++ DS +++        
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 766 ------------------------ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
                                    L GT  Y+APE+      T+ CD +S GV+  E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 802 KGKHP 806
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.6 bits (97), Expect = 0.002
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 35/203 (17%)

Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSN-DAAAKNL 701
           + + + EV  + E+ H+NIV+     L+   + L+I+ E+   C    +  N     K  
Sbjct: 56  KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF---CDAGDLSRNIQKCYKMF 112

Query: 702 GWTRR---MNMIKGIVDALSYMHNDCFPP----IVHRDISSKNVLL-------------- 740
           G       +++ + ++ AL+Y HN    P    ++HRD+  +N+ L              
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 741 ---DFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGV 795
              +    A + DFG++K +  +S   +   GT  Y +PEL    T    +K D+++ G 
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGC 231

Query: 796 LALEVIKGKHPRDFISSMSFSSL 818
           +  E+  GK P  F  + +FS L
Sbjct: 232 IIYELCSGKTP--FHKANNFSQL 252

Length = 1021

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 43/243 (17%)

Query: 648 FLNEVKALTEIWHRNIVKVYGFCLHVRHL-FIVYEYFKMCSLAVIL-----SNDAAAKNL 701
            L E   L  + H+NI+ +   C+      F++Y Y    +L + L           + L
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP-- 759
              + ++M   I   +SY+H      ++H+DI+++N ++D E +  ++D  +++ L P  
Sbjct: 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Query: 760 -----DSSN----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 809
                D+ N    W         +A E     + +   DV+SFGVL  E++  G+ P   
Sbjct: 172 YHCLGDNENRPVKW---------MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Query: 810 ISSMSFSSLNLNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
           I     ++         + D  RL  P  N  D+L     V   C   +PE RP+  ++ 
Sbjct: 223 IDPFEMAAY--------LKDGYRLAQPI-NCPDELF---AVMACCWALDPEERPSFSQLV 270

Query: 869 QLL 871
           Q L
Sbjct: 271 QCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 30/125 (24%), Positives = 50/125 (40%), Gaps = 47/125 (37%)

Query: 729 VHRDISSKNVLLDFENEAHVSDFGI---------AKF------LKPDSSN----WTE--- 766
           +HRDI   N+L+D +    ++DFG+         +K+      ++ DS      W +   
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 767 -------------------------LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
                                    L GT  Y+APE+      T+ CD +S GV+  E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 802 KGKHP 806
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.0 bits (94), Expect = 0.004
 Identities = 56/304 (18%), Positives = 107/304 (35%), Gaps = 67/304 (22%)

Query: 609 CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           C        +   K  +  ++AVKK +     +   +     E+    ++ H NI+  Y 
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ-QEIITSRQLQHPNILP-YV 65

Query: 669 FCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
               V   L++V       S   +L      + L       ++K +++AL Y+H+  F  
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKGF-- 122

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAK------------FLKPDSS----NWTELAGTY 771
            +HR + + ++LL  + +  +S    +                P SS     W       
Sbjct: 123 -IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL------ 175

Query: 772 GYVAPELAYT--MKVTEKCDVYSFGVLA-------------------LEVIKGKHPRDFI 810
              +PE+         EK D+YS G+ A                   LE ++G  P   +
Sbjct: 176 ---SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC-LL 231

Query: 811 SSMSFSSLNLNIALDEMLDPRLPTPSRNVHD---KLIS-----IVEVTISCVDENPESRP 862
              ++     +++     +   P    +V     +  S      VE+   C+  +PESRP
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEH-PNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPESRP 287

Query: 863 TMQK 866
           +  +
Sbjct: 288 SASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	873
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
PRK10345	210	hypothetical protein; Provisional	99.73
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.71
smart00090	237	RIO RIO-like kinase.	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
PLN03150	623	hypothetical protein; Provisional	99.47
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.41
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.39
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.34
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.3
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.3
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.28
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.24
PLN03150	623	hypothetical protein; Provisional	99.24
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.21
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.19
KOG3087	229	consensus Serine/threonine protein kinase [General	99.19
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.19
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.16
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.15
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.12
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.01
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.91
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.79
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.62
PRK09902	216	hypothetical protein; Provisional	98.58
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.57
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.55
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.51
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.51
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.46

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.1e-104  Score=982.43  Aligned_cols=834  Identities=33%  Similarity=0.532  Sum_probs=596.7

Q ss_pred             cCCcccccCCccccCCCCCCEEECCCCcccccCCcccc-CCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            5 YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLG-NLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         5 ~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      ++|++++.+|..|..+++|+.|+|++|++++.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++
T Consensus        77 ~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~  154 (968)
T PLN00113         77 SGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSG  154 (968)
T ss_pred             cCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccc
Confidence            56778888888888888888888888888766776543 778888888888877766664  346677777777777776


Q ss_pred             CCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCC
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGN  163 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  163 (873)
                      ..|..++++++|++|+|++|.+.+.+|..+.++++|++|+|++|.+.+.+|..|+.+++|++|+|++|.+.+..+..+++
T Consensus       155 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~  234 (968)
T PLN00113        155 EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG  234 (968)
T ss_pred             cCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhc
Confidence            66777777777777777777776666777777777777777777776666777777777777777777776666666677


Q ss_pred             CCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEe
Q 039344          164 LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN  243 (873)
Q Consensus       164 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  243 (873)
                      +++|++|++++|.+++..|..++++++|++|++++|.+.+..|..+.++++|++|++++|.+.+..|..+..+++|++|+
T Consensus       235 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  314 (968)
T PLN00113        235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH  314 (968)
T ss_pred             CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEE
Confidence            77777777777777666666677777777777777776666666666666777777777766666666666666666666


Q ss_pred             cccccCCCCCchhhcCCCCCcEEEccCCcCcCcC-CcCCCCCCCCeEEccCccccccccccc------------------
Q 039344          244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPI-PILRNLTSLERVRLDRNYLTGNISESF------------------  304 (873)
Q Consensus       244 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~------------------  304 (873)
                      +++|.+.+..|..+..+++|+.|++++|.+.+.. ..+..+++|+.|++++|.+++..+..+                  
T Consensus       315 l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~  394 (968)
T PLN00113        315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG  394 (968)
T ss_pred             CCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecc
Confidence            6666666666666666666666666666665532 245555666666666666555444444                  


Q ss_pred             ------ccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccc
Q 039344          305 ------YIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGK  378 (873)
Q Consensus       305 ------~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~  378 (873)
                            ..+++|+.|++++|++++..|..|..+++|+.|++++|++++.+|..+..+++|+.|+|++|.+.+.+|..+ .
T Consensus       395 ~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~  473 (968)
T PLN00113        395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-G  473 (968)
T ss_pred             cCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-c
Confidence                  444555555555555555555555555555555555555555555555555556666666666555555443 3


Q ss_pred             cccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccce
Q 039344          379 LNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEK  458 (873)
Q Consensus       379 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  458 (873)
                      ..+|+.|++++|++++..|..+..+++|+.|+|++|++.+.+|..++.+.  +|+.|+|++|.+++.+|..+..+++|+.
T Consensus       474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  551 (968)
T PLN00113        474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK--KLVSLDLSHNQLSGQIPASFSEMPVLSQ  551 (968)
T ss_pred             cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc--CCCEEECCCCcccccCChhHhCcccCCE
Confidence            46778888888888888888888999999999999999999999998876  9999999999999999999999999999


Q ss_pred             ecccCccccCCCchhhhccCCCcEEecCCCcccccCCCCCcccCCCcccccCCCCcccCccC--ccccccccccccccee
Q 039344          459 LNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKG--LLSCKALKSNKQALRT  536 (873)
Q Consensus       459 L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l~g~~~~--~~~c~~~~~~~~~~~~  536 (873)
                      |+|++|++++.+|..+..+++|+.+++++|++.|.+|..+.|......++.||+++||..+.  .++|.....     +.
T Consensus       552 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-----~~  626 (968)
T PLN00113        552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-----TP  626 (968)
T ss_pred             EECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc-----cc
Confidence            99999999999999999999999999999999999999999998888999999999986532  345643211     12


Q ss_pred             eEEEeehHHHHHHHHHHHHHHHHhhhhhccccccccCCCCCCCCCcceec----ccccccCHHHHHHHhcCCCCCceeee
Q 039344          537 IWVVVVFPLLGFVALLISLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVL----TFEGKIIYEEIIRATNDFDDEHCIGK  612 (873)
Q Consensus       537 ~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~~lg~  612 (873)
                      .+.++++.++++++++++++++++++++++.....+ .. . ..+.+...    .......++++   ...|...+.||+
T Consensus       627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~  700 (968)
T PLN00113        627 SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKR-VE-N-EDGTWELQFFDSKVSKSITINDI---LSSLKEENVISR  700 (968)
T ss_pred             eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccc-cc-c-ccccccccccccccchhhhHHHH---HhhCCcccEEcc
Confidence            222333333333333333333333333332211111 00 0 01111111    11112333443   345778889999


Q ss_pred             cCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCChhhH
Q 039344          613 GGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVI  691 (873)
Q Consensus       613 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~  691 (873)
                      |+||.||+|+. .+|+.||||++.....       ...+|++.+++++|||||+++|+|.+.+..++||||+++|+|.++
T Consensus       701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~  773 (968)
T PLN00113        701 GKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV  773 (968)
T ss_pred             CCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHH
Confidence            99999999986 5789999999864321       112468889999999999999999999999999999999999999


Q ss_pred             hcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcccccccc
Q 039344          692 LSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY  771 (873)
Q Consensus       692 l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~  771 (873)
                      ++      .++|.++.+++.|+++|++|||+.+.++|+||||||+||+++.++.+++. ||.+......    ....+++
T Consensus       774 l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~  842 (968)
T PLN00113        774 LR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISS  842 (968)
T ss_pred             Hh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccc
Confidence            84      27899999999999999999996656699999999999999999988876 6665443221    2236789


Q ss_pred             ccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc-----hhhhhhh-hhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-----SFSSLNL-NIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       772 ~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      .|+|||++.+..++.++|||||||++|||+||+.||+.....     .|..... ......+.++.+........++...
T Consensus       843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (968)
T PLN00113        843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE  922 (968)
T ss_pred             cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence            999999999999999999999999999999999998643211     1221111 1123344555543332233445667


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          846 IVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+++.+||+.||++||+|+||+++|+
T Consensus       923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~  949 (968)
T PLN00113        923 VMNLALHCTATDPTARPCANDVLKTLE  949 (968)
T ss_pred             HHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence            889999999999999999999999985

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3e-60  Score=589.09  Aligned_cols=488  Identities=39%  Similarity=0.559  Sum_probs=419.9

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCcc-CCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG-NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      ..++.|+|++|++++.+|.+|..+++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|.  ..+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            4699999999999999999999999999999999999988887654 999999999999999987775  5689999999


Q ss_pred             ccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc
Q 039344          100 LDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  179 (873)
                      |++|.+++.+|..+.++++|++|+|++|.+.+.+|..|..+++|++|+|++|.+.+..+..+..+++|++|+|++|.+++
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            99999998999999999999999999999998999999999999999999999998889999999999999999999999


Q ss_pred             CCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcC
Q 039344          180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRN  259 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  259 (873)
                      ..|..++++++|++|++++|.+++..|..++++++|++|++++|++.+..|..+.++++|++|++++|.+.+..|..+..
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~  306 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ  306 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence            99999999999999999999999899999999999999999999999889999999999999999999999999999999


Q ss_pred             CCCCcEEEccCCcCcCcC-CcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeee
Q 039344          260 LVKLTILLLGHNQFRGPI-PILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD  338 (873)
Q Consensus       260 l~~L~~L~L~~N~l~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  338 (873)
                      +++|+.|++++|.+.+.. ..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+..|..+..+++|+.|+
T Consensus       307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~  386 (968)
T PLN00113        307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI  386 (968)
T ss_pred             CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEE
Confidence            999999999999998744 4688999999999999999988888899999999999999999887777777666666666


Q ss_pred             eccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCccccccc----------------
Q 039344          339 FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGS----------------  402 (873)
Q Consensus       339 l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----------------  402 (873)
                      +++|++.+.+|..++.+++|+.|+|++|.+++.+|..+..+++|+.|++++|.+++..+..+..                
T Consensus       387 l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~  466 (968)
T PLN00113        387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG  466 (968)
T ss_pred             CcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeee
Confidence            6666666666666666666666666666666555555555555555555555555444433322                


Q ss_pred             -------ccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhh
Q 039344          403 -------LVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFE  475 (873)
Q Consensus       403 -------l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  475 (873)
                             ..+|+.|||++|++++.+|..+.++.  +|+.|+|++|.+++.+|..+..+++|++|+|++|.+++.+|..|.
T Consensus       467 ~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  544 (968)
T PLN00113        467 GLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS--ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS  544 (968)
T ss_pred             ecCcccccccceEEECcCCccCCccChhhhhhh--ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence                   35667777777777777777777665  889999999999999999999999999999999999999999999


Q ss_pred             ccCCCcEEecCCCcccccCCCCC-cccCCCcccccCCC
Q 039344          476 KMNGLLHIDISYNELRGSIPNST-TFKDAPIEALQGNK  512 (873)
Q Consensus       476 ~~~~L~~l~ls~N~l~~~~p~~~-~~~~~~~~~~~~n~  512 (873)
                      .+++|+.|||++|+++|.+|..- .+.......+.+|.
T Consensus       545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~  582 (968)
T PLN00113        545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH  582 (968)
T ss_pred             CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence            99999999999999999988742 23344445556665

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=424.92  Aligned_cols=281  Identities=39%  Similarity=0.672  Sum_probs=239.7

Q ss_pred             cccccCHHHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEE
Q 039344          588 FEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY  667 (873)
Q Consensus       588 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~  667 (873)
                      ....++++|+..||++|...+.||+|+||.||+|...+|+.||||++.......   .++|.+|++++.+++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence            455689999999999999999999999999999999999999999887543321   36699999999999999999999


Q ss_pred             eEEEecc-eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          668 GFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       668 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      |||.+.+ ..++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.++|+|||||++|||+|+++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999988 599999999999999999876544 78999999999999999999999988899999999999999999999


Q ss_pred             EEeccccccccCCCCCCcccc-ccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccc------cchhhhhh
Q 039344          747 HVSDFGIAKFLKPDSSNWTEL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS------SMSFSSLN  819 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~------~~~~~~~~  819 (873)
                      ||+|||+|+............ .||.+|+|||++..+..++|+|||||||++.|++||+.|.+...      -..|....
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            999999996554312332333 89999999999999999999999999999999999999887432      12444333


Q ss_pred             hh-hhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          820 LN-IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       820 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .. ....+++|+++.............+..++.+|++.+|++||+|.||+++|+
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            33 368889999986322221256777999999999999999999999999873

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=400.19  Aligned_cols=256  Identities=29%  Similarity=0.518  Sum_probs=211.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-eeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-HLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  680 (873)
                      .++.+.+.+|+|+||+||+|.+.....||||++......... .++|.+|+.++.+++|||||+++|+|.+.. ..++||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            344555669999999999999994444999999875444433 679999999999999999999999999887 799999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC-eeeCCCCCCCeeeCCCC-CeEEeccccccccC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP-IVHRDISSKNVLLDFEN-EAHVSDFGIAKFLK  758 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~  758 (873)
                      ||+++|+|.++++.. ....+++..++++|.+||+||+|||++   + |||||||++|||++.++ ++||+|||+++...
T Consensus       120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            999999999999875 345699999999999999999999999   7 99999999999999998 99999999998776


Q ss_pred             CCCCCccccccccccccccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          759 PDSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ......+...||+.|||||++.  ..+|+.|+||||||+++|||+||+.||............    ...  ..+...+.
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v----~~~--~~Rp~~p~  269 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV----VVG--GLRPPIPK  269 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH----Hhc--CCCCCCCc
Confidence            5434445578999999999999  668999999999999999999999999865542211111    111  12222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .    ....+..++.+||+.||.+||++.+++..|+
T Consensus       270 ~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  270 E----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             c----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence            1    2334888999999999999999999999875

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-47  Score=378.29  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=212.6

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-eeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-HLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  680 (873)
                      +++..+.||+|..|+||+++++ +++.+|+|++...  .+....+++.+|++++++.+||+||++||.|...+ ..+++|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            4455688999999999999765 7899999999543  34455789999999999999999999999999988 599999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||++|+|++++...   +++++....+++.+|++||.|||+ +   +|+||||||+|||++..|+|||||||.++.+..
T Consensus       158 EYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            999999999998654   458999999999999999999996 6   999999999999999999999999999988764


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .  ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||.....   ......+.+..++++..|..+.. 
T Consensus       232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~ppP~lP~~-  305 (364)
T KOG0581|consen  232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEPPPRLPEG-  305 (364)
T ss_pred             h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCCCCCCCcc-
Confidence            4  45678999999999999999999999999999999999999999875411   11223344555666444333322 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ....++..|+..|+++||.+||+++|+++
T Consensus       306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             23345899999999999999999999875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-46  Score=393.84  Aligned_cols=250  Identities=26%  Similarity=0.426  Sum_probs=222.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..|...+.||+|||+.||.++. .+|+.||+|++.+.........+.+.+|+++.++++|||||+++++|++....|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6699999999999999999987 889999999998766666666788999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |+|+.++|.+++..   .+++++.+++.+++||+.|+.|||++   +|+|||||..|+|++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            99999999999863   35699999999999999999999999   9999999999999999999999999999999988


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      .+...+.+|||.|.|||++.....+..+||||+|||||-|+.|++||+.        ...++....+.......|..-  
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety~~Ik~~~Y~~P~~l--  241 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETYNKIKLNEYSMPSHL--  241 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHHHHHHhcCccccccc--
Confidence            8888889999999999999998999999999999999999999999763        333444444444444444422  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        .....++|.++++.||.+|||+++|+.
T Consensus       242 --s~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  242 --SAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              223679999999999999999999975

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-46  Score=377.52  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=217.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCc----chhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGE----MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      .+.|.+.+.||+|+||.|-+|. .++|+.||||++++.....    ........+|+++|++++|||||+++++++..+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            4668889999999999999995 5689999999997653322    1123346799999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeEEeccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSDFG  752 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg  752 (873)
                      .||||||++||.|.+++....   .+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999986543   466777789999999999999999   99999999999999866   679999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCC---CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      +|+... ....+.+.+|||.|.|||++.+..+   ..++|+||+||++|-+++|.+||.....       .....+++..
T Consensus       325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------~~sl~eQI~~  396 (475)
T KOG0615|consen  325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------DPSLKEQILK  396 (475)
T ss_pred             hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-------CccHHHHHhc
Confidence            999876 5677889999999999999987653   3478999999999999999999763221       1224567778


Q ss_pred             CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +++...+..+........++|.+|+..||++|||++|+++
T Consensus       397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            8888777777777888999999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-46  Score=389.30  Aligned_cols=251  Identities=28%  Similarity=0.493  Sum_probs=209.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +.+...+.||+|.||+||.|++.....||+|.++...    ...++|.+|+++|++++|++||+++|+|..++.+|||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            3455668899999999999999977799999998642    224789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      ||+.|+|.+++.. ..+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+...++.
T Consensus       282 ~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  282 YMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             ecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9999999999987 3345688999999999999999999999   99999999999999999999999999999555444


Q ss_pred             CCcc-ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcC-CCCCCCCch
Q 039344          762 SNWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN  838 (873)
Q Consensus       762 ~~~~-~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  838 (873)
                      +..+ ...-+..|.|||.+..++++.|||||||||+||||+| |+.||..+...+        .++.+.. .+++.|. .
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~GyRlp~P~-~  428 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERGYRLPRPE-G  428 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhccCcCCCCC-C
Confidence            3322 2334678999999999999999999999999999999 999987544332        2233322 3444443 3


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +++   .++++|..||+.+|++|||++.+...++
T Consensus       429 CP~---~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  429 CPD---EVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             CCH---HHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            333   4889999999999999999998877664

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-46  Score=357.26  Aligned_cols=258  Identities=24%  Similarity=0.345  Sum_probs=214.1

Q ss_pred             cCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeE-EEe-cceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF-CLH-VRHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~-~~~~~l  678 (873)
                      .+|++.++||+|.||+||++. ..+|..||.|.++-. .-+....++...|+.++++++|||||+++++ +.+ ....++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            457788999999999999995 678999999999833 2333456889999999999999999999984 333 344899


Q ss_pred             EEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      |||||..|+|...+...+ ..+.+++..++++..|++.|+.++|++. +.  |.||||||.||+++.+|.+|++|||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence            999999999999986544 4456899999999999999999999942 24  8899999999999999999999999999


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ++........+.+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+.        +.......+.++..+..
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~qgd~~~~  248 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQGDYPPL  248 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHcCCCCCC
Confidence            9988777778899999999999999999999999999999999999999998753        22333344445555432


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      +  ....+..+.++|..|+.+||+.||+.-.+++.+
T Consensus       249 p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  249 P--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             c--HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            2  234566799999999999999999865555443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.8e-45  Score=402.59  Aligned_cols=256  Identities=24%  Similarity=0.425  Sum_probs=215.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ..+....+.||+|+||+||+|+..      +...||||.++.....  ...++|.+|++++..++|||||+++|+|.+++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            345566688999999999999743      4567999999876443  34789999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccc-------c----ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC
Q 039344          675 HLFIVYEYFKMCSLAVILSNDA-------A----AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE  743 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~-------~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~  743 (873)
                      ..++|+|||..|+|.+||....       .    ..+++..+.+.||.|||.||+||.++   .+|||||.++|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            9999999999999999995432       1    22378889999999999999999999   99999999999999999


Q ss_pred             CCeEEeccccccccCCCCCCc-c-ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhh
Q 039344          744 NEAHVSDFGIAKFLKPDSSNW-T-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       744 ~~~kl~Dfg~a~~~~~~~~~~-~-~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~  820 (873)
                      ..|||+|||++|..-..+++. . ...-+.+|||||.|..++||.+||||||||++||+++ |+.||..        ...
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g--------lSn  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG--------LSN  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc--------cch
Confidence            999999999999765443332 1 2345789999999999999999999999999999998 9999654        445


Q ss_pred             hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +++++.+.++++-..++.++   ..++++|..||+..|++||+++||-.+|+
T Consensus       712 ~EVIe~i~~g~lL~~Pe~CP---~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  712 QEVIECIRAGQLLSCPENCP---TEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             HHHHHHHHcCCcccCCCCCC---HHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence            56666676777655555444   45999999999999999999999998875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=360.68  Aligned_cols=203  Identities=28%  Similarity=0.473  Sum_probs=182.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+..... .....+-+..|+.+++.++|||||++++++.+++..|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            467888899999999999999764 689999999986543 233466788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC------CCeEEecccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE------NEAHVSDFGI  753 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~------~~~kl~Dfg~  753 (873)
                      ||||.||+|.++++...   .+++..++.++.|+|.|+++||++   +||||||||+|||++..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999997654   589999999999999999999999   99999999999999875      3589999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      ||.+.+ .....+.+|++-|||||++..+.|+.|+|+||+|+++|||++|+.||+...
T Consensus       162 AR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  162 ARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            998874 345567899999999999999999999999999999999999999998544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.8e-48  Score=386.42  Aligned_cols=453  Identities=32%  Similarity=0.459  Sum_probs=365.2

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeec
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYL  100 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  100 (873)
                      ..++.|++++|.++ .+.+.+.++..|.+|.+++|+++ ..|.+++.+..++.|+.++|++. .+|..+..+.+|+.|+.
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            45788888888887 55566788888888888888888 77888888888888888888888 78888888888888888


Q ss_pred             cccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccC
Q 039344          101 DTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS  180 (873)
Q Consensus       101 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  180 (873)
                      ++|++. ..|+.++.+..|+.|+..+|+++ ..|.++..+.+|..|++.+|++...++..+. ++.|++||...|-++ .
T Consensus       122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t  197 (565)
T KOG0472|consen  122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T  197 (565)
T ss_pred             ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence            888888 67778888888888888888887 6777888888888888888888877776666 888888888888887 6


Q ss_pred             CCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCC
Q 039344          181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL  260 (873)
Q Consensus       181 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  260 (873)
                      +|+.++.+.+|..|||..|++. ..| .|.+|..|.+|.++.|+|+........++.++..|||+.|+++ ..|+.++-+
T Consensus       198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL  274 (565)
T KOG0472|consen  198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL  274 (565)
T ss_pred             CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence            6777888888888888888888 556 6888888888888888888444445558888888888888888 678888888


Q ss_pred             CCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCccccccccc--------------------------------------
Q 039344          261 VKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISE--------------------------------------  302 (873)
Q Consensus       261 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~--------------------------------------  302 (873)
                      ++|+.||+++|.+++.+..++++ .|+.|-+.||.+..+-.+                                      
T Consensus       275 rsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~  353 (565)
T KOG0472|consen  275 RSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE  353 (565)
T ss_pred             hhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence            88888888888888888888888 888888888876532111                                      


Q ss_pred             ---ccccCCCccEEeccCccccccCCCCCCCC--CCCCeeeeccccCCccCCccccCCCCCC-EEeccCCccCCCCCccc
Q 039344          303 ---SFYIYPNLTYIDLSQNNFYGEISSDWGRC--PKLSTLDFSINNITGNVPPEIGHSSQLG-VLDLSSNHIVGEIPIEL  376 (873)
Q Consensus       303 ---~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~l~~N~i~~~~~~~~~~~~~L~-~L~Ls~N~i~~~~~~~~  376 (873)
                         ........+.|++++-+++....+.|..-  .-....++++|++. ++|..+..+..+. .+.+++|.+ +.+|..+
T Consensus       354 ~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l  431 (565)
T KOG0472|consen  354 SFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLEL  431 (565)
T ss_pred             cccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHH
Confidence               01123357788888888885544444332  23778999999997 6787776665554 455555555 4899999


Q ss_pred             cccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhccc
Q 039344          377 GKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSL  456 (873)
Q Consensus       377 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L  456 (873)
                      ..+++|+.|+|++|-+. .+|..++.+..|+.||+|.|++. .+|..+..+.  .|+.+-.++|++..+.|..+..|.+|
T Consensus       432 ~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq--~lEtllas~nqi~~vd~~~l~nm~nL  507 (565)
T KOG0472|consen  432 SQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQ--TLETLLASNNQIGSVDPSGLKNMRNL  507 (565)
T ss_pred             Hhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHH--HHHHHHhccccccccChHHhhhhhhc
Confidence            99999999999999998 58889999999999999999996 7888776654  66777778899999888889999999


Q ss_pred             ceecccCccccCCCchhhhccCCCcEEecCCCccc
Q 039344          457 EKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR  491 (873)
Q Consensus       457 ~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~  491 (873)
                      ..|||.+|.|. .+|..+++|.+|++|++.||+++
T Consensus       508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            99999999998 67888999999999999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=352.71  Aligned_cols=245  Identities=27%  Similarity=0.380  Sum_probs=211.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.++||+|+||+||.++. .+++.+|+|++++...-+....+...+|..++.+++||.||+++-.|.+.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            47899999999999999999965 46899999999877555555567789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      +||+.||.|..++.++.   .+++..+..++..|+.||.|||++   +||||||||+|||+|++|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999997554   489999999999999999999999   999999999999999999999999999997666


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      ......+.+||+.|||||++.+..|+.++|.||+|+++|||++|.+||....        .....+.+...+.+.+....
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~~k~~~~p~~l  249 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILKGKLPLPPGYL  249 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhcCcCCCCCccC
Confidence            6666667899999999999999999999999999999999999999977533        33444555555544333311


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC
Q 039344          840 HDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      .   ....+++.+.+..||++|.
T Consensus       250 s---~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  250 S---EEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C---HHHHHHHHHHhccCHHHhc
Confidence            1   2378899999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=341.33  Aligned_cols=261  Identities=22%  Similarity=0.388  Sum_probs=209.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.|+...++|+|+||.||+++.+ +|+.||||+|.... .+....+-.++|++++++++|+|+|.++++|......++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            35777789999999999999865 69999999998653 33445666789999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |||+..-|++.-+   ....++.+.+.++++|++.|+.|+|++   +++||||||+|||++.+|.+||||||+||.+...
T Consensus        81 E~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9999766655532   223488899999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh---h---hhhhcC----
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI---A---LDEMLD----  829 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~---~---~~~~~~----  829 (873)
                      ...++..+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+..+.+.--.....   .   ..+++.    
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            888889999999999999887 77999999999999999999999998866543211110000   0   011110    


Q ss_pred             ---CCCCCCC------chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 ---PRLPTPS------RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ---~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         =++|.+.      ...+.....+.++++.|++.||++|++-++++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               0112111      111233346789999999999999999998864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=379.24  Aligned_cols=267  Identities=26%  Similarity=0.472  Sum_probs=220.8

Q ss_pred             ccccccCHHHHHHHhcC---------CCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHH
Q 039344          587 TFEGKIIYEEIIRATND---------FDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVK  653 (873)
Q Consensus       587 ~~~~~~~~~e~~~~~~~---------~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~  653 (873)
                      +.....+|+|.-.|..+         ..+.++||.|.||.|++|+++    ....||||.++....  .....+|..|+.
T Consensus       605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAs  682 (996)
T KOG0196|consen  605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEAS  682 (996)
T ss_pred             eecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhh
Confidence            34455566666555444         355789999999999999865    245799999986533  344688999999


Q ss_pred             HHHhccCCceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 039344          654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDI  733 (873)
Q Consensus       654 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl  733 (873)
                      +|.++.||||+++.|+....+..++|.|||++|+|+.||+...  +++++.+...|.++||.||+||.+.   ++|||||
T Consensus       683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDL  757 (996)
T KOG0196|consen  683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDL  757 (996)
T ss_pred             hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhh
Confidence            9999999999999999999999999999999999999998655  5599999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCeEEeccccccccCCCCC-Ccccccc--ccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcc
Q 039344          734 SSKNVLLDFENEAHVSDFGIAKFLKPDSS-NWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF  809 (873)
Q Consensus       734 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~g--~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~  809 (873)
                      .++|||++.+-.+|++|||++|.+.++.. .+++..|  +.+|.|||.+.-++++.+|||||||++|||.++ |..||..
T Consensus       758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd  837 (996)
T KOG0196|consen  758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  837 (996)
T ss_pred             hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence            99999999999999999999998876653 3333333  568999999999999999999999999999887 9999754


Q ss_pred             cccchhhhhhhhhhhhhhc-CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          810 ISSMSFSSLNLNIALDEML-DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       810 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+        ++.+..+. +-++|.|-    +++.++.++|..||++|-.+||.+++++..|+
T Consensus       838 mSN--------QdVIkaIe~gyRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  838 MSN--------QDVIKAIEQGYRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD  889 (996)
T ss_pred             cch--------HHHHHHHHhccCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence            322        22333333 33455443    45567999999999999999999999998874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=356.93  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=214.5

Q ss_pred             HHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecce
Q 039344          598 IRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       598 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  675 (873)
                      .+...+|..++.||+|+|++|++|+. .+++.||||++.+.........+.+..|-++|..| .||.|++++-.|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            55668899999999999999999964 57999999998765443333356688999999999 89999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .|+|+||+++|.|.+++++.   +.+++.-++.++.+|+.|++|||++   |||||||||+|||+|+||++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            99999999999999999765   4589999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCC-------------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh
Q 039344          756 FLKPDSSN-------------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI  822 (873)
Q Consensus       756 ~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~  822 (873)
                      .+.+....             ...++||..|.+||++.+...+..+|+|+|||++|+|+.|.+||.....        ..
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yl  294 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--------YL  294 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------HH
Confidence            87553221             1458999999999999999999999999999999999999999875333        23


Q ss_pred             hhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .++++++-.+..+....    ..+.+++.+.+..||.+|++..++.+
T Consensus       295 iFqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  295 IFQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence            34444444443333222    24789999999999999999998875

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=367.52  Aligned_cols=389  Identities=26%  Similarity=0.289  Sum_probs=261.8

Q ss_pred             CEEEcccCCCCCCCCcccccc--cccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEcc
Q 039344           72 SDLELSNNKLSGSIPPSLGNL--SNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIY  149 (873)
Q Consensus        72 ~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  149 (873)
                      ..||.+++.+..+....+.+.  +.-+.|++++|++..+.+..|.++++|+++++.+|.++ .+|...+...+|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence            457777777764322222222  23456888888888777777888888888888888887 677766666668888888


Q ss_pred             CCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCc
Q 039344          150 SNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSI  229 (873)
Q Consensus       150 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  229 (873)
                      +|.|+.+..+.+..++.|+.||||.|.|+.+...+|..-.++++|+|++|.|+....+.|.++.+|..|.|++|+|+...
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence            88887777777777777777777777777555555665566666666666666555556666666666666666666544


Q ss_pred             ccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCC
Q 039344          230 PISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPN  309 (873)
Q Consensus       230 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~  309 (873)
                      +..|.++++|+.|+|..|.|.-.--.                       .|.++++|+.|.|..|.|.......|..+.+
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~l-----------------------tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~k  270 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGL-----------------------TFQGLPSLQNLKLQRNDISKLDDGAFYGLEK  270 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhh-----------------------hhcCchhhhhhhhhhcCcccccCcceeeecc
Confidence            44555555555555555555422233                       4555555555555555555555566666666


Q ss_pred             ccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecC
Q 039344          310 LTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAH  389 (873)
Q Consensus       310 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~  389 (873)
                      +++|+|+.|++...-..++.++++|+.|++|+|.|..+.++.++..++|++|+|++|+|+...+.+|..+..|++|+|++
T Consensus       271 me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~  350 (873)
T KOG4194|consen  271 MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSH  350 (873)
T ss_pred             cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccc
Confidence            66666666666655556666666666666666666666666666666777777777777666666677777777777777


Q ss_pred             ccccCCcccccccccccccccccccccccccCCC---cCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccc
Q 039344          390 NQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKS---LGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL  466 (873)
Q Consensus       390 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  466 (873)
                      |.++..-..+|..+++|++|||++|.|+..+.++   |.+  ++.|+.|+|.+|+|....-.+|..++.|+.|||.+|.|
T Consensus       351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~g--l~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai  428 (873)
T KOG4194|consen  351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNG--LPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI  428 (873)
T ss_pred             cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhcc--chhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence            7776544456777778888888888887544443   333  34788888888888877777788888888888888888


Q ss_pred             cCCCchhhhccCCCcEEecCC
Q 039344          467 SGLIPSCFEKMNGLLHIDISY  487 (873)
Q Consensus       467 ~~~~~~~~~~~~~L~~l~ls~  487 (873)
                      ..+-|+.|..| .|++|-++.
T Consensus       429 aSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  429 ASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             eeecccccccc-hhhhhhhcc
Confidence            88888888888 777776654

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=368.50  Aligned_cols=388  Identities=27%  Similarity=0.274  Sum_probs=347.0

Q ss_pred             CCceEEccCCcccccCCCCccCC--CCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccc
Q 039344           46 NLATLYIHTNSLSGSIPGEIGNF--RFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ  123 (873)
Q Consensus        46 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (873)
                      +-+.|+++++.+..+.-..+.++  +.-+.||+++|++..+-+..|.++++|+.+++.+|.++ .+|.......+|+.|+
T Consensus        53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~  131 (873)
T KOG4194|consen   53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD  131 (873)
T ss_pred             CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence            34678999999884433333322  34567999999999888899999999999999999999 7888777778899999


Q ss_pred             ccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcc
Q 039344          124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY  203 (873)
Q Consensus       124 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~  203 (873)
                      |.+|.|+..-.+.++.++.|+.|||+.|.|+.+....|..-.++++|+|++|+|+......|.++.+|.+|.|+.|+++.
T Consensus       132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt  211 (873)
T KOG4194|consen  132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT  211 (873)
T ss_pred             eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence            99999998778899999999999999999999999999998999999999999999888999999999999999999998


Q ss_pred             cCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcC-cCCcCCC
Q 039344          204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRN  282 (873)
Q Consensus       204 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~l~~  282 (873)
                      ..+..|.++++|+.|+|..|+|.-.....|.++++|+.|.|..|.|.......|..+.++++|+|+.|+++. ...++.+
T Consensus       212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfg  291 (873)
T KOG4194|consen  212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFG  291 (873)
T ss_pred             cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccc
Confidence            888899999999999999999985546789999999999999999999999999999999999999999987 4558999


Q ss_pred             CCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEe
Q 039344          283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLD  362 (873)
Q Consensus       283 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~  362 (873)
                      +++|+.|+|++|.|..+..+.+...++|++|+||+|+|+...+..|..+..|+.|+|+.|.|...-..+|..+++|+.||
T Consensus       292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld  371 (873)
T KOG4194|consen  292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD  371 (873)
T ss_pred             cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999877677888999999999


Q ss_pred             ccCCccCCCC---CccccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccc
Q 039344          363 LSSNHIVGEI---PIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL  437 (873)
Q Consensus       363 Ls~N~i~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~L  437 (873)
                      |++|.|+..+   ...|.++++|++|.|.+|+|..+...+|..+..|++|||.+|.|...-|.+|..+   +|++|-+
T Consensus       372 Lr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m---~Lk~Lv~  446 (873)
T KOG4194|consen  372 LRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM---ELKELVM  446 (873)
T ss_pred             CcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc---hhhhhhh
Confidence            9999987644   3457789999999999999998777889999999999999999988888888876   5666655

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=360.59  Aligned_cols=249  Identities=24%  Similarity=0.441  Sum_probs=212.5

Q ss_pred             cCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..|....+||+|+.|.||.|+ ..+++.||||++.......   .+-+.+|+.+|+..+|+|||++++.|...+..|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            457778899999999999995 5578999999997643333   366889999999999999999999999889999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+.+....    +++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus       350 Eym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999986543    89999999999999999999999   9999999999999999999999999999998887


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ....++.+|||.|||||+.....|++|.||||+|++++||+.|.+||-...+..-......     --.+++..+..   
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-----ng~P~lk~~~k---  494 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-----NGTPKLKNPEK---  494 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-----cCCCCcCCccc---
Confidence            7777889999999999999999999999999999999999999999876544321111111     11233333322   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ....+.+|+.+|++.||++||++.|+++
T Consensus       495 -lS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 -LSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence             2345899999999999999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=358.83  Aligned_cols=241  Identities=29%  Similarity=0.492  Sum_probs=202.7

Q ss_pred             CCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          605 DDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       605 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      ...+-||.|+.|.||+|++. ++.||||+++.-          -..+|+-+++++||||+.+.|+|.+...+|||||||.
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            34578999999999999998 889999998631          1257888999999999999999999999999999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW  764 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  764 (873)
                      .|-|...+...   ..++......|.++||.|+.|||.+   +|||||||.-||||..+..|||+|||-++..... ...
T Consensus       196 ~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk  268 (904)
T KOG4721|consen  196 QGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK  268 (904)
T ss_pred             cccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh
Confidence            99999999654   4588888999999999999999999   9999999999999999999999999999877655 455


Q ss_pred             cccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHH
Q 039344          765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI  844 (873)
Q Consensus       765 ~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (873)
                      ..++||..|||||+++..+.++|+||||||||+|||+||..||..+....+..    .+-...+  .++.+.    .+..
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVGsNsL--~LpvPs----tcP~  338 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVGSNSL--HLPVPS----TCPD  338 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE----eccCCcc--cccCcc----cCch
Confidence            56899999999999999999999999999999999999999998655331110    0001111  223222    1233


Q ss_pred             HHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 039344          845 SIVEVTISCVDENPESRPTMQKVCQLLKI  873 (873)
Q Consensus       845 ~l~~li~~cl~~dP~~RPs~~ev~~~L~~  873 (873)
                      .+.-+++.||+..|..||++.+++..|+|
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            58889999999999999999999998876

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=342.21  Aligned_cols=261  Identities=24%  Similarity=0.374  Sum_probs=213.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||.|..++||+|+ .+.++.||||++.-.....  ..+.+.+|+..|+.++||||++.+..|..+...|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            4679999999999999999996 5678999999997654433  368899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |.||.+|++.+++......+ +++..+..|.+++++||.|||++   |.+|||||+.|||++.+|.|||+|||.+..+..
T Consensus       103 mpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999999997655433 89999999999999999999999   999999999999999999999999999877655


Q ss_pred             CCCCc----ccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          760 DSSNW----TELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       760 ~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .....    .+.+||+.|||||++..  ..|+.|+||||||+...|+.+|+.||...+++..--...+.........  .
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~--~  256 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS--G  256 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc--c
Confidence            44322    45689999999999654  3589999999999999999999999987766543333222211111100  1


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+........+.+++..|+++||++|||++++++
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111122233457899999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2e-45  Score=367.61  Aligned_cols=444  Identities=32%  Similarity=0.443  Sum_probs=367.6

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      |++|.+....|. +.+++.+.+|++++|+++ ..|.+++.+..++.|+.++|+++ ++|+.++.+.+|..|+.++|.+. 
T Consensus        52 ls~N~l~~l~~d-l~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-  127 (565)
T KOG0472|consen   52 LSHNDLEVLRED-LKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-  127 (565)
T ss_pred             hccCchhhccHh-hhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-
Confidence            466777665554 788888999999999987 77888888888888999999988 88888888888999999998888 


Q ss_pred             CCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCC
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGN  163 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  163 (873)
                      ..|+.++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|+++...|..+ .++.|++|++.+|.++. .|..+++
T Consensus       128 el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~t-lP~~lg~  204 (565)
T KOG0472|consen  128 ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLET-LPPELGG  204 (565)
T ss_pred             ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhhc-CChhhcc
Confidence            77888888888888888888888 678888888888888888888884444444 48888888888888854 5667888


Q ss_pred             CCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccc-cCCCCCCEEEccCcccCCCcccccCCCCCccEE
Q 039344          164 LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL  242 (873)
Q Consensus       164 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  242 (873)
                      +.+|..|+|.+|+|. ..| .|.+++.|++|+++.|+|. .+|... .+++++..|||.+|+++ ..|+.+.-+.+|.+|
T Consensus       205 l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rL  280 (565)
T KOG0472|consen  205 LESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERL  280 (565)
T ss_pred             hhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhh
Confidence            888888888888887 555 7888888888888888888 555554 48888888888888888 678888888888888


Q ss_pred             ecccccCCCCCchhhcCCCCCcEEEccCCcCcC------------------------------------------cCCcC
Q 039344          243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG------------------------------------------PIPIL  280 (873)
Q Consensus       243 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------------------------------------~~~~l  280 (873)
                      |+++|.|+ ..|..++++ +|+.|.+.+|.+..                                          ..+..
T Consensus       281 DlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~  358 (565)
T KOG0472|consen  281 DLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDI  358 (565)
T ss_pred             cccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccch
Confidence            88888888 467788888 88888888887641                                          01112


Q ss_pred             CCCCCCCeEEccCcccccccccccccCC--CccEEeccCccccccCCCCCCCCCCCCe-eeeccccCCccCCccccCCCC
Q 039344          281 RNLTSLERVRLDRNYLTGNISESFYIYP--NLTYIDLSQNNFYGEISSDWGRCPKLST-LDFSINNITGNVPPEIGHSSQ  357 (873)
Q Consensus       281 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~l~~N~i~~~~~~~~~~~~~  357 (873)
                      ..+.+.+.|++++-+++.++.+.|..-.  -.+.++++.|++. ++|..+..+..+.+ +.+++|.+ +.+|..+..+++
T Consensus       359 ~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~k  436 (565)
T KOG0472|consen  359 YAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQK  436 (565)
T ss_pred             hhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhc
Confidence            2345688999999999999988886543  4889999999998 78888877776654 45555555 488999999999


Q ss_pred             CCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccc
Q 039344          358 LGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL  437 (873)
Q Consensus       358 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~L  437 (873)
                      |..|+|++|.+. .+|.+++.+..|+.|+++.|.+. ..|+.+..+..++.+-.++|+++...|..+.+++  +|+.|||
T Consensus       437 Lt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~--nL~tLDL  512 (565)
T KOG0472|consen  437 LTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMR--NLTTLDL  512 (565)
T ss_pred             ceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhh--hcceecc
Confidence            999999999997 79999999999999999999998 6888888888899999999999865555588777  9999999


Q ss_pred             cCCccCcccchhhhhhcccceecccCcccc
Q 039344          438 SRNFLREAIPSQICIMQSLEKLNLSHNSLS  467 (873)
Q Consensus       438 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  467 (873)
                      .+|.|. .+|..+++|++|+.|++++|+++
T Consensus       513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             CCCchh-hCChhhccccceeEEEecCCccC
Confidence            999998 58889999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.1e-41  Score=319.70  Aligned_cols=260  Identities=22%  Similarity=0.336  Sum_probs=208.6

Q ss_pred             cCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|...+++|+|.||.||+|+ ..+|+.||||+++.....+ .......+|+..++.++|+||+.++++|.+.+...+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            457778899999999999996 4689999999998653332 22456789999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++ .+|...+....  ..++..++..++.++++|++|||++   .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        81 Efm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9998 68888886544  4588999999999999999999999   9999999999999999999999999999999887


Q ss_pred             CCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh----------------h
Q 039344          761 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI----------------A  823 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~----------------~  823 (873)
                      ....+..+.|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+..+.+.-......                .
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            7777667899999999998875 5899999999999999999988877755433211111110                0


Q ss_pred             hhhhcCCCCCCC--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          824 LDEMLDPRLPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       824 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ..++.  ..|.+  ......+..+..+++.+++..||.+|.++.|+++.
T Consensus       235 Y~~~~--~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQ--QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHh--cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11111  01111  11122334457899999999999999999998763

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=357.27  Aligned_cols=262  Identities=24%  Similarity=0.379  Sum_probs=210.1

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      +++....+++.+.+.||+|.||+||+|++. | .||||++........ ..+.|+.|+..+++-+|.||+=+.|||..+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            555556677888899999999999999986 3 589999987766554 5789999999999999999999999999877


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      . .+|..+|+|.+|+.+++...  ..++..+.+.||+|||+||.|||.+   +|+|||||..||++.+++.|||+|||++
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence            7 99999999999999998655  4588899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCC--CCCCcccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC
Q 039344          755 KFLKP--DSSNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       755 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      ..-..  .........|..-|||||+++.   .+|++++||||||+|+|||+||..||. ....+..-  ... ......
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi--fmV-GrG~l~  611 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII--FMV-GRGYLM  611 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE--EEe-cccccC
Confidence            65322  1222334567888999999974   468999999999999999999999987 32211000  000 000011


Q ss_pred             CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       830 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +++   ......+.+++.+++..||..++++||.+.+++..|+
T Consensus       612 pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  612 PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            122   1222334556889999999999999999999998664

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=362.23  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=206.4

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeCC--C--cE-EEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLAS--G--EI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ..++....++||+|+||.||+|+++.  +  .. ||||..+..........++|.+|+++|+.++|||||++||++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34556666999999999999997643  2  23 8999988644344556789999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ++++|||+|.||+|.+++.....  .++..++.+++.++|.||+|||++   +++||||.++|+|++.++.+||+|||++
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999976543  589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhh-c-CCC
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEM-L-DPR  831 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~-~-~~~  831 (873)
                      +.............-+..|+|||.+..+.|++++|||||||++||+++ |..||.......        ....+ . +-+
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--------v~~kI~~~~~r  381 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--------VKAKIVKNGYR  381 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--------HHHHHHhcCcc
Confidence            865411111111235678999999999999999999999999999999 889987644331        11222 1 112


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.+. .   ....+..++.+||..+|++||+|.++.+.++
T Consensus       382 ~~~~~-~---~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  382 MPIPS-K---TPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             CCCCC-C---CHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence            22222 1   2234778888999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-41  Score=344.40  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=199.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc--eeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR--HLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  678 (873)
                      .++...+.||+|+||+||++... +|+..|||.+.......   .+.+.+|+.++++++|||||+.+|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            45777899999999999999765 49999999987542111   567899999999999999999999754443  6999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-CCCeEEecccccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFL  757 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~~  757 (873)
                      +|||+++|+|.+++.+...  .+++..+..+++||++|++|||++   ||+||||||+|||++. ++.+||+|||++...
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999999976553  599999999999999999999999   9999999999999999 799999999999877


Q ss_pred             CCCC---CCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          758 KPDS---SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       758 ~~~~---~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ....   .......||+.|||||++..+. ...++||||+||++.||+||+.||...  ...........    .....|
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig----~~~~~P  242 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIG----REDSLP  242 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHh----ccCCCC
Confidence            6311   2233578999999999999643 345899999999999999999997642  11111111111    111122


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .-+..   ......+++.+|+..||++||||+++++.
T Consensus       243 ~ip~~---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  243 EIPDS---LSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             CCCcc---cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            11111   22247889999999999999999999864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.5e-41  Score=349.80  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=213.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+....+++ .+.+.+|+++++.++|||||.++++|+...+.|+|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            56788889999999999999765 6889999999776554432 567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+.| +|..++...   +.++++.+..++.+++.|+.|||+.   +|.|||+||+||+++..|.+|+||||+|+.+...
T Consensus        81 e~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99996 999999654   4599999999999999999999999   9999999999999999999999999999988877


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ....+...|||-|||||...+++|+..+|.||+||++||+++|++||.        .......+..+.......+.    
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--------a~si~~Lv~~I~~d~v~~p~----  221 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--------ARSITQLVKSILKDPVKPPS----  221 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--------HHHHHHHHHHHhcCCCCCcc----
Confidence            667778899999999999999999999999999999999999999964        23333344444443333333    


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+..++...+.+||..|.+..++++
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            23445899999999999999999988764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=346.08  Aligned_cols=261  Identities=22%  Similarity=0.356  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecc-eeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVR-HLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  677 (873)
                      .++|.+.++||.|.||+||+|+. .+|+.||||+++.......  .-.-.+|+..+++++ ||||+++.+++.+.+ ..|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            36788889999999999999964 5799999999986543321  122469999999998 999999999999888 999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +|||||+ ++|.+.+...  .+.+++..+..|+.||++||+|+|.+   |++|||+||+|||+.....+||+|||+||.+
T Consensus        87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            9999998 8999999765  56799999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccccccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhh-------------hhhhhh
Q 039344          758 KPDSSNWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS-------------LNLNIA  823 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~-------------~~~~~~  823 (873)
                      ... ..++..+.|.+|+|||++ +++-|+.+.|+||+|||++|+.+-++-|.+....+...             ......
T Consensus       161 ~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  161 RSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             ccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            643 455677899999999975 56789999999999999999999888887654321110             001011


Q ss_pred             hhhhcCCCCCCCCch-----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          824 LDEMLDPRLPTPSRN-----VHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       824 ~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      +...+.-+++.....     ......+..+++.+|+++||.+||||++.++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            222222222211111     11233468899999999999999999999864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=378.90  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=209.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC--CCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA--SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ...+..+.||+|+||.||.|...  +|.    .||+|.+++.  .+.....+|.+|..+|++++|||||+++|+|.+...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            44556789999999999999765  343    4899988765  334447899999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhccccc----ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAA----AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      .++++|||++|+|..|+++.+.    ...++..+.+.++.+||+|++||+++   ++|||||.++|+|+++...|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999987632    34578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcc-cc-ccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhc
Q 039344          752 GIAKFLKPDSSNWT-EL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       752 g~a~~~~~~~~~~~-~~-~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      |+|+.+....++.. .. .-+..|||||.+.++.++.|||||||||++||++| |..||....+.+..       ..-.-
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-------~~~~~  919 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-------LDVLE  919 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------HHHHh
Confidence            99996544333322 22 33568999999999999999999999999999999 99998754443221       11223


Q ss_pred             CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       829 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +++++.+. ++++   .++++|..||+.+|++||++.++++.+.
T Consensus       920 ggRL~~P~-~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  920 GGRLDPPS-YCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             CCccCCCC-CCCh---HHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            44555443 3444   4889999999999999999999998764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=318.81  Aligned_cols=239  Identities=25%  Similarity=0.343  Sum_probs=208.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|+..+.||.|+||.|.+++.+ +|..+|.|++.+...-+....+-..+|..+++.+.||.++++++.|.+.+..||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56888899999999999999865 68899999998765555555677889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++||.+..++++.   +++++..++.+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||.|+.+...
T Consensus       124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999654   4599999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .-+.+|||.|+|||.+.+..+..++|-|||||++|||+.|..||.....        -...+.++.+++..|..-..
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~fP~~fs~  266 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVKFPSYFSS  266 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcccCCcccCH
Confidence               3457999999999999999999999999999999999999999875443        33455666667666654333


Q ss_pred             HHHHHHHHHHhhcccCCCCCC
Q 039344          841 DKLISIVEVTISCVDENPESR  861 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~R  861 (873)
                          ++.+++.+.++.|-.+|
T Consensus       267 ----~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  267 ----DAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----HHHHHHHHHHhhhhHhh
Confidence                37889999999998888

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=342.53  Aligned_cols=258  Identities=22%  Similarity=0.358  Sum_probs=209.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .....++++||+|-||.|.......+..||||+++.....  ....+|.+|+++|.+++||||++++|+|..++.+++|+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            3456778999999999999999988899999999876433  33689999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |||++|+|..|+..+.... ...+...+|+.||+.|++||.+.   .+||||+.++|+|+|.++++||+|||++|.+-..
T Consensus       615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999998775433 45566788999999999999999   9999999999999999999999999999966544


Q ss_pred             CCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh--CCCCCcccccchhhhhhhhhhhhhhcCCC----C
Q 039344          761 SSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISSMSFSSLNLNIALDEMLDPR----L  832 (873)
Q Consensus       761 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~----~  832 (873)
                      +++.  ...+-+.+|||||.+.-++++.+||||+||+++||+++  ...||....+....     +...++++..    .
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-----en~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-----ENAGEFFRDQGRQVV  765 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-----HhhhhhcCCCCccee
Confidence            4332  23455789999999999999999999999999999886  77887643332211     1122222211    1


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+..   +...+++++.+||..|.++||+++++...|+
T Consensus       766 l~~P~~---cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  766 LSRPPA---CPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             ccCCCc---CcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence            112222   2345889999999999999999999987663

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-40  Score=341.72  Aligned_cols=262  Identities=25%  Similarity=0.391  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  677 (873)
                      .+.|+..++||+|.||.||+|+ ..+|+.||+|+++..... .....-..+||.++++++||||+++.+...+.  +.+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            3557777899999999999996 568999999999865432 23456678999999999999999999998876  7899


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      ||+|||+. +|.-++...  .-.+++.++..+++|++.||+|+|++   ||.|||||.+|||||.+|.+||+|||+|+++
T Consensus       195 lVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            99999985 455454432  23589999999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCC-CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-------hhhhhh---
Q 039344          758 KPDSS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-------LNIALD---  825 (873)
Q Consensus       758 ~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-------~~~~~~---  825 (873)
                      ..... .++..+.|.+|.|||.+.+. .|+.++|+||.|||+.||++|++.|.+..........       .+..+.   
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            77654 47888999999999998875 5999999999999999999999998753322111111       011111   


Q ss_pred             ----hhcCCCCCCCC---chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 ----EMLDPRLPTPS---RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ----~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ..+.+..+...   +..........+++..++..||.+|.||.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                11111111000   001112235678999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=348.59  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=210.5

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCC-c-chhHHHHHHHHHHHHhcc-CCceeeEEeEEEecce
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPG-E-MTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRH  675 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  675 (873)
                      ....|.+.+.||+|+||+|+.|+. .+|+.||+|++...... . ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            346899999999999999999964 57899999976653111 1 123456778999999998 9999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEeccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIA  754 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a  754 (873)
                      +|+||||+.+|.|.+++..   .+++.+.++.+++.|++.|++|||++   ||+||||||+||+++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999976   34588899999999999999999999   99999999999999999 99999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCC-CC-CcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMK-VT-EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ...........+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+....        ......+..+.+
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~ki~~~~~  240 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRKIRKGEF  240 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHHHhcCCc
Confidence            98754455667889999999999999977 85 789999999999999999999986222        222223444444


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+....   ...+..++.+|+..||.+|+++.++++
T Consensus       241 ~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            4443220   334789999999999999999999973

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-40  Score=310.12  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=213.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      -++|++++.||+|.||.||.|+.+ ++-.||+|++.+..........++.+|+++-..++||||+++|+||.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            378999999999999999999754 6789999999876555555567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      +||...|.+...+.... ..++++.....++.|+|.|+.|+|.+   +|+||||||+|+|++.++..|++|||.+.... 
T Consensus       101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999997544 35588999999999999999999999   99999999999999999999999999997543 


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                       .....+.+||..|.|||+..+..++..+|+|++|++.||++.|.+||....        ..+...++..-++..+..  
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k~~~~~p~~--  244 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRKVDLKFPST--  244 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHHccccCCcc--
Confidence             455567899999999999999999999999999999999999999987432        223333333333333322  


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ......++|.+|+..+|.+|.+..|+++
T Consensus       245 --is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  245 --ISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             --cChhHHHHHHHHhccCccccccHHHHhh
Confidence              1234789999999999999999999876

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-39  Score=353.68  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH  672 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  672 (873)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|++.....  ....+.+.+|+.+++.+ +||||++++++|..
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            356799999999999999999963      2457899999875322  22346789999999999 89999999999876


Q ss_pred             c-ceeEEEEEeccCCChhhHhccccc------------------------------------------------------
Q 039344          673 V-RHLFIVYEYFKMCSLAVILSNDAA------------------------------------------------------  697 (873)
Q Consensus       673 ~-~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  697 (873)
                      . +..++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 468999999999999999864321                                                      


Q ss_pred             -----ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC--ccccccc
Q 039344          698 -----AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGT  770 (873)
Q Consensus       698 -----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~  770 (873)
                           ...+++..+..++.||++|++|||++   +|+||||||+||+++.++.+||+|||+++........  .....++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 13477888999999999999999999   9999999999999999999999999999865433221  1233456


Q ss_pred             cccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHH
Q 039344          771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEV  849 (873)
Q Consensus       771 ~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  849 (873)
                      +.|+|||++.+..++.++|||||||++|||++ |..||........       ....+.++.......   .....+.++
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~---~~~~~l~~l  309 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRLKDGTRMRAPE---NATPEIYRI  309 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-------HHHHHhcCCCCCCCC---CCCHHHHHH
Confidence            78999999999999999999999999999997 9999875332110       011111111111111   112348899


Q ss_pred             HhhcccCCCCCCCCHHHHHHHhc
Q 039344          850 TISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       850 i~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+||+.||++|||+.|+++.|+
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~  332 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILG  332 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHH
Confidence            99999999999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-39  Score=345.71  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=215.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .-|+.++.||.|+.|.|-.|+. .+|+.+|||++.+...-.......+.+|+-+|+-+.||||+++|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4578889999999999999975 589999999997764444444677899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|.|.+++...   +++++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+.+||+|||+|... ..
T Consensus        92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-VP  164 (786)
T ss_pred             EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-cC
Confidence            999999999999654   4599999999999999999999999   9999999999999999999999999999754 45


Q ss_pred             CCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      +.-..+.+|+|.|.|||++.+.+| +.++||||.|||+|.++||+.||++        .+....+..+..+.+..+....
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--------dNir~LLlKV~~G~f~MPs~Is  236 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--------DNIRVLLLKVQRGVFEMPSNIS  236 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--------ccHHHHHHHHHcCcccCCCcCC
Confidence            566778899999999999999998 5789999999999999999999883        3334445555566665554333


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .    +..+++.+|+..||+.|-|++||.+.
T Consensus       237 ~----eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  237 S----EAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             H----HHHHHHHHHhccCccccccHHHHhhC
Confidence            3    37899999999999999999999763

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=330.31  Aligned_cols=258  Identities=25%  Similarity=0.397  Sum_probs=201.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc--cCCceeeEEeEEEecc----e
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI--WHRNIVKVYGFCLHVR----H  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~  675 (873)
                      ...+..+++|+|.||.||+|.+. ++.||||+|..      ...+.|.+|-++.+..  +|+||++++++-....    .
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            34555678999999999999998 69999999863      2357788888887654  8999999999987655    7


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCeeeCCCCCeEEe
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC------FPPIVHRDISSKNVLLDFENEAHVS  749 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~Dlk~~Nill~~~~~~kl~  749 (873)
                      +++|+||.+.|+|.+++..+    .++|.+..+|+..+++||+|||+..      .|+|+|||||++|||+..|+++.|+
T Consensus       283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            99999999999999999754    4899999999999999999999864      3789999999999999999999999


Q ss_pred             ccccccccCCCCC--CccccccccccccccccccCC------CCCcchhHHHHHHHHHHHhCCCCCc--ccc----cc--
Q 039344          750 DFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRD--FIS----SM--  813 (873)
Q Consensus       750 Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~sDv~s~G~il~el~tg~~P~~--~~~----~~--  813 (873)
                      |||+|..+.+...  .....+||.+|||||++.+..      .-.+.||||+|.|+|||++...-++  ..+    ++  
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            9999998876533  333578999999999987642      2246899999999999998543331  111    11  


Q ss_pred             -----hhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          814 -----SFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       814 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                           .-.+.....++.+..+|.++..+... ..+..+.+.+..||+.||+.|.|+.=|-+++
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~  500 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM  500 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence                 11112222233444455555544333 4456788999999999999999998887765

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=326.12  Aligned_cols=249  Identities=22%  Similarity=0.364  Sum_probs=214.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||.|.||.|-+|+. ..|+.||||.+++....+....-.+.+|+++|..++||||+.+|.+|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45688889999999999999964 78999999999987776665556688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||..+|.|++++.+.+   .+++.++..+++||..|+.|+|.+   +|+|||||.+|||+|.++++||+|||++..+. 
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~-  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA-  204 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence            99999999999997654   599999999999999999999999   99999999999999999999999999998765 


Q ss_pred             CCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      +....++++|+|-|.+||.+.+.+| .+.+|.||+||++|-++.|..|||+.+.        ...+.++-.+.+..+...
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~GaYrEP~~P  276 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGAYREPETP  276 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhcccccCCCCC
Confidence            4466788999999999999999998 5789999999999999999999886432        223344444444433322


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .     ...-+|+.|+..+|++|.|..+|..
T Consensus       277 S-----dA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  277 S-----DASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             c-----hHHHHHHHHHhcCcccchhHHHHhh
Confidence            1     2457889999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-38  Score=336.74  Aligned_cols=246  Identities=21%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe----cceeEEEEEec
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRHLFIVYEYF  683 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  683 (873)
                      ..||+|++|.||+|... |+.||||+++..........+.|.+|+.++++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            67999999999999984 89999999986544444445778899999999999999999999977    34689999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN  763 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  763 (873)
                      ++|+|.+++...   ..+++..+.+++.+++.|++|||+..  +++||||||+||++++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            999999999654   35889999999999999999999742  78899999999999999999999999998654322  


Q ss_pred             cccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          764 WTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       764 ~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...........    ....  ..+.+.+.    .
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~----i~~~--~~~~~~~~----~  246 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINK--NNSLKLPL----D  246 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhc--CCCCCCCC----c
Confidence             23467899999999876  6789999999999999999999999875432211111    0111  11222221    1


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+.+++.+||+.||++|||++|+++.|+
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            2335889999999999999999999999885

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=329.11  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=205.1

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCC-----------cchhHHHHHHHHHHHHhccCCceeeE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPG-----------EMTFQQEFLNEVKALTEIWHRNIVKV  666 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~niv~l  666 (873)
                      ..-++|++.+.||+|.||.|-+|+.. +++.||+|++.+....           .....+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999754 7899999998643111           11123578999999999999999999


Q ss_pred             EeEEEe--cceeEEEEEeccCCChhhHhcccccccC-CChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC
Q 039344          667 YGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE  743 (873)
Q Consensus       667 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~  743 (873)
                      +.+..+  .+..|||+|||..|.+.+.=    ..+. +++.++++++.+++.||+|||.+   ||+||||||+|+|++++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence            999876  45789999999998876542    2233 89999999999999999999999   99999999999999999


Q ss_pred             CCeEEeccccccccCCC-----CCCccccccccccccccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcccccch
Q 039344          744 NEAHVSDFGIAKFLKPD-----SSNWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMS  814 (873)
Q Consensus       744 ~~~kl~Dfg~a~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~G~il~el~tg~~P~~~~~~~~  814 (873)
                      |++||+|||.+......     +......+|||.|+|||.+.++.    .+.+.||||+||++|.++.|+.||-.     
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-----  321 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-----  321 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-----
Confidence            99999999999866222     22334578999999999988743    35789999999999999999999653     


Q ss_pred             hhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ....+..+.++...+..+...  +....+.++|.+++.+||+.|.+..+|..
T Consensus       322 ---~~~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  322 ---DFELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             ---chHHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhhee
Confidence               333445566666666555432  33456889999999999999999998864

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=336.17  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=210.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ...|+..+.||+|.||.||+|. ..+++.||+|++......+  ..+++.+|+.++..++++||.+.||.+..+...+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            3457777999999999999996 4578999999998654333  367899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+.||++.+.+....   .+++..+..+++++..|+.|+|++   +.+|||||+.||++..+|.+|++|||.+..+..
T Consensus        90 Mey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999985443   357888889999999999999999   999999999999999999999999999988877


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      ......+++|||.|||||++.+..|+.|+||||+|++.+||.+|.+|+....++...-..          ++-.+|.- .
T Consensus       164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------pk~~PP~L-~  232 (467)
T KOG0201|consen  164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------PKSAPPRL-D  232 (467)
T ss_pred             hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------cCCCCCcc-c
Confidence            666667899999999999999889999999999999999999999998765543211111          11111111 1


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+....+.+|+..|+++||+.||+|.++++
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            134445899999999999999999999975

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.7e-38  Score=339.87  Aligned_cols=261  Identities=20%  Similarity=0.337  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC-----------------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCcee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS-----------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV  664 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  664 (873)
                      .+|.+.+.||+|+||.||++...+                 +..||+|.+....  ......+|.+|+.++++++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence            578889999999999999997532                 3469999987542  223356799999999999999999


Q ss_pred             eEEeEEEecceeEEEEEeccCCChhhHhcccc----------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039344          665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDA----------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI  728 (873)
Q Consensus       665 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  728 (873)
                      ++++++.+.+..++||||+++++|.+++....                ....+++..+.+++.|++.|++|||+.   +|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            99999999999999999999999999885432                112467888999999999999999999   99


Q ss_pred             eeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh--CC
Q 039344          729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GK  804 (873)
Q Consensus       729 ~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t--g~  804 (873)
                      +||||||+||+++.++.+||+|||+++........  .....++..|+|||++.++.++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999999866433221  123345788999999988899999999999999999997  55


Q ss_pred             CCCcccccchhhhhhhhhhhhhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          805 HPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       805 ~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .||.............. ........ ....+.    .....+.+++.+||+.||++|||+.+|.+.|+
T Consensus       240 ~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDEQVIENAGE-FFRDQGRQVYLFRPP----PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHHHHHHHHHH-HhhhccccccccCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            67654332211111000 00000000 000111    11235889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.1e-39  Score=336.44  Aligned_cols=252  Identities=24%  Similarity=0.327  Sum_probs=204.3

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..++|+..++||+|+||.||+|+. .+|+.+|+|++++..-......+-+..|-.+|....+|.||++|-.|.+....||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            357899999999999999999975 4799999999988755555556778899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||++||++..+|.+.   +.+++..+..++.+++-|++-+|+.   |++||||||+|+|||..|++||+|||++.-+.
T Consensus       219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999654   4599999999999999999999999   99999999999999999999999999985331


Q ss_pred             C-----------------------CCC----Cc--------------------cccccccccccccccccCCCCCcchhH
Q 039344          759 P-----------------------DSS----NW--------------------TELAGTYGYVAPELAYTMKVTEKCDVY  791 (873)
Q Consensus       759 ~-----------------------~~~----~~--------------------~~~~g~~~y~aPE~~~~~~~~~~sDv~  791 (873)
                      .                       +..    ..                    ...+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                       000    00                    135799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC--CCCCCchhHHHHHHHHHHHhhcccCCCCCCCC---HHH
Q 039344          792 SFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR--LPTPSRNVHDKLISIVEVTISCVDENPESRPT---MQK  866 (873)
Q Consensus       792 s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e  866 (873)
                      |+|||+|||+.|.+||....+..        ....++..+  +..|..  .+......++|.+|+. ||++|.-   ++|
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            99999999999999987544332        222222211  111111  1112347899999999 9999964   555


Q ss_pred             HH
Q 039344          867 VC  868 (873)
Q Consensus       867 v~  868 (873)
                      |.
T Consensus       442 IK  443 (550)
T KOG0605|consen  442 IK  443 (550)
T ss_pred             Hh
Confidence            54

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.5e-39  Score=346.61  Aligned_cols=244  Identities=22%  Similarity=0.283  Sum_probs=199.3

Q ss_pred             ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCC
Q 039344          608 HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC  686 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~  686 (873)
                      +.||+|+||.||+|+. .+|+.||+|+++............+.+|+.++++++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 478999999987543222333466789999999999999999999999999999999999999


Q ss_pred             ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccc
Q 039344          687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE  766 (873)
Q Consensus       687 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  766 (873)
                      +|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            999888643   3588999999999999999999999   9999999999999999999999999999865444444455


Q ss_pred             cccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHH
Q 039344          767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISI  846 (873)
Q Consensus       767 ~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  846 (873)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~p~~~----~~~~  222 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPRTL----SPEA  222 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC----CHHH
Confidence            67999999999999999999999999999999999999998643211        11122222222222221    2347


Q ss_pred             HHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          847 VEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       847 ~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      .+++.+||+.||++||     ++.++++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            8999999999999999     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-39  Score=339.73  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=216.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce-eEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH-LFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv  679 (873)
                      ++|...+++|+|+||.++.++.+ ++..+++|++......+.. .+....|+.++++++|||||.+.+.|.+++. .++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            57888999999999999999654 6788999999876555443 4477899999999999999999999999888 9999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |+|++||++.+.+.+.+ +..++++++.+|+.|++.|+.|||++   .|+|||||+.|||++.++.|+|+|||+|+.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998765 45689999999999999999999998   999999999999999999999999999999988


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC-CCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL-PTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  838 (873)
                      +.....+.+||+.||.||.+.+.+|..|+|+||+||++|||++-+++|....        ....+.++..... +.+.. 
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~~~~Plp~~-  229 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRGLYSPLPSM-  229 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhccCCCCCcc-
Confidence            8777788999999999999999999999999999999999999999987433        2222333333332 22222 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                         +...+..+|..|++.+|+.||++.+++.+
T Consensus       230 ---ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  230 ---YSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               23458899999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-39  Score=340.69  Aligned_cols=247  Identities=25%  Similarity=0.329  Sum_probs=202.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999765 68999999986532222233566889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999998643   3588999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...  
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~--  221 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAGKLEFPRHL--  221 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCcCCCccC--
Confidence               22357899999999999888999999999999999999999998753322        11222222232222211  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                        ...+.+++.+||+.||.+||+     ++++++
T Consensus       222 --~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         222 --DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             --CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence              224789999999999999995     888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-38  Score=337.40  Aligned_cols=254  Identities=22%  Similarity=0.255  Sum_probs=201.3

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|+..+.||+|+||+||+|.. .+|+.||+|++.............+.+|+.+++.++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999975 5799999999865432222234567899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|+|..++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++..... 
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-  155 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence            999999988775432 23588999999999999999999999   9999999999999999999999999999875432 


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......|++.|+|||++.+..++.++||||+||++|||++|+.||.........    ..............+..    
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~----  227 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR----EEVDRRVKEDQEEYSEK----  227 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH----HHHHHHhhcccccCCcc----
Confidence            2234457899999999999999999999999999999999999998753321110    01111111111111111    


Q ss_pred             HHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                      ....+.+++.+||+.||++||+     ++++++
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1234789999999999999997     788765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=319.81  Aligned_cols=261  Identities=23%  Similarity=0.363  Sum_probs=206.6

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc--cCCceeeEEeEEEec---
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI--WHRNIVKVYGFCLHV---  673 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~---  673 (873)
                      ....+..+.+.||+|.||.||+|++. |+.||||+|...  .    .+.+.+|.++++.+  +|+||+.+++.-..+   
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--d----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--D----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc--c----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            34567888899999999999999999 999999999742  1    35677888888765  999999999886543   


Q ss_pred             -ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCCeeeCCCCCeE
Q 039344          674 -RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND-----CFPPIVHRDISSKNVLLDFENEAH  747 (873)
Q Consensus       674 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~Dlk~~Nill~~~~~~k  747 (873)
                       .+.|+|.+|.+.|+|.|||.+.    .++.+..++++..+|.||+|||..     ..|.|.|||||+.|||+.+++.+.
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence             3689999999999999999763    488999999999999999999964     458999999999999999999999


Q ss_pred             EeccccccccCCCCCC----ccccccccccccccccccCC----C-C-CcchhHHHHHHHHHHHhC----------CCCC
Q 039344          748 VSDFGIAKFLKPDSSN----WTELAGTYGYVAPELAYTMK----V-T-EKCDVYSFGVLALEVIKG----------KHPR  807 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~----~-~-~~sDv~s~G~il~el~tg----------~~P~  807 (873)
                      |+|+|+|.........    ....+||.+|||||++...-    + + ..+||||||.|+||++..          +.||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            9999999877654332    24678999999999986432    1 2 358999999999999862          4566


Q ss_pred             cccccc-hhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          808 DFISSM-SFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       808 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      ...-+. .......+....+-+.|.++..+.. .+.+..+.++|+.||..+|..|.|+-.+.+.|
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence            543322 2222223333444456666666654 45677899999999999999999998887765

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=342.27  Aligned_cols=241  Identities=23%  Similarity=0.292  Sum_probs=195.9

Q ss_pred             eeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||+|+||.||+|+.. +++.||+|++.............+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 6889999998653222233356788999999999999999999999999999999999999999


Q ss_pred             hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccc
Q 039344          689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA  768 (873)
Q Consensus       689 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  768 (873)
                      .+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||+++.............
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            9998653   3588999999999999999999999   999999999999999999999999999986544333444567


Q ss_pred             cccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHH
Q 039344          769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE  848 (873)
Q Consensus       769 g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  848 (873)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...+.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~  222 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQEPLRFPDGF----DRDAKD  222 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCCCCCcC----CHHHHH
Confidence            999999999999999999999999999999999999998643221        11222222222222221    234789


Q ss_pred             HHhhcccCCCCCCCC---HHHHH
Q 039344          849 VTISCVDENPESRPT---MQKVC  868 (873)
Q Consensus       849 li~~cl~~dP~~RPs---~~ev~  868 (873)
                      ++.+||+.||++||+   +.|++
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHH
Confidence            999999999999985   55554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=340.18  Aligned_cols=246  Identities=22%  Similarity=0.319  Sum_probs=209.9

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      .-++|...++||+|.||+|+++..+ +++.+|||++++...-..+..+..+.|.+++... +||.++.+++.|...++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3478999999999999999999765 6889999999987665555678889999998877 5999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      .||||+.||++..+.+    .+.+++.++..+|..|+.||.|||++   +||+||||.+|||+|.+|.+||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            9999999999554433    34599999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      -..+...++.+|||.|||||++.+..|+.++|-|||||+||||+.|..||.+.+        .++.++.++......|..
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--------Eee~FdsI~~d~~~yP~~  590 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD--------EEEVFDSIVNDEVRYPRF  590 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHhcCCCCCCCc
Confidence            655567778999999999999999999999999999999999999999987433        344455555544444432


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~  864 (873)
                      -    ..+...+++++++++|++|.-+
T Consensus       591 l----s~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  591 L----SKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             c----cHHHHHHHHHHhccCcccccCC
Confidence            2    2347889999999999999755

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.4e-38  Score=341.31  Aligned_cols=244  Identities=23%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCC
Q 039344          608 HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC  686 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~  686 (873)
                      +.||+|+||.||+++. .+|+.||+|+++............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999987543222333466788999999999999999999999999999999999999


Q ss_pred             ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccc
Q 039344          687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE  766 (873)
Q Consensus       687 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  766 (873)
                      +|..++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            998888543   3588999999999999999999999   9999999999999999999999999998764433334445


Q ss_pred             cccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHH
Q 039344          767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISI  846 (873)
Q Consensus       767 ~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  846 (873)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~~p~~~----~~~~  222 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEIRFPRTL----SPEA  222 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCCCCC----CHHH
Confidence            67999999999999999999999999999999999999998643221        11122222222222211    2247


Q ss_pred             HHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          847 VEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       847 ~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      .+++.+||+.||++||     ++.++++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            8999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-38  Score=343.88  Aligned_cols=247  Identities=24%  Similarity=0.297  Sum_probs=202.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999865 68999999987532222233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999998643   3578899999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      .   ....|++.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...  
T Consensus       172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~p~~~--  238 (329)
T PTZ00263        172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGRLKFPNWF--  238 (329)
T ss_pred             c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCCcCCCCCC--
Confidence            2   2357899999999999999999999999999999999999998643322        11222223333322211  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                        ...+.+++.+||+.||++||+     ++++++
T Consensus       239 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        239 --DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             --CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              124789999999999999997     677653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-38  Score=310.97  Aligned_cols=261  Identities=23%  Similarity=0.301  Sum_probs=203.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  678 (873)
                      ++|+..+.|++|.||.||+|+. ++++.||+|+++.....+ ...-.-.+|+.++.+.+|||||.+-.+..-  -+..|+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            5577889999999999999975 478999999998654222 222346799999999999999999988763  457999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||||+ -+|...++.-.  +++...++..++.|+++|++|||++   .|+|||||++|+|+...|.+||+|||+||.+.
T Consensus       155 VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999998 47777776543  5689999999999999999999999   99999999999999999999999999999999


Q ss_pred             CCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh----------------
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN----------------  821 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~----------------  821 (873)
                      .....++..+.|.+|.|||.+.+. .|+.+.|+||+|||+.|++++++-|.+...........+                
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            888888999999999999988765 589999999999999999999998876443321111111                


Q ss_pred             hhhhhhcCCCCCCC--CchhHH--HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 IALDEMLDPRLPTP--SRNVHD--KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ~~~~~~~~~~~~~~--~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+..+-.+..+..  ......  ....-++++...+..||++|-||.|.++
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            00100000000000  000000  1134678899999999999999999865

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.9e-38  Score=340.62  Aligned_cols=244  Identities=23%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCC
Q 039344          608 HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC  686 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~  686 (873)
                      +.||+|+||.||+++. .+|+.||+|++.............+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999997543333334567889999999999999999999999999999999999999


Q ss_pred             ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccc
Q 039344          687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE  766 (873)
Q Consensus       687 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  766 (873)
                      +|..++...   ..+++.++..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            998888543   3588999999999999999999999   9999999999999999999999999999765433344445


Q ss_pred             cccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHH
Q 039344          767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISI  846 (873)
Q Consensus       767 ~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  846 (873)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+...    ...+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~~~~~p~~~----~~~~  222 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEDIKFPRTL----SADA  222 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccCCccCCCCC----CHHH
Confidence            679999999999999899999999999999999999999986432211        1111222222222221    2247


Q ss_pred             HHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          847 VEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       847 ~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      .+++.+||+.||++||     ++.++++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            8999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-38  Score=331.20  Aligned_cols=249  Identities=32%  Similarity=0.514  Sum_probs=192.8

Q ss_pred             CCceeeecCCeEEEEEEeC-----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          606 DEHCIGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       606 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..+.||+|+||.||+|.+.     .+..|+||.+...  ......++|.+|++.+++++||||++++|++...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            4578999999999999876     3567999999643  22233688999999999999999999999999888899999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++.... ...+++..+..|+.||++|++|||++   +++||||+++||+++.++.+||+|||+++.....
T Consensus        81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999997652 34589999999999999999999999   9999999999999999999999999999876322


Q ss_pred             CCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ...  .........|+|||.+.+..++.++||||||+++||+++ |+.||.......+        ...+.++.......
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~--------~~~~~~~~~~~~~~  228 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI--------IEKLKQGQRLPIPD  228 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH--------HHHHHTTEETTSBT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccceecc
Confidence            221  123456778999999999999999999999999999999 7899764322211        12222222111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .   ....+.+++.+||+.+|++||++.++++.|
T Consensus       229 ~---~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 N---CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             T---SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c---hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1   122488999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=333.66  Aligned_cols=259  Identities=24%  Similarity=0.377  Sum_probs=212.5

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      ++++-...+..+.++||.|.||.||.|.++ -.-.||||.++.+    ....++|..|+.+|+.++|||+|+++|+|..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            455555677888999999999999999876 3567999999853    33478999999999999999999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ..+|||.|||..|+|.+|+.+... ..++.--.+.||.||+.||+||..+   .+|||||.++|+|+.++..+|++|||+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999976543 3466777889999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcc-ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          754 AKFLKPDSSNWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       754 a~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      ++.+..+.+... ...-++.|.|||.+.-..++.|+|||+|||++||+.| |-.||..++--.     ..+.++.-..  
T Consensus       412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----VY~LLEkgyR--  484 (1157)
T KOG4278|consen  412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYGLLEKGYR--  484 (1157)
T ss_pred             hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHhcccc--
Confidence            999876544322 1223678999999999999999999999999999998 889987644322     2222222221  


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +..+ +.   +...++++|+.||+++|.+||+++|+-+.++
T Consensus       485 M~~P-eG---CPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  485 MDGP-EG---CPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ccCC-CC---CCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            1111 12   2335899999999999999999999988775

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.7e-38  Score=344.99  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      .++|++.+.||+|+||.||+|+.      .++..||||+++....  ....+.+.+|+.+++.+ +||||++++++|.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            45788999999999999999963      2466899999875432  22346788999999999 899999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhccccc--------------------------------------------------------
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAA--------------------------------------------------------  697 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  697 (873)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999998864221                                                        


Q ss_pred             ----------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          698 ----------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       698 ----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                                      ...+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            12478889999999999999999999   99999999999999999999999999998665432


Q ss_pred             CC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          762 SN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       762 ~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ..  .....++..|+|||++.+..++.++|||||||++|||++ |..||.......    ..............  +. .
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~~~~~~~--~~-~  341 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIKEGYRMLS--PE-C  341 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHHhCccCCC--CC-C
Confidence            21  112334667999999999999999999999999999998 888986432211    00001111111111  11 1


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+.+++.+||+.||++||++.||++.|+
T Consensus       342 ---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~  372 (375)
T cd05104         342 ---APSEMYDIMKSCWDADPLKRPTFKQIVQLIE  372 (375)
T ss_pred             ---CCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence               1224889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-38  Score=341.76  Aligned_cols=247  Identities=22%  Similarity=0.286  Sum_probs=201.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC--CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ++|++.+.||+|+||.||+|....  +..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568999999999999999997542  368999998653222233356788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999998654   3588999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+... 
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~-  251 (340)
T PTZ00426        184 R---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--------IYQKILEGIIYFPKFL-  251 (340)
T ss_pred             C---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCCCCCCCC-
Confidence            2   234578999999999998889999999999999999999999987533221        1122222222222211 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                         ...+.+++.+|++.||++|+     +++++++
T Consensus       252 ---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        252 ---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence               12377999999999999995     8888865

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.9e-38  Score=344.99  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH  672 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  672 (873)
                      ..++|++.+.||+|+||.||+|+.      .++..||+|+++.....  ...+.+.+|+.+++.+ +||||++++++|..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            346799999999999999999863      23457999999754322  2346788999999999 89999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccc--------------------------------------------------------
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDA--------------------------------------------------------  696 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------  696 (873)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999885421                                                        


Q ss_pred             -----------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC--
Q 039344          697 -----------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--  763 (873)
Q Consensus       697 -----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  763 (873)
                                 ...++++.++.+++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+++........  
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       112467888999999999999999999   9999999999999999999999999999865433221  


Q ss_pred             ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       764 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......    ...........+..+  ..    .
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~~~~~~~~~~~--~~----~  340 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKMVKRGYQMSRP--DF----A  340 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHHHHcccCccCC--CC----C
Confidence            112335668999999998899999999999999999997 999987432211    000111111111111  11    1


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          843 LISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+.+++.+||+.||++||++.++++.|+
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQ  370 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            234889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=301.02  Aligned_cols=261  Identities=22%  Similarity=0.331  Sum_probs=207.6

Q ss_pred             HhcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  673 (873)
                      ..++|++.+.+|+|||+-||.++ ..+++.+|+|++....   .+..+..++|++..++++|||++++++++..+     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            34789999999999999999996 6678999999997654   23357889999999999999999999887543     


Q ss_pred             ceeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      ...|++++|...|++.+.+.... .+..+++.+.++|+.+|++|+++||+.. ++++||||||.||++.+++.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence            35899999999999999997655 3447899999999999999999999982 359999999999999999999999999


Q ss_pred             cccccCCCCC---------Cccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh
Q 039344          753 IAKFLKPDSS---------NWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       753 ~a~~~~~~~~---------~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~  820 (873)
                      .++...-...         .+.....|..|.|||.+.   +...++++||||+||++|+|+.|..||+.+...      .
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------G  248 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------G  248 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc------C
Confidence            9986543221         233456789999999875   345689999999999999999999999853321      0


Q ss_pred             hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....-.+..+.+..+...  ..+.++.++++.|++.||.+||++.+++..++
T Consensus       249 gSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  249 GSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             CeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            000111222333322221  13456899999999999999999999988764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=342.34  Aligned_cols=256  Identities=20%  Similarity=0.272  Sum_probs=204.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+..|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999865 58999999987543222333567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            999999999998643   3588999999999999999999999   999999999999999999999999999986543 


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        ......|++.|+|||++.+..++.++||||+||++|||++|+.||.............. .......+....+.   .
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~---~  227 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY-WKETLQRPVYDDPR---F  227 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh-ccccccCCCCCccc---c
Confidence              23346789999999999999999999999999999999999999875332211110000 00001111111100   1


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .....+.+++.+||..+|++||+++++++.
T Consensus       228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            123357899999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-38  Score=301.32  Aligned_cols=254  Identities=21%  Similarity=0.345  Sum_probs=215.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCC-----CcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLP-----GEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      -..|...+.+|+|..++|.+.. .++|..+|+|++.....     ...+..++-.+|+++++++ .||+|+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            3557778899999999998874 45788899998854322     1223456678899999999 799999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...++|+|.|+.|.|.+++...-   .+++++..+|++|+.+|++|||.+   .||||||||+|||+|++.++||+|||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999996543   489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhh
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      |+.+.+ +......+|||+|.|||.+..      ..|+..+|.|+.||+||-++.|.+||.        ....--.+..+
T Consensus       170 a~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--------HRkQmlMLR~I  240 (411)
T KOG0599|consen  170 ACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--------HRKQMLMLRMI  240 (411)
T ss_pred             eeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--------HHHHHHHHHHH
Confidence            998875 456677899999999998763      247888999999999999999999964        23333345556


Q ss_pred             cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +.+++....+.+.+......++|.+|++.||.+|-|++|+++
T Consensus       241 meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  241 MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            677777777777777888999999999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.4e-37  Score=323.87  Aligned_cols=250  Identities=26%  Similarity=0.451  Sum_probs=202.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+|++.+.||+|+||.||+|+.+++..+|+|.+.....    ..+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            45788899999999999999998888999998764321    24678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|+|.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            999999999986533  3488999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC-CCCCCch
Q 039344          762 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR-LPTPSRN  838 (873)
Q Consensus       762 ~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  838 (873)
                      .. .....++..|+|||.+.+..++.++||||||+++||+++ |+.||........        ...+.... ...+.. 
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--------~~~i~~~~~~~~~~~-  225 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--------VEMISRGFRLYRPKL-  225 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHHHHCCCCCCCCCC-
Confidence            21 122335568999999988889999999999999999999 8999864332211        11111111 111111 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+.+++.+||+.+|++||+++++++.|.
T Consensus       226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               1234889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-37  Score=335.80  Aligned_cols=259  Identities=22%  Similarity=0.320  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+++.. +|..||+|.+....  .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999765 68899999987542  223356799999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          82 MEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             eecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999999998653   34889999999999999999999862  699999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh------------------
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN------------------  821 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~------------------  821 (873)
                      .  ......|++.|+|||++.+..++.++||||+||++|||++|+.||..............                  
T Consensus       157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            2  22345789999999999998999999999999999999999999864322111000000                  


Q ss_pred             --------------------hhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          822 --------------------IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       822 --------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                                          .....+.....+...  .......+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                000000000000000  00123458899999999999999999999763

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-37  Score=326.41  Aligned_cols=260  Identities=21%  Similarity=0.286  Sum_probs=208.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999754 78999999886543334444567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||++++++.+++.... ....+++..+..++.|++.|++|||++   +++||||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885432 234478899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........+++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .     ......+.....+...  .
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~-----~~~~~~~~~~~~~~~~--~  230 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-L-----FSLCQKIEQCDYPPLP--T  230 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-H-----HHHHHHHhcCCCCCCC--h
Confidence            443334456888999999998888899999999999999999999997532211 0     0111111111111111  1


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......+.+++.+||+.+|++||++.+|++.++
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~  263 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK  263 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence            123345889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-37  Score=336.90  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=195.1

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|+.. +++.||+|++...........+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 6889999999765333333456678888888777 899999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      ++|..++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            9998887543   3589999999999999999999999   999999999999999999999999999976443333444


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-hhhhhhhhcCCCCCCCCchhHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-LNIALDEMLDPRLPTPSRNVHDKLI  844 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  844 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+........... .......+.......+...    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~----~~  230 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL----SV  230 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCC----CH
Confidence            567899999999999999999999999999999999999999643221111111 1111222222222222221    22


Q ss_pred             HHHHHHhhcccCCCCCCCCH
Q 039344          845 SIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       845 ~l~~li~~cl~~dP~~RPs~  864 (873)
                      .+.+++.+||+.||++||++
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCC
Confidence            47899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-37  Score=337.09  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=198.7

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+..|..+++.+ +||||+++++++.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999764 6889999999764333333346688899999988 799999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|.+++...   +.+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            9998887543   4589999999999999999999999   999999999999999999999999999975433333444


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhh-hhhhhhhhhhcCCCCCCCCchhHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS-LNLNIALDEMLDPRLPTPSRNVHDKLI  844 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+......... .........+.......+...    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----~~  230 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL----SV  230 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC----CH
Confidence            5679999999999999999999999999999999999999997432211000 001111222222222222221    22


Q ss_pred             HHHHHHhhcccCCCCCCCC------HHHHHH
Q 039344          845 SIVEVTISCVDENPESRPT------MQKVCQ  869 (873)
Q Consensus       845 ~l~~li~~cl~~dP~~RPs------~~ev~~  869 (873)
                      .+.+++.+|++.||.+||+      ++++++
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            4789999999999999997      567653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-37  Score=326.09  Aligned_cols=253  Identities=21%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .++|++.+.||+|+||.||+|..+    .+..||+|.++....  ......+.+|+..++.++||||++++|++...+..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            356888999999999999999653    466899999876432  22346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++....  ..+++.+++.++.|++.|++|||++   +++||||||+||+++.++.++++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999999986532  3589999999999999999999999   999999999999999999999999998765


Q ss_pred             cCCCCCC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC-CC
Q 039344          757 LKPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR-LP  833 (873)
Q Consensus       757 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~  833 (873)
                      ....... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||........        ...+.+.. .+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--------~~~~~~~~~~~  228 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--------IKAVEDGFRLP  228 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--------HHHHHCCCCCC
Confidence            4322111 112334678999999999999999999999999999875 9999865332211        11111111 11


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.    .....+.+++.+||+.+|++||+++++.+.|+
T Consensus       229 ~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         229 APR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             CCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence            111    12335889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=330.23  Aligned_cols=250  Identities=25%  Similarity=0.423  Sum_probs=204.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC---CCc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA---SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      +.....++||+|-||.||+|.+.   .|+  .||||.-+.....  ...+.|..|+.+|+.++||||++++|+|.+ ...
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            44455689999999999999653   243  4788887654332  336889999999999999999999999975 568


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      |+|||.++.|.|..++....  ..++......++.||+.|++|||+.   .+|||||..+|||+.....+|++|||++|.
T Consensus       466 WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence            99999999999999997544  4688889999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCCccc-cccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhc-CCCCC
Q 039344          757 LKPDSSNWTE-LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML-DPRLP  833 (873)
Q Consensus       757 ~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~  833 (873)
                      +.++.+...+ ..-+..|||||.+.-.+++.+||||.|||.+||++. |..||.+..+-+..        ..+- ..++|
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------~~iEnGeRlP  612 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------GHIENGERLP  612 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------EEecCCCCCC
Confidence            8876554332 334678999999999999999999999999999987 99998765443222        2222 23444


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .+. .+   +..++.++.+||++||.+||++.|+...|
T Consensus       613 ~P~-nC---Pp~LYslmskcWayeP~kRPrftei~~~l  646 (974)
T KOG4257|consen  613 CPP-NC---PPALYSLMSKCWAYEPSKRPRFTEIKAIL  646 (974)
T ss_pred             CCC-CC---ChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence            443 22   33588999999999999999999998776

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=340.25  Aligned_cols=249  Identities=23%  Similarity=0.365  Sum_probs=195.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|+..+.||+|+||.||+|+.. +|+.||+|++....  .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            44566789999999999999764 68999999986532  2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|....       ..++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999986432       245677889999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          761 SSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ........|+..|+|||++..     ...+.++|||||||++|||++|+.||.......+........    .......+
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~  297 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQPPEAP  297 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccCCCCCC
Confidence            433445679999999998743     223568999999999999999999987332222221111110    01111111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .    .....+.+++.+||+.||++||++.|+++.
T Consensus       298 ~----~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        298 A----TASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1    122348899999999999999999999863

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-37  Score=336.68  Aligned_cols=247  Identities=22%  Similarity=0.311  Sum_probs=196.4

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHH---HhccCCceeeEEeEEEecceeEEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL---TEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      |++.+.||+|+||.||+|+.. +|+.||||+++..........+.+.+|+.++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999754 6899999998754222222345566776655   456799999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|..++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888753    3589999999999999999999999   999999999999999999999999999876544


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........|++.|+|||.+.+..++.++||||+||++|||++|+.||.......        ....+.......+... 
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~~~~p~~~-  224 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--------VFDSIVNDEVRYPRFL-  224 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCCC-
Confidence            4444455679999999999999899999999999999999999999987433211        1122222222222111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                         ...+.+++.+||+.||.+||     ++.++++
T Consensus       225 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         225 ---SREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               22478899999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7e-38  Score=339.53  Aligned_cols=244  Identities=23%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCC
Q 039344          608 HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC  686 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~  686 (873)
                      +.||+|+||.||+++. .+|+.||+|++.............+..|+++++.++||||+++++++.+.+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 478999999987543223333466788999999999999999999999999999999999999


Q ss_pred             ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       687 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      +|..++...   ..+++..+..++.|++.|++|||+ .   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            999888543   358999999999999999999997 6   999999999999999999999999999976544444444


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~----~~~  222 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPRTL----SPE  222 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHhcCCCCCCCCC----CHH
Confidence            567999999999999999999999999999999999999998643221        11111112222222211    224


Q ss_pred             HHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          846 IVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       846 l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      +.+++.+||+.||++|+     ++.++++
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            78999999999999996     8998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=312.79  Aligned_cols=264  Identities=19%  Similarity=0.299  Sum_probs=204.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc-eeeEEeEEEecc-----
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN-IVKVYGFCLHVR-----  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----  674 (873)
                      ..|...++||+|+||+||+|+. .+|+.||+|+++.....+ .......+|+.+++.++|+| ||++++++....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4466667899999999999975 578999999998654421 12355689999999999999 999999998877     


Q ss_pred             -eeEEEEEeccCCChhhHhcccccc-cCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDAAA-KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                       ..++|+||++ .+|..++...... ..++...+..++.|+++|++|||++   +|+||||||+||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             7899999987 6888888654422 3466688999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hhh
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IAL  824 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~~  824 (873)
                      +|+...-+...++..++|..|.|||++.+. .|+...|+||+||+++||++++.-|.+..+...-.....       ..+
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999877666678888999999999998876 689999999999999999999888876443211000000       000


Q ss_pred             ---hhhcCCC-----CCCCCchhHHH---HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          825 ---DEMLDPR-----LPTPSRNVHDK---LISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       825 ---~~~~~~~-----~~~~~~~~~~~---~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                         ..+.+.+     ...+.......   .....+++.+|++++|.+|.|++.+++.
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               0000111     11011111111   1257899999999999999999998763

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=331.71  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=219.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  678 (873)
                      ...|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.........+.+.+|+.+|+++. |||||.+++++++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            467888899999999999999766 59999999998765544434578999999999997 9999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC----CCeEEeccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE----NEAHVSDFGIA  754 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~----~~~kl~Dfg~a  754 (873)
                      |||++.||.|.+.+...    .+++..+..++.|++.+++|||+.   ||+|||+||+|+|+...    +.+|++|||+|
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999998765    299999999999999999999999   99999999999999643    47999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ..... .......+||+.|+|||++....|+.++||||+||++|.|++|..||......        .....+..+.+..
T Consensus       187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~~i~~~~~~f  257 (382)
T KOG0032|consen  187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFLAILRGDFDF  257 (382)
T ss_pred             eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHHHHHcCCCCC
Confidence            98877 66777899999999999999999999999999999999999999998754422        2223455555555


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+......+.+++.+|+..||.+|+|+.++++
T Consensus       258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            55555666677899999999999999999999986

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.4e-37  Score=328.05  Aligned_cols=255  Identities=23%  Similarity=0.399  Sum_probs=204.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      .+|++.+.||+|+||.||+|....      +..||+|.++...  .....++|.+|+..++.++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            468889999999999999997542      2579999987542  22335678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          676 LFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      .+++|||+++++|.+++.....             ...+++..+..++.|++.|++|||+.   +++||||||+||+++.
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence            9999999999999999865321             14578889999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ++.++|+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.......     
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-----  234 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-----  234 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence            99999999999986543322  1233456788999999998899999999999999999998 999986432211     


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+..+..+...   ......+.+++.+||+.||++||+++||++.|+
T Consensus       235 ---~~~~i~~~~~~~~~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         235 ---VIEMIRSRQLLPCP---EDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             ---HHHHHHcCCcCCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence               11111112211111   122345899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-37  Score=336.16  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=197.6

Q ss_pred             ceeeecCCeEEEEEEe----CCCcEEEEEEccCCCC-CcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          608 HCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      +.||+|+||.||+++.    .+++.||+|++..... ........+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    3578999999865321 1112235678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +++++|.+++...   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            9999999988543   3478888999999999999999999   999999999999999999999999999976544333


Q ss_pred             CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||......        .....+..+....+...    
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~~~~~~~~~----  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKGKLNLPPYL----  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC----
Confidence            344567999999999999888999999999999999999999998753321        12223333333322221    


Q ss_pred             HHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          843 LISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      ...+.+++.+||+.||++||     +++++++
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            22478999999999999999     7887764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-37  Score=335.96  Aligned_cols=239  Identities=24%  Similarity=0.352  Sum_probs=194.2

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||+||+|+.+ +++.||+|++...........+.+..|..+++.. +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 6889999998754222223346677888888877 699999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            9999888643   3588999999999999999999999   999999999999999999999999999876543334444


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~----~~~  222 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVVYPTWL----SQD  222 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCCCCCCCC----CHH
Confidence            567999999999999888999999999999999999999998743322        11222222222222211    224


Q ss_pred             HHHHHhhcccCCCCCCCCH
Q 039344          846 IVEVTISCVDENPESRPTM  864 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~  864 (873)
                      +.+++.+|++.||++||++
T Consensus       223 ~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHcccCHHHCCCC
Confidence            7899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3e-37  Score=331.57  Aligned_cols=261  Identities=19%  Similarity=0.293  Sum_probs=198.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.......  ....+.+|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            467999999999999999999865 68999999987543222  234677899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||++ +++.+++...  ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          82 FEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99996 5777766543  23478899999999999999999999   999999999999999999999999999976544


Q ss_pred             CCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh--------hh------
Q 039344          760 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI--------AL------  824 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~--------~~------  824 (873)
                      .........+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+....-.....        ..      
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            4444455678999999998865 45788999999999999999999999754322100000000        00      


Q ss_pred             hhhcCCCCCC-CCchhH------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 DEMLDPRLPT-PSRNVH------DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~~~~~~~~~~-~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......... ......      .....+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000000 000000      01134779999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-37  Score=333.80  Aligned_cols=243  Identities=24%  Similarity=0.349  Sum_probs=193.2

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 6889999998754322222345566677777654 899999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|..++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            9999888543   3588999999999999999999999   999999999999999999999999999986544444445


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+..    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~----~~~~  222 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--------LFDSILNDRPHFPRW----ISKE  222 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCCC----CCHH
Confidence            5679999999999999899999999999999999999999987533221        111222222211111    1224


Q ss_pred             HHHHHhhcccCCCCCCCCHH-HHH
Q 039344          846 IVEVTISCVDENPESRPTMQ-KVC  868 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~-ev~  868 (873)
                      +.+++.+||+.||++||++. ++.
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHH
Confidence            77899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.2e-37  Score=328.62  Aligned_cols=260  Identities=18%  Similarity=0.264  Sum_probs=199.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++......  ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            56889999999999999999764 68999999987543222  2356789999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++ ++.+++....  ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            99985 8888875432  3478899999999999999999999   9999999999999999999999999999865544


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-------hhhh---------
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-------LNIA---------  823 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-------~~~~---------  823 (873)
                      ........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||............       ....         
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            444445678999999998865 56889999999999999999999998643321110000       0000         


Q ss_pred             hhhhcCCCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 LDEMLDPRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......+......  ...........+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0001111100000  000011234789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-37  Score=328.81  Aligned_cols=249  Identities=23%  Similarity=0.274  Sum_probs=197.8

Q ss_pred             eeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||+|+||+||++... +|+.||+|++...........+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999754 7899999998654322222345678899999999999999999999999999999999999999


Q ss_pred             hhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcccc
Q 039344          689 AVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL  767 (873)
Q Consensus       689 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  767 (873)
                      ..++.... ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            88875422 334689999999999999999999999   99999999999999999999999999998765544444456


Q ss_pred             ccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHH
Q 039344          768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIV  847 (873)
Q Consensus       768 ~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  847 (873)
                      .|++.|+|||++.+..++.++||||+||++|||++|+.||........    ...............+.    .....+.
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~----~~~~~~~  229 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRILNDSVTYPD----KFSPASK  229 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHHhhcccCCCCcc----cCCHHHH
Confidence            789999999999999999999999999999999999999874332110    11111122222222221    1233478


Q ss_pred             HHHhhcccCCCCCCC-----CHHHHHH
Q 039344          848 EVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       848 ~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      +++.+||+.||++||     +++++++
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         230 SFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            999999999999999     6777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.1e-37  Score=335.11  Aligned_cols=244  Identities=22%  Similarity=0.312  Sum_probs=197.5

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|+.. +++.||+|++...........+.+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 5789999998754322223345677888888876 799999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      ++|..++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            9999888543   3588999999999999999999999   999999999999999999999999999986544444445


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~----~~~  222 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDDVLYPVWL----SKE  222 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC----CHH
Confidence            567899999999999989999999999999999999999998754322        11222222222222111    224


Q ss_pred             HHHHHhhcccCCCCCCC-------CHHHHHH
Q 039344          846 IVEVTISCVDENPESRP-------TMQKVCQ  869 (873)
Q Consensus       846 l~~li~~cl~~dP~~RP-------s~~ev~~  869 (873)
                      +.+++.+|++.||++||       +++++++
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            78999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.1e-37  Score=326.93  Aligned_cols=256  Identities=23%  Similarity=0.425  Sum_probs=206.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ..+|.+.+.||+|+||.||+|+..      +++.||+|.+.....  .+..+.+.+|+++++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            356888899999999999999753      347899999875432  223578999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccc-----------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC
Q 039344          675 HLFIVYEYFKMCSLAVILSNDA-----------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE  743 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~  743 (873)
                      ..++||||+++++|.+++....           ....+++.++..++.|++.|++|||++   +++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence            9999999999999999986532           123478899999999999999999999   99999999999999999


Q ss_pred             CCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhh
Q 039344          744 NEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       744 ~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~  820 (873)
                      +.++|+|||+++.......  ......+++.|+|||++.+..++.++||||+||++|||++ |..||.......      
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            9999999999976543221  1223345788999999999999999999999999999998 999976433221      


Q ss_pred             hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        ....+..+........   ....+.+++.+||+.||++||++.||++.|+
T Consensus       233 --~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 --VIECITQGRLLQRPRT---CPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHHHHHcCCcCCCCCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              1222222222222111   2234889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.9e-37  Score=329.25  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            36889999999999999999875 6889999998754322 223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++.+..+...   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99998877655432   23588999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-------hhhhhhh-cCC-
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-------NIALDEM-LDP-  830 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-------~~~~~~~-~~~-  830 (873)
                      .. ......|++.|+|||++.+..++.++||||+||++|||++|+.||.............       ....... .++ 
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            22 2334578999999999998889999999999999999999999997543211000000       0000000 000 


Q ss_pred             ----CCCCC---Cc----hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          831 ----RLPTP---SR----NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       831 ----~~~~~---~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ..+..   ..    ........+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                00000   00    00112345889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.4e-37  Score=325.95  Aligned_cols=257  Identities=21%  Similarity=0.326  Sum_probs=202.7

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      +.++|++.+.||+|+||.||+|...      +++.||+|++....  ......++.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4577999999999999999998643      35679999986432  222356789999999999999999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhccccc-------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAA-------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      ...++||||+++++|.+++.....       ....++..+..++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            999999999999999999865321       12357888999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~  823 (873)
                      +++|||+++.........  ....+++.|+|||++.+..++.++|||||||++|||++ |..||.......        .
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--------~  230 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--------V  230 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence            999999997654322211  12345778999999998889999999999999999999 788876432211        1


Q ss_pred             hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .........+.....   ....+.+++.+||+.+|++||++.|+++.|+
T Consensus       231 ~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         231 LRFVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHcCCcCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111111111111111   1234889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-37  Score=325.08  Aligned_cols=255  Identities=25%  Similarity=0.456  Sum_probs=209.6

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      +...+|++.+.||+|+||.||+|...+++.+|+|.+.....   ...+++.+|+.+++.++||||+++++++.+....++
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            34567899999999999999999988899999999875422   234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          80 ITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999997643 34589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCC
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPS  836 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  836 (873)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......        ....+... +.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~  227 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------VYDQITAGYRMPCPA  227 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHHhCCcCCCCC
Confidence            44333334456778999999988889999999999999999998 899986433211        11111111 111111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          .....+.+++.+||+.||++|||++++++.|+
T Consensus       228 ----~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         228 ----KCPQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             ----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                12234789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.9e-37  Score=333.58  Aligned_cols=244  Identities=21%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC-CceeeEEeEEEecceeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH-RNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  680 (873)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|++++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788899999999999999765 578999999875432222335678889999999965 56889999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            999999999888543   3478999999999999999999999   9999999999999999999999999998754333


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||......        .....+.......+...  
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~~~~~~~--  224 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNVSYPKSL--  224 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC--
Confidence            33444567999999999999999999999999999999999999998743321        11222222222222221  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCH
Q 039344          841 DKLISIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~  864 (873)
                        ...+.+++.+||+.||.+|++.
T Consensus       225 --~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         225 --SKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CHHHHHHHHHHhhcCHHHcCCC
Confidence              2247899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=344.51  Aligned_cols=252  Identities=22%  Similarity=0.349  Sum_probs=206.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCC-cEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeE-EEe-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASG-EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGF-CLH-----  672 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~-----  672 (873)
                      ..++++.++|.+|||+.||.|....+ ..||+|++...   ++...+...+|+++|+.|+ |||||.+++. ...     
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            45677889999999999999987655 99999998754   4555788999999999996 9999999993 221     


Q ss_pred             -cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          673 -VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       673 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                       .-.+++.||||++|.|-+++...-. ..+++.++++|+.++++|+++||.. .++|+|||||.+|||++.+|..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence             2357899999999999999975443 3499999999999999999999997 457999999999999999999999999


Q ss_pred             ccccccCCCCCCcc---------cccccccccccccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh
Q 039344          752 GIAKFLKPDSSNWT---------ELAGTYGYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN  819 (873)
Q Consensus       752 g~a~~~~~~~~~~~---------~~~g~~~y~aPE~~---~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~  819 (873)
                      |.|...........         ...-|+.|+|||++   .+...++|+|||++||++|-||....||+..+..      
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------  264 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------  264 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence            99975443331111         23468999999986   4677899999999999999999999999854332      


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                            .++++.+..+..  +.+...+.+||..||+.||.+||++.+|++.+
T Consensus       265 ------aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  265 ------AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             ------eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence                  344555544432  23455699999999999999999999998875

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=301.72  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=209.8

Q ss_pred             hcCCCCCceeeecCCeEEEEE-EeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+.|++.+.||+|+|+.||+. ...+|+.+|+|.+....-.. ...+++.+|+++-+.++|||||++.+...+.+..|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            456778889999999999998 45679999998876432222 2468899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a~~  756 (873)
                      +|+|.|+.+..-+...   ...++..+-..+.||++++.|+|.+   +|||||+||+|+++-..   --+|++|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999986555332   2367788889999999999999999   99999999999999533   3599999999998


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      +. +...+-..+|||+|||||++...+|+..+|||+-||++|-++.|..||....        .....+.+..+....+.
T Consensus       163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQIKAGAYDYPS  233 (355)
T ss_pred             eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHHhccccCCCC
Confidence            88 6677788999999999999999999999999999999999999999976432        22234455555555444


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+........+++.+|+..||.+|-|+.|.+.
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            444445556889999999999999999998764

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4e-37  Score=333.34  Aligned_cols=244  Identities=21%  Similarity=0.286  Sum_probs=197.6

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788899999999999999765 5789999998754332223345577788888777 6899999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999999888543   3488999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||.......        ....+.......+...  
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~--  224 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHNVAYPKSM--  224 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCcC--
Confidence            344445679999999999999999999999999999999999999987533221        1222222222222221  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCH
Q 039344          841 DKLISIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~  864 (873)
                        ...+.+++.+|++.||++|+++
T Consensus       225 --s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         225 --SKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CHHHHHHHHHHcccCHHhcCCC
Confidence              2347899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=342.31  Aligned_cols=249  Identities=27%  Similarity=0.465  Sum_probs=206.2

Q ss_pred             CCCCceeeecCCeEEEEEE-eCCCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          604 FDDEHCIGKGGQGSVYMSK-LASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ....++||.|+||+||+|. .+.|+    +||+|++......  ...+++.+|+-.|.+++|||+++++|+|.... ..+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            4456899999999999995 34454    5889988765333  23588999999999999999999999997665 789


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |.+|++.|+|.++++.++  ..+..+..+.|..|||+||.|||.+   ++|||||.++|||+.+...+|+.|||+|+...
T Consensus       775 vtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            999999999999998765  4588899999999999999999999   99999999999999999999999999999988


Q ss_pred             CCCCCccccc--cccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          759 PDSSNWTELA--GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       759 ~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ++...+....  -.+.|||-|.+....|+.++|||||||.+||++| |..||+.+...++......       ..+++.+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------geRLsqP  922 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------GERLSQP  922 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------cccCCCC
Confidence            7766554433  3578999999999999999999999999999999 9999887554332222111       2334444


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      +.    +..+++-++.+||..|+..||+++++...+
T Consensus       923 pi----CtiDVy~~mvkCwmid~~~rp~fkel~~~f  954 (1177)
T KOG1025|consen  923 PI----CTIDVYMVMVKCWMIDADSRPTFKELAEEF  954 (1177)
T ss_pred             CC----ccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence            33    234588999999999999999999998876

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.3e-37  Score=320.47  Aligned_cols=251  Identities=25%  Similarity=0.420  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+|++.+.||+|+||+||.|+..++..||+|.+.....    ..+++.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            46788899999999999999888777899999864321    24678999999999999999999999998889999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++++++.+++....  ..+++..++.++.||+.|++|||+.   +++|+||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            999999999986533  2589999999999999999999999   99999999999999999999999999998664432


Q ss_pred             CC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          762 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       762 ~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .. .....++..|+|||+..+..++.++||||||+++|||++ |+.||........        ...+........... 
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~-  225 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--------VEKVSQGLRLYRPHL-  225 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--------HHHHhcCCCCCCCCC-
Confidence            21 112335678999999988889999999999999999998 9999864332111        111111111111111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        ....+.+++.+||+.+|++||++.++++.++
T Consensus       226 --~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 --ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              1235889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=311.83  Aligned_cols=262  Identities=23%  Similarity=0.368  Sum_probs=203.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-----c
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-----V  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~  673 (873)
                      ....|...+.||+|+||.|..|.. .+|+.||+|++..+.... ...+...+|+..++.++|+||+.+++++..     .
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~-~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ-IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch-HHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            345566678999999999999965 479999999998665443 346778999999999999999999999865     3


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...|+|+|+|+ .+|...++...   .++.+.+..+++|+++|++|+|+.   +|+|||+||+|++++.+...||+|||+
T Consensus        99 ~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            46899999995 78888886543   489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCC--CCCCccccccccccccccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhh-------hhhhhhh
Q 039344          754 AKFLKP--DSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-------SLNLNIA  823 (873)
Q Consensus       754 a~~~~~--~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~-------~~~~~~~  823 (873)
                      ||....  ....++..+.|.+|.|||.+. ...|+.+.||||.|||+.||++|+.-|.+.......       +....+.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            998764  345567788999999999764 567999999999999999999999998764422110       0000000


Q ss_pred             --------hhhhcC--CCCC-CCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 --------LDEMLD--PRLP-TPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 --------~~~~~~--~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                              ....+.  +..+ .+. ...+.......+++.+|+..||.+|+|++|.++
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                    111111  1111 110 011122234779999999999999999999875

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-38  Score=343.73  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=204.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||+||+|+.. +|+.||+|++...........+.+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999865 78999999987543323234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998654   4588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             C-----------------------------CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          761 S-----------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       761 ~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      .                             .......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            3                             12234578999999999999999999999999999999999999987543


Q ss_pred             cchhhhhhhhhhhhhhcC--CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 039344          812 SMSFSSLNLNIALDEMLD--PRLPTPSRNVHDKLISIVEVTISCVDENPESRPT-MQKVCQL  870 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~  870 (873)
                      ....        ...+..  .....+...  .....+.+++.+|+. ||++||+ ++++++.
T Consensus       235 ~~~~--------~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQET--------YNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH--------HHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2211        111111  111111111  012347899999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.5e-37  Score=322.43  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=208.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+. .+|+.+|||.+...........+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999975 578999999886543333344568899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||+++++|.+++.... ....+++..++.++.|++.|++|||++   +++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 234589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........++..|+|||++.+..++.++||||+|+++|+|++|..||......      .......+.....+....  
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~--  230 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPLPS--  230 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCCCCCCCc--
Confidence            444344457889999999999888999999999999999999999998642211      001111111111111110  


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......+.+++.+||+.||++|||+.+|++.++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~  263 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAK  263 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence            112335889999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.9e-37  Score=332.44  Aligned_cols=244  Identities=24%  Similarity=0.315  Sum_probs=196.9

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||+||+|+.. +++.||+|+++............+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 5789999998754322223345677888888888 799999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      ++|..++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            9999887543   3589999999999999999999999   999999999999999999999999999975433333344


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...|++.|+|||++.+..++.++||||+||++|+|++|+.||........        ...+.......+..    ....
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--------~~~i~~~~~~~~~~----~~~~  222 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--------FQSILEDEVRYPRW----LSKE  222 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--------HHHHHcCCCCCCCc----CCHH
Confidence            55789999999999999999999999999999999999999875432211        11122222222211    1234


Q ss_pred             HHHHHhhcccCCCCCCCCH-----HHHHH
Q 039344          846 IVEVTISCVDENPESRPTM-----QKVCQ  869 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~-----~ev~~  869 (873)
                      +.+++.+||+.||.+||++     .++++
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            7899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.3e-37  Score=338.14  Aligned_cols=256  Identities=22%  Similarity=0.375  Sum_probs=201.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  673 (873)
                      .++|.+.+.||+|+||.||+|+..      .+..||||++.....  ....+.+.+|+++++++. ||||++++++|.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            467889999999999999999742      234799999975422  233567999999999995 99999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhccccc--------------------------------------------------------
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAA--------------------------------------------------------  697 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  697 (873)
                      +..|+||||+++|+|.+++.....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            999999999999999988854210                                                        


Q ss_pred             -------------------------------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee
Q 039344          698 -------------------------------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL  740 (873)
Q Consensus       698 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill  740 (873)
                                                           ...+++..+..++.|++.|++|||+.   +|+||||||+||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence                                                 12477888899999999999999999   99999999999999


Q ss_pred             CCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhh
Q 039344          741 DFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSS  817 (873)
Q Consensus       741 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~  817 (873)
                      +.++.+||+|||+++........  .....+++.|+|||.+.+..++.++|||||||++|||++ |..||........  
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence            99999999999999866433221  123456788999999999899999999999999999997 9999864321100  


Q ss_pred             hhhhhhhhhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          818 LNLNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       818 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                           ....+..+ +.+.+.    .....+.+++.+||+.||++||++.+|.++|+
T Consensus       349 -----~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         349 -----FYNKIKSGYRMAKPD----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             -----HHHHHhcCCCCCCCc----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence                 00111111 111111    12335889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.3e-37  Score=320.88  Aligned_cols=252  Identities=23%  Similarity=0.402  Sum_probs=204.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.++||+|+||.||+|...++..||+|.+....    ...+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            46789999999999999999998888899999976421    12477899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++.... ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999986543 34588899999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCc
Q 039344          761 SSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSR  837 (873)
Q Consensus       761 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  837 (873)
                      ... .....++..|+|||++.+..++.++||||+||++|+|+| |+.||........        ...+... +.+... 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~-  227 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--------MSALQRGYRMPRME-  227 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH--------HHHHHcCCCCCCCC-
Confidence            221 122345678999999988889999999999999999998 9999864322111        1111111 111111 


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         .....+.+++.+||+.+|++||+++++.+.|+
T Consensus       228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence               12234789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-36  Score=319.42  Aligned_cols=260  Identities=23%  Similarity=0.319  Sum_probs=209.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..........+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999876 89999999887533333334577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||+++++|..++.... ....+++.++..++.+++.|++|||+.   +++||||+|+||+++.++.++++|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 234578999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........+++.|+|||.+.+..++.++||||+||++|+|++|+.||......      .....+.......+....  
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~--  230 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEKCDYPPLPA--  230 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhhhcCCCCCCCh--
Confidence            433334456888999999999888999999999999999999999998532210      011111111111111111  


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......+.+++.+||..+|++||++.++++.|+
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~  263 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAK  263 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence            122335889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.6e-37  Score=336.05  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=194.8

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----cee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----RHL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  676 (873)
                      +|++.+.||+|+||.||+|+.. +|+.||+|++...... ......+.+|+.+++.++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            4788899999999999999754 7899999998743222 12245688999999999999999999998643     247


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      |+||||++ +++.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99999996 6888887543   3589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC---Ccccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh-------------
Q 039344          757 LKPDSS---NWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL-------------  818 (873)
Q Consensus       757 ~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~-------------  818 (873)
                      ......   .+....|++.|+|||++.+  ..++.++||||+||++|||+||+.||...........             
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            532221   2244578999999999865  5788999999999999999999999865332110000             


Q ss_pred             ------hhhhhhhhhcCCCCCCC-CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          819 ------NLNIALDEMLDPRLPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       819 ------~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            ........+.. ..+.+ ..........+.+++.+||+.||++||+++|+++
T Consensus       233 ~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         233 SRVRNEKARRYLSSMRK-KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhhhhhHHHHHHhhcc-cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  00000111111 11111 0000111234789999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.1e-37  Score=330.99  Aligned_cols=243  Identities=23%  Similarity=0.311  Sum_probs=193.4

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|+.+ +|+.||+|+++..........+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999765 6889999998754221122245567788887765 899999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|..++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||+++..........
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            9999888543   3588999999999999999999999   999999999999999999999999999875433334445


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+..    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--------~~~~~~~~~~~~~~~----~~~~  222 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--------LFESIRVDTPHYPRW----ITKE  222 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCC----CCHH
Confidence            5679999999999999999999999999999999999999987433211        111111111111111    1224


Q ss_pred             HHHHHhhcccCCCCCCCCHH-HHH
Q 039344          846 IVEVTISCVDENPESRPTMQ-KVC  868 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~-ev~  868 (873)
                      +.+++.+||+.||++||++. ++.
T Consensus       223 ~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         223 SKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHH
Confidence            78999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.1e-37  Score=338.63  Aligned_cols=203  Identities=26%  Similarity=0.337  Sum_probs=175.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.++..++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999754 68999999987543222333467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999998653   3589999999999999999999999   9999999999999999999999999999755321


Q ss_pred             CC-----------------------------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 039344          761 SS-----------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH  805 (873)
Q Consensus       761 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~  805 (873)
                      ..                                   .....+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                   0123579999999999999999999999999999999999999


Q ss_pred             CCccc
Q 039344          806 PRDFI  810 (873)
Q Consensus       806 P~~~~  810 (873)
                      ||...
T Consensus       235 Pf~~~  239 (363)
T cd05628         235 PFCSE  239 (363)
T ss_pred             CCCCC
Confidence            98753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=319.88  Aligned_cols=252  Identities=26%  Similarity=0.440  Sum_probs=203.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.+.||+|+||+||+|..+    +...||+|.++...  .....++|.+|+..++.++||||+++++++.+.+..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            57889999999999999999764    24579999987543  2233567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++++|.+++....  ..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.++++|||+++..
T Consensus        82 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          82 IITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999986543  3589999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCCcc--ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCC
Q 039344          758 KPDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLP  833 (873)
Q Consensus       758 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~  833 (873)
                      ........  ...++..|+|||.+.+..++.++||||||+++||+++ |..||.......        ....+.+. ..+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~  228 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------VIKAVEDGYRLP  228 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence            53222222  2234578999999998899999999999999999998 999975422111        11111111 111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.    .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       229 ~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         229 PPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111    12335889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8e-37  Score=326.38  Aligned_cols=261  Identities=21%  Similarity=0.332  Sum_probs=195.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC--CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc---cCCceeeEEeEEEe----
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA--SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---WHRNIVKVYGFCLH----  672 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  672 (873)
                      .+|++.+.||+|+||.||+|+..  +|+.||+|+++...... .....+.+|+.+++.+   +||||++++++|..    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            36889999999999999999753  46889999987543222 1234566777777665   69999999999863    


Q ss_pred             -cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          673 -VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       673 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                       ....++||||++ +++.+++.... ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence             346899999997 68888886433 23488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------hh
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------AL  824 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~~  824 (873)
                      |+++..... .......|++.|+|||.+.+..++.++||||+||++|||++|+.||...............       ..
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999866533 2334457899999999998888999999999999999999999999754432111111000       00


Q ss_pred             -------hhhcCCCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 -------DEMLDPRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 -------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                             ..........+.. ...+....+.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                   0000001000000 00112235779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-36  Score=330.26  Aligned_cols=200  Identities=24%  Similarity=0.380  Sum_probs=174.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+++.. +|+.+|+|.+....  .....+.+.+|+++++.++||||++++++|.+.+..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            368999999999999999999765 68889999886542  222356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999998643   34788899999999999999999752  799999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      .  ......|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            2  22335689999999999988899999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=318.46  Aligned_cols=252  Identities=25%  Similarity=0.453  Sum_probs=204.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|++|.||+|...+++.||+|.++....    ..+++.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            467889999999999999999988788999999875322    2467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++.... ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999999986543 34589999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CCCc-cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCc
Q 039344          761 SSNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSR  837 (873)
Q Consensus       761 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  837 (873)
                      .... .....+..|+|||++.+..++.++||||||+++||+++ |+.||.......        ....+... ..+.+. 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  227 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQGYRMPCPP-  227 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCCC-
Confidence            2111 11223457999999998899999999999999999999 999986433211        11111111 111111 


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         .....+.+++.+||+.+|++||++.++.+.|+
T Consensus       228 ---~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         228 ---GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             ---cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence               12235889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.8e-37  Score=329.80  Aligned_cols=243  Identities=22%  Similarity=0.329  Sum_probs=192.4

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 5789999998754221122235567788887764 899999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|.+++...   ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            9999988643   3588999999999999999999999   999999999999999999999999999975433333344


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||........        ...+.......+..    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--------~~~i~~~~~~~~~~----~~~~  222 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--------FQSIRMDNPCYPRW----LTRE  222 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCCCCCcc----CCHH
Confidence            56789999999999998999999999999999999999999875332111        11111111111111    1224


Q ss_pred             HHHHHhhcccCCCCCCCCHH-HHH
Q 039344          846 IVEVTISCVDENPESRPTMQ-KVC  868 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~-ev~  868 (873)
                      +.+++.+||+.||++||++. ++.
T Consensus       223 ~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         223 AKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HHHHHHHHhccCHhhcCCChHHHH
Confidence            78999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4e-37  Score=333.31  Aligned_cols=240  Identities=23%  Similarity=0.303  Sum_probs=191.3

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHH-HHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||+||+|+.. +|+.||+|++...........+.+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999864 78999999986532222222344555555 46788999999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|..++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            9999888643   3588999999999999999999999   999999999999999999999999999976543334444


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~----~~~  222 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILNKPLRLKPNI----SVS  222 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC----CHH
Confidence            567999999999999999999999999999999999999998643221        11222222222222111    234


Q ss_pred             HHHHHhhcccCCCCCCCCHH
Q 039344          846 IVEVTISCVDENPESRPTMQ  865 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~  865 (873)
                      +.+++.+|++.||++||++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCC
Confidence            78999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=326.70  Aligned_cols=254  Identities=22%  Similarity=0.249  Sum_probs=201.3

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|++.+.||+|+||+||++... +++.||+|++.............+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999754 689999999865332222223557889999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999998875432 24589999999999999999999999   99999999999999999999999999998754322


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                       ......|++.|+|||++.+..++.++||||+||++||+++|+.||.........    ......+.......+.    .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~----~  227 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR----EEVERRVKEDQEEYSE----K  227 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH----HHHHHHhhhcccccCc----c
Confidence             223457899999999999888999999999999999999999998753321110    0111111111111111    1


Q ss_pred             HHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      ....+.+++.+||+.||++||     +++++++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            233478999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-37  Score=339.78  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=200.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999764 6889999998643222222245578999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++...    .++...+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999988543    378888999999999999999999   999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccccccccC----CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC--C
Q 039344          760 DSS-NWTELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR--L  832 (873)
Q Consensus       760 ~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~  832 (873)
                      ... ......||+.|+|||++.+.    .++.++||||+||++|||++|+.||......        .....+....  +
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~  266 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKNSL  266 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCcC
Confidence            322 22346799999999998653    3788999999999999999999998753321        1112222211  1


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPES--RPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  869 (873)
                      ..+.  .......+.+++.+|++.+|++  ||+++|+++
T Consensus       267 ~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         267 TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            1111  1112335789999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-37  Score=336.09  Aligned_cols=240  Identities=23%  Similarity=0.306  Sum_probs=195.0

Q ss_pred             ceeeecCCeEEEEEEe----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEec
Q 039344          608 HCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      +.||+|+||.||+++.    .+|+.||+|++...... ......+..|++++++++||||+++++++.+.+..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999864    36889999998753221 112355778999999999999999999999999999999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN  763 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  763 (873)
                      ++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            999999988543   3589999999999999999999999   9999999999999999999999999999876544334


Q ss_pred             ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHH
Q 039344          764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL  843 (873)
Q Consensus       764 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  843 (873)
                      .....|++.|+|||.+.+..++.++||||+||++|||++|+.||......        .....+.......+...    .
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~~~~p~~~----~  222 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAKLGMPQFL----S  222 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC----C
Confidence            44567899999999999888999999999999999999999998743321        11222222222222211    2


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHH
Q 039344          844 ISIVEVTISCVDENPESRPTMQK  866 (873)
Q Consensus       844 ~~l~~li~~cl~~dP~~RPs~~e  866 (873)
                      ..+.+++.+||+.||++||++.+
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCC
Confidence            24789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=345.33  Aligned_cols=249  Identities=21%  Similarity=0.229  Sum_probs=200.8

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-C-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-S-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+...   .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4888999999999999999654 3 678888876432   2233456788999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||+++|+|.+++.... ....+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999999998875432 234588899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC-CCC
Q 039344          760 DSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP-TPS  836 (873)
Q Consensus       760 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  836 (873)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......        ........+... .+.
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~~~~  293 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDPFPC  293 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCCc
Confidence            322  233456999999999999999999999999999999999999998643221        112222222221 111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .    ....+.+++.+||+.||++||+++++++
T Consensus       294 ~----~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        294 P----VSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             c----CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1    1234889999999999999999999874

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.7e-37  Score=339.61  Aligned_cols=253  Identities=20%  Similarity=0.260  Sum_probs=196.0

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|+..+.||+|+||+||+|+. .+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999975 4688999999875432233345678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|+|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999998643   3488889999999999999999999   99999999999999999999999999976431100


Q ss_pred             C-----------------------------------------------CccccccccccccccccccCCCCCcchhHHHH
Q 039344          762 S-----------------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFG  794 (873)
Q Consensus       762 ~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G  794 (873)
                      .                                               ......||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                               01234699999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhh--cccCCCCCCCCHHHHHH
Q 039344          795 VLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTIS--CVDENPESRPTMQKVCQ  869 (873)
Q Consensus       795 ~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev~~  869 (873)
                      |++|||+||+.||.........    ............+.....    ...+.+++.+  |+..+|..||+++++++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~----s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQ----LKVINWENTLHIPPQVKL----SPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHH----HHHHccccccCCCCCCCC----CHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999999998743321100    000000001111211111    1236677777  66667777999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-36  Score=317.14  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=207.1

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+...... ....+++.+|+++++.++||||+++++++.+.+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4778899999999999999764 6899999998643222 2345778999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++.... ...+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999987542 34688999999999999999999999   99999999999999999999999999998776554


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......|++.|+|||+..+..++.++||||||+++|||++|+.||......        ...........+....   .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~  224 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIRGVFPPVSQ---M  224 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCcc---c
Confidence            4444567889999999999988999999999999999999999998743321        1111222222221111   1


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ....+.+++.+||+.+|++||++.++++.
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            22358899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-36  Score=352.23  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=201.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|++.++||+|+||.||+|+.. +|+.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999764 68999999997654444444677999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc--------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          681 EYFKMCSLAVILSNDA--------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      ||+++++|.+++....        .....++..+.+++.||++|++|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421        123356778899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC------------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccch
Q 039344          753 IAKFLKPDSS------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS  814 (873)
Q Consensus       753 ~a~~~~~~~~------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~  814 (873)
                      +++.......                  ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                  1113468999999999999999999999999999999999999987532211


Q ss_pred             hhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHh
Q 039344          815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP-TMQKVCQLL  871 (873)
Q Consensus       815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L  871 (873)
                      ...   .   ....++....+.   .+....+.+++.+|++.||++|| +++++.+.|
T Consensus       239 i~~---~---~~i~~P~~~~p~---~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        239 ISY---R---DVILSPIEVAPY---REIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             hhh---h---hhccChhhcccc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            100   0   111111110111   11223478899999999999996 555565554

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-36  Score=327.68  Aligned_cols=252  Identities=24%  Similarity=0.450  Sum_probs=199.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+|++.+.||+|+||.||+|+.. +|+    .||+|++....  .....+++.+|+.+++.++||||++++|+|... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            56899999999999999999753 344    38999986432  223357799999999999999999999999764 56


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++|+||+++|++.+++....  ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            79999999999999987543  3478899999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcc--ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .........  ...++..|+|||++.+..++.++|||||||++||+++ |+.||+......+..     ....  ....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-----~~~~--~~~~~  231 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEK--GERLP  231 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHhC--CCCCC
Confidence            654433222  2234668999999999999999999999999999998 999987533221111     1111  11222


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+..    ....+.+++.+||+.+|++||++.++++.+.
T Consensus       232 ~~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         232 QPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2211    1234789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-36  Score=335.10  Aligned_cols=253  Identities=18%  Similarity=0.276  Sum_probs=195.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||.||++.. .+++.||+|+..         .+.+.+|++++++++||||+++++++......++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            36799999999999999999975 478999999743         24567899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      +|++. +++..++...   ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus       162 ~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        162 LPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99986 6787777543   3588999999999999999999999   999999999999999999999999999975432


Q ss_pred             C-CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccch--------hh--------------
Q 039344          760 D-SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS--------FS--------------  816 (873)
Q Consensus       760 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~--------~~--------------  816 (873)
                      . ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ..              
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            2 223345679999999999999899999999999999999999998864221100        00              


Q ss_pred             --h-hhhhhhhhhhcC---CCC--CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          817 --S-LNLNIALDEMLD---PRL--PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       817 --~-~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        . ............   ...  ...+.........+.+++.+||+.||++|||++|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              0 000000000000   000  0011111223446889999999999999999999975

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=340.71  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.............+.+|+++++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999764 68999999987532222233456789999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999998653   3589999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CC--------------------------------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh
Q 039344          761 SS--------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK  802 (873)
Q Consensus       761 ~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t  802 (873)
                      ..                                      .....+||+.|+|||++.+..++.++||||+||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            10                                      0012468999999999999899999999999999999999


Q ss_pred             CCCCCcccccchhhhhhhhhhhhhhcC--CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 039344          803 GKHPRDFISSMSFSSLNLNIALDEMLD--PRLPTPSRNVHDKLISIVEVTISCVDENPESRPT---MQKVCQ  869 (873)
Q Consensus       803 g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~  869 (873)
                      |..||.......        ....+..  ..+..+...  .....+.+++.+|+. +|.+|++   ++|+++
T Consensus       235 G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQE--------TYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHH--------HHHHHHcCCCccCCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999987533221        1111111  111111110  112246788889996 8999997   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-36  Score=329.53  Aligned_cols=246  Identities=22%  Similarity=0.310  Sum_probs=194.9

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||+||+|+.. +++.||+|++...........+.+..|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 6789999999765333333456688999999888 699999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      ++|..++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            9998887543   3589999999999999999999999   999999999999999999999999999976433333444


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+......... ........+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~----~~~  229 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIRIPRFL----SVK  229 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCCCCCCC----CHH
Confidence            5679999999999999999999999999999999999999996432211000 01111122222222222211    123


Q ss_pred             HHHHHhhcccCCCCCCCCH
Q 039344          846 IVEVTISCVDENPESRPTM  864 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~  864 (873)
                      +.+++.+||+.||++|+++
T Consensus       230 ~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         230 ASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHHHHhccCHHHcCCC
Confidence            7799999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.1e-37  Score=338.02  Aligned_cols=254  Identities=21%  Similarity=0.288  Sum_probs=199.2

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.++...|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999865 688999999864322222234568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|+|.+++...    .+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+|+...
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999998543    378889999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CccccccccccccccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC--
Q 039344          759 PDSS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR--  831 (873)
Q Consensus       759 ~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--  831 (873)
                      .... ......||+.|+|||++.+..    ++.++||||+||++|||++|+.||......        .....+.+..  
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~  265 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIMDHKNS  265 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCcc
Confidence            3322 223567999999999987543    778999999999999999999998743321        1122222211  


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPES--RPTMQKVCQL  870 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  870 (873)
                      +..+..  ......+.+++..|+..++.+  ||+++|+++.
T Consensus       266 ~~~p~~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNFPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCCCc--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            111111  112234678888999865544  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.4e-36  Score=321.39  Aligned_cols=254  Identities=20%  Similarity=0.346  Sum_probs=201.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+|++.+.||+|+||.||+|..     .++..||+|.+....  .....+.+.+|++++++++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            5678889999999999999974     356789999987532  222346788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccc--------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          677 FIVYEYFKMCSLAVILSNDA--------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      |+||||+++++|.+++....              ....+++.++..++.|++.|++|||++   +++||||||+||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence            99999999999999985322              123478889999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ++.+||+|||+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |..||........    
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~----  235 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV----  235 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence            99999999999986643321  1223345678999999988889999999999999999998 9999764322111    


Q ss_pred             hhhhhhhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          820 LNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       820 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          .+..... ..+.+..    ....+.+++.+||+.||++||++.++.+.|+
T Consensus       236 ----~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         236 ----IEMVRKRQLLPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             ----HHHHHcCCcCCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence                1111111 1111111    1234788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-37  Score=309.65  Aligned_cols=254  Identities=19%  Similarity=0.246  Sum_probs=210.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.|+..+.||.|.-|+||+++.++ +..+|+|++.+..............|-++++.++||.++.+|+.++.++..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456677899999999999998763 5889999998765554444566788999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |||+||+|....+++. .+.+++..++.+|..|+-||+|||..   |||.|||||+||||.++|++.|+||.++......
T Consensus       157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999998887644 56799999999999999999999999   9999999999999999999999999998543110


Q ss_pred             C---------------------------------C-----------------------CccccccccccccccccccCCC
Q 039344          761 S---------------------------------S-----------------------NWTELAGTYGYVAPELAYTMKV  784 (873)
Q Consensus       761 ~---------------------------------~-----------------------~~~~~~g~~~y~aPE~~~~~~~  784 (873)
                      .                                 .                       .....+||-.|.|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence            0                                 0                       0013578999999999999999


Q ss_pred             CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC-
Q 039344          785 TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT-  863 (873)
Q Consensus       785 ~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-  863 (873)
                      +.++|.|+|||++|||+.|..||.+        ...++.+..++...+..+...  ..+..+.++|++.+.+||.+|.- 
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG--------~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKG--------SNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCC--------CCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhcc
Confidence            9999999999999999999999764        333444555555555444332  44556899999999999999987 


Q ss_pred             ---HHHHHH
Q 039344          864 ---MQKVCQ  869 (873)
Q Consensus       864 ---~~ev~~  869 (873)
                         |+||.+
T Consensus       383 ~rGA~eIK~  391 (459)
T KOG0610|consen  383 KRGAAEIKR  391 (459)
T ss_pred             ccchHHhhc
Confidence               777754

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-36  Score=322.34  Aligned_cols=255  Identities=23%  Similarity=0.418  Sum_probs=202.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      +++|.+.+.||+|+||.||++..      .++..+|+|.+....   ....+.+.+|++++++++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            46788999999999999999974      234568999886532   233567999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccc----------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          675 HLFIVYEYFKMCSLAVILSNDA----------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      ..++||||+++++|.+++....          ....+++..+..++.|++.|++|||++   +++||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            9999999999999999986432          123489999999999999999999999   999999999999999999


Q ss_pred             CeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLN  821 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~  821 (873)
                      .++|+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......       
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------  230 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------  230 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            999999999986543321  1223345778999999998889999999999999999998 899976433211       


Q ss_pred             hhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          822 IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ....+...........   ....+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       231 -~~~~i~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~  277 (288)
T cd05093         231 -VIECITQGRVLQRPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ  277 (288)
T ss_pred             -HHHHHHcCCcCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence             1111222221111111   1234889999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-37  Score=310.68  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=194.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----e
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----H  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  675 (873)
                      -.|...+++|.|+||.||+|... +++.||||+........       -+|+++|+.++|||||++.-+|....     .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            34666799999999999999754 57899999987543322       37999999999999999999886432     3


Q ss_pred             eEEEEEeccCCChhhHhccc-ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEecccc
Q 039344          676 LFIVYEYFKMCSLAVILSND-AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGI  753 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~  753 (873)
                      ..+||||++ .+|.+.++.. ..+..++...+.-+.+|+.+|++|||+.   +|+||||||.|+|+|.+ |.+||||||.
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            468999998 5777777532 2345688888999999999999999998   99999999999999987 8999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhh-------hhhhhhhhh
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-------SLNLNIALD  825 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~-------~~~~~~~~~  825 (873)
                      |+.+...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.......       +....+.+.
T Consensus       173 AK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  173 AKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             ceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9998766555 445678899999998875 5899999999999999999999998865432111       111111111


Q ss_pred             hh-------cCCCCCCCC--c-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EM-------LDPRLPTPS--R-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~-------~~~~~~~~~--~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+       ..+.+....  . .......+..+++.+++.++|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            11       111111110  0 11122335889999999999999999998874

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-36  Score=320.02  Aligned_cols=249  Identities=23%  Similarity=0.267  Sum_probs=194.9

Q ss_pred             eeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||+|+||.||+++.+ +|+.||+|++...........+.+..|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999754 6899999998643222222234566799999999999999999999999999999999999999


Q ss_pred             hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccc
Q 039344          689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA  768 (873)
Q Consensus       689 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  768 (873)
                      .+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++...... .......
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA  155 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence            88875433 23488999999999999999999999   9999999999999999999999999999866432 2233457


Q ss_pred             cccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHH
Q 039344          769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE  848 (873)
Q Consensus       769 g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  848 (873)
                      |++.|+|||++.+..++.++||||+||++|||++|+.||.......    ...................   .....+.+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~  228 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLEDEVKFEHQ---NFTEESKD  228 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhccccccccc---cCCHHHHH
Confidence            8999999999998889999999999999999999999986422110    0111111222222221111   12234789


Q ss_pred             HHhhcccCCCCCCCCHHHHHHH
Q 039344          849 VTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       849 li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ++.+||+.||++||+++|+++.
T Consensus       229 li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HHHHHhccCHhhCCCCccchhh
Confidence            9999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.6e-37  Score=331.39  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=200.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      .++|++.+.||+|+||.||+|..      .+++.||+|+++....  ....+.+..|+.++.++ +||||++++++|...
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            45789999999999999999953      2357899999875432  22346688899999999 899999999988654


Q ss_pred             -ceeEEEEEeccCCChhhHhccccc-------------------------------------------------------
Q 039344          674 -RHLFIVYEYFKMCSLAVILSNDAA-------------------------------------------------------  697 (873)
Q Consensus       674 -~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------  697 (873)
                       ...+++|||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             568899999999999998854221                                                       


Q ss_pred             ---ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc--cccccccc
Q 039344          698 ---AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYG  772 (873)
Q Consensus       698 ---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~  772 (873)
                         ...+++..+..++.||+.|++|||++   +|+||||||+||+++.++.++|+|||+++.+.......  ....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12578999999999999999999999   99999999999999999999999999998764433221  23445678


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHh
Q 039344          773 YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTI  851 (873)
Q Consensus       773 y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  851 (873)
                      |+|||++.+..++.++||||+||++|||++ |..||........    ............  .+.    .....+.+++.
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~~----~~~~~~~~l~~  310 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCRRLKEGTRMR--APE----YATPEIYSIML  310 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----HHHHHhccCCCC--CCc----cCCHHHHHHHH
Confidence            999999999999999999999999999998 9999864322110    000111101111  111    11234889999


Q ss_pred             hcccCCCCCCCCHHHHHHHhc
Q 039344          852 SCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       852 ~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +||+.+|++||++.|+++.|+
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~  331 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILG  331 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-36  Score=328.97  Aligned_cols=244  Identities=21%  Similarity=0.287  Sum_probs=195.9

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +|+..+.||+|+||+||+|+.. +|+.||+|++...........+.+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777899999999999999754 68999999987542222223456788888888885 678889999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999999888543   3589999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...  
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~~~p~~~--  224 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNVSYPKSL--  224 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCccC--
Confidence            33334567899999999999989999999999999999999999998753321        11222222222222211  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCH
Q 039344          841 DKLISIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~  864 (873)
                        ...+.+++.+|++.+|.+|++.
T Consensus       225 --~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         225 --SKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CHHHHHHHHHHcccCHhhCCCC
Confidence              2247889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=329.21  Aligned_cols=247  Identities=25%  Similarity=0.397  Sum_probs=203.2

Q ss_pred             CCCceeeecCCeEEEEEEeC--CCc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          605 DDEHCIGKGGQGSVYMSKLA--SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       605 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ...+.||+|.||.|++|.+.  +|+  .||||.++......  ...+|.+|+.+|.+++|||++++||+..+ ....|||
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34578999999999999764  454  58999998765543  35889999999999999999999999987 6788999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |.++.|+|.+.|++ .....+-....-.++.|||.||.||.++   ++|||||.++|+++-....|||+|||+.|-+...
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999988 4445678888899999999999999999   9999999999999999999999999999988765


Q ss_pred             CCCcc---ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcC-CCCCCC
Q 039344          761 SSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTP  835 (873)
Q Consensus       761 ~~~~~---~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  835 (873)
                      ...+.   ...-...|+|||.+...+++.+||||+|||.+|||+| |..||.+..        ....++.+-+ .+++.+
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKNIDAGERLPRP  337 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHhccccccCCCC
Confidence            54442   1223567999999999999999999999999999998 888865433        2222222222 344443


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      . +   +..+++++++.||...|++|||+..+.+.
T Consensus       338 k-~---csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  338 K-Y---CSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             C-C---ChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            3 2   34469999999999999999999999754

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=307.54  Aligned_cols=248  Identities=28%  Similarity=0.440  Sum_probs=209.5

Q ss_pred             CCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |.+..+||+|+||+||+|.+ .+|..+|+|.+...     ...+++..|+.+|++.+.|++|++||.+......|+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            66778999999999999954 57999999998643     2368999999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      |.-|+..++++-.  .+++++.++..+++.-++|++|||..   .-+|||||+.|||++.+|.+|++|||.|-.+.+...
T Consensus       110 CGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  110 CGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             cCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            9999999999644  35799999999999999999999998   889999999999999999999999999988776655


Q ss_pred             CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      ...+..|||.|||||++..-.|..++||||+|+...||..|++||..+.++.-.-         ++....|+........
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIPT~PPPTF~KPE~W  255 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIPTKPPPTFKKPEEW  255 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------eccCCCCCCCCChHhh
Confidence            6667899999999999998889999999999999999999999998766542110         1111111111122233


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          843 LISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ...+-+++++|+-..|++|.|+.++++.
T Consensus       256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  256 SSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            4458899999999999999999988763

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-36  Score=331.16  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=197.9

Q ss_pred             CCCCCceeeecCCeEEEEEEe----CCCcEEEEEEccCCCC-CcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEeccee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  676 (873)
                      +|++.+.||+|+||.||+++.    .+++.||+|++..... ......+.+..|+.+++.+ +||+|+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999875    3688999999864321 1222345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999988543   3488999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          757 LKPDSS-NWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       757 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ...... ......||+.|+|||++.+.. ++.++||||+||++|||+||+.||.........    ......+.....+.
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~~~~  230 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKCDPPF  230 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcCCCCC
Confidence            543322 223457899999999988654 788999999999999999999998643321110    01111122222222


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      +...    ...+.+++.+||+.||++||     +++++++
T Consensus       231 ~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         231 PSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            2111    22478999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.9e-37  Score=330.87  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=190.4

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHH-HHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|+.. +|+.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 68899999986532222222344555554 57888999999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      ++|..++...   ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            9998887543   3578889999999999999999999   999999999999999999999999999976433333344


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~----~~~  222 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--------QMYDNILHKPLQLPGGK----TVA  222 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--------HHHHHHhcCCCCCCCCC----CHH
Confidence            567899999999999888999999999999999999999998643211        11222233333222221    224


Q ss_pred             HHHHHhhcccCCCCCCCCHH
Q 039344          846 IVEVTISCVDENPESRPTMQ  865 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~  865 (873)
                      +.+++.+|++.||.+||++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCC
Confidence            78999999999999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=339.77  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=196.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+++. .+|+.||+|++...........+.+.+|+++++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999975 478999999986432222233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999998643   3588899999999999999999999   9999999999999999999999999999643211


Q ss_pred             CC-----------------------------------------------CccccccccccccccccccCCCCCcchhHHH
Q 039344          761 SS-----------------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSF  793 (873)
Q Consensus       761 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~  793 (873)
                      ..                                               ......||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                               0012468999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC--CCCCCCCchhHHHHHHHHHHHhhcccCCCCCC---CCHHHHH
Q 039344          794 GVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD--PRLPTPSRNVHDKLISIVEVTISCVDENPESR---PTMQKVC  868 (873)
Q Consensus       794 G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~  868 (873)
                      ||++|||++|+.||........        ...+..  ..+..+..  ......+.+++.+|+. +|.+|   +++.|++
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~--------~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHET--------YRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHH--------HHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999999864332111        111111  11111110  0112347789999997 66665   5999987


Q ss_pred             HH
Q 039344          869 QL  870 (873)
Q Consensus       869 ~~  870 (873)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.7e-36  Score=322.58  Aligned_cols=255  Identities=19%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      .+|.+.+.||+|+||.||+|+..      ++..||+|++.....  ....+.+.+|+.+++.++||||+++++++.+...
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            34667789999999999999753      357899999975432  2235678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          676 LFIVYEYFKMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      .++++||++++++.+++....             ....+++..+.+++.|++.|++|+|+.   +|+||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            999999999999999985321             123478888999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ++.+||+|||+++.......  ......+++.|+|||++.++.++.++||||+||++|||++ |..||......      
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------  233 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------  233 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence            99999999999886543322  1223445778999999988889999999999999999998 88887643221      


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        ...+.+.++........   ....+.+++.+||+.+|++||+++++++.|+
T Consensus       234 --~~~~~i~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         234 --DVIEMIRNRQVLPCPDD---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             --HHHHHHHcCCcCCCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence              12222222222111111   2234789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.7e-37  Score=332.40  Aligned_cols=240  Identities=23%  Similarity=0.311  Sum_probs=191.1

Q ss_pred             ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHH-HHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||+||+|+. .+|+.||+|++.............+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999975 478999999986542222223345556655 46778999999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |++..++...   ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            9998887543   3588999999999999999999999   999999999999999999999999999976543334444


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+..........    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~~~~~~~----~~~~  222 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKPLVLRPG----ASLT  222 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCCccCCCC----CCHH
Confidence            5679999999999999999999999999999999999999986433211        112222222221111    1224


Q ss_pred             HHHHHhhcccCCCCCCCCHH
Q 039344          846 IVEVTISCVDENPESRPTMQ  865 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~  865 (873)
                      +.+++.+|++.+|++||++.
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCC
Confidence            77899999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.5e-36  Score=316.38  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=201.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|.+.+.||+|+||.||+|... +++.||+|++...    ....+++.+|+++++.++||||+++++++...+..++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            45788899999999999999754 5889999998643    122467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++.... ...+++..++.++.|++.|++|||++   +++||||||+||++++++.+||+|||.++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999986533 24588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCc-cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 SSNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.........     .........  ..+.. 
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-----~~~~~~~~~--~~~~~-  229 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----ELLEKGYRM--ERPEG-  229 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----HHHHCCCCC--CCCCC-
Confidence            2211 12234568999999998999999999999999999998 99997643221111     111111111  11111 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+.+++.+||+.+|++||++.++.+.|+
T Consensus       230 ---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         230 ---CPPKVYELMRACWQWNPSDRPSFAEIHQAFE  260 (263)
T ss_pred             ---CCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence               1234889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=315.08  Aligned_cols=251  Identities=27%  Similarity=0.454  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+|++.+.||+|+||.||+|+.+++..+|+|++.....    ....+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            45788899999999999999988788899999864322    13578899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            999999999986533  2589999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CCc-cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          762 SNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       762 ~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      ... ....++..|+|||.+.+..++.++||||||+++||+++ |+.||+.........     ........  ..+..  
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----~~~~~~~~--~~~~~--  225 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-----SVSAGYRL--YRPKL--  225 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-----HHHcCCcC--CCCCC--
Confidence            111 11223457999999998899999999999999999999 899986433221111     11111111  11111  


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        ....+.+++.+||+.+|++||++.|+++.|.
T Consensus       226 --~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         226 --APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             --CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence              2335889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.5e-37  Score=331.47  Aligned_cols=241  Identities=22%  Similarity=0.280  Sum_probs=189.8

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHH-HHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||+||+|+.. +++.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 67889999986432211122234444444 46778999999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      +++.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            9999988643   3477888899999999999999999   999999999999999999999999999976544444445


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+..........    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~----~~~~  222 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKPLQLKPN----ITNS  222 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCcCCCCC----CCHH
Confidence            5679999999999999999999999999999999999999986433221        111222222211111    1224


Q ss_pred             HHHHHhhcccCCCCCCCCHHH
Q 039344          846 IVEVTISCVDENPESRPTMQK  866 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~e  866 (873)
                      +.+++.+|++.||.+||++.+
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCC
Confidence            789999999999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.5e-37  Score=335.22  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=200.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999754 78999999987543323334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999986542  3589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC----
Q 039344          761 SSN-WTELAGTYGYVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD----  829 (873)
Q Consensus       761 ~~~-~~~~~g~~~y~aPE~~~------~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----  829 (873)
                      ... .....||+.|+|||++.      ...++.++||||+||++|||++|+.||........        ...+..    
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--------~~~i~~~~~~  227 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--------YNNIMNFQRF  227 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--------HHHHHcCCCc
Confidence            322 22346899999999986      45678899999999999999999999864332211        111111    


Q ss_pred             CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+....    ....+.+++.+|++ +|.+||+++++++
T Consensus       228 ~~~~~~~~----~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 LKFPEDPK----VSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCCCCC----CCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11111111    12347889999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-36  Score=321.38  Aligned_cols=254  Identities=24%  Similarity=0.457  Sum_probs=203.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      .+|.+.+.||+|+||.||+|+..      ++..+++|.+...   .....+.+.+|++.+++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            56888899999999999999642      3556889988643   22234678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          676 LFIVYEYFKMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      .++||||+++++|.+++....             ....+++..++.++.|++.|++|||++   +++||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            999999999999999986532             123478999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ++.++|+|||+++.......  ......++..|+|||++.+..++.++|||||||++|||+| |+.||.......     
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----  233 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----  233 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999976543321  1223456788999999999899999999999999999999 999976433221     


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ..+.+..+........   ....+.+++.+||+.+|++||++.+|+++|+
T Consensus       234 ---~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         234 ---VIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             ---HHHHHhCCCCCCCCcc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence               1111222222211111   1234889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=343.89  Aligned_cols=256  Identities=23%  Similarity=0.271  Sum_probs=203.3

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc---
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR---  674 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  674 (873)
                      ....+|.+.+.||+|+||+||+|+. .+|+.||||++...... ......+.+|+..+..++|+||+++++.+...+   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3457899999999999999999975 57999999998754332 223466889999999999999999988775432   


Q ss_pred             -----eeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          675 -----HLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       675 -----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                           ..++||||+++|+|.+++.... ....+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 3689999999999999986533 334688999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCC--CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          749 SDFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       749 ~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      +|||+++.+....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~~  256 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMHK  256 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence            9999998764321  1223467999999999999999999999999999999999999998743221        11122


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+........   ....+.+++.+||+.||.+||++.++++
T Consensus       257 ~~~~~~~~~~~~---~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        257 TLAGRYDPLPPS---ISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HhcCCCCCCCCC---CCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            222222111111   1234889999999999999999999875

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.3e-36  Score=315.24  Aligned_cols=251  Identities=23%  Similarity=0.412  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.++||+|+||.||+|..++++.||+|.+.....    ..+++.+|+.++++++||||+++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            467889999999999999999988899999999874322    2467899999999999999999999874 45689999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999986543 34589999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCc
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSR  837 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  837 (873)
                      .. ......++..|+|||++.+..++.++||||||+++||+++ |+.||........        ...+.+. +.+.+..
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  227 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--------IQNLERGYRMPRPDN  227 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--------HHHHHcCCCCCCCCC
Confidence            22 1223345678999999988889999999999999999999 9999864332211        1111111 1111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ....+.+++.+||+.+|++||+++++.+.|+
T Consensus       228 ----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         228 ----CPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ----CCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence                1234889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.3e-36  Score=320.20  Aligned_cols=263  Identities=21%  Similarity=0.352  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-----------------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-----------------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI  663 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  663 (873)
                      .++|++.+.||+|+||.||+++..                 ++..||+|++....  .....+.+.+|+.+++.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            356899999999999999998532                 24468999987542  22335679999999999999999


Q ss_pred             eeEEeEEEecceeEEEEEeccCCChhhHhccccc--------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 039344          664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAA--------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS  735 (873)
Q Consensus       664 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~  735 (873)
                      +++++++...+..++||||+++++|.+++.....        ...+++..+..++.|++.|++|||+.   +++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence            9999999999999999999999999999865331        12467888999999999999999999   999999999


Q ss_pred             CCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh--CCCCCcccc
Q 039344          736 KNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFIS  811 (873)
Q Consensus       736 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t--g~~P~~~~~  811 (873)
                      +||+++.++.++|+|||+++.+......  .....+++.|+|||...++.++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999999865433211  122334678999999888889999999999999999998  778876433


Q ss_pred             cchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          812 SMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....................+.+..    ....+.+++.+||+.||++||++.+|++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 DEQVIENTGEFFRDQGRQVYLPKPAL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             hHHHHHHHHHHHhhccccccCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            22211111000000000111111111    1235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.1e-36  Score=316.77  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=201.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||.||+|+. .+++.||+|++.....   .....+.+|+.++++++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            35799999999999999999985 5788999999864322   2245678999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+|||++|+||+++.++.++|+|||+++....
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            9999999999988543   3578999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          760 DSSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .........+++.|+|||.+.   ...++.++||||+||++|||++|+.||............   .......+..... 
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~-  234 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---SKSNFQPPKLKDK-  234 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee---ecCCCCCCCCccc-
Confidence            333334456888999999874   344778999999999999999999997533211100000   0001111111111 


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                         ......+.+++.+||+.+|++||+++++++.+
T Consensus       235 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         235 ---TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               11234588999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-36  Score=321.04  Aligned_cols=263  Identities=20%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC---------------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS---------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK  665 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  665 (873)
                      ..+|++.+.||+|+||.||+++...               ...||+|+++....  ....+.|.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence            3578999999999999999986532               23589999875422  223467899999999999999999


Q ss_pred             EEeEEEecceeEEEEEeccCCChhhHhccccc---------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 039344          666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAA---------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSK  736 (873)
Q Consensus       666 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~  736 (873)
                      +++++......++||||+++++|.+++.....         ...+++..+..++.|++.|++|||+.   +++||||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            99999999999999999999999999854321         12367889999999999999999999   9999999999


Q ss_pred             CeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh--CCCCCccccc
Q 039344          737 NVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISS  812 (873)
Q Consensus       737 Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t--g~~P~~~~~~  812 (873)
                      ||+++.++.+||+|||+++........  .....++..|+|||+...+.++.++|||||||++|||++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999999765432211  122345678999999998889999999999999999998  6667664332


Q ss_pred             chhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          813 MSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......... ...............   .....+.+++.+||+.||++||++++|++.|+
T Consensus       239 ~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENTGE-FFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHH-hhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            211111100 000000000000000   11235899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.1e-37  Score=339.39  Aligned_cols=251  Identities=20%  Similarity=0.245  Sum_probs=195.2

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999754 689999999864322222234668899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+|..+....
T Consensus        82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999998653   3478888999999999999999999   99999999999999999999999999975331000


Q ss_pred             -------------------------------------------CCccccccccccccccccccCCCCCcchhHHHHHHHH
Q 039344          762 -------------------------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL  798 (873)
Q Consensus       762 -------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~  798 (873)
                                                                 .......||+.|+|||++.+..++.++||||+||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       0011346899999999999999999999999999999


Q ss_pred             HHHhCCCCCcccccchhhhhhhhhhhhhhc-CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCC---CHHHHHH
Q 039344          799 EVIKGKHPRDFISSMSFSSLNLNIALDEML-DPRLPTPSRNVHDKLISIVEVTISCVDENPESRP---TMQKVCQ  869 (873)
Q Consensus       799 el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev~~  869 (873)
                      ||++|+.||...........     ..... ....+....    ....+.+++.+|+ .+|.+|+   ++.++++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~-----i~~~~~~~~~~~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLK-----VINWETTLHIPSQAK----LSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHH-----HhccCccccCCCCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999875432211110     00000 001111111    1223667777776 4999999   8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.9e-36  Score=320.23  Aligned_cols=262  Identities=23%  Similarity=0.383  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC-----------------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS-----------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI  663 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  663 (873)
                      ..+|++.+.||+|+||.||+|+...                 +..||+|++......  ...+.+.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            3678999999999999999986542                 346899998754322  345788999999999999999


Q ss_pred             eeEEeEEEecceeEEEEEeccCCChhhHhcccc--------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 039344          664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDA--------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS  735 (873)
Q Consensus       664 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~  735 (873)
                      +++++++...+..++||||+++++|.+++....        ....+++..++.++.|++.|++|||+.   +++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence            999999999999999999999999999986543        122588999999999999999999999   999999999


Q ss_pred             CCeeeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh--CCCCCcccc
Q 039344          736 KNVLLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFIS  811 (873)
Q Consensus       736 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t--g~~P~~~~~  811 (873)
                      +||+++.++.++++|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999986543321  1223456778999999988889999999999999999998  677775432


Q ss_pred             cchhhhhhhhhhhhhhcC-CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          812 SMSFSSLNLNIALDEMLD-PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ........ ......... ...+.+.    .....+.+++.+||+.||++||++.|+++.|+
T Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQQVIENA-GHFFRDDGRQIYLPRPP----NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hHHHHHHH-HhccccccccccCCCcc----CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            21110000 000000000 0011111    11235899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7e-36  Score=312.08  Aligned_cols=247  Identities=26%  Similarity=0.435  Sum_probs=196.2

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC  686 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~  686 (873)
                      +.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|+++++.++||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46999999999999764 789999998864322  233567899999999999999999999999999999999999999


Q ss_pred             ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc--
Q 039344          687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--  764 (873)
Q Consensus       687 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  764 (873)
                      ++.+++....  ..+++..++.++.|++.|++|||++   +++||||||+||+++.++.+|++|||+++.........  
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999986432  3578999999999999999999999   99999999999999999999999999997654321111  


Q ss_pred             cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHH
Q 039344          765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL  843 (873)
Q Consensus       765 ~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  843 (873)
                      .....+..|+|||.+.++.++.++||||+|+++||+++ |..||.......     ........  .+...+.    ...
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~~--~~~~~~~----~~~  222 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQG--VRLPCPE----LCP  222 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHcC--CCCCCcc----cCC
Confidence            11123457999999998889999999999999999998 888876432211     11111111  1111111    112


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          844 ISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       844 ~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+.+++.+||+.+|++||++.++.+.|+
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            35889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.9e-36  Score=322.59  Aligned_cols=257  Identities=21%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      ...++|++.+.||+|+||.||+|...      ....+|+|.+.....  .....++.+|+++++++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34467888999999999999999753      236799999875422  22346688999999999 8999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccc-------------ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSND-------------AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      ..+..+++|||+++++|.+++...             .....+++..++.++.|++.|++|||+.   +|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            999999999999999999998642             2234688999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+||+|||.++.+......  .....++..|+|||++.+..++.++|||||||++||+++ |..||........
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            9999999999999999876543221  122334678999999988889999999999999999997 9999764322111


Q ss_pred             hhhhhhhhhhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                              ...+..+. ...+..    ....+.+++.+||+.||++|||+.|+++.|+
T Consensus       244 --------~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         244 --------FKLLKEGYRMEKPQN----CTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             --------HHHHHcCCcCCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence                    11111111 111111    1234889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.2e-36  Score=313.67  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=203.8

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|+||.||+++.. +++.+|+|.++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4778899999999999999764 688999999864322  2235678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++++++.+++.... ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++++|||.++......
T Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999998875432 34578899999999999999999999   99999999999999999999999999998765444


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........        ..............   .
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~---~  223 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--------ILKVCQGSYKPLPS---H  223 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--------HHHHhcCCCCCCCc---c
Confidence            444456788999999999988899999999999999999999999874321111        11111111111111   1


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ....+.+++.+||+.||++||++.+++.+
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            12347899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-36  Score=337.10  Aligned_cols=252  Identities=20%  Similarity=0.263  Sum_probs=193.7

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|+..+.||+|+||+||+|+. .+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999975 4688999999875322223335678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|+|.+++...   ..+++..+..++.||+.|++|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999998653   3478889999999999999999999   99999999999999999999999999975331100


Q ss_pred             -----------------------------------------------CCccccccccccccccccccCCCCCcchhHHHH
Q 039344          762 -----------------------------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFG  794 (873)
Q Consensus       762 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G  794 (873)
                                                                     .......||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 039344          795 VLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT---MQKVCQ  869 (873)
Q Consensus       795 ~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~  869 (873)
                      |++|||++|+.||...........    ..........+.....    .....+++.+++ .+|++|++   ++++++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~----i~~~~~~~~~p~~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMK----VINWQTSLHIPPQAKL----SPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHH----HHccCCCcCCCCcccC----CHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999875332211000    0000001111111111    123566666665 49999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9e-36  Score=312.76  Aligned_cols=251  Identities=25%  Similarity=0.454  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||.||+|...++..||+|.+.....    ..+.+.+|+.++++++|+|++++++++. ....+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            356888999999999999999988888999999875322    2367899999999999999999999885 45678999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            9999999999986533 24589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCc-cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCc
Q 039344          761 SSNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSR  837 (873)
Q Consensus       761 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  837 (873)
                      .... ....++..|+|||+..+..++.++||||||+++||+++ |..||........        ...+... ..+.+. 
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~-  226 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV--------LEQVERGYRMPCPQ-  226 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCCCCCCC-
Confidence            2221 22345668999999988889999999999999999999 8999864332211        1111111 111111 


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         .....+.+++.+||+.+|++|||++++.+.|+
T Consensus       227 ---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         227 ---DCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             ---cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence               12335889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.9e-36  Score=319.93  Aligned_cols=254  Identities=23%  Similarity=0.344  Sum_probs=197.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++...  .....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            67899999999999999999765 333  47888876422  222346789999999999 7999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          678 IVYEYFKMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      +|+||+++++|.+++....             ....+++..+..++.|++.|++|||++   +|+||||||+||+++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence            9999999999999986532             123478899999999999999999999   999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~  823 (873)
                      .+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.......        .
T Consensus       157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~  227 (297)
T cd05089         157 ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------L  227 (297)
T ss_pred             eEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence            999999999864322111 111223457999999988889999999999999999997 999986433211        1


Q ss_pred             hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..............   .....+.+++.+||+.+|.+||+++++++.|+
T Consensus       228 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         228 YEKLPQGYRMEKPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             HHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111111111111   11234789999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-35  Score=311.21  Aligned_cols=244  Identities=23%  Similarity=0.361  Sum_probs=193.0

Q ss_pred             eeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          609 CIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       609 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      .||+|+||.||+|...   .+..||+|++....  .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            3899999999999653   45679999987542  2233567999999999999999999999885 4578999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      ++|.+++....  ..+++..+.+++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++..........
T Consensus        79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99999986432  3589999999999999999999999   999999999999999999999999999986644332221


Q ss_pred             ---ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC-CCCCCchhH
Q 039344          766 ---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR-LPTPSRNVH  840 (873)
Q Consensus       766 ---~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  840 (873)
                         ...++..|+|||.+....++.++|||||||++||+++ |+.||.........        ..+.... ...+. .  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~-~--  222 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM--------SFIEQGKRLDCPA-E--  222 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH--------HHHHCCCCCCCCC-C--
Confidence               1223568999999988889999999999999999996 99998754332111        1111111 11111 1  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ...++.+++.+||..+|++||++.+|.+.|+
T Consensus       223 -~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         223 -CPPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             -CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence             1234789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.7e-36  Score=319.18  Aligned_cols=257  Identities=21%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+....  .......+.+|+..++.++||||+++++++.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4578999999999999999999643      24579999886432  222345688999999999999999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhccccc-------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAA-------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      ...++||||+++|+|.+++.....       ....++..+..++.|++.|++|||++   +|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999964321       12356778899999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~  823 (873)
                      +++|||+++........  .....++..|+|||.+.++.++.++|||||||++|||++ |..||......        ..
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~  230 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QV  230 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence            99999999865433221  122345678999999998889999999999999999998 78887643221        11


Q ss_pred             hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+.++........   ....+.+++.+||+.||++||++.++++.|+
T Consensus       231 ~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  276 (288)
T cd05061         231 LKFVMDGGYLDQPDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLLK  276 (288)
T ss_pred             HHHHHcCCCCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            122222221111111   1235889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=312.09  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=214.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .-|...+.||+|.|+.|-+|+.- +|+.||||++.+....+. ....+.+|++.|+-++|||||++|.+.......|+|.
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45778889999999999999754 799999999987644433 3466889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-CCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-FENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  759 (873)
                      |.-.+|+|++|+-++..  .+.+..+.+++.||+.|+.|+|+.   .||||||||+||.+- +-|-||+.|||++..+.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999977654  388899999999999999999999   999999999998765 568999999999987765


Q ss_pred             CCCCccccccccccccccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      . ....+.+|+..|-|||++.+..|+ +++||||+|||+|.+++|+.||...        +..+.+..++|-++..|.. 
T Consensus       172 G-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA--------NDSETLTmImDCKYtvPsh-  241 (864)
T KOG4717|consen  172 G-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA--------NDSETLTMIMDCKYTVPSH-  241 (864)
T ss_pred             c-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc--------cchhhhhhhhcccccCchh-
Confidence            4 556778999999999999998885 6799999999999999999997643        3345567778877776653 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...++.++|..|+..||++|.+.+||+.
T Consensus       242 ---vS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  242 ---VSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---hhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence               4455899999999999999999999864

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-36  Score=333.43  Aligned_cols=258  Identities=20%  Similarity=0.281  Sum_probs=200.1

Q ss_pred             HHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          596 EIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       596 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ++....++|++.+.||+|+||.||+++.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            33445688999999999999999999765 68899999986432222223456789999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||+++|+|.+++...    .++...+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999988543    378888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC-CccccccccccccccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC
Q 039344          755 KFLKPDSS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       755 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      +....... ......||+.|+|||++.+..    ++.++||||+||++|||++|+.||......        .....+..
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~  261 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMN  261 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHc
Confidence            87654322 223567999999999987543    788999999999999999999998743321        11112211


Q ss_pred             C--CCCCCCchhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 039344          830 P--RLPTPSRNVHDKLISIVEVTISCVDENPES--RPTMQKVCQL  870 (873)
Q Consensus       830 ~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  870 (873)
                      .  ....+..  .+....+.+++.+|+..++.+  ||+++|+++.
T Consensus       262 ~~~~~~~~~~--~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HKNSLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcccCCCc--CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1  1111111  112334778899999844433  7899988763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.2e-36  Score=319.87  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=202.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+......   ..+.+.+|+.+++.++||||+++++.+......++||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            5788889999999999999975 46899999998754322   2467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.++.....
T Consensus        97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999853    2478899999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC--CCCCCCch
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRN  838 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  838 (873)
                      ........+++.|+|||.+.+..++.++|||||||++|+|++|+.||.........       ......+  ....+.  
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~--  240 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-------YLIATNGTPELQNPE--  240 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-------HHHhcCCCCCCCCcc--
Confidence            33334457889999999999888999999999999999999999998653321110       0011111  111111  


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        .....+.+++.+||..+|++||++.++++
T Consensus       241 --~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         241 --KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             --ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence              12235789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.2e-36  Score=322.29  Aligned_cols=260  Identities=17%  Similarity=0.271  Sum_probs=198.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|+++......  ....+.+|+.++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            56888999999999999999765 67889999987543222  2356778999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++ ++.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            99985 7777765432  3478899999999999999999999   9999999999999999999999999999765444


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-------hhhh--------
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-------NIAL--------  824 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-------~~~~--------  824 (873)
                      ........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||.............       ....        
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            444445578899999998865 457899999999999999999999987533211100000       0000        


Q ss_pred             -hhhcCCCCCC-CC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 -DEMLDPRLPT-PS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 -~~~~~~~~~~-~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       .....+.... +. .........+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             0000011000 00 000112235789999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.2e-36  Score=312.84  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+|++.++||+|+||.||+|+..++..||+|++.....    ..+.+.+|+++++.++||||+++++++. ....++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence            56899999999999999999887777899999874322    2367899999999999999999999875 456799999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++++++.+++.... ...+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.++|+|||.++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          81 YMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             cCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999997542 23578999999999999999999999   99999999999999999999999999998665433


Q ss_pred             CCc-cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCch
Q 039344          762 SNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRN  838 (873)
Q Consensus       762 ~~~-~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  838 (873)
                      ... ....++..|+|||+..+..++.++||||+|+++||++| |+.||........        ....... ..+..   
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--------~~~~~~~~~~~~~---  225 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------LDQVERGYRMPCP---  225 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--------HHHHhcCCCCCCc---
Confidence            221 23345678999999988889999999999999999999 8888764332111        1111111 11111   


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       .+....+.+++.+||+.+|++||+++++.+.|+
T Consensus       226 -~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         226 -PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             -cccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence             123345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.3e-36  Score=317.58  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=199.2

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec----
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV----  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----  673 (873)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|++.....    ....+..|+.+++++ +||||+++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4567888899999999999999764 688999999864321    236788999999998 799999999998753    


Q ss_pred             --ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          674 --RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       674 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                        ...++||||++++++.+++.... ...+++..+..++.|++.|++|||++   +|+||||+|+||++++++.++|+||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence              45899999999999999986532 34588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      |+++.............|++.|+|||++.     +..++.++||||+||++|||++|+.||..........     ....
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~  230 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR  230 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc
Confidence            99987654444445567899999999986     3457889999999999999999999986433211100     0001


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........ .    .....+.+++.+||..+|.+|||+.++++
T Consensus       231 ~~~~~~~~-~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAPRLKS-K----KWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCCCC-C----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00111111 1    11234789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-35  Score=313.86  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=196.4

Q ss_pred             CCCCceeeecCCeEEEEEEeCC-Cc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------c
Q 039344          604 FDDEHCIGKGGQGSVYMSKLAS-GE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------R  674 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  674 (873)
                      |.+.+.||+|+||.||+|...+ +.  .||+|.++.... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3567899999999999998654 32  589998875432 223357789999999999999999999988532      2


Q ss_pred             eeEEEEEeccCCChhhHhcccc---cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      ..+++|||+++|++.+++....   ....+++..+..++.|++.|++|||++   +|+||||||+||++++++.++|+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            4689999999999998874322   223478999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhc
Q 039344          752 GIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       752 g~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      |+++........  .....+++.|+|||+..+..++.++||||||+++|||++ |+.||........        ...+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------~~~~~  228 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI--------YDYLR  228 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHHHH
Confidence            999876543221  122345678999999998889999999999999999999 8899864332211        11111


Q ss_pred             CCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          829 DPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       829 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+. .+.+.    .....+.+++.+||+.||++|||++++++.|+
T Consensus       229 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         229 QGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE  269 (272)
T ss_pred             cCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111 11111    12234889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.7e-36  Score=328.44  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=202.0

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEe
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLH  672 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  672 (873)
                      ..++|.+.+.||+|+||.||+|+..      .++.||+|+++.....  ...+.+.+|+.++.++. ||||++++++|..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            3456888899999999999999753      3468999999754322  22457889999999997 9999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhccccc-------------------------------------------------------
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAA-------------------------------------------------------  697 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------  697 (873)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999864321                                                       


Q ss_pred             ----------------------------------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 039344          698 ----------------------------------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKN  737 (873)
Q Consensus       698 ----------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~N  737 (873)
                                                              ...+++..+..++.|++.|++|||+.   +++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                    12356778899999999999999999   99999999999


Q ss_pred             eeeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccch
Q 039344          738 VLLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS  814 (873)
Q Consensus       738 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~  814 (873)
                      |++++++.+|++|||+++.......  ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986543221  1223456788999999998889999999999999999998 899986433211


Q ss_pred             hhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..    ......  ..+...+..    ....+.+++.+||+.+|++||+++|+++.|+
T Consensus       350 ~~----~~~~~~--~~~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~ell~~L~  397 (401)
T cd05107         350 QF----YNAIKR--GYRMAKPAH----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG  397 (401)
T ss_pred             HH----HHHHHc--CCCCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            10    000000  011111111    1235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-35  Score=311.29  Aligned_cols=245  Identities=25%  Similarity=0.404  Sum_probs=194.2

Q ss_pred             eeeecCCeEEEEEEe---CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          609 CIGKGGQGSVYMSKL---ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       609 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      .||+|+||.||+|.+   .+++.+|+|+++.... .....+++.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999964   3578899999864422 2334578999999999999999999999985 4567899999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc-
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW-  764 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-  764 (873)
                      ++|.+++...   ..+++..+..++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999998643   3588999999999999999999999   99999999999999999999999999998765433221 


Q ss_pred             --cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          765 --TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       765 --~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                        ....++..|+|||.+....++.++|||||||++|||++ |+.||...........     .....  ..+.+..    
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-----i~~~~--~~~~~~~----  222 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-----IESGE--RMECPQR----  222 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHCCC--CCCCCCC----
Confidence              12234578999999988888999999999999999998 9999875432211111     11111  1111111    


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+.+++.+||+.||++||++++|++.|+
T Consensus       223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             CCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence            1234789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-35  Score=315.00  Aligned_cols=252  Identities=23%  Similarity=0.380  Sum_probs=196.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+|++.+.||+|+||+||+|... +|+    .|++|.+...  .......++..|+..++++.||||+++++++. ....
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            57888899999999999999763 454    4777877532  12223467888888999999999999999885 4457


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++++||+++|+|.+++....  ..+++..+..++.||+.|++|||+.   +++||||||+||+++.++.+||+|||.++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            88999999999999986533  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ......  ......++..|+|||++.++.++.++||||||+++||+++ |+.||.........     .....  ....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-----~~~~~--~~~~~  231 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-----DLLEK--GERLA  231 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----HHHHC--CCcCC
Confidence            644322  2233456778999999998899999999999999999998 99998643321111     01110  01111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+..    ....+..++.+||..||++|||+.|+.+.|+
T Consensus       232 ~~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         232 QPQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             CCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1111    1224678999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-36  Score=315.95  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            367888999999999999999754      24689999986432  2223467889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhccccc-------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeE
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAA-------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH  747 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k  747 (873)
                      ..++||||+++++|.+++.....       ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            99999999999999999865332       22468889999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhh
Q 039344          748 VSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIAL  824 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~  824 (873)
                      |+|||+++.......  ......++..|+|||.+.++.++.++|||||||++||+++ |..||........        .
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--------~  231 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--------L  231 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--------H
Confidence            999999986543322  1223456788999999988889999999999999999998 9999864322111        1


Q ss_pred             hhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          825 DEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       825 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....++. ...+...    ...+.+++.+||+.+|++|||+.++++.|+
T Consensus       232 ~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         232 KFVIDGGHLDLPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHhcCCCCCCCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111111 1112111    335889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-36  Score=318.55  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=200.7

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |++.+.||+|+||+||+++.. +++.||+|.+........ ......+|+..+++++||||+++++++.+....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence            567889999999999999866 567899999986533222 123345699999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++++++.+++.   ....+++..+..++.|+++|++|||+.   +++|+||||+||++++++.++|+|||.+........
T Consensus        80 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             ccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999987   234589999999999999999999999   999999999999999999999999999986533444


Q ss_pred             Cccccccccccccccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          763 NWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      ......++..|+|||++. +..++.++||||+|+++|+|++|..||.........................     ....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  228 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----QSRE  228 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----SHTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----ccch
Confidence            555677899999999998 7889999999999999999999999988542111111111111000000000     0000


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.+++.+||+.||++||++.++++
T Consensus       229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  229 KSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0145899999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.2e-36  Score=317.41  Aligned_cols=259  Identities=20%  Similarity=0.289  Sum_probs=199.6

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++..... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4788899999999999999764 6899999998754322 2234678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++ +++.+++........+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            998 68888876554445689999999999999999999999   99999999999999999999999999998665443


Q ss_pred             CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh----------------hhh
Q 039344          762 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN----------------IAL  824 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~----------------~~~  824 (873)
                      .......+++.|+|||.+.+. .++.++||||+||++|||+||+.||..............                ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            333445678899999987654 468899999999999999999999874332110000000                000


Q ss_pred             h----hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 D----EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .    ....+.....   ......++.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSA---VKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHh---cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0    0000000000   0011234679999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-35  Score=312.18  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=190.7

Q ss_pred             ceeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      +.||+|+||.||+|...   ++..+|+|+++....  ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            35899999999999754   345789998865432  2234578899999999999999999999999999999999999


Q ss_pred             CCChhhHhccccc--ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          685 MCSLAVILSNDAA--AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       685 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +|+|.+++.....  ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999865432  23456778889999999999999999   999999999999999999999999999975433221


Q ss_pred             C--ccccccccccccccccccC-------CCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          763 N--WTELAGTYGYVAPELAYTM-------KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       763 ~--~~~~~g~~~y~aPE~~~~~-------~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .  .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||.....................++..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL  235 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence            1  1234567889999988642       35789999999999999996 999986533221111111110111111111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..      .....+.+++.+|| .+|++|||++||++.|+
T Consensus       236 ~~------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         236 KL------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CC------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11      11224778899999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.9e-36  Score=317.53  Aligned_cols=256  Identities=21%  Similarity=0.395  Sum_probs=203.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      .++|++.+.||+|+||.||+|...      ++..||+|++.....  ....+++.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            467899999999999999999753      467899999875422  233567999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccc-------------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 039344          675 HLFIVYEYFKMCSLAVILSNDA-------------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS  735 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~  735 (873)
                      ..++||||+++++|.+++....                   ....+++..++.++.|++.|++|||+.   +++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            9999999999999999986421                   112467888999999999999999999   999999999


Q ss_pred             CCeeeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCccccc
Q 039344          736 KNVLLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS  812 (873)
Q Consensus       736 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~  812 (873)
                      +||+++.++.++|+|||.++.+.....  .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876543321  1122344667999999988889999999999999999998 8888753322


Q ss_pred             chhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          813 MSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .        .....+.+.........   ....+.+++.+||+.+|++||++.|+++.|+
T Consensus       239 ~--------~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 E--------EVIYYVRDGNVLSCPDN---CPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H--------HHHHHHhcCCCCCCCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1        11122222222111111   2235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=321.20  Aligned_cols=246  Identities=28%  Similarity=0.432  Sum_probs=200.5

Q ss_pred             CCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |...+.||.|+||.||.|+. .+.+.||||++.-......+..+++..|+..+.+++|||++.+-|+|-.+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55567899999999999975 57889999999766555555568899999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      |- |+-.+++.-..  +++-+.++..|..+.++||+|||+.   +.||||||+.|||+++.|.||++|||.|....+.. 
T Consensus       108 Cl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-  180 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-  180 (948)
T ss_pred             Hh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence            97 56667765433  4578888999999999999999999   99999999999999999999999999998776543 


Q ss_pred             Ccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          763 NWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                         +++|||.|||||++..   +.|+-++||||+|++..|+...++|+-.+..+.        .+--+.....|...  .
T Consensus       181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------ALYHIAQNesPtLq--s  247 (948)
T KOG0577|consen  181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTLQ--S  247 (948)
T ss_pred             ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--------HHHHHHhcCCCCCC--C
Confidence               4689999999999863   569999999999999999999999965444331        11111111111111  1


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+....+.+|+..|+++-|++|||.+++++
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            223345889999999999999999999875

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-35  Score=316.60  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=199.9

Q ss_pred             CCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.....  ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4778899999999999999753      235788888865422  22346788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccc---------------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 039344          677 FIVYEYFKMCSLAVILSNDA---------------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS  735 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~  735 (873)
                      ++|+||+++++|.+++....                     ....+++..++.++.|++.|++|||+.   +++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence            99999999999999885421                     123478899999999999999999999   999999999


Q ss_pred             CCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCccccc
Q 039344          736 KNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS  812 (873)
Q Consensus       736 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~  812 (873)
                      +||++++++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999999865433221  122345678999999988889999999999999999998 9999864332


Q ss_pred             chhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          813 MSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....     ........  +.+..    ....+.+++.+||+.+|++||+++++++.|+
T Consensus       236 ~~~~~-----~~~~~~~~--~~~~~----~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         236 ERLFN-----LLKTGYRM--ERPEN----CSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             HHHHH-----HHhCCCCC--CCCCC----CCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            21111     11111111  11111    1235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-35  Score=315.81  Aligned_cols=256  Identities=23%  Similarity=0.401  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ..+|...+.||+|+||.||++..      .++..+|+|.+...   .....+.+.+|++.++.++|+||+++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            35678889999999999999963      24568899987643   2233567999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhccccc------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAA------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      ..+++|||+++++|.+++.....            ...+++..+..++.|++.|++|||+.   +++||||||+||++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence            99999999999999999865432            13478999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ++.++|+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||........    
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----  233 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA----  233 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH----
Confidence            99999999999976543221  1122345678999999998899999999999999999998 8999764332211    


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI  873 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  873 (873)
                          ......+........   ....+.+++.+||+.||++||+++||.+.|+.
T Consensus       234 ----~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 ----IECITQGRELERPRT---CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ----HHHHHcCccCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                111111111111111   12347899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-35  Score=315.07  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=201.2

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      .+++|.+.+.||+|++|.||+|...      .+..||+|.+....  .......|..|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3467889999999999999999765      35678999876432  222346789999999999999999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhccccc----ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---Ce
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAA----AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EA  746 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~  746 (873)
                      +..++||||+++++|.+++.....    ...+++..+.+++.||+.|++|||++   +++||||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence            999999999999999999865432    12588999999999999999999999   999999999999998765   59


Q ss_pred             EEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~  823 (873)
                      |++|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||...........     
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-----  233 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-----  233 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----
Confidence            99999999876332211  112233568999999998999999999999999999997 9999875332211111     


Q ss_pred             hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...  ..+...+..    ....+.+++.+||+.+|++||++.+|++.|+
T Consensus       234 ~~~--~~~~~~~~~----~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTG--GGRLDPPKG----CPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHc--CCcCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            100  111111111    1235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.8e-35  Score=308.65  Aligned_cols=248  Identities=24%  Similarity=0.392  Sum_probs=198.2

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCC
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS  687 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~  687 (873)
                      ++||+|+||.||+|...++..||+|.++....  ......+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36899999999999988899999999875432  2234578899999999999999999999999999999999999999


Q ss_pred             hhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc-cc
Q 039344          688 LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW-TE  766 (873)
Q Consensus       688 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~  766 (873)
                      +.+++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++++|||+++......... ..
T Consensus        79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            999886432  3478999999999999999999999   99999999999999999999999999997544322111 12


Q ss_pred             cccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       767 ~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ..+++.|+|||++.+..++.++||||||+++|++++ |..||.........     .......  +...+..    ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-----~~~~~~~--~~~~~~~----~~~~  222 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-----EQVEKGY--RMSCPQK----CPDD  222 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-----HHHHcCC--CCCCCCC----CCHH
Confidence            234567999999998889999999999999999998 99998643221111     1111111  1111111    2235


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 039344          846 IVEVTISCVDENPESRPTMQKVCQLLKI  873 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~ev~~~L~~  873 (873)
                      +.+++.+||+.+|++||++.|+++.|..
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~  250 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELAA  250 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence            8899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=313.53  Aligned_cols=254  Identities=23%  Similarity=0.375  Sum_probs=199.7

Q ss_pred             CCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce----
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH----  675 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  675 (873)
                      |.+.+.||+|+||.||+|...    .+..||+|+++..... ......+.+|++.++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            567889999999999999754    2467999998754322 2234678999999999999999999999876554    


Q ss_pred             --eEEEEEeccCCChhhHhcccc---cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 039344          676 --LFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD  750 (873)
Q Consensus       676 --~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D  750 (873)
                        .+++|||++++++..++....   ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence              799999999999998885432   224588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhh
Q 039344          751 FGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       751 fg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      ||+++.........  ....++..|+|||++.+..++.++|||||||++|||++ |..||........        .+..
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~--------~~~~  228 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI--------YDYL  228 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHH
Confidence            99998765443221  12234678999999988889999999999999999999 8899865332211        1122


Q ss_pred             cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          828 LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .++.......   .....+.+++.+||+.||++||++.|+++.|+
T Consensus       229 ~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         229 RHGNRLKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLE  270 (273)
T ss_pred             HcCCCCCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            2221111111   12335889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-35  Score=319.51  Aligned_cols=255  Identities=22%  Similarity=0.363  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe--------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL--------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      .++|.+.+.||+|+||.||+|+.        .++..||+|.+.....  ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            46788899999999999999963        1345799999874322  22356789999999999 8999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      .....++||||+++++|.+++.....             ...+++..+..++.||+.|++|||++   +++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999875321             23578889999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+||+|||.++........  .....+++.|+|||++.+..++.++||||||+++||+++ |..||........
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9999999999999999876543222  122345678999999998889999999999999999998 7888764332111


Q ss_pred             hhhhhhhhhhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .        ..+.... ...+.    .....+.+++.+||+.+|++||++.|+++.|+
T Consensus       249 ~--------~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~  294 (304)
T cd05101         249 F--------KLLKEGHRMDKPA----NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD  294 (304)
T ss_pred             H--------HHHHcCCcCCCCC----CCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            1        1111111 11111    12235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-35  Score=310.28  Aligned_cols=250  Identities=24%  Similarity=0.438  Sum_probs=200.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      ++|.+.+.||+|++|.||+|....+..||+|.+....    ...+.+.+|+.+++.++|||++++++++. .+..++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            5688889999999999999998877789999876432    12467889999999999999999999885 456789999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999986533 23478999999999999999999999   99999999999999999999999999998664332


Q ss_pred             CC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCch
Q 039344          762 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRN  838 (873)
Q Consensus       762 ~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  838 (873)
                      .. .....++..|+|||+..+..++.++||||+|+++|||+| |+.||....+...        ...+... ..+.+.  
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~--  226 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--------LEQVERGYRMPCPQ--  226 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCCCCc--
Confidence            21 122345678999999998889999999999999999999 8999864332111        1111111 111111  


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        .....+.+++.+||+.||++||+++++.+.|+
T Consensus       227 --~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         227 --GCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             --ccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence              12345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-35  Score=320.19  Aligned_cols=255  Identities=22%  Similarity=0.369  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC--------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      .++|.+.+.||+|+||.||+|+..        ++..+|+|.+.....  .....++.+|+++++.+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            357899999999999999999742        235799999875422  22346788999999999 7999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      ..+..++||||+++++|.+++.....             ...+++.++..++.|++.|++|||+.   +++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence            99999999999999999999975431             23478999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.++|+|||.++.........  ....+++.|+|||++.+..++.++||||+||++|||++ |+.||........
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            99999999999999997654322111  11234568999999998889999999999999999998 8888764321111


Q ss_pred             hhhhhhhhhhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                              ........ ...+.    .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       252 --------~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         252 --------FKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             --------HHHHHcCCCCCCCC----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                    11111111 11111    11235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.5e-36  Score=317.12  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=204.6

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeCC-----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-c
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLAS-----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-V  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~  673 (873)
                      ..++|.+.+.||+|+||.||+|....     +..|++|++....  .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            35678899999999999999998765     6889999986432  23335778899999999999999999999876 4


Q ss_pred             ceeEEEEEeccCCChhhHhcccccc-----cCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAA-----KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                      ...++++||++++++.+++......     ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6789999999999999998654322     4589999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhh
Q 039344          749 SDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       749 ~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      +|||+++.+......  .....++..|+|||++.+..++.++||||+|+++||+++ |+.||.......+...     ..
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----~~  233 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-----LK  233 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH-----HH
Confidence            999999866443221  122345678999999988889999999999999999999 9999875433221111     11


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..  .+.....    .....+.+++.+||+.||++|||+.++++.|+
T Consensus       234 ~~--~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         234 DG--YRLAQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             cC--CCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            10  1111111    11234889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-35  Score=313.05  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....  .....+++.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            3678889999999999999975 578999999986542  2233567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++..+.       .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999986552       367888999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        ......++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ..........++..+....  .
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~  223 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVLPV--G  223 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCCCCCCC--C
Confidence              2234578999999999999899999999999999999999999986432211000 0001111111111111000  0


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .....+.+++.+||+.+|++||+++|+++.
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            112247899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-35  Score=312.76  Aligned_cols=252  Identities=25%  Similarity=0.442  Sum_probs=201.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      .+|++.+.||+|+||.||+|+..    .+..+|+|.++....  ....+.+..|+.+++.++||||+++++++.+.+..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            56888999999999999999753    234799999875422  223567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++..
T Consensus        82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999999986543  3589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcc---ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CC
Q 039344          758 KPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RL  832 (873)
Q Consensus       758 ~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~  832 (873)
                      ........   ...++..|+|||++.+..++.++||||||+++||+++ |..||........        ...+.+. +.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--------~~~~~~~~~~  228 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--------IKAIEEGYRL  228 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--------HHHHhCCCcC
Confidence            54332211   1223568999999998889999999999999999886 9999764322111        1111111 11


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+.    .....+.+++.+||+.+|++||++.++++.|+
T Consensus       229 ~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         229 PAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             CCCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence            1111    12235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=311.51  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=201.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCc--chhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGE--MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      +.|.+.+.||+|++|.||.|.. .+++.||+|.+.......  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999975 468999999986543221  2224578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |+||++++++.+++...   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999988643   3478899999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          759 PDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       759 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      .....   .....++..|+|||++.+..++.++||||+|+++||+++|+.||.........   .... ..  ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~-~~--~~~~~~~  229 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIA-TQ--PTNPQLP  229 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHh-cc--CCCCCCC
Confidence            32211   12345788999999999988999999999999999999999998643322110   0000 00  0111111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .    .....+.+++.+||+.+|++||++.++++.
T Consensus       230 ~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         230 S----HVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             c----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1    122347899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-35  Score=318.80  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      .++|.+.+.||+|+||.||+|..      .++..||+|+++....  ....+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            45788999999999999999963      2355799999875422  22346789999999999 799999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      +..++||||+++++|.+++..... ..+++.++..++.|++.|++|||++   +++|+||||+||+++.++.++++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999865332 3379999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          754 AKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       754 a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      ++........  .....++..|+|||.+.+..++.++||||+||++|||++ |+.||........    .........  
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----~~~~~~~~~--  261 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----FYKLIKEGY--  261 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----HHHHHHcCC--
Confidence            9865433221  122345678999999999899999999999999999998 9999864332110    000111100  


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+..    ....+.+++.+||+.+|++||++.|+++.|+
T Consensus       262 ~~~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         262 RMAQPEH----APAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             cCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            1111111    1234889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.8e-36  Score=319.50  Aligned_cols=254  Identities=23%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  676 (873)
                      .++|++.+.||+|+||.||+|+.. ++.  .+|+|.+....  .....+.+.+|++++.++ +||||+++++++.+.+..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            467888999999999999999764 454  45777765322  223356788999999999 899999999999999999


Q ss_pred             EEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC
Q 039344          677 FIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE  743 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~  743 (873)
                      ++||||+++++|.+++.....             ...+++.+++.++.|++.|++|||++   +++||||||+||+++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            999999999999999865431             23578999999999999999999999   99999999999999999


Q ss_pred             CCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhh
Q 039344          744 NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNI  822 (873)
Q Consensus       744 ~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~  822 (873)
                      +.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||.......        
T Consensus       161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------  231 (303)
T ss_pred             CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence            999999999986432111 1111234567999999988889999999999999999998 999986432211        


Q ss_pred             hhhhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+... ....+..    ....+.+++.+||+.+|++||+++++++.++
T Consensus       232 ~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         232 LYEKLPQGYRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             HHHHHhcCCcCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111111 1111111    1234789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.4e-36  Score=316.73  Aligned_cols=253  Identities=21%  Similarity=0.255  Sum_probs=199.4

Q ss_pred             CCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |+..+.||+|+||+||+|.. .+++.||+|.+.............+.+|+++++.++|+||+++.+++.+.+..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999976 46899999998654332223345678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++++++.+++.... ...+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++...... .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-E  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-C
Confidence            99999998886433 23589999999999999999999999   9999999999999999999999999999765432 2


Q ss_pred             CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      ......|+..|+|||++.+..++.++|+||+||++||+++|+.||.........    ..............+.    ..
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~----~~~~~~~~~~~~~~~~----~~  228 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR----EEVDRRVLETEEVYSA----KF  228 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhhhccccccCc----cC
Confidence            223457899999999999888999999999999999999999998743321110    0111111111111111    11


Q ss_pred             HHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          843 LISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                      ...+.+++.+||+.||++||+     ++++++
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            224789999999999999999     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=310.48  Aligned_cols=252  Identities=26%  Similarity=0.481  Sum_probs=205.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|.+.+.||+|+||.||+|..+++..||+|.+.....    ..+++.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            467999999999999999999988888999999874322    2467899999999999999999999999889999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++.... ...+++.++..++.|++.|++|||++   +++||||||+||+++.++.++++|||.++.....
T Consensus        81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             eccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999986543 24589999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCc
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSR  837 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  837 (873)
                      .. ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||......        .....+... +.+.+..
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  228 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPRPPN  228 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC
Confidence            11 1112334568999999998889999999999999999998 99998643221        111111111 1111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ....+.+++.+||+.+|++||+++++.+.|+
T Consensus       229 ----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         229 ----CPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             ----CCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence                1234889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.5e-35  Score=310.39  Aligned_cols=249  Identities=28%  Similarity=0.425  Sum_probs=203.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|+..+.||+|+||.||+|+..+ ++.||+|.+....     ..+++.+|++++++++||||+++++++.+....|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            678899999999999999998764 7899999986431     1578999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999985432  4589999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........++..|+|||++.+..++.++||||||+++|+|++|+.||.........     ........+....    ..
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~----~~  223 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----FMIPNKPPPTLSD----PE  223 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----hhhccCCCCCCCc----hh
Confidence            43334456888999999999889999999999999999999999998743321100     0000000111111    11


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||+.+|++||++.|+++
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            12235889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.7e-35  Score=308.44  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=207.3

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|+..+.||+|+||.||.++. .+++.+++|++....... ...+++.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            478889999999999999874 468899999986543222 335678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999987543 34589999999999999999999999   99999999999999999999999999998765544


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......+++.|+|||...+..++.++||||+|+++|||++|..||+.....        .....+..+.......   .
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~---~  224 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQGNYTPVVS---V  224 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCCcc---c
Confidence            3444567899999999998888899999999999999999999998643221        1122222222222111   1


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      ....+.+++.+||+.+|++||++.++++..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         225 YSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            233588999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-35  Score=315.28  Aligned_cols=249  Identities=24%  Similarity=0.426  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|++.+.||.|++|.||+|.. .+|+.||+|.+.....   ...+.+.+|+..++.++||||+++++++...+..++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4688899999999999999974 5789999999865322   22467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++..    ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          96 EYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999999998853    2488999999999999999999999   9999999999999999999999999998876554


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........+++.|+|||.+.+..++.++|||||||++|++++|+.||.........     ........+....+.    
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~----  239 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNGTPELQNPE----  239 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcCCcccCCcc----
Confidence            43334456889999999999888999999999999999999999998754322110     001000011111111    


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||..||++||++.++++
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            12234788999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.1e-35  Score=311.55  Aligned_cols=257  Identities=24%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             HHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          598 IRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       598 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      +.+++.+.....||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            345566666789999999999999754 67889999886432   22346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-CCCeEEecccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAK  755 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~  755 (873)
                      ++|+||+++++|.+++.........++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+|||.+.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999999987543221237788899999999999999999   9999999999999987 6799999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .............+++.|+|||++....  ++.++||||+|+++|+|++|+.||.........  ........ ..+.++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~~-~~~~~~  234 (268)
T cd06624         158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFK-IHPEIP  234 (268)
T ss_pred             ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhhc-cCCCCC
Confidence            6654333334456889999999986644  788999999999999999999998643221100  00000000 011111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .      .....+.+++.+||+.+|++||++.|+++
T Consensus       235 ~------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         235 E------SLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             c------ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            1      12234789999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3e-35  Score=312.92  Aligned_cols=256  Identities=24%  Similarity=0.400  Sum_probs=197.7

Q ss_pred             CCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--cee
Q 039344          604 FDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHL  676 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  676 (873)
                      |...+.||+|+||+||++..     .+++.||+|.++....  ....+.+.+|++++++++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            47889999999999988642     3678899999875422  12346788999999999999999999998753  458


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++...    .+++.++..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999998543    489999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccch-----hhh-hhhhhhhhhh
Q 039344          757 LKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-----FSS-LNLNIALDEM  827 (873)
Q Consensus       757 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-----~~~-~~~~~~~~~~  827 (873)
                      ........   ....++..|+|||.+.+..++.++||||||+++|||+||+.||.......     ... ........+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            65432211   12345667999999988889999999999999999999999976432110     000 0000011111


Q ss_pred             cCCCC--CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          828 LDPRL--PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       828 ~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+...  +.+.    .....+.+++.+||+.+|++|||++++++.|+
T Consensus       237 ~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~  279 (283)
T cd05080         237 LERGMRLPCPK----NCPQEVYILMKNCWETEAKFRPTFRSLIPILK  279 (283)
T ss_pred             hhcCCCCCCCC----CCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            11111  1111    12235889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=312.82  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=203.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||.|++|.||+|+.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++.+....++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            35788899999999999999765 68999999987542  2233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++...    .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||+++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999998643    589999999999999999999999   9999999999999999999999999999887654


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........+++.|+|||++.+..++.++||||||+++|+|+||+.||..........     .......+.....     
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~-----  221 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-----LIPKNNPPSLEGN-----  221 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-----HhhhcCCCCCccc-----
Confidence            334445678889999999998889999999999999999999999986433211110     0111111111111     


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||..+|++||+++++++
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            02234789999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3e-35  Score=308.36  Aligned_cols=248  Identities=26%  Similarity=0.443  Sum_probs=198.6

Q ss_pred             ceeeecCCeEEEEEEeCC--C--cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEec
Q 039344          608 HCIGKGGQGSVYMSKLAS--G--EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      +.||+|++|.||+|...+  +  ..||+|.+......  ...+.+.+|+..+++++||||+++++++.+ ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999997643  3  36899998765432  446789999999999999999999999988 8899999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN  763 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  763 (873)
                      ++++|.+++..... ..+++..++.++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||+++........
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999876443 4689999999999999999999999   9999999999999999999999999999877543322


Q ss_pred             c---cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          764 W---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       764 ~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .   ....++..|+|||++.+..++.++||||+||++|||++ |+.||............     .. .......+.   
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~-~~~~~~~~~---  224 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-----DK-EGERLERPE---  224 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----Hh-cCCcCCCCc---
Confidence            1   12346778999999998899999999999999999998 99998643322111110     10 011111111   


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       .....+.+++.+||+.+|++||+++++++.|.
T Consensus       225 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 -ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             12235889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.9e-36  Score=331.73  Aligned_cols=251  Identities=23%  Similarity=0.316  Sum_probs=195.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|+..+.||+|+||+||+++.. +++.||+|+++..........+.+.+|+.++..++||+|+++++++.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999764 68999999987532222333567888999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999998643   3488999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CC-----------------------------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 039344          761 SS-----------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH  805 (873)
Q Consensus       761 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~  805 (873)
                      ..                                   .....+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                   0113468999999999999999999999999999999999999


Q ss_pred             CCcccccchhhhhhhhhhhhhhcC--CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 039344          806 PRDFISSMSFSSLNLNIALDEMLD--PRLPTPSRNVHDKLISIVEVTISCVDENPESRPT---MQKVCQ  869 (873)
Q Consensus       806 P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~  869 (873)
                      ||........        ...+..  .....+...  .....+.+++.+|+ .||++|++   ++|+++
T Consensus       235 Pf~~~~~~~~--------~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQET--------YRKVMNWKETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHHHH--------HHHHHcCCCceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9875432211        111111  111111110  01123667777766 49999985   566653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.6e-35  Score=311.02  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=188.8

Q ss_pred             ceeeecCCeEEEEEEeCC---CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKGGQGSVYMSKLAS---GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      +.||+|+||+||+|...+   ...+|+|.+....  .......+.+|+..++.++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            358999999999996543   3568888776432  22334678899999999999999999999999999999999999


Q ss_pred             CCChhhHhccccc--ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          685 MCSLAVILSNDAA--AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       685 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +|+|.+++.....  ....++.....++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            9999999876442  23356778899999999999999999   999999999999999999999999999875433221


Q ss_pred             C--cccccccccccccccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          763 N--WTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       763 ~--~~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .  .....+++.|+|||+...       ..++.++||||+||++|||++ |..||....+.........     ..+.++
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-----~~~~~~  230 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR-----EQDIKL  230 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh-----ccCccC
Confidence            1  123345678999998643       356789999999999999999 7888764332211000000     011111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+. ........+.+++..|| .||++||++++|++.|.
T Consensus       231 ~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111 01112234677888999 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-35  Score=327.94  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=196.5

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----ee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----HL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  676 (873)
                      +|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            478889999999999999975 4789999999865322 2223467889999999999999999999998766     78


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      |+||||+. +++.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999997 5677766432   3589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh--------------
Q 039344          757 LKPDSS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL--------------  820 (873)
Q Consensus       757 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~--------------  820 (873)
                      ...... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||.............              
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            543322 23345678999999998774 47899999999999999999999997543221110000              


Q ss_pred             -hhhhhhhcCCCCCCCCc-----hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 -NIALDEMLDPRLPTPSR-----NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 -~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ......+.......+..     ...+....+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence             00000010100000000     00111235789999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-35  Score=307.50  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=202.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||.||+|... |+.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            357888999999999999999876 88999999975422    3577999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999865432 3589999999999999999999999   9999999999999999999999999999876322


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCch
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRN  838 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  838 (873)
                      ..   ....+..|+|||++.++.++.++||||+|+++||+++ |..||........        ....... +...+.  
T Consensus       156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~--  222 (256)
T cd05039         156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------VPHVEKGYRMEAPE--  222 (256)
T ss_pred             cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--------HHHHhcCCCCCCcc--
Confidence            21   2344668999999988889999999999999999997 9999864321111        1111111 111111  


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        .....+.+++.+||+.+|++||++.|++++|+
T Consensus       223 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         223 --GCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             --CCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence              11235889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.3e-35  Score=318.46  Aligned_cols=255  Identities=21%  Similarity=0.359  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC--------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      .++|.+.+.||+|+||.||+|+..        .+..||+|+++....  .....++..|+.+++.+ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            367888999999999999999642        245789999875322  22356788999999999 6999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +.+..++||||+++++|.+++....             ....+++.++.+++.|++.|++|||++   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            9999999999999999999986532             123588999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+||+|||.++.........  ....++..|+|||++.+..++.++||||||+++||+++ |+.||........
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998665332211  12234467999999998889999999999999999999 8899764332111


Q ss_pred             hhhhhhhhhhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .        ....... ...+.    .....+.+++.+||+.+|++||++.|+++.|+
T Consensus       246 ~--------~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~  291 (314)
T cd05099         246 F--------KLLREGHRMDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALD  291 (314)
T ss_pred             H--------HHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1        1111111 11111    11224789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.8e-35  Score=311.99  Aligned_cols=249  Identities=22%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |++.+.||+|+||.||+|... ++..+++|.+...   .....+.+.+|+++++.++||||+++++++......++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            567788999999999999765 5778899988543   223356788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++++++..++...  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++........
T Consensus        84 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          84 CAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             cCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            9999998887542  23589999999999999999999999   999999999999999999999999999976544333


Q ss_pred             Cccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          763 NWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ......+++.|+|||++.     +..++.++||||+||++|||++|+.||...........     ......+....+..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~  233 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK-----IAKSEPPTLAQPSR  233 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH-----HhhcCCCCCCCccc
Confidence            334457889999999874     34577899999999999999999999865332111000     00001111111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ....+.+++.+||+.+|++||+++++++
T Consensus       234 ----~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         234 ----WSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1235889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-35  Score=308.67  Aligned_cols=248  Identities=28%  Similarity=0.465  Sum_probs=202.9

Q ss_pred             ceeeecCCeEEEEEEeCC----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEec
Q 039344          608 HCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      +.||+|+||.||+|....    +..||+|.+.......  ..+.+.+|++.++.++|+||+++++++.+....++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            469999999999997653    7889999987653332  3578999999999999999999999999999999999999


Q ss_pred             cCCChhhHhccccc------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          684 KMCSLAVILSNDAA------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       684 ~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      ++++|.+++.....      ...+++..+..++.|++.|++|||++   +++||||+|+||+++.++.++|+|||.++..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999976521      25689999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCC--CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCC
Q 039344          758 KPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLP  833 (873)
Q Consensus       758 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~  833 (873)
                      ....  .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||........        .....++ ...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~  227 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--------LEYLRKGYRLP  227 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCCCC
Confidence            6543  22234457889999999988889999999999999999999 6999875432211        1111111 111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.    .....+.+++.+||+.+|++||++.|+++.|+
T Consensus       228 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 KPE----YCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCc----cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            111    11335889999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-35  Score=308.65  Aligned_cols=240  Identities=20%  Similarity=0.370  Sum_probs=187.7

Q ss_pred             ceeeecCCeEEEEEEeCC-------------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          608 HCIGKGGQGSVYMSKLAS-------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      +.||+|+||.||+|+..+             ...||+|.+....   ....+.+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            368999999999997532             2358888876432   223467889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC-------eE
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE-------AH  747 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-------~k  747 (873)
                      ..++||||++++++..++....  ..+++..+..++.||++|++|||++   +|+||||||+||+++.++.       ++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999998876432  3488999999999999999999999   9999999999999987664       89


Q ss_pred             EeccccccccCCCCCCccccccccccccccccc-cCCCCCcchhHHHHHHHHHHH-hCCCCCcccccchhhhhhhhhhhh
Q 039344          748 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~G~il~el~-tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ++|||.+......    ....++..|+|||.+. +..++.++|||||||++|||+ +|..||........         .
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---------~  219 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---------E  219 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---------H
Confidence            9999998755322    2345788899999886 466889999999999999998 58888754221111         1


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+...........    ...+.+++.+||+.||++||++.++++.|.
T Consensus       220 ~~~~~~~~~~~~~----~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 RFYEGQCMLVTPS----CKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHhcCccCCCCC----hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1111111111111    224789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-35  Score=316.34  Aligned_cols=263  Identities=23%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             CHHHHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEE
Q 039344          593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFC  670 (873)
Q Consensus       593 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  670 (873)
                      .++++..+.++|++.+.||+|+||.||+|... +++.+|+|++....    ....++.+|+.+++++ +||||+++++++
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            34555667899999999999999999999764 68899999875421    1235688899999999 699999999988


Q ss_pred             E-----ecceeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          671 L-----HVRHLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       671 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      .     ..+..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.   +++||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence            4     3456899999999999998875422 234578899999999999999999999   999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCcccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN  819 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~  819 (873)
                      .++++|||+++.............|++.|+|||++..     ..++.++||||+||++|||++|+.||..........  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--  239 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--  239 (286)
T ss_pred             CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--
Confidence            9999999999876544333344578999999998753     447889999999999999999999986433211000  


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                         .......+....+..    ....+.+++.+||+.||++||++.|+++..
T Consensus       240 ---~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 ---KIPRNPPPTLHQPEL----WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ---hccccCCCcccCCCC----cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence               000001111111111    122488999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-35  Score=316.57  Aligned_cols=250  Identities=24%  Similarity=0.420  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            36788999999999999999975 5799999999865322   2246688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||++++++.+++..    ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            999999999998854    2478899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........+++.|+|||.+.+..++.++||||+||++|++++|+.||...........     ......+....+.   
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~---  239 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGTPELQNPE---  239 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCCCCCCCCcc---
Confidence            44333445788999999999988899999999999999999999999864332110000     0000011111111   


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       .....+.+++.+||+.+|++||+++++++
T Consensus       240 -~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         240 -RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             12234788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-35  Score=306.87  Aligned_cols=245  Identities=26%  Similarity=0.405  Sum_probs=194.5

Q ss_pred             ceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEec
Q 039344          608 HCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      ++||+|+||.||+|...    .+..||+|.+......  ...+++.+|+.+++.+.||||+++++++. ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46999999999999643    2368999998755332  34577999999999999999999999876 45679999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN  763 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  763 (873)
                      ++++|.+++....   .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999996543   588999999999999999999999   9999999999999999999999999999876544332


Q ss_pred             cc---ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          764 WT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       764 ~~---~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      ..   ...++..|+|||.+.+..++.++||||||+++||+++ |..||............     ...  ...+.+..  
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-----~~~--~~~~~~~~--  222 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-----ESG--ERLPRPEE--  222 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-----HcC--CcCCCCCC--
Confidence            22   1223467999999998899999999999999999998 99998754332111111     110  11111111  


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        ....+.+++.+||..+|++||++.++.+.|+
T Consensus       223 --~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~  253 (257)
T cd05060         223 --CPQEIYSIMLSCWKYRPEDRPTFSELESTFR  253 (257)
T ss_pred             --CCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence              1235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-35  Score=322.34  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++....  ....+.+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35799999999999999999963      3578899999975422  22246788999999999 789999999988654


Q ss_pred             -ceeEEEEEeccCCChhhHhccccc-------------------------------------------------------
Q 039344          674 -RHLFIVYEYFKMCSLAVILSNDAA-------------------------------------------------------  697 (873)
Q Consensus       674 -~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------  697 (873)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             467999999999999998854210                                                       


Q ss_pred             ---------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC--ccc
Q 039344          698 ---------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTE  766 (873)
Q Consensus       698 ---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~  766 (873)
                               ...+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++........  ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     12367888899999999999999999   9999999999999999999999999999865433221  122


Q ss_pred             cccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       767 ~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||........    ........  .+...+...    ...
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~--~~~~~~~~~----~~~  310 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEG--TRMRAPDYT----TPE  310 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHHHHhcc--CCCCCCCCC----CHH
Confidence            345678999999988889999999999999999997 9999864322110    00011110  111111111    124


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          846 IVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+++.+||+.+|++||++.|+++.|+
T Consensus       311 ~~~~~~~cl~~~p~~Rps~~eil~~l~  337 (343)
T cd05103         311 MYQTMLDCWHGEPSQRPTFSELVEHLG  337 (343)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-35  Score=315.68  Aligned_cols=254  Identities=22%  Similarity=0.267  Sum_probs=200.0

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|+..+.||+|+||+||++... +++.||+|.+...........+.+..|+.+++.++|++|+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677789999999999999754 689999999865433333334557789999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999998885432 23588999999999999999999999   99999999999999999999999999997654322


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                       ......|+..|+|||++.+..++.++||||+||++|+|++|+.||......... .......... ....+  .    .
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~-~~~~~--~----~  227 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEV-QEEYS--E----K  227 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhh-hhhcC--c----c
Confidence             223457899999999999999999999999999999999999998753321100 0011111111 01111  1    1


Q ss_pred             HHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                      ....+.+++.+||+.||++|||     ++|+++
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1224789999999999999999     888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.9e-35  Score=311.58  Aligned_cols=248  Identities=23%  Similarity=0.393  Sum_probs=199.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            56888999999999999999865 5889999998643   2233577889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++..++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+......
T Consensus        89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            9999999988775432  3488999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC---CC
Q 039344          761 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP---RL  832 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~  832 (873)
                      ........+++.|+|||++.     ...++.++|||||||++|||++|+.||.......        ....+...   ..
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  235 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEPPTL  235 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--------HHHHHhcCCCccC
Confidence            33334456888999999885     3446789999999999999999999986432211        11111111   11


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+.    .....+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 SQPS----KWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111    12234789999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=321.62  Aligned_cols=256  Identities=23%  Similarity=0.261  Sum_probs=194.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999864 68999999986422222223466889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...  ...+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998642  23588999999999999999999999   9999999999999999999999999999765443


Q ss_pred             CCC-cccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          761 SSN-WTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       761 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ... .....||+.|+|||++..     ..++.++||||+||++|||++|+.||............    ........++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i----~~~~~~~~~~~  231 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI----MNHKEHFQFPP  231 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCcccCCC
Confidence            322 223468999999999863     45788999999999999999999998643321111100    00000011111


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCC--CCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPE--SRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~ev~~  869 (873)
                      ....   ....+.+++.+|+..+++  .||+++++++
T Consensus       232 ~~~~---~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         232 DVTD---VSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             ccCC---CCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            1111   223467788887754333  3789988875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=332.85  Aligned_cols=257  Identities=22%  Similarity=0.253  Sum_probs=189.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  673 (873)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++....       ....+|+.+++.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            45799999999999999999976 468999999885321       2345799999999999999999987432      


Q ss_pred             --ceeEEEEEeccCCChhhHhccc-ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEe
Q 039344          674 --RHLFIVYEYFKMCSLAVILSND-AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVS  749 (873)
Q Consensus       674 --~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~  749 (873)
                        ...++||||+++ ++.+++... .....+++..+..++.||+.||+|||++   +|+||||||+||+++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence              246799999985 666655432 2345689999999999999999999999   999999999999999765 69999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------
Q 039344          750 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------  821 (873)
Q Consensus       750 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------  821 (873)
                      |||+|+.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|.+||..............       
T Consensus       214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9999987654322 2345789999999988764 689999999999999999999999975432211000000       


Q ss_pred             hhhhh----hcCCCCCCCC-chh-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 IALDE----MLDPRLPTPS-RNV-----HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ~~~~~----~~~~~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....    ..+-.++... ...     ......+.+++.+||+.||.+|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00000    0000011000 000     001235789999999999999999999874

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.8e-35  Score=307.63  Aligned_cols=252  Identities=28%  Similarity=0.416  Sum_probs=200.5

Q ss_pred             CCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCC---cchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG---EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      +|.+.+.||+|+||+||+|...+|+.+|+|.+......   .....+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47888999999999999998888999999988654222   122245688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998643   3478899999999999999999999   999999999999999999999999999876532


Q ss_pred             C------CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          760 D------SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       760 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .      ........++..|+|||++.+..++.++||||+|+++|++++|+.||........  .. .........+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~-~~~~~~~~~~~~~  231 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MF-YIGAHRGLMPRLP  231 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HH-HhhhccCCCCCCC
Confidence            1      1112345688899999999988899999999999999999999999864332110  00 0000000011111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ..    ....+.+++.+||+.+|++||++.++++
T Consensus       232 --~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         232 --DS----FSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --CC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              11    2234789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2e-35  Score=324.73  Aligned_cols=260  Identities=20%  Similarity=0.293  Sum_probs=196.6

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  673 (873)
                      ..++|++.+.||+|+||.||++... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3478999999999999999999754 6889999998754332 22346788999999999999999999998643     


Q ss_pred             -ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          674 -RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       674 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                       ...++||||+++ ++...+.     ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence             347999999985 5555543     2378889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-------------
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-------------  819 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-------------  819 (873)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............             
T Consensus       165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99865432 2233457899999999999989999999999999999999999999753321100000             


Q ss_pred             -hhhhhhhhcCCC----------------CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          820 -LNIALDEMLDPR----------------LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       820 -~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                       .......+.+..                .+............+.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence             000000010000                000000011122357899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-36  Score=326.97  Aligned_cols=243  Identities=23%  Similarity=0.255  Sum_probs=188.3

Q ss_pred             eeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc---cCCceeeEEeEEEecceeEEEEEeccC
Q 039344          610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---WHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       610 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      ||+|+||+||+|+.. +|+.||+|++.............+..|..++...   +||||+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999764 6899999998643222222234455666666655   699999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.++|+|||+++..........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            9999888543   4588999999999999999999999   999999999999999999999999999976544333444


Q ss_pred             ccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHH
Q 039344          766 ELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI  844 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (873)
                      ...||+.|+|||++.+. .++.++||||+||++|||++|+.||.......        ....+.......+...   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~---~~~  223 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVRFPKNV---LSD  223 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHcCCCCCCCcc---CCH
Confidence            56799999999998764 47899999999999999999999986433211        1112222222212111   122


Q ss_pred             HHHHHHhhcccCCCCCCC----CHHHHHH
Q 039344          845 SIVEVTISCVDENPESRP----TMQKVCQ  869 (873)
Q Consensus       845 ~l~~li~~cl~~dP~~RP----s~~ev~~  869 (873)
                      .+.+++.+||+.||++||    ++.++++
T Consensus       224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            477899999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.7e-35  Score=311.55  Aligned_cols=253  Identities=23%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ..+|++.+.||+|+||+||+|+. .+|+    .||+|++....  .....+++.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            36788899999999999999974 3454    48999987542  223356788999999999999999999999754 5


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++++||+++|++.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            679999999999999986532  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          756 FLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       756 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .........  ....+++.|+|||...+..++.++|||||||++||+++ |..||+.........     .....  ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~--~~~  230 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-----LLEKG--ERL  230 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHCC--CcC
Confidence            765433221  12234678999999998889999999999999999998 899986433211111     11111  111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+.    .....+.+++.+||+.||++||++.++++.|+
T Consensus       231 ~~~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         231 PQPP----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             CCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111    12234789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-35  Score=312.50  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=199.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+. .+++.||+|.++....   .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            4677888999999999999975 4688999999865422   22356788999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   +.+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          86 EFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            999999999988543   3588999999999999999999999   9999999999999999999999999999766544


Q ss_pred             CCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ........|+..|+|||++.   ...++.++||||+||++|+|++|+.||...........   ........+...... 
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~-  235 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL---MTKSNFQPPKLKDKM-  235 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh---hhccCCCCCcccccC-
Confidence            33334557899999999874   45578899999999999999999999754322110000   000011111111111 


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         .....+.+++.+||+.+|++||+++++++
T Consensus       236 ---~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         236 ---KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ---CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence               11234789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.1e-35  Score=309.35  Aligned_cols=252  Identities=27%  Similarity=0.477  Sum_probs=200.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CC---cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      .+|+..+.||+|+||.||+|+.+ ++   ..+|+|.......  ....+++..|+++++.++||||+++.+++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            46788899999999999999864 23   3789998865422  223567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++..
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999986432  3589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCCc-c--ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CC
Q 039344          758 KPDSSNW-T--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RL  832 (873)
Q Consensus       758 ~~~~~~~-~--~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~  832 (873)
                      ....... .  ....+..|+|||++.+..++.++|||||||++||+++ |+.||.......+        ...+... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~--------~~~i~~~~~~  229 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--------MKAINDGFRL  229 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--------HHHHhcCCCC
Confidence            4332211 1  1223457999999988889999999999999999998 9999864332111        1111111 11


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +...    +....+.+++.+||+.+|++||++.+|++.|+
T Consensus       230 ~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         230 PAPM----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1111    12345889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.8e-35  Score=306.57  Aligned_cols=250  Identities=25%  Similarity=0.441  Sum_probs=201.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+|++.+.||+|+||.||+|...+++.+|+|++.....    ...++.+|++++++++|||++++++++......++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            46788899999999999999887788999999864322    13578999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++....  ..++++.+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            999999999886432  3478999999999999999999999   99999999999999999999999999997654322


Q ss_pred             CC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCch
Q 039344          762 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRN  838 (873)
Q Consensus       762 ~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  838 (873)
                      .. .....++..|+|||++.++.++.++||||+|+++||+++ |+.||.........        ..+... +...+.. 
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~-  225 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV--------ETINAGFRLYKPRL-  225 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH--------HHHhCCCCCCCCCC-
Confidence            11 112335678999999998889999999999999999998 99998643321111        111111 1111111 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+.+++.+||+.+|++||++.++++.|.
T Consensus       226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence               1235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.1e-35  Score=306.30  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=197.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEE-ecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCL-HVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  680 (873)
                      .+|.+.+.||+|+||.||++... |..||+|.+...     ...+.+.+|+.+++.++|+|++++++++. +....++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            57888999999999999999876 788999998642     12467899999999999999999999865 456789999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++..... ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+|++|||+++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999865432 3478999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .   ....++..|+|||++.+..++.++||||+||++|||++ |+.||...........     ......+..+   .  
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~---~--  222 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAP---D--  222 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhcCCCCCCC---C--
Confidence            2   22345678999999998889999999999999999998 9999764321111100     1110111111   1  


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       .....+.+++.+||+.+|++|||++++++.|+
T Consensus       223 -~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         223 -GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence             12235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-35  Score=323.31  Aligned_cols=258  Identities=21%  Similarity=0.341  Sum_probs=195.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      .++|++.+.||+|+||.||+++. .+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+     
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            47899999999999999999975 46899999998754322 223467889999999999999999999986543     


Q ss_pred             -eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                       ..|+||||+++ ++...+.     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999985 4544442     2378888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccch-hhhhh-------------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-FSSLN-------------  819 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-~~~~~-------------  819 (873)
                      ++..... .......||+.|+|||.+.+..++.++||||+||++|+|++|+.||....... +....             
T Consensus       170 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         170 ARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            9765432 22334578999999999999999999999999999999999999997543211 00000             


Q ss_pred             hhhhhhhhcC--CCCCC------------C--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          820 LNIALDEMLD--PRLPT------------P--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       820 ~~~~~~~~~~--~~~~~------------~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..........  +..+.            +  ..........+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000011111  00000            0  0000011235789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-35  Score=313.55  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=193.0

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc---cCCceeeEEeEEEe-----c
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---WHRNIVKVYGFCLH-----V  673 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~  673 (873)
                      +|++.+.||+|+||+||+|+.. +|+.||+|.++...... .....+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4788899999999999999765 68999999987543222 1124456777777665   69999999999864     3


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...++||||++ +++.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            45799999998 47888776433 23489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hhhh-
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IALD-  825 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~~~-  825 (873)
                      ++...... ......++..|+|||++.+..++.++||||+||++|||++|+.||..............       .... 
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            98764322 22345688999999999988899999999999999999999999864332111000000       0000 


Q ss_pred             ------hhcCCCCCCCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 ------EMLDPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            ....+..+.+. ....+....+.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  00000000000 000122335789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.2e-35  Score=313.55  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=200.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||++... ++..+|+|.+....  ......++.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36889999999999999999754 68889999886432  2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+..  +++||||||+||+++.++.++|+|||++......
T Consensus        79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            999999999998654   45889999999999999999999732  8999999999999999999999999998765332


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh--------------------
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL--------------------  820 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~--------------------  820 (873)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.............                    
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              2234578899999999988889999999999999999999999986432111100000                    


Q ss_pred             --------hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          821 --------NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       821 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                              ....+.......+...  .......+.+++.+||+.+|++||+++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0000000000000000  00123358899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.3e-35  Score=310.21  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=198.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cc
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VR  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  674 (873)
                      .+|++.+.||+|+||+||++..     .+++.||+|++...   .....+.+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            5688889999999999999974     35889999998653   22335678999999999999999999998754  34


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.++|+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            6899999999999999986432  3488999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh--------hhhh
Q 039344          755 KFLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN--------LNIA  823 (873)
Q Consensus       755 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~--------~~~~  823 (873)
                      +.........   ....++..|+|||++.+..++.++||||+||++|||++|..|+...... +....        ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHH
Confidence            8765433221   1122345699999999888999999999999999999988775432211 10000        0000


Q ss_pred             hhhhcCC--CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+....  ..+.+..    ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         235 LIELLKNNGRLPAPPG----CPAEIYAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             HHHHHhcCCcCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            1111111  1111111    1234889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.3e-35  Score=305.89  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=201.5

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cceeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VRHLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  680 (873)
                      +|++.+.||+|++|.||++... +++.||+|++...... ....+.+.+|++++++++|+|++++++.+.. ....++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4788899999999999999754 5788999998653222 2234668899999999999999999998764 44679999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999986532 34589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........+++.|+|||++.+..++.++||||+|+++|++++|+.||+.......        .........+....   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~~~~---  224 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--------VYRIIEGKLPPMPK---  224 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--------HHHHHhcCCCCCcc---
Confidence            4444456788999999999999999999999999999999999999874322111        11111222211111   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         225 DYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            12235889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.9e-35  Score=308.05  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=205.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.......  ..+.+.+|++.++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            46889999999999999999754 68899999986543222  3578999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |+++++++.+++........+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999997644435689999999999999999999999   9999999999999999999999999999776544


Q ss_pred             CCCc----cccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          761 SSNW----TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       761 ~~~~----~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ....    ....|+..|+|||++... .++.++|||||||++|||++|+.||............    ... ..+.....
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~  230 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT----LQN-DPPSLETG  230 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH----hcC-CCCCcCCc
Confidence            3321    234688899999998877 7889999999999999999999998754332110000    000 01111111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      . ........+.+++.+||+.||++||+++++++
T Consensus       231 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         231 A-DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             c-ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0 00122345889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5e-35  Score=311.30  Aligned_cols=260  Identities=22%  Similarity=0.390  Sum_probs=200.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--c
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--R  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  674 (873)
                      ..|++.+.||+|+||.||.++.     .+++.||+|.++....  ....+.+.+|+.+++.++||||+++++++.+.  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            4578889999999999999973     3578899999875422  23356799999999999999999999999875  5


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            6899999999999999986432  3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchh-------hhhhhhhhh
Q 039344          755 KFLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSF-------SSLNLNIAL  824 (873)
Q Consensus       755 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~-------~~~~~~~~~  824 (873)
                      +........   .....++..|+|||++.+..++.++||||||+++||++|++.|+........       .........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            876543321   1234567789999999888899999999999999999998876432111000       000000011


Q ss_pred             hhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          825 DEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       825 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....++. .+.+.    .....+.+++.+||+.+|++||++.++++.++
T Consensus       237 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  281 (284)
T cd05079         237 RVLEEGKRLPRPP----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE  281 (284)
T ss_pred             HHHHcCccCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            1111111 11111    12345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.6e-35  Score=318.81  Aligned_cols=259  Identities=18%  Similarity=0.275  Sum_probs=192.9

Q ss_pred             CCceeeec--CCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          606 DEHCIGKG--GQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       606 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      +.++||+|  +|++||+++. .+|+.||+|++....... ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45789999  6889999965 578999999987543322 2345678899999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++++++.+++..... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++++|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999999865332 3488999999999999999999999   999999999999999999999999987544322111


Q ss_pred             C-------cccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC----
Q 039344          763 N-------WTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD----  829 (873)
Q Consensus       763 ~-------~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----  829 (873)
                      .       .....++..|+|||++.+  ..++.++||||+||++|||++|+.||.....................+    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            1       112346778999999876  458899999999999999999999997533211100000000000000    


Q ss_pred             ---------------C-----------CCCC----CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 ---------------P-----------RLPT----PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ---------------~-----------~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                     .           ....    ...........+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                           0           0000    00001112335889999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-35  Score=307.61  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=191.8

Q ss_pred             ceeeecCCeEEEEEEeC-CCc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEEec
Q 039344          608 HCIGKGGQGSVYMSKLA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      +.||+|+||.||+|+.+ ++.  .+|+|.++...  .....+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            36899999999999875 343  46888876432  223346788999999999 8999999999999999999999999


Q ss_pred             cCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 039344          684 KMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD  750 (873)
Q Consensus       684 ~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D  750 (873)
                      ++++|.+++....             ....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence            9999999986532             122478999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcC
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      ||+++...... .......+..|+|||++.+..++.++|||||||++|||++ |..||.......        ....+..
T Consensus       156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~  226 (270)
T cd05047         156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQ  226 (270)
T ss_pred             CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHhC
Confidence            99986332111 1111233567999999988889999999999999999997 999986432211        1111111


Q ss_pred             C-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          830 P-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       830 ~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      . ....+..    ....+.+++.+||+.+|.+||+++++++.|+
T Consensus       227 ~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         227 GYRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             CCCCCCCCc----CCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            1 1111111    1234789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-35  Score=309.69  Aligned_cols=239  Identities=19%  Similarity=0.349  Sum_probs=186.2

Q ss_pred             eeeecCCeEEEEEEeCC-------------------------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce
Q 039344          609 CIGKGGQGSVYMSKLAS-------------------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI  663 (873)
Q Consensus       609 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  663 (873)
                      .||+|+||.||+|....                         ...||+|++...   ......+|.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            59999999999996421                         134888887642   22234678899999999999999


Q ss_pred             eeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC
Q 039344          664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE  743 (873)
Q Consensus       664 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~  743 (873)
                      ++++++|.+....++||||+++++|..++....  ..+++..+..++.|+++|++|||++   +|+||||||+||+++.+
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999999999999999999999999999886432  3588999999999999999999999   99999999999999865


Q ss_pred             C-------CeEEeccccccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHH-hCCCCCcccccch
Q 039344          744 N-------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMS  814 (873)
Q Consensus       744 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~-tg~~P~~~~~~~~  814 (873)
                      +       .++++|||.+......    ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.......
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            4       3899999998654322    22357788999998865 56789999999999999995 6999986433211


Q ss_pred             hhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..         .........+....    ..+.+++.+||+.+|++||++.++++.|+
T Consensus       230 ~~---------~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KE---------RFYEKKHRLPEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH---------HHHHhccCCCCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            10         11111111111111    24789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=306.30  Aligned_cols=253  Identities=26%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+......   ..+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            57888999999999999999764 6788999998754322   3578899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++....  ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+......
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999999886542  3588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccC---CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ........++..|+|||.+.+.   .++.++||||+|+++|||+||+.||.........   ..............    
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~----  227 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL---FLISKSNFPPPKLK----  227 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhccCCCcccc----
Confidence            3333445688899999998776   7889999999999999999999998643321100   00000100111111    


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........+.+++.+||..+|++||++.+++.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11223446889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=318.76  Aligned_cols=246  Identities=26%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             eeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCC
Q 039344          609 CIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS  687 (873)
Q Consensus       609 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~  687 (873)
                      ++|+|.||+||-|+.. +...+|||.+.....   ...+-+.+|+..-+.++|+|||+++|.|.+.+.+-+.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            7999999999999865 456789999865322   235778999999999999999999999999999999999999999


Q ss_pred             hhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-CCCCeEEeccccccccCCCCCCccc
Q 039344          688 LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-FENEAHVSDFGIAKFLKPDSSNWTE  766 (873)
Q Consensus       688 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~  766 (873)
                      |.+.+...-..-.-.+...-.+.+||++|+.|||.+   .|||||||-+|||++ -.|.+||+|||-++++..-.....+
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            999997654322236677788999999999999999   999999999999997 4689999999999998877666778


Q ss_pred             cccccccccccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHH
Q 039344          767 LAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI  844 (873)
Q Consensus       767 ~~g~~~y~aPE~~~~~~--~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (873)
                      +.||..|||||++..++  |+.++|||||||.+.||.||++||...+...-+-  .   ...+..-..+.|.    +...
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--F---kVGmyKvHP~iPe----elsa  806 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--F---KVGMYKVHPPIPE----ELSA  806 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--h---hhcceecCCCCcH----HHHH
Confidence            89999999999998765  7889999999999999999999987655331100  0   0111122222222    2334


Q ss_pred             HHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          845 SIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       845 ~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+|.+|+.+||.+||++.++++
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhcc
Confidence            5789999999999999999999875

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.6e-35  Score=306.70  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=203.8

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|+||.||+++. .+|+.||+|++....... ...+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            478889999999999999975 468899999986532222 234678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++++++.+++.... ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999999886533 23478899999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......|++.|+|||+..+..++.++|||||||++|++++|+.||......        .....+..+..+....   .
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~---~  224 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRGSYPPVSS---H  224 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcCCCCCCcc---c
Confidence            3333456888999999999888999999999999999999999998643221        1122222222221111   1


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.+++.+||+.+|.+||++.+|++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         225 YSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2234889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-36  Score=310.29  Aligned_cols=253  Identities=25%  Similarity=0.421  Sum_probs=204.3

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      .....|++.++||+||.+.||++...+.+.+|+|++.... .+......|..|+..+.++ .|.+||++++|-..++..|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            3456799999999999999999999988999999876543 3444578899999999999 5999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      |||||-+ .+|..++...... ..+| .++.+.+|++.|+.+.|.+   ||||.||||.|+|+- .|.+||+|||.|..+
T Consensus       437 mvmE~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             EEeeccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            9999754 7899998765432 2334 7788899999999999999   999999999999987 599999999999988


Q ss_pred             CCCCCCc--cccccccccccccccccCC-----------CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhh
Q 039344          758 KPDSSNW--TELAGTYGYVAPELAYTMK-----------VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL  824 (873)
Q Consensus       758 ~~~~~~~--~~~~g~~~y~aPE~~~~~~-----------~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~  824 (873)
                      ..+....  ...+||+.|||||.+....           .+.+|||||+|||+|+|+.|+.||.....       ....+
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl  582 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKL  582 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHH
Confidence            7665532  4678999999999986543           45789999999999999999999763221       23345


Q ss_pred             hhhcCCCC--CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 DEMLDPRL--PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+.+|..  ..+.-....   ++.++++.|+++||.+||+..|+++
T Consensus       583 ~aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhc
Confidence            56666643  222111111   2789999999999999999999986

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.9e-35  Score=305.56  Aligned_cols=252  Identities=23%  Similarity=0.422  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||.||+|...++..+|+|.+...    ....+.+.+|+.+++.++|+||+++++++.+ ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            4678899999999999999999877888999988643    1224678999999999999999999999887 7789999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++.... ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999986543 34578899999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 SSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ... .....++..|+|||++....++.++|+|||||++|+++| |+.||..........     ....  +...+...  
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-----~~~~--~~~~~~~~--  226 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-----ALER--GYRMPRPE--  226 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHhC--CCCCCCcc--
Confidence            221 122345677999999998889999999999999999999 999986433211111     0010  01111111  


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        .....+.+++.+||+.+|++||++.++.+.|+
T Consensus       227 --~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         227 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             --cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence              12235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=288.84  Aligned_cols=262  Identities=19%  Similarity=0.340  Sum_probs=218.3

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      ++|..+.+.     +.||+|+|+.|--+. ..+|..+|||++.+.   .......+.+|++++... .|+||+++++||+
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            455544443     679999999999874 678999999999764   334467899999999998 5999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---CeEE
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHV  748 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl  748 (873)
                      ++..+|+|||.|.||++..++++..   .+++.++.++.++|+.||+|||.+   ||.|||+||+|||.....   -+||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence            9999999999999999999987654   489999999999999999999999   999999999999997665   4899


Q ss_pred             eccccccccCCCC-------CCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccc--cch
Q 039344          749 SDFGIAKFLKPDS-------SNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFIS--SMS  814 (873)
Q Consensus       749 ~Dfg~a~~~~~~~-------~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~--~~~  814 (873)
                      |||.++.-+....       ....+.+|+..|||||+..     ...|+.++|.||+|||+|-|+.|.+||.+.=  +..
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            9999886443211       1234678999999999753     3358899999999999999999999997432  222


Q ss_pred             h-----hhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          815 F-----SSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       815 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      |     .....+..++.+.++++.+|...+.+.+....+++...+..|+.+|.++..+++
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            3     344556678899999999998888888888999999999999999999988865

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=295.73  Aligned_cols=263  Identities=20%  Similarity=0.283  Sum_probs=215.9

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEE
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY  667 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~  667 (873)
                      .+++.....+++....+.+|.||.||.|.+.      +.+.|.||.++.....  -....+..|...+....|||+..+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHHHHHHhcCcCCCcccee
Confidence            3555566677888889999999999999543      3456778888754332  2356788999999999999999999


Q ss_pred             eEEEec-ceeEEEEEeccCCChhhHhc-----ccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC
Q 039344          668 GFCLHV-RHLFIVYEYFKMCSLAVILS-----NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD  741 (873)
Q Consensus       668 ~~~~~~-~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~  741 (873)
                      +++.++ ...+.+|.++.-|+|..|+.     +....+.++..+...++.|++.|++|||++   +|+|.||.++|+++|
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            998764 56788999999999999997     444555677888999999999999999999   999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhh
Q 039344          742 FENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSL  818 (873)
Q Consensus       742 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~  818 (873)
                      +.-++||+|-.++|.+.+.+++.  .....+..||+||.+....|+.++|||||||++|||+| |+.||..++++++..+
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            99999999999999998876653  33456789999999999999999999999999999999 9999987777655444


Q ss_pred             hhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          819 NLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..        |+..-..+..+++   +++.++.-||+.+|++||++++++..|.
T Consensus       511 lk--------dGyRlaQP~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  511 LK--------DGYRLAQPFNCPD---ELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             Hh--------ccceecCCCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            33        3333333344555   3888999999999999999999998763

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.1e-35  Score=316.00  Aligned_cols=194  Identities=21%  Similarity=0.368  Sum_probs=159.7

Q ss_pred             CceeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cceeEEEEE
Q 039344          607 EHCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHLFIVYE  681 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  681 (873)
                      .++||+|+||+||+|+..   +++.||+|.+.....     ...+.+|+.++++++||||+++++++..  ....++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999854   567899999864321     2457899999999999999999999864  456899999


Q ss_pred             eccCCChhhHhcccc------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee----CCCCCeEEecc
Q 039344          682 YFKMCSLAVILSNDA------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL----DFENEAHVSDF  751 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Df  751 (873)
                      |+. +++.+++....      ....+++..+..++.|++.|++|||++   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            987 47777764322      123478899999999999999999999   99999999999999    45678999999


Q ss_pred             ccccccCCCCC---CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          752 GIAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       752 g~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      |+++.......   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            99987654322   23346789999999998764 588999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=310.45  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            56888899999999999999764 6889999998643   2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++....  ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          82 EFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            9999999999986432  3589999999999999999999999   9999999999999999999999999998765544


Q ss_pred             CCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          761 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ........+++.|+|||.+.     +..++.++||||+|+++|||++|+.||.........     ........+.+..+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~  231 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-----LKILKSEPPTLDQP  231 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-----HHHhcCCCCCcCCc
Confidence            43444557899999999875     345678999999999999999999998753322111     00111111111111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..    ....+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~----~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         232 SK----WSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             cc----CCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            11    1234789999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-34  Score=305.83  Aligned_cols=250  Identities=31%  Similarity=0.489  Sum_probs=200.2

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcc------hhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEM------TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      +|.+...||+|++|.||+|.. .+++.||+|.+........      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367789999999999999975 4688999998875533321      123568899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999998653   3478899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC
Q 039344          756 FLKPDSS------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       756 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      .......      ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||.........     ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~  229 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-----FKIGENAS  229 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-----HHHhccCC
Confidence            7653211      112345788999999999888999999999999999999999998753321100     00111111


Q ss_pred             CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +..+.      .....+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         230 PEIPS------NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CcCCc------ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            12211      12235789999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.3e-35  Score=308.08  Aligned_cols=257  Identities=25%  Similarity=0.424  Sum_probs=202.2

Q ss_pred             CCCCCceeeecCCeEEEEEEeCC--CcEEEEEEccCCCC-------CcchhHHHHHHHHHHHHh-ccCCceeeEEeEEEe
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLAS--GEIIAVKKFHSPLP-------GEMTFQQEFLNEVKALTE-IWHRNIVKVYGFCLH  672 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  672 (873)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+.....       .......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999998764  78899998754321       122234567788888765 699999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhccc-ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          673 VRHLFIVYEYFKMCSLAVILSND-AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      .+..++||||++++++.+++... .....+++..++.++.|++.|+.|||+..  +++||||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887542 23345889999999999999999999631  8999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      |.+....... ......++..|+|||.+.+..++.++||||||+++||+++|+.||........        .....++.
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--------~~~~~~~~  229 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--------ATKIVEAV  229 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--------HHHHhhcc
Confidence            9998765443 33456788999999999988899999999999999999999999864322111        11111121


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......  ......+.+++.+||+.||++||++.|+.++++
T Consensus       230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111111  011234889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=319.17  Aligned_cols=250  Identities=23%  Similarity=0.377  Sum_probs=202.5

Q ss_pred             CCCCCceeeecCCeEEEEEEeCCC-cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLASG-EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|.+...||.|+||.||+|..++. -..|.|++...   ..+..++|.-|++++....||+||++++.|..++..|++.|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            355667799999999999976643 34455665432   23346889999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      ||.||-.+.++-.-  +..+++.++.-+++|+++||.|||++   .|+|||||+.|||++-+|.++|+|||.+.......
T Consensus       110 FC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             ecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            99999999887644  35699999999999999999999999   99999999999999999999999999986554444


Q ss_pred             CCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          762 SNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .....+.|||+|||||+..     +.+|+.++||||||+.+.||..+.+|.....++...     ..+..--.|.+..+.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl-----lKiaKSePPTLlqPS  259 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-----LKIAKSEPPTLLQPS  259 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH-----HHHhhcCCCcccCcc
Confidence            4456789999999999754     578999999999999999999999997654443211     111222233444444


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .|..    .+.+++.+|+..||+.||+++++++
T Consensus       260 ~Ws~----~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  260 HWSR----SFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hhhh----HHHHHHHHHHhcCCccCCCHHHHhh
Confidence            4433    4889999999999999999999876

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7e-35  Score=307.26  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=187.9

Q ss_pred             ceeeecCCeEEEEEEeCCC---cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKGGQGSVYMSKLASG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      +.||+|+||+||+|+..++   ..+++|.+.....  ....+.+.+|+..++.++||||++++++|.+....++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3599999999999975433   3456666654322  2235789999999999999999999999999999999999999


Q ss_pred             CCChhhHhccccc-ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC--
Q 039344          685 MCSLAVILSNDAA-AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--  761 (873)
Q Consensus       685 ~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  761 (873)
                      +|+|.+++..... ....++..+..++.||+.|++|||+.   +++||||||+||+++.++.++|+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999875432 23456777889999999999999999   99999999999999999999999999986432211  


Q ss_pred             CCcccccccccccccccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          762 SNWTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .......++..|+|||++..       ..++.++|||||||++|||++ |..||.....................++...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence            11234567889999998753       235779999999999999997 5678764332211111111111112222222


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..      ....+.+++..|| .+|++||++++|++.|.
T Consensus       236 ~~------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 LP------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11      1234778899999 67999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.5e-35  Score=307.95  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=202.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..|+..+.||.|+||.||+|... +++.||+|.+.....  ....+.+.+|+.+++.+.||||+++++++.+....++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45777889999999999999764 688999999864322  223577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++..    ..+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999999998854    3478899999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........++..|+|||++.+..++.++|||||||++|||+||+.||.........        ........+   ....
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------~~~~~~~~~---~~~~  223 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--------FLIPKNNPP---TLTG  223 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--------hhhhcCCCC---CCch
Confidence            33333456788999999999888999999999999999999999998643322111        111111111   1112


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            234568899999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.1e-35  Score=318.63  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC--------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH  672 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  672 (873)
                      .+|++.+.||+|+||.||+|+..        .+..||+|.+....  .....+++.+|+.+++++ +||||++++++|.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            56889999999999999999642        12368999887432  222357889999999999 79999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCee
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVL  739 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nil  739 (873)
                      .+..+++|||+++|+|.+++....             ....+++.++..++.|++.|++|||++   +++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence            999999999999999999986532             223578899999999999999999999   9999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhh
Q 039344          740 LDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFS  816 (873)
Q Consensus       740 l~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~  816 (873)
                      ++.++.+||+|||+++.........  ....++..|+|||++.+..++.++||||||+++|||++ |..||.......+ 
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-  245 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-  245 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-
Confidence            9999999999999998665432221  12234567999999999999999999999999999998 8888764332211 


Q ss_pred             hhhhhhhhhhhcCCCC-CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          817 SLNLNIALDEMLDPRL-PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       817 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                             ...+..+.. ..+.    .....+.+++.+||+.+|++||++.|+++.|+
T Consensus       246 -------~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         246 -------FKLLKEGHRMDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             -------HHHHHcCCCCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                   111111111 1111    11234889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.1e-35  Score=308.80  Aligned_cols=256  Identities=23%  Similarity=0.411  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ++|++.+.||+|+||.||+|+.+      +.+.|++|.+....  .....+++.+|++++++++||||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            56888999999999999999854      34679999876432  22235779999999999999999999999999899


Q ss_pred             eEEEEEeccCCChhhHhcccccc------cCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAA------KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVS  749 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~  749 (873)
                      .++||||+++++|.+++......      ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999998754422      1589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCC-CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhh
Q 039344          750 DFGIAKFLKPDS-SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       750 Dfg~a~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      |||+++...... .......++..|+|||.+.+..++.++||||+|+++|++++ |..||........        ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~--------~~~~  231 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--------LNRL  231 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH--------HHHH
Confidence            999987543221 22334456788999999988888999999999999999998 8888754322111        1111


Q ss_pred             cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          828 LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..........  ......+.+++.+||+.+|++||++.++++.|+
T Consensus       232 ~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKLELPVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCcCCCCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111111000  011235889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.3e-35  Score=310.70  Aligned_cols=261  Identities=21%  Similarity=0.353  Sum_probs=200.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|+..+.||+|++|.||+|+.+ +|+.||+|++...... ....+.+.+|+.+++.++|||++++++++......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            36888899999999999999875 6899999998654222 122456889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++.+..+....   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999999888776432   3489999999999999999999999   9999999999999999999999999999877654


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh---h---hhhh-------
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN---I---ALDE-------  826 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~---~---~~~~-------  826 (873)
                      ........++..|+|||++.+ ..++.++||||+|+++|||++|+.||..............   .   ...+       
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            433444567889999999876 4578899999999999999999999875432210000000   0   0000       


Q ss_pred             ---hcCCCCCCCC---chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 ---MLDPRLPTPS---RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+......   .........+.+++.+||+.+|++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               0000000000   000112345889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-35  Score=311.81  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=200.1

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|+..+.||+|+||.||+|... +++.||+|.+.....  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4566688999999999999754 578899999864422  2235678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++++++.+++..    ..+++..+..++.|+++|+.|||++   +++|+||+|+||++++++.++++|||++.......
T Consensus        83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999998853    3478999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......++..|+|||++.+..++.++|||||||++|||++|+.||..........        .......+...   ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~~~---~~  224 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------LIPKNSPPTLE---GQ  224 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--------hhhcCCCCCCC---cc
Confidence            33334567889999999999889999999999999999999999976432221111        11111111111   11


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            2335889999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-35  Score=327.12  Aligned_cols=192  Identities=22%  Similarity=0.325  Sum_probs=165.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ...|.+.+.||+|+||.||+|... +++.||||...         ...+.+|++++++++|+|||++++++...+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            346889999999999999999765 57889999642         13456899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||++. +++..++....  ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99996 67877775432  3589999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 039344          760 DSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR  807 (873)
Q Consensus       760 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~  807 (873)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            322  122456899999999999999999999999999999999988764

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.2e-35  Score=314.62  Aligned_cols=260  Identities=17%  Similarity=0.251  Sum_probs=198.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+.......  ....+.+|+..++.++||||+++++++...+..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            57889999999999999999764 68899999986543222  2356778999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++ +++.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            9998 58888775432  3578899999999999999999999   9999999999999999999999999999765444


Q ss_pred             CCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-------hhhhhhhhcC---
Q 039344          761 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-------LNIALDEMLD---  829 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-------~~~~~~~~~~---  829 (873)
                      ........+++.|+|||.+.+. .++.++||||+||++|||+||+.||............       .......+..   
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            3334445678999999987654 4788999999999999999999998753321110000       0000000000   


Q ss_pred             ---CCCCCCCc-----hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 ---PRLPTPSR-----NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ---~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+....     ........+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               00000000     00112235789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.7e-35  Score=307.86  Aligned_cols=253  Identities=27%  Similarity=0.491  Sum_probs=200.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CC---cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      .+|++.+.||+|+||.||+|... ++   ..||+|.+....  .....++|..|+.+++.++||||+++++++.++...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            45788899999999999999764 23   369999987542  2333578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++++|.+++....  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999999986532  3589999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCC--cc-ccc--cccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          758 KPDSSN--WT-ELA--GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       758 ~~~~~~--~~-~~~--g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      ......  .. ...  .+..|+|||++.+..++.++||||+||++||+++ |..||.........     .....  +.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-----~~i~~--~~~  229 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-----NAIEQ--DYR  229 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-----HHHHc--CCc
Confidence            433221  11 111  2457999999998899999999999999999886 99998643321111     11111  111


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.+.    +....+.+++.+||+.+|.+||+++++++.|+
T Consensus       230 ~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         230 LPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             CCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            12111    12234789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.1e-35  Score=322.47  Aligned_cols=258  Identities=21%  Similarity=0.284  Sum_probs=195.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  673 (873)
                      .++|.+.+.||+|+||.||+|... .++.||||++...... ....+.+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            468999999999999999999754 6889999998754322 22346788999999999999999999987543      


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...|+||||+++ ++...+.     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 5665553     2378889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-------------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-------------  820 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-------------  820 (873)
                      ++..... .......+++.|+|||++.+..++.++||||+||++|||++|+.||.............             
T Consensus       173 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         173 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9865432 22334578999999999999999999999999999999999999997543221100000             


Q ss_pred             -hhhhhhhcCCCC--------------CCC--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 -NIALDEMLDPRL--------------PTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 -~~~~~~~~~~~~--------------~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ..........+.              ..+  ..........+.+++.+|++.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             000000000000              000  0000111235789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-35  Score=313.02  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|.++...  .....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36888899999999999999865 78999999886532  2223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++..++........+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.++|+|||.+......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999998876433446899999999999999999999632  8999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccccCC------CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          761 SSNWTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                        ......+++.|+|||.+.+..      ++.++||||+||++|+|++|+.||.......     .......+.+...+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~  229 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQLSAIVDGDPPT  229 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHHHHHHhhcCCCC
Confidence              223346788999999986543      4789999999999999999999986432211     111122222222211


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..   ......+.+++.+||+.+|++||+++++++
T Consensus       230 ~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         230 LP---SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CC---cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11   113345789999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-35  Score=324.15  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=195.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ..+|.+.+.||+|+||.||++...   .++.||+|.+...        ....+|+++++.++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999643   4678999987532        23458999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +|||++. +++.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999986 677777732   34589999999999999999999999   9999999999999999999999999999766


Q ss_pred             CCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh---------------
Q 039344          758 KPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL---------------  820 (873)
Q Consensus       758 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~---------------  820 (873)
                      ......  .....||+.|+|||++.+..++.++||||+||++|||++|+.||.............               
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            543222  234578999999999999999999999999999999999999986433210000000               


Q ss_pred             ------hhhhhhh---cCCCCCCCCch-hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 ------NIALDEM---LDPRLPTPSRN-VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ------~~~~~~~---~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            .......   ..+....+... .......+.+++.+|++.||++||++.|++.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                  0000000   00111100000 0011235778999999999999999999975

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-34  Score=310.19  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH  672 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  672 (873)
                      .++..+.++|.+.+.||+|+||.||+|.. .+++.+|+|++....    .....+.+|+.+++++ +|||++++++++..
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            44455678899999999999999999976 468899999986421    2246678899999999 89999999999875


Q ss_pred             c-----ceeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          673 V-----RHLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       673 ~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      .     +..++||||+++++|.+++.... ....+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     35899999999999999886432 334689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccccccccccCC-----CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK-----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN  821 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~  821 (873)
                      ||+|||+++.............|+..|+|||.+....     ++.++||||+||++|||++|+.||..........    
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~----  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF----  243 (291)
T ss_pred             EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH----
Confidence            9999999987654333333456888999999876432     6789999999999999999999986433211000    


Q ss_pred             hhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       .......+....+.    .....+.+++.+||+.+|++||++.|+++
T Consensus       244 -~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 -KIPRNPPPTLLHPE----KWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHhcCCCCCCCccc----ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             00000111111111    12235889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-34  Score=308.32  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  678 (873)
                      ++|+..+.||.|++|.||++... +++.+|+|.+.....  ......+.+|+++++.++||||++++++|.+.  +..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            35778899999999999999874 688999999875422  23357799999999999999999999998653  46899


Q ss_pred             EEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          679 VYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      ||||+++++|.+++.... ....++...+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999998875422 234578899999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      .....  ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+.....................+.++....
T Consensus       156 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         156 VNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            43221  2345788899999999999999999999999999999999998754321000001111111111111111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........+.+++.+||+.+|.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00112345889999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.9e-35  Score=305.32  Aligned_cols=247  Identities=27%  Similarity=0.389  Sum_probs=189.8

Q ss_pred             ceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cceeEEEEEe
Q 039344          608 HCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VRHLFIVYEY  682 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  682 (873)
                      +.||+|+||.||+|...    ++..||+|++...  ......+.+.+|+.+++.++||||+++++++.. ++..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            46899999999999753    2457999987542  222335678899999999999999999998764 5568999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +.+++|.+++....  ...++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        79 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          79 MKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999999986532  3367788899999999999999999   999999999999999999999999999976543211


Q ss_pred             ----CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          763 ----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       763 ----~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                          ......++..|+|||+..+..++.++|||||||++|||++| ..||.......        .......+.......
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~  225 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--------ITVYLLQGRRLLQPE  225 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcCCCCCCCC
Confidence                11223456789999999888899999999999999999995 55554322211        111111221111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .   .+..+.+++.+||+.+|++||++.++++.|+
T Consensus       226 ~---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         226 Y---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             c---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            1   1234889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.5e-35  Score=312.04  Aligned_cols=262  Identities=21%  Similarity=0.292  Sum_probs=201.0

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCC--cchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      +|++.+.||+|++|.||+|... +|+.||+|++......  .....+.+..|+++++.++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999764 6899999999765332  122345677899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+ +++|.+++....  ..+++..+..++.|+++||+|||++   +++||||+|+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999986543  3589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------hhh------
Q 039344          760 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------ALD------  825 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~~~------  825 (873)
                      .........+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+..........       ...      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            4444444567888999998865 45788999999999999999998887654432111000000       000      


Q ss_pred             hhcCCC--CCCC-CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          826 EMLDPR--LPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       826 ~~~~~~--~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ......  .+.+ ..........+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000  0000 00001123458899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.8e-35  Score=312.07  Aligned_cols=261  Identities=21%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....... ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46888899999999999999875 58999999987543322 33567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.++....   ..+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999999988876432   3489999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh----------hh------h
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL----------NI------A  823 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~----------~~------~  823 (873)
                      ........++..|+|||++.+ ..++.++||||||+++|||++|+.||.............          ..      .
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence            444445568899999998875 346789999999999999999999986433211000000          00      0


Q ss_pred             hhhhcCCCCCCCCc---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 LDEMLDPRLPTPSR---NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+..+.......   ........+.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000111100000   00112345889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=345.52  Aligned_cols=443  Identities=30%  Similarity=0.356  Sum_probs=267.8

Q ss_pred             CCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc
Q 039344           23 LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        23 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  102 (873)
                      |++||+++|.+. ..|..+..+.+|+.|.++.|-|. ..|.+..++++|++|.|.+|.+. ..|..+..+.+|+.|+++.
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~  123 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF  123 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence            777777777776 67777777777777777777777 66677777777777777777777 6777777777777777777


Q ss_pred             cccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCC
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP  182 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~  182 (873)
                      |++. .+|..+..+..++.+..++|......+..    . ++.+++..|.+.+.....+..++.  .|+|++|.+...  
T Consensus       124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~----~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~--  193 (1081)
T KOG0618|consen  124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQT----S-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL--  193 (1081)
T ss_pred             hccC-CCchhHHhhhHHHHHhhhcchhhhhhccc----c-chhhhhhhhhcccchhcchhhhhe--eeecccchhhhh--
Confidence            7776 56666766677777777666211112211    1 455555555555444444444444  567777766521  


Q ss_pred             ccccCCC--------------------CCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEE
Q 039344          183 PSLGNLS--------------------NLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL  242 (873)
Q Consensus       183 ~~~~~l~--------------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  242 (873)
                       .+..++                    +|+.|+.++|.++...+..  .-.+|+++++++|+++ ..|.++..+.+|+.+
T Consensus       194 -dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l  269 (1081)
T KOG0618|consen  194 -DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEAL  269 (1081)
T ss_pred             -hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEe
Confidence             233333                    4444555555544222111  1245666666666666 344666666666666


Q ss_pred             ecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCC-ccEEeccCcccc
Q 039344          243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPN-LTYIDLSQNNFY  321 (873)
Q Consensus       243 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~-L~~L~Ls~N~l~  321 (873)
                      +..+|.++ ..|..+..+.+|+.|.+.+|.+...++...+++.|++|+|..|.|...+...|..... |..|+.+.|.+.
T Consensus       270 ~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~  348 (1081)
T KOG0618|consen  270 NANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS  348 (1081)
T ss_pred             cccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc
Confidence            66666664 4556666666666666666666666666666666666666666666655555544443 666666666665


Q ss_pred             ccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccc
Q 039344          322 GEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG  401 (873)
Q Consensus       322 ~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  401 (873)
                      ......-..++.|+.|.+.+|.+++..-+.+-...+|+.|+|++|++.......+.++..|++|+|++|+++ .+|..+.
T Consensus       349 ~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva  427 (1081)
T KOG0618|consen  349 TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVA  427 (1081)
T ss_pred             ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHH
Confidence            433222233456666777777776665556666666777777777766333345566666777777777766 4566666


Q ss_pred             cccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCc
Q 039344          402 SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLL  481 (873)
Q Consensus       402 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~  481 (873)
                      .+..|++|...+|+|. ..| .+..+.  .|+.+|+|.|+|+...-.....-++|++|||++|.-.......|..+..+.
T Consensus       428 ~~~~L~tL~ahsN~l~-~fP-e~~~l~--qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~  503 (1081)
T KOG0618|consen  428 NLGRLHTLRAHSNQLL-SFP-ELAQLP--QLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLS  503 (1081)
T ss_pred             hhhhhHHHhhcCCcee-ech-hhhhcC--cceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhh
Confidence            6667777777777665 455 444444  666677777766653322222226677777777664334445555555555


Q ss_pred             EEecCCC
Q 039344          482 HIDISYN  488 (873)
Q Consensus       482 ~l~ls~N  488 (873)
                      ..++.-|
T Consensus       504 ~~~i~~~  510 (1081)
T KOG0618|consen  504 QMDITLN  510 (1081)
T ss_pred             heecccC
Confidence            5555544

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-35  Score=314.27  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=204.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|+..+.||+|++|.||+|... +++.||+|.+...........+.+..|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999765 58999999997654333334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+.+++|.+++.... ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999986432 34689999999999999999999999   9999999999999999999999999998755322


Q ss_pred             CC-----------------------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          761 SS-----------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       761 ~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      ..                             ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                             1112467889999999998889999999999999999999999986433


Q ss_pred             cchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 039344          812 SMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT----MQKVCQ  869 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ev~~  869 (873)
                      ..        .....+.+.....+...  .....+.+++.+||+.||++||+    ++|+++
T Consensus       237 ~~--------~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RD--------ETFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hH--------HHHHHHhcCCccCCCcc--ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            21        11222222222222111  12345899999999999999999    777664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.8e-35  Score=309.99  Aligned_cols=247  Identities=25%  Similarity=0.335  Sum_probs=202.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999765 68999999986543323334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998654   4588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .....+++.|+|||.+.+...+.++||||+|+++|+|++|+.||......        ........+....+...  
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~--  221 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKILEGKVRFPSFF--  221 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCccCCccC--
Confidence               23356889999999998888899999999999999999999998643311        11222223333222221  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                        ...+.+++.+||+.||.+||     +++|+++
T Consensus       222 --~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         222 --SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              23478999999999999999     7777753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.9e-35  Score=310.03  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=201.5

Q ss_pred             CHHHHHHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEE
Q 039344          593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFC  670 (873)
Q Consensus       593 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  670 (873)
                      ...++......|++.+.||+|+||.||+|+. .+++.||+|.+....    ....++..|+.+++++ +||||+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            3445555667899999999999999999976 468899999975431    2245688899999998 799999999998


Q ss_pred             Ee------cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          671 LH------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       671 ~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      ..      ....+++|||++++++.+++.... ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            53      457899999999999999886533 23478888999999999999999999   999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN  819 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~  819 (873)
                      .++|+|||+++.............|++.|+|||.+.     ...++.++||||+||++|||++|+.||.......     
T Consensus       159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-----  233 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-----  233 (282)
T ss_pred             CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----
Confidence            999999999876543333344567899999999876     3457889999999999999999999986432211     


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ..........+..  ........+.+++.+||+.||.+||++.|+++
T Consensus       234 ---~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 ---ALFLIPRNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---hhhhHhhCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence               0000111111000  00112335889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-34  Score=308.77  Aligned_cols=260  Identities=26%  Similarity=0.425  Sum_probs=203.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cc
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VR  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  674 (873)
                      ++|+..+.||+|+||.||+|+..     +++.||||.+......  ...+.|.+|++.++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            46778899999999999999753     4788999998754332  345789999999999999999999999987  55


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||++++++.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            7899999999999999996543  2489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCcc---ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhh--hh----hhhhhhh
Q 039344          755 KFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS--SL----NLNIALD  825 (873)
Q Consensus       755 ~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~--~~----~~~~~~~  825 (873)
                      ...........   ...++..|+|||.+.+..++.++||||||+++|||++|+.|+.........  ..    .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            87753322211   223456799999998888999999999999999999999997643211100  00    0011111


Q ss_pred             hhcCC--CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          826 EMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       826 ~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+..  +.+.+.    .....+.+++.+||+.+|++||++.||+++|+
T Consensus       237 ~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05038         237 ELLKEGERLPRPP----SCPDEVYDLMKLCWEAEPQDRPSFADLILIVD  281 (284)
T ss_pred             HHHHcCCcCCCCc----cCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence            11111  111111    11235889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=301.17  Aligned_cols=248  Identities=27%  Similarity=0.434  Sum_probs=198.2

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCC
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS  687 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~  687 (873)
                      ++||+|+||.||+|...+++.||+|.+......  ...+.+.+|++++++++||||+++++++.+....++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            469999999999998877999999998754332  345789999999999999999999999999999999999999999


Q ss_pred             hhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc--c
Q 039344          688 LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--T  765 (873)
Q Consensus       688 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~  765 (873)
                      +.+++....  ..+++..+..++.+++.|++|||++   +++||||+|+||+++.++.++|+|||.++.........  .
T Consensus        79 l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          79 LLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            999986432  3578899999999999999999999   99999999999999999999999999997654221111  1


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI  844 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (873)
                      ...++..|+|||.+.++.++.++||||+||++|||+| |..||.........     ......  ...+.+.    ....
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----~~~~~~--~~~~~~~----~~~~  222 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----ERIESG--YRMPAPQ----LCPE  222 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----HHHhcC--CCCCCCc----cCCH
Confidence            1233567999999988889999999999999999999 88887643321111     111110  1111111    1223


Q ss_pred             HHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 039344          845 SIVEVTISCVDENPESRPTMQKVCQLLKI  873 (873)
Q Consensus       845 ~l~~li~~cl~~dP~~RPs~~ev~~~L~~  873 (873)
                      .+.+++.+||..+|++||++.|+++.|+.
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            58899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.5e-34  Score=302.69  Aligned_cols=254  Identities=27%  Similarity=0.438  Sum_probs=208.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++......  ...+.+.+|+..+++++|+||+++++++...+..++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            36888899999999999999776 5999999998764332  34578999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||+++++|.+++...   ..+++..+..++.|+++|++|+|+ .   +++||||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998654   458999999999999999999999 8   999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........++..|+|||.+.+..++.++||||||+++|+|++|+.||.......+.     .....+.....+..... 
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-  226 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF-----ELMQAICDGPPPSLPAE-  226 (264)
T ss_pred             CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH-----HHHHHHhcCCCCCCCcc-
Confidence            444444556889999999999888999999999999999999999998754421111     11122222221111111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                       .....+.+++.+||+.+|++||++.++++.
T Consensus       227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         227 -EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             023458899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.7e-35  Score=319.05  Aligned_cols=255  Identities=23%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+++.+ +++.||+|++.+.........+.+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999865 57889999986422122222455888999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999996532  3588899999999999999999999   9999999999999999999999999999765433


Q ss_pred             CCC-ccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC--CC
Q 039344          761 SSN-WTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RL  832 (873)
Q Consensus       761 ~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~  832 (873)
                      ... .....||+.|+|||++.     ...++.++|||||||++|||++|+.||........        ...+...  +.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~--------~~~i~~~~~~~  227 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YGKIMNHKERF  227 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH--------HHHHhCCCccc
Confidence            222 22357899999999986     34578899999999999999999999875432211        1111111  11


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPES--RPTMQKVCQL  870 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  870 (873)
                      +.+.. .......+.+++.+|+..++.+  |++++|+++.
T Consensus       228 ~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11110 1112334778888888655444  6889988753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-35  Score=319.34  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=196.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+++.. +++.||+|++...........+.+.+|..++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999765 67889999986432222223455788999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999996532  3588899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-cccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC--CCC
Q 039344          761 SSN-WTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD--PRL  832 (873)
Q Consensus       761 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~  832 (873)
                      ... .....|++.|+|||++.+     +.++.++||||+||++|||++|+.||.......        ....+..  .+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~  227 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHEERF  227 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--------HHHHHHcCCCcc
Confidence            322 223568999999999875     467889999999999999999999986433211        1111111  111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPES--RPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  869 (873)
                      +.+.. ..+....+.+++.+|+..++++  |++++++++
T Consensus       228 ~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         228 QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            11111 1112335788899998866544  467887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-35  Score=306.69  Aligned_cols=240  Identities=21%  Similarity=0.398  Sum_probs=187.5

Q ss_pred             ceeeecCCeEEEEEEeCC--------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          608 HCIGKGGQGSVYMSKLAS--------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      +.||+|+||.||+|....        ...||+|.+...   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            368999999999996532        234788877532   223346788999999999999999999999998999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC--------eEEecc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE--------AHVSDF  751 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~--------~kl~Df  751 (873)
                      |||+++|+|.+++....  ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999999986543  2578999999999999999999999   9999999999999988765        699999


Q ss_pred             ccccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCC-CCCcccccchhhhhhhhhhhhhhcC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGK-HPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      |.+......    ....++..|+|||++.+. .++.++||||+|+++||+++|. .||........         .....
T Consensus       153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---------~~~~~  219 (258)
T cd05078         153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---------LQFYE  219 (258)
T ss_pred             ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---------HHHHH
Confidence            998755432    234678899999998864 5788999999999999999985 55543222111         00111


Q ss_pred             CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       830 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+...+...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       220 ~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DRHQLPAPK----WTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ccccCCCCC----cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111111111    124789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.7e-35  Score=310.87  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=203.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||++... +|+.||+|++....  .....+.+.+|+++++.++||||+++++++......++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            56788899999999999999754 68899999876432  2233577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   +.+++..+..++.+++.|+.|||+..  +++||||+|+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999999988543   35889999999999999999999732  8999999999999999999999999998754322


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchh---hhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSF---SSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      .  .....|+..|+|||++.+..++.++|||||||++|++++|+.||+.......   ...........+.....+....
T Consensus       158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence            1  2235689999999999888899999999999999999999999875332100   0001111122222221111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                        .+....+.+++.+||+.||++||++.|+++.
T Consensus       236 --~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         236 --SDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             --hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              1123458899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=306.30  Aligned_cols=248  Identities=26%  Similarity=0.441  Sum_probs=200.2

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc---CCceeeEEeEEEecceeEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW---HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  678 (873)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+......  ...+++.+|+.+++.++   |||++++++++.+....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            467788999999999999975 57899999998754322  23467889999999996   9999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++++|.+++...    .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999988542    588999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ..........|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...........     ......+.++..  
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~--  225 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-----IPKSKPPRLEDN--  225 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-----cccCCCCCCCcc--
Confidence            555444556788999999988754 468899999999999999999999875332211100     000001111110  


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         .....+.+++.+||+.||++||++.++++
T Consensus       226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         226 ---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence               12335889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.7e-35  Score=307.19  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=203.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|+..+.||+|++|.||++... +++.||+|.+......  ...+++.+|++.++.++||||+++++++......++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            35778889999999999999765 6899999998764322  34577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|+|+ .   +++||||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999986543  458889999999999999999999 7   999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      ....  ...++..|+|||.+.+..++.++||||+|+++|++++|+.||.......   ...............+..... 
T Consensus       154 ~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-  227 (265)
T cd06605         154 SLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNEPPPRLPSG-  227 (265)
T ss_pred             HHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcCCCCCCChh-
Confidence            2221  2568889999999999899999999999999999999999986432110   000111222222221111111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       .....+.+++.+||..+|++|||+.++++
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         228 -KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             13345889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=306.03  Aligned_cols=251  Identities=26%  Similarity=0.464  Sum_probs=200.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+|++.+.||+|+||.||+|..+ +|+    .||+|.......  .....++.+|+..+++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            56888899999999999999754 333    589998765432  2335678999999999999999999999987 788


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++|++.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999999986543  3489999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCCcc--ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CC
Q 039344          757 LKPDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RL  832 (873)
Q Consensus       757 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~  832 (873)
                      .........  ...++..|+|||.+....++.++||||||+++||+++ |+.||+......+.        ..+... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--------~~~~~~~~~  230 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP--------DLLEKGERL  230 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH--------HHHhCCCCC
Confidence            654333222  1223568999999988889999999999999999998 99998753322111        111111 12


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+...    ...+.+++.+||..+|.+||++.++++.|+
T Consensus       231 ~~~~~~----~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         231 PQPPIC----TIDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             CCCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            222211    124789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.4e-35  Score=311.79  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=199.1

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |.....||+|+||.||++... +++.||+|++....   ....+.+.+|+..++.++||||+++++.+...+..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            333467999999999999764 68899999986432   22346688999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++++++.+++..    ..+++.++..++.||+.|++|||++   +++||||||+||+++.++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            999999998743    2478999999999999999999999   999999999999999999999999999976544433


Q ss_pred             CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      ......|+..|+|||.+.+..++.++||||+|+++||+++|+.||.........     ........+......    ..
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~----~~  244 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-----RRIRDNLPPRVKDSH----KV  244 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcCCCcccccc----cc
Confidence            334457889999999998888999999999999999999999998743322111     011111222222111    12


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          843 LISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ...+.+++.+||+.||.+|||++++++.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2347889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-35  Score=338.56  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=198.9

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cce
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRH  675 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  675 (873)
                      ....+|.+.+.||+|+||+||+|+.. +++.||+|.+...... ......|..|+.+++.++|||||+++++|.+  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34578999999999999999999764 5778999988654322 2335678999999999999999999998865  356


Q ss_pred             eEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCCeeeCCC-------
Q 039344          676 LFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCF----PPIVHRDISSKNVLLDFE-------  743 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~Dlk~~Nill~~~-------  743 (873)
                      +|+||||+++++|.+++.... ....+++..++.|+.||+.||+|||+...    .+|+||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999986532 23468999999999999999999998521    259999999999999642       


Q ss_pred             ----------CCeEEeccccccccCCCCCCcccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          744 ----------NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       744 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                                +.+||+|||+++...... ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      348999999998664332 2234578999999999864  457899999999999999999999987433


Q ss_pred             cchhhhhhhhhhhhhhcC-CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          812 SMSFSSLNLNIALDEMLD-PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....       ....+.. +.++...     ....+.++|..||+.+|++||++.|+++
T Consensus       248 ~~~q-------li~~lk~~p~lpi~~-----~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFSQ-------LISELKRGPDLPIKG-----KSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHHH-------HHHHHhcCCCCCcCC-----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            2211       1111111 1221111     1234889999999999999999999874

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-34  Score=303.13  Aligned_cols=238  Identities=24%  Similarity=0.420  Sum_probs=188.5

Q ss_pred             ceeeecCCeEEEEEEeCCCc-----------EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          608 HCIGKGGQGSVYMSKLASGE-----------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      +.||+|+||.||+|...+..           .|++|.+......    ...+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999875432           4777776543211    5788999999999999999999999988 778


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-------CeEEe
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-------EAHVS  749 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-------~~kl~  749 (873)
                      ++||||+++++|.+++.....  .+++..+..++.|++.|++|||++   +|+||||||+||+++.++       .+|++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999999875432  588999999999999999999999   999999999999999888       79999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccC--CCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhh
Q 039344          750 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       750 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      |||+++....    .....++..|+|||++.+.  .++.++||||+|+++||+++ |..||.........     .... 
T Consensus       151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-----~~~~-  220 (259)
T cd05037         151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-----RFYQ-  220 (259)
T ss_pred             CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-----HHHh-
Confidence            9999986543    2234567789999998876  78899999999999999999 57776543211110     0000 


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       .....+.+..      ..+.+++.+||+.+|++||++.++++.|+
T Consensus       221 -~~~~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 -DQHRLPMPDC------AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -cCCCCCCCCc------hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             1111111111      35889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-34  Score=311.77  Aligned_cols=255  Identities=22%  Similarity=0.270  Sum_probs=198.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||++... +++.||+|.+...........+.+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999765 57899999986543222233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999998543   3588999999999999999999999   9999999999999999999999999998642111


Q ss_pred             CC---------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          761 SS---------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       761 ~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ..               ......++..|+|||++.+..++.++|+||||+++||+++|..||.......        ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--------~~~  226 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------LFG  226 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHH
Confidence            00               0112357788999999988889999999999999999999999986432211        111


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .........+... ......+.+++.+||+.+|++||++.++.+.+
T Consensus       227 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         227 QVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             HHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence            1111111111100 01223478999999999999999965555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2e-34  Score=303.52  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=203.3

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cceeEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHLFIV  679 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  679 (873)
                      +|++.+.||.|+||.||+|.. .+|+.||+|++...... ....+.+..|+++++.++||||+++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            477889999999999999965 46889999998654322 2335678899999999999999999998764  4567999


Q ss_pred             EEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHH-----hCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          680 YEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMH-----NDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      |||+++++|.+++.... ....+++..++.++.|++.|++|||     +.   +++||||+|+||+++.++.+|++|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence            99999999999986532 2356899999999999999999999     66   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      +..............+++.|+|||++.+..++.++||||||+++|+|++|+.||........        ...+..+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~  228 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--------ASKIKEGKFR  228 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH--------HHHHhcCCCC
Confidence            98776544434456789999999999988899999999999999999999999875332111        1112222221


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ....   .....+.+++.+|++.+|++||++.+|++.
T Consensus       229 ~~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 RIPY---RYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCcc---ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1111   123358899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-34  Score=302.04  Aligned_cols=246  Identities=26%  Similarity=0.437  Sum_probs=197.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+|++.+.||+|+||.||++.. +++.||+|.++...     ..+.+.+|+.+++.++|||++++++++... ..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            4688899999999999999975 47889999986431     246788999999999999999999998765 4699999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++..... 
T Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            999999999986543 23578999999999999999999999   9999999999999999999999999999764322 


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        ......+..|+|||++.+..++.++||||+|+++|||++ |+.||.........        ..+.......+..   
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~---  220 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK--------ECVEKGYRMEPPE---  220 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH--------HHHhCCCCCCCCC---
Confidence              122344678999999988889999999999999999997 99998643321111        1111111111111   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....+.+++.+||+.+|++||+++++++.|+
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            12235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-34  Score=303.68  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCC--cchhHHHHHHHHHHHHhccCCceeeEEeEEEe--ccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  676 (873)
                      .+|+..+.||+|+||.||+|.. .++..||+|++......  .....+.+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999976 46899999988644221  22234568899999999999999999999875  3578


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++++||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            9999999999999998643   3478899999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCC---CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .....   .......++..|+|||.+.+..++.++||||+||++||+++|+.||..........    ........+.++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~  231 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KIATQPTNPQLP  231 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH----HHhcCCCCCCCc
Confidence            54321   12233457889999999998889999999999999999999999987433211100    000000111111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .      .....+..++ +||..+|++||+++||++
T Consensus       232 ~------~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         232 S------HISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             h------hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1      1122356666 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-34  Score=311.49  Aligned_cols=194  Identities=21%  Similarity=0.380  Sum_probs=158.7

Q ss_pred             CceeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cceeEEEEE
Q 039344          607 EHCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHLFIVYE  681 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  681 (873)
                      ..+||+|+||+||+|+..   ++..||+|.+....     ....+.+|+.+++.++||||+++++++..  ....++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            368999999999999864   45789999886432     12467899999999999999999999854  457899999


Q ss_pred             eccCCChhhHhcccc------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee----CCCCCeEEecc
Q 039344          682 YFKMCSLAVILSNDA------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL----DFENEAHVSDF  751 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Df  751 (873)
                      |+++ ++.+++....      ....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9875 6666654221      223478889999999999999999999   99999999999999    56678999999


Q ss_pred             ccccccCCCCC---CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          752 GIAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       752 g~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      |+++.......   ......+|+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            99987654322   22345789999999998764 578999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-34  Score=304.09  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=198.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      ..+|.+.+.||+|+||.||+|...+    ...||+|.......  ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            3568888999999999999997543    24689998865422  2345689999999999999999999999875 457


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            89999999999999986532  3489999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcC-CCCC
Q 039344          757 LKPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD-PRLP  833 (873)
Q Consensus       757 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~  833 (873)
                      ....... .....++..|+|||.+....++.++||||+|+++||+++ |+.||........        ...+.. .+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--------~~~~~~~~~~~  228 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--------IGRIENGERLP  228 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--------HHHHHcCCcCC
Confidence            6543221 112234568999999988889999999999999999996 9999864332111        111111 1112


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+..    ....+.+++.+||..+|++|||+.++++.|+
T Consensus       229 ~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         229 MPPN----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1211    1235889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=306.45  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=201.3

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecc---
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVR---  674 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~---  674 (873)
                      ++++|++.+.||+|++|.||+|+.+ +++.+++|++.....    ..+.+.+|+.+++++ +|+||+++++++.+..   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4688999999999999999999874 678999999864322    246789999999999 7999999999997644   


Q ss_pred             ---eeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 039344          675 ---HLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD  750 (873)
Q Consensus       675 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D  750 (873)
                         ..++||||+++++|.+++.... ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence               4899999999999999886533 235689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCcccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ||.+..............++..|+|||++..     ..++.++||||+||++|++++|+.||.......        ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~  228 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALF  228 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHH
Confidence            9999876544444445668899999998753     346788999999999999999999986432211        111


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+.....+ ...........+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 KIPRNPPP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HhhccCCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111111 11111123345889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=308.67  Aligned_cols=260  Identities=18%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|++|.||+|+.+ +++.||+|.+.......  ....+.+|+++++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            67888999999999999999765 68999999987543222  1245678999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++ +|.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          83 EYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            99984 8888876433  3578999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccc-hhhhhhh-------hhhhhh-----
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-SFSSLNL-------NIALDE-----  826 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-~~~~~~~-------~~~~~~-----  826 (873)
                      ........++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .......       ......     
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            233333456888999998875 45788999999999999999999998643311 0000000       000000     


Q ss_pred             -hcCCCCCCCC-ch------hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 -MLDPRLPTPS-RN------VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 -~~~~~~~~~~-~~------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       .......... ..      .......+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             0000000000 00      0001135779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.6e-35  Score=311.92  Aligned_cols=247  Identities=24%  Similarity=0.415  Sum_probs=197.8

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |.....||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+..++.++||||+++++++...+..++||||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            334557999999999999764 689999999864322   2246688999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++++++..++..    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||+++.......
T Consensus       100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999987743    3488999999999999999999999   999999999999999999999999999976554433


Q ss_pred             CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      ......++..|+|||++.+..++.++||||+||++|||++|+.||...........     ......+......    ..
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~----~~  243 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-----LRDSPPPKLKNAH----KI  243 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HhccCCCCccccC----CC
Confidence            34456789999999999988899999999999999999999999864332211100     0000011111111    11


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          843 LISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+.+++.+||+.+|++||+++++++
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            234789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.6e-34  Score=302.70  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=201.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +-|+..+.||+|+||.||+|.. .+++.||+|.+.....  ....+.+.+|+..+++++||||+++++++.+.+..++||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            3477788999999999999975 4688999998764322  223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++..    ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          82 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            99999999998853    3478999999999999999999999   9999999999999999999999999999766544


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........++..|+|||++.+..++.++||||+||++|+|++|..||.........        ..+.....+....   
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~---  223 (277)
T cd06641         155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL--------FLIPKNNPPTLEG---  223 (277)
T ss_pred             hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH--------HHHhcCCCCCCCc---
Confidence            33334456888999999998888899999999999999999999998643321111        1111111111111   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||+.+|.+||++.++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            12234789999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.2e-34  Score=300.75  Aligned_cols=251  Identities=28%  Similarity=0.425  Sum_probs=200.1

Q ss_pred             CCCCceeeecCCeEEEEEEeCC-----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKLAS-----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      +++.+.||+|+||.||+++..+     +..||+|++......  ...+.+..|++.++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            4567899999999999997653     488999998654222  135789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      +|||++++++.+++..... ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.++...
T Consensus        79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence            9999999999999865432 1289999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcc-ccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          759 PDSSNWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       759 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ....... ...+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||........        .............
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~  226 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV--------LEYLKKGYRLPKP  226 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHhcCCCCCCC
Confidence            4422211 2336789999999988889999999999999999998 7888764222111        1111111111111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      ..   ....+.+++.+||..+|++|||+.++++.|
T Consensus       227 ~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 EN---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             Cc---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11   233588999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.8e-34  Score=302.31  Aligned_cols=252  Identities=29%  Similarity=0.450  Sum_probs=201.9

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+.+|+++++.++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            4778899999999999999754 7899999998755332 3356789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999998653   3478899999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCcc----ccccccccccccccccCC---CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          762 SNWT----ELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       762 ~~~~----~~~g~~~y~aPE~~~~~~---~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ....    ...+++.|+|||++.+..   ++.++||||||+++||+++|+.||...... +...   ........+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~---~~~~~~~~~~~~~  229 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIM---FHVGAGHKPPIPD  229 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHH---HHHhcCCCCCCCc
Confidence            3222    356788999999988766   788999999999999999999998643211 1000   0011111112221


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..    .....+.+++.+||+.+|++||++.+++.
T Consensus       230 ~~----~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         230 SL----QLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             cc----ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11    11234779999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-34  Score=301.71  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=200.4

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCC--cchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      +|+..+.||+|++|.||+|... +++.|++|.+......  .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999876 7899999998653221  223456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      +||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999998643   3478999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. ......++..|+|||.+.... ++.++|+||+|+++|++++|+.||...........     ...  ....+.... 
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-----~~~--~~~~~~~~~-  225 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-----IGR--SKELPPIPD-  225 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-----HHh--cccCCCcCC-
Confidence            32 234456889999999987766 88999999999999999999999865332111100     000  011111111 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        .....+.+++.+||+.+|++||++.++++
T Consensus       226 --~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         226 --HLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              11234788999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-34  Score=304.71  Aligned_cols=248  Identities=25%  Similarity=0.419  Sum_probs=195.5

Q ss_pred             ceeeecCCeEEEEEEeCC-------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          608 HCIGKGGQGSVYMSKLAS-------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.||+|+||.||+|+..+       ++.+|+|.+.....  .....++.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            368999999999997542       35789998864322  123567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc----cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-----CeEEecc
Q 039344          681 EYFKMCSLAVILSNDA----AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-----EAHVSDF  751 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-----~~kl~Df  751 (873)
                      ||+++++|.+++....    ....+++.++..++.|++.|++|||+.   +++|+||||+||+++.++     .++++||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence            9999999999986532    123478899999999999999999999   999999999999999887     8999999


Q ss_pred             ccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhc
Q 039344          752 GIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       752 g~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      |+++.......  ......++..|+|||++.++.++.++|||||||++|||++ |+.||.........        ..+.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~--------~~~~  227 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL--------QHVT  227 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH--------HHHh
Confidence            99976543221  1122345678999999999999999999999999999998 99998643322111        1111


Q ss_pred             C-CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          829 D-PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       829 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      . .....+.    .....+.+++.+||..+|++||++++|++.|+
T Consensus       228 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AGGRLQKPE----NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cCCccCCcc----cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1 1111111    12345889999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9e-35  Score=318.07  Aligned_cols=258  Identities=19%  Similarity=0.302  Sum_probs=194.7

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec----
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV----  673 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  673 (873)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            3457899999999999999999975 47889999998754222 12245678999999999999999999988643    


Q ss_pred             --ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          674 --RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       674 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                        ...|+++|++ ++++.+++..    ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence              3468999987 6788877643    3489999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-------hhhh
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-------LNIA  823 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-------~~~~  823 (873)
                      |+++.....   .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||............       ....
T Consensus       163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999865432   234578999999999876 46889999999999999999999998643321100000       0000


Q ss_pred             --------hhhhcCCCCCCCC-chh----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 --------LDEMLDPRLPTPS-RNV----HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 --------~~~~~~~~~~~~~-~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                              ...... .++... ...    ......+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    000000 000000 000    001123679999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=329.35  Aligned_cols=260  Identities=17%  Similarity=0.229  Sum_probs=190.8

Q ss_pred             HHHHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC------CceeeEEe
Q 039344          596 EIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH------RNIVKVYG  668 (873)
Q Consensus       596 e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~  668 (873)
                      ++.....+|++.+.||+|+||+||+|.. .+++.||||+++...    ....++..|+.+++.++|      ++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            3344567899999999999999999975 468899999986421    123456677777777754      45899999


Q ss_pred             EEEec-ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCC--
Q 039344          669 FCLHV-RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFEN--  744 (873)
Q Consensus       669 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~--  744 (873)
                      ++... +..++|||++ ++++.+++...   ..+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++  
T Consensus       199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        199 YFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence            98764 5788999987 56777777543   358999999999999999999997 5   999999999999998765  


Q ss_pred             --------------CeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCccc
Q 039344          745 --------------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI  810 (873)
Q Consensus       745 --------------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~  810 (873)
                                    .+||+|||.+....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                          49999999886432   2233567999999999999999999999999999999999999999754


Q ss_pred             ccchhhhhhhhh---------------hhhhhcCC--CC-C-CCCc-----------hhHHHHHHHHHHHhhcccCCCCC
Q 039344          811 SSMSFSSLNLNI---------------ALDEMLDP--RL-P-TPSR-----------NVHDKLISIVEVTISCVDENPES  860 (873)
Q Consensus       811 ~~~~~~~~~~~~---------------~~~~~~~~--~~-~-~~~~-----------~~~~~~~~l~~li~~cl~~dP~~  860 (873)
                      ............               ....+.+.  .+ + ....           ........+.+|+.+||+.||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            432111000000               00000000  00 0 0000           00001234779999999999999


Q ss_pred             CCCHHHHHH
Q 039344          861 RPTMQKVCQ  869 (873)
Q Consensus       861 RPs~~ev~~  869 (873)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999985

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-34  Score=303.73  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=198.4

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCc-------chhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGE-------MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      +|.+.+.||+|+||.||+|.. .+|+.||+|.++......       ....+.+.+|+.+++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999975 468999999886432111       112356888999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998654   3588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC--CccccccccccccccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          755 KFLKPDSS--NWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       755 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      +.......  ......++..|+|||.+....  ++.++||||+|+++||+++|..||.........   .. .......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~-~~~~~~~~  231 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM---FK-LGNKRSAP  231 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH---HH-hhccccCC
Confidence            76543211  122346788999999987654  788999999999999999999998643221100   00 00000111


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..  +.....+....+.+++.+||+.+|++||++++|++
T Consensus       232 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 PI--PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cC--CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11  11111223345889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8e-35  Score=313.44  Aligned_cols=196  Identities=26%  Similarity=0.378  Sum_probs=171.8

Q ss_pred             cCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-C-----CceeeEEeEEEecc
Q 039344          602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-H-----RNIVKVYGFCLHVR  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~  674 (873)
                      .+|.+.+.||+|+||.|.+|. .++++.||||+++..    .....+-..|+.++..++ |     -|+|+++++|...+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            378999999999999999995 567999999999853    344567788999999996 3     47999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC--CeEEeccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN--EAHVSDFG  752 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~--~~kl~Dfg  752 (873)
                      +.|+|+|.+. -+|.+++...... .++...++.++.||+.||.+||+.   +|||+||||+|||+...+  .+||+|||
T Consensus       262 HlciVfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  262 HLCIVFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ceeeeehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            9999999886 7999999876643 489999999999999999999999   999999999999998654  69999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      .|++....-.   +..-+..|+|||++.+.+|+.+.|+||||||++||++|.+-|.+
T Consensus       337 SSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  337 SSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            9987654433   45667889999999999999999999999999999999777754

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-34  Score=306.17  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=205.0

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++.|+..+.+|+|++|.||+|..+ +++.|++|++.....    ..+.+.+|++.++.++|+|++++++++......++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            4566888899999999999999876 688999999875422    35678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |+||+++++|.+++....  ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            999999999999997643  3689999999999999999999998   99999999999999999999999999987665


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ..........++..|+|||++.+..++.++|||||||++|+|++|+.||..........        .......+.. ..
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~~-~~  238 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--------LITTKGIPPL-KN  238 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhcCCCCC-cc
Confidence            44333344567889999999988889999999999999999999999987533221111        1111111100 00


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1112335889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-34  Score=308.21  Aligned_cols=260  Identities=20%  Similarity=0.295  Sum_probs=196.3

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|+..+.||+|+||.||+|+.. +|+.||+|++...... ......+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4778899999999999999764 6899999998654222 1223567889999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++ +++.+++...  ...+++..+..++.||++|++|||+.   +++||||||+||+++.++.++|+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            998 4777776533  24589999999999999999999999   99999999999999999999999999998765444


Q ss_pred             CCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccch-hhhhhhh-------h---hhhhhcC
Q 039344          762 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMS-FSSLNLN-------I---ALDEMLD  829 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-~~~~~~~-------~---~~~~~~~  829 (873)
                      .......+++.|+|||.+.+.. ++.++||||+||++|||+||+.|+....+.. .......       .   ......+
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            4444556788999999887654 6889999999999999999999964322110 0000000       0   0000000


Q ss_pred             C-CCCCC-Cc-----hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 P-RLPTP-SR-----NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ~-~~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      . ..+.. ..     ........+.+++.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0 00000 00     00112345789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.5e-34  Score=308.74  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=197.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ..+|+..+.||+|+||.||+|... +|+    .||+|.+.....  .....++.+|+.+++.++||||++++|+|... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            357888899999999999999753 454    478888764322  22345788999999999999999999998754 4


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++++||+++|++.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            679999999999999986432  3478899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          756 FLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       756 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ........  .....++..|+|||++.+..++.++|||||||++||+++ |+.||..........     ....  ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~--~~~~  230 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-----LLEK--GERL  230 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHC--CCCC
Confidence            76543322  122345678999999998889999999999999999997 999986432111111     1110  1112


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+..    ....+.+++.+||..+|++||+++++++.|+
T Consensus       231 ~~~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         231 PQPPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            21111    1234789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.9e-34  Score=307.02  Aligned_cols=261  Identities=21%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|+..+.||.|++|.||+|+.. +|+.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788899999999999999764 68999999987543222 224578899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+. +++..++.... ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 67888876533 34589999999999999999999999   99999999999999999999999999998665443


Q ss_pred             CCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------------hhhhh
Q 039344          762 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------------ALDEM  827 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------------~~~~~  827 (873)
                      .......+++.|+|||.+.+.. ++.++||||||+++|||+||+.||...............             .....
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            3344456788999999887654 588999999999999999999998643321100000000             00000


Q ss_pred             cC--CCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LD--PRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..  +......  .........+.+++.+||+.||++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00  0000000  000011234678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.9e-34  Score=307.85  Aligned_cols=250  Identities=23%  Similarity=0.384  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+...   .....+.+.+|+.+++.++||||+++++++...+..|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            6788899999999999999975 46889999998643   2222467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++...    .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999999998542    378889999999999999999999   9999999999999999999999999998766554


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........+++.|+|||.+....++.++||||||+++|++++|+.||..........       .....+......  ..
T Consensus       169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~~~~--~~  239 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPELQN--PE  239 (293)
T ss_pred             ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehhcCCCCCCCC--cc
Confidence            444445578889999999988889999999999999999999999987543221100       000011111111  11


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            123357899999999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-34  Score=314.70  Aligned_cols=192  Identities=21%  Similarity=0.342  Sum_probs=164.3

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|.....         ....|+.++++++||||+++++++.+....++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3467999999999999999999765 5778999975421         23468999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+. +++.+++...  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       135 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999996 5777777543  24589999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR  807 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~  807 (873)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            22 2233457899999999999999999999999999999999865553

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-34  Score=307.91  Aligned_cols=261  Identities=21%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  678 (873)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++..... ......+.+|+.++++++||||+++++++...  ...++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            56888899999999999999875 6889999998754322 22234677899999999999999999999877  88999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||++ +++.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.++...
T Consensus        84 v~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999998 48888876433  3589999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------hhh---hh
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------ALD---EM  827 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~~~---~~  827 (873)
                      ..........+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||...............       ...   .+
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            5434444456788999999887644 688999999999999999999998754322111000000       000   00


Q ss_pred             ---c-----CCCCCCCCchhHH--HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 ---L-----DPRLPTPSRNVHD--KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ---~-----~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         .     .............  ....+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence               0     0000000000000  1334789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8e-34  Score=298.91  Aligned_cols=251  Identities=23%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCC--CcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--cee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLP--GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  676 (873)
                      ++|++.+.||+|+||.||.|+.. +|+.||+|.+.....  ......+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999764 689999998764321  1222346788999999999999999999988763  467


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++...   ..+++..+.+++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999988643   3478888999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .....   .......++..|+|||.+.+..++.++|||||||++||+++|+.||........       .......+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~  228 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-------IFKIATQPTNP  228 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-------HHHHhcCCCCC
Confidence            54321   122335688899999999888899999999999999999999999864321110       00111111111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...   ......+.+++.+||. +|++||+++|+++
T Consensus       229 ~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         229 VLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            111   1223357788999995 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.8e-34  Score=298.43  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=200.6

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+....... ...+.+.+|+++++.++|||++++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            477889999999999999975 468899999987543222 235778999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEeccccccccCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPD  760 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~  760 (873)
                      |+++++|.+++.... ...+++..+..++.+++.|++|||++   +++||||+|+||+++.++ .++++|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999986533 34478999999999999999999999   999999999999998654 5899999999876543


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      . ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||+........        .............   
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---  223 (256)
T cd08220         156 S-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV--------LKIMSGTFAPISD---  223 (256)
T ss_pred             c-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH--------HHHHhcCCCCCCC---
Confidence            2 223356888999999999888899999999999999999999998653322111        1111111111111   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||+.+|++|||+.|+++
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11234889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.1e-34  Score=305.11  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=196.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..|+..+.||+|+||.||+|+.. +|+.||+|++...........+++.+|+++++.++||||++++++|.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999764 68999999986543333334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++ |++.+++....  ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9998 56666654322  3589999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                          ....+++.|+|||++.   ...++.++||||||+++|||+||+.||.........        ........+... 
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~~-  235 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------YHIAQNDSPTLS-  235 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH--------HHHhcCCCCCCC-
Confidence                2346788999999874   356788999999999999999999998643322110        001111111100 


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                       .......+.+++.+||+.+|++||++.++++.
T Consensus       236 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         236 -SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             11223458899999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=305.40  Aligned_cols=260  Identities=20%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |++.+.||+|++|.||+|... +|+.||+|++...... ....+.+.+|++.++.++|||++++++++.+.+..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            567789999999999999754 7999999998754322 22245688999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++ +++.+++..... ..+++..+..++.|+++|++|||+.   +++||||+|+||+++.++.++|+|||.++.......
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            96 688888865432 3589999999999999999999999   999999999999999999999999999976644333


Q ss_pred             CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-----------------hhh
Q 039344          763 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-----------------IAL  824 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-----------------~~~  824 (873)
                      ......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||..............                 ...
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            33344668899999987664 468899999999999999999999865432110000000                 000


Q ss_pred             hhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+..................+.+++.+||+.||++||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000001112235789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=333.09  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=207.4

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC--------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGF  669 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  669 (873)
                      ...++..+.+.+|+|+||.|++|...        ....||||.++.....  ...+.+..|+++|+.+ +|+||+.++|+
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            33455566679999999999999632        1457999999876544  3468899999999999 69999999999


Q ss_pred             EEecceeEEEEEeccCCChhhHhcccc-----------cc--cCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 039344          670 CLHVRHLFIVYEYFKMCSLAVILSNDA-----------AA--KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSK  736 (873)
Q Consensus       670 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~  736 (873)
                      |.+.+..++|+||+..|+|.+++...+           ..  ..++..+.+.++.|||.|++||++.   +++|||+.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            999999999999999999999997655           01  1378889999999999999999999   9999999999


Q ss_pred             CeeeCCCCCeEEeccccccccCCCCCCc-cccc--cccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCccccc
Q 039344          737 NVLLDFENEAHVSDFGIAKFLKPDSSNW-TELA--GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS  812 (873)
Q Consensus       737 Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~  812 (873)
                      |||+.++..+||+|||+|+......... ....  -+..|||||.+....|+.+||||||||++||++| |..||.....
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999999765544332 2223  2456999999999999999999999999999999 8999875321


Q ss_pred             chhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          813 MSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .       ....+.+.++.....+..+.   .+++++|+.||+.+|++||++.++++.++
T Consensus       528 ~-------~~l~~~l~~G~r~~~P~~c~---~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  528 T-------EELLEFLKEGNRMEQPEHCS---DEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             H-------HHHHHHHhcCCCCCCCCCCC---HHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            1       11122222333323333333   34889999999999999999999998874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=286.82  Aligned_cols=244  Identities=24%  Similarity=0.290  Sum_probs=205.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      -++|...++||+|.||.|.+++- .+|+.+|+|++++...-......--..|-++++..+||.+..+--.|...+..|.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999975 47999999999887655554456667889999999999999988888899999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+.||.|..++++.+   .+++...+.+-..|+.|+.|||++   +||.||+|.+|.++|+||++||+|||+++.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999998887643   488999999999999999999999   999999999999999999999999999987666


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      ......+.+|||.|.|||++.+..|..++|.|.+||+||||++|+.||...+..        ..++-++-..+..|....
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--------kLFeLIl~ed~kFPr~ls  392 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--------KLFELILMEDLKFPRTLS  392 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--------HHHHHHHhhhccCCccCC
Confidence            666778899999999999999999999999999999999999999998653332        222222223333333322


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC
Q 039344          840 HDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      ++    ...++...+.+||.+|.
T Consensus       393 ~e----AktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  393 PE----AKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HH----HHHHHHHHhhcChHhhc
Confidence            33    56778889999999995

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.5e-34  Score=305.24  Aligned_cols=262  Identities=19%  Similarity=0.268  Sum_probs=196.0

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ++.+|.+.+.||+|+||.||+|.. .+|+.||+|++.......  ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            357899999999999999999975 468999999986543222  23467789999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||++ +++.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++...
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            999996 66666654322  3477888999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchh-hhhhh-------h--------
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSF-SSLNL-------N--------  821 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~-~~~~~-------~--------  821 (873)
                      ..........+++.|+|||++.+. .++.++||||+||++|||++|+.||+...+... .....       .        
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            433333445678899999998754 478899999999999999999999975432100 00000       0        


Q ss_pred             --hhhhhhcCCCCCCCCch---hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 --IALDEMLDPRLPTPSRN---VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 --~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ...........+.....   .......+.+++.+|++.||.+|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              00000000000000000   0001235789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=306.20  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=200.3

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            6888999999999999999765 688999999875432 22335778999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |++++.+..+...   ...+++.++..++.||+.|++|||+.   +++||||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998777665533   23488999999999999999999999   99999999999999999999999999998766543


Q ss_pred             C-CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------h---hh--hhh
Q 039344          762 S-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------I---AL--DEM  827 (873)
Q Consensus       762 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~---~~--~~~  827 (873)
                      . ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||..............       .   ..  ...
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            3 33445678899999999888 789999999999999999999999874322110000000       0   00  000


Q ss_pred             cCC-CCCCCC-ch------hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LDP-RLPTPS-RN------VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~~-~~~~~~-~~------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+ ..+... ..      .......+.+++.+||..+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000 000000 00      0011345889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.2e-34  Score=303.73  Aligned_cols=261  Identities=20%  Similarity=0.325  Sum_probs=200.0

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|++|.||+|+.. +|+.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            4788899999999999999875 6899999998754322  224567789999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++ ++.+++........+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||+++......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 7888776544445689999999999999999999999   99999999999999999999999999998665433


Q ss_pred             CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-------hhhhhhh-----c
Q 039344          762 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-------NIALDEM-----L  828 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-------~~~~~~~-----~  828 (873)
                      .......++..|+|||.+.+. .++.++||||+||++|++++|+.||.............       ......+     .
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            333445678899999987654 46889999999999999999999987543211100000       0000000     0


Q ss_pred             CCCCCCCCch-----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          829 DPRLPTPSRN-----VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       829 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.....     .......+.+++.+|++.||.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0111111000     0112345789999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-34  Score=302.05  Aligned_cols=251  Identities=26%  Similarity=0.345  Sum_probs=203.6

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||.|+||.||+|+.. +++.||+|.+...........+.+.+|++.+++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999865 689999999875433333346789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++...   ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998654   3588999999999999999999999   99999999999999999999999999998665432


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                       ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.......     ...............+..    
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~----  224 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQETADVLYPAT----  224 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhccccccCccc----
Confidence             2334568889999999988889999999999999999999999987544210     011111111111111211    


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCH--HHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTM--QKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~--~ev~~  869 (873)
                      ....+.+++.+||+.||.+||++  +|+++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            12458899999999999999999  77653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=340.15  Aligned_cols=452  Identities=28%  Similarity=0.319  Sum_probs=293.5

Q ss_pred             cCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccc
Q 039344           12 SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGN   91 (873)
Q Consensus        12 ~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   91 (873)
                      .+|..+-.-..++.|+++.|-+-...-+.+.+.-+|+.|+|++|++. ..|..+..+.+|+.|+++.|.|. ..|.+..+
T Consensus        12 ~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~   89 (1081)
T KOG0618|consen   12 LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSN   89 (1081)
T ss_pred             ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhh
Confidence            45555544455899999999987433445566667999999999999 89999999999999999999999 78899999


Q ss_pred             ccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEE
Q 039344           92 LSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQ  171 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  171 (873)
                      +.+|++|.|.+|++. ..|..+..+++|++|+++.|.+. ..|..+..+..++++..++|...    ..++... ++.++
T Consensus        90 ~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~~lg~~~-ik~~~  162 (1081)
T KOG0618|consen   90 MRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----QRLGQTS-IKKLD  162 (1081)
T ss_pred             hhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh----hhhcccc-chhhh
Confidence            999999999999998 79999999999999999999998 78999999999999999999221    1223322 88899


Q ss_pred             ccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCC
Q 039344          172 LSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG  251 (873)
Q Consensus       172 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  251 (873)
                      |..|.+.+.++..+..+..  .|+|.+|.+. .  ..+..+..|+.|....|++....    -..++|+.|+.+.|.++.
T Consensus       163 l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~  233 (1081)
T KOG0618|consen  163 LRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTT  233 (1081)
T ss_pred             hhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCccee
Confidence            9999998877777766665  6999999987 2  24666777888888888776321    123567777777777662


Q ss_pred             CCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCC
Q 039344          252 AIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRC  331 (873)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l  331 (873)
                      ..+.  ..-.+|+++++++|+++..+.++..+.+|+.|+...|.++.++.. .....+|+.|++..|.+. -+|.....+
T Consensus       234 ~~~~--p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~~lp~r-i~~~~~L~~l~~~~nel~-yip~~le~~  309 (1081)
T KOG0618|consen  234 LDVH--PVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLVALPLR-ISRITSLVSLSAAYNELE-YIPPFLEGL  309 (1081)
T ss_pred             eccc--cccccceeeecchhhhhcchHHHHhcccceEecccchhHHhhHHH-HhhhhhHHHHHhhhhhhh-hCCCccccc
Confidence            2221  112456777777777776666667777777777777777544433 334456666677666665 455555566


Q ss_pred             CCCCeeeeccccCCccCCccc-cCCC-CCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccccccccc
Q 039344          332 PKLSTLDFSINNITGNVPPEI-GHSS-QLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHL  409 (873)
Q Consensus       332 ~~L~~L~l~~N~i~~~~~~~~-~~~~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  409 (873)
                      +.|++|+|..|+|.. .|+.+ ..+. .|+.|+.+.|++....-..-.....|+.|++.+|.+++..-+.+...++|+.|
T Consensus       310 ~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL  388 (1081)
T KOG0618|consen  310 KSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL  388 (1081)
T ss_pred             ceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence            667777777776653 33322 2222 24445555555442111111223444555555555554444444455555555


Q ss_pred             cccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCc
Q 039344          410 DLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNE  489 (873)
Q Consensus       410 ~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~  489 (873)
                      +||+|+|.......+.+++  .|++|+||+|+|+. +|..+..+..|+.|...+|+|. ..| .+..++.|+.+|||.|+
T Consensus       389 hLsyNrL~~fpas~~~kle--~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~  463 (1081)
T KOG0618|consen  389 HLSYNRLNSFPASKLRKLE--ELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNN  463 (1081)
T ss_pred             eecccccccCCHHHHhchH--HhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccch
Confidence            5555555322222233333  45555555555542 4445555555555555555554 233 44455555555555555


Q ss_pred             cc
Q 039344          490 LR  491 (873)
Q Consensus       490 l~  491 (873)
                      |+
T Consensus       464 L~  465 (1081)
T KOG0618|consen  464 LS  465 (1081)
T ss_pred             hh
Confidence            54

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8e-34  Score=299.57  Aligned_cols=254  Identities=22%  Similarity=0.394  Sum_probs=200.2

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCc---chhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      +|+..+.||+|++|.||+|+. .+++.||+|.+.......   ....+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999975 578999999987543222   1235678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFL  757 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~  757 (873)
                      ||||+++++|.+++...   ..+++..+..++.|++.|++|||++   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999998643   3588999999999999999999999   999999999999998876 5999999999876


Q ss_pred             CCCCCC----ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          758 KPDSSN----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       758 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ......    .....++..|+|||.+.+..++.++||||+|+++|++++|+.||...........     ..+.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~  229 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----IFKIASATTA  229 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----HHHHhccCCC
Confidence            543211    1234678899999999888899999999999999999999999864322111110     1111000000


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .  .........+.+++.+||+.+|.+||++.++++
T Consensus       230 ~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 P--SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             C--CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0  001122345889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-34  Score=306.40  Aligned_cols=263  Identities=19%  Similarity=0.278  Sum_probs=196.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecce----
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRH----  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~----  675 (873)
                      ++|++.+.||+|+||.||+|... +|+.||+|+.+...... .....+.+|+.+++.+ +||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            36888999999999999999764 68999999986543222 2246788899999999 56999999999987655    


Q ss_pred             -eEEEEEeccCCChhhHhccccc--ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-CCCeEEecc
Q 039344          676 -LFIVYEYFKMCSLAVILSNDAA--AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDF  751 (873)
Q Consensus       676 -~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Df  751 (873)
                       .|+||||+++ ++.+++.....  ...+++..+..++.||+.|++|||++   +++||||+|+||+++. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999985 78877754332  24579999999999999999999999   9999999999999998 889999999


Q ss_pred             ccccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hh
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IA  823 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~  823 (873)
                      |.++.+...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||..............       ..
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999866443333334467888999998765 4578999999999999999999999875432211100000       00


Q ss_pred             hhhhc-------CCCCCCC--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 LDEML-------DPRLPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ~~~~~-------~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....       .+.....  ....+.....+.+++.+||++||++||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000       0000000  0000112345889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.4e-34  Score=303.21  Aligned_cols=248  Identities=23%  Similarity=0.388  Sum_probs=199.1

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|...+.||+|++|.||+|.. .+++.|++|++....   ....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            355567999999999999975 478899999885432   1224568899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++..    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            9999999999865    3488999999999999999999999   99999999999999999999999999987654433


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......|++.|+|||.+.+..++.++||||+||++|||++|+.||...........     ......+......    .
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~----~  240 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-----IRDNLPPKLKNLH----K  240 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-----HHhcCCCCCcccc----c
Confidence            333445688999999999888899999999999999999999999864332211111     1111111111111    1


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            2235889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.8e-34  Score=302.70  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=192.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHH-HHhccCCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA-LTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++.......  ...++..|+.. ++..+||||+++++++...+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            46888999999999999999765 69999999987543222  23455666665 5666899999999999999999999


Q ss_pred             EEeccCCChhhHhccc-ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          680 YEYFKMCSLAVILSND-AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||++ +++.+++... .....+++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||.++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99997 6777776542 23356899999999999999999999853  89999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccccccccc----CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          759 PDSSNWTELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ... ......++..|+|||.+.+    ..++.++|+||+||++|||++|+.||...... +..  ..... ....+..+.
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~--~~~~~-~~~~~~~~~  230 (283)
T cd06617         156 DSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQ--LKQVV-EEPSPQLPA  230 (283)
T ss_pred             ccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHH--HHHHH-hcCCCCCCc
Confidence            321 2223467889999998865    34688999999999999999999998632211 000  00000 111111111


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        .   .....+.+++.+||..+|++||+++++++
T Consensus       231 --~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         231 --E---KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --c---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              1   12235889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-35  Score=312.42  Aligned_cols=248  Identities=21%  Similarity=0.350  Sum_probs=193.2

Q ss_pred             CCCceeeecCCeEEEEEEeC-CCcEEEEEEccC-CCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc--eeEEEE
Q 039344          605 DDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHS-PLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR--HLFIVY  680 (873)
Q Consensus       605 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  680 (873)
                      +...+||+|+|-+||+|... +|..||=-.++. .........+.|..|+++++.|+||||+++|.++.+..  ...+|.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999654 566665322211 11122334588999999999999999999999998755  488999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a~~~~~  759 (873)
                      |.+..|+|..|..+.+   +.+.+....|++||++||.|||++ .|+|+|||||-+||||+.+ |.|||+|.|+|+....
T Consensus       123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999997664   478899999999999999999998 5799999999999999865 7999999999997754


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                        .+.....|||.|||||+.. ..|.+.+||||||++|+||+|+.+||..-...       ......+..+..|..-...
T Consensus       199 --s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  199 --SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             --cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHHHhhcc
Confidence              3444589999999999866 77999999999999999999999998643221       1112233333322211110


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .  ...+.++|.+|+.. ..+|||+.|+++
T Consensus       269 ~--dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 K--DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             C--CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            0  12488999999999 889999999975

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.6e-34  Score=300.60  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=195.8

Q ss_pred             CCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      |.+.+.||+|+||.||+|...    +++.||+|++....... ...+++.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567789999999999999753    46889999987543222 23567889999999999999999999986532     


Q ss_pred             -eeEEEEEeccCCChhhHhcccc---cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD  750 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D  750 (873)
                       ..++++||+++|++..++....   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence             2478999999999988875332   122478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhh
Q 039344          751 FGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       751 fg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      ||.++........  .....+++.|++||.+.+..++.++||||+|+++|||++ |+.||........        ...+
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~--------~~~~  228 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI--------YNYL  228 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH--------HHHH
Confidence            9999866433211  122345678999999988889999999999999999999 8888764322111        1111


Q ss_pred             cCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          828 LDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       828 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ... ....+.    .....+.+++.+||+.+|++||++.++++.|+
T Consensus       229 ~~~~~~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~  270 (273)
T cd05074         229 IKGNRLKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE  270 (273)
T ss_pred             HcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111 111111    12235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.6e-37  Score=325.96  Aligned_cols=363  Identities=27%  Similarity=0.372  Sum_probs=237.3

Q ss_pred             CCCCCEEECCCCccc-ccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccccccccee
Q 039344           20 LKSLSDLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATL   98 (873)
Q Consensus        20 l~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L   98 (873)
                      ++-++-.|+++|.++ +..|....++++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..|+.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            344666788888887 667888888888888888888888 77888888888888888888887 566677778888888


Q ss_pred             eccccccCC-CCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcC
Q 039344           99 YLDTNSLSN-SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNF  177 (873)
Q Consensus        99 ~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i  177 (873)
                      ++..|+++. -+|..+..+..|+.||||+|+++ +.|..+..-+++-.|+||+|+|..++...|.++..|-.||||+|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            888887774 36777777788888888888887 6777777777788888888888777777777777777777777777


Q ss_pred             ccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccC-CCcccccCCCCCccEEecccccCCCCCchh
Q 039344          178 NGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS-GSIPISMGNLSNLTYLNLFENSLSGAIPYE  256 (873)
Q Consensus       178 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  256 (873)
                      . .+|+.+..+..|++|.|++|.+...--..+..+++|+.|.+++.+-+ ..+|.++..+.+|..+|+|.|.+. ..|..
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec  240 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC  240 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence            7 45666677777777777777776433344555666667777666533 235556666666666666666666 55666


Q ss_pred             hcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccc-cCCCCCCCCCCCC
Q 039344          257 YRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG-EISSDWGRCPKLS  335 (873)
Q Consensus       257 ~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~  335 (873)
                      +-++++|+.|+|++|+|+...-......+|+.|+|+.|+++. .+.+...+++|+.|++.+|+++- -+|+.++.+.+|+
T Consensus       241 ly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Le  319 (1255)
T KOG0444|consen  241 LYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLE  319 (1255)
T ss_pred             HhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhH
Confidence            666666666666666666543333444455555555555552 23344455555555555555432 2444455555555


Q ss_pred             eeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCc
Q 039344          336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHN  390 (873)
Q Consensus       336 ~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N  390 (873)
                      .+..++|++. ..|+.+..+..|+.|.|+.|++. ..|+++.-++.|..|++..|
T Consensus       320 vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN  372 (1255)
T KOG0444|consen  320 VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN  372 (1255)
T ss_pred             HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence            5555555543 44555555555555555555544 44555555555555555554

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.6e-37  Score=326.01  Aligned_cols=357  Identities=26%  Similarity=0.360  Sum_probs=229.1

Q ss_pred             cCCccc-ccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            5 YNNSLY-DSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         5 ~~n~~~-~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +.|.++ +.+|.+...++++++|.|...++. .+|++++.|.+|++|.+++|++. .+.+.+..++.|+.+++.+|++..
T Consensus        15 sgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKn   92 (1255)
T KOG0444|consen   15 SGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKN   92 (1255)
T ss_pred             cCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhcccccc
Confidence            345555 566777777777777777777765 66677777777777777777766 556666666777777777776652


Q ss_pred             -CCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccC
Q 039344           84 -SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG  162 (873)
Q Consensus        84 -~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  162 (873)
                       -+|..+..|..|..||||+|+++ ..|..+..-+++-.|+||+|+|..+....|.+|..|-.|+||+|++... |..+.
T Consensus        93 sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-PPQ~R  170 (1255)
T KOG0444|consen   93 SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-PPQIR  170 (1255)
T ss_pred             CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc-CHHHH
Confidence             24555666667777777777776 5666666666777777777777633334456666677777777776543 33456


Q ss_pred             CCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCc-ccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccE
Q 039344          163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS-YSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY  241 (873)
Q Consensus       163 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  241 (873)
                      .+.+|++|+|++|.+....-..+..+++|+.|++++.+-+ ..+|..+..+.+|..+++|.|.+. ..|..+-.+.+|+.
T Consensus       171 RL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~Lrr  249 (1255)
T KOG0444|consen  171 RLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRR  249 (1255)
T ss_pred             HHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhhe
Confidence            6666777777777665433333444556666666665543 235666666677777777777766 56666666777777


Q ss_pred             EecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccc-cccccccccCCCccEEeccCccc
Q 039344          242 LNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLT-GNISESFYIYPNLTYIDLSQNNF  320 (873)
Q Consensus       242 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~L~~L~Ls~N~l  320 (873)
                      |+||+|+|+. .......-.+|++|+|+.|+++..+.++..++.|+.|++.+|+++ +-++...+.+.+|+.+..++|.+
T Consensus       250 LNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L  328 (1255)
T KOG0444|consen  250 LNLSGNKITE-LNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL  328 (1255)
T ss_pred             eccCcCceee-eeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc
Confidence            7777777662 233333445666677777777766666677777777777777665 22344556666667777776666


Q ss_pred             cccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccC
Q 039344          321 YGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIV  369 (873)
Q Consensus       321 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~  369 (873)
                      . ..|+.+++|.+|+.|.|+.|++. .+|+++.-++.|+.|||..|.--
T Consensus       329 E-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  329 E-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             c-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            5 66666777777777777777665 46666666677777777766543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-34  Score=307.80  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=211.4

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ....|.+.+.||.|.|+.|..|+. .+|..||+|.+.+....... .+.+.+|+++|+.++|||||+++.+.+.+...|+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            346788899999999999999975 47999999999876554433 4559999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+.+|.+++++.....   ..+..+..+..|+..|++|||++   .|||||||++|++++.++.+||+|||++.++.
T Consensus       133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999976653   55578888999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      . .....+.+|++.|.|||++.+..| ++++|+||+|+++|.++.|..||++..        ..+.-++.+.+++..+..
T Consensus       207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------lk~Lr~rvl~gk~rIp~~  277 (596)
T KOG0586|consen  207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------LKELRPRVLRGKYRIPFY  277 (596)
T ss_pred             c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------cccccchheeeeecccce
Confidence            3 455667899999999999999887 578999999999999999999988432        222233344445444433


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...    ++.+++.+++..+|.+|++.+++++
T Consensus       278 ms~----dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  278 MSC----DCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eec----hhHHHHHHhhccCccccCCHHHhhh
Confidence            222    3678999999999999999999875

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.1e-34  Score=303.57  Aligned_cols=260  Identities=22%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|++|.||+|+.. +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            4788899999999999999864 68999999987643222 234678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+ +++|.+++....  ..+++.+++.++.||++|++|||+.   +++|+||||+||+++.++.++++|||.+.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999886543  4589999999999999999999999   99999999999999999999999999998765433


Q ss_pred             C-CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------h---------
Q 039344          762 S-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------A---------  823 (873)
Q Consensus       762 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~---------  823 (873)
                      . ......++..|+|||++.+. .++.++||||+|+++|||++|..||....+..........       .         
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            2 23445788999999988654 4688999999999999999998887643321110000000       0         


Q ss_pred             hhhhcCCCCC-CCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 LDEMLDPRLP-TPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......+... .+. ....+....+.+++.+|++.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000000000 000 000112346889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-33  Score=295.25  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=203.5

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|+..+.||+|++|.||++... +++.+++|++.....   ...+.+.+|++.++.++|||++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4778899999999999999875 788999999876433   235789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++....  ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999999986543  4589999999999999999999998   99999999999999999999999999998766543


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      . .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...........     ......+..+....    
T Consensus       153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~----  222 (253)
T cd05122         153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-----IATNGPPGLRNPEK----  222 (253)
T ss_pred             c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-----HHhcCCCCcCcccc----
Confidence            2 3345688899999999888899999999999999999999999875432111110     11111111111111    


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1234889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.4e-34  Score=298.83  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|+||.||+|... +|..||+|.+....... ...+.+.+|+.+++.++|+||+++++.+.+....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4778899999999999999765 58899999986532221 224568899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC-eEEeccccccccCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE-AHVSDFGIAKFLKPD  760 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~  760 (873)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++. ++++|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999986543 23478999999999999999999999   9999999999999998864 699999999876544


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........|++.|+|||+..+..++.++||||+|+++||+++|+.||........        ..............   
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~---  224 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--------VLKICQGYFAPISP---  224 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--------HHHHhcccCCCCCC---
Confidence            3333345688999999999888899999999999999999999999864332111        11111222111111   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||+.+|++|||+.|+++
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         225 NFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11234889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-33  Score=297.35  Aligned_cols=243  Identities=26%  Similarity=0.338  Sum_probs=197.2

Q ss_pred             eeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||.|++|.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999865 5899999998765433334457799999999999999999999999999999999999999999


Q ss_pred             hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccc
Q 039344          689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA  768 (873)
Q Consensus       689 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  768 (873)
                      .+++.+.   ..+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++|+|||.++...... ......
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            9998654   2488999999999999999999999   99999999999999999999999999998765432 222346


Q ss_pred             cccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC--CCCCCCCchhHHHHHHH
Q 039344          769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD--PRLPTPSRNVHDKLISI  846 (873)
Q Consensus       769 g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l  846 (873)
                      +++.|+|||.+.+..++.++|+||+|+++|++++|+.||......      .......+.+  .....+...    ...+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~----~~~~  223 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGNGKLEFPNYI----DKAA  223 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccCCCCCCCccc----CHHH
Confidence            788999999998888999999999999999999999998754311      1111122221  111112111    2358


Q ss_pred             HHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          847 VEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       847 ~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                      .+++.+||+.+|++||+     ++|+++
T Consensus       224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         224 KDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            89999999999999999     788765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.7e-34  Score=302.62  Aligned_cols=247  Identities=26%  Similarity=0.293  Sum_probs=193.9

Q ss_pred             eeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||+|+||+||++.. .+|+.||+|.+...........+.+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999965 46899999998654322222345677899999999999999999999999999999999999999


Q ss_pred             hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccc
Q 039344          689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA  768 (873)
Q Consensus       689 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  768 (873)
                      .+++..... ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+..... ........
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence            999865432 3589999999999999999999999   999999999999999999999999999976543 22233456


Q ss_pred             cccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHH
Q 039344          769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE  848 (873)
Q Consensus       769 g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  848 (873)
                      ++..|+|||++.+..++.++||||+|+++|+|++|+.||........    ...............+..    ....+.+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~  227 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLEMAVEYPDK----FSPEAKD  227 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhccccccccCCcc----CCHHHHH
Confidence            78899999999888899999999999999999999999865332110    001111111111111111    1234789


Q ss_pred             HHhhcccCCCCCCC-----CHHHHHH
Q 039344          849 VTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       849 li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      ++.+||+.+|++||     ++.++++
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHh
Confidence            99999999999999     6666754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-33  Score=300.97  Aligned_cols=260  Identities=20%  Similarity=0.214  Sum_probs=185.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC----CcEEEEEEccCCCCCcchh--------HHHHHHHHHHHHhccCCceeeEEe
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTF--------QQEFLNEVKALTEIWHRNIVKVYG  668 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~  668 (873)
                      ..+|.+.+.||+|+||+||+|...+    +..+|+|+...........        ......+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4679999999999999999998654    3456666543221111000        011223334455668999999999


Q ss_pred             EEEecc----eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          669 FCLHVR----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       669 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      .+....    ..++++|++. .++.+.+...   ...++..+..++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            776543    3467777764 3555555332   2356788899999999999999999   999999999999999999


Q ss_pred             CeEEeccccccccCCCCC-------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc-hhh
Q 039344          745 EAHVSDFGIAKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-SFS  816 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-~~~  816 (873)
                      .++|+|||+|+.+.....       ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999987643221       112346899999999999999999999999999999999999999765321 111


Q ss_pred             hhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          817 SLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..........+..+....+.     ....+.+++..||..+|++||+++++++.|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIKN-----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHHHhhhhhhccCC-----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11111122233223222111     1234889999999999999999999999874

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.9e-34  Score=305.59  Aligned_cols=262  Identities=24%  Similarity=0.327  Sum_probs=197.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  677 (873)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++...... .....+.+|+.++++++|+||+++++++...  +..+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            467999999999999999999764 68999999987543222 1224567899999999999999999998754  5689


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++ ++.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++..
T Consensus        85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            99999974 7877775432  4589999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------hh-----
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------AL-----  824 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~~-----  824 (873)
                      ...........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...............       ..     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            654334444456788999998865 45789999999999999999999998754332111110000       00     


Q ss_pred             ----hhhcCCCCCCC--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 ----DEMLDPRLPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ----~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ..+..+..+..  ..........+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                00000000000  0000011345778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-35  Score=278.11  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=193.9

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+....+|.|..|.||+++.. +|..+|||.+....  ..+..+.+...++++..- ..|.||+.+|||......++.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            344567999999999999765 68999999998653  333456778888876665 48999999999999988999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      .|..+ .+..+.+  ..+++++.-+-++...++.||.||..++  +|+|||+||+|||+|+.|.+|+||||.+-++.+..
T Consensus       172 lMs~C-~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMSTC-AEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHH-HHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            88644 3344432  2345888888899999999999999886  99999999999999999999999999998776443


Q ss_pred             CCccccccccccccccccccC---CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          762 SNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~---~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                       ..+..+|-+.|||||.+...   +|+-++||||||+.++|+.||.+||......       .+.+..+++...|.. ..
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln~ePP~L-~~  317 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLNEEPPLL-PG  317 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHhcCCCCC-Cc
Confidence             33456789999999998744   5888999999999999999999998753321       112233333222111 11


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+.+++..|+++|+.+||...++++
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1123446899999999999999999999876

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.6e-33  Score=302.77  Aligned_cols=247  Identities=28%  Similarity=0.405  Sum_probs=195.8

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|+..+.||+|+||.||+|+. .+++.||+|++...........+.+..|+++++.++|||++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            367788999999999999975 4688999999875433333345678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++ ++.+.+...  ...+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++...... 
T Consensus       106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            9974 676666433  24589999999999999999999999   9999999999999999999999999998754432 


Q ss_pred             CCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC-CCCCCc
Q 039344          762 SNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR-LPTPSR  837 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  837 (873)
                         ....+++.|+|||++.   .+.++.++|||||||++|||++|+.||........        ...+.... ......
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  247 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPTLQSN  247 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--------HHHHHhccCCCCCCc
Confidence               2346788999999874   45688899999999999999999999764321111        11111111 111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                         .....+.+++.+||+.+|++||++.++++.
T Consensus       248 ---~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         248 ---EWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             ---cccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence               123347899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=296.73  Aligned_cols=249  Identities=24%  Similarity=0.284  Sum_probs=201.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+.|+.-++||+|+||.||-.+. .+|+.+|.|++.+.......-......|-.++++++.+.||.+--+|+..+..|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            46788889999999999999864 47999999988654433333345577899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      +..|.||+|..++..... ..+++.++..+|.+|+.||++||..   +||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999877654 4599999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      . ...+..+||.+|||||++..+.|+...|.||+||++|||+.|+.||.....        ....+++-......+..+.
T Consensus       340 g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kvk~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  340 G-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KVKREEVDRRTLEDPEEYS  410 (591)
T ss_pred             C-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------hhhHHHHHHHHhcchhhcc
Confidence            4 344556999999999999999999999999999999999999999763221        1111111111111112222


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC
Q 039344          840 HDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      ...+.+..++....++.||.+|.
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRL  433 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhc
Confidence            22334577888899999999996

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=304.36  Aligned_cols=263  Identities=20%  Similarity=0.325  Sum_probs=195.7

Q ss_pred             CCCCCceeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLF  677 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  677 (873)
                      .|++.+.||+|+||.||+|...   +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999764   4789999999864322233346778999999999999999999999988  7899


Q ss_pred             EEEEeccCCChhhHhcccc--cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC----CCCeEEecc
Q 039344          678 IVYEYFKMCSLAVILSNDA--AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF----ENEAHVSDF  751 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~----~~~~kl~Df  751 (873)
                      +||||+++ ++.+.+....  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999985 5666554332  223588899999999999999999999   9999999999999999    899999999


Q ss_pred             ccccccCCCCC---CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccch-----hhhhhhhh
Q 039344          752 GIAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-----FSSLNLNI  822 (873)
Q Consensus       752 g~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-----~~~~~~~~  822 (873)
                      |+++.......   ......++..|+|||++.+. .++.++||||+||++|+|++|+.||.......     ........
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322   22344678899999987664 57889999999999999999999987433211     00000000


Q ss_pred             hhh------------------------hhcCCCCCCCCchh-H----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          823 ALD------------------------EMLDPRLPTPSRNV-H----DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       823 ~~~------------------------~~~~~~~~~~~~~~-~----~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+.                        .......+...... .    .....+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000                        00000111000000 0    12235889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-34  Score=297.55  Aligned_cols=246  Identities=22%  Similarity=0.265  Sum_probs=188.3

Q ss_pred             ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHH-HhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          608 HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.||+|+||.||+|... +|+.||+|.+.............+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999764 6899999998654222222223445555544 344899999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      ++|.+++...   ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||+++....    ..
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            9999998643   3488999999999999999999999   999999999999999999999999999875432    22


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHH
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS  845 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  845 (873)
                      ...+++.|+|||.+.+..++.++||||+|+++||+++|..||........        ...+.......+..........
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--------FDNILSRRINWPEEVKEFCSPE  223 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhcccCCCCcccccCCHH
Confidence            34678899999999888889999999999999999999999864332211        1111111111111111112345


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          846 IVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       846 l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      +.+++.+||+.+|++||++.++.+.+
T Consensus       224 ~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         224 AVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHHHccCCHHHccCCCcHHHHH
Confidence            88999999999999999776554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-33  Score=301.89  Aligned_cols=262  Identities=22%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|++|+||+|+.. +|+.||+|++....... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            46888999999999999999765 68999999986543221 23466889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-CCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~  759 (873)
                      ||++ +++.+++.... ....++..+..++.||+.|++|||++   +++||||+|+||+++. ++.+||+|||+++....
T Consensus        81 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             eccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9997 47777764332 23367888889999999999999999   9999999999999985 45799999999976544


Q ss_pred             CCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh---hhhhhh--------
Q 039344          760 DSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN---IALDEM--------  827 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~---~~~~~~--------  827 (873)
                      .........+++.|+|||++.+. .++.++||||+||++|+|+||+.||..............   ......        
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            33333445678899999988764 578899999999999999999999864332110000000   000000        


Q ss_pred             ----cCCCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 ----LDPRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ----~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ..+......  ...+.....+.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                000000000  000111234789999999999999999999975

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-33  Score=301.87  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=193.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  679 (873)
                      ++|...+.||+|+||.||++... +|+.||+|.+......  .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            34566788999999999999754 6899999998754322  33567889999999996 99999999999999999999


Q ss_pred             EEeccCCChhhHhcc--cccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          680 YEYFKMCSLAVILSN--DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      |||+.. ++.++...  ......+++..+..++.|++.|++|||+..  +++||||||+||+++.++.++|+|||+++..
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            999874 54443221  112245899999999999999999999742  8999999999999999999999999999765


Q ss_pred             CCCCCCccccccccccccccccccC---CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC---CC
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD---PR  831 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~  831 (873)
                      ...... ....|+..|+|||++.+.   .++.++||||+||++|||++|+.||.....       ......+...   +.
T Consensus       159 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~  230 (288)
T cd06616         159 VDSIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGDPPI  230 (288)
T ss_pred             ccCCcc-ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCCCCc
Confidence            433222 234678899999998776   688999999999999999999999864321       0011111111   11


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ++..  ........+.+++.+||+.+|++||++++|++
T Consensus       231 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         231 LSNS--EEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCCc--CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111  11123345889999999999999999999976

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-33  Score=296.59  Aligned_cols=245  Identities=22%  Similarity=0.235  Sum_probs=186.7

Q ss_pred             eeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHh---ccCCceeeEEeEEEecceeEEEEEecc
Q 039344          609 CIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE---IWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       609 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      .||+|+||.||+++.. +++.||+|.+.............+.+|..+++.   .+||+|+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999764 689999999875433222222334455544443   379999999999999999999999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW  764 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  764 (873)
                      +++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++.......  .
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~  152 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence            99999888643   3589999999999999999999999   99999999999999999999999999997554322  2


Q ss_pred             ccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHH
Q 039344          765 TELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL  843 (873)
Q Consensus       765 ~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  843 (873)
                      ....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..........  .... .......++  .    ...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~-~~~~~~~~~--~----~~~  223 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRM-TLTVNVELP--D----SFS  223 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHH-hhcCCcCCc--c----ccC
Confidence            23468999999998864 557899999999999999999999986433211110  0000 000111111  1    122


Q ss_pred             HHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 039344          844 ISIVEVTISCVDENPESRP-----TMQKVCQL  870 (873)
Q Consensus       844 ~~l~~li~~cl~~dP~~RP-----s~~ev~~~  870 (873)
                      ..+.+++.+||+.||++||     +++|+++.
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            3578999999999999999     59988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.9e-34  Score=324.84  Aligned_cols=254  Identities=28%  Similarity=0.456  Sum_probs=197.1

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-----
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-----  672 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----  672 (873)
                      +-..+|+..+.||+||||.||+++.+ ||+.||||++....  .......+.+|+..+.+++|||||+++..+.+     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            34567888899999999999999877 89999999998664  33446779999999999999999998711100     


Q ss_pred             --------------------------------------------------------------------------------
Q 039344          673 --------------------------------------------------------------------------------  672 (873)
Q Consensus       673 --------------------------------------------------------------------------------  672 (873)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------c--------ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHH
Q 039344          673 --------------------------V--------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS  718 (873)
Q Consensus       673 --------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~  718 (873)
                                                +        ...||-||||+..++++++++.....  .....++++++|++|++
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence                                      0        12478899999989888886654321  45678999999999999


Q ss_pred             HHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC------------------CCCCCccccccccccccccccc
Q 039344          719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK------------------PDSSNWTELAGTYGYVAPELAY  780 (873)
Q Consensus       719 ~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~g~~~y~aPE~~~  780 (873)
                      |+|++   |+|||||||.||++|+++.|||+|||+|+...                  ....+.+..+||.-|+|||++.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            99999   99999999999999999999999999998721                  0112345678999999999987


Q ss_pred             cCC---CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCC
Q 039344          781 TMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDEN  857 (873)
Q Consensus       781 ~~~---~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  857 (873)
                      +..   |+.|+|+||+|||++||+.   ||..       .......+...-++.+|.+..-.......=..+|.+++++|
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGT-------SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCc-------hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence            654   9999999999999999985   4442       11222334455566666662222223333468899999999


Q ss_pred             CCCCCCHHHHHH
Q 039344          858 PESRPTMQKVCQ  869 (873)
Q Consensus       858 P~~RPs~~ev~~  869 (873)
                      |.+||||.|++.
T Consensus       859 P~kRPtA~eLL~  870 (1351)
T KOG1035|consen  859 PSKRPTATELLN  870 (1351)
T ss_pred             CccCCCHHHHhh
Confidence            999999999975

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-33  Score=321.60  Aligned_cols=265  Identities=17%  Similarity=0.227  Sum_probs=186.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC--CCcEEEEEEc--------------cCCCCCcchhHHHHHHHHHHHHhccCCcee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA--SGEIIAVKKF--------------HSPLPGEMTFQQEFLNEVKALTEIWHRNIV  664 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~--------------~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  664 (873)
                      ..+|++.+.||+|+||+||++..+  +++.+++|.+              .+...........+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998643  2222222211              111111222345688999999999999999


Q ss_pred             eEEeEEEecceeEEEEEeccCCChhhHhcccc--cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDA--AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       665 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      ++++++.+.+..|+|+|++. +++.+++....  ........++..++.|++.||+|||++   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            99999999999999999986 46666654322  122234567788999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC-Ccccccchhhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNL  820 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P-~~~~~~~~~~~~~~  820 (873)
                      ++.+||+|||+++.+..... ......||..|+|||++.+..++.++|||||||++|||++|..| +.............
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            99999999999987654332 22346799999999999999999999999999999999998764 33221110000000


Q ss_pred             hh-----hhhh----------hcC-CCCCCCCchhH------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 NI-----ALDE----------MLD-PRLPTPSRNVH------DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ~~-----~~~~----------~~~-~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..     ...+          +++ ..+........      .....+.+++.+|++.||++|||+.|+++
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00     0000          000 00000000000      01124677899999999999999999986

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-33  Score=299.44  Aligned_cols=243  Identities=24%  Similarity=0.411  Sum_probs=195.8

Q ss_pred             ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCC
Q 039344          608 HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC  686 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~  686 (873)
                      ..||+|+||.||+|.. .+|+.||+|++....   ......+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            5799999999999976 478999999875432   223567889999999999999999999999999999999999999


Q ss_pred             ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccc
Q 039344          687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE  766 (873)
Q Consensus       687 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  766 (873)
                      ++.+++..    ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+............
T Consensus       103 ~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         103 ALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            99988743    2478999999999999999999999   9999999999999999999999999998766543333344


Q ss_pred             cccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHH
Q 039344          767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISI  846 (873)
Q Consensus       767 ~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  846 (873)
                      ..+++.|+|||++.+..++.++||||+|+++|+|++|..||..........     .......+......    .....+
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~l  246 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-----MIRDNLPPKLKNLH----KVSPSL  246 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhhCCcccCCcc----cCCHHH
Confidence            568899999999988888999999999999999999999986433221111     11111112211111    112347


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHH
Q 039344          847 VEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       847 ~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+++.+||+.+|.+||++.++++
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhc
Confidence            88999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.3e-33  Score=291.62  Aligned_cols=250  Identities=27%  Similarity=0.396  Sum_probs=204.2

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIV  679 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  679 (873)
                      +|...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++.+++++||||+++++++.+.  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4677899999999999999876 7899999998755332 23457899999999999999999999999988  889999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      +||++++++.+++....   .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999986543   689999999999999999999998   999999999999999999999999999987765


Q ss_pred             CCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC-CCCCCCC
Q 039344          760 DSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPS  836 (873)
Q Consensus       760 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  836 (873)
                      ...  ......++..|+|||...+...+.++||||+|+++|++++|..||.......       ........ ...+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~  226 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-------AALYKIGSSGEPPEIP  226 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHhccccCCCcCCC
Confidence            433  1344578889999999988889999999999999999999999987544110       01111111 1111111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .   .....+.+++.+|++.+|++||++.++++
T Consensus       227 ~---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         227 E---HLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             c---ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1   11345889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=291.16  Aligned_cols=249  Identities=24%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|++|.||+|+.. +++.|++|.+...... ....+.+.+|++++++++|||++++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4778899999999999999765 6789999999765432 2345789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++++|.+++...   ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999998654   4589999999999999999999999   99999999999999999999999999998776554


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......++..|+|||...+..++.++||||+|+++|+|++|+.||........       ............+..    
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~----  222 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-------LFRIVQDDHPPLPEG----  222 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHhccCCCCCCCC----
Confidence            444456788999999998888888999999999999999999999864332110       000001111111111    


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.+++.+||+.+|++||++.+++.
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         223 ISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1234789999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=278.27  Aligned_cols=253  Identities=21%  Similarity=0.255  Sum_probs=209.0

Q ss_pred             HhcCCCCC-ceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe----
Q 039344          600 ATNDFDDE-HCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH----  672 (873)
Q Consensus       600 ~~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----  672 (873)
                      .+++|++. ++||-|-.|.|.... ..+|+.+|+|++...        ....+|++.--.. .|||||.++++|++    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            35667664 689999999999885 457999999998743        4456888874444 79999999999975    


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---CeEEe
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVS  749 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~  749 (873)
                      .+...+|||.|+||.|...+...+ ...+++.++..|++||+.|+.|||+.   .|.||||||+|+|.....   .+||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence            346789999999999999987654 35699999999999999999999999   999999999999997543   68999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC
Q 039344          750 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       750 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      |||+|+.-.. .....+.+-||.|.|||++...+|+..+|+||+||++|-|++|.+||........    ......++..
T Consensus       207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai----spgMk~rI~~  281 (400)
T KOG0604|consen  207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKRRIRT  281 (400)
T ss_pred             ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC----ChhHHhHhhc
Confidence            9999986543 3455677889999999999999999999999999999999999999875443321    1222344455


Q ss_pred             CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +.+.++.+.+.+.+.+..++|+.++..+|.+|.|+.+++.
T Consensus       282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            6677777777888889999999999999999999999875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=334.81  Aligned_cols=252  Identities=28%  Similarity=0.431  Sum_probs=201.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      +-++.....||.|.||.||-|. ..+|+..|+|.++..... ......+.+|+.++..++|||+|+.||+-.+.+..+|.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3456777899999999999985 567999999988754322 44457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||||++|+|.+.+...+   ..++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999986543   356667778889999999999999   999999999999999999999999999998866


Q ss_pred             CCCC----ccccccccccccccccccCC---CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          760 DSSN----WTELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       760 ~~~~----~~~~~g~~~y~aPE~~~~~~---~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ....    ....+||+.|||||++.+.+   ...+.||||+|||+.||+||+.||...+.. |.     ....-......
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~a-----IMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WA-----IMYHVAAGHKP 1460 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hH-----HHhHHhccCCC
Confidence            5322    34678999999999998754   456899999999999999999997643321 21     11111112222


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +.|..    ...+-.+++.+|+..||++|-++.|+++
T Consensus      1461 q~P~~----ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 QIPER----LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CCchh----hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            22222    2334678899999999999999988875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-33  Score=297.58  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=196.7

Q ss_pred             eeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||+|+||.||+++.. +|+.+|+|.+...........+.+.+|++.+++++||||+++++.+......|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 5999999998754333334467789999999999999999999999999999999999999999


Q ss_pred             hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC------
Q 039344          689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS------  762 (873)
Q Consensus       689 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------  762 (873)
                      .+++....   .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99986533   589999999999999999999999   999999999999999999999999999876543321      


Q ss_pred             --CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          763 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       763 --~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        ......++..|+|||.......+.++||||+|+++|++++|+.||.......        ............+...  
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~--  224 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--------IFQNILNGKIEWPEDV--  224 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCcCCCccc--
Confidence              2234567889999999988888999999999999999999999987433221        1111222222211111  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .....+.+++.+||+.+|++|||+.++.+.|
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            0133578999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.4e-33  Score=292.02  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=205.7

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|.+.+.||+|+||.||++... +++.||+|++...... ....+.+.+|++.++.++|||++++.+.+...+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4778899999999999999765 6889999998754322 2345678999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          682 YFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |+++++|.+++.... ....+++..+..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999987643 235689999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........|++.|+|||...+..++.++||||+|+++|+|++|+.||+.......        .........+....   
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~---  225 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL--------ALKILKGQYPPIPS---  225 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH--------HHHHhcCCCCCCCC---
Confidence            4333445788899999999888899999999999999999999999875432111        11111221211111   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||..+|++||++.++++
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11234889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-33  Score=294.60  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=204.5

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|++.+.||+|+||.||+++. .+++.+|+|.+....... ....++.+|+++++.++||||+++++++.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            477889999999999999965 478899999987543322 235678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          682 YFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |++++++.+++.... ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||+++.....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999986533 234588999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        ......+++.|+|||.+.+..++.++|+||+|+++||+++|+.||........        .........+....   
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~---  223 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--------RYKVQRGKYPPIPP---  223 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHhcCCCCCCch---
Confidence              22235678899999999998899999999999999999999999875432211        11112222222211   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            233458999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.7e-33  Score=301.34  Aligned_cols=249  Identities=26%  Similarity=0.396  Sum_probs=194.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.|+..+.||+|+||.||+|+.. +++.||+|.+...........+++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999864 67889999986433333333567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+. |++.+.+....  ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 57776664332  3478999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                          ....+++.|+|||.+.   ...++.++||||+||++|+|++|+.||.........        ........+... 
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~-  235 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------YHIAQNESPALQ-  235 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--------HHHhhcCCCCcC-
Confidence                2346788999999874   345788999999999999999999997643221110        111111111110 


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                       .......+.+++.+||+.+|++||+++++++.
T Consensus       236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence             01123357899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-33  Score=306.22  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=196.7

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec--ce
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV--RH  675 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~  675 (873)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....... .....+.+|+.+++++ +||||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            3467888999999999999999865 68899999886432222 2245677899999999 999999999998653  36


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||++ ++|..++...    .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            899999998 5888887543    578889999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-----Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh----------
Q 039344          756 FLKPDSS-----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN----------  819 (873)
Q Consensus       756 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~----------  819 (873)
                      .......     ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||............          
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            6644322     2234568889999998765 45788999999999999999999998643322110000          


Q ss_pred             ---------hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          820 ---------LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       820 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                               ..........................+.+++.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                     000001111111111111111123458899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-33  Score=295.06  Aligned_cols=259  Identities=23%  Similarity=0.358  Sum_probs=195.9

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc---cCCceeeEEeEEEecce----
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---WHRNIVKVYGFCLHVRH----  675 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----  675 (873)
                      |++.+.||+|+||.||+|+.+ +++.||+|+++...... .....+.+|+.+++++   +|||++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            567789999999999999876 48999999997543322 2235566788877766   59999999999988776    


Q ss_pred             -eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          676 -LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       676 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                       .+++|||+.+ ++.+++..... ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence             8999999984 78888764332 3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh----h------
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA----L------  824 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~----~------  824 (873)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++|+.||................    .      
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         155 RIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             eeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            8765432 2233457889999999999899999999999999999999999987543221111000000    0      


Q ss_pred             ----hhhcCCCCCCC-CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 ----DEMLDPRLPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ----~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ........... .....+....+.+++.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                00000000000 1111223356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.7e-33  Score=304.28  Aligned_cols=259  Identities=21%  Similarity=0.341  Sum_probs=196.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  673 (873)
                      ...+|+..+.||+|+||.||+|+.. +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            3578999999999999999999754 7899999998654322 22345678899999999999999999998643     


Q ss_pred             -ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          674 -RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       674 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                       ...|+||||+. +++.+.+..     .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence             35799999997 477776642     278889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccch-hhhhh------------
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-FSSLN------------  819 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-~~~~~------------  819 (873)
                      +++...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||....... +....            
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            998764332 2234567889999999999999999999999999999999999987433211 00000            


Q ss_pred             -hhhhhhhhcCCCC----------------CCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          820 -LNIALDEMLDPRL----------------PTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       820 -~~~~~~~~~~~~~----------------~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       .........+.+.                +.... ........+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0000000000000                00000 00112345789999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-33  Score=296.47  Aligned_cols=259  Identities=23%  Similarity=0.373  Sum_probs=197.1

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeEEEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVY  680 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  680 (873)
                      |++.+.||+|++|.||+|+.. +|+.+|+|++.... ......+.+.+|+++++.++|||++++++++.+.  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            567789999999999999865 58899999998653 2223356788999999999999999999999988  8899999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++ ++.+++....  ..+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.++++|||.+......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            99985 7887775432  3589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CC-Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hhhhhh----
Q 039344          761 SS-NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IALDEM----  827 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~~~~~----  827 (873)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............       ......    
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            32 2233456788999998765 4578899999999999999999999875432211100000       000000    


Q ss_pred             ----cCCCCCCCC---chhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 ----LDPRLPTPS---RNVHD-KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ----~~~~~~~~~---~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ..+....+.   ..... ....+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                000000000   00001 1346889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-33  Score=291.43  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=196.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCC--CcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--cee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLP--GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  676 (873)
                      .+|++.+.||+|+||.||+|+. .+++.||+|.+.....  ......+.+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688999999999999999975 4689999998753211  1223346788999999999999999999998764  468


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++|+||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999988543   3478899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .....   .......++..|+|||.+.+..++.++|||||||++|++++|+.||.......       ........+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~  228 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-------AIFKIATQPTKP  228 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-------HHHHHHcCCCCC
Confidence            54321   12234568889999999988888999999999999999999999986432211       111111111111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....   .....+.+++.+||+ +|.+||++.+++.
T Consensus       229 ~~p~---~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         229 MLPD---GVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCc---ccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111   122348899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=306.68  Aligned_cols=202  Identities=30%  Similarity=0.460  Sum_probs=177.4

Q ss_pred             CCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc------e
Q 039344          603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR------H  675 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  675 (873)
                      .|...+.||+|+||.||+|+ ..+|+.||||.++....  ....+...+|++++++++|||||+++++-++..      .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            34556889999999999998 56899999999987543  233677899999999999999999999876543      4


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC--CCCC--eEEecc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD--FENE--AHVSDF  751 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--~~~~--~kl~Df  751 (873)
                      ..+|||||.+|+|+..+.+......+++.+.+.+...++.|+.|||++   +|+||||||.||++-  ++|+  -||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            689999999999999998877777799999999999999999999999   999999999999984  4453  799999


Q ss_pred             ccccccCCCCCCccccccccccccccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCccc
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFI  810 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDv~s~G~il~el~tg~~P~~~~  810 (873)
                      |.|+.++++ +.....+||..|.+||... .+.|+..+|.|||||++|+++||..||...
T Consensus       169 G~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  169 GAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            999988755 4777899999999999988 588999999999999999999999999743

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-33  Score=298.72  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=203.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  679 (873)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...........+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999765 78999999987543333333567889999999998 99999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999998654   3589999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCC--------------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh
Q 039344          760 DSS--------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN  819 (873)
Q Consensus       760 ~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~  819 (873)
                      ...                    ......++..|+|||...+..++.++||||+|+++|++++|+.||......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence            321                    122345788999999988888999999999999999999999998744321      


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTM----QKVCQ  869 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ev~~  869 (873)
                        .............+...    ...+.+++.+||+.+|.+||++    +++++
T Consensus       229 --~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 --LTFQKILKLEYSFPPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HHHHHHHhcCCCCCCcc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              11122222222222211    2347899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9e-33  Score=297.86  Aligned_cols=246  Identities=27%  Similarity=0.396  Sum_probs=193.0

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |...+.||+|+||+||+|+.. +|+.||+|++...........+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999764 6889999998754333333456788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +. +++.+++...  ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            97 5666666432  24588999999999999999999999   999999999999999999999999999864322   


Q ss_pred             Cccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          763 NWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                       .....|+..|+|||++.   ...++.++|||||||++|||++|..||...........        ......+...  .
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~--~  242 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------IAQNDSPTLQ--S  242 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--------HHhcCCCCCC--c
Confidence             22456888999999974   35678899999999999999999999765432211111        0011111100  0


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111234789999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=281.51  Aligned_cols=255  Identities=26%  Similarity=0.343  Sum_probs=195.0

Q ss_pred             CCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHH-hccCCceeeEEeEEEecceeEEEEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT-EIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .+....||.|+||+|++... +.|+..|||+++....  ....+++..|.+... .-+.||||++||.+..++..|+-||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            33346799999999999854 5799999999987644  233577888888754 4489999999999999999999999


Q ss_pred             eccCCChhhHhcc--cccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          682 YFKMCSLAVILSN--DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       682 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      .|. -+++.+...  ......+++.-...|..-.++||+||....  .|+|||+||+|||+|..|.+||||||.+-.+..
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            997 455544422  113345778878888889999999999875  899999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          760 DSSNWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      . -..+.-+|-..|||||.+...  .|+-+|||||+|+++||+.||+.||..     |.....+......-++..-....
T Consensus       221 S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-----w~svfeql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  221 S-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-----WDSVFEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             H-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-----HHHHHHHHHHHHcCCCCeecCcc
Confidence            2 223334677889999998743  378899999999999999999999874     43322222222222333222233


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+....+..+|..|+.+|-..||.+.++.+
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            33445667999999999999999999998865

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.5e-33  Score=299.32  Aligned_cols=264  Identities=23%  Similarity=0.366  Sum_probs=196.9

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc---
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR---  674 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  674 (873)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++..... ......+.+|+++++.++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            45678999999999999999999875 5889999998754322 222456788999999999999999999987654   


Q ss_pred             -------eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeE
Q 039344          675 -------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH  747 (873)
Q Consensus       675 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k  747 (873)
                             ..++|+||+++ ++...+...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                   78999999986 666665433  23589999999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCC-CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh--
Q 039344          748 VSDFGIAKFLKPDSS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA--  823 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~--  823 (873)
                      |+|||.+........ ......++..|+|||.+.+. .++.++||||+||++|||++|+.||................  
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999987654332 22334567889999987653 46889999999999999999999987543221110000000  


Q ss_pred             -----hhhhc--------CCCCCC--CC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 -----LDEML--------DPRLPT--PS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 -----~~~~~--------~~~~~~--~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                           ...+.        ++....  .. .........+.+++.+||+.||.+||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 00000        000000  00 000011345889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.2e-33  Score=297.67  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=193.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||.||+|...+ ++.||||.++.....  ....++..|+..+.+.. ||||+++++++.+....++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            4678889999999999999998764 899999998754222  22456777887777774 9999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      ||||++ +++.++....  ...+++..+..++.|++.|++|||+ .   +|+||||+|+||+++.++.++|+|||++...
T Consensus        92 v~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          92 CMELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EeeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999986 4666665432  2368899999999999999999997 5   8999999999999999999999999999766


Q ss_pred             CCCCCCccccccccccccccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ..... .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......       ........+...+
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~  237 (296)
T cd06618         166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPP  237 (296)
T ss_pred             cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCC
Confidence            43322 23345788999999987654    788999999999999999999998642211       0111112221111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ..... ......+.+++.+||+.||++||++.++++.
T Consensus       238 ~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPPN-EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCC-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11100 0122358899999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=296.26  Aligned_cols=259  Identities=22%  Similarity=0.341  Sum_probs=200.3

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |++.+.||+|++|.||+|... +|+.+++|++....... .....+..|++++++++|+||+++++++......++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            567789999999999999764 78999999987543322 3356788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +++ ++.+++....  ..+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+|||.+........
T Consensus        80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            985 7777775432  4589999999999999999999999   999999999999999999999999999987765443


Q ss_pred             CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hhhhhhcC-----
Q 039344          763 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IALDEMLD-----  829 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~~~~~~~-----  829 (873)
                      ......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||..............       .....+.+     
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            33345678899999998876 688999999999999999999999865432211100000       00000000     


Q ss_pred             ----C--CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 ----P--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ----~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          +  ...............+.+++.+||+.||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                0  000000111223456889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=305.51  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=194.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      +++|++.+.||+|+||.||+|.. .+|+.||+|++....  .......+.+|+.++++++||||+++++++....     
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            46899999999999999999975 478999999986421  2223466889999999999999999999876543     


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++|+||+++ ++.+.+..    ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            47999999974 77666643    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh-------hhhhh
Q 039344          755 KFLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL-------NLNIA  823 (873)
Q Consensus       755 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~-------~~~~~  823 (873)
                      +.......   ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...........       ...+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            76543222   1223567899999998754 4678899999999999999999999864332110000       00000


Q ss_pred             hhhhcCCC-------CCCCC--c---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          824 LDEMLDPR-------LPTPS--R---NVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       824 ~~~~~~~~-------~~~~~--~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ...+.+..       .+...  .   ........+.+++.+||+.||++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11000000       00000  0   001123458899999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.7e-33  Score=294.90  Aligned_cols=256  Identities=20%  Similarity=0.269  Sum_probs=191.9

Q ss_pred             CCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEec--ceeEEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHV--RHLFIV  679 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  679 (873)
                      |++.+.||+|+||.||+|.. .+++.||+|+++.......  .....+|+..+.++. |||++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            56778999999999999975 4689999999875432221  234557888899885 99999999999987  889999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||++ +++.+++....  ..+++.++..++.|++.|++|||+.   +++||||+|+||+++. +.+||+|||.++....
T Consensus        79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99997 57777765432  3589999999999999999999999   9999999999999999 9999999999987643


Q ss_pred             CCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-------hhhhhh-----
Q 039344          760 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-------NIALDE-----  826 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-------~~~~~~-----  826 (873)
                      .. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.............       ......     
T Consensus       152 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         152 KP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             CC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            32 2233467889999997654 557889999999999999999999997543221100000       000000     


Q ss_pred             hcCCCCCCCCc-----hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPSR-----NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+...+....     ........+.+++.+||+++|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000     00122456899999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-33  Score=304.64  Aligned_cols=262  Identities=22%  Similarity=0.300  Sum_probs=197.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----R  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  674 (873)
                      ..+|.+.+.||+|+||+||+|+. .+|+.||+|++....... .....+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45789999999999999999975 478999999987543222 2245677899999999999999999988654     3


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++|+||+. +++.+++...   ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999997 6788777543   4589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhh-------hhhhh----
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS-------LNLNI----  822 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~-------~~~~~----  822 (873)
                      +.............++..|+|||.+.. ..++.++|||||||++|+|++|+.||..........       .....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            876544333344567889999998765 458899999999999999999999986432110000       00000    


Q ss_pred             ----hhhhhcC--CCCCCC--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          823 ----ALDEMLD--PRLPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       823 ----~~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                          .......  +..+..  ..........+.+++.+||+.+|++|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                0000000  000000  00011223457899999999999999999999863

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.1e-33  Score=300.63  Aligned_cols=258  Identities=17%  Similarity=0.210  Sum_probs=190.8

Q ss_pred             CCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          606 DEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       606 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      +.+.+|.|+++.||++.. +++.||+|++..... .....+.+.+|++.++.++||||+++++++.+.+..+++|||+++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            344455555555555555 699999999875422 223457799999999999999999999999999999999999999


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC---
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS---  762 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  762 (873)
                      +++.+++..... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++++|||.+........   
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999999875432 3478899999999999999999999   999999999999999999999999999875543221   


Q ss_pred             ----CccccccccccccccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh----------
Q 039344          763 ----NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE----------  826 (873)
Q Consensus       763 ----~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~----------  826 (873)
                          ......++..|+|||++.+.  .++.++||||+||++|||++|+.||...................          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                11234567789999998763  47889999999999999999999987543221100000000000          


Q ss_pred             ----------hcCCCC--CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 ----------MLDPRL--PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ----------~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                ..++..  .............+.+++.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                      000000  0011111222346889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-32  Score=290.64  Aligned_cols=244  Identities=21%  Similarity=0.225  Sum_probs=186.7

Q ss_pred             eeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHH---HHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          609 CIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA---LTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       609 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      .||+|+||.||+|+. .+|+.||+|.+.............+..|..+   ++...||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999975 4689999999875432222212234444443   344579999999999999999999999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW  764 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  764 (873)
                      +++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++......  .
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~  152 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence            99999888543   3589999999999999999999999   99999999999999999999999999997654322  2


Q ss_pred             cccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHH
Q 039344          765 TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL  843 (873)
Q Consensus       765 ~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  843 (873)
                      ....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...........  .   ..........+..    ..
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~---~~~~~~~~~~~~~----~s  223 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--D---RMTLTMAVELPDS----FS  223 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--H---HHhhccCCCCCCc----CC
Confidence            235689999999998754 588999999999999999999999875432111100  0   0011111111111    12


Q ss_pred             HHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          844 ISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       844 ~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      ..+.+++.+|+..+|.+||     ++.++++
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            3588999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.9e-33  Score=296.10  Aligned_cols=256  Identities=21%  Similarity=0.300  Sum_probs=198.6

Q ss_pred             CCCCCceeeecCCeEEEEEEe----CCCcEEEEEEccCCCC-CcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEeccee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  676 (873)
                      +|++.+.||+|++|.||+++.    .+++.||||.++.... ......+.+.+|+.+++++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477789999999999999864    3578899999864321 1222345688999999999 699999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++...   ..+++..+..++.|+++|++|||+.   +++||||+|+||+++.++.++++|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999988643   3478899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCCc-cccccccccccccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSSNW-TELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ........ ....|+..|+|||...+..  .+.++||||+|+++|||++|..||...........    ....+.....+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~  230 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE----ISRRILKSKPP  230 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH----HHHHHHccCCC
Confidence            54433222 2345788999999987665  67899999999999999999999864322111111    11111122222


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+..    ....+.+++.+||+.||++|||+.++.+.|+
T Consensus       231 ~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         231 FPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             CCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            2211    1224789999999999999999888876653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.9e-33  Score=303.80  Aligned_cols=261  Identities=22%  Similarity=0.326  Sum_probs=197.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe----cce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~  675 (873)
                      ..+|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            478999999999999999999754 6999999998754322 2234667889999999999999999998763    346


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+. +++.+++...   ..+++..+..++.||+.|++|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999996 6888887543   3489999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCC----Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh------------
Q 039344          756 FLKPDSS----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL------------  818 (873)
Q Consensus       756 ~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~------------  818 (873)
                      .......    ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...........            
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            6543222    1234568889999998765 4578999999999999999999999975432110000            


Q ss_pred             ---hhhhhhhhhc---CCCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          819 ---NLNIALDEML---DPRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       819 ---~~~~~~~~~~---~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ..........   ......+.. ........+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               0000000110   111111100 01122446899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.9e-32  Score=286.79  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=190.3

Q ss_pred             HHHHHhcCCCCCcee--eecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          596 EIIRATNDFDDEHCI--GKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       596 e~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      +.....++|++.+.+  |+|+||.||+++. .+++.+|+|.+.......        .|+.....+ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEe
Confidence            334445677777766  9999999999975 468889999986432111        122222222 6999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEec
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSD  750 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~D  750 (873)
                      ..+..++||||+++++|.+++....   .+++.++..++.|++.|++|||+.   +++||||||+||+++.++ .++++|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            9999999999999999999986543   589999999999999999999999   999999999999999998 999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      ||.++......    ...++..|+|||++.+..++.++||||+|+++|||++|+.||..........   ...... ...
T Consensus       154 fg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~-~~~  225 (267)
T PHA03390        154 YGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL---ESLLKR-QQK  225 (267)
T ss_pred             CccceecCCCc----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH---HHHHHh-hcc
Confidence            99997654322    2467889999999998889999999999999999999999987433221110   111111 111


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPT-MQKVCQ  869 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~  869 (873)
                      ..+...    .....+.+++.+||+.+|++||+ ++++++
T Consensus       226 ~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 KLPFIK----NVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cCCccc----ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            111111    22335889999999999999996 588875

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.8e-32  Score=297.67  Aligned_cols=255  Identities=20%  Similarity=0.288  Sum_probs=190.0

Q ss_pred             ceeeec--CCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKG--GQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      ..||+|  +||+||+|+. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  9999999976 479999999987543322 234678899999999999999999999999999999999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW  764 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  764 (873)
                      ++++.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..........
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999998875432 3488899999999999999999999   99999999999999999999999998654332211110


Q ss_pred             -------cccccccccccccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------------h
Q 039344          765 -------TELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------------I  822 (873)
Q Consensus       765 -------~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------------~  822 (873)
                             ....++..|+|||++.+.  .++.++||||+||++|||++|+.||..............             .
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   112345679999998764  468899999999999999999999864321100000000             0


Q ss_pred             hhh------------------------hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          823 ALD------------------------EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       823 ~~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...                        .+......  ..........+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            000                        00000000  0111234456899999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-32  Score=295.85  Aligned_cols=261  Identities=21%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc------
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR------  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  674 (873)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....... .....+.+|+.++++++||||+++++++...+      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            57899999999999999999764 68999999986543222 12345678999999999999999999987654      


Q ss_pred             --eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          675 --HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       675 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                        ..++||||+.+ ++.+.+....  ..+++.++..++.|++.|++|||++   +++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999974 7777765432  3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC----CccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh------
Q 039344          753 IAKFLKPDSS----NWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN------  821 (873)
Q Consensus       753 ~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~------  821 (873)
                      .+........    ......++..|+|||.+.+.. ++.++||||+|+++|||++|+.||..............      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9986643322    122345778899999876643 68899999999999999999999865332110000000      


Q ss_pred             -hhh------hhhcCCCCCCCCc-hhH------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 -IAL------DEMLDPRLPTPSR-NVH------DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 -~~~------~~~~~~~~~~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ...      .....-..+.... ...      .....+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             000      0000000000000 000      01124678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-33  Score=302.52  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=199.7

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----ee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----HL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  676 (873)
                      +|++.+.||+|++|.||+|+.. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4788899999999999999865 589999999875432 1233567899999999999999999999998765     78


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      |+||||++ +++.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+..
T Consensus        80 ~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999998 4788877543   2689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC---CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-----------
Q 039344          757 LKPDS---SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-----------  821 (873)
Q Consensus       757 ~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-----------  821 (873)
                      .....   .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..............           
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            76543   223445678899999999887 789999999999999999999999875432211000000           


Q ss_pred             ----hhhhhhcC---CCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          822 ----IALDEMLD---PRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       822 ----~~~~~~~~---~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                          ........   ........ ........+.+++.+||+.+|++||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                00000000   00000000 001123457899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-33  Score=273.93  Aligned_cols=204  Identities=23%  Similarity=0.367  Sum_probs=170.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC---C--CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA---S--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  674 (873)
                      ...|+....||+|.||.||+|..+   +  .+.+|+|+++....+.. ......+|+..++.++|||++.+..++.. +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            356889999999999999999432   2  23789999986544332 34667899999999999999999999877 78


Q ss_pred             eeEEEEEeccCCChhhHhccc--ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC----CCeEE
Q 039344          675 HLFIVYEYFKMCSLAVILSND--AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE----NEAHV  748 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~----~~~kl  748 (873)
                      ..++++||.+. +|..+++-+  ...+.++...+..|+.||+.|+.|||++   -|.||||||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence            89999999984 666666433  3445688889999999999999999999   89999999999999888    89999


Q ss_pred             eccccccccCCCCCC---ccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          749 SDFGIAKFLKPDSSN---WTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       749 ~Dfg~a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      +|||+||.+...-..   ....+.|.+|.|||.+.+.+ |+.+.||||+|||+.||+|-.+-|.+
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999999988765433   34567899999999988764 89999999999999999997766653

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.4e-33  Score=290.28  Aligned_cols=252  Identities=22%  Similarity=0.298  Sum_probs=196.7

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCC--cchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      +|.+.+.||+|+||.||+++.. .+..+++|..+.....  .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778899999999999999764 3445666665432211  112234577899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          680 YEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||++++++.+++.... ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++. +.++++|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999998886432 335689999999999999999999999   9999999999999975 679999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ..........|++.|+|||...+..++.++||||+|+++|++++|..||......        ........+..+...  
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~--  226 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVEGPTPSLP--  226 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCCc--
Confidence            5444444566888999999998888899999999999999999999998632211        111112222222111  


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ......+.+++.+||+.+|++||++.|+++
T Consensus       227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         227 -ETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             122345889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=300.72  Aligned_cols=261  Identities=20%  Similarity=0.256  Sum_probs=193.3

Q ss_pred             cCCC-CCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcc-----------hhHHHHHHHHHHHHhccCCceeeEEe
Q 039344          602 NDFD-DEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEM-----------TFQQEFLNEVKALTEIWHRNIVKVYG  668 (873)
Q Consensus       602 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~~  668 (873)
                      ++|. +.+.||+|+||+||+|... +++.||+|++........           .....+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 4577999999999999754 689999999865422210           01125779999999999999999999


Q ss_pred             EEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       669 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                      ++...+..++||||++ +++.+++...   ..+++.....++.|++.|++|||+.   +++||||+|+||+++.++.+++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 6888887542   3488999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCC--------------CCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccc
Q 039344          749 SDFGIAKFLKP--------------DSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSM  813 (873)
Q Consensus       749 ~Dfg~a~~~~~--------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~  813 (873)
                      +|||.++....              .........+++.|+|||.+.+. .++.++||||+||++|||++|+.||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999976651              11122234567889999998764 3688999999999999999999998754432


Q ss_pred             hhhhhhhh-------hhhhhhc--------CCCCCCCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          814 SFSSLNLN-------IALDEML--------DPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       814 ~~~~~~~~-------~~~~~~~--------~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........       ..+....        ....+... .........+.+++.+||+.+|++||+++|++.
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11100000       0000000        00000000 000111345789999999999999999999975

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-32  Score=298.17  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=196.4

Q ss_pred             HHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cce
Q 039344          598 IRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VRH  675 (873)
Q Consensus       598 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  675 (873)
                      ...+++|++.+.||+|+||.||+|+.. +|+.||+|++....... ...+.+.+|+++++.++||||+++++++.. ...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            456788999999999999999999754 79999999986543222 234678899999999999999999999875 557


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++|+||+. +++..++..    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.++
T Consensus        85 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehhc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            899999984 688877753    2477888889999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-------hhhhhhhh
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-------LNIALDEM  827 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-------~~~~~~~~  827 (873)
                      ....   ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||............       ..+.....
T Consensus       157 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         157 IQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             ccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            5432   2233467889999998766 56889999999999999999999998643321000000       00000000


Q ss_pred             cC-----------CCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LD-----------PRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~-----------~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+           ...+.+.. ........+.+++.+||+.+|++||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00           00000100 00112245889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=293.35  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |+..+.||+|++|.||+|+.. +++.||+|++..... .....+.+..|+.+++.++|+|++++++++.+.+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            556788999999999999765 589999999876532 223356788999999999999999999999999999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      ++ +++.+++....  ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.++.......
T Consensus        80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            98 58999886543  3589999999999999999999999   999999999999999999999999999987655443


Q ss_pred             CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-------hhhhhhh---h--cC
Q 039344          763 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-------LNIALDE---M--LD  829 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-------~~~~~~~---~--~~  829 (873)
                      ......++..|+|||.+.+. .++.++||||+|+++||+++|+.||............       .......   .  .+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            44445567889999998776 7889999999999999999999998653321110000       0000000   0  00


Q ss_pred             CCCCCC---C--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 PRLPTP---S--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ~~~~~~---~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+..   .  ...+.....+.+++.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            011000   0  000111345899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=290.73  Aligned_cols=258  Identities=23%  Similarity=0.345  Sum_probs=195.2

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEEEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      |++.+.||+|++|+||+|+.. +++.||+|++.......  ......+|+..+++++ |||++++++++.+.+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            567789999999999999875 57899999987543221  1234567899999998 9999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+ ++++.+++.... ...+++..+..++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||.++......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            99 788888876543 24589999999999999999999999   99999999999999999999999999998665332


Q ss_pred             CCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-------------hhhhhhh
Q 039344          762 SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-------------NIALDEM  827 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-------------~~~~~~~  827 (873)
                       ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............             .......
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             2234567889999998754 457889999999999999999999986433211100000             0000000


Q ss_pred             cCCCCCCCCc-----hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LDPRLPTPSR-----NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+...+....     ........+.+++.+||+.+|++||+++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            1111110000     00011245889999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=285.91  Aligned_cols=242  Identities=26%  Similarity=0.342  Sum_probs=198.0

Q ss_pred             eeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||+|+||.||++... +++.+|+|.+.............+..|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 5899999998765443333456889999999999999999999999999999999999999999


Q ss_pred             hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccc
Q 039344          689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA  768 (873)
Q Consensus       689 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  768 (873)
                      .+++....   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99986542   488999999999999999999998   999999999999999999999999999987654433344556


Q ss_pred             cccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHH
Q 039344          769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE  848 (873)
Q Consensus       769 g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  848 (873)
                      ++..|+|||...+...+.++|+||||+++|++++|+.||.....        ......+.....+.+...    ...+.+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~  222 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEFL----SPEARD  222 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC----CHHHHH
Confidence            88899999999888889999999999999999999999864332        111222222233222221    234789


Q ss_pred             HHhhcccCCCCCCCCH---HHHHH
Q 039344          849 VTISCVDENPESRPTM---QKVCQ  869 (873)
Q Consensus       849 li~~cl~~dP~~RPs~---~ev~~  869 (873)
                      ++.+||..||++||++   +++.+
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHh
Confidence            9999999999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-32  Score=294.39  Aligned_cols=253  Identities=21%  Similarity=0.283  Sum_probs=195.8

Q ss_pred             CCCCCceeeecCCeEEEEEEe----CCCcEEEEEEccCCCCC-cchhHHHHHHHHHHHHhc-cCCceeeEEeEEEeccee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLPG-EMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  676 (873)
                      +|++.+.||+|+||.||.|+.    .+|+.||+|++...... .....+.+.+|+.+++.+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    36899999998753221 222346688899999999 699999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999998643   3478889999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccccccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSS-NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ...... ......|+..|+|||.+...  .++.++||||||+++|+|++|+.||........    .............+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~~~~  230 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSEPP  230 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhccCCC
Confidence            543321 22245688999999998753  467899999999999999999999864322100    01111122221212


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      .+..    ....+.+++.+||+.||++||     ++.++++
T Consensus       231 ~~~~----~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         231 YPQE----MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCcc----CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1111    123478999999999999997     6676654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-32  Score=298.65  Aligned_cols=256  Identities=21%  Similarity=0.351  Sum_probs=191.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      ..+|...+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.+++.++||||+++++++....     
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            36899999999999999999975 468999999987543222 22456889999999999999999999987542     


Q ss_pred             -eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                       .+++|+||+.. ++..+..     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence             46999999864 6665542     3488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hh--
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IA--  823 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~--  823 (873)
                      ++....   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............       ..  
T Consensus       164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         164 ARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            976532   2233467889999999876 4578899999999999999999999975332110000000       00  


Q ss_pred             ------hhhhcC--CCCCCCCc--hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 ------LDEMLD--PRLPTPSR--NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ------~~~~~~--~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            ......  +..+....  ..+.....+.+++.+||+.||++||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  000000  00000000  00011234789999999999999999999974

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-32  Score=296.88  Aligned_cols=264  Identities=20%  Similarity=0.318  Sum_probs=196.9

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH  672 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  672 (873)
                      ..++....++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            445566778999999999999999999974 57899999998754222 2224568889999999999999999998864


Q ss_pred             c------ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          673 V------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       673 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      .      ...+++++++ ++++.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence            3      3467888876 6788877643    2488999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-----
Q 039344          747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-----  820 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-----  820 (873)
                      ||+|||+++....   ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.............     
T Consensus       160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999976532   2233567889999998766 467889999999999999999999986433211000000     


Q ss_pred             --hhhhh--------hhcC--CCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 --NIALD--------EMLD--PRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 --~~~~~--------~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        .....        .+..  +..+...  .........+.+++.+|++.||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence              00000        0000  0000000  000011234789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.6e-32  Score=296.44  Aligned_cols=262  Identities=22%  Similarity=0.334  Sum_probs=192.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      .++|++.+.||+|+||.||+|... +++.||+|++......+. ....+.+|+++++.++||||+++++++.+..     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            468999999999999999999764 689999998865432221 1345678999999999999999999875433     


Q ss_pred             ---eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          675 ---HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       675 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                         ..++|+||+.+ ++...+...  ...+++..+..++.|+++|++|||+.   +++||||||+||+++.++.++|+||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence               46999999875 566655432  23589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCC-----------ccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh
Q 039344          752 GIAKFLKPDSSN-----------WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN  819 (873)
Q Consensus       752 g~a~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~  819 (873)
                      |+++........           .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||............
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999865433221           1233567889999987654 4788999999999999999999998754332111100


Q ss_pred             hhh-------------hhhh----hcCCCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          820 LNI-------------ALDE----MLDPRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       820 ~~~-------------~~~~----~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...             ....    ......+.... ........+.+++.+|++.||++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000             0000    00001110000 00111235789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.1e-32  Score=317.99  Aligned_cols=148  Identities=24%  Similarity=0.342  Sum_probs=132.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++............+..|+.+++.++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999865 78999999997644334444577889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      ||+.+++|.+++...   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998643   3478899999999999999999999   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-32  Score=295.95  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc----
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR----  674 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  674 (873)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            467899999999999999999964 5789999999865322 2223456889999999999999999999987543    


Q ss_pred             --eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          675 --HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       675 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                        .+++||||+ ++++.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence              468999998 6788877743    3588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hhh
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IAL  824 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~~  824 (873)
                      +++.....   .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||..............       ...
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         164 LARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99865432   223467889999998876 4578899999999999999999999874332110000000       000


Q ss_pred             h--------hhcC--CCCCCC--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 D--------EMLD--PRLPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~--------~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .        ....  +.....  ..........+.+++.+|++.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0        0000  000000  0000112234789999999999999999999874

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-32  Score=298.19  Aligned_cols=254  Identities=24%  Similarity=0.401  Sum_probs=208.7

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe----
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH----  672 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----  672 (873)
                      ..++.|++.+.||.|.+|.||+++ .++|+.+|+|+.......    .+++..|.++++.. +|||++.++|++..    
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            345678899999999999999996 457889999998754333    46788999999988 79999999999964    


Q ss_pred             -cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          673 -VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       673 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                       ++++|+|||||.+|+..+.+.+.. +.++.|+.+.-|+..++.|+.+||..   .++|||+|-.|||+++++.||++||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence             568999999999999999998766 77899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      |++..++..-....+..|||.|||||++...     .|+.++|+||+|++..||..|++|+..+.++..     -..+.+
T Consensus       168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----LF~IpR  242 (953)
T KOG0587|consen  168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPR  242 (953)
T ss_pred             eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----hccCCC
Confidence            9999887666666678999999999998643     467789999999999999999999765544311     000111


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      --.|++..+.    .....+.++|..|+..|-++||++.++++
T Consensus       243 NPPPkLkrp~----kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 NPPPKLKRPK----KWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCccccchh----hHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1112222222    33456899999999999999999998875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-33  Score=281.90  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=195.4

Q ss_pred             cCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCC--C--cchhHHHHHHHHHHHHhccCCceeeEEeEEE-ecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLP--G--EMTFQQEFLNEVKALTEIWHRNIVKVYGFCL-HVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~  675 (873)
                      ++|-+.+.||+|+|+.||+|. ....+.||||+-.....  .  .....+-..+|.++-+.+.||.||++|+|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            456667899999999999994 56688999998653322  1  1123445789999999999999999999997 5678


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CCCeEEeccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAHVSDFG  752 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Dfg  752 (873)
                      +|-|.|||+|.+|+.++..+.   .++++++..|+.||+.||.||... .++|+|-||||.|||+-.   -|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            899999999999999997654   489999999999999999999987 468999999999999954   4789999999


Q ss_pred             cccccCCCCCC-------ccccccccccccccccccC----CCCCcchhHHHHHHHHHHHhCCCCCcccccc-hhhhhhh
Q 039344          753 IAKFLKPDSSN-------WTELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFISSM-SFSSLNL  820 (873)
Q Consensus       753 ~a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~----~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-~~~~~~~  820 (873)
                      +++.++++.+.       .+...||.+|.+||.+.-+    +.+.|+||||+|||+|+++.|+.||...... .+...+.
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            99998776543       2356899999999976533    4678999999999999999999999753321 1111111


Q ss_pred             hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 039344          821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC  868 (873)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  868 (873)
                      -..-.++.   +|..+    ....+...+|++|+++.-++|..+.++.
T Consensus       699 IlkAtEVq---FP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  699 ILKATEVQ---FPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhcceecc---CCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            10111111   11111    1223467899999999999998877764

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=9.4e-32  Score=292.65  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-C--CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec----c
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-S--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV----R  674 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~  674 (873)
                      +|++.+.||+|+||.||+++.. +  +..||+|++...... ....+.+.+|+++++++ +||||+++++++...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4778899999999999999865 3  778999998643222 22346788999999999 599999999976432    4


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++++||+. ++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            5788899886 6888887543   3588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC----Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh-------hhhh
Q 039344          755 KFLKPDSS----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL-------NLNI  822 (873)
Q Consensus       755 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~-------~~~~  822 (873)
                      +.......    ......|+..|+|||++.+ ..++.++||||+||++|++++|+.||...........       ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            86643221    1233568899999998765 4678999999999999999999999875332110000       0000


Q ss_pred             hhhhhcCC----------CCCCC--CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          823 ALDEMLDP----------RLPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       823 ~~~~~~~~----------~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+..+          ..+..  ..........+.+++.+|++.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000          00000  0000011235889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=4.6e-32  Score=296.24  Aligned_cols=258  Identities=19%  Similarity=0.322  Sum_probs=195.2

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce---
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH---  675 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  675 (873)
                      ..++|++.+.||+|++|.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++|||++++++++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3577999999999999999999865 6889999998654222 2234667889999999999999999998866554   


Q ss_pred             ---eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          676 ---LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       676 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                         .++|+||+ +++|.+++..    ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 5688888754    3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hh-
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IA-  823 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~-  823 (873)
                      .+......   .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||..............       .. 
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            99865432   233467889999998765 3578899999999999999999999864332211100000       00 


Q ss_pred             -------hhhhcCC--CCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 -------LDEMLDP--RLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 -------~~~~~~~--~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                             ...+...  ......  .........+.+++.+|++.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                   0000000  000000  000011345889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=8.2e-33  Score=285.39  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             CceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccC
Q 039344          607 EHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      .++||.|.||+||-|+ .++|+.||||++.+-.-... ....+.+|+.++++++||.||.+...|+..+..++|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            4789999999999996 46899999999876433222 246789999999999999999999999999999999999987


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeEEeccccccccCCCCC
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~  762 (873)
                      .-|.-++..+  .+++++.....++.||+.|+.|||.+   +|+|+||||+|||+...   ..+||||||.||.+.. ..
T Consensus       648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ks  721 (888)
T KOG4236|consen  648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KS  721 (888)
T ss_pred             hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-hh
Confidence            6666666543  35699999999999999999999999   99999999999999754   3799999999998764 44


Q ss_pred             CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      .....+|||.|.|||+++.+.|...-|+||.|||+|.-+.|..||....+.          -+++....+-.+...+.+.
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----------ndQIQNAaFMyPp~PW~ei  791 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----------NDQIQNAAFMYPPNPWSEI  791 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch----------hHHhhccccccCCCchhhc
Confidence            556789999999999999999999999999999999999999998743332          1222233332233333455


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHH
Q 039344          843 LISIVEVTISCVDENPESRPTMQKVC  868 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RPs~~ev~  868 (873)
                      .....++|...++..-++|-+.+..+
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            55678999999999999999887643

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=6.8e-32  Score=294.77  Aligned_cols=258  Identities=24%  Similarity=0.318  Sum_probs=190.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  673 (873)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||+|++.....   ...+.+.+|+++++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            36788999999999999999976 4689999999865432   2346788999999999999999999876543      


Q ss_pred             --------ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-CC
Q 039344          674 --------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-EN  744 (873)
Q Consensus       674 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~  744 (873)
                              ...++||||++ +++.+++..    ..+++..+..++.||+.|++|||+.   +++||||||+||+++. ++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                    35789999997 588777643    3488999999999999999999999   9999999999999985 45


Q ss_pred             CeEEeccccccccCCCCC---Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~  820 (873)
                      .++++|||.++.......   ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.............
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            789999999986543221   1123457889999997654 457889999999999999999999996433211100000


Q ss_pred             h-----------h---hh-hhhc-CCCCCCCC-c-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 N-----------I---AL-DEML-DPRLPTPS-R-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ~-----------~---~~-~~~~-~~~~~~~~-~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .           .   .. .... ........ . ........+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0           0   00 0000 00000000 0 00012235789999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=243.36  Aligned_cols=260  Identities=20%  Similarity=0.293  Sum_probs=195.4

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      +|...++||+|.||+||+|+. .+++.||+|+++.....+ .......+|+.+++.++|+|||+++++...++...+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            355568899999999999975 468999999998654332 334668899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      ||. -.|..+...-  .+.++.+....++.|+++|+.|+|++   .+.|||+||.|.+++.+|+.|++|||+|+-+.-+-
T Consensus        82 ~cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             Hhh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            997 4666666432  34588899999999999999999999   99999999999999999999999999999877666


Q ss_pred             CCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCC-Ccccccchhh-------hhhhhhhhhhh---cC
Q 039344          762 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP-RDFISSMSFS-------SLNLNIALDEM---LD  829 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P-~~~~~~~~~~-------~~~~~~~~~~~---~~  829 (873)
                      .-++..+.|.+|.+|.++.+.+ |+...|+||.||++.|+.....| |...+-....       +...+..+..+   -|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            5667778899999999999876 78889999999999999985555 4432211000       00001111111   11


Q ss_pred             ----CCCCCCCchh---HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 ----PRLPTPSRNV---HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 ----~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          |.++....+.   +.-...=.+++++.+.-+|.+|-+++..++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                1111111111   111112357777788889999999998876

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=274.85  Aligned_cols=245  Identities=22%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      ...+|....+||+|+||.|.+|..+ +.+.+|||++++...-.....+--+.|-+++.-. +-|.++++...|..-+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3467999999999999999999654 5778999999876544333345556677777666 5788999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      .||||+.||+|--+++.-   +.+-+..+..+|..||-||-|||++   ||+.||||..||++|.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999998877543   3477788899999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      -.+.....+.+|||.|+|||.+...+|+..+|.|||||++|||+.|++||+..+.        .+.+..+.+.....+..
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI~ehnvsyPKs  572 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAIMEHNVSYPKS  572 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHHccCcCccc
Confidence            5556667789999999999999999999999999999999999999999886443        34455555555555544


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC
Q 039344          838 NVHDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      ...    +...+....+...|.+|.
T Consensus       573 lSk----EAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  573 LSK----EAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ccH----HHHHHHHHHhhcCCcccc
Confidence            333    356777888889999985

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-33  Score=310.18  Aligned_cols=256  Identities=24%  Similarity=0.272  Sum_probs=204.1

Q ss_pred             HHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          596 EIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       596 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ++.-..++|.+.++||+|+||.|..++.+ +++.||.|++.+..--......-|..|-++|..-+.+=|+.+.-+|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            33444688999999999999999999864 68899999987532111222467899999999888999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      +.|+||||++||+|-..+.+..   +++++.++.++..|+-||+-+|+.   |+|||||||+|||+|..|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence            9999999999999999997654   589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC-Cccccccccccccccccc----c-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhc
Q 039344          755 KFLKPDSS-NWTELAGTYGYVAPELAY----T-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       755 ~~~~~~~~-~~~~~~g~~~y~aPE~~~----~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      -.+..++. .....+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||....        ..+....++
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY~KIm  294 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETYGKIM  294 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHHHHHh
Confidence            88875554 345678999999999886    2 568999999999999999999999976322        222233333


Q ss_pred             CC--CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCC---HHHHH
Q 039344          829 DP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPT---MQKVC  868 (873)
Q Consensus       829 ~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~  868 (873)
                      +-  .+.+|.  ..+.+....++|.+.+. +|+.|..   ++++.
T Consensus       295 ~hk~~l~FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  295 NHKESLSFPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             chhhhcCCCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            32  333331  12244457777877765 6677766   66654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-32  Score=289.19  Aligned_cols=239  Identities=21%  Similarity=0.271  Sum_probs=191.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      ++.|.....+|.|+|+.|-.+. ..+++..+||++.+...       +..+|+.++... +||||++..+++.+....|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence            4567777889999999998875 45788899999976522       233667665555 79999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee-CCCCCeEEecccccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL-DFENEAHVSDFGIAKFL  757 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill-~~~~~~kl~Dfg~a~~~  757 (873)
                      |||++.++-+.+.+.....   .. ..+..|+.+|+.|+.|||++   ||||||+||+|||+ +..++++|+|||.++..
T Consensus       394 v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            9999999988777644332   22 67778999999999999999   99999999999999 68899999999999877


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ...   ..+.+-|..|.|||+.....|++++|+||+|+++|+|++|+.||...+..       .+....+..++..    
T Consensus       467 ~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s----  532 (612)
T KOG0603|consen  467 ERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS----  532 (612)
T ss_pred             chh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc----
Confidence            654   33446688899999999999999999999999999999999998754432       2223333333333    


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ...+....+++.+|++.||.+||+|+++..
T Consensus       533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              122334789999999999999999999853

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=261.43  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=200.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      -.+|...++||+|+|+.|..++.+ +.+.+|+|++++....+.+...=...|-.+..+. +||.+|.+...|..+...+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            367899999999999999999764 6788999999876444433333344566665555 79999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |.||++||+|..++.+.   ..++++.+..+...|+-|+.|||++   ||+.||+|..||++|.+|.+|++|+|+++.--
T Consensus       329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999998777554   3599999999999999999999999   99999999999999999999999999998766


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .+....++.+|||.|.|||.+++..|...+|.|++||+|+||+.|+.||+..+.........+-.+.-++...+..+...
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl  482 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL  482 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence            66667778999999999999999999999999999999999999999999655221111111222233333333333221


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCC
Q 039344          839 VHDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      .    .....+++.-+.+||.+|.
T Consensus       483 s----vkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  483 S----VKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             e----hhhHHHHHHhhcCCcHHhc
Confidence            1    1245677788999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=272.08  Aligned_cols=268  Identities=21%  Similarity=0.296  Sum_probs=201.2

Q ss_pred             cccCHHHHHHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-C-Cc----
Q 039344          590 GKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-H-RN----  662 (873)
Q Consensus       590 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----  662 (873)
                      |...++.-...+.+|.+...+|+|.||.|-.... ..+..||||+++..    ....+..+-|+++++++. + |+    
T Consensus        77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~r  152 (415)
T KOG0671|consen   77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFR  152 (415)
T ss_pred             ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence            3344443334478899999999999999999854 35799999999743    233566788999999993 2 22    


Q ss_pred             eeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       663 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      +|.+.+||...++.|+|+|.+ |-++.+++..... .+++..++..|++|++++++|||+.   +++|.||||+||++..
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVS  227 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEec
Confidence            788999999999999999987 3588999976543 4588999999999999999999999   9999999999999841


Q ss_pred             --------------------CCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh
Q 039344          743 --------------------ENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK  802 (873)
Q Consensus       743 --------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t  802 (873)
                                          +..|+++|||.|++-....   ...+.|..|.|||++.+-.++.++||||+|||++|+.|
T Consensus       228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence                                2359999999998755433   55788999999999999999999999999999999999


Q ss_pred             CCCCCcccccch---hhhhhhhhhhhhhc----------CCCC-----------------CCC----CchhHHHHHHHHH
Q 039344          803 GKHPRDFISSMS---FSSLNLNIALDEML----------DPRL-----------------PTP----SRNVHDKLISIVE  848 (873)
Q Consensus       803 g~~P~~~~~~~~---~~~~~~~~~~~~~~----------~~~~-----------------~~~----~~~~~~~~~~l~~  848 (873)
                      |..-|...++.+   +-+.........++          .+++                 +.+    -.....+...+++
T Consensus       305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD  384 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD  384 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence            999887544221   00000000000000          0000                 000    0001233446999


Q ss_pred             HHhhcccCCCCCCCCHHHHHH
Q 039344          849 VTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       849 li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ++.+|+..||.+|+|+.|+++
T Consensus       385 Ll~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  385 LLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHccCccccccHHHHhc
Confidence            999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=281.20  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=204.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCc-EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+++....||-|+||.|-+++.+..+ .+|+|++++...-+....+-+..|-.+|...+.|.||++|..|.+.+..|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555678999999999999876444 48899887765555555566889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |-|-||.+...+++..   .++...+..++.-+.+|++|||++   +||.|||||+|.++|.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999996553   588888999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ...|+ ++|||.|.|||++.....+.++|.||+|+++||+++|.+||...+++......... ++.+--|+.        
T Consensus       574 ~KTwT-FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id~i~~Pr~--------  643 (732)
T KOG0614|consen  574 RKTWT-FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-IDKIEFPRR--------  643 (732)
T ss_pred             Cceee-ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hhhhhcccc--------
Confidence            77765 89999999999999999999999999999999999999999987766444333322 233222221        


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCC
Q 039344          841 DKLISIVEVTISCVDENPESRPT  863 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs  863 (873)
                       ......++|++....+|.+|.-
T Consensus       644 -I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  644 -ITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -cchhHHHHHHHHHhcCcHhhhc
Confidence             1123568888999999999974

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.4e-30  Score=268.94  Aligned_cols=219  Identities=20%  Similarity=0.210  Sum_probs=174.8

Q ss_pred             cCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCChhhH
Q 039344          613 GGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVI  691 (873)
Q Consensus       613 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~  691 (873)
                      |.+|.||+++. .+++.||+|+++...        .+..|...+....||||+++++++.+....++||||+++++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            89999999975 478999999987531        233455555566799999999999999999999999999999998


Q ss_pred             hcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcccccccc
Q 039344          692 LSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY  771 (873)
Q Consensus       692 l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~  771 (873)
                      +...   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+......   .....++.
T Consensus        76 l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~  146 (237)
T cd05576          76 ISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN  146 (237)
T ss_pred             HHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence            8643   2488999999999999999999999   9999999999999999999999999988765432   22345577


Q ss_pred             ccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHh
Q 039344          772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTI  851 (873)
Q Consensus       772 ~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  851 (873)
                      .|+|||.+.+..++.++||||+|+++|||++|+.|++.....          .........+  ..    ....+.+++.
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~--~~----~~~~~~~li~  210 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIP--EW----VSEEARSLLQ  210 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCc--cc----CCHHHHHHHH
Confidence            899999998888999999999999999999999886532110          0000000111  11    1234789999


Q ss_pred             hcccCCCCCCCCH
Q 039344          852 SCVDENPESRPTM  864 (873)
Q Consensus       852 ~cl~~dP~~RPs~  864 (873)
                      +|++.||++||++
T Consensus       211 ~~l~~dp~~R~~~  223 (237)
T cd05576         211 QLLQFNPTERLGA  223 (237)
T ss_pred             HHccCCHHHhcCC
Confidence            9999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.6e-30  Score=295.54  Aligned_cols=259  Identities=19%  Similarity=0.194  Sum_probs=168.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-C----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeE-----
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-S----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF-----  669 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-----  669 (873)
                      ..++|.+.+.||+|+||.||+|+.. +    +..||+|++......     +....|  .+....+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4578999999999999999999865 4    689999987643211     111111  1111122222222211     


Q ss_pred             -EEecceeEEEEEeccCCChhhHhcccccc-----------------cCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 039344          670 -CLHVRHLFIVYEYFKMCSLAVILSNDAAA-----------------KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHR  731 (873)
Q Consensus       670 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  731 (873)
                       +......++||||+++++|.+++......                 .......+..++.|++.||+|||++   +|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence             24566789999999999999988643210                 0112334568999999999999999   99999


Q ss_pred             CCCCCCeeeCC-CCCeEEeccccccccCCCC-CCccccccccccccccccccC----------------------CCCCc
Q 039344          732 DISSKNVLLDF-ENEAHVSDFGIAKFLKPDS-SNWTELAGTYGYVAPELAYTM----------------------KVTEK  787 (873)
Q Consensus       732 Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~  787 (873)
                      ||||+|||++. ++.+||+|||+|+.+.... .......+++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999996 5799999999998654332 223456789999999965322                      23456


Q ss_pred             chhHHHHHHHHHHHhCCCCCcccccchhhhhhh-----hhhhhhhcCCCCCCCCch----hHHHHHHHHHHHhhcccCCC
Q 039344          788 CDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-----NIALDEMLDPRLPTPSRN----VHDKLISIVEVTISCVDENP  858 (873)
Q Consensus       788 sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP  858 (873)
                      +||||+||++|||+++..|++.... .+.....     ...+.....+........    .........+++.+|++.||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            7999999999999998877542110 0000000     000111111111100000    00011134589999999999


Q ss_pred             CCCCCHHHHHH
Q 039344          859 ESRPTMQKVCQ  869 (873)
Q Consensus       859 ~~RPs~~ev~~  869 (873)
                      ++|||++++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1e-29  Score=263.66  Aligned_cols=239  Identities=27%  Similarity=0.443  Sum_probs=192.6

Q ss_pred             CCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCChhhHh
Q 039344          614 GQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL  692 (873)
Q Consensus       614 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l  692 (873)
                      +||.||+|... +|+.+|+|++........  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999876 489999999876433221  578999999999999999999999999999999999999999999998


Q ss_pred             cccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccccccc
Q 039344          693 SNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG  772 (873)
Q Consensus       693 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~  772 (873)
                      ....   .+++..+..++.+++.++.|||+.   +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus        79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  151 (244)
T smart00220       79 KKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE  151 (244)
T ss_pred             Hhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence            6533   278899999999999999999999   99999999999999999999999999998765432 3344567889


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhh
Q 039344          773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTIS  852 (873)
Q Consensus       773 y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  852 (873)
                      |+|||......++.++||||+|+++|++++|..||......       .........+........ ......+.+++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~  223 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFPPPE-WKISPEAKDLIRK  223 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCcccc-ccCCHHHHHHHHH
Confidence            99999998888899999999999999999999998642111       111111112222111110 0022358899999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 039344          853 CVDENPESRPTMQKVCQ  869 (873)
Q Consensus       853 cl~~dP~~RPs~~ev~~  869 (873)
                      ||..+|++||++.++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      224 LLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HccCCchhccCHHHHhh
Confidence            99999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-31  Score=240.06  Aligned_cols=203  Identities=24%  Similarity=0.392  Sum_probs=165.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHh-ccCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++..-...||+|++|.|-+.++ .+|...|+|+++.....  ...+...+|+.+..+ ..+|.+|.+||.....+..|+
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            34455567899999999988864 57999999999865443  235667888887544 479999999999999999999


Q ss_pred             EEEeccCCChhhHhccc-ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          679 VYEYFKMCSLAVILSND-AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      .||.|. .+++.+.... ..+...++.-.-+||..+..|+.|||++.  .|+|||+||+|||++.+|++|+||||.+-.+
T Consensus       123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999987 5666554332 24556888889999999999999999986  8999999999999999999999999999766


Q ss_pred             CCCCCCcccccccccccccccccc----CCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      .+.- ..+--.|-..|||||.+..    ..|+-||||||+|+.+.||.++++||+.
T Consensus       200 ~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  200 VDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             hhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            5322 2222457778999998763    3588999999999999999999999884

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=285.89  Aligned_cols=243  Identities=25%  Similarity=0.408  Sum_probs=188.6

Q ss_pred             CCCCceeeecCCeE-EEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEEE
Q 039344          604 FDDEHCIGKGGQGS-VYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       604 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      |...+++|.|+.|+ ||+|... |+.||||++...      ...-..+|+..++.- .|||||++++.-.+....|+..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            44457899999997 6899987 899999998632      234567999999888 69999999999999999999999


Q ss_pred             eccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CC--CeEEecccccc
Q 039344          682 YFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---EN--EAHVSDFGIAK  755 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~--~~kl~Dfg~a~  755 (873)
                      .|. ++|.+++.... ..........+.+..|++.|+++||+.   +||||||||.||||+.   ++  .++|+|||+++
T Consensus       584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            997 89999997641 111122245678899999999999998   9999999999999986   34  69999999999


Q ss_pred             ccCCCCCCc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          756 FLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       756 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      .+..+....   ....||-+|+|||++....-+.++|+||+||++|+.++| .+||......          ...++.+.
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R----------~~NIl~~~  729 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----------QANILTGN  729 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh----------hhhhhcCc
Confidence            987765544   356789999999999998888899999999999999985 9998742211          11111111


Q ss_pred             CCCC-CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          832 LPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       832 ~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..-. -....++  ...++|.+|++++|..||+|.+|+.
T Consensus       730 ~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 YTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1000 0000111  4679999999999999999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.6e-31  Score=252.15  Aligned_cols=262  Identities=21%  Similarity=0.366  Sum_probs=190.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-------  672 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  672 (873)
                      ...|....++|+|.||.||+|+.+ +|+.||+|+..-.... ........+|+.++..++|+|++.+++.|..       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            345666788999999999999754 6788899876432211 1223557899999999999999999988853       


Q ss_pred             -cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          673 -VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       673 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                       ...+|+||.+|+. +|.-.+.+..  .+++..++.++++++..|+.|+|..   .|+|||+|+.|+|++.+|.+||+||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence             2358999999984 5666665432  4588899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCC----CCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccc-------------
Q 039344          752 GIAKFLKPDS----SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-------------  813 (873)
Q Consensus       752 g~a~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-------------  813 (873)
                      |+|+.+....    ..++..+.|.+|.+||.+.+ ..|+++.|||..|||+.||+||.+-+......             
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            9997664332    23556678999999998876 46899999999999999999998876532211             


Q ss_pred             ---hhhhhhhhhhhhhhcCCCCCCCC-chhHHHHH------HHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          814 ---SFSSLNLNIALDEMLDPRLPTPS-RNVHDKLI------SIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       814 ---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         .|.....-.....+--+.++... ....+...      ...+++.+++..||.+|+++++++.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence               11111111111111111111100 00011111      3568889999999999999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4e-29  Score=277.70  Aligned_cols=265  Identities=15%  Similarity=0.168  Sum_probs=181.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-----------------CCCcEEEEEEccCCCCCcc-----------hhHHHHHHH
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-----------------ASGEIIAVKKFHSPLPGEM-----------TFQQEFLNE  651 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e  651 (873)
                      ..++|++.++||+|+||+||+|..                 ..++.||||++........           ...+.+..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999953                 2456899999864322110           011234457


Q ss_pred             HHHHHhccCCce-----eeEEeEEEe--------cceeEEEEEeccCCChhhHhccccc---------------------
Q 039344          652 VKALTEIWHRNI-----VKVYGFCLH--------VRHLFIVYEYFKMCSLAVILSNDAA---------------------  697 (873)
Q Consensus       652 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------  697 (873)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677888753        3568999999999999999864211                     


Q ss_pred             ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC-Cccccccccccccc
Q 039344          698 AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-NWTELAGTYGYVAP  776 (873)
Q Consensus       698 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~g~~~y~aP  776 (873)
                      ....++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+++....... ......+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12346778899999999999999999   999999999999999999999999999976543221 11122347899999


Q ss_pred             cccccCCC----------------------CCcchhHHHHHHHHHHHhCCC-CCcccccchhhhhh---hhhhhhhhcCC
Q 039344          777 ELAYTMKV----------------------TEKCDVYSFGVLALEVIKGKH-PRDFISSMSFSSLN---LNIALDEMLDP  830 (873)
Q Consensus       777 E~~~~~~~----------------------~~~sDv~s~G~il~el~tg~~-P~~~~~~~~~~~~~---~~~~~~~~~~~  830 (873)
                      |.+.....                      ..+.||||+||++|||++|.. |+............   ....+......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      124799999999999999886 66532211100000   00001111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENP---ESRPTMQKVCQ  869 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ev~~  869 (873)
                      ......  .........+++.+++..+|   .+|+|++|+++
T Consensus       460 ~~~~~~--~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KYDFSL--LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCCccc--ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            111111  11123357889999999766   68999999975

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-31  Score=249.86  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----cee
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----RHL  676 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  676 (873)
                      +.+-.+.||-|+||.||.+.. ++|+.||.|++..... .....+.+.+|+.++..++|.|++..++...-.     ...
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            345568899999999999865 5899999999865432 223457899999999999999999988876532     246


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      |++.|.|. .+|..++..   ...++.+.+.-+.+||++|++|||+.   +|.||||||.|.+++.+...||||||+||.
T Consensus       133 YV~TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            88888886 577777644   34588899999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCC-CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh---------------h
Q 039344          757 LKPDS-SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL---------------N  819 (873)
Q Consensus       757 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~---------------~  819 (873)
                      -+.+. .+++..+.|..|.|||.+.+. .|+.+.||||.||++.|++..+.-|....+....+.               .
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            76553 356777889999999999875 489999999999999999998888765443211111               1


Q ss_pred             hhhhhhhhcCCCCCCCCc-------hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          820 LNIALDEMLDPRLPTPSR-------NVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      .+....-++.+....+..       ...+.-.....+...++..||++|.+.++.++.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            111122222222211110       000111235677788999999999998887653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.7e-29  Score=263.82  Aligned_cols=213  Identities=24%  Similarity=0.335  Sum_probs=177.1

Q ss_pred             CHHHHHHHhcC---CCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEe
Q 039344          593 IYEEIIRATND---FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG  668 (873)
Q Consensus       593 ~~~e~~~~~~~---~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  668 (873)
                      .|..+.++.-+   |...+.||-|+||+|.+++. .+...+|.|.+++...-......-.++|-+++..-..+=||++|-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            45556665433   66678999999999999964 456678999987654333334556788999999999999999999


Q ss_pred             EEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       669 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                      .|.+++.+|+||+|++||++-.+|-+.   +.+.++.++.++..+..|+++.|..   |+|||||||+|||||.+|++||
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceee
Confidence            999999999999999999999988654   3478888999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCC--------CC-----------c-----------------------cccccccccccccccccCCCCC
Q 039344          749 SDFGIAKFLKPDS--------SN-----------W-----------------------TELAGTYGYVAPELAYTMKVTE  786 (873)
Q Consensus       749 ~Dfg~a~~~~~~~--------~~-----------~-----------------------~~~~g~~~y~aPE~~~~~~~~~  786 (873)
                      .|||+++-+....        .+           |                       ...+||+.|+|||++....++.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            9999986442210        00           0                       0257999999999999999999


Q ss_pred             cchhHHHHHHHHHHHhCCCCCcccc
Q 039344          787 KCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       787 ~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      -+|.||.|||+|||+.|+.||....
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADT  875 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCC
Confidence            9999999999999999999987533

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=260.51  Aligned_cols=423  Identities=24%  Similarity=0.282  Sum_probs=238.6

Q ss_pred             ECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc-ccc
Q 039344           27 ELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT-NSL  105 (873)
Q Consensus        27 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l  105 (873)
                      +=++-+++ .+|..+-  +.-.+++|..|+|+.+.|++|+.+++|+.||||+|.|+.+-|++|.++.+|..|.+.+ |+|
T Consensus        52 dCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI  128 (498)
T KOG4237|consen   52 DCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI  128 (498)
T ss_pred             EccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence            33444454 5555443  4566677777777766666777777777777777777766677777777766666655 677


Q ss_pred             CCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccc
Q 039344          106 SNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL  185 (873)
Q Consensus       106 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~  185 (873)
                      +.+..+.|.+|.+|+.|.+.-|++.-...+.|..+++|..|.+..|.+..+....|..+.+++.+.+..|.+..     .
T Consensus       129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----d  203 (498)
T KOG4237|consen  129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----D  203 (498)
T ss_pred             hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----c
Confidence            65555567777777777777777765555667777777777777777766666666677777777766666321     1


Q ss_pred             cCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCC-CCccEEecccccCCCCC-chhhcCCCCC
Q 039344          186 GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNL-SNLTYLNLFENSLSGAI-PYEYRNLVKL  263 (873)
Q Consensus       186 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~-~~~~~~l~~L  263 (873)
                      ++++.+....       ...|..++...-..-..+.++++..+.+..|... ..+..=-.+.+...++. ...|..+++|
T Consensus       204 CnL~wla~~~-------a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L  276 (498)
T KOG4237|consen  204 CNLPWLADDL-------AMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL  276 (498)
T ss_pred             cccchhhhHH-------hhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence            1111111100       0112223333334444444444443333333221 11111111111121122 2335555555


Q ss_pred             cEEEccCCcCcCc-CCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccc
Q 039344          264 TILLLGHNQFRGP-IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN  342 (873)
Q Consensus       264 ~~L~L~~N~l~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  342 (873)
                      +.|+|++|+++.. ..+|.++..+++|+|.+|+|..+....|.++..|+.|+|++|+|+...|.+|..+..|.+|+|-.|
T Consensus       277 ~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N  356 (498)
T KOG4237|consen  277 RKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN  356 (498)
T ss_pred             eEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence            5555555555552 234555555555555555555555555555555555555556555555555555555555555555


Q ss_pred             cCCc----------------cCCccccCCCCCCEEeccCCccCC---CCCccccccccccEEEecCccccCCcccccccc
Q 039344          343 NITG----------------NVPPEIGHSSQLGVLDLSSNHIVG---EIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSL  403 (873)
Q Consensus       343 ~i~~----------------~~~~~~~~~~~L~~L~Ls~N~i~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  403 (873)
                      .+.-                ....--+....++.+.++++.+.+   ..|++....            -++.-|   ..+
T Consensus       357 p~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~------------~s~~cP---~~c  421 (498)
T KOG4237|consen  357 PFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCL------------TSSPCP---PPC  421 (498)
T ss_pred             cccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCC------------CCCCCC---CCc
Confidence            4320                001112334456777777776642   122222111            111111   234


Q ss_pred             cccccc-cccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcE
Q 039344          404 VQLEHL-DLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLH  482 (873)
Q Consensus       404 ~~L~~L-~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~  482 (873)
                      +.+.+. .-|++.+ ..+|..+..    .-++|++.+|.++. +|.+  .+.+| .+||++|+|+..--..|.+|++|.+
T Consensus       422 ~c~~tVvRcSnk~l-k~lp~~iP~----d~telyl~gn~~~~-vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~t  492 (498)
T KOG4237|consen  422 TCLDTVVRCSNKLL-KLLPRGIPV----DVTELYLDGNAITS-VPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLST  492 (498)
T ss_pred             chhhhhHhhcccch-hhcCCCCCc----hhHHHhcccchhcc-cCHH--HHhhh-hcccccCceehhhcccccchhhhhe
Confidence            445444 3444444 477777664    56789999999985 5555  66778 9999999999888888999999999


Q ss_pred             EecCCC
Q 039344          483 IDISYN  488 (873)
Q Consensus       483 l~ls~N  488 (873)
                      |-||||
T Consensus       493 lilsyn  498 (498)
T KOG4237|consen  493 LILSYN  498 (498)
T ss_pred             eEEecC
Confidence            999997

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-28  Score=250.63  Aligned_cols=133  Identities=21%  Similarity=0.407  Sum_probs=112.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-----C---CceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-----H---RNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~  671 (873)
                      ..+|.+.++||.|.|++||++. ..+.+.||+|+.+..    ..+.+....||+++++++     |   ..||+++++|.
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            3678899999999999999996 457889999998853    344567889999999984     3   36999999997


Q ss_pred             e----cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC
Q 039344          672 H----VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD  741 (873)
Q Consensus       672 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~  741 (873)
                      .    +.+.|||+|++ |.+|..++...... -++...+.+|++||+.||.|||.+|  ||+|.||||+|||+.
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            5    44789999987 46787777665543 3889999999999999999999999  999999999999994

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-29  Score=262.14  Aligned_cols=203  Identities=22%  Similarity=0.328  Sum_probs=171.8

Q ss_pred             HHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhH-----HHHHHHHHHHHhcc---CCceeeEEe
Q 039344          598 IRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQ-----QEFLNEVKALTEIW---HRNIVKVYG  668 (873)
Q Consensus       598 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-----~~~~~e~~~l~~l~---h~niv~l~~  668 (873)
                      .....+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-...+.     ..+-.|+.+|..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            344567999999999999999999766 456788998866533222222     23668999999997   999999999


Q ss_pred             EEEecceeEEEEEecc-CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeE
Q 039344          669 FCLHVRHLFIVYEYFK-MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH  747 (873)
Q Consensus       669 ~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k  747 (873)
                      +|++++.+|++||-.. +-+|.+++...   ..+++.++.-|.+||+.|+++||+.   +|||||||-+||.++.+|-+|
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEE
Confidence            9999999999999764 44888888544   4589999999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCc
Q 039344          748 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRD  808 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~  808 (873)
                      |+|||.|.....  ..+..++||.+|.|||++.+.+| ...-|||++|+++|-++....||.
T Consensus       711 lidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999976543  34567899999999999999998 456899999999999999999975

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.1e-28  Score=229.72  Aligned_cols=253  Identities=19%  Similarity=0.310  Sum_probs=191.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEec--cee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHV--RHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~  676 (873)
                      .++|++.+++|+|.++.||.|. ..+.+.++||+++..      ..+.+.+|+.+++.+. ||||++++++..++  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            4678899999999999999996 567889999998743      1477999999999996 99999999998764  567


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAK  755 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~  755 (873)
                      .+|+||+.+.+.....      ..++...+...+.+++.|+.|+|+.   ||.|||+||.|+++|... ..+++|+|+|.
T Consensus       111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            8999999988776554      3477778899999999999999999   999999999999999764 69999999999


Q ss_pred             ccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccc-cc----hhhhhh----------
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFIS-SM----SFSSLN----------  819 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~-~~----~~~~~~----------  819 (873)
                      ++.+... +.-.+.+..|.-||.+.+- .|+..-|+|||||++..|+..+.||-... +.    ..+...          
T Consensus       182 FYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  182 FYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             hcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            9987544 3345677889999988764 47888999999999999999999974211 11    000000          


Q ss_pred             -----hhhhhhhhcCCCCCCCCc------hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          820 -----LNIALDEMLDPRLPTPSR------NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       820 -----~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                           .+...+.+++.....++.      ...-......+++.+.+.+|-++|||++|.+.
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 000111111111111110      00111234778999999999999999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=4.9e-27  Score=237.82  Aligned_cols=212  Identities=31%  Similarity=0.594  Sum_probs=184.4

Q ss_pred             eeecCCeEEEEEEeCC-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCCh
Q 039344          610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL  688 (873)
Q Consensus       610 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  688 (873)
                      ||+|++|.||++.... ++.+++|++.......  ..+.+.+|+..++.++|++++++++++......++++||++++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999998764 8999999987543321  346799999999999999999999999999999999999999999


Q ss_pred             hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-CCCeEEeccccccccCCCCCCcccc
Q 039344          689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTEL  767 (873)
Q Consensus       689 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~  767 (873)
                      .+++....  ..+++..+..++.+++++++|||+.   +++|+||+|.||+++. ++.++++|||.+.............
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            99986542  3588999999999999999999999   9999999999999999 8999999999998765543223445


Q ss_pred             ccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHH
Q 039344          768 AGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISI  846 (873)
Q Consensus       768 ~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  846 (873)
                      .+...|++||..... .++.++|+|++|++++++                                           ..+
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~  190 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL  190 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence            678899999998877 788999999999999998                                           247


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          847 VEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       847 ~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .+++.+|++.+|++||+++++++.+
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhCC
Confidence            8999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=9.3e-29  Score=263.42  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|+..+.+|.|.||.||+|+. .+++..|+|+++-....+   .+.+..|+-+++..+|||||.++|-+...+..|+.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            46788999999999999999975 478999999998653333   46677899999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||||.+|+|++..+..   .++++.++..+++...+|++|||+.   +-+|||||-.||++++.|++|++|||.+..+..
T Consensus        91 MEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            9999999999987543   4588999999999999999999999   889999999999999999999999999987766


Q ss_pred             CCCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          760 DSSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .-.......||+.|||||+..   .+.|..++|||+.|+...|+-.-+.|.-...++...-....   ..+..+.+....
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk---S~~qpp~lkDk~  241 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK---SGFQPPTLKDKT  241 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc---cCCCCCcccCCc
Confidence            555566789999999999753   55688999999999999999988888332222211101110   111123333333


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+    ...+-+|++.|+..+|++||+++.+++
T Consensus       242 kw----s~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  242 KW----SEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cc----hHHHHHHHHHHhcCCCccCCChhhhee
Confidence            33    234789999999999999999987654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-30  Score=257.58  Aligned_cols=410  Identities=22%  Similarity=0.219  Sum_probs=251.2

Q ss_pred             cCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEccc-CCCCCCCCcccc
Q 039344           12 SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSN-NKLSGSIPPSLG   90 (873)
Q Consensus        12 ~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~   90 (873)
                      .+|..++  +...+++|..|+|+.+.|++|..+++|+.|+|++|+|+.+-|++|.++++|..|.+.+ |+|+....++|.
T Consensus        60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~  137 (498)
T KOG4237|consen   60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG  137 (498)
T ss_pred             cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence            4677777  4678999999999999999999999999999999999999999999999998887766 999988889999


Q ss_pred             cccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCc------------cccc
Q 039344           91 NLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLS------------ASIL  158 (873)
Q Consensus        91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~------------~~~~  158 (873)
                      +|..|+.|.+.-|++..+..+.|..+++|..|.+.+|.+...-..+|..+..++++++..|.+-            ...+
T Consensus       138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~  217 (498)
T KOG4237|consen  138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNP  217 (498)
T ss_pred             hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhch
Confidence            9999999999999999888899999999999999999998444458999999999999998831            1222


Q ss_pred             cccCCCCCCCEEEccCCcCccCCCccccCC-CCCcEEeccCCCCcccCC-ccccCCCCCCEEEccCcccCCCcccccCCC
Q 039344          159 GKIGNLKSLSNLQLSENNFNGSIPPSLGNL-SNLATLYLDTNSLSYSIP-SELGNLRSLSNLSLGYNKLSGSIPISMGNL  236 (873)
Q Consensus       159 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  236 (873)
                      -.++......-..+.++++..+.+..|... ..+..=..+.+....+.| ..|..+++|+.|+|++|+|+.+-+.+|.+.
T Consensus       218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~  297 (498)
T KOG4237|consen  218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA  297 (498)
T ss_pred             hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence            223333333333444444443333322211 111111111111111222 345555555555555555555555555555


Q ss_pred             CCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcC-CcCCCCCCCCeEEccCccccccc-ccccccCCCccEEe
Q 039344          237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPI-PILRNLTSLERVRLDRNYLTGNI-SESFYIYPNLTYID  314 (873)
Q Consensus       237 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~L~~L~  314 (873)
                      ..+++|.|..|+|..+....|.++..|+.|+|.+|+|+... .+|..+.+|.+|+|-.|.+...= ...+..+       
T Consensus       298 a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W-------  370 (498)
T KOG4237|consen  298 AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW-------  370 (498)
T ss_pred             hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHH-------
Confidence            55555555555555555555555555555555555555432 24555555555555555443210 0000000       


Q ss_pred             ccCccccccCCCCCCCCCCCCeeeeccccCCc---cCCccc---------cCCCCCCEEeccCCccCCCCCccccccccc
Q 039344          315 LSQNNFYGEISSDWGRCPKLSTLDFSINNITG---NVPPEI---------GHSSQLGVLDLSSNHIVGEIPIELGKLNFF  382 (873)
Q Consensus       315 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~---~~~~~~---------~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L  382 (873)
                      |..+.-. ..|. -.+-..++.+.++.+.+.+   ..|++.         ..++-+.+..=..|+....+|..+..  ..
T Consensus       371 lr~~~~~-~~~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~--d~  446 (498)
T KOG4237|consen  371 LRKKSVV-GNPR-CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIPV--DV  446 (498)
T ss_pred             HhhCCCC-CCCC-CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCCc--hh
Confidence            0000000 0000 0011123333333333221   112211         12233433333333333355554422  45


Q ss_pred             cEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCC
Q 039344          383 IKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN  440 (873)
Q Consensus       383 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N  440 (873)
                      ++|++.+|.++. +|..  .+.+| .+|||+|+|...--..|.++.  +|.+|-||+|
T Consensus       447 telyl~gn~~~~-vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~t--ql~tlilsyn  498 (498)
T KOG4237|consen  447 TELYLDGNAITS-VPDE--LLRSL-LLDLSNNRISSLSNYTFSNMT--QLSTLILSYN  498 (498)
T ss_pred             HHHhcccchhcc-cCHH--HHhhh-hcccccCceehhhcccccchh--hhheeEEecC
Confidence            678899999984 5554  66777 899999999866666777766  8888888876

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-28  Score=237.28  Aligned_cols=256  Identities=20%  Similarity=0.284  Sum_probs=192.8

Q ss_pred             cCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------c
Q 039344          602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------R  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  674 (873)
                      .+|.-.+.+|.|+- .|..|. .-.++.||+|+...+... ....+...+|...+..+.|+||++++.++.-.      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            45666678888888 555553 346899999999877444 33356778999999999999999999999643      3


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..|+|||+|. .++...+.     ..++.+....+..|++.|++|||+.   ||+||||||+||++..+...||.|||+|
T Consensus        95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            5799999997 57766665     2377788999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc-hh--------------hhhh
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-SF--------------SSLN  819 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-~~--------------~~~~  819 (873)
                      +..... -..+..+.+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.... .|              ....
T Consensus       166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            875543 3556778899999999999988999999999999999999999887643321 11              0000


Q ss_pred             hhh------h--------h-hhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          820 LNI------A--------L-DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       820 ~~~------~--------~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...      .        + +.+-|..++...+..+-......+++.+|+..+|++|-+++++++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            000      0        0 000111111111111122234789999999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-28  Score=231.45  Aligned_cols=248  Identities=19%  Similarity=0.313  Sum_probs=181.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeE-EEecceeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGF-CLHVRHLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~  677 (873)
                      .+.|.+.+.+|+|.||.+-+++++ +.+.+++|.+..+..    ..++|.+|...--.+ .|.||+.-|++ |...+.+.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            467899999999999999999765 678899999876533    368899998876666 69999988865 56677889


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-C-CCeEEecccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-E-NEAHVSDFGIAK  755 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~-~~~kl~Dfg~a~  755 (873)
                      .++||++.|+|.+-+...+    +.+....+++.|++.|+.|||++   .+||||||.+||||-. | ..+|+||||.++
T Consensus        99 F~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999988875432    67788899999999999999999   9999999999999943 3 479999999997


Q ss_pred             ccCCCCCCccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      ..+.   .....--+..|.|||.....     ...+.+|||.||+++|.++||+.||.......    ........+..+
T Consensus       172 k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d----~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  172 KVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD----KPYWEWEQWLKR  244 (378)
T ss_pred             ccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC----chHHHHHHHhcc
Confidence            5432   22223345679999976532     24567999999999999999999987322111    111112222222


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQK  866 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  866 (873)
                      ..+..+............+.++-+.++|++|=...+
T Consensus       245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             cCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence            222222222222334667778889999988843333

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.1e-25  Score=230.55  Aligned_cols=199  Identities=31%  Similarity=0.525  Sum_probs=171.8

Q ss_pred             CCCCceeeecCCeEEEEEEeCC-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |...+.||+|++|.||++...+ ++.+|+|.+......  ...+.+.+|++.++.++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            5667899999999999998764 889999999764333  2357899999999999999999999999998999999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC-
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS-  761 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  761 (873)
                      +++++|.+++.....  .+++..+..++.+++.++.|||+.   +++|+|++++||+++.++.++|+|||.+....... 
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999999865432  178899999999999999999999   99999999999999999999999999998775442 


Q ss_pred             CCcccccccccccccccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          762 SNWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~-~~~~~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      .......++..|++||.. ....++.++|||++|++++||++|+.||+.
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122345677889999998 666778899999999999999999999853

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=2.1e-26  Score=238.39  Aligned_cols=261  Identities=20%  Similarity=0.252  Sum_probs=201.6

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc------CCceeeEEeEEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW------HRNIVKVYGFCL  671 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~  671 (873)
                      .....|.+....|+|-|++|..|+.. .|..||||+++..    ....+.=..|++++++|+      --|+++++..|.
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            34577888899999999999999754 5789999999853    222455678999999995      357999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEec
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSD  750 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~D  750 (873)
                      ...++|||+|-+. .+|.+.+......-.+....+..++.|+.-||..|...   +|+|.||||.||||++.. ..||||
T Consensus       505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeecc
Confidence            9999999999775 78999998777666688899999999999999999998   999999999999999876 579999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccch-----------hhhhh
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-----------FSSLN  819 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-----------~~~~~  819 (873)
                      ||.|.+...  ...+....+..|.|||++.+-+|+...|+||.||.+||+.||+.-|.+..+-.           +....
T Consensus       581 fGSA~~~~e--neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  581 FGSASFASE--NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             Ccccccccc--ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            999987653  34445556778999999999999999999999999999999998876421100           00000


Q ss_pred             h--hhhhhhhcC--------------------------C------CC---CCCCchhHHHHHHHHHHHhhcccCCCCCCC
Q 039344          820 L--NIALDEMLD--------------------------P------RL---PTPSRNVHDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       820 ~--~~~~~~~~~--------------------------~------~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      .  ....++.+|                          |      .+   +..+...+.....+.+++.+|+..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            0  000011111                          1      00   011222344566789999999999999999


Q ss_pred             CHHHHHH
Q 039344          863 TMQKVCQ  869 (873)
Q Consensus       863 s~~ev~~  869 (873)
                      |..+.++
T Consensus       739 t~nqAL~  745 (752)
T KOG0670|consen  739 TVNQALK  745 (752)
T ss_pred             CHHHHhc
Confidence            9998875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.2e-25  Score=229.56  Aligned_cols=201  Identities=26%  Similarity=0.382  Sum_probs=167.4

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeE
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGF  669 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  669 (873)
                      +.+....+.|..+++||+|.|++||+|...    ..+.||+|.+.....     ...+.+|++++..+ .+.||+++.++
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhh
Confidence            344455678999999999999999999543    467899999875433     35688999999999 59999999999


Q ss_pred             EEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEE
Q 039344          670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHV  748 (873)
Q Consensus       670 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl  748 (873)
                      +...+...+|+||++.....++...      ++..++..+++.+..||+++|++   |||||||||+|++.+.. +.-.|
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceE
Confidence            9999999999999999999888743      66888999999999999999999   99999999999999854 67899


Q ss_pred             eccccccccCCCC-------------CC-------------------------------cccccccccccccccccc-CC
Q 039344          749 SDFGIAKFLKPDS-------------SN-------------------------------WTELAGTYGYVAPELAYT-MK  783 (873)
Q Consensus       749 ~Dfg~a~~~~~~~-------------~~-------------------------------~~~~~g~~~y~aPE~~~~-~~  783 (873)
                      +|||+|..+....             ..                               ....+||++|.|||++.. ..
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            9999997221100             00                               013569999999998875 45


Q ss_pred             CCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          784 VTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       784 ~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      .+.++||||.|||+.-++++++||-.
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             cCCccceeeccceeehhhcccccccc
Confidence            68899999999999999999999853

>PLN03210 Resistant to P

Probab=99.92  E-value=3.6e-24  Score=266.06  Aligned_cols=336  Identities=23%  Similarity=0.248  Sum_probs=159.8

Q ss_pred             ccccCCCCCceEEccCCc------ccccCCCCccCCC-CCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCc
Q 039344           39 HSLGNLTNLATLYIHTNS------LSGSIPGEIGNFR-FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPS  111 (873)
Q Consensus        39 ~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  111 (873)
                      .+|.++++|+.|.+..+.      +...+|+.|..++ +|+.|.+.++.++ .+|..| ...+|+.|++.+|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            344444555544443332      1122334343332 3445555444444 334333 2344555555554444 3444


Q ss_pred             cccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCC
Q 039344          112 ELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNL  191 (873)
Q Consensus       112 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L  191 (873)
                      .+..+++|+.|+|+++.....+|. ++.+++|++|+|++|......+..+..+++|+.|++++|.....+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            444445555555544432223332 4444455555554443323334444444555555555443222333322 34455


Q ss_pred             cEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccC-------CCCCchhhcCCCCCc
Q 039344          192 ATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL-------SGAIPYEYRNLVKLT  264 (873)
Q Consensus       192 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l-------~~~~~~~~~~l~~L~  264 (873)
                      +.|++++|......|..   .++|++|++++|.+. ..|..+ .+++|++|++.++..       ....+..+...++|+
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence            55555544332223221   234455555555544 233222 344444444444221       111111222334555


Q ss_pred             EEEccCCcCcC-cCCcCCCCCCCCeEEccCcc-cccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccc
Q 039344          265 ILLLGHNQFRG-PIPILRNLTSLERVRLDRNY-LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN  342 (873)
Q Consensus       265 ~L~L~~N~l~~-~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  342 (873)
                      .|++++|.... .+..+.++++|+.|++++|. +..++.. . .+++|+.|++++|.....+|..   .++|+.|+|++|
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~-~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n  856 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG-I-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT  856 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC-C-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence            56665554333 33345555666666665553 3332221 1 4566666666665443333332   346777777777


Q ss_pred             cCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCc
Q 039344          343 NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHN  390 (873)
Q Consensus       343 ~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N  390 (873)
                      .|+ .+|..+..+++|+.|+|++|.--..+|.....+++|+.+++++|
T Consensus       857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence            776 46777777777777777774433356666777777777777766

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=2.4e-23  Score=258.76  Aligned_cols=340  Identities=22%  Similarity=0.246  Sum_probs=244.7

Q ss_pred             cCCCCccCCCCCCEEEcccCCC------CCCCCccccccc-ccceeeccccccCCCCCccccCCcccCcccccccccccc
Q 039344           60 SIPGEIGNFRFFSDLELSNNKL------SGSIPPSLGNLS-NLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGS  132 (873)
Q Consensus        60 ~~p~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  132 (873)
                      ..+.+|.++++|+.|.+.++..      ...+|..|..++ +|+.|++.++.++ .+|..| .+.+|++|++++|.+. .
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence            3456677888888888876542      234566676664 5888888888887 667776 4678888888888887 5


Q ss_pred             cCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCC
Q 039344          133 IPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNL  212 (873)
Q Consensus       133 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  212 (873)
                      ++..+..+++|+.|+|++|......+ .+..+++|++|+|++|.....+|..+..+++|+.|++++|..-..+|..+ ++
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            77778888888888888765322223 47778888888888877656778888888888888888865443566554 68


Q ss_pred             CCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc-------CC-cCCCCC
Q 039344          213 RSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP-------IP-ILRNLT  284 (873)
Q Consensus       213 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-------~~-~l~~l~  284 (873)
                      ++|+.|++++|......|..   .++|++|++++|.+.. .|..+ .+++|+.|++.++.....       .+ .....+
T Consensus       704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~  778 (1153)
T PLN03210        704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSP  778 (1153)
T ss_pred             CCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccc
Confidence            88888888888654344432   4578888888888763 44433 567788887776443211       11 122346


Q ss_pred             CCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEecc
Q 039344          285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS  364 (873)
Q Consensus       285 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls  364 (873)
                      +|+.|++++|......+..+..+++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|..   .++|+.|+|+
T Consensus       779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls  854 (1153)
T PLN03210        779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS  854 (1153)
T ss_pred             cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence            78888888887666666678888888888888876544666655 6788888888887654444442   3678888888


Q ss_pred             CCccCCCCCccccccccccEEEecCc-cccCCcccccccccccccccccccc
Q 039344          365 SNHIVGEIPIELGKLNFFIKLVLAHN-QLSGQLSPKLGSLVQLEHLDLSSNR  415 (873)
Q Consensus       365 ~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~  415 (873)
                      +|.|+ .+|..+..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus       855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            88887 67888888888888888885 555 466677788888888888875

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=5.6e-25  Score=265.59  Aligned_cols=194  Identities=18%  Similarity=0.210  Sum_probs=139.6

Q ss_pred             hccC-CceeeEEeEE-------EecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039344          657 EIWH-RNIVKVYGFC-------LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI  728 (873)
Q Consensus       657 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  728 (873)
                      .++| +||++++++|       .+.+.++.++||+ +++|.+++...  ...+++.++..++.||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3456 6888888887       2334677888987 46999999643  24589999999999999999999999   99


Q ss_pred             eeCCCCCCCeeeCC-------------------CCCeEEeccccccccCCCCC----------------Ccccccccccc
Q 039344          729 VHRDISSKNVLLDF-------------------ENEAHVSDFGIAKFLKPDSS----------------NWTELAGTYGY  773 (873)
Q Consensus       729 ~H~Dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~----------------~~~~~~g~~~y  773 (873)
                      +||||||+|||++.                   ++.+|++|||+++.......                ......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566777777654321000                01123578899


Q ss_pred             ccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhc
Q 039344          774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISC  853 (873)
Q Consensus       774 ~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  853 (873)
                      ||||++.+..++.++|||||||++|||++|..|+......      ..........+...       ........++.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  248 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT------MSSLRHRVLPPQIL-------LNWPKEASFCLWL  248 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH------HHHHHHhhcChhhh-------hcCHHHHHHHHHh
Confidence            9999999999999999999999999999998886521110      00011111111110       1112356788899


Q ss_pred             ccCCCCCCCCHHHHHH
Q 039344          854 VDENPESRPTMQKVCQ  869 (873)
Q Consensus       854 l~~dP~~RPs~~ev~~  869 (873)
                      |+++|.+||++.|+++
T Consensus       249 L~~~P~~Rps~~eil~  264 (793)
T PLN00181        249 LHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CCCChhhCcChHHHhh
Confidence            9999999999999976

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=4.1e-24  Score=209.69  Aligned_cols=165  Identities=24%  Similarity=0.292  Sum_probs=123.9

Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      |+|.+++...  ...+++.+++.++.|++.|++|||++   +      ||+||+++.++.+|+  ||.++......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            6788888643  24589999999999999999999999   5      999999999999999  99998765422    


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHH-
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI-  844 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  844 (873)
                       ..|++.|+|||++.+..++.++|||||||++|||+||+.||........   ........... ..+........... 
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~  138 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA---ILEILLNGMPA-DDPRDRSNLESVSAA  138 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH---HHHHHHHHhcc-CCccccccHHHHHhh
Confidence             2688999999999999999999999999999999999999864332211   01111111111 11110001111122 


Q ss_pred             -HHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          845 -SIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       845 -~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       .+.+++.+||+.+|++||++.|+++.+.
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence             5899999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=4.8e-23  Score=236.68  Aligned_cols=261  Identities=25%  Similarity=0.317  Sum_probs=121.0

Q ss_pred             CCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEeccc
Q 039344          167 LSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE  246 (873)
Q Consensus       167 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  246 (873)
                      -..|+|+.|.++ .+|..+.  ++|+.|++++|+++ .+|..   +++|++|++++|+|+. +|..   .++|+.|++++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS  271 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence            445555555555 3344333  24555555555555 23321   3455555555555552 2321   23455555555


Q ss_pred             ccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCC
Q 039344          247 NSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISS  326 (873)
Q Consensus       247 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~  326 (873)
                      |.++.. |..   ..+|+.|++++|+++..+.   ..++|+.|++++|.+++++.    ....                 
T Consensus       272 N~L~~L-p~l---p~~L~~L~Ls~N~Lt~LP~---~p~~L~~LdLS~N~L~~Lp~----lp~~-----------------  323 (788)
T PRK15387        272 NPLTHL-PAL---PSGLCKLWIFGNQLTSLPV---LPPGLQELSVSDNQLASLPA----LPSE-----------------  323 (788)
T ss_pred             Cchhhh-hhc---hhhcCEEECcCCccccccc---cccccceeECCCCccccCCC----Cccc-----------------
Confidence            555421 211   1334445555554443222   12344444444444443321    1123                 


Q ss_pred             CCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCccccccccccc
Q 039344          327 DWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQL  406 (873)
Q Consensus       327 ~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  406 (873)
                             |+.|++++|++++ +|.   ...+|++|+|++|+|+ .+|..   ..+|+.|++++|+|+. +|..   ..+|
T Consensus       324 -------L~~L~Ls~N~L~~-LP~---lp~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L  384 (788)
T PRK15387        324 -------LCKLWAYNNQLTS-LPT---LPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGL  384 (788)
T ss_pred             -------ccccccccCcccc-ccc---cccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Cccc---cccc
Confidence                   4444444444432 222   1124445555555544 22321   1234444555555543 2321   1345


Q ss_pred             ccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecC
Q 039344          407 EHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDIS  486 (873)
Q Consensus       407 ~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls  486 (873)
                      +.|+|++|+|+ .+|...     .+|+.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..+..+++|..|+|+
T Consensus       385 ~~LdLs~N~Lt-~LP~l~-----s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        385 KELIVSGNRLT-SLPVLP-----SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ceEEecCCccc-CCCCcc-----cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            55555555554 233322     145556666666654 3332   234556666666666 345666666666666666


Q ss_pred             CCcccccCCC
Q 039344          487 YNELRGSIPN  496 (873)
Q Consensus       487 ~N~l~~~~p~  496 (873)
                      +|+|+|.+|.
T Consensus       454 ~N~Ls~~~~~  463 (788)
T PRK15387        454 GNPLSERTLQ  463 (788)
T ss_pred             CCCCCchHHH
Confidence            6666665554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=7.4e-23  Score=235.18  Aligned_cols=85  Identities=20%  Similarity=0.170  Sum_probs=56.8

Q ss_pred             CCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEecc
Q 039344          285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS  364 (873)
Q Consensus       285 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls  364 (873)
                      +|+.|++++|.|++++..    .++|+.|++++|++++ +|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt~LP~l----~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTSLPVL----PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccCCCCc----ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            455555555555543321    2457777777777764 4432   246777888888887 578888888888888888


Q ss_pred             CCccCCCCCccccc
Q 039344          365 SNHIVGEIPIELGK  378 (873)
Q Consensus       365 ~N~i~~~~~~~~~~  378 (873)
                      +|++++..+..+..
T Consensus       454 ~N~Ls~~~~~~L~~  467 (788)
T PRK15387        454 GNPLSERTLQALRE  467 (788)
T ss_pred             CCCCCchHHHHHHH
Confidence            88888766665533

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=8.2e-23  Score=217.76  Aligned_cols=184  Identities=18%  Similarity=0.214  Sum_probs=138.8

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC--CCcEEEEEEccCCCC--CcchhHHHHHHHHHHHHhccCCceee-EEeEEEec
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA--SGEIIAVKKFHSPLP--GEMTFQQEFLNEVKALTEIWHRNIVK-VYGFCLHV  673 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~  673 (873)
                      ....+|.+.+.||+|+||+||+|+..  +++.||||+......  ......+.|.+|++++++++|+|+++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34578999999999999999999764  578889998753211  12223566999999999999999985 4432    


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeeeCCCCCeEEeccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDI-SSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl-k~~Nill~~~~~~kl~Dfg  752 (873)
                      +..|+||||+++++|... .  .    ..   ...++.++++|++|||+.   ||+|||| ||+||+++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            457999999999999632 1  1    01   146788999999999999   9999999 9999999999999999999


Q ss_pred             cccccCCCCCC--------ccccccccccccccccccCC------CCCcchhHHHHHHHHHHHhCCCCC
Q 039344          753 IAKFLKPDSSN--------WTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPR  807 (873)
Q Consensus       753 ~a~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~------~~~~sDv~s~G~il~el~tg~~P~  807 (873)
                      +|+.+......        .....+++.|+|||++...+      .+..+|-|        +.||..-+
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW--------~~TGDlg~  218 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW--------LATGKKVY  218 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE--------EeCCCEEE
Confidence            99977543311        13456788899999886433      23346666        44666554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-23  Score=201.08  Aligned_cols=249  Identities=20%  Similarity=0.313  Sum_probs=184.7

Q ss_pred             CCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEec
Q 039344          604 FDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      .....+|.+...|..|+|+++ |..+++|++...... ....++|..|.-.++-+.||||+.++|.|.......++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            344567899999999999998 555667776543222 222467899999999999999999999999999999999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCee-eCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV-HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~-H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +.|+|+..+++... -..+..++.+++.+|++|++|||+..  +++ ---+.++.|++|++.+++|+ .+-+++..+.. 
T Consensus       270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe~-  344 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV-  344 (448)
T ss_pred             cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeecc-
Confidence            99999999987653 34677889999999999999999974  444 44689999999999988874 12222111111 


Q ss_pred             CccccccccccccccccccCCCC---CcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          763 NWTELAGTYGYVAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~---~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                         ...-.|.||+||.++..+-+   .++|+|||++++||+.|...||....+++..-...-    +-+...+|+..  .
T Consensus       345 ---gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----eglrv~ippgi--s  415 (448)
T KOG0195|consen  345 ---GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----EGLRVHIPPGI--S  415 (448)
T ss_pred             ---ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----ccccccCCCCc--c
Confidence               12236789999999876543   478999999999999999999987665532211111    11222333222  2


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ..+..++.-|+..||.+||.++.|+-.|+
T Consensus       416 ----~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  416 ----RHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             ----HHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence                23678888899999999999999887764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-21  Score=209.74  Aligned_cols=254  Identities=20%  Similarity=0.232  Sum_probs=187.3

Q ss_pred             CCCCCceeeecCCeEEEEEEeCCC--cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC----CceeeEEeEE-Eecce
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLASG--EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH----RNIVKVYGFC-LHVRH  675 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~  675 (873)
                      .|.+.+.||+|+||.||.+.....  +.+|+|..........   ..+..|..++..+..    +++.++++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999986543  4788888765422221   257788888888862    6899999998 57778


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-----CCeEEec
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-----NEAHVSD  750 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-----~~~kl~D  750 (873)
                      .++||+.+ |.+|.++..... .+.++.....+++.|++.+|+++|+.   |++||||||.|+.+...     ..+.+.|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            89999976 578988775544 56799999999999999999999999   99999999999999865     3589999


Q ss_pred             ccccc--ccCCCCC-------C-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh
Q 039344          751 FGIAK--FLKPDSS-------N-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       751 fg~a~--~~~~~~~-------~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~  820 (873)
                      ||+|+  .+.....       . .....||..|+++....+...+.+.|+||++.++.|+..|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99998  3322211       1 123569999999999999999999999999999999999999986544221111111


Q ss_pred             hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      ..........    .....+.   .+.++...+-..+..++|....+...+
T Consensus       251 ~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l  294 (322)
T KOG1164|consen  251 KDPRKLLTDR----FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELL  294 (322)
T ss_pred             HHhhhhcccc----ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence            1111111111    0111112   244445555557888999998887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.7e-22  Score=229.94  Aligned_cols=254  Identities=19%  Similarity=0.289  Sum_probs=186.8

Q ss_pred             CCceeeecCCeEEEEEEe-CCCcEEEEEEccC---CCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          606 DEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHS---PLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       606 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      ...++|.|++|.|+.+.. ...+..+.|.++.   +..........+..|+.+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            457899999998887743 3444455555442   222222223336778888889999999888887777666666699


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++ +|..++...   ..++..++..+.+|+..|++|+|+.   ||.|||+|++|++++.+|.+||+|||.+.....+.
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 998888654   3488889999999999999999999   99999999999999999999999999998765544


Q ss_pred             CC----ccccccccccccccccccCCCCC-cchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          762 SN----WTELAGTYGYVAPELAYTMKVTE-KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       762 ~~----~~~~~g~~~y~aPE~~~~~~~~~-~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      +.    ....+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||..........  ........ ......+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~~~-~~~~~~~~  551 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYSDQ-RNIFEGPN  551 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccccc-cccccChH
Confidence            32    34678999999999999999876 4899999999999999999986433221000  00000000 00001111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .-..........++.++++.||++|-|+++|++
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            122333445788999999999999999999976

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=2.9e-20  Score=203.46  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=197.5

Q ss_pred             CCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCC-ceeeEEeEEEecceeEEEEEe
Q 039344          604 FDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-NIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  682 (873)
                      |...+.+|.|+||.||++...  ..+++|.+.............+.+|+..++.+.|+ +++++++++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999877  78899998766544433467899999999999888 799999999777778999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEeccccccccCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  761 (873)
                      +.++++.+++........++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999996665432112578889999999999999999999   999999999999999998 79999999998665443


Q ss_pred             C------Ccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          762 S------NWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       762 ~------~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .      ......|+..|+|||.+.+   ..+...+|+||+|++++++++|..||....... ..............+..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTPSL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-cHHHHHHHHHhcCCccc
Confidence            2      2356789999999999987   578889999999999999999999976543210 00000111111111100


Q ss_pred             CCC-Cch-hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTP-SRN-VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~-~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ... ... .......+.+++.+|+..+|..|.++.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            000 000 0111235778999999999999998887653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.9e-21  Score=183.32  Aligned_cols=257  Identities=19%  Similarity=0.273  Sum_probs=195.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  677 (873)
                      ....|.+.++||.|+||.+|.|. ..+|+.||+|.-.....     ...+..|..+.+.++ ...|+.+..|..+...-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            34679999999999999999995 67899999999765432     245778889999886 478888888888888899


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeEEeccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSDFGIA  754 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a  754 (873)
                      +||+.. |-+|.+.+.-..  ..++.+.++-.|-|++.-++|+|.+   +++||||||+|+|+.-+   ..+.++|||+|
T Consensus        88 lVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            999986 468888775332  4588999999999999999999999   99999999999999755   36889999999


Q ss_pred             cccCCCCCC-------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhh
Q 039344          755 KFLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       755 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      +.+.+....       -....||..|.+--...+...+.+.|+=|+|.++...-.|..||.......     .....+.+
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t-----k~QKyEkI  236 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT-----KKQKYEKI  236 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh-----HHHHHHHH
Confidence            887553322       235679999999988888888999999999999999999999988654321     11222333


Q ss_pred             cCCCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          828 LDPRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       828 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+...+.+ -+...+.++.-.+.-|-..-=++-|...-+.+.++
T Consensus       237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            3333332211 12222334666667777777777788776666554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.3e-21  Score=224.76  Aligned_cols=202  Identities=26%  Similarity=0.462  Sum_probs=104.3

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      +...|++++++++ .+|..+.  ++|+.|+|++|+++ .+|..+.  .+|++|++++|+++ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            3456666666666 4555443  45666666666666 4454443  35666666666666 3444443  356666666


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI  181 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  181 (873)
                      +|++. .+|..+.  .+|+.|++++|+++ .+|..+.  ++|+.|++++|+++.++. .+.  ++|+.|++++|+++. +
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~-~lp--~sL~~L~Ls~N~Lt~-L  319 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPA-HLP--SGITHLNVQSNSLTA-L  319 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcc-cch--hhHHHHHhcCCcccc-C
Confidence            66666 4454443  35666666666665 3454442  356666666665554322 111  245555555555553 2


Q ss_pred             CccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCC
Q 039344          182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS  250 (873)
Q Consensus       182 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  250 (873)
                      |..+.  ++|+.|++++|.++. +|..+.  ++|+.|++++|+|+ .+|..+.  ++|++|+|++|+++
T Consensus       320 P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt  380 (754)
T PRK15370        320 PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT  380 (754)
T ss_pred             Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence            32221  345555555555552 333332  45555555555554 2333221  34555555555554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=2.3e-21  Score=224.66  Aligned_cols=241  Identities=28%  Similarity=0.441  Sum_probs=188.1

Q ss_pred             cccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCC
Q 039344            3 CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLS   82 (873)
Q Consensus         3 ~~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~   82 (873)
                      |+.+++++. +|..+.  +.|+.|+|++|+|+ .+|..+.  ++|++|++++|+++ .+|..+.  .+|+.|+|++|.+.
T Consensus       184 ~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~  254 (754)
T PRK15370        184 RLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT  254 (754)
T ss_pred             EeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC
Confidence            567778774 677776  58999999999999 5676654  58999999999999 6777664  57999999999999


Q ss_pred             CCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccC
Q 039344           83 GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG  162 (873)
Q Consensus        83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  162 (873)
                       .+|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|+++.++...  
T Consensus       255 -~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l--  323 (754)
T PRK15370        255 -ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETL--  323 (754)
T ss_pred             -cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCccc--
Confidence             6777665  58999999999999 5777664  58999999999999 4665553  57999999999998754332  


Q ss_pred             CCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEE
Q 039344          163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL  242 (873)
Q Consensus       163 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  242 (873)
                       .++|+.|++++|.++. +|..+.  ++|+.|++++|+++ .+|..+.  ++|++|+|++|+|+. +|..+.  ..|+.|
T Consensus       324 -~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~L  393 (754)
T PRK15370        324 -PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIM  393 (754)
T ss_pred             -cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHH
Confidence             2689999999999985 565553  69999999999998 5676554  689999999999994 454443  368889


Q ss_pred             ecccccCCCCCchhh----cCCCCCcEEEccCCcCc
Q 039344          243 NLFENSLSGAIPYEY----RNLVKLTILLLGHNQFR  274 (873)
Q Consensus       243 ~L~~n~l~~~~~~~~----~~l~~L~~L~L~~N~l~  274 (873)
                      ++++|++.. +|..+    ..++++..|++.+|++.
T Consensus       394 dLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        394 QASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence            999998873 44432    23355555555555554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=4.6e-20  Score=182.04  Aligned_cols=201  Identities=19%  Similarity=0.306  Sum_probs=169.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEE-eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      .-.|.++++||+|.||.++.|+ +-+++.||||.-.....     ..++..|.+..+.+ ..++|...|-|..++.+-.+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            3579999999999999999996 45799999998643321     35677889999888 57999999988888888899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-----CeEEecccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-----EAHVSDFGI  753 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-----~~kl~Dfg~  753 (873)
                      |+|.+ |-+|.+.+.-.  +.+++.+.+..+|.|++.-++|+|++   .+|.|||||+|+||...+     .+.++|||+
T Consensus       102 VidLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            99986 46787777533  34699999999999999999999999   999999999999998655     489999999


Q ss_pred             ccccCCCCCC-------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCccccc
Q 039344          754 AKFLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS  812 (873)
Q Consensus       754 a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~  812 (873)
                      |+.+.+....       .....||.+||+--...+.+.+.+.|.=|+|-|++..+.|..||.+...
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            9988665432       2356799999999999999999999999999999999999999886543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-21  Score=220.93  Aligned_cols=244  Identities=20%  Similarity=0.228  Sum_probs=182.9

Q ss_pred             CCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHH--HhccCCceeeEEeEEEecceeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL--TEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++...+.+|.+.|=+|.+|+.++|. |+||+|.+..+.-  ..+.|.++++..  ..++|||++++.-+-...+..|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~--sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTI--SLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCC--CchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHH
Confidence            5777889999999999999999888 8899987654221  234455554444  4448999999998888888899999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc--C
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL--K  758 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~--~  758 (873)
                      +|+. .+|+|.+....   -+...+.+.|+.|++.|+.-+|..   ||+|||||.+|||++.-..+.|+||..-+..  .
T Consensus       101 qyvk-hnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHh-hhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            9987 58888886543   267788899999999999999999   9999999999999999999999999765432  1


Q ss_pred             C-CCCCc----cccccccccccccccccC----------C-CCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhh---
Q 039344          759 P-DSSNW----TELAGTYGYVAPELAYTM----------K-VTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSL---  818 (873)
Q Consensus       759 ~-~~~~~----~~~~g~~~y~aPE~~~~~----------~-~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~---  818 (873)
                      . .+..+    .+......|.|||.+...          . .+++.||||+||+++|+++ |++||...+-+.....   
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~  253 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD  253 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence            1 11222    233345579999987542          1 5678999999999999998 7888874332222111   


Q ss_pred             hhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          819 NLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ..+..++.+.|.              .+++++..|++.||.+|.++++.++.
T Consensus       254 ~~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence            111222222221              37899999999999999999999875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=1e-20  Score=186.77  Aligned_cols=185  Identities=12%  Similarity=0.150  Sum_probs=140.2

Q ss_pred             ccccCHHHHH--HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHH------HHHHHHHHHhccC
Q 039344          589 EGKIIYEEII--RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQE------FLNEVKALTEIWH  660 (873)
Q Consensus       589 ~~~~~~~e~~--~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h  660 (873)
                      +....|.++.  ....+|...+++|.|+||.||.+.. ++..+|+|.++..........+.      +.+|+..+.++.|
T Consensus        16 ~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~   94 (232)
T PRK10359         16 DNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS   94 (232)
T ss_pred             CCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH
Confidence            3333344443  2367899999999999999999866 47789999998665544333233      6799999999999


Q ss_pred             CceeeEEeEEEec--------ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 039344          661 RNIVKVYGFCLHV--------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRD  732 (873)
Q Consensus       661 ~niv~l~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D  732 (873)
                      |+|..+.+++...        +..++||||++|.++.++..       .+.    ....+++.++..+|..   |++|||
T Consensus        95 ~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~D  160 (232)
T PRK10359         95 EGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGD  160 (232)
T ss_pred             CCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCC
Confidence            9999999986643        35799999999999987731       222    2456999999999999   999999


Q ss_pred             CCCCCeeeCCCCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 039344          733 ISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI  801 (873)
Q Consensus       733 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~  801 (873)
                      ++|+||+++.+| ++++|||..+..... ....           .+.....+..++|+||+|+.+....
T Consensus       161 ikp~Nili~~~g-i~liDfg~~~~~~e~-~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        161 PHKGNFIVSKNG-LRIIDLSGKRCTAQR-KAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CChHHEEEeCCC-EEEEECCCcccccch-hhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            999999999988 999999988755321 1111           1333445667899999999876554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=1.5e-20  Score=191.27  Aligned_cols=236  Identities=20%  Similarity=0.251  Sum_probs=153.2

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc----------CCceeeEEeEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW----------HRNIVKVYGFCL  671 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~  671 (873)
                      .+...+.||.|+++.||.++.. +|+.+|+|++..+........+++.+|.-....+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4556789999999999999865 58999999987665555555677888876665532          323333333332


Q ss_pred             e---------c---c-----eeEEEEEeccCCChhhHhcc---ccc-ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 039344          672 H---------V---R-----HLFIVYEYFKMCSLAVILSN---DAA-AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVH  730 (873)
Q Consensus       672 ~---------~---~-----~~~lv~e~~~~~~L~~~l~~---~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  730 (873)
                      -         .   .     ..+++|+-+. ++|.+++..   ... ........+..+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence            1         1   1     2366777764 677776532   111 11233445677778999999999999   9999


Q ss_pred             CCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccccccccccccccccC--------CCCCcchhHHHHHHHHHHHh
Q 039344          731 RDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM--------KVTEKCDVYSFGVLALEVIK  802 (873)
Q Consensus       731 ~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~sDv~s~G~il~el~t  802 (873)
                      +||+|+|++++.+|.++|+||+.......   .......+..|.|||.....        .++.+.|.|++|+++|.+++
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999998875442   22223455789999976442        47889999999999999999


Q ss_pred             CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCC
Q 039344          803 GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESR  861 (873)
Q Consensus       803 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  861 (873)
                      |+.||+..........            .+    ..+.+....+..+|..+++++|++|
T Consensus       246 ~~lPf~~~~~~~~~~~------------~f----~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW------------DF----SRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG------------GG----TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc------------cc----hhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999985443211111            11    1112344468899999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=3.3e-20  Score=182.16  Aligned_cols=143  Identities=17%  Similarity=0.223  Sum_probs=109.8

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcch-----------------------hHHHHHHHHHHHHhccCCce
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT-----------------------FQQEFLNEVKALTEIWHRNI  663 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni  663 (873)
                      ...||+|+||.||+|...+|+.||||+++........                       .......|+..++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998888999999999754321111                       01122459999999988877


Q ss_pred             eeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCeeeCC
Q 039344          664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM-HNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       664 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      .....+..  ...++||||++++++......   ...++...+..++.|++.+++|+ |+.   ||+||||||+||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            54443322  234899999998776544321   23578899999999999999999 688   999999999999998 


Q ss_pred             CCCeEEeccccccccC
Q 039344          743 ENEAHVSDFGIAKFLK  758 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~  758 (873)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            5889999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=4.8e-19  Score=174.95  Aligned_cols=143  Identities=19%  Similarity=0.253  Sum_probs=112.3

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcch-----------------------hHHHHHHHHHHHHhccCCce
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT-----------------------FQQEFLNEVKALTEIWHRNI  663 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni  663 (873)
                      ...||+|++|.||+|+..+|+.||||+++........                       ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998878999999998765321100                       01224678999999999987


Q ss_pred             eeEEeEEEecceeEEEEEeccCCChhhH-hcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeC
Q 039344          664 VKVYGFCLHVRHLFIVYEYFKMCSLAVI-LSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLD  741 (873)
Q Consensus       664 v~l~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~  741 (873)
                      .....+....  .++||||++++++... +..    ..++..+...++.|++.++.++|+ .   ||+||||||+||+++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            6555444332  4899999998855433 321    346788899999999999999999 8   999999999999999


Q ss_pred             CCCCeEEeccccccccCC
Q 039344          742 FENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       742 ~~~~~kl~Dfg~a~~~~~  759 (873)
                       ++.++|+|||+++....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             89999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2e-19  Score=194.58  Aligned_cols=210  Identities=25%  Similarity=0.418  Sum_probs=157.6

Q ss_pred             HHhccCCceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCe-eeCCC
Q 039344          655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI-VHRDI  733 (873)
Q Consensus       655 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~Dl  733 (873)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....  ..+++.....++++|+.|++|+|+-   +| +|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            356789999999999999999999999999999999997633  4589999999999999999999997   55 89999


Q ss_pred             CCCCeeeCCCCCeEEeccccccccCCC--CCCccccccccccccccccccCC-------CCCcchhHHHHHHHHHHHhCC
Q 039344          734 SSKNVLLDFENEAHVSDFGIAKFLKPD--SSNWTELAGTYGYVAPELAYTMK-------VTEKCDVYSFGVLALEVIKGK  804 (873)
Q Consensus       734 k~~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~-------~~~~sDv~s~G~il~el~tg~  804 (873)
                      +++|+++|....+|++|||+.......  ...........-|.|||.+....       .+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999999876431  11111222345699999987642       466799999999999999999


Q ss_pred             CCCcccccchhhhhhhhhhhhhhcCCCCCCCCc-h-hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          805 HPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR-N-VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       805 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .||+......-....... +..  ++.-+..+. . ..+....+..++..||..+|++||++++|...++
T Consensus       156 ~~~~~~~~~~~~~eii~~-~~~--~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILR-VKK--GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             CccccccccCChHHHHHH-HHh--cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            999854322111111111 111  111111111 1 1122235889999999999999999999987664

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=8.4e-19  Score=168.90  Aligned_cols=185  Identities=10%  Similarity=0.040  Sum_probs=136.4

Q ss_pred             CCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCc-chhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEEEEe
Q 039344          605 DDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE-MTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       605 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-. ......+.+|++++++++ |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998876 47777777765321110 011225789999999994 5889999987    346999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDI-SSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      +.|.+|......          ....++.|++++++++|+.   ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999888654311          1135778999999999999   9999999 7999999999999999999998655433


Q ss_pred             CC-----cc--------ccccccccccccccccC-CCC-CcchhHHHHHHHHHHHhCCCCC
Q 039344          762 SN-----WT--------ELAGTYGYVAPELAYTM-KVT-EKCDVYSFGVLALEVIKGKHPR  807 (873)
Q Consensus       762 ~~-----~~--------~~~g~~~y~aPE~~~~~-~~~-~~sDv~s~G~il~el~tg~~P~  807 (873)
                      ..     ..        -...++.|++|+.-.-- ..+ .+.+-++-|.-+|.++|++.|+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            21     00        11246677777753321 222 4578889999999999999984

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=5.8e-19  Score=178.12  Aligned_cols=194  Identities=22%  Similarity=0.346  Sum_probs=137.7

Q ss_pred             cCCceeeEEeEEEe---------------------------cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHH
Q 039344          659 WHRNIVKVYGFCLH---------------------------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK  711 (873)
Q Consensus       659 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~  711 (873)
                      +|||||++.++|.+                           ....|+||...+ .+|+.++....    .+...+.-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            59999999987754                           124689998765 78988886543    56667778889


Q ss_pred             HHHHHHHHHHhCCCCCeeeCCCCCCCeeeC--CCC--CeEEeccccccccCCC------CCCcccccccccccccccccc
Q 039344          712 GIVDALSYMHNDCFPPIVHRDISSKNVLLD--FEN--EAHVSDFGIAKFLKPD------SSNWTELAGTYGYVAPELAYT  781 (873)
Q Consensus       712 ~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--~~~--~~kl~Dfg~a~~~~~~------~~~~~~~~g~~~y~aPE~~~~  781 (873)
                      |+++|+.|||.+   ||.|||+|++|||+.  +|+  ...++|||++---+..      .+..-...|...-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   999999999999994  333  4788999987422111      112223457788999998765


Q ss_pred             CCC------CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhccc
Q 039344          782 MKV------TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVD  855 (873)
Q Consensus       782 ~~~------~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  855 (873)
                      .+-      -.|.|.|+.|.+.||+++...||...+.+.......++       ..+|.-++..+   ..+.+++...++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe-------~qLPalp~~vp---p~~rqlV~~lL~  495 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE-------SQLPALPSRVP---PVARQLVFDLLK  495 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh-------hhCCCCcccCC---hHHHHHHHHHhc
Confidence            431      24899999999999999999998864444322222211       12222222222   237788999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 039344          856 ENPESRPTMQKVCQL  870 (873)
Q Consensus       856 ~dP~~RPs~~ev~~~  870 (873)
                      .||.+|++..-....
T Consensus       496 r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANV  510 (598)
T ss_pred             CCccccCCccHHHhH
Confidence            999999987654443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=1.8e-20  Score=203.11  Aligned_cols=276  Identities=24%  Similarity=0.248  Sum_probs=136.4

Q ss_pred             EEECCCCccc-ccCCccccCCCCCceEEccCCcccc----cCCCCccCCCCCCEEEcccCCCCC------CCCccccccc
Q 039344           25 DLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSG----SIPGEIGNFRFFSDLELSNNKLSG------SIPPSLGNLS   93 (873)
Q Consensus        25 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~   93 (873)
                      .|+|..+.++ ...+..|..+.+|++|++++|.++.    .++..+...+++++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4666666666 3444555666667777777777642    244455556667777777666552      1223444455


Q ss_pred             ccceeeccccccCCCCCccccCCcc---cCccccccccccc----ccCccccCC-CCCcEEEccCCCCccccccccCCCC
Q 039344           94 NLATLYLDTNSLSNSIPSELGNLRS---LSNLQLNNNILSG----SIPHSLGNL-TNLATLYIYSNSLSASILGKIGNLK  165 (873)
Q Consensus        94 ~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~  165 (873)
                      +|+.|++++|.+....+..+..+.+   |++|++++|.+++    .+...+..+ ++|+.|++++|.++.....      
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~------  155 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE------  155 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH------
Confidence            5666666555555433333333333   5555555555442    112223333 4455555555544421100      


Q ss_pred             CCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCccc----CCccccCCCCCCEEEccCcccCCCc----ccccCCCC
Q 039344          166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYS----IPSELGNLRSLSNLSLGYNKLSGSI----PISMGNLS  237 (873)
Q Consensus       166 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~  237 (873)
                                    ..+..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++..    ...+..++
T Consensus       156 --------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~  221 (319)
T cd00116         156 --------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK  221 (319)
T ss_pred             --------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence                          0112233334444444444444421    1122333345555555555544221    12234455


Q ss_pred             CccEEecccccCCCCCchhhc-----CCCCCcEEEccCCcCcC-----cCCcCCCCCCCCeEEccCccccccc----ccc
Q 039344          238 NLTYLNLFENSLSGAIPYEYR-----NLVKLTILLLGHNQFRG-----PIPILRNLTSLERVRLDRNYLTGNI----SES  303 (873)
Q Consensus       238 ~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~-----~~~~l~~l~~L~~L~L~~n~l~~~~----~~~  303 (873)
                      +|++|++++|.+++.....+.     ..+.|+.|++++|.++.     ....+..+++|+++++++|.++...    ...
T Consensus       222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~  301 (319)
T cd00116         222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES  301 (319)
T ss_pred             CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence            566666666655532222221     12566666666666642     1223444566777777777776442    223


Q ss_pred             cccC-CCccEEeccCccc
Q 039344          304 FYIY-PNLTYIDLSQNNF  320 (873)
Q Consensus       304 ~~~~-~~L~~L~Ls~N~l  320 (873)
                      +... +.|++|++.+|.+
T Consensus       302 ~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         302 LLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HhhcCCchhhcccCCCCC
Confidence            3334 6777777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.6e-19  Score=194.50  Aligned_cols=227  Identities=24%  Similarity=0.316  Sum_probs=176.1

Q ss_pred             eeeecCCeEEEEEE----eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEEEEec
Q 039344          609 CIGKGGQGSVYMSK----LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       609 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      .+|+|+||.|+.++    ...|..+|.|..++........ .-...|..++...+ ||.+|++.-.+..+...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            37899999999774    3346778888877654332221 24557778888886 999999999999999999999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN  763 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  763 (873)
                      .+|.+...+....   .+++.........++-+++++|+.   +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus        80 rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             ccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9999987775543   366777778888999999999999   9999999999999999999999999999866433222


Q ss_pred             ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHH
Q 039344          764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL  843 (873)
Q Consensus       764 ~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  843 (873)
                          +||..|||||++.  ....+.|.||||++++||+||..||..            +....++...+..+..    ..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p~~----l~  211 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMPRE----LS  211 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCchh----hh
Confidence                8999999999988  466789999999999999999999864            2233333334443332    22


Q ss_pred             HHHHHHHhhcccCCCCCCCCH
Q 039344          844 ISIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       844 ~~l~~li~~cl~~dP~~RPs~  864 (873)
                      ....+++..+...+|..|.-.
T Consensus       212 ~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  212 AEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHHhhCHHHHhcc
Confidence            335677777888888888543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=2.8e-20  Score=201.59  Aligned_cols=269  Identities=23%  Similarity=0.250  Sum_probs=184.2

Q ss_pred             ccCCccc-ccCCccccCCCCCCEEECCCCcccc----cCCccccCCCCCceEEccCCccc------ccCCCCccCCCCCC
Q 039344            4 IYNNSLY-DSIPSELRNLKSLSDLELGNNKLSG----SIPHSLGNLTNLATLYIHTNSLS------GSIPGEIGNFRFFS   72 (873)
Q Consensus         4 ~~~n~~~-~~~p~~~~~l~~l~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~------~~~p~~~~~l~~L~   72 (873)
                      +..+++. ...+..+..+..|++|+++++.++.    .++..+...++|++|+++++.+.      ..++..+..+++|+
T Consensus         5 L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~   84 (319)
T cd00116           5 LKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ   84 (319)
T ss_pred             cccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCcee
Confidence            4566676 6777788888999999999999953    35667778889999999999887      23445677889999


Q ss_pred             EEEcccCCCCCCCCcccccccc---cceeeccccccCC----CCCccccCC-cccCcccccccccccc----cCccccCC
Q 039344           73 DLELSNNKLSGSIPPSLGNLSN---LATLYLDTNSLSN----SIPSELGNL-RSLSNLQLNNNILSGS----IPHSLGNL  140 (873)
Q Consensus        73 ~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~n~l~~~----~~~~~~~l  140 (873)
                      +|++++|.+....+..+..+.+   |++|++++|+++.    .+...+..+ ++|++|++++|.+++.    ++..+..+
T Consensus        85 ~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~  164 (319)
T cd00116          85 ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRAN  164 (319)
T ss_pred             EEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhC
Confidence            9999999998767777777776   9999999999983    233456667 8999999999999842    34456777


Q ss_pred             CCCcEEEccCCCCcccc----ccccCCCCCCCEEEccCCcCccCC----CccccCCCCCcEEeccCCCCcccCCcccc--
Q 039344          141 TNLATLYIYSNSLSASI----LGKIGNLKSLSNLQLSENNFNGSI----PPSLGNLSNLATLYLDTNSLSYSIPSELG--  210 (873)
Q Consensus       141 ~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--  210 (873)
                      ++|++|++++|.+++..    ...+..+++|++|+|++|.+++..    ...+..+++|++|++++|.+++.....+.  
T Consensus       165 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~  244 (319)
T cd00116         165 RDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA  244 (319)
T ss_pred             CCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH
Confidence            88999999999887422    223445568888888888876432    23455566777777777777642222221  


Q ss_pred             ---CCCCCCEEEccCcccCCC----cccccCCCCCccEEecccccCCCCC----chhhcCC-CCCcEEEccCCc
Q 039344          211 ---NLRSLSNLSLGYNKLSGS----IPISMGNLSNLTYLNLFENSLSGAI----PYEYRNL-VKLTILLLGHNQ  272 (873)
Q Consensus       211 ---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l-~~L~~L~L~~N~  272 (873)
                         ..+.|++|++++|.++..    ....+..+++|+++++++|.++...    ...+... +.|+.|++.+|.
T Consensus       245 ~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence               135666666666666521    1223344456666666666665332    2222223 455555555543

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=6.2e-20  Score=164.00  Aligned_cols=154  Identities=29%  Similarity=0.517  Sum_probs=95.4

Q ss_pred             CCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           20 LKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        20 l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      +..++.|.|++|+++ .+|..++.+.+|+.|++++|+|+ .+|..+..++.|+.|+++-|++. +.|..|+.++.|+.||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            445666667777776 55556666777777777777776 66666666666666666666666 6666666666666666


Q ss_pred             ccccccCC-CCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCc
Q 039344          100 LDTNSLSN-SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       100 L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      |++|++.. .+|..|..+..|+-|+|++|.+. .+|..++++++|+.|.+..|.+-+ .|..++.++.|++|++.+|+++
T Consensus       109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHhcccceee
Confidence            66666653 45666666666666666666665 556566666666666666555532 2334444444444444444444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=5e-18  Score=196.40  Aligned_cols=199  Identities=21%  Similarity=0.250  Sum_probs=160.7

Q ss_pred             HHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc---CCceeeEEeEEEe
Q 039344          596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW---HRNIVKVYGFCLH  672 (873)
Q Consensus       596 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  672 (873)
                      +.....+.|.+.+.+|+|+||+||+|...+|+.||+|+-+.+..-+--...      +++.+|+   -+.|..+...+.-
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHcc
Confidence            344556789999999999999999999888999999998766443322222      3334443   2334444444445


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-------CCC
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-------ENE  745 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-------~~~  745 (873)
                      .+.-++|+||.+.|+|.+++.   ..+.++|.-...++.|+++.+++||..   +||||||||+|+++..       ...
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             CCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence            667789999999999999997   345689999999999999999999999   9999999999999953       235


Q ss_pred             eEEeccccccccC--CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 039344          746 AHVSDFGIAKFLK--PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP  806 (873)
Q Consensus       746 ~kl~Dfg~a~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P  806 (873)
                      ++|+|||.+..+.  ++.......++|-.+-.+|+..+.+.+.++|-|.++.+++.|+.|++-
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9999999997663  334456778889999999999999999999999999999999999875

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=3.1e-17  Score=162.22  Aligned_cols=137  Identities=14%  Similarity=0.148  Sum_probs=105.2

Q ss_pred             CCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-----cCCceeeEEeEEEecc---e
Q 039344          604 FDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-----WHRNIVKVYGFCLHVR---H  675 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~  675 (873)
                      +...+.||+|+||.||. ...++.. +||++.....   ...+.+.+|+.+++.+     .||||++++|+++++.   .
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            34568899999999996 3344444 6888765322   2346799999999999     5799999999998863   3


Q ss_pred             -eEEEEEe--ccCCChhhHhcccccccCCChHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCCeeeCCC----CCeE
Q 039344          676 -LFIVYEY--FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL-SYMHNDCFPPIVHRDISSKNVLLDFE----NEAH  747 (873)
Q Consensus       676 -~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~Dlk~~Nill~~~----~~~k  747 (873)
                       +.+|+||  +.+++|.+++.+.    .+++.  ..++.+++.++ +|||++   +|+||||||+||+++..    +.++
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence             3478999  5589999999542    24444  35577888777 999999   99999999999999743    3799


Q ss_pred             Eeccccc
Q 039344          748 VSDFGIA  754 (873)
Q Consensus       748 l~Dfg~a  754 (873)
                      |+||+-+
T Consensus       150 LiDg~G~  156 (210)
T PRK10345        150 VCDNIGE  156 (210)
T ss_pred             EEECCCC
Confidence            9995434

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.71  E-value=1.3e-19  Score=161.99  Aligned_cols=153  Identities=34%  Similarity=0.596  Sum_probs=66.8

Q ss_pred             CCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEc
Q 039344           69 RFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYI  148 (873)
Q Consensus        69 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  148 (873)
                      .+.+.|.||+|+++ .+|..+..+.+|+.|++.+|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|||
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            33444444444444 33444444444444444444444 34444444444444444444444 34444444444444444


Q ss_pred             cCCCCc-cccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccC
Q 039344          149 YSNSLS-ASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS  226 (873)
Q Consensus       149 ~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  226 (873)
                      ++|.+. ...|+.|..++.|+.|+|++|.++ .+|..++++++|+.|.+..|.+- ..|..++.++.|++|.+.+|+++
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence            444443 123333444444444444444443 33333444444444444444443 33444444444444444444444

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=7.5e-17  Score=163.90  Aligned_cols=147  Identities=18%  Similarity=0.218  Sum_probs=113.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEE--eCCCcEEEEEEccCCCCCcc---------------------hhHHHHHHHHHHHHh
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSK--LASGEIIAVKKFHSPLPGEM---------------------TFQQEFLNEVKALTE  657 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~e~~~l~~  657 (873)
                      ...|.+.+.||+|+||.||+|.  ..+|+.||+|+++.......                     .....+..|++.+++
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458888999999999999998  56899999999875421100                     011235689999999


Q ss_pred             ccCC--ceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC-eeeCCCC
Q 039344          658 IWHR--NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP-IVHRDIS  734 (873)
Q Consensus       658 l~h~--niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dlk  734 (873)
                      +.+.  .+++++++    ...++||||+++.++.......   ......+...++.|++.++++||+.   + ++|||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik  176 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS  176 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence            9753  34455543    2358999999998876654221   2345566789999999999999999   8 9999999


Q ss_pred             CCCeeeCCCCCeEEeccccccccC
Q 039344          735 SKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       735 ~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |+||+++ ++.++++|||.+....
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999 8899999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=5e-18  Score=179.57  Aligned_cols=242  Identities=17%  Similarity=0.261  Sum_probs=166.8

Q ss_pred             CCCCCceeeecCCeEEEEEEeCCC----cEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEE------eEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLASG----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVY------GFCL  671 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~------~~~~  671 (873)
                      ...+.+..++.+++.++......+    +.++.+......   ........+++-.+... +|+..+..-      ....
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~  321 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK  321 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence            344556667777777766543322    333333332221   01123334444444444 344433211      0111


Q ss_pred             -----ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          672 -----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       672 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                           .....|+.|++|...+|.+|+.........++.....++.|++.|++|   +   +.+|+|+||.||+...+..+
T Consensus       322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~  395 (516)
T KOG1033|consen  322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQL  395 (516)
T ss_pred             ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhh
Confidence                 123578999999999999999877777788999999999999999999   6   89999999999999999999


Q ss_pred             EEeccccccccCCCC------CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          747 HVSDFGIAKFLKPDS------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ||.|||+........      ...+...||..||+||.+.+..|+.|+||||+|++++|+++ -..+++.          
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------  465 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------  465 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------
Confidence            999999998776544      13456789999999999999999999999999999999997 3333221          


Q ss_pred             hhhhhhhhcCCCCCCCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 039344          820 LNIALDEMLDPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVC  868 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  868 (873)
                       -....++-++.+|... ...++    =+.++.+++...|.+||++.++.
T Consensus       466 -~~t~~d~r~g~ip~~~~~d~p~----e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  466 -IATLTDIRDGIIPPEFLQDYPE----EYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             -HHhhhhhhcCCCChHHhhcCcH----HHHHHHHhcCCCcccCchHHHHh
Confidence             2234445555555221 11122    35788899999999999776654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=8.2e-17  Score=160.57  Aligned_cols=148  Identities=17%  Similarity=0.194  Sum_probs=114.9

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcc-------------------hhHHHHHHHHHHH
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEM-------------------TFQQEFLNEVKAL  655 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l  655 (873)
                      .++.+....|.+.+.||+|+||.||++..++|+.||||+++.......                   .....+..|...+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            344555556888899999999999999988899999998764321100                   0112367788899


Q ss_pred             HhccCC--ceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 039344          656 TEIWHR--NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDI  733 (873)
Q Consensus       656 ~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl  733 (873)
                      ..+.|+  .+++.++.    ...++||||++++++......         .....++.+++.++.++|+.   +++||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            999887  44555543    345899999999988765321         34567889999999999998   9999999


Q ss_pred             CCCCeeeCCCCCeEEeccccccccC
Q 039344          734 SSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       734 k~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      +|+||++++++.++|+|||.+....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.8e-16  Score=158.88  Aligned_cols=137  Identities=17%  Similarity=0.312  Sum_probs=114.9

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcc-----hhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEM-----TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      +.||+|++|.||+|+. .|..|++|+.........     .....+.+|+..+..++|++++....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 578899998664322111     1124578899999999999998888888778888999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++|+++.+++....      + .+..++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.++.
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999998875321      2 7889999999999999999   999999999999999 88999999999874

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=9.8e-16  Score=176.36  Aligned_cols=141  Identities=18%  Similarity=0.281  Sum_probs=113.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEc-cCCCCC----cchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKF-HSPLPG----EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ...|...+.||+|+||+||+|...... +++|+. .+....    .....+.+.+|+++++.++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            344567899999999999999876444 444432 221111    11123568899999999999999988888887778


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+++++|.+++.           ....++.++++++.|||+.   +++|||+||+||++ .++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999998874           3567899999999999999   99999999999999 67899999999997


Q ss_pred             cc
Q 039344          756 FL  757 (873)
Q Consensus       756 ~~  757 (873)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=8e-16  Score=153.98  Aligned_cols=133  Identities=19%  Similarity=0.330  Sum_probs=107.7

Q ss_pred             eeeecCCeEEEEEEeCCCcEEEEEEccCCCCCc-----chhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEec
Q 039344          609 CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE-----MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       609 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      .||+|+||.||+|... |..|++|+........     ......+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            3799999999999854 7889999865432111     111355778999999999887766666666677789999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      +|+++.+.+.....          .++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999888743211          7899999999999999   999999999999999 89999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=3.6e-15  Score=147.62  Aligned_cols=140  Identities=19%  Similarity=0.266  Sum_probs=100.9

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHH---------------------HHHHHHHHHhccCCc--e
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQE---------------------FLNEVKALTEIWHRN--I  663 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~n--i  663 (873)
                      .+.||+|+||+||+|...+|+.||||+++............                     ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987542221111111                     135666666664433  4


Q ss_pred             eeEEeEEEecceeEEEEEeccCCChhhH-hcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeC
Q 039344          664 VKVYGFCLHVRHLFIVYEYFKMCSLAVI-LSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLD  741 (873)
Q Consensus       664 v~l~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~  741 (873)
                      .+.+++    ...++||||++++.+... +....    .. .++..++.+++.++.++|. .   +|+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            555543    235899999998543211 11100    11 5678899999999999999 7   999999999999999


Q ss_pred             CCCCeEEeccccccccCC
Q 039344          742 FENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       742 ~~~~~kl~Dfg~a~~~~~  759 (873)
                       ++.++++|||.++....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             99999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=9.1e-15  Score=139.47  Aligned_cols=135  Identities=16%  Similarity=0.158  Sum_probs=114.1

Q ss_pred             CCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC--CceeeEEeEEEecceeEEEEEec
Q 039344          606 DEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       606 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      +.+.+|+|.++.||+++..+ ..+++|.......     ...+.+|+..++.++|  ..+++++++....+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            45789999999999999864 7899999865422     3578899999999976  58999999988888899999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      +++.+..+          +......++.+++++++++|.....+++|||++|+||++++++.++++|||.++.
T Consensus        76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            98766543          4566778899999999999986444799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=9.8e-16  Score=173.47  Aligned_cols=206  Identities=23%  Similarity=0.311  Sum_probs=135.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+|+..+.|..|+||.||.++++ +.+.+|.|+-+.         ..+.+-  ++.....|.+|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq---------~lilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---------NLILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhccccc---------chhhhc--cccccCCccee----------------
Confidence            67899999999999999999876 356677744221         111110  11111223222                


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                           |+=...+..   .+.++..        ++.+++|+|+.   ||+|||+||+|.+|+.-|.+|+.|||+++..-..
T Consensus       136 -----gDc~tllk~---~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKN---IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhccc---CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                 222222211   1223322        27889999999   9999999999999999999999999998754211


Q ss_pred             CC---------------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          761 SS---------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       761 ~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ..               .....+||+.|.|||++....|...+|.|++|+|+||.+-|+.||....+.+.......   +
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis---d  273 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---D  273 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh---h
Confidence            10               01246899999999999999999999999999999999999999876533321111111   1


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCC
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      ++.   ++...   .....+..+++.+.++.+|..|-
T Consensus       274 ~i~---wpE~d---ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 DIE---WPEED---EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hcc---ccccC---cCCCHHHHHHHHHHHHhChHhhc
Confidence            111   11110   01112367888899999999994

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=4.9e-14  Score=143.66  Aligned_cols=139  Identities=15%  Similarity=0.239  Sum_probs=107.1

Q ss_pred             Cceee-ecCCeEEEEEEeCCCcEEEEEEccCCCC----------CcchhHHHHHHHHHHHHhccCCce--eeEEeEEEec
Q 039344          607 EHCIG-KGGQGSVYMSKLASGEIIAVKKFHSPLP----------GEMTFQQEFLNEVKALTEIWHRNI--VKVYGFCLHV  673 (873)
Q Consensus       607 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  673 (873)
                      ...|| .|+.|+||.++.. +..++||.+.....          ........+.+|++++..++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999886 77889998854211          011223567889999999998875  7777775432


Q ss_pred             c----eeEEEEEeccC-CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          674 R----HLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       674 ~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                      .    ..++|||++++ .++.+++...    .++..    .+.+++.++.+||+.   ||+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 6888887532    23333    356899999999999   9999999999999999999999


Q ss_pred             ecccccccc
Q 039344          749 SDFGIAKFL  757 (873)
Q Consensus       749 ~Dfg~a~~~  757 (873)
                      +|||.++..
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=2e-15  Score=172.38  Aligned_cols=251  Identities=21%  Similarity=0.283  Sum_probs=184.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC--CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  678 (873)
                      ..|...+.||+|+|+.|-......  ...+|+|.+..+. ...........|..+-+.+. |+|++.+++...+....++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            457777889999999999886533  4456666665443 22333445556777777775 9999999999999999999


Q ss_pred             EEEeccCCChhhHh-cccccccCCChHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCCeeeCCCC-CeEEecccccc
Q 039344          679 VYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYMH-NDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~  755 (873)
                      +.+|..++++.+.+ ....  ...+......+..|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999998887 3322  13556667788999999999999 77   999999999999999999 99999999998


Q ss_pred             ccCC-CCC--Ccccccc-ccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          756 FLKP-DSS--NWTELAG-TYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       756 ~~~~-~~~--~~~~~~g-~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      .+.. ...  ......| ++.|+|||...+.. ..+..|+||.|+++.-+++|..||+........       ...+...
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------~~~~~~~  246 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------YSSWKSN  246 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------ceeeccc
Confidence            7765 222  2345677 99999999988854 466799999999999999999998754432211       1111111


Q ss_pred             C---CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 039344          831 R---LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC  868 (873)
Q Consensus       831 ~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  868 (873)
                      +   -..++.   .......++..+++..+|..|.+.+++.
T Consensus       247 ~~~~~~~~~~---~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  247 KGRFTQLPWN---SISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccccCccc---cCChhhhhcccccccCCchhcccccccc
Confidence            1   011111   1112356777888889999999887764

>PLN03150 hypothetical protein; Provisional

Probab=99.47  E-value=6.5e-14  Score=162.75  Aligned_cols=119  Identities=31%  Similarity=0.515  Sum_probs=97.3

Q ss_pred             ccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEe
Q 039344          405 QLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHID  484 (873)
Q Consensus       405 ~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~  484 (873)
                      .++.|+|++|.+.|.+|..++.+.  +|+.|+|++|.+++.+|..+..+++|+.|+|++|+++|.+|..+..+++|+.||
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~--~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~  496 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLR--HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN  496 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCC--CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence            477888999999888888888766  888999999999888888889999999999999999999999999999999999


Q ss_pred             cCCCcccccCCCCCc--ccCCCcccccCCCCcccCccCcccccc
Q 039344          485 ISYNELRGSIPNSTT--FKDAPIEALQGNKGLYGDVKGLLSCKA  526 (873)
Q Consensus       485 ls~N~l~~~~p~~~~--~~~~~~~~~~~n~~l~g~~~~~~~c~~  526 (873)
                      |++|+++|.+|..-.  +.......+.+|+.+|+.+ +...|..
T Consensus       497 Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~~  539 (623)
T PLN03150        497 LNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACGP  539 (623)
T ss_pred             CcCCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCcc
Confidence            999999999887422  2233345688999999854 4567853

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.43  E-value=1e-14  Score=154.52  Aligned_cols=177  Identities=33%  Similarity=0.549  Sum_probs=124.8

Q ss_pred             CCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEE
Q 039344          307 YPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLV  386 (873)
Q Consensus       307 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~  386 (873)
                      +..-...||+.|++. ++|..+..+..|+.+.|..|.|. .+|..+..+..|.+|||+.|+++ ..|..++.++ |+.|.
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            344456677777776 66666777777777777777776 57777777777777777777776 5666665553 67777


Q ss_pred             ecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccc
Q 039344          387 LAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL  466 (873)
Q Consensus       387 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  466 (873)
                      +++|+++ .+|+.++.+..|.+||.|.|.+. .+|..++.+.  +|+.|+++.|++.. .|.+++.| .|..||+|+|++
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~--slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNki  223 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLT--SLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNKI  223 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHH--HHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCce
Confidence            7777777 46666777777777777777775 6677777665  77777777777764 45555554 477777777777


Q ss_pred             cCCCchhhhccCCCcEEecCCCcccccC
Q 039344          467 SGLIPSCFEKMNGLLHIDISYNELRGSI  494 (873)
Q Consensus       467 ~~~~~~~~~~~~~L~~l~ls~N~l~~~~  494 (873)
                      + .+|-+|.+|..|++|-|..|+|+.+.
T Consensus       224 s-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  224 S-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             e-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            7 56777777777777777777777443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=2.6e-12  Score=142.68  Aligned_cols=143  Identities=19%  Similarity=0.256  Sum_probs=101.1

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcch---------------------------h----------HHHHH
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT---------------------------F----------QQEFL  649 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------------------------~----------~~~~~  649 (873)
                      .+.||.|++|.||+|+.++|+.||||+.+........                           .          .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3689999999999999999999999998654211100                           0          01255


Q ss_pred             HHHHHHHhcc-----CCceeeEEeEE-EecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHH-HHHHHHh
Q 039344          650 NEVKALTEIW-----HRNIVKVYGFC-LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD-ALSYMHN  722 (873)
Q Consensus       650 ~e~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~  722 (873)
                      +|+..+.+++     ++++ .+-.++ ......++||||++|+++.++......  ..   .+..++.+++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh
Confidence            5666555552     3333 222232 224457999999999999887643211  11   24456666666 4678898


Q ss_pred             CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       723 ~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      .   |++|+|++|.||+++.++.++++|||++..+.
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   99999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=4.3e-13  Score=149.45  Aligned_cols=195  Identities=39%  Similarity=0.539  Sum_probs=105.6

Q ss_pred             EEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCc-ccCcccccccccccccCccccCCCCCcEEEccCC
Q 039344           73 DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLR-SLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSN  151 (873)
Q Consensus        73 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  151 (873)
                      .|++..|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            4566666654 23334444456666666666666 4455555553 6666666666665 44445566666666666666


Q ss_pred             CCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCccc
Q 039344          152 SLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPI  231 (873)
Q Consensus       152 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  231 (873)
                      ++..+... ...+++|+.|++++|+++ .+|........|++|++++|.+. ..+..+..+..+..+.+.+|++.. .+.
T Consensus       174 ~l~~l~~~-~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         174 DLSDLPKL-LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             hhhhhhhh-hhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence            66543322 224556666666666665 33333333444666666666433 344445555556666666666552 244


Q ss_pred             ccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc
Q 039344          232 SMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP  276 (873)
Q Consensus       232 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  276 (873)
                      .+..++++++|++++|.++....  +..+.+++.|++++|.+...
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~  292 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNA  292 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCcccccc
Confidence            45555556666666666554333  55555555555555555543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.41  E-value=6.5e-15  Score=155.88  Aligned_cols=173  Identities=30%  Similarity=0.477  Sum_probs=95.8

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeec
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYL  100 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  100 (873)
                      +.-...||+.|++. .+|.+++.+..|..|.|..|.+. .+|.+++++..|++|||+.|+++ .+|..+..|+ |+.|.+
T Consensus        75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~  150 (722)
T KOG0532|consen   75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV  150 (722)
T ss_pred             cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence            33444555666655 55555665666666666666665 55556666666666666666665 4555555555 556666


Q ss_pred             cccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccC
Q 039344          101 DTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS  180 (873)
Q Consensus       101 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  180 (873)
                      ++|+++ .+|..++.++.|.+||.+.|.+. .+|..++++.+|+.|.+..|++..+++ .+. .-.|..||+|.|++. .
T Consensus       151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~-El~-~LpLi~lDfScNkis-~  225 (722)
T KOG0532|consen  151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPE-ELC-SLPLIRLDFSCNKIS-Y  225 (722)
T ss_pred             ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCH-HHh-CCceeeeecccCcee-e
Confidence            666665 45555555555666666666655 455555555555555555555544322 222 223555555555555 4


Q ss_pred             CCccccCCCCCcEEeccCCCCc
Q 039344          181 IPPSLGNLSNLATLYLDTNSLS  202 (873)
Q Consensus       181 ~~~~~~~l~~L~~L~L~~n~l~  202 (873)
                      +|-.|.+|+.|++|-|.+|.+.
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCC
Confidence            4555555555555555555554

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.39  E-value=4.4e-13  Score=149.45  Aligned_cols=200  Identities=40%  Similarity=0.550  Sum_probs=140.8

Q ss_pred             eEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccccc-ccceeeccccccCCCCCccccCCcccCccccccc
Q 039344           49 TLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLS-NLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNN  127 (873)
Q Consensus        49 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  127 (873)
                      .|+++.|++. ..+..+..+..++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            5777777775 33344555567777888888777 5555666663 7888888888877 55667777788888888888


Q ss_pred             ccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCc
Q 039344          128 ILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPS  207 (873)
Q Consensus       128 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  207 (873)
                      +++ .+|...+.+++|+.|++++|++..+.. ....+..|++|.+++|.+. ..+..+.++.++..+.+.+|++. ..+.
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~-~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~  249 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKISDLPP-EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE  249 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccccCch-hhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence            877 556555577778888888888765433 2344455788888888544 35566777777888888888877 3466


Q ss_pred             cccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhh
Q 039344          208 ELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY  257 (873)
Q Consensus       208 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  257 (873)
                      .++.++++++|++++|+++...+  ++.+.+++.|++++|.+....+...
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            77778888888888888874433  7778888888888888876555443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.34  E-value=3e-14  Score=142.90  Aligned_cols=217  Identities=22%  Similarity=0.272  Sum_probs=105.4

Q ss_pred             ccCCCCCCEEECCCCcccc----cCCccccCCCCCceEEccCC---cccccCCCCccCCCCCCEEEcccCCCCCCCCccc
Q 039344           17 LRNLKSLSDLELGNNKLSG----SIPHSLGNLTNLATLYIHTN---SLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSL   89 (873)
Q Consensus        17 ~~~l~~l~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n---~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~   89 (873)
                      +..+..+++|+|++|.+..    .+.+.+...++|++.++++-   ++...+|+++.                 .+..++
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~-----------------~l~~aL   88 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK-----------------MLSKAL   88 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH-----------------HHHHHH
Confidence            4556667777777777652    23344555566666666652   22223333221                 111223


Q ss_pred             ccccccceeeccccccCCCCCcc----ccCCcccCcccccccccccccCc-------------cccCCCCCcEEEccCCC
Q 039344           90 GNLSNLATLYLDTNSLSNSIPSE----LGNLRSLSNLQLNNNILSGSIPH-------------SLGNLTNLATLYIYSNS  152 (873)
Q Consensus        90 ~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~n~  152 (873)
                      ..+++|++|+||.|.+....+..    +..+.+|++|.|.+|.+...-..             -.+.-++|+++...+|+
T Consensus        89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr  168 (382)
T KOG1909|consen   89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR  168 (382)
T ss_pred             hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence            33445555555555554332222    23345566666666655421111             12233566777777776


Q ss_pred             Cccccc----cccCCCCCCCEEEccCCcCccC----CCccccCCCCCcEEeccCCCCccc----CCccccCCCCCCEEEc
Q 039344          153 LSASIL----GKIGNLKSLSNLQLSENNFNGS----IPPSLGNLSNLATLYLDTNSLSYS----IPSELGNLRSLSNLSL  220 (873)
Q Consensus       153 l~~~~~----~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L  220 (873)
                      +..-..    ..|...+.|+.+.++.|.|...    ....|..+++|+.|||.+|.++..    +...++.+++|++|++
T Consensus       169 len~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l  248 (382)
T KOG1909|consen  169 LENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNL  248 (382)
T ss_pred             cccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecc
Confidence            653222    2344556666666666666422    123455566666666666666522    2233444555555555


Q ss_pred             cCcccCCCcccccC-----CCCCccEEecccccCC
Q 039344          221 GYNKLSGSIPISMG-----NLSNLTYLNLFENSLS  250 (873)
Q Consensus       221 ~~N~l~~~~~~~~~-----~l~~L~~L~L~~n~l~  250 (873)
                      ++|.+......++.     ..++|+.|++.+|.|+
T Consensus       249 ~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  249 GDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             cccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            55555543333221     2344444444444443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.4e-12  Score=139.90  Aligned_cols=249  Identities=27%  Similarity=0.295  Sum_probs=180.5

Q ss_pred             cCCCCCceeee--cCCeEEEEEEe---CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGK--GGQGSVYMSKL---ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  675 (873)
                      ..|.+.+.+|.  |.+|.||.++.   .++..+|+|+-+.+...... ...=.+|+..-+.+ .|++.++.+..++..+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCc
Confidence            34666788999  99999999975   46888999986554442221 12234666766666 49999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEec
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD----ALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSD  750 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~D  750 (873)
                      .++-.|++. .++..+.+...  ..++....+.+..+..+    |+.++|+.   .++|-|+||.||+...+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence            999999987 66666654332  23666777788888888    99999999   99999999999999999 8899999


Q ss_pred             cccccccCCCCCCc-----cccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          751 FGIAKFLKPDSSNW-----TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       751 fg~a~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ||+...+....-..     ....|...|++||...+ -++.++|+|++|.+..+..++-.+...-....|.......   
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---  342 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---  342 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence            99998876544211     12257788999998654 4788999999999999999987764432112222211111   


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                              .+.+.+.....++...+..+++.+|..|++++.+..
T Consensus       343 --------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  343 --------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                    111122222234556888999999999999887754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=3.9e-12  Score=126.43  Aligned_cols=199  Identities=21%  Similarity=0.317  Sum_probs=137.7

Q ss_pred             HHhccCCceeeEEeEEEecc-----eeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039344          655 LTEIWHRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI  728 (873)
Q Consensus       655 l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  728 (873)
                      +-.+.|.|||++..|+.+.+     ...++.|||..|++..+|++.+ ....+....-.+|+.||..||.|||+. .|+|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            44456999999999987644     4688999999999999997654 334567777889999999999999995 6799


Q ss_pred             eeCCCCCCCeeeCCCCCeEEeccccccccCCCCC-----CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhC
Q 039344          729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG  803 (873)
Q Consensus       729 ~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg  803 (873)
                      +|+++..+-|++..+|-+|+.--- -....+...     ......+-++|.|||+-.....+.++|||+||....||.-+
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999999974211 111111000     01122356899999987777778899999999999999877


Q ss_pred             CCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          804 KHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       804 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..--....    .....++.......+-   ..  ..     =+.++.+|++..|..||+|.+++.
T Consensus       279 Eiq~tnse----S~~~~ee~ia~~i~~l---en--~l-----qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSE----SKVEVEENIANVIIGL---EN--GL-----QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCc----ceeehhhhhhhheeec---cC--cc-----ccCcCcccccCCCCCCcchhhhhc
Confidence            65411100    0111111111111111   00  00     135677899999999999998753

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.30  E-value=5.7e-13  Score=130.24  Aligned_cols=131  Identities=31%  Similarity=0.349  Sum_probs=81.2

Q ss_pred             CCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccccccccc
Q 039344          330 RCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHL  409 (873)
Q Consensus       330 ~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  409 (873)
                      .++-|+.||||+|.|+ .+.+...-.+.++.|++|+|.|.. + ..++.+++|+.|+|++|.++. ...+-.++.++++|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHh-hhhhHhhhcCEeee
Confidence            3455666777777665 344555566677777777777652 2 236666677777777776663 33444566777777


Q ss_pred             cccccccccccCCCcCchh-hhhhhcccccCCccCcc-cchhhhhhcccceecccCccccCC
Q 039344          410 DLSSNRLSNSIPKSLGNLE-LIHLSELDLSRNFLREA-IPSQICIMQSLEKLNLSHNSLSGL  469 (873)
Q Consensus       410 ~Ls~N~l~~~~~~~~~~l~-~~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~  469 (873)
                      .|++|.|.     +++++. +.+|..||+++|+|... -...+++++-|+.|.|.+|+|+++
T Consensus       358 ~La~N~iE-----~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  358 KLAQNKIE-----TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             ehhhhhHh-----hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            77777774     233332 44677777777777653 234566677777777777776643

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.28  E-value=1.6e-13  Score=137.75  Aligned_cols=186  Identities=22%  Similarity=0.288  Sum_probs=108.7

Q ss_pred             cccCCCccEEeccCccccccCCCCC----CCCCCCCeeeeccccCCccCC-------------ccccCCCCCCEEeccCC
Q 039344          304 FYIYPNLTYIDLSQNNFYGEISSDW----GRCPKLSTLDFSINNITGNVP-------------PEIGHSSQLGVLDLSSN  366 (873)
Q Consensus       304 ~~~~~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~l~~N~i~~~~~-------------~~~~~~~~L~~L~Ls~N  366 (873)
                      +...|+|++||||+|.+....+..|    .++..|+.|.|.+|.+.-...             ...+..++|+++..+.|
T Consensus        88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN  167 (382)
T KOG1909|consen   88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN  167 (382)
T ss_pred             HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence            3444566666666666654443333    345666666666666542111             11234456777777777


Q ss_pred             ccCCCCC----ccccccccccEEEecCccccCC----cccccccccccccccccccccccc----cCCCcCchhhhhhhc
Q 039344          367 HIVGEIP----IELGKLNFFIKLVLAHNQLSGQ----LSPKLGSLVQLEHLDLSSNRLSNS----IPKSLGNLELIHLSE  434 (873)
Q Consensus       367 ~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~~~L~~  434 (873)
                      ++.....    ..+...+.|+.+.+..|.|...    +..++..+++|+.|||.+|-++..    +.+.+..  +++|+.
T Consensus       168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s--~~~L~E  245 (382)
T KOG1909|consen  168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSS--WPHLRE  245 (382)
T ss_pred             ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcc--cchhee
Confidence            7654222    2344456667777777766432    223456677777777777777532    2223332  236777


Q ss_pred             ccccCCccCcccchhhh-----hhcccceecccCccccC----CCchhhhccCCCcEEecCCCccc
Q 039344          435 LDLSRNFLREAIPSQIC-----IMQSLEKLNLSHNSLSG----LIPSCFEKMNGLLHIDISYNELR  491 (873)
Q Consensus       435 L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~~~~L~~l~ls~N~l~  491 (873)
                      |+++++.+......++.     ..++|+.|+|.+|.|+.    .+-.+....+.|..|+|++|.+.
T Consensus       246 l~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  246 LNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             ecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            77777777665544443     35778888888888872    33344556788888888888874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=1.7e-11  Score=137.22  Aligned_cols=146  Identities=18%  Similarity=0.275  Sum_probs=94.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC-CcEEEEEEccCCCCCc---------------------------c----hhHH---
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGE---------------------------M----TFQQ---  646 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---------------------------~----~~~~---  646 (873)
                      .+|+. +.||.|++|.||+|+.++ |+.||||+.+......                           .    +..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999987 9999999997542110                           0    0111   


Q ss_pred             ---HHHHHHHHHHhcc----CCceeeEEeEEEe-cceeEEEEEeccCCChhhHhcccccc---cCCChHHHHHHHHHHHH
Q 039344          647 ---EFLNEVKALTEIW----HRNIVKVYGFCLH-VRHLFIVYEYFKMCSLAVILSNDAAA---KNLGWTRRMNMIKGIVD  715 (873)
Q Consensus       647 ---~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~  715 (873)
                         +|.+|+.-+.+++    +...+.+-.++.+ ....++||||++|+.+.++-.-...+   ..+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               2444554444442    3333333333332 45678999999999997642111111   112222233333333  


Q ss_pred             HHHHHHhCCCCCeeeCCCCCCCeeeCCCC----CeEEeccccccccC
Q 039344          716 ALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFGIAKFLK  758 (873)
Q Consensus       716 ~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg~a~~~~  758 (873)
                           ...   |++|+|++|.||+++.++    .+++.|||++..+.
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 345   999999999999999988    99999999997664

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=3.5e-11  Score=131.78  Aligned_cols=168  Identities=20%  Similarity=0.270  Sum_probs=128.7

Q ss_pred             EeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCC
Q 039344          622 KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNL  701 (873)
Q Consensus       622 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  701 (873)
                      +..++.+|.|...+....   ...+...+-++.++.++||||+++++.++.++..|+|+|.+.  .|..++.+      +
T Consensus        33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l  101 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------L  101 (690)
T ss_pred             eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------h
Confidence            455788888888765432   335667788899999999999999999999999999999874  55555543      3


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcccccccccccccccccc
Q 039344          702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT  781 (873)
Q Consensus       702 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~  781 (873)
                      +......-+.||+.||.|||..|  +++|+++....|++++.|+.||++|.++..............--..|..|+.+..
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence            35566677899999999999776  8999999999999999999999999988655433321112222334677776543


Q ss_pred             CCCCCcchhHHHHHHHHHHHhCC
Q 039344          782 MKVTEKCDVYSFGVLALEVIKGK  804 (873)
Q Consensus       782 ~~~~~~sDv~s~G~il~el~tg~  804 (873)
                      ..  -..|.|-||+++||++.|.
T Consensus       180 s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCcc
Confidence            33  2369999999999999983

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.24  E-value=1.4e-10  Score=112.42  Aligned_cols=140  Identities=16%  Similarity=0.214  Sum_probs=101.2

Q ss_pred             CceeeecCCeEEEEEEeCC-------CcEEEEEEccCCCC----------Cc---------chhHHHHH----HHHHHHH
Q 039344          607 EHCIGKGGQGSVYMSKLAS-------GEIIAVKKFHSPLP----------GE---------MTFQQEFL----NEVKALT  656 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~----------~~---------~~~~~~~~----~e~~~l~  656 (873)
                      ...||.|..+.||.|...+       +..+|||+++....          ++         ....+.+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997543       57899998753211          01         11233344    8999999


Q ss_pred             hccC--CceeeEEeEEEecceeEEEEEeccCCChhh-HhcccccccCCChHHHHHHHHHHHHHHHHH-HhCCCCCeeeCC
Q 039344          657 EIWH--RNIVKVYGFCLHVRHLFIVYEYFKMCSLAV-ILSNDAAAKNLGWTRRMNMIKGIVDALSYM-HNDCFPPIVHRD  732 (873)
Q Consensus       657 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~D  732 (873)
                      ++..  -++++++++    ...++||||+.+..+.. .+.+    ..++.++...+..+++.++.+| |..   +++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9953  567777765    45689999998653321 1211    1244456677889999999999 777   999999


Q ss_pred             CCCCCeeeCCCCCeEEeccccccccC
Q 039344          733 ISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       733 lk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ++++||+++ ++.+.++|||.|....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 5789999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03150 hypothetical protein; Provisional

Probab=99.24  E-value=2e-11  Score=142.15  Aligned_cols=113  Identities=33%  Similarity=0.459  Sum_probs=101.7

Q ss_pred             cccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceec
Q 039344          381 FFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLN  460 (873)
Q Consensus       381 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  460 (873)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|.+.|.+|..++.+.  +|+.|||++|++++.+|..++.+++|+.|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~--~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~  496 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT--SLEVLDLSYNSFNGSIPESLGQLTSLRILN  496 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCC--CCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence            478899999999999999999999999999999999999999998876  999999999999999999999999999999


Q ss_pred             ccCccccCCCchhhhcc-CCCcEEecCCCcccccCC
Q 039344          461 LSHNSLSGLIPSCFEKM-NGLLHIDISYNELRGSIP  495 (873)
Q Consensus       461 L~~N~l~~~~~~~~~~~-~~L~~l~ls~N~l~~~~p  495 (873)
                      |++|+++|.+|..+..+ .++..+++++|+..+..|
T Consensus       497 Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        497 LNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            99999999999998764 567899999998665444

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=5.4e-11  Score=115.67  Aligned_cols=129  Identities=18%  Similarity=0.121  Sum_probs=95.9

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce-eeEEeEEEecceeEEEEEeccCC
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI-VKVYGFCLHVRHLFIVYEYFKMC  686 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~~  686 (873)
                      +.++.|.++.||+++.. |+.|++|........    ...+..|+.+++.+.+.++ ++++++.  ....++||||+++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            56899999999999876 778999997643211    2346788999998865554 4555543  33458999999998


Q ss_pred             ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC--FPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       687 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      ++...    .       .....++.+++++++.||+..  ..+++|||++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~----~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE----D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc----c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            77543    0       111345679999999999982  12259999999999999 6789999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.21  E-value=1.4e-12  Score=134.52  Aligned_cols=158  Identities=24%  Similarity=0.263  Sum_probs=66.9

Q ss_pred             ccccceeeccccccCCCCC--ccccCCcccCcccccccccccc--cCccccCCCCCcEEEccCCCCccccccc-cCCCCC
Q 039344           92 LSNLATLYLDTNSLSNSIP--SELGNLRSLSNLQLNNNILSGS--IPHSLGNLTNLATLYIYSNSLSASILGK-IGNLKS  166 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~  166 (873)
                      +.+|+...|.++.+. ..+  .....|++++.|||++|-+...  +.+-...|++|+.|+|+.|++....... -..+++
T Consensus       120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            455555555555554 222  2344455555555555555421  2223344555555555555554211111 113344


Q ss_pred             CCEEEccCCcCccCC-CccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcc-cccCCCCCccEEec
Q 039344          167 LSNLQLSENNFNGSI-PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP-ISMGNLSNLTYLNL  244 (873)
Q Consensus       167 L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L  244 (873)
                      |+.|.|+.|.++.-. ...+..+|+|+.|+|..|..-........-+..|++|+|++|++-...- ...+.++.|+.|++
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl  278 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL  278 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence            555555555444110 1112234445555555543111222222334445555555554432210 12334444555555


Q ss_pred             ccccCC
Q 039344          245 FENSLS  250 (873)
Q Consensus       245 ~~n~l~  250 (873)
                      +.+.+.
T Consensus       279 s~tgi~  284 (505)
T KOG3207|consen  279 SSTGIA  284 (505)
T ss_pred             cccCcc
Confidence            554444

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.20  E-value=2e-12  Score=144.13  Aligned_cols=105  Identities=27%  Similarity=0.224  Sum_probs=42.0

Q ss_pred             CCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeee
Q 039344          259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD  338 (873)
Q Consensus       259 ~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  338 (873)
                      .+++|+.|++.+|+|......+..+++|++|++++|.|+.+.  .+..++.|+.|++++|.|..  ...+..++.|+.++
T Consensus        93 ~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~  168 (414)
T KOG0531|consen   93 KLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLD  168 (414)
T ss_pred             cccceeeeeccccchhhcccchhhhhcchheecccccccccc--chhhccchhhheeccCcchh--ccCCccchhhhccc
Confidence            334444444444444433322334444444444444444321  12223334444444444431  12222344444444


Q ss_pred             eccccCCccCC-ccccCCCCCCEEeccCCcc
Q 039344          339 FSINNITGNVP-PEIGHSSQLGVLDLSSNHI  368 (873)
Q Consensus       339 l~~N~i~~~~~-~~~~~~~~L~~L~Ls~N~i  368 (873)
                      +++|++...-+ . ...+.+++.+++.+|.+
T Consensus       169 l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i  198 (414)
T KOG0531|consen  169 LSYNRIVDIENDE-LSELISLEELDLGGNSI  198 (414)
T ss_pred             CCcchhhhhhhhh-hhhccchHHHhccCCch
Confidence            44444443222 1 23344444444444444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=3.4e-12  Score=124.93  Aligned_cols=132  Identities=30%  Similarity=0.316  Sum_probs=82.1

Q ss_pred             CCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccE
Q 039344          162 GNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY  241 (873)
Q Consensus       162 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  241 (873)
                      ...+.|+++|||+|.|+ .+.++..-++.++.|++++|.+..+  +.+..+++|+.||||+|.++ ....+=..+.++++
T Consensus       281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            34456777777777776 4445555566777777777777622  23666777777777777776 34444456667777


Q ss_pred             EecccccCCCCCchhhcCCCCCcEEEccCCcCcC--cCCcCCCCCCCCeEEccCcccccc
Q 039344          242 LNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG--PIPILRNLTSLERVRLDRNYLTGN  299 (873)
Q Consensus       242 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~l~~l~~L~~L~L~~n~l~~~  299 (873)
                      |.|++|.|...  ..+..+-+|..||+++|+|..  ....++++|-|+.|.|.+|.+..+
T Consensus       357 L~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  357 LKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             eehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            77777776532  335556667777777777765  233455666666666666666543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.19  E-value=1.6e-11  Score=116.62  Aligned_cols=105  Identities=29%  Similarity=0.344  Sum_probs=28.0

Q ss_pred             CCCcEEeccCCCCcccCCcccc-CCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEE
Q 039344          189 SNLATLYLDTNSLSYSIPSELG-NLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILL  267 (873)
Q Consensus       189 ~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  267 (873)
                      ..+++|+|++|.|+. +. .++ .+.+|+.|+|++|+|+..  ..+..+++|++|++++|.|+.+.+.....+++|++|+
T Consensus        19 ~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   19 VKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY   94 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred             ccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence            345555555555552 21 233 355566666666666532  2355556666666666666643322223456666666


Q ss_pred             ccCCcCcC--cCCcCCCCCCCCeEEccCcccc
Q 039344          268 LGHNQFRG--PIPILRNLTSLERVRLDRNYLT  297 (873)
Q Consensus       268 L~~N~l~~--~~~~l~~l~~L~~L~L~~n~l~  297 (873)
                      +++|+|..  ....+..+++|+.|+|.+|.++
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            66666654  2223455555666666666555

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.19  E-value=2e-10  Score=105.68  Aligned_cols=146  Identities=16%  Similarity=0.223  Sum_probs=109.5

Q ss_pred             CCceeeecCCeEEEEEEeCCCcEEEEEEc-----cCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          606 DEHCIGKGGQGSVYMSKLASGEIIAVKKF-----HSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       606 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ....+-+|+.+.|+++.+. |+.+.||.-     +.+.....-..+..++|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578999999999999998 777666643     2222222223566889999999987666666666676777778999


Q ss_pred             EeccC-CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---CeEEeccccccc
Q 039344          681 EYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKF  756 (873)
Q Consensus       681 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~Dfg~a~~  756 (873)
                      ||+++ .++.+++....... ...+.....+.+|-+.+.-||..   +++||||.++||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 47777776544322 22233378899999999999999   999999999999998776   358999999864

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.19  E-value=2.2e-12  Score=133.11  Aligned_cols=212  Identities=22%  Similarity=0.168  Sum_probs=90.8

Q ss_pred             CCCCcEEEccCCCCccccc-cccCCCCCCCEEEccCCcCccC--CCccccCCCCCcEEeccCCCCcccCCc-cccCCCCC
Q 039344          140 LTNLATLYIYSNSLSASIL-GKIGNLKSLSNLQLSENNFNGS--IPPSLGNLSNLATLYLDTNSLSYSIPS-ELGNLRSL  215 (873)
Q Consensus       140 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L  215 (873)
                      +.+|+.+.|.++.+..... +....|++++.||||.|-+...  +......+++|+.|+|+.|++..-..+ .-..+++|
T Consensus       120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~l  199 (505)
T KOG3207|consen  120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHL  199 (505)
T ss_pred             HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhh
Confidence            4445555555544432211 2333445555555555544321  111223344455555555544311100 01133445


Q ss_pred             CEEEccCcccCCC-cccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcC--CcCCCCCCCCeEEcc
Q 039344          216 SNLSLGYNKLSGS-IPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPI--PILRNLTSLERVRLD  292 (873)
Q Consensus       216 ~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~l~~l~~L~~L~L~  292 (873)
                      +.|.|+.|.++-. +......+++|+.|+|..|.....-.....-+..|+.|+|++|++-...  +....++.|+.|+++
T Consensus       200 K~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls  279 (505)
T KOG3207|consen  200 KQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLS  279 (505)
T ss_pred             heEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcc
Confidence            5555555554411 1111233455555555555322222333334455555555555554422  344555555555555


Q ss_pred             CcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCcc-CCccccCCCCCCEEeccCCccC
Q 039344          293 RNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGN-VPPEIGHSSQLGVLDLSSNHIV  369 (873)
Q Consensus       293 ~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~L~~L~Ls~N~i~  369 (873)
                      .|.++++.....      ..+            .-...+++|++|+++.|+|.+. .-..+..+.+|+.|.+..|.+.
T Consensus       280 ~tgi~si~~~d~------~s~------------~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  280 STGIASIAEPDV------ESL------------DKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccCcchhcCCCc------cch------------hhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            555554321111      000            0012345566666666655321 1123344556666666677665

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=1.4e-10  Score=107.64  Aligned_cols=134  Identities=20%  Similarity=0.306  Sum_probs=102.4

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEc-cCCCC----CcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEe
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKF-HSPLP----GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY  682 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  682 (873)
                      ..+++|+-+.+|.+.+. |..+++|.- .+.-.    ...-......+|+.++.+++--.|...+-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999776 444555542 22111    1111234577899999999766766666677778888999999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++|..+.+.+...          ...++..+-.-+.-||..   ||+|||+.++||.+..++ +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888544          245777888889999999   999999999999998655 99999999974

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.16  E-value=1e-11  Score=117.92  Aligned_cols=126  Identities=32%  Similarity=0.368  Sum_probs=37.0

Q ss_pred             ccCCCCCceEEccCCcccccCCCCcc-CCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccc-cCCcc
Q 039344           41 LGNLTNLATLYIHTNSLSGSIPGEIG-NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEL-GNLRS  118 (873)
Q Consensus        41 ~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~  118 (873)
                      +.+..++++|+|++|+|+.+  +.++ .+.+|+.|+|++|.|+.+  ..+..+++|++|++++|+|+. ++..+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred             cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence            34445567777777777732  2344 456677777777777633  246666777777777777763 33333 34667


Q ss_pred             cCccccccccccccc-CccccCCCCCcEEEccCCCCcccc---ccccCCCCCCCEEE
Q 039344          119 LSNLQLNNNILSGSI-PHSLGNLTNLATLYIYSNSLSASI---LGKIGNLKSLSNLQ  171 (873)
Q Consensus       119 L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~  171 (873)
                      |++|+|++|+|.... -..+..+++|+.|+|.+|.+....   ...+..+|+|+.||
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            777777777765321 134555666666666666665321   11234455555554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.15  E-value=3.6e-12  Score=142.03  Aligned_cols=266  Identities=27%  Similarity=0.306  Sum_probs=179.5

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeec
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYL  100 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  100 (873)
                      +.++.++..++.+....-. ...+..++.+.+..|.+. .+-..+..+.+|+.|++.+|+|. .+...+..+++|++|+|
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~l  125 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDL  125 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheec
Confidence            3455566666655421111 146677777778888887 33445677788888888888887 34334777888888888


Q ss_pred             cccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccc-cccCCCCCCCEEEccCCcCcc
Q 039344          101 DTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASIL-GKIGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       101 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~  179 (873)
                      ++|.|+.+  ..+..++.|+.|++++|.|+.  ...+..++.|+.+++++|++..+.. . ...+.+++.+++..|.+..
T Consensus       126 s~N~I~~i--~~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~  200 (414)
T KOG0531|consen  126 SFNKITKL--EGLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE  200 (414)
T ss_pred             cccccccc--cchhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence            88888753  345566668888888888873  2346667888888888888876555 2 4677788888888888863


Q ss_pred             CCCccccCCCCCcEEeccCCCCcccCCccccCCC--CCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhh
Q 039344          180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLR--SLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY  257 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  257 (873)
                      .  ..+..+..+..+++..|.++...+  +..+.  .|+.+++++|++. ..+..+..+.++..|++..|++...  ..+
T Consensus       201 i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~  273 (414)
T KOG0531|consen  201 I--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGL  273 (414)
T ss_pred             c--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccc
Confidence            3  344455556666888888874322  22233  3788888888887 3335667778888888888888643  235


Q ss_pred             cCCCCCcEEEccCCcCcCc-----CCcCCCCCCCCeEEccCcccccccc
Q 039344          258 RNLVKLTILLLGHNQFRGP-----IPILRNLTSLERVRLDRNYLTGNIS  301 (873)
Q Consensus       258 ~~l~~L~~L~L~~N~l~~~-----~~~l~~l~~L~~L~L~~n~l~~~~~  301 (873)
                      .....+..+.+..|++...     .......+.++.+.+..|.+.....
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  274 ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             cccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            5566777777888877631     1225667788888888888775443

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.12  E-value=3.6e-11  Score=142.59  Aligned_cols=208  Identities=29%  Similarity=0.357  Sum_probs=139.0

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCc--ccccCCCCccCCCCCCEEEcccCCCCCCCCcccc
Q 039344           13 IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNS--LSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLG   90 (873)
Q Consensus        13 ~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~   90 (873)
                      .|... +....+.+.+-+|.+. .++... .++.|+.|-+.+|.  +..+..+.|..++.|.+|||++|.=-+.+|..++
T Consensus       516 ~~~~~-~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~  592 (889)
T KOG4658|consen  516 IPQVK-SWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG  592 (889)
T ss_pred             ccccc-chhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh
Confidence            44433 3367888888888887 455543 34579999999886  6656666688899999999998876668899999


Q ss_pred             cccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCC--CccccccccCCCCCCC
Q 039344           91 NLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNS--LSASILGKIGNLKSLS  168 (873)
Q Consensus        91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~  168 (873)
                      +|.+|++|+|+++.++ .+|..+.+++.|.+|++..+.-...+|..+..+++|++|.+....  .+......+..+.+|+
T Consensus       593 ~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~  671 (889)
T KOG4658|consen  593 ELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLE  671 (889)
T ss_pred             hhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchh
Confidence            9999999999999988 789999999999999998887655566767778899998887654  2223333445555555


Q ss_pred             EEEccCCcCccCCCccccCCCCCc----EEeccCCCCcccCCccccCCCCCCEEEccCcccCC
Q 039344          169 NLQLSENNFNGSIPPSLGNLSNLA----TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG  227 (873)
Q Consensus       169 ~L~L~~n~i~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  227 (873)
                      .+........  +-..+..++.|.    .+.+..+... ..+..+..+.+|+.|.+.++.+..
T Consensus       672 ~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e  731 (889)
T KOG4658|consen  672 NLSITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE  731 (889)
T ss_pred             hheeecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence            5555433320  011122222222    3333233333 344556677777777777777653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=1.1e-10  Score=127.11  Aligned_cols=247  Identities=19%  Similarity=0.180  Sum_probs=173.4

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe--CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecce
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL--ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  675 (873)
                      ....+|..+..||.|.|+.|+....  .++..+++|.......+... ...-..|+.+...+ .|.++++.+..+.+...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            3456788999999999999998753  46788999988765443321 12224566666656 58888988888877788


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEeccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIA  754 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a  754 (873)
                      .|+--||+.+++.....   .....++...++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||.+
T Consensus       341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            88999999999887665   2334477888999999999999999999   99999999999999886 78899999998


Q ss_pred             cccCCCCCCcccccccccc-ccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          755 KFLKPDSSNWTELAGTYGY-VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ..+.....  ....++..| .+|+......+..+.|+||||.-+.|..+|..--..       ...    ...+..+..+
T Consensus       415 t~~~~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~----~~~i~~~~~p  481 (524)
T KOG0601|consen  415 TRLAFSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQ----SLTIRSGDTP  481 (524)
T ss_pred             cccceecc--cccccccccccchhhccccccccccccccccccccccccCcccCcc-------ccc----ceeeeccccc
Confidence            75321111  111122233 355556667788899999999999999987653110       000    1111222222


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......    ..+..+.+.+...++..||.+.+...
T Consensus       482 ~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  482 NLPGLK----LQLQVLLKVMINPDRKRRPSAVELSL  513 (524)
T ss_pred             CCCchH----HhhhhhhhhhcCCccccchhhhhhcc
Confidence            222111    23667777899999999999877654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=1.4e-09  Score=111.03  Aligned_cols=143  Identities=20%  Similarity=0.229  Sum_probs=110.9

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC--CceeeEEeEEEec---ceeEEEEEe
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIVKVYGFCLHV---RHLFIVYEY  682 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~  682 (873)
                      +.++.|.++.||+++..+|+.+++|........  .....+..|+++++.+++  ..+++++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            578999999999998877789999997654321  123568899999999965  4467788887654   366899999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC--------------------------------------  724 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  724 (873)
                      ++|.++.+.+..    ..++..+...++.++++++.+||+..                                      
T Consensus        82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999888765431    23667778888888999998888531                                      


Q ss_pred             ---------------CCCeeeCCCCCCCeeeCC--CCCeEEeccccccc
Q 039344          725 ---------------FPPIVHRDISSKNVLLDF--ENEAHVSDFGIAKF  756 (873)
Q Consensus       725 ---------------~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~  756 (873)
                                     ...++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           146799999999999998  56789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.01  E-value=8.3e-09  Score=106.63  Aligned_cols=256  Identities=16%  Similarity=0.204  Sum_probs=161.2

Q ss_pred             CCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEE------Ee-cce
Q 039344          604 FDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFC------LH-VRH  675 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~-~~~  675 (873)
                      ...++.||+|+.+.+|-..--  ...+-|+++.+-....   .   ..+..|... .||-+-.-+.|-      .+ ...
T Consensus        13 i~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             cCCCccccCCccceeeecchh--hchhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            345678999999999965221  1235688876543321   1   223333333 465433212111      11 223


Q ss_pred             eEEEEEeccCC-ChhhHhcc---cccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          676 LFIVYEYFKMC-SLAVILSN---DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       676 ~~lv~e~~~~~-~L~~~l~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      ..+.|..+.+. ....++.-   .+......|...+++++.++.+.+.||..   |.+-||+.++|+|+.+++.+.+.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence            67788877654 33333322   22333478999999999999999999999   9999999999999999999999987


Q ss_pred             ccccccCCCCCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhC-CCCCcccccchhhhhhhh----
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSFSSLNLN----  821 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg-~~P~~~~~~~~~~~~~~~----  821 (873)
                      ..-.. ...+......+|...|.+||.-.     +...+...|-|.+||++++++.| ++||.++....-.....+    
T Consensus       162 Dsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         162 DSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             cceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence            65443 33445566778999999999643     34456789999999999998885 999986542211111000    


Q ss_pred             -hhh---hhhcCCCCCCCCchhHH-HHHHHHHHHhhcccCC--CCCCCCHHHHHHHh
Q 039344          822 -IAL---DEMLDPRLPTPSRNVHD-KLISIVEVTISCVDEN--PESRPTMQKVCQLL  871 (873)
Q Consensus       822 -~~~---~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~d--P~~RPs~~ev~~~L  871 (873)
                       ..+   .+.-.+..+.+..+.-. -..++..+..+|+...  +.-|||++-++..|
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl  297 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL  297 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence             000   01111222222221111 1234667777888764  56799999887765

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.00  E-value=1.8e-10  Score=136.73  Aligned_cols=180  Identities=30%  Similarity=0.363  Sum_probs=134.1

Q ss_pred             CCCCEEECCCCc--ccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccccccccee
Q 039344           21 KSLSDLELGNNK--LSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATL   98 (873)
Q Consensus        21 ~~l~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L   98 (873)
                      +.|+.|-+..|.  +..+.++.|..++.|++|||++|.--+.+|..++.+-+|++|+|+++.++ .+|..+.+|..|.+|
T Consensus       545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L  623 (889)
T KOG4658|consen  545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL  623 (889)
T ss_pred             CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence            379999999997  66555566888999999999998777799999999999999999999999 899999999999999


Q ss_pred             eccccccCCCCCccccCCcccCcccccccccc--cccCccccCCCCCcEEEccCCCCccccccccCCCCCCC----EEEc
Q 039344           99 YLDTNSLSNSIPSELGNLRSLSNLQLNNNILS--GSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLS----NLQL  172 (873)
Q Consensus        99 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L  172 (873)
                      ++..+.-...+|.....+.+|++|.+......  ...-..+..+.+|+.+.......  .....+..+..|.    .+.+
T Consensus       624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~  701 (889)
T KOG4658|consen  624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSI  701 (889)
T ss_pred             ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhh
Confidence            99998766567888888999999999766532  22333455566666665543332  1112233344443    3333


Q ss_pred             cCCcCccCCCccccCCCCCcEEeccCCCCccc
Q 039344          173 SENNFNGSIPPSLGNLSNLATLYLDTNSLSYS  204 (873)
Q Consensus       173 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~  204 (873)
                      .++... ..+..+..+.+|+.|.+.++.+...
T Consensus       702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~  732 (889)
T KOG4658|consen  702 EGCSKR-TLISSLGSLGNLEELSILDCGISEI  732 (889)
T ss_pred             cccccc-eeecccccccCcceEEEEcCCCchh
Confidence            333332 4456778889999999999998743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.96  E-value=1.6e-10  Score=131.92  Aligned_cols=251  Identities=19%  Similarity=0.228  Sum_probs=168.9

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..+.+.+.+-+-+|+++.++.++-. .|...+.|.......-.....+....+-.+.-..+||-+++..--+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3456777778889999999988643 343333433322111111011222222223333355767665555555677899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |++|..++++...++...   ..+.+........+.++.+|||+.   .+.|+|++|.|.+...++..+++|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence            999999999998887654   345556666777899999999998   78999999999999999999999998443221


Q ss_pred             CC--------C-----------------------CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 039344          759 PD--------S-----------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR  807 (873)
Q Consensus       759 ~~--------~-----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~  807 (873)
                      ..        .                       .......||+.|.+||...+.....++|.|+.|++++|.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            10        0                       0011356899999999999999999999999999999999999997


Q ss_pred             cccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 039344          808 DFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ  865 (873)
Q Consensus       808 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  865 (873)
                      ....+        +..++.+..+..+-+.. .........+++.+.+..+|.+|-.|.
T Consensus      1036 na~tp--------q~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETP--------QQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcch--------hhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcc
Confidence            64332        23334444433332211 112233467788888899999997654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=1.3e-08  Score=98.51  Aligned_cols=129  Identities=26%  Similarity=0.354  Sum_probs=85.5

Q ss_pred             EEEEEEeCCCcEEEEEEccCCCCC-----------------------cchhHHHHHHHHHHHHhccCC--ceeeEEeEEE
Q 039344          617 SVYMSKLASGEIIAVKKFHSPLPG-----------------------EMTFQQEFLNEVKALTEIWHR--NIVKVYGFCL  671 (873)
Q Consensus       617 ~V~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  671 (873)
                      .||.|...+|+.+|+|..+.....                       .........+|.+.|+++...  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999999999999987542110                       001133477899999999755  567777553 


Q ss_pred             ecceeEEEEEecc--CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          672 HVRHLFIVYEYFK--MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM-HNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       672 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                         ..++||||++  |..+..+....     ++.+....++.+++..+..+ |..   |++|||+.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               3579999999  65554443221     12345667788888866664 677   99999999999999987 9999


Q ss_pred             eccccccccC
Q 039344          749 SDFGIAKFLK  758 (873)
Q Consensus       749 ~Dfg~a~~~~  758 (873)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=3.3e-08  Score=101.87  Aligned_cols=144  Identities=20%  Similarity=0.121  Sum_probs=103.2

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCc--------chhHHHHHHHHHHHHhccCCc--eeeEEeEEEe-----
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE--------MTFQQEFLNEVKALTEIWHRN--IVKVYGFCLH-----  672 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  672 (873)
                      +.+-+.....|++.... |+.|.||......-..        ......+.+|...+..+...+  .++++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            45555555667777664 7889999774322100        000124789999999885444  3455666653     


Q ss_pred             cceeEEEEEeccCC-ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-------CC
Q 039344          673 VRHLFIVYEYFKMC-SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-------EN  744 (873)
Q Consensus       673 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-------~~  744 (873)
                      ....++|+|++++. ++.+++.... ....+...+..++.+++..+.-||..   ||+|+|++++|||++.       ++
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999986 7888874321 12345667789999999999999999   9999999999999985       46


Q ss_pred             CeEEeccccccc
Q 039344          745 EAHVSDFGIAKF  756 (873)
Q Consensus       745 ~~kl~Dfg~a~~  756 (873)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            799999998864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.88  E-value=1.6e-09  Score=84.48  Aligned_cols=61  Identities=41%  Similarity=0.567  Sum_probs=42.4

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCC
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKL   81 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l   81 (873)
                      ++|++|++++|+++.+.+++|.++++|++|++++|+++.+.|++|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566777777777766666777777777777777777766666777777777777777654

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=2.5e-08  Score=98.49  Aligned_cols=138  Identities=22%  Similarity=0.241  Sum_probs=101.9

Q ss_pred             CCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCC-----------------CCc--chhHHHHHHHHHHHHhccCC--c
Q 039344          604 FDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPL-----------------PGE--MTFQQEFLNEVKALTEIWHR--N  662 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------~~~--~~~~~~~~~e~~~l~~l~h~--n  662 (873)
                      ..++..||.|.-+.||.|..+.|.++|||.=+...                 ...  ........+|.++|..+...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34568899999999999999999999999532110                 011  01134467899999999655  7


Q ss_pred             eeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       663 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      +++.+++    +...+||||++|-.|...-        ++.+....++..|++-+.-.-..   ||||||+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            7777776    4568999999986664331        23444555666677766666666   9999999999999999


Q ss_pred             CCCeEEeccccccc
Q 039344          743 ENEAHVSDFGIAKF  756 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~  756 (873)
                      ||.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.82  E-value=2.6e-09  Score=83.29  Aligned_cols=61  Identities=36%  Similarity=0.508  Sum_probs=38.4

Q ss_pred             CCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccccc
Q 039344           45 TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSL  105 (873)
Q Consensus        45 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  105 (873)
                      ++|++|++++|+++.+.+++|.++++|++|++++|+++.+.+.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566666666666655555666666666666666666655566666666666666666653

...

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.79  E-value=2e-07  Score=99.35  Aligned_cols=170  Identities=19%  Similarity=0.264  Sum_probs=127.7

Q ss_pred             CCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe----cceeEEEEEeccCC-C
Q 039344          614 GQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRHLFIVYEYFKMC-S  687 (873)
Q Consensus       614 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~~-~  687 (873)
                      -..+.|++.. .||..|++|+++.......   .....-+++++++.|+|+|++.+++..    +...++||+|.++. +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            3456789864 4899999999964432221   223456789999999999999998873    34689999998875 6


Q ss_pred             hhhHhcccc------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          688 LAVILSNDA------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       688 L~~~l~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      |.+..-...            .+...+++..|.++.|+..||.++|+.   |+.-+-+.+++|+++.+.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence            665543221            122356788999999999999999999   99999999999999999999999888887


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP  806 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P  806 (873)
                      .+..+..              |-+.   --.+-|.-.+|.+++.+.||..-
T Consensus       442 vl~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  442 VLQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             eecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            6654431              1111   12367999999999999999654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.62  E-value=1.3e-09  Score=119.14  Aligned_cols=126  Identities=29%  Similarity=0.261  Sum_probs=76.9

Q ss_pred             CccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCc-cccccccccEEEe
Q 039344          309 NLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI-ELGKLNFFIKLVL  387 (873)
Q Consensus       309 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~L  387 (873)
                      .|...+.+.|.+. .....+.-++.|+.|||++|+++..  +.+..++.|++|||++|.++ .+|. ...++ .|..|++
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence            4666666777665 4445555566777777777777643  36677777777777777776 3443 22233 3777777


Q ss_pred             cCccccCCcccccccccccccccccccccccccCCCcCchh-hhhhhcccccCCccC
Q 039344          388 AHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE-LIHLSELDLSRNFLR  443 (873)
Q Consensus       388 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~~~L~~L~Ls~N~l~  443 (873)
                      ++|.++.  -..+.++.+|+.||||+|-|++.  ..+..|- +..|+.|+|.+|.+-
T Consensus       240 rnN~l~t--L~gie~LksL~~LDlsyNll~~h--seL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  240 RNNALTT--LRGIENLKSLYGLDLSYNLLSEH--SELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cccHHHh--hhhHHhhhhhhccchhHhhhhcc--hhhhHHHHHHHHHHHhhcCCccc
Confidence            7777763  12456777788888888877631  1111111 235666677777664

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=8.7e-07  Score=86.10  Aligned_cols=141  Identities=18%  Similarity=0.151  Sum_probs=102.8

Q ss_pred             eeecCCeEEEEEEeCCCcEEEEEEccCCCCCc---chhHHHHHHHHHHHHhccC--CceeeEEeEEEe-----cceeEEE
Q 039344          610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWH--RNIVKVYGFCLH-----VRHLFIV  679 (873)
Q Consensus       610 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~-----~~~~~lv  679 (873)
                      -|+||.+.|++.... |+.+-+|+-.......   ..-...|.+|...++.+..  -.++++. ++..     ....++|
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467899999998876 4468888754211111   1124679999999999953  2355555 3331     1246899


Q ss_pred             EEeccC-CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC--eEEeccccccc
Q 039344          680 YEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE--AHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~--~kl~Dfg~a~~  756 (873)
                      +|-+++ -+|.+++..... .+.+...+..+..+|+..++-||+.   |+.|+|+.+.||+++.++.  ++++||--++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997765 478888754332 3467778889999999999999999   9999999999999987776  99999987763

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.57  E-value=9.8e-10  Score=120.13  Aligned_cols=127  Identities=30%  Similarity=0.312  Sum_probs=86.8

Q ss_pred             ccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEecc
Q 039344          118 SLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLD  197 (873)
Q Consensus       118 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~  197 (873)
                      .|...+.+.|.+. ....++.-++.|+.|+|++|++..+.  .+..|++|++|||++|.+..+.--...++. |..|.++
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            4667777777777 56667777788888888888876543  677778888888888887744333333343 7888888


Q ss_pred             CCCCcccCCccccCCCCCCEEEccCcccCCCcc-cccCCCCCccEEecccccCC
Q 039344          198 TNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP-ISMGNLSNLTYLNLFENSLS  250 (873)
Q Consensus       198 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~  250 (873)
                      +|.++. + ..+.++++|+.||+++|-|.+... ..+..+..|+.|.|.+|.+-
T Consensus       241 nN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            887773 2 246677788888888887764321 23445667778888888774

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.55  E-value=2.8e-08  Score=109.90  Aligned_cols=150  Identities=17%  Similarity=0.298  Sum_probs=100.8

Q ss_pred             HHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC----Cccc-----cccccccccccccc
Q 039344          710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS----NWTE-----LAGTYGYVAPELAY  780 (873)
Q Consensus       710 ~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~-----~~g~~~y~aPE~~~  780 (873)
                      +.+++.|+.|+|...  ++||++|.|++|.++..+.+|++.|+.+........    .++.     ......|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345669999999874  999999999999999999999999999875544221    1111     12356799999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHhCCCC-CcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCC
Q 039344          781 TMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPE  859 (873)
Q Consensus       781 ~~~~~~~sDv~s~G~il~el~tg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  859 (873)
                      ....+.++|+||+||++|.+..|..+ ++..+.........  ...+.  +.....    .....++.+=+.+.+..++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--~~~~~--~~~~~s----~~~p~el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--NLLNA--GAFGYS----NNLPSELRESLKKLLNGDSA  254 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--ccccc--cccccc----ccCcHHHHHHHHHHhcCCcc
Confidence            98889999999999999999954444 43322111100000  00000  000000    11223467778889999999


Q ss_pred             CCCCHHHHHH
Q 039344          860 SRPTMQKVCQ  869 (873)
Q Consensus       860 ~RPs~~ev~~  869 (873)
                      .||++.++..
T Consensus       255 ~rp~~~~l~~  264 (700)
T KOG2137|consen  255 VRPTLDLLLS  264 (700)
T ss_pred             cCcchhhhhc
Confidence            9998776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=1.1e-06  Score=87.85  Aligned_cols=106  Identities=15%  Similarity=0.256  Sum_probs=85.2

Q ss_pred             HHHHHHHHHHHhccC--CceeeEEeEEEecc----eeEEEEEeccCC-ChhhHhcccccccCCChHHHHHHHHHHHHHHH
Q 039344          646 QEFLNEVKALTEIWH--RNIVKVYGFCLHVR----HLFIVYEYFKMC-SLAVILSNDAAAKNLGWTRRMNMIKGIVDALS  718 (873)
Q Consensus       646 ~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~  718 (873)
                      ....+|...+..+..  -.+++++++.+...    ..++|+|++++. +|.+++.....   .+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            457888888888853  34567777776532    458999999985 78888864322   556678899999999999


Q ss_pred             HHHhCCCCCeeeCCCCCCCeeeCCCC---CeEEecccccccc
Q 039344          719 YMHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKFL  757 (873)
Q Consensus       719 ~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~Dfg~a~~~  757 (873)
                      -||..   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.51  E-value=6.8e-09  Score=100.87  Aligned_cols=113  Identities=24%  Similarity=0.128  Sum_probs=63.3

Q ss_pred             CCCCCeeeeccccCCccCCcc-----ccCCCCCCEEeccCCccCCCCCc-----cccccccccEEEecCccccCC----c
Q 039344          331 CPKLSTLDFSINNITGNVPPE-----IGHSSQLGVLDLSSNHIVGEIPI-----ELGKLNFFIKLVLAHNQLSGQ----L  396 (873)
Q Consensus       331 l~~L~~L~l~~N~i~~~~~~~-----~~~~~~L~~L~Ls~N~i~~~~~~-----~~~~l~~L~~L~L~~N~l~~~----~  396 (873)
                      -|.|++.....|++.. .+..     +..-.+|+.+.+..|.|......     .+..+.+|+.|+|+.|-++-.    +
T Consensus       156 kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~L  234 (388)
T COG5238         156 KPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYL  234 (388)
T ss_pred             CCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHH
Confidence            4567777777777652 2222     11224677777777776532211     233456677777777766532    3


Q ss_pred             ccccccccccccccccccccccccCCC----cCchhhhhhhcccccCCccCc
Q 039344          397 SPKLGSLVQLEHLDLSSNRLSNSIPKS----LGNLELIHLSELDLSRNFLRE  444 (873)
Q Consensus       397 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~~~L~~L~Ls~N~l~~  444 (873)
                      ..++...+.|+.|.+.+|-++....++    |.....++|+.|...+|...+
T Consensus       235 a~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~  286 (388)
T COG5238         235 ADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRG  286 (388)
T ss_pred             HHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcC
Confidence            334555666777777777776544333    333334566666666666554

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.51  E-value=1.1e-08  Score=99.56  Aligned_cols=208  Identities=19%  Similarity=0.211  Sum_probs=125.2

Q ss_pred             cCCcccCcccccccccccccCc----cccCCCCCcEEEccCCCCcc----------ccccccCCCCCCCEEEccCCcCcc
Q 039344          114 GNLRSLSNLQLNNNILSGSIPH----SLGNLTNLATLYIYSNSLSA----------SILGKIGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       114 ~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~L~~n~l~~----------~~~~~~~~l~~L~~L~L~~n~i~~  179 (873)
                      ..+..+.+++||+|-|......    .+++-.+|+..+++.-....          ....++.+|++|+..+||.|.+..
T Consensus        27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~  106 (388)
T COG5238          27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS  106 (388)
T ss_pred             HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence            3355666666666666543322    33444556666555432211          113345678888889999888876


Q ss_pred             CCCc----cccCCCCCcEEeccCCCCcccCCccc-------------cCCCCCCEEEccCcccCCCccc----ccCCCCC
Q 039344          180 SIPP----SLGNLSNLATLYLDTNSLSYSIPSEL-------------GNLRSLSNLSLGYNKLSGSIPI----SMGNLSN  238 (873)
Q Consensus       180 ~~~~----~~~~l~~L~~L~L~~n~l~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~  238 (873)
                      ..|+    .+++-+.|++|.|++|.+....-.-+             .+-+.|++.....|++..-...    .+..-.+
T Consensus       107 ~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~  186 (388)
T COG5238         107 EFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHEN  186 (388)
T ss_pred             ccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcC
Confidence            5554    34566889999999998863222222             2347788888888888632111    2223357


Q ss_pred             ccEEecccccCCCCC-----chhhcCCCCCcEEEccCCcCcC-----cCCcCCCCCCCCeEEccCcccccccccccc---
Q 039344          239 LTYLNLFENSLSGAI-----PYEYRNLVKLTILLLGHNQFRG-----PIPILRNLTSLERVRLDRNYLTGNISESFY---  305 (873)
Q Consensus       239 L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~-----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~---  305 (873)
                      |+++.+.+|.|.-..     -..+..+.+|+.|||++|-++.     ...++...+.|++|.+.+|-++..+...+.   
T Consensus       187 lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f  266 (388)
T COG5238         187 LKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRF  266 (388)
T ss_pred             ceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHh
Confidence            888888888876331     1224456788888888888764     223455666677888888877755543322   


Q ss_pred             ---cCCCccEEeccCcccc
Q 039344          306 ---IYPNLTYIDLSQNNFY  321 (873)
Q Consensus       306 ---~~~~L~~L~Ls~N~l~  321 (873)
                         ..|+|..|-..+|.+.
T Consensus       267 ~e~~~p~l~~L~~~Yne~~  285 (388)
T COG5238         267 NEKFVPNLMPLPGDYNERR  285 (388)
T ss_pred             hhhcCCCccccccchhhhc
Confidence               2345555555555443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.46  E-value=1.6e-06  Score=85.12  Aligned_cols=156  Identities=19%  Similarity=0.267  Sum_probs=104.0

Q ss_pred             cCHHHHHHHhcCCCCCc---eeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcch----------------hHH-----H
Q 039344          592 IIYEEIIRATNDFDDEH---CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT----------------FQQ-----E  647 (873)
Q Consensus       592 ~~~~e~~~~~~~~~~~~---~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------~~~-----~  647 (873)
                      .+.+.+........+..   .|+.|..+.||+|...++..+|||+++.....-..                ..+     =
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34455555555555544   45567778899999888999999998643221110                000     0


Q ss_pred             HHHHHHHHHhcc--CCceeeEEeEEEecceeEEEEEeccCCCh-hhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC
Q 039344          648 FLNEVKALTEIW--HRNIVKVYGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC  724 (873)
Q Consensus       648 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~  724 (873)
                      ..+|..-|+++.  +-.+++.+++..    -.+||||+..... .-.|..    -.+..++...+..++++.+.-|-..+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            345666666663  455666666643    4799999875411 111111    11223357778888999999988843


Q ss_pred             CCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       725 ~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                        ++||+||+.-|||+. ++.+.++|||-|....
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence              999999999999999 8999999999997654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	873
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-39
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-12
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-39
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-37
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-37
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-21
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-10
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		3e-10
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		4e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		4e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-08
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-08
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		4e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-08
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-08
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		7e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-08
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		7e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-08
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		8e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		1e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-07
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		5e-07
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		3e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-06
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		2e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-06
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		4e-06
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		1e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-06
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		4e-06
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		1e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-06
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		7e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-06
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		9e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		4e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		5e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		6e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		1e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-05
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		9e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-04
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		1e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3zyi_A	452	Netring2 In Complex With Ngl2 Length = 452		3e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  162 bits (409), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 166/567 (29%), Positives = 241/567 (42%), Gaps = 85/567 (14%)
Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP- 62
           + +N+    IP  L +  +L  L++  NKLSG    ++   T L  L I +N   G IP 
Sbjct: 204 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 262
Query: 63  -----------------GEIGNF-----RFFSDLELSNNKLSGSIPPSLGNLSNLATLYL 100
                            GEI +F        + L+LS N   G++PP  G+ S L +L L
Sbjct: 263 LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 322
Query: 101 DTNSLSNSIPSEXXXXXXXXXXXXXXXXX-XXXXPHSLGNLT-NLATLYIYSNSLSASIL 158
            +N+ S  +P +                      P SL NL+ +L TL + SN+ S  IL
Sbjct: 323 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 382
Query: 159 GKIGN--LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPXXXXXXXXXX 216
             +      +L  L L  N F G IPP+L N S L +L+L                    
Sbjct: 383 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL-------------------- 422
Query: 217 XXXXXYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP 276
                +N LSG+IP S+G+LS L  L L+ N L G IP E   +  L  L+L  N   G 
Sbjct: 423 ----SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 478
Query: 277 IPI-LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS 335
           IP  L N T+L  + L  N LTG I +      NL  + LS N+F G I ++ G C  L 
Sbjct: 479 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 538
Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI--------------------- 374
            LD + N   G +P  +   S      +++N I G+  +                     
Sbjct: 539 WLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 594
Query: 375 -----ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLEL 429
                +L +L+      +      G  SP   +   +  LD+S N LS  IPK +G++  
Sbjct: 595 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY 654
Query: 430 IHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNE 489
           + +  L+L  N +  +IP ++  ++ L  L+LS N L G IP     +  L  ID+S N 
Sbjct: 655 LFI--LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 712
Query: 490 LRGSIPNSTTFKDAPIEALQGNKGLYG 516
           L G IP    F+  P      N GL G
Sbjct: 713 LSGPIPEMGQFETFPPAKFLNNPGLCG 739

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 122/285 (42%), Gaps = 55/285 (19%)
Query: 267 LLGHNQFRGPIPILRNLTSLERVRLDRNYLTG-----------------NISESFYIYP- 308
            L ++   G +   +   SL  + L RN L+G                 N+S +   +P 
Sbjct: 80  FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 139
Query: 309 ---------NLTYIDLSQNNFYGEISSDW---GRCPKLSTLDFSINNITGNVPPEIGHSS 356
                    +L  +DLS N+  G     W     C +L  L  S N I+G+V  ++    
Sbjct: 140 KVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCV 197
Query: 357 QLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRL 416
            L  LD+SSN+    IP  LG  +    L ++ N+LSG  S  + +  +L+ L++SSN+ 
Sbjct: 198 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 256
Query: 417 SNSIP----KSLGNLELIH-----------------LSELDLSRNFLREAIPSQICIMQS 455
              IP    KSL  L L                   L+ LDLS N    A+P        
Sbjct: 257 VGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 316
Query: 456 LEKLNLSHNSLSGLIP-SCFEKMNGLLHIDISYNELRGSIPNSTT 499
           LE L LS N+ SG +P     KM GL  +D+S+NE  G +P S T
Sbjct: 317 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 361

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 166/567 (29%), Positives = 241/567 (42%), Gaps = 85/567 (14%)
Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP- 62
           + +N+    IP  L +  +L  L++  NKLSG    ++   T L  L I +N   G IP 
Sbjct: 207 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265
Query: 63  -----------------GEIGNF-----RFFSDLELSNNKLSGSIPPSLGNLSNLATLYL 100
                            GEI +F        + L+LS N   G++PP  G+ S L +L L
Sbjct: 266 LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325
Query: 101 DTNSLSNSIPSEXXXXXXXXXXXXXXXXX-XXXXPHSLGNLT-NLATLYIYSNSLSASIL 158
            +N+ S  +P +                      P SL NL+ +L TL + SN+ S  IL
Sbjct: 326 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
Query: 159 GKIGN--LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPXXXXXXXXXX 216
             +      +L  L L  N F G IPP+L N S L +L+L                    
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL-------------------- 425
Query: 217 XXXXXYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP 276
                +N LSG+IP S+G+LS L  L L+ N L G IP E   +  L  L+L  N   G 
Sbjct: 426 ----SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481
Query: 277 IPI-LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS 335
           IP  L N T+L  + L  N LTG I +      NL  + LS N+F G I ++ G C  L 
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541
Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI--------------------- 374
            LD + N   G +P  +   S      +++N I G+  +                     
Sbjct: 542 WLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 375 -----ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLEL 429
                +L +L+      +      G  SP   +   +  LD+S N LS  IPK +G++  
Sbjct: 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY 657
Query: 430 IHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNE 489
           + +  L+L  N +  +IP ++  ++ L  L+LS N L G IP     +  L  ID+S N 
Sbjct: 658 LFI--LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715
Query: 490 LRGSIPNSTTFKDAPIEALQGNKGLYG 516
           L G IP    F+  P      N GL G
Sbjct: 716 LSGPIPEMGQFETFPPAKFLNNPGLCG 742

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 122/285 (42%), Gaps = 55/285 (19%)
Query: 267 LLGHNQFRGPIPILRNLTSLERVRLDRNYLTG-----------------NISESFYIYP- 308
            L ++   G +   +   SL  + L RN L+G                 N+S +   +P 
Sbjct: 83  FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142
Query: 309 ---------NLTYIDLSQNNFYGEISSDW---GRCPKLSTLDFSINNITGNVPPEIGHSS 356
                    +L  +DLS N+  G     W     C +L  L  S N I+G+V  ++    
Sbjct: 143 KVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCV 200
Query: 357 QLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRL 416
            L  LD+SSN+    IP  LG  +    L ++ N+LSG  S  + +  +L+ L++SSN+ 
Sbjct: 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 417 SNSIP----KSLGNLELIH-----------------LSELDLSRNFLREAIPSQICIMQS 455
              IP    KSL  L L                   L+ LDLS N    A+P        
Sbjct: 260 VGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 456 LEKLNLSHNSLSGLIP-SCFEKMNGLLHIDISYNELRGSIPNSTT 499
           LE L LS N+ SG +P     KM GL  +D+S+NE  G +P S T
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  154 bits (389), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 156/290 (53%), Gaps = 19/290 (6%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLP--GEMTFQQEFLNEVK 653
           E+  A+++F +++ +G+GG G VY  +LA G ++AVK+        GE+ FQ     EV+
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ----TEVE 87
Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKG 712
            ++   HRN++++ GFC+      +VY Y    S+A  L     ++  L W +R  +  G
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTELAGTY 771
               L+Y+H+ C P I+HRD+ + N+LLD E EA V DFG+AK +   D      + GT 
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTI 207
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL---------NI 822
           G++APE   T K +EK DV+ +GV+ LE+I G+   D     +   + L           
Sbjct: 208 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 267
Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            L+ ++D  L    ++  +++  +++V + C   +P  RP M +V ++L+
Sbjct: 268 KLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  152 bits (384), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 155/290 (53%), Gaps = 19/290 (6%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLP--GEMTFQQEFLNEVK 653
           E+  A+++F +++ +G+GG G VY  +LA G ++AVK+        GE+ FQ     EV+
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ----TEVE 79
Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKG 712
            ++   HRN++++ GFC+      +VY Y    S+A  L     ++  L W +R  +  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTELAGTY 771
               L+Y+H+ C P I+HRD+ + N+LLD E EA V DFG+AK +   D      + G  
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL---------NI 822
           G++APE   T K +EK DV+ +GV+ LE+I G+   D     +   + L           
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            L+ ++D  L    ++  +++  +++V + C   +P  RP M +V ++L+
Sbjct: 260 KLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 140/281 (49%), Gaps = 24/281 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ATN+FD +  IG G  G VY   L  G  +A+K+     P      +EF  E++ L+   
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR---RTPESSQGIEEFETEIETLSFCR 93
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALS 718
           H ++V + GFC     + ++Y+Y +  +L   L  +D    ++ W +R+ +  G    L 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL----AGTYGYV 774
           Y+H      I+HRD+ S N+LLD      ++DFGI+K  K    + T L     GT GY+
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKGTLGYI 208
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKH------PRDFI--SSMSFSSLNLNIALDE 826
            PE     ++TEK DVYSFGV+  EV+  +       PR+ +  +  +  S N N  L++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQ 267
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           ++DP L    R   + L    +  + C+  + E RP+M  V
Sbjct: 268 IVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 139/281 (49%), Gaps = 24/281 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ATN+FD +  IG G  G VY   L  G  +A+K+     P      +EF  E++ L+   
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR---RTPESSQGIEEFETEIETLSFCR 93
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALS 718
           H ++V + GFC     + ++Y+Y +  +L   L  +D    ++ W +R+ +  G    L 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL----AGTYGYV 774
           Y+H      I+HRD+ S N+LLD      ++DFGI+K  K      T L     GT GY+
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGYI 208
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKH------PRDFI--SSMSFSSLNLNIALDE 826
            PE     ++TEK DVYSFGV+  EV+  +       PR+ +  +  +  S N N  L++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQ 267
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           ++DP L    R   + L    +  + C+  + E RP+M  V
Sbjct: 268 IVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 136/298 (45%), Gaps = 35/298 (11%)
Query: 586 LTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVK-----KFHSPLPG 640
           L F+G +  +++     D + +  IG G  G+V+ ++   G  +AVK      FH+    
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA---- 75
Query: 641 EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN 700
                 EFL EV  +  + H NIV   G      +L IV EY    SL  +L    A + 
Sbjct: 76  --ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
           L   RR++M   +   ++Y+HN   PPIVHRD+ S N+L+D +    V DFG+++     
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX 192
Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH------PRDFISSMS 814
                  AGT  ++APE+       EK DVYSFGV+  E+   +       P   ++++ 
Sbjct: 193 FLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252
Query: 815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           F    L I              RN++ ++ +I+E    C    P  RP+   +  LL+
Sbjct: 253 FKCKRLEI-------------PRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 586 LTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVK-----KFHSPLPG 640
           L F+G +  +++     D + +  IG G  G+V+ ++   G  +AVK      FH+    
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA---- 75
Query: 641 EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN 700
                 EFL EV  +  + H NIV   G      +L IV EY    SL  +L    A + 
Sbjct: 76  --ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
           L   RR++M   +   ++Y+HN   PPIVHR++ S N+L+D +    V DFG+++     
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192
Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH------PRDFISSMS 814
             +    AGT  ++APE+       EK DVYSFGV+  E+   +       P   ++++ 
Sbjct: 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252
Query: 815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           F    L I              RN++ ++ +I+E    C    P  RP+   +  LL+
Sbjct: 253 FKCKRLEI-------------PRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  109 bits (272), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 141/295 (47%), Gaps = 25/295 (8%)
Query: 594 YEEIIRATNDFDDE------HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLP-GEMTFQQ 646
           + E+   TN+FD+       + +G+GG G VY   + +   +AVKK  + +       +Q
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           +F  E+K + +  H N+V++ GF      L +VY Y    SL   LS       L W  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--W 764
             + +G  + ++++H +     +HRDI S N+LLD    A +SDFG+A+  +  +     
Sbjct: 136 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX 192
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-------KHPRDFISSMSFSS 817
           + + GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  +       
Sbjct: 193 SRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  D  +D ++        + + S+      C+ E    RP ++KV QLL+
Sbjct: 252 DEEKTIED-YIDKKMNDADSTSVEAMYSVAS---QCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 25/295 (8%)
Query: 594 YEEIIRATNDFDDE------HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLP-GEMTFQQ 646
           + E+   TN+FD+       + +G+GG G VY   + +   +AVKK  + +       +Q
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           +F  E+K + +  H N+V++ GF      L +VY Y    SL   LS       L W  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--W 764
             + +G  + ++++H +     +HRDI S N+LLD    A +SDFG+A+  +  +     
Sbjct: 136 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX 192
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-------KHPRDFISSMSFSS 817
             + GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  +       
Sbjct: 193 XRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  D  +D ++        + + S+      C+ E    RP ++KV QLL+
Sbjct: 252 DEEKTIED-YIDKKMNDADSTSVEAMYSVAS---QCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 25/295 (8%)
Query: 594 YEEIIRATNDFDDE------HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLP-GEMTFQQ 646
           + E+   TN+FD+       + +G+GG G VY   + +   +AVKK  + +       +Q
Sbjct: 11  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 69
Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           +F  E+K + +  H N+V++ GF      L +VY Y    SL   LS       L W  R
Sbjct: 70  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 129
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--W 764
             + +G  + ++++H +     +HRDI S N+LLD    A +SDFG+A+  +  +     
Sbjct: 130 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMX 186
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-------KHPRDFISSMSFSS 817
             + GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  +       
Sbjct: 187 XRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 245
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  D  +D ++        + + S+      C+ E    RP ++KV QLL+
Sbjct: 246 DEEKTIED-YIDKKMNDADSTSVEAMYSVAS---QCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 25/295 (8%)
Query: 594 YEEIIRATNDFDDE------HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLP-GEMTFQQ 646
           + E+   TN+FD+       +  G+GG G VY   + +   +AVKK  + +       +Q
Sbjct: 8   FYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 66
Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           +F  E+K   +  H N+V++ GF      L +VY Y    SL   LS       L W  R
Sbjct: 67  QFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXR 126
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK--PDSSNW 764
             + +G  + ++++H +     +HRDI S N+LLD    A +SDFG+A+  +        
Sbjct: 127 CKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXX 183
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-------KHPRDFISSMSFSS 817
           + + GT  Y APE A   ++T K D+YSFGV+ LE+I G       + P+  +       
Sbjct: 184 SRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 242
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  D +        S +V     +   V   C+ E    RP ++KV QLL+
Sbjct: 243 DEEKTIEDYIDKKXNDADSTSVE----AXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 38/281 (13%)
Query: 610 IGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKG  G ++ ++   +GE++ +K+    +  +   Q+ FL EVK +  + H N++K  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKEL---IRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                + L  + EY K  +L  +I S D+      W++R++  K I   ++Y+H+     
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFL--------------KPDSSNWTELAGTYGY 773
           I+HRD++S N L+       V+DFG+A+ +              KPD      + G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISSMSFSSLNLNIALDEMLDPR 831
           +APE+       EK DV+SFG++  E+I      P     +M F  LN+   LD    P 
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-GLNVRGFLDRYCPPN 247
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            P           S   +T+ C D +PE RP+  K+   L+
Sbjct: 248 CPP----------SFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 28/263 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V + K      +AVK       G M+ + EF  E + + ++ H  +VK YG 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMS-EDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 670 CLHVRHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           C     ++IV EY    C L  + S+    K L  ++ + M   + + ++++ +  F   
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVT 785
           +HRD++++N L+D +    VSDFG+ +++  D   +    GT     + APE+ +  K +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 786 EKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
            K DV++FG+L  EV   GK P D  +       N  + L      RL  P    H    
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVVLKVSQGHRLYRP----HLASD 232
Query: 845 SIVEVTISCVDENPESRPTMQKV 867
           +I ++  SC  E PE RPT Q++
Sbjct: 233 TIYQIMYSCWHELPEKRPTFQQL 255

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 140/285 (49%), Gaps = 30/285 (10%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKF---HSPLPGEMTFQ-QEFLNEVKA 654
           A N+ + E  IGKGG G V+  +L   + ++A+K      S    EM  + QEF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           ++ + H NIVK+YG   +   +  V E+     L   L + A    + W+ ++ ++  I 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENE-----AHVSDFGIAKFLKPDSSNWTELAG 769
             + YM N   PPIVHRD+ S N+ L   +E     A V+DFG+++       + + L G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---QSVHSVSGLLG 188
Query: 770 TYGYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-LNIALDE 826
            + ++APE   A     TEK D YSF ++   ++ G+ P D     S+  +  +N+  +E
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINMIREE 245
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            L P +P    +   +L +++E+   C   +P+ RP    + + L
Sbjct: 246 GLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  TEL GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 24/273 (8%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           E  IG GG G VY +     E+      H P        +    E K    + H NI+ +
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
            G CL   +L +V E+ +   L  +LS      ++     +N    I   ++Y+H++   
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLHDEAIV 127
Query: 727 PIVHRDISSKNVLL-------DFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           PI+HRD+ S N+L+       D  N+   ++DFG+A+  +   +     AG Y ++APE+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGAYAWMAPEV 185
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
                 ++  DV+S+GVL  E++ G+ P   I  ++ +     +A++++    LP PS  
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA---YGVAMNKL---ALPIPS-T 238
Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             +    ++E    C + +P SRP+   +   L
Sbjct: 239 CPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 139/285 (48%), Gaps = 30/285 (10%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKF---HSPLPGEMTFQ-QEFLNEVKA 654
           A N+ + E  IGKGG G V+  +L   + ++A+K      S    EM  + QEF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           ++ + H NIVK+YG   +   +  V E+     L   L + A    + W+ ++ ++  I 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENE-----AHVSDFGIAKFLKPDSSNWTELAG 769
             + YM N   PPIVHRD+ S N+ L   +E     A V+DFG ++       + + L G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---QSVHSVSGLLG 188
Query: 770 TYGYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-LNIALDE 826
            + ++APE   A     TEK D YSF ++   ++ G+ P D     S+  +  +N+  +E
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINMIREE 245
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            L P +P    +   +L +++E+   C   +P+ RP    + + L
Sbjct: 246 GLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T+L GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 182
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 240 DLISRLLK----------HNPSQRPMLREVLE 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T+L GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T+L GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A++        +M  QQ+      +NE+  + E  + NI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 135
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HRDI S N+LL  +    ++DFG    + P+ S  +E+ GT  ++APE+     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA 192
Query: 784 VTEKCDVYSFGVLALEVIKGKHP 806
              K D++S G++A+E+I+G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T+L GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 178
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 236 DLISRLLK----------HNPSQRPMLREVLE 257

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +      SS  T L+GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEM 178
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 236 DLISRLLK----------HNPSQRPMLREVLE 257

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 149 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 203
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 260
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 261 DLISRLLK----------HNPSQRPMLREVLE 282

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 194
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 251
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 252 DLISRLLK----------HNPSQRPMLREVLE 273

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 238 DLISRLLK----------HNPSQRPMLREVLE 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 238
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 239 DLISRLLK----------HNPSQRPMLREVLE 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 176
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 233
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 234 DLISRLLK----------HNPSQRPMLREVLE 255

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 139/285 (48%), Gaps = 30/285 (10%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKF---HSPLPGEMTFQ-QEFLNEVKA 654
           A N+ + E  IGKGG G V+  +L   + ++A+K      S    EM  + QEF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           ++ + H NIVK+YG   +   +  V E+     L   L + A    + W+ ++ ++  I 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENE-----AHVSDFGIAKFLKPDSSNWTELAG 769
             + YM N   PPIVHRD+ S N+ L   +E     A V+DF +++       + + L G
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---QSVHSVSGLLG 188
Query: 770 TYGYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-LNIALDE 826
            + ++APE   A     TEK D YSF ++   ++ G+ P D     S+  +  +N+  +E
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINMIREE 245
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            L P +P    +   +L +++E+   C   +P+ RP    + + L
Sbjct: 246 GLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 240 DLISRLLK----------HNPSQRPMLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 238 DLISRLLK----------HNPSQRPMLREVLE 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 231
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 232 DLISRLLK----------HNPSQRPMLREVLE 253

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS   +L GT  Y+ PE+
Sbjct: 149 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 203
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 260
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 261 DLISRLLK----------HNPSQRPMLREVLE 282

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE 
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEX 182
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 240 DLISRLLK----------HNPSQRPXLREVLE 261

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS   +L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 180
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 238 DLISRLLK----------HNPSQRPMLREVLE 259

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A++        +M  QQ+      +NE+  + E  + NI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 135
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 784 VTEKCDVYSFGVLALEVIKGKHP 806
              K D++S G++A+E+I+G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  +++FG +  +   SS  T L GT  Y+ PE+
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 179
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 236
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 237 DLISRLLK----------HNPSQRPMLREVLE 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 180
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 238 DLISRLLK----------HNPSQRPMLREVLE 259

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A++        +M  QQ+      +NE+  + E  + NI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 135
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+     
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 192
Query: 784 VTEKCDVYSFGVLALEVIKGKHP 806
              K D++S G++A+E+I+G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A++        +M  QQ+      +NE+  + E  + NI
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 136
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+     
Sbjct: 137 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 193
Query: 784 VTEKCDVYSFGVLALEVIKGKHP 806
              K D++S G++A+E+I+G+ P
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++  + + I+A+K        +   + +   EV+  + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQDTYKRISRVEFTFPDFVTEGAR 234
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 235 DLISRLLK----------HNPSQRPMLREVLE 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 180
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 238 DLISRLLK----------HNPSQRPMLREVLE 259

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  +++FG +  +   SS  T L GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 238 DLISRLLK----------HNPSQRPMLREVLE 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 179
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 236
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 237 DLISRLLK----------HNPSQRPMLREVLE 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 132/270 (48%), Gaps = 34/270 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G V++    + + +A+K       G M+ +++F+ E + + ++ H  +V++YG 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           CL    + +V+E+ +   L+  L       AA+ L     + M   + + ++Y+   C  
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 121
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
            ++HRD++++N L+       VSDFG+ +F+  D   +T   GT     + +PE+    +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 178
Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD-EMLDPRLPTPSRNVHD 841
            + K DV+SFGVL  EV  +GK P +   + S S +  +I+    +  PRL +       
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAS------- 228
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLL 871
               + ++   C  E PE RP   ++ + L
Sbjct: 229 --THVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 132/270 (48%), Gaps = 34/270 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G V++    + + +A+K       G M+ +++F+ E + + ++ H  +V++YG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           CL    + +V+E+ +   L+  L       AA+ L     + M   + + ++Y+   C  
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 123
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
            ++HRD++++N L+       VSDFG+ +F+  D   +T   GT     + +PE+    +
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 180
Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD-EMLDPRLPTPSRNVHD 841
            + K DV+SFGVL  EV  +GK P +   + S S +  +I+    +  PRL +       
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAS------- 230
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLL 871
               + ++   C  E PE RP   ++ + L
Sbjct: 231 --THVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY     L  +             R    I  + +ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 178
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 236 DLISRLLK----------HNPSQRPMLREVLE 257

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 132/270 (48%), Gaps = 34/270 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G V++    + + +A+K       G M+ +++F+ E + + ++ H  +V++YG 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           CL    + +V+E+ +   L+  L       AA+ L     + M   + + ++Y+   C  
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 126
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
            ++HRD++++N L+       VSDFG+ +F+  D   +T   GT     + +PE+    +
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 183
Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD-EMLDPRLPTPSRNVHD 841
            + K DV+SFGVL  EV  +GK P +   + S S +  +I+    +  PRL +       
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAS------- 233
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLL 871
               + ++   C  E PE RP   ++ + L
Sbjct: 234 --THVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 131/270 (48%), Gaps = 34/270 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G V++    + + +A+K       G M+ + +F+ E + + ++ H  +V++YG 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKE---GSMS-EDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           CL    + +V+E+ +   L+  L       AA+ L     + M   + + ++Y+   C  
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 143
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
            ++HRD++++N L+       VSDFG+ +F+  D   +T   GT     + +PE+    +
Sbjct: 144 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 200
Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD-EMLDPRLPTPSRNVHD 841
            + K DV+SFGVL  EV  +GK P +   + S S +  +I+    +  PRL +       
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAS------- 250
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLL 871
               + ++   C  E PE RP   ++ + L
Sbjct: 251 --THVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 71/266 (26%), Positives = 127/266 (47%), Gaps = 24/266 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK---PGTMS-PESFLEEAQIMKKLKHDKLVQLYA- 71
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  D   + L     ++M   +   ++Y+    +   +
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 127
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ S N+L+       ++DFG+A+ ++ +     + A     + APE A   + T K 
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 789 DVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTPSRNVHDKLISI 846
           DV+SFG+L  E++ KG+ P        +  +N    L+++    R+P P     D  IS+
Sbjct: 188 DVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP----QDCPISL 235
Query: 847 VEVTISCVDENPESRPTMQKVCQLLK 872
            E+ I C  ++PE RPT + +   L+
Sbjct: 236 HELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY        +             R    I  + +ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEY---APRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 240 DLISRLLK----------HNPSQRPMLREVLE 261

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 131/272 (48%), Gaps = 23/272 (8%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            + + E  +G+G  G V  +K  + ++ A+K+  S      + ++ F+ E++ L+ + H 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES-----ESERKAFIVELRQLSRVNHP 62
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NIVK+YG CL+   + +V EY +  SL  +L              M+        ++Y+H
Sbjct: 63  NIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 722 NDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           +     ++HRD+   N+LL        + DFG A  ++   ++ T   G+  ++APE+  
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 177
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL-NLNIALDEMLDPRLPTPSRNV 839
               +EKCDV+S+G++  EVI  + P D I   +F  +  ++      L   LP P    
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP---- 233
Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                 I  +   C  ++P  RP+M+++ +++
Sbjct: 234 ------IESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 131/272 (48%), Gaps = 23/272 (8%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            + + E  +G+G  G V  +K  + ++ A+K+  S      + ++ F+ E++ L+ + H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES-----ESERKAFIVELRQLSRVNHP 61
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NIVK+YG CL+   + +V EY +  SL  +L              M+        ++Y+H
Sbjct: 62  NIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 722 NDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           +     ++HRD+   N+LL        + DFG A  ++   ++ T   G+  ++APE+  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL-NLNIALDEMLDPRLPTPSRNV 839
               +EKCDV+S+G++  EVI  + P D I   +F  +  ++      L   LP P    
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP---- 232
Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                 I  +   C  ++P  RP+M+++ +++
Sbjct: 233 ------IESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 22/268 (8%)
Query: 604 FDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           FD    +G+G  GSVY +    +G+I+A+K+   P+  ++   QE + E+  + +    +
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCDSPH 85
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           +VK YG       L+IV EY    S++ I+      K L       +++  +  L Y+H 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH- 142
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
             F   +HRDI + N+LL+ E  A ++DFG+A  L    +    + GT  ++APE+   +
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 783 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS-RNVHD 841
                 D++S G+ A+E+ +GK P   I  M              + P  P P+ R    
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI----------FMIPTNPPPTFRKPEL 250
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQ 869
              +  +    C+ ++PE R T  ++ Q
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQ 278

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIWHRNI 663
           IG+G  G+VY +  +A+G+ +A++        +M  QQ+      +NE+  + E  + NI
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V      L    L++V EY    SL  +++     +     +   + +  + AL ++H++
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 136
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 783
               ++HR+I S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+     
Sbjct: 137 ---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 193
Query: 784 VTEKCDVYSFGVLALEVIKGKHP 806
              K D++S G++A+E+I+G+ P
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           DFD    +GKG  G+VY+++   S  I+A+K        +   + +   EV+  + + H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NI+++YG+      ++++ EY     L  +             R    I  + +ALSY H
Sbjct: 73  NILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           +     ++HRDI  +N+LL    E  ++DFG +  +   SS  T L GT  Y+ PE+   
Sbjct: 130 SK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHP 806
               EK D++S GVL  E + G  P
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 131/270 (48%), Gaps = 34/270 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G V++    + + +A+K       G M+ +++F+ E + + ++ H  +V++YG 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           CL    + +V E+ +   L+  L       AA+ L     + M   + + ++Y+   C  
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 124
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
            ++HRD++++N L+       VSDFG+ +F+  D   +T   GT     + +PE+    +
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 181
Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD-EMLDPRLPTPSRNVHD 841
            + K DV+SFGVL  EV  +GK P +   + S S +  +I+    +  PRL +       
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAS------- 231
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLL 871
               + ++   C  E PE RP   ++ + L
Sbjct: 232 --THVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 23/272 (8%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           A  DF+    +GKG  G+VY+++    + I+A+K        +   + +   EV+  + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+++YG+      ++++ EY        +             R    I  + +ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEY---APRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H+     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEM 182
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                  EK D++S GVL  E + GK P     + ++      I+  E   P   T  +R
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++  +L+            NP  RP +++V +
Sbjct: 240 DLISRLLK----------HNPSQRPMLREVLE 261

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 137/278 (49%), Gaps = 34/278 (12%)
Query: 607 EHCIGKGGQGSVYMSKL-ASGE---IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWH 660
           E  IG G  G V   +L A G+    +A+K     L G  T +Q  EFL+E   + +  H
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKT----LKGGYTERQRREFLSEASIMGQFEH 76
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-NDAAAKNLGWTRRMNMIKGIVDALSY 719
            NI+++ G   +   + I+ E+ +  +L   L  ND     +   + + M++GI   + Y
Sbjct: 77  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRY 133
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YV 774
           +    +   VHRD++++N+L++      VSDFG+++FL+ +SS+ TE +   G     + 
Sbjct: 134 LAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           APE     K T   D +S+G++  EV+  G+ P         S+ ++  A+++  D RLP
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERP-----YWDMSNQDVINAIEQ--DYRLP 243
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            P     D   S+ ++ + C  ++  +RP   +V   L
Sbjct: 244 PPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 69/270 (25%), Positives = 131/270 (48%), Gaps = 34/270 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G V++    + + +A+K       G M+ +++F+ E + + ++ H  +V++YG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           CL    + +V+E+ +   L+  L       AA+ L     + M   + + ++Y+      
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE---A 122
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
            ++HRD++++N L+       VSDFG+ +F+  D   +T   GT     + +PE+    +
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 180
Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD-EMLDPRLPTPSRNVHD 841
            + K DV+SFGVL  EV  +GK P +   + S S +  +I+    +  PRL +       
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLAS------- 230
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLL 871
               + ++   C  E PE RP   ++ + L
Sbjct: 231 --THVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           DFD    +GKG  G+VY+++   S  I+A+K        +   + +   EV+  + + H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NI+++YG+      ++++ EY     L  +             R    I  + +ALSY H
Sbjct: 73  NILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           +     ++HRDI  +N+LL    E  ++DFG +  +   SS    L GT  Y+ PE+   
Sbjct: 130 SK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEG 184
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHP 806
               EK D++S GVL  E + G  P
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ + +SG+++AVKK       ++  QQ      NEV  + +  H N+V+
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK------GIVDALSY 719
           +Y   L    L++V E+ +  +L  I+++           RMN  +       ++ ALS 
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSV 262
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APEL 
Sbjct: 263 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 319
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             +    + D++S G++ +E++ G+ P
Sbjct: 320 SRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ + +SG+++AVKK       ++  QQ      NEV  + +  H N+V+
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSY 719
           +Y   L    L++V E+ +  +L  I+++           RMN      +   ++ ALS 
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSV 185
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APEL 
Sbjct: 186 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 242
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             +    + D++S G++ +E++ G+ P
Sbjct: 243 SRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 112/249 (44%), Gaps = 15/249 (6%)
Query: 276 PIPILRNLTSLERVRL----DRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRC 331
           P PI  +L +L  +        N L G I  +      L Y+ ++  N  G I     + 
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 332 PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLN-FFIKLVLAHN 390
             L TLDFS N ++G +PP I     L  +    N I G IP   G  +  F  + ++ N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 391 QLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG---NLELIHLSELDLSRNFLREAIP 447
           +L+G++ P   +L  L  +DLS N L        G   N + IHL++  L+ +       
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL------ 237
Query: 448 SQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEA 507
            ++ + ++L  L+L +N + G +P    ++  L  +++S+N L G IP     +   + A
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297
Query: 508 LQGNKGLYG 516
              NK L G
Sbjct: 298 YANNKCLCG 306

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 28/261 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K +  + H  +V++YG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FI+ EY     L   L            + + M K + +A+ Y+ +  F   +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 133
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L++ +    VSDFG+++++  D   +T   G+     +  PE+    K + 
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 787 KCDVYSFGVLALEVIK-GKHPRD-FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           K D+++FGVL  E+   GK P + F +S +   +   + L     P L +      +K+ 
Sbjct: 192 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLAS------EKVY 242
Query: 845 SIVEVTISCVDENPESRPTMQ 865
           +I+    SC  E  + RPT +
Sbjct: 243 TIM---YSCWHEKADERPTFK 260

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 28/261 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K +  + H  +V++YG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FI+ EY     L   L            + + M K + +A+ Y+ +  F   +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 126
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L++ +    VSDFG+++++  D   +T   G+     +  PE+    K + 
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 787 KCDVYSFGVLALEVIK-GKHPRD-FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           K D+++FGVL  E+   GK P + F +S +   +   + L     P L +      +K+ 
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLAS------EKVY 235
Query: 845 SIVEVTISCVDENPESRPTMQ 865
           +I+    SC  E  + RPT +
Sbjct: 236 TIM---YSCWHEKADERPTFK 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 28/261 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K +  + H  +V++YG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FI+ EY     L   L            + + M K + +A+ Y+ +  F   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 127
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L++ +    VSDFG+++++  D   +T   G+     +  PE+    K + 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 787 KCDVYSFGVLALEVIK-GKHPRD-FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           K D+++FGVL  E+   GK P + F +S +   +   + L     P L +      +K+ 
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLAS------EKVY 236
Query: 845 SIVEVTISCVDENPESRPTMQ 865
           +I+    SC  E  + RPT +
Sbjct: 237 TIM---YSCWHEKADERPTFK 254

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 28/261 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K +  + H  +V++YG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FI+ EY     L   L            + + M K + +A+ Y+ +  F   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 142
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L++ +    VSDFG+++++  D   +T   G+     +  PE+    K + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 787 KCDVYSFGVLALEVIK-GKHPRD-FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           K D+++FGVL  E+   GK P + F +S +   +   + L     P L +      +K+ 
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLAS------EKVY 251
Query: 845 SIVEVTISCVDENPESRPTMQ 865
           +I+    SC  E  + RPT +
Sbjct: 252 TIM---YSCWHEKADERPTFK 269

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 28/261 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K +  + H  +V++YG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FI+ EY     L   L            + + M K + +A+ Y+ +  F   +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 122
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L++ +    VSDFG+++++  D   +T   G+     +  PE+    K + 
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 787 KCDVYSFGVLALEVIK-GKHPRD-FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           K D+++FGVL  E+   GK P + F +S +   +   + L     P L +      +K+ 
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLAS------EKVY 231
Query: 845 SIVEVTISCVDENPESRPTMQ 865
           +I+    SC  E  + RPT +
Sbjct: 232 TIM---YSCWHEKADERPTFK 249

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ + +SG+++AVKK       ++  QQ      NEV  + +  H N+V+
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSY 719
           +Y   L    L++V E+ +  +L  I+++           RMN      +   ++ ALS 
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSV 142
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APEL 
Sbjct: 143 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 199
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             +    + D++S G++ +E++ G+ P
Sbjct: 200 SRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ + +SG+++AVKK       ++  QQ      NEV  + +  H N+V+
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSY 719
           +Y   L    L++V E+ +  +L  I+++           RMN      +   ++ ALS 
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSV 140
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APEL 
Sbjct: 141 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 197
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             +    + D++S G++ +E++ G+ P
Sbjct: 198 SRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 29/275 (10%)
Query: 607 EHCIGKGGQGSVY--MSKLASGEI---IAVKKFHSPLPGEMTFQQ-EFLNEVKALTEIWH 660
           +  IG G  G VY  M K +SG+    +A+K   +   G    Q+ +FL E   + +  H
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA---GYTEKQRVDFLGEAGIMGQFSH 105
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NI+++ G     + + I+ EY +  +L   L       ++   + + M++GI   + Y+
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMKYL 163
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGT--YGYVAPE 777
            N  +   VHRD++++N+L++      VSDFG+++ L+ D  + +T   G     + APE
Sbjct: 164 ANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                K T   DV+SFG++  EV+  G+ P         S+  +  A+++    RLPTP 
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERP-----YWELSNHEVMKAINDGF--RLPTP- 272
Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
               D   +I ++ + C  +    RP    +  +L
Sbjct: 273 ---MDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 28/261 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K +  + H  +V++YG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FI+ EY     L   L            + + M K + +A+ Y+ +  F   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 127
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L++ +    VSDFG+++++  D   +T   G+     +  PE+    K + 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 787 KCDVYSFGVLALEVIK-GKHPRD-FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           K D+++FGVL  E+   GK P + F +S +   +   + L     P L +      +K+ 
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLAS------EKVY 236
Query: 845 SIVEVTISCVDENPESRPTMQ 865
           +I+    SC  E  + RPT +
Sbjct: 237 TIM---YSCWHEKADERPTFK 254

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ + +SG+++AVKK       ++  QQ      NEV  + +  H N+V+
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSY 719
           +Y   L    L++V E+ +  +L  I+++           RMN      +   ++ ALS 
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSV 135
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APEL 
Sbjct: 136 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 192
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             +    + D++S G++ +E++ G+ P
Sbjct: 193 SRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 44/278 (15%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+  +L A   ++AVK     LP ++  + +FL E + L +  H NIV++ G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 179
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
            C   + ++IV E  +       L  + A   L     + M+      + Y+ + C    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----------YVAPE 777
           +HRD++++N L+  +N   +SDFG+++          E  G Y            + APE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR---------EEADGVYAASGGLRQVPVKWTAPE 285
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP--RLPT 834
                + + + DV+SFG+L  E    G  P   +S         N    E ++   RLP 
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---------NQQTREFVEKGGRLPC 336
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           P     D +  ++E    C    P  RP+   + Q L+
Sbjct: 337 PEL-CPDAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ + +SG+++AVKK       ++  QQ      NEV  + +  H N+V+
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSY 719
           +Y   L    L++V E+ +  +L  I+++           RMN      +   ++ ALS 
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSV 131
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H      ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APEL 
Sbjct: 132 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 188
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             +    + D++S G++ +E++ G+ P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 136/278 (48%), Gaps = 34/278 (12%)
Query: 607 EHCIGKGGQGSVYMSKL-ASGE---IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWH 660
           E  IG G  G V   +L A G+    +A+K     L G  T +Q  EFL+E   + +  H
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKT----LKGGYTERQRREFLSEASIMGQFEH 74
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-NDAAAKNLGWTRRMNMIKGIVDALSY 719
            NI+++ G   +   + I+ E+ +  +L   L  ND     +   + + M++GI   + Y
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRY 131
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YV 774
           +    +   VHRD++++N+L++      VSDFG+++FL+ +SS+ T  +   G     + 
Sbjct: 132 LAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           APE     K T   D +S+G++  EV+  G+ P         S+ ++  A+++  D RLP
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERP-----YWDMSNQDVINAIEQ--DYRLP 241
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            P     D   S+ ++ + C  ++  +RP   +V   L
Sbjct: 242 PPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG   V++++ L     +AVK   + L  + +F   F  E +    + H  IV VY 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 669 FCLHVRHL----FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                       +IV EY    +L  I+  +     +   R + +I     AL++ H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYT 781
              I+HRD+   N+++   N   V DFGIA+ +    ++ T+ A   GT  Y++PE A  
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
             V  + DVYS G +  EV+ G+ P  F      S    ++  D       P P    H+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVRED-------PIPPSARHE 244
Query: 842 KLISIVE-VTISCVDENPESR 861
            L + ++ V +  + +NPE+R
Sbjct: 245 GLSADLDAVVLKALAKNPENR 265

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 69/261 (26%), Positives = 122/261 (46%), Gaps = 28/261 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V   K      +A+K       G M+ + EF+ E K +  + H  +V++YG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C   R +FI+ EY     L   L            + + M K + +A+ Y+ +  F   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 142
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD++++N L++ +    VSDFG+++++  D    T   G+     +  PE+    K + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE--TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 787 KCDVYSFGVLALEVIK-GKHPRD-FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           K D+++FGVL  E+   GK P + F +S +   +   + L     P L +      +K+ 
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLAS------EKVY 251
Query: 845 SIVEVTISCVDENPESRPTMQ 865
           +I+    SC  E  + RPT +
Sbjct: 252 TIM---YSCWHEKADERPTFK 269

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  F   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGF---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+A+ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 385
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRNVHDKLI 844
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P         
Sbjct: 444 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPE---- 491
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
           S+ ++   C  + PE RPT + +   L+
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG   V++++ L     +AVK   + L  + +F   F  E +    + H  IV VY 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 669 FCLHVRHL----FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                       +IV EY    +L  I+  +     +   R + +I     AL++ H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYT 781
              I+HRD+   N+++   N   V DFGIA+ +    ++ T+ A   GT  Y++PE A  
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
             V  + DVYS G +  EV+ G+ P  F      S    ++  D       P P    H+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVRED-------PIPPSARHE 244
Query: 842 KLISIVE-VTISCVDENPESR 861
            L + ++ V +  + +NPE+R
Sbjct: 245 GLSADLDAVVLKALAKNPENR 265

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/319 (25%), Positives = 137/319 (42%), Gaps = 57/319 (17%)
Query: 586 LTFEGKI----------IYEEIIRATNDFDDE---------HCIGKGGQGSVYMSKL-AS 625
           L F+GK+           YEE  RA   F  E           IG G  G V   +L   
Sbjct: 14  LYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVP 73
Query: 626 GEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY 682
           G+    +A+K   +        +++FL+E   + +  H NI+++ G     R   IV EY
Sbjct: 74  GQRDVPVAIKALKAGYTERQ--RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131
Query: 683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
            +  SL   L        +   + + M++G+   + Y+ +  +   VHRD++++NVL+D 
Sbjct: 132 MENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDS 186
Query: 743 ENEAHVSDFGIAKFLKPD-SSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALE 799
                VSDFG+++ L+ D  + +T   G     + APE       +   DV+SFGV+  E
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 800 VIK-GKHP------RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTIS 852
           V+  G+ P      RD ISS+                 RLP P    H    ++ ++ + 
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEEGY-------------RLPAPMGCPH----ALHQLMLD 289
Query: 853 CVDENPESRPTMQKVCQLL 871
           C  ++   RP   ++  +L
Sbjct: 290 CWHKDRAQRPRFSQIVSVL 308

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 119/263 (45%), Gaps = 28/263 (10%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG   V++++ L     +AVK   + L  + +F   F  E +    + H  IV VY 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 669 FCLHVRHL----FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                       +IV EY    +L  I+  +     +   R + +I     AL++ H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYT 781
              I+HRD+   N+++   N   V DFGIA+ +    ++ T+ A   GT  Y++PE A  
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHP--RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
             V  + DVYS G +  EV+ G+ P   D   S+++  +  +           P P    
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVRED-----------PIPPSAR 242
Query: 840 HDKLISIVE-VTISCVDENPESR 861
           H+ L + ++ V +  + +NPE+R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENR 265

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 77
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + WT   G      + APE A   + T 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 192 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 243
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  + PE RPT + +   L+
Sbjct: 244 -------LMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 128/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 61
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ EY    SL   L   A A+ +   + 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDHIKL 119
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D      
Sbjct: 120 LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 236
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 237 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 283

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 141/302 (46%), Gaps = 35/302 (11%)
Query: 587 TFEGKIIYEEIIRATNDFDDE---------HCIGKGGQGSVYMSKL---ASGEI-IAVKK 633
           TF     YE+  +  ++F  E           +G G  G V   +L   +  EI +A+K 
Sbjct: 21  TFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 634 FHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS 693
                  +   +++FL E   + +  H NI+++ G     + + IV EY +  SL   L 
Sbjct: 81  LKVGYTEKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 694 NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI 753
              A   +   + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+
Sbjct: 139 KHDAQFTV--IQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGL 193
Query: 754 AKFLKPD-SSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 809
           ++ L+ D  + +T   G     + +PE     K T   DV+S+G++  EV+  G+ P   
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--- 250
Query: 810 ISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                 S+ ++  A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  
Sbjct: 251 --YWEMSNQDVIKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 870 LL 871
           +L
Sbjct: 303 IL 304

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG   V++++ L     +AVK   + L  + +F   F  E +    + H  IV VY 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 669 FCLHVRHL----FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                       +IV EY    +L  I+  +     +   R + +I     AL++ H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYT 781
              I+HRD+   N+++   N   V DFGIA+ +    ++ T+ A   GT  Y++PE A  
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
             V  + DVYS G +  EV+ G+ P  F      S    ++  D       P P    H+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVRED-------PIPPSARHE 244
Query: 842 KLISIVE-VTISCVDENPESR 861
            L + ++ V +  + +NPE+R
Sbjct: 245 GLSADLDAVVLKALAKNPENR 265

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTPSRNVHDKLI 844
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P         
Sbjct: 361 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPE---- 408
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
           S+ ++   C  + PE RPT + +   L+
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 26/262 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG   V++++ L     +AVK   + L  + +F   F  E +    + H  IV VY 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 669 FCLHVRHL----FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                       +IV EY    +L  I+  +     +   R + +I     AL++ H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN----WTELAGTYGYVAPELAY 780
              I+HRD+   N+L+   N   V DFGIA+ +  DS N       + GT  Y++PE A 
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIA-DSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
              V  + DVYS G +  EV+ G+ P  F      S    ++  D       P P    H
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVRED-------PIPPSARH 243
Query: 841 DKLISIVE-VTISCVDENPESR 861
           + L + ++ V +  + +NPE+R
Sbjct: 244 EGLSADLDAVVLKALAKNPENR 265

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTPSRNVHDKLI 844
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P         
Sbjct: 361 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPE---- 408
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
           S+ ++   C  + PE RPT + +   L+
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 610 IGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+  +L A   ++AVK     LP ++  + +FL E + L +  H NIV++ G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 179
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
            C   + ++IV E  +       L  + A   L     + M+      + Y+ + C    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-----TYGYVAPELAYTMK 783
           +HRD++++N L+  +N   +SDFG++   + ++      +G        + APE     +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS---REEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 784 VTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVH 840
            + + DV+SFG+L  E    G  P   +S         N    E ++   RLP P     
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLS---------NQQTREFVEKGGRLPCPEL-CP 341
Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           D +  ++E    C    P  RP+   + Q L+
Sbjct: 342 DAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 78  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 135
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 136 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 247
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 248 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+ + L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 248 -VSEEPIYIVGEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTPSRNVHDKLI 844
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P         
Sbjct: 361 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPE---- 408
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
           S+ ++   C  + PE RPT + +   L+
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 134/319 (42%), Gaps = 57/319 (17%)
Query: 586 LTFEGKI----------IYEEIIRATNDFDDE---------HCIGKGGQGSVYMSKL-AS 625
           L F+GK+           YEE  RA   F  E           IG G  G V   +L   
Sbjct: 14  LYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVP 73
Query: 626 GEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY 682
           G+    +A+K   +        +++FL+E   + +  H NI+++ G     R   IV EY
Sbjct: 74  GQRDVPVAIKALKAGYTERQ--RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131
Query: 683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
            +  SL   L        +   + + M++G+   + Y+ +  +   VHRD++++NVL+D 
Sbjct: 132 MENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDS 186
Query: 743 ENEAHVSDFGIAKFLKPDSSNWTELAG---TYGYVAPELAYTMKVTEKCDVYSFGVLALE 799
                VSDFG+++ L+ D        G      + APE       +   DV+SFGV+  E
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 800 VIK-GKHP------RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTIS 852
           V+  G+ P      RD ISS+                 RLP P    H    ++ ++ + 
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEEGY-------------RLPAPMGCPH----ALHQLMLD 289
Query: 853 CVDENPESRPTMQKVCQLL 871
           C  ++   RP   ++  +L
Sbjct: 290 CWHKDRAQRPRFSQIVSVL 308

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG   V++++ L     +AVK   + L  + +F   F  E +    + H  IV VY 
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 669 FCLHVRHL----FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                       +IV EY    +L  I+  +     +   R + +I     AL++ H + 
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 153
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYT 781
              I+HRD+   N+++   N   V DFGIA+ +    ++ T+ A   GT  Y++PE A  
Sbjct: 154 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
             V  + DVYS G +  EV+ G+ P  F      S    ++  D       P P    H+
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVRED-------PIPPSARHE 261
Query: 842 KLISIVE-VTISCVDENPESR 861
            L + ++ V +  + +NPE+R
Sbjct: 262 GLSADLDAVVLKALAKNPENR 282

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 118
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 230
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 231 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV EY +  SL   L    A   +   
Sbjct: 88  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--I 145
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 146 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 257
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 258 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +D++ +  IG G    V  +  A   E +A+K+ +  L    T   E L E++A+++  H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHH 67
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN-----LGWTRRMNMIKGIVD 715
            NIV  Y   +    L++V +     S+  I+ +  A        L  +    +++ +++
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-----SSNWTELAGT 770
            L Y+H +     +HRD+ + N+LL  +    ++DFG++ FL        +       GT
Sbjct: 128 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 771 YGYVAPELAYTMKVTE-KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++APE+   ++  + K D++SFG+ A+E+  G  P      M    L L        D
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN------D 238
Query: 830 PRLPTPSRNVHDKLI------SIVEVTISCVDENPESRPT 863
           P  P+    V DK +      S  ++   C+ ++PE RPT
Sbjct: 239 P--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V +++   SG  +AVK        ++  QQ      NEV  + +  H N+V+
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           +Y   L    L+++ E+ +  +L  I+S       L   +   + + ++ AL+Y+H    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             ++HRDI S ++LL  +    +SDFG    +  D      L GT  ++APE+       
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 786 EKCDVYSFGVLALEVIKGKHP 806
            + D++S G++ +E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIWHRNIVK 665
           IG+G  G V ++ +  +G+ +AVKK       ++  QQ      NEV  + +  H N+V 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           +Y   L    L++V E+ +  +L  I+++    +    T  +++++    ALSY+HN   
Sbjct: 107 MYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQG- 161
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             ++HRDI S ++LL  +    +SDFG    +  +      L GT  ++APE+   +   
Sbjct: 162 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 786 EKCDVYSFGVLALEVIKGKHP 806
            + D++S G++ +E+I G+ P
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPP 240

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +D++ +  IG G    V  +  A   E +A+K+ +  L    T   E L E++A+++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHH 72
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN-----LGWTRRMNMIKGIVD 715
            NIV  Y   +    L++V +     S+  I+ +  A        L  +    +++ +++
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-----PDSSNWTELAGT 770
            L Y+H +     +HRD+ + N+LL  +    ++DFG++ FL        +       GT
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 771 YGYVAPELAYTMKVTE-KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++APE+   ++  + K D++SFG+ A+E+  G  P      M    L L        D
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN------D 243
Query: 830 PRLPTPSRNVHDKLI------SIVEVTISCVDENPESRPT 863
           P  P+    V DK +      S  ++   C+ ++PE RPT
Sbjct: 244 P--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMS-PEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 249 -VSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 303
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+ + +  + + +T   G      + APE A   + T 
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTPSRNVHDKLI 844
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P         
Sbjct: 362 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPE---- 409
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
           S+ ++   C  ++PE RPT + +   L+
Sbjct: 410 SLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 72/271 (26%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + +I H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKIRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 195 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 247 -------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 21/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M    +   +AVK      PG M+ Q  FL E   +  + H  +V++Y  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA-FLEEANLMKTLQHDKLVRLYAV 76
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY    SL   L +D   K L   + ++    I + ++Y+    +   +
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---I 132
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + NVL+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 789 DVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIV 847
           DV+SFG+L  E++  GK P         ++ ++  AL +    R+P    N  D+L  I+
Sbjct: 193 DVWSFGILLYEIVTYGKIPYP-----GRTNADVMTALSQGY--RMPR-VENCPDELYDIM 244
Query: 848 EVTISCVDENPESRPTMQKVCQLL 871
           ++   C  E  E RPT   +  +L
Sbjct: 245 KM---CWKEKAEERPTFDYLQSVL 265

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+++ N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 195 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 247 -------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 13/245 (5%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKK--FHSPLPGEMTFQQEFLNEVKALTEIW 659
           +DFD    +GKG  G+VY+++    + I   K  F S L  E   + +   E++  + + 
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRREIEIQSHLR 72
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+++Y +    + ++++ E+     L   L            R    ++ + DAL Y
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHY 129
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
            H      ++HRDI  +N+L+ ++ E  ++DFG +  +   S     + GT  Y+ PE+ 
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMI 184
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
                 EK D++  GVL  E + G  P D  S        +N+  D    P L   S+++
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFLSDGSKDL 242
Query: 840 HDKLI 844
             KL+
Sbjct: 243 ISKLL 247

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 13/245 (5%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKK--FHSPLPGEMTFQQEFLNEVKALTEIW 659
           +DFD    +GKG  G+VY+++    + I   K  F S L  E   + +   E++  + + 
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRREIEIQSHLR 73
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+++Y +    + ++++ E+     L   L            R    ++ + DAL Y
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHY 130
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
            H      ++HRDI  +N+L+ ++ E  ++DFG +  +   S     + GT  Y+ PE+ 
Sbjct: 131 CHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMI 185
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
                 EK D++  GVL  E + G  P D  S        +N+  D    P L   S+++
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFLSDGSKDL 243
Query: 840 HDKLI 844
             KL+
Sbjct: 244 ISKLL 248

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 195 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 247 -------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 69
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 70  VVSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 125
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 184 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 235
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 236 -------LMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 71
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 72  VVSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 127
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 186 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 237
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 238 -------LMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 195 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 247 -------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/269 (26%), Positives = 125/269 (46%), Gaps = 30/269 (11%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       V+DFG+A+ ++ +     + A     + APE A   + T K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 789 DVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHDKL 843
           DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD  
Sbjct: 197 DVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD-- 246
Query: 844 ISIVEVTISCVDENPESRPTMQKVCQLLK 872
                +   C  ++PE RPT + +   L+
Sbjct: 247 -----LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 36/292 (12%)
Query: 598 IRATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQE 647
           +R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RD 57
Query: 648 FLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           F  E++ L  + H NIVK  G C     R+L ++ EY    SL   L      + +   +
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIK 115
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
            +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D     
Sbjct: 116 LLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 172
Query: 766 ELAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSS 817
                     + APE     K +   DV+SFGV+  E+     K K  P +F+  +    
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 818 LNLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
               I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 233 QGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 280

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 73
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 74  VVSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 129
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 188 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 239
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  + PE RPT + +   L+
Sbjct: 240 -------LMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVCEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 195 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 247 -------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 38/300 (12%)
Query: 590 GKIIYEEIIRATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLP 639
           G + +E+  R    F++ H      +GKG  GSV M +       +GE++AVKK      
Sbjct: 1   GAMAFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 58
Query: 640 GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAA 697
             +   ++F  E++ L  + H NIVK  G C     R+L ++ EY    SL   L     
Sbjct: 59  EHL---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--H 113
Query: 698 AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL 757
            + +   + +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L
Sbjct: 114 KERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVL 170
Query: 758 KPDSSNWTELAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDF 809
             D               + APE     K +   DV+SFGV+  E+     K K  P +F
Sbjct: 171 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 230
Query: 810 ISSMSFSSLNLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
           +  +        I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 231 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 286

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 130/273 (47%), Gaps = 26/273 (9%)
Query: 607 EHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           E  IG G  G V   +L      EI +A+K   +    +   +++FL+E   + +  H N
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--RRDFLSEASIMGQFDHPN 76
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           I+ + G     + + I+ EY +  SL   L  +     +   + + M++GI   + Y+ +
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSD 134
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGT--YGYVAPELA 779
             +   VHRD++++N+L++      VSDFG+++ L+ D  + +T   G     + APE  
Sbjct: 135 MSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 780 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
              K T   DV+S+G++  EV+  G+ P         S+ ++  A++E    RLP P   
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQDVIKAIEEGY--RLPPP--- 241
Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             D  I++ ++ + C  +    RP   ++  +L
Sbjct: 242 -MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 63
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + 
Sbjct: 64  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 121
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D      
Sbjct: 122 LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 178
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 179 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 238
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 239 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 285

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 36/307 (11%)
Query: 586 LTFEGKIIYEEIIRATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFH 635
           L F+G +      R    F++ H      +GKG  GSV M +       +GE++AVKK  
Sbjct: 20  LYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ 79
Query: 636 SPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILS 693
                 +   ++F  E++ L  + H NIVK  G C     R+L ++ EY    SL   L 
Sbjct: 80  HSTEEHL---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 694 NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI 753
                + +   + +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+
Sbjct: 137 K--HKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGL 191
Query: 754 AKFLKPDSSNWTELAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH- 805
            K L  D               + APE     K +   DV+SFGV+  E+     K K  
Sbjct: 192 TKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251
Query: 806 PRDFISSMSFSSLNLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESR 861
           P +F+  +        I   L E+L  + RLP P     D++  I+     C + N   R
Sbjct: 252 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQR 307
Query: 862 PTMQKVC 868
           P+ + + 
Sbjct: 308 PSFRDLA 314

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 65
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + 
Sbjct: 66  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 123
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D      
Sbjct: 124 LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 180
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 181 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 240
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 241 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 287

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 77
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 192 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 243
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  + PE RPT + +   L+
Sbjct: 244 -------LMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 61
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 119
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D      
Sbjct: 120 LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 236
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 237 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 283

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 21/261 (8%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G V+      + +++A+K     L       ++   E+  L++     + K YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L     A      +   M+K I+  L Y+H++     
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KK 141
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL  + +  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 201
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           D++S G+ A+E+ KG+ P   +  M              L P+   P+  V D   S  E
Sbjct: 202 DIWSLGITAIELAKGEPPNSDMHPMRVL----------FLIPKNNPPTL-VGDFTKSFKE 250
Query: 849 VTISCVDENPESRPTMQKVCQ 869
              +C++++P  RPT +++ +
Sbjct: 251 FIDACLNKDPSFRPTAKELLK 271

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 57
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + 
Sbjct: 58  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 115
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D      
Sbjct: 116 LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 173 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 232
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 233 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 279

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 62
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + 
Sbjct: 63  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 120
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D      
Sbjct: 121 LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 177
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 178 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 237
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 238 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 284

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 28/275 (10%)
Query: 607 EHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           E  IG G  G V    L      EI +A+K   S    +   +++FL+E   + +  H N
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPN 95
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           ++ + G       + I+ E+ +  SL   L  +     +   + + M++GI   + Y+ +
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLAD 153
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPE 777
             +   VHRD++++N+L++      VSDFG+++FL+ D+S+ T  +   G     + APE
Sbjct: 154 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                K T   DV+S+G++  EV+  G+ P      M+   +   I  D  L P +  PS
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVINAIEQDYRLPPPMDCPS 267
Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                   ++ ++ + C  ++   RP   ++   L
Sbjct: 268 --------ALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 139/304 (45%), Gaps = 35/304 (11%)
Query: 585 VLTFEGKIIYEEIIRATNDFDDE---------HCIGKGGQGSVYMSKL---ASGEI-IAV 631
           V TF     +E+  +A  +F  E           IG G  G V   +L      EI +A+
Sbjct: 3   VRTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAI 62
Query: 632 KKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVI 691
           K   +    +   +++FL+E   + +  H NI+ + G     + + I+ EY +  SL   
Sbjct: 63  KTLKAGYTDKQ--RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 120
Query: 692 LSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF 751
           L  +     +   + + M++GI   + Y+ +      VHRD++++N+L++      VSDF
Sbjct: 121 LRKNDGRFTV--IQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDF 175
Query: 752 GIAKFLKPD-SSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPR 807
           G+++ L+ D  + +T   G     + APE     K T   DV+S+G++  EV+  G+ P 
Sbjct: 176 GMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP- 234
Query: 808 DFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                   S+ ++  A++E    RLP P     D  I++ ++ + C  +    RP   ++
Sbjct: 235 ----YWDMSNQDVIKAIEEGY--RLPPP----MDCPIALHQLMLDCWQKERSDRPKFGQI 284
Query: 868 CQLL 871
             +L
Sbjct: 285 VNML 288

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV E  +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 32/295 (10%)
Query: 586 LTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTF 644
           L F+G   Y++      D   +H +G G  G VY        + +AVK     L  +   
Sbjct: 10  LYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTME 65
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
            +EFL E   + EI H N+V++ G C      +I+ E+    +L   L  +   + +   
Sbjct: 66  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAV 124
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
             + M   I  A+ Y+    F   +HRD++++N L+   +   V+DFG+++ +  D+  +
Sbjct: 125 VLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--Y 179
Query: 765 TELAGT---YGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN 819
           T  AG      + APE LAY  K + K DV++FGVL  E+   G  P        +  ++
Sbjct: 180 TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGID 230
Query: 820 LNIALDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L+  + E+L  D R+  P          + E+  +C   NP  RP+  ++ Q  +
Sbjct: 231 LS-QVYELLEKDYRMERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 114/231 (49%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+ + G     + + IV EY +  SL   L  +     +   
Sbjct: 67  RRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--I 124
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 125 QLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 181
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P         ++ ++
Sbjct: 182 YTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP-----YWEMTNQDV 236
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A++E    RLP+P     D   ++ ++ + C  +   SRP   ++  +L
Sbjct: 237 IKAVEEGY--RLPSP----MDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 59
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + 
Sbjct: 60  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 117
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HR+++++N+L++ EN   + DFG+ K L  D   +  
Sbjct: 118 LQYTSQICKGMEYLGTKRY---IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 174
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 175 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 234
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 235 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 281

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 604 FDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F  E++
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 63
Query: 654 ALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
            L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + +    
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 121
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D   +       
Sbjct: 122 QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 772 G---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSLNLNIA 823
               + APE     K +   DV+SFGV+  E+     K K  P +F+  +        I 
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 824 --LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
             L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 239 FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 280

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV E  +  SL   L    A   +   
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--I 118
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 230
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 231 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKK-FHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G GG  +VY+++     I +A+K  F  P   E T ++ F  EV   +++ H+NIV + 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                    ++V EY +  +L+  + +      L     +N    I+D + + H+     
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---MR 131
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT-ELAGTYGYVAPELAYTMKVTE 786
           IVHRDI  +N+L+D      + DFGIAK L   S   T  + GT  Y +PE A      E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 787 KCDVYSFGVLALEVIKGKHP 806
             D+YS G++  E++ G+ P
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP 211

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 25/263 (9%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G V+      + +++A+K     L       ++   E+  L++     + K YG
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L        L  T+   +++ I+  L Y+H++     
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---KK 145
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL    E  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 205
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR--LPTPSRNVHDKLISI 846
           D++S G+ A+E+ +G+ P   +  M              L P+   PT   N    L   
Sbjct: 206 DIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYSKPLKEF 255
Query: 847 VEVTISCVDENPESRPTMQKVCQ 869
           VE   +C+++ P  RPT +++ +
Sbjct: 256 VE---ACLNKEPSFRPTAKELLK 275

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 604 FDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F  E++
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 81
Query: 654 ALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
            L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + +    
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTS 139
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D           
Sbjct: 140 QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 772 G---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSLNLNIA 823
               + APE     K +   DV+SFGV+  E+     K K  P +F+  +        I 
Sbjct: 197 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 256
Query: 824 --LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
             L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 257 FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 298

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 604 FDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F  E++
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 81
Query: 654 ALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
            L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + +    
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 139
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D           
Sbjct: 140 QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 772 G---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSLNLNIA 823
               + APE     K +   DV+SFGV+  E+     K K  P +F+  +        I 
Sbjct: 197 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 256
Query: 824 --LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
             L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 257 FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 298

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 70/271 (25%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY     L   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVMEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 195 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 247 -------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 71/274 (25%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 607 EHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           E  IG G  G V   +L      EI +A+K   +    +   +++FL+E   + +  H N
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--RRDFLSEASIMGQFDHPN 70
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           I+ + G     + + I+ EY +  SL A +  ND         + + M++GI   + Y+ 
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRGIGSGMKYLS 127
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGTYG--YVAPEL 778
           +  +   VHRD++++N+L++      VSDFG+++ L+ D  + +T   G     + APE 
Sbjct: 128 DMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 779 AYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
               K T   DV+S+G++  EV+  G+ P         S+ ++  A++E    RLP P  
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQDVIKAIEEGY--RLPPPM- 236
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
              D  I++ ++ + C  +    RP   ++  +L
Sbjct: 237 ---DCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 604 FDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F  E++
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 63
Query: 654 ALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
            L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + +    
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 121
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D           
Sbjct: 122 QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 772 G---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSLNLNIA 823
               + APE     K +   DV+SFGV+  E+     K K  P +F+  +        I 
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 824 --LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
             L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 239 FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 280

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 27/267 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M    +   +AVK      PG M+ Q  FL E   +  + H  +V++Y  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA-FLEEANLMKTLQHDKLVRLYAV 75
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ E+    SL   L +D   K L   + ++    I + ++Y+    +   +
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---I 131
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + NVL+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 789 DVYSFGVLALEVIK-GKHP---RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
           +V+SFG+L  E++  GK P   R     MS  S    +       PR+     N  D+L 
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM-------PRM----ENCPDELY 240
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLL 871
            I+++   C  E  E RPT   +  +L
Sbjct: 241 DIMKM---CWKEKAEERPTFDYLQSVL 264

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 70/271 (25%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 80
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    ++IV EY     L   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 81  VVSEEPIYIVTEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 786
           HRD+ + N+L+       V+DFG+A+ +  + + +T   G      + APE A   + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 787 KCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHD 841
           K DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD
Sbjct: 195 KSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  +   C  ++PE RPT + +   L+
Sbjct: 247 -------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 604 FDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F  E++
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 61
Query: 654 ALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
            L  + H NIVK  G C     R+L ++ EY    SL   L      + +   + +    
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 119
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D           
Sbjct: 120 QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 772 G---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSLNLNIA 823
               + APE     K +   DV+SFGV+  E+     K K  P +F+  +        I 
Sbjct: 177 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 236
Query: 824 --LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
             L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 237 FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 278

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 599 RATNDFDDEHC-----IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEF 648
           R    F++ H      +GKG  GSV M +       +GE++AVKK        +   ++F
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 61
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
             E++ L  + H NIVK  G C     R+L ++ E+    SL   L      + +   + 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKERIDHIKL 119
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +     I   + Y+    +   +HRD++++N+L++ EN   + DFG+ K L  D      
Sbjct: 120 LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 767 LAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKH-PRDFISSMSFSSL 818
                    + APE     K +   DV+SFGV+  E+     K K  P +F+  +     
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 236
Query: 819 NLNIA--LDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
              I   L E+L  + RLP P     D++  I+     C + N   RP+ +
Sbjct: 237 GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFR 283

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 610 IGKGGQGSVYM-SKLASG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +G G  G V++  + +SG    I  + K  S +P E     +   E++ L  + H NI+K
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-----QIEAEIEVLKSLDHPNIIK 84
Query: 666 VYGFCLHVRHLFIVYEYFKMCS----LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           ++       +++IV E    C     L  I+S  A  K L       ++K +++AL+Y H
Sbjct: 85  IFEVFEDYHNMYIVME---TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +     +VH+D+  +N+L   +   H    + DFG+A+  K D  + T  AGT  Y+APE
Sbjct: 142 SQ---HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPE 196
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
           + +   VT KCD++S GV+   ++ G  P    +  S   +       E   P      R
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTGCLP---FTGTSLEEVQQKATYKE---PNYAVECR 249
Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKV 867
            +  + + +++  ++   ++PE RP+  +V
Sbjct: 250 PLTPQAVDLLKQMLT---KDPERRPSAAQV 276

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 30/269 (11%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++Y  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYA- 70
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +    + IV EY    SL   L  +   K L   + ++M   I   ++Y+    +   V
Sbjct: 71  VVSEEPIXIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 126
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       V+DFG+A+ ++ +     + A     + APE A   + T K 
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 789 DVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEM-LDPRLPTP---SRNVHDKL 843
           DV+SFG+L  E+  KG+ P        +  +     LD++    R+P P     ++HD  
Sbjct: 187 DVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPCPPECPESLHD-- 236
Query: 844 ISIVEVTISCVDENPESRPTMQKVCQLLK 872
                +   C  + PE RPT + +   L+
Sbjct: 237 -----LMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 25/263 (9%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G V+      + +++A+K     L       ++   E+  L++     + K YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L        L  T+   +++ I+  L Y+H++     
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---KK 140
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL    E  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 200
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR--LPTPSRNVHDKLISI 846
           D++S G+ A+E+ +G+ P   +  M              L P+   PT   N    L   
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYSKPLKEF 250
Query: 847 VEVTISCVDENPESRPTMQKVCQ 869
           VE   +C+++ P  RPT +++ +
Sbjct: 251 VE---ACLNKEPSFRPTAKELLK 270

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IGKG  G V +     G  +AVK   +         Q FL E   +T++ H N+V++ G 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 670 CLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
            +  +  L+IV EY    SL   L +   +  LG    +     + +A+ Y+  + F   
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF--- 123
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTMKVTE 786
           VHRD++++NVL+  +N A VSDFG+ K      ++ T+  G     + APE     K + 
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 787 KCDVYSFGVLALEV 800
           K DV+SFG+L  E+
Sbjct: 179 KSDVWSFGILLWEI 192

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 25/263 (9%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G V+      + +++A+K     L       ++   E+  L++     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L        L  T+   +++ I+  L Y+H++     
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---KK 125
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL    E  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 185
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR--LPTPSRNVHDKLISI 846
           D++S G+ A+E+ +G+ P   +  M              L P+   PT   N    L   
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYSKPLKEF 235
Query: 847 VEVTISCVDENPESRPTMQKVCQ 869
           VE   +C+++ P  RPT +++ +
Sbjct: 236 VE---ACLNKEPSFRPTAKELLK 255

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IGKG  G V +     G  +AVK   +         Q FL E   +T++ H N+V++ G 
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 670 CLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
            +  +  L+IV EY    SL   L +   +  LG    +     + +A+ Y+  + F   
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF--- 138
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTMKVTE 786
           VHRD++++NVL+  +N A VSDFG+ K      ++ T+  G     + APE     K + 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 787 KCDVYSFGVLALEV 800
           K DV+SFG+L  E+
Sbjct: 194 KSDVWSFGILLWEI 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 25/263 (9%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G V+      + +++A+K     L       ++   E+  L++     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L        L  T+   +++ I+  L Y+H++     
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---KK 125
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL    E  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 185
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR--LPTPSRNVHDKLISI 846
           D++S G+ A+E+ +G+ P   +  M              L P+   PT   N    L   
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYSKPLKEF 235
Query: 847 VEVTISCVDENPESRPTMQKVCQ 869
           VE   +C+++ P  RPT +++ +
Sbjct: 236 VE---ACLNKEPSFRPTAKELLK 255

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 13/245 (5%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKK--FHSPLPGEMTFQQEFLNEVKALTEIW 659
           +DF+    +GKG  G+VY+++      I   K  F S +  E   + +   E++    + 
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKE-GVEHQLRREIEIQAHLH 81
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+++Y +    R ++++ EY     L   L            R   +++ + DAL Y
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC---TFDEQRTATIMEELADALMY 138
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
            H      ++HRDI  +N+LL  + E  ++DFG +  +   S     + GT  Y+ PE+ 
Sbjct: 139 CHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMI 193
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
                 EK D++  GVL  E++ G  P  F S+    +    + +D      +PT ++++
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPP--FESASHNETYRRIVKVDLKFPASVPTGAQDL 251
Query: 840 HDKLI 844
             KL+
Sbjct: 252 ISKLL 256

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 114/231 (49%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H NI+++ G     + + IV E  +  SL   L    A   +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--I 147
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +      VHRD++++N+L++      VSDFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDV 259
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A+DE    RLP P     D   ++ ++ + C  ++  +RP  +++  +L
Sbjct: 260 IKAVDEGY--RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 603 DFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTF--QQEFLNEVKALTEIW 659
           D++  + IG G  G    + + + G+I+  K+      G MT   +Q  ++EV  L E+ 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLRELK 63
Query: 660 HRNIVKVYGFCLHVRH--LFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKGIVDA 716
           H NIV+ Y   +   +  L+IV EY +   LA +++     +  L     + ++  +  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 717 LSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           L   H  +D    ++HRD+   NV LD +    + DFG+A+ L  D     E  GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 775 APELAYTMKVTEKCDVYSFGVLALEV 800
           +PE    M   EK D++S G L  E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 232
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 233 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 232
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 233 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 74  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 187
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 237
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 238 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 232
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 233 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 232
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 233 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 603 DFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTF--QQEFLNEVKALTEIW 659
           D++  + IG G  G    + + + G+I+  K+      G MT   +Q  ++EV  L E+ 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLRELK 63
Query: 660 HRNIVKVYGFCLHVRH--LFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKGIVDA 716
           H NIV+ Y   +   +  L+IV EY +   LA +++     +  L     + ++  +  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 717 LSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           L   H  +D    ++HRD+   NV LD +    + DFG+A+ L  D+S      GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 775 APELAYTMKVTEKCDVYSFGVLALEV 800
           +PE    M   EK D++S G L  E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNE 651
           Y++      D   +H +G G  G VY        + +AVK        E T + +EFL E
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 266
Query: 652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              + EI H N+V++ G C      +I+ E+    +L   L  +   + +     + M  
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 325
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I  A+ Y+    F   +HR+++++N L+   +   V+DFG+++ +  D+  +T  AG  
Sbjct: 326 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 380
Query: 772 ---GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
               + APE LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E
Sbjct: 381 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYE 430
Query: 827 ML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +L  D R+  P     +K   + E+  +C   NP  RP+  ++ Q  +
Sbjct: 431 LLEKDYRMERP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 187
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 237
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 238 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 232
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 233 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 72
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 132 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 186
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 187 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 236
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 237 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 128 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 183 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 232
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 233 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 70
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 130 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 184
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 185 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 234
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 235 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 70
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 130 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 184
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 185 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 234
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 235 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 69
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 70  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 129 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPE 183
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 184 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 233
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 234 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 70
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE
Sbjct: 130 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPE 184
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 185 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 234
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 235 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 603 DFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTF--QQEFLNEVKALTEIW 659
           D++  + IG G  G    + + + G+I+  K+      G MT   +Q  ++EV  L E+ 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLRELK 63
Query: 660 HRNIVKVYGFCLHVRH--LFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKGIVDA 716
           H NIV+ Y   +   +  L+IV EY +   LA +++     +  L     + ++  +  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 717 LSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           L   H  +D    ++HRD+   NV LD +    + DFG+A+ L  D+S      GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 775 APELAYTMKVTEKCDVYSFGVLALEV 800
           +PE    M   EK D++S G L  E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 67/267 (25%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           E  +G G  G V+M+       +AVK      PG M+ +  FL E   +  + H  +VK+
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA-FLAEANVMKTLQHDKLVKL 75
Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           +        ++I+ E+    SL   L +D  +K     + ++    I + ++++    + 
Sbjct: 76  HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY- 132
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVT 785
             +HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T
Sbjct: 133 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 786 EKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
            K DV+SFG+L +E++  G+ P   +S+          AL+     R+P P  N  ++L 
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-----ALERGY--RMPRP-ENCPEELY 242
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLL 871
           +I+   + C    PE RPT + +  +L
Sbjct: 243 NIM---MRCWKNRPEERPTFEYIQSVL 266

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNE 651
           Y++      D   +H +G G  G VY        + +AVK        E T + +EFL E
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 305
Query: 652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              + EI H N+V++ G C      +I+ E+    +L   L  +   + +     + M  
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMAT 364
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I  A+ Y+    F   +HR+++++N L+   +   V+DFG+++ +  D+  +T  AG  
Sbjct: 365 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 419
Query: 772 ---GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
               + APE LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E
Sbjct: 420 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYE 469
Query: 827 ML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +L  D R+  P     +K   + E+  +C   NP  RP+  ++ Q  +
Sbjct: 470 LLEKDYRMERPE-GCPEK---VYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 607 EHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           E  IG G  G V    L      EI +A+K   S    +   +++FL+E   + +  H N
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPN 69
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           ++ + G       + I+ E+ +  SL   L  +     +   + + M++GI   + Y+ +
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLAD 127
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPE 777
             +   VHR ++++N+L++      VSDFG+++FL+ D+S+ T  +   G     + APE
Sbjct: 128 MNY---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                K T   DV+S+G++  EV+  G+ P      M+   +   I  D  L P +  PS
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVINAIEQDYRLPPPMDCPS 241
Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                   ++ ++ + C  ++   RP   ++   L
Sbjct: 242 --------ALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 123/272 (45%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 88
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L   A+       + +++ +     + Y+H      I+
Sbjct: 89  STKPQ-LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAPELAYTMK 783
           HRD+ S N+ L  +N   + DFG+A     + S W+      +L+G+  ++APE+     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 784 ---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM-----LDPRLPTP 835
               + + DVY+FG++  E++ G+ P        +S++N    + EM     L P L   
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
             N   ++  ++     C+ +  + RP+  ++
Sbjct: 251 RSNCPKRMKRLM---AECLKKKRDERPSFPRI 279

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 610 IGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++           ++AVK    P    +  +++F  E + LT + H +I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHI 79
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSL----------AVILSND---AAAKNLGWTRRMNMI 710
           VK YG C     L +V+EY K   L          A+IL +     A   LG ++ +++ 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG- 769
             I   + Y+ +  F   VHRD++++N L+       + DFG+++ +   S+++  + G 
Sbjct: 140 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 194
Query: 770 ---TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++ PE     K T + DV+SFGV+  E+   GK P      +S + +   I   
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNTEVIECITQG 251
Query: 826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            +L+     P          + +V + C    P+ R  ++++ ++L
Sbjct: 252 RVLERPRVCPK--------EVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           E  +G G  G V+M+       +AVK      PG M+ +  FL E   +  + H  +VK+
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA-FLAEANVMKTLQHDKLVKL 248
Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           +        ++I+ E+    SL   L +D  +K     + ++    I + ++++    + 
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY- 305
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVT 785
             +HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 786 EKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLI 844
            K DV+SFG+L +E++  G+ P         S+  +  AL+     R+P P  N  ++L 
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYP-----GMSNPEVIRALERGY--RMPRPE-NCPEELY 415
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLL 871
           +I+   + C    PE RPT + +  +L
Sbjct: 416 NIM---MRCWKNRPEERPTFEYIQSVL 439

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 30/268 (11%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 76
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L   A+       + +++ +     + Y+H      I+
Sbjct: 77  STKPQ-LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMK---V 784
           HRD+ S N+ L  +N   + DFG+A  K     S  + +L+G+  ++APE+         
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 785 TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM-----LDPRLPTPSRNV 839
           + + DVY+FG++  E++ G+ P        +S++N    + EM     L P L     N 
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIEMVGRGSLSPDLSKVRSNC 242
Query: 840 HDKLISIVEVTISCVDENPESRPTMQKV 867
             ++  ++     C+ +  + RP+  ++
Sbjct: 243 PKRMKRLM---AECLKKKRDERPSFPRI 267

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 24/264 (9%)
Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   IG G  G+VY ++ + + E++A+KK            Q+ + EV+ L ++ H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
            ++  G  L     ++V EY  + S + +L  +   K L       +  G +  L+Y+H+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                ++HRD+ + N+LL       + DFG A  + P +       GT  ++APE+   M
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 225
Query: 783 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
              +   K DV+S G+  +E+ + K P   + +M+  S   +IA +E   P L   S + 
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPAL--QSGHW 278
Query: 840 HDKLISIVEVTISCVDENPESRPT 863
            +   + V+   SC+ + P+ RPT
Sbjct: 279 SEYFRNFVD---SCLQKIPQDRPT 299

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ++ +  +  +GKG  G V + K   +G+  AVK        + T ++  L EV+ L ++ 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+K+Y F     + ++V E +    L        + K         +I+ ++  ++Y
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 164
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           MH +    IVHRD+  +N+LL+ +++     + DFG++   +  S    +  GT  Y+AP
Sbjct: 165 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAP 220
Query: 777 ELAYTMKVTEKCDVYSFGVL 796
           E+ +     EKCDV+S GV+
Sbjct: 221 EVLHGT-YDEKCDVWSTGVI 239

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ++ +  +  +GKG  G V + K   +G+  AVK        + T ++  L EV+ L ++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+K+Y F     + ++V E +    L        + K         +I+ ++  ++Y
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           MH +    IVHRD+  +N+LL+ +++     + DFG++   +  S    +  GT  Y+AP
Sbjct: 142 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAP 197
Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           E+ +     EKCDV+S GV+   ++ G  P
Sbjct: 198 EVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IGKG  G V +     G  +AVK   +         Q FL E   +T++ H N+V++ G 
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 670 CLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
            +  +  L+IV EY    SL   L +   +  LG    +     + +A+ Y+  + F   
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNF--- 310
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTE 786
           VHRD++++NVL+  +N A VSDFG+ K      ++ T+  G     + APE     K + 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 787 KCDVYSFGVLALEV 800
           K DV+SFG+L  E+
Sbjct: 366 KSDVWSFGILLWEI 379

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ++ +  +  +GKG  G V + K   +G+  AVK        + T ++  L EV+ L ++ 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+K+Y F     + ++V E +    L        + K         +I+ ++  ++Y
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 165
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           MH +    IVHRD+  +N+LL+ +++     + DFG++   +  S    +  GT  Y+AP
Sbjct: 166 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAP 221
Query: 777 ELAYTMKVTEKCDVYSFGVL 796
           E+ +     EKCDV+S GV+
Sbjct: 222 EVLHGT-YDEKCDVWSTGVI 240

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 88
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 L IV ++ +  SL   L   A+       + +++ +     + Y+H      I+
Sbjct: 89  ST-APQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAPELAYTMK 783
           HRD+ S N+ L  +N   + DFG+A     + S W+      +L+G+  ++APE+     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 784 ---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM-----LDPRLPTP 835
               + + DVY+FG++  E++ G+ P        +S++N    + EM     L P L   
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
             N   ++  ++     C+ +  + RP+  ++
Sbjct: 251 RSNCPKRMKRLM---AECLKKKRDERPSFPRI 279

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 34/288 (11%)
Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNE 651
           Y++      D   +H +G G  G VY        + +AVK        E T + +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 64
Query: 652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              + EI H N+V++ G C      +I+ E+    +L   L  +   + +     + M  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 123
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
            I  A+ Y+    F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 771 --YGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
               + APE LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYE 228
Query: 827 ML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +L  D R+  P          + E+  +C   NP  RP+  ++ Q  +
Sbjct: 229 LLEKDYRMERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 136/268 (50%), Gaps = 27/268 (10%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G VY +K   +G + A K   +    E+   ++++ E++ L    H  IVK+ G
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 75
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
              H   L+I+ E+    ++ A++L  D   + L   +   + + +++AL+++H+     
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---R 129
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGI-AKFLKPDSSNWTELAGTYGYVAPE--LAYTMKV 784
           I+HRD+ + NVL+  E +  ++DFG+ AK LK          GT  ++APE  +  TMK 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKD 188
Query: 785 TE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
           T    K D++S G+  +E+ + + P   ++ M    + L IA  +   P L TPS+    
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSD--PPTLLTPSKWS-- 241
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQ 869
             +   +     +D+NPE+RP+  ++ +
Sbjct: 242 --VEFRDFLKIALDKNPETRPSAAQLLE 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 128/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 69
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 70  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+   T  AG      + APE
Sbjct: 129 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 183
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 184 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 233
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 234 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 265

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IGKG  G V +     G  +AVK   +         Q FL E   +T++ H N+V++ G 
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQLLGV 73
Query: 670 CLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
            +  +  L+IV EY    SL   L +   +  LG    +     + +A+ Y+  + F   
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF--- 129
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTMKVTE 786
           VHRD++++NVL+  +N A VSDFG+ K      ++ T+  G     + APE       + 
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 787 KCDVYSFGVLALEV 800
           K DV+SFG+L  E+
Sbjct: 185 KSDVWSFGILLWEI 198

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 136/268 (50%), Gaps = 27/268 (10%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G VY +K   +G + A K   +    E+   ++++ E++ L    H  IVK+ G
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 83
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
              H   L+I+ E+    ++ A++L  D   + L   +   + + +++AL+++H+     
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---R 137
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGI-AKFLKPDSSNWTELAGTYGYVAPE--LAYTMKV 784
           I+HRD+ + NVL+  E +  ++DFG+ AK LK          GT  ++APE  +  TMK 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKD 196
Query: 785 TE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
           T    K D++S G+  +E+ + + P   ++ M    + L IA  +   P L TPS+    
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSD--PPTLLTPSKWS-- 249
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQ 869
             +   +     +D+NPE+RP+  ++ +
Sbjct: 250 --VEFRDFLKIALDKNPETRPSAAQLLE 275

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 76/276 (27%), Positives = 128/276 (46%), Gaps = 34/276 (12%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 73
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+   T  AG      + APE
Sbjct: 133 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 187
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML--DPRLP 833
            LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E+L  D R+ 
Sbjct: 188 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYELLEKDYRME 237
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            P     +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 238 RP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 34/288 (11%)
Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNE 651
           Y++      D   +H +G G  G VY        + +AVK        E T + +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 64
Query: 652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              + EI H N+V++ G C      +I+ E+    +L   L  +   + +     + M  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMAT 123
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
            I  A+ Y+    F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 771 --YGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
               + APE LAY  K + K DV++FGVL  E+   G  P        +  ++L+  + E
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLS-QVYE 228
Query: 827 ML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +L  D R+  P          + E+  +C   NP  RP+  ++ Q  +
Sbjct: 229 LLEKDYRMERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ++ +  +  +GKG  G V + K   +G+  AVK        + T ++  L EV+ L ++ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+K+Y F     + ++V E +    L        + K         +I+ ++  ++Y
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 147
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           MH +    IVHRD+  +N+LL+ +++     + DFG++   +  S    +  GT  Y+AP
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAP 203
Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           E+ +     EKCDV+S GV+   ++ G  P
Sbjct: 204 EVLHGT-YDEKCDVWSTGVILYILLSGCPP 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 30/274 (10%)
Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWH 660
           D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI H
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 66
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE 777
               F   +HRD++++N L+   +   V+DFG+++ +  D+   T  AG      + APE
Sbjct: 126 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 180
Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
            LAY  K + K DV++FGVL  E+   G  P   I       L     L++  D R+  P
Sbjct: 181 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK--DYRMERP 232
Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                +K   + E+  +C   NP  RP+  ++ Q
Sbjct: 233 -EGCPEK---VYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 24/264 (9%)
Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   IG G  G+VY ++ + + E++A+KK            Q+ + EV+ L ++ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
            ++  G  L     ++V EY  + S + +L  +   K L       +  G +  L+Y+H+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                ++HRD+ + N+LL       + DFG A  + P +       GT  ++APE+   M
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 186
Query: 783 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
              +   K DV+S G+  +E+ + K P   + +M+  S   +IA +E   P L   S + 
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPAL--QSGHW 239
Query: 840 HDKLISIVEVTISCVDENPESRPT 863
            +   + V+   SC+ + P+ RPT
Sbjct: 240 SEYFRNFVD---SCLQKIPQDRPT 260

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 116/262 (44%), Gaps = 23/262 (8%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG  G VY      + E++A+K     L       ++   E+  L++     I + +G
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L    L+I+ EY    S   +L        L  T    +++ I+  L Y+H++     
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSER---K 137
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRDI + NVLL  + +  ++DFG+A  L           GT  ++APE+        K 
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS-RNVHDKLISIV 847
           D++S G+ A+E+ KG+ P   +  M              L P+   P+    H K     
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRVL----------FLIPKNSPPTLEGQHSK--PFK 245
Query: 848 EVTISCVDENPESRPTMQKVCQ 869
           E   +C++++P  RPT +++ +
Sbjct: 246 EFVEACLNKDPRFRPTAKELLK 267

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 46/296 (15%)
Query: 609 CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           C+GKG  G V+      GE +AVK F S        + E  N V     + H NI+    
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM----LRHENILGFIA 98
Query: 669 FCLHVRH----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
             +  RH    L+++  Y +M SL   L        L     + ++  I   L+++H + 
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 725 F-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-----GTYGYV 774
           F     P I HRD+ SKN+L+    +  ++D G+A  +   S+N  ++      GT  Y+
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 775 APE-LAYTMKVT-----EKCDVYSFGVLALEVIKGKHPRDFISSM------------SFS 816
           APE L  T++V      ++ D+++FG++  EV +       +               SF 
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 273
Query: 817 SLNLNIALDEMLDPRLPTPSRNVHD-KLISIVEVTISCVDENPESRPTMQKVCQLL 871
            +   + +D+    R   P+R   D  L S+ ++   C  +NP +R T  ++ + L
Sbjct: 274 DMRKVVCVDQQ---RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 326

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 30/266 (11%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           E  +G G  G V+M+       +AVK      PG M+ +  FL E   +  + H  +VK+
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA-FLAEANVMKTLQHDKLVKL 242
Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           +        ++I+ E+    SL   L +D  +K     + ++    I + ++++    + 
Sbjct: 243 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY- 299
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
             +HRD+ + N+L+       ++DFG+A+        WT         APE       T 
Sbjct: 300 --IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT---------APEAINFGSFTI 348
Query: 787 KCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
           K DV+SFG+L +E++  G+ P         S+  +  AL+     R+P P  N  ++L +
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPYP-----GMSNPEVIRALERGY--RMPRPE-NCPEELYN 400
Query: 846 IVEVTISCVDENPESRPTMQKVCQLL 871
           I+   + C    PE RPT + +  +L
Sbjct: 401 IM---MRCWKNRPEERPTFEYIQSVL 423

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 129/290 (44%), Gaps = 45/290 (15%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVK 665
           E  +G G  G+V       G  +AVK+        + F    L E+K LTE   H N+++
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALMEIKLLTESDDHPNVIR 91
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN---MIKGIVDALSYMHN 722
            Y      R L+I  E   +    ++ S + + +NL   +  N   +++ I   ++++H+
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 723 DCFPPIVHRDISSKNVLL--------DFENEAH-----VSDFGIAKFLKPDS----SNWT 765
                I+HRD+  +N+L+        D +  A      +SDFG+ K L         N  
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 766 ELAGTYGYVAPEL---AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLN 821
             +GT G+ APEL   +   ++T   D++S G +   ++ KGKHP     S   + +   
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 822 IALDEMLDPRLPTPSRNVHDK--LISIVEVTISCVDENPESRPTMQKVCQ 869
            +LDEM         + +HD+  +    ++    +D +P  RPT  KV +
Sbjct: 269 FSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 129/294 (43%), Gaps = 49/294 (16%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVK 665
           E  +G G  G+V       G  +AVK+        + F    L E+K LTE   H N+++
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALMEIKLLTESDDHPNVIR 73
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN---MIKGIVDALSYMHN 722
            Y      R L+I  E   +    ++ S + + +NL   +  N   +++ I   ++++H+
Sbjct: 74  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 723 DCFPPIVHRDISSKNVLL--------DFENEAH-----VSDFGIAKFLKPDSS----NWT 765
                I+HRD+  +N+L+        D +  A      +SDFG+ K L    S    N  
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 766 ELAGTYGYVAPE-------LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSS 817
             +GT G+ APE       L    ++T   D++S G +   ++ KGKHP     S   + 
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDK--LISIVEVTISCVDENPESRPTMQKVCQ 869
           +    +LDEM         + +HD+  +    ++    +D +P  RPT  KV +
Sbjct: 251 IRGIFSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 610 IGKGGQGSVYMSKLASG------EIIAVKKFHSPLPGE-----MTFQQEFLNEVKALTEI 658
           +G G  G V + K  +G      ++I   +F      +       F +E  NE+  L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NI+K++      ++ ++V E+++   L   + N             N++K I+  + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGIC 160
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           Y+H      IVHRDI  +N+LL+ +N      + DFG++ F   D      L   Y Y+A
Sbjct: 161 YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY-YIA 216
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           PE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 217 PEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 42/235 (17%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
           +R  +DF++   +G+G  G V  ++ A      A+KK         T     L+EV  L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLA 57
Query: 657 EIWHRNIVKVYGFCLHVRH-------------LFIVYEYFKMCSLAVILSNDAAAKNLGW 703
            + H+ +V+ Y   L  R+             LFI  EY +  +L  ++ ++    NL  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQ 113
Query: 704 TRR--MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------ 755
            R     + + I++ALSY+H+     I+HRD+   N+ +D      + DFG+AK      
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 756 -FLKPDSS-------NWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI 801
             LK DS        N T   GT  YVA E L  T    EK D+YS G++  E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 42/235 (17%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
           +R  +DF++   +G+G  G V  ++ A      A+KK         T     L+EV  L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLA 57
Query: 657 EIWHRNIVKVYGFCLHVRH-------------LFIVYEYFKMCSLAVILSNDAAAKNLGW 703
            + H+ +V+ Y   L  R+             LFI  EY +  +L  ++ ++    NL  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE----NLNQ 113
Query: 704 TRR--MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------ 755
            R     + + I++ALSY+H+     I+HRD+   N+ +D      + DFG+AK      
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 756 -FLKPDSS-------NWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI 801
             LK DS        N T   GT  YVA E L  T    EK D+YS G++  E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 129/290 (44%), Gaps = 45/290 (15%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVK 665
           E  +G G  G+V       G  +AVK+        + F    L E+K LTE   H N+++
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALMEIKLLTESDDHPNVIR 91
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN---MIKGIVDALSYMHN 722
            Y      R L+I  E   +    ++ S + + +NL   +  N   +++ I   ++++H+
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 723 DCFPPIVHRDISSKNVLL--------DFENEAH-----VSDFGIAKFLKPDS----SNWT 765
                I+HRD+  +N+L+        D +  A      +SDFG+ K L         N  
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 766 ELAGTYGYVAPEL---AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLN 821
             +GT G+ APEL   +   ++T   D++S G +   ++ KGKHP     S   + +   
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 822 IALDEMLDPRLPTPSRNVHDK--LISIVEVTISCVDENPESRPTMQKVCQ 869
            +LDEM         + +HD+  +    ++    +D +P  RPT  KV +
Sbjct: 269 FSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 85  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 139
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 200 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 252
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 253 L---CWKERPEDRPTFDYLRSVLE 273

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 192 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 244
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 245 L---CWKERPEDRPTFDYLRSVLE 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 192 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 244
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 245 L---CWKERPEDRPTFDYLRSVLE 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 137
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 198 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 250
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 251 L---CWKERPEDRPTFDYLRSVLE 271

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 78  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 132
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 193 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 245
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 246 L---CWKERPEDRPTFDYLRSVLE 266

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 79  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 133
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 194 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 246
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 247 L---CWKERPEDRPTFDYLRSVLE 267

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 86  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 140
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 201 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 253
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 254 L---CWKERPEDRPTFDYLRSVLE 274

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIW 659
            D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI 
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIK 65
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEY 124
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAP 776
           +    F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + AP
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAP 179
Query: 777 E-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           E LAY  K + K DV++FGVL  E+   G  P   I       L     L++  D R+  
Sbjct: 180 ESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK--DYRMER 231
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           P          + E+  +C   NP  RP+  ++ Q  +
Sbjct: 232 PEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 118/264 (44%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++       E A     + APE       T K 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 192 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 244
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 245 L---CWKERPEDRPTFDYLRSVLE 265

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 610 IGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++           ++AVK          + +Q+F  E + LT + H++I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 105
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVIL------------SNDAAAKNLGWTRRMNMIK 711
           V+ +G C   R L +V+EY +   L   L              D A   LG  + + +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
            +   + Y+    F   VHRD++++N L+       + DFG+++ +   S+++  + G  
Sbjct: 166 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 220
Query: 771 ---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
                ++ PE     K T + DV+SFGV+  E+   GK P   +S+    +++      E
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQGRE 278
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           +  PR   P          +  +   C    P+ R +++ V
Sbjct: 279 LERPRACPP---------EVYAIMRGCWQREPQQRHSIKDV 310

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 46/296 (15%)
Query: 609 CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           C+GKG  G V+      GE +AVK F S        + E  N V     + H NI+    
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM----LRHENILGFIA 69
Query: 669 FCLHVRH----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
             +  RH    L+++  Y +M SL   L        L     + ++  I   L+++H + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 725 F-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-----GTYGYV 774
           F     P I HRD+ SKN+L+    +  ++D G+A  +   S+N  ++      GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 775 APE-LAYTMKVT-----EKCDVYSFGVLALEVIKGKHPRDFISSM------------SFS 816
           APE L  T++V      ++ D+++FG++  EV +       +               SF 
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 817 SLNLNIALDEMLDPRLPTPSRNVHD-KLISIVEVTISCVDENPESRPTMQKVCQLL 871
            +   + +D+    R   P+R   D  L S+ ++   C  +NP +R T  ++ + L
Sbjct: 245 DMRKVVCVDQQ---RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 137
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 198 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 250
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 251 L---CWKERPEDRPTFDYLRSVLE 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 87  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 141
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 202 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 254
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 255 L---CWKERPEDRPTFDYLRSVLE 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 192 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 244
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 245 L---CWKERPEDRPTFDYLRSVLE 265

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 72  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 126
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 187 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 239
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 240 L---CWKERPEDRPTFDYLRSVLE 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 82  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 136
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HRD+ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 197 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 249
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 250 L---CWKERPEDRPTFDYLRSVLE 270

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 13/272 (4%)
Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +F  E  IG+G    VY +  L  G  +A+KK       +   + + + E+  L ++ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM-NMIKGIVDALSYM 720
           N++K Y   +    L IV E      L+ ++ +    K L   R +      +  AL +M
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRDI   NV +       + D G+ +F    ++    L GT  Y++PE  +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
                 K D++S G L  E+   + P  +   M+  SL   I   E  D   P PS +  
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKI---EQCD-YPPLPSDHYS 264
Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++L  +V +   C++ +PE RP +  V  + K
Sbjct: 265 EELRQLVNM---CINPDPEKRPDVTYVYDVAK 293

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 46/296 (15%)
Query: 609 CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           C+GKG  G V+      GE +AVK F S        + E  N V     + H NI+    
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM----LRHENILGFIA 69
Query: 669 FCLHVRH----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
             +  RH    L+++  Y +M SL   L        L     + ++  I   L+++H + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 725 F-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-----GTYGYV 774
           F     P I HRD+ SKN+L+    +  ++D G+A  +   S+N  ++      GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 775 APE-LAYTMKVT-----EKCDVYSFGVLALEVIKGKHPRDFISSM------------SFS 816
           APE L  T++V      ++ D+++FG++  EV +       +               SF 
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 817 SLNLNIALDEMLDPRLPTPSRNVHD-KLISIVEVTISCVDENPESRPTMQKVCQLL 871
            +   + +D+    R   P+R   D  L S+ ++   C  +NP +R T  ++ + L
Sbjct: 245 DMRKVVCVDQQ---RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 123/278 (44%), Gaps = 30/278 (10%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIW 659
            D   +H +G G  G VY        + +AVK        E T + +EFL E   + EI 
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIK 65
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEY 124
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAP 776
           +    F   +HRD++++N L+   +   V+DFG+++ +  D+   T  AG      + AP
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAP 179
Query: 777 E-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           E LAY  K + K DV++FGVL  E+   G  P   I       L     L++  D R+  
Sbjct: 180 ESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK--DYRMER 231
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           P          + E+  +C   NP  RP+  ++ Q  +
Sbjct: 232 PEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG+G  G VY ++   GE  A+KK       E       + E+  L E+ H NIVK+Y  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDV 68
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L +V+E+     L  +L  D     L      + +  +++ ++Y H+     ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKC 788
           HRD+  +N+L++ E E  ++DFG+A+        +T    T  Y AP+ L  + K +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 789 DVYSFGVLALEVIKG 803
           D++S G +  E++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG+G  G VY ++   GE  A+KK       E       + E+  L E+ H NIVK+Y  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDV 68
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L +V+E+     L  +L  D     L      + +  +++ ++Y H+     ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKC 788
           HRD+  +N+L++ E E  ++DFG+A+        +T    T  Y AP+ L  + K +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 789 DVYSFGVLALEVIKG 803
           D++S G +  E++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 596 EIIR--ATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           +I+R   T  F   H I     G  Y  K+   EI+   K           Q E  N+ +
Sbjct: 9   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-----------QVEHTNDER 57
Query: 654 -ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             L+ + H  I++++G     + +F++ +Y +   L  +L       N            
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN---PVAKFYAAE 114
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           +  AL Y+H+     I++RD+  +N+LLD      ++DFG AK++ PD +    L GT  
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT--YXLCGTPD 168
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  T    +  D +SFG+L  E++ G  P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ++ +  +  +GKG  G V + K   +G+  AVK        + T ++  L EV+ L ++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI K+Y F     + ++V E +    L        + K         +I+ ++  ++Y
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
            H +    IVHRD+  +N+LL+ +++     + DFG++   +  S    +  GT  Y+AP
Sbjct: 142 XHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKXKDKIGTAYYIAP 197
Query: 777 ELAYTMKVTEKCDVYSFGVL 796
           E+ +     EKCDV+S GV+
Sbjct: 198 EVLHGT-YDEKCDVWSTGVI 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG+G  G VY ++   GE  A+KK       E       + E+  L E+ H NIVK+Y  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDV 68
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L +V+E+     L  +L  D     L      + +  +++ ++Y H+     ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKC 788
           HRD+  +N+L++ E E  ++DFG+A+        +T    T  Y AP+ L  + K +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 789 DVYSFGVLALEVIKG 803
           D++S G +  E++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 49/294 (16%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVK 665
           E  +G G  G+V       G  +AVK+        + F    L E+K LTE   H N+++
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALMEIKLLTESDDHPNVIR 73
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN---MIKGIVDALSYMHN 722
            Y      R L+I  E   +    ++ S + + +NL   +  N   +++ I   ++++H+
Sbjct: 74  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 723 DCFPPIVHRDISSKNVLL--------DFENEAH-----VSDFGIAKFLKPDS----SNWT 765
                I+HRD+  +N+L+        D +  A      +SDFG+ K L         N  
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 766 ELAGTYGYVAPE-------LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSS 817
             +GT G+ APE       L    ++T   D++S G +   ++ KGKHP     S   + 
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDK--LISIVEVTISCVDENPESRPTMQKVCQ 869
           +    +LDEM         + +HD+  +    ++    +D +P  RPT  KV +
Sbjct: 251 IRGIFSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 610 IGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++           ++AVK          + +Q+F  E + LT + H++I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 76
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVIL------------SNDAAAKNLGWTRRMNMIK 711
           V+ +G C   R L +V+EY +   L   L              D A   LG  + + +  
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
            +   + Y+    F   VHRD++++N L+       + DFG+++ +   S+++  + G  
Sbjct: 137 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 191
Query: 771 ---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
                ++ PE     K T + DV+SFGV+  E+   GK P   +S+    +++      E
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQGRE 249
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           +  PR   P          +  +   C    P+ R +++ V
Sbjct: 250 LERPRACPP---------EVYAIMRGCWQREPQQRHSIKDV 281

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 610 IGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++           ++AVK          + +Q+F  E + LT + H++I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 82
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVIL------------SNDAAAKNLGWTRRMNMIK 711
           V+ +G C   R L +V+EY +   L   L              D A   LG  + + +  
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
            +   + Y+    F   VHRD++++N L+       + DFG+++ +   S+++  + G  
Sbjct: 143 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 197
Query: 771 ---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
                ++ PE     K T + DV+SFGV+  E+   GK P   +S+    +++      E
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQGRE 255
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           +  PR   P          +  +   C    P+ R +++ V
Sbjct: 256 LERPRACPP---------EVYAIMRGCWQREPQQRHSIKDV 287

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 8/208 (3%)
Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           DF   + +GKG    VY ++ + +G  +A+K        +    Q   NEVK   ++ H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +I+++Y +     ++++V E      +   L N    K        + +  I+  + Y+H
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLH 129
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAY 780
           +     I+HRD++  N+LL       ++DFG+A  LK P   ++T L GT  Y++PE+A 
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIAT 185
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRD 808
                 + DV+S G +   ++ G+ P D
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 42/235 (17%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
           +R  +DF++   +G+G  G V  ++ A      A+KK         T     L+EV  L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVXLLA 57
Query: 657 EIWHRNIVKVYGFCLHVRH-------------LFIVYEYFKMCSLAVILSNDAAAKNLGW 703
            + H+ +V+ Y   L  R+             LFI  EY +  +L  ++ ++    NL  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE----NLNQ 113
Query: 704 TRR--MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------ 755
            R     + + I++ALSY+H+     I+HR++   N+ +D      + DFG+AK      
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 756 -FLKPDSS-------NWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI 801
             LK DS        N T   GT  YVA E L  T    EK D YS G++  E I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 20/264 (7%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++Y  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMS-PDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 ++I+ EY +  SL   L   +  K L   + ++M   I + ++++    +   +
Sbjct: 73  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---I 127
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 788
           HR++ + N+L+       ++DFG+A+ ++ +     E A     + APE       T K 
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+SFG+L  E++   H R     M+   +  N+        R+  P  N  ++L  ++ 
Sbjct: 188 DVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGY----RMVRPD-NCPEELYQLMR 240
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +   C  E PE RPT   +  +L+
Sbjct: 241 L---CWKERPEDRPTFDYLRSVLE 261

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/312 (23%), Positives = 138/312 (44%), Gaps = 38/312 (12%)
Query: 581 GLLSVLTFEG----KIIYEEIIRATNDFDDEHCIGKGGQGSVYM---SKLASGEIIAVKK 633
           G L VL F+G     + ++  ++   D  + H     G+ S+Y    +   +GE++AVK 
Sbjct: 13  GALEVL-FQGPGDPTVFHKRYLKKIRDLGEGHF----GKVSLYCYDPTNDGTGEMVAVKA 67
Query: 634 FHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFC--LHVRHLFIVYEYFKMCSLAVI 691
             +    +   +  +  E+  L  ++H +I+K  G C       L +V EY  + SL   
Sbjct: 68  LKADAGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY 125
Query: 692 LSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF 751
           L       ++G  + +   + I + ++Y+H   +   +HRD++++NVLLD +    + DF
Sbjct: 126 LPR----HSIGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDF 178
Query: 752 GIAKFLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-----KG 803
           G+AK +      +    +      + APE     K     DV+SFGV   E++       
Sbjct: 179 GLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238
Query: 804 KHPRDFISSMSFSSLNLNI-ALDEMLD--PRLPTPSRNVHDKLISIVEVTISCVDENPES 860
             P  F+  +  +   + +  L E+L+   RLP P +   +    +  +  +C +     
Sbjct: 239 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE----VYHLMKNCWETEASF 294
Query: 861 RPTMQKVCQLLK 872
           RPT + +  +LK
Sbjct: 295 RPTFENLIPILK 306

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           +++FL E   + +  H N+V + G     + + IV E+ +  +L   L        +   
Sbjct: 88  RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--I 145
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSN 763
           + + M++GI   + Y+ +  +   VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 146 QLVGMLRGIAAGMRYLADMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV 202
Query: 764 WTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL 820
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P         S+ ++
Sbjct: 203 YTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQDV 257
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             A++E    RLP P     D    + ++ + C  +    RP  +++  +L
Sbjct: 258 IKAIEEGY--RLPAPM----DCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 127/284 (44%), Gaps = 40/284 (14%)
Query: 610 IGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++           ++AVK            +++F  E + LT + H +I
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 77
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSL----------AVILSNDAAAKNLGWTRRMNMIKGI 713
           VK YG C+    L +V+EY K   L          AV+++       L  ++ +++ + I
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG---- 769
              + Y+ +  F   VHRD++++N L+       + DFG+++ +   S+++  + G    
Sbjct: 138 AAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTML 192
Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML 828
              ++ PE     K T + DV+S GV+  E+   GK P        +  L+ N  ++ + 
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------WYQLSNNEVIECIT 244
Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             R+    R    +   + E+ + C    P  R  ++ +  LL+
Sbjct: 245 QGRVLQRPRTCPQE---VYELMLGCWQREPHMRKNIKGIHTLLQ 285

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 120/263 (45%), Gaps = 28/263 (10%)
Query: 624 ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYE 681
            +GE++AVK   +    +   +  +  E+  L  ++H +I+K  G C     + L +V E
Sbjct: 41  GTGEMVAVKALKADCGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVME 98
Query: 682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD 741
           Y  + SL   L   +    +G  + +   + I + ++Y+H+  +   +HR+++++NVLLD
Sbjct: 99  YVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHSQHY---IHRNLAARNVLLD 151
Query: 742 FENEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLA 797
            +    + DFG+AK + P+   +  +         + APE     K     DV+SFGV  
Sbjct: 152 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 798 LEVI-----KGKHPRDFISSMSFSSLNLNI-ALDEMLD--PRLPTPSRNVHDKLISIVEV 849
            E++         P  F+  +  +   + +  L E+L+   RLP P +        +  +
Sbjct: 211 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCP----CEVYHL 266
Query: 850 TISCVDENPESRPTMQKVCQLLK 872
             +C +     RPT + +  +LK
Sbjct: 267 MKNCWETEASFRPTFENLIPILK 289

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G VY  + + +G++ A+K        E   +QE +N +K  +   HRNI   YG
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-INMLKKYSH--HRNIATYYG 88
Query: 669 FCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
             +          L++V E+    S+  ++ N      L       + + I+  LS++H 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                ++HRDI  +NVLL    E  + DFG++  L           GT  ++APE+    
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 783 KVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-- 835
           +  +     K D++S G+ A+E+ +G  P           ++   AL   L PR P P  
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPP--------LCDMHPMRAL--FLIPRNPAPRL 254
Query: 836 -SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            S+    K  S +E   SC+ +N   RP  +   QL+K
Sbjct: 255 KSKKWSKKFQSFIE---SCLVKNHSQRPATE---QLMK 286

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSV-YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 654
           EI+RA         IGKG  G V  + K  + ++ A+K  +     E    +    E++ 
Sbjct: 18  EILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68
Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           +  + H  +V ++        +F+V +      L   L  +   K    T ++  I  +V
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE--TVKL-FICELV 125
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL Y+ N     I+HRD+   N+LLD     H++DF IA  L P  +  T +AGT  Y+
Sbjct: 126 MALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGTKPYM 181
Query: 775 APELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMS 814
           APE+  + K    +   D +S GV A E+++G+ P    SS S
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 42/284 (14%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIW 659
            D   +H +G G  G VY+       + +AVK        E T + +EFL E   + EI 
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIK 86
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H N+V++ G C      +IV EY    +L   L  +   + +     + M   I  A+ Y
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQISSAMEY 145
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAP 776
           +    F   +HRD++++N L+   +   V+DFG+++ +  D+  +T  AG      + AP
Sbjct: 146 LEKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAP 200
Query: 777 E-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD------EML 828
           E LAY    + K DV++FGVL  E+   G  P        +  ++L+   D       M 
Sbjct: 201 ESLAYN-TFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYDLLEKGYRME 251
Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            P    P          + E+  +C   +P  RP+  +  Q  +
Sbjct: 252 QPEGCPP---------KVYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 119/263 (45%), Gaps = 28/263 (10%)
Query: 624 ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYE 681
            +GE++AVK   +    +   +  +  E+  L  ++H +I+K  G C     + L +V E
Sbjct: 41  GTGEMVAVKALKADCGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVME 98
Query: 682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD 741
           Y  + SL   L       ++G  + +   + I + ++Y+H   +   +HR+++++NVLLD
Sbjct: 99  YVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQHY---IHRNLAARNVLLD 151
Query: 742 FENEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLA 797
            +    + DFG+AK + P+   +  +         + APE     K     DV+SFGV  
Sbjct: 152 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 798 LEVI-----KGKHPRDFISSMSFSSLNLNI-ALDEMLD--PRLPTPSRNVHDKLISIVEV 849
            E++         P  F+  +  +   + +  L E+L+   RLP P +        +  +
Sbjct: 211 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCP----CEVYHL 266
Query: 850 TISCVDENPESRPTMQKVCQLLK 872
             +C +     RPT + +  +LK
Sbjct: 267 MKNCWETEASFRPTFENLIPILK 289

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 136/296 (45%), Gaps = 32/296 (10%)
Query: 586 LTFEGKIIYEEIIRATNDFDDEHCIGKGGQGS---VYMSKLASGEIIAVKKFHSPLPGEM 642
           L F+    YE + R  N  D    IG+ G G+   VY ++     ++A  K       E 
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNL 701
              ++++ E+  L    H NIVK+     +  +L+I+ E+    ++ AV+L      + L
Sbjct: 78  L--EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPL 132
Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
             ++   + K  +DAL+Y+H++    I+HRD+ + N+L   + +  ++DFG++       
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 189
Query: 762 SNWTELAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFS 816
                  GT  ++APE+       +     K DV+S G+  +E+ + + P   ++ M   
Sbjct: 190 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--- 246
Query: 817 SLNLNIALDEMLDPRLPTPSR---NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            + L IA  E   P L  PSR   N  D L         C+++N ++R T  ++ Q
Sbjct: 247 RVLLKIAKSE--PPTLAQPSRWSSNFKDFL-------KKCLEKNVDARWTTSQLLQ 293

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 136/296 (45%), Gaps = 32/296 (10%)
Query: 586 LTFEGKIIYEEIIRATNDFDDEHCIGKGGQGS---VYMSKLASGEIIAVKKFHSPLPGEM 642
           L F+    YE + R  N  D    IG+ G G+   VY ++     ++A  K       E 
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNL 701
              ++++ E+  L    H NIVK+     +  +L+I+ E+    ++ AV+L      + L
Sbjct: 78  L--EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPL 132
Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
             ++   + K  +DAL+Y+H++    I+HRD+ + N+L   + +  ++DFG++       
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 762 SNWTELAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFS 816
                  GT  ++APE+       +     K DV+S G+  +E+ + + P   ++ M   
Sbjct: 190 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--- 246
Query: 817 SLNLNIALDEMLDPRLPTPSR---NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            + L IA  E   P L  PSR   N  D L         C+++N ++R T  ++ Q
Sbjct: 247 RVLLKIAKSE--PPTLAQPSRWSSNFKDFL-------KKCLEKNVDARWTTSQLLQ 293

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 136/296 (45%), Gaps = 32/296 (10%)
Query: 586 LTFEGKIIYEEIIRATNDFDDEHCIGKGGQGS---VYMSKLASGEIIAVKKFHSPLPGEM 642
           L F+    YE + R  N  D    IG+ G G+   VY ++     ++A  K       E 
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNL 701
              ++++ E+  L    H NIVK+     +  +L+I+ E+    ++ AV+L      + L
Sbjct: 78  L--EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPL 132
Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
             ++   + K  +DAL+Y+H++    I+HRD+ + N+L   + +  ++DFG++       
Sbjct: 133 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 762 SNWTELAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFS 816
                  GT  ++APE+       +     K DV+S G+  +E+ + + P   ++ M   
Sbjct: 190 QRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--- 246
Query: 817 SLNLNIALDEMLDPRLPTPSR---NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            + L IA  E   P L  PSR   N  D L         C+++N ++R T  ++ Q
Sbjct: 247 RVLLKIAKSE--PPTLAQPSRWSSNFKDFL-------KKCLEKNVDARWTTSQLLQ 293

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 118/282 (41%), Gaps = 44/282 (15%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V   +   +G I+A+KKF      +M  ++  + E+K L ++ H N+V +  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV-KKIAMREIKLLKQLRHENLVNLLE 91
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            C   +  ++V+E+        IL + +     L +      +  I++ + + H+     
Sbjct: 92  VCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---N 144
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTE 786
           I+HRDI  +N+L+       + DFG A+ L      + +   T  Y APEL    +K  +
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 787 KCDVYSFGVLALEVIKG-------------------------KHPRDFISSMSFSSLNL- 820
             DV++ G L  E+  G                         +H   F  +  F+ + L 
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            I   E L+ R P  S         ++++   C+  +P+ RP
Sbjct: 265 EIKEREPLERRYPKLSE-------VVIDLAKKCLHIDPDKRP 299

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           EF++E   +  + H ++V++ G CL      +       C L  +  +     N+G    
Sbjct: 86  EFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEH---KDNIGSQLL 142
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +N    I   + Y+       +VHRD++++NVL+   N   ++DFG+A+ L+ D   +  
Sbjct: 143 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 199
Query: 767 LAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA 823
             G     ++A E  +  K T + DV+S+GV   E++  G  P D I +     L     
Sbjct: 200 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL----- 254
Query: 824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           L++    RLP P        I +  V + C   + +SRP  +++
Sbjct: 255 LEK--GERLPQPPICT----IDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 20/225 (8%)
Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           EF++E   +  + H ++V++ G CL      +       C L  +  +     N+G    
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEH---KDNIGSQLL 119
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           +N    I   + Y+       +VHRD++++NVL+   N   ++DFG+A+ L+ D   +  
Sbjct: 120 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176
Query: 767 LAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA 823
             G     ++A E  +  K T + DV+S+GV   E++  G  P D I +     L     
Sbjct: 177 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL----- 231
Query: 824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
           L++    RLP P        I +  V + C   + +SRP  +++ 
Sbjct: 232 LEK--GERLPQPPICT----IDVYMVMVKCWMIDADSRPKFKELA 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    + +S   + E+ A K     L  +   +++   E+     + H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +F+V E   +C    +L      K L        ++ IV    Y+H +    +
Sbjct: 85  FFEDNDFVFVVLE---LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 789 DVYSFGVLALEVIKGKHP 806
           DV+S G +   ++ GK P
Sbjct: 199 DVWSIGCIMYTLLVGKPP 216

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    + +S   + E+ A K     L  +   +++   E+     + H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +F+V E   +C    +L      K L        ++ IV    Y+H +    +
Sbjct: 85  FFEDNDFVFVVLE---LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 789 DVYSFGVLALEVIKGKHP 806
           DV+S G +   ++ GK P
Sbjct: 199 DVWSIGCIMYTLLVGKPP 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    + +S   + E+ A K     L  +   +++   E+     + H+++V  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +F+V E   +C    +L      K L        ++ IV    Y+H +    +
Sbjct: 89  FFEDNDFVFVVLE---LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 202
Query: 789 DVYSFGVLALEVIKGKHP 806
           DV+S G +   ++ GK P
Sbjct: 203 DVWSIGCIMYTLLVGKPP 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 30/264 (11%)
Query: 624 ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFIVYE 681
            +GE++AVK        ++  +  +  E++ L  ++H +IVK  G C     + + +V E
Sbjct: 36  GTGEMVAVKALKEGCGPQL--RSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 93
Query: 682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD 741
           Y  + SL   L        +G  + +   + I + ++Y+H   +   +HR ++++NVLLD
Sbjct: 94  YVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLD 146
Query: 742 FENEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLA 797
            +    + DFG+AK + P+   +  +         + APE     K     DV+SFGV  
Sbjct: 147 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 205
Query: 798 LEVI------KGKHPRDFISSMSFSSLNLNI-ALDEMLD--PRLPTPSRNVHDKLISIVE 848
            E++      +  H + F   +  +   + +  L E+L+   RLP P R        I  
Sbjct: 206 YELLTYCDSNQSPHTK-FTELIGHTQGQMTVLRLTELLERGERLPRPDRCP----CEIYH 260
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +  +C +     RPT Q +  +L+
Sbjct: 261 LMKNCWETEASFRPTFQNLVPILQ 284

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVY 667
           +GKG  G V+ S    +GE++AVKK           Q+ F  E+  LTE+  H NIV + 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 668 GFCL--HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
                 + R +++V++Y +    AVI +N      L    +  ++  ++  + Y+H+   
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANI-----LEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKF---------------------LKPDSSNW 764
             ++HRD+   N+LL+ E    V+DFG+++                         D    
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 765 TELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGK 804
           T+   T  Y APE L  + K T+  D++S G +  E++ GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    + +S   + E+ A K     L  +   +++   E+     + H+++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +F+V E   +C    +L      K L        ++ IV    Y+H +    +
Sbjct: 109 FFEDNDFVFVVLE---LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 789 DVYSFGVLALEVIKGKHP 806
           DV+S G +   ++ GK P
Sbjct: 223 DVWSIGCIMYTLLVGKPP 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    + +S   + E+ A K     L  +   +++   E+     + H+++V  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +F+V E   +C    +L      K L        ++ IV    Y+H +    +
Sbjct: 107 FFEDNDFVFVVLE---LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 220
Query: 789 DVYSFGVLALEVIKGKHP 806
           DV+S G +   ++ GK P
Sbjct: 221 DVWSIGCIMYTLLVGKPP 238

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G+ +AV+          + Q+ F  EV+ +  + H NIVK++
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLF 79
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L++V EY    S   +     A   +         + IV A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEY---ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-E 786
           IVHRD+ ++N+LLD +    ++DFG +       +   E  G+  Y APEL    K    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKYDGP 192
Query: 787 KCDVYSFGVLALEVIKGKHPRD 808
           + DV+S GV+   ++ G  P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    + +S   + E+ A K     L  +   +++   E+     + H+++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +F+V E   +C    +L      K L        ++ IV    Y+H +    +
Sbjct: 83  FFEDNDFVFVVLE---LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 789 DVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           DV+S G +   ++ GK P     +       L I  +E   P+   P   V   LI    
Sbjct: 197 DVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP---VAASLIQ--- 247
Query: 849 VTISCVDENPESRPTMQKV 867
                +  +P +RPT+ ++
Sbjct: 248 ---KMLQTDPTARPTINEL 263

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G VY +K + G I+A+K+       E       + E+  L E+ H NIV +   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM-NMIKGIVDALSYMHNDCFPPI 728
               R L +V+E+ +     V+  N    ++      +  +++G+  A  + H      I
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV--AHCHQHR-----I 140
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEK 787
           +HRD+  +N+L++ +    ++DFG+A+       ++T    T  Y AP+ L  + K +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 788 CDVYSFGVLALEVIKGK 804
            D++S G +  E+I GK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 599 RATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
           R   DF+   C+G+GG G V+ +K    +   A+K+    LP     +++ + EVKAL +
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAK 59
Query: 658 IWHRNIVKVYGFCLHVR------------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           + H  IV+ +   L               +L+I  +  +  +L   ++     +    + 
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
            +++   I +A+ ++H+     ++HRD+   N+    ++   V DFG+   +  D    T
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 766 EL------------AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
            L             GT  Y++PE  +    + K D++S G++  E++
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
            + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+   
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--- 110
Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN 763
              + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D + 
Sbjct: 111 KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 764 WTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
           +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 168 YK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           +G+G  G VY +K + G I+A+K+       E       + E+  L E+ H NIV +   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM-NMIKGIVDALSYMHNDCFPPI 728
               R L +V+E+ +     V+  N    ++      +  +++G+  A  + H      I
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV--AHCHQHR-----I 140
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEK 787
           +HRD+  +N+L++ +    ++DFG+A+       ++T    T  Y AP+ L  + K +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 788 CDVYSFGVLALEVIKGK 804
            D++S G +  E+I GK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 92
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 93  STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 146
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAPELAYTMK 783
           HRD+ S N+ L  +    + DFG+A     + S W+      +L+G+  ++APE+   ++
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEV---IR 199
Query: 784 VTEK------CDVYSFGVLALEVIKGKHP 806
           + +K       DVY+FG++  E++ G+ P
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NIVK++       H F+V E   + +   +       K+   T    +++ +V A+S+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVME---LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSH 121
Query: 720 MHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           MH+     +VHRD+  +N+L   EN   E  + DFG A+   PD+        T  Y AP
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           EL       E CD++S GV+   ++ G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 10/214 (4%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 654
           +I     DF+    +GKG  G V++++   + +  A+K     +       +  + E + 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 655 LTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
           L+  W    +  + FC      +LF V EY     L   +    +      +R       
Sbjct: 72  LSLAWEHPFL-THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAE 127
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           I+  L ++H+     IV+RD+   N+LLD +    ++DFG+ K      +   E  GT  
Sbjct: 128 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPD 184
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 100
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 101 STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAPELAYTMK 783
           HRD+ S N+ L  +    + DFG+A     + S W+      +L+G+  ++APE+   ++
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEV---IR 207
Query: 784 VTEK------CDVYSFGVLALEVIKGKHP 806
           + +K       DVY+FG++  E++ G+ P
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 24/241 (9%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL 688
           +AVK     +  +     +F+ EV A+  + HRN++++YG  L    + +V E   + SL
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 107
Query: 689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
              L        LG   R  +   + + + Y+ +  F   +HRD++++N+LL   +   +
Sbjct: 108 LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKI 162
Query: 749 SDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
            DFG+ + L  +  ++         + + APE   T   +   D + FGV   E+   G+
Sbjct: 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222
Query: 805 HPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P        +  LN +  L ++     RLP P     D    I  V + C    PE RP
Sbjct: 223 EP--------WIGLNGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRP 270
Query: 863 T 863
           T
Sbjct: 271 T 271

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 100
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 101 STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           HRD+ S N+ L  +    + DFG+A  K     S  + +L+G+  ++APE+   +++ +K
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 211
Query: 788 ------CDVYSFGVLALEVIKGKHP 806
                  DVY+FG++  E++ G+ P
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 77
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 78  STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           HRD+ S N+ L  +    + DFG+A  K     S  + +L+G+  ++APE+   +++ +K
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 188
Query: 788 ------CDVYSFGVLALEVIKGKHP 806
                  DVY+FG++  E++ G+ P
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 24/241 (9%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL 688
           +AVK     +  +     +F+ EV A+  + HRN++++YG  L    + +V E   + SL
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 101
Query: 689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
              L        LG   R  +   + + + Y+ +  F   +HRD++++N+LL   +   +
Sbjct: 102 LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKI 156
Query: 749 SDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
            DFG+ + L  +  ++         + + APE   T   +   D + FGV   E+   G+
Sbjct: 157 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 216
Query: 805 HPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P        +  LN +  L ++     RLP P     D    I  V + C    PE RP
Sbjct: 217 EP--------WIGLNGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRP 264
Query: 863 T 863
           T
Sbjct: 265 T 265

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 37/284 (13%)
Query: 610 IGKGGQGSVYM-----SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G+G  G V +     +   +GE++AVK        ++  +  +  E++ L  ++H +IV
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQL--RSGWQREIEILRTLYHEHIV 73
Query: 665 KVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G C     + + +V EY  + SL   L        +G  + +   + I + ++Y+H 
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHA 129
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL-----AGTYGYVAPE 777
             +   +HR ++++NVLLD +    + DFG+AK + P+   +  +     +  + Y APE
Sbjct: 130 QHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWY-APE 184
Query: 778 LAYTMKVTEKCDVYSFGVLALEVI------KGKHPRDFISSMSFSSLNLNI-ALDEMLD- 829
                K     DV+SFGV   E++      +  H + F   +  +   + +  L E+L+ 
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTK-FTELIGHTQGQMTVLRLTELLER 243
Query: 830 -PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             RLP P R        I  +  +C +     RPT Q +  +L+
Sbjct: 244 GERLPRPDRCP----CEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 77
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 78  STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           HRD+ S N+ L  +    + DFG+A  K     S  + +L+G+  ++APE+   +++ +K
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 188
Query: 788 ------CDVYSFGVLALEVIKGKHP 806
                  DVY+FG++  E++ G+ P
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 99
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 100 STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 153
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           HRD+ S N+ L  +    + DFG+A  K     S  + +L+G+  ++APE+   +++ +K
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 210
Query: 788 ------CDVYSFGVLALEVIKGKHP 806
                  DVY+FG++  E++ G+ P
Sbjct: 211 NPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
            + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+   
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--- 104
Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN 763
              + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D + 
Sbjct: 105 KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 764 WTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
           +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 162 YK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
            + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+   
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--- 106
Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN 763
              + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D + 
Sbjct: 107 KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 764 WTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
           +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 164 YK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
            + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+   
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--- 110
Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN 763
              + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D + 
Sbjct: 111 KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 764 WTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
           +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 168 YK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 74
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 75  STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 128
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           HRD+ S N+ L  +    + DFG+A  K     S  + +L+G+  ++APE+   +++ +K
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 185
Query: 788 ------CDVYSFGVLALEVIKGKHP 806
                  DVY+FG++  E++ G+ P
Sbjct: 186 NPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 72
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 73  ST-APQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           HRD+ S N+ L  +    + DFG+A  K     S  + +L+G+  ++APE+   +++ +K
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 183
Query: 788 ------CDVYSFGVLALEVIKGKHP 806
                  DVY+FG++  E++ G+ P
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 72
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 73  STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAPELAYTMK 783
           HRD+ S N+ L  +    + DFG+A     + S W+      +L+G+  ++APE+   ++
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLAT----EKSRWSGSHQFEQLSGSILWMAPEV---IR 179
Query: 784 VTEK------CDVYSFGVLALEVIKGKHP 806
           + +K       DVY+FG++  E++ G+ P
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + +    +P P ++   Q F NEV  L +  H NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 72
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
               + L IV ++ +  SL   L            + +++ +     + Y+H      I+
Sbjct: 73  STKPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 730 HRDISSKNVLLDFENEAHVSDFGIA--KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           HRD+ S N+ L  +    + DFG+A  K     S  + +L+G+  ++APE+   +++ +K
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 183
Query: 788 ------CDVYSFGVLALEVIKGKHP 806
                  DVY+FG++  E++ G+ P
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+  +   +G+I+A+KKF      +   ++  L E++ L ++ H N+V +  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH-NDCFPP 727
                R L +V+EY   C   V+   D   + +      ++    + A+++ H ++C   
Sbjct: 70  VFRRKRRLHLVFEY---CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC--- 123
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTE 786
            +HRD+  +N+L+   +   + DFG A+ L   S  + +   T  Y +PEL     +   
Sbjct: 124 -IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 787 KCDVYSFGVLALEVIKG 803
             DV++ G +  E++ G
Sbjct: 183 PVDVWAIGCVFAELLSG 199

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V + K   +G   A+K          +     L+EV  L ++ H NI+K+Y 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 669 FCLHVRHLFIVYEYFKMCSL--AVILSN-----DAAAKNLGWTRRMNMIKGIVDALSYMH 721
           F    R+ ++V E ++   L   +IL       DAA           ++K ++   +Y+H
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----------IMKQVLSGTTYLH 138
Query: 722 NDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
                 IVHRD+  +N+LL+ ++      + DFG++   +       E  GT  Y+APE+
Sbjct: 139 KH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEV 194
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
               K  EKCDV+S GV+   ++ G  P
Sbjct: 195 -LRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
             + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+  
Sbjct: 413 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD-- 469
Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D +
Sbjct: 470 -KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525
Query: 763 NWTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
            +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 526 YYK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHE 65
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 66  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
             + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+  
Sbjct: 412 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD-- 468
Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D +
Sbjct: 469 -KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524
Query: 763 NWTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
            +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 525 YYK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F+ +  +G G    V +++  A+G++ AVK    P       +    NE+  L +I H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCI--PKKALKGKESSIENEIAVLRKIKHEN 81
Query: 663 IVKVYGFCLHVRHLFIVYE-------YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           IV +        HL++V +       + ++         DA+           +I+ ++D
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS----------TLIRQVLD 131
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           A+ Y+H      IVHRD+  +N+L    D E++  +SDFG++K ++      +   GT G
Sbjct: 132 AVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPG 187
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           YVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 10/202 (4%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G+ +AVK          + Q+ F  EV+ +  + H NIVK++
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLF 79
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L++V EY    S   +     A   +         + IV A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEY---ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-E 786
           IVHRD+ ++N+LLD +    ++DFG +       +      G+  Y APEL    K    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 787 KCDVYSFGVLALEVIKGKHPRD 808
           + DV+S GV+   ++ G  P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 10/202 (4%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G+ +AVK          + Q+ F  EV+ +  + H NIVK++
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLF 79
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L++V EY    S   +     A   +         + IV A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEY---ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-E 786
           IVHRD+ ++N+LLD +    ++DFG +       +      G+  Y APEL    K    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 787 KCDVYSFGVLALEVIKGKHPRD 808
           + DV+S GV+   ++ G  P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 130/434 (29%), Positives = 184/434 (42%), Gaps = 114/434 (26%)
Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           NN L D  P  L+NL  L D+ + NN+++   P  L NLTNL  L +  N ++   P  +
Sbjct: 72  NNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXX 125
            N    + LELS+N +S     +L  L++L  L   +N +++  P               
Sbjct: 126 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFSSNQVTDLKP--------------- 168
Query: 126 XXXXXXXXPHSLGNLTNLATLYIYSNSLS-ASILGKIGNLKSLSNLQLSENNFNGSIPPS 184
                      L NLT L  L I SN +S  S+L K+ NL+SL    ++ NN    I P 
Sbjct: 169 -----------LANLTTLERLDISSNKVSDISVLAKLTNLESL----IATNNQISDITP- 212
Query: 185 LGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNL 244
           LG L+NL  L L+ N L                      K  G    ++ +L+NLT L+L
Sbjct: 213 LGILTNLDELSLNGNQL----------------------KDIG----TLASLTNLTDLDL 246
Query: 245 FENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESF 304
             N +S   P     L KLT L LG NQ     P L  LT+L  + L+ N L  +IS   
Sbjct: 247 ANNQISNLAPLS--GLTKLTELKLGANQISNISP-LAGLTALTNLELNENQL-EDISP-I 301
Query: 305 YIYPNLTYIDLSQNNFYGEIS--SDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLD 362
               NLTY+ L    ++  IS  S      KL  L FS N ++                D
Sbjct: 302 SNLKNLTYLTL----YFNNISDISPVSSLTKLQRLFFSNNKVS----------------D 341
Query: 363 LSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN---- 418
           +SS          L  L     L   HNQ+S  L+P L +L ++  L L+    +N    
Sbjct: 342 VSS----------LANLTNINWLSAGHNQIS-DLTP-LANLTRITQLGLNDQAWTNAPVN 389
Query: 419 -----SIPKSLGNL 427
                SIP ++ N+
Sbjct: 390 YKANVSIPNTVKNV 403

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNY 295
           L+NLT +N   N L+   P   +NL KL  +L+ +NQ     P L NLT+L  + L  N 
Sbjct: 62  LNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQ 118
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
           +T    +      NL  ++LS N    +IS+  G    L  L FS N +T   P  + + 
Sbjct: 119 ITD--IDPLKNLTNLNRLELSSNTI-SDISALSGLT-SLQQLSFSSNQVTDLKP--LANL 172
Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP----------------- 398
           + L  LD+SSN  V +I + L KL     L+  +NQ+S  ++P                 
Sbjct: 173 TTLERLDISSNK-VSDISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQL 229
Query: 399 ----KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
                L SL  L  LDL++N++SN  P S     L  L+EL L  N +    P  +  + 
Sbjct: 230 KDIGTLASLTNLTDLDLANNQISNLAPLS----GLTKLTELKLGANQISNISP--LAGLT 283
Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
           +L  L L+ N L  + P     +  L ++ + +N +    P S+  K
Sbjct: 284 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 328

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 24/241 (9%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL 688
           +AVK     +  +     +F+ EV A+  + HRN++++YG  L    + +V E   + SL
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 101
Query: 689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
              L        LG   R  +   + + + Y+ +  F   +HRD++++N+LL   +   +
Sbjct: 102 LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKI 156
Query: 749 SDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
            DFG+ + L  +  ++         + + APE   T   +   D + FGV   E+   G+
Sbjct: 157 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 216
Query: 805 HPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P        +  LN +  L ++     RLP P     D    I  V + C    PE RP
Sbjct: 217 EP--------WIGLNGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRP 264
Query: 863 T 863
           T
Sbjct: 265 T 265

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 24/241 (9%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL 688
           +AVK     +  +     +F+ EV A+  + HRN++++YG  L    + +V E   + SL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 97
Query: 689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
              L        LG   R  +   + + + Y+ +  F   +HRD++++N+LL   +   +
Sbjct: 98  LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKI 152
Query: 749 SDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
            DFG+ + L  +  ++         + + APE   T   +   D + FGV   E+   G+
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 805 HPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P        +  LN +  L ++     RLP P     D    I  V + C    PE RP
Sbjct: 213 EP--------WIGLNGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRP 260
Query: 863 T 863
           T
Sbjct: 261 T 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 24/241 (9%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL 688
           +AVK     +  +     +F+ EV A+  + HRN++++YG  L    + +V E   + SL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 97
Query: 689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
              L        LG   R  +   + + + Y+ +  F   +HRD++++N+LL   +   +
Sbjct: 98  LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKI 152
Query: 749 SDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
            DFG+ + L  +  ++         + + APE   T   +   D + FGV   E+   G+
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 805 HPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P        +  LN +  L ++     RLP P     D    I  V + C    PE RP
Sbjct: 213 EP--------WIGLNGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRP 260
Query: 863 T 863
           T
Sbjct: 261 T 261

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 601 TNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
             D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLN 63
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H N+VK YG   H R   I Y + + CS   +         +           ++  + Y
Sbjct: 64  HENVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPE 777
           +H      I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 778 LAYTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
           L    +   E  DV+S G++   ++ G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 601 TNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
             D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLN 62
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H N+VK YG   H R   I Y + + CS   +         +           ++  + Y
Sbjct: 63  HENVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPE 777
           +H      I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPE
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 778 LAYTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
           L    +   E  DV+S G++   ++ G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G+ +AVK          + Q+ F  EV+ +  + H NIVK++
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLF 79
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L++V EY    S   +     A   +         + IV A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEY---ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-E 786
           IVHRD+ ++N+LLD +    ++DFG +       +      G   Y APEL    K    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 787 KCDVYSFGVLALEVIKGKHPRD 808
           + DV+S GV+   ++ G  P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINAMLNHE 65
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 66  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 102/316 (32%), Positives = 141/316 (44%), Gaps = 71/316 (22%)
Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           NN L D  P  L+NL  L D+ + NN+++   P  L NLTNL  L +  N ++   P  +
Sbjct: 72  NNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXX 125
            N    + LELS+N +S     +L  L++L  L   +N +++  P               
Sbjct: 126 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFSSNQVTDLKP--------------- 168
Query: 126 XXXXXXXXPHSLGNLTNLATLYIYSNSLS-ASILGKIGNLKSLSNLQLSENNFNGSIPPS 184
                      L NLT L  L I SN +S  S+L K+ NL+SL    ++ NN    I P 
Sbjct: 169 -----------LANLTTLERLDISSNKVSDISVLAKLTNLESL----IATNNQISDITP- 212
Query: 185 LGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNL 244
           LG L+NL  L L+ N L                      K  G    ++ +L+NLT L+L
Sbjct: 213 LGILTNLDELSLNGNQL----------------------KDIG----TLASLTNLTDLDL 246
Query: 245 FENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESF 304
             N +S   P     L KLT L LG NQ     P L  LT+L  + L+ N L  +IS   
Sbjct: 247 ANNQISNLAPLS--GLTKLTELKLGANQISNISP-LAGLTALTNLELNENQL-EDISP-I 301
Query: 305 YIYPNLTYIDLSQNNF 320
               NLTY+ L  NN 
Sbjct: 302 SNLKNLTYLTLYFNNI 317

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNY 295
           L+NLT +N   N L+   P   +NL KL  +L+ +NQ     P L NLT+L  + L  N 
Sbjct: 62  LNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQ 118
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
           +T    +      NL  ++LS N    +IS+  G    L  L FS N +T   P  + + 
Sbjct: 119 ITD--IDPLKNLTNLNRLELSSNTI-SDISALSG-LTSLQQLSFSSNQVTDLKP--LANL 172
Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP----------------- 398
           + L  LD+SSN  V +I + L KL     L+  +NQ+S  ++P                 
Sbjct: 173 TTLERLDISSNK-VSDISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQL 229
Query: 399 ----KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
                L SL  L  LDL++N++SN  P S     L  L+EL L  N +    P  +  + 
Sbjct: 230 KDIGTLASLTNLTDLDLANNQISNLAPLS----GLTKLTELKLGANQISNISP--LAGLT 283
Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
           +L  L L+ N L  + P     +  L ++ + +N +    P S+  K
Sbjct: 284 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 328

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 121/277 (43%), Gaps = 40/277 (14%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 66
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 120
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L  + +N  E  GT  Y++PE
Sbjct: 121 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRSYMSPE 176
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD-------P 830
                  + + D++S G+  +E+  G++PR              +A+ E+LD       P
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRP------------PMAIFELLDYIVNEPPP 224
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           +LP+   +     +   +    C+ +NP  R  ++++
Sbjct: 225 KLPSAVFS-----LEFQDFVNKCLIKNPAERADLKQL 256

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 66  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 63
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 64  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 66  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 66  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 102/316 (32%), Positives = 141/316 (44%), Gaps = 71/316 (22%)
Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           NN L D  P  L+NL  L D+ + NN+++   P  L NLTNL  L +  N ++   P  +
Sbjct: 72  NNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXX 125
            N    + LELS+N +S     +L  L++L  L   +N +++  P               
Sbjct: 126 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVTDLKP--------------- 168
Query: 126 XXXXXXXXPHSLGNLTNLATLYIYSNSLS-ASILGKIGNLKSLSNLQLSENNFNGSIPPS 184
                      L NLT L  L I SN +S  S+L K+ NL+SL    ++ NN    I P 
Sbjct: 169 -----------LANLTTLERLDISSNKVSDISVLAKLTNLESL----IATNNQISDITP- 212
Query: 185 LGNLSNLATLYLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNL 244
           LG L+NL  L L+ N L                      K  G    ++ +L+NLT L+L
Sbjct: 213 LGILTNLDELSLNGNQL----------------------KDIG----TLASLTNLTDLDL 246
Query: 245 FENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESF 304
             N +S   P     L KLT L LG NQ     P L  LT+L  + L+ N L  +IS   
Sbjct: 247 ANNQISNLAPLS--GLTKLTELKLGANQISNISP-LAGLTALTNLELNENQL-EDISP-I 301
Query: 305 YIYPNLTYIDLSQNNF 320
               NLTY+ L  NN 
Sbjct: 302 SNLKNLTYLTLYFNNI 317

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNY 295
           L+NLT +N   N L+   P   +NL KL  +L+ +NQ     P L NLT+L  + L  N 
Sbjct: 62  LNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQ 118
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
           +T    +      NL  ++LS N    +IS+  G    L  L+FS N +T   P  + + 
Sbjct: 119 ITD--IDPLKNLTNLNRLELSSNTI-SDISALSG-LTSLQQLNFSSNQVTDLKP--LANL 172
Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP----------------- 398
           + L  LD+SSN  V +I + L KL     L+  +NQ+S  ++P                 
Sbjct: 173 TTLERLDISSNK-VSDISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQL 229
Query: 399 ----KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
                L SL  L  LDL++N++SN  P S     L  L+EL L  N +    P  +  + 
Sbjct: 230 KDIGTLASLTNLTDLDLANNQISNLAPLS----GLTKLTELKLGANQISNISP--LAGLT 283
Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
           +L  L L+ N L  + P     +  L ++ + +N +    P S+  K
Sbjct: 284 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 328

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 601 TNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
             D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLN 63
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H N+VK YG   H R   I Y + + CS   +         +           ++  + Y
Sbjct: 64  HENVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPE 777
           +H      I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 778 LAYTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
           L    +   E  DV+S G++   ++ G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 601 TNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
             D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLN 63
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H N+VK YG   H R   I Y + + CS   +         +           ++  + Y
Sbjct: 64  HENVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPE 777
           +H      I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 778 LAYTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
           L    +   E  DV+S G++   ++ G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 16/239 (6%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--IVDAL 717
             +  + Y F  H R  F++ EY     L   LS +       +T       G  IV AL
Sbjct: 65  PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEERARFYGAEIVSAL 118
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           +          D +  GV+  E++ G+ P     +     L   I ++E+  PR  +P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPE 231

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 37/285 (12%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMS------KLASGEIIAVKKFHSPLPGEMTFQQEFL 649
           E IR   DF D   +G G    V ++      KL + + IA K       G M       
Sbjct: 14  EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSME------ 64
Query: 650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR--M 707
           NE+  L +I H NIV +        HL+++ +      L      D   +   +T R   
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF-----DRIVEKGFYTERDAS 119
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVL---LDFENEAHVSDFGIAKFLKPDSSNW 764
            +I  ++DA+ Y+H+     IVHRD+  +N+L   LD +++  +SDFG++K   P  S  
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVL 175
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL 824
           +   GT GYVAPE+      ++  D +S GV+A  ++ G  P        F   N     
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--------FYDENDAKLF 227
Query: 825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           +++L       S    D   S  +     ++++PE R T ++  Q
Sbjct: 228 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 603 DFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+VK YG   H R   I Y + + CS   +         +           ++  + Y+H
Sbjct: 65  NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 779
                 I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL 
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 780 YTMKV-TEKCDVYSFGVLALEVIKGKHPRD 808
              +   E  DV+S G++   ++ G+ P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 10/202 (4%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G+ +AV+          + Q+ F  EV+ +  + H NIVK++
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLF 79
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L++V EY    S   +     A   +         + IV A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEY---ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-E 786
           IVHRD+ ++N+LLD +    ++DFG +       +      G+  Y APEL    K    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 787 KCDVYSFGVLALEVIKGKHPRD 808
           + DV+S GV+   ++ G  P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 16/239 (6%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--IVDAL 717
             +  + Y F  H R  F++ EY     L   LS +       +T       G  IV AL
Sbjct: 65  PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEERARFYGAEIVSAL 118
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           +          D +  GV+  E++ G+ P     +     L   I ++E+  PR  +P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPE 231

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 25/170 (14%)
Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-------DAAAK 699
           + L EV  L  + H NI+K+Y F    R+ ++V E +K   L   + +       DAA  
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV- 140
Query: 700 NLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-FENEA--HVSDFGIAKF 756
                    +IK ++  ++Y+H      IVHRD+  +N+LL+  E +A   + DFG++  
Sbjct: 141 ---------IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + +     E  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 189 FE-NQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G  +A+K          + Q+ F  EV+ +  + H NIVK++
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLF 77
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L+++ EY    S   +     A   +      +  + IV A+ Y H      
Sbjct: 78  EVIETEKTLYLIMEY---ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KR 131
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-E 786
           IVHRD+ ++N+LLD +    ++DFG +              G+  Y APEL    K    
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDTFCGSPPYAAPELFQGKKYDGP 190
Query: 787 KCDVYSFGVLALEVIKGKHPRD 808
           + DV+S GV+   ++ G  P D
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFD 212

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 10/204 (4%)
Query: 607 EHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +  IGKG    V +++ + +G  +AVK          + Q+ F  EV+ +  + H NIVK
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVK 78
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           ++      + L++V EY    S   +     A   +         + IV A+ Y H    
Sbjct: 79  LFEVIETEKTLYLVMEY---ASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY- 134
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 785
             IVHRD+ ++N+LLD +    ++DFG +       +      G+  Y APEL    K  
Sbjct: 135 --IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 786 -EKCDVYSFGVLALEVIKGKHPRD 808
             + DV+S GV+   ++ G  P D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 16/239 (6%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--IVDAL 717
             +  + Y F  H R  F++ EY     L   LS +       +T       G  IV AL
Sbjct: 65  PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEERARFYGAEIVSAL 118
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           +          D +  GV+  E++ G+ P     +     L   I ++E+  PR  +P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPE 231

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 24/241 (9%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL 688
           +AVK     +  +     +F+ EV A+  + HRN++++YG  L    + +V E   + SL
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 107
Query: 689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
              L        LG   R  +   + + + Y+ +  F   +HRD++++N+LL   +   +
Sbjct: 108 LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKI 162
Query: 749 SDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
            DFG+ + L  +  +          + + APE   T   +   D + FGV   E+   G+
Sbjct: 163 GDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222
Query: 805 HPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P        +  LN +  L ++     RLP P     D    I  V + C    PE RP
Sbjct: 223 EP--------WIGLNGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRP 270
Query: 863 T 863
           T
Sbjct: 271 T 271

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G+ +AVK          + Q+ F  EV+ +  + H NIVK++
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLF 72
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM---IKGIVDALSYMHNDC 724
                 + L++V EY    S   +     A    GW +        + IV A+ Y H   
Sbjct: 73  EVIETEKTLYLVMEY---ASGGEVFDYLVAH---GWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              IVHRD+ ++N+LLD +    ++DFG +       +      G+  Y APEL    K 
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 785 T-EKCDVYSFGVLALEVIKGKHPRD 808
              + DV+S GV+   ++ G  P D
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 29/281 (10%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKF-HSPLPGEMTFQQEFLNEVK 653
           E IR   DF D   +G G    V +++   + +++A+K      L G+   +    NE+ 
Sbjct: 14  EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK---EGSMENEIA 68
Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR--MNMIK 711
            L +I H NIV +        HL+++ +      L      D   +   +T R    +I 
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF-----DRIVEKGFYTERDASRLIF 123
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVL---LDFENEAHVSDFGIAKFLKPDSSNWTELA 768
            ++DA+ Y+H+     IVHRD+  +N+L   LD +++  +SDFG++K   P  S  +   
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTAC 179
Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML 828
           GT GYVAPE+      ++  D +S GV+A  ++ G  P        F   N     +++L
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--------FYDENDAKLFEQIL 231
Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                  S    D   S  +     ++++PE R T ++  Q
Sbjct: 232 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 130/303 (42%), Gaps = 35/303 (11%)
Query: 578 NSRGLLSVLTFEGKIIYEEIIR--ATNDFDDEHCIGKGGQGSVYMS-KLASGE------- 627
             R L+  LT  G+   + ++R     +F     +G G  G+VY    +  GE       
Sbjct: 23  QERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA 82
Query: 628 IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           I+ +++  SP        +E L+E   +  + + ++ ++ G CL      I       C 
Sbjct: 83  IMELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCL 137
Query: 688 LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH 747
           L  +  +     N+G    +N    I   ++Y+ +     +VHRD++++NVL+       
Sbjct: 138 LDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK 191
Query: 748 VSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
           ++DFG+AK L  +   +    G     ++A E       T + DV+S+GV   E++  G 
Sbjct: 192 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 251
Query: 805 HPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTM 864
            P D I +   SS+     L++    RLP P        I +  + + C   + +SRP  
Sbjct: 252 KPYDGIPASEISSI-----LEK--GERLPQPPICT----IDVYMIMVKCWMIDADSRPKF 300
Query: 865 QKV 867
           +++
Sbjct: 301 REL 303

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 16/239 (6%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--IVDAL 717
             +  + Y F  H R  F++ EY     L   LS +       +T       G  IV AL
Sbjct: 65  PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEERARFYGAEIVSAL 118
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           +          D +  GV+  E++ G+ P     +     L   I ++E+  PR  +P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPE 231

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 611 GKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFC 670
            +G  G V+ ++L + E +AVK F  P+  + ++Q E+  EV +L  + H NI++  G  
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIF--PIQDKQSWQNEY--EVYSLPGMKHENILQFIG-- 85
Query: 671 LHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
              R       L+++  + +  SL+  L     A  + W    ++ + +   L+Y+H D 
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 725 -------FPPIVHRDISSKNVLLDFENEAHVSDFGIA-KFLKPDSSNWTE-LAGTYGYVA 775
                   P I HRDI SKNVLL     A ++DFG+A KF    S+  T    GT  Y+A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 776 PE-----LAYTMKVTEKCDVYSFGV----LALEVIKGKHPRDFISSMSFSSLNLNIALDE 826
           PE     + +      + D+Y+ G+    LA        P D         +  + +L++
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261
Query: 827 MLDPRLPTPSRNV-------HDKLISIVEVTISCVDENPESR 861
           M +  +    R V       H  +  + E    C D + E+R
Sbjct: 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 73
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F         V +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 16/239 (6%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--IVDAL 717
             +  + Y F  H R  F++ EY     L   LS +       +T       G  IV AL
Sbjct: 68  PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEERARFYGAEIVSAL 121
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 122 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           +          D +  GV+  E++ G+ P     +     L   I ++E+  PR  +P 
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPE 234

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IGKG    V +++ + +G  +A+K          + Q+ F  EV+ +  + H NIVK++ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L+++ EY    S   +     A   +      +  + IV A+ Y H      I
Sbjct: 82  VIETEKTLYLIMEY---ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRI 135
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-EK 787
           VHRD+ ++N+LLD +    ++DFG +              G   Y APEL    K    +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 788 CDVYSFGVLALEVIKGKHPRD 808
            DV+S GV+   ++ G  P D
Sbjct: 195 VDVWSLGVILYTLVSGSLPFD 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
             + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+  
Sbjct: 68  ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD-- 124
Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D +
Sbjct: 125 -KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180
Query: 763 NWTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
            +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 181 YYK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 118 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 26/198 (13%)
Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V + K   +G   A+K          +     L+EV  L ++ H NI+K+Y 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 669 FCLHVRHLFIVYEYFKMCSL--AVILSN-----DAAAKNLGWTRRMNMIKGIVDALSYMH 721
           F    R+ ++V E ++   L   +IL       DAA           ++K ++   +Y+H
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----------IMKQVLSGTTYLH 121
Query: 722 NDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
                 IVHRD+  +N+LL+ ++      + DFG++   +       E  GT  Y+APE+
Sbjct: 122 K---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEV 177
Query: 779 AYTMKVTEKCDVYSFGVL 796
               K  EKCDV+S GV+
Sbjct: 178 -LRKKYDEKCDVWSCGVI 194

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 117 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
             + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+  
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD-- 116
Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D +
Sbjct: 117 -KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 763 NWTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
            +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 173 YYK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 29/281 (10%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKF-HSPLPGEMTFQQEFLNEVK 653
           E IR   DF D   +G G    V +++   + +++A+K      L G+   +    NE+ 
Sbjct: 14  EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK---EGSMENEIA 68
Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR--MNMIK 711
            L +I H NIV +        HL+++ +      L      D   +   +T R    +I 
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF-----DRIVEKGFYTERDASRLIF 123
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVL---LDFENEAHVSDFGIAKFLKPDSSNWTELA 768
            ++DA+ Y+H+     IVHRD+  +N+L   LD +++  +SDFG++K   P  S  +   
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTAC 179
Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML 828
           GT GYVAPE+      ++  D +S GV+A  ++ G  P        F   N     +++L
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--------FYDENDAKLFEQIL 231
Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                  S    D   S  +     ++++PE R T ++  Q
Sbjct: 232 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 119 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 116 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 29/281 (10%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKF-HSPLPGEMTFQQEFLNEVK 653
           E IR   DF D   +G G    V +++   + +++A+K      L G+   +    NE+ 
Sbjct: 14  EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK---EGSMENEIA 68
Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR--MNMIK 711
            L +I H NIV +        HL+++ +      L      D   +   +T R    +I 
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF-----DRIVEKGFYTERDASRLIF 123
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVL---LDFENEAHVSDFGIAKFLKPDSSNWTELA 768
            ++DA+ Y+H+     IVHRD+  +N+L   LD +++  +SDFG++K   P  S  +   
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTAC 179
Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML 828
           GT GYVAPE+      ++  D +S GV+A  ++ G  P        F   N     +++L
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--------FYDENDAKLFEQIL 231
Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                  S    D   S  +     ++++PE R T ++  Q
Sbjct: 232 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 16/239 (6%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--IVDAL 717
             +  + Y F  H R  F++ EY     L   LS +       +T       G  IV AL
Sbjct: 65  PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEERARFYGAEIVSAL 118
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           +          D +  GV+  E++ G+ P     +     L   I ++E+  PR  +P 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPE 231

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    Y ++ + + E+ A K     +  +   +++   E+     + + ++V  +G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +++V E   +C    +L      K +        ++  +  + Y+HN+    +
Sbjct: 94  FFEDDDFVYVVLE---ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + +  + DFG+A  ++ D     +L GT  Y+APE+      + + 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEV 207
Query: 789 DVYSFGVLALEVIKGKHP 806
           D++S G +   ++ GK P
Sbjct: 208 DIWSLGCILYTLLVGKPP 225

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
             + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+  
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD-- 126
Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D +
Sbjct: 127 -KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 763 NWTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
            +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 183 YYK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
             + E L E   + ++ +  IV++ G C       +V E  ++  L   L  +   K+  
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD-- 126
Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               + ++  +   + Y+    F   VHRD++++NVLL  ++ A +SDFG++K L+ D +
Sbjct: 127 -KNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 763 NWTELAGTYG-----YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
            +   A T+G     + APE     K + K DV+SFGVL  E    G+ P
Sbjct: 183 YYK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 16/239 (6%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--IVDAL 717
             +  + Y F  H R  F++ EY     L   LS +       +T       G  IV AL
Sbjct: 70  PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEERARFYGAEIVSAL 123
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            Y+H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 124 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           +          D +  GV+  E++ G+ P     +     L   I ++E+  PR  +P 
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPE 236

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 24/241 (9%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL 688
           +AVK     +  +     +F+ EV A+  + HRN++++YG  L    + +V E   + SL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 97
Query: 689 AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
              L        LG   R  +   + + + Y+ +  F   +HRD++++N+LL   +   +
Sbjct: 98  LDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKI 152
Query: 749 SDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GK 804
            DFG+ + L  +  +          + + APE   T   +   D + FGV   E+   G+
Sbjct: 153 GDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 805 HPRDFISSMSFSSLNLNIALDEM--LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P        +  LN +  L ++     RLP P     D    I  V + C    PE RP
Sbjct: 213 EP--------WIGLNGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRP 260
Query: 863 T 863
           T
Sbjct: 261 T 261

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 610 IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G+G  G V + +       +GE +AVK       G      +   E++ L  ++H NIV
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIV 86
Query: 665 KVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G C       + ++ E+    SL   L  +    NL   +++     I   + Y+ +
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLGS 144
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELA 779
             +   VHRD++++NVL++ E++  + DFG+ K ++ D    T   +      + APE  
Sbjct: 145 RQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 780 YTMKVTEKCDVYSFGVLALEVI 801
              K     DV+SFGV   E++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 610 IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G+G  G V + +       +GE +AVK       G      +   E++ L  ++H NIV
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIV 74
Query: 665 KVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G C       + ++ E+    SL   L  +    NL   +++     I   + Y+ +
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLGS 132
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELA 779
             +   VHRD++++NVL++ E++  + DFG+ K ++ D    T   +      + APE  
Sbjct: 133 RQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 780 YTMKVTEKCDVYSFGVLALEVI 801
              K     DV+SFGV   E++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELL 211

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 129/285 (45%), Gaps = 40/285 (14%)
Query: 604 FDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQ---EFLNEVKALTE-- 657
           +D +  IG+G    V      A+G   AVK        E+T ++   E L EV+  T   
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM------EVTAERLSPEQLEEVREATRRE 149
Query: 658 -------IWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
                    H +I+ +         +F+V++  +   L   L+   A   L      +++
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIM 206
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
           + +++A+S++H +    IVHRD+  +N+LLD   +  +SDFG +  L+P      EL GT
Sbjct: 207 RSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELCGT 262
Query: 771 YGYVAPE-LAYTMKVT-----EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL 824
            GY+APE L  +M  T     ++ D+++ GV+   ++ G  P        F      + L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP--------FWHRRQILML 314
Query: 825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             +++ +    S    D+  ++ ++    +  +PE+R T ++  Q
Sbjct: 315 RMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    Y ++ + + E+ A K     +  +   +++   E+     + + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +++V E   +C    +L      K +        ++  +  + Y+HN+    +
Sbjct: 110 FFEDDDFVYVVLE---ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + +  + DFG+A  ++ D     +L GT  Y+APE+      + + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEV 223
Query: 789 DVYSFGVLALEVIKGKHP 806
           D++S G +   ++ GK P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 10/202 (4%)
Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            IGKG    V +++ + +G+ +AVK          + Q+ F  EV+    + H NIVK++
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIXKVLNHPNIVKLF 79
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                 + L++V EY    S   +     A             + IV A+ Y H      
Sbjct: 80  EVIETEKTLYLVXEY---ASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-E 786
           IVHRD+ ++N+LLD +    ++DFG +       +      G   Y APEL    K    
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 787 KCDVYSFGVLALEVIKGKHPRD 808
           + DV+S GV+   ++ G  P D
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 8   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 65
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 66  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQ 122
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I + ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 123 IAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 232
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 233 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 266

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 72
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 129
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 239
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 240 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 273

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 57  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 110
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 165
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 166 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 280
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 281 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 306

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 70
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 127
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 237
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 238 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 56  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 109
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 164
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 165 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 279
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 280 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 305

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 23/233 (9%)
Query: 640 GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK 699
           G  +FQ    + + A+  + H +IV++ G C     L +V +Y  + SL   +     A 
Sbjct: 73  GRQSFQA-VTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA- 129
Query: 700 NLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP 759
            LG    +N    I   + Y+       +VHR+++++NVLL   ++  V+DFG+A  L P
Sbjct: 130 -LGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 185
Query: 760 DSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFS 816
           D     ++E      ++A E  +  K T + DV+S+GV   E++  G  P        ++
Sbjct: 186 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--------YA 237
Query: 817 SLNLNIALDEMLD-PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            L L    D +    RL  P     D  + +V V    +DEN   RPT +++ 
Sbjct: 238 GLRLAEVPDLLEKGERLAQPQICTID--VYMVMVKCWMIDEN--IRPTFKELA 286

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 119/258 (46%), Gaps = 32/258 (12%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           +AVK   S    +   ++  ++E+K ++ +  H NIV + G C H   + ++ EY     
Sbjct: 71  VAVKMLKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 688 LAVILSNDAAA-------KNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVL 739
           L   L   A A       + L     ++    +   ++++ + +C    +HRD++++NVL
Sbjct: 129 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVL 184
Query: 740 LDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLA 797
           L   + A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S+G+L 
Sbjct: 185 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 244
Query: 798 LEVIK---GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCV 854
            E+       +P   ++S  +  +       +M  P      +N++    SI++   +C 
Sbjct: 245 WEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAF--APKNIY----SIMQ---ACW 292
Query: 855 DENPESRPTMQKVCQLLK 872
              P  RPT Q++C  L+
Sbjct: 293 ALEPTHRPTFQQICSFLQ 310

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 640 GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK 699
           G  +FQ    + + A+  + H +IV++ G C     L +V +Y  + SL   +     A 
Sbjct: 55  GRQSFQA-VTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA- 111
Query: 700 NLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP 759
            LG    +N    I   + Y+       +VHR+++++NVLL   ++  V+DFG+A  L P
Sbjct: 112 -LGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167
Query: 760 DSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFS 816
           D     ++E      ++A E  +  K T + DV+S+GV   E++  G  P        ++
Sbjct: 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--------YA 219
Query: 817 SLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            L L   + ++L+   RL  P     D  + +V V    +DEN   RPT +++ 
Sbjct: 220 GLRLA-EVPDLLEKGERLAQPQICTID--VYMVMVKCWMIDEN--IRPTFKELA 268

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 71
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 128
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 238
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 239 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 37  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 90
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 145
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS----NWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 146 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 260
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 261 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 286

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 75
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQ 132
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 242
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 243 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 654
           +I     DF     +GKG  G V++++   + +  A+K     +       +  + E + 
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 655 LTEIWHRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
           L+  W    +  + FC      +LF V EY     L   +    +      +R       
Sbjct: 71  LSLAWEHPFL-THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAE 126
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           I+  L ++H+     IV+RD+   N+LLD +    ++DFG+ K      +      GT  
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD 183
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 69
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 126
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 236
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 237 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 270

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 30  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 83
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 138
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 139 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 253
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 254 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 279

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 71
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 128
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 238
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 239 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 68
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 125
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 235
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 236 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 70
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 127
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 237
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 238 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 74
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 75  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQ 131
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 132 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 241
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 242 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 275

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    Y ++ + + E+ A K     +  +   +++   E+     + + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +++V E   +C    +L      K +        ++  +  + Y+HN+    +
Sbjct: 110 FFEDDDFVYVVLE---ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + +  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEV 223
Query: 789 DVYSFGVLALEVIKGKHP 806
           D++S G +   ++ GK P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 91
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 146
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 147 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 261
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 262 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL      ++  D+++ G +  +++ G  P
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 68
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 125
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 235
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 236 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
           +RA   + D   +G G  G+V  +    +G  +A+KK + P   E+ F +    E++ L 
Sbjct: 23  VRAV--YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLK 79
Query: 657 EIWHRNIVKVYGFCLHVRHL--FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
            + H N++ +         L  F  + Y  M  +   L      + LG  R   ++  ++
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDF-YLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG---TY 771
             L Y+H      I+HRD+   N+ ++ + E  + DFG+A+  + DS    E+ G   T 
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADS----EMXGXVVTR 189
Query: 772 GYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
            Y APE+    M+ T+  D++S G +  E+I GK
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    Y ++ + + E+ A K     +  +   +++   E+     + + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      +++V E   +C    +L      K +        ++  +  + Y+HN+    +
Sbjct: 110 FFEDDDFVYVVLE---ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+ L+ + +  + DFG+A  ++ D      L GT  Y+APE+      + + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEV 223
Query: 789 DVYSFGVLALEVIKGKHP 806
           D++S G +   ++ GK P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 93
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 94  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 150
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 151 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 260
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 261 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 294

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 71
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQ 128
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 238
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 239 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 606 DEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           D   +GKG  G VY  +  S ++ IA+K+       +  + Q    E+     + H+NIV
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIV 82
Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           +  G       + I  E     SL+ +L +                K I++ L Y+H++ 
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 725 FPPIVHRDISSKNVLLD-FENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--AYT 781
              IVHRDI   NVL++ +     +SDFG +K L   +       GT  Y+APE+     
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHP 806
               +  D++S G   +E+  GK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK    L G     + F N E++ + ++ H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG-----KAFKNRELQIMRKLDHC 73
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 74
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 135 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 190
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 101
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 102 VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE   
Sbjct: 158 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 213
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 214 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 264
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 265 CPPTLYSLM---TKCWAYDPSRRP 285

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 606 DEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           D   +GKG  G VY  +  S ++ IA+K+       +  + Q    E+     + H+NIV
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIV 68
Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           +  G       + I  E     SL+ +L +                K I++ L Y+H++ 
Sbjct: 69  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 127
Query: 725 FPPIVHRDISSKNVLLD-FENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--AYT 781
              IVHRDI   NVL++ +     +SDFG +K L   +       GT  Y+APE+     
Sbjct: 128 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 782 MKVTEKCDVYSFGVLALEVIKGKHP 806
               +  D++S G   +E+  GK P
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 33  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 86
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 141
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 142 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 256
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 257 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 282

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 73
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 74  VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE   
Sbjct: 130 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 236
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 237 CPPTLYSLM---TKCWAYDPSRRP 257

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 91
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 146
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 147 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 261
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 262 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 123/262 (46%), Gaps = 36/262 (13%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           +AVK   S    +   ++  ++E+K ++ +  H NIV + G C H   + ++ EY     
Sbjct: 79  VAVKMLKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 688 L-------AVILSNDAA---AKNLGWTRRM-NMIKGIVDALSYMHN-DCFPPIVHRDISS 735
           L       + +L  D A   A +   TR + +    +   ++++ + +C    +HRD+++
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAA 192
Query: 736 KNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSF 793
           +NVLL   + A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S+
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 794 GVLALEVIK---GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVT 850
           G+L  E+       +P   ++S  +  +       +M  P      +N++    SI++  
Sbjct: 253 GILLWEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAF--APKNIY----SIMQ-- 301
Query: 851 ISCVDENPESRPTMQKVCQLLK 872
            +C    P  RPT Q++C  L+
Sbjct: 302 -ACWALEPTHRPTFQQICSFLQ 322

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 122/277 (44%), Gaps = 36/277 (12%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 82
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 136
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 137 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 192
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD-------P 830
                  + + D++S G+  +E+  G++P   I S S S     +A+ E+LD       P
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP---IGSGSGS-----MAIFELLDYIVNEPPP 244
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           +LP+   +     +   +    C+ +NP  R  ++++
Sbjct: 245 KLPSGVFS-----LEFQDFVNKCLIKNPAERADLKQL 276

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 36  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 89
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 144
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 145 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 259
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 260 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 285

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 453
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 454 VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE   
Sbjct: 510 KRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 616
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 617 CPPTLYSLM---TKCWAYDPSRRP 637

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK            + F N E++ + ++ H 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 77
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 138 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 193
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 73
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 37  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 90
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 145
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 146 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 260
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 261 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 286

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK            + F N E++ + ++ H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 73
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 35  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 88
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 143
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGY 773
            Y+ +  F   VHRD++++N +LD +    V+DFG+A+ +         N T       +
Sbjct: 144 KYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 258
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 259 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 284

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 81
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 142 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 197
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 92
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 153 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 208
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 119/258 (46%), Gaps = 32/258 (12%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           +AVK   S    +   ++  ++E+K ++ +  H NIV + G C H   + ++ EY     
Sbjct: 79  VAVKMLKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 688 LAVILSNDAAA-------KNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVL 739
           L   L   A A       + L     ++    +   ++++ + +C    +HRD++++NVL
Sbjct: 137 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVL 192
Query: 740 LDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLA 797
           L   + A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S+G+L 
Sbjct: 193 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 252
Query: 798 LEVIK---GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCV 854
            E+       +P   ++S  +  +       +M  P      +N++    SI++   +C 
Sbjct: 253 WEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAF--APKNIY----SIMQ---ACW 300
Query: 855 DENPESRPTMQKVCQLLK 872
              P  RPT Q++C  L+
Sbjct: 301 ALEPTHRPTFQQICSFLQ 318

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 113/269 (42%), Gaps = 33/269 (12%)
Query: 610 IGKGGQGSVYMS-KLASGE-------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +G G  G+VY    +  GE       I  +++  SP        +E L+E   +  +   
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-----KANKEILDEAYVMAGVGSP 79
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            + ++ G CL      +       C L  +  N      LG    +N    I   +SY+ 
Sbjct: 80  YVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRG---RLGSQDLLNWCMQIAKGMSYLE 136
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELA 779
           +     +VHRD++++NVL+   N   ++DFG+A+ L  D + +    G     ++A E  
Sbjct: 137 D---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 780 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
              + T + DV+S+GV   E++  G  P D I +     L     L++    RLP P   
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-----LEK--GERLPQPPIC 246
Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKV 867
                I +  + + C   + E RP  +++
Sbjct: 247 T----IDVYMIMVKCWMIDSECRPRFREL 271

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 85
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 201
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 85
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 201
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 73
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 74  VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE   
Sbjct: 130 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 236
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 237 CPPTLYSLM---TKCWAYDPSRRP 257

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 610 IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +GKG  GSV + +       +G ++AVK+     P +   Q++F  E++ L  +    IV
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIV 74
Query: 665 KVYG--FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G  +    + L +V EY     L   L    A   L  +R +     I   + Y+ +
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 132
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG---YVAPELA 779
                 VHRD++++N+L++ E    ++DFG+AK L  D   +           + APE  
Sbjct: 133 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 780 YTMKVTEKCDVYSFGVLALEVI 801
                + + DV+SFGV+  E+ 
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELF 211

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             YV+PEL       +  D+++ G +  +++ G  P  F +   +      I L+     
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 252
Query: 831 RLPTPSRNVHDKLI 844
           +    +R++ +KL+
Sbjct: 253 KFFPKARDLVEKLL 266

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             YV+PEL       +  D+++ G +  +++ G  P  F +   +      I L+     
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 253
Query: 831 RLPTPSRNVHDKLI 844
           +    +R++ +KL+
Sbjct: 254 KFFPKARDLVEKLL 267

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             YV+PEL       +  D+++ G +  +++ G  P  F +   +      I L+     
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 255
Query: 831 RLPTPSRNVHDKLI 844
           +    +R++ +KL+
Sbjct: 256 KFFPKARDLVEKLL 269

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 453
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 454 VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE   
Sbjct: 510 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 616
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 617 CPPTLYSLM---TKCWAYDPSRRP 637

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 76
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 77  VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE   
Sbjct: 133 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 188
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 189 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 239
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 240 CPPTLYSLM---TKCWAYDPSRRP 260

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 62
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 119
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 229
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 230 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 263

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 73
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             YV+PEL       +  D+++ G +  +++ G  P  F +   +      I L+     
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 252
Query: 831 RLPTPSRNVHDKLI 844
           +    +R++ +KL+
Sbjct: 253 KFFPKARDLVEKLL 266

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 29/279 (10%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 69
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIK 711
             +  + + ++ ++ G CL      I+    ++     +L      K N+G    +N   
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIM----QLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G  
Sbjct: 126 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 772 --GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML 828
              ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++  
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK-- 235
Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
             RLP P        I +  + + C   + +SRP  +++
Sbjct: 236 GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 270

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 78
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 79  VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE   
Sbjct: 135 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 190
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 241
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 242 CPPTLYSLM---TKCWAYDPSRRP 262

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK            + F N E++ + ++ H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 107
Query: 662 NIVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 223
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK            + F N E++ + ++ H 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 78
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 139 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 194
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             YV+PEL       +  D+++ G +  +++ G  P  F +   +      I L+     
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 260
Query: 831 RLPTPSRNVHDKLI 844
           +    +R++ +KL+
Sbjct: 261 KFFPKARDLVEKLL 274

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYXQRTLREIKILLRFRHENIIGIND 92
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGT 770
           IV AL Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S  +      GT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             YV+PEL       +  D+++ G +  +++ G  P  F +   +      I L+     
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 237
Query: 831 RLPTPSRNVHDKLI 844
           +    +R++ +KL+
Sbjct: 238 KFFPKARDLVEKLL 251

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 86
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 147 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 202
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IG G  G+VY  K      + + K   P P +    Q F NEV  L +  H NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQF---QAFRNEVAVLRKTRHVNILLFMGY 100
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
            +   +L IV ++ +  SL   L        +   + +++ +     + Y+H      I+
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---II 154
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAPELAYTMK 783
           HRD+ S N+ L       + DFG+A       S W+      +  G+  ++APE+     
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATV----KSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 784 ---VTEKCDVYSFGVLALEVIKGKHPRDFI 810
               + + DVYS+G++  E++ G+ P   I
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHI 240

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 610 IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +GKG  GSV + +       +G ++AVK+     P +   Q++F  E++ L  +    IV
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIV 75
Query: 665 KVYG--FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G  +    + L +V EY     L   L    A   L  +R +     I   + Y+ +
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 133
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG---YVAPELA 779
                 VHRD++++N+L++ E    ++DFG+AK L  D   +           + APE  
Sbjct: 134 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 780 YTMKVTEKCDVYSFGVLALEVI 801
                + + DV+SFGV+  E+ 
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELF 212

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 609 CIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           CIG+G  G V    YMS       +A+K   +     +  +++FL E   + +  H +IV
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPHIV 74
Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHND 723
           K+ G       ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ + 
Sbjct: 75  KLIGVITE-NPVWIIME---LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYT 781
            F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE    
Sbjct: 131 RF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 186
Query: 782 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRNV 839
            + T   DV+ FGV   E++  G  P        F  +  N  +  + +  RLP P  N 
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-NC 237
Query: 840 HDKLISIVEVTISCVDENPESRP 862
              L S++     C   +P  RP
Sbjct: 238 PPTLYSLM---TKCWAYDPSRRP 257

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEI 658
            DF+    IG+G  G V + K+ + E I   K  +    EM  + E   F  E   L   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKRAETACFREERDVLVNG 147
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLGWTRRMNMIKGIVDA 716
             + I  ++       HL++V +Y+    L  +LS   D   +++       M+  I D+
Sbjct: 148 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DS 206
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVA 775
           +  +H       VHRDI   NVLLD      ++DFG    +  D +  + +A GT  Y++
Sbjct: 207 IHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 260
Query: 776 PELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 806
           PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 610 IGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +GKG  GSV + +       +G ++AVK+     P +   Q++F  E++ L  +    IV
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIV 87
Query: 665 KVYG--FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G  +    + L +V EY     L   L    A   L  +R +     I   + Y+ +
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 145
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG---YVAPELA 779
                 VHRD++++N+L++ E    ++DFG+AK L  D   +           + APE  
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 780 YTMKVTEKCDVYSFGVLALEVI 801
                + + DV+SFGV+  E+ 
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELF 224

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK            + F N E++ + ++ H 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 152
Query: 662 NIVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 213 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 268
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 120/279 (43%), Gaps = 29/279 (10%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 68
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIK 711
             +  + + ++ ++ G CL      I     ++     +L      K N+G    +N   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT----QLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G  
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 772 --GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEML 828
              ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++  
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK-- 234
Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
             RLP P        I +  + + C   + +SRP  +++
Sbjct: 235 GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 111
Query: 662 NIVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 172 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 227
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK    L G     + F N E++ + ++ H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG-----KAFKNRELQIMRKLDHC 73
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK    L G     + F N E++ + ++ H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG-----KAFKNRELQIMRKLDHC 73
Query: 662 NIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEI 658
            DF+    IG+G  G V + K+ + E I   K  +    EM  + E   F  E   L   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKRAETACFREERDVLVNG 131
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLGWTRRMNMIKGIVDA 716
             + I  ++       HL++V +Y+    L  +LS   D   +++       M+  I D+
Sbjct: 132 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DS 190
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVA 775
           +  +H       VHRDI   NVLLD      ++DFG    +  D +  + +A GT  Y++
Sbjct: 191 IHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 244
Query: 776 PELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 806
           PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 609 CIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           CIG+G  G V    YMS       +A+K   +     +  +++FL E   + +  H +IV
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPHIV 71
Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHND 723
           K+ G       ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ + 
Sbjct: 72  KLIGVITE-NPVWIIME---LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYT 781
            F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE    
Sbjct: 128 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 183
Query: 782 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRNV 839
            + T   DV+ FGV   E++  G  P        F  +  N  +  + +  RLP P  N 
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-NC 234
Query: 840 HDKLISIVEVTISCVDENPESRP 862
              L S++     C   +P  RP
Sbjct: 235 PPTLYSLM---TKCWAYDPSRRP 254

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 609 CIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           CIG+G  G V    YMS       +A+K   +     +  +++FL E   + +  H +IV
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPHIV 76
Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHND 723
           K+ G       ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ + 
Sbjct: 77  KLIGVITE-NPVWIIME---LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 132
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYT 781
            F   VHRDI+++NVL+   +   + DFG++++++ DS+ +    G     ++APE    
Sbjct: 133 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 188
Query: 782 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRNV 839
            + T   DV+ FGV   E++  G  P        F  +  N  +  + +  RLP P  N 
Sbjct: 189 RRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-NC 239
Query: 840 HDKLISIVEVTISCVDENPESRP 862
              L S++     C   +P  RP
Sbjct: 240 PPTLYSLM---TKCWAYDPSRRP 259

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 109
Query: 662 NIVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 170 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 225
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 23/219 (10%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSP--------LPGEMTFQQEFLN 650
           AT+ ++    IG G  G+VY ++   SG  +A+K    P        LP     +   L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 651 EVKALTEIWHRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
            ++A     H N+V++   C   R      + +V+E+     L   L + A    L    
Sbjct: 67  RLEAFE---HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAET 121
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
             ++++  +  L ++H +C   IVHRD+  +N+L+       ++DFG+A+      +  T
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LT 177
Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
            +  T  Y APE+          D++S G +  E+ + K
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK            + F N E++ + ++ H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 107
Query: 662 NIVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 223
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 16/217 (7%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-- 659
            DFD    IG+G    V + +L   + I   K    +  E+    E ++ V+    ++  
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV---VKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 660 ---HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
              H  +V ++        LF V EY     L   +      + L           I  A
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA 118
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF-LKPDSSNWTELAGTYGYVA 775
           L+Y+H      I++RD+   NVLLD E    ++D+G+ K  L+P  +  +   GT  Y+A
Sbjct: 119 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIA 174
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 812
           PE+          D ++ GVL  E++ G+ P D + S
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 211

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLAFRHENIIGIND 90
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 144
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+  ++  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 145 --ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 88
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 143 --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 88
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 143 --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 39  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 92
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 147
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDS-SNWTELAGTYGY 773
            ++ +  F   VHRD++++N +LD +    V+DFG+A+ +   + DS  N T       +
Sbjct: 148 KFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 262
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 263 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 288

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 70
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 127
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG AK L  +   +    G   
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 237
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 238 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 97  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 150
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 205
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDS-SNWTELAGTYGY 773
            ++ +  F   VHRD++++N +LD +    V+DFG+A+ +   + DS  N T       +
Sbjct: 206 KFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 320
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 321 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 346

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 101
Query: 662 NIVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y Y 
Sbjct: 162 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 217
Query: 775 APELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           APEL +     T   DV+S G +  E++ G+
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 75
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQ 132
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG AK L  +   +    G   
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 242
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 243 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 23/241 (9%)
Query: 575 SPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKK 633
           S G+S      LT  G+    EI    ND ++   +G G  G V+  +   +G +IAVK+
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEI----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ 57
Query: 634 FHSPLPGEMTFQQEFLNEVKALTEIWH-RNIVKVYGFCLHVRHLFIVYEYFKMCS--LAV 690
                 G     +  L ++  + +      IV+ +G  +    +FI  E    C+  L  
Sbjct: 58  MRRS--GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD 750
            +      + LG      M   IV AL Y+       ++HRD+   N+LLD   +  + D
Sbjct: 116 RMQGPIPERILG-----KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCD 168
Query: 751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKH 805
           FGI+  L  D +     AG   Y+APE       T+     + DV+S G+  +E+  G+ 
Sbjct: 169 FGISGRLVDDKAK-DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 806 P 806
           P
Sbjct: 228 P 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 88
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 143 --ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 16/217 (7%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-- 659
            DFD    IG+G    V + +L   + I   K    +  E+    E ++ V+    ++  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV---VKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 660 ---HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
              H  +V ++        LF V EY     L   +      + L           I  A
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA 122
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF-LKPDSSNWTELAGTYGYVA 775
           L+Y+H      I++RD+   NVLLD E    ++D+G+ K  L+P  +  +   GT  Y+A
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIA 178
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 812
           PE+          D ++ GVL  E++ G+ P D + S
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 39  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 92
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 147
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDS-SNWTELAGTYGY 773
            ++ +  F   VHRD++++N +LD +    V+DFG+A+ +   + DS  N T       +
Sbjct: 148 KFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 262
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 263 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 288

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 120/264 (45%), Gaps = 31/264 (11%)
Query: 608 HCIGKGGQGSV----YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
            CIG+G  G V    YMS       +A+K   +      + +++FL E   + +  H +I
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHI 73
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK-NLGWTRRMNMIKGIVDALSYMHN 722
           VK+ G  +    ++I+ E   +C+L  + S     K +L     +     +  AL+Y+ +
Sbjct: 74  VKLIGV-ITENPVWIIME---LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAY 780
             F   VHRDI+++NVL+   +   + DFG++++++ DS+      G     ++APE   
Sbjct: 130 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESIN 185
Query: 781 TMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLD-PRLPTPSRN 838
             + T   DV+ FGV   E+ + G  P        F  +  N  +  + +  RLP P  N
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPP-N 236
Query: 839 VHDKLISIVEVTISCVDENPESRP 862
               L S++     C   +P  RP
Sbjct: 237 CPPTLYSLM---TKCWAYDPSRRP 257

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 72
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 129
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG AK L  +   +    G   
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 239
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 240 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 273

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 7/206 (3%)
Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   +G+GG G V+  ++ A+G++ A KK +     +    Q  + E K L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 663 IVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYM 720
           IV + Y F      L +V        +   + N D         R +     IV  L ++
Sbjct: 247 IVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H      I++RD+  +NVLLD +    +SD G+A  LK   +     AGT G++APEL  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
             +     D ++ GV   E+I  + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 7/206 (3%)
Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   +G+GG G V+  ++ A+G++ A KK +     +    Q  + E K L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 663 IVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYM 720
           IV + Y F      L +V        +   + N D         R +     IV  L ++
Sbjct: 247 IVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H      I++RD+  +NVLLD +    +SD G+A  LK   +     AGT G++APEL  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
             +     D ++ GV   E+I  + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 96
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 150
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 151 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 240

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 88
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 143 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 56/284 (19%)
Query: 610 IGKGGQGSV-YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI----- 663
           +G+G  G V  M  + SG+I+AVK+  + +  +   Q+  L ++    +I  R +     
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDL----DISMRTVDCPFT 112
Query: 664 VKVYGFCLHVRHLFIVYE---------YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           V  YG       ++I  E         Y ++      +  D   K         +   IV
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK---------IAVSIV 163
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H+     ++HRD+   NVL++   +  + DFGI+ +L  DS   T  AG   Y+
Sbjct: 164 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DSVAKTIDAGCKPYM 220
Query: 775 APEL--------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE 826
           APE          Y++    K D++S G+  +E+   + P D   +  F  L   +   E
Sbjct: 221 APERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGT-PFQQLKQVV---E 272
Query: 827 MLDPRLPTPSRNVHDKL-ISIVEVTISCVDENPESRPTMQKVCQ 869
              P+LP       DK     V+ T  C+ +N + RPT  ++ Q
Sbjct: 273 EPSPQLPA------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 126/299 (42%), Gaps = 50/299 (16%)
Query: 609 CIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           C+GKG  G V+   L  GE +AVK F S        + E  N V     + H NI+    
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVL----LRHDNILGFIA 69
Query: 669 FCLHVR----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
             +  R     L+++  Y +  SL   L       +L     + +       L+++H + 
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEI 125
Query: 725 F-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-----GTYGYV 774
           F     P I HRD  S+NVL+    +  ++D G+A  +    S++ ++      GT  Y+
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 775 APELAYTMKVTEKC-------DVYSFGVLALEVIKGKHPRDFISSM------------SF 815
           APE+    ++   C       D+++FG++  E+ +       +               SF
Sbjct: 185 APEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSF 243
Query: 816 SSLNLNIALDEMLDPRLPT-PSRNVHDKLIS-IVEVTISCVDENPESRPTMQKVCQLLK 872
             +   + +D+    + PT P+R   D ++S + ++   C   NP +R T  ++ + L+
Sbjct: 244 EDMKKVVCVDQ----QTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQ 298

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 7/206 (3%)
Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   +G+GG G V+  ++ A+G++ A KK +     +    Q  + E K L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 663 IVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYM 720
           IV + Y F      L +V        +   + N D         R +     IV  L ++
Sbjct: 247 IVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H      I++RD+  +NVLLD +    +SD G+A  LK   +     AGT G++APEL  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
             +     D ++ GV   E+I  + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 90
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 144
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 145 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 92
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 16/217 (7%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-- 659
            DFD    IG+G    V + +L   + I   +    +  E+    E ++ V+    ++  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV---VKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 660 ---HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
              H  +V ++        LF V EY     L   +      + L           I  A
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA 165
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF-LKPDSSNWTELAGTYGYVA 775
           L+Y+H      I++RD+   NVLLD E    ++D+G+ K  L+P  +  T   GT  Y+A
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 221
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 812
           PE+          D ++ GVL  E++ G+ P D + S
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 91
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 146
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDS-SNWTELAGTYGY 773
            ++ +  F   VHRD++++N +LD +    V+DFG+A+ +   + DS  N T       +
Sbjct: 147 KFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 261
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 262 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 43  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 96
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 151
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDS-SNWTELAGTYGY 773
            ++ +  F   VHRD++++N +LD +    V+DFG+A+ +   + DS  N T       +
Sbjct: 152 KFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 266
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 267 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 292

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 108
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 162
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 163 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 7/206 (3%)
Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   +G+GG G V+  ++ A+G++ A KK +     +    Q  + E K L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 663 IVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYM 720
           IV + Y F      L +V        +   + N D         R +     IV  L ++
Sbjct: 247 IVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H      I++RD+  +NVLLD +    +SD G+A  LK   +     AGT G++APEL  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
             +     D ++ GV   E+I  + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 88
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 143 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 68
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 125
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG AK L  +   +    G   
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 235
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 236 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/319 (23%), Positives = 133/319 (41%), Gaps = 75/319 (23%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNE--VKALTEIWHRNIVKVY 667
           IG+G  G+VY   L     +AVK F          +Q F+NE  +  +  + H NI +  
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVF------SFANRQNFINEKNIYRVPLMEHDNIARFI 73
Query: 668 GFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                V         +V EY+   SL   LS   +     W     +   +   L+Y+H 
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHT 129
Query: 723 DC------FPPIVHRDISSKNVLLDFENEAHVSDFGIA------KFLKP---DSSNWTEL 767
           +        P I HRD++S+NVL+  +    +SDFG++      + ++P   D++  +E+
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 768 AGTYGYVAPEL---AYTMKVTE----KCDVYSFGVLALEVIK------------------ 802
            GT  Y+APE+   A  ++  E    + D+Y+ G++  E+                    
Sbjct: 190 -GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 803 ----GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENP 858
               G HP       +F  + + ++  E   P+ P   +     + S+ E    C D++ 
Sbjct: 249 QTEVGNHP-------TFEDMQVLVS-REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 859 ESRPTMQ----KVCQLLKI 873
           E+R T Q    ++ +L+ I
Sbjct: 301 EARLTAQXAEERMAELMMI 319

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 16/217 (7%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-- 659
            DFD    IG+G    V + +L   + I   K    +  E+    E ++ V+    ++  
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV---VKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 660 ---HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
              H  +V ++        LF V EY     L   +      + L           I  A
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA 133
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF-LKPDSSNWTELAGTYGYVA 775
           L+Y+H      I++RD+   NVLLD E    ++D+G+ K  L+P  +  +   GT  Y+A
Sbjct: 134 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIA 189
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 812
           PE+          D ++ GVL  E++ G+ P D + S
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 226

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 36  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 89
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 144
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDS-SNWTELAGTYGY 773
            ++ +  F   VHRD++++N +LD +    V+DFG+A+ +   + DS  N T       +
Sbjct: 145 KFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 259
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 260 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 285

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 44/276 (15%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLP--------GEMTFQQEFLNEVKALTEIWHR 661
           IG+G  G VY   L   +    KK H  +         GE++   +FL E   + +  H 
Sbjct: 38  IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVS---QFLTEGIIMKDFSHP 91
Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDAL 717
           N++ + G CL       +V  Y K   L   + N+      K+L     +     +   +
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 146
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDS-SNWTELAGTYGY 773
            ++ +  F   VHRD++++N +LD +    V+DFG+A+ +   + DS  N T       +
Sbjct: 147 KFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPR- 831
           +A E   T K T K DV+SFGVL  E++ +G  P   +++   +   L      +L P  
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEY 261
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            P P          + EV + C     E RP+  ++
Sbjct: 262 CPDP----------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG G V       +GE +A+K+    L  +   ++ +  E++ + ++ H N+V    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 79
Query: 669 FCLHVRHL------FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
               ++ L       +  EY +   L   L+       L       ++  I  AL Y+H 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 723 DCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +    I+HRD+  +N++L    +     + D G AK L       TE  GT  Y+APEL 
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPELL 195
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
              K T   D +SFG LA E I G  P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG G V       +GE +A+K+    L  +   ++ +  E++ + ++ H N+V    
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 80
Query: 669 FCLHVRHL------FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
               ++ L       +  EY +   L   L+       L       ++  I  AL Y+H 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 723 DCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +    I+HRD+  +N++L    +     + D G AK L       TE  GT  Y+APEL 
Sbjct: 141 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPELL 196
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
              K T   D +SFG LA E I G  P
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  LS+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 71
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQ 128
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 238
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  +   C   + +SRP  +++
Sbjct: 239 ERLPQPPICT----IDVYMIMRKCWMIDADSRPKFREL 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 101/225 (44%), Gaps = 20/225 (8%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           +E L+E   +  + + ++ ++ G CL      I+      C L  +  +     N+G   
Sbjct: 69  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHK---DNIGSQY 125
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
            +N    I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   + 
Sbjct: 126 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 766 ELAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNI 822
              G     ++A E       T + DV+S+GV   E++  G  P D I +   SS+    
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---- 238
Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            L++    RLP P        I +  + + C   + +SRP  +++
Sbjct: 239 -LEK--GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 614 GQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           G+GS    KLA    +G+ +A+K  +  +  +   Q     E+  L  + H +I+K+Y  
Sbjct: 22  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 81
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 + +V EY        I+  D  ++     RR    + I+ A+ Y H      IV
Sbjct: 82  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCHRH---KIV 134
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKC 788
           HRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  +    + 
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEV 193
Query: 789 DVYSFGVLALEVIKGKHPRD 808
           DV+S GV+   ++  + P D
Sbjct: 194 DVWSCGVILYVMLCRRLPFD 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 614 GQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           G+GS    KLA    +G+ +A+K  +  +  +   Q     E+  L  + H +I+K+Y  
Sbjct: 17  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 76
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 + +V EY        I+  D  ++     RR    + I+ A+ Y H      IV
Sbjct: 77  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCHRH---KIV 129
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKC 788
           HRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  +    + 
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEV 188
Query: 789 DVYSFGVLALEVIKGKHPRD 808
           DV+S GV+   ++  + P D
Sbjct: 189 DVWSCGVILYVMLCRRLPFD 208

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 93
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 147
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 148 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 86
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 140
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 141 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 94
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 148
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 149 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 238

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 85
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 139
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 140 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 229

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 92
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N F     +GKGG G V   ++ A+G++ A KK       +   +   LNE + L ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLGWT-----RRMNMIK 711
           R +V           L   YE      L + L N    K    ++G       R +    
Sbjct: 244 RFVVS----------LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   L  +H +    IV+RD+  +N+LLD      +SD G+A  + P+        GT 
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTV 349
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           GY+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 86
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 140
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 141 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 123/262 (46%), Gaps = 36/262 (13%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           +AVK   S    +   ++  ++E+K ++ +  H NIV + G C H   + ++ EY     
Sbjct: 79  VAVKMLKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 688 L-------AVILSNDAA---AKNLGWTRRM-NMIKGIVDALSYMHN-DCFPPIVHRDISS 735
           L       + +L  D A   A +   TR + +    +   ++++ + +C    +HRD+++
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAA 192
Query: 736 KNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSF 793
           +NVLL   + A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S+
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 794 GVLALEVIK---GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVT 850
           G+L  E+       +P   ++S  +  +       +M  P      +N++    SI++  
Sbjct: 253 GILLWEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAF--APKNIY----SIMQ-- 301
Query: 851 ISCVDENPESRPTMQKVCQLLK 872
            +C    P  RPT Q++C  L+
Sbjct: 302 -ACWALEPTHRPTFQQICSFLQ 322

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLAFRHENIIGIND 90
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 144
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 145 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 614 GQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           G+GS    KLA    +G+ +A+K  +  +  +   Q     E+  L  + H +I+K+Y  
Sbjct: 23  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 82
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 + +V EY        I+  D  ++     RR    + I+ A+ Y H      IV
Sbjct: 83  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCHRH---KIV 135
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKC 788
           HRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  +    + 
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEV 194
Query: 789 DVYSFGVLALEVIKGKHPRD 808
           DV+S GV+   ++  + P D
Sbjct: 195 DVWSCGVILYVMLCRRLPFD 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKELNH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+        +  + +A   +      + +  ++  L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMV 205

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 68
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQ 125
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 235
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  +   C   + +SRP  +++
Sbjct: 236 ERLPQPPICT----IDVYMIMRKCWMIDADSRPKFREL 269

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEV---KAL 655
           AT+ ++    IG G  G+VY ++   SG  +A+K    P  GE       + EV   + L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN-GEEGLPISTVREVALLRRL 60
Query: 656 TEIWHRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
               H N+V++   C   R      + +V+E+     L   L + A    L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLM 118
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
           +  +  L ++H +C   IVHRD+  +N+L+       ++DFG+A+      +    +  T
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPVVVT 174
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
             Y APE+          D++S G +  E+ + K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEV---KAL 655
           AT+ ++    IG G  G+VY ++   SG  +A+K    P  GE       + EV   + L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN-GEEGLPISTVREVALLRRL 60
Query: 656 TEIWHRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
               H N+V++   C   R      + +V+E+     L   L + A    L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLM 118
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
           +  +  L ++H +C   IVHRD+  +N+L+       ++DFG+A+      + +  +  T
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-T 174
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
             Y APE+          D++S G +  E+ + K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 601 TNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKK---FHSPLPGEMTFQQEFLNEVKALT 656
           ++DF  +  +G+G  G V   +   +GEI+A+KK   F  PL     F    L E+K L 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-----FALRTLREIKILK 64
Query: 657 EIWHRNIVKVYGFCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              H NI+ ++         +   ++I+ E  +     VI +   +  ++ +      I 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIY 119
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-------- 763
             + A+  +H      ++HRD+   N+L++   +  V DFG+A+ +   +++        
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 764 --WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEV 800
              TE   T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 601 TNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKK---FHSPLPGEMTFQQEFLNEVKALT 656
           ++DF  +  +G+G  G V   +   +GEI+A+KK   F  PL     F    L E+K L 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-----FALRTLREIKILK 64
Query: 657 EIWHRNIVKVYGFCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              H NI+ ++         +   ++I+ E  +     VI +   +  ++ +      I 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIY 119
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-------- 763
             + A+  +H      ++HRD+   N+L++   +  V DFG+A+ +   +++        
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 764 --WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEV 800
              TE   T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+  M  L   + + +A   +      + +  ++  L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N F     +GKGG G V   ++ A+G++ A KK       +   +   LNE + L ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLGWT-----RRMNMIK 711
           R +V           L   YE      L + L N    K    ++G       R +    
Sbjct: 244 RFVVS----------LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            I   L  +H +    IV+RD+  +N+LLD      +SD G+A  + P+        GT 
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTV 349
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           GY+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           +E L+E   +  + + ++ ++ G CL      I       C L  +  +     N+G   
Sbjct: 69  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQY 125
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
            +N    I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   + 
Sbjct: 126 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 766 ELAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNI 822
              G     ++A E       T + DV+S+GV   E++  G  P D I +   SS+    
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---- 238
Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            L++    RLP P        I +  + + C   + +SRP  +++
Sbjct: 239 -LEK--GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+  M     +  + +A   +      + +  ++  L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 121 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 78
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 79  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 135
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 136 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 245
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  +   C   + +SRP  +++
Sbjct: 246 ERLPQPPICT----IDVYMIMRKCWMIDADSRPKFREL 279

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 614 GQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           G+GS    KLA    +G+ +A+K  +  +  +   Q     E+  L  + H +I+K+Y  
Sbjct: 13  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 72
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 + +V EY        I+  D  ++     RR    + I+ A+ Y H      IV
Sbjct: 73  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF--FQQIISAVEYCHRH---KIV 125
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKC 788
           HRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE ++  +    + 
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEV 184
Query: 789 DVYSFGVLALEVIKGKHPRD 808
           DV+S GV+   ++  + P D
Sbjct: 185 DVWSCGVILYVMLCRRLPFD 204

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 56/284 (19%)
Query: 610 IGKGGQGSV-YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI----- 663
           +G+G  G V  M  + SG+I+AVK+  + +  +   Q+  L ++    +I  R +     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDL----DISMRTVDCPFT 68
Query: 664 VKVYGFCLHVRHLFIVYE---------YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           V  YG       ++I  E         Y ++      +  D   K         +   IV
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK---------IAVSIV 119
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H+     ++HRD+   NVL++   +  + DFGI+ +L  D +   + AG   Y+
Sbjct: 120 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYM 176
Query: 775 APEL--------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE 826
           APE          Y++    K D++S G+  +E+   + P D   +  F  L   +   E
Sbjct: 177 APERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGT-PFQQLKQVV---E 228
Query: 827 MLDPRLPTPSRNVHDKLIS-IVEVTISCVDENPESRPTMQKVCQ 869
              P+LP       DK  +  V+ T  C+ +N + RPT  ++ Q
Sbjct: 229 EPSPQLPA------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKELNH 68
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+        +  + +A   +      + +  ++  L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMV 205

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKELNH 61
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+        +  + +A   +      + +  ++  L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMV 198

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 46/185 (24%), Positives = 83/185 (44%), Gaps = 8/185 (4%)
Query: 625 SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK 684
           +G  +AVK  +      +    +   E++ L    H +I+K+Y         F+V EY  
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN 744
              L   +      + +   R   + + I+ A+ Y H      +VHRD+  +NVLLD   
Sbjct: 95  GGELFDYICKHGRVEEMEARR---LFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHM 148
Query: 745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKG 803
            A ++DFG++  +  D     +  G+  Y APE ++  +    + D++S GV+   ++ G
Sbjct: 149 NAKIADFGLSNMMS-DGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 804 KHPRD 808
             P D
Sbjct: 208 TLPFD 212

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 118/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +  G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 68
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 125
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG+AK L  +   +    G   
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 235
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  + + C   + +SRP  +++
Sbjct: 236 ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+  M  L   + + +A   +      + +  ++  L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 119 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 8/207 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           ++F+    +GKG  G V ++++  +G++ AVK     +  +    +  + E + L+   +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 661 RNIVKVYGFCLHV-RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
              +     C      LF V E+     L   +     ++     R       I+ AL +
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMF 139
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H+     I++RD+   NVLLD E    ++DFG+ K    +        GT  Y+APE+ 
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
             M      D ++ GVL  E++ G  P
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 92
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++     +  ++ +      +  I+  L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+        +  + +A   +      + +  ++  L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+
Sbjct: 119 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEV---KAL 655
           AT+ ++    IG G  G+VY ++   SG  +A+K    P  GE       + EV   + L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN-GEEGLPISTVREVALLRRL 60
Query: 656 TEIWHRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
               H N+V++   C   R      + +V+E+     L   L + A    L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLM 118
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
           +  +  L ++H +C   IVHRD+  +N+L+       ++DFG+A+      +    +  T
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVT 174
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
             Y APE+          D++S G +  E+ + K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+  M  L   + + +A   +      + +  ++  L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+        +  + +A   +      + +  ++  L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKELNH 60
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A++K  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 92
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
           L EV+ L ++ H NI+K++         +IV E +    L          K         
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR 125
Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKFLKPDSSNWT 765
           +IK +   ++YMH      IVHRD+  +N+LL+ +    +  + DFG++   +  ++   
Sbjct: 126 IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMK 181
Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +  GT  Y+APE+       EKCDV+S GV+   ++ G  P
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
           L EV+ L ++ H NI+K++         +IV E +    L          K         
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR 125
Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKFLKPDSSNWT 765
           +IK +   ++YMH      IVHRD+  +N+LL+ +    +  + DFG++   +  ++   
Sbjct: 126 IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMK 181
Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +  GT  Y+APE+       EKCDV+S GV+   ++ G  P
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 65
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 180
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMV 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 125
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL  +L      K  G      + K    ++  L
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGL 179
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 180 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 235
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  + + D++S G+  +E+  G++P
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 118/288 (40%), Gaps = 47/288 (16%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 92
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L     +K   +    ++ K   D L+  H
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----SKRNEFVPYKDLYK---DFLTLEH 145
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+  +  PD     +
Sbjct: 146 LICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 205
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 253
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 254 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 96/205 (46%), Gaps = 8/205 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 781 TMK-VTEKCDVYSFGVLALEVIKGK 804
             K  +   D++S G +  E++  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 11/237 (4%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N+F+    +GKG  G V + K  A+G   A+K     +          L E + L    H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
             +  + Y F  H R  F++ EY     L   LS +   +     R       IV AL Y
Sbjct: 68  PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDY 123
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H++    +V+RD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+ 
Sbjct: 124 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                    D +  GV+  E++ G+ P     +     L   I ++E+  PR   P 
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLFELILMEEIRFPRTLGPE 235

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 649 LNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
           L EV+ L ++ H NI+K++         +IV E +    L          K         
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR 125
Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKFLKPDSSNWT 765
           +IK +   ++YMH      IVHRD+  +N+LL+ +    +  + DFG++   + ++    
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMK 181
Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +  GT  Y+APE+       EKCDV+S GV+   ++ G  P
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFC--LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
           ++   E+  L ++ H N+VK+       +  HL++V+E      +  + +    +++   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN 763
               ++IKGI     Y+H   +  I+HRDI   N+L+  +    ++DFG++   K   + 
Sbjct: 141 FYFQDLIKGI----EYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 764 WTELAGTYGYVAPE-LAYTMKV--TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL 820
            +   GT  ++APE L+ T K+   +  DV++ GV     + G+ P  F+       L+ 
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMDE-RIMCLHS 250
Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESR 861
            I    +  P  P  + ++ D +  +       +D+NPESR
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRM-------LDKNPESR 284

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 19/227 (8%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           ++E   EV  L  + H NIV+          L+IV +Y   C    +     A K + + 
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY---CEGGDLFKRINAQKGVLFQ 123
Query: 705 RR--MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
               ++    I  AL ++H+     I+HRDI S+N+ L  +    + DFGIA+ L     
Sbjct: 124 EDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI 822
                 GT  Y++PE+        K D+++ G +  E+   KH        +F + ++  
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH--------AFEAGSMKN 232
Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            + +++    P  S +    L S+V         NP  RP++  + +
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILE 276

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 595 EEIIRATNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           EE+  AT+       +G+G  G V+ M    +G   AVKK    +     F+ E L    
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-----FRAEELMACA 140
Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI 713
            LT      IV +YG       + I  E  +  SL  ++        L   R +  +   
Sbjct: 141 GLTSP---RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC---LPEDRALYYLGQA 194
Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           ++ L Y+H+     I+H D+ + NVLL  + + A + DFG A  L+PD    + L G Y 
Sbjct: 195 LEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYI 251
Query: 772 ----GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                ++APE+        K DV+S   + L ++ G HP
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 70
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I+      C L  +  +     N+G    +N    
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 127
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG AK L  +   +    G   
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 237
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  +   C   + +SRP  +++
Sbjct: 238 ERLPQPPICT----IDVYMIMRKCWMIDADSRPKFREL 271

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 8/185 (4%)
Query: 625 SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK 684
           +G  +AVK  +      +    +   E++ L    H +I+K+Y         F+V EY  
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN 744
              L   +      + +   R   + + I+ A+ Y H      +VHRD+  +NVLLD   
Sbjct: 95  GGELFDYICKHGRVEEMEARR---LFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHM 148
Query: 745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKG 803
            A ++DFG++  +  D        G+  Y APE ++  +    + D++S GV+   ++ G
Sbjct: 149 NAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 804 KHPRD 808
             P D
Sbjct: 208 TLPFD 212

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 8/207 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N+F+    +GKG  G V + K  A+G   A+K     +          L E + L    H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
             +  + Y F  H R  F++ EY     L   LS +   +     R       IV AL Y
Sbjct: 70  PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDY 125
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H++    +V+RD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+ 
Sbjct: 126 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 183
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
                    D +  GV+  E++ G+ P
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    SGE +A+KK   P   E+ F +    E+  L  + H N++ +  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAYRELLLLKHMQHENVIGLLD 108
Query: 669 FCLHVRHLFIVYEY-----FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                  L   Y++     F    L  I+  + + + + +     ++  ++  L Y+H+ 
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHSA 163
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-M 782
               +VHRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+  + M
Sbjct: 164 G---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV---VTRWYRAPEVILSWM 217
Query: 783 KVTEKCDVYSFGVLALEVIKGK 804
              +  D++S G +  E++ GK
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 601 TNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKK---FHSPLPGEMTFQQEFLNEVKALT 656
           ++DF  +  +G+G  G V   +   +GEI+A+KK   F  PL     F    L E+K L 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-----FALRTLREIKILK 64
Query: 657 EIWHRNIVKVYGFCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              H NI+ ++         +   ++I+ E  +     VI +   +  ++ +      I 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIY 119
Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-------- 763
             + A+  +H      ++HRD+   N+L++   +  V DFG+A+ +   +++        
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 764 --WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEV 800
               E   T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 44/81 (54%)
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           I++RD+   NV+LD E    ++DFG+ K    D     E  GT  Y+APE+       + 
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKS 200
Query: 788 CDVYSFGVLALEVIKGKHPRD 808
            D +++GVL  E++ G+ P D
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFD 221

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 42/287 (14%)
Query: 236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNY 295
           L+NLT +N   N L+   P   +NL KL  +L+ +NQ     P L NLT+L  + L  N 
Sbjct: 62  LNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQ 118
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
           +T    +      NL  ++LS N    +IS+  G    L  L+F  N +T   P  + + 
Sbjct: 119 ITD--IDPLKNLTNLNRLELSSNTI-SDISALSGLT-SLQQLNFG-NQVTDLKP--LANL 171
Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP----------------- 398
           + L  LD+SSN  V +I + L KL     L+  +NQ+S  ++P                 
Sbjct: 172 TTLERLDISSNK-VSDISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQL 228
Query: 399 ----KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
                L SL  L  LDL++N++SN  P S     L  L+EL L  N +    P  +  + 
Sbjct: 229 KDIGTLASLTNLTDLDLANNQISNLAPLS----GLTKLTELKLGANQISNISP--LAGLT 282
Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
           +L  L L+ N L  + P     +  L ++ + +N +    P S+  K
Sbjct: 283 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 327

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 11/237 (4%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N+F+    +GKG  G V + K  A+G   A+K     +          L E + L    H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 661 RNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
             +  + Y F  H R  F++ EY     L   LS +   +     R       IV AL Y
Sbjct: 69  PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDY 124
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H++    +V+RD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+ 
Sbjct: 125 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                    D +  GV+  E++ G+ P     +     L   I ++E+  PR   P 
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLFELILMEEIRFPRTLGPE 236

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 27/278 (9%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEII----AVKKFHSPLPGEMTFQQEFLNEV 652
           I    +F     +G G  G+VY    +  GE +    A+K+       +    +E L+E 
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEA 70
Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG 712
             +  + + ++ ++ G CL      I       C L  +  +     N+G    +N    
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 127
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           I   ++Y+ +     +VHRD++++NVL+       ++DFG AK L  +   +    G   
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++A E       T + DV+S+GV   E++  G  P D I +   SS+     L++   
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--G 237
Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
            RLP P        I +  +   C   + +SRP  +++
Sbjct: 238 ERLPQPPICT----IDVYMIMRKCWMIDADSRPKFREL 271

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 119/271 (43%), Gaps = 45/271 (16%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           +AVK   S    +   ++  ++E+K ++ +  H NIV + G C H   + ++ EY     
Sbjct: 64  VAVKMLKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 121
Query: 688 LAVILSNDAAA--------------------KNLGWTRRMNMIKGIVDALSYMHN-DCFP 726
           L   L   A A                    + L     ++    +   ++++ + +C  
Sbjct: 122 LLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC-- 179
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKV 784
             +HRD++++NVLL   + A + DFG+A+ +  DS+   +        ++APE  +    
Sbjct: 180 --IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 237
Query: 785 TEKCDVYSFGVLALEVIK---GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
           T + DV+S+G+L  E+       +P   ++S  +  +       +M  P      +N++ 
Sbjct: 238 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAF--APKNIY- 291
Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              SI++   +C    P  RPT Q++C  L+
Sbjct: 292 ---SIMQ---ACWALEPTHRPTFQQICSFLQ 316

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 173
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  + + D++S G+  +E+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 42/287 (14%)
Query: 236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNY 295
           L+NLT +N   N L+   P   +NL KL  +L+ +NQ     P L NLT+L  + L  N 
Sbjct: 62  LNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQ 118
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
           +T    +      NL  ++LS N    +IS+  G    L  L+F  N +T   P  + + 
Sbjct: 119 ITD--IDPLKNLTNLNRLELSSNTI-SDISALSGLT-SLQQLNFG-NQVTDLKP--LANL 171
Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP----------------- 398
           + L  LD+SSN  V +I + L KL     L+  +NQ+S  ++P                 
Sbjct: 172 TTLERLDISSNK-VSDISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQL 228
Query: 399 ----KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
                L SL  L  LDL++N++SN  P S     L  L+EL L  N +    P  +  + 
Sbjct: 229 KDIGTLASLTNLTDLDLANNQISNLAPLS----GLTKLTELKLGANQISNISP--LAGLT 282
Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
           +L  L L+ N L  + P     +  L ++ + +N +    P S+  K
Sbjct: 283 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 327

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 165
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 222
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 223 TVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 164
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 221
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 222 TVDIWSVGCIMAELLTGR 239

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 609 CIGKGGQGSVYMSKLASG----EIIAVK-------KFHSPLPGEMTFQQEFLNEVKALTE 657
            +G+G  G V++ K  SG    ++ A+K       K    +  +M        E   L E
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--------ERDILVE 82
Query: 658 IWHRNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDA--AAKNLGWTRRMNMIKGIV 714
           + H  IVK+ Y F    + L+++ ++ +   L   LS +     +++ +      +  + 
Sbjct: 83  VNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----YLAELA 136
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H+     I++RD+  +N+LLD E    ++DFG++K             GT  Y+
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSMSFSSLNLNIALDEMLDP 830
           APE+      T+  D +SFGVL  E++ G  P   +D   +M+   L   + + + L P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM-ILKAKLGMPQFLSP 251

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 609 CIGKGGQGSVYMSKLASG----EIIAVK-------KFHSPLPGEMTFQQEFLNEVKALTE 657
            +G+G  G V++ K  SG    ++ A+K       K    +  +M        E   L E
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--------ERDILVE 82
Query: 658 IWHRNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDA--AAKNLGWTRRMNMIKGIV 714
           + H  IVK+ Y F    + L+++ ++ +   L   LS +     +++ +      +  + 
Sbjct: 83  VNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----YLAELA 136
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H+     I++RD+  +N+LLD E    ++DFG++K             GT  Y+
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSMSFSSLNLNIALDEMLDP 830
           APE+      T+  D +SFGVL  E++ G  P   +D   +M+   L   + + + L P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM-ILKAKLGMPQFLSP 251

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 151
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ ++E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 152 IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 208
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 209 TVDIWSVGCIMAELLTGR 226

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 128/313 (40%), Gaps = 62/313 (19%)
Query: 224 KLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRN 282
           ++  SIP+      N  YLNL ENS+       +++L  L IL L  N  R   +     
Sbjct: 28  EVPASIPV------NTRYLNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNG 81
Query: 283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN 342
           L SL  + L  N LT   +++F     L  + L  N      S  + R P L  LD    
Sbjct: 82  LPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLD---- 137
Query: 343 NITGNVPPEIGHSSQLGVLDLSS-NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
                    +G   +L  +  ++   +V    + LG  N              +  P L 
Sbjct: 138 ---------LGELKRLEYISEAAFEGLVNLRYLNLGMCNL-------------KDIPNLT 175
Query: 402 SLVQLEHLDLSSNRLSNSIP------KSLGNLELIHLSELDLSRNFLREAIPSQICIMQS 455
           +LV+LE L+LS NRL    P       SL  L L+H     + RN   +        ++S
Sbjct: 176 ALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDD--------LKS 227
Query: 456 LEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNE-------------LRGSIPNSTTFKD 502
           LE+LNLSHN+L  L    F  ++ L  + +++N              L+ ++P++TT   
Sbjct: 228 LEELNLSHNNLMSLPHDLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPSNTTCC- 286
Query: 503 APIEALQGNKGLY 515
           A   A  G KG Y
Sbjct: 287 ARCHAPAGLKGRY 299

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 150
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 207
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 208 TVDIWSVGCIMAELLTGR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 90
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDAL 717
             IV  YG       + I  E+    SL      D   K  G      + K    ++  L
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           +Y+       I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y++PE
Sbjct: 145 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 200
Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  + + D++S G+  +E+  G++P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 51/291 (17%)
Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           DF +   IG GG G V+ +K    G+   +K+            ++   EVKAL ++ H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVKALAKLDHV 64
Query: 662 NIVKVYGFCL-----------------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           NIV  Y  C                    + LFI  E+    +L   +      K L   
Sbjct: 65  NIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKV 122
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
             + + + I   + Y+H+     +++RD+   N+ L    +  + DFG+   LK D    
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR- 178
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD--FISSMSFSSLNLNI 822
               GT  Y++PE   +    ++ D+Y+ G++  E++   H  D  F +S  F+ L   I
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFETSKFFTDLRDGI 235
Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
            + ++ D +     + +  KL+S          + PE RP   ++ + L +
Sbjct: 236 -ISDIFDKK----EKTLLQKLLS----------KKPEDRPNTSEILRTLTV 271

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 147
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ ++E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 148 IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 204
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 205 TVDIWSVGCIMAELLTGR 222

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMT--FQQEFLNEVKALTEIWHRNIVKV 666
           +G+G   +VY ++   + +I+A+KK       E      +  L E+K L E+ H NI+ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
                H  ++ +V+++ +   L VI+ +++        +   ++   +  L Y+H     
Sbjct: 78  LDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
            I+HRD+   N+LLD      ++DFG+AK     +  +     T  Y APEL +  ++  
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 787 -KCDVYSFGVLALEVI 801
              D+++ G +  E++
Sbjct: 192 VGVDMWAVGCILAELL 207

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 198
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 199 TVDIWSVGCIMAELLTGR 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 21/242 (8%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N+F+    +GKG  G V + K  A+G   A+K     +          L E + L    H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 661 RNIVKV-YGFCLHVRHLFIVY-----EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
             +  + Y F  H R  F++      E F   S   + S D A +  G          IV
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYG--------AEIV 261
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL Y+H++    +V+RD+  +N++LD +    ++DFG+ K    D +      GT  Y+
Sbjct: 262 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 319
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE+          D +  GV+  E++ G+ P     +     L   I ++E+  PR   
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLFELILMEEIRFPRTLG 376
Query: 835 PS 836
           P 
Sbjct: 377 PE 378

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 98
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 155
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 156 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 212
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 213 TVDIWSVGCIMAELLTGR 230

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 609 CIGKGGQGSVYMSKLASG----EIIAVK-------KFHSPLPGEMTFQQEFLNEVKALTE 657
            +G+G  G V++ K  SG    ++ A+K       K    +  +M        E   L E
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--------ERDILVE 83
Query: 658 IWHRNIVKV-YGFCLHVRHLFIVYEYFKMCSLAVILSNDA--AAKNLGWTRRMNMIKGIV 714
           + H  IVK+ Y F    + L+++ ++ +   L   LS +     +++ +      +  + 
Sbjct: 84  VNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----YLAELA 137
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H+     I++RD+  +N+LLD E    ++DFG++K             GT  Y+
Sbjct: 138 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 194
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSMSFSSLNLNIALDEMLDP 830
           APE+      T+  D +SFGVL  E++ G  P   +D   +M+   L   + + + L P
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM-ILKAKLGMPQFLSP 252

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 21/242 (8%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N+F+    +GKG  G V + K  A+G   A+K     +          L E + L    H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 661 RNIVKV-YGFCLHVRHLFIVY-----EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
             +  + Y F  H R  F++      E F   S   + S D A +  G          IV
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYG--------AEIV 258
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL Y+H++    +V+RD+  +N++LD +    ++DFG+ K    D +      GT  Y+
Sbjct: 259 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE+          D +  GV+  E++ G+ P     +     L   I ++E+  PR   
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLFELILMEEIRFPRTLG 373
Query: 835 PS 836
           P 
Sbjct: 374 PE 375

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 108
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN-----MIKGIVDALSYMHND 723
               +R   I  E  K   L   L      K L      N      +  I+  L Y+H+ 
Sbjct: 109 I---IRAPTI--EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS- 162
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y APE+  
Sbjct: 163 --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 10/206 (4%)
Query: 602 NDFDDEHCIGKGGQGSV-YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V  +    SG I+A K  H  L  +   + + + E++ L E   
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 73
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             IV  YG       + I  E+    SL  +L     AK +       +   ++  L+Y+
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYL 130
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
                  I+HRD+   N+L++   E  + DFG++  L    +N     GT  Y+APE   
Sbjct: 131 REKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMAPERLQ 186
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
               + + D++S G+  +E+  G++P
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 92
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +     E   T  Y APE+  
Sbjct: 147 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +     ++ +A+KK  SP   + T+ Q  L E+K L    H NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 93
Query: 669 FCL-----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    ++ ++IV +  +     ++ +   +  ++ +      +  I+  L Y+H+ 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 147
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+LL+   +  + DFG+A+   PD  +     E   T  Y APE+  
Sbjct: 148 --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 101/226 (44%), Gaps = 44/226 (19%)
Query: 610 IGKGGQGSVYMSKLASG-------EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           IG+G  G V+ ++ A G        ++AVK        +M  Q +F  E   + E  + N
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPN 111
Query: 663 IVKVYGFCLHVRHLFIVYEYFK---------------MCSLA-VILSNDAAAKNLG---- 702
           IVK+ G C   + + +++EY                 +CSL+   LS  A   + G    
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 703 -WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI------AK 755
               ++ + + +   ++Y+    F   VHRD++++N L+       ++DFG+      A 
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
           + K D ++    A    ++ PE  +  + T + DV+++GV+  E+ 
Sbjct: 229 YYKADGND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 151
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 208
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 209 TVDIWSVGCIMAELLTGR 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNAMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEI 658
            DF+    IG+G  G V + KL + + +   K  +    EM  + E   F  E   L   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNG 131
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLGWTRRMNMIKGIVDA 716
             + I  ++       +L++V +Y+    L  +LS   D   + +       M+  I D+
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI-DS 190
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVA 775
           +  +H       VHRDI   N+L+D      ++DFG    L  D +  + +A GT  Y++
Sbjct: 191 VHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 776 PELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 806
           PE+   M     +   +CD +S GV   E++ G+ P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 129
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+  +  PD     +
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 294
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 33/236 (13%)
Query: 582 LLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE 641
           ++ VL  +GK   +  I  TN       IG G  G V+ +KL   + +A+KK        
Sbjct: 24  VIKVLASDGKTGEQREIAYTNC----KVIGNGSFGVVFQAKLVESDEVAIKKVLQ----- 74
Query: 642 MTFQQEFLN-EVKALTEIWHRNIVKVYGFCL------HVRHLFIVYEYFKMCSLAVILSN 694
               + F N E++ +  + H N+V +  F            L +V EY       V  ++
Sbjct: 75  ---DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY---VPETVYRAS 128
Query: 695 DAAAKNLGWTRRMNMIK----GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVS 749
              AK L  T  M +IK     ++ +L+Y+H+     I HRDI  +N+LLD  +    + 
Sbjct: 129 RHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLI 184
Query: 750 DFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGK 804
           DFG AK L     N + +   Y Y APEL +     T   D++S G +  E+++G+
Sbjct: 185 DFGSAKILIAGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + +       T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNY 295
           L+NLT +N   N L+   P   +NL KL  +L+ +NQ     P L NLT+L  + L  N 
Sbjct: 66  LNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQ 122
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD-FSINNITGNVPPEIGH 354
           +T    +      NL  ++LS N       SD      L++L   S  N   ++ P + +
Sbjct: 123 ITD--IDPLKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKP-LAN 174
Query: 355 SSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP---------------- 398
            + L  LD+SSN  V +I + L KL     L+  +NQ+S  ++P                
Sbjct: 175 LTTLERLDISSNK-VSDISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQ 231
Query: 399 -----KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
                 L SL  L  LDL++N++SN  P S     L  L+EL L  N +    P  +  +
Sbjct: 232 LKDIGTLASLTNLTDLDLANNQISNLAPLS----GLTKLTELKLGANQISNISP--LAGL 285
Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
            +L  L L+ N L  + P     +  L ++ + +N +    P S+  K
Sbjct: 286 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 331

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 92
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+  +  PD     +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 257
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNY 295
           L+NLT +N   N L+   P   +NL KL  +L+ +NQ     P L NLT+L  + L  N 
Sbjct: 67  LNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQ 123
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD-FSINNITGNVPPEIGH 354
           +T    +      NL  ++LS N       SD      L++L   S  N   ++ P + +
Sbjct: 124 ITD--IDPLKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKP-LAN 175
Query: 355 SSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP---------------- 398
            + L  LD+SSN  V +I + L KL     L+  +NQ+S  ++P                
Sbjct: 176 LTTLERLDISSNK-VSDISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQ 232
Query: 399 -----KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
                 L SL  L  LDL++N++SN  P S     L  L+EL L  N +    P  +  +
Sbjct: 233 LKDIGTLASLTNLTDLDLANNQISNLAPLS----GLTKLTELKLGANQISNISP--LAGL 286
Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
            +L  L L+ N L  + P     +  L ++ + +N +    P S+  K
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 332

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 63
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 122 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 150
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 207
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 208 TVDIWSVGCIMAELLTGR 225

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 33/281 (11%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 92
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSND----AAAKNL--GWTRRMNMIKGIVD 715
           +V + G C      L ++ E+ K  +L+  L +        K+L   +    ++I     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGY 773
               M        +HRD++++N+LL  +N   + DFG+A+  +  PD     +      +
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           +APE  +    T + DV+SFGVL  E+   G  P               + +DE    RL
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKIDEEFXRRL 260
Query: 833 PTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
              +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 128/313 (40%), Gaps = 62/313 (19%)
Query: 224 KLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRN 282
           ++  SIP+      N  YLNL ENS+       +++L  L IL L  N  R   +     
Sbjct: 28  EVPASIPV------NTRYLNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNG 81
Query: 283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN 342
           L SL  + L  N LT   +++F     L  + L  N      S  + R P L  LD    
Sbjct: 82  LPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLD---- 137
Query: 343 NITGNVPPEIGHSSQLGVLDLSS-NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
                    +G   +L  +  ++   +V    + LG  N              +  P L 
Sbjct: 138 ---------LGELKRLEYISEAAFEGLVNLRYLNLGMCNL-------------KDIPNLT 175
Query: 402 SLVQLEHLDLSSNRLSNSIP------KSLGNLELIHLSELDLSRNFLREAIPSQICIMQS 455
           +LV+LE L+LS NRL    P       SL  L L+H     + RN   +        ++S
Sbjct: 176 ALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDD--------LKS 227
Query: 456 LEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNE-------------LRGSIPNSTTFKD 502
           LE+LNLSHN+L  L    F  ++ L  + +++N              L+ ++P++TT   
Sbjct: 228 LEELNLSHNNLMSLPHDLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPSNTTCC- 286
Query: 503 APIEALQGNKGLY 515
           A   A  G KG Y
Sbjct: 287 ARCHAPAGLKGRY 299

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
           + +++ F     +G G   +VY      +G  +A+K+    L  E       + E+  + 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTAIREISLMK 58
Query: 657 EIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR---MNMIK-- 711
           E+ H NIV++Y        L +V+E+     +   L     ++ +G T R   +N++K  
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEF-----MDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 712 --GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
              ++  L++ H +    I+HRD+  +N+L++   +  + DFG+A+      + ++    
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 770 TYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGK 804
           T  Y AP+ L  +   +   D++S G +  E+I GK
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + +       T  Y APE+    M   +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWMHYNQ 198
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 199 TVDIWSVGCIMAELLTGR 216

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 604 FDDEHC-----IGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           F++ H      +GKG  GSV + +       +G ++AVK+     P +   Q++F  E++
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQ 60
Query: 654 ALTEIWHRNIVKVYG--FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
            L  +    IVK  G  +      L +V EY     L   L    A   L  +R +    
Sbjct: 61  ILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSS 118
Query: 712 GIVDALSYM-HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
            I   + Y+    C    VHRD++++N+L++ E    ++DFG+AK L  D          
Sbjct: 119 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG 174
Query: 771 YG---YVAPELAYTMKVTEKCDVYSFGVLALEV 800
                + APE       + + DV+SFGV+  E+
Sbjct: 175 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 94/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+        +  + +A   +      + +  ++  L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 119 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 156
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 157 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 213
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 214 TVDIWSVGCIMAELLTGR 231

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 83
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+  +  PD     +
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 248
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G+V+ +K   + EI+A+K+       E       L E+  L E+ H+NIV+++ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHD 68
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L +V+E+   C   +    D+   +L      + +  ++  L + H+     +
Sbjct: 69  VLHSDKKLTLVFEF---CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEK 787
           +HRD+  +N+L++   E  ++DFG+A+        ++    T  Y  P++ +  K+ +  
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 788 CDVYSFGVLALEVIKGKHP 806
            D++S G +  E+     P
Sbjct: 183 IDMWSAGCIFAELANAARP 201

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 595 EEIIRATNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           EE+  AT+       +G+G  G V+ M    +G   AVKK    +     F+ E L    
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-----FRAEELMACA 121
Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI 713
            LT      IV +YG       + I  E  +  SL  ++        L   R +  +   
Sbjct: 122 GLTSP---RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC---LPEDRALYYLGQA 175
Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTY- 771
           ++ L Y+H+     I+H D+ + NVLL  + + A + DFG A  L+PD      L G Y 
Sbjct: 176 LEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 772 ----GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                ++APE+        K DV+S   + L ++ G HP
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 157
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 214
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 215 TVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 165
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 222
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 223 TVDIWSVGCIMAELLTGR 240

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 121/275 (44%), Gaps = 27/275 (9%)
Query: 595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVK---KFHSPLPGEMTFQQEFLN 650
           +E+    +DF+    IG+G    V + K+  +G++ A+K   K+     GE++    F  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FRE 110
Query: 651 EVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
           E   L     R I +++       +L++V EY+    L  +LS     + +        +
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYL 168
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-G 769
             IV A+  +H   +   VHRDI   N+LLD      ++DFG    L+ D +  + +A G
Sbjct: 169 AEIVMAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 770 TYGYVAPELAYTMKVTE-------KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI 822
           T  Y++PE+   +           +CD ++ GV A E+  G+ P  F +  +  +    +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP--FYADSTAETYGKIV 283
Query: 823 ALDE-----MLDPRLPTPSRNVHDKLISIVEVTIS 852
              E     ++D  +P  +R+   +L+   E  + 
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLG 318

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 164
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 221
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 222 TVDIWSVGCIMAELLTGR 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 157
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 214
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 215 TVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 150
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 207
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 208 TVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 168
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 225
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 226 TVDIWSVGCIMAELLTGR 243

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 157
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 214
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 215 TVDIWSVGCIMAELLTGR 232

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 92
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+  +  PD     +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 257
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   ++++ H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKLNHQ 108
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 169 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 223
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 276
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 277 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 305

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 147
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 204
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 205 TVDIWSVGCIMAELLTGR 222

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 142
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 199
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 200 TVDIWSVGCIMAELLTGR 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 83
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+  +  PD     +
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 248
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 147
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 204
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 205 TVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 147
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 204
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 205 TVDIWSVGCIMAELLTGR 222

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 50/223 (22%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IGKG  G V+M K   GE +AVK F +    E ++ +E   E+     + H NI+   GF
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRE--TEIYQTVLMRHENIL---GF 96
Query: 670 CL-------HVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
                        L+++ +Y +  SL   L S    AK++     + +    V  L ++H
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-----LKLAYSSVSGLCHLH 151
Query: 722 NDCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIA-KFLKPDSSNWTEL-----AGT 770
            + F     P I HRD+ SKN+L+       ++D G+A KF+    +N  ++      GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI--SDTNEVDIPPNTRVGT 209
Query: 771 YGYVAPEL-----------AYTMKVTEKCDVYSFGVLALEVIK 802
             Y+ PE+           +Y M      D+YSFG++  EV +
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIM-----ADMYSFGLILWEVAR 247

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 44/288 (15%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 93
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L +    + + +    ++ K   D L+  H
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKTPEDLYK---DFLTLEH 149
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+ +   PD     +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 257
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 30/288 (10%)
Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERV-RLDRNY 295
           SN+T LNL  N L    P  +    +L IL  G N      P L  +  L +V  L  N 
Sbjct: 25  SNITVLNLTHNQLRRLPPTNFTRYSQLAILDAGFNSISKLEPELCQILPLLKVLNLQHNE 84
Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG--------- 346
           L+    ++F    NLT +DL  N+ +   S+ +     L  LD S N ++          
Sbjct: 85  LSQISDQTFVFCTNLTELDLMSNSIHKIKSNPFKNQKNLIKLDLSHNGLSSTKLGTGVQL 144
Query: 347 -----------------NVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAH 389
                            +   E   +S L  LDLSSN +    P     +     L+L +
Sbjct: 145 ENLQELLLAKNKILALRSEELEFLGNSSLRKLDLSSNPLKEFSPGCFQTIGKLFALLLNN 204
Query: 390 NQLSGQLSPKLG---SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAI 446
            QL+  L+ KL    S   +++L L++N+L  +   +   L+  +L++LDLS N L +  
Sbjct: 205 AQLNPHLTEKLCWELSNTSIQNLSLANNQLLATSESTFSGLKWTNLTQLDLSYNNLHDVG 264
Query: 447 PSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSI 494
                 + SL  L+L +N++  L P  F  ++ L ++ +     + S+
Sbjct: 265 NGSFSYLPSLRYLSLEYNNIQRLSPRSFYGLSNLRYLSLKRAFTKQSV 312

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 152
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV---ATRWYRAPEIMLNWMHYNQ 209
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 210 TVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 156
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 157 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 213
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 214 TVDIWSVGCIMAELLTGR 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+ K       E       + E+  L E+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETE-GVPSTAIREISLLKELNH 61
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 781 TMK-VTEKCDVYSFGVLALEVIKGK 804
             K  +   D++S G +  E++  +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+ K       E       + E+  L E+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETE-GVPSTAIREISLLKELNH 60
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE+  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 781 TMK-VTEKCDVYSFGVLALEVIKGK 804
             K  +   D++S G +  E++  +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV---K 665
           +G G  GSV  +    SGE +A+KK   P   E+ F +    E+  L  + H N++    
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAYRELLLLKHMQHENVIGLLD 90
Query: 666 VYGFCLHVRHLFIVYEY--FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V+     +R+ +  Y    F    L  I+    + + + +     ++  ++  L Y+H+ 
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHSA 145
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-M 782
               +VHRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+  + M
Sbjct: 146 G---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV---VTRWYRAPEVILSWM 199
Query: 783 KVTEKCDVYSFGVLALEVIKGK 804
              +  D++S G +  E++ GK
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 152
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 209
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 210 TVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 150
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 207
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 208 TVDIWSVGCIMAELLTGR 225

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V + K   +G  +AVK  +      +    +   E++ L    H +I+K+Y 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN--LGWTRRMNMIKGIVDALSYMHNDCFP 726
                  +F+V EY     L      D   KN  L       + + I+  + Y H     
Sbjct: 84  VISTPSDIFMVMEYVSGGELF-----DYICKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVT 785
            +VHRD+  +NVLLD    A ++DFG++  +  D        G+  Y APE ++  +   
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 786 EKCDVYSFGVLALEVIKGKHPRD 808
            + D++S GV+   ++ G  P D
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFD 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 87
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 144
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 145 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 201
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 202 TVDIWSVGCIMAELLTGR 219

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 120/304 (39%), Gaps = 64/304 (21%)
Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           DF +   IG GG G V+ +K    G+   +++            ++   EVKAL ++ H 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYN-------NEKAEREVKALAKLDHV 65
Query: 662 NIVKVYGFCL------------------------------HVRHLFIVYEYFKMCSLAVI 691
           NIV  Y  C                                 + LFI  E+    +L   
Sbjct: 66  NIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 692 LSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF 751
           +      K L     + + + I   + Y+H+     ++HRD+   N+ L    +  + DF
Sbjct: 125 IEKRRGEK-LDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD--F 809
           G+   LK D    T   GT  Y++PE   +    ++ D+Y+ G++  E++   H  D  F
Sbjct: 181 GLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAF 236
Query: 810 ISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            +S  F+ L   I  D + D +  T    +  KL+S          + PE RP   ++ +
Sbjct: 237 ETSKFFTDLRDGIISD-IFDKKEKT----LLQKLLS----------KKPEDRPNTSEILR 281
Query: 870 LLKI 873
            L +
Sbjct: 282 TLTV 285

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKELNH 60
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 151
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 208
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 209 TVDIWSVGCIMAELLTGR 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 152
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV---ATRWYRAPEIMLNWMHYNQ 209
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 210 TVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N   ++ L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ ++E  + DFG+ +    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V  +        +A+KK  SP   + T+ Q  L E++ L    H N++ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQ-TYCQRTLREIQILLRFRHENVIGIRD 108
Query: 669 FCLH-----VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                    +R ++IV +  +     ++ S   +  ++ +      +  I+  L Y+H+ 
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGLKYIHS- 162
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPELAY 780
               ++HRD+   N+L++   +  + DFG+A+   P+  +    TE   T  Y APE+  
Sbjct: 163 --ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 781 TMK-VTEKCDVYSFGVLALE------VIKGKH 805
             K  T+  D++S G +  E      +  GKH
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 86
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 143
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 144 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 200
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 201 TVDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 198
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 199 TVDIWSVGCIMAELLTGR 216

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 120 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 142
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 199
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 200 TVDIWSVGCIMAELLTGR 217

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 152
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV---ATRWYRAPEIMLNWMHYNQ 209
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 210 TVDIWSVGCIMAELLTGR 227

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   ++++ H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKLNHQ 94
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 155 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 209
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 262
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 263 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 291

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N      L       +I  I+  L Y+H+     
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 198
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 199 TVDIWSVGCIMAELLTGR 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNH 62
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NIVK+         L++V+E+     L   + + +A   +      + +  ++  L++ 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+  
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 781 TMK-VTEKCDVYSFGVLALEVI 801
             K  +   D++S G +  E++
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 28/268 (10%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQ---QEFLNEVKALTEIWHRNIVKV 666
           +G+G  GSV    L   +  ++K     +  + + Q   +EFL+E   + +  H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 667 YGFCLH-----VRHLFIVYEYFKMCSLAVIL---SNDAAAKNLGWTRRMNMIKGIVDALS 718
            G C+      +    ++  + K   L   L     +   K++     +  +  I   + 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA-KFLKPDSSNWTELAGT-YGYVAP 776
           Y+ N  F   +HRD++++N +L  +    V+DFG++ K    D      +A     ++A 
Sbjct: 162 YLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 777 ELAYTMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
           E       T K DV++FGV   E+  +G  P   + +       L+         RL  P
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-------GHRLKQP 271
Query: 836 SRNVHDKLISIVEVTISCVDENPESRPT 863
                D L  + E+  SC   +P  RPT
Sbjct: 272 ----EDCLDELYEIMYSCWRTDPLDRPT 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 119 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 168
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    +   +     T  Y APE+    M   +
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV---ATRWYRAPEIMLNWMHYNQ 225
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 226 TVDIWSVGCIMAELLTGR 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 83
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+ +   PD     +
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 248
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 151
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M   +
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 208
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 209 TVDIWSVGCIMAELLTGR 226

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    + +    G     
Sbjct: 195 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLP 249
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 302
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 303 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 331

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+         T    T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGXVATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 610 IGKGGQGSV---YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +G G  GSV   Y ++L   + +AVKK   P    +  ++ +  E++ L  + H N++ +
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 667 YGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
                    +    E + + +L    L+N   ++ L       ++  ++  L Y+H+   
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG- 151
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKV 784
             I+HRD+   NV ++ ++E  + DFG+A+    + + +     T  Y APE+    M  
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV---ATRWYRAPEIMLNWMHY 206
Query: 785 TEKCDVYSFGVLALEVIKGK 804
            +  D++S G +  E+++GK
Sbjct: 207 NQTVDIWSVGCIMAELLQGK 226

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 83
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+ +   PD     +
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 248
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 100
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 161 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 215
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 268
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 269 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 297

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 32/271 (11%)
Query: 607 EHCIGKGGQGSVYMSKL---ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +  IGKG  G VY  +    A   I    K  S +  EM   + FL E   +  + H N+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNV 84
Query: 664 VKVYGFCLH---VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           + + G  L    + H+ + Y    MC   ++    +  +N      ++    +   + Y+
Sbjct: 85  LALIGIMLPPEGLPHVLLPY----MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVA 775
               F   VHRD++++N +LD      V+DFG+A+ +  D   ++     +      + A
Sbjct: 141 AEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHARLPVKWTA 196
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
            E   T + T K DV+SFGVL  E++ +G  P   I     +              RLP 
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-------GRRLPQ 249
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
           P         S+ +V   C + +P  RPT +
Sbjct: 250 PEYCPD----SLYQVMQQCWEADPAVRPTFR 276

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 85
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS----NDAAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 146 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 200
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 253
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 254 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 282

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 92
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     ++       D L+  H
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+ +   PD     +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 257
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKEL 59
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 118 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 779 AYTMK-VTEKCDVYSFGVLALEVIKGK 804
               K  +   D++S G +  E++  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           +  +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIVK+         L++V+E+     L   + + +A   +      + +  ++  L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           + H+     ++HRD+  +N+L++ E    ++DFG+A+        +     T  Y APE+
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 779 AYTMK-VTEKCDVYSFGVLALEVI 801
               K  +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 108
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 169 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 223
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 276
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 277 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 305

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 110
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 171 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 225
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 278
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 279 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 307

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 24/220 (10%)
Query: 600 ATNDFDDEHCIGKGGQGSV-YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
              D  D   IG+G  GSV  M    SG+I+AVK+  S +  E   +Q  ++    +   
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSS 78
Query: 659 WHRNIVKVYGFCLHVRHLFIVYE--------YFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
               IV+ YG        +I  E        ++K   +  +L +    + LG      + 
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKY--VYSVLDDVIPEEILG-----KIT 131
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
              V AL+++  +    I+HRDI   N+LLD      + DFGI+  L  DS   T  AG 
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGC 188
Query: 771 YGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             Y+APE     A       + DV+S G+   E+  G+ P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 111
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    + +    G     
Sbjct: 172 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLP 226
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 279
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 280 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 308

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTE 786
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLI 844
           + DV+S+G+   E+         + S  +  + ++    +M+    R+ +P     +   
Sbjct: 250 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE--- 299
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
            + ++  +C D +P  RPT +++ QL++
Sbjct: 300 -MYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 56/284 (19%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI----- 663
           +G+G  G V   + + SG+I AVK+  + +  +   Q+  L ++    +I  R +     
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQE--QKRLLXDL----DISXRTVDCPFT 95
Query: 664 VKVYGFCLHVRHLFIVYE---------YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           V  YG       ++I  E         Y ++      +  D   K         +   IV
Sbjct: 96  VTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGK---------IAVSIV 146
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H+     ++HRD+   NVL++   +    DFGI+ +L  D +   + AG   Y 
Sbjct: 147 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-AGCKPYX 203
Query: 775 APEL--------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE 826
           APE          Y++    K D++S G+  +E+   + P D   +  F  L   +   E
Sbjct: 204 APERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYDSWGT-PFQQLKQVV---E 255
Query: 827 MLDPRLPTPSRNVHDKL-ISIVEVTISCVDENPESRPTMQKVCQ 869
              P+LP       DK     V+ T  C+ +N + RPT  ++ Q
Sbjct: 256 EPSPQLPA------DKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVYSEQDELDFLMEALIISKFNHQ 108
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 169 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 223
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 276
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 277 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 305

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 113/264 (42%), Gaps = 38/264 (14%)
Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCS 687
           +AVK   S    +   ++  ++E+K ++ +  H NIV + G C H   + ++ EY     
Sbjct: 79  VAVKMLKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 688 LAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDI 733
           L   L                   + L     ++    +   ++++ + +C    +HRD+
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDV 192
Query: 734 SSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVY 791
           +++NVLL   + A + DFG+A+ +  DS+   +        ++APE  +    T + DV+
Sbjct: 193 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 252
Query: 792 SFGVLALEVIK---GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVE 848
           S+G+L  E+       +P   ++S  +  +       +M  P    P         +I  
Sbjct: 253 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAF-APK--------NIYS 300
Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
           +  +C    P  RPT Q++C  L+
Sbjct: 301 IMQACWALEPTHRPTFQQICSFLQ 324

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 165
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DFG+A+    +         T  Y APE+    M   +
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---XVATRWYRAPEIMLNWMHYNQ 222
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 223 TVDIWSVGCIMAELLTGR 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 155 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 209
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 262
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 263 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 291

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           +E + E + + ++ +  IV++ G C     L +V E      L   L      + +  + 
Sbjct: 55  EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSN 111
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
              ++  +   + Y+    F   VHRD++++NVLL   + A +SDFG++K L  D S +T
Sbjct: 112 VAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168
Query: 766 -ELAGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
              AG +   + APE     K + + DV+S+GV   E +  G+ P
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 33/218 (15%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHS-----PLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G   +V+  +   +G++ A+K F++     P+  +M        E + L ++ H+NI
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-------REFEVLKKLNHKNI 69
Query: 664 VKVYGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           VK++        RH  ++ E+    SL  +L   + A  L  +  + +++ +V  ++++ 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 722 NDCFPPIVHRDISSKNVLL----DFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            +    IVHR+I   N++     D ++   ++DFG A+ L+ D   +  L GT  Y+ P+
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPD 185
Query: 778 LAYTMKVTEK---------CDVYSFGVLALEVIKGKHP 806
           + Y   V  K          D++S GV       G  P
Sbjct: 186 M-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 120
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS----NDAAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 181 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 235
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 288
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 289 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 317

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHS-----PLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G   +V+  +   +G++ A+K F++     P+  +M        E + L ++ H+NI
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-------REFEVLKKLNHKNI 69
Query: 664 VKVYGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           VK++        RH  ++ E+    SL  +L   + A  L  +  + +++ +V  ++++ 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 722 NDCFPPIVHRDISSKNVLL----DFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            +    IVHR+I   N++     D ++   ++DFG A+ L+ D   +  L GT  Y+ P+
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPD 185
Query: 778 L--------AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +         +  K     D++S GV       G  P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 94
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +V + G C      L ++ E+ K  +L+  L    + +N     +        D L+  H
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 722 NDCFP-------------PIVHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTE 766
             C+                +HRD++++N+LL  +N   + DFG+A+  +  PD     +
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALD 825
                 ++APE  +    T + DV+SFGVL  E+   G  P               + +D
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKID 259
Query: 826 EMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
           E    RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 260 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 594 YEEIIRA-------TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVK---KFHSPLPGEM 642
           YE+I++          D+D    IG+G  G V + +  AS ++ A+K   KF      + 
Sbjct: 60  YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS 119
Query: 643 TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNL 701
            F  E  + +      W   +V+++      ++L++V EY     L  ++SN D   K  
Sbjct: 120 AFFWEERDIMAFANSPW---VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-- 174
Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
            W +       +V AL  +H+     ++HRD+   N+LLD      ++DFG    +K D 
Sbjct: 175 -WAKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDE 226
Query: 762 SNWTEL---AGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 806
           +         GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 227 TGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS----NDAAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 208
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 261
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 262 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 290

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 610 IGKGGQGSV---YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +G G  GSV   Y ++L   + +AVKK   P    +  ++ +  E++ L  + H N++ +
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 667 YGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
                    +    E + + +L    L+N    + L       ++  ++  L Y+H+   
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG- 151
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKV 784
             I+HRD+   NV ++ ++E  + DFG+A+    + + +     T  Y APE+    M  
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV---ATRWYRAPEIMLNWMHY 206
Query: 785 TEKCDVYSFGVLALEVIKGK 804
            +  D++S G +  E+++GK
Sbjct: 207 NQTVDIWSVGCIMAELLQGK 226

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS----NDAAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLP 208
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 261
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 262 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 290

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 610 IGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQE--FLNEVKALTEIWHR 661
           +G G  G VY  +++      S   +AVK     LP   + Q E  FL E   +++  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGT---- 770
            Y+  + F   +HRDI+++N LL        A + DFG+A+ +    +++    G     
Sbjct: 155 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY--RASYYRKGGCAMLP 209
Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             ++ PE       T K D +SFGVL  E+         +  M + S +    L+ +   
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------LGYMPYPSKSNQEVLEFVTSG 262
Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
               P +N    +  I+     C    PE RP
Sbjct: 263 GRMDPPKNCPGPVYRIM---TQCWQHQPEDRP 291

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 611 GKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV---- 666
            +G  G V+ ++L + + +AVK F  PL  + ++Q E   E+ +   + H N+++     
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIF--PLQDKQSWQSE--REIFSTPGMKHENLLQFIAAE 78
Query: 667 -YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND-- 723
             G  L V  L+++  +    SL   L  +     + W    ++ + +   LSY+H D  
Sbjct: 79  KRGSNLEVE-LWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVP 133
Query: 724 -CF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGTYGYVA 775
            C      P I HRD  SKNVLL  +  A ++DFG+A   +P     +     GT  Y+A
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMA 193
Query: 776 PE-----LAYTMKVTEKCDVYSFGVLALEVI 801
           PE     + +      + D+Y+ G++  E++
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + D+G+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTE 786
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLI 844
           + DV+S+G+   E+         + S  +  + ++    +M+    R+ +P     +   
Sbjct: 227 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE--- 276
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
            + ++  +C D +P  RPT +++ QL++
Sbjct: 277 -MYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTE 786
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLI 844
           + DV+S+G+   E+         + S  +  + ++    +M+    R+ +P     +   
Sbjct: 250 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE--- 299
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
            + ++  +C D +P  RPT +++ QL++
Sbjct: 300 -MYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTE 786
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 244
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLI 844
           + DV+S+G+   E+         + S  +  + ++    +M+    R+ +P     +   
Sbjct: 245 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE--- 294
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
            + ++  +C D +P  RPT +++ QL++
Sbjct: 295 -MYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 39/241 (16%)
Query: 610 IGKGGQGSVYMSKLASG----EIIAVKKFHSPLPGEMTFQQEFLNEVKA----LTEIWHR 661
           +GKGG G V+  +  +G    +I A+K     +   +    +     KA    L E+ H 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81
Query: 662 NIVK-VYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
            IV  +Y F    + L+++ EY      F       I   D A   L           I 
Sbjct: 82  FIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLA---------EIS 131
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H      I++RD+  +N++L+ +    ++DFG+ K    D +      GT  Y+
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYM 188
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE+          D +S G L  +++ G  P        F+  N    +D++L  +L  
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP--------FTGENRKKTIDKILKCKLNL 240
Query: 835 P 835
           P
Sbjct: 241 P 241

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 39/241 (16%)
Query: 610 IGKGGQGSVYMSKLASG----EIIAVKKFHSPLPGEMTFQQEFLNEVKA----LTEIWHR 661
           +GKGG G V+  +  +G    +I A+K     +   +    +     KA    L E+ H 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81
Query: 662 NIVK-VYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
            IV  +Y F    + L+++ EY      F       I   D A   L           I 
Sbjct: 82  FIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLA---------EIS 131
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL ++H      I++RD+  +N++L+ +    ++DFG+ K    D +      GT  Y+
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE+          D +S G L  +++ G  P        F+  N    +D++L  +L  
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP--------FTGENRKKTIDKILKCKLNL 240
Query: 835 P 835
           P
Sbjct: 241 P 241

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTE 786
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 183 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 242
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLI 844
           + DV+S+G+   E+         + S  +  + ++    +M+    R+ +P     +   
Sbjct: 243 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE--- 292
Query: 845 SIVEVTISCVDENPESRPTMQKVCQLLK 872
            + ++  +C D +P  RPT +++ QL++
Sbjct: 293 -MYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K   + WT L GT  
Sbjct: 171 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPE 224
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/340 (20%), Positives = 142/340 (41%), Gaps = 45/340 (13%)
Query: 555 LIGLFFKFQRRKNDSQTQQSSPGNSRGLLSV--LTFEGKIIY--EEIIRATNDFDDEHCI 610
           L+ + + F R++N+S+      GN     SV    F    +Y  +E   A         +
Sbjct: 1   LVIMLYVFHRKRNNSRL-----GNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSREL 55
Query: 611 GKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    ++
Sbjct: 56  GQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHV 112
Query: 664 VKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
           V++ G     +   ++ E          + SL   + N+        ++ + M   I D 
Sbjct: 113 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YG 772
           ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G       
Sbjct: 173 MAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 227
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  L
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGL 280
Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 281 LDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 317

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           ND   +  IG+G  G V  +++    +    A+K+       +    ++F  E++ L ++
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 72
Query: 659 WHR-NIVKVYGFCLHVRHLFIVYEYFKMCSL------AVILSNDAA-------AKNLGWT 704
            H  NI+ + G C H  +L++  EY    +L      + +L  D A       A  L   
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
           + ++    +   + Y+    F   +HRD++++N+L+     A ++DFG+++         
Sbjct: 133 QLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQE 183
Query: 765 TELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSS 817
             +  T G     ++A E L Y++  T   DV+S+GVL  E++  G  P      M+ + 
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP---YCGMTCAE 239
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           L   +     L+  L     N  D++  ++     C  E P  RP+  ++
Sbjct: 240 LYEKLPQGYRLEKPL-----NCDDEVYDLMR---QCWREKPYERPSFAQI 281

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           ND   +  IG+G  G V  +++    +    A+K+       +    ++F  E++ L ++
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 82
Query: 659 WHR-NIVKVYGFCLHVRHLFIVYEYFKMCSL------AVILSNDAA-------AKNLGWT 704
            H  NI+ + G C H  +L++  EY    +L      + +L  D A       A  L   
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
           + ++    +   + Y+    F   +HRD++++N+L+     A ++DFG+++         
Sbjct: 143 QLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQE 193
Query: 765 TELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSS 817
             +  T G     ++A E L Y++  T   DV+S+GVL  E++  G  P      M+ + 
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP---YCGMTCAE 249
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           L   +     L+  L     N  D++  ++     C  E P  RP+  ++
Sbjct: 250 LYEKLPQGYRLEKPL-----NCDDEVYDLMR---QCWREKPYERPSFAQI 291

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 8/207 (3%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEII-AVKKFHSPLPGEMTFQQEFLNEVKALTE-IW 659
           +DF     IGKG  G V +++  + E+  AVK        +   ++  ++E   L + + 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H  +V ++        L+ V +Y     L   L  +   +     R       I  AL Y
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGY 154
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H+     IV+RD+  +N+LLD +    ++DFG+ K     +S  +   GT  Y+APE+ 
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +        D +  G +  E++ G  P
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%)
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           I++RD+   NV+LD E    ++DFG+ K    D        GT  Y+APE+       + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 788 CDVYSFGVLALEVIKGKHP 806
            D ++FGVL  E++ G+ P
Sbjct: 202 VDWWAFGVLLYEMLAGQAP 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%)
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           I++RD+   NV+LD E    ++DFG+ K    D        GT  Y+APE+       + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 788 CDVYSFGVLALEVIKGKHP 806
            D ++FGVL  E++ G+ P
Sbjct: 523 VDWWAFGVLLYEMLAGQAP 541

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 41/286 (14%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR-N 662
           +G+G  G V       + K A+   +AVK          +  +  ++E+K L  I H  N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLN 94
Query: 663 IVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSN-----------DAAAKNLGWTRRMNMI 710
           +V + G C      L ++ E+ K  +L+  L +           D     L     +   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSNWTELA 768
             +   + ++ +      +HRD++++N+LL  +N   + DFG+A+ +   PD     +  
Sbjct: 155 FQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEM 827
               ++APE  +    T + DV+SFGVL  E+   G  P               + +DE 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------------GVKIDEE 259
Query: 828 LDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQLL 871
              RL   +R       +  + +  + C    P  RPT  ++ + L
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV---K 665
           +G G  GSV  S  + SG  IAVKK   P    +  ++ +  E++ L  + H N++    
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           V+     +     VY    +  +   L+N    + L       +I  I+  L Y+H+   
Sbjct: 118 VFTPATSLEEFNDVYLVTHL--MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS--- 172
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKV 784
             I+HRD+   N+ ++ + E  + DFG+A+    + + +     T  Y APE+    M  
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHY 229
Query: 785 TEKCDVYSFGVLALEVIKGK 804
               D++S G +  E++ G+
Sbjct: 230 NMTVDIWSVGCIMAELLTGR 249

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G+V+ +K   + EI+A+K+       E       L E+  L E+ H+NIV+++ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHD 68
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L +V+E+   C   +    D+   +L      + +  ++  L + H+     +
Sbjct: 69  VLHSDKKLTLVFEF---CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEK 787
           +HRD+  +N+L++   E  +++FG+A+        ++    T  Y  P++ +  K+ +  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 788 CDVYSFGVLALEVIKGKHP 806
            D++S G +  E+     P
Sbjct: 183 IDMWSAGCIFAELANAGRP 201

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 1/176 (0%)
Query: 28  LGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNN-KLSGSIP 86
           L  N++S     S  +  NL  L++H+N+L+G              L+LS+N +L    P
Sbjct: 38  LHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDP 97
Query: 87  PSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXXXXXXXXXPHSLGNLTNLATL 146
            +   L +L TL+LD   L    P                        ++  +L NL  L
Sbjct: 98  TTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQALPDNTFRDLGNLTHL 157
Query: 147 YIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS 202
           +++ N + +        L SL  L L +N+     P +  +L  L TLYL  N+LS
Sbjct: 158 FLHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLS 213

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 50/185 (27%), Positives = 73/185 (39%), Gaps = 2/185 (1%)
Query: 136 SLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSEN-NFNGSIPPSLGNLSNLATL 194
           S  +  NL  L+++SN+L+         L  L  L LS+N       P +   L +L TL
Sbjct: 50  SFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDPTTFRGLGHLHTL 109
Query: 195 YLDTNSLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIP 254
           +LD   L    P                N L      +  +L NLT+L L  N +     
Sbjct: 110 HLDRCGLQELGPGLFRGLAALQYLYLQDNNLQALPDNTFRDLGNLTHLFLHGNRIPSVPE 169
Query: 255 YEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYI 313
           + +R L  L  LLL  N      P   R+L  L  + L  N L+   +E      +L Y+
Sbjct: 170 HAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLSMLPAEVLVPLRSLQYL 229
Query: 314 DLSQN 318
            L+ N
Sbjct: 230 RLNDN 234

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 33  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 89
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   ++N+        ++ + M   I D
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 204
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 257
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 258 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 295

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 35/278 (12%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           IGKG  G VY  +   GE+ A++        E   +  F  EV A  +  H N+V   G 
Sbjct: 41  IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKA-FKREVMAYRQTRHENVVLFMGA 97
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
           C+   HL I+    K  +L  ++ +     ++  TR+  + + IV  + Y+H      I+
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ--IAQEIVKGMGYLHAKG---IL 152
Query: 730 HRDISSKNVLLDFENEAHVSDFG---IAKFLKPDSSNWTELA---GTYGYVAPELAYTMK 783
           H+D+ SKNV  D   +  ++DFG   I+  L+       +L    G   ++APE+   + 
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE-DKLRIQNGWLCHLAPEIIRQLS 210
Query: 784 ---------VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
                     ++  DV++ G +  E+    H R++     F +      + +M     P 
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYEL----HAREW----PFKTQPAEAIIWQMGTGMKPN 262
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            S+    K IS  ++ + C     E RPT  K+  +L+
Sbjct: 263 LSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 610 IGKGGQGSV---YMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +G G  GSV   Y ++L   + +AVKK   P    +  ++ +  E++ L  + H N++ +
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 84
Query: 667 YGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
                    +    E + + +L    L+N    + L       ++  ++  L Y+H+   
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS--- 141
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKV 784
             I+HRD+   NV ++ + E  + DFG+A+    + + +     T  Y APE+    M  
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV---ATRWYRAPEIMLNWMHY 198
Query: 785 TEKCDVYSFGVLALEVIKGK 804
            +  D++S G +  E+++GK
Sbjct: 199 NQTVDIWSVGCIMAELLQGK 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + DF +A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     WT L GT  
Sbjct: 136 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPE 189
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 190 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 658
             D++    IG+G  G V + +  S   +   K  S           F  E + +     
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 659 --WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVD 715
             W   +V+++      R+L++V EY     L  ++SN D   K   W R       +V 
Sbjct: 133 SPW---VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVL 184
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYV 774
           AL  +H+  F   +HRD+   N+LLD      ++DFG    +  +     + A GT  Y+
Sbjct: 185 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 775 APELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 806
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     WT L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/253 (22%), Positives = 105/253 (41%), Gaps = 42/253 (16%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN----------- 694
           ++ L+E   L ++ H +++K+YG C     L ++ EY K  SL   L             
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 695 ------------DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
                       D  A  +G    ++    I   + Y+       +VHRD++++N+L+  
Sbjct: 131 GGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAE 185
Query: 743 ENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
             +  +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E+
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 801 IK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPE 859
           +  G +P   I        NL      M  P       N  +++  ++   + C  + P+
Sbjct: 246 VTLGGNPYPGIPPERL--FNLLKTGHRMERP------DNCSEEMYRLM---LQCWKQEPD 294
Query: 860 SRPTMQKVCQLLK 872
            RP    + + L+
Sbjct: 295 KRPVFADISKDLE 307

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 658
             D++    IG+G  G V + +  S   +   K  S           F  E + +     
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 659 --WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVD 715
             W   +V+++      R+L++V EY     L  ++SN D   K   W R       +V 
Sbjct: 128 SPW---VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVL 179
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYV 774
           AL  +H+  F   +HRD+   N+LLD      ++DFG    +  +     + A GT  Y+
Sbjct: 180 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 775 APELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 806
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 27/153 (17%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL   N   + DFG+A+  +  PD     +      ++APE  +    + 
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 787 KCDVYSFGVLALEVIK-GKHP-------RDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
           K DV+S+GVL  E+   G  P        DF S +             M  P   TP   
Sbjct: 281 KSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGM--------RMRAPEYSTP--- 329
Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                  I ++ + C   +P+ RP   ++ + L
Sbjct: 330 ------EIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL  +N   + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS- 845
           + DV+SFGVL  E+           S+  S     + +DE    RL   +R       + 
Sbjct: 275 QSDVWSFGVLLWEIF----------SLGASPYP-GVKIDEEFCRRLKEGTRMRAPDYTTP 323
Query: 846 -IVEVTISCVDENPESRPTMQKVCQLL 871
            + +  + C    P  RPT  ++ + L
Sbjct: 324 EMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  LAGT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 598 IRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFH-SPLPGEMTFQQEFLNEVKAL 655
           IR T  F +   +G G    V++ K   +G++ A+K    SP   + + +    NE+  L
Sbjct: 7   IRKTFIFME--VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE----NEIAVL 60
Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYE-------YFKMCSLAVILSNDAAAKNLGWTRRMN 708
            +I H NIV +        H ++V +       + ++    V    DA+           
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---------- 110
Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAKFLKPDSSNWT 765
           +I+ ++ A+ Y+H +    IVHRD+  +N+L    +  ++  ++DFG++K     +   +
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMS 165
Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
              GT GYVAPE+      ++  D +S GV+   ++ G  P
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 17/148 (11%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL  +N   + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 787 KCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
           + DV+SFGVL  E+   G  P               + +DE    RL   +R       +
Sbjct: 273 QSDVWSFGVLLWEIFSLGASPYP------------GVKIDEEFCRRLKEGTRMRAPDYTT 320
Query: 846 --IVEVTISCVDENPESRPTMQKVCQLL 871
             + +  + C    P  RPT  ++ + L
Sbjct: 321 PEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/279 (20%), Positives = 118/279 (42%), Gaps = 32/279 (11%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 18  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 74
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 75  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG--TYGY 773
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +           G     +
Sbjct: 135 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 191
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           ++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  L 
Sbjct: 192 MSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLL 244
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               N  D L+ ++ +   C   NP+ RP+  ++   +K
Sbjct: 245 DKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIK 280

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 23  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 79
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   ++N+        ++ + M   I D
Sbjct: 80  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 140 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 194
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 195 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 247
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 248 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 285

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 116/280 (41%), Gaps = 34/280 (12%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 81
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YG 772
           ++Y++   F   VHRD++++N ++  +    + DFG+ + +    +++    G       
Sbjct: 142 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 196
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           ++APE       T   D++SFGV+  E+         ++   +  L+    L  ++D   
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGY 249
Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                N  +++  ++ +   C   NP+ RPT  ++  LLK
Sbjct: 250 LDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 286

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/253 (22%), Positives = 105/253 (41%), Gaps = 42/253 (16%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN----------- 694
           ++ L+E   L ++ H +++K+YG C     L ++ EY K  SL   L             
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 695 ------------DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
                       D  A  +G    ++    I   + Y+       +VHRD++++N+L+  
Sbjct: 131 GGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAE 185
Query: 743 ENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
             +  +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E+
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 801 IK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPE 859
           +  G +P   I        NL      M  P       N  +++  ++   + C  + P+
Sbjct: 246 VTLGGNPYPGIPPERL--FNLLKTGHRMERP------DNCSEEMYRLM---LQCWKQEPD 294
Query: 860 SRPTMQKVCQLLK 872
            RP    + + L+
Sbjct: 295 KRPVFADISKDLE 307

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 39/164 (23%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           Q+   E +   ++ H NIV+++     ++     Y  F + +   +  +  A +      
Sbjct: 50  QKLEREARICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 106
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSS 762
             + I+ I+++++Y H++    IVHR++  +N+LL  + +     ++DFG+A  +  DS 
Sbjct: 107 ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 162
Query: 763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            W   AGT GY++PE+      ++  D+++ GV+   ++ G  P
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 39/164 (23%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           Q+   E +   ++ H NIV+++     ++     Y  F + +   +  +  A +      
Sbjct: 49  QKLEREARICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 105
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSS 762
             + I+ I+++++Y H++    IVHR++  +N+LL  + +     ++DFG+A  +  DS 
Sbjct: 106 ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 161
Query: 763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            W   AGT GY++PE+      ++  D+++ GV+   ++ G  P
Sbjct: 162 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 39/164 (23%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           Q+   E +   ++ H NIV+++     ++     Y  F + +   +  +  A +      
Sbjct: 50  QKLEREARICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 106
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSS 762
             + I+ I+++++Y H++    IVHR++  +N+LL  + +     ++DFG+A  +  DS 
Sbjct: 107 ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 162
Query: 763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            W   AGT GY++PE+      ++  D+++ GV+   ++ G  P
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  +  FG+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL  +N   + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS- 845
           + DV+SFGVL  E+           S+  S     + +DE    RL   +R       + 
Sbjct: 282 QSDVWSFGVLLWEIF----------SLGASPYP-GVKIDEEFCRRLKEGTRMRAPDYTTP 330
Query: 846 -IVEVTISCVDENPESRPTMQKVCQLL 871
            + +  + C    P  RPT  ++ + L
Sbjct: 331 EMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +HRD++++N+LL  +N   + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS- 845
           + DV+SFGVL  E+           S+  S     + +DE    RL   +R       + 
Sbjct: 280 QSDVWSFGVLLWEIF----------SLGASPYP-GVKIDEEFCRRLKEGTRMRAPDYTTP 328
Query: 846 -IVEVTISCVDENPESRPTMQKVCQLL 871
            + +  + C    P  RPT  ++ + L
Sbjct: 329 EMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 30/278 (10%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 79
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG--TYGYV 774
           ++Y++   F   VHRD++++N ++  +    + DFG+ + +           G     ++
Sbjct: 140 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE       T   D++SFGV+  E+         ++   +  L+    L  ++D     
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYLD 249
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              N  +++  ++ +   C   NP+ RPT  ++  LLK
Sbjct: 250 QPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 284

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 658
             D++    IG+G  G V + +  S   +   K  S           F  E + +     
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 659 --WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVD 715
             W   +V+++      R+L++V EY     L  ++SN D   K   W R       +V 
Sbjct: 133 SPW---VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYT--AEVVL 184
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA-GTYGYV 774
           AL  +H+  F   +HRD+   N+LLD      ++DFG    +  +     + A GT  Y+
Sbjct: 185 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 775 APELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 806
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 116/280 (41%), Gaps = 34/280 (12%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YG 772
           ++Y++   F   VHRD++++N ++  +    + DFG+ + +    +++    G       
Sbjct: 143 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 197
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           ++APE       T   D++SFGV+  E+         ++   +  L+    L  ++D   
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGY 250
Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                N  +++  ++ +   C   NP+ RPT  ++  LLK
Sbjct: 251 LDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 287

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           +E + E + + ++ +  IV++ G C     L +V E      L   L      + +  + 
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSN 437
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
              ++  +   + Y+    F   VHR+++++NVLL   + A +SDFG++K L  D S +T
Sbjct: 438 VAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494
Query: 766 EL-AGTY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 806
              AG +   + APE     K + + DV+S+GV   E +  G+ P
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 11/180 (6%)
Query: 631 VKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAV 690
           +KK  S        ++E   EV  L ++ H N++ ++    +   + ++ E      L  
Sbjct: 45  IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EA 746
            L   A  ++L      + IK I+D ++Y+H      I H D+  +N++L  +N      
Sbjct: 105 FL---AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158
Query: 747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + DFG+A  ++ D   +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 159 KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 42/79 (53%)
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           I++RD+  +N+LLD E    ++DFG++K             GT  Y+APE+      +  
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHS 210
Query: 788 CDVYSFGVLALEVIKGKHP 806
            D +S+GVL  E++ G  P
Sbjct: 211 ADWWSYGVLMFEMLTGSLP 229

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 30/278 (10%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG--TYGYV 774
           ++Y++   F   VHRD++++N ++  +    + DFG+ + +           G     ++
Sbjct: 143 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE       T   D++SFGV+  E+         ++   +  L+    L  ++D     
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              N  +++  ++ +   C   NP+ RPT  ++  LLK
Sbjct: 253 QPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 287

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 18/170 (10%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHV----RHLFIVYEYFKMCSLAVILSNDAAAKN 700
           +Q F  E + L  + H NIV+ Y          + + +V E     +L   L      K 
Sbjct: 69  RQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKI 128
Query: 701 ---LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKF 756
                W R+      I+  L ++H    PPI+HRD+   N+ +        + D G+A  
Sbjct: 129 KVLRSWCRQ------ILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            +  +S    + GT  + APE  Y  K  E  DVY+FG   LE    ++P
Sbjct: 182 KR--ASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + D G+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + D G+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYG 668
           +G G +G++    +     +AVK+    LP   +F      EV+ L E   H N+++   
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFAD---REVQLLRESDEHPNVIRY-- 83
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT--RRMNMIKGIVDALSYMHNDCFP 726
           FC      F   +Y  +   A  L      K+        + +++     L+++H+    
Sbjct: 84  FCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---L 137
Query: 727 PIVHRDISSKNVLLDFEN-----EAHVSDFGIAKFL---KPDSSNWTELAGTYGYVAPEL 778
            IVHRD+   N+L+   N     +A +SDFG+ K L   +   S  + + GT G++APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 779 AYTMKVTEKC--------DVYSFGVLALEVI-KGKHP 806
                ++E C        D++S G +   VI +G HP
Sbjct: 198 -----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/253 (22%), Positives = 105/253 (41%), Gaps = 42/253 (16%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN----------- 694
           ++ L+E   L ++ H +++K+YG C     L ++ EY K  SL   L             
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 695 ------------DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
                       D  A  +G    ++    I   + Y+       +VHRD++++N+L+  
Sbjct: 131 GGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAE 185
Query: 743 ENEAHVSDFGIAKFLKPDSSNWTELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
             +  +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E+
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 801 IK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPE 859
           +  G +P   I        NL      M  P       N  +++  ++   + C  + P+
Sbjct: 246 VTLGGNPYPGIPPERL--FNLLKTGHRMERP------DNCSEEMYRLM---LQCWKQEPD 294
Query: 860 SRPTMQKVCQLLK 872
            RP    + + L+
Sbjct: 295 KRPVFADISKDLE 307

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 614 GQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF 669
           G+GS    KLA+     + +A+K     L  +         E+  L  + H +I+K+Y  
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV 729
                 + +V EY        I+      ++ G  RR    + I+ A+ Y H      IV
Sbjct: 78  ITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEG--RRF--FQQIICAIEYCHRH---KIV 130
Query: 730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEKC 788
           HRD+  +N+LLD      ++DFG++  +  D +      G+  Y APE+    +    + 
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 789 DVYSFGVLALEVIKGKHPRD--FISSMSFSSLN 819
           DV+S G++   ++ G+ P D  FI ++ F  +N
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNL-FKKVN 221

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 33  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 89
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 204
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 257
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 258 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 295

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 20  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 76
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 137 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 191
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 244
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 245 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 282

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  GSV  +    +G  +AVKK   P    +  ++ +  E++ L  + H N++ +  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 669 FCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                R L    + + +  L    L+N    + L       +I  I+  L Y+H+     
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 145
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 786
           I+HRD+   N+ ++ + E  + D G+A+    + + +     T  Y APE+    M   +
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 202
Query: 787 KCDVYSFGVLALEVIKGK 804
             D++S G +  E++ G+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/278 (21%), Positives = 112/278 (40%), Gaps = 30/278 (10%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG--TYGYV 774
           ++Y++   F   VHRD++++N ++  +    + DFG+ + +           G     ++
Sbjct: 143 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE       T   D++SFGV+  E+         ++   +  L+    L  ++D     
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              N  +++  ++ +   C   NP  RPT  ++  LLK
Sbjct: 253 QPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLK 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 26  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 82
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 143 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 197
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 250
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 251 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 288

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/290 (22%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           ND   +  IG+G  G V  +++    +    A+K+       +    ++F  E++ L ++
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 79
Query: 659 WHR-NIVKVYGFCLHVRHLFIVYEYFKMCSL------AVILSNDAA-------AKNLGWT 704
            H  NI+ + G C H  +L++  EY    +L      + +L  D A       A  L   
Sbjct: 80  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
           + ++    +   + Y+    F   +HR+++++N+L+     A ++DFG+++         
Sbjct: 140 QLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSR------GQE 190
Query: 765 TELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSS 817
             +  T G     ++A E L Y++  T   DV+S+GVL  E++  G  P      M+ + 
Sbjct: 191 VYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP---YCGMTCAE 246
Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           L   +     L+  L     N  D++  ++     C  E P  RP+  ++
Sbjct: 247 LYEKLPQGYRLEKPL-----NCDDEVYDLMR---QCWREKPYERPSFAQI 288

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/279 (20%), Positives = 117/279 (41%), Gaps = 32/279 (11%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 27  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 83
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG--TYGY 773
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +           G     +
Sbjct: 144 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 200
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           ++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  L 
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLL 253
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 254 DKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 289

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSND----AAAKNL 701
            +F NE++ +T+I +   +   G   +   ++I+YEY +  S   IL  D       KN 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS---ILKFDEYFFVLDKNY 144
Query: 702 GWTRRMNMIKGIV----DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL 757
                + +IK I+    ++ SY+HN+    I HRD+   N+L+D      +SDFG ++++
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 758 KPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGV 795
                  +   GTY ++ PE      +Y      K D++S G+
Sbjct: 203 VDKKIKGSR--GTYEFMPPEFFSNESSYN---GAKVDIWSLGI 240

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDX 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
              T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 40/291 (13%)
Query: 230 PISMGNLSNLTYLNLFENSLSGAIPYE--YRNLVKLTILLLGHNQFRGPI--PILRNLTS 285
           P +   L +L  L L+   LS A+  +  +RNL  LT L L  NQ R     P    L S
Sbjct: 90  PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS 149
Query: 286 LERVRLDRN--YLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPK------LSTL 337
           L+ +    N  +L             L++  L+ N+ Y  +S DWG+C        L  L
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209
Query: 338 DFSIN----NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS 393
           D S N    +ITGN    I  S    +  + ++HI+G          F        N  +
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSL--ILAHHIMG------AGFGFHNIKDPDQNTFA 261
Query: 394 GQLSPKLGSLVQLEHLDLSSN---RLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI 450
           G           + HLDLS      L++ + ++L +L++     L+L+ N + +      
Sbjct: 262 GLARSS------VRHLDLSHGFVFSLNSRVFETLKDLKV-----LNLAYNKINKIADEAF 310
Query: 451 CIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
             + +L+ LNLS+N L  L  S F  +  + +ID+  N +  +I    TFK
Sbjct: 311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI--AIIQDQTFK 359

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 27  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 83
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 144 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 198
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 251
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 252 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 289

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 601 TNDFDDEH----CIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           T D  DE+     IG G  G V  ++   +G+ +A+KK  +     +T  +  L E+K L
Sbjct: 50  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKIL 108
Query: 656 TEIWHRNIVKV---------YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
               H NI+ +         YG     + +++V +  +     +I S+    + L     
Sbjct: 109 KHFKHDNIIAIKDILRPTVPYG---EFKSVYVVLDLMESDLHQIIHSS----QPLTLEHV 161
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSNW 764
              +  ++  L YMH+     ++HRD+   N+L++   E  + DFG+A+ L   P    +
Sbjct: 162 RYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 765 --TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKH 805
             TE   T  Y APEL  ++ + T+  D++S G +  E++  + 
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 24  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 80
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 141 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 195
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 196 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 248
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 249 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 286

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDX 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 26  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 82
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N ++  +    + DFG+ + +    +++    G      
Sbjct: 143 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 197
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 250
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L  ++ +   C   NP+ RP+  ++   +K
Sbjct: 251 LLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 288

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V+ M    +G   AVKK    +     F+ E L     L+      IV +YG
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSP---RIVPLYG 117
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                  + I  E  +  SL  ++            R +  +   ++ L Y+H      I
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---RI 171
Query: 729 VHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTY-----GYVAPELAYTM 782
           +H D+ + NVLL  + + A + DFG A  L+PD    + L G Y      ++APE+    
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 783 KVTEKCDVYSFGVLALEVIKGKHP 806
               K D++S   + L ++ G HP
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 30/278 (10%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG--TYGYV 774
           ++Y++   F   VHRD++++N ++  +    + DFG+ + +   +       G     ++
Sbjct: 143 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE       T   D++SFGV+  E+         ++   +  L+    L  ++D     
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              N  +++  ++ +   C   NP+ RPT  ++  LLK
Sbjct: 253 QPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 287

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 597 IIRATNDFDDEHCIGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           I+  ++ +D    IG G  G +  M    + E++AVK        +   Q+E +N     
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH---- 70
Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
             + H NIV+     L   HL I+ EY     L   + N   A            + ++ 
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLS 127
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAH--VSDFGIAK----FLKPDSSNWTELAG 769
            +SY H+     I HRD+  +N LLD        + DFG +K      +P S+      G
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VG 179
Query: 770 TYGYVAPELAYTMKVTEK-CDVYSFGVLALEVIKGKHP 806
           T  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 601 TNDFDDEH----CIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           T D  DE+     IG G  G V  ++   +G+ +A+KK  +     +T  +  L E+K L
Sbjct: 49  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKIL 107
Query: 656 TEIWHRNIVKV---------YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
               H NI+ +         YG     + +++V +  +     +I S+    + L     
Sbjct: 108 KHFKHDNIIAIKDILRPTVPYG---EFKSVYVVLDLMESDLHQIIHSS----QPLTLEHV 160
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL--KPDSSNW 764
              +  ++  L YMH+     ++HRD+   N+L++   E  + DFG+A+ L   P    +
Sbjct: 161 RYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 765 --TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKH 805
             TE   T  Y APEL  ++ + T+  D++S G +  E++  + 
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 610 IGKGGQGSVYMSKLASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +G+G  G VY   +A G +       +A+K  +      M  + EFLNE   + E    +
Sbjct: 20  LGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 76
Query: 663 IVKVYGFCLHVRHLFIVYEYFK-------MCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +V++ G     +   ++ E          + SL   + N+        ++ + M   I D
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----Y 771
            ++Y++ + F   VHRD++++N  +  +    + DFG+ + +    +++    G      
Sbjct: 137 GMAYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 191
Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
            +++PE       T   DV+SFGV+  E+         ++   +  L+    L  +++  
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGG 244
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L     N  D L+ ++ +   C   NP+ RP+  ++   +K
Sbjct: 245 LLDKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIK 282

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 65/288 (22%), Positives = 116/288 (40%), Gaps = 49/288 (17%)
Query: 619 YMSKLASGEIIAVKKFH--SPLPGEMT---------------FQQEFLNEVKALTEIWHR 661
           +M +L       V K H   P PGE T                ++EF +E      + H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+V + G     + L +++ Y     L   L   +   ++G T     +K  ++   ++H
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 722 ----------NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
                           +VH+D++++NVL+  +    +SD G+  F +  ++++ +L G  
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLGNS 190
Query: 771 ---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
                ++APE     K +   D++S+GV+  EV   G  P    S         N  + E
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---------NQDVVE 241
Query: 827 MLDPR--LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           M+  R  LP P     D    +  + I C +E P  RP  + +   L+
Sbjct: 242 MIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 171 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 224
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           Q+   E +   ++ H NIV+++     ++     Y  F + +   +  +  A +      
Sbjct: 73  QKLEREARICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 129
Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSS 762
             + I+ I+++++Y H++    IVHR++  +N+LL  + +     ++DFG+A  +  DS 
Sbjct: 130 ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 185
Query: 763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 796
            W   AGT GY++PE+      ++  D+++ GV+
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 137 IVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 190
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 145 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 198
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 199 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 171 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 224
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 143 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 196
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 143 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 196
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 258
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
              T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 45/286 (15%)
Query: 619 YMSKLASGEIIAVKKFH--SPLPGEMT---------------FQQEFLNEVKALTEIWHR 661
           +M +L       V K H   P PGE T                ++EF +E      + H 
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           N+V + G     + L +++ Y     L   L   +   ++G T     +K  ++   ++H
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 722 NDCFPP----------IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
                           +VH+D++++NVL+  +    +SD G+  F +  ++++ +L G  
Sbjct: 150 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLGNS 207
Query: 771 ---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDE 826
                ++APE     K +   D++S+GV+  EV   G  P    S+     +  N  +  
Sbjct: 208 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV-- 265
Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                LP P     D    +  + I C +E P  RP  + +   L+
Sbjct: 266 -----LPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V+ M    +G   AVKK    +     F+ E L     L+      IV +YG
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSP---RIVPLYG 133
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                  + I  E  +  SL  ++        L   R +  +   ++ L Y+H      I
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTR---RI 187
Query: 729 VHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTY-----GYVAPELAYTM 782
           +H D+ + NVLL  + + A + DFG A  L+PD    + L G Y      ++APE+    
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 783 KVTEKCDVYSFGVLALEVIKGKHP 806
               K D++S   + L ++ G HP
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG+AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V+ M    +G   AVKK    +     F+ E L     L+      IV +YG
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSP---RIVPLYG 131
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                  + I  E  +  SL  ++            R +  +   ++ L Y+H      I
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---RI 185
Query: 729 VHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTY-----GYVAPELAYTM 782
           +H D+ + NVLL  + + A + DFG A  L+PD    + L G Y      ++APE+    
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 783 KVTEKCDVYSFGVLALEVIKGKHP 806
               K D++S   + L ++ G HP
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 100/238 (42%), Gaps = 32/238 (13%)
Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
           + + F      ++++ H+++V  YG C+      +V E+ K  SL   L  +    N+ W
Sbjct: 55  YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA--------HVSDFGIAK 755
             ++ + K +  A+ ++  +    ++H ++ +KN+LL  E +          +SD GI+ 
Sbjct: 115 --KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
Query: 756 FLKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMS 814
            + P       L     +V PE     K +    D +SFG    E+  G           
Sbjct: 170 TVLPKDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG-------GDKP 218
Query: 815 FSSLNLNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            S+L+    L    D  +LP P      K   +  +  +C+D  P+ RP+ + + + L
Sbjct: 219 LSALDSQRKLQFYEDRHQLPAP------KAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN--EAHVSDFGIAK-FLKPDSSNW 764
           N+++ I  AL Y+HN     I HRDI  +N L       E  + DFG++K F K ++  +
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 765 ---TELAGTYGYVAPELAYTMKVT--EKCDVYSFGVLALEVIKGKHP 806
              T  AGT  +VAPE+  T   +   KCD +S GVL   ++ G  P
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 116/268 (43%), Gaps = 35/268 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVY 667
           IG GG   V+       +I A+K  +       T    + NE+  L ++   +  I+++Y
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLY 78
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            + +  +++++V E    C    + S     K++    R +  K +++A+  +H      
Sbjct: 79  DYEITDQYIYMVME----CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 131
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVT 785
           IVH D+   N L+  +    + DFGIA  ++PD+++  +    GT  Y+ PE    M  +
Sbjct: 132 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 786 EK-----------CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLP 833
            +            DV+S G +   +  GK P +  I+ +S         L  ++DP   
Sbjct: 191 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIIDPNHE 242
Query: 834 TPSRNVHDKLISIVEVTISCVDENPESR 861
               ++ +K   + +V   C+  +P+ R
Sbjct: 243 IEFPDIPEK--DLQDVLKCCLKRDPKQR 268

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 6/195 (3%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L    + + +  L     +      L   R   ++  ++  + ++H+     I
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---I 147
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M   E  
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 789 DVYSFGVLALEVIKG 803
           D++S GV+  E+IKG
Sbjct: 207 DIWSVGVIMGEMIKG 221

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK--PDSSNW 764
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+ +       N 
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
           T       ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 597 IIRATNDFDDEHCIGKGGQGSVYMSK--LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 654
           + RA   ++    IG+G  G V+ ++     G  +A+K+      GE       + EV  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAV 64
Query: 655 LTEIW---HRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           L  +    H N+V+++  C   R      L +V+E+     L   L +      +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETI 122
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
            +M+  ++  L ++H+     +VHRD+  +N+L+    +  ++DFG+A+      +  T 
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTS 178
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
           +  T  Y APE+          D++S G +  E+ + K
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR----DINNIDY 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 46/176 (26%), Positives = 68/176 (38%), Gaps = 1/176 (0%)
Query: 28  LGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNN-KLSGSIP 86
           L  N++S     S     NL  L++H+N L+               L+LS+N +L    P
Sbjct: 38  LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 97
Query: 87  PSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXXXXXXXXXPHSLGNLTNLATL 146
            +   L  L TL+LD   L    P                         +  +L NL  L
Sbjct: 98  ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 157
Query: 147 YIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS 202
           +++ N +S+        L SL  L L +N      P +  +L  L TLYL  N+LS
Sbjct: 158 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 213

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 51/179 (28%), Positives = 72/179 (40%), Gaps = 2/179 (1%)
Query: 142 NLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI-PPSLGNLSNLATLYLDTNS 200
           NL  L+++SN L+         L  L  L LS+N    S+ P +   L  L TL+LD   
Sbjct: 56  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 115
Query: 201 LSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL 260
           L    P                N L      +  +L NLT+L L  N +S      +R L
Sbjct: 116 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 175
Query: 261 VKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
             L  LLL  N+     P   R+L  L  + L  N L+   +E+      L Y+ L+ N
Sbjct: 176 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 147 VSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR----DINNIDY 199
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+ ++   +G+ +A+KK       E  F    L E+K L  + H N+V +  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 84
Query: 669 FCL-----HVRHLFIVYEYFKMCS--LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            C      + R    +Y  F  C   LA +LSN      L   +R+  ++ +++ L Y+H
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 142
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK 755
            +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 143 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 46/176 (26%), Positives = 68/176 (38%), Gaps = 1/176 (0%)
Query: 28  LGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNN-KLSGSIP 86
           L  N++S     S     NL  L++H+N L+               L+LS+N +L    P
Sbjct: 39  LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
Query: 87  PSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXXXXXXXXXPHSLGNLTNLATL 146
            +   L  L TL+LD   L    P                         +  +L NL  L
Sbjct: 99  ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158
Query: 147 YIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS 202
           +++ N +S+        L SL  L L +N      P +  +L  L TLYL  N+LS
Sbjct: 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 51/179 (28%), Positives = 72/179 (40%), Gaps = 2/179 (1%)
Query: 142 NLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI-PPSLGNLSNLATLYLDTNS 200
           NL  L+++SN L+         L  L  L LS+N    S+ P +   L  L TL+LD   
Sbjct: 57  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 201 LSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL 260
           L    P                N L      +  +L NLT+L L  N +S      +R L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 261 VKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
             L  LLL  N+     P   R+L  L  + L  N L+   +E+      L Y+ L+ N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVY 667
           IG GG   V+       +I A+K  +       T    + NE+  L ++   +  I+++Y
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLY 94
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            + +  +++++V E    C    + S     K++    R +  K +++A+  +H      
Sbjct: 95  DYEITDQYIYMVME----CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVT 785
           IVH D+   N L+  +    + DFGIA  ++PD+++  +    GT  Y+ PE    M  +
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 786 EK-----------CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLP 833
            +            DV+S G +   +  GK P +  I+ +S     L+  +D   +   P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHEIEFP 262
Query: 834 T-PSRNVHDKLISIVEVTISCVDENPESR 861
             P +++ D       V   C+  +P+ R
Sbjct: 263 DIPEKDLQD-------VLKCCLKRDPKQR 284

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG+AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 149 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 201
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVY 667
           IG GG   V+       +I A+K  +       T    + NE+  L ++   +  I+++Y
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLY 75
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            + +  +++++V E    C    + S     K++    R +  K +++A+  +H      
Sbjct: 76  DYEITDQYIYMVME----CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVT 785
           IVH D+   N L+  +    + DFGIA  ++PD+++  +    GT  Y+ PE    M  +
Sbjct: 129 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 786 EK-----------CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLP 833
            +            DV+S G +   +  GK P +  I+ +S     L+  +D   +   P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHEIEFP 243
Query: 834 T-PSRNVHDKLISIVEVTISCVDENPESR 861
             P +++ D       V   C+  +P+ R
Sbjct: 244 DIPEKDLQD-------VLKCCLKRDPKQR 265

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 612 KGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCL 671
           + G G  Y +K      I  ++  S   G    ++E   EV  L EI H NI+ ++    
Sbjct: 47  QKGTGKEYAAKF-----IKKRRLXSSRRG--VSREEIEREVNILREIRHPNIITLHDIFE 99
Query: 672 HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHR 731
           +   + ++ E      L   L   A  ++L        +K I+D + Y+H+     I H 
Sbjct: 100 NKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHF 153
Query: 732 DISSKNVLLDFEN----EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 787
           D+  +N++L  +N       + DFGIA  ++   + +  + GT  +VAPE+     +  +
Sbjct: 154 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGLE 212
Query: 788 CDVYSFGVLALEVIKGKHP 806
            D++S GV+   ++ G  P
Sbjct: 213 ADMWSIGVITYILLSGASP 231

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 152 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 204
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVY 667
           IG GG   V+       +I A+K  +       T    + NE+  L ++   +  I+++Y
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLY 74
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            + +  +++++V E    C    + S     K++    R +  K +++A+  +H      
Sbjct: 75  DYEITDQYIYMVME----CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 127
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVT 785
           IVH D+   N L+  +    + DFGIA  ++PD+++  +    GT  Y+ PE    M  +
Sbjct: 128 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 786 EK-----------CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLP 833
            +            DV+S G +   +  GK P +  I+ +S     L+  +D   +   P
Sbjct: 187 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHEIEFP 242
Query: 834 T-PSRNVHDKLISIVEVTISCVDENPESR 861
             P +++ D       V   C+  +P+ R
Sbjct: 243 DIPEKDLQD-------VLKCCLKRDPKQR 264

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              N    + + +   
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 115/280 (41%), Gaps = 34/280 (12%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 83
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YG 772
           ++Y++   F   VHR+++++N ++  +    + DFG+ + +    +++    G       
Sbjct: 144 MAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 198
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           ++APE       T   D++SFGV+  E+         ++   +  L+    L  ++D   
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGY 251
Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                N  +++  ++ +   C   NP  RPT  ++  LLK
Sbjct: 252 LDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLK 288

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 6/195 (3%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L    + + +  L     +      L   R   ++  ++  + ++H+     I
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---I 147
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M   E  
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 789 DVYSFGVLALEVIKG 803
           D++S GV+  E+IKG
Sbjct: 207 DIWSVGVIMGEMIKG 221

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 631 VKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAV 690
           +KK  S        ++E   EV  L ++ H N++ ++    +   + ++ E   + S   
Sbjct: 45  IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE---LVSGGE 101
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EA 746
           +    A  ++L      + IK I+D ++Y+H      I H D+  +N++L  +N      
Sbjct: 102 LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + DFG+A  ++ D   +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 159 KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 631 VKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAV 690
           +KK  S        ++E   EV  L ++ H N++ ++    +   + ++ E   + S   
Sbjct: 45  IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE---LVSGGE 101
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EA 746
           +    A  ++L      + IK I+D ++Y+H      I H D+  +N++L  +N      
Sbjct: 102 LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + DFG+A  ++ D   +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 159 KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+ ++   +G+ +A+KK       E  F    L E+K L  + H N+V +  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 84
Query: 669 FCL-----HVRHLFIVYEYFKMCS--LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            C      + R    +Y  F  C   LA +LSN      L   +R+  ++ +++ L Y+H
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 142
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK 755
            +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 143 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 99/238 (41%), Gaps = 32/238 (13%)
Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGW 703
           + + F      ++++ H+++V  YG C       +V E+ K  SL   L  +    N+ W
Sbjct: 55  YSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA--------HVSDFGIAK 755
             ++ + K +  A+ ++  +    ++H ++ +KN+LL  E +          +SD GI+ 
Sbjct: 115 --KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
Query: 756 FLKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMS 814
            + P       L     +V PE     K +    D +SFG    E+  G           
Sbjct: 170 TVLPKDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG-------GDKP 218
Query: 815 FSSLNLNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            S+L+    L    D  +LP P      K   +  +  +C+D  P+ RP+ + + + L
Sbjct: 219 LSALDSQRKLQFYEDRHQLPAP------KAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDSSNWTELAG 769
           I+  L +MHN     +V+RD+   N+LLD      +SD G+A      KP +S      G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 352
Query: 770 TYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T+GY+APE L   +      D +S G +  ++++G  P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDSSNWTELAG 769
           I+  L +MHN     +V+RD+   N+LLD      +SD G+A      KP +S      G
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 351
Query: 770 TYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T+GY+APE L   +      D +S G +  ++++G  P
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 115/280 (41%), Gaps = 34/280 (12%)
Query: 610 IGKGGQGSVY---MSKLASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY      +  GE    +AVK  +      +  + EFLNE   +      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--DAAAKNLG-----WTRRMNMIKGIVDA 716
           V++ G     +   +V E      L   L +    A  N G         + M   I D 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT----YG 772
           ++Y++   F   VHR+++++N ++  +    + DFG+ + +    +++    G       
Sbjct: 143 MAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 197
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           ++APE       T   D++SFGV+  E+         ++   +  L+    L  ++D   
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGY 250
Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                N  +++  ++ +   C   NP  RPT  ++  LLK
Sbjct: 251 LDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLK 287

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 77/163 (47%), Gaps = 11/163 (6%)
Query: 650 NEVKALTEIWHRNIVKVYG--FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM 707
            E++ L  + H+N++++    +    + +++V EY  +C +  +L +    K     +  
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC-VCGMQEML-DSVPEKRFPVCQAH 112
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT-- 765
                ++D L Y+H+     IVH+DI   N+LL       +S  G+A+ L P +++ T  
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 766 ELAGTYGYVAPELAYTMKVTE--KCDVYSFGVLALEVIKGKHP 806
              G+  +  PE+A  +      K D++S GV    +  G +P
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+ ++   +G+ +A+KK       E  F    L E+K L  + H N+V +  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 84
Query: 669 FCL-----HVRHLFIVYEYFKMCS--LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            C      + R    +Y  F  C   LA +LSN      L   +R+  ++ +++ L Y+H
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 142
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK 755
            +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 143 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDSSNWTELAG 769
           I+  L +MHN     +V+RD+   N+LLD      +SD G+A      KP +S      G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 352
Query: 770 TYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T+GY+APE L   +      D +S G +  ++++G  P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL---KPDSSNWTELAG 769
           I+  L +MHN     +V+RD+   N+LLD      +SD G+A      KP +S      G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 352
Query: 770 TYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T+GY+APE L   +      D +S G +  ++++G  P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           ++E   EV  L EI H NI+ ++    +   + ++ E      L   L   A  ++L   
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTED 115
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFGIAKFLKPD 760
                +K I+D + Y+H+     I H D+  +N++L  +N       + DFGIA  ++  
Sbjct: 116 EATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 171
Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 172 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  ++  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+++D +    V+DFG AK +K     W  L GT  
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPE 204
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V+ ++   +G+ +A+KK       E  F    L E+K L  + H N+V +  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 83
Query: 669 FCL-----HVRHLFIVYEYFKMCS--LAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            C      + R    +Y  F  C   LA +LSN      L   +R+  ++ +++ L Y+H
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIH 141
Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK 755
            +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 142 RN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           ++E   EV  L EI H NI+ ++    +   + ++ E      L   L   A  ++L   
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTED 108
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFGIAKFLKPD 760
                +K I+D + Y+H+     I H D+  +N++L  +N       + DFGIA  ++  
Sbjct: 109 EATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 164
Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +  IGKG  G V+  K   GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 34  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENIL-- 86
Query: 667 YGFCLH-------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDA 716
            GF             L++V +Y +  SL   L+               MIK        
Sbjct: 87  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASG 138
Query: 717 LSYMHNDCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ 765
           L+++H +       P I HRD+ SKN+L+       ++D G+A  ++ DS+  T      
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 196
Query: 766 ELAGTYGYVAPEL---AYTMKVTE---KCDVYSFGVLALEV-----IKGKHPR------D 808
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 256
Query: 809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            + S         +  ++ L P +P   ++  + L  + ++   C   N  +R T  ++ 
Sbjct: 257 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 315
Query: 869 QLL 871
           + L
Sbjct: 316 KTL 318

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 14/225 (6%)
Query: 275 GPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN--NFYGEIS-SDWGRC 331
           G  P L+ L SL+R+    N      SE     P+L ++DLS+N  +F G  S SD+G  
Sbjct: 317 GQFPTLK-LKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGT- 372
Query: 332 PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHI--VGEIPIELGKLNFFIKLVLAH 389
             L  LD S N +       +G   QL  LD   +++  + E  + L   N  I L ++H
Sbjct: 373 TSLKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISH 430
Query: 390 NQLSGQLSPKLGSLVQLEHLDLSSNRLS-NSIPKSLGNLELIHLSELDLSRNFLREAIPS 448
                  +     L  LE L ++ N    N +P      EL +L+ LDLS+  L +  P+
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT--ELRNLTFLDLSQCQLEQLSPT 488
Query: 449 QICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGS 493
               + SL+ LN+SHN+   L    ++ +N L  +D S N +  S
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +  IGKG  G V+  K   GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENIL-- 99
Query: 667 YGFCLH-------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDA 716
            GF             L++V +Y +  SL   L+               MIK        
Sbjct: 100 -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASG 151
Query: 717 LSYMHNDCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ 765
           L+++H +       P I HRD+ SKN+L+       ++D G+A  ++ DS+  T      
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 209
Query: 766 ELAGTYGYVAPEL---AYTMKVTE---KCDVYSFGVLALEV-----IKGKHPR------D 808
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            + S         +  ++ L P +P   ++  + L  + ++   C   N  +R T  ++ 
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 328
Query: 869 QLL 871
           + L
Sbjct: 329 KTL 331

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 11/180 (6%)
Query: 631 VKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAV 690
           +KK  S        ++E   EV  L ++ H NI+ ++    +   + ++ E      L  
Sbjct: 45  IKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD 104
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EA 746
            L   A  ++L      + IK I+D ++Y+H      I H D+  +N++L  +N      
Sbjct: 105 FL---AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + DFG+A  ++ D   +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 159 KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           + +D    +G G  G V+ +++ A+G   A K   +P   +   ++    E++ ++ + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRH 213
Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             +V ++        + ++YE+     L   ++++     +     +  ++ +   L +M
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHM 271
Query: 721 HNDCFPPIVHRDISSKNVLLDFE--NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           H + +   VH D+  +N++   +  NE  + DFG+   L P  S      GT  + APE+
Sbjct: 272 HENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-KVTTGTAEFAAPEV 327
Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           A    V    D++S GVL+  ++ G  P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 631 VKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAV 690
           +KK  S        ++E   EV  L ++ H N++ ++    +   + ++ E   + S   
Sbjct: 45  IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE---LVSGGE 101
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EA 746
           +    A  ++L      + IK I+D ++Y+H      I H D+  +N++L  +N      
Sbjct: 102 LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + DFG+A  ++ D   +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 159 KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 631 VKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAV 690
           +KK  S        ++E   EV  L ++ H N++ ++    +   + ++ E   + S   
Sbjct: 45  IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE---LVSGGE 101
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EA 746
           +    A  ++L      + IK I+D ++Y+H      I H D+  +N++L  +N      
Sbjct: 102 LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            + DFG+A  ++ D   +  + GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 159 KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVY 667
           IG GG   V+       +I A+K  +       T    + NE+  L ++   +  I+++Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLY 122
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            + +  +++++V E    C    + S     K++    R +  K +++A+  +H      
Sbjct: 123 DYEITDQYIYMVME----CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVT 785
           IVH D+   N L+  +    + DFGIA  ++PD+++  +    GT  Y+ PE    M  +
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 786 EK-----------CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLP 833
            +            DV+S G +   +  GK P +  I+ +S     L+  +D   +   P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHEIEFP 290
Query: 834 T-PSRNVHDKLISIVEVTISCVDENPESR 861
             P +++ D       V   C+  +P+ R
Sbjct: 291 DIPEKDLQD-------VLKCCLKRDPKQR 312

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 597 IIRATNDFDDEHCIGKGGQGSVYMSK--LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 654
           + RA   ++    IG+G  G V+ ++     G  +A+K+      GE       + EV  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAV 64
Query: 655 LTEIW---HRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           L  +    H N+V+++  C   R      L +V+E+     L   L +      +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETI 122
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
            +M+  ++  L ++H+     +VHRD+  +N+L+    +  ++DFG+A+      +  T 
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTS 178
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
           +  T  Y APE+          D++S G +  E+ + K
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 83/196 (42%), Gaps = 17/196 (8%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V+  +    G + AVK+  SP  G         +  + L E+     V  + 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-------DRARKLAEVGSHEKVGQHP 117
Query: 669 FCLHVRHLF----IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
            C+ +   +    I+Y   ++C  ++    +A   +L   +    ++  + AL+++H+  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              +VH D+   N+ L       + DFG+   L    +   +  G   Y+APEL      
Sbjct: 178 ---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGDPRYMAPELLQGSYG 233
Query: 785 TEKCDVYSFGVLALEV 800
           T   DV+S G+  LEV
Sbjct: 234 T-AADVFSLGLTILEV 248

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVY 667
           IG GG   V+       +I A+K  +       T    + NE+  L ++   +  I+++Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLY 122
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            + +  +++++V E    C    + S     K++    R +  K +++A+  +H      
Sbjct: 123 DYEITDQYIYMVME----CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVT 785
           IVH D+   N L+  +    + DFGIA  ++PD+++  +    GT  Y+ PE    M  +
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 786 EK-----------CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLP 833
            +            DV+S G +   +  GK P +  I+ +S     L+  +D   +   P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHEIEFP 290
Query: 834 T-PSRNVHDKLISIVEVTISCVDENPESR 861
             P +++ D       V   C+  +P+ R
Sbjct: 291 DIPEKDLQD-------VLKCCLKRDPKQR 312

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 14/225 (6%)
Query: 275 GPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN--NFYGEIS-SDWGRC 331
           G  P L+ L SL+R+    N      SE     P+L ++DLS+N  +F G  S SD+G  
Sbjct: 341 GQFPTLK-LKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTI 397
Query: 332 PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHI--VGEIPIELGKLNFFIKLVLAH 389
             L  LD S N +       +G   QL  LD   +++  + E  + L   N  I L ++H
Sbjct: 398 -SLKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISH 454
Query: 390 NQLSGQLSPKLGSLVQLEHLDLSSNRLS-NSIPKSLGNLELIHLSELDLSRNFLREAIPS 448
                  +     L  LE L ++ N    N +P      EL +L+ LDLS+  L +  P+
Sbjct: 455 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT--ELRNLTFLDLSQCQLEQLSPT 512
Query: 449 QICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGS 493
               + SL+ LN+SHN+   L    ++ +N L  +D S N +  S
Sbjct: 513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 557

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 597 IIRATNDFDDEHCIGKGGQGSVYMSK--LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 654
           + RA   ++    IG+G  G V+ ++     G  +A+K+      GE       + EV  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAV 64
Query: 655 LTEIW---HRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
           L  +    H N+V+++  C   R      L +V+E+     L   L +      +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETI 122
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
            +M+  ++  L ++H+     +VHRD+  +N+L+    +  ++DFG+A+      +  T 
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTS 178
Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
           +  T  Y APE+          D++S G +  E+ + K
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 604 FDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +D    +G G  G V+ +++ A+G   A K   +P   +   ++    E++ ++ + H  
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPT 109
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           +V ++        + ++YE+     L   ++++     +     +  ++ +   L +MH 
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHE 167
Query: 723 DCFPPIVHRDISSKNVLLDFE--NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           + +   VH D+  +N++   +  NE  + DFG+   L P  S      GT  + APE+A 
Sbjct: 168 NNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVAE 223
Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP 806
              V    D++S GVL+  ++ G  P
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEV 800
             G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +  IGKG  G V+  K   GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENIL-- 66
Query: 667 YGFCLH-------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDA 716
            GF             L++V +Y +  SL   L+               MIK        
Sbjct: 67  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASG 118
Query: 717 LSYMHNDCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ 765
           L+++H +       P I HRD+ SKN+L+       ++D G+A  ++ DS+  T      
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 176
Query: 766 ELAGTYGYVAPEL---AYTMKVTE---KCDVYSFGVLALEV-----IKGKHPR------D 808
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 236
Query: 809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            + S         +  ++ L P +P   ++  + L  + ++   C   N  +R T  ++ 
Sbjct: 237 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 295
Query: 869 QLL 871
           + L
Sbjct: 296 KTL 298

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +  IGKG  G V+  K   GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENIL-- 61
Query: 667 YGFCLH-------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDA 716
            GF             L++V +Y +  SL   L+               MIK        
Sbjct: 62  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASG 113
Query: 717 LSYMHNDCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ 765
           L+++H +       P I HRD+ SKN+L+       ++D G+A  ++ DS+  T      
Sbjct: 114 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 171
Query: 766 ELAGTYGYVAPEL---AYTMKVTE---KCDVYSFGVLALEV-----IKGKHPR------D 808
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 231
Query: 809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            + S         +  ++ L P +P   ++  + L  + ++   C   N  +R T  ++ 
Sbjct: 232 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 290
Query: 869 QLL 871
           + L
Sbjct: 291 KTL 293

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +  IGKG  G V+  K   GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENIL-- 63
Query: 667 YGFCLH-------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDA 716
            GF             L++V +Y +  SL   L+               MIK        
Sbjct: 64  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASG 115
Query: 717 LSYMHNDCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ 765
           L+++H +       P I HRD+ SKN+L+       ++D G+A  ++ DS+  T      
Sbjct: 116 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 173
Query: 766 ELAGTYGYVAPEL---AYTMKVTE---KCDVYSFGVLALEV-----IKGKHPR------D 808
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 233
Query: 809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            + S         +  ++ L P +P   ++  + L  + ++   C   N  +R T  ++ 
Sbjct: 234 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 292
Query: 869 QLL 871
           + L
Sbjct: 293 KTL 295

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 584 SVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEM 642
           S  +F G+  +E++ +   D      +G+G    V     L + +  AVK      PG +
Sbjct: 2   STDSFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHI 53
Query: 643 TFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNL 701
             +     EV+ L +   HRN++++  F       ++V+E  +  S   ILS+    ++ 
Sbjct: 54  --RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS---ILSHIHKRRHF 108
Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLK 758
                  +++ +  AL ++HN     I HRD+  +N+L +  N+     + DFG+   +K
Sbjct: 109 NELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIK 165
Query: 759 --PDSS--NWTEL---AGTYGYVAPEL--AYTMKVT---EKCDVYSFGVLALEVIKGKHP 806
              D S  +  EL    G+  Y+APE+  A++ + +   ++CD++S GV+   ++ G  P
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY- 667
           +G GG G V+ +      + +A+KK     P  +   +  L E+K +  + H NIVKV+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALREIKIIRRLDHDNIVKVFE 75
Query: 668 -------------GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
                        G    +  ++IV EY +   LA +L      +         +++G  
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRG-- 132
Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAG---T 770
             L Y+H+     ++HRD+   N+ ++ E+    + DFG+A+ + P  S+   L+    T
Sbjct: 133 --LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 771 YGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGK 804
             Y +P L  +    T+  D+++ G +  E++ GK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 115/260 (44%), Gaps = 24/260 (9%)
Query: 561 KFQRR--KNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSV 618
           K +RR   N+S+   S   N   +   LT + + +Y + +R  +++     +G G  G V
Sbjct: 108 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEV 165
Query: 619 YMS------KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH 672
            ++      K  +  II+ +KF      E         E++ L ++ H  I+K+  F   
Sbjct: 166 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FD 224
Query: 673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRD 732
               +IV E  +   L   +  +   K    T ++   + ++ A+ Y+H +    I+HRD
Sbjct: 225 AEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL-AVQYLHEN---GIIHRD 278
Query: 733 ISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY---TMKVTE 786
           +  +NVLL  + E     ++DFG +K L  ++S    L GT  Y+APE+     T     
Sbjct: 279 LKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 337
Query: 787 KCDVYSFGVLALEVIKGKHP 806
             D +S GV+    + G  P
Sbjct: 338 AVDCWSLGVILFICLSGYPP 357

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +  IGKG  G V+  K   GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENIL-- 60
Query: 667 YGFCLH-------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK---GIVDA 716
            GF             L++V +Y +  SL   L+               MIK        
Sbjct: 61  -GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASG 112
Query: 717 LSYMHNDCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT------ 765
           L+++H +       P I HRD+ SKN+L+       ++D G+A  ++ DS+  T      
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 170
Query: 766 ELAGTYGYVAPEL---AYTMKVTE---KCDVYSFGVLALEV-----IKGKHPR------D 808
              GT  Y+APE+   +  MK  E   + D+Y+ G++  E+     I G H        D
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
            + S         +  ++ L P +P   ++  + L  + ++   C   N  +R T  ++ 
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIK 289
Query: 869 QLL 871
           + L
Sbjct: 290 KTL 292

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           Y+AP +  +    +  D ++ GVL  E+  G  P
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNW 764
           + I+ I++A+ + H      +VHRD+  +N+LL  + +     ++DFG+A  ++ D   W
Sbjct: 107 HCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW 163
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 796
              AGT GY++PE+       +  D+++ GV+
Sbjct: 164 FGFAGTPGYLSPEVLRKEAYGKPVDIWACGVI 195

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 72/161 (44%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK------FLKPD 760
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+      + K  
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
           ++    +     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 251 TNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V+   + A+G  +A K   +     M  ++E  NE+  + ++ H N++++Y 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                  + +V EY     L   + +++   NL     +  +K I + + +MH      I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEGIRHMHQ---MYI 208
Query: 729 VHRDISSKNVLLDFENEAHVS--DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           +H D+  +N+L    +   +   DFG+A+  KP         GT  ++APE+     V+ 
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSF 267
Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN 819
             D++S GV+A  ++ G  P  F+      +LN
Sbjct: 268 PTDMWSVGVIAYMLLSGLSP--FLGDNDAETLN 298

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNW 764
           + I+ I++++++ H      IVHRD+  +N+LL  +++     ++DFG+A  ++ D   W
Sbjct: 107 HCIQQILESVNHCH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW 163
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
              AGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 164 FGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 6/195 (3%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L    + + +  L     +      L   R   ++  ++  + ++H+     I
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---I 147
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M   E  
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 789 DVYSFGVLALEVIKG 803
           D++S G +  E+IKG
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRN 662
           +G G  G V       +SK      +AVK        + + ++  ++E+K +T++  H N
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHEN 110
Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVIL----------SNDAA----AKNLGWTRRMN 708
           IV + G C     +++++EY   C    +L          S D       K L     +N
Sbjct: 111 IVNLLGACTLSGPIYLIFEY---CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 709 MIKGIVDALSYMHNDC-------FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
           ++    D L + +          F   VHRD++++NVL+       + DFG+A+ +  D 
Sbjct: 168 VLT-FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225
Query: 762 SNWTELAGT---YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
           SN+           ++APE  +    T K DV+S+G+L  E+ 
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNW 764
           + I+ I++++++ H      IVHRD+  +N+LL  +++     ++DFG+A  ++ D   W
Sbjct: 107 HCIQQILESVNHCH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW 163
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
              AGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 164 FGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/282 (21%), Positives = 112/282 (39%), Gaps = 25/282 (8%)
Query: 595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLASGE----IIAVKKFHSPLPGEMTFQQEFLN 650
           E+++     F     +GKG  GSV  ++L   +     +AVK   + +      + EFL 
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLR 74
Query: 651 EVKALTEIWHRNIVKVYGFCLHVRHL------FIVYEYFKMCSLAVILSNDAAAKNLGWT 704
           E   + E  H ++ K+ G  L  R         ++  + K   L   L      +N    
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
               +++ +VD    M        +HRD++++N +L  +    V+DFG+++ +       
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 765 TELAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLN 821
              A      ++A E       T   DV++FGV   E++ +G+ P   I +      N  
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNYL 252
Query: 822 IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
           I  + +  P  P     V+D       +   C   +P+ RP+
Sbjct: 253 IGGNRLKQP--PECMEEVYD-------LMYQCWSADPKQRPS 285

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 115/260 (44%), Gaps = 24/260 (9%)
Query: 561 KFQRR--KNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSV 618
           K +RR   N+S+   S   N   +   LT + + +Y + +R  +++     +G G  G V
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEV 151
Query: 619 YMS------KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH 672
            ++      K  +  II+ +KF      E         E++ L ++ H  I+K+  F   
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FD 210
Query: 673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRD 732
               +IV E  +   L   +  +   K    T ++   + ++ A+ Y+H +    I+HRD
Sbjct: 211 AEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL-AVQYLHEN---GIIHRD 264
Query: 733 ISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY---TMKVTE 786
           +  +NVLL  + E     ++DFG +K L  ++S    L GT  Y+APE+     T     
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 323
Query: 787 KCDVYSFGVLALEVIKGKHP 806
             D +S GV+    + G  P
Sbjct: 324 AVDCWSLGVILFICLSGYPP 343

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 610 IGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  G +  M    S E++AVK        +   ++E +N       + H NIV+   
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 81
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L   HL IV EY     L   + N   A            + ++  +SY H      +
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQV 135
Query: 729 VHRDISSKNVLLDFENEAH--VSDFGIAK----FLKPDSSNWTELAGTYGYVAPELAYTM 782
            HRD+  +N LLD        + DFG +K      +P S+      GT  Y+APE+    
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 190
Query: 783 KVTEK-CDVYSFGVLALEVIKGKHP 806
           +   K  DV+S GV    ++ G +P
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 10/151 (6%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+ +       +H+++V E  +   L   L      K         ++  I   + Y
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGKTVEY 136
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENE----AHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           +H+     +VHRD+   N+L   E+       + DFG AK L+ ++        T  +VA
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVA 193
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           PE+       E CD++S G+L   ++ G  P
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 6/195 (3%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L    + + +  L     +      L   R   ++  ++  + ++H+     I
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---I 147
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M   E  
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 789 DVYSFGVLALEVIKG 803
           D++S G +  E+IKG
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           IV AL ++H      I++RDI  +N+LLD      ++DFG++K F+  ++    +  GT 
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 772 GYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 806
            Y+AP++         +  D +S GVL  E++ G  P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 669 FCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                      + ++IV E        VI         L   R   ++  ++  + ++H+
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS 144
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                I+HRD+   N+++  +    + DFG+A+          E+   Y Y APE+   M
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY-YRAPEVILGM 200
Query: 783 KVTEKCDVYSFGVLALEVIKG 803
              E  D++S G +  E+IKG
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++  Y    +L   L              N    + + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 23/205 (11%)
Query: 610 IGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  G +  M    S E++AVK            ++E +N       + H NIV+   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKE 82
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L   HL IV EY     L   + N   A            + ++  +SY H      +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQV 136
Query: 729 VHRDISSKNVLLDFENEAH--VSDFGIAK----FLKPDSSNWTELAGTYGYVAPELAYTM 782
            HRD+  +N LLD        + DFG +K      +P S+      GT  Y+APE+    
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 191
Query: 783 KVTEK-CDVYSFGVLALEVIKGKHP 806
           +   K  DV+S GV    ++ G +P
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 14/170 (8%)
Query: 644 FQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
            ++  L EV  L ++  H NI+++          F+V++  K   L   L+         
Sbjct: 53  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 112
Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
             + M  +  ++ AL  ++      IVHRD+  +N+LLD +    ++DFG +  L P   
Sbjct: 113 TRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GE 165
Query: 763 NWTELAGTYGYVAPE-LAYTMK-----VTEKCDVYSFGVLALEVIKGKHP 806
              E+ GT  Y+APE +  +M        ++ D++S GV+   ++ G  P
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 142 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
             G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 68/157 (43%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L                   + L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
             G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/269 (21%), Positives = 115/269 (42%), Gaps = 37/269 (13%)
Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVY 667
           IG GG   V+       +I A+K  +       T    + NE+  L ++   +  I+++Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLY 122
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            + +  +++++V E    C    + S     K++    R +  K +++A+  +H      
Sbjct: 123 DYEITDQYIYMVME----CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVT 785
           IVH D+   N L+  +    + DFGIA  ++PD+++  +    G   Y+ PE    M  +
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 786 EK-----------CDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDPRLP 833
            +            DV+S G +   +  GK P +  I+ +S     L+  +D   +   P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDPNHEIEFP 290
Query: 834 T-PSRNVHDKLISIVEVTISCVDENPESR 861
             P +++ D       V   C+  +P+ R
Sbjct: 291 DIPEKDLQD-------VLKCCLKRDPKQR 312

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 23/205 (11%)
Query: 610 IGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  G +  M    + E++AVK        +   ++E +N       + H NIV+   
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L   HL IV EY     L   + N   A            + ++  +SY H      +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYAHA---MQV 136
Query: 729 VHRDISSKNVLLDFENEAH--VSDFGIAK----FLKPDSSNWTELAGTYGYVAPELAYTM 782
            HRD+  +N LLD        ++DFG +K      +P S+      GT  Y+APE+    
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-----VGTPAYIAPEVLLKK 191
Query: 783 KVTEK-CDVYSFGVLALEVIKGKHP 806
           +   K  DV+S GV    ++ G +P
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 6/195 (3%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L    + + +  L     +      L   R   ++  ++  + ++H+     I
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---I 147
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M   E  
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 789 DVYSFGVLALEVIKG 803
           D++S G +  E+IKG
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK +K     W  L GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPE 203
Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            +APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 145 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
             G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 238

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 10/151 (6%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+ +       +H+++V E  +   L   L      K         ++  I   + Y
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGKTVEY 136
Query: 720 MHNDCFPPIVHRDISSKNVLLDFENE----AHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           +H+     +VHRD+   N+L   E+       + DFG AK L+ ++        T  +VA
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVA 193
Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           PE+       E CD++S G+L   ++ G  P
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
             G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
             G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 138 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
             G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 20/238 (8%)
Query: 627 EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC 686
            I+A+K     L  +  F+     E +    +   ++V ++ F      L++        
Sbjct: 60  RIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGV 119
Query: 687 SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA 746
            LA  L        L   R + +++ I    S +         HRD+  +N+L+  ++ A
Sbjct: 120 DLAAXLRRQGP---LAPPRAVAIVRQIG---SALDAAHAAGATHRDVKPENILVSADDFA 173
Query: 747 HVSDFGIAKFLKPDSSNWTELAGTYG---YVAPELAYTMKVTEKCDVYSFGVLALEVIKG 803
           ++ DFGIA          T+L  T G   Y APE       T + D+Y+   +  E + G
Sbjct: 174 YLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231
Query: 804 KHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESR 861
             P      +S    ++N A        +P PS       ++   V      +NPE R
Sbjct: 232 SPPYQG-DQLSVXGAHINQA--------IPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++ EY    +L   L              +    + L     
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +         
Sbjct: 146 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 767 LAGT--YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
             G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 239

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 6/195 (3%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L    + + +  L     +      L   R   ++  ++  + ++H+     I
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 147
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 788
           +HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M   E  
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 789 DVYSFGVLALEVIKG 803
           D++S G +  E+IKG
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 26/161 (16%)
Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILS-------------NDAAAKNLGWTRR 706
           H+NI+ + G C     L+++  Y    +L   L              N    + + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
           ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+    D +N   
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 767 LAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
              T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 14/227 (6%)
Query: 275 GPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN--NFYGEIS-SDWGRC 331
           G  P L+ L SL+R+    N      SE     P+L ++DLS+N  +F G  S SD+G  
Sbjct: 317 GQFPTLK-LKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGT- 372
Query: 332 PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHI--VGEIPIELGKLNFFIKLVLAH 389
             L  LD S N +       +G   QL  LD   +++  + E  + L   N  I L ++H
Sbjct: 373 TSLKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISH 430
Query: 390 NQLSGQLSPKLGSLVQLEHLDLSSNRLS-NSIPKSLGNLELIHLSELDLSRNFLREAIPS 448
                  +     L  LE L ++ N    N +P      EL +L+ LDLS+  L +  P+
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT--ELRNLTFLDLSQCQLEQLSPT 488
Query: 449 QICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIP 495
               + SL+ LN++ N L  +    F+++  L  I +  N    S P
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA---HVSDFGIAKFLKPDSSNW 764
           + I  I+++++++H      IVHRD+  +N+LL  + +     ++DFG+A  ++ +   W
Sbjct: 134 HCIHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW 190
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
              AGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 191 FGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 101/241 (41%), Gaps = 35/241 (14%)
Query: 584 SVLTFEGKIIYEEIIRATND-FDDEHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGE 641
           S+++       +E  R   D F  E   G+G  G+V + K  S G  +A+KK    +  +
Sbjct: 4   SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQD 59
Query: 642 MTFQQEFLNEVKALTEIWHRNIVKV--YGFCLHVR-----HLFIVYEY----FKMCSLAV 690
             F+   L  ++ L  + H NIV++  Y + L  R     +L +V EY       C    
Sbjct: 60  PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119
Query: 691 ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI--VHRDISSKNVLLDFENEA-- 746
                A    L       +I+ I      +H    P +   HRDI   NVL+   NEA  
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSI----GCLH---LPSVNVCHRDIKPHNVLV---NEADG 169
Query: 747 --HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKG 803
              + DFG AK L P   N   +   Y Y APEL +     T   D++S G +  E++ G
Sbjct: 170 TLKLCDFGSAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
Query: 804 K 804
           +
Sbjct: 229 E 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKXVNHKNIISLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 91  VFTPQKTL----EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 842 K 842
           +
Sbjct: 263 R 263

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSN- 414
           +QL  LDL++ H+ G +P  +  LN   KLVL+ N           +   L HL +  N 
Sbjct: 275 TQLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHFDQLCQISAANFPSLTHLYIRGNV 333
Query: 415 ---RLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIP 471
               L     + LGNL+ + LS  D+  +   +    Q+  +  L+ LNLSHN   GL  
Sbjct: 334 KKLHLGVGCLEKLGNLQTLDLSHNDIEAS---DCCSLQLKNLSHLQTLNLSHNEPLGLQS 390
Query: 472 SCFEKMNGLLHIDISYNELRGSIPNS 497
             F++   L  +D+++  L  + P S
Sbjct: 391 QAFKECPQLELLDLAFTRLHINAPQS 416

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 610 IGKGGQGSVYMSKLAS--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G+G  G VY     +  GE I V          +  +++F++E   +  + H +IVK+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILS-NDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCF 725
           G  +     +I+ E +    L   L  N  + K L  T  +  ++ I  A++Y+ + +C 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQ-ICKAMAYLESINC- 130
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD---SSNWTELAGTYGYVAPELAYTM 782
              VHRDI+ +N+L+       + DFG++++++ +    ++ T L     +++PE     
Sbjct: 131 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFR 185
Query: 783 KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
           + T   DV+ F V   E++  GK P  ++ +         I + E  D RLP P      
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV------IGVLEKGD-RLPKPD----- 233
Query: 842 KLISIVEVTI--SCVDENPESRPTMQK-VCQL 870
            L   V  T+   C D +P  RP   + VC L
Sbjct: 234 -LCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 610 IGKGGQGSVYMSKLAS--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G+G  G VY     +  GE I V          +  +++F++E   +  + H +IVK+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILS-NDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCF 725
           G  +     +I+ E +    L   L  N  + K L  T  +  ++ I  A++Y+ + +C 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQ-ICKAMAYLESINC- 134
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD---SSNWTELAGTYGYVAPELAYTM 782
              VHRDI+ +N+L+       + DFG++++++ +    ++ T L     +++PE     
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFR 189
Query: 783 KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
           + T   DV+ F V   E++  GK P  ++ +         I + E  D RLP P      
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV------IGVLEKGD-RLPKPD----- 237
Query: 842 KLISIVEVTI--SCVDENPESRPTMQK-VCQL 870
            L   V  T+   C D +P  RP   + VC L
Sbjct: 238 -LCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 78/165 (47%), Gaps = 9/165 (5%)
Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
            Q+   E +    + H NIV+++       H +++   F + +   +  +  A +     
Sbjct: 65  HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI---FDLVTGGELFEDIVAREYYSEA 121
Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSDFGIAKFLKPDS 761
              + I+ I++A+ + H      +VHRD+  +N+LL  +       ++DFG+A  ++ + 
Sbjct: 122 DASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 178
Query: 762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             W   AGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 179 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 91
Query: 669 FCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                      + ++IV E        VI         L   R   ++  ++  + ++H+
Sbjct: 92  VFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS 145
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M
Sbjct: 146 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 783 KVTEKCDVYSFGVLALEVIKG 803
              E  D++S G +  E+IKG
Sbjct: 202 GYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 669 FCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                      + ++IV E        VI         L   R   ++  ++  + ++H+
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS 144
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 783 KVTEKCDVYSFGVLALEVIKG 803
              E  D++S G +  E+IKG
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 669 FCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                      + ++IV E        VI         L   R   ++  ++  + ++H+
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS 144
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M
Sbjct: 145 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 783 KVTEKCDVYSFGVLALEVIKG 803
              E  D++S G +  E+IKG
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V+   + A+G +   K  ++P P +   +    NE+  + ++ H  ++ ++ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHD 115
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                  + ++ E+     L   ++  A    +     +N ++   + L +MH      I
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 729 VHRDISSKNVLLDFENEAHVS--DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
           VH DI  +N++ + +  + V   DFG+A  L PD       A T  + APE+     V  
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIVDREPVGF 229
Query: 787 KCDVYSFGVLALEVIKGKHP 806
             D+++ GVL   ++ G  P
Sbjct: 230 YTDMWAIGVLGYVLLSGLSP 249

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 68  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  TE   T  Y
Sbjct: 128 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCYTPYY 183
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKXVNHKNIISLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 91  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 144
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 145 -AGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 842 K 842
           +
Sbjct: 263 R 263

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +     G  +AVKK   P   + T  +    E+  L  + H+NI+ +  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLN 88
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAK----NLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +    +     L   R   ++  ++  + ++H+  
Sbjct: 89  VFTPQKTL----EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS-- 142
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTM 782
              I+HRD+   N+++  +    + DFG+A   +  S+N+  T    T  Y APE+   M
Sbjct: 143 -AGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 783 KVTEKCDVYSFGVLALEVIKG 803
              E  D++S G +  E++KG
Sbjct: 199 GYKENVDIWSVGCIMGELVKG 219

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 67/177 (37%), Gaps = 24/177 (13%)
Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
           L+L +NKLS     +   LT L  LY++ N L     G     +    L +++NKL    
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALP 101
Query: 86  PPSLGNLSNLATLYLDTNSLSNSIPSEXXXXXXXXXXXXXXXXXXXXXPHSLGNLTNLAT 145
                 L NLA L LD N L  S+P                       P    +LT L  
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLP-----------------------PRVFDSLTKLTY 137
Query: 146 LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS 202
           L +  N L +   G    L SL  L+L  N        +   L+ L TL LD N L 
Sbjct: 138 LSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 69/180 (38%), Gaps = 25/180 (13%)
Query: 140 LTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTN 199
           LT L  LY+  N L     G    LK+L  L +++N            L NLA L LD N
Sbjct: 60  LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN 119
Query: 200 SLSYSIPXXXXXXXXXXXXXXXYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRN 259
            L  S+P                       P    +L+ LTYL+L  N L       +  
Sbjct: 120 QLK-SLP-----------------------PRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155
Query: 260 LVKLTILLLGHNQF-RGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
           L  L  L L +NQ  R P      LT L+ ++LD N L      +F     L  + L +N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAHVSDFGIAKFLKPDSSNW 764
           + +K I++A++Y+H +    IVHRD+  +N+L      +    ++DFG++K ++      
Sbjct: 152 DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T + GT GY APE+        + D++S G++   ++ G  P
Sbjct: 209 T-VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 84  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 143
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 144 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 199
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 200 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKXVNHKNIISLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 91  VFTPQKTL----EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHS-- 144
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 145 -AGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 842 K 842
           +
Sbjct: 263 R 263

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 76  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 136 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 191
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 192 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 74  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 134 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 189
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 190 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 83
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 84  VFTPQKTL----EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG 139
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 140 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 842 K 842
           +
Sbjct: 256 R 256

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 120 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 180 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 235
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 236 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 229
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 91  VFTPQKTL----EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG 146
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 842 K 842
           +
Sbjct: 263 R 263

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 75  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 135 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 190
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 191 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFGIAKFLKPDSSNWTELA 768
           I   + Y+H      +VHRD+   N+L   E+       + DFG AK L+ ++       
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            T  +VAPE+         CD++S GVL   ++ G  P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 610 IGKGGQGSVYMS------KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G G  G V ++      K  + +II+ +KF      E         E++ L ++ H  I
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           +K+  F       +IV E  +   L   +  +   K    T ++   + ++ A+ Y+H +
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL-AVQYLHEN 139
Query: 724 CFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
               I+HRD+  +NVLL  + E     ++DFG +K L  ++S    L GT  Y+APE+  
Sbjct: 140 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLV 195
Query: 781 TMKVT---EKCDVYSFGVLALEVIKGKHP 806
           ++         D +S GV+    + G  P
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 43/137 (31%), Positives = 64/137 (46%), Gaps = 5/137 (3%)
Query: 346 GNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQ 405
            +VP  I  ++Q  +L L  N I    P     L    +L L  NQL         SL Q
Sbjct: 32  ASVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89
Query: 406 LEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNS 465
           L  LDL +N+L+  +P ++ +  L+HL EL +  N L E +P  I  +  L  L L  N 
Sbjct: 90  LTVLDLGTNQLT-VLPSAVFD-RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQ 146
Query: 466 LSGLIPSCFEKMNGLLH 482
           L  +    F++++ L H
Sbjct: 147 LKSIPHGAFDRLSSLTH 163

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 112/240 (46%), Gaps = 33/240 (13%)
Query: 584 SVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEM 642
           S  +F G+  +E++ +   D      +G+G    V     L + +  AVK      PG +
Sbjct: 2   STDSFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHI 53
Query: 643 TFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNL 701
             +     EV+ L +   HRN++++  F       ++V+E  +  S   ILS+    ++ 
Sbjct: 54  --RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS---ILSHIHKRRHF 108
Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLK 758
                  +++ +  AL ++HN     I HRD+  +N+L +  N+     + DF +   +K
Sbjct: 109 NELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 759 --PDSS--NWTEL---AGTYGYVAPEL--AYTMKVT---EKCDVYSFGVLALEVIKGKHP 806
              D S  +  EL    G+  Y+APE+  A++ + +   ++CD++S GV+   ++ G  P
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 68  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 128 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 183
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 69  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 129 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 184
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 185 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 610 IGKGGQGSVYMS------KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G G  G V ++      K  + +II+ +KF      E         E++ L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           +K+  F       +IV E  +   L   +  +   K    T ++   + ++ A+ Y+H +
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL-AVQYLHEN 133
Query: 724 CFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
               I+HRD+  +NVLL  + E     ++DFG +K L  ++S    L GT  Y+APE+  
Sbjct: 134 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLV 189
Query: 781 TMKVT---EKCDVYSFGVLALEVIKGKHP 806
           ++         D +S GV+    + G  P
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 610 IGKGGQGSVYMSKLA--SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G+G  G VY        GE I V          +  +++F++E   +  + H +IVK+ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILS-NDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCF 725
           G  +     +I+ E +    L   L  N  + K L  T  +  ++ I  A++Y+ + +C 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQ-ICKAMAYLESINC- 146
Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD---SSNWTELAGTYGYVAPELAYTM 782
              VHRDI+ +N+L+       + DFG++++++ +    ++ T L     +++PE     
Sbjct: 147 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFR 201
Query: 783 KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
           + T   DV+ F V   E++  GK P  ++ +         I + E  D RLP P      
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV------IGVLEKGD-RLPKPD----- 249
Query: 842 KLISIVEVTI--SCVDENPESRPTMQK-VCQL 870
            L   V  T+   C D +P  RP   + VC L
Sbjct: 250 -LCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 610 IGKGGQGSVYMS------KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G G  G V ++      K  + +II+ +KF      E         E++ L ++ H  I
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           +K+  F       +IV E  +   L   +  +   K    T ++   + ++ A+ Y+H +
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL-AVQYLHEN 132
Query: 724 CFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
               I+HRD+  +NVLL  + E     ++DFG +K L  ++S    L GT  Y+APE+  
Sbjct: 133 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLV 188
Query: 781 TMKVT---EKCDVYSFGVLALEVIKGKHP 806
           ++         D +S GV+    + G  P
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 14/165 (8%)
Query: 337 LDFSINNITGNVPPEIGHSSQLGVLDLSSNHI-----VGEIPIELGKLNFFIKLVLAHNQ 391
           LDFS N +T  V    GH ++L  L L  N +     + E+  ++  L    +L ++ N 
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ---QLDISQNS 385
Query: 392 LSGQLSPKLGSLVQ-LEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI 450
           +S        S  + L  L++SSN L+++I + L       +  LDL  N ++ +IP Q+
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP----RIKVLDLHSNKIK-SIPKQV 440
Query: 451 CIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIP 495
             +++L++LN++ N L  +    F+++  L  I +  N    S P
Sbjct: 441 VKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 610 IGKGGQGSVYMS------KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G G  G V ++      K  + +II+ +KF      E         E++ L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           +K+  F       +IV E  +   L   +  +   K    T ++   + ++ A+ Y+H +
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL-AVQYLHEN 133
Query: 724 CFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
               I+HRD+  +NVLL  + E     ++DFG +K L  ++S    L GT  Y+APE+  
Sbjct: 134 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLV 189
Query: 781 TMKVT---EKCDVYSFGVLALEVIKGKHP 806
           ++         D +S GV+    + G  P
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 185
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAVILSNDAAA--------KNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V+   D            +  +T R    ++K I +A
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 185
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 18/201 (8%)
Query: 610 IGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A  E  +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 92
Query: 669 FCL------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                      + ++IV E        VI         L   R   ++  ++  + ++H+
Sbjct: 93  VFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS 146
Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                I+HRD+   N+++  +    + DFG+A+     S        T  Y APE+   M
Sbjct: 147 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 783 KVTEKCDVYSFGVLALEVIKG 803
              E  D++S G +  E+IKG
Sbjct: 203 GYKENVDIWSVGCIMGEMIKG 223

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 649 LNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM 707
           L EV  L ++  H NI+++          F+V++  K   L   L+           + M
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTEL 767
             +  ++ AL  ++      IVHRD+  +N+LLD +    ++DFG +  L P      E+
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 183
Query: 768 AGTYGYVAPEL----------AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            GT  Y+APE+           Y  +V    D++S GV+   ++ G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 610 IGKGGQGSVYMS-KLASGEIIAVKKFH-----SPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G VY +    + E +A+K+         +PG        + EV  L E+ HRNI
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHRNI 95
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDALSY 719
           +++     H   L +++EY +      +  N   +        M +IK     +++ +++
Sbjct: 96  IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVS--------MRVIKSFLYQLINGVNF 147
Query: 720 MHN-DCFPPIVHRDISSKNVLLDFENEAH-----VSDFGIAKFLKPDSSNWTELAGTYGY 773
            H+  C    +HRD+  +N+LL   + +      + DFG+A+        +T    T  Y
Sbjct: 148 CHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 774 VAPE-LAYTMKVTEKCDVYSFGVLALEVI 801
             PE L  +   +   D++S   +  E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 610 IGKGGQGSVYMS------KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G G  G V ++      K  + +II+ +KF      E         E++ L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           +K+  F       +IV E  +   L   +  +   K    T ++   + ++ A+ Y+H +
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL-AVQYLHEN 133
Query: 724 CFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
               I+HRD+  +NVLL  + E     ++DFG +K L  ++S    L GT  Y+APE+  
Sbjct: 134 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLV 189
Query: 781 TMKVT---EKCDVYSFGVLALEVIKGKHP 806
           ++         D +S GV+    + G  P
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFGIAKFLKPDSSNWTELA 768
           I   + Y+H      +VHRD+   N+L   E+       + DFG AK L+ ++       
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            T  +VAPE+         CD++S GVL    + G  P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 128
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 129 VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 182
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 183 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 842 K 842
           +
Sbjct: 301 R 301

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 91
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 92  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 145
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 146 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 842 K 842
           +
Sbjct: 264 R 264

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 89
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 90  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 143
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 144 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 202 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 261
Query: 842 K 842
           +
Sbjct: 262 R 262

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 23/205 (11%)
Query: 610 IGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  G +  M    S E++AVK        +   ++E +N       + H NIV+   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L   HL IV EY     L   + N   A            + ++  +SY H      +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQV 136
Query: 729 VHRDISSKNVLLDFENEAH--VSDFGIAK----FLKPDSSNWTELAGTYGYVAPELAYTM 782
            HRD+  +N LLD        +  FG +K      +P S+      GT  Y+APE+    
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKK 191
Query: 783 KVTEK-CDVYSFGVLALEVIKGKHP 806
           +   K  DV+S GV    ++ G +P
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 83
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 84  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 137
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 138 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 842 K 842
           +
Sbjct: 256 R 256

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 91  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 144
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 145 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 842 K 842
           +
Sbjct: 263 R 263

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 84
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 85  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 138
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 139 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 256
Query: 842 K 842
           +
Sbjct: 257 R 257

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 84
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 85  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 138
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 139 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 256
Query: 842 K 842
           +
Sbjct: 257 R 257

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 90
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 91  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 144
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 145 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 842 K 842
           +
Sbjct: 263 R 263

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 91
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 92  VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 145
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 146 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 842 K 842
           +
Sbjct: 264 R 264

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 33/271 (12%)
Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+GG   V + + L  G   A+K+    L  E   ++E   E        H NI+++  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 669 FCLHVR----HLFIVYEYFKMCSLAVILSNDAAAKN-LGWTRRMNMIKGIVDALSYMHND 723
           +CL  R      +++  +FK  +L   +       N L   + + ++ GI   L  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGI--AKFLKPDSS-------NWTELAGTYGYV 774
            +    HRD+   N+LL  E +  + D G      +  + S       +W     T  Y 
Sbjct: 154 GY---AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 775 APELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
           APEL        + E+ DV+S G +   ++ G+ P D +      S+ L +  +++  P+
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAVQ-NQLSIPQ 268
Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRP 862
            P  S  +   L S++ V       +P  RP
Sbjct: 269 SPRHSSALWQLLNSMMTV-------DPHQRP 292

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 610 IGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G QG V  +  A     +A+KK   P   + T  +    E+  +  + H+NI+ +  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLN 128
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
                + L    E F+   L + L +          L   R   ++  ++  + ++H+  
Sbjct: 129 VFTPQKTL----EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-- 182
Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 784
              I+HRD+   N+++  +    + DFG+A+     S   T    T  Y APE+   M  
Sbjct: 183 -AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 785 TEKCDVYSFGVLALEVIKGK--HP-RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            E  D++S G +  E+++ K   P RD+I   +     L     E +    PT    V +
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 842 K 842
           +
Sbjct: 301 R 301

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 610 IGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G   +VY  K   +  ++A+K+    L  E       + EV  L ++ H NIV ++ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                + L +V+EY     L   L +     N+   +    +  ++  L+Y H      +
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ---KV 121
Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEK 787
           +HRD+  +N+L++   E  ++DFG+A+     +  +     T  Y  P+ L  +   + +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 788 CDVYSFGVLALEVIKGK 804
            D++  G +  E+  G+
Sbjct: 182 IDMWGVGCIFYEMATGR 198

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 171 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 225
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 226 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 261

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 166 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 220
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 20/153 (13%)
Query: 670 CLHVRHLFIVYEYF---KMCSLAV--------ILSNDAAAKNLGWTRRM--NMIKGIVDA 716
           C H+  +  VYE     + C L V        + S      +  +T R    + K I +A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEA 173
Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 773
           + Y+H+     I HRD+  +N+L   +    +   +DFG AK     +S  T     Y Y
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-Y 229
Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           VAPE+    K  + CD +S GV+   ++ G  P
Sbjct: 230 VAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPP 262

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 19/203 (9%)
Query: 610 IGKGGQG-SVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  G +  M    S E++AVK        +   ++E +N       + H NIV+   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
             L   HL IV EY     L   + N   A            + ++  +SY H      +
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQV 136
Query: 729 VHRDISSKNVLLDFENEAH--VSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKV 784
            HRD+  +N LLD        +  FG +K   L    S   +  GT  Y+APE+    + 
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH---SQPKDTVGTPAYIAPEVLLKKEY 193
Query: 785 TEK-CDVYSFGVLALEVIKGKHP 806
             K  DV+S GV    ++ G +P
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 152 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 206
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 100/259 (38%), Gaps = 47/259 (18%)
Query: 231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERV 289
           +  G  SN  YLNL EN++       +R+L  L +L LG N  R   +     L SL  +
Sbjct: 69  VPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTL 128
Query: 290 RLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD----------- 338
            L  N+LT   S +F     L  + L  N      S  + R P L  LD           
Sbjct: 129 ELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS 188
Query: 339 --------------FSINNITG--NVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFF 382
                           + NI    N+ P +G    L  L++S NH     P     L+  
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIKDMPNLTPLVG----LEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 383 IKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN-- 440
            KL + ++Q+S         L  L  L+L+ N LS S+P  L    L +L EL L  N  
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT-PLRYLVELHLHHNPW 302
Query: 441 -----------FLREAIPS 448
                      +LRE IP+
Sbjct: 303 NCDCDILWLAWWLREYIPT 321

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 152 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 206
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 124 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 178
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 166 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 220
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 152 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 206
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 151 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 205
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 151 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 205
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 152 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 206
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 166 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 220
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 151 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 205
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 151 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 205
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 158 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 212
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 627 EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMC 686
           +I+ V KF S  PG  T  ++   E      + H +IV++         L++V+E+    
Sbjct: 55  KIVDVAKFTSS-PGLST--EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA 111
Query: 687 SLAV-ILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL-DFEN 744
            L   I+    A          + ++ I++AL Y H++    I+HRD+  +NVLL   EN
Sbjct: 112 DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKEN 168
Query: 745 EAHVS--DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK 802
            A V   DFG+A  L           GT  ++APE+       +  DV+  GV+   ++ 
Sbjct: 169 SAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 803 GKHP 806
           G  P
Sbjct: 229 GCLP 232

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 146 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 200
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 236

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +++A+ + HN C   ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT 
Sbjct: 139 VLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 193
Query: 772 GYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	873
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-141
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-139
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-130
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-126
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-102
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-98
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-42
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-97
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-96
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-94
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-87
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-45
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-91
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-77
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-73
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-71
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-46
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-41
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-86
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-76
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-68
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-59
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-86
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-83
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-78
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-75
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-68
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-83
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-82
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-82
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-74
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-70
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-76
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-65
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-61
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-48
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-36
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-32
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-71
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-64
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-61
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-22
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-60
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-53
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-60
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-33
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-10
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-54
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-54
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-54
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-52
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-54
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-53
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-48
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-48
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-37
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-45
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-43
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-42
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-37
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-37
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-41
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-40
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-41
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-40
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-41
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-36
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-37
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-36
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-38
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-32
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-35
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-07
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-33
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-10
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-33
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-33
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-09
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-29
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-32
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-30
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-08
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-30
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-29
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-11
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-04
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-25
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-24
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-24
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-05
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-13
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-07
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-11
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-06
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-08
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-20
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-19
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-05
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-16
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-16
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-07
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-05
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-07
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-05
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-11
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-11
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-11
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	7e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-10
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-10
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-04
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-06
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	6e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  435 bits (1122), Expect = e-141
 Identities = 150/524 (28%), Positives = 229/524 (43%), Gaps = 35/524 (6%)

Query: 4   IYNNSLYDSIP-SELRNLKSLSDLELGNNKLSGSIPHSL---GNLTNLATLYIHTNSLSG 59
           + +N+L      S    L SL  L+L  N +SG+             L  L I  N +SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192

Query: 60  SIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
            +   +        L++S+N  S  IP  LG+ S L  L +  N LS      +     L
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTEL 249

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKI-GNLKSLSNLQLSENNFN 178
             L +++N   G IP     L +L  L +  N  +  I   + G   +L+ L LS N+F 
Sbjct: 250 KLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLS 237
           G++PP  G+ S L +L L +N+ S  +P + L  +R L  L L +N+ SG +P S+ NLS
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLS 367

Query: 238 -NLTYLNLFENSLSGAIPYEYRN--LVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDR 293
            +L  L+L  N+ SG I           L  L L +N F G IP  L N + L  + L  
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427

Query: 294 NYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIG 353
           NYL+G I  S      L  + L  N   GEI  +      L TL    N++TG +P  + 
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487

Query: 354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
           + + L  + LS+N + GEIP  +G+L     L L++N  SG +  +LG    L  LDL++
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547

Query: 414 NRLSNSIPKSLGNL------------------ELIHLSELDLSRNFLRE--AIPSQICIM 453
           N  + +IP ++                           E   + N L        Q+  +
Sbjct: 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607

Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            +    N++     G     F+    ++ +D+SYN L G IP  
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  431 bits (1111), Expect = e-139
 Identities = 157/509 (30%), Positives = 240/509 (47%), Gaps = 20/509 (3%)

Query: 1   LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGS 60
           L     N  + ++ S L +L  L  L L N+ ++GS+        +L +L +  NSLSG 
Sbjct: 57  LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115

Query: 61  IP--GEIGNFRFFSDLELSNNKLSGSIP-PSLGNLSNLATLYLDTNSLSNSIPSEL---G 114
           +     +G+      L +S+N L           L++L  L L  NS+S +         
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175

Query: 115 NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE 174
               L +L ++ N +SG +   +    NL  L + SN+ S  I   +G+  +L +L +S 
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISG 232

Query: 175 NNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM- 233
           N  +G    ++   + L  L + +N     IP     L+SL  LSL  NK +G IP  + 
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLS 290

Query: 234 GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRL 291
           G    LT L+L  N   GA+P  + +   L  L L  N F G +P   L  +  L+ + L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350

Query: 292 DRNYLTGNISESF-YIYPNLTYIDLSQNNFYGEISSDWGRCPK--LSTLDFSINNITGNV 348
             N  +G + ES   +  +L  +DLS NNF G I  +  + PK  L  L    N  TG +
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410

Query: 349 PPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEH 408
           PP + + S+L  L LS N++ G IP  LG L+    L L  N L G++  +L  +  LE 
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470

Query: 409 LDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSG 468
           L L  N L+  IP  L N    +L+ + LS N L   IP  I  +++L  L LS+NS SG
Sbjct: 471 LILDFNDLTGEIPSGLSNCT--NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528

Query: 469 LIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            IP+       L+ +D++ N   G+IP +
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  408 bits (1051), Expect = e-130
 Identities = 157/521 (30%), Positives = 231/521 (44%), Gaps = 62/521 (11%)

Query: 4   IYNNSLYDSIPSELR-NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
           +  N     IP  L     +L+ L+L  N   G++P   G+ + L +L + +N+ SG +P
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 63  GE-IGNFRFFSDLELSNNKLSGSIPPSLGNLS-NLATLYLDTNSLSNSIPSELGN--LRS 118
            + +   R    L+LS N+ SG +P SL NLS +L TL L +N+ S  I   L      +
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           L  L L NN  +G IP +L N + L +L++  N LS +I   +G+L  L +L+L  N   
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSN 238
           G IP  L  +  L TL LD N L+  IPS L N  +L+ +SL  N+L+G IP  +G L N
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLT 297
           L  L L  NS SG IP E  +   L  L L  N F G IP  +   +      +  N++ 
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIA 571

Query: 298 GNISESFYIYPNLTYIDLSQN--NFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
           G                 + N   F G  S    R    +  + +     G+  P   ++
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631

Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNR 415
             +  LD+S N + G IP E+G + +   L L HN +SG +  ++G L  L  LDLSSN+
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691

Query: 416 LSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFE 475
           L   IP+++  L                            L +++LS+N+LS        
Sbjct: 692 LDGRIPQAMSAL--------------------------TMLTEIDLSNNNLS-------- 717

Query: 476 KMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYG 516
                           G IP    F+  P      N GL G
Sbjct: 718 ----------------GPIPEMGQFETFPPAKFLNNPGLCG 742

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  398 bits (1024), Expect = e-126
 Identities = 149/494 (30%), Positives = 226/494 (45%), Gaps = 23/494 (4%)

Query: 19  NLKSLSDLELGNNKLS---GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLE 75
               ++ ++L +  L+    ++  SL +LT L +L++  + ++GS+          + L+
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 76  LSNNKLSGSIPP--SLGNLSNLATLYLDTNSLSNSIP-SELGNLRSLSNLQLNNNILSGS 132
           LS N LSG +    SLG+ S L  L + +N+L      S    L SL  L L+ N +SG+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 133 IPHSL---GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLS 189
                        L  L I  N +S  +   +    +L  L +S NNF+  I P LG+ S
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGI-PFLGDCS 223

Query: 190 NLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
            L  L +  N LS      +     L  L++  N+  G IP     L +L YL+L EN  
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281

Query: 250 SGAIPYE-YRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNI-SESFYI 306
           +G IP         LT L L  N F G +P    + + LE + L  N  +G +  ++   
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341

Query: 307 YPNLTYIDLSQNNFYGEISSDWGRC-PKLSTLDFSINNITGNVPPEIGHS--SQLGVLDL 363
              L  +DLS N F GE+          L TLD S NN +G + P +  +  + L  L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401

Query: 364 SSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKS 423
            +N   G+IP  L   +  + L L+ N LSG +   LGSL +L  L L  N L   IP+ 
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461

Query: 424 LGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHI 483
           L  ++   L  L L  N L   IPS +    +L  ++LS+N L+G IP    ++  L  +
Sbjct: 462 LMYVK--TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519

Query: 484 DISYNELRGSIPNS 497
            +S N   G+IP  
Sbjct: 520 KLSNNSFSGNIPAE 533

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 52.2 bits (126), Expect = 6e-07
 Identities = 20/73 (27%), Positives = 36/73 (49%), Gaps = 4/73 (5%)

Query: 431 HLSELDLSRNFLRE---AIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISY 487
            ++ +DLS   L     A+ S +  +  LE L LS++ ++G +   F+    L  +D+S 
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSR 109

Query: 488 NELRGSIPNSTTF 500
           N L G +   T+ 
Sbjct: 110 NSLSGPVTTLTSL 122

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  329 bits (846), Expect = e-102
 Identities = 80/528 (15%), Positives = 170/528 (32%), Gaps = 45/528 (8%)

Query: 7   NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSG----SIP 62
           +         L +   ++ L L     SG +P ++G LT L  L + ++          P
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLG--NLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
             I         +        +        + S+L    ++++    SI          +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186

Query: 121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
            +   +N ++  +  ++  LT L   Y+ ++   A  + +    ++    Q        +
Sbjct: 187 QIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY-----KT 240

Query: 181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL--------SGSIPIS 232
                 NL +L  + +        +P+ L  L  +  +++  N+                
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 233 MGNLSNLTYLNLFENSL-SGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRL 291
                 +  + +  N+L +  +    + + KL +L   +NQ  G +P   +   L  + L
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNL 360

Query: 292 DRNYLTGNISESFYIYPNLTYIDLSQNNFYG-EISSDWGRCPKLSTLDFSINNITG---- 346
             N +T   +        +  +  + N         D      +S +DFS N I      
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420

Query: 347 ---NVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG-------QL 396
               + P       +  ++LS+N I           +    + L  N L+          
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480

Query: 397 SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSL 456
           +    +   L  +DL  N+L+  +        L +L  +DLS N   +  P+Q     +L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538

Query: 457 EKLNLSH------NSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
           +   + +      N      P        L  + I  N++R  +    
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI 585

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  320 bits (821), Expect = 2e-98
 Identities = 72/514 (14%), Positives = 171/514 (33%), Gaps = 47/514 (9%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLG--NLTNLATLYIHTNSLSGSIPGEIGNFR 69
             P  +    S    +        +        + ++L    I+++    SI        
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183

Query: 70  FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNIL 129
             + +   +N ++  +  ++  L+ L   Y+  +        E     +    Q      
Sbjct: 184 KDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ----- 237

Query: 130 SGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNF--------NGSI 181
             +      NL +L  + +Y+      +   +  L  +  + ++ N          +   
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297

Query: 182 PPSLGNLSNLATLYLDTNSLSY-SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLT 240
                    +  +Y+  N+L    + + L  ++ L  L   YN+L G +P + G+   L 
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLA 356

Query: 241 YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG--PIPILRNLTSLERVRLDRNYLTG 298
            LNL  N ++           ++  L   HN+ +    I   ++++ +  +    N +  
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416

Query: 299 NISESFYIYP-------NLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG----- 346
              ++F           N++ I+LS N         +     LS+++   N +T      
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476

Query: 347 --NVPPEIGHSSQLGVLDLSSNHIVGEIP-IELGKLNFFIKLVLAHNQLSGQLSPKLGSL 403
             +      ++  L  +DL  N +           L + + + L++N  S     +  + 
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535

Query: 404 VQLEHL------DLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLE 457
             L+        D   NR     P+ +       L++L +  N +R+ +  +I    ++ 
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCP--SLTQLQIGSNDIRK-VNEKI--TPNIS 590

Query: 458 KLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
            L++  N    +  S            + Y++ +
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  250 bits (640), Expect = 1e-72
 Identities = 76/480 (15%), Positives = 147/480 (30%), Gaps = 92/480 (19%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
                 Y +   +  NLK L+D+E+ N      +P  L  L  +  + +  N        
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS---- 287

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNL 122
                           K              +  +Y+  N+L    + + L  ++ L  L
Sbjct: 288 ------------GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGML 335

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
           +   N L G +P + G+   LA+L +  N ++       G  + + NL  + N     IP
Sbjct: 336 ECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIP 393

Query: 183 PSL--GNLSNLATLYLDTNSLS-------YSIPSELGNLRSLSNLSLGYNKLSGSIPISM 233
                 ++S ++ +    N +          +        ++S+++L  N++S       
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453

Query: 234 GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDR 293
              S L+ +NL  N L+                 +  N  +      +N   L  + L  
Sbjct: 454 STGSPLSSINLMGNMLTE----------------IPKNSLKDENENFKNTYLLTSIDLRF 497

Query: 294 NYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIG 353
           N LT    +                             P L  +D S N+ +   P +  
Sbjct: 498 NKLTKLSDDFRA-----------------------TTLPYLVGIDLSYNSFSK-FPTQPL 533

Query: 354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
           +SS L    + +                        N+   +    +     L  L + S
Sbjct: 534 NSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGS 575

Query: 414 NRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC 473
           N +   + + +      ++S LD+  N       S +C         L ++     I  C
Sbjct: 576 NDIR-KVNEKI----TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD-IRGC 629

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  249 bits (637), Expect = 3e-72
 Identities = 78/462 (16%), Positives = 153/462 (33%), Gaps = 33/462 (7%)

Query: 70  FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNIL 129
            +  L   N    G       N +    L    +         L +   ++ L L     
Sbjct: 38  IWDALNGKNWSQQGFGTQPGANWNFNKEL----DMWGAQPGVSLNSNGRVTGLSLEGFGA 93

Query: 130 SGSIPHSLGNLTNLATLYIYSNSLS----ASILGKIGNLKSLSNLQLSENNFNGSIPPSL 185
           SG +P ++G LT L  L + S+             I    S    Q    ++  +     
Sbjct: 94  SGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYD 153

Query: 186 G--NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
              + S+L    ++++    SI          + +    N ++  +  ++  L+ L    
Sbjct: 154 PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFY 212

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
           +  +        E               Q++       NL  L  V +        +   
Sbjct: 213 MGNSPFVAENICEAWENENSEYA----QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268

Query: 304 FYIYPNLTYIDLSQNNF--------YGEISSDWGRCPKLSTLDFSINNI-TGNVPPEIGH 354
               P +  I+++ N            +  +D     K+  +    NN+ T  V   +  
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328

Query: 355 SSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSN 414
             +LG+L+   N + G++P   G       L LA+NQ++   +   G   Q+E+L  + N
Sbjct: 329 MKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387

Query: 415 RLSNSIPKSLGNLELIHLSELDLSRNFLR-------EAIPSQICIMQSLEKLNLSHNSLS 467
           +L   IP       +  +S +D S N +        + +        ++  +NLS+N +S
Sbjct: 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446

Query: 468 GLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQ 509
                 F   + L  I++  N L     NS   ++   +   
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  163 bits (415), Expect = 2e-42
 Identities = 49/321 (15%), Positives = 114/321 (35%), Gaps = 24/321 (7%)

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           L  ++   N  ++S         +  N +   +       +S+ +   +T L+L     S
Sbjct: 35  LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRGPIPI-----LRNLTSLERVRLDRNYLTGNI--SES 303
           G +P     L +L +L LG +  +    +     +    S E+ +  R +        + 
Sbjct: 95  GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL 363
              + +L    ++ +     I        K + +    NNIT  V   +   ++L    +
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYM 213

Query: 364 SSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKS 423
            ++  V E   E  +          + Q       K  +L  L  +++ +      +P  
Sbjct: 214 GNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268

Query: 424 LGNLELIHLSELDLSRNFLREA--------IPSQICIMQSLEKLNLSHNSLSGL-IPSCF 474
           L  L    +  ++++ N               +   + + ++ + + +N+L    + +  
Sbjct: 269 LKALP--EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326

Query: 475 EKMNGLLHIDISYNELRGSIP 495
           +KM  L  ++  YN+L G +P
Sbjct: 327 QKMKKLGMLECLYNQLEGKLP 347

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  318 bits (816), Expect = 3e-97
 Identities = 129/548 (23%), Positives = 197/548 (35%), Gaps = 35/548 (6%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           + +NS+     +     K+L  L+L +N LS +   +   L NL  L +  N +      
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163

Query: 64  EIGNFRFFS--DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELG---NLRS 118
           E+  F   S   LELS+N++    P     +  L  L+L+   L  S+  +L       S
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223

Query: 119 LSNLQLNNNILSGSIPHSLGNL--TNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENN 176
           + NL L+N+ LS +   +   L  TNL  L +  N+L+         L  L    L  NN
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283

Query: 177 FNGSIPPSLGNLSNLATLYLDTN---------SLSYSIPSELGNLRSLSNLSLGYNKLSG 227
                  SL  L N+  L L  +         SL          L+ L +L++  N + G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343

Query: 228 SIPISMGNLSNLTYLNLFENSLSGAIPYE----YRNLVKLTILLLGHNQFRGPIP-ILRN 282
                   L NL YL+L  +  S                L IL L  N+           
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403

Query: 283 LTSLERVRLDRNYLTGNIS-ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
           L  LE + L  N +   ++ + +    N+  I LS N +     + +   P L  L    
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463

Query: 342 NNITG--NVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS------ 393
             +    + P        L +LDLS+N+I       L  L     L L HN L+      
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA 523

Query: 394 --GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQIC 451
             G     L  L  L  L+L SN       +   +L    L  +DL  N L     S   
Sbjct: 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL--FELKIIDLGLNNLNTLPASVFN 581

Query: 452 IMQSLEKLNLSHNSLSGLIPSCFEK-MNGLLHIDISYNELRGSIPNSTTFKDAPIEALQG 510
              SL+ LNL  N ++ +    F      L  +D+ +N    +  +   F +   E    
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTN 641

Query: 511 NKGLYGDV 518
              L    
Sbjct: 642 IPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  316 bits (811), Expect = 1e-96
 Identities = 120/533 (22%), Positives = 217/533 (40%), Gaps = 31/533 (5%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           +  L   +P +L    +++ L L +N+L      +    + L +L +  N++S   P   
Sbjct: 13  HLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN 125
                   L L +N+LS     +    +NL  L+L +NS+     +     ++L  L L+
Sbjct: 70  QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS 129

Query: 126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLK--SLSNLQLSENNFNGSIPP 183
           +N LS +   +   L NL  L + +N + A    ++      SL  L+LS N      P 
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELG---NLRSLSNLSLGYNKLSGSIPISMGNL--SN 238
               +  L  L+L+   L  S+  +L       S+ NLSL  ++LS +   +   L  +N
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLT 297
           LT L+L  N+L+      +  L +L    L +N  +      L  L ++  + L R++  
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309

Query: 298 GNIS---------ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNV 348
            +IS          SF     L ++++  N+  G  S+ +     L  L  S +  +   
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369

Query: 349 PPEIG----HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPK-LGSL 403
                      S L +L+L+ N I          L     L L  N++  +L+ +    L
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLR--EAIPSQICIMQSLEKLNL 461
             +  + LS N+       S   +    L  L L R  L+  ++ PS    +++L  L+L
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVP--SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487

Query: 462 SHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGL 514
           S+N+++ +     E +  L  +D+ +N L     +       PI  L+G   L
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH--ANPGGPIYFLKGLSHL 538

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  310 bits (795), Expect = 3e-94
 Identities = 116/522 (22%), Positives = 189/522 (36%), Gaps = 30/522 (5%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           +N L            +L++L L +N +     +      NL TL +  N LS +  G  
Sbjct: 82  HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSN--LATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
                  +L LSNNK+       L   +N  L  L L +N +    P     +  L  L 
Sbjct: 142 VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201

Query: 124 LNNNILSGSIPHSLG---NLTNLATLYIYSNSLSASILGKIGNLK--SLSNLQLSENNFN 178
           LNN  L  S+   L      T++  L + ++ LS +       LK  +L+ L LS NN N
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYN---------KLSGSI 229
                S   L  L   +L+ N++ +     L  L ++  L+L  +          L    
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321

Query: 230 PISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL-----T 284
             S   L  L +LN+ +N + G     +  L+ L  L L ++                 +
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381

Query: 285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSINN 343
            L  + L +N ++   S++F    +L  +DL  N    E++   W     +  +  S N 
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 344 ITGNVPPEIGHSSQLGVLDLSSNHI--VGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
                         L  L L    +  V   P     L     L L++N ++      L 
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501

Query: 402 SLVQLEHLDLSSNRLSNSIPKSLGNLE------LIHLSELDLSRNFLREAIPSQICIMQS 455
            L +LE LDL  N L+     +           L HL  L+L  N   E        +  
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561

Query: 456 LEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
           L+ ++L  N+L+ L  S F     L  +++  N +       
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  291 bits (747), Expect = 2e-87
 Identities = 113/499 (22%), Positives = 185/499 (37%), Gaps = 29/499 (5%)

Query: 22  SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKL 81
           S    +  + KL+  +P  L   TN+  L +  N L          +   + L++  N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 82  SGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLT 141
           S   P     L  L  L L  N LS           +L+ L L +N +     +      
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 142 NLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSN--LATLYLDTN 199
           NL TL +  N LS++ LG    L++L  L LS N         L   +N  L  L L +N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 200 SLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMG---NLSNLTYLNLFENSLSGAIPYE 256
            +    P     +  L  L L   +L  S+   +      +++  L+L  + LS      
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 257 YRNL--VKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYI 313
           +  L    LT+L L +N            L  LE   L+ N +    S S +   N+ Y+
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301

Query: 314 DLSQNNFYGEIS---------SDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS 364
           +L ++     IS           +     L  L+   N+I G           L  L LS
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361

Query: 365 SNHIVGEIPIELGKLNFFIK----LVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
           ++            ++        L L  N++S   S     L  LE LDL  N +   +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421

Query: 421 PKS-LGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGL--IPSCFEKM 477
                  LE  ++ E+ LS N   +   +   ++ SL++L L   +L  +   PS F+ +
Sbjct: 422 TGQEWRGLE--NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479

Query: 478 NGLLHIDISYNELRGSIPN 496
             L  +D+S N +     +
Sbjct: 480 RNLTILDLSNNNIANINDD 498

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  278 bits (712), Expect = 2e-82
 Identities = 100/479 (20%), Positives = 172/479 (35%), Gaps = 27/479 (5%)

Query: 45  TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNS 104
            +          L+  +P ++      + L L++N+L      +    S L +L +  N+
Sbjct: 4   VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 105 LSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNL 164
           +S   P     L  L  L L +N LS     +    TNL  L++ SNS+           
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 165 KSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELG--NLRSLSNLSLGY 222
           K+L  L LS N  + +   +   L NL  L L  N +      EL      SL  L L  
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 223 NKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYE---YRNLVKLTILLLGHNQFRGPIP- 278
           N++    P     +  L  L L    L  ++  +         +  L L ++Q       
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 279 ILRNL--TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLST 336
               L  T+L  + L  N L    ++SF   P L Y  L  NN     S        +  
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 337 LD---------FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVL 387
           L+          S+ ++             L  L++  N I G        L     L L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360

Query: 388 AHNQLSGQLSPKLG----SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLR 443
           +++  S +          +   L  L+L+ N++S     +   L   HL  LDL  N + 
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG--HLEVLDLGLNEIG 418

Query: 444 EAIPSQ-ICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
           + +  Q    ++++ ++ LS+N    L  + F  +  L  + +    L+    + + F+
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  172 bits (438), Expect = 3e-45
 Identities = 67/315 (21%), Positives = 106/315 (33%), Gaps = 22/315 (6%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLG----NLTNLATLYIHTNSLSG 59
           + +N +     +    L +L  L L N+  S     +        + L  L +  N +S 
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395

Query: 60  SIPGEIGNFRFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSELGNLRS 118
                         L+L  N++   +       L N+  +YL  N       +    + S
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455

Query: 119 LSNLQLNNNILSG--SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENN 176
           L  L L    L    S P     L NL  L + +N+++      +  L+ L  L L  NN
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515

Query: 177 --------FNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGS 228
                     G     L  LS+L  L L++N           +L  L  + LG N L+  
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575

Query: 229 IPISMGNLSNLTYLNLFENSLSGAIPYEYR-NLVKLTILLLGHNQFRGPIPILR------ 281
                 N  +L  LNL +N ++      +      LT L +  N F      +       
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635

Query: 282 NLTSLERVRLDRNYL 296
           N T      L  +YL
Sbjct: 636 NETHTNIPELSSHYL 650

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.8 bits (239), Expect = 2e-20
 Identities = 36/143 (25%), Positives = 59/143 (41%), Gaps = 5/143 (3%)

Query: 355 SSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSN 414
           +    V D S   +  ++P +L        L L HNQL    +       QL  LD+  N
Sbjct: 3   TVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 415 RLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCF 474
            +S   P+    L    L  L+L  N L +          +L +L+L  NS+  +  + F
Sbjct: 60  TISKLEPELCQKLP--MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

Query: 475 EKMNGLLHIDISYNELRGSIPNS 497
            K   L+ +D+S+N L  +   +
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGT 140

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  299 bits (768), Expect = 4e-91
 Identities = 105/513 (20%), Positives = 188/513 (36%), Gaps = 29/513 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +  N L         +   L  L+L   ++      +  +L++L+TL +  N +     G
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNL 122
                     L      L+      +G+L  L  L +  N + +  +P    NL +L +L
Sbjct: 95  AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154

Query: 123 QLNNNILSGSIPHSLGNLTNL----ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
            L++N +       L  L  +     +L +  N ++    G    +  L  L L  N  +
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDS 213

Query: 179 GSIPP-SLGNLSNLATLYLDTNSLSYSI---PSELGNLRSLSNLSLGYNKLS------GS 228
            ++    +  L+ L    L              +   L  L NL++   +L+        
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273

Query: 229 IPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLE 287
           I      L+N++  +L   ++     +          L L + +F   P   L++L  L 
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRL- 330

Query: 288 RVRLDRNYLTGNISESFYIYPNLTYIDLSQN--NFYGEISSDWGRCPKLSTLDFSINNIT 345
                     G  + S    P+L ++DLS+N  +F G  S        L  LD S N + 
Sbjct: 331 ----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

Query: 346 GNVPPEIGHSSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQLSGQLSPKLGSLV 404
             +        QL  LD   +++           L   I L ++H       +     L 
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445

Query: 405 QLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN 464
            LE L ++ N    +    +   EL +L+ LDLS+  L +  P+    + SL+ LN+SHN
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFT-ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504

Query: 465 SLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
           +   L    ++ +N L  +D S N +  S    
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  261 bits (669), Expect = 5e-77
 Identities = 107/519 (20%), Positives = 176/519 (33%), Gaps = 41/519 (7%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSL-SGSIPGE 64
            N +          L SL  L      L+      +G+L  L  L +  N + S  +P  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNL----ATLYLDTNSLSNSIPSELGNLRSLS 120
             N      L+LS+NK+       L  L  +     +L L  N ++   P     +R L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LH 203

Query: 121 NLQLNNNILSGSIP-HSLGNLTNLATLYIYSNSLSASILGK---IGNLKSLSNLQLSENN 176
            L L NN  S ++    +  L  L    +           +      L+ L NL + E  
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 177 FN------GSIPPSLGNLSNLATLYLDTNSLSYSIP-SELGNLRSL-------------- 215
                     I      L+N+++  L + ++      S     + L              
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLK 323

Query: 216 --SNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS--GAIPYEYRNLVKLTILLLGHN 271
             S   L +    G    S  +L +L +L+L  N LS  G           L  L L  N
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 272 QFRGPIPILRNLTSLERVRLDRNYLTGNISES-FYIYPNLTYIDLSQNNFYGEISSDWGR 330
                      L  LE +    + L      S F    NL Y+D+S  +     +  +  
Sbjct: 384 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 331 CPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAH 389
              L  L  + N+   N  P+I      L  LDLS   +    P     L+    L ++H
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503

Query: 390 NQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQ 449
           N      +     L  L+ LD S N +  S  + L +     L+ L+L++N        Q
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF-PSSLAFLNLTQNDFACTCEHQ 562

Query: 450 --ICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDIS 486
             +  ++   +L +    +    PS  + M  +L ++I+
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  251 bits (643), Expect = 2e-73
 Identities = 102/462 (22%), Positives = 154/462 (33%), Gaps = 43/462 (9%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           L+LS N L      S  +   L  L L    +         +L  LS L L  N +    
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG-SIPPSLGNLSNLA 192
             +   L++L  L     +L++     IG+LK+L  L ++ N      +P    NL+NL 
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSN----LSLGYNKLSGSIPISMGNLSNLTYLNLFENS 248
            L L +N +     ++L  L  +      L L  N ++  I         L  L L  N 
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNF 211

Query: 249 LSGAIPYE-YRNLVKLTILLLGHNQFRG-------PIPILRNLTSLERVRLDRNYL---T 297
            S  +     + L  L +  L   +FR            L  L +L        YL    
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271

Query: 298 GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNIT------------ 345
            +I + F    N++   L       E   D+        L+                   
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329

Query: 346 -------GNVPPEIGHSSQLGVLDLSSNHI--VGEIPIELGKLNFFIKLVLAHNQLSGQL 396
                  G           L  LDLS N +   G              L L+ N +   +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388

Query: 397 SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSL 456
           S     L QLEHLD   + L      S+    L +L  LD+S    R A       + SL
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFL-SLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 457 EKLNLSHNSLSGLIPSC-FEKMNGLLHIDISYNELRGSIPNS 497
           E L ++ NS         F ++  L  +D+S  +L    P +
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  244 bits (624), Expect = 9e-71
 Identities = 91/487 (18%), Positives = 154/487 (31%), Gaps = 55/487 (11%)

Query: 30  NNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSL 89
                  IP +L    +   L +  N L         +F     L+LS  ++      + 
Sbjct: 16  ELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 90  GNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIY 149
            +LS+L+TL L  N + +        L SL  L      L+      +G+L  L  L + 
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 150 SNSLSASILGK-IGNLKSLSNLQLSENNFNGSIPPSLGNLSNL----ATLYLDTNSLSYS 204
            N + +  L +   NL +L +L LS N         L  L  +     +L L  N +++ 
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 205 IPSELGNLRSLSNLSLGYNKLSGSIP-ISMGNLSNLTYLNLFENSLSGAIPYEY------ 257
            P     +R L  L+L  N  S ++    +  L+ L    L           E       
Sbjct: 193 QPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 258 RNLVKLTILLLGHNQFRG----PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYI 313
             L  LTI               I +   LT++    L    +      S+       ++
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHL 309

Query: 314 DLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHI--VGE 371
           +L    F    +       +L+       +  G           L  LDLS N +   G 
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364

Query: 372 IPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIH 431
                        L L+ N +   +S     L QLEHLD   + L      S+       
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV------- 416

Query: 432 LSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
                                +++L  L++SH          F  ++ L  + ++ N  +
Sbjct: 417 ------------------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 492 GSIPNST 498
            +     
Sbjct: 459 ENFLPDI 465

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  175 bits (445), Expect = 2e-46
 Identities = 62/327 (18%), Positives = 108/327 (33%), Gaps = 30/327 (9%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
           Y +   D I      L ++S   L +  +      S         L +           +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLK 323

Query: 65  IGNFRFFSD-------------------LELSNNKLS--GSIPPSLGNLSNLATLYLDTN 103
           + + +  +                    L+LS N LS  G    S    ++L  L L  N
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 104 SLSNSIPSELGNLRSLSNLQLNNNILSGSIPHS-LGNLTNLATLYIYSNSLSASILGKIG 162
            +  ++ S    L  L +L   ++ L      S   +L NL  L I       +  G   
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442

Query: 163 NLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLG 221
            L SL  L+++ N+F  +  P     L NL  L L    L    P+   +L SL  L++ 
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502

Query: 222 YNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVK-LTILLLGHNQFRGPIPI- 279
           +N            L++L  L+   N +  +   E ++    L  L L  N F       
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562

Query: 280 --LRNLTSLERVRLDRNYLTGNISESF 304
             L+ +    ++ ++   +        
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  160 bits (406), Expect = 2e-41
 Identities = 56/264 (21%), Positives = 91/264 (34%), Gaps = 8/264 (3%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLS--GSIPHSLGNLTNLATLYIHTNSLSGSI 61
           +   S          +L SL  L+L  N LS  G    S    T+L  L +  N +   +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388

Query: 62  PGEIGNFRFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
                       L+  ++ L      S   +L NL  L +       +       L SL 
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448

Query: 121 NLQLNNNILSGSI-PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
            L++  N    +  P     L NL  L +    L         +L SL  L +S NNF  
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNL-RSLSNLSLGYNKLSGSIPIS--MGNL 236
                   L++L  L    N +  S   EL +   SL+ L+L  N  + +      +  +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 568

Query: 237 SNLTYLNLFENSLSGAIPYEYRNL 260
            +   L +    +  A P + + +
Sbjct: 569 KDQRQLLVEVERMECATPSDKQGM 592

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  131 bits (332), Expect = 5e-32
 Identities = 62/241 (25%), Positives = 96/241 (39%), Gaps = 8/241 (3%)

Query: 259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
            +  +T   +  N ++ P  +  +  +L+   L  N L    S SF+ +P L  +DLS+ 
Sbjct: 6   VVPNITYQCMELNFYKIPDNLPFSTKNLD---LSFNPLRHLGSYSFFSFPELQVLDLSRC 62

Query: 319 NFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGK 378
                    +     LSTL  + N I           S L  L     ++       +G 
Sbjct: 63  EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 379 LNFFIKLVLAHNQL-SGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLS--EL 435
           L    +L +AHN + S +L     +L  LEHLDLSSN++ +     L  L  + L    L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 436 DLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS-CFEKMNGLLHIDISYNELRGSI 494
           DLS N +    P     +  L KL L +N  S  +   C + + GL    +   E R   
Sbjct: 183 DLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241

Query: 495 P 495
            
Sbjct: 242 N 242

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  294 bits (753), Expect = 2e-86
 Identities = 90/530 (16%), Positives = 165/530 (31%), Gaps = 51/530 (9%)

Query: 7   NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
           +   D    +L N   ++ L L      G +P ++G LT L  L   T+S + S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 67  NFRFFSDLELSNN-------KLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
                   E   +       K+       L     L         +         +L+  
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
               L N I    I  ++  LT L  +Y  ++  +              +          
Sbjct: 429 QIGNLTNRI--TFISKAIQRLTKLQIIYFANSPFTYDN-----IAVDWEDANSDYAKQYE 481

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG---------SIP 230
           +   S  NL +L  + L        +P  L +L  L +L++  N+             + 
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 231 ISMGNLSNLTYLNLFENSLSGAIPYEY--RNLVKLTILLLGHNQFRGPIPILRNLTSLER 288
                   +    +  N+L    P     + +VKL +L   HN+ R  +        L  
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTD 599

Query: 289 VRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG-EISSDWGRCPKLSTLDFSINNITGN 347
           ++LD N +     +       +  +  S N         +      + ++DFS N I   
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS- 658

Query: 348 VPPEIGHS------SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS-------G 394
               I  S           + LS N I           +    ++L++N ++        
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718

Query: 395 QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
                  +   L  +DL  N+L+ S+        L +LS +D+S N      P+Q     
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSS 776

Query: 455 SLEKLNLSH------NSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
            L+   + H      N +    P+       L+ + I  N++R  +    
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  266 bits (682), Expect = 1e-76
 Identities = 78/552 (14%), Positives = 173/552 (31%), Gaps = 81/552 (14%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLG--------------------- 42
           +        +P  +  L  L  L  G +  + S                           
Sbjct: 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389

Query: 43  ---------NLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLS 93
                    NL++L    I+ N     I  +       + +    N+++  I  ++  L+
Sbjct: 390 MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLT 448

Query: 94  NLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSL 153
            L  +Y   +  +    +         +   +      +   S  NL +L  + +Y+   
Sbjct: 449 KLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503

Query: 154 SASILGKIGNLKSLSNLQLSENNFNG---------SIPPSLGNLSNLATLYLDTNSLSYS 204
              +   + +L  L +L ++ N              +         +   Y+  N+L   
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-E 562

Query: 205 IPSE--LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY-RNLV 261
            P+   L  +  L  L   +NK+   +  + G    LT L L  N +   IP ++     
Sbjct: 563 FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTD 619

Query: 262 KLTILLLGHNQFRG--PIPILRNLTSLERVRLDRNYLTGNISESFYIYP-----NLTYID 314
           ++  L   HN+ +    I   +++  +  V    N +                 N + + 
Sbjct: 620 QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679

Query: 315 LSQNNFYGEISSDWGRCPKLSTLDFSINNIT-------GNVPPEIGHSSQLGVLDLSSNH 367
           LS N      +  +     +ST+  S N +T               ++  L  +DL  N 
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739

Query: 368 IVGEIP--IELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDL------SSNRLSNS 419
           +   +        L +   + +++N  S     +  +  QL+   +        NR+   
Sbjct: 740 LT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQ 797

Query: 420 IPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNG 479
            P  +       L +L +  N +R+ +  ++     L  L+++ N    +  +       
Sbjct: 798 WPTGITTCP--SLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852

Query: 480 LLHIDISYNELR 491
                + Y++ +
Sbjct: 853 AGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  244 bits (623), Expect = 1e-68
 Identities = 81/501 (16%), Positives = 174/501 (34%), Gaps = 46/501 (9%)

Query: 20  LKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNN 79
                 L+  N +      ++  +  N        +        ++ N    + L L+  
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLNWNFN-KELDMWGDQPGVDLDNNGRVTGLSLAGF 333

Query: 80  KLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPH-SLG 138
              G +P ++G L+ L  L   T+S + S         +    +   + +        L 
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393

Query: 139 NLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG------SIPPSLGNLSNLA 192
               L    +  ++++     ++  +K  S + L +            I  ++  L+ L 
Sbjct: 394 YDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQ 451

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGA 252
            +Y   +  +Y   +         + +  Y K   +  +S  NL +LT + L+       
Sbjct: 452 IIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506

Query: 253 IPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTY 312
           +P    +L +L  L +  N+      +  + T               +++     P +  
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWT--------------RLADDEDTGPKIQI 552

Query: 313 IDLSQNNFYG-EISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGE 371
             +  NN      S+   +  KL  LD   N +        G + +L  L L  N I  E
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-E 609

Query: 372 IPIELGK-LNFFIKLVLAHNQLSGQLSP-KLGSLVQLEHLDLSSNRLS---NSIPKSLGN 426
           IP +     +    L  +HN+L    +     S+  +  +D S N++     +I  S+ +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD 669

Query: 427 LELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGL-------IPSCFEKMNG 479
            + I+ S + LS N +++           +  + LS+N ++ +           ++    
Sbjct: 670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729

Query: 480 LLHIDISYNELRGSIPNSTTF 500
           L  ID+ +N+L  S+ +    
Sbjct: 730 LTTIDLRFNKLT-SLSDDFRA 749

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  217 bits (554), Expect = 2e-59
 Identities = 77/477 (16%), Positives = 140/477 (29%), Gaps = 92/477 (19%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
               Y++      NLK L+D+EL N      +P  L +L  L +L I  N    +   + 
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPS-ELGNLRSLSNLQL 124
                              +         +   Y+  N+L     S  L  +  L  L  
Sbjct: 536 D---------------WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580

Query: 125 NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP- 183
            +N +      + G    L  L +  N +             +  L  S N     IP  
Sbjct: 581 VHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637

Query: 184 -SLGNLSNLATLYLDTNSLSYSIPSELG------NLRSLSNLSLGYNKLSGSIPISMGNL 236
            +  ++  + ++    N +  S    +          + S ++L YN++           
Sbjct: 638 FNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATG 696

Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYL 296
           S ++ + L  N ++                 +  N  +      +N   L  + L  N L
Sbjct: 697 SPISTIILSNNLMTS----------------IPENSLKPKDGNYKNTYLLTTIDLRFNKL 740

Query: 297 TGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSS 356
           T  +S+ F                           P LS +D S N  +   P +  +SS
Sbjct: 741 TS-LSDDFRA----------------------TTLPYLSNMDVSYNCFSS-FPTQPLNSS 776

Query: 357 QLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRL 416
           QL    +                          N++  Q    + +   L  L + SN +
Sbjct: 777 QLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818

Query: 417 SNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC 473
              + + L       L  LD++ N       + +C         L ++     I  C
Sbjct: 819 R-KVDEKL----TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ-DIRGC 869

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  275 bits (706), Expect = 7e-86
 Identities = 80/270 (29%), Positives = 130/270 (48%), Gaps = 7/270 (2%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGS--IPHSLGNLTNLATLYIH-TNSLSGSIP 62
           N +    +         +++L+L    L     IP SL NL  L  LYI   N+L G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
             I        L +++  +SG+IP  L  +  L TL    N+LS ++P  + +L +L  +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 123 QLNNNILSGSIPHSLGNLTNLAT-LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI 181
             + N +SG+IP S G+ + L T + I  N L+  I     NL +L+ + LS N   G  
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213

Query: 182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY 241
               G+  N   ++L  NSL++ +   +G  ++L+ L L  N++ G++P  +  L  L  
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 242 LNLFENSLSGAIPYEYRNLVKLTILLLGHN 271
           LN+  N+L G IP    NL +  +    +N
Sbjct: 273 LNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  267 bits (686), Expect = 7e-83
 Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 10/291 (3%)

Query: 12  SIPSELRNLKSLSD----LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGS--IPGEI 65
            I  +L N  +LS      +  N    G +  +      +  L +   +L     IP  +
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 66  GNFRFFSDLELSN-NKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL 124
            N  + + L +   N L G IPP++  L+ L  LY+   ++S +IP  L  +++L  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 125 NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSN-LQLSENNFNGSIPP 183
           + N LSG++P S+ +L NL  +    N +S +I    G+   L   + +S N   G IPP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
           +  NL NLA + L  N L        G+ ++   + L  N L+  +   +G   NL  L+
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRN 294
           L  N + G +P     L  L  L +  N   G IP   NL   +      N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  256 bits (657), Expect = 1e-78
 Identities = 81/255 (31%), Positives = 124/255 (48%), Gaps = 7/255 (2%)

Query: 4   IYNNSLY--DSIPSELRNLKSLSDLELGN-NKLSGSIPHSLGNLTNLATLYIHTNSLSGS 60
           +   +L     IPS L NL  L+ L +G  N L G IP ++  LT L  LYI   ++SG+
Sbjct: 57  LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 61  IPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
           IP  +   +    L+ S N LSG++PPS+ +L NL  +  D N +S +IP   G+   L 
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176

Query: 121 N-LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
             + ++ N L+G IP +  NL NLA + +  N L        G+ K+   + L++N+   
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
            +   +G   NL  L L  N +  ++P  L  L+ L +L++ +N L G IP   GNL   
Sbjct: 236 DL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRF 293

Query: 240 TYLNLFENSLSGAIP 254
                  N      P
Sbjct: 294 DVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  246 bits (631), Expect = 5e-75
 Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 12/292 (4%)

Query: 108 SIPSELGNLRSLSN----LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLS--ASILGKI 161
            I  +LGN  +LS+        N    G +  +      +  L +   +L     I   +
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 162 GNLKSLSNLQLS-ENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL 220
            NL  L+ L +   NN  G IPP++  L+ L  LY+   ++S +IP  L  +++L  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 221 GYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKL-TILLLGHNQFRGPIPI 279
            YN LSG++P S+ +L NL  +    N +SGAIP  Y +  KL T + +  N+  G IP 
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 280 -LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD 338
              NL +L  V L RN L G+ S  F    N   I L++N+   ++    G    L+ LD
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLD 250

Query: 339 FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHN 390
              N I G +P  +     L  L++S N++ GEIP + G L  F     A+N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  227 bits (582), Expect = 6e-68
 Identities = 78/320 (24%), Positives = 129/320 (40%), Gaps = 33/320 (10%)

Query: 204 SIPSELGNLRSLSN----LSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG--AIPYEY 257
            I  +LGN  +LS+             G +  +      +  L+L   +L     IP   
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 258 RNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQ 317
            NL  L  L +G                        N L G I  +      L Y+ ++ 
Sbjct: 73  ANLPYLNFLYIGGI----------------------NNLVGPIPPAIAKLTQLHYLYITH 110

Query: 318 NNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELG 377
            N  G I     +   L TLDFS N ++G +PP I     L  +    N I G IP   G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 378 KL-NFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELD 436
                F  + ++ N+L+G++ P   +L  L  +DLS N L        G+ +  +  ++ 
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDK--NTQKIH 227

Query: 437 LSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
           L++N L   +   + + ++L  L+L +N + G +P    ++  L  +++S+N L G IP 
Sbjct: 228 LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 497 STTFKDAPIEALQGNKGLYG 516
               +   + A   NK L G
Sbjct: 287 GGNLQRFDVSAYANNKCLCG 306

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  269 bits (690), Expect = 3e-83
 Identities = 88/290 (30%), Positives = 153/290 (52%), Gaps = 15/290 (5%)

Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
             E+  A+++F +++ +G+GG G VY  +LA G ++AVK+           + +F  EV+
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQFQTEVE 79

Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKG 712
            ++   HRN++++ GFC+      +VY Y    S+A  L     +   L W +R  +  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-WTELAGTY 771
               L+Y+H+ C P I+HRD+ + N+LLD E EA V DFG+AK +    ++  T + GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL---------NI 822
           G++APE   T K +EK DV+ +GV+ LE+I G+   D     +   + L           
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259

Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            L+ ++D  L        +++  +++V + C   +P  RP M +V ++L+
Sbjct: 260 KLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  276 bits (709), Expect = 1e-82
 Identities = 96/505 (19%), Positives = 171/505 (33%), Gaps = 13/505 (2%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
              N L     +    L +L+ L+L   ++      +  +   L TL +  N L      
Sbjct: 40  FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            +   +    L      +S      L N   L +LYL +N +S+    +      L  L 
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLS-ASILGKIGNLKSLSNLQLSENNFNGSIP 182
             NN +       + +L     L +  N    A I     +     +L          I 
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIF 219

Query: 183 PSLGN--LSNLATLYLDTNSLSYSIPSELGNLRSLS--NLSLGYNKLSGSIPISMGNLSN 238
             L N  + +L     +        P+    L  +S  +++L  +        +    S 
Sbjct: 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG 279

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLT 297
           L  L+L    LS  +P     L  L  L+L  N+F     I   N  SL  + +  N   
Sbjct: 280 LQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338

Query: 298 GNI-SESFYIYPNLTYIDLSQNNFY--GEISSDWGRCPKLSTLDFSINNITGNVPPEIGH 354
             + +       NL  +DLS ++       +        L +L+ S N            
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398

Query: 355 SSQLGVLDLSSNHIVG-EIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
             QL +LDL+   +   +       L+    L L+H+ L          L  L+HL+L  
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458

Query: 414 NRLSNSIPKSLGNLE-LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS 472
           N       +   +L+ L  L  L LS   L          ++ +  ++LSHN L+     
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518

Query: 473 CFEKMNGLLHIDISYNELRGSIPNS 497
               +   ++++++ N +   +P+ 
Sbjct: 519 ALSHLK-GIYLNLASNHISIILPSL 542

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  276 bits (707), Expect = 2e-82
 Identities = 102/507 (20%), Positives = 180/507 (35%), Gaps = 19/507 (3%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +    +Y       ++   L  L L  N L      +L     L  L+     +S     
Sbjct: 64  LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN-- 121
            + N +    L L +N +S    P       L  L    N++      ++ +L+  +N  
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183

Query: 122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGN--LKSLSNLQLSENNFNG 179
           L LN N ++  I     +     +L          I   + N  ++SL      + +   
Sbjct: 184 LNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

Query: 180 SIPPSLGNLS--NLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLS 237
             P     L   ++ ++ L  +       +       L  L L    LS  +P  +  LS
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS 301

Query: 238 NLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRNY 295
            L  L L  N           N   LT L +  N  R  +    L NL +L  + L  + 
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 296 LT--GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI- 352
           +      +       +L  ++LS N      +  +  CP+L  LD +   +         
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421

Query: 353 GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG---QLSPKLGSLVQLEHL 409
            +   L VL+LS + +          L     L L  N       Q +  L +L +LE L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481

Query: 410 DLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGL 469
            LS   LS+    +  +L+   ++ +DLS N L  +    +  ++ +  LNL+ N +S +
Sbjct: 482 VLSFCDLSSIDQHAFTSLK--MMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISII 538

Query: 470 IPSCFEKMNGLLHIDISYNELRGSIPN 496
           +PS    ++    I++  N L  +  N
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDCTCSN 565

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  255 bits (653), Expect = 1e-74
 Identities = 100/508 (19%), Positives = 176/508 (34%), Gaps = 41/508 (8%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
               N  L+  IP +L    +   L    N L              + L+L+  ++    
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 86  PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLAT 145
             +  +   L TL L  N L     + L   ++L +L      +S      L N   L +
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 146 LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS-YS 204
           LY+ SN +S+  L K    + L  L    N  +      + +L     L L+ N      
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 205 IPSELGNLRSLSNLSLGYNKLSGSIPISMGNLS--------------------------- 237
           I     +     +L+ G  +    I   + N +                           
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 238 -NLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYL 296
            ++  +NL ++         +     L  L L           L  L++L+++ L  N  
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313

Query: 297 TGNISESFYIYPNLTYIDLSQNNFYGEISSDW-GRCPKLSTLDFSINNIT--GNVPPEIG 353
                 S   +P+LT++ +  N    E+ +        L  LD S ++I        ++ 
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373

Query: 354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPK-LGSLVQLEHLDLS 412
           + S L  L+LS N  +        +      L LA  +L  + +     +L  L+ L+LS
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433

Query: 413 SNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSL---EKLNLSHNSLSGL 469
            + L  S  +    L    L  L+L  N   +    +   +Q+L   E L LS   LS +
Sbjct: 434 HSLLDISSEQLFDGLP--ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491

Query: 470 IPSCFEKMNGLLHIDISYNELRGSIPNS 497
               F  +  + H+D+S+N L  S   +
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEA 519

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  242 bits (621), Expect = 3e-70
 Identities = 96/458 (20%), Positives = 162/458 (35%), Gaps = 18/458 (3%)

Query: 49  TLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNS 108
           T       L+  IPG +        LE S N L      +   L NL  L L    +   
Sbjct: 16  TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 109 IPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLS 168
                 +   L  L L  N L      +L     L  L+     +S+     + N K+L 
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 169 NLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSN--LSLGYNKLS 226
           +L L  N+ +    P       L  L    N++ Y    ++ +L+  +N  L+L  N ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 227 GSIPISMGNLSNLTYLNLFENSLSGAIPYEYRN--LVKLTILLLGHNQFRGPIPIL---R 281
             I     + +    LN         I    +N  +  L +            P +    
Sbjct: 193 -GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 282 NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI 341
              S+E + L ++Y     S +F+ +  L  +DL+  +   E+ S       L  L  S 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310

Query: 342 NNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQL--SGQLSP 398
           N           +   L  L +  N    E+    L  L    +L L+H+ +  S   + 
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 399 KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIP-SQICIMQSLE 457
           +L +L  L+ L+LS N   +   ++        L  LDL+   L+     S    +  L+
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECP--QLELLDLAFTRLKVKDAQSPFQNLHLLK 428

Query: 458 KLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIP 495
            LNLSH+ L       F+ +  L H+++  N       
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  188 bits (480), Expect = 4e-51
 Identities = 69/333 (20%), Positives = 116/333 (34%), Gaps = 12/333 (3%)

Query: 6   NNSLYDSIPSELRNLKSLS--DLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +    D  P+    L  +S   + L  +       ++    + L  L +    LS  +P 
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNL 122
            +        L LS NK       S  N  +L  L +  N+    + +  L NL +L  L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355

Query: 123 QLNNNIL--SGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
            L+++ +  S      L NL++L +L +  N   +           L  L L+       
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 181 IPPS-LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMG---NL 236
              S   NL  L  L L  + L  S       L +L +L+L  N               L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475

Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNY 295
             L  L L    LS    + + +L  +  + L HN+        L +L  +  + L  N+
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534

Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDW 328
           ++  +     I      I+L QN      S+ +
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  103 bits (258), Expect = 7e-23
 Identities = 38/196 (19%), Positives = 64/196 (32%), Gaps = 4/196 (2%)

Query: 332 PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQ 391
                L+FS N +             L  LDL+   I           +    LVL  N 
Sbjct: 33  NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92

Query: 392 LSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQIC 451
           L       L     L+HL      +S+     L N +   L  L L  N +      +  
Sbjct: 93  LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK--TLESLYLGSNHISSIKLPKGF 150

Query: 452 IMQSLEKLNLSHNSLSGLIPSCFEKMNGL--LHIDISYNELRGSIPNSTTFKDAPIEALQ 509
             + L+ L+  +N++  L       +     L ++++ N++ G  P +            
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFG 210

Query: 510 GNKGLYGDVKGLLSCK 525
           G + L    KGL +  
Sbjct: 211 GTQNLLVIFKGLKNST 226

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  258 bits (660), Expect = 8e-76
 Identities = 106/511 (20%), Positives = 186/511 (36%), Gaps = 26/511 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +  N L         N   L  L+L   ++      +   L +L+ L +  N +    PG
Sbjct: 39  LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNL 122
                    +L     KL+      +G L  L  L +  N + +  +P+   NL +L ++
Sbjct: 99  SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158

Query: 123 QLNNNILSGSIPHSLGNLTNLA----TLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
            L+ N +     + L  L        +L +  N +   I  +      L  L L  N  +
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNS 217

Query: 179 GSIPP-SLGNLSNLATLYL------DTNSLSYSIPSELGNLRSLS--NLSLGYNKLSGSI 229
            +I    L NL+ L    L      D  +L    PS +  L  ++     L Y       
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD 277

Query: 230 PISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERV 289
            +    L+N++ ++L   S+      +     K   L +   Q +   P L +L  L+ +
Sbjct: 278 IVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPTL-DLPFLKSL 333

Query: 290 RLDRNYLTGNISESFYIYPNLTYIDLSQNNFY--GEISSDWGRCPKLSTLDFSINNITGN 347
            L  N  +  IS      P+L+Y+DLS+N     G  S        L  LD S N     
Sbjct: 334 TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII- 390

Query: 348 VPPEIGHSSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQL 406
           +        +L  LD   + +           L   + L +++             L  L
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450

Query: 407 EHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL 466
             L ++ N   ++   ++      +L+ LDLS+  L +        +  L+ LN+SHN+L
Sbjct: 451 NTLKMAGNSFKDNTLSNVFAN-TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509

Query: 467 SGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
             L  S + ++  L  +D S+N +  S    
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  229 bits (586), Expect = 2e-65
 Identities = 109/470 (23%), Positives = 176/470 (37%), Gaps = 35/470 (7%)

Query: 35  GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSN 94
           GS+   +  + N+ T       LS  +P +I       +++LS N L      S  N S 
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 95  LATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLS 154
           L  L L    +          L  LSNL L  N +    P S   LT+L  L      L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 155 ASILGKIGNLKSLSNLQLSENNFNG-SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLR 213
           +     IG L +L  L ++ N  +   +P    NL+NL  + L  N +     ++L  LR
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 214 SLSN----LSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIP-YEYRNLVKLTILLL 268
                   L +  N +   I         L  L L  N  S  I     +NL  L +  L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

Query: 269 GHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW 328
              +F+      RNL        + + + G           +    L+  N + +    +
Sbjct: 237 ILGEFKD----ERNLEI-----FEPSIMEGLCD------VTIDEFRLTYTNDFSDDIVKF 281

Query: 329 GRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLA 388
                +S +  +  +I      ++    +   L +    +     ++L  L     L L 
Sbjct: 282 HCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK---SLTLT 336

Query: 389 HNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPS 448
            N+ S  +S K  +L  L +LDLS N LS S   S  +L    L  LDLS N     + +
Sbjct: 337 MNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSA 393

Query: 449 QICIMQSLEKLNLSHNSLSGLIP-SCFEKMNGLLHIDISYNELRGSIPNS 497
               ++ L+ L+  H++L  +   S F  +  LL++DISY   +      
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  216 bits (552), Expect = 8e-61
 Identities = 96/454 (21%), Positives = 159/454 (35%), Gaps = 28/454 (6%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSG-SIPHSLGNLTNLATLYIHTNSLSGSIPG 63
               L       +  L +L  L + +N +    +P    NLTNL  + +  N +      
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171

Query: 64  EIGNFRFFSD----LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE-LGNLRS 118
           ++   R        L++S N +   I         L  L L  N  S++I    L NL  
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230

Query: 119 LSNLQLNNNILSGSI------PHSLGNLTNLAT--LYIYSNSLSASILGKIGNLKSLSNL 170
           L   +L               P  +  L ++      +   +  +  + K   L ++S +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290

Query: 171 QLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP 230
            L+  +        +       +L +    L    P+   +L  L +L+L  NK S  I 
Sbjct: 291 SLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS--IS 343

Query: 231 ISMGNLSNLTYLNLFENSLS--GAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLER 288
                L +L+YL+L  N+LS  G   Y       L  L L  N           L  L+ 
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQH 403

Query: 289 VRLDRNYLTGNISES-FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGN 347
           +    + L      S F     L Y+D+S  N   +    +     L+TL  + N+   N
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463

Query: 348 VPPEI-GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQL 406
               +  +++ L  LDLS   +          L+    L ++HN L    S     L  L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523

Query: 407 EHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN 440
             LD S NR+  S        +   L+  +L+ N
Sbjct: 524 STLDCSFNRIETSKGILQHFPK--SLAFFNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  179 bits (457), Expect = 5e-48
 Identities = 82/377 (21%), Positives = 131/377 (34%), Gaps = 23/377 (6%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIP-HSLGNLTNLATLYIHTNSLSGSIPGE 64
            N + D I  +      L +L L  N  S +I    L NL  L    +           E
Sbjct: 190 LNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248

Query: 65  IGNFRFFS--------DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNL 116
           I               +  L+              L+N++ + L   S+      ++   
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKH 306

Query: 117 RSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENN 176
               +L +    L    P    +L  L +L +  N  S  I  K   L SLS L LS N 
Sbjct: 307 FKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNA 361

Query: 177 FNGSIPPSLGNL--SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM- 233
            + S   S  +L  ++L  L L  N     + +    L  L +L   ++ L      S  
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420

Query: 234 GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRL 291
            +L  L YL++   +        +  L  L  L +  N F+      +  N T+L  + L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480

Query: 292 DRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPE 351
            +  L       F     L  +++S NN     SS + +   LSTLD S N I  +    
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540

Query: 352 IGHSSQLGVLDLSSNHI 368
                 L   +L++N +
Sbjct: 541 QHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  143 bits (362), Expect = 9e-36
 Identities = 58/273 (21%), Positives = 95/273 (34%), Gaps = 12/273 (4%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
             S+      ++        L +   +L    P    +L  L +L +  N  S  I  + 
Sbjct: 294 GVSI--KYLEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKGS--ISFKK 346

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNL--SNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
                 S L+LS N LS S   S  +L  ++L  L L  N     + +    L  L +L 
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLD 405

Query: 124 LNNNILSGSIPHS-LGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
             ++ L      S   +L  L  L I   +      G    L SL+ L+++ N+F  +  
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

Query: 183 PS-LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY 241
            +   N +NL  L L    L          L  L  L++ +N L          L +L+ 
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525

Query: 242 LNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR 274
           L+   N +  +          L    L +N   
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  131 bits (331), Expect = 7e-32
 Identities = 52/227 (22%), Positives = 82/227 (36%), Gaps = 7/227 (3%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNL--TNLATLYIHTNSLSGSI 61
           +  N    SI  +   L SLS L+L  N LS S   S  +L   +L  L +  N     +
Sbjct: 335 LTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IM 391

Query: 62  PGEIGNFRFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
                       L+  ++ L      S   +L  L  L +   +           L SL+
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451

Query: 121 NLQL-NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
            L++  N+    ++ +   N TNL  L +    L     G    L  L  L +S NN   
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS 226
                   L +L+TL    N +  S        +SL+  +L  N ++
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  237 bits (608), Expect = 1e-71
 Identities = 87/324 (26%), Positives = 146/324 (45%), Gaps = 32/324 (9%)

Query: 566 KNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLAS 625
              S+   S          V     ++   ++  ATN+FD +  IG G  G VY   L  
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 626 GEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF 683
           G  +A+K+         + Q  +EF  E++ L+   H ++V + GFC     + ++Y+Y 
Sbjct: 63  GAKVALKRRTP-----ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 684 KMCSLAVILS-NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF 742
           +  +L   L  +D    ++ W +R+ +  G    L Y+H      I+HRD+ S N+LLD 
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174

Query: 743 ENEAHVSDFGIAKFLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 799
                ++DFGI+K    +       T + GT GY+ PE     ++TEK DVYSFGV+  E
Sbjct: 175 NFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 800 VIKGKHPRDFISSMSFSSLNLNIA-----------LDEMLDPRLPTPSRNVHDKLISIVE 848
           V+  +         S     +N+A           L++++DP L    +   + L    +
Sbjct: 234 VLCARSAIV----QSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGD 287

Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
             + C+  + E RP+M  V   L+
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  218 bits (558), Expect = 1e-64
 Identities = 85/300 (28%), Positives = 141/300 (47%), Gaps = 35/300 (11%)

Query: 594 YEEIIRATNDFDDEHC------IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQ-- 645
           + E+   TN+FD+         +G+GG G VY   + +   +AVKK  + +    T +  
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT-TEELK 74

Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           Q+F  E+K + +  H N+V++ GF      L +VY Y    SL   LS       L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW- 764
           R  + +G  + ++++H +     +HRDI S N+LLD    A +SDFG+A+      +   
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTV 190

Query: 765 --TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-- 820
             + + GT  Y+APE A   ++T K D+YSFGV+ LE+I G    D           L  
Sbjct: 191 MTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQLLLD 245

Query: 821 --------NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                      +++ +D ++   +      + ++  V   C+ E    RP ++KV QLL+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  217 bits (555), Expect = 1e-61
 Identities = 111/516 (21%), Positives = 185/516 (35%), Gaps = 36/516 (6%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
           C+  N  +  IP  L    S  +L+L  N L     +S  +   L  L +    +     
Sbjct: 14  CMELN--FYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
           G   +    S L L+ N +      +   LS+L  L     +L++     +G+L++L  L
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129

Query: 123 QL-NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSN----LQLSENNF 177
            + +N I S  +P    NLTNL  L + SN + +     +  L  +      L LS N  
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 178 NGSIPPSLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGS---IPISM 233
           N  I P       L  L L  N  S ++    +  L  L    L   +            
Sbjct: 190 N-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 234 GNLSNLTYLNLFENSLSG------AIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLE 287
             L  L  L + E  L+        I   +  L  ++   L        +         +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQ 307

Query: 288 RVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNIT-- 345
            + L         +       +L  +  + N      S      P L  LD S N ++  
Sbjct: 308 HLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAFSEVD--LPSLEFLDLSRNGLSFK 362

Query: 346 GNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPK--LGSL 403
           G        ++ L  LDLS N ++  +      L     L   H+ L  Q+S      SL
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 420

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI-CIMQSLEKLNLS 462
             L +LD+S      +       L    L  L ++ N  +E     I   +++L  L+LS
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLS--SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 463 HNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
              L  L P+ F  ++ L  ++++ N+L+ S+P+  
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGI 513

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  116 bits (292), Expect = 3e-27
 Identities = 59/257 (22%), Positives = 90/257 (35%), Gaps = 16/257 (6%)

Query: 1   LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGS 60
           +      S+      +         LEL N K        L +L  L        + + +
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL--------TFTSN 335

Query: 61  IPGEIGNFRFFSDLE---LSNNKLS--GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGN 115
             G   +      LE   LS N LS  G    S    ++L  L L  N +  ++ S    
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394

Query: 116 LRSLSNLQLNNNILSGSIPHS-LGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE 174
           L  L +L   ++ L      S   +L NL  L I       +  G    L SL  L+++ 
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454

Query: 175 NNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM 233
           N+F  +  P     L NL  L L    L    P+   +L SL  L++  N+L        
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514

Query: 234 GNLSNLTYLNLFENSLS 250
             L++L  + L  N   
Sbjct: 515 DRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (255), Expect = 1e-22
 Identities = 53/234 (22%), Positives = 83/234 (35%), Gaps = 29/234 (12%)

Query: 1   LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLS--GSIPHSLGNLTNLATLYIHTNSLS 58
           L  +   S          +L SL  L+L  N LS  G    S    T+L  L        
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD------- 379

Query: 59  GSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIP-SELGNLR 117
                            LS N +  ++  +   L  L  L    ++L      S   +LR
Sbjct: 380 -----------------LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421

Query: 118 SLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKI-GNLKSLSNLQLSENN 176
           +L  L +++     +       L++L  L +  NS   + L  I   L++L+ L LS+  
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 177 FNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP 230
                P +  +LS+L  L + +N L          L SL  + L  N    S P
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  212 bits (541), Expect = 1e-60
 Identities = 120/493 (24%), Positives = 202/493 (40%), Gaps = 40/493 (8%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           I  ++  + I +    L       LG   ++ ++     +L  + TL      +  SI G
Sbjct: 8   ITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG 63

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            +      + +  SNN+L+   P  L NL+ L  + ++ N +++  P  L NL +L+ L 
Sbjct: 64  -VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           L NN ++   P  L NLTNL  L + SN++S   +  +  L SL  L    N      P 
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP- 172

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            L NL+ L  L + +N +  S  S L  L +L +L    N++S   P+  G L+NL  L+
Sbjct: 173 -LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELS 227

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
           L  N L         +L  LT L L +NQ    +  L  LT L  ++L  N ++      
Sbjct: 228 LNGNQLKDIGTLA--SLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISN--ISP 282

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL 363
                 LT ++L++N       S       L+ L    NNI+      +   ++L  L  
Sbjct: 283 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFF 338

Query: 364 SSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKS 423
            +N +       L  L     L   HNQ+S  L+P L +L ++  L L+    +N+    
Sbjct: 339 YNNKV--SDVSSLANLTNINWLSAGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVNY 394

Query: 424 LGNLELIHLSELDLSRNFLREAI-PSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLH 482
             N+ +      +  +N     I P+ I    S  + +++ N  S          +  + 
Sbjct: 395 KANVSI-----PNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYT-NEVSYTFSQPVT 448

Query: 483 IDISYNELRGSIP 495
           I        G++ 
Sbjct: 449 IGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  190 bits (485), Expect = 8e-53
 Identities = 92/422 (21%), Positives = 169/422 (40%), Gaps = 36/422 (8%)

Query: 76  LSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPH 135
             +  ++         L+      L   ++++++     +L  ++ LQ +   +      
Sbjct: 9   TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SID 62

Query: 136 SLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLY 195
            +  L NL  +   +N L+   +  + NL  L ++ ++ N      P  L NL+NL  L 
Sbjct: 63  GVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118

Query: 196 LDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPY 255
           L  N ++   P  L NL +L+ L L  N +S     ++  L++L  L+   N ++   P 
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPL 173

Query: 256 EYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDL 315
              NL  L  L +  N+    I +L  LT+LE +    N ++        I  NL  + L
Sbjct: 174 A--NLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSL 228

Query: 316 SQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE 375
           + N    +I +       L+ LD + N I+      +   ++L  L L +N I    P  
Sbjct: 229 NGNQL-KDIGT-LASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP-- 282

Query: 376 LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSEL 435
           L  L     L L  NQL       + +L  L +L L  N +S+  P  + +L    L  L
Sbjct: 283 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLT--KLQRL 336

Query: 436 DLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIP 495
               N + +   S +  + ++  L+  HN +S L P     +  +  + ++      +  
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392

Query: 496 NS 497
           N 
Sbjct: 393 NY 394

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  207 bits (528), Expect = 2e-60
 Identities = 69/309 (22%), Positives = 124/309 (40%), Gaps = 40/309 (12%)

Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
            E +   +          +G  G V+ ++L   E +AVK F  P+  + ++Q E+  EV 
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF--PIQDKQSWQNEY--EVY 70

Query: 654 ALTEIWHRNIVKVYGFCLHVRH----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM 709
           +L  + H NI++  G           L+++  + +  SL+  L  +     + W    ++
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHI 126

Query: 710 IKGIVDALSYMHNDCF-------PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
            + +   L+Y+H D         P I HRDI SKNVLL     A ++DFG+A   +   S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 763 NW--TELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS- 814
                   GT  Y+APE+      +      + D+Y+ G++  E+       D       
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 815 ---FSSLNLNIALDEM--------LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
                 +  + +L++M          P L       H  +  + E    C D + E+R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 864 MQKVCQLLK 872
              V + + 
Sbjct: 306 AGCVGERIT 314

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  199 bits (507), Expect = 1e-57
 Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 21/272 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            + + E  +G+G  G V  +K    + +A+K+  S      + ++ F+ E++ L+ + H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHP 61

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NIVK+YG CL+   + +V EY +  SL  +L              M+        ++Y+H
Sbjct: 62  NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 722 NDCFPPIVHRDISSKNVLLDFENE-AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           +     ++HRD+   N+LL        + DFG A  ++   ++ T   G+  ++APE+  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
               +EKCDV+S+G++  EVI  + P D I   +F      I        R P    N+ 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-----IMWAVHNGTRPPLIK-NLP 230

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             + S++     C  ++P  RP+M+++ +++ 
Sbjct: 231 KPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  211 bits (539), Expect = 2e-57
 Identities = 118/525 (22%), Positives = 200/525 (38%), Gaps = 54/525 (10%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
             + N     +P  L   + L    L  N +      S   L  L  L + +     +I 
Sbjct: 11  YRFCN--LTQVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 63  GEIGNFRFFSDLE---LSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSI--PSELGNLR 117
            E   FR   +L    L ++K+    P +   L +L  L L    LS+++       NL+
Sbjct: 66  KEA--FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 118 SLSNLQL-NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNL--KSLSNLQLSE 174
           +L+ L L  N I S  +  S G L +L ++   SN +      ++  L  K+LS   L+ 
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 175 NNFNGSIPPSLGNLSN------LATLYLDTNSLSYSIPS------------ELGNLRSLS 216
           N+    +    G   N      L  L +  N  +  I               L     + 
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 217 NLSLGYNKLSGSIPISMGNL--SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR 274
               G++ +      +   L  S++ +L+L    +       +  L  L +L L +N+  
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303

Query: 275 G-PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPK 333
                    L +L+ + L  N L    S +FY  P + YIDL +N+        +    K
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363

Query: 334 LSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIK-LVLAHNQL 392
           L TLD   N +T      I     +  + LS N +     + L K+N     + L+ N+L
Sbjct: 364 LQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL-----VTLPKINLTANLIHLSENRL 413

Query: 393 SG-QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQIC 451
               +   L  +  L+ L L+ NR S+       +     L +L L  N L+ A  +++C
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE-NPSLEQLFLGENMLQLAWETELC 472

Query: 452 I-----MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
                 +  L+ L L+HN L+ L P  F  +  L  + ++ N L 
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  136 bits (343), Expect = 5e-33
 Identities = 74/452 (16%), Positives = 154/452 (34%), Gaps = 53/452 (11%)

Query: 19  NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFS--DLEL 76
           N  ++      +N +S S   SL    ++       +++              S   L+L
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273

Query: 77  SNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHS 136
           S+  +          L +L  L L  N ++         L +L  L L+ N+L      +
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333

Query: 137 LGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYL 196
              L  +A + +  N ++         L+ L  L L +N        ++  + ++  ++L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFL 388

Query: 197 DTNSLSYSIPSELGNLRSLSNLSLGYNKLSG-SIPISMGNLSNLTYLNLFENSLSGAIPY 255
             N L  ++P       + + + L  N+L    I   +  + +L  L L +N  S     
Sbjct: 389 SGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS-CSG 443

Query: 256 EY--RNLVKLTILLLGHNQFRG------PIPILRNLTSLERVRLDRNYLTGNISESFYIY 307
           +        L  L LG N  +          +   L+ L+ + L+ NYL       F   
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503

Query: 308 PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH 367
             L  + L+ N              +L+ L  +               + L +LD+S N 
Sbjct: 504 TALRGLSLNSN--------------RLTVLSHND------------LPANLEILDISRNQ 537

Query: 368 IVGEIPIELGKLNFFIKLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNR--LSNSIPKSL 424
           ++   P     L+      + HN+   +       + +   ++ ++     +    P S 
Sbjct: 538 LLAPNPDVFVSLSVL---DITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSF 594

Query: 425 GNLELIHLSELDLSRNFLREAIPSQICIMQSL 456
             + L  LS        + +++   + I+ ++
Sbjct: 595 SGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.5 bits (165), Expect = 1e-11
 Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 3/103 (2%)

Query: 403 LVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICI-MQSLEKLNL 461
           L   E L LS N +      S   LE   L  L+L   +    I  +    + +L  L+L
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLE--QLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80

Query: 462 SHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAP 504
             + +  L P  F+ +  L  + + +  L  ++     F++  
Sbjct: 81  GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.7 bits (150), Expect = 7e-10
 Identities = 55/278 (19%), Positives = 90/278 (32%), Gaps = 27/278 (9%)

Query: 1   LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSG-SIPHSLGNLTNLATLYIHTNSLSG 59
           +    N      I   L  +  L  L L  N+ S  S   +     +L  L++  N L  
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465

Query: 60  SIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
           +   E+                          LS+L  LYL+ N L++  P    +L +L
Sbjct: 466 AWETELC-------------------WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
             L LN+N L+    + L    NL  L I  N L A          SLS L ++ N F  
Sbjct: 507 RGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNP---DVFVSLSVLDITHNKFIC 561

Query: 180 SIPPS-LGNLSNLATLYLDTNSLSYSIPS-ELGNLRSLSNLSLGYNKLSGSIPISMGNLS 237
               S   N  N   + +            +  +  SL +LS         +     +L 
Sbjct: 562 ECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLF 621

Query: 238 NLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG 275
            +  + L    ++     ++R    +         F+ 
Sbjct: 622 IVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKD 659

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  190 bits (485), Expect = 1e-54
 Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 13/271 (4%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            D + +  IG G  G+V+ ++   G  +AVK              EFL EV  +  + H 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHP 94

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NIV   G      +L IV EY    SL  +L    A + L   RR++M   +   ++Y+H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           N   PPIVHR++ S N+L+D +    V DFG+++       +    AGT  ++APE+   
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
               EK DVYSFGV+  E+   + P  +  +++ + +   +        RL  P  N++ 
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP--W-GNLNPAQVVAAVGFKCK---RLEIPR-NLNP 266

Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++ +I+E    C    P  RP+   +  LL+
Sbjct: 267 QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  191 bits (488), Expect = 2e-54
 Identities = 90/366 (24%), Positives = 157/366 (42%), Gaps = 26/366 (7%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
                 +    P    +L       L    ++  +      L ++  L +    ++ SI 
Sbjct: 6   ATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ 60

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
           G I        L L+ N+++   P  L NL  L  LY+ TN +++   S L NL +L  L
Sbjct: 61  G-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLREL 115

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
            LN + +S   P  L NLT + +L + +N    S L  + N+  L+ L ++E+      P
Sbjct: 116 YLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP 172

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
             + NL++L +L L+ N +    P  L +L SL   +   N+++   P+   N++ L  L
Sbjct: 173 --IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLNSL 226

Query: 243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISE 302
            +  N ++   P    NL +LT L +G NQ    I  +++LT L+ + +  N ++     
Sbjct: 227 KIGNNKITDLSPLA--NLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISD--IS 281

Query: 303 SFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLD 362
                  L  + L+ N    E     G    L+TL  S N+IT      +   S++   D
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSAD 339

Query: 363 LSSNHI 368
            ++  I
Sbjct: 340 FANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  189 bits (483), Expect = 8e-54
 Identities = 89/395 (22%), Positives = 167/395 (42%), Gaps = 50/395 (12%)

Query: 23  LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLS 82
            + L      ++   P    +L       +   S++  +          + L ++  K++
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 83  GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTN 142
            SI   +  L+NL  L L+ N +++  P  L NL  L+NL +  N +  +   +L NLTN
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111

Query: 143 LATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS 202
           L  LY+  +++S      + NL  + +L L  N+ N S    L N++ L  L +  + + 
Sbjct: 112 LRELYLNEDNISDIS--PLANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLTVTESKVK 168

Query: 203 YSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVK 262
              P  + NL  L +LSL YN++    P+   +L++L Y   + N ++   P    N+ +
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITPVA--NMTR 222

Query: 263 LTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG 322
           L  L +G+N+    +  L NL+ L  + +  N ++ +I+                     
Sbjct: 223 LNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQIS-DINA-------------------- 260

Query: 323 EISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFF 382
                     KL  L+   N I+      + + SQL  L L++N +  E    +G L   
Sbjct: 261 -----VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 383 IKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLS 417
             L L+ N ++      L SL +++  D ++  + 
Sbjct: 314 TTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  186 bits (474), Expect = 2e-52
 Identities = 90/373 (24%), Positives = 157/373 (42%), Gaps = 28/373 (7%)

Query: 72  SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG 131
           + L      ++   P    +L+      L   S+++ +      L S++ L +    ++ 
Sbjct: 3   ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA- 57

Query: 132 SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNL 191
           SI   +  LTNL  L +  N ++   +  + NL  L+NL +  N    +   +L NL+NL
Sbjct: 58  SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNL 112

Query: 192 ATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG 251
             LYL+ +++S   P  L NL  + +L+LG N     +   + N++ L YL + E+ +  
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD 169

Query: 252 AIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLT 311
             P    NL  L  L L +NQ     P L +LTSL       N +T            L 
Sbjct: 170 VTPIA--NLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITD--ITPVANMTRLN 224

Query: 312 YIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGE 371
            + +  N       S      +L+ L+   N I+      +   ++L +L++ SN I   
Sbjct: 225 SLKIGNNKI--TDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD- 279

Query: 372 IPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIH 431
               L  L+    L L +NQL  +    +G L  L  L LS N +++  P  L +L    
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS--K 334

Query: 432 LSELDLSRNFLRE 444
           +   D +   +++
Sbjct: 335 MDSADFANQVIKK 347

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  180 bits (458), Expect = 2e-50
 Identities = 86/373 (23%), Positives = 157/373 (42%), Gaps = 28/373 (7%)

Query: 119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
            + L      ++   P    +L       +   S++  +      L+S++ L ++     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGEKVA 57

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSN 238
            SI   +  L+NL  L L+ N ++   P  L NL  L+NL +G NK++     ++ NL+N
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTG 298
           L  L L E+++S   P    NL K+  L LG N     +  L N+T L  + +  + +  
Sbjct: 112 LRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD 169

Query: 299 NISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQL 358
                     +L  + L+ N       S       L      +N IT      + + ++L
Sbjct: 170 --VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD--ITPVANMTRL 223

Query: 359 GVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN 418
             L + +N I    P  L  L+    L +  NQ+S  ++  +  L +L+ L++ SN++S+
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INA-VKDLTKLKMLNVGSNQISD 279

Query: 419 SIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMN 478
                L NL    L+ L L+ N L       I  + +L  L LS N ++ + P     ++
Sbjct: 280 --ISVLNNLS--QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333

Query: 479 GLLHIDISYNELR 491
            +   D +   ++
Sbjct: 334 KMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  156 bits (396), Expect = 5e-42
 Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 17/247 (6%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +  +++ D  P  L NL  +  L LG N     +   L N+T L  L +  + +    P 
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP- 172

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            I N      L L+ N++    P  L +L++L       N +++  P  + N+  L++L+
Sbjct: 173 -IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           + NN ++   P  L NL+ L  L I +N +S   +  + +L  L  L +  N  +     
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--IS 281

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            L NLS L +L+L+ N L       +G L +L+ L L  N ++   P++  +LS +   +
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSAD 339

Query: 244 LFENSLS 250
                + 
Sbjct: 340 FANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 72.6 bits (179), Expect = 9e-14
 Identities = 31/163 (19%), Positives = 67/163 (41%), Gaps = 14/163 (8%)

Query: 334 LSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS 393
            +TL      I    P      ++     L    +   +  E  +L    KLV+A  +++
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57

Query: 394 GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
                 +  L  LE+L+L+ N++++  P  L NL    L+ L +  N +     S +  +
Sbjct: 58  SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLV--KLTNLYIGTNKIT--DISALQNL 109

Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
            +L +L L+ +++S + P     +  +  +++  N     +  
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  196 bits (500), Expect = 4e-54
 Identities = 101/508 (19%), Positives = 183/508 (36%), Gaps = 39/508 (7%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           + S   SIPS L    ++  L+L  NK++      L    NL  L + ++ ++       
Sbjct: 14  SRSF-TSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70

Query: 66  GNFRFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNLQ 123
            +      L+LS+N LS S+  S  G LS+L  L L  N      + S   NL +L  L+
Sbjct: 71  YSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129

Query: 124 L-NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
           + N    S         LT+L  L I + SL       + +++ + +L L  +     + 
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
                LS++  L L   +L+    S L      S +     + S     S   L  L   
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249

Query: 243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILR-NLTSLERVRLDRNYLTGNIS 301
            L  + +       + +     +     ++      + +    ++ R+ + + YL  ++S
Sbjct: 250 ILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303

Query: 302 ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPE---IGHSSQL 358
             + +   +  I +  +  +    S       L  LD S N +           G    L
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 359 GVLDLSSNHIVGEIPIELGKLNFFIKLV---LAHNQLSGQLSPKLGSLVQLEHLDLSSNR 415
             L LS NH+   +      L     L    ++ N     +        ++  L+LSS  
Sbjct: 364 QTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421

Query: 416 LSNSIPKSLGNLELIHLS---------------ELDLSRNFLREAIPSQICIMQSLEKLN 460
           +          LE++ +S               EL +SRN L+  +P    +   L  + 
Sbjct: 422 IRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMK 479

Query: 461 LSHNSLSGLIPSCFEKMNGLLHIDISYN 488
           +S N L  +    F+++  L  I +  N
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  181 bits (460), Expect = 8e-49
 Identities = 100/455 (21%), Positives = 180/455 (39%), Gaps = 39/455 (8%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           L+LS NK++      L   +NL  L L ++ ++        +L SL +L L++N LS   
Sbjct: 31  LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90

Query: 134 PHSLGNLTNLATLYIYSNSLSA-SILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNL 191
               G L++L  L +  N      +     NL +L  L++        I       L++L
Sbjct: 91  SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150

Query: 192 ATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG 251
             L +   SL       L ++R + +L+L  ++ +  + I    LS++ YL L + +L+ 
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

Query: 252 AIPYEYRNLVKLTILLLGHNQ--------FRGPIPILRNLTSLERVRLDRNYLTGNIS-- 301
                       + +     +        F   + +LR +  L  V  D   L G     
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270

Query: 302 ---------ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI 352
                            +  + + Q   + ++S+ +    K+  +    + +   VP   
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSF 329

Query: 353 GHS-SQLGVLDLSSNHIVGEIPIELGKLNFFIKL---VLAHNQLS--GQLSPKLGSLVQL 406
                 L  LDLS N +V E          +  L   VL+ N L    +    L +L  L
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389

Query: 407 EHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL 466
             LD+S N     +P S    E   +  L+LS   +R  + +  CI Q+LE L++S+N+L
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPE--KMRFLNLSSTGIRV-VKT--CIPQTLEVLDVSNNNL 443

Query: 467 SGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
                     +  L  + IS N+L+ ++P+++ F 
Sbjct: 444 DSF----SLFLPRLQELYISRNKLK-TLPDASLFP 473

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  142 bits (361), Expect = 6e-36
 Identities = 59/357 (16%), Positives = 135/357 (37%), Gaps = 22/357 (6%)

Query: 166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL 225
           +         +F  SIP  L   + + +L L  N ++Y    +L    +L  L L  +++
Sbjct: 6   ASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 226 SGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR--GPIPILRNL 283
           +     +  +L +L +L+L +N LS      +  L  L  L L  N ++  G   +  NL
Sbjct: 63  NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122

Query: 284 TSLERVRLDRNYLTGNISE-SFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN 342
           T+L+ +R+        I    F    +L  +++   +     S        +  L   ++
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182

Query: 343 NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG-------- 394
                +       S +  L+L   ++       L        +     + S         
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242

Query: 395 --QLSPKLGSLVQLEHLDLSSNRL------SNSIPKSLGNLELIHLSELDLSRNFLREAI 446
             +L   +  L ++E  D + N L       + +   LG +E + +  L + + +L   +
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302

Query: 447 PSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDA 503
            +   +++ ++++ + ++ +  +  S  + +  L  +D+S N +      ++  K A
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  138 bits (349), Expect = 2e-34
 Identities = 67/408 (16%), Positives = 119/408 (29%), Gaps = 44/408 (10%)

Query: 4   IYNNSLYD-SIPSELRNLKSLSDLELGNNKLSGSIP-HSLGNLTNLATLYIHTNSLSGSI 61
           +  N      + S   NL +L  L +GN +    I       LT+L  L I   SL    
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164

Query: 62  PGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN 121
              + + R    L L  ++ +  +      LS++  L L   +L+    S L      S 
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224

Query: 122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG------------------N 163
           ++      S     S   L  L    +  + +        G                   
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284

Query: 164 LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYN 223
             ++  L + +      +      L  +  + ++ + +     S   +L+SL  L L  N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344

Query: 224 KLSGSI---PISMGNLSNLTYLNLFENSLS--GAIPYEYRNLVKLTILLLGHNQFRGPIP 278
            +           G   +L  L L +N L            L  LT L +  N F     
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPD 404

Query: 279 ILRNLTSLERVRLDRNYLTG-----------------NISESFYIYPNLTYIDLSQNNFY 321
             +    +  + L    +                   N+       P L  + +S+N   
Sbjct: 405 SCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKL- 463

Query: 322 GEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIV 369
            +   D    P L  +  S N +           + L  + L +N   
Sbjct: 464 -KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 76.3 bits (188), Expect = 2e-14
 Identities = 39/164 (23%), Positives = 68/164 (41%), Gaps = 9/164 (5%)

Query: 331 CPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHN 390
           C      D    + T ++P  +  ++ +  LDLS N I      +L        L+L  +
Sbjct: 4   CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60

Query: 391 QLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQ 449
           +++  +      SL  LEHLDLS N LS+      G L    L  L+L  N  +    + 
Sbjct: 61  RIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLS--SLKYLNLMGNPYQTLGVTS 117

Query: 450 ICI-MQSLEKLNLSH-NSLSGLIPSCFEKMNGLLHIDISYNELR 491
           +   + +L+ L + +  + S +    F  +  L  ++I    LR
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  191 bits (487), Expect = 4e-53
 Identities = 111/501 (22%), Positives = 186/501 (37%), Gaps = 82/501 (16%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
           ++++L   +P E  N+KS ++     ++   + P   G    +A   +            
Sbjct: 19  HSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------- 70

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL 124
               R   +LEL+N  LS S+P    +L    +L    NSL+  +P    +L+SL     
Sbjct: 71  ----RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNN 121

Query: 125 NNNILSGSIPH---------------SLGNLTNLATLYIYSNSLSASILGKIGNLKSLSN 169
           N   LS   P                 L N + L  + + +NSL   +     +L+ ++ 
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA- 179

Query: 170 LQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSI 229
                N       P L NL  L  +Y D NSL   +P    +L    ++  G N L   +
Sbjct: 180 --AGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNILE-EL 230

Query: 230 PISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERV 289
           P  + NL  LT +    N L   +P        L  L +  N       + ++LT L+  
Sbjct: 231 P-ELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDLPELPQSLTFLDVS 285

Query: 290 RLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVP 349
               + L+          PNL Y++ S N     I S     P L  L+ S N +   +P
Sbjct: 286 ENIFSGLSELP-------PNLYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI-ELP 333

Query: 350 PEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHL 409
                  +L  L  S NH+  E+P     L    +L + +N L  +      S+  L   
Sbjct: 334 ALPP---RLERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLR-- 383

Query: 410 DLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGL 469
              ++ L   +P+   NL+     +L +  N LRE  P      +S+E L ++   +   
Sbjct: 384 --MNSHL-AEVPELPQNLK-----QLHVETNPLRE-FPDIP---ESVEDLRMNSERVVDP 431

Query: 470 IPSCFEKMNGLLHIDISYNEL 490
                E  + L      ++  
Sbjct: 432 YEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  181 bits (461), Expect = 1e-49
 Identities = 102/479 (21%), Positives = 177/479 (36%), Gaps = 73/479 (15%)

Query: 19  NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSN 78
           +   L +    ++ L+  +P    N+ +    Y   +    + P   G  R  +   L +
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 79  NKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLG 138
                              L L+   LS S+P    +L SL     + N L+  +P    
Sbjct: 68  CLDR-----------QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQ 111

Query: 139 NLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT 198
           +L +L        +LS            L  L +S N       P L N S L  + +D 
Sbjct: 112 SLKSLLVDNNNLKALS-------DLPPLLEYLGVSNNQLEKL--PELQNSSFLKIIDVDN 162

Query: 199 NSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYR 258
           NSL   +P    +L  ++    G N+L   +P  + NL  LT +    NSL   +P    
Sbjct: 163 NSLK-KLPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDL-- 213

Query: 259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
             + L  ++ G+N     +P L+NL  L  +  D N L   + +     P+L  +++  N
Sbjct: 214 -PLSLESIVAGNNILEE-LPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDN 267

Query: 319 NFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGK 378
               ++         L   +   + ++   P        L  L+ SSN I   +      
Sbjct: 268 YL-TDLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPS 318

Query: 379 LNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLS 438
           L    +L +++N+L  +L      L   E L  S N L+  +P+   NL+     +L + 
Sbjct: 319 LE---ELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQNLK-----QLHVE 365

Query: 439 RNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            N LRE  P     ++ L ++N     +  L  +       L  + +  N LR   P+ 
Sbjct: 366 YNPLRE-FPDIPESVEDL-RMNSHLAEVPELPQN-------LKQLHVETNPLR-EFPDI 414

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  169 bits (429), Expect = 2e-45
 Identities = 95/437 (21%), Positives = 166/437 (37%), Gaps = 64/437 (14%)

Query: 61  IPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
           I     +  F  +    ++ L+  +P    N+ +    Y   +    + P   G  R ++
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
             +L + +                 L + +  LS S+     +L+SL     S N+    
Sbjct: 62  VSRLRDCL-----------DRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-E 105

Query: 181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLT 240
           +P    +L +L     +  +LS   P        L  L +  N+L   +P  + N S L 
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156

Query: 241 YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNI 300
            +++  NSL   +P        L  +  G+NQ    +P L+NL  L  +  D N L   +
Sbjct: 157 IIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLK-KL 210

Query: 301 SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGV 360
            +      +L  I    N    E   +    P L+T+    N +   +P        L  
Sbjct: 211 PDLP---LSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEA 261

Query: 361 LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
           L++  N++  ++P     L     L ++ N  S  LS    +   L +L+ SSN +  S+
Sbjct: 262 LNVRDNYLT-DLPELPQSLT---FLDVSENIFS-GLSELPPN---LYYLNASSNEI-RSL 312

Query: 421 PKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGL 480
                +LE     EL++S N L E +P+       LE+L  S N L+ +          L
Sbjct: 313 CDLPPSLE-----ELNVSNNKLIE-LPALPP---RLERLIASFNHLAEVPEL----PQNL 359

Query: 481 LHIDISYNELRGSIPNS 497
             + + YN LR   P+ 
Sbjct: 360 KQLHVEYNPLR-EFPDI 375

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  158 bits (402), Expect = 6e-42
 Identities = 92/431 (21%), Positives = 147/431 (34%), Gaps = 70/431 (16%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           + N  L  S+P    +L+SL       N L+  +P    +L +L     +  +LS   P 
Sbjct: 78  LNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL 132

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
                     L +SNN+L     P L N S L  + +D NSL   +P    +L  ++   
Sbjct: 133 -------LEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA--- 179

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
             NN L   +P  L NL  L  +Y  +NSL            SL ++    N       P
Sbjct: 180 AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLP----DLPLSLESIVAGNNIL--EELP 231

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            L NL  L T+Y D N L  ++P    +L +L+   +  N L+  +P    +L+ L    
Sbjct: 232 ELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSE 286

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
              + LS   P        L  L    N+ R    +  +L  L    +  N L   +   
Sbjct: 287 NIFSGLSELPP-------NLYYLNASSNEIRSLCDLPPSLEELN---VSNNKLI-ELPAL 335

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGH--------- 354
               P L  +  S N+   E+         L  L    N +    P              
Sbjct: 336 P---PRLERLIASFNHL-AEVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSH 387

Query: 355 -------SSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLE 407
                     L  L + +N +  E P     +     L +   ++         +  +LE
Sbjct: 388 LAEVPELPQNLKQLHVETNPLR-EFPDIPESVE---DLRMNSERVVDPYEFAHETTDKLE 443

Query: 408 HLDLSSNRLSN 418
                 +   +
Sbjct: 444 DDVFEHHHHHH 454

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  184 bits (470), Expect = 5e-53
 Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 26/280 (9%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT-FQQEFLNEVKALTEIWH 660
            +   E  IG GG G VY +    G+ +AVK        +++   +    E K    + H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NI+ + G CL   +L +V E+ +   L  +LS     K +     +N    I   ++Y+
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYL 121

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAH--------VSDFGIAKFLKPDSSNWTELAGTYG 772
           H++   PI+HRD+ S N+L+  + E          ++DFG+A+     +      AG Y 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYA 179

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           ++APE+      ++  DV+S+GVL  E++ G+ P   I  ++ +       L       L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------AL 233

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           P PS    +    ++E    C + +P SRP+   +   L 
Sbjct: 234 PIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  185 bits (471), Expect = 6e-53
 Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 28/283 (9%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQ----QEFLNEVKALT 656
           N+ + E  IGKGG G V+  +L     ++A+K          T      QEF  EV  ++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 657 EIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
            + H NIVK+YG         +V E+     L   L +   A  + W+ ++ ++  I   
Sbjct: 79  NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENE-----AHVSDFGIAKFLKPDSSNWTELAGTY 771
           + YM N   PPIVHRD+ S N+ L   +E     A V+DFG+++     S   + L G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSV--SGLLGNF 190

Query: 772 GYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD 829
            ++APE   A     TEK D YSF ++   ++ G+ P D  S      +N+         
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--- 247

Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            R   P  +   +L +++E    C   +P+ RP    + + L 
Sbjct: 248 -RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  174 bits (444), Expect = 2e-49
 Identities = 48/276 (17%), Positives = 107/276 (38%), Gaps = 24/276 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
              +    + +   G ++  +   G  I VK            + +F  E   L    H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR-DFNEECPRLRIFSHP 67

Query: 662 NIVKVYGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           N++ V G C      H  ++  +    SL  +L ++     +  ++ +     +   +++
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAF 126

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 778
           +H    P I    ++S++V++D +  A +S   +    +              +VAPE  
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEAL 180

Query: 779 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
                       D++SF VL  E++  + P  F + +S   + + +AL+ +   R   P 
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP--F-ADLSNMEIGMKVALEGL---RPTIPP 234

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             +   +  +++    C++E+P  RP    +  +L+
Sbjct: 235 -GISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  176 bits (448), Expect = 3e-49
 Identities = 52/282 (18%), Positives = 104/282 (36%), Gaps = 20/282 (7%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLT--NLATLYIHTNSLSGS 60
              + + + S      N  +          L  +    L + T      L + +  L   
Sbjct: 39  YNADRNRWHS-AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-Q 95

Query: 61  IPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
            P +         + +    L   +P ++   + L TL L  N L  ++P+ + +L  L 
Sbjct: 96  FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153

Query: 121 NLQLNNNILSGSIPHSLGN---------LTNLATLYIYSNSLSASILGKIGNLKSLSNLQ 171
            L +        +P  L +         L NL +L +    +  S+   I NL++L +L+
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212

Query: 172 LSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL-GYNKLSGSIP 230
           +  +  + ++ P++ +L  L  L L   +   + P   G    L  L L   + L  ++P
Sbjct: 213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLP 270

Query: 231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQ 272
           + +  L+ L  L+L        +P     L    I+L+  + 
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  173 bits (442), Expect = 2e-48
 Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 18/251 (7%)

Query: 12  SIPSELRNLKS--LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFR 69
           +    L +        LEL +  L    P     L++L  + I    L   +P  +  F 
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127

Query: 70  FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGN---------LRSLS 120
               L L+ N L  ++P S+ +L+ L  L +        +P  L +         L +L 
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186

Query: 121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
           +L+L    +  S+P S+ NL NL +L I ++ LS ++   I +L  L  L L       +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244

Query: 181 IPPSLGNLSNLATLYL-DTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
            PP  G  + L  L L D ++L  ++P ++  L  L  L L        +P  +  L   
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 240 TYLNLFENSLS 250
             + +  +  +
Sbjct: 304 CIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  165 bits (421), Expect = 1e-45
 Identities = 58/317 (18%), Positives = 102/317 (32%), Gaps = 36/317 (11%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSG------------ 59
           S      +     +L    +         L           +    +             
Sbjct: 3   SSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET 62

Query: 60  -------SIPGEIGNFRFFS--DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIP 110
                  +    + +        LEL +  L    P     LS+L  + +D   L   +P
Sbjct: 63  RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120

Query: 111 SELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSL---------SASILGKI 161
             +     L  L L  N L  ++P S+ +L  L  L I +            S    G+ 
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179

Query: 162 GNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLG 221
             L +L +L+L       S+P S+ NL NL +L +  + LS ++   + +L  L  L L 
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237

Query: 222 YNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-L 280
                 + P   G  + L  L L + S    +P +   L +L  L L        +P  +
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297

Query: 281 RNLTSLERVRLDRNYLT 297
             L +   + +  +   
Sbjct: 298 AQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  161 bits (409), Expect = 6e-44
 Identities = 57/347 (16%), Positives = 106/347 (30%), Gaps = 26/347 (7%)

Query: 83  GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTN 142
           GS      + S    LY   ++        L   +   N   N             N  N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57

Query: 143 LATLYIYSNSLSASILGKIGNLKS--LSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNS 200
                    +L  +    + +        L+L         P     LS+L  + +D   
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 201 LSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL 260
           L   +P  +     L  L+L  N L  ++P S+ +L+ L  L++        +P    + 
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 261 VKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF 320
                               + L +L+ +RL+   +  ++  S     NL  + +  +  
Sbjct: 174 DAS--------------GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218

Query: 321 YGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLN 380
              +       PKL  LD        N PP  G  + L  L L     +  +P+++ +L 
Sbjct: 219 -SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277

Query: 381 FFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL 427
              KL L       +L   +  L     + +  +  +          
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  157 bits (398), Expect = 2e-42
 Identities = 54/316 (17%), Positives = 112/316 (35%), Gaps = 38/316 (12%)

Query: 35  GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG----------- 83
           GS  H   + +    LY   ++        +  ++   + + +    +            
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 84  --------SIPPSLGNLS--NLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
                   +    L + +      L L +  L    P +   L  L ++ ++   L   +
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGN------ 187
           P ++     L TL +  N L  ++   I +L  L  L +        +P  L +      
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 188 ---LSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNL 244
              L NL +L L+   +  S+P+ + NL++L +L +  + LS ++  ++ +L  L  L+L
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236

Query: 245 FENSLSGAIPYEYRNLVKLTIL-LLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNISE 302
              +     P  +     L  L L   +     +P+ +  LT LE++ L        +  
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPS 295

Query: 303 SFYIYPNLTYIDLSQN 318
                P    I +  +
Sbjct: 296 LIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  154 bits (391), Expect = 1e-41
 Identities = 55/368 (14%), Positives = 105/368 (28%), Gaps = 56/368 (15%)

Query: 108 SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL 167
           S      +     NL    +         L              +   +         + 
Sbjct: 3   SSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRH-------YNADRNRWHSAWRQANS 55

Query: 168 SNLQLSENNFNG--SIPPSLGNLS--NLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYN 223
           +N Q+         +    L + +      L L +  L    P +   L  L ++++   
Sbjct: 56  NNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 224 KLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL 283
            L   +P +M   + L  L L  N L  A+P    +L +L  L +               
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRAC------------ 160

Query: 284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINN 343
                                   P LT +     +   + S +      L +L      
Sbjct: 161 ------------------------PELTELPEPLAST--DASGEHQGLVNLQSLRLEWTG 194

Query: 344 ITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSL 403
           I  ++P  I +   L  L + ++ +   +   +  L    +L L          P  G  
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSH 463
             L+ L L       ++P  +  L    L +LDL        +PS I  + +   + +  
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLT--QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310

Query: 464 NSLSGLIP 471
           +  + L  
Sbjct: 311 HLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  147 bits (372), Expect = 5e-39
 Identities = 43/221 (19%), Positives = 74/221 (33%), Gaps = 13/221 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           I    L   +P  ++    L  L L  N L  ++P S+ +L  L  L I        +P 
Sbjct: 111 IDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168

Query: 64  EIGNFRFFS---------DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELG 114
            + +               L L    +  S+P S+ NL NL +L +  + LS ++   + 
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226

Query: 115 NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE 174
           +L  L  L L       + P   G    L  L +   S   ++   I  L  L  L L  
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 175 NNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSL 215
                 +P  +  L     + +  +  +           + 
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  130 bits (330), Expect = 2e-33
 Identities = 52/329 (15%), Positives = 96/329 (29%), Gaps = 44/329 (13%)

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSN 238
           GS      + S    LY   ++        L   +   N        +        N +N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 239 LTYLNLFENSLSGAIPY-EYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLT 297
                    +L       E         L L              L+ L+ + +D   L 
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM 117

Query: 298 GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQ 357
                                    E+     +   L TL  + N +   +P  I   ++
Sbjct: 118 -------------------------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151

Query: 358 LGVLDLSSNHIVGEIPIELGKLNFFI---------KLVLAHNQLSGQLSPKLGSLVQLEH 408
           L  L + +   + E+P  L   +             L L    +   L   + +L  L+ 
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210

Query: 409 LDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSG 468
           L + ++ LS ++  ++ +L    L ELDL         P        L++L L   S   
Sbjct: 211 LKIRNSPLS-ALGPAIHHLP--KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267

Query: 469 LIPSCFEKMNGLLHIDISYNELRGSIPNS 497
            +P    ++  L  +D+        +P+ 
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  178 bits (453), Expect = 2e-48
 Identities = 71/425 (16%), Positives = 134/425 (31%), Gaps = 22/425 (5%)

Query: 84  SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNL 143
           +I     N +      +  +SL  ++ S   +  ++  L L+ N LS      L   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 144 ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY 203
             L + SN L       + +L +L  L L+ N         L    ++ TL+   N++S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG-AIPYEYRNLVK 262
            +       +   N+ L  NK++    +  G  S + YL+L  N +          +   
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 263 LTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG 322
           L  L L +N     +        L+ + L  N L   +   F     +T+I L  N    
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227

Query: 323 EISSDWGRCPKLSTLDFSINNITGNVPPE-IGHSSQLGVLDLSSNHIVGEIPIELGKLNF 381
            I         L   D   N        +    + ++  +   +   +     E   +  
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287

Query: 382 FIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSL--GNLELIHLSELDLSR 439
                          +P    L+ L+  + +      S  + L           E+D  +
Sbjct: 288 LGH--YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345

Query: 440 NFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKM---NGLLHIDISYNELRGSIPN 496
              R  I       Q+   L     +L   + +        +G L   +   EL+ +   
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405

Query: 497 STTFK 501
            +  +
Sbjct: 406 QSPLQ 410

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  175 bits (446), Expect = 2e-47
 Identities = 72/463 (15%), Positives = 148/463 (31%), Gaps = 21/463 (4%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
           +I    +N       ++ ++ L  ++     +  N+  L +  N LS     ++  F   
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 72  SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG 131
             L LS+N L       L +LS L TL L+ N +      EL    S+  L   NN +S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 132 SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG-SIPPSLGNLSN 190
            +            +Y+ +N ++       G    +  L L  N  +  +      +   
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           L  L L  N +   +  ++     L  L L  NKL+  +     + + +T+++L  N L 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNL 310
             I    R    L    L  N F           +     + +  +     ++       
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 311 TYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGN----VPPEIGHSSQLGVLDLSSN 366
           T             +    R   L   + ++ +  G+    +  E  + ++   +D    
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346

Query: 367 HIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGN 426
                I     +    I L      L  Q+S    +  +L+     +      +  +   
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEE 405

Query: 427 LELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGL 469
              + L    + R +    +  Q     ++   ++  +  + L
Sbjct: 406 QSPLQLLRAIVKR-YEEMYVEQQSVQNNAIRDWDMYQHKETQL 447

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  163 bits (413), Expect = 4e-43
 Identities = 62/477 (12%), Positives = 149/477 (31%), Gaps = 27/477 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           + ++SL  ++ S  ++  ++ +L+L  N LS      L   T L  L + +N L      
Sbjct: 17  VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
           ++ +      L+L+NN +       L    ++ TL+   N++S  +       +   N+ 
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIY 126

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSA-SILGKIGNLKSLSNLQLSENNFNGSIP 182
           L NN ++       G  + +  L +  N +   +      +  +L +L L  N     + 
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
             +   + L TL L +N L+  +  E  +   ++ +SL  NKL   I  ++    NL + 
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNIS 301
           +L  N        ++       +  +     +          T                +
Sbjct: 243 DLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301

Query: 302 ESFYIYPNLTYIDLS----QNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQ 357
                   L   + +    Q +    +  +     +   +D         +         
Sbjct: 302 PFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQA 361

Query: 358 LGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG--QLSPKLGSLVQLEHLDLSSNR 415
              L+     +  ++             +            + +   L  L  +      
Sbjct: 362 KITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEE 421

Query: 416 LSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS 472
           +         N     + + D+ ++   +       + +   + +L+  S +  +  
Sbjct: 422 MYVEQQSVQNNA----IRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQE 474

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  144 bits (364), Expect = 8e-37
 Identities = 56/351 (15%), Positives = 114/351 (32%), Gaps = 19/351 (5%)

Query: 161 IGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL 220
             N       ++++++   ++     +  N+  L L  N LS    ++L     L  L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 221 GYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPI 279
             N L  ++ +   +LS L  L+L  N +   +         +  L   +N         
Sbjct: 66  SSNVLYETLDL--ESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSCSR 118

Query: 280 LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG-EISSDWGRCPKLSTLD 338
            +   ++    L  N +T            + Y+DL  N       +        L  L+
Sbjct: 119 GQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 339 FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
              N I  +V  ++  +  L  LDLSSN +   +  E         + L +N+L   +  
Sbjct: 176 LQYNFIY-DVKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 399 KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEK 458
            L     LEH DL  N        +L +    +     +++  +++              
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCG---TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

Query: 459 LNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQ 509
            +        L     +++  L   + +    +GS       +       +
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  174 bits (442), Expect = 2e-48
 Identities = 68/321 (21%), Positives = 117/321 (36%), Gaps = 53/321 (16%)

Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
             E     ++      IG+G  G+VY   L     +AVK F          +Q F+NE  
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF------ANRQNFINEKN 57

Query: 654 --ALTEIWHRNIVKVYGFCLHV-----RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR 706
              +  + H NI +       V         +V EY+   SL   LS         W   
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSS 113

Query: 707 MNMIKGIVDALSYMHND------CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
             +   +   L+Y+H +        P I HRD++S+NVL+  +    +SDFG++  L  +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 761 SSNW--------TELAGTYGYVAPE-------LAYTMKVTEKCDVYSFGVLALEVIKGKH 805
                           GT  Y+APE       L       ++ D+Y+ G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 806 PRDFISSMS------FSSLNLNIALDEMLD--------PRLPTPSRNVHDKLISIVEVTI 851
                 S+        + +  +   ++M          P+ P   +     + S+ E   
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 852 SCVDENPESRPTMQKVCQLLK 872
            C D++ E+R T Q   + + 
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  168 bits (428), Expect = 1e-46
 Identities = 74/293 (25%), Positives = 123/293 (41%), Gaps = 33/293 (11%)

Query: 595 EEIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
             I R  +D      +GKG  G         +GE++ +K+       E T Q+ FL EVK
Sbjct: 4   HRIFRP-SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEET-QRTFLKEVK 59

Query: 654 ALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI 713
            +  + H N++K  G     + L  + EY K  +L  I+ +        W++R++  K I
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDI 117

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL--------------KP 759
              ++Y+H+     I+HRD++S N L+       V+DFG+A+ +              KP
Sbjct: 118 ASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN 819
           D      + G   ++APE+       EK DV+SFG++  E+I   +              
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR-----T 229

Query: 820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++  L+         P  N       I      C D +PE RP+  K+   L+
Sbjct: 230 MDFGLNVRGFLDRYCPP-NCPPSFFPITV---RCCDLDPEKRPSFVKLEHWLE 278

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  163 bits (414), Expect = 6e-45
 Identities = 68/295 (23%), Positives = 123/295 (41%), Gaps = 38/295 (12%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
             C+GKG  G V+      GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRET--ELYNTVMLRHENILGF 67

Query: 667 YGFCLHVRH----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
               +  RH    L+++  Y +M SL   L        L     + ++  I   L+++H 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHI 123

Query: 723 DCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS----NWTELAGTYGY 773
           + F     P I HRD+ SKN+L+    +  ++D G+A      ++          GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 774 VAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS--FSSLN-LNIAL 824
           +APE+             ++ D+++FG++  EV +       +      F  +   + + 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 825 DEMLDP------RLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++M         R   P+R      L S+ ++   C  +NP +R T  ++ + L 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  163 bits (415), Expect = 6e-45
 Identities = 68/322 (21%), Positives = 118/322 (36%), Gaps = 42/322 (13%)

Query: 566 KNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLAS 625
            N S     S        S+   E  I +E++       +    IGKG  G VY  +   
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWDIPFEQL-------EIGELIGKGRFGQVYHGRW-H 55

Query: 626 GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKM 685
           GE+ A++        E   +  F  EV A  +  H N+V   G C+   HL I+    K 
Sbjct: 56  GEV-AIRLIDIERDNEDQLK-AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113

Query: 686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE 745
            +L  ++ +  A   L   +   + + IV  + Y+H      I+H+D+ SKNV  D   +
Sbjct: 114 RTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGK 167

Query: 746 AHVSDFGIAK-----FLKPDSSNWTELAGTYGYVAPEL---------AYTMKVTEKCDVY 791
             ++DFG+                    G   ++APE+            +  ++  DV+
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227

Query: 792 SFGVLALEVIKGKHPRDFISSMSFSSLN-LNIALDEMLDPRLPTPSRNVHDKLISIVEVT 850
           + G +  E+   + P        F +     I        +       +  ++  I+   
Sbjct: 228 ALGTIWYELHAREWP--------FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL-- 277

Query: 851 ISCVDENPESRPTMQKVCQLLK 872
             C     E RPT  K+  +L+
Sbjct: 278 -FCWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  161 bits (410), Expect = 5e-44
 Identities = 78/334 (23%), Positives = 134/334 (40%), Gaps = 48/334 (14%)

Query: 568 DSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGE 627
           D   Q  S G+  GL  +L      I ++I            IGKG  G V+M K   GE
Sbjct: 13  DLIEQSQSSGSGSGL-PLLVQR--TIAKQI-------QMVKQIGKGRYGEVWMGKW-RGE 61

Query: 628 IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRHLFIVYEYF 683
            +AVK F +    E ++ +E   E+     + H NI+      +        L+++ +Y 
Sbjct: 62  KVAVKVFFTT--EEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117

Query: 684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF-----PPIVHRDISSKNV 738
           +  SL   L +      L     + +    V  L ++H + F     P I HRD+ SKN+
Sbjct: 118 ENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173

Query: 739 LLDFENEAHVSDFGIAKFLKPDSSNW----TELAGTYGYVAPEL------AYTMKVTEKC 788
           L+       ++D G+A     D++          GT  Y+ PE+          +     
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233

Query: 789 DVYSFGVLALEVIKGKHPRDFISS--MSFSSLN-LNIALDEMLDP------RLPTPSR-N 838
           D+YSFG++  EV +       +    + +  L   + + ++M +       R   P+R +
Sbjct: 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             + L  + ++   C   NP SR T  +V + L 
Sbjct: 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  158 bits (402), Expect = 2e-43
 Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 20/276 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
                   IG G  G+VY  K   G++ AVK  +   P     Q  F NEV  L +  H 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHV 80

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NI+   G+      L IV ++ +  SL   L            + +++ +     + Y+H
Sbjct: 81  NILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH 137

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK--PDSSNWTELAGTYGYVAPEL- 778
                 I+HRD+ S N+ L  +N   + DFG+A        S  + +L+G+  ++APE+ 
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 779 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
               +   + + DVY+FG++  E++ G+ P    S+++     + +     L P L    
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIEMVGRGSLSPDLSKVR 251

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            N   ++  ++     C+ +  + RP+  ++   ++
Sbjct: 252 SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  159 bits (405), Expect = 2e-43
 Identities = 68/334 (20%), Positives = 127/334 (38%), Gaps = 48/334 (14%)

Query: 568 DSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGE 627
           D     ++ G+  GL  +L      I   I+        +  IGKG  G V+  K   GE
Sbjct: 18  DLIYDMTTSGSGSGL-PLLVQR--TIARTIVL-------QESIGKGRFGEVWRGKW-RGE 66

Query: 628 IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR----HLFIVYEYF 683
            +AVK F S    E ++ +E   E+     + H NI+               L++V +Y 
Sbjct: 67  EVAVKIFSSRE--ERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122

Query: 684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF-----PPIVHRDISSKNV 738
           +  SL   L+       +     + +       L+++H +       P I HRD+ SKN+
Sbjct: 123 EHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 739 LLDFENEAHVSDFGIAKFLKPDSS----NWTELAGTYGYVAPEL------AYTMKVTEKC 788
           L+       ++D G+A      +           GT  Y+APE+          +  ++ 
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238

Query: 789 DVYSFGVLALEVIKGKHPRDFISSMS---FSSLNLNIALDEMLDP------RLPTPSR-N 838
           D+Y+ G++  E+ +               +  +  + +++EM         R   P+R  
Sbjct: 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 298

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             + L  + ++   C   N  +R T  ++ + L 
Sbjct: 299 SCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  158 bits (402), Expect = 2e-42
 Identities = 84/390 (21%), Positives = 146/390 (37%), Gaps = 24/390 (6%)

Query: 53  HTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE 112
                   I   +     F D+ +               L+N   +    +++     + 
Sbjct: 5   PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 64

Query: 113 LGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQL 172
           L + R +  L LN+  +     ++      +  LY+  N++         N+  L+ L L
Sbjct: 65  LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124

Query: 173 SENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIP 230
             N+ + S+P  +  N   L TL +  N+L   I  +      SL NL L  N+L+    
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH--- 179

Query: 231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERV 289
           + +  + +L + N+  N LS          + +  L   HN       P+   LT L   
Sbjct: 180 VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL--- 231

Query: 290 RLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVP 349
           +L  N LT   +     YP L  +DLS N     +   + +  +L  L  S N +   + 
Sbjct: 232 KLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 350 PEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHL 409
                   L VLDLS NH++  +     + +    L L HN +    + KL +   L++L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNL 344

Query: 410 DLSSNRLS-NSIPKSLGNLELIHLSELDLS 438
            LS N    NS+     N+    + + D  
Sbjct: 345 TLSHNDWDCNSLRALFRNVARPAVDDADQH 374

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  155 bits (394), Expect = 2e-41
 Identities = 79/388 (20%), Positives = 141/388 (36%), Gaps = 49/388 (12%)

Query: 107 NSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKS 166
             I S L       ++ ++              L N   +   ++++       + + + 
Sbjct: 11  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70

Query: 167 LSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL 225
           +  L L++      I   +      +  LY+  N++ Y  P    N+  L+ L L  N L
Sbjct: 71  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129

Query: 226 SGSIPISM-GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLT 284
           S S+P  +  N   LT L++  N+L       ++    L  L L  N+    +  L  + 
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD-LSLIP 186

Query: 285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISS-DWGRCPKLSTLDFSINN 343
           SL    +  N L+     +  I   +  +D S N+    I+        +L+ L    NN
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNS----INVVRGPVNVELTILKLQHNN 237

Query: 344 ITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSL 403
           +T      + +   L  +DLS N +  +I                              +
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELE-KIMYHP-----------------------FVKM 271

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSH 463
            +LE L +S+NRL  ++      +    L  LDLS N L   +         LE L L H
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIP--TLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH 327

Query: 464 NSLSGLIPSCFEKMNGLLHIDISYNELR 491
           NS+  L  S     + L ++ +S+N+  
Sbjct: 328 NSIVTLKLSTH---HTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  144 bits (364), Expect = 2e-37
 Identities = 70/318 (22%), Positives = 122/318 (38%), Gaps = 19/318 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
             N+++     + L + + +  L L + ++     ++      +  LY+  N++    P 
Sbjct: 52  FKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH 111

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
              N    + L L  N LS S+P  +  N   L TL +  N+L            SL NL
Sbjct: 112 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
           QL++N L+  +   L  + +L    +  N LS      +    ++  L  S N+ N  + 
Sbjct: 171 QLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR 221

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
             +     L  L L  N+L+      L N   L  + L YN+L   +      +  L  L
Sbjct: 222 GPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277

Query: 243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISE 302
            +  N L  A+    + +  L +L L HN              LE + LD N +    + 
Sbjct: 278 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV---TL 333

Query: 303 SFYIYPNLTYIDLSQNNF 320
               +  L  + LS N++
Sbjct: 334 KLSTHHTLKNLTLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  142 bits (359), Expect = 8e-37
 Identities = 62/345 (17%), Positives = 124/345 (35%), Gaps = 19/345 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           I   +       E   L +   +   N+ +       L +   +  L ++   +      
Sbjct: 28  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY 87

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
                     L +  N +   +PP    N+  L  L L+ N LS+       N   L+ L
Sbjct: 88  AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 146

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
            ++NN L      +    T+L  L + SN L+      +  + SL +  +S N  +    
Sbjct: 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS---- 199

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
            +L     +  L    NS++  +   +     L+ L L +N L+      + N   L  +
Sbjct: 200 -TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEV 253

Query: 243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISE 302
           +L  N L   + + +  + +L  L + +N+        + + +L+ + L  N+L  ++  
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVER 312

Query: 303 SFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGN 347
           +   +  L  + L  N+    +         L  L  S N+   N
Sbjct: 313 NQPQFDRLENLYLDHNSI-VTLKLS--THHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 19/127 (14%), Positives = 45/127 (35%), Gaps = 3/127 (2%)

Query: 372 IPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIH 431
           I   L     F  + +           +  +L   + +   ++ +       L +     
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR--Q 70

Query: 432 LSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
           +  L+L+   + E          +++KL +  N++  L P  F+ +  L  + +  N+L 
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 492 GSIPNST 498
            S+P   
Sbjct: 131 -SLPRGI 136

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  153 bits (389), Expect = 2e-41
 Identities = 57/331 (17%), Positives = 110/331 (33%), Gaps = 17/331 (5%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
           +I    +N       ++ ++ L  ++     +  N+  L +  N LS     ++  F   
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 72  SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG 131
             L LS+N L       L +LS L TL L+ N +      EL    S+  L   NN +S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 132 SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG-SIPPSLGNLSN 190
            +            +Y+ +N ++       G    +  L L  N  +  +      +   
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           L  L L  N +   +  ++     L  L L  NKL+  +     + + +T+++L  N L 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNL 310
             I    R    L    L  N F           +     + +  +   ++        +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTV 285

Query: 311 TYIDLSQNNFYGEISSDWG-RCPKLSTLDFS 340
             +         ++ + +  R   L      
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  148 bits (376), Expect = 9e-40
 Identities = 60/331 (18%), Positives = 107/331 (32%), Gaps = 17/331 (5%)

Query: 84  SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNL 143
           +I     N +      +  +SL  ++ S   +  ++  L L+ N LS      L   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 144 ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY 203
             L + SN L       + +L +L  L L+ N         L    ++ TL+   N++S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG-AIPYEYRNLVK 262
            +       +   N+ L  NK++    +  G  S + YL+L  N +          +   
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 263 LTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG 322
           L  L L +N     +        L+ + L  N L   +   F     +T+I L  N    
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227

Query: 323 EISSDWGRCPKLSTLDFSINNIT-GNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNF 381
            I         L   D   N    G +      + ++  +   +   +     E   +  
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287

Query: 382 FIKLVLAHNQLSGQLSPKLGSLVQLEHLDLS 412
                          +P    L+ L H    
Sbjct: 288 LGH--YGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  141 bits (358), Expect = 2e-37
 Identities = 53/302 (17%), Positives = 99/302 (32%), Gaps = 17/302 (5%)

Query: 161 IGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL 220
             N       ++++++   ++     +  N+  L L  N LS    ++L     L  L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 221 GYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPI 279
             N L  ++ +   +LS L  L+L  N +   +         +  L   +N         
Sbjct: 66  SSNVLYETLDL--ESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSCSR 118

Query: 280 LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG-EISSDWGRCPKLSTLD 338
            +   ++    L  N +T            + Y+DL  N       +        L  L+
Sbjct: 119 GQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 339 FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
              N I  +V  ++  +  L  LDLSSN +   +  E         + L +N+L   +  
Sbjct: 176 LQYNFIY-DVKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 399 KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEK 458
            L     LEH DL  N             +   +  +             + C + +L  
Sbjct: 232 ALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 459 LN 460
             
Sbjct: 291 YG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  141 bits (358), Expect = 3e-37
 Identities = 58/322 (18%), Positives = 117/322 (36%), Gaps = 28/322 (8%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           + ++SL  ++ S  ++  ++ +L+L  N LS      L   T L  L + +N L      
Sbjct: 17  VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
           ++ +      L+L+NN +       L    ++ TL+   N++S  +       +   N+ 
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIY 126

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSA-SILGKIGNLKSLSNLQLSENNFNGSIP 182
           L NN ++       G  + +  L +  N +   +      +  +L +L L  N     + 
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
             +   + L TL L +N L+  +  E  +   ++ +SL  NKL   I  ++    NL + 
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNIS 301
           +L  N               L      + + +      ++ LT           L    +
Sbjct: 243 DLRGNGFH---------CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293

Query: 302 ESFYIYPNLT---YIDLSQNNF 320
                 P       I L  ++ 
Sbjct: 294 YCCEDLPAPFADRLIALGHHHH 315

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  153 bits (388), Expect = 1e-39
 Identities = 91/488 (18%), Positives = 180/488 (36%), Gaps = 39/488 (7%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
           ++   N L   +P  L        L I  N +S     +I +      L +S+N++    
Sbjct: 5   VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 86  PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHS--LGNLTNL 143
                    L  L L  N L   I        +L +L L+ N    ++P     GN++ L
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQL 117

Query: 144 ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY 203
             L + +  L  S +  I +L     L +    +     P    L +  T  L     + 
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTN 175

Query: 204 SIPSELGNLRSLSNLSLGYNKLSG--------------SIPISMGNLSNLTYLNLFENSL 249
                + ++   +  +L  + +                +   +   LSNLT  N+     
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235

Query: 250 SGAIPYEYRNLVKLTILLLGHNQFRGPIP------ILRNLTSLERVRLDRNYLTGNISES 303
           S     +      +    + + + +G +          +L +L   ++  +      S  
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL 363
           + I+ N+   + + +           +      LDFS N +T  V    GH ++L  L L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355

Query: 364 SSNHI--VGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL-GSLVQLEHLDLSSNRLSNSI 420
             N +  + +I     ++    +L ++ N +S             L  L++SSN L+++I
Sbjct: 356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415

Query: 421 PKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGL 480
            + L       +  LDL  N + ++IP Q+  +++L++LN++ N L  +    F+++  L
Sbjct: 416 FRCL----PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL 470

Query: 481 LHIDISYN 488
             I +  N
Sbjct: 471 QKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  142 bits (359), Expect = 7e-36
 Identities = 87/448 (19%), Positives = 161/448 (35%), Gaps = 33/448 (7%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           L +S N +S      + +LS L  L +  N +     S     + L  L L++N L   I
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KI 84

Query: 134 PHSLGNLTNLATLYIYSNSL-SASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLA 192
                   NL  L +  N+  +  I  + GN+  L  L LS  +   S    + +L+   
Sbjct: 85  S--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP-----ISMGNLSNLTYLNLFEN 247
            L +   +       +   L+  +  SL     +         +S+  ++NL   N+   
Sbjct: 143 VLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

Query: 248 SLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRN----------LTSLERVRLDRNYLT 297
                  Y    L KL       N     I    N           T++    +    L 
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260

Query: 298 GNISESFYIYPN-----LTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI 352
           G +    + Y       L+   +  + F    S  +     ++  +F+++          
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 353 GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS--GQLSPKLGSLVQLEHLD 410
              S    LD S+N +   +    G L     L+L  NQL    +++     +  L+ LD
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380

Query: 411 LSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLI 470
           +S N +S    K   +     L  L++S N L + I    C+   ++ L+L  N +  + 
Sbjct: 381 ISQNSVSYDEKKGDCS-WTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIKSIP 437

Query: 471 PSCFEKMNGLLHIDISYNELRGSIPNST 498
                K+  L  ++++ N+L+ S+P+  
Sbjct: 438 KQVV-KLEALQELNVASNQLK-SVPDGI 463

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  104 bits (262), Expect = 1e-23
 Identities = 59/389 (15%), Positives = 117/389 (30%), Gaps = 55/389 (14%)

Query: 4   IYNNSLYDSIP--SELRNLKSLSDLELGNNKLSGSIPHSL-------------------- 41
           +  N+  D++P   E  N+  L  L L    L  S    +                    
Sbjct: 97  LSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155

Query: 42  --GNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG-----------SIPPS 88
               L +  T  +H    +      I +    +   L  + +             SI   
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215

Query: 89  LGNLSNLATLYLDTNSLSNSIPSELGNLR--------SLSNLQLNNNILSGSIPHSLGNL 140
           L     L+ L L+    + +    +  L         S+SN++L   +      +S  +L
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275

Query: 141 TNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNS 200
             L+   + S+              +++    + +            +S    L    N 
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335

Query: 201 LSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMG---NLSNLTYLNLFENSLSGAIPYEY 257
           L+ ++    G+L  L  L L  N+L   +         + +L  L++ +NS+S       
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394

Query: 258 -RNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYID 314
                 L  L +  N     I   +   +  L+   L  N +  +I +       L  ++
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLD---LHSNKIK-SIPKQVVKLEALQELN 450

Query: 315 LSQNNFYGEISSDWGRCPKLSTLDFSINN 343
           ++ N         + R   L  +    N 
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTNP 479

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 90.3 bits (224), Expect = 5e-19
 Identities = 40/179 (22%), Positives = 70/179 (39%), Gaps = 8/179 (4%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
              +            +     L+  NN L+ ++  + G+LT L TL +  N L   +  
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSK 365

Query: 64  EIGNFRFFSDLE---LSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
                     L+   +S N +S            +L +L + +N L+++I   L     +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRI 423

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
             L L++N +  SIP  +  L  L  L + SN L +   G    L SL  + L  N ++
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.2 bits (164), Expect = 1e-11
 Identities = 38/196 (19%), Positives = 71/196 (36%), Gaps = 7/196 (3%)

Query: 308 PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSSN 366
              T +++SQN      +SD     KL  L  S N I   +   +   + +L  LDLS N
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79

Query: 367 HIVGEIPIELGKLNFFIKLVLAHNQL-SGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
            +V         L     L L+ N   +  +  + G++ QL+ L LS+  L  S    + 
Sbjct: 80  KLVKISCHPTVNLKH---LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136

Query: 426 NLELIHLSELDLSRNFLREAIPS-QICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHID 484
           +L +  +  +       +E     Q    +SL  +  ++     ++    + +  L   +
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196

Query: 485 ISYNELRGSIPNSTTF 500
           I             + 
Sbjct: 197 IKCVLEDNKCSYFLSI 212

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  152 bits (386), Expect = 1e-39
 Identities = 79/329 (24%), Positives = 123/329 (37%), Gaps = 31/329 (9%)

Query: 166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL 225
               L L +N           +  +L  L L+ N +S   P    NL +L  L L  N+L
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 226 SGSIPISM-GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNL 283
              IP+ +   LSNLT L++ EN +   + Y +++L  L  L +G N            L
Sbjct: 93  K-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGL 151

Query: 284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSIN 342
            SLE++ L++  LT   +E+      L  + L   N    I    + R  +L  L+ S  
Sbjct: 152 NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHW 210

Query: 343 NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGS 402
                + P   +   L  L ++  ++   +P                          +  
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA-----------------------VRH 246

Query: 403 LVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLS 462
           LV L  L+LS N +S      L  L    L E+ L    L    P     +  L  LN+S
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELL--RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304

Query: 463 HNSLSGLIPSCFEKMNGLLHIDISYNELR 491
            N L+ L  S F  +  L  + +  N L 
Sbjct: 305 GNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  151 bits (383), Expect = 3e-39
 Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 13/300 (4%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +  N +      E  +   L +LEL  N +S   P +  NL NL TL + +N L   IP 
Sbjct: 39  LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPL 97

Query: 64  EIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLRS 118
            +  F   S+L    +S NK+   +      +L NL +L +  N L   I       L S
Sbjct: 98  GV--FTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS 153

Query: 119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           L  L L    L+     +L +L  L  L +   +++A        L  L  L++S   + 
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLS 237
            ++ P+     NL +L +   +L+ ++P   + +L  L  L+L YN +S      +  L 
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272

Query: 238 NLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYL 296
            L  + L    L+   PY +R L  L +L +  NQ       +  ++ +LE + LD N L
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  142 bits (360), Expect = 3e-36
 Identities = 78/325 (24%), Positives = 132/325 (40%), Gaps = 14/325 (4%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
           +     +   ++P  +   T    L +  N +      E  +F    +LEL+ N +S ++
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71

Query: 86  PP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNNILSGSIPHSLGNLTNL 143
            P +  NL NL TL L +N L   IP      L +L+ L ++ N +   + +   +L NL
Sbjct: 72  EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130

Query: 144 ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLS 202
            +L +  N L          L SL  L L + N   SIP  +L +L  L  L L   +++
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189

Query: 203 YSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYE-YRNLV 261
                    L  L  L + +     ++  +     NLT L++   +L+ A+PY   R+LV
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248

Query: 262 KLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF 320
            L  L L +N        +L  L  L+ ++L    L      +F     L  +++S N  
Sbjct: 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308

Query: 321 YGEISSD-WGRCPKLSTLDFSINNI 344
              +    +     L TL    N +
Sbjct: 309 -TTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 39/197 (19%), Positives = 77/197 (39%), Gaps = 14/197 (7%)

Query: 308 PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSSN 366
                +DL +N        ++   P L  L+ + N ++  V P    +   L  L L SN
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90

Query: 367 HIVGEIPIE----LGKLNFFIKLVLAHNQLSGQLSPKL-GSLVQLEHLDLSSNRLSNSIP 421
            +   IP+     L  L     L ++ N++   L   +   L  L+ L++  N L     
Sbjct: 91  RLK-LIPLGVFTGLSNLTK---LDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISH 145

Query: 422 KSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLL 481
           ++   L    L +L L +  L       +  +  L  L L H +++ +    F+++  L 
Sbjct: 146 RAFSGLN--SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203

Query: 482 HIDISYNELRGSIPNST 498
            ++IS+     ++  + 
Sbjct: 204 VLEISHWPYLDTMTPNC 220

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 90.2 bits (224), Expect = 5e-19
 Identities = 41/177 (23%), Positives = 71/177 (40%), Gaps = 4/177 (2%)

Query: 4   IYNNSLYDSIPSE-LRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
           +   +L  SIP+E L +L  L  L L +  ++    +S   L  L  L I       ++ 
Sbjct: 159 LEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN 121
                    + L +++  L+ ++P  ++ +L  L  L L  N +S    S L  L  L  
Sbjct: 218 PNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQE 276

Query: 122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           +QL    L+   P++   L  L  L +  N L+        ++ +L  L L  N   
Sbjct: 277 IQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  153 bits (388), Expect = 3e-39
 Identities = 96/467 (20%), Positives = 170/467 (36%), Gaps = 28/467 (5%)

Query: 60  SIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
            I   +     F D+ +               L+N   +    +++     + L + R +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
             L LN+  +     ++      +  LY+  N++         N+  L+ L L  N+ + 
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 180 SIPPSL-GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSN 238
           S+P  +  N   L TL +  N+L            SL NL L  N+L+    + +  + +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS 193

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLT 297
           L + N+  N LS          + +  L   HN       P+   LT L   +L  N LT
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT 245

Query: 298 GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQ 357
              +     YP L  +DLS N     +   + +  +L  L  S N +   +         
Sbjct: 246 D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302

Query: 358 LGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLS 417
           L VLDLS NH++  +     + +    L L HN +    + KL +   L++L LS N   
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 358

Query: 418 -NSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM--QSLEKLNLSHNSLSGLIPSCF 474
            NS+     N+    + + D       +      C    +      L + +L+ ++    
Sbjct: 359 CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVV---- 414

Query: 475 EKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGL 521
           EK+        + + +      S          LQGN+ L  +V  L
Sbjct: 415 EKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  153 bits (387), Expect = 5e-39
 Identities = 97/524 (18%), Positives = 172/524 (32%), Gaps = 58/524 (11%)

Query: 10  YDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFR 69
           Y  I S L+      D+ +               L N   +                   
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVT------------------ 57

Query: 70  FFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNI 128
                   N+ +   +P + L +   +  L L+   +            ++  L +  N 
Sbjct: 58  ------FKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110

Query: 129 LSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS-LGN 187
           +    PH   N+  L  L +  N LS+   G   N   L+ L +S NN    I       
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169

Query: 188 LSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFEN 247
            ++L  L L +N L+  +   L  + SL + ++ YN LS     ++     +  L+   N
Sbjct: 170 TTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221

Query: 248 SLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIY 307
           S++  +       V+LTIL L HN        L N   L  V L  N L   +   F   
Sbjct: 222 SIN-VVRGP--VNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 277

Query: 308 PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH 367
             L  + +S N     ++      P L  LD S N++  +V        +L  L L  N 
Sbjct: 278 QRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335

Query: 368 IVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL 427
           IV    ++L   +    L L+HN      +        +    +        I   L + 
Sbjct: 336 IV---TLKLSTHHTLKNLTLSHNDWDC--NSLRALFRNVARPAVDDADQHCKIDYQLEHG 390

Query: 428 --------ELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNG 479
                     +      ++   + E +        + + +N   +    +       + G
Sbjct: 391 LCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450

Query: 480 LLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLS 523
              ++   NELR  +   T   +  I+  Q  +GL+ ++   L 
Sbjct: 451 NEQLEAEVNELRAEVQQLT---NEQIQQEQLLQGLHAEIDTNLR 491

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  147 bits (372), Expect = 4e-37
 Identities = 69/404 (17%), Positives = 130/404 (32%), Gaps = 25/404 (6%)

Query: 75  ELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP 134
                     I  +L        +++D  +       E   L +   +   N+ +     
Sbjct: 9   VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 68

Query: 135 HSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS-LGNLSNLAT 193
             L +   +  L +    +            ++  L +  N     +PP    N+  L  
Sbjct: 69  ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 127

Query: 194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAI 253
           L L+ N LS        N   L+ LS+  N L      +    ++L  L L  N L+  +
Sbjct: 128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV 186

Query: 254 PYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYI 313
                 +  L    + +N     +  L    ++E +    N +             LT +
Sbjct: 187 D--LSLIPSLFHANVSYNL----LSTLAIPIAVEELDASHNSINVVRGPVN---VELTIL 237

Query: 314 DLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEI 372
            L  NN     ++     P L  +D S N +   +         +L  L +S+N +V  +
Sbjct: 238 KLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-AL 293

Query: 373 PIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHL 432
            +    +     L L+HN L   +        +LE+L L  N +      +   L+ + L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTL 352

Query: 433 SELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEK 476
           S  D   N LR        + +++ +  +        I    E 
Sbjct: 353 SHNDWDCNSLRA-------LFRNVARPAVDDADQHCKIDYQLEH 389

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  144 bits (364), Expect = 4e-36
 Identities = 80/479 (16%), Positives = 160/479 (33%), Gaps = 41/479 (8%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           I   +       E   L +   +   N+ +       L +   +  L ++   +      
Sbjct: 34  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY 93

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
                     L +  N +   +PP +  N+  L  L L+ N LS+       N   L+ L
Sbjct: 94  AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNS----------------LSASILGKIGNLKS 166
            ++NN L      +    T+L  L + SN                 +S ++L  +    +
Sbjct: 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIA 212

Query: 167 LSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS 226
           +  L  S N+ N  +   +     L  L L  N+L+      L N   L  + L YN+L 
Sbjct: 213 VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE 267

Query: 227 GSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSL 286
             +      +  L  L +  N L  A+    + +  L +L L HN              L
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRL 326

Query: 287 ERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG 346
           E + LD N +    +     +  L  + LS N+       +  R    +    ++++   
Sbjct: 327 ENLYLDHNSIV---TLKLSTHHTLKNLTLSHND----WDCNSLRALFRNVARPAVDDADQ 379

Query: 347 NVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQL 406
           +   +      L   +    +        L +L  +I L     ++  +   +  +   +
Sbjct: 380 HCKIDYQLEHGLCCKESDKPY--------LDRLLQYIALTSVVEKVQ-RAQGRCSATDTI 430

Query: 407 EHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNS 465
             +   S+ ++      L   E +     +L    +++    QI   Q L+ L+   ++
Sbjct: 431 NSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAE-VQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  143 bits (361), Expect = 9e-36
 Identities = 78/376 (20%), Positives = 139/376 (36%), Gaps = 28/376 (7%)

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILG-----KIGNLKSLSNLQLSENNF 177
           Q   N+      +   +         Y   +           +   L +   +    +  
Sbjct: 4   QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63

Query: 178 NGSIPPS-LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNL 236
              +P + L +   +  L L+   +            ++  L +G+N +    P    N+
Sbjct: 64  R-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122

Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNY 295
             LT L L  N LS      + N  KLT L + +N          +  TSL+ ++L  N 
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182

Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
           LT          P+L + ++S N       S       +  LD S N+I   V   +  +
Sbjct: 183 LTHVDLSLI---PSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--N 231

Query: 356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNR 415
            +L +L L  N++  +    L      +++ L++N+L   +      + +LE L +S+NR
Sbjct: 232 VELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289

Query: 416 LSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFE 475
           L  ++      +    L  LDLS N L   +         LE L L HNS+  L  S   
Sbjct: 290 LV-ALNLYGQPIP--TLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHH 345

Query: 476 KMNGLLHIDISYNELR 491
               L ++ +S+N+  
Sbjct: 346 ---TLKNLTLSHNDWD 358

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  144 bits (365), Expect = 5e-38
 Identities = 71/310 (22%), Positives = 127/310 (40%), Gaps = 25/310 (8%)

Query: 22  SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKL 81
            L  ++  +  L   +P  L    + A L +  N ++    G+  N +    L L NNK+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 82  SGSIPP-SLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNL 140
           S  I P +   L  L  LYL  N L   +P ++   ++L  L+++ N ++         L
Sbjct: 89  S-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGL 144

Query: 141 TNLATLYIYSNSLSASIL--GKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT 198
             +  + + +N L +S +  G    +K LS +++++ N   +IP  L    +L  L+LD 
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201

Query: 199 NSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY 257
           N ++  + +  L  L +L+ L L +N +S     S+ N  +L  L+L  N L   +P   
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259

Query: 258 RNLVKLTILLLGHNQFR-------GPIPILRNLTSLERVRLDRNYLT-GNISES-FYIYP 308
            +   + ++ L +N           P        S   V L  N +    I  S F    
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319

Query: 309 NLTYIDLSQN 318
               + L   
Sbjct: 320 VRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  134 bits (339), Expect = 1e-34
 Identities = 64/278 (23%), Positives = 127/278 (45%), Gaps = 21/278 (7%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           NN + +    + +NLK+L  L L NNK+S   P +   L  L  LY+  N L   +P ++
Sbjct: 61  NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM 119

Query: 66  GNFRFFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNS-IPSE-LGNLRSLSNL 122
              +   +L +  N+++  +       L+ +  + L TN L +S I +     ++ LS +
Sbjct: 120 --PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 176

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
           ++ +  ++ +IP  L    +L  L++  N ++      +  L +L+ L LS N+ + ++ 
Sbjct: 177 RIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVD 232

Query: 183 P-SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG------SIPISMGN 235
             SL N  +L  L+L+ N L   +P  L + + +  + L  N +S         P     
Sbjct: 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 291

Query: 236 LSNLTYLNLFENSLSGAI--PYEYRNLVKLTILLLGHN 271
            ++ + ++LF N +      P  +R +     + LG+ 
Sbjct: 292 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  132 bits (334), Expect = 5e-34
 Identities = 64/307 (20%), Positives = 110/307 (35%), Gaps = 27/307 (8%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           ++ S+  L   +P  L    + A L L  N ++     +  NL++L  L L NN +S   
Sbjct: 36  VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLA 192
           P +   L  L  LY+  N L           K+L  L++ EN     +       L+ + 
Sbjct: 93  PGAFAPLVKLERLYLSKNQLKEL---PEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMI 148

Query: 193 TLYLDTNSL-SYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
            + L TN L S  I +     ++ LS + +    ++    I  G   +LT L+L  N ++
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKIT 205

Query: 251 GAIPYEY-RNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYP 308
             +     + L  L  L L  N         L N   L  + L+ N L   +      + 
Sbjct: 206 -KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263

Query: 309 NLTYIDLSQNNFYGEISSDW-------GRCPKLSTLDFSINNIT-GNVPPEIGHS-SQLG 359
            +  + L  NN    I S+         +    S +    N +    + P          
Sbjct: 264 YIQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 322

Query: 360 VLDLSSN 366
            + L + 
Sbjct: 323 AVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (277), Expect = 2e-26
 Identities = 75/324 (23%), Positives = 118/324 (36%), Gaps = 45/324 (13%)

Query: 190 NLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
           +L  +      L   +P +L      + L L  NK++        NL NL  L L  N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 250 SGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYP 308
           S   P  +  LVKL  L L  NQ +  P  + + L  L   R+  N +T      F    
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKSVFNGLN 145

Query: 309 NLTYIDLSQNNFY-GEISSDW-GRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSN 366
            +  ++L  N      I +       KLS +  +  NIT  +P   G    L  L L  N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202

Query: 367 HIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGN 426
            I  ++                           L  L  L  L LS N +S     SL N
Sbjct: 203 KI-TKVDAAS-----------------------LKGLNNLAKLGLSFNSISAVDNGSLAN 238

Query: 427 LELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCF------EKMNGL 480
               HL EL L+ N L + +P  +   + ++ + L +N++S +  + F       K    
Sbjct: 239 TP--HLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295

Query: 481 LHIDISYNELRGSIPNSTTFKDAP 504
             + +  N ++      +TF+   
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVY 319

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (272), Expect = 8e-26
 Identities = 51/234 (21%), Positives = 102/234 (43%), Gaps = 23/234 (9%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +  N L   +P ++   K+L +L +  N+++         L  +  + + TN L  S   
Sbjct: 107 LSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-SSGI 162

Query: 64  EIGNFRFFSDLE---LSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSL 119
           E G F+    L    +++  ++ +IP  L    +L  L+LD N ++  + +  L  L +L
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNL 218

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
           + L L+ N +S     SL N  +L  L++ +N L   + G + + K +  + L  NN + 
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 276

Query: 180 SIPPS-------LGNLSNLATLYLDTNSLSY-SIPSEL-GNLRSLSNLSLGYNK 224
           +I  +           ++ + + L +N + Y  I       +   + + LG  K
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  150 bits (379), Expect = 5e-38
 Identities = 76/363 (20%), Positives = 134/363 (36%), Gaps = 48/363 (13%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +  + L  ++P  L     ++ L + +N L+ S+P     L     L +  N L+ S+P 
Sbjct: 47  VGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPALPPELRT---LEVSGNQLT-SLPV 98

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
                   S        L           S L  L++  N L+ S+P     L+ LS   
Sbjct: 99  LPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPGLQELS--- 147

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           +++N L+ S+P     L     L+ Y+N L+ S+      L+ LS   +S+N    S+P 
Sbjct: 148 VSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPT 198

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
               L     L+   N L+ S+P+    L+    L +  N+L+ S+P+       L  L 
Sbjct: 199 LPSELYK---LWAYNNRLT-SLPALPSGLKE---LIVSGNRLT-SLPVLPS---ELKELM 247

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
           +  N L+ ++P        L  L +  NQ       L +L+S   V L+ N L+     +
Sbjct: 248 VSGNRLT-SLPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS---ERT 300

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL 363
                 +T              +      +   L  +  +    VP   G  +      +
Sbjct: 301 LQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL--VPAREGEPAPADRWHM 358

Query: 364 SSN 366
              
Sbjct: 359 FGQ 361

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  149 bits (377), Expect = 1e-37
 Identities = 81/399 (20%), Positives = 138/399 (34%), Gaps = 92/399 (23%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           L +  + L+ ++P  L    ++ TL +  N+L  S+P+    LR+L    ++ N L+ S+
Sbjct: 45  LNVGESGLT-TLPDCLPA--HITTLVIPDNNL-TSLPALPPELRTLE---VSGNQLT-SL 96

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLAT 193
           P     L  L+        L A           L  L +  N    S+P     L  L  
Sbjct: 97  PVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPGLQEL-- 146

Query: 194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAI 253
             +  N L+ S+P+    L     L    N+L+ S+P+     S L  L++ +N L+ ++
Sbjct: 147 -SVSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPML---PSGLQELSVSDNQLA-SL 196

Query: 254 PYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYI 313
           P     L KL      +N+          LTSL                     P L   
Sbjct: 197 PTLPSELYKLWAY---NNR----------LTSL---------------------PAL--- 219

Query: 314 DLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIP 373
                               L  L  S N +T ++P       +L  L +S N +   +P
Sbjct: 220 -----------------PSGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLP 257

Query: 374 IELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLS 433
           +    L   + L +  NQL+ +L   L  L     ++L  N LS    ++L  +      
Sbjct: 258 MLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGY 313

Query: 434 ELDL-SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIP 471
              +   +    + P +   +       L         P
Sbjct: 314 SGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  145 bits (367), Expect = 2e-36
 Identities = 64/327 (19%), Positives = 117/327 (35%), Gaps = 48/327 (14%)

Query: 164 LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYN 223
               + L + E+    ++P  L    ++ TL +  N+L+ S+P+    LR    L +  N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELR---TLEVSGN 91

Query: 224 KLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL 283
           +L+ S+P+    L  L+  +     L             L  L +  NQ      +   L
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLTSLPVLPPGL 143

Query: 284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINN 343
             L    +  N L  ++         L  +    N     +         L  L  S N 
Sbjct: 144 QELS---VSDNQLA-SLPALP---SELCKLWAYNNQL-TSLPMLPS---GLQELSVSDNQ 192

Query: 344 ITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSL 403
           +  ++P       +L  L   +N +   +P     L    +L+++ N+L+  L       
Sbjct: 193 LA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPS-- 241

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSH 463
            +L+ L +S NRL+ S+P     L       L + RN L   +P  +  + S   +NL  
Sbjct: 242 -ELKELMVSGNRLT-SLPMLPSGLL-----SLSVYRNQLTR-LPESLIHLSSETTVNLEG 293

Query: 464 NSLSGLIPSCFEKMNGLLHIDISYNEL 490
           N LS       + +  +         +
Sbjct: 294 NPLSERT---LQALREITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 90.3 bits (224), Expect = 9e-19
 Identities = 39/180 (21%), Positives = 69/180 (38%), Gaps = 30/180 (16%)

Query: 330 RCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAH 389
                + L+   + +T  +P  +   + +  L +  N++   +P    +L     L ++ 
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSG 90

Query: 390 NQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIH------------LSELDL 437
           NQL+  L      L++L         L  ++P  L  L +              L EL +
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSV 148

Query: 438 SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
           S N L   +P+       L KL   +N L+ L P       GL  + +S N+L  S+P  
Sbjct: 149 SDNQLAS-LPALPS---ELCKLWAYNNQLTSL-PMLPS---GLQELSVSDNQLA-SLPTL 199

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 82.6 bits (204), Expect = 2e-16
 Identities = 39/173 (22%), Positives = 64/173 (36%), Gaps = 15/173 (8%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
            YNN L  S+P+    LK L    +  N+L+ S+P     L  L    +  N L+ S+P 
Sbjct: 208 AYNNRL-TSLPALPSGLKELI---VSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPM 258

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
                     L +  N+L+  +P SL +LS+  T+ L+ N LS     +     + +   
Sbjct: 259 LPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGY 313

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENN 176
               I       S    T    L   ++ L  +  G+             +N 
Sbjct: 314 SGPIIRFDMAGASAPRETRALHLAA-ADWLVPAREGEPAPADRWHMFGQEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 15/85 (17%), Positives = 37/85 (43%), Gaps = 8/85 (9%)

Query: 413 SNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS 472
            +R   ++ + +        + L++  + L   +P  +     +  L +  N+L+ L P+
Sbjct: 23  ESRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSL-PA 78

Query: 473 CFEKMNGLLHIDISYNELRGSIPNS 497
              +   L  +++S N+L  S+P  
Sbjct: 79  LPPE---LRTLEVSGNQLT-SLPVL 99

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  140 bits (354), Expect = 1e-35
 Identities = 94/406 (23%), Positives = 153/406 (37%), Gaps = 46/406 (11%)

Query: 74  LELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSG 131
           ++LS N ++  +   S   L +L  L ++  +    I +     L SL  L+L+ N    
Sbjct: 35  VDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93

Query: 132 SIPHSLGNLTNLATLYIYSNSLSASIL--GKIGNLKSLSNLQLSENNFNGSIPPS--LGN 187
               +   L NL  L +   +L  ++L       L SL  L L +NN    I P+    N
Sbjct: 94  LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLN 152

Query: 188 LSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFEN 247
           +     L L  N +      +L N +      L               LS++T  ++ E 
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------RLSSITLQDMNEY 198

Query: 248 SLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYI 306
            L             +T L L  N F+        +  +  +++      + N+  SF  
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF-- 256

Query: 307 YPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSS 365
             +  + D     F G  +S       + T D S + I   +   +  H + L  L L+ 
Sbjct: 257 -GHTNFKDPDNFTFKGLEASG------VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308

Query: 366 NHIVGEIPIE----LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIP 421
           N I  +I       L  L    KL L+ N L    S    +L +LE LDLS N +  ++ 
Sbjct: 309 NEIN-KIDDNAFWGLTHLL---KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALG 363

Query: 422 KSLGNLELIHLSELDLSRNFLREAIPSQI-CIMQSLEKLNLSHNSL 466
                  L +L EL L  N L+ ++P  I   + SL+K+ L  N  
Sbjct: 364 DQSFL-GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  129 bits (327), Expect = 4e-32
 Identities = 73/390 (18%), Positives = 131/390 (33%), Gaps = 43/390 (11%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
            +P    ++  +   +L  N ++     S   L +L  L +   +    I      FR  
Sbjct: 24  QVPELPAHVNYV---DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGL 78

Query: 72  S---DLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSL-SNSIPSEL-GNLRSLSNLQLN 125
           S    L+L  N+    +       L+NL  L L   +L    +       L SL  L L 
Sbjct: 79  SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137

Query: 126 NNILSGSIPHSL-GNLTNLATLYIYSN---SLSASILGKIG-------NLKSLSNLQLSE 174
           +N +    P S   N+     L +  N   S+    L            L S++   ++E
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197

Query: 175 NNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNL-------------SLG 221
                    +    +++ TL L  N    S+     +  + + +             S G
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257

Query: 222 YNKLSGSIPISMGNL--SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIP 278
           +         +   L  S +   +L ++ +   +   + +   L  L L  N+       
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN 317

Query: 279 ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTL 337
               LT L ++ L +N+L    S  F     L  +DLS N+    +    +   P L  L
Sbjct: 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKEL 376

Query: 338 DFSINNITGNVPPEIGHS-SQLGVLDLSSN 366
               N +  +VP  I    + L  + L +N
Sbjct: 377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  127 bits (320), Expect = 3e-31
 Identities = 78/367 (21%), Positives = 142/367 (38%), Gaps = 41/367 (11%)

Query: 166 SLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYN 223
            ++ + LS N+    +   S   L +L  L ++  +    I +     L SL  L L YN
Sbjct: 31  HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 224 KLSGSIPISM-GNLSNLTYLNLFENSL-SGAIPYEY-RNLVKLTILLLGHNQFR--GPIP 278
           +    +       L+NL  L L + +L    +   + + L  L +L+L  N  +   P  
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 279 ILRNLTSLERVRLDRNYLTGNISESFY--IYPNLTYIDLSQNNFY--GEISSDWGRC--- 331
              N+     + L  N +     E        + T + LS        E    W +C   
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 332 ---PKLSTLDFSINNITGNVPPEI---GHSSQLGVLDLSSNHIVGE-----IPIELGKLN 380
                ++TLD S N    ++          +++  L LS+++ +G         +     
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268

Query: 381 FF-------IKLVLAHNQLSGQLSPKL-GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHL 432
           F            L+ +++   L   +      LE L L+ N ++     +   L   HL
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT--HL 325

Query: 433 SELDLSRNFLREAIPSQICI-MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
            +L+LS+NFL   I S++   +  LE L+LS+N +  L    F  +  L  + +  N+L+
Sbjct: 326 LKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384

Query: 492 GSIPNST 498
            S+P+  
Sbjct: 385 -SVPDGI 390

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  105 bits (263), Expect = 5e-24
 Identities = 62/302 (20%), Positives = 108/302 (35%), Gaps = 36/302 (11%)

Query: 5   YNNSLYDS-IPSEL-RNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSI 61
              +L  + +     + L SL  L L +N +    P S   N+     L +  N +    
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170

Query: 62  PGEIGNF--RFFSDLELSNNKL--------SGSIPPSLGNLSNLATLYLDTNSLSNSIPS 111
             ++ NF  + F+ L LS+  L              +    +++ TL L  N    S+  
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230

Query: 112 ELGNLRSLSNLQ-------------LNNNILSGSIPHSLGNL--TNLATLYIYSNSLSAS 156
              +  + + +Q               +         +   L  + + T  +  + + A 
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFAL 290

Query: 157 ILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSEL-GNLRS 214
           +     +   L  L L++N  N  I   +   L++L  L L  N L  SI S +  NL  
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDK 348

Query: 215 LSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQ 272
           L  L L YN +  ++       L NL  L L  N L  ++P   +  L  L  + L  N 
Sbjct: 349 LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406

Query: 273 FR 274
           + 
Sbjct: 407 WD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 84.0 bits (208), Expect = 4e-17
 Identities = 48/243 (19%), Positives = 84/243 (34%), Gaps = 23/243 (9%)

Query: 1   LPCIYNNSLYDSIPSELR--NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLS 58
           +  I    L +          L S++  ++    L      +    T++ TL +  N   
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225

Query: 59  GSIPGEIGNFRFFSDLE-------------LSNNKLSGSIPPSLGNL--SNLATLYLDTN 103
            S+     +    + ++               +         +   L  S + T  L  +
Sbjct: 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285

Query: 104 SLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG 162
            +  ++   +  +   L  L L  N ++    ++   LT+L  L +  N L +       
Sbjct: 286 KIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE 344

Query: 163 NLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSL 220
           NL  L  L LS N+   ++   S   L NL  L LDTN L  S+P      L SL  + L
Sbjct: 345 NLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402

Query: 221 GYN 223
             N
Sbjct: 403 HTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 78.2 bits (193), Expect = 3e-15
 Identities = 46/245 (18%), Positives = 85/245 (34%), Gaps = 21/245 (8%)

Query: 284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSIN 342
             +  V L  N +      SF    +L ++ + Q      I ++ +     L  L    N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 343 NITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIELG---KLNFFIKLVLAHNQLSGQLSP 398
                +        + L VL L+  ++     +       L     LVL  N +  ++ P
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNL-DGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQP 146

Query: 399 K--LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICI---- 452
                ++ +   LDL+ N++ +   + L N +  H + L LS   L++     +      
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206

Query: 453 ----MQSLEKLNLSHNSLSGLIPSCF---EKMNGLLHIDISYNELRGSIPNSTTFKDAPI 505
                 S+  L+LS N     +   F        +  + +S +   GS    T FKD   
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266

Query: 506 EALQG 510
              +G
Sbjct: 267 FTFKG 271

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 41/196 (20%), Positives = 78/196 (39%), Gaps = 27/196 (13%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLE-------------LGNNKLSGSIPHSLGNL--TNLA 48
           +  N   +S+     +  + + ++              G+         +   L  + + 
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278

Query: 49  TLYIHTNSLSGSIPGEIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYLDTNS 104
           T  +  + +  ++   +  F  F+DLE   L+ N+++  I   +   L++L  L L  N 
Sbjct: 279 TCDLSKSKIF-ALLKSV--FSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334

Query: 105 LSNSIPSEL-GNLRSLSNLQLNNNILSGSIPH-SLGNLTNLATLYIYSNSLSASILGKIG 162
           L  SI S +  NL  L  L L+ N +  ++   S   L NL  L + +N L +   G   
Sbjct: 335 LG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392

Query: 163 NLKSLSNLQLSENNFN 178
            L SL  + L  N ++
Sbjct: 393 RLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 68.2 bits (167), Expect = 5e-12
 Identities = 34/190 (17%), Positives = 57/190 (30%), Gaps = 12/190 (6%)

Query: 332 PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE----LGKLNFFIKLVL 387
             ++ +D S+N+I             L  L +        I       L  L     L L
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI---ILKL 86

Query: 388 AHNQLSGQLSPK-LGSLVQLEHLDLSSNRL-SNSIPKSLGNLELIHLSELDLSRNFLREA 445
            +NQ   QL       L  LE L L+   L    +  +     L  L  L L  N +++ 
Sbjct: 87  DYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK-PLTSLEMLVLRDNNIKKI 144

Query: 446 IPSQI-CIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAP 504
            P+     M+    L+L+ N +  +         G     +  + +     N        
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204

Query: 505 IEALQGNKGL 514
                 N  +
Sbjct: 205 CGNPFKNTSI 214

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  139 bits (351), Expect = 4e-35
 Identities = 77/440 (17%), Positives = 153/440 (34%), Gaps = 52/440 (11%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
             S  D  P +  N  S                 S   L  L +L  H +S++  + G I
Sbjct: 8   TQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-I 60

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN 125
                 + L  ++N ++ ++   L   +NL  L  D+N L+ ++   +  L  L+ L  +
Sbjct: 61  EKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114

Query: 126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL 185
            N L+      +     L  L    N+L+      + +   L+ L    N         +
Sbjct: 115 TNKLT---KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKK--ITKLDV 166

Query: 186 GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLF 245
              + L TL    N ++     ++   + L+ L+   N ++    + +     LT+L+  
Sbjct: 167 TPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCS 220

Query: 246 ENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTG-NISESF 304
            N L+     +   L +LT      N     + +   L+ L  +   +  L   +++ + 
Sbjct: 221 SNKLTE---IDVTPLTQLTYFDCSVNPLT-ELDV-STLSKLTTLHCIQTDLLEIDLTHN- 274

Query: 305 YIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS 364
                L Y          E+  D     +L  LD     IT     ++  + +L  L L+
Sbjct: 275 ---TQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLN 326

Query: 365 SNHIVGEIPIE-LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKS 423
           +  +  E+ +    KL     L   +  +       +G +  L +   +  +      ++
Sbjct: 327 NTELT-ELDVSHNTKLK---SLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTITMPKET 380

Query: 424 LGNLEL---IHLSELDLSRN 440
           L N  L   +    LD   N
Sbjct: 381 LTNNSLTIAVSPDLLDQFGN 400

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  135 bits (343), Expect = 4e-34
 Identities = 75/420 (17%), Positives = 141/420 (33%), Gaps = 44/420 (10%)

Query: 71  FSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILS 130
           F+    +  ++  +   S   L+ L +L    +S+++   + +  L  L+ L   +N ++
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77

Query: 131 GSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSN 190
            ++   L   TNL  L   SN L+      +  L  L+ L    N     +  S      
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLT-KLDVS--QNPL 128

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           L  L    N+L+  I   + +   L+ L    NK    + ++    + LT L+   N ++
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKIT 183

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNL 310
                +      L  L    N     +  L     L  +    N LT            L
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNITK-LD-LNQNIQLTFLDCSSNKLT---EIDVTPLTQL 235

Query: 311 TYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVG 370
           TY D S N        D     KL+TL     ++      ++ H++QL          + 
Sbjct: 236 TYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIK 289

Query: 371 EIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELI 430
           E+ +          L      ++      L    +L +L L++  L+  +  S       
Sbjct: 290 ELDV--THNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELDVS----HNT 339

Query: 431 HLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
            L  L      +++   S +  + +L     +      +        N  L I +S + L
Sbjct: 340 KLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLT--NNSLTIAVSPDLL 395

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  127 bits (322), Expect = 2e-31
 Identities = 73/407 (17%), Positives = 144/407 (35%), Gaps = 42/407 (10%)

Query: 93  SNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNS 152
            N A+       +  +       L +L++L  +N+ ++  +   +  LT L  L   SN+
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75

Query: 153 LSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNL 212
           ++ ++   +    +L+ L    N    ++   +  L+ L  L  DTN L+     ++   
Sbjct: 76  IT-TL--DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126

Query: 213 RSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQ 272
             L+ L+   N L+    I + + + LT L+   N     +        +LT L    N+
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNK 181

Query: 273 FRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCP 332
               + +      L R+  D N +T            LT++D S N        D     
Sbjct: 182 ITE-LDV-SQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKL---TEIDVTPLT 233

Query: 333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQL 392
           +L+  D S+N +T     ++   S+L  L      ++    I+L      I       + 
Sbjct: 234 QLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRK 287

Query: 393 SGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICI 452
             +L   +    QL  LD  +  ++         L       L L+   L E +   +  
Sbjct: 288 IKELD--VTHNTQLYLLDCQAAGITELDLSQNPKLV-----YLYLNNTELTE-LD--VSH 337

Query: 453 MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTT 499
              L+ L+  +  +     S   K+  L +   +  +       + T
Sbjct: 338 NTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLT 382

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  111 bits (279), Expect = 5e-26
 Identities = 59/349 (16%), Positives = 119/349 (34%), Gaps = 46/349 (13%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
             +N L +   + L  L  L+      NKL+      +     L  L    N+L+  I  
Sbjct: 92  CDSNKLTNLDVTPLTKLTYLN---CDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID- 143

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            + +    ++L+   NK    +   +   + L TL    N ++     ++   + L+ L 
Sbjct: 144 -VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            + N ++  +   L     L  L   SN L+      +  L  L+    S N     +  
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELDV 250

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
           S   LS L TL+     L   I   L +   L        +    + ++  + + L  L+
Sbjct: 251 S--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLD 303

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
                ++     +     KL  L L + +    + +  + T L+ +     ++  + S  
Sbjct: 304 CQAAGIT---ELDLSQNPKLVYLYLNNTELTE-LDV-SHNTKLKSLSCVNAHIQ-DFSSV 357

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI 352
             I P L     ++                +     + N++T  V P++
Sbjct: 358 GKI-PALNNNFEAEGQT-----------ITMPKETLTNNSLTIAVSPDL 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  110 bits (277), Expect = 1e-25
 Identities = 59/351 (16%), Positives = 110/351 (31%), Gaps = 39/351 (11%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
              N L     S+   L  L+      N L+  I   + + T L  L  H N     +  
Sbjct: 113 CDTNKLTKLDVSQNPLLTYLN---CARNTLT-EID--VSHNTQLTELDCHLNKKITKLD- 165

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            +      + L+ S NK++      +     L  L  DTN+++  +   L     L+ L 
Sbjct: 166 -VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLD 218

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            ++N L+  I   +  LT L       N L+      +  L  L+ L   + +       
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL----- 267

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            +    N   +Y            ++ +   L  L      ++  + +S      L YL 
Sbjct: 268 EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLS--QNPKLVYLY 324

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
           L    L+  +     +  KL  L   +   +     +  + +L               E+
Sbjct: 325 LNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTITMPKET 380

Query: 304 F-----YIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVP 349
                  I  +   +D   N     I    G     +T   +  N++ + P
Sbjct: 381 LTNNSLTIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 51.2 bits (123), Expect = 9e-07
 Identities = 22/159 (13%), Positives = 45/159 (28%), Gaps = 11/159 (6%)

Query: 1   LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGS 60
           L              ++ +   L  L+     ++  +   L     L  LY++   L+  
Sbjct: 277 LIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-E 332

Query: 61  IPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
           +   + +      L   N  +       +G +  L   +             L N     
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388

Query: 121 NLQLNNNILSG---SIPHSLGNLTNLATLYIYSNSLSAS 156
            +  +     G   +I    G + + AT  I   +LS  
Sbjct: 389 AVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTD 427

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  133 bits (336), Expect = 2e-34
 Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 21/257 (8%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+GG G VY ++      I+A+K     L  +  F+     E +    +   ++V ++ 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
           F      L++         LA +L        L   R + +++ I  AL   H       
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYTMKVT 785
            HRD+  +N+L+  ++ A++ DFGIA          T+L    GT  Y+APE       T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS 845
            + D+Y+   +  E + G  P        +    L++    +    +P PS       ++
Sbjct: 214 YRADIYALTCVLYECLTGSPP--------YQGDQLSVMGAHINQA-IPRPSTVRPGIPVA 264

Query: 846 IVEVTISCVDENPESRP 862
              V    + +NPE R 
Sbjct: 265 FDAVIARGMAKNPEDRY 281

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  131 bits (332), Expect = 5e-34
 Identities = 56/299 (18%), Positives = 120/299 (40%), Gaps = 46/299 (15%)

Query: 599 RATNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
           R   DF+   C+G+GG G V+           A+K+    LP     +++ + EVKAL +
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 59

Query: 658 IWHRNIVKVYGFCLH------------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           + H  IV+ +   L               +L+I  +  +  +L   ++     +    + 
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK------- 758
            +++   I +A+ ++H+     ++HRD+   N+    ++   V DFG+   +        
Sbjct: 120 CLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 759 -----PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM 813
                P  +  T   GT  Y++PE  +    + K D++S G++  E++   +P  F + M
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--FSTQM 231

Query: 814 SFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                  ++      + + P      +     +V+     +  +P  RP       +++
Sbjct: 232 ERVRTLTDV-----RNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAI---NIIE 279

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  131 bits (332), Expect = 7e-34
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 35/285 (12%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI 658
            +F  E  IG+G    VY +  L  G  +A+KK    +   M  +   + + E+  L ++
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQL 89

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR-------MNMIK 711
            H N++K Y   +    L IV E      L+ ++      K+    +R            
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMI------KHFKKQKRLIPERTVWKYFV 143

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
            +  AL +MH+     ++HRDI   NV +       + D G+ +F    ++    L GT 
Sbjct: 144 QLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS-SMSFSSLNLNIALDEMLDP 830
            Y++PE  +      K D++S G L  E+   + P  F    M+  SL   I   +   P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDY--P 256

Query: 831 RLPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
            LP+   S  +   L++       C++ +PE RP +  V  + K 
Sbjct: 257 PLPSDHYSEELRQ-LVN------MCINPDPEKRPDVTYVYDVAKR 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  130 bits (330), Expect = 7e-34
 Identities = 64/258 (24%), Positives = 121/258 (46%), Gaps = 21/258 (8%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G GG  +VY+++       +A+K    P   +    + F  EV   +++ H+NIV +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
                   ++V EY +  +L+  + +      L     +N    I+D + + H+     I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---RI 132

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE---LAGTYGYVAPELAYTMKVT 785
           VHRDI  +N+L+D      + DFGIAK L    ++ T+   + GT  Y +PE A      
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKL-I 844
           E  D+YS G++  E++ G+ P +  +++S       IA+  + D  +P  + +V   +  
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDS-VPNVTTDVRKDIPQ 242

Query: 845 SIVEVTISCVDENPESRP 862
           S+  V +   +++  +R 
Sbjct: 243 SLSNVILRATEKDKANRY 260

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  132 bits (333), Expect = 8e-34
 Identities = 72/310 (23%), Positives = 115/310 (37%), Gaps = 26/310 (8%)

Query: 22  SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKL 81
            L  ++  +  L  ++P  +    +   L +  N +S     +    +    L L NNK+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 82  SGSIPP-SLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNL 140
           S  I   +   L  L  LY+  N L   IP  L    SL  L++++N +          L
Sbjct: 91  S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGL 146

Query: 141 TNLATLYIYSNSLSASIL--GKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT 198
            N+  + +  N L  S    G    LK L+ L++SE      IP  L     L  L+LD 
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDL--PETLNELHLDH 202

Query: 199 NSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY 257
           N +  +I  E L     L  L LG+N++      S+  L  L  L+L  N LS  +P   
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260

Query: 258 RNLVKLTILLLGHNQFR-------GPIPILRNLTSLERVRLDRNYLT-GNISES-FYIYP 308
            +L  L ++ L  N           P+           + L  N +    +  + F    
Sbjct: 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320

Query: 309 NLTYIDLSQN 318
           +   I     
Sbjct: 321 DRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  129 bits (326), Expect = 7e-33
 Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 22/271 (8%)

Query: 14  PSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSD 73
             + + L+ L  L L NNK+S     +   L  L  LYI  N L   IP  +       +
Sbjct: 71  KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVE 127

Query: 74  LELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNS-IPSELGNLRSLSNLQLNNNILSG 131
           L + +N++   +P      L N+  + +  N L NS       +   L+ L+++   L+ 
Sbjct: 128 LRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT- 185

Query: 132 SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSN 190
            IP  L     L  L++  N + A  L  +     L  L L  N     I   SL  L  
Sbjct: 186 GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPT 242

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-------GNLSNLTYLN 243
           L  L+LD N LS  +P+ L +L+ L  + L  N ++  + ++           +    ++
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300

Query: 244 LFENSLSGAI--PYEYRNLVKLTILLLGHNQ 272
           LF N +      P  +R +     +  G+ +
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  123 bits (311), Expect = 5e-31
 Identities = 69/307 (22%), Positives = 109/307 (35%), Gaps = 28/307 (9%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           ++ S+  L  ++P  +    +   L L  N +S     +   L+ L  L L NN +S   
Sbjct: 38  VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLA 192
             +   L  L  LYI  N L   I        SL  L++ +N     +P      L N+ 
Sbjct: 95  EKAFSPLRKLQKLYISKNHLV-EI--PPNLPSSLVELRIHDNRIR-KVPKGVFSGLRNMN 150

Query: 193 TLYLDTNSLSYS-IPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG 251
            + +  N L  S       +   L+ L +   KL+G   I       L  L+L  N +  
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQ- 206

Query: 252 AIPYEY-RNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRNYLTGNISESFYIYP 308
           AI  E      KL  L LGHNQ R  I    L  L +L  + LD N L+  +        
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264

Query: 309 NLTYIDLSQNNFYGEISSD-------WGRCPKLSTLDFSINNIT-GNVPPEI-GHSSQLG 359
            L  + L  NN   ++  +         +    + +    N +    V P      +   
Sbjct: 265 LLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323

Query: 360 VLDLSSN 366
            +   + 
Sbjct: 324 AIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  107 bits (270), Expect = 1e-25
 Identities = 64/323 (19%), Positives = 105/323 (32%), Gaps = 44/323 (13%)

Query: 190 NLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
           +L  +      L  ++P E+      + L L  N +S         L +L  L L  N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 250 SGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYP 308
           S      +  L KL  L +  N     P  +  +L  L   R+  N +       F    
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVEL---RIHDNRIRKVPKGVFSGLR 147

Query: 309 NLTYIDLSQNNFY-GEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH 367
           N+  I++  N               KL+ L  S   +T  +P        L  L L  N 
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNK 204

Query: 368 IVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL 427
           I   I +E                        L    +L  L L  N++      SL  L
Sbjct: 205 IQ-AIELED-----------------------LLRYSKLYRLGLGHNQIRMIENGSLSFL 240

Query: 428 ELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNG------LL 481
               L EL L  N L   +P+ +  ++ L+ + L  N+++ +  + F  +          
Sbjct: 241 P--TLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297

Query: 482 HIDISYNELRGSIPNSTTFKDAP 504
            I +  N +        TF+   
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVT 320

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  102 bits (256), Expect = 9e-24
 Identities = 61/312 (19%), Positives = 108/312 (34%), Gaps = 28/312 (8%)

Query: 166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL 225
            L  +Q S+     ++P  +    +   L L  N +S     +   L+ L  L L  NK+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 226 SGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLT 284
           S     +   L  L  L + +N L   IP        L  L +  N+ R  P  +   L 
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147

Query: 285 SLERVRLDRNYLT-GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINN 343
           ++  + +  N L         +    L Y+ +S+                L+ L    N 
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL---TGIPKDLPETLNELHLDHNK 204

Query: 344 ITGNVPPEI-GHSSQLGVLDLSSNHIVGEIP----IELGKLNFFIKLVLAHNQLSGQLSP 398
           I   +  E     S+L  L L  N I   I       L  L    +L L +N+LS ++  
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLR---ELHLDNNKLS-RVPA 258

Query: 399 KLGSLVQLEHLDLSSNRLS----NSIPKSLGNLELIHLSELDLSRNFLREAI--PSQICI 452
            L  L  L+ + L +N ++    N        ++  + + + L  N +      P+    
Sbjct: 259 GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

Query: 453 MQSLEKLNLSHN 464
           +     +   + 
Sbjct: 319 VTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 25/133 (18%), Positives = 48/133 (36%), Gaps = 13/133 (9%)

Query: 5   YNNSLYDSIPSE-LRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
            +N +  +I  E L     L  L LG+N++      SL  L  L  L++  N LS  +P 
Sbjct: 201 DHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPS-------LGNLSNLATLYLDTNSLSNSI--PSELG 114
            + + +    + L  N ++  +  +           +    + L  N +      P+   
Sbjct: 259 GLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317

Query: 115 NLRSLSNLQLNNN 127
            +     +Q  N 
Sbjct: 318 CVTDRLAIQFGNY 330

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (329), Expect = 1e-33
 Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 28/271 (10%)

Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
            IG+G   +VY      +   +A  +     L      +Q F  E + L  + H NIV+ 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE--RQRFKEEAEMLKGLQHPNIVRF 90

Query: 667 YGFCLHV----RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           Y          + + +V E     +L   L      K +      +  + I+  L ++H 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH- 146

Query: 723 DCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
              PPI+HRD+   N+ +        + D G+A   +   +    + GT  ++APE+ Y 
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YE 203

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
            K  E  DVY+FG+  LE+   ++P     +    +         +         +    
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRVTSGVKPASFD---KVAIP 257

Query: 842 KLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++  I+E    C+ +N + R +   +  LL 
Sbjct: 258 EVKEIIE---GCIRQNKDERYS---IKDLLN 282

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  136 bits (343), Expect = 1e-33
 Identities = 95/507 (18%), Positives = 181/507 (35%), Gaps = 61/507 (12%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
            N +L   +P +L        L L  N +S      +  L+ L  L +  N +  S+   
Sbjct: 39  SNRNL-THVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLD-- 92

Query: 65  IGNFRFFSDLE---LSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIP--SELGNLRSL 119
              F F  DLE   +S+N+L  +I      +++L  L L  N     +P   E GNL  L
Sbjct: 93  FHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKL 148

Query: 120 SNLQLNNNILSGSIPHSLGNL-TNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           + L L+           + +L  +   L + S  +       +      + L L  +  +
Sbjct: 149 TFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPNS 207

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSY-------SIPSELGNLRSLSNLSLGYNKLSGSIPI 231
                   +++ L  L L    L+        +  SEL    +L N++L + + +    +
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267

Query: 232 SMGNL---SNLTYLNLFENSLSGAIPYEY-----RNLVKLTILLLGHNQFRGPIP-ILRN 282
            +        + YLN++  +++  I  E        L  L I  + +  F      +   
Sbjct: 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327

Query: 283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN 342
              +    L  +              + T+++ +QN F   +        +L TL    N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387

Query: 343 NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL-G 401
            +  N       +  +  L+                           N L+     +   
Sbjct: 388 GLK-NFFKVALMTKNMSSLETLDVS---------------------LNSLNSHAYDRTCA 425

Query: 402 SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNL 461
               +  L+LSSN L+ S+ + L       +  LDL  N +  +IP  +  +Q+L++LN+
Sbjct: 426 WAESILVLNLSSNMLTGSVFRCL----PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNV 480

Query: 462 SHNSLSGLIPSCFEKMNGLLHIDISYN 488
           + N L  +    F+++  L +I +  N
Sbjct: 481 ASNQLKSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  129 bits (325), Expect = 2e-31
 Identities = 78/447 (17%), Positives = 158/447 (35%), Gaps = 33/447 (7%)

Query: 74  LELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSG 131
           L LS N +S  +    +  LS L  L L  N +  S+   +    + L  L +++N L  
Sbjct: 57  LSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ- 113

Query: 132 SIPHSLGNLTNLATLYIYSNSL-SASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSN 190
           +I      + +L  L +  N      +  + GNL  L+ L LS   F   +        +
Sbjct: 114 NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLH 170

Query: 191 LATLYLDTNSLSYS-IPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
           L+ + LD  S       +E   + + + L L ++  S        +++ L +L L    L
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230

Query: 250 SGAIPYEYRNLVKLTILLLGHNQFRG-----------PIPILRNLTSLERVRLDRNYLTG 298
           +          +                          +        +E + +    +T 
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290

Query: 299 NISESFYIY-----PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIG 353
            I    + Y      +L    +    F     + +    +++    SI++          
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350

Query: 354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS--GQLSPKLGSLVQLEHLDL 411
             S    L+ + N     +      L     L+L  N L    +++    ++  LE LD+
Sbjct: 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410

Query: 412 SSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIP 471
           S N L++             +  L+LS N L  ++    C+   ++ L+L +N +  + P
Sbjct: 411 SLNSLNSHAYDRTCAW-AESILVLNLSSNMLTGSVFR--CLPPKVKVLDLHNNRIMSI-P 466

Query: 472 SCFEKMNGLLHIDISYNELRGSIPNST 498
                +  L  ++++ N+L+ S+P+  
Sbjct: 467 KDVTHLQALQELNVASNQLK-SVPDGV 492

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  118 bits (296), Expect = 9e-28
 Identities = 83/430 (19%), Positives = 151/430 (35%), Gaps = 48/430 (11%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHS--LGNLTNLATLYIHTNSL-SGS 60
           + +N L  +I      + SL  L+L  N     +P     GNLT L  L +         
Sbjct: 107 VSHNRL-QNISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162

Query: 61  IPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
           +            L+L +  + G    SL    N   L+L  +  S        ++ +L 
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALG 221

Query: 121 NLQLNNNILSGSIPHSLGN----------LTNLATLYIYSNSLSASILGKIGNLKSLSNL 170
           +LQL+N  L+      L            L N+   +I +    +  L +    + +  L
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281

Query: 171 QLSENNFNGSIPP-----SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL 225
            +        I       S   L +L   ++      +S  +       ++   L  +  
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

Query: 226 SGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTS 285
                +   + S+ T+LN  +N  + ++      L +L  L+L  N           L +
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG----------LKN 391

Query: 286 LERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF-YGEISSDWGRCPKLSTLDFSINNI 344
             +V L    ++           +L  +D+S N+               +  L+ S N +
Sbjct: 392 FFKVALMTKNMS-----------SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440

Query: 345 TGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLV 404
           TG+V   +    ++ VLDL +N I   IP ++  L    +L +A NQL          L 
Sbjct: 441 TGSVFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLT 497

Query: 405 QLEHLDLSSN 414
            L+++ L  N
Sbjct: 498 SLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 89.9 bits (223), Expect = 8e-19
 Identities = 54/328 (16%), Positives = 112/328 (34%), Gaps = 24/328 (7%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSN 238
            +P           L L  NS+S     ++  L  L  L L +N++  S+   +     +
Sbjct: 45  HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR--GPIPILRNLTSLERVRLDRNYL 296
           L YL++  N L   I      +  L  L L  N F          NLT L  + L     
Sbjct: 102 LEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158

Query: 297 TGNISESFYIYPNLTYIDLSQNNFYGE-ISSDWGRCPKLSTLDFSINNITGNVPPEIGHS 355
              +      + +L+ I L   +++ +   ++  + P  + L    +  +          
Sbjct: 159 R-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217

Query: 356 SQLGVLDLSSNHI-------VGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQ--- 405
           + LG L LS+  +       +     EL +    + + L H + + + S KL        
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277

Query: 406 LEHLDLSSNRLSNSIPK---SLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLS 462
           +E+L++ +  ++  I +   +     L  L    +       +  +   +   +    LS
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337

Query: 463 HNSLSGLIPSCFEKMNGLLHIDISYNEL 490
            +    +   C    +    ++ + N  
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVF 365

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 87.2 bits (216), Expect = 7e-18
 Identities = 59/332 (17%), Positives = 110/332 (33%), Gaps = 38/332 (11%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNL-----TNLATLYIHTNSLS 58
           +  +           ++ +L  L+L N KL+      L             L +    + 
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260

Query: 59  GSIPGEIGNFRFF-----SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEL 113
            +    +  F+FF       L + N  ++  I       S  A                 
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETA----------------- 303

Query: 114 GNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLS 173
             L+SL    + N +   S          +    +  +      +    +  S + L  +
Sbjct: 304 --LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361

Query: 174 ENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL----SGSI 229
           +N F  S+      L  L TL L  N L  +        +++S+L      L    S + 
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAY 420

Query: 230 PISMGNLSNLTYLNLFENSLSGAIPYEYRNLV-KLTILLLGHNQFRGPIPILRNLTSLER 288
             +     ++  LNL  N L+G++    R L  K+ +L L +N+       + +L +L+ 
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVF---RCLPPKVKVLDLHNNRIMSIPKDVTHLQALQE 477

Query: 289 VRLDRNYLTGNISESFYIYPNLTYIDLSQNNF 320
           + +  N L       F    +L YI L  N +
Sbjct: 478 LNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 57/276 (20%), Positives = 99/276 (35%), Gaps = 19/276 (6%)

Query: 228 SIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSL 286
            +P           L+L +NS+S     +   L +L +L L HN+ R     +      L
Sbjct: 45  HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102

Query: 287 ERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF-YGEISSDWGRCPKLSTLDFSINNIT 345
           E + +  N L    + S     +L ++DLS N+F    +  ++G   KL+ L  S     
Sbjct: 103 EYLDVSHNRLQ---NISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159

Query: 346 GNVPPEIGHSSQLGV--LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSL 403
             +         L    LDL S HI G     L   N    L L  +  S        S+
Sbjct: 160 -QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPNSLFSVQVNMSV 217

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ--------S 455
             L HL LS+ +L++   + L            L    L+    +  C ++         
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277

Query: 456 LEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
           +E LN+ + +++  I       +      +    ++
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  130 bits (328), Expect = 5e-33
 Identities = 62/285 (21%), Positives = 111/285 (38%), Gaps = 21/285 (7%)

Query: 51  YIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSI 109
              + SL+ SIP  +        L+LSNN+++  I  S L    NL  L L +N ++ +I
Sbjct: 37  KGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TI 91

Query: 110 PSEL-GNLRSLSNLQLNNNILSGSIPHSL-GNLTNLATLYIYSNSLSA-SILGKIGNLKS 166
             +   +L SL +L L+ N LS ++  S    L++L  L +  N            +L  
Sbjct: 92  EEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK 150

Query: 167 LSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNK 224
           L  L++   +    I       L+ L  L +D + L  S   + L +++++S+L L   +
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQ 209

Query: 225 LSGSIPISMGNLSNLTYLNLFEN--------SLSGAIPYEYRNLVKLTILLLGHNQFRGP 276
               + I +   S++  L L +          LS               + +        
Sbjct: 210 HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQV 269

Query: 277 IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFY 321
           + +L  ++ L  +   RN L       F    +L  I L  N + 
Sbjct: 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (261), Expect = 2e-24
 Identities = 56/315 (17%), Positives = 106/315 (33%), Gaps = 54/315 (17%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSN 238
           SIP  L     + +L L  N ++Y   S+L    +L  L L  N ++ +I      +L +
Sbjct: 45  SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 239 LTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQFR--GPIPILRNLTSLERVRLDRNY 295
           L +L+L  N LS  +    ++ L  LT L L  N ++  G   +  +LT L+ +R+    
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160

Query: 296 LTGNISE-SFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-G 353
               I    F     L  +++  ++              +S L   +      +      
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219

Query: 354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
            +S +  L+L    +                     ++LS   +  L       ++ ++ 
Sbjct: 220 VTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITD 263

Query: 414 NRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC 473
             L   + K L  +                            L +L  S N L  +    
Sbjct: 264 ESLF-QVMKLLNQI--------------------------SGLLELEFSRNQLKSVPDGI 296

Query: 474 FEKMNGLLHIDISYN 488
           F+++  L  I +  N
Sbjct: 297 FDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (255), Expect = 2e-23
 Identities = 44/235 (18%), Positives = 90/235 (38%), Gaps = 17/235 (7%)

Query: 4   IYNNSLYDSIPSEL-RNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSI 61
           + +N + ++I  +   +L SL  L+L  N LS ++  S    L++L  L +  N      
Sbjct: 83  LTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLG 140

Query: 62  PGEI-GNFRFFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
              +  +      L + N      I       L+ L  L +D + L +  P  L +++++
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKI--------GNLKSLSNLQ 171
           S+L L+       +   +   +++  L +    L      ++            +  N++
Sbjct: 201 SHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260

Query: 172 LSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKL 225
           +++ +    +   L  +S L  L    N L  S+P      L SL  + L  N  
Sbjct: 261 ITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 43/258 (16%), Positives = 85/258 (32%), Gaps = 45/258 (17%)

Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYL 296
             +  L+L  N ++     + +  V L  L+L  N           + ++E         
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG----------INTIE--------- 92

Query: 297 TGNISESFYIYPNLTYIDLSQNNFYGEISSDW-GRCPKLSTLDFSINNITGNVPPEI-GH 354
                +SF    +L ++DLS N     +SS W      L+ L+   N         +  H
Sbjct: 93  ----EDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSH 147

Query: 355 SSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
            ++L +L + +     +I  +    L F  +L +  + L       L S+  + HL L  
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207

Query: 414 NRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC 473
            +    + +   ++    +  L+L    L                     + LS    + 
Sbjct: 208 KQHI-LLLEIFVDV-TSSVECLELRDTDLD----------------TFHFSELSTGETNS 249

Query: 474 FEKMNGLLHIDISYNELR 491
             K     ++ I+   L 
Sbjct: 250 LIKKFTFRNVKITDESLF 267

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 66.7 bits (163), Expect = 9e-12
 Identities = 41/203 (20%), Positives = 73/203 (35%), Gaps = 22/203 (10%)

Query: 306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS-SQLGVLDLS 364
           +   +  +DLS N      +SD  RC  L  L  + N I   +  +   S   L  LDLS
Sbjct: 50  LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLS 108

Query: 365 SNHIVGEIPIE----LGKLNFFIKLVLAHNQLSGQLSPK--LGSLVQLEHLDLSSNRLSN 418
            N++   +       L  L     L L  N     L        L +L+ L + +     
Sbjct: 109 YNYLS-NLSSSWFKPLSSLT---FLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT 163

Query: 419 SIPK----SLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCF 474
            I +     L  LE     EL++  + L+   P  +  +Q++  L L       L+    
Sbjct: 164 KIQRKDFAGLTFLE-----ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218

Query: 475 EKMNGLLHIDISYNELRGSIPNS 497
           +  + +  +++   +L     + 
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSE 241

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 28/114 (24%), Positives = 47/114 (41%), Gaps = 6/114 (5%)

Query: 385 LVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLRE 444
            V+         +    S  +      SS  L+ SIP  L       +  LDLS N +  
Sbjct: 12  GVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL----TEAVKSLDLSNNRITY 66

Query: 445 AIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
              S +    +L+ L L+ N ++ +    F  +  L H+D+SYN L  ++ +S 
Sbjct: 67  ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW 119

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  133 bits (336), Expect = 8e-33
 Identities = 66/406 (16%), Positives = 129/406 (31%), Gaps = 36/406 (8%)

Query: 7   NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIG 66
           +  Y    S     +  +      N+    +   L  +   + L ++  +LS S+P  + 
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP 79

Query: 67  NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
                + LE++ N L  S+P    +L     L    N L +++P    +L+   +L ++N
Sbjct: 80  PQ--ITVLEITQNALI-SLPELPASLE---YLDACDNRL-STLPELPASLK---HLDVDN 129

Query: 127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
           N L+  +P     L     +   +N L+  +     +L+ LS   +  N     +P    
Sbjct: 130 NQLT-MLPELPALLE---YINADNNQLT-MLPELPTSLEVLS---VRNNQLT-FLPELPE 180

Query: 187 NLSNLATLYLDTNSLSYSIPSELGNLRSLSN----LSLGYNKLSGSIPISMGNLSNLTYL 242
           +L     L + TN L  S+P+                   N+++  IP ++ +L     +
Sbjct: 181 SLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTI 235

Query: 243 NLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISE 302
            L +N LS  I               G   +       +N            +   N   
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQP-DYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294

Query: 303 SFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLD 362
                 +    +   N F                       +      ++  S++L    
Sbjct: 295 DVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVA-AWLEKLSASAELRQQS 352

Query: 363 LSSNHIVGEIPIELGKLNF--FIKLVLAHNQLSGQLSPKLGSLVQL 406
            +      E   +   L +    K +L H    G      G+L+ L
Sbjct: 353 FAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (291), Expect = 4e-27
 Identities = 71/366 (19%), Positives = 118/366 (32%), Gaps = 60/366 (16%)

Query: 108 SIPSELGNLRSLSNLQLNNNI--LSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLK 165
           SI   + N  SLS     N I         +       A      N   + +  K   + 
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLL--KECLIN 59

Query: 166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL 225
             S LQL+  N + S+P +L     +  L +  N+L  S+P    +L     L    N+L
Sbjct: 60  QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLE---YLDACDNRL 112

Query: 226 SGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTS 285
           S ++P      ++L +L++  N L+  +P        L  +   +NQ      +    TS
Sbjct: 113 S-TLP---ELPASLKHLDVDNNQLT-MLPEL---PALLEYINADNNQLTM---LPELPTS 161

Query: 286 LERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNIT 345
           LE + +  N LT  + E      +L  +D+S N               L +L        
Sbjct: 162 LEVLSVRNNQLTF-LPELP---ESLEALDVSTN--------------LLESL-------- 195

Query: 346 GNVPPEIGHSSQL----GVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG 401
              P     +              N I   IP  +  L+    ++L  N LS ++   L 
Sbjct: 196 ---PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251

Query: 402 SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNL 461
                                S G    +H    D    +  E   S +  +    +   
Sbjct: 252 QQTAQPDYHGPRIYF----SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEE 307

Query: 462 SHNSLS 467
             N+ S
Sbjct: 308 HANTFS 313

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  106 bits (267), Expect = 3e-24
 Identities = 63/312 (20%), Positives = 99/312 (31%), Gaps = 34/312 (10%)

Query: 204 SIPSELGNLRSLSNLSLGYNKLSG---SIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL 260
           SI   + N  SLS  S  YN +SG       +              N     +      +
Sbjct: 2   SIMLPINNNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LI 58

Query: 261 VKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNN 319
            + + L L        P  +   +T LE   + +N L  ++ E      +L Y+D   N 
Sbjct: 59  NQFSELQLNRLNLSSLPDNLPPQITVLE---ITQNALI-SLPELP---ASLEYLDACDNR 111

Query: 320 FYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKL 379
               +S+       L  LD   N +T  +P        L  ++  +N +   +P     L
Sbjct: 112 ----LSTLPELPASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSL 162

Query: 380 NFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE--LIHLSELDL 437
                L + +NQL+  L     SL   E LD+S+N L  S+P                  
Sbjct: 163 E---VLSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214

Query: 438 SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
             N +   IP  I  +     + L  N LS  I     +                S    
Sbjct: 215 RENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

Query: 498 TTFKDAPIEALQ 509
            T      +A+ 
Sbjct: 274 NTLHRPLADAVT 285

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 76.5 bits (188), Expect = 1e-14
 Identities = 49/274 (17%), Positives = 93/274 (33%), Gaps = 26/274 (9%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
             NN L   +P    +L+ LS   + NN+L+  +P    +L     L + TN L  S+P 
Sbjct: 147 ADNNQL-TMLPELPTSLEVLS---VRNNQLT-FLPELPESLE---ALDVSTNLLE-SLPA 197

Query: 64  EIGNF----RFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
                              N+++  IP ++ +L    T+ L+ N LS+ I   L    + 
Sbjct: 198 VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
            +        S S      N  +       +     +    +  +      +   N F+ 
Sbjct: 257 PDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA 314

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
                L  LS+  +   +T+     + + L  L + + L      ++     S  +   L
Sbjct: 315 ----FLDRLSDTVS-ARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVAL 369

Query: 240 TYLNL-----FENSLSGAIPYEYRNLVKLTILLL 268
           T+ NL        +  G    +   L+ L   + 
Sbjct: 370 TWNNLRKTLLVHQASEGLFDNDTGALLSLGREMF 403

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 28/127 (22%), Positives = 47/127 (37%), Gaps = 10/127 (7%)

Query: 372 IPIELGKLNFF-IKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELI 430
           + I L   N F +     +N +SG  +    +  + E   L      N     L    + 
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENR-NEAVSLLKECLIN 59

Query: 431 HLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
             SEL L+R  L   +P  +     +  L ++ N+L  L P        L ++D   N L
Sbjct: 60  QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISL-PELPA---SLEYLDACDNRL 112

Query: 491 RGSIPNS 497
             ++P  
Sbjct: 113 S-TLPEL 118

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (327), Expect = 3e-32
 Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 36/281 (12%)

Query: 603 DFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHR 661
            F  +  +G G +G++    +     +AVK+                 EV+ L E   H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLA-VILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           N+++ +      +  +I  E     +L   +   D A   L     + +++     L+++
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHL 134

Query: 721 HNDCFPPIVHRDISSKNVLLDFENE-----AHVSDFGIAKFLKPDSS---NWTELAGTYG 772
           H+     IVHRD+   N+L+   N      A +SDFG+ K L          + + GT G
Sbjct: 135 HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 773 YVAPEL---AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEML 828
           ++APE+         T   D++S G +   VI +G HP         + L    +LD   
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD--C 249

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                       + LI         +  +P+ RP+ + V +
Sbjct: 250 LHPEKHEDVIARE-LIE------KMIAMDPQKRPSAKHVLK 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (319), Expect = 3e-32
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 22/261 (8%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY- 667
           +G GG   V++++ L     +AVK   + L  + +F   F  E +    + H  IV VY 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 668 -GF--CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
            G          +IV EY    +L  I+  +     +   R + +I     AL++ H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN- 135

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE---LAGTYGYVAPELAYT 781
              I+HRD+   N+++   N   V DFGIA+ +    ++ T+   + GT  Y++PE A  
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD 841
             V  + DVYS G +  EV+ G+ P    S +S       +A   + +     PS     
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVRED-PIPPSARHEG 245

Query: 842 KLISIVEVTISCVDENPESRP 862
               +  V +  + +NPE+R 
Sbjct: 246 LSADLDAVVLKALAKNPENRY 266

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  129 bits (325), Expect = 6e-32
 Identities = 69/254 (27%), Positives = 100/254 (39%), Gaps = 11/254 (4%)

Query: 71  FSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILS 130
           FS +      L   +P  +   +N   L L  N +     +   +LR L  LQL+ N + 
Sbjct: 45  FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101

Query: 131 GSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL-GNLS 189
                +   L NL TL ++ N L+    G    L  L  L L  N    SIP      + 
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIP 160

Query: 190 NLATLYL-DTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFEN 247
           +L  L L +   LS  I       L +L  L+L    L   IP ++  L  L  L+L  N
Sbjct: 161 SLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217

Query: 248 SLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYI 306
            LS   P  ++ L+ L  L +  +Q +        NL SL  + L  N LT    + F  
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277

Query: 307 YPNLTYIDLSQNNF 320
             +L  I L  N +
Sbjct: 278 LHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  119 bits (301), Expect = 7e-29
 Identities = 68/265 (25%), Positives = 103/265 (38%), Gaps = 12/265 (4%)

Query: 14  PSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSD 73
           PS        S +      L   +P  +   TN   L +H N +         + R    
Sbjct: 36  PSVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEI 92

Query: 74  LELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNNILSG 131
           L+LS N +  +I   +   L+NL TL L  N L+ +IP+     L  L  L L NN +  
Sbjct: 93  LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES 150

Query: 132 SIPHSLGNLTNLATLYIYS-NSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSN 190
              ++   + +L  L +     LS    G    L +L  L L+  N      P+L  L  
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPNLTPLIK 208

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSL 249
           L  L L  N LS   P     L  L  L +  +++   I  +   NL +L  +NL  N+L
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267

Query: 250 SGAIPYEYRNLVKLTILLLGHNQFR 274
           +      +  L  L  + L HN + 
Sbjct: 268 TLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  114 bits (288), Expect = 3e-27
 Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 35/249 (14%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
            N +     +  ++L+ L  L+L  N +      +   L NL TL               
Sbjct: 73  ENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE-------------- 118

Query: 66  GNFRFFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQ 123
                     L +N+L+ +IP  +   LS L  L+L  N +  SIPS     + SL  L 
Sbjct: 119 ----------LFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166

Query: 124 L-NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
           L     LS     +   L+NL  L +   +L    +  +  L  L  L LS N+ + +I 
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AIR 223

Query: 183 P-SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLT 240
           P S   L +L  L++  + +     +   NL+SL  ++L +N L+  +P  +   L +L 
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 241 YLNLFENSL 249
            ++L  N  
Sbjct: 283 RIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  106 bits (266), Expect = 2e-24
 Identities = 57/281 (20%), Positives = 103/281 (36%), Gaps = 35/281 (12%)

Query: 189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENS 248
           +  + +     +L   +P  +    +   L+L  N++      S  +L +L  L L  N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 249 LSGAIPYEYRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRNYLTGNISESFYI 306
           +       +  L  L  L L  N+    IP      L+ L+ + L  N +    S +F  
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158

Query: 307 YPNLTYIDLSQNNFYGEISSDW-GRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
            P+L  +DL +      IS         L  L+ ++ N+     P +    +L  LDLS 
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSG 216

Query: 366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
           NH+                  +      G        L+ L+ L +  +++      +  
Sbjct: 217 NHLS----------------AIRPGSFQG--------LMHLQKLWMIQSQIQVIERNAFD 252

Query: 426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL 466
           NL+   L E++L+ N L          +  LE+++L HN  
Sbjct: 253 NLQ--SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  100 bits (252), Expect = 1e-22
 Identities = 72/279 (25%), Positives = 111/279 (39%), Gaps = 35/279 (12%)

Query: 213 RSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQ 272
              S +      L   +P  +   +N   LNL EN +       +++L  L IL L  N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 273 FRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGR 330
            R   I     L +L  + L  N LT   + +F     L  + L  N     I S  + R
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNR 158

Query: 331 CPKLSTLDFS-INNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAH 389
            P L  LD   +  ++                 +S     G     L  L +   L LA 
Sbjct: 159 IPSLRRLDLGELKRLS----------------YISEGAFEG-----LSNLRY---LNLAM 194

Query: 390 NQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQ 449
             L     P L  L++L+ LDLS N LS   P S   L   HL +L + ++ ++    + 
Sbjct: 195 CNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLM--HLQKLWMIQSQIQVIERNA 250

Query: 450 ICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
              +QSL ++NL+HN+L+ L    F  ++ L  I + +N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 23/231 (9%)

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW-GRCPKL 334
           P  I  N   L    L  N +      SF    +L  + LS+N+    I          L
Sbjct: 59  PDGISTNTRLL---NLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANL 114

Query: 335 STLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIE----LGKLNFFIKLVLAH 389
           +TL+   N +T  +P     + S+L  L L +N I   IP      +  L     L L  
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR---LDLGE 169

Query: 390 -NQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIP 447
             +LS  +S      L  L +L+L+   L   IP       LI L ELDLS N L    P
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP---LIKLDELDLSGNHLSAIRP 224

Query: 448 SQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
                +  L+KL +  + +  +  + F+ +  L+ I++++N L   +P+  
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 6/94 (6%)

Query: 405 QLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN 464
           Q   +      L   +P  +      +   L+L  N ++    +    ++ LE L LS N
Sbjct: 44  QFSKVICVRKNLR-EVPDGI----STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98

Query: 465 SLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
            +  +    F  +  L  +++  N L  +IPN  
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGA 131

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  125 bits (316), Expect = 8e-32
 Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 21/256 (8%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           +  L  S+P+ +    S + LEL +NKL          LT L  L + +N LS       
Sbjct: 16  SKGL-TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK---GC 69

Query: 66  GNFRFFS-----DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE--LGNLRS 118
            +   F       L+LS N +  ++  +   L  L  L    ++L   +       +LR+
Sbjct: 70  CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRN 127

Query: 119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASIL-GKIGNLKSLSNLQLSENNF 177
           L  L +++     +       L++L  L +  NS   + L      L++L+ L LS+   
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187

Query: 178 NGSIPP-SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM--G 234
              + P +  +LS+L  L +  N+           L SL  L    N +  +        
Sbjct: 188 E-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQH 245

Query: 235 NLSNLTYLNLFENSLS 250
             S+L +LNL +N  +
Sbjct: 246 FPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  124 bits (314), Expect = 1e-31
 Identities = 58/255 (22%), Positives = 108/255 (42%), Gaps = 10/255 (3%)

Query: 72  SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILS- 130
           +++  ++  L+ S+P  +   S+   L L++N L +        L  L+ L L++N LS 
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 131 -GSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL-GNL 188
            G    S    T+L  L +  N +  ++      L+ L +L    +N       S+  +L
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125

Query: 189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFEN 247
            NL  L +       +       L SL  L +  N    +    +   L NLT+L+L + 
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185

Query: 248 SLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFY- 305
            L    P  + +L  L +L + HN F        + L SL+ +    N++  +  +    
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245

Query: 306 IYPNLTYIDLSQNNF 320
              +L +++L+QN+F
Sbjct: 246 FPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  113 bits (284), Expect = 1e-27
 Identities = 60/275 (21%), Positives = 104/275 (37%), Gaps = 32/275 (11%)

Query: 97  TLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSAS 156
            +  ++  L+ S+P+ +    S + L+L +N L          LT L  L + SN LS  
Sbjct: 11  EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 157 ILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLS 216
                                      S    ++L  L L  N +  ++ S    L  L 
Sbjct: 68  GCC----------------------SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 104

Query: 217 NLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG 275
           +L   ++ L      S+  +L NL YL++       A    +  L  L +L +  N F+ 
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164

Query: 276 PIP--ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPK 333
                I   L +L  + L +  L      +F    +L  +++S NNF+   +  +     
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224

Query: 334 LSTLDFSINNITGNVPPEI--GHSSQLGVLDLSSN 366
           L  LD+S+N+I      +      S L  L+L+ N
Sbjct: 225 LQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  106 bits (267), Expect = 2e-25
 Identities = 58/309 (18%), Positives = 102/309 (33%), Gaps = 62/309 (20%)

Query: 166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL 225
           S + ++ +      S+P  +   S+   L L++N L          L  L+ LSL  N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 226 SGSIPISMG---NLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR--GPIPIL 280
           S             ++L YL+L  N +   +   +  L +L  L   H+  +      + 
Sbjct: 65  S-FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122

Query: 281 RNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDF 339
            +L +L  + +   +     +  F    +L  + ++ N+F      D +     L+ LD 
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 340 SINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
           S   +   + P      S L VL++S N+                   L           
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNF----------------FSLDTFPYKC---- 221

Query: 399 KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEK 458
               L  L+ LD S N +  S  + L +                            SL  
Sbjct: 222 ----LNSLQVLDYSLNHIMTSKKQELQHFP-------------------------SSLAF 252

Query: 459 LNLSHNSLS 467
           LNL+ N  +
Sbjct: 253 LNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (259), Expect = 2e-24
 Identities = 58/236 (24%), Positives = 91/236 (38%), Gaps = 17/236 (7%)

Query: 263 LTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLT--GNISESFYIYPNLTYIDLSQNN 319
            T L L  N+ +  P  +   LT L ++ L  N L+  G  S+S +   +L Y+DLS N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 320 FYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIE--- 375
               +SS++    +L  LDF  +N+       +      L  LD+S  H           
Sbjct: 90  V-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147

Query: 376 -LGKLNFFIKLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLS 433
            L  L     L +A N       P     L  L  LDLS  +L    P +  +L    L 
Sbjct: 148 GLSSLEV---LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS--SLQ 202

Query: 434 ELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLL-HIDISYN 488
            L++S N            + SL+ L+ S N +        +     L  ++++ N
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 41/182 (22%), Positives = 68/182 (37%), Gaps = 12/182 (6%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIP 62
           +  N +  ++ S    L+ L  L+  ++ L      S+  +L NL  L I          
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAF 142

Query: 63  GEIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLR 117
             I  F   S LE   ++ N    +  P     L NL  L L    L   +      +L 
Sbjct: 143 NGI--FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 199

Query: 118 SLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNL-KSLSNLQLSENN 176
           SL  L +++N            L +L  L    N +  S   ++ +   SL+ L L++N+
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 259

Query: 177 FN 178
           F 
Sbjct: 260 FA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 10/172 (5%)

Query: 332 PKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHI--VGEIPIELGKLNFFIKLVLA 388
              + L+   N +  ++P  +    +QL  L LSSN +   G              L L+
Sbjct: 28  SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86

Query: 389 HNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPS 448
            N +   +S     L QLEHLD   + L      S+    L +L  LD+S    R    +
Sbjct: 87  FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL-SLRNLIYLDISHTHTRV-AFN 143

Query: 449 QICI-MQSLEKLNLSHNS-LSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
            I   + SLE L ++ NS     +P  F ++  L  +D+S  +L   +  + 
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  128 bits (324), Expect = 9e-32
 Identities = 59/251 (23%), Positives = 92/251 (36%), Gaps = 11/251 (4%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           +  +   LS  +P  +   SN   L L  N++         +L  L  LQL  N +    
Sbjct: 59  VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLA 192
             +   L +L TL ++ N L+    G    L  L  L L  N    SIP  +   + +L 
Sbjct: 116 VGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLM 174

Query: 193 TLYL-DTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
            L L +   L   I       L +L  L+LG   +   +P ++  L  L  L +  N   
Sbjct: 175 RLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP 231

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYPN 309
              P  +  L  L  L + ++Q           L SL  + L  N L+    + F     
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291

Query: 310 LTYIDLSQNNF 320
           L  + L  N +
Sbjct: 292 LVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  122 bits (308), Expect = 9e-30
 Identities = 59/276 (21%), Positives = 94/276 (34%), Gaps = 33/276 (11%)

Query: 22  SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKL 81
             S +      LS  +P  +   +N   L +  N++         +      L+L  N +
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 82  SGSIPP-SLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNL 140
              I   +   L++L TL L  N L+  IP                         +   L
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIP-----------------------SGAFEYL 146

Query: 141 TNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTN 199
           + L  L++ +N + +        + SL  L L E      I   +   L NL  L L   
Sbjct: 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206

Query: 200 SLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRN 259
           ++   +P+ L  L  L  L +  N      P S   LS+L  L +  + +S      +  
Sbjct: 207 NIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264

Query: 260 LVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRN 294
           L  L  L L HN     P  +   L  L  + L  N
Sbjct: 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  116 bits (293), Expect = 9e-28
 Identities = 65/249 (26%), Positives = 98/249 (39%), Gaps = 35/249 (14%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
            N++        R+L  L  L+LG N +      +   L +L TL               
Sbjct: 84  ENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLE-------------- 129

Query: 66  GNFRFFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQ 123
                     L +N L+  IP  +   LS L  L+L  N +  SIPS     + SL  L 
Sbjct: 130 ----------LFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLD 177

Query: 124 L-NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
           L     L      +   L NL  L +   ++    +  +  L  L  L++S N+F   I 
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFP-EIR 234

Query: 183 P-SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLT 240
           P S   LS+L  L++  + +S    +    L SL  L+L +N LS S+P  +   L  L 
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293

Query: 241 YLNLFENSL 249
            L+L  N  
Sbjct: 294 ELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  108 bits (272), Expect = 4e-25
 Identities = 58/280 (20%), Positives = 97/280 (34%), Gaps = 33/280 (11%)

Query: 189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENS 248
           +  + +      LS  +P  +    +   L+L  N +      +  +L +L  L L  NS
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 249 LSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIY 307
           +       +  L  L  L L  N     P      L+ L  + L  N +    S +F   
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170

Query: 308 PNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSN 366
           P+L  +DL +      IS   +     L  L+  + NI     P +     L  L++S N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGN 228

Query: 367 HIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGN 426
           H   EI                              L  L+ L + ++++S     +   
Sbjct: 229 HFP-EIRPGS-----------------------FHGLSSLKKLWVMNSQVSLIERNAFDG 264

Query: 427 LELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL 466
           L    L EL+L+ N L          ++ L +L+L HN  
Sbjct: 265 LA--SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 25/232 (10%)

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD--WGRCPK 333
           P  I  N   L    L  N +    +++F    +L  + L +N+   +I      G    
Sbjct: 70  PQGIPSNTRYL---NLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNG-LAS 124

Query: 334 LSTLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIE----LGKLNFFIKLVLA 388
           L+TL+   N +T  +P     + S+L  L L +N I   IP      +  L     L L 
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMR---LDLG 179

Query: 389 H-NQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAI 446
              +L   +S      L  L++L+L    +   +P       L+ L EL++S N   E  
Sbjct: 180 ELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP---LVGLEELEMSGNHFPEIR 234

Query: 447 PSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
           P     + SL+KL + ++ +S +  + F+ +  L+ +++++N L  S+P+  
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 11/155 (7%)

Query: 4   IYNNSLYDSIPSE-LRNLKSLSDLELG-NNKLSGSIPHSLGNLTNLATLYIHTNSLSGSI 61
           + NN + +SIPS     + SL  L+LG   KL      +   L NL  L +   ++   +
Sbjct: 154 LRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DM 211

Query: 62  PGEIGNFRFFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSL 119
           P  +       +LE+S N     I P S   LS+L  L++  + +S  I       L SL
Sbjct: 212 P-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASL 268

Query: 120 SNLQLNNNILSGSIPHS-LGNLTNLATLYIYSNSL 153
             L L +N LS S+PH     L  L  L+++ N  
Sbjct: 269 VELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 6/94 (6%)

Query: 405 QLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN 464
           Q   +  +   LS  +P+ +      +   L+L  N ++         +  LE L L  N
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI----PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 465 SLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
           S+  +    F  +  L  +++  N L   IP+  
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGA 142

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  124 bits (313), Expect = 9e-32
 Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 24/278 (8%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTF--QQEFLNEVKALTEI 658
            D++  + IG G  G    + + + G+I+  K+      G MT   +Q  ++EV  L E+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLREL 62

Query: 659 WHRNIVKVYGFCLHVR--HLFIVYEYFKMCSLA-VILSNDAAAKNLGWTRRMNMIKGIVD 715
            H NIV+ Y   +      L+IV EY +   LA VI       + L     + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 716 ALSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGY 773
           AL   H  +D    ++HRD+   NV LD +    + DFG+A+ L  D+S      GT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           ++PE    M   EK D++S G L  E+     P  F +  S   L   I   +    R+P
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF-SQKELAGKIREGKF--RRIP 237

Query: 834 TP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL 870
              S  +++ +I+        ++     RP+++++ + 
Sbjct: 238 YRYSDELNE-IIT------RMLNLKDYHRPSVEEILEN 268

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (317), Expect = 1e-31
 Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 26/275 (9%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI 658
             +     IG+G  G    +     G    +K+ +      M+ +  +E   EV  L  +
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANM 80

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
            H NIV+          L+IV +Y +   L   + N          + ++    I  AL 
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALK 139

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           ++H+     I+HRDI S+N+ L  +    + DFGIA+ L           GT  Y++PE+
Sbjct: 140 HVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR 837
                   K D+++ G +  E+   KH   F  + S  +L L I       P +    S 
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVLKIISGSF--PPVSLHYSY 251

Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++   L+S           NP  RP+   V  +L+
Sbjct: 252 DLRS-LVS------QLFKRNPRDRPS---VNSILE 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (312), Expect = 2e-31
 Identities = 57/294 (19%), Positives = 110/294 (37%), Gaps = 49/294 (16%)

Query: 599 RATNDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQ-QEFLNEVKALT 656
           R   DF +   IG GG G V+       G+   +K         + +  ++   EVKAL 
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALA 59

Query: 657 EIWHRNIVKVYGF----------------CLHVRHLFIVYEYFKMCSLAVILSNDAAAKN 700
           ++ H NIV   G                     + LFI  E+    +L   +      + 
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEK 118

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
           L     + + + I   + Y+H+     +++RD+   N+ L    +  + DFG+   LK D
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL 820
                   GT  Y++PE   +    ++ D+Y+ G++  E++            +F +   
Sbjct: 176 GKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------AFETSKF 227

Query: 821 NIALDEMLDPRLPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
                ++ D  +     +     L+         + + PE RP   ++ + L +
Sbjct: 228 ---FTDLRDGIISDIFDKKEKT-LLQ------KLLSKKPEDRPNTSEILRTLTV 271

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  125 bits (317), Expect = 3e-31
 Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 46/292 (15%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKA 654
            +     D      IG+G  G V+  +L +    +AVK     LP ++  + +FL E + 
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARI 165

Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           L +  H NIV++ G C   + ++IV E  +       L  +     L     + M+    
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAA 223

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN----------- 763
             + Y+ + C    +HRD++++N L+  +N   +SDFG+++                   
Sbjct: 224 AGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280

Query: 764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNI 822
           WT         APE     + + + DV+SFG+L  E    G  P   +S         N 
Sbjct: 281 WT---------APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---------NQ 322

Query: 823 ALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              E ++   RLP P     D   ++  +   C    P  RP+   + Q L+
Sbjct: 323 QTREFVEKGGRLPCP-ELCPD---AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (309), Expect = 1e-30
 Identities = 65/317 (20%), Positives = 116/317 (36%), Gaps = 36/317 (11%)

Query: 563 QRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSK 622
                  +    +  N   LL+         Y E +        +  +G+G  G V+  K
Sbjct: 22  SGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH---WMTHQPRVGRGSFGEVHRMK 78

Query: 623 -LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE 681
              +G   AVK        ++  +   + E+ A   +    IV +YG       + I  E
Sbjct: 79  DKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130

Query: 682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD 741
             +  SL  ++        L   R +  +   ++ L Y+H      I+H D+ + NVLL 
Sbjct: 131 LLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLS 184

Query: 742 FE-NEAHVSDFGIAKFLKPDSSNWTE-----LAGTYGYVAPELAYTMKVTEKCDVYSFGV 795
            + + A + DFG A  L+PD    +      + GT  ++APE+        K D++S   
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244

Query: 796 LALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVD 855
           + L ++ G HP           L L IA +    P    P  +        ++     + 
Sbjct: 245 MMLHMLNGCHPWTQYFRG---PLCLKIASEPP--PIREIPP-SCAPLTAQAIQ---EGLR 295

Query: 856 ENPESRPTMQKVCQLLK 872
           + P  R +     +L +
Sbjct: 296 KEPVHRASAM---ELRR 309

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (319), Expect = 3e-30
 Identities = 57/266 (21%), Positives = 99/266 (37%), Gaps = 47/266 (17%)

Query: 607 EHCIGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           + CI  GG G +Y   LA     +G  + +K       G+   Q   + E + L E+ H 
Sbjct: 85  KGCIAHGGLGWIY---LALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHP 139

Query: 662 NIVKVYGFCLHVRH-----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
           +IV+++ F  H         +IV EY    SL       +  + L     +  +  I+ A
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPA 194

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           LSY+H+     +V+ D+  +N++L  E +  + D G    +         L GT G+ AP
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAP 246

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           E+  T   T   D+Y+ G     +               +          +       P 
Sbjct: 247 EIVRT-GPTVATDIYTVGRTLAALTLDLPT--------RNG-------RYVDGLPEDDPV 290

Query: 837 RNVHDKLISIVEVTISCVDENPESRP 862
              +D    ++      +D +P  R 
Sbjct: 291 LKTYDSYGRLLR---RAIDPDPRQRF 313

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  120 bits (303), Expect = 5e-30
 Identities = 56/291 (19%), Positives = 107/291 (36%), Gaps = 37/291 (12%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            +     +G+GG   V + + L  G   A+K+       E   ++E   E        H 
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHP 86

Query: 662 NIVKVYGFCL----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR--MNMIKGIVD 715
           NI+++  +CL         +++  +FK  +L   +      K    T    + ++ GI  
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICR 145

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA------- 768
            L  +H        HRD+   N+LL  E +  + D G             +         
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 769 --GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI 822
              T  Y APEL    ++ + + E+ DV+S G +   ++ G+ P  +             
Sbjct: 203 QRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALA 259

Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
             +++  P+ P  S  +   L++      S +  +P  RP +  +   L+ 
Sbjct: 260 VQNQLSIPQSPRHSSALWQ-LLN------SMMTVDPHQRPHIPLLLSQLEA 303

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  118 bits (298), Expect = 2e-29
 Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 28/311 (9%)

Query: 15  SELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDL 74
                L +   +  G + ++ ++     +L  + TL      ++ +I G +        L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 75  ELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP 134
           EL +N+++  + P L NL+ +  L L  N L N   S +  L+S+  L L +  ++   P
Sbjct: 69  ELKDNQIT-DLAP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 135 HSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATL 194
             L  L+NL  LY+  N ++   +  +  L +L  L +     +  + P L NLS L TL
Sbjct: 125 --LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178

Query: 195 YLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIP 254
             D N +S  I S L +L +L  + L  N++S   P++  N SNL  + L   +++    
Sbjct: 179 KADDNKIS-DI-SPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPV 234

Query: 255 YEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYID 314
           +   NLV   ++         P  I  N T          Y + N++ +   + N     
Sbjct: 235 FYNNNLVVPNVVKGPSGAPIAPATISDNGT----------YASPNLTWNLTSFINNVSYT 284

Query: 315 LSQNNFYGEIS 325
            +Q+  +   +
Sbjct: 285 FNQSVTFKNTT 295

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 64/264 (24%), Positives = 110/264 (41%), Gaps = 20/264 (7%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
             +   +       ++ L +L  LEL +N+++  +   L NLT +  L +  N L  ++ 
Sbjct: 47  SAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS 101

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
             I   +    L+L++ +++   P  L  LSNL  LYLD N ++N   S L  L +L  L
Sbjct: 102 A-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYL 156

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
            + N  +S   P  L NL+ L TL    N +S   +  + +L +L  + L  N  +  + 
Sbjct: 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQIS-DVS 211

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
           P L N SNL  + L   +++        NL   + +           P ++ +       
Sbjct: 212 P-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASP 268

Query: 243 NLFENSLS--GAIPYEYRNLVKLT 264
           NL  N  S    + Y +   V   
Sbjct: 269 NLTWNLTSFINNVSYTFNQSVTFK 292

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 58/285 (20%), Positives = 109/285 (38%), Gaps = 21/285 (7%)

Query: 185 LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNL 244
              L+N   +    ++++        +L  ++ LS     ++    +    L+NL  L L
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLEL 70

Query: 245 FENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESF 304
            +N ++   P +  NL K+T L L  N  +  +  +  L S++ + L    +T       
Sbjct: 71  KDNQITDLAPLK--NLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD--VTPL 125

Query: 305 YIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS 364
               NL  + L  N       S       L  L      ++ ++ P + + S+L  L   
Sbjct: 126 AGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKAD 181

Query: 365 SNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSL 424
            N I  +I   L  L   I++ L +NQ+S  +SP L +   L  + L++  ++N      
Sbjct: 182 DNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYN 237

Query: 425 GNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGL 469
            NL    +    +         P+ I    +    NL+ N  S +
Sbjct: 238 NNL----VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 56/286 (19%), Positives = 111/286 (38%), Gaps = 43/286 (15%)

Query: 198 TNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY 257
           T   + ++      L +   ++ G + ++ ++  +  +L  +T L+ F   ++     +Y
Sbjct: 4   TQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQY 61

Query: 258 RNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQ 317
             L  L  L L  NQ    +  L+NLT +  + L  N L  N+  +     ++  +DL+ 
Sbjct: 62  --LNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTS 116

Query: 318 NNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELG 377
                                  I ++T      +   S L VL L  N I   I   L 
Sbjct: 117 TQ---------------------ITDVTP-----LAGLSNLQVLYLDLNQIT-NIS-PLA 148

Query: 378 KLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL 437
            L     L + + Q+S  L+P L +L +L  L    N++S+  P +     L +L E+ L
Sbjct: 149 GLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLA----SLPNLIEVHL 202

Query: 438 SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHI 483
             N + +  P  +    +L  + L++ +++         +     +
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 38/214 (17%), Positives = 83/214 (38%), Gaps = 40/214 (18%)

Query: 277 IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLST 336
           I     L +  ++   ++ +T  ++++      +T +                       
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVTQADL--DGITTLSAFGTG----------------- 52

Query: 337 LDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQL 396
               +  I G     + + + L  L+L  N I  ++   L  L    +L L+ N L   +
Sbjct: 53  ----VTTIEG-----VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NV 100

Query: 397 SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSL 456
           S  +  L  ++ LDL+S ++++  P  L  L   +L  L L  N +    P  +  + +L
Sbjct: 101 SA-IAGLQSIKTLDLTSTQITDVTP--LAGL--SNLQVLYLDLNQITNISP--LAGLTNL 153

Query: 457 EKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
           + L++ +  +S L P     ++ L  +    N++
Sbjct: 154 QYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (298), Expect = 2e-29
 Identities = 56/279 (20%), Positives = 97/279 (34%), Gaps = 36/279 (12%)

Query: 599 RATNDFDDEHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
                F     +G G  G V+       G + AVK+  SP  G    +   L EV +  +
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEK 112

Query: 658 IW-HRNIVKVYGFCLHVRHLFIVYEYFKMC--SLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           +  H   V++         L++  E    C  SL           +L   +    ++  +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTEL---CGPSLQQHCEAWG--ASLPEAQVWGYLRDTL 167

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
            AL+++H+     +VH D+   N+ L       + DFG+   L    +   +  G   Y+
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYM 223

Query: 775 APEL---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
           APEL   +Y        DV+S G+  LEV                 L         L P 
Sbjct: 224 APELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGW--QQLRQGY-----LPPE 272

Query: 832 LPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                S  +   ++         ++ +P+ R T + +  
Sbjct: 273 FTAGLSSELRS-VLV------MMLEPDPKLRATAEALLA 304

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (300), Expect = 3e-29
 Identities = 27/293 (9%), Positives = 73/293 (24%), Gaps = 43/293 (14%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +  G +  V++   +   E  A+K F        +  +       A   +   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 669 FC--------------------------LHVRHLFIVYEYFKMCSLAVILS----NDAAA 698
                                         V +  ++        L ++ S         
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 699 KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK 758
            + G      +   ++   + + +     +VH   +  N+ +  +    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---W 242

Query: 759 PDSSNWTELAGTYGYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS 816
              +     +    Y   E   A T   T   + +  G+    V     P   ++     
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 817 SLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           S           D         + D + +++      ++ +   R    +  +
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (301), Expect = 7e-29
 Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 49/306 (16%)

Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           +E+ ++  N    E  +G G  G+V       G  +AVK+          F    L E+K
Sbjct: 9   FEQSLK--NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIK 60

Query: 654 ALTEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLA-VILSNDAAAKNLGWTRRMNM-- 709
            LTE   H N+++ Y      R L+I  E     +L  ++ S + + +NL   +  N   
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 710 -IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH-------------VSDFGIAK 755
            ++ I   ++++H+     I+HRD+  +N+L+   +                +SDFG+ K
Sbjct: 120 LLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

Query: 756 FLKPDSSNWT----ELAGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVI-KG 803
            L    S++       +GT G+ APEL           ++T   D++S G +   ++ KG
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 804 KHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
           KHP     S   + +    +LDEM      +      D LIS        +D +P  RPT
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKRPT 289

Query: 864 MQKVCQ 869
             KV +
Sbjct: 290 AMKVLR 295

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (286), Expect = 5e-28
 Identities = 64/272 (23%), Positives = 107/272 (39%), Gaps = 30/272 (11%)

Query: 609 CIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
            +GKG  G VY  + L++   IA+K+            Q    E+     + H+NIV+  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLKHKNIVQYL 85

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
           G       + I  E     SL+ +L +                K I++ L Y+H++    
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 728 IVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE--LAYTMKV 784
           IVHRDI   NVL++  +    +SDFG +K L   +       GT  Y+APE         
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 785 TEKCDVYSFGVLALEVIKGKHP-RDFISSMS--FSSLNLNIALDEMLDPRLPTP-SRNVH 840
            +  D++S G   +E+  GK P  +     +  F      + + + + P +P   S    
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-----KVGMFK-VHPEIPESMSAEAK 256

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             +       + C + +P+ R        LL 
Sbjct: 257 AFI-------LKCFEPDPDKRAC---ANDLLV 278

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  117 bits (295), Expect = 8e-28
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 36/275 (13%)

Query: 607 EHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +H +G G  G VY        + +AVK         M   +EFL E   + EI H N+V+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAVMKEIKHPNLVQ 280

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           + G C      +I+ E+    +L   L      + +     + M   I  A+ Y+    F
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF 339

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTM 782
              +HR+++++N L+   +   V+DFG+++ +  D+  +T  AG      + APE     
Sbjct: 340 ---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN 394

Query: 783 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTP---S 836
           K + K DV++FGVL  E+   G  P   I             + E+L+   R+  P    
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYELLEKDYRMERPEGCP 445

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             V+       E+  +C   NP  RP+  ++ Q  
Sbjct: 446 EKVY-------ELMRACWQWNPSDRPSFAEIHQAF 473

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (285), Expect = 1e-27
 Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 43/280 (15%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           FD    +G+G  GSVY +    +G+I+A+K+   P+  ++   QE + E+  + +    +
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCDSPH 85

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDA 716
           +VK YG       L+IV EY    S++ I+            + +       +++  +  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKG 137

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           L Y+H       +HRDI + N+LL+ E  A ++DFG+A  L    +    + GT  ++AP
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP- 835
           E+   +      D++S G+ A+E+ +GK P   I  M         A+   + P  P P 
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AI--FMIPTNPPPT 244

Query: 836 ---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                   D     V+    C+ ++PE R T     QLL+
Sbjct: 245 FRKPELWSDNFTDFVKQ---CLVKSPEQRATAT---QLLQ 278

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  113 bits (284), Expect = 1e-27
 Identities = 69/307 (22%), Positives = 115/307 (37%), Gaps = 62/307 (20%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
           R  +DF++   +G+G  G V  ++        A+KK    +          L+EV  L  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTEEKLSTILSEVMLLAS 58

Query: 658 IWHRNIVKVYGFCLHVRH-------------LFIVYEY-------FKMCSLAVILSNDAA 697
           + H+ +V+ Y   L  R+             LFI  EY         + S  +    D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 698 AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL 757
            +         + + I++ALSY+H+     I+HRD+   N+ +D      + DFG+AK +
Sbjct: 119 WR---------LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

Query: 758 KPDSSNWTELA--------------GTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIK 802
                     +              GT  YVA E L  T    EK D+YS G++  E+I 
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

Query: 803 GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRP 862
                 F + M   ++   +    +  P  P    N       I+      +D +P  RP
Sbjct: 227 P-----FSTGMERVNILKKLRSVSIEFP--PDFDDNKMKVEKKIIR---LLIDHDPNKRP 276

Query: 863 TMQKVCQ 869
             + +  
Sbjct: 277 GARTLLN 283

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  112 bits (283), Expect = 1e-27
 Identities = 62/298 (20%), Positives = 105/298 (35%), Gaps = 50/298 (16%)

Query: 599 RATNDFDDEHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
           R T +F +   IG G  GSV+   K   G I A+K+   PL G    +Q  L EV A   
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAV 66

Query: 658 IW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSLA-VILSNDAAAKNLGWTRRMNMIKGIVD 715
           +  H ++V+ +       H+ I  EY    SLA  I  N             +++  +  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVS-------------------DFGIAKF 756
            L Y+H+     +VH DI   N+ +   +  + +                   D G    
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 757 LKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSF 815
           +    S+     G   ++A E L        K D+++  +  +     +           
Sbjct: 184 I----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-- 237

Query: 816 SSLNLNIALDEMLDPRLPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                 I    +  PR+P   S+   + L+         +  +PE RP+      L+K
Sbjct: 238 ----HEIRQGRL--PRIPQVLSQEFTE-LLK------VMIHPDPERRPSAM---ALVK 279

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  112 bits (281), Expect = 2e-27
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 14/226 (6%)

Query: 30  NNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPP-S 88
              L  ++P  +        +++H N +S          R  + L L +N L+  I   +
Sbjct: 20  QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAA 75

Query: 89  LGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNNILSGSIPH-SLGNLTNLATL 146
              L+ L  L L  N+   S+       L  L  L L+   L   +       L  L  L
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134

Query: 147 YIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSI 205
           Y+  N+L A       +L +L++L L  N  + S+P  +   L +L  L L  N ++  +
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HV 192

Query: 206 PSE-LGNLRSLSNLSLGYNKLSGSIPIS-MGNLSNLTYLNLFENSL 249
                 +L  L  L L  N LS ++P   +  L  L YL L +N  
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  111 bits (280), Expect = 2e-27
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 32/226 (14%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           + L  N++S     S     NL  L+L +N L+    +    L  L  L L++N    S+
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 134 P-HSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNL 191
              +   L  L TL++    L                           + P     L+ L
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQ-------------------------ELGPGLFRGLAAL 131

Query: 192 ATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSL 249
             LYL  N+L  ++P +   +L +L++L L  N++S S+P      L +L  L L +N +
Sbjct: 132 QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRV 189

Query: 250 SGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRN 294
           +   P+ +R+L +L  L L  N     P   L  L +L+ +RL+ N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  104 bits (261), Expect = 8e-25
 Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 11/204 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           ++ N +     +  R  ++L+ L L +N L+     +   L  L  L +  N+   S+  
Sbjct: 39  LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98

Query: 64  EIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLRS 118
               F     L    L    L   + P     L+ L  LYL  N+L  ++P +   +L +
Sbjct: 99  AT--FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGN 154

Query: 119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           L++L L+ N +S     +   L +L  L ++ N ++        +L  L  L L  NN +
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214

Query: 179 GSIPPS-LGNLSNLATLYLDTNSL 201
            ++P   L  L  L  L L+ N  
Sbjct: 215 -ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 92.7 bits (231), Expect = 8e-21
 Identities = 53/220 (24%), Positives = 77/220 (35%), Gaps = 18/220 (8%)

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW-GRCPKL 334
           P+ I      +    L  N ++   + SF    NLT + L  N     I +        L
Sbjct: 27  PVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALL 82

Query: 335 STLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIE----LGKLNFFIKLVLAH 389
             LD S N    +V P       +L  L L    +  E+       L  L     L L  
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ---YLYLQD 138

Query: 390 NQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPS 448
           N L   L       L  L HL L  NR+S+   ++   L    L  L L +N +    P 
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH--SLDRLLLHQNRVAHVHPH 195

Query: 449 QICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
               +  L  L L  N+LS L       +  L ++ ++ N
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 9/179 (5%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIP-HSLGNLTNLATLYIHTNSLSGSIPG 63
           ++N L     +    L  L  L+L +N    S+   +   L  L TL++    L   +  
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122

Query: 64  EIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
             G FR  + L+   L +N L  ++P  +  +L NL  L+L  N +S+        L SL
Sbjct: 123 --GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179

Query: 120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
             L L+ N ++   PH+  +L  L TLY+++N+LSA     +  L++L  L+L++N + 
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 55/281 (19%), Positives = 83/281 (29%), Gaps = 57/281 (20%)

Query: 189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENS 248
               T       L  ++P  +    +   + L  N++S     S     NLT L L  N 
Sbjct: 11  EPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67

Query: 249 LSGAIPYEYRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRNYLTGNISESFYI 306
           L+      +  L  L  L L  N     +       L  L  + LDR  L          
Sbjct: 68  LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ--------- 118

Query: 307 YPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLSS 365
                  +L    F G           L  L    N +   +P +       L  L L  
Sbjct: 119 -------ELGPGLFRG--------LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162

Query: 366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
           N I                  +      G        L  L+ L L  NR+++  P +  
Sbjct: 163 NRIS----------------SVPERAFRG--------LHSLDRLLLHQNRVAHVHPHAFR 198

Query: 426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL 466
           +L    L  L L  N L       +  +++L+ L L+ N  
Sbjct: 199 DLG--RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 44/196 (22%), Positives = 75/196 (38%), Gaps = 14/196 (7%)

Query: 306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLS 364
           I      I L  N      ++ +  C  L+ L    N +   +        + L  LDLS
Sbjct: 30  IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLS 88

Query: 365 SNHIVGEIPIE----LGKLNFFIKLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNS 419
            N  +  +       LG+L+    L L    L  +L P     L  L++L L  N L   
Sbjct: 89  DNAQLRSVDPATFHGLGRLHT---LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQAL 144

Query: 420 IPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNG 479
              +  +L   +L+ L L  N +          + SL++L L  N ++ + P  F  +  
Sbjct: 145 PDDTFRDL--GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 480 LLHIDISYNELRGSIP 495
           L+ + +  N L  ++P
Sbjct: 203 LMTLYLFANNLS-ALP 217

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 16/91 (17%), Positives = 32/91 (35%), Gaps = 5/91 (5%)

Query: 408 HLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLS 467
                   L  ++P  +          + L  N +     +     ++L  L L  N L+
Sbjct: 15  TTSCPQQGLQ-AVPVGI----PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69

Query: 468 GLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
            +  + F  +  L  +D+S N    S+  +T
Sbjct: 70  RIDAAAFTGLALLEQLDLSDNAQLRSVDPAT 100

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  111 bits (279), Expect = 3e-27
 Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 52/293 (17%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
            I    ++      IG G  G V++    + + +A+K       G M+ +++F+ E + +
Sbjct: 4   VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMS-EEDFIEEAEVM 57

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
            ++ H  +V++YG CL    + +V E+ +   L+  L              + M   + +
Sbjct: 58  MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCE 115

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSN------WT 765
            ++Y+   C    +HRD++++N L+       VSDFG+ +F+  D    S+       W 
Sbjct: 116 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIAL 824
                    +PE+    + + K DV+SFGVL  EV  +GK P +  S         N  +
Sbjct: 173 ---------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEV 214

Query: 825 DEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            E +    RL  P   S +V+       ++   C  E PE RP   ++ + L 
Sbjct: 215 VEDISTGFRLYKPRLASTHVY-------QIMNHCWRERPEDRPAFSRLLRQLA 260

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  114 bits (287), Expect = 5e-27
 Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 30/271 (11%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           E  +G G  G V+M+       +AVK      PG M+  + FL E   +  + H  +VK+
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMS-VEAFLAEANVMKTLQHDKLVKL 248

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           +        ++I+ E+    SL   L +D         + ++    I + ++++    + 
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNY- 305

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV---APELAYTMK 783
             +HRD+ + N+L+       ++DFG+A+ ++ +   +T   G    +   APE      
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGS 361

Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVH 840
            T K DV+SFG+L +E++  G+ P   +S         N  +   L+   R+P P  N  
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMS---------NPEVIRALERGYRMPRP-ENCP 411

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           ++L +I+   + C    PE RPT + +  +L
Sbjct: 412 EELYNIM---MRCWKNRPEERPTFEYIQSVL 439

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (278), Expect = 6e-27
 Identities = 64/283 (22%), Positives = 126/283 (44%), Gaps = 43/283 (15%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              +     IG+G  G+VY +  +A+G+ +A+++    L  +   +   +NE+  + E  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKE-LIINEILVMRENK 75

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGI 713
           + NIV      L    L++V EY    SL  +++             M+      + +  
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDEGQIAAVCREC 125

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGY 773
           + AL ++H++    ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           +APE+        K D++S G++A+E+I+G+ P    + +         AL   L     
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------AL--YLIATNG 232

Query: 834 TPS----RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           TP       +       +     C++ + E R + +   +LL+
Sbjct: 233 TPELQNPEKLSAIFRDFLNR---CLEMDVEKRGSAK---ELLQ 269

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (286), Expect = 6e-27
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 38/275 (13%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           E  +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 244

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVIL-SNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           Y        ++IV EY    SL   L       K L   + ++M   I   ++Y+    +
Sbjct: 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTM 782
              VHRD+ + N+L+       V+DFG+A+ ++ +   +T   G      + APE A   
Sbjct: 302 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYG 356

Query: 783 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTP---S 836
           + T K DV+SFG+L  E+  KG+ P   +          N  + + ++   R+P P    
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCPPECP 407

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            ++H       ++   C  + PE RPT + +   L
Sbjct: 408 ESLH-------DLMCQCWRKEPEERPTFEYLQAFL 435

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (278), Expect = 6e-27
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 36/277 (12%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            F     IGKG  G V+      + +++A+K     L       ++   E+  L++    
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            + K YG  L    L+I+ EY    S   +L        L  T+   +++ I+  L Y+H
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH 136

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 781
           ++     +HRDI + NVLL    E  ++DFG+A  L           GT  ++APE+   
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193

Query: 782 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP------ 835
                K D++S G+ A+E+ +G+ P   +  M          L   L P+   P      
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMK--------VL--FLIPKNNPPTLEGNY 243

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           S+ + +  +       +C+++ P  RPT     +LLK
Sbjct: 244 SKPLKE-FVE------ACLNKEPSFRPT---AKELLK 270

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  111 bits (279), Expect = 6e-27
 Identities = 70/324 (21%), Positives = 133/324 (41%), Gaps = 48/324 (14%)

Query: 563 QRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATN---DFDDEHCIGKGGQGSVY 619
               +       +     G+++   F+  +    ++   +     D    IG+G  G V 
Sbjct: 5   HHHSSGVDLGTENLYFQSGVVTHEQFKAAL--RMVVDQGDPRLLLDSYVKIGEGSTGIVC 62

Query: 620 MSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI 678
           +++   SG  +AVK     L  +   ++   NEV  + +  H N+V++Y   L    L++
Sbjct: 63  LAREKHSGRQVAVKMM--DLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119

Query: 679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIVDALSYMHNDCFPPIVHRD 732
           + E+ +  +L  I+S            R+N      + + ++ AL+Y+H      ++HRD
Sbjct: 120 LMEFLQGGALTDIVSQ----------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166

Query: 733 ISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYS 792
           I S ++LL  +    +SDFG    +  D      L GT  ++APE+        + D++S
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226

Query: 793 FGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS----RNVHDKLISIVE 848
            G++ +E++ G+ P    S +         A+        P P       V   L   +E
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQ--------AM--KRLRDSPPPKLKNSHKVSPVLRDFLE 276

Query: 849 VTISCVDENPESRPTMQKVCQLLK 872
                +  +P+ R T Q   +LL 
Sbjct: 277 R---MLVRDPQERATAQ---ELLD 294

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  109 bits (276), Expect = 6e-27
 Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 52/293 (17%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           E+ R   +      +G G  G V + K      +AVK       G M+ + EF  E + +
Sbjct: 4   ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMS-EDEFFQEAQTM 57

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
            ++ H  +VK YG C     ++IV EY     L   L +    K L  ++ + M   + +
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCE 115

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSN------WT 765
            ++++ +  F   +HRD++++N L+D +    VSDFG+ +++  D    S        W+
Sbjct: 116 GMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIAL 824
                    APE+ +  K + K DV++FG+L  EV   GK P        +     +  +
Sbjct: 173 ---------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP--------YDLYTNSEVV 215

Query: 825 DEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              +    RL  P   S  ++       ++  SC  E PE RPT Q++   ++
Sbjct: 216 -LKVSQGHRLYRPHLASDTIY-------QIMYSCWHELPEKRPTFQQLLSSIE 260

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  113 bits (284), Expect = 2e-26
 Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 36/274 (13%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           E  +G+G  G V+M        +A+K      PG M+  + FL E + + ++ H  +V++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 327

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           Y        ++IV EY    SL   L  +   K L   + ++M   I   ++Y+    + 
Sbjct: 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY- 384

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 783
             VHRD+ + N+L+       V+DFG+A+ ++ +   +T   G      + APE A   +
Sbjct: 385 --VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGR 440

Query: 784 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTP---SR 837
            T K DV+SFG+L  E+  KG+ P   +          N  + + ++   R+P P     
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCPPECPE 491

Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           ++H       ++   C  + PE RPT + +   L
Sbjct: 492 SLH-------DLMCQCWRKEPEERPTFEYLQAFL 518

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  109 bits (275), Expect = 3e-26
 Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 27/281 (9%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIW 659
            D  D   IG+G  GSV  M    SG+I+AVK+       +   Q++ L ++   +    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRM--NMIKGIVDA 716
              IV+ YG        +I  E   M  S         +  +      +   +    V A
Sbjct: 80  CPYIVQFYGALFREGDCWICMEL--MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           L+++  +    I+HRDI   N+LLD      + DFGI+  L  DS   T  AG   Y+AP
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 194

Query: 777 E----LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           E     A       + DV+S G+   E+  G+ P    +S+ F  L   +   +   P+L
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-FDQLTQ-VVKGDP--PQL 250

Query: 833 PTPSRNVH-DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                       I+ V     C+ ++   RP  +   +LLK
Sbjct: 251 SNSEEREFSPSFINFVN---LCLTKDESKRPKYK---ELLK 285

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  107 bits (270), Expect = 6e-26
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 52/292 (17%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           EI     D      +G G  G V   K      +A+K       G M+ + EF+ E K +
Sbjct: 20  EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMS-EDEFIEEAKVM 73

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
             + H  +V++YG C   R +FI+ EY     L   L            + + M K + +
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCE 131

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSN------WT 765
           A+ Y+ +  F   +HRD++++N L++ +    VSDFG+++++  D    S        W+
Sbjct: 132 AMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIAL 824
                     PE+    K + K D+++FGVL  E+   GK P +  +         N   
Sbjct: 189 ---------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------NSET 230

Query: 825 DEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            E +    RL  P   S  V+        +  SC  E  + RPT + +   +
Sbjct: 231 AEHIAQGLRLYRPHLASEKVY-------TIMYSCWHEKADERPTFKILLSNI 275

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  107 bits (270), Expect = 7e-26
 Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 52/293 (17%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKA 654
           E+ R   D   +H +G G  G VY        + +AVK         M   +EFL E   
Sbjct: 9   EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAV 62

Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           + EI H N+V++ G C      +I+ E+    +L   L  +   + +     + M   I 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQIS 121

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSN------W 764
            A+ Y+    F   +HRD++++N L+   +   V+DFG+++ +  D     +       W
Sbjct: 122 SAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178

Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIA 823
           T         APE     K + K DV++FGVL  E+   G  P   I             
Sbjct: 179 T---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQ 220

Query: 824 LDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           + E+L+   R+  P      V+       E+  +C   NP  RP+  ++ Q  
Sbjct: 221 VYELLEKDYRMERPEGCPEKVY-------ELMRACWQWNPSDRPSFAEIHQAF 266

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (272), Expect = 7e-26
 Identities = 37/274 (13%), Positives = 98/274 (35%), Gaps = 28/274 (10%)

Query: 608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
                  +      +    EI    +         +       +++ +     +N V   
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
                  +L+I  +  +  +L   ++   + ++      +++   I +A+ ++H+     
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS------------NWTELAGTYGYVA 775
           ++HRD+   N+    ++   V DFG+   +  D                T   GT  Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
           PE  +    + K D++S G++  E++   +   F + M    +     + ++ + + P  
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL---YS--FSTQMERVRI-----ITDVRNLKFPLL 294

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
               + +   +V+     +  +P  RP    + +
Sbjct: 295 FTQKYPQEHMMVQ---DMLSPSPTERPEATDIIE 325

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (269), Expect = 1e-25
 Identities = 63/298 (21%), Positives = 129/298 (43%), Gaps = 49/298 (16%)

Query: 594 YEEIIRATN---DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFL 649
           YE + R  +    ++    +G G  G VY +K   +G + A K        E   + +++
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE-DYI 64

Query: 650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN- 708
            E++ L    H  IVK+ G   H   L+I+ E+    ++  I+            R +  
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--------DRGLTE 116

Query: 709 -----MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN 763
                + + +++AL+++H+     I+HRD+ + NVL+  E +  ++DFG++         
Sbjct: 117 PQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173

Query: 764 WTELAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFSSL 818
                GT  ++APE+     + +     K D++S G+  +E+ + + P   ++ M     
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---- 229

Query: 819 NLNIALDEMLDPRLPTPS----RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                L  +   +   P+         +    +++    +D+NPE+RP+     QLL+
Sbjct: 230 ----VL--LKIAKSDPPTLLTPSKWSVEFRDFLKI---ALDKNPETRPSAA---QLLE 275

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  108 bits (272), Expect = 1e-25
 Identities = 62/304 (20%), Positives = 113/304 (37%), Gaps = 45/304 (14%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DF+    +G G  G V+ +S   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 90

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             IV  YG       + I  E+    SL  +L     A  +       +   ++  L+Y+
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYL 147

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
                  I+HRD+   N+L++   E  + DFG++  L  DS   +   GT  Y++PE   
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPERLQ 203

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHP---------------RDFISSMSFSSLNLNIALD 825
               + + D++S G+  +E+  G++P               +    +             
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 826 EMLDPRLPTPSRNVHDKLISIVEVTI-----------------SCVDENPESRPTMQKVC 868
                    P   + + L  IV                      C+ +NP  R  ++   
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK--- 320

Query: 869 QLLK 872
           QL+ 
Sbjct: 321 QLMV 324

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  106 bits (267), Expect = 2e-25
 Identities = 67/293 (22%), Positives = 111/293 (37%), Gaps = 55/293 (18%)

Query: 610 IGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +GKG  GSV M +       +GE++AVKK            ++F  E++ L  + H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 665 KVYGFCLHVRH--LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G C       L ++ EY    SL   L      + +   + +     I   + Y+  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT 132

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------------WTELAGT 770
             +   +HRD++++N+L++ EN   + DFG+ K L  D               W      
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----- 184

Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-------NIA 823
               APE     K +   DV+SFGV+  E+           +     +            
Sbjct: 185 ----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

Query: 824 LDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           L E+L    RLP P      ++        +   C + N   RP+ + +   +
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIY-------MIMTECWNNNVNQRPSFRDLALRV 286

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (272), Expect = 2e-25
 Identities = 37/297 (12%), Positives = 89/297 (29%), Gaps = 60/297 (20%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA---LTEIWH----- 660
           +G+    +   +    +GE   V   +          ++   EV     L  I +     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 661 --------------RNIVKVYGFCLHVRHLFIVYEYFKM----CSL----AVILSNDAAA 698
                             K+    L  R ++++  +F       +L     V+LS+ +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 699 KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK 758
           K+L    R+ +   ++  L+ +H+     +VH  +   +++LD      ++ F      +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 759 PDSSNWTELAGTYG---YVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFI 810
             +S  + +   +      A  +          +T   D ++ G+    +     P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 811 SSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                +     +   E +        + V   L+         +    E R    + 
Sbjct: 317 ----NTDDAA-LGGSEWIFRSCKNIPQPVRA-LLE------GFLRYPKEDRLLPLQA 361

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (268), Expect = 2e-25
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 32/281 (11%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIW 659
           ND ++   +G G  G V+ M    +G +IAVK+      G     +  L ++  +     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKSHD 82

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
              IV+ +G  +    +FI  E    C+  +          +       M   IV AL Y
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYY 139

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +       ++HRD+   N+LLD   +  + DFGI+  L  D       AG   Y+APE  
Sbjct: 140 LKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERI 196

Query: 780 YTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
                T+     + DV+S G+  +E+  G+ P     +  F  L   +  +E   P LP 
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEVLTK-VLQEEP--PLLPG 252

Query: 835 P---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               S +     +        C+ ++   RP      +LL+
Sbjct: 253 HMGFSGDFQS-FVK------DCLTKDHRKRPKYN---KLLE 283

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  106 bits (266), Expect = 2e-25
 Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 30/273 (10%)

Query: 610 IGKGGQGSVYMS--KLASGEII--AVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +G G  G V        SG+ +  AVK     +  +     +F+ EV A+  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           +YG  L    + +V E   + SL   L       +            + + + Y+ +  F
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTM 782
              +HRD++++N+LL   +   + DFG+ + L  +  ++         + + APE   T 
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 783 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP---RLPTPSRN 838
             +   D + FGV   E+   G+ P        +  LN +  L   +D    RLP P   
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQIL-HKIDKEGERLPRP--- 247

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             D    I  V + C    PE RPT   +   L
Sbjct: 248 -EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  106 bits (266), Expect = 2e-25
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 52/283 (18%)

Query: 610 IGKGGQGSVYMSKL--ASGEI-IAVKKFHSPLPGEM--TFQQEFLNEVKALTEIWHRNIV 664
           +G G  G+V             +AVK              + E L E   + ++ +  IV
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILK---NEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           ++ G C       +V E  ++  L   L  +   +++     + ++  +   + Y+    
Sbjct: 82  RMIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN 137

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------------WTELAGTYG 772
           F   VHRD++++NVLL  ++ A +SDFG++K L+ D +             W        
Sbjct: 138 F---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY------- 187

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP- 830
             APE     K + K DV+SFGVL  E    G+ P        +  +  +     ML+  
Sbjct: 188 --APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--------YRGMKGSEVT-AMLEKG 236

Query: 831 -RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            R+  P          + ++   C   + E+RP    V   L+
Sbjct: 237 ERMGCP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  107 bits (268), Expect = 3e-25
 Identities = 59/289 (20%), Positives = 103/289 (35%), Gaps = 42/289 (14%)

Query: 607 EHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIV 664
              + +GG   VY ++ + SG   A+K+  S    E    +  + EV  + ++  H NIV
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 665 KVYGFCLHVRH-------LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
           +        +         F++        L   L    +   L     + +      A+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA--------- 768
            +MH    PPI+HRD+  +N+LL  +    + DFG A  +                    
Sbjct: 150 QHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 769 ---GTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI 822
               T  Y  PE+        + EK D+++ G +   +   +HP  F        +N   
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKLRIVNGKY 266

Query: 823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           ++     P   T     H  LI       + +  NPE R ++ +V   L
Sbjct: 267 SI-----PPHDTQYTVFHS-LIR------AMLQVNPEERLSIAEVVHQL 303

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  105 bits (264), Expect = 3e-25
 Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 39/276 (14%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            DF+    +GKG  G+VY+++   S  I+A+K        +   + +   EV+  + + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 661 RNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
            NI+++YG+      ++++ EY      ++             A           I  + 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---------YITELA 119

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +ALSY H+     ++HRDI  +N+LL    E  ++DFG +    P S     L GT  Y+
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD-LCGTLDYL 174

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
            PE+       EK D++S GVL  E + GK P        F +         +       
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--------FEANTYQETYKRISRVEFTF 226

Query: 835 P---SRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
           P   +    D LIS        +  NP  RP +++V
Sbjct: 227 PDFVTEGARD-LIS------RLLKHNPSQRPMLREV 255

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  106 bits (266), Expect = 3e-25
 Identities = 58/283 (20%), Positives = 117/283 (41%), Gaps = 47/283 (16%)

Query: 609 CIGKGGQGSVYMSKLASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIWHRN--IVK 665
            IG GG   V+       +I A+K  +      +      + NE+  L ++   +  I++
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT--LDSYRNEIAYLNKLQQHSDKIIR 92

Query: 666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
           +Y + +  +++++V E      L   L      K++    R +  K +++A+  +H    
Sbjct: 93  LYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG- 147

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPEL----- 778
             IVH D+   N L+  +    + DFGIA  ++PD+++       GT  Y+ PE      
Sbjct: 148 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 779 ------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA-LDEMLDPR 831
                     K++ K DV+S G +   +  GK P        F  +   I+ L  ++DP 
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------FQQIINQISKLHAIIDPN 256

Query: 832 LPTP-----SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                     +++ D ++        C+  +P+ R ++ ++  
Sbjct: 257 HEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIPELLA 292

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  104 bits (263), Expect = 4e-25
 Identities = 62/281 (22%), Positives = 116/281 (41%), Gaps = 50/281 (17%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
              +G G  G V+M        +AVK       G M+    FL E   + ++ H+ +V++
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS-PDAFLAEANLMKQLQHQRLVRL 73

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
           Y        ++I+ EY +  SL   L   +    L   + ++M   I + ++++    + 
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNY- 130

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSN------WTELAGTYGYVAP 776
             +HRD+ + N+L+       ++DFG+A+ ++ +             WT         AP
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------AP 179

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLP 833
           E       T K DV+SFG+L  E++  G+ P   ++         N  + + L+   R+ 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMV 230

Query: 834 TP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            P      ++       ++   C  E PE RPT   +  +L
Sbjct: 231 RPDNCPEELY-------QLMRLCWKERPEDRPTFDYLRSVL 264

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  110 bits (275), Expect = 4e-25
 Identities = 64/335 (19%), Positives = 113/335 (33%), Gaps = 19/335 (5%)

Query: 23  LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLS 82
           + +    +  +    P             +   S++ ++            +  +N+ + 
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 83  GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTN 142
            S+   +  L N+  L+L+ N L++     L NL++L  L L+ N +   +  SL +L  
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKK 110

Query: 143 LATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS 202
           L +L +  N +S   +  + +L  L +L L  N    +    L  L+ L TL L+ N +S
Sbjct: 111 LKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS 166

Query: 203 YSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVK 262
             I   L  L  L NL L  N +S    ++   L NL  L LF             NLV 
Sbjct: 167 -DI-VPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 263 LTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG 322
              +         P  I  +    E+  +  +        SF  Y  +T           
Sbjct: 223 PNTVKNTDGSLVTPEII-SDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGR 281

Query: 323 EISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQ 357
                         +D ++          I     
Sbjct: 282 VTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKP 316

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  101 bits (253), Expect = 2e-22
 Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 18/263 (6%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
            +   S+ D++      L S+  +   N+ +  S+   +  L N+  L+++ N L+  I 
Sbjct: 27  NLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIK 81

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
             + N +    L L  NK+   +   L +L  L +L L+ N +S+     L +L  L +L
Sbjct: 82  P-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDING--LVHLPQLESL 136

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
            L NN ++      L  LT L TL +  N +S   +  +  L  L NL LS+N+ +  + 
Sbjct: 137 YLGNNKIT--DITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHIS-DLR 191

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
             L  L NL  L L +        +   NL   + +      L     IS  +  +    
Sbjct: 192 A-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKP 248

Query: 243 NLFENSLSGAIPYEYRNLVKLTI 265
           N+  +         +     +TI
Sbjct: 249 NVKWHLPEFTNEVSFIFYQPVTI 271

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 93.6 bits (232), Expect = 6e-20
 Identities = 57/276 (20%), Positives = 100/276 (36%), Gaps = 25/276 (9%)

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           +      +  +    P            +L    ++ ++  +   L+++  +    + + 
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNL 310
                +Y  L  +T L L  N+    I  L NL +L  + LD N +  ++  S      L
Sbjct: 57  SVQGIQY--LPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKL 111

Query: 311 TYIDLSQNNFYGEIS--SDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHI 368
             + L  N     IS  +     P+L +L    N IT ++   +   ++L  L L  N I
Sbjct: 112 KSLSLEHNG----ISDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 165

Query: 369 VGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE 428
             +I   L  L     L L+ N +S  L   L  L  L+ L+L S    N       N  
Sbjct: 166 S-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSN-- 219

Query: 429 LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN 464
           L+  + +  +   L    P  I      EK N+  +
Sbjct: 220 LVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 88.6 bits (219), Expect = 3e-18
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 14/209 (6%)

Query: 15  SELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDL 74
             L NLK+L  L L  NK+   +  SL +L  L +L +  N +S  I G + +      L
Sbjct: 81  KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESL 136

Query: 75  ELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP 134
            L NNK++  I   L  L+ L TL L+ N +S+     L  L  L NL L+ N +S  + 
Sbjct: 137 YLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLR 191

Query: 135 HSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG----SIPPSLGNLSN 190
            +L  L NL  L ++S       +    NL   + ++ ++ +       S        + 
Sbjct: 192 -ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNV 250

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLS 219
              L   TN +S+     +   ++ +   
Sbjct: 251 KWHLPEFTNEVSFIFYQPVTIGKAKARFH 279

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 83.6 bits (206), Expect = 1e-16
 Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 24/223 (10%)

Query: 277 IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISS--DWGRCPKL 334
           I          +  L +  +T  ++++     ++  I  + ++    I S       P +
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSD----IKSVQGIQYLPNV 67

Query: 335 STLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQLS 393
           + L  + N +T ++ P + +   LG L L  N I     ++ L KL     L L HN +S
Sbjct: 68  TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSSLKDLKKLK---SLSLEHNGIS 122

Query: 394 GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
             ++  L  L QLE L L +N++++     L  L    L  L L  N + +     +  +
Sbjct: 123 -DING-LVHLPQLESLYLGNNKITD--ITVLSRL--TKLDTLSLEDNQISDI--VPLAGL 174

Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
             L+ L LS N +S L       +  L  +++   E      N
Sbjct: 175 TKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 215

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 82.8 bits (204), Expect = 2e-16
 Identities = 42/242 (17%), Positives = 87/242 (35%), Gaps = 23/242 (9%)

Query: 259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
              +     L              L S++++  + + +  ++ +     PN+T + L+ N
Sbjct: 19  AFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 75

Query: 319 NFYGEIS--SDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIEL 376
                ++          L  L    N I  ++   +    +L  L L  N I  +I   L
Sbjct: 76  K----LTDIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GL 127

Query: 377 GKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE-LIHLSEL 435
             L     L L +N+++  ++  L  L +L+ L L  N++S+     +  L  L  L  L
Sbjct: 128 VHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-----IVPLAGLTKLQNL 180

Query: 436 DLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIP 495
            LS+N + +     +  +++L+ L L          +    +     +  +   L     
Sbjct: 181 YLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238

Query: 496 NS 497
            S
Sbjct: 239 IS 240

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 4e-25
 Identities = 67/296 (22%), Positives = 111/296 (37%), Gaps = 55/296 (18%)

Query: 607 EHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
              +GKG  GSV M +       +GE++AVKK            ++F  E++ L  + H 
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHD 102

Query: 662 NIVKVYGFCLHVRH--LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           NIVK  G C       L ++ EY    SL   L      + +   + +     I   + Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEY 160

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------------WTEL 767
           +    +   +HRD++++N+L++ EN   + DFG+ K L  D               W   
Sbjct: 161 LGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-- 215

Query: 768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL------- 820
                  APE     K +   DV+SFGV+  E+           +     +         
Sbjct: 216 -------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268

Query: 821 NIALDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
              L E+L    RLP P      ++        +   C + N   RP+ + +   +
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIY-------MIMTECWNNNVNQRPSFRDLALRV 317

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  106 bits (266), Expect = 5e-25
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 58/299 (19%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQ-EFLN 650
           EI    +    E  IG G  G V   +L      ++ +A+K       G    Q+ +FL+
Sbjct: 45  EIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLS 99

Query: 651 EVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
           E   + +  H NI+++ G     R   IV EY +  SL   L            + + M+
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGML 157

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------- 763
           +G+   + Y+ +  +   VHRD++++NVL+D      VSDFG+++ L+ D          
Sbjct: 158 RGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214

Query: 764 -----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSS 817
                WT         APE       +   DV+SFGV+  EV+  G+ P        + +
Sbjct: 215 KIPIRWT---------APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP--------YWN 257

Query: 818 LNLNIALDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           +     +   ++   RLP P      +H       ++ + C  ++   RP   ++  +L
Sbjct: 258 MTNRDVI-SSVEEGYRLPAPMGCPHALH-------QLMLDCWHKDRAQRPRFSQIVSVL 308

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (263), Expect = 5e-25
 Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 35/283 (12%)

Query: 602 NDFDDEHCIGKGGQGSVY-MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIW 659
           +D +    +G+G  G V  M  + SG+I+AVK+           Q+  L ++  ++  + 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVD 64

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
               V  YG       ++I  E                 + +       +   IV AL +
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-- 777
           +H+     ++HRD+   NVL++   +  + DFGI+ +L  D       AG   Y+APE  
Sbjct: 125 LHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181

Query: 778 ------LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
                   Y++    K D++S G+  +E+   + P  + S  +       +  +    P+
Sbjct: 182 NPELNQKGYSV----KSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVVEEP--SPQ 233

Query: 832 LPTP--SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           LP    S    D   S       C+ +N + RPT     +L++
Sbjct: 234 LPADKFSAEFVD-FTS------QCLKKNSKERPTYP---ELMQ 266

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (266), Expect = 6e-25
 Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 37/278 (13%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   IG G  G+VY ++ + + E++A+KK            Q+ + EV+ L ++ H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMC--SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            ++  G  L     ++V EY   C  S + +L  +   K L       +  G +  L+Y+
Sbjct: 116 TIQYRGCYLREHTAWLVMEY---CLGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRD+ + N+LL       + DFG A  + P +S      GT  ++APE+  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVIL 223

Query: 781 TMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-- 835
            M   +   K DV+S G+  +E+ + K P   +++MS        AL      +  +P  
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------AL--YHIAQNESPAL 273

Query: 836 -SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            S +  +   + V+    C+ + P+ RPT +    LLK
Sbjct: 274 QSGHWSEYFRNFVDS---CLQKIPQDRPTSE---VLLK 305

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (270), Expect = 8e-25
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 42/276 (15%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
              IGKG  G V +     G  +AVK             Q FL E   +T++ H N+V++
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 251

Query: 667 YGFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
            G  +  +  L+IV EY    SL   L +      LG    +     + +A+ Y+  + F
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF 310

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELA 779
              VHRD++++NVL+  +N A VSDFG+ K              WT         APE  
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 358

Query: 780 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPS 836
              K + K DV+SFG+L  E+   G+ P   I             +   ++   ++  P 
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPRVEKGYKMDAP- 408

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                 +  ++    +C   +  +RPT  ++ + L+
Sbjct: 409 DGCPPAVYDVM---KNCWHLDAATRPTFLQLREQLE 441

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (264), Expect = 9e-25
 Identities = 55/274 (20%), Positives = 104/274 (37%), Gaps = 51/274 (18%)

Query: 610 IGKGGQGSVYMSKL----ASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWHRNI 663
           +G G  G+VY           +I +A+K+             +E L+E   +  + + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
            ++ G CL    + ++ +      L   +       N+G    +N    I   ++Y+ + 
Sbjct: 80  CRLLGICLT-STVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-----------NWTELAGTYG 772
                VHRD++++NVL+       ++DFG+AK L  +              W        
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP- 830
             A E       T + DV+S+GV   E++  G  P        +  +     +  +L+  
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------YDGIP-ASEISSILEKG 235

Query: 831 -RLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
            RLP P        I +  +   C   + +SRP 
Sbjct: 236 ERLPQP----PICTIDVYMIMRKCWMIDADSRPK 265

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  105 bits (264), Expect = 1e-24
 Identities = 57/278 (20%), Positives = 112/278 (40%), Gaps = 37/278 (13%)

Query: 609 CIGKGGQGSVYMSKLASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIV 664
            IG GG   V+       +I A+K           +     + NE+  L ++      I+
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 72

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           ++Y + +  +++++V E      L   L      K++    R +  K +++A+  +H   
Sbjct: 73  RLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPEL---- 778
              IVH D+   N L+  +    + DFGIA  ++PD+++       GT  Y+ PE     
Sbjct: 129 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 779 -------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
                      K++ K DV+S G +   +  GK P  F   ++  S    I         
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEF 242

Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
              P +++ D ++        C+  +P+ R ++ ++  
Sbjct: 243 PDIPEKDLQD-VLK------CCLKRDPKQRISIPELLA 273

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (260), Expect = 1e-24
 Identities = 72/279 (25%), Positives = 115/279 (41%), Gaps = 48/279 (17%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
              IGKG  G V +     G  +AVK             Q FL E   +T++ H N+V++
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 79

Query: 667 YGFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF 725
            G  +  +  L+IV EY    SL   L +      LG    +     + +A+ Y+  + F
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF 138

Query: 726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELA 779
              VHRD++++NVL+  +N A VSDFG+ K              WT         APE  
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 186

Query: 780 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTP- 835
              K + K DV+SFG+L  E+   G+ P   I             +   ++   ++  P 
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPRVEKGYKMDAPD 237

Query: 836 --SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                V+       EV  +C   +   RP+  ++ + L+
Sbjct: 238 GCPPAVY-------EVMKNCWHLDAAMRPSFLQLREQLE 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  103 bits (260), Expect = 1e-24
 Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 54/287 (18%)

Query: 607 EHCIGKGGQGSVYMSKL--ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +  +G G  GSV          +I +A+K             +E + E + + ++ +  I
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYI 72

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V++ G C     L +V E      L   L      + +  +    ++  +   + Y+   
Sbjct: 73  VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------------WTELAGTY 771
            F   VHRD++++NVLL   + A +SDFG++K L  D S             W       
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY------ 180

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP 830
              APE     K + + DV+S+GV   E +  G+ P        +  +     +   ++ 
Sbjct: 181 ---APECINFRKFSSRSDVWSYGVTMWEALSYGQKP--------YKKMKGPEVM-AFIEQ 228

Query: 831 --RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             R+  P      ++        +   C     E RP    V Q ++
Sbjct: 229 GKRMECPPECPPELY-------ALMSDCWIYKWEDRPDFLTVEQRMR 268

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (265), Expect = 1e-24
 Identities = 57/284 (20%), Positives = 114/284 (40%), Gaps = 49/284 (17%)

Query: 609 CIGKGGQGSVYMSKLASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIV 664
            IG GG   V+       +I A+K           +     + NE+  L ++      I+
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 119

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           ++Y + +  +++++V E      L   L      K++    R +  K +++A+  +H   
Sbjct: 120 RLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPEL---- 778
              IVH D+   N L+  +    + DFGIA  ++PD+++  +    G   Y+ PE     
Sbjct: 176 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 779 -------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-ALDEMLDP 830
                      K++ K DV+S G +   +  GK P        F  +   I  L  ++DP
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------FQQIINQISKLHAIIDP 283

Query: 831 RLPTP-----SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                      +++ D ++        C+  +P+ R ++ ++  
Sbjct: 284 NHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIPELLA 320

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  103 bits (260), Expect = 2e-24
 Identities = 69/304 (22%), Positives = 128/304 (42%), Gaps = 64/304 (21%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +D++ +  IG G    V  +      E +A+K+    L    T   E L E++A+++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MIKGIV 714
            NIV  Y   +    L++V +     S+  I+ +   AK    +  ++      +++ ++
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSGVLDESTIATILREVL 131

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA------ 768
           + L Y+H +     +HRD+ + N+LL  +    ++DFG++ FL     + T         
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA-TGGDITRNKVRKTFV 187

Query: 769 GTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA 823
           GT  ++APE+      Y      K D++SFG+ A+E+  G  P        +        
Sbjct: 188 GTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAP--------YHKYPPMKV 235

Query: 824 LDEMLDPRLPTP---------------SRNVHDKLISIVEVTISCVDENPESRPTMQKVC 868
           L  ML  +   P                ++    +IS       C+ ++PE RPT  +  
Sbjct: 236 L--MLTLQNDPPSLETGVQDKEMLKKYGKSFRK-MIS------LCLQKDPEKRPTAAE-- 284

Query: 869 QLLK 872
            LL+
Sbjct: 285 -LLR 287

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  104 bits (261), Expect = 2e-24
 Identities = 69/295 (23%), Positives = 109/295 (36%), Gaps = 54/295 (18%)

Query: 607 EHCIGKGGQGSVYM-----SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
              +GKG  GSV +         +G ++AVK+           Q++F  E++ L  +   
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSD 84

Query: 662 NIVKVYGFCLHVRH--LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
            IVK  G         L +V EY     L   L    A   L  +R +     I   + Y
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEY 142

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS------------NWTEL 767
           + +      VHRD++++N+L++ E    ++DFG+AK L  D               W   
Sbjct: 143 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197

Query: 768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNL--NIAL 824
                  APE       + + DV+SFGV+  E+           +             AL
Sbjct: 198 -------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250

Query: 825 DEMLDP-----RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             +L+      RLP P      VH       E+   C   +P+ RP+   +   L
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVH-------ELMKLCWAPSPQDRPSFSALGPQL 298

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (258), Expect = 2e-24
 Identities = 56/305 (18%), Positives = 114/305 (37%), Gaps = 59/305 (19%)

Query: 593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSKL-------ASGEI-IAVKKFHSPLPGEMTF 644
           ++ +I     D      +G+G    ++              E  + +K           +
Sbjct: 1   VFHKIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNY 55

Query: 645 QQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWT 704
            + F      ++++ H+++V  YG C+      +V E+ K  SL   L  +    N+ W 
Sbjct: 56  SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW- 114

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH--------VSDFGIAKF 756
            ++ + K +  A+ ++  +     +H ++ +KN+LL  E +          +SD GI+  
Sbjct: 115 -KLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170

Query: 757 LKPDSS-----NWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDF 809
           + P         W           PE +     +    D +SFG    E+   G  P   
Sbjct: 171 VLPKDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--- 218

Query: 810 ISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                 S+L+    L +  +   +LP P      K   +  +  +C+D  P+ RP+ + +
Sbjct: 219 -----LSALDSQRKL-QFYEDRHQLPAP------KAAELANLINNCMDYEPDHRPSFRAI 266

Query: 868 CQLLK 872
            + L 
Sbjct: 267 IRDLN 271

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  102 bits (257), Expect = 3e-24
 Identities = 31/260 (11%), Positives = 59/260 (22%), Gaps = 47/260 (18%)

Query: 607 EHCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
               G       +    A        +A+              QE L+    L+ I    
Sbjct: 36  LIFHGGVPPLQFW---QALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           + +V           +V E+ +  SL      + A  +      +  ++ +  A    H 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQ-----EVADTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                +         V         VS  G                     +        
Sbjct: 148 A---GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD------ 178

Query: 783 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK 842
               + D+   G     ++  + P     +   S L      +     +   P+    D 
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLA---PAERDTAGQPIEPADIDRDI 232

Query: 843 LISIVEVTISCVDENPESRP 862
              I  V    V  +   R 
Sbjct: 233 PFQISAVAARSVQGDGGIRS 252

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  103 bits (258), Expect = 3e-24
 Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 53/295 (17%)

Query: 607 EHCIGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
              +G+G  G V + +       +GE +AVK    P  G      +   E++ L  ++H 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH-IADLKKEIEILRNLYHE 83

Query: 662 NIVKVYGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           NIVK  G C       + ++ E+    SL   L  +     +   +++     I   + Y
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDY 141

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------------WTEL 767
           + +  +   VHRD++++NVL++ E++  + DFG+ K ++ D               W   
Sbjct: 142 LGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196

Query: 768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLN-----LN 821
                  APE     K     DV+SFGV   E++         ++               
Sbjct: 197 -------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249

Query: 822 IALDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             L   L    RLP P      V+       ++   C +  P +R + Q + +  
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVY-------QLMRKCWEFQPSNRTSFQNLIEGF 297

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  106 bits (266), Expect = 6e-24
 Identities = 59/290 (20%), Positives = 113/290 (38%), Gaps = 39/290 (13%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKL--ASGEI-IAVKKFHSPLPGEMTFQQEFLNEV 652
            + R      D   +G G  GSV          +I +A+K             +E + E 
Sbjct: 331 FLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREA 387

Query: 653 KALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL-AVILSNDAAAKNLGWTRRMNMIK 711
           + + ++ +  IV++ G C     L +V E      L   ++      + +  +    ++ 
Sbjct: 388 QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLH 443

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT- 770
            +   + Y+    F   VHR+++++NVLL   + A +SDFG++K L  D S +T  +   
Sbjct: 444 QVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500

Query: 771 --YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEM 827
               + APE     K + + DV+S+GV   E +  G+ P        +  +     +   
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--------YKKMKGPEVM-AF 551

Query: 828 LDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++   R+  P      ++        +   C     E RP    V Q ++
Sbjct: 552 IEQGKRMECPPECPPELY-------ALMSDCWIYKWEDRPDFLTVEQRMR 594

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  101 bits (254), Expect = 6e-24
 Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 20/223 (8%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
            IP  L    S  +L+L  N L     +S  +   L  L +    +  +I    G ++  
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE--DGAYQSL 75

Query: 72  SDLE---LSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNN 126
           S L    L+ N +  S+       LS+L  L     +L+ S+ +   G+L++L  L + +
Sbjct: 76  SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAH 133

Query: 127 N-ILSGSIPHSLGNLTNLATLYIYSN---SLSASILGKIGNLKSLS-NLQLSENNFNGSI 181
           N I S  +P    NLTNL  L + SN   S+  + L  +  +  L+ +L LS N  N  I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 182 PPSLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYN 223
            P       L  L LDTN L  S+P      L SL  + L  N
Sbjct: 193 QPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 58/228 (25%), Positives = 90/228 (39%), Gaps = 18/228 (7%)

Query: 77  SNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHS 136
                   IP +L    +   L L  N L +       +   L  L L+   +  +I   
Sbjct: 15  MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70

Query: 137 L-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL-GNLSNLATL 194
              +L++L+TL +  N + +  LG    L SL  L   E N   S+     G+L  L  L
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKEL 129

Query: 195 YLDTNSLSYSIPSE--LGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTY----LNLFEN 247
            +  N +  S        NL +L +L L  NK+  SI  +    L  +      L+L  N
Sbjct: 130 NVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 248 SLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRN 294
            ++  I       ++L  L L  NQ +  P  I   LTSL+++ L  N
Sbjct: 188 PMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 18/215 (8%)

Query: 284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISS-DWG---RCPKLSTLDF 339
            S + + L  N L    S SF+ +P L  +DLS+      I + + G       LSTL  
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE----IQTIEDGAYQSLSHLSTLIL 83

Query: 340 SINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
           + N I  ++        S L  L     ++       +G L    +L +AHN +     P
Sbjct: 84  TGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 399 KL-GSLVQLEHLDLSSNRLSNSIP----KSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
           +   +L  LEHLDLSSN++  SI     + L  + L++L  LDLS N +   I       
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL-SLDLSLNPMNF-IQPGAFKE 199

Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
             L++L L  N L  +    F+++  L  I +  N
Sbjct: 200 IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 14/180 (7%)

Query: 5   YNNSLYDSIPSEL-RNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIP 62
               +  +I     ++L  LS L L  N +  S+       L++L  L     +L+ S+ 
Sbjct: 60  SRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLE 116

Query: 63  -GEIGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSE----LGNL 116
              IG+ +   +L +++N +     P    NL+NL  L L +N +  SI       L  +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQM 175

Query: 117 RSLS-NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSEN 175
             L+ +L L+ N ++  I         L  L + +N L +   G    L SL  + L  N
Sbjct: 176 PLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 41/197 (20%), Positives = 75/197 (38%), Gaps = 13/197 (6%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSN 238
            IP +L    +   L L  N L +       +   L  L L   ++  +I      +LS+
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 239 LTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYL 296
           L+ L L  N +  ++    +  L  L  L+             + +L +L+ + +  N +
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 297 TGNIS-ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKL----STLDFSINNITGNVPPE 351
                 E F    NL ++DLS N       +D     ++     +LD S+N +   + P 
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195

Query: 352 IGHSSQLGVLDLSSNHI 368
                +L  L L +N +
Sbjct: 196 AFKEIRLKELALDTNQL 212

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 29/119 (24%), Positives = 51/119 (42%), Gaps = 7/119 (5%)

Query: 384 KLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFL 442
            L L+ N L   L      S  +L+ LDLS   +  +I        L HLS L L+ N +
Sbjct: 32  NLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ-SLSHLSTLILTGNPI 88

Query: 443 REAIPSQI-CIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTF 500
           + ++       + SL+KL     +L+ L       +  L  +++++N ++ S      F
Sbjct: 89  Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF 145

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 5/94 (5%)

Query: 406 LEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICI-MQSLEKLNLSHN 464
            ++LDLS N L +    S  +     L  LDLSR  ++  I       +  L  L L+ N
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSF--PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 465 SLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
            +  L    F  ++ L  +      L  S+ N  
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLA-SLENFP 119

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 6e-24
 Identities = 73/294 (24%), Positives = 123/294 (41%), Gaps = 52/294 (17%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              F+    +G G  G VY  + + +G++ A+K     + G+   ++E   E+  L +  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE--EEEIKQEINMLKKYS 78

Query: 660 -HRNIVKVYG------FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN---- 708
            HRNI   YG             L++V E+    S+  ++ N            +     
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWI 131

Query: 709 --MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
             + + I+  LS++H      ++HRDI  +NVLL    E  + DFG++  L         
Sbjct: 132 AYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188

Query: 767 LAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN 821
             GT  ++APE+    +  +     K D++S G+ A+E+ +G  P   +  M        
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------- 241

Query: 822 IALDEMLDPRLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            AL   L PR P P   S+    K  S +E    C+ +N   RP  +   QL+K
Sbjct: 242 -AL--FLIPRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRPATE---QLMK 286

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (255), Expect = 8e-24
 Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 55/293 (18%)

Query: 610 IGKGGQGSVYM-----SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV 664
           +G+G  G V +     +   +GE++AVK       G    +  +  E+  L  ++H +I+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQH-RSGWKQEIDILRTLYHEHII 96

Query: 665 KVYGFCLHVRH--LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           K  G C       L +V EY  + SL   L       ++G  + +   + I + ++Y+H 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------------WTELAGT 770
             +   +HRD++++NVLLD +    + DFG+AK +                  W      
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----- 204

Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLN-----LNIAL 824
               APE     K     DV+SFGV   E++      +   +               + L
Sbjct: 205 ----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260

Query: 825 DEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            E+L+   RLP P      V+        +  +C +     RPT + +  +LK
Sbjct: 261 TELLERGERLPRPDKCPAEVY-------HLMKNCWETEASFRPTFENLIPILK 306

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  101 bits (253), Expect = 1e-23
 Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           +DFD    +GKG  G+VY+++   +  I+A+K        +   + +   E++  + + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 661 RNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
            NI+++Y +    + ++++ E+      +K            +A           ++ + 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT---------FMEELA 124

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           DAL Y H      ++HRDI  +N+L+ ++ E  ++DFG +    P     T + GT  Y+
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYL 179

Query: 775 APEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            PE+     +  KV    D++  GVL  E + G  P
Sbjct: 180 PPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP 211

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (254), Expect = 3e-23
 Identities = 36/235 (15%), Positives = 73/235 (31%), Gaps = 27/235 (11%)

Query: 593 IYEEIIRATNDFDDEHCIGKGGQGSVYM------SKLASGEIIAVKKFHSPLPGEMTFQQ 646
              E    +      H +G+G    VY       +   + +   +K      P E     
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---Y 112

Query: 647 EFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSL--AVILSNDAAAKNLGWT 704
                ++ L        +K Y   L      +V E +   +L  A+ L  +   K +   
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH-----------VSDFGI 753
             ++    ++  +  +H+     I+H DI   N +L                  + D G 
Sbjct: 173 LVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 754 AKFLK--PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +  +K  P  + +T    T G+   E+        + D +        ++ G + 
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =   99 bits (250), Expect = 3e-23
 Identities = 58/280 (20%), Positives = 112/280 (40%), Gaps = 43/280 (15%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            +     +GKGG    +      + E+ A K     L  +   +++   E+     + H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 662 NIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           ++V  +GF      +F+V E        ++      L+   A            ++ IV 
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY---------YLRQIVL 126

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
              Y+H +    ++HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+A
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-----NIALDEMLDP 830
           PE+      + + DV+S G +   ++ GK P        F +  L      I  +E   P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--------FETSCLKETYLRIKKNEYSIP 235

Query: 831 R-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           + +   + +    LI         +  +P +RPT+ ++  
Sbjct: 236 KHINPVAAS----LIQ------KMLQTDPTARPTINELLN 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (252), Expect = 3e-23
 Identities = 58/273 (21%), Positives = 111/273 (40%), Gaps = 43/273 (15%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKGG    +      + E+ A K     L  +   +++   E+     + H+++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 669 FCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           F      +F+V E        ++      L+   A            ++ IV    Y+H 
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY---------YLRQIVLGCQYLHR 159

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
           +    ++HRD+   N+ L+ + E  + DFG+A  ++ D      L GT  Y+APE+    
Sbjct: 160 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216

Query: 783 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-----NIALDEMLDPR-LPTPS 836
             + + DV+S G +   ++ GK P        F +  L      I  +E   P+ +   +
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPP--------FETSCLKETYLRIKKNEYSIPKHINPVA 268

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            +    LI         +  +P +RPT+ ++  
Sbjct: 269 AS----LIQ------KMLQTDPTARPTINELLN 291

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (251), Expect = 4e-23
 Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 59/301 (19%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKL----ASGEI-IAVKKFHSPLPGEMTFQQ-EFL 649
           EI    +    +  IG G  G VY   L       E+ +A+K       G    Q+ +FL
Sbjct: 40  EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFL 94

Query: 650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM 709
            E   + +  H NI+++ G     + + I+ EY +  +L   L            + + M
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGM 152

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------ 763
           ++GI   + Y+ N  +   VHRD++++N+L++      VSDFG+++ L+ D         
Sbjct: 153 LRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209

Query: 764 ------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFS 816
                 WT         APE     K T   DV+SFG++  EV+  G+ P        + 
Sbjct: 210 GKIPIRWT---------APEAISYRKFTSASDVWSFGIVMWEVMTYGERP--------YW 252

Query: 817 SLNLNIALDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            L+ +  + + ++   RLPTP      ++       ++ + C  +    RP    +  +L
Sbjct: 253 ELSNHEVM-KAINDGFRLPTPMDCPSAIY-------QLMMQCWQQERARRPKFADIVSIL 304

Query: 872 K 872
            
Sbjct: 305 D 305

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 96.6 bits (241), Expect = 5e-23
 Identities = 33/182 (18%), Positives = 68/182 (37%), Gaps = 10/182 (5%)

Query: 91  NLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYS 150
                    L  +S +N   +++ +L  +    L N  ++      +    N+  L I +
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 151 NSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELG 210
                +    I  L +L  L++   +      P+L  L++L  L +  ++   SI +++ 
Sbjct: 76  IHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 211 NLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGH 270
            L  ++++ L YN     I   +  L  L  LN+  + +      E  +  KL  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFS 190

Query: 271 NQ 272
             
Sbjct: 191 QT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 95.8 bits (239), Expect = 9e-23
 Identities = 33/185 (17%), Positives = 72/185 (38%), Gaps = 10/185 (5%)

Query: 43  NLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT 102
                    +  +S +     ++ +      + L+N  ++  +   +    N+  L ++ 
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG 162
              +N   + +  L +L  L++    ++     +L  LT+L  L I  ++   SIL KI 
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGY 222
            L  ++++ LS N     I P L  L  L +L +  + +       + +   L+ L    
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFS 190

Query: 223 NKLSG 227
             + G
Sbjct: 191 QTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 28/184 (15%), Positives = 69/184 (37%), Gaps = 9/184 (4%)

Query: 115 NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE 174
             ++  N  L  +  +     +   + +L  + + + +++  + G I    ++ +L ++ 
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 175 NNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMG 234
            +     P  +  LSNL  L +    ++      L  L SL+ L + ++    SI   + 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 235 NLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRN 294
            L  +  ++L  N     I    + L +L  L +  +        + +   L ++     
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQ 191

Query: 295 YLTG 298
            + G
Sbjct: 192 TIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 90.8 bits (226), Expect = 6e-21
 Identities = 30/177 (16%), Positives = 68/177 (38%), Gaps = 10/177 (5%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
            +  +S  +   +++ +L  ++   L N  ++      +    N+  L I+    +   P
Sbjct: 29  LLGQSSTANITEAQMNSLTYIT---LANINVTDLTG--IEYAHNIKDLTINNIHATNYNP 83

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
             I        L +    ++    P+L  L++L  L +  ++  +SI +++  L  ++++
Sbjct: 84  --ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
            L+ N     I   L  L  L +L I  + +       I +   L+ L        G
Sbjct: 142 DLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 31/187 (16%), Positives = 70/187 (37%), Gaps = 15/187 (8%)

Query: 163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGY 222
             K+  N  L +++   +   +   +++L  + L   +++  + + +    ++ +L++  
Sbjct: 21  TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 223 NKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILR 281
              +   PIS   LSNL  L +    ++         L  LT+L + H+      +  + 
Sbjct: 76  IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 282 NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEIS--SDWGRCPKLSTLDF 339
            L  +  + L  N    +I       P L  +++  +     +         PKL+ L  
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG----VHDYRGIEDFPKLNQLYA 188

Query: 340 SINNITG 346
               I G
Sbjct: 189 FSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 29/159 (18%), Positives = 62/159 (38%), Gaps = 9/159 (5%)

Query: 332 PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQ 391
             L+ +  +  N+T ++   I ++  +  L +++ H     P  +  L+   +L +    
Sbjct: 44  NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99

Query: 392 LSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQIC 451
           ++    P L  L  L  LD+S +   +SI   +  L    ++ +DLS N     I   + 
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP--KVNSIDLSYNGAITDI-MPLK 156

Query: 452 IMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
            +  L+ LN+  + +        E    L  +      +
Sbjct: 157 TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 23/116 (19%), Positives = 50/116 (43%), Gaps = 6/116 (5%)

Query: 373 PIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHL 432
            I   ++N    + LA+  ++  L+  +     ++ L +++   +N  P S     L +L
Sbjct: 37  NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNPIS----GLSNL 90

Query: 433 SELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
             L +    +       +  + SL  L++SH++    I +    +  +  ID+SYN
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 16/96 (16%), Positives = 39/96 (40%), Gaps = 8/96 (8%)

Query: 403 LVQLEHLDLSSNRLSNSIPKSLGNLE-LIHLSELDLSRNFLREAIPSQICIMQSLEKLNL 461
           +  L ++ L++  ++      L  +E   ++ +L ++        P  I  + +LE+L +
Sbjct: 43  MNSLTYITLANINVT-----DLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95

Query: 462 SHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
               ++         +  L  +DIS++    SI   
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  100 bits (252), Expect = 5e-23
 Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 56/288 (19%)

Query: 607 EHCIGKGGQGSVYMSKL---ASGEI-IAVKKFHSPLPGEMTFQQ-EFLNEVKALTEIWHR 661
           +  +G G  G V   +L   +  EI +A+K       G    Q+ +FL E   + +  H 
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHP 106

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NI+++ G     + + IV EY +  SL   L            + + M++GI   + Y+ 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS 164

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN------------WTELAG 769
           +  +   VHRD++++N+L++      VSDFG+ + L+ D               WT    
Sbjct: 165 DMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEML 828
                +PE     K T   DV+S+G++  EV+  G+ P        +  ++    + + +
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVI-KAV 263

Query: 829 DP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           D   RLP P      ++       ++ + C  ++  +RP  +++  +L
Sbjct: 264 DEGYRLPPPMDCPAALY-------QLMLDCWQKDRNNRPKFEQIVSIL 304

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 11/207 (5%)

Query: 43  NLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT 102
            + +   +     +L+ ++P ++   +  + L LS N L      +L   + L  L LD 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG 162
             L+  +  + G L  L  L L++N L  S+P     L  L  L +  N L++  LG + 
Sbjct: 65  AELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 163 NLKSLSNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSL 220
            L  L  L L  N    ++PP L      L  L L  N+L+  +P+ L   L +L  L L
Sbjct: 122 GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLL 179

Query: 221 GYNKLSGSIPISMGNLSNLTYLNLFEN 247
             N L  +IP        L +  L  N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 52/197 (26%), Positives = 80/197 (40%), Gaps = 11/197 (5%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
              +L  ++P +L   K  + L L  N L      +L   T L  L +    L+  +   
Sbjct: 18  DKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-V 72

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQ 123
            G       L+LS+N+L  S+P     L  L  L +  N L+ S+P      L  L  L 
Sbjct: 73  DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130

Query: 124 LNNNILSGSIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
           L  N L  ++P  L      L  L + +N+L+    G +  L++L  L L EN+   +IP
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 183 PSLGNLSNLATLYLDTN 199
                   L   +L  N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 59/256 (23%), Positives = 91/256 (35%), Gaps = 60/256 (23%)

Query: 187 NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE 246
            +++   +  D  +L+ ++P +L   +  + L L  N L      ++   + LT LNL  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 247 NSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES-FY 305
             L+  +      L  L  L L HNQ +    + + L +L  + +  N LT ++      
Sbjct: 65  AELT-KLQ-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121

Query: 306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
               L  + L  N              +L TL           PP        G+L    
Sbjct: 122 GLGELQELYLKGN--------------ELKTL-----------PP--------GLLT--- 145

Query: 366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL-GSLVQLEHLDLSSNRLSNSIPKSL 424
                       KL    KL LA+N L+ +L   L   L  L+ L L  N L  +IPK  
Sbjct: 146 ---------PTPKLE---KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPK-- 189

Query: 425 GNLELIHLSELDLSRN 440
           G      L    L  N
Sbjct: 190 GFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 13/210 (6%)

Query: 281 RNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFS 340
             + S   V  D+  LT   +    +  + T + LS+N  Y    +      +L+ L+  
Sbjct: 7   SKVASHLEVNCDKRNLT---ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 341 INNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL 400
              +T       G    LG LDLS N +   +P+    L     L ++ N+L+  L    
Sbjct: 64  RAELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119

Query: 401 -GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICI-MQSLEK 458
              L +L+ L L  N L  ++P  L       L +L L+ N L   +P+ +   +++L+ 
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLT-PTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176

Query: 459 LNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
           L L  NSL  +    F     L    +  N
Sbjct: 177 LLLQENSLYTIPKGFFGSHL-LPFAFLHGN 205

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 51/274 (18%)

Query: 610 IGKGGQGSVYMSKLA----SGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWHRNI 663
           +G G  G+VY           +I +A+K+             +E L+E   +  + + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
            ++ G CL    + ++ +      L   +       N+G    +N    I   ++Y+ + 
Sbjct: 80  CRLLGICLT-STVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-----------NWTELAGTYG 772
                VHRD++++NVL+       ++DFG+AK L  +              W        
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP- 830
             A E       T + DV+S+GV   E++  G  P D I             +  +L+  
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEKG 235

Query: 831 -RLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
            RLP P        I +  + + C   + +SRP 
Sbjct: 236 ERLPQP----PICTIDVYMIMVKCWMIDADSRPK 265

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (256), Expect = 6e-23
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 39/229 (17%)

Query: 597 IIRATNDFDD----EHCIGKGGQGSVYMSK-LASGEIIAVKKFH-SPLPGEMTFQQEFLN 650
           I        +       +G G  G V + +   +    A+K    + +        + L 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS--NSKLLE 85

Query: 651 EVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS----LAVILS------NDAAAKN 700
           EV  L  + H NI+K+Y F    R+ ++V E             I+        DAA   
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC---YKGGELFDEIIHRMKFNEVDAA--- 139

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFL 757
                   +IK ++  ++Y+H      IVHRD+  +N+LL+ + +     + DFG++   
Sbjct: 140 -------VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

Query: 758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           +       E  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 190 ENQKK-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 99.2 bits (247), Expect = 9e-23
 Identities = 53/280 (18%), Positives = 97/280 (34%), Gaps = 23/280 (8%)

Query: 231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI----LRNLTSL 286
           +  G  S    L   +         +    + L  L +   +    I      +  ++ L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 287 ERVRLDRNYLTGNI--SESFYIYPNLTYIDLSQNNFYGEISSDWG----RCPKLSTLDFS 340
           + + L+   +TG           P+L  ++L   ++    +          P L  L  +
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157

Query: 341 INNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE----LGKLNFFIKLVLAHNQ---LS 393
             +       ++     L  LDLS N  +GE  +       K      L L +      S
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217

Query: 394 GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
           G  S    + VQL+ LDLS N L      +        L+ L+LS   L++ +P    + 
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLR-DAAGAPSCDWPSQLNSLNLSFTGLKQ-VPK--GLP 273

Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGS 493
             L  L+LS+N L        +++  + ++ +  N    S
Sbjct: 274 AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.9 bits (228), Expect = 3e-20
 Identities = 52/273 (19%), Positives = 90/273 (32%), Gaps = 23/273 (8%)

Query: 66  GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPS---ELGNLRSLSNL 122
           G       L+  + +        +    +L  L +    + + I      +  +  L  L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 123 QLNNNILSGSIPHSLGNLT--NLATLYIYSNSLSA--SILGKIGNL--KSLSNLQLSENN 176
            L N  ++G+ P  L   T  +L  L + + S +   + L ++       L  L +++ +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 177 FNGSIPPSLGNLSNLATLYLDTNSLSYSI-------PSELGNLRSLSNLSLGYNKLSGSI 229
                   +     L+TL L  N             P +   L+ L+  + G    SG  
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 230 PISMGNLSNLTYLNLFENSLSGAIPYEY-RNLVKLTILLLGHNQFRG-PIPILRNLTSLE 287
                    L  L+L  NSL  A          +L  L L     +  P  +   L+ L+
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLD 280

Query: 288 RVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF 320
              L  N L  N S      P +  + L  N F
Sbjct: 281 ---LSYNRLDRNPSPDE--LPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.0 bits (218), Expect = 5e-19
 Identities = 48/228 (21%), Positives = 76/228 (33%), Gaps = 19/228 (8%)

Query: 15  SELRNLKSLSDLELGNNKLSGSIPHSLGNLT--NLATLYIHTNSLSG--SIPGEIGNFRF 70
             +  +  L +L L N +++G+ P  L   T  +L  L +   S +   +   E+  +  
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148

Query: 71  FS--DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSI-------PSELGNLRSLSN 121
                L ++           +     L+TL L  N             P +   L+ L+ 
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASI-LGKIGNLKSLSNLQLSENNFNGS 180
                   SG           L  L +  NSL  +           L++L LS       
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267

Query: 181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGS 228
           +P  L   + L+ L L  N L    PS    L  + NLSL  N    S
Sbjct: 268 VPKGL--PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 34/200 (17%), Positives = 59/200 (29%), Gaps = 30/200 (15%)

Query: 309 NLTYIDLSQNNFYGEISSDWGR---CPKLSTLDFSINNITGNVPPEIG--HSSQLGVLDL 363
           +L  + +        I     R      L  L      +TG  PP +       L +L+L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 364 SSNHIVGEIPIELGKLNFFI-----KLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN 418
            +          L +L  ++      L +A          ++     L  LDLS N    
Sbjct: 129 RNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 419 SIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMN 478
                                  +    P +   +Q L   N    + SG+  +      
Sbjct: 188 ERG-------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 479 GLLHIDISYNELRGSIPNST 498
            L  +D+S+N LR +    +
Sbjct: 229 QLQGLDLSHNSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 37/158 (23%), Positives = 52/158 (32%), Gaps = 13/158 (8%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSI-------PHSLGNLTNLATLYIHTNS 56
           I      +    ++R   +LS L+L +N   G         P     L  LA       +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 57  LSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSELGN 115
            SG              L+LS+N L  +         S L +L L    L   +P  L  
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272

Query: 116 LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSL 153
              LS L L+ N L    P S   L  +  L +  N  
Sbjct: 273 PAKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 27/180 (15%), Positives = 55/180 (30%), Gaps = 9/180 (5%)

Query: 339 FSINNITGNVPPEI--GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQL 396
            S  N  G    E+  G  S   +L             ++ K     +L +   ++  ++
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 397 SP---KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN----FLREAIPSQ 449
                ++  +  L+ L L +  ++ + P  L       L+ L+L               Q
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144

Query: 450 ICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQ 509
             +   L+ L+++                 L  +D+S N   G     +         LQ
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 31/123 (25%), Positives = 42/123 (34%), Gaps = 10/123 (8%)

Query: 13  IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFS 72
            P +   L+ L+    G    SG           L  L +  NSL  +      +  + S
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP--SCDWPS 253

Query: 73  DLE---LSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNIL 129
            L    LS   L   +P  L   + L+ L L  N L    PS    L  + NL L  N  
Sbjct: 254 QLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPF 308

Query: 130 SGS 132
             S
Sbjct: 309 LDS 311

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (250), Expect = 1e-22
 Identities = 42/225 (18%), Positives = 86/225 (38%), Gaps = 31/225 (13%)

Query: 601 TNDFDDEHCIGKGGQ--GSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFL-NEVKALT 656
              ++    IGKG +   +V +++   +GE + V++    L         FL  E+    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81

Query: 657 EIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN------MI 710
              H NIV      +    L++V  +    S   ++          +   MN      ++
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-------HFMDGMNELAIAYIL 134

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL-------KPDSSN 763
           +G++ AL Y+H+      VHR + + ++L+  + + ++S       +       +     
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 764 WTELAGTYGYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 806
                    +++PE+          K D+YS G+ A E+  G  P
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 64/276 (23%), Positives = 108/276 (39%), Gaps = 49/276 (17%)

Query: 607 EHCIGKGGQGSVYMSKL----ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
              +G G  G+V+         S +I + +K       G  +FQ    + + A+  + H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQ-AVTDHMLAIGSLDHA 75

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +IV++ G C     L +V +Y  + SL   +        LG    +N    I   + Y+ 
Sbjct: 76  HIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE 132

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-----------NWTELAGT 770
                  VHR+++++NVLL   ++  V+DFG+A  L PD              W      
Sbjct: 133 EHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----- 184

Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLD 829
               A E  +  K T + DV+S+GV   E++  G  P   +             + ++L+
Sbjct: 185 ----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR---------LAEVPDLLE 231

Query: 830 P--RLPTPSRNVHDKLISIVEVTISCVDENPESRPT 863
              RL  P        I +  V + C   +   RPT
Sbjct: 232 KGERLAQP----QICTIDVYMVMVKCWMIDENIRPT 263

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  100 bits (252), Expect = 2e-22
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 46/229 (20%)

Query: 597 IIRATNDFDD----EHCIGKGGQGSVYMSK-LASGEIIAVK----------KFHSPLPGE 641
           + +      +       +G G  G V + K        A+K          ++       
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 642 MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS----LAVILS---- 693
             F +E  NE+  L  + H NI+K++      ++ ++V E+            I++    
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF---YEGGELFEQIINRHKF 143

Query: 694 --NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---V 748
              DAA          N++K I+  + Y+H      IVHRDI  +N+LL+ +N      +
Sbjct: 144 DECDAA----------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190

Query: 749 SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 797
            DFG++ F   D     +  GT  Y+APE     K  EKCDV+S GV+ 
Sbjct: 191 VDFGLSSFFSKDYK-LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 98.7 bits (246), Expect = 2e-22
 Identities = 44/255 (17%), Positives = 80/255 (31%), Gaps = 12/255 (4%)

Query: 46  NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNS 104
           +        + ++  IP ++   R   +L     KL   I   +     +L  + +  N 
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65

Query: 105 LSNSIPSE-LGNLRSLSNLQL-NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG 162
           +   I ++   NL  L  +++   N L    P +  NL NL  L I +  +         
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125

Query: 163 NLKSLSNLQLSENNFNGSIPPSL--GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL 220
           +      L + +N    +I  +   G       L+L+ N +     S     +       
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185

Query: 221 GYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPIL 280
             N L           S    L++    +     Y   NL KL      + +    +P L
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK---LPTL 242

Query: 281 RNLTSLERVRLDRNY 295
             L +L    L    
Sbjct: 243 EKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 91.4 bits (227), Expect = 6e-20
 Identities = 55/243 (22%), Positives = 84/243 (34%), Gaps = 22/243 (9%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
            IPS+L   ++  +L     KL      +     +L  + I  N +   I      F   
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA--DVFSNL 78

Query: 72  SDLE----LSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLN 125
             L        N L   I P    NL NL  L +    +   +P     +      L + 
Sbjct: 79  PKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQ 136

Query: 126 NNILSGSIPH-SLGNLT-NLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           +NI   +I   S   L+     L++  N +   I     N   L  L LS+NN    +P 
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPN 195

Query: 184 -SLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY 241
                 S    L +    +  S+PS  L NL+ L   S    K    +P ++  L  L  
Sbjct: 196 DVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALME 250

Query: 242 LNL 244
            +L
Sbjct: 251 ASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 47/282 (16%), Positives = 93/282 (32%), Gaps = 40/282 (14%)

Query: 190 NLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
           +        + ++  IPS+L   R+   L     KL      +     +L  + + +N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 250 SGAIPYE-YRNLVKLTILLLGH-NQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYI 306
              I  + + NL KL  + +   N          +NL +L+ + +    +          
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126

Query: 307 YPNLTYIDLSQNNFYGEISSDW--GRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS 364
                 +D+  N     I  +   G   +   L  + N I   +     + +QL  L+LS
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185

Query: 365 SNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKS 423
            N                       N L  +L             LD+S  R+ +     
Sbjct: 186 DN-----------------------NNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYG 221

Query: 424 LGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNS 465
           L NL+   L           + +P+ +  + +L + +L++ S
Sbjct: 222 LENLK--KLRARSTYNL---KKLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 41/209 (19%), Positives = 69/209 (33%), Gaps = 24/209 (11%)

Query: 4   IYNNSLYDSIPSE-LRNLKSLSDLELGN-NKLSGSIPHSLGNLTNLATLYIHTNSLSGSI 61
           I  N + + I ++   NL  L ++ +   N L    P +  NL NL  L I    +   +
Sbjct: 61  ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HL 119

Query: 62  PGEIGNFRFFS-----DLELSNNKLSGSIPPSL--GNLSNLATLYLDTNSLSNSIPSELG 114
           P    +           L++ +N    +I  +   G       L+L+ N +     S   
Sbjct: 120 P----DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN 175

Query: 115 NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSN---SLSASILGKIGNLKSLSNLQ 171
             +       +NN L           +    L I      SL +  L  +  L++ S   
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235

Query: 172 LSENNFNGSIPPSLGNLSNLATLYLDTNS 200
           L +        P+L  L  L    L   S
Sbjct: 236 LKK-------LPTLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 34/227 (14%)

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKL 334
           P  + RN   L   R     L      +F  + +L  I++SQN+    I +D +   PKL
Sbjct: 25  PSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 335 STLDFSINNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS 393
             +     N    + PE   +   L  L +S+  I       L  ++             
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-----HLPDVHKI----------- 125

Query: 394 GQLSPKLGSLVQLEHLDLSSNRLSNSIP-KSLGNLELIHLSELDLSRNFLREAIPSQICI 452
                     +Q   LD+  N   ++I   S   L       L L++N ++E I +    
Sbjct: 126 --------HSLQKVLLDIQDNINIHTIERNSFVGLS-FESVILWLNKNGIQE-IHNSAFN 175

Query: 453 MQSLEKLNLSH-NSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
              L++LNLS  N+L  L    F   +G + +DIS   +  S+P+  
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 35/174 (20%), Positives = 59/174 (33%), Gaps = 16/174 (9%)

Query: 12  SIPSE-LRNLKSLSDLELGNNKLSGSIPH-SLGNLTNLATLYIHTNSLSGSIPGEIGNFR 69
            I  E  +NL +L  L + N  +   +P     +      L I  N    +I     +F 
Sbjct: 94  YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER--NSFV 150

Query: 70  FFS----DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQL 124
             S     L L+ N +   I  S  N + L  L L  N+    +P++          L +
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209

Query: 125 NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           +   +     + L NL  L     Y+       L  +  L +L    L+    +
Sbjct: 210 SRTRIHSLPSYGLENLKKLRARSTYNL----KKLPTLEKLVALMEASLT-YPSH 258

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 41/204 (20%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +GKG  G V       + +  AVK  + +    +       L EV+ L ++ H NI+K++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKLF 87

Query: 668 GFCLHVRHLFIVYEYFKMCS----LAVILSN------DAAAKNLGWTRRMNMIKGIVDAL 717
                    +IV E     +       I+        DAA           +IK +   +
Sbjct: 88  EILEDSSSFYIVGEL---YTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGI 134

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +YMH      IVHRD+  +N+LL+ + +     + DFG++   + ++    +  GT  Y+
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYI 190

Query: 775 APEL---AYTMKVTEKCDVYSFGV 795
           APE+    Y     EKCDV+S GV
Sbjct: 191 APEVLRGTY----DEKCDVWSAGV 210

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (251), Expect = 2e-22
 Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 36/228 (15%)

Query: 597 IIRATNDFDD----EHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNE 651
           +  +T  F D    +  +GKG  G V + K   +G+  AVK        + T ++  L E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS----LAVILS------NDAAAKNL 701
           V+ L ++ H NI+K+Y F     + ++V E     +       I+S       DAA    
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV---YTGGELFDEIISRKRFSEVDAA---- 129

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLK 758
                  +I+ ++  ++YMH +    IVHRD+  +N+LL+ +++     + DFG++   +
Sbjct: 130 ------RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                  +  GT  Y+APE+       EKCDV+S GV+   ++ G  P
Sbjct: 181 ASKK-MKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 16/235 (6%)

Query: 15  SELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDL 74
                        L    ++ ++      L ++  +  + + +  S+ G I      + L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73

Query: 75  ELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP 134
            L+ NKL+  I P L NL NL  L+LD N + +   S L +L+ L +L L +N +S  I 
Sbjct: 74  FLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS-DIN 128

Query: 135 HSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATL 194
             L +L  L +LY+ +N +  + +  +  L  L  L L +N  +  I P L  L+ L  L
Sbjct: 129 G-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183

Query: 195 YLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
           YL  N +S  +   L  L++L  L L   +          NL     +   + SL
Sbjct: 184 YLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 62/283 (21%), Positives = 104/283 (36%), Gaps = 19/283 (6%)

Query: 24  SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG 83
           S+       +                  +   S++ ++            +  +N+ +  
Sbjct: 5   SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59

Query: 84  SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNL 143
           S+   +  L N+  L+L+ N L++     L NL++L  L L+ N +   +  SL +L  L
Sbjct: 60  SVQG-IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKL 114

Query: 144 ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY 203
            +L +  N +S   +  + +L  L +L L  N    +    L  L+ L TL L+ N +S 
Sbjct: 115 KSLSLEHNGIS--DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS- 169

Query: 204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKL 263
            I   L  L  L NL L  N +S    ++   L NL  L LF             NLV  
Sbjct: 170 DI-VPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVP 226

Query: 264 TILLLGHNQFRGPIPILRNLT-SLERVRLDRNYLTGNISESFY 305
             +         P  I  +       V+      T  +S  FY
Sbjct: 227 NTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 54/271 (19%), Positives = 103/271 (38%), Gaps = 19/271 (7%)

Query: 96  ATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSA 155
           +        +                  L    ++ ++      L ++  +   ++ +  
Sbjct: 5   SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59

Query: 156 SILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSL 215
           S+ G I  L +++ L L+ N     I P L NL NL  L+LD N +   + S L +L+ L
Sbjct: 60  SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKL 114

Query: 216 SNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG 275
            +LSL +N +S    +   +L  L  L L  N ++         L KL  L L  NQ   
Sbjct: 115 KSLSLEHNGISDINGLV--HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISD 170

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS 335
            I  L  LT L+ + L +N+++ ++        NL  ++L       +  +        +
Sbjct: 171 -IVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227

Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSN 366
           T+  +  ++    P  I         ++  +
Sbjct: 228 TVKNTDGSLV--TPEIISDDGDYEKPNVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 18/248 (7%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
            +   S+ D++      L S+  +   N+ +  S+   +  L N+  L+++ N L+  I 
Sbjct: 30  NLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIK 84

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
             + N +    L L  NK+   +   L +L  L +L L+ N +S+   + L +L  L +L
Sbjct: 85  P-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISD--INGLVHLPQLESL 139

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
            L NN ++      L  LT L TL +  N +S   +  +  L  L NL LS+N+ +  + 
Sbjct: 140 YLGNNKIT--DITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHIS-DLR 194

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL 242
             L  L NL  L L +        +   NL   + +      L     IS  +  +    
Sbjct: 195 A-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKP 251

Query: 243 NLFENSLS 250
           N+  +   
Sbjct: 252 NVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 39/236 (16%), Positives = 85/236 (36%), Gaps = 25/236 (10%)

Query: 259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
              +     L              L S++++  + + +  ++ +     PN+T + L+ N
Sbjct: 22  AFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 78

Query: 319 NFYGEIS--SDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE- 375
                ++          L  L    N +  ++   +    +L  L L  N I     +  
Sbjct: 79  K----LTDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLVH 132

Query: 376 LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE-LIHLSE 434
           L +L     L L +N+++  ++  L  L +L+ L L  N++S      +  L  L  L  
Sbjct: 133 LPQLE---SLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQN 182

Query: 435 LDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
           L LS+N + +     +  +++L+ L L          +    +     +  +   L
Sbjct: 183 LYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.8 bits (249), Expect = 4e-22
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 35/201 (17%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +GKG  G V   K   + +  AVK  + +    +       L EV+ L ++ H NI+K++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKLF 87

Query: 668 GFCLHVRHLFIVYEYFKMCS----LAVILS------NDAAAKNLGWTRRMNMIKGIVDAL 717
                    +IV E     +       I+       +DAA           +IK +   +
Sbjct: 88  EILEDSSSFYIVGEL---YTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGI 134

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +YMH      IVHRD+  +N+LL+ + +     + DFG++   + ++    +  GT  Y+
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYI 190

Query: 775 APELAYTMKVTEKCDVYSFGV 795
           APE+       EKCDV+S GV
Sbjct: 191 APEV-LRGTYDEKCDVWSAGV 210

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 98.2 bits (244), Expect = 5e-22
 Identities = 34/300 (11%), Positives = 83/300 (27%), Gaps = 65/300 (21%)

Query: 610 IGKGGQGSVY-MSKLASGEIIAVKKFHSPL-------------------------PGEMT 643
           +G+    +    +   +GE   V   +                              +  
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 644 FQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHLFIVYEYFKMCSLAV---ILSNDAAA 698
               F+     + +   + +++V        V   F +Y   +         +LS+ +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 699 KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK 758
           K+L    R+ +   ++  L+ +H+     +VH  +   +++LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 759 PDSSNWTELAGTYGYVAPEL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPR 807
                    + + G+  PEL                +T   D ++ G++   +     P 
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 808 DFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                   +        + +       P   V   L+         +    E R    + 
Sbjct: 313 -------ITKDAALGGSEWIFRSCKNIPQ-PVRA-LLE------GFLRYPKEDRLLPLQA 357

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 97.4 bits (243), Expect = 6e-22
 Identities = 53/242 (21%), Positives = 91/242 (37%), Gaps = 41/242 (16%)

Query: 575 SPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYM-SKLASGE-----I 628
           SPG S G   +L        + +     +  +   IGKG    V       +G+     I
Sbjct: 2   SPGISGGGGGILDMADD---DVLFEDVYELCEV--IGKGPFSVVRRCINRETGQQFAVKI 56

Query: 629 IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY------ 682
           + V KF S         ++   E      + H +IV++         L++V+E+      
Sbjct: 57  VDVAKFTSS---PGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL 113

Query: 683 ----FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH-NDCFPPIVHRDISSKN 737
                K      + S   A+         + ++ I++AL Y H N+    I+HRD+    
Sbjct: 114 CFEIVKRADAGFVYSEAVAS---------HYMRQILEALRYCHDNN----IIHRDVKPHC 160

Query: 738 VLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFG 794
           VLL  +  +    +  FG+A  L           GT  ++APE+       +  DV+  G
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220

Query: 795 VL 796
           V+
Sbjct: 221 VI 222

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.9 bits (244), Expect = 6e-22
 Identities = 47/245 (19%), Positives = 94/245 (38%), Gaps = 30/245 (12%)

Query: 564 RRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYM-SK 622
           R K D             +      +   + +  +    D  +E  +G G  G V+   +
Sbjct: 15  RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEE--LGSGAFGVVHRCVE 72

Query: 623 LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY 682
            A+G +   K  ++P P +   +    NE+  + ++ H  ++ ++        + ++ E+
Sbjct: 73  KATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129

Query: 683 ------F-KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS 735
                 F ++ +    +S              N ++   + L +MH      IVH DI  
Sbjct: 130 LSGGELFDRIAAEDYKMSEAEVI---------NYMRQACEGLKHMHEH---SIVHLDIKP 177

Query: 736 KNVLLDFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYS 792
           +N++ + +  + V   DFG+A  L PD         T  + APE +     V    D+++
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP-VGFYTDMWA 235

Query: 793 FGVLA 797
            GVL 
Sbjct: 236 IGVLG 240

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.1 bits (242), Expect = 1e-21
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 603 DFDDEHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
                  +G G  G V+   + A+G  +A K   +    +   ++E  NE+  + ++ H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146

Query: 662 NIVKVYGFCLHVRHLFIVYEY------F-KMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
           N++++Y        + +V EY      F ++   +  L+                +K I 
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI---------LFMKQIC 197

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTELAGTYG 772
           + + +MH      I+H D+  +N+L    +   +   DFG+A+  KP         GT  
Sbjct: 198 EGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPE 253

Query: 773 YVAPE-LAYTMKVTEKCDVYSFGVLA 797
           ++APE + Y   V+   D++S GV+A
Sbjct: 254 FLAPEVVNYD-FVSFPTDMWSVGVIA 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 35/200 (17%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G    V++  +  +G++ A+K                 NE+  L +I H NIV +  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73

Query: 669 FCLHVRHLFIVYEYFKMCS----LAVILS------NDAAAKNLGWTRRMNMIKGIVDALS 718
                 H ++V +     S       IL        DA+           +I+ ++ A+ 
Sbjct: 74  IYESTTHYYLVMQL---VSGGELFDRILERGVYTEKDAS----------LVIQQVLSAVK 120

Query: 719 YMHNDCFPPIVHRDISSKNVLL-DFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVA 775
           Y+H +    IVHRD+  +N+L    E  + +  +DFG++K  +      +   GT GYVA
Sbjct: 121 YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVA 175

Query: 776 PELAYTMKVTEKCDVYSFGV 795
           PE+      ++  D +S GV
Sbjct: 176 PEVLAQKPYSKAVDCWSIGV 195

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 29/203 (14%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +G G    V    + ++G   A K   K  S        ++E   EV  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 666 VYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           ++    +   + ++ E       F   +    LS + A          + IK I+D ++Y
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFIKQILDGVNY 130

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           +H      I H D+  +N++L  +N       + DFG+A  ++     +  + GT  +VA
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVA 186

Query: 776 PE-LAYTMKVTEKCDVYSFGVLA 797
           PE + Y   +  + D++S GV+ 
Sbjct: 187 PEIVNYE-PLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 29/203 (14%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +G G    V    +  +G+  A K   K           ++E   EV  L EI H NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 666 VYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           ++    +   + ++ E       F   +    L+ D A            +K I+D + Y
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---------QFLKQILDGVHY 123

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           +H+     I H D+  +N++L  +N  +    + DFGIA  ++  +  +  + GT  +VA
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVA 179

Query: 776 PE-LAYTMKVTEKCDVYSFGVLA 797
           PE + Y   +  + D++S GV+ 
Sbjct: 180 PEIVNYE-PLGLEADMWSIGVIT 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 31/223 (13%)

Query: 590 GKIIYEEIIRATNDFDDEHCIGKGGQGSVYM-SKLASGEIIAVK---KFHSPLPGEMTFQ 645
           G +  +E +    D  +E  +G G    V    + ++G   A K   K  +        +
Sbjct: 1   GTVFRQENVDDYYDTGEE--LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 58

Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAK 699
           ++   EV  L EI H N++ ++    +   + ++ E       F   +    L+ + A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT- 117

Query: 700 NLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH----VSDFGIAK 755
                     +K I++ + Y+H+     I H D+  +N++L   N       + DFG+A 
Sbjct: 118 --------EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

Query: 756 FLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLA 797
            +   +  +  + GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 167 KIDFGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.5 bits (236), Expect = 2e-21
 Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 30/210 (14%)

Query: 601 TNDFDDE----HCIGKGGQGSVYM-SKLASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKA 654
           +  F D       +GKG    V       +G   A K  +   L       Q+   E + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARI 58

Query: 655 LTEIWHRNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMN 708
             ++ H NIV+++         ++V++       F+        S   A+          
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------- 109

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLL-DFENEAHV--SDFGIAKFLKPDSSNWT 765
            I+ I+++++Y H++    IVHR++  +N+LL      A V  +DFG+A  +    + W 
Sbjct: 110 CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 165

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGV 795
             AGT GY++PE+      ++  D+++ GV
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 29/203 (14%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +G G    V    + ++G   A K   K  S        ++E   EV  L ++ H NI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 666 VYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           ++    +   + ++ E       F   +    LS + A          + IK I+D ++Y
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFIKQILDGVNY 130

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           +H      I H D+  +N++L  +N       + DFG+A  ++     +  + GT  +VA
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVA 186

Query: 776 PE-LAYTMKVTEKCDVYSFGVLA 797
           PE + Y   +  + D++S GV+ 
Sbjct: 187 PEIVNYE-PLGLEADMWSIGVIT 208

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.0 bits (242), Expect = 2e-21
 Identities = 43/197 (21%), Positives = 86/197 (43%), Gaps = 25/197 (12%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +GKG    V    K+ +G+  A    ++         Q+   E +    + H NIV+++ 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 669 FCLHVRHLFIVYEY-------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
                 H +++++          + +       DA+          + I+ I++A+ + H
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HCIQQILEAVLHCH 127

Query: 722 NDCFPPIVHRDISSKNVLL-DFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
                 +VHR++  +N+LL      A V  +DFG+A  ++ +   W   AGT GY++PE+
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184

Query: 779 AYTMKVTEKCDVYSFGV 795
                  +  D+++ GV
Sbjct: 185 LRKDPYGKPVDLWACGV 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.7 bits (241), Expect = 3e-21
 Identities = 60/256 (23%), Positives = 99/256 (38%), Gaps = 36/256 (14%)

Query: 561 KFQRR--KNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSV 618
           K +RR   N+S+   S   N   +   LT + + +Y + +R          +G G  G V
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKT--LGSGACGEV 151

Query: 619 YM-SKLASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH 672
            +  +  + + +A++     KF      E         E++ L ++ H  I+K+  F   
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-D 210

Query: 673 VRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
               +IV E       F        L                    ++ A+ Y+H +   
Sbjct: 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAVQYLHENG-- 259

Query: 727 PIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTM 782
            I+HRD+  +NVLL  + E     ++DFG +K L   S     L GT  Y+APE L    
Sbjct: 260 -IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVG 317

Query: 783 KV--TEKCDVYSFGVL 796
                   D +S GV+
Sbjct: 318 TAGYNRAVDCWSLGVI 333

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 37/221 (16%)

Query: 599 RATNDFDDE----HCIGKGGQGSVYM-SKLASGEIIAVKKF------HSPLPGEMTFQQE 647
            +T+ F +       +G+G    V       + +  AVK                  ++ 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 648 FLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKN 700
            L EV  L ++  H NI+++          F+V++       F   +  V LS     K 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK- 128

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
                   +++ +++ +  +H      IVHRD+  +N+LLD +    ++DFG +  L P 
Sbjct: 129 --------IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 761 SSNWTELAGTYGYVAPE-LAYTMKV-----TEKCDVYSFGV 795
                E+ GT  Y+APE +  +M        ++ D++S GV
Sbjct: 178 EK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 58/300 (19%), Positives = 111/300 (37%), Gaps = 40/300 (13%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVK--------------KFHSPLPGEMTFQQE 647
           ND+     + +G    + + +    +  A+K              K ++      +   +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 648 FLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNL 701
           F NE++ +T+I +   +   G   +   ++I+YEY       K      +L  +      
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
               +  +IK ++++ SY+HN     I HRD+   N+L+D      +SDFG ++++  D 
Sbjct: 150 IQVIK-CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDK 205

Query: 762 SNWTELAGTYGYVAPELAYTMKVT--EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN 819
                  GTY ++ PE           K D++S G+    +     P  F   +S   L 
Sbjct: 206 KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKISLVELF 262

Query: 820 LNIALDEMLDPRLPTPSRNVHDKLISIVE---VTISCVD-------ENPESRPTMQKVCQ 869
            NI    +  P              S      ++   +D       +NP  R T +   +
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 47/212 (22%), Positives = 96/212 (45%), Gaps = 21/212 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G   +V+  +   +G++ A+K F++            + E + L ++ H+NIVK++ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74

Query: 669 F--CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
                  RH  ++ E+    SL  +L   + A  L  +  + +++ +V  ++++  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 727 PIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 778
            IVHR+I   N++     +      ++DFG A+ L+ D   +  L GT  Y+ P++    
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190

Query: 779 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                +  K     D++S GV       G  P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 594 YEEIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVK---KFHSPLPGEMTFQQEFL 649
           ++  I     F  +  +G G  G V++ +  +SG    +K   K  S +P E        
Sbjct: 16  FQGTIDDLFIFKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-----IE 68

Query: 650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS----LAVILSNDAAAKNLGWTR 705
            E++ L  + H NI+K++       +++IV E    C     L  I+S  A  K L    
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET---CEGGELLERIVSAQARGKALSEGY 125

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSS 762
              ++K +++AL+Y H+     +VH+D+  +N+L    +      + DFG+A+  K D  
Sbjct: 126 VAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

Query: 763 NWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGV 795
             T  AGT  Y+APE       VT KCD++S GV
Sbjct: 183 -STNAAGTALYMAPEVFKR--DVTFKCDIWSAGV 213

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 93.4 bits (233), Expect = 3e-21
 Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 26/273 (9%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKK-FHSPLPGEMTFQQEFLNEVKALTEIW 659
            DF   + +GKG    VY ++ + +G  +A+K      +      Q+   NEVK   ++ 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H +I+++Y +     ++++V E      +   L      K        + +  I+  + Y
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLY 127

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H+     I+HRD++  N+LL       ++DFG+A  LK        L GT  Y++PE+A
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP---S 836
                  + DV+S G +   ++ G+ P        F +  +   L++++      P   S
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPP--------FDTDTVKNTLNKVVLADYEMPSFLS 236

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
               D LI         +  NP  R ++  V  
Sbjct: 237 IEAKD-LIH------QLLRRNPADRLSLSSVLD 262

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 50/204 (24%), Positives = 78/204 (38%), Gaps = 32/204 (15%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G G  G V +  +  + + +A+K     KF      E         E++ L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 664 VKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
           +K+  F       +IV E       F        L                    ++ A+
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 127

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYV 774
            Y+H +    I+HRD+  +NVLL  + E     ++DFG +K L   S     L GT  Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183

Query: 775 APE-LAYTMKV--TEKCDVYSFGV 795
           APE L            D +S GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 59/287 (20%), Positives = 108/287 (37%), Gaps = 55/287 (19%)

Query: 607 EHCIGKGGQGSVYMSKLASGEI----IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWHR 661
              +G+G  G VY     + +     +AVK              ++F++E   +  + H 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +IVK+ G        +I+ E +    L   L  +    +L     +     I  A++Y+ 
Sbjct: 74  HIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE 130

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN----------WTELAGTY 771
           +      VHRDI+ +N+L+       + DFG++++++ +             W       
Sbjct: 131 SINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP 830
              +PE     + T   DV+ F V   E++  GK P        F  L  N  +  +L+ 
Sbjct: 182 ---SPESINFRRFTTASDVWMFAVCMWEILSFGKQP--------FFWLE-NKDVIGVLEK 229

Query: 831 --RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             RLP P      ++        +   C D +P  RP   ++   L 
Sbjct: 230 GDRLPKPDLCPPVLY-------TLMTRCWDYDPSDRPRFTELVCSLS 269

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.8 bits (241), Expect = 6e-21
 Identities = 43/198 (21%), Positives = 82/198 (41%), Gaps = 26/198 (13%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V+     A+G   A K   +P   +   ++    E++ ++ + H  +V ++ 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHD 221

Query: 669 FCLHVRHLFIVYEY------F-KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
                  + ++YE+      F K+      +S D A            ++ +   L +MH
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV---------EYMRQVCKGLCHMH 272

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
            +     VH D+  +N++   +    +   DFG+   L P   +     GT  + APE+A
Sbjct: 273 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVA 328

Query: 780 YTMKVTEKCDVYSFGVLA 797
               V    D++S GVL+
Sbjct: 329 EGKPVGYYTDMWSVGVLS 346

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.8 bits (236), Expect = 6e-21
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 42/223 (18%)

Query: 599 RATNDFDDE----HCIGKGGQGSVYM-SKLASGEIIAVK-----KFHSPLPGEMTFQQEF 648
            A  +F  +      IG+G    V      A+G   AVK                 ++  
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 649 LNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCS---L------AVILSNDAAA 698
             E   L ++  H +I+ +         +F+V++         L       V LS     
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL---MRKGELFDYLTEKVALSEKETR 203

Query: 699 KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK 758
                     +++ +++A+S++H +    IVHRD+  +N+LLD   +  +SDFG +  L+
Sbjct: 204 S---------IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251

Query: 759 PDSSNWTELAGTYGYVAPE-LAYTMKVTEK-----CDVYSFGV 795
           P      EL GT GY+APE L  +M  T        D+++ GV
Sbjct: 252 PGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 94.5 bits (235), Expect = 1e-20
 Identities = 47/212 (22%), Positives = 96/212 (45%), Gaps = 21/212 (9%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G   +V+  +   +G++ A+K F++            + E + L ++ H+NIVK++ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74

Query: 669 F--CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
                  RH  ++ E+    SL  +L   + A  L  +  + +++ +V  ++++  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 727 PIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 778
            IVHR+I   N++     +      ++DFG A+ L+ D   +  L GT  Y+ P++    
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190

Query: 779 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                +  K     D++S GV       G  P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 44/199 (22%), Positives = 85/199 (42%), Gaps = 29/199 (14%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V+   + +S +    K     +  + T Q     E+  L    HRNI+ ++ 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKF----VKVKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 669 FCLHVRHLFIVYEY------F-KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
               +  L +++E+      F ++ + A  L+              + +  + +AL ++H
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---------SYVHQVCEALQFLH 119

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPE-L 778
           +     I H DI  +N++      + +   +FG A+ LKP   N+  L     Y APE  
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVH 175

Query: 779 AYTMKVTEKCDVYSFGVLA 797
            + + V+   D++S G L 
Sbjct: 176 QHDV-VSTATDMWSLGTLV 193

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 595 EEIIRATNDFDDE----HCIGKGGQGSVYM-SKLASGEIIAVKKFH-SPLPGEMTFQQEF 648
           E ++ A+  F D       +GKG    V       +G   A K  +   L       Q+ 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKL 75

Query: 649 LNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEY-------FKMCSLAVILSNDAAAKNL 701
             E +   ++ H NIV+++         ++V++          + +       DA+    
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---- 131

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL-DFENEAHV--SDFGIAKFLK 758
                 + I+ I+++++Y H++    IVHR++  +N+LL      A V  +DFG+A  + 
Sbjct: 132 ------HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 795
              + W   AGT GY++PE+      ++  D+++ GV
Sbjct: 183 DSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 94.6 bits (236), Expect = 1e-20
 Identities = 87/452 (19%), Positives = 143/452 (31%), Gaps = 77/452 (17%)

Query: 74  LELSNNKLS-GSIPPSLGNLSNLATLYLDTNSLSN----SIPSELGNLRSLSNLQLNNNI 128
           L++   +LS       L  L     + LD   L+      I S L    +L+ L L +N 
Sbjct: 8   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 67

Query: 129 LSGSIPHSLGNL-----TNLATLYIYSNSLS---ASILGK-IGNLKSLSNLQLSENNFNG 179
           L     H +          +  L + +  L+     +L   +  L +L  L LS+N    
Sbjct: 68  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 127

Query: 180 SIPPSLG-----NLSNLATLYLDTNSLSY----SIPSELGNLRSLSNLSLGYNKLS--GS 228
           +    L          L  L L+  SLS      + S L        L++  N ++  G 
Sbjct: 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187

Query: 229 IPISMG---NLSNLTYLNLFENSLS----GAIPYEYRNLVKLTILLLGHNQFRGP----- 276
             +  G   +   L  L L    ++      +     +   L  L LG N+         
Sbjct: 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAEL 247

Query: 277 -IPILRNLTSLERVRLDRNYLT----GNISESFYIYPNLTYIDLSQNNFYGE-----ISS 326
              +L   + L  + +    +T    G++        +L  + L+ N    E       +
Sbjct: 248 CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 307

Query: 327 DWGRCPKLSTLDFSINNITGNVPPEIG----HSSQLGVLDLSSNHIVGEIPIELGKLNFF 382
                 +L +L     + T             +  L  L +S+N +      EL +    
Sbjct: 308 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG--- 364

Query: 383 IKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL--ELIHLSELDLSRN 440
               L                  L  L L+   +S+S   SL         L ELDLS N
Sbjct: 365 ----LGQPG------------SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408

Query: 441 FLREAIPSQICIM-----QSLEKLNLSHNSLS 467
            L +A   Q+          LE+L L     S
Sbjct: 409 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 88.9 bits (221), Expect = 1e-18
 Identities = 73/462 (15%), Positives = 150/462 (32%), Gaps = 95/462 (20%)

Query: 141 TNLATLYIYSNSLSASILGKIG-NLKSLSNLQLSENNFN----GSIPPSLGNLSNLATLY 195
            ++ +L I    LS +   ++   L+    ++L +          I  +L     LA L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 196 LDTNSLSYSIPSELGNL-----RSLSNLSLGYNKLS----GSIPISMGNLSNLTYLNLFE 246
           L +N L       +          +  LSL    L+    G +  ++  L  L  L+L +
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 247 NSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLT----GNISE 302
           N L  A          L +L  G         +L     LE+++L+   L+      ++ 
Sbjct: 123 NLLGDA---------GLQLLCEG---------LLDPQCRLEKLQLEYCSLSAASCEPLAS 164

Query: 303 SFYIYPNLTYIDLSQNNFYGEISSDWG--------RCP--KLSTLDFSINNITGNVPPEI 352
                P+   + +S N+      ++ G        +    +L  L      +T +   ++
Sbjct: 165 VLRAKPDFKELTVSNNDI-----NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219

Query: 353 G----HSSQLGVLDLSSNHI----VGEIPIELGKLNFFIK-LVLAHNQLSGQ----LSPK 399
                  + L  L L SN +    + E+   L   +  ++ L +    ++ +    L   
Sbjct: 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279

Query: 400 LGSLVQLEHLDLSSNRLSNSIPKSLGNL---ELIHLSELDLSRNFLR----EAIPSQICI 452
           L +   L+ L L+ N L +   + L          L  L +              S +  
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339

Query: 453 MQSLEKLNLSHNSLSG----LIPSCFEKMNGLL-HIDISYNELRGSIPNSTTFKDAP--I 505
            + L +L +S+N L       +     +   +L  + ++  ++        +        
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV--------SDSSCSSLA 391

Query: 506 EALQGNKGLY---------GDVKGLLSCKALKSNKQALRTIW 538
             L  N  L          GD   L   ++++     L  + 
Sbjct: 392 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 433

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 80.8 bits (200), Expect = 5e-16
 Identities = 71/399 (17%), Positives = 126/399 (31%), Gaps = 70/399 (17%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNL-----TNLATLYIHTNSLS----GSIP 62
            I S LR   +L++L L +N+L     H +          +  L +    L+    G + 
Sbjct: 47  DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 106

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLG-----NLSNLATLYLDTNSLSN----SIPSEL 113
             +       +L LS+N L  +    L          L  L L+  SLS      + S L
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166

Query: 114 GNLRSLSNLQLNNNILSGS----IPHSLGNLT-NLATLYIYSNSLSASILGKIG----NL 164
                   L ++NN ++ +    +   L +    L  L + S  +++     +     + 
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226

Query: 165 KSLSNLQLSENNFNGS-----IPPSLGNLSNLATLYLDTNSLSY----SIPSELGNLRSL 215
            SL  L L  N           P  L   S L TL++    ++      +   L    SL
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286

Query: 216 SNLSLGYNKL--SGSIPISMG---NLSNLTYLNLFENSLSG----AIPYEYRNLVKLTIL 266
             LSL  N+L   G+  +          L  L +   S +                L  L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346

Query: 267 LLGHNQFRGP------IPILRNLTSLERVRLDRNYLT----GNISESFYIYPNLTYIDLS 316
            + +N+            + +  + L  + L    ++     +++ +     +L  +DLS
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406

Query: 317 QNNFYGEISSDWG----------RCPKLSTLDFSINNIT 345
            N        D G              L  L       +
Sbjct: 407 NNCL-----GDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.4 bits (116), Expect = 8e-06
 Identities = 35/212 (16%), Positives = 63/212 (29%), Gaps = 36/212 (16%)

Query: 355 SSQLGVLDLSSNHIVGEIPIELGK-LNFFIKLVLAHNQLSGQ----LSPKLGSLVQLEHL 409
           S  +  LD+    +      EL   L     + L    L+      +S  L     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 410 DLSSNRLSNSIPKSLGNL---ELIHLSELDLSRNFLRE----AIPSQICIMQSLEKLNLS 462
           +L SN L +     +          + +L L    L       + S +  + +L++L+LS
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 463 HNSLSG----LIPSCFEKMN-GLLHIDISYNELRGSIPNSTTFKDAPI--EALQGNKGLY 515
            N L      L+          L  + + Y  L        +          L+      
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL--------SAASCEPLASVLRAKPDFK 173

Query: 516 ---------GDVKGLLSCKALKSNKQALRTIW 538
                     +    + C+ LK +   L  + 
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 63/286 (22%), Positives = 110/286 (38%), Gaps = 55/286 (19%)

Query: 607 EHCIGKGGQGSVYMSKLASGE----IIAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIWHR 661
             CIG+G  G V+     S E     +A+K              ++FL E   + +  H 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 76

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           +IVK+ G       ++I+ E   +  L   L       +L     +     +  AL+Y+ 
Sbjct: 77  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE 133

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----SSN------WTELAGTY 771
           +  F   VHRDI+++NVL+   +   + DFG++++++      +S       W       
Sbjct: 134 SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184

Query: 772 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP 830
              APE     + T   DV+ FGV   E++  G  P        F  +  N  +   ++ 
Sbjct: 185 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVK-NNDVIGRIEN 232

Query: 831 --RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
             RLP P      ++        +   C   +P  RP   ++   L
Sbjct: 233 GERLPMPPNCPPTLY-------SLMTKCWAYDPSRRPRFTELKAQL 271

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 58/178 (32%), Positives = 82/178 (46%), Gaps = 14/178 (7%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPG 63
            +N L          L  L  L L +NKL  ++P  +   L NL TL++  N L  ++P 
Sbjct: 45  QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPI 102

Query: 64  EIGNFRFFSDLE---LSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRS 118
            +  F    +L    L  N+L  S+PP +  +L+ L  L L  N L  S+P  +   L S
Sbjct: 103 GV--FDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158

Query: 119 LSNLQLNNNILSGSIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSEN 175
           L  L+L NN L   +P      LT L TL + +N L     G   +L+ L  LQL EN
Sbjct: 159 LKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 62/194 (31%), Positives = 93/194 (47%), Gaps = 20/194 (10%)

Query: 13  IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFS 72
           IP++ + L      +L +NKLS     +   LT L  LY++ N L  ++P   G F+   
Sbjct: 35  IPADTKKL------DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA--GIFKELK 85

Query: 73  DLE---LSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNN 127
           +LE   +++NKL  ++P  +   L NLA L LD N L  S+P  +  +L  L+ L L  N
Sbjct: 86  NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143

Query: 128 ILSGSIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SL 185
            L  S+P  +   LT+L  L +Y+N L     G    L  L  L+L  N     +P  + 
Sbjct: 144 ELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201

Query: 186 GNLSNLATLYLDTN 199
            +L  L  L L  N
Sbjct: 202 DSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 10/184 (5%)

Query: 45  TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTN 103
            +   L + +N LS               L L++NKL  ++P  +   L NL TL++  N
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 104 SLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPHSL-GNLTNLATLYIYSNSLSASILGKI 161
            L  ++P  +   L +L+ L+L+ N L  S+P  +  +LT L  L +  N L +   G  
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVF 153

Query: 162 GNLKSLSNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLS 219
             L SL  L+L  N     +P      L+ L TL LD N L   +P     +L  L  L 
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQ 211

Query: 220 LGYN 223
           L  N
Sbjct: 212 LQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 49/183 (26%), Positives = 74/183 (40%), Gaps = 9/183 (4%)

Query: 189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFEN 247
           ++   L L +N LS         L  L  L L  NKL  ++P  +   L NL  L + +N
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 248 SLSGAIPYE-YRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISE-SF 304
            L  A+P   +  LV L  L L  NQ +  P  +  +LT L  + L  N L  ++ +  F
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153

Query: 305 YIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDL 363
               +L  + L  N         + +  +L TL    N +   VP        +L +L L
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQL 212

Query: 364 SSN 366
             N
Sbjct: 213 QEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 50/193 (25%), Positives = 79/193 (40%), Gaps = 22/193 (11%)

Query: 306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEI-GHSSQLGVLDLS 364
           I  +   +DL  N      S  + R  KL  L  + N +   +P  I      L  L ++
Sbjct: 35  IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVT 93

Query: 365 SNHIV---GEIPIELGKLNFFIKLVLAHNQLSGQLSPKL-GSLVQLEHLDLSSNRLSNSI 420
            N +      +  +L  L    +L L  NQL   L P++  SL +L +L L  N L  S+
Sbjct: 94  DNKLQALPIGVFDQLVNLA---ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SL 148

Query: 421 PK----SLGNLELIHLSELDLSRNFLREAIPSQICI-MQSLEKLNLSHNSLSGLIPSCFE 475
           PK     L +L+     EL L  N L+  +P      +  L+ L L +N L  +    F+
Sbjct: 149 PKGVFDKLTSLK-----ELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202

Query: 476 KMNGLLHIDISYN 488
            +  L  + +  N
Sbjct: 203 SLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 7/182 (3%)

Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNY 295
           ++   L+L  N LS      +  L KL +L L  N+ +  P  I + L +LE + +  N 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96

Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSINNITGNVPPEIGH 354
           L       F    NL  + L +N     +    +    KL+ L    N +  ++P  +  
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 355 S-SQLGVLDLSSNHIVGEIPIEL-GKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLS 412
             + L  L L +N +   +P     KL     L L +NQL         SL +L+ L L 
Sbjct: 155 KLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213

Query: 413 SN 414
            N
Sbjct: 214 EN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 17/169 (10%)

Query: 337 LDFSINNITGNVPPEIGHS-SQLGVLDLSSNHIVGEIPI----ELGKLNFFIKLVLAHNQ 391
           LD   N ++ ++P +  H  ++L +L L+ N +   +P     EL  L     L +  N+
Sbjct: 42  LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLET---LWVTDNK 96

Query: 392 LSGQLSPKL-GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI 450
           L   L   +   LV L  L L  N+L  S+P  + +  L  L+ L L  N L+ ++P  +
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD-SLTKLTYLSLGYNELQ-SLPKGV 152

Query: 451 CI-MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
              + SL++L L +N L  +    F+K+  L  + +  N+L+  +P   
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 53.4 bits (129), Expect = 9e-08
 Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 7/115 (6%)

Query: 384 KLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFL 442
           KL L  N+LS  L  K    L +L  L L+ N+L  ++P  +   EL +L  L ++ N L
Sbjct: 41  KLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFK-ELKNLETLWVTDNKL 97

Query: 443 REAIPSQICI-MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
           + A+P  +   + +L +L L  N L  L P  F+ +  L ++ + YNEL+ S+P 
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 94.0 bits (233), Expect = 7e-20
 Identities = 58/288 (20%), Positives = 99/288 (34%), Gaps = 40/288 (13%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY- 667
           +G GG G V       +GE +A+K+    L  +   ++ +  E++ + ++ H N+V    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 79

Query: 668 -----GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                          +  EY +   L   L+       L       ++  I  AL Y+H 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 723 DCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +    I+HRD+  +N++L    +     + D G AK L           GT  Y+APEL 
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAPELL 195

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFISSMSFSSLNLNI 822
              K T   D +SFG LA E I G  P                  +    +         
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255

Query: 823 ALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
               +  P  L        ++ +  +      +  +   R T  +   
Sbjct: 256 FSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNPN 297

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 48/236 (20%), Positives = 82/236 (34%), Gaps = 17/236 (7%)

Query: 15  SELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDL 74
                L +     LG   ++  +      L+ +       +++  S+ G +  F    +L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68

Query: 75  ELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP 134
            LS+N++S  + P L +L+ L  L ++ N L N        L  L    L+NN L     
Sbjct: 69  HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--T 121

Query: 135 HSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATL 194
            SL +L NL  L I +N L +  +  +G L  L  L L  N    +    L  L  +  +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWI 177

Query: 195 YLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
            L               L   + +     +      IS  N  +     +      
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS--NGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 47/252 (18%), Positives = 89/252 (35%), Gaps = 23/252 (9%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
             L    ++  +      LS +     D +++ +   + +    +L  L L++N +S  +
Sbjct: 24  QNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHNQIS-DL 78

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG---SIPPSLGNLSN 190
              L +LT L  L +  N        ++ NL  + +  LS    +        SL +L N
Sbjct: 79  S-PLKDLTKLEELSVNRN--------RLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKN 129

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           L  L +  N L  SI   LG L  L  L L  N+++ +  ++   L  + +++L      
Sbjct: 130 LEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCV 185

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNL 310
                    L     +     ++  P  I  N  S     +          E  Y +   
Sbjct: 186 NEPVKYQPELYITNTVKDPDGRWISPYYIS-NGGSYVDGCVLWELPV-YTDEVSYKFSEY 243

Query: 311 TYIDLSQNNFYG 322
             +  ++  F G
Sbjct: 244 INVGETEAIFDG 255

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 35/192 (18%), Positives = 73/192 (38%), Gaps = 19/192 (9%)

Query: 277 IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLST 336
           +     L +  +  L +  +T ++  S      +   +   +N   +  +       L  
Sbjct: 12  VFPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKE 67

Query: 337 LDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQL 396
           L  S N I+ ++ P +   ++L  L ++ N +     I    L+   +L L +N+L    
Sbjct: 68  LHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNELR-DT 121

Query: 397 SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE-LIHLSELDLSRNFLREAIPSQICIMQS 455
              L  L  LE L + +N+L +     +  L  L  L  LDL  N +       +  ++ 
Sbjct: 122 DS-LIHLKNLEILSIRNNKLKS-----IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKK 173

Query: 456 LEKLNLSHNSLS 467
           +  ++L+     
Sbjct: 174 VNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 34/199 (17%), Positives = 79/199 (39%), Gaps = 16/199 (8%)

Query: 235 NLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRN 294
            L+N    NL + S++  +  +   L  +      ++  +  +  ++  T+L+ + L  N
Sbjct: 17  GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHN 73

Query: 295 YLTGNISESFYIYPNLTYIDLSQNNFYGEISS-DWGRCPKLSTLDFSINNITGNVPPEIG 353
            ++ ++         L  + +++N     + + +      LS L    N +  +    + 
Sbjct: 74  QIS-DL-SPLKDLTKLEELSVNRNR----LKNLNGIPSACLSRLFLDNNELR-DTDS-LI 125

Query: 354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
           H   L +L + +N +   I   LG L+    L L  N+++      L  L ++  +DL+ 
Sbjct: 126 HLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTG 181

Query: 414 NRLSNSIPKSLGNLELIHL 432
            +  N   K    L + + 
Sbjct: 182 QKCVNEPVKYQPELYITNT 200

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 46/249 (18%), Positives = 80/249 (32%), Gaps = 62/249 (24%)

Query: 137 LGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYL 196
              L N     +   S++   L     L  + N     +N   S+   +   +NL  L+L
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70

Query: 197 DTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYE 256
             N +S  + S L +L  L  LS+  N+L     ++    + L+ L L  N L       
Sbjct: 71  SHNQIS-DL-SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDTDSLI 125

Query: 257 YRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLS 316
             +L  L IL + +N+       L+++  L  +                    L  +DL 
Sbjct: 126 --HLKNLEILSIRNNK-------LKSIVMLGFL------------------SKLEVLDLH 158

Query: 317 QNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIEL 376
            N                      I N  G     +    ++  +DL+    V E     
Sbjct: 159 GNE---------------------ITNTGG-----LTRLKKVNWIDLTGQKCVNEPVKYQ 192

Query: 377 GKLNFFIKL 385
            +L     +
Sbjct: 193 PELYITNTV 201

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 16/177 (9%)

Query: 315 LSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI 374
           + +     ++  D          +    ++T  V       S +   +  +++I     +
Sbjct: 3   IQRPTPINQVFPD-PGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGM 59

Query: 375 ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSE 434
           +        +L L+HNQ+S  LSP L  L +LE L ++ NRL N     L  +    LS 
Sbjct: 60  Q--FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN-----LNGIPSACLSR 110

Query: 435 LDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
           L L  N LR+     +  +++LE L++ +N L  +       ++ L  +D+  NE+ 
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 30/141 (21%), Positives = 48/141 (34%), Gaps = 10/141 (7%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +  N L +        L  L    L NN+L      SL +L NL  L I  N L  SI  
Sbjct: 92  VNRNRLKNLNGIPSACLSRLF---LDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM 145

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
            +G       L+L  N+++ +    L  L  +  + L      N        L   + ++
Sbjct: 146 -LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVK 202

Query: 124 LNNNILSGSIPHS-LGNLTNL 143
             +         S  G+  + 
Sbjct: 203 DPDGRWISPYYISNGGSYVDG 223

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 52/244 (21%), Positives = 100/244 (40%), Gaps = 30/244 (12%)

Query: 563 QRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSK 622
                  Q+  S   ++    + L  +  I        ++ F+ E  +G+G    VY  K
Sbjct: 14  GTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK 73

Query: 623 -LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE 681
              + +  A+K     +  ++        E+  L  + H NI+K+         + +V E
Sbjct: 74  QKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128

Query: 682 Y------F-KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDIS 734
                  F ++         DAA          + +K I++A++Y+H +    IVHRD+ 
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAA----------DAVKQILEAVAYLHENG---IVHRDLK 175

Query: 735 SKNVLL-DFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 791
            +N+L      +A +  +DFG++K ++        + GT GY APE+        + D++
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMW 234

Query: 792 SFGV 795
           S G+
Sbjct: 235 SVGI 238

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 41/203 (20%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG+G  G V ++    +    A KK        +     F  E++ +  + H NI+++Y 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKY---FVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 669 FCLHVRHLFIVYEYFKMCS----LAVILS------NDAAAKNLGWTRRMNMIKGIVDALS 718
                  +++V E    C+       ++       +DAA           ++K ++ A++
Sbjct: 74  TFEDNTDIYLVMEL---CTGGELFERVVHKRVFRESDAA----------RIMKDVLSAVA 120

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           Y H      + HRD+  +N L   ++      + DFG+A   KP         GT  YV+
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVS 176

Query: 776 PEL---AYTMKVTEKCDVYSFGV 795
           P++    Y      +CD +S GV
Sbjct: 177 PQVLEGLY----GPECDEWSAGV 195

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 19/229 (8%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           +    +   IPS   + ++L    L    L     H+  NL N++ +Y+  +     +  
Sbjct: 18  VTCKDI-QRIPSLPPSTQTLK---LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES 73

Query: 64  EI-GNFRFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSNSIPSE--LGNLRSL 119
               N    + +E+ N +    I P  L  L  L  L +    L    P    + +    
Sbjct: 74  HSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIF 132

Query: 120 SNLQLNNNILSGSIP-HSLGNLTN-LATLYIYSNSLSASILGKIGNLKSLSNLQLSENNF 177
             L++ +N    SIP ++   L N   TL +Y+N  + S+ G   N   L  + L++N +
Sbjct: 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKY 191

Query: 178 NGSIPPSL--GNLSNLATLYLDTNSLSYSIPSE----LGNLRSLSNLSL 220
              I      G  S  + L +   S++ ++PS+    L  L + +  +L
Sbjct: 192 LTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 48/228 (21%), Positives = 87/228 (38%), Gaps = 40/228 (17%)

Query: 72  SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNNILS 130
            D  ++   +   IP       +  TL L    L  +IPS    NL ++S + ++ ++  
Sbjct: 14  EDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTL 68

Query: 131 GSIP-HSLGNLTNLATLYIYSN----SLSASILGKIGNLKSLS----------------- 168
             +  HS  NL+ +  + I +      +    L ++  LK L                  
Sbjct: 69  QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYS 128

Query: 169 -----NLQLSENNFNGSIPP-SLGNLSN-LATLYLDTNSLSYSIPSELGNLRSLSNLSLG 221
                 L++++N +  SIP  +   L N   TL L  N  + S+     N   L  + L 
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187

Query: 222 YNKLSGSIPISM--GNLSNLTYLNLFENSLSGAIPYE-YRNLVKLTIL 266
            NK    I      G  S  + L++ + S++ A+P +   +L +L   
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 33/207 (15%), Positives = 72/207 (34%), Gaps = 12/207 (5%)

Query: 283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW-GRCPKLSTLDFSI 341
             S + ++L   +L    S +F   PN++ I +S +    ++ S       K++ ++   
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 342 NNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIP--IELGKLNFFIKLVLAHNQLSGQLSP 398
                 + P+       L  L + +  +    P   ++   + F  L +  N     +  
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 399 KL--GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQIC--IMQ 454
               G   +   L L +N  + S+           L  + L++N     I       +  
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQG--YAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205

Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLL 481
               L++S  S++ L     E +  L+
Sbjct: 206 GPSLLDVSQTSVTALPSKGLEHLKELI 232

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 15/118 (12%), Positives = 37/118 (31%), Gaps = 5/118 (4%)

Query: 384 KLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFL 442
            L L    L   +      +L  +  + +S +     +        L  ++ +++     
Sbjct: 35  TLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFY-NLSKVTHIEIRNTRN 92

Query: 443 REAIPSQICI-MQSLEKLNLSHNSLSGLIP-SCFEKMNGLLHIDISYNELRGSIPNST 498
              I       +  L+ L + +  L      +     +    ++I+ N    SIP + 
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 47/207 (22%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEI-WHRN 662
           +G+G            S +  AVK        +              E+ AL     H N
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----------KEITALKLCEGHPN 67

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCS----LAVILS------NDAAAKNLGWTRRMNMIKG 712
           IVK++       H F+V E     +       I         +A+           +++ 
Sbjct: 68  IVKLHEVFHDQLHTFLVMEL---LNGGELFERIKKKKHFSETEAS----------YIMRK 114

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAG 769
           +V A+S+MH+     +VHRD+  +N+L   EN+     + DFG A+   PD+        
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVL 796
           T  Y APEL       E CD++S GV+
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVI 198

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 69/287 (24%), Positives = 112/287 (39%), Gaps = 48/287 (16%)

Query: 610 IGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWHR 661
           +G G  G VY  ++       S   +AVK     LP   + Q   +FL E   +++  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL----SNDAAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGYV 774
            Y+  + F   +HRDI+++N LL       V    DFG+A+ +    +++    G    +
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYR-KGGCAML 207

Query: 775 -----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEM 827
                 PE        T K D +SFGVL  E+   G  P     S S      N  + E 
Sbjct: 208 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP---YPSKS------NQEVLEF 257

Query: 828 LDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +    R+  P +N    +  I+     C    PE RP    + + ++
Sbjct: 258 VTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 300

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 51/230 (22%), Positives = 86/230 (37%), Gaps = 43/230 (18%)

Query: 587 TFEGKIIYEEIIRATNDFDDE----HCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGE 641
           T     I +++ R +  F D       IG G           A+    AVK         
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------ 56

Query: 642 MTFQQEFLNEVKAL-TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCS----LAVILS--- 693
              +++   E++ L     H NI+ +       +++++V E          L  IL    
Sbjct: 57  -KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL---MKGGELLDKILRQKF 112

Query: 694 ---NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH--- 747
               +A+A          ++  I   + Y+H      +VHRD+   N+L   E+      
Sbjct: 113 FSEREASA----------VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESI 159

Query: 748 -VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 796
            + DFG AK L+ ++        T  +VAPE+         CD++S GVL
Sbjct: 160 RICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.0 bits (218), Expect = 7e-19
 Identities = 50/236 (21%), Positives = 87/236 (36%), Gaps = 51/236 (21%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWHRNIVKV 666
           IG+G  G V +  +  +  I A+K  +     ++  +  +    EV+ + ++ H NI ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 667 YGFCLHVRHLFIVYEY---------------------------FKMCSLAVILSNDAAAK 699
           Y      +++ +V E                             ++C             
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 700 NLGWTRRMN----------MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV- 748
             G+   ++          +++ I  AL Y+HN     I HRDI  +N L        + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 749 -SDFGIAKFLKP----DSSNWTELAGTYGYVAPEL--AYTMKVTEKCDVYSFGVLA 797
             DFG++K        +    T  AGT  +VAPE+          KCD +S GVL 
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 87.3 bits (217), Expect = 9e-19
 Identities = 47/220 (21%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 597 IIRATNDFDD-----EHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLN 650
             ++  +F++        +G+G    V      ++G+  A K       G+   + E L+
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILH 77

Query: 651 EVKALTEIWHR-NIVKVYGFCLHVRHLFIVYEY------FKMC--SLAVILSNDAAAKNL 701
           E+  L        ++ ++    +   + ++ EY      F +C   LA ++S +      
Sbjct: 78  EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI--- 134

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLK 758
                  +IK I++ + Y+H +    IVH D+  +N+LL          + DFG+++ + 
Sbjct: 135 ------RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 759 PDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLA 797
                  E+ GT  Y+APE L Y   +T   D+++ G++A
Sbjct: 186 HACE-LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 34/290 (11%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGE----IIAVKKFHSPLPGEMTFQQEFLNE 651
            I         +  IGKG  G VY  +           A+K     +       + FL E
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQ-VEAFLRE 72

Query: 652 VKALTEIWHRNIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
              +  + H N++ + G  L       ++  Y     L   + +    +N      ++  
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFG 130

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
             +   + Y+    F   VHRD++++N +LD      V+DFG+A+ +  D   ++     
Sbjct: 131 LQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHR 186

Query: 771 YGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIAL 824
           +  +     A E   T + T K DV+SFGVL  E++ +G  P   I             L
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID---------PFDL 237

Query: 825 DEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              L    RLP P     D L  +++    C + +P  RPT + +   ++
Sbjct: 238 THFLAQGRRLPQP-EYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVE 283

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 89.9 bits (223), Expect = 1e-18
 Identities = 85/437 (19%), Positives = 155/437 (35%), Gaps = 82/437 (18%)

Query: 482 HIDISYNELRGSIPNS-TTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRT---I 537
              ISY   +G+ P     F    ++ +Q +     D KG+L  K   + +    T   +
Sbjct: 247 EEGISYLTDKGANPTHLADFNQ--VQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSL 304

Query: 538 WVVVVFPLL--GFVALLI----SLIGLFFKFQRRKNDSQTQQSSPGNSRGLLSVLTFEGK 591
            +      L  G+  L+     S I    K   R   S  + ++          ++    
Sbjct: 305 TIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSET 364

Query: 592 IIYEEIIRATNDFDD---------------EHCIGKGGQGSVYMS--KLASGEII--AVK 632
             Y EII   + +                   CIG+G  G V+           +  A+K
Sbjct: 365 DDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424

Query: 633 KFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL 692
              +     +  +++FL E   + +  H +IVK+ G       ++I+ E   +  L   L
Sbjct: 425 TCKNCTSDSV--REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL 481

Query: 693 -SNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF 751
                   +L     +     +  AL+Y+ +  F   VHRDI+++NVL+   +   + DF
Sbjct: 482 QVRK---FSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDF 535

Query: 752 GIAKFLKPDS----------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 801
           G++++++  +            W          APE     + T   DV+ FGV   E++
Sbjct: 536 GLSRYMEDSTYYKASKGKLPIKWM---------APESINFRRFTSASDVWMFGVCMWEIL 586

Query: 802 -KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVD 855
             G  P        F  +  N  +   ++   RLP P      ++        +   C  
Sbjct: 587 MHGVKP--------FQGVKNNDVI-GRIENGERLPMPPNCPPTLY-------SLMTKCWA 630

Query: 856 ENPESRPTMQKVCQLLK 872
            +P  RP   ++   L 
Sbjct: 631 YDPSRRPRFTELKAQLS 647

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 65/281 (23%), Positives = 109/281 (38%), Gaps = 38/281 (13%)

Query: 607 EHCIGKGGQGSVYMSKLASGE----IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWH 660
              IG+G  G VY   L   +      AVK     L       +  +FL E   + +  H
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS----LNRITDIGEVSQFLTEGIIMKDFSH 149

Query: 661 RNIVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
            N++ + G CL       +V  Y K   L   + N+    N      +     +   + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 207

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV----- 774
           + +  F   VHRD++++N +LD +    V+DFG+A+ +     +      T   +     
Sbjct: 208 LASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWM 263

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDP--R 831
           A E   T K T K DV+SFGVL  E++ +G  P   ++            +   L    R
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---------TFDITVYLLQGRR 314

Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           L  P     D L  ++   + C     E RP+  ++   + 
Sbjct: 315 LLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 351

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 70/287 (24%), Positives = 110/287 (38%), Gaps = 48/287 (16%)

Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWHR 661
           +G G  G VY      M    S   +AVK     LP   + Q   +FL E   +++  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL----SNDAAAKNLGWTRRMNMIKGIVDAL 717
           NIV+  G  L     FI+ E      L   L       +   +L     +++ + I    
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHV---SDFGIAKFLKPDSSNWTELAGTYGYV 774
            Y+  + F   +HRDI+++N LL       V    DFG+A+ +    + +    G    +
Sbjct: 195 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAML 248

Query: 775 -----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEM 827
                 PE        T K D +SFGVL  E+   G  P     S S      N  + E 
Sbjct: 249 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP---YPSKS------NQEVLEF 298

Query: 828 LDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +    R+  P +N    +  I+     C    PE RP    + + ++
Sbjct: 299 VTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 341

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 66/289 (22%), Positives = 109/289 (37%), Gaps = 54/289 (18%)

Query: 607 EHCIGKGGQGSVYMSKLASGE----IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWH 660
              IG+G  G VY   L   +      AVK     L       +  +FL E   + +  H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS----LNRITDIGEVSQFLTEGIIMKDFSH 85

Query: 661 RNIVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
            N++ + G CL       +V  Y K   L   + N+    N      +     +   + Y
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKY 143

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL-------KPDSSN------WTE 766
           + +  F   VHRD++++N +LD +    V+DFG+A+ +         + +       W  
Sbjct: 144 LASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM- 199

Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALD 825
                   A E   T K T K DV+SFGVL  E++ +G  P   ++            + 
Sbjct: 200 --------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---------TFDIT 242

Query: 826 EMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             L    RL  P     D L  ++   + C     E RP+  ++   + 
Sbjct: 243 VYLLQGRRLLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 66/301 (21%), Positives = 124/301 (41%), Gaps = 71/301 (23%)

Query: 610 IGKGGQGSVYMSKLASGE------IIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +G+G  G V++++  +        ++AVK  K        +  +++F  E + LT + H 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTNLQHE 77

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMC---------------SLAVILSNDAAAKNLGWTRR 706
           +IVK YG C     L +V+EY  M                 + V      A   LG ++ 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEY--MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL------KPD 760
           +++   I   + Y+ +  F   VHRD++++N L+       + DFG+++ +      +  
Sbjct: 136 LHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192

Query: 761 SSN-----WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSM 813
                   W           PE + Y  K T + DV+SFGV+  E+   GK P       
Sbjct: 193 GHTMLPIRWM---------PPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP------- 235

Query: 814 SFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            +  L+ N  + E +     L  P R    ++  ++     C    P+ R  ++++ ++L
Sbjct: 236 -WFQLS-NTEVIECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIKEIYKIL 289

Query: 872 K 872
            
Sbjct: 290 H 290

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 57/292 (19%), Positives = 110/292 (37%), Gaps = 58/292 (19%)

Query: 610 IGKGGQGSVYMSKLASGE------IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIWHR 661
           +G+G  G VY               +A+K     +    + ++  EFLNE   + E    
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKT----VNEAASMRERIEFLNEASVMKEFNCH 88

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-------SNDAAAKNLGWTRRMNMIKGIV 714
           ++V++ G     +   ++ E      L   L       +N+        ++ + M   I 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL------KPDSSN----- 763
           D ++Y++ + F   VHRD++++N ++  +    + DFG+ + +      +          
Sbjct: 149 DGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNI 822
           W          +PE       T   DV+SFGV+  E+    + P      +S      N 
Sbjct: 206 WM---------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLS------NE 247

Query: 823 ALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            +   +     L  P  N  D L  ++     C   NP+ RP+  ++   +K
Sbjct: 248 QVLRFVMEGGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 65/296 (21%), Positives = 121/296 (40%), Gaps = 62/296 (20%)

Query: 610 IGKGGQGSVYMSKLASGE------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G+G  G V++++  +        ++AVK          + +Q+F  E + LT + H++I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK---EASESARQDFQREAELLTMLQHQHI 105

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSL------------AVILSNDAAAKNLGWTRRMNMIK 711
           V+ +G C   R L +V+EY +   L             +    D A   LG  + + +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL------KPDSSN-- 763
            +   + Y+    F   VHRD++++N L+       + DFG+++ +      +       
Sbjct: 166 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 764 ---WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSL 818
              W           PE + Y  K T + DV+SFGV+  E+   GK P      +S    
Sbjct: 223 PIRWM---------PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP---WYQLS---- 265

Query: 819 NLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             N    + +     L  P R    ++ +I+     C    P+ R +++ V   L+
Sbjct: 266 --NTEAIDCITQGRELERP-RACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 315

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 52/291 (17%)

Query: 607 EHCIGKGGQGSVYMSKLASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
              +G+G  GSV    L   +     +AVK        +    +EFL+E   + +  H N
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPN 97

Query: 663 IVKVYGFCL-----HVRHLFIVYEYFKMCSLAVIL---SNDAAAKNLGWTRRMNMIKGIV 714
           ++++ G C+      +    ++  + K   L   L     +   K++     +  +  I 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-----------N 763
             + Y+ N  F   +HRD++++N +L  +    V+DFG++K +                 
Sbjct: 158 LGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 764 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNI 822
           W          A E       T K DV++FGV   E+  +G  P        +  +  N 
Sbjct: 215 WI---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--------YPGVQ-NH 256

Query: 823 ALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
            + + L    RL  P  +  D+L  I+    SC   +P  RPT   +   L
Sbjct: 257 EMYDYLLHGHRLKQP-EDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 58/290 (20%), Positives = 111/290 (38%), Gaps = 53/290 (18%)

Query: 610 IGKGGQGSVYMSKLASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           +GKG  GSV  ++L   +     +AVK   + +       +EFL E   + E  H ++ K
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAK 89

Query: 666 VYGFCL------HVRHLFIVYEYFKMCSLAVIL---SNDAAAKNLGWTRRMNMIKGIVDA 716
           + G  L       +    ++  + K   L   L          NL     +  +  I   
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-----------NWT 765
           + Y+ +  F   +HRD++++N +L  +    V+DFG+++ +                 W 
Sbjct: 150 MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIAL 824
                    A E       T   DV++FGV   E++ +G+ P        ++ +  N  +
Sbjct: 207 ---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--------YAGIE-NAEI 248

Query: 825 DEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              L    RL  P     +++  ++     C   +P+ RP+   +   L+
Sbjct: 249 YNYLIGGNRLKQP-PECMEEVYDLMY---QCWSADPKQRPSFTCLRMELE 294

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 75/358 (20%), Positives = 140/358 (39%), Gaps = 78/358 (21%)

Query: 557 GLFFKF-QRRKNDSQTQ--QSSPGNSRGLLSVLTFEGKIIYE---EIIRATNDFDDEHCI 610
           G+ +K+ Q+ K   + +  +S  GNS   +       ++ Y    E  R    F     +
Sbjct: 1   GVDYKYKQKPKYQVRWKIIESYEGNSYTFID----PTQLPYNEKWEFPRNNLQFGKT--L 54

Query: 611 GKGGQGSVYM------SKLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIW-HR 661
           G G  G V         K  +   +AVK     L         +  ++E+K ++ +  H 
Sbjct: 55  GAGAFGKVVEATAFGLGKEDAVLKVAVKM----LKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMC-------------SLAVILSNDAAAKNLGWTRRMN 708
           NIV + G C H   + ++ EY   C              L    +   A         ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEY--CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS-----SN 763
               +   ++++ +      +HRD++++NVLL   + A + DFG+A+ +  DS      N
Sbjct: 169 FSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 764 ------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFS 816
                 W          APE  +    T + DV+S+G+L  E+   G +P        + 
Sbjct: 226 ARLPVKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--------YP 268

Query: 817 SLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            + +N    +++    ++  P       + SI++   +C    P  RPT Q++C  L+
Sbjct: 269 GILVNSKFYKLVKDGYQMAQP-AFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 44/221 (19%), Positives = 78/221 (35%), Gaps = 50/221 (22%)

Query: 601 TNDFDD-----EHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 654
                D     +  +G G  G V       +G+  A+K  +           +   EV  
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDH 74

Query: 655 LTEIW-HRNIVKVYGFC----LHVRHLFIVYEYFKMCS-----------LAVILSNDAAA 698
             +     +IV +           R L I+ E                      +   AA
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMEC---MEGGELFSRIQERGDQAFTEREAA 131

Query: 699 KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAK 755
           +         +++ I  A+ ++H+     I HRD+  +N+L   + +     ++DFG AK
Sbjct: 132 E---------IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

Query: 756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 796
               ++        T  YVAPE+    K  + CD++S GV+
Sbjct: 180 ETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 50/233 (21%), Positives = 88/233 (37%), Gaps = 61/233 (26%)

Query: 601 TNDFDD-----EHCIGKGGQGSVYM-SKLASGEIIAVK---KFHSPLPGEMTFQQEFLNE 651
           +  F+D     E  +G+G    V     L + +  AVK   K   P             E
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIR----SRVFRE 60

Query: 652 VKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCS----LAVILSN------DAAAKN 700
           V+ L +   HRN++++  F       ++V+E          L+ I         +A+   
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK---MRGGSILSHIHKRRHFNELEAS--- 114

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVS-----DFGIAK 755
                   +++ +  AL ++HN     I HRD+  +N+L   E+   VS     DF +  
Sbjct: 115 -------VVVQDVASALDFLHN---KGIAHRDLKPENIL--CEHPNQVSPVKICDFDLGS 162

Query: 756 FLKPDSS-------NWTELAGTYGYVAPE-----LAYTMKVTEKCDVYSFGVL 796
            +K +               G+  Y+APE             ++CD++S GV+
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 50/226 (22%), Positives = 82/226 (36%), Gaps = 54/226 (23%)

Query: 598 IRATNDFDD----EHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEV 652
           I+     DD       +G G  G V       + E  A+K              +   EV
Sbjct: 54  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREV 105

Query: 653 KALTEIW-HRNIVKVYGFC----LHVRHLFIVYEYFKMCS----LAVILS--------ND 695
           +         +IV++           + L IV E           + I           +
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC---LDGGELFSRIQDRGDQAFTERE 162

Query: 696 AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVS-----D 750
           A+           ++K I +A+ Y+H+     I HRD+  +N+L  + ++   +     D
Sbjct: 163 AS----------EIMKSIGEAIQYLHSIN---IAHRDVKPENLL--YTSKRPNAILKLTD 207

Query: 751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 796
           FG AK     +S  T    T  YVAPE+    K  + CD++S GV+
Sbjct: 208 FGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 12/159 (7%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLE---LSNNKLS 82
           L+L +  L+     +   LT L  L +  N L  ++    G F   ++L    L+NN+L+
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLS--AGVFDDLTELGTLGLANNQLA 96

Query: 83  GSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPHSL-GN 139
            S+P  +  +L+ L  LYL  N L  S+PS +   L  L  L+LN N L  SIP      
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153

Query: 140 LTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           LTNL TL + +N L +   G    L  L  + L  N F+
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 18/156 (11%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPG 63
            +  L     +  R L  L+ L L  N+L  ++   +  +LT L TL +  N L+ S+P 
Sbjct: 43  QSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPL 100

Query: 64  EIGNFRFFS-----DLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNL 116
            +    F        L L  N+L  S+P  +   L+ L  L L+TN L  SIP+     L
Sbjct: 101 GV----FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154

Query: 117 RSLSNLQLNNNILSGSIPH-SLGNLTNLATLYIYSN 151
            +L  L L+ N L  S+PH +   L  L T+ ++ N
Sbjct: 155 TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 53/191 (27%), Positives = 73/191 (38%), Gaps = 33/191 (17%)

Query: 108 SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL 167
           S+PS  G       L L +  L+     +   LT L  L +  N L              
Sbjct: 28  SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT------------ 73

Query: 168 SNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLS 226
               LS   F+         L+ L TL L  N L+ S+P  +  +L  L  L LG N+L 
Sbjct: 74  ----LSAGVFDD--------LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK 120

Query: 227 GSIPISM-GNLSNLTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQFRG-PIPILRNL 283
            S+P  +   L+ L  L L  N L  +IP   +  L  L  L L  NQ +  P      L
Sbjct: 121 -SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRL 178

Query: 284 TSLERVRLDRN 294
             L+ + L  N
Sbjct: 179 GKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 7/156 (4%)

Query: 169 NLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLSG 227
            L L           +   L+ L  L LD N L  ++ + +  +L  L  L L  N+L+ 
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96

Query: 228 SIPISM-GNLSNLTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQFRG-PIPILRNLT 284
           S+P+ +  +L+ L  L L  N L  ++P   +  L KL  L L  NQ +  P      LT
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155

Query: 285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF 320
           +L+ + L  N L      +F     L  I L  N F
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 8/159 (5%)

Query: 45  TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTN 103
            +   L + +  L+             + L L  N+L  ++   +  +L+ L TL L  N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 104 SLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPHSL-GNLTNLATLYIYSNSLSASILGKI 161
            L+ S+P  +  +L  L  L L  N L  S+P  +   LT L  L + +N L +   G  
Sbjct: 94  QLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151

Query: 162 GNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTN 199
             L +L  L LS N    S+P  +   L  L T+ L  N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 7/151 (4%)

Query: 348 VPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLE 407
           VP  I   ++   LDL S  +          L     L L +NQL    +     L +L 
Sbjct: 29  VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86

Query: 408 HLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQIC-IMQSLEKLNLSHNSL 466
            L L++N+L+ S+P  + +  L  L +L L  N L +++PS +   +  L++L L+ N L
Sbjct: 87  TLGLANNQLA-SLPLGVFD-HLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQL 143

Query: 467 SGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
             +    F+K+  L  + +S N+L+ S+P+ 
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 48/222 (21%), Positives = 73/222 (32%), Gaps = 73/222 (32%)

Query: 194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSLSGA 252
           L L +  L+    +    L  L+ L+L YN+L  ++   +  +L+ L  L L  N L+  
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98

Query: 253 IPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTY 312
               + +L +L  L LG NQ          L SL     DR  LT            L  
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQ----------LKSLPSGVFDR--LT-----------KLKE 135

Query: 313 IDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEI 372
           + L+ N              +L ++            P        G  D          
Sbjct: 136 LRLNTN--------------QLQSI------------PA-------GAFD---------- 152

Query: 373 PIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSN 414
             +L  L     L L+ NQL          L +L+ + L  N
Sbjct: 153 --KLTNLQ---TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 18/160 (11%)

Query: 337 LDFSINNITGNVPPEIGHSSQLGVLDLSSNHI------VGEIPIELGKLNFFIKLVLAHN 390
           LD     +           ++L  L+L  N +      V +   ELG L       LA+N
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLG------LANN 93

Query: 391 QLSGQLSPKL-GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQ 449
           QL+  L   +   L QL+ L L  N+L  S+P  + +  L  L EL L+ N L+ +IP+ 
Sbjct: 94  QLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFD-RLTKLKELRLNTNQLQ-SIPAG 149

Query: 450 IC-IMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
               + +L+ L+LS N L  +    F+++  L  I +  N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.9 bits (195), Expect = 6e-16
 Identities = 65/317 (20%), Positives = 118/317 (37%), Gaps = 77/317 (24%)

Query: 593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGE---IIAVKKFHSPLPGEMTFQQ--E 647
           IY  +      F D   IG+G  G V  +++         A+K+    +    +     +
Sbjct: 18  IYPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKR----MKEYASKDDHRD 71

Query: 648 FLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSL-------------AVILS 693
           F  E++ L ++  H NI+ + G C H  +L++  EY    +L                  
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131

Query: 694 NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI 753
            ++ A  L   + ++    +   + Y+    F   +HRD++++N+L+     A ++DFG+
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGL 188

Query: 754 AKFLKPDSSN------------WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEV 800
           ++                    W          A E L Y+   T   DV+S+GVL  E+
Sbjct: 189 SR----GQEVYVKKTMGRLPVRWM---------AIESLNYS-VYTTNSDVWSYGVLLWEI 234

Query: 801 I-KGKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTP---SRNVHDKLISIVEVTISCV 854
           +  G  P   ++            L E L    RL  P      V+       ++   C 
Sbjct: 235 VSLGGTPYCGMT---------CAELYEKLPQGYRLEKPLNCDDEVY-------DLMRQCW 278

Query: 855 DENPESRPTMQKVCQLL 871
            E P  RP+  ++   L
Sbjct: 279 REKPYERPSFAQILVSL 295

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 57/292 (19%), Positives = 100/292 (34%), Gaps = 81/292 (27%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           +G G  G V+ +      + + VK     K       E     +   E+  L+ + H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 664 VKVYGFCLHVRHLFIVYEY-------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
           +KV     +     +V E        F        L    A+          + + +V A
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY---------IFRQLVSA 142

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
           + Y+       I+HRDI  +N+++  +    + DFG A +L+     +T   GT  Y AP
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAP 198

Query: 777 EL----AYTMKVTEKCDVYSFGVL--AL-----------EVIKGKH--PRDFISSMSFSS 817
           E+     Y      + +++S GV    L           E ++     P      +S   
Sbjct: 199 EVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPP----YLVSKEL 251

Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           ++L   +  +L P                           PE R T++K+  
Sbjct: 252 MSL---VSGLLQP--------------------------VPERRTTLEKLVT 274

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 62/283 (21%), Positives = 102/283 (36%), Gaps = 61/283 (21%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVK-------KFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +GKGG G+V+    L     +A+K          SPL   +T   E     K      H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 662 NIVKVYGFCLHVRHLFIVYEY-------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
            ++++  +        +V E        F   +    L    +       R       +V
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------RCF--FGQVV 149

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTYGY 773
            A+ + H+     +VHRDI  +N+L+D     A + DFG    L      +T+  GT  Y
Sbjct: 150 AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVY 204

Query: 774 VAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD 829
             PE      Y         V+S G+L  +++ G  P +                 E+L+
Sbjct: 205 SPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERD--------------QEILE 247

Query: 830 PRLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             L  P   S +    LI        C+   P SRP+++++  
Sbjct: 248 AELHFPAHVSPDCCA-LIR------RCLAPKPSSRPSLEEILL 283

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 47/200 (23%), Positives = 76/200 (38%), Gaps = 40/200 (20%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIP--HSLGNLTNLATLYIHTNSLSGSIPGEIGNFR 69
           ++P  L +    + L+L +N LS  +    +   LTNL +L                   
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLL------------------ 70

Query: 70  FFSDLELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNN 127
                 LS+N L+  I   +   + NL  L L +N L  ++      +L++L  L L NN
Sbjct: 71  ------LSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN 122

Query: 128 ILSGSIP-HSLGNLTNLATLYIYSNSLS---ASILGKIGNLKSLSNLQLSENNFNGSIPP 183
            +   +  ++  ++  L  LY+  N +S     ++     L  L  L LS N        
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181

Query: 184 SLGNLSNL--ATLYLDTNSL 201
            L  L       LYL  N L
Sbjct: 182 DLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 40/163 (24%), Positives = 59/163 (36%), Gaps = 12/163 (7%)

Query: 166 SLSNLQLSENNFNGSIPP--SLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGY 222
             + L LS NN    +    +   L+NL +L L  N L+  I SE    + +L  L L  
Sbjct: 40  YTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 223 NKLSGSIPISM-GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR----GPI 277
           N L  ++   +  +L  L  L L+ N +       + ++ +L  L L  NQ        I
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156

Query: 278 PILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLS-QNN 319
                L  L  + L  N L           P      L   NN
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 45/165 (27%), Positives = 67/165 (40%), Gaps = 12/165 (7%)

Query: 284 TSLERVRLDRNYLTG-NISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSI 341
           +    + L  N L+      +     NL  + LS N+    ISS+ +   P L  LD S 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSS 97

Query: 342 NNITGNVPPEI-GHSSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQLSGQLSPK 399
           N++   +   +      L VL L +NHIV  +       +    KL L+ NQ+S +   +
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154

Query: 400 ----LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN 440
                  L +L  LDLSSN+L       L  L     + L L  N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 39/159 (24%), Positives = 64/159 (40%), Gaps = 14/159 (8%)

Query: 336 TLDFSINNITGNVPPEIGHS--SQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQL 392
            LD S NN++  +  E   +  + L  L LS NH+   I  E    +     L L+ N L
Sbjct: 43  LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHL 100

Query: 393 SGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI- 450
              L       L  LE L L +N +      +  ++    L +L LS+N +    P ++ 
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMA--QLQKLYLSQNQISR-FPVELI 156

Query: 451 ---CIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDIS 486
                +  L  L+LS N L  L  +  +K+   +   + 
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 8/118 (6%)

Query: 384 KLVLAHNQLSGQLSPK--LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNF 441
            L L+HN LS +L  +     L  L  L LS N L+    ++   +   +L  LDLS N 
Sbjct: 43  LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP--NLRYLDLSSNH 99

Query: 442 LREAIPSQICI-MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
           L   +   +   +Q+LE L L +N +  +  + FE M  L  + +S N++    P   
Sbjct: 100 LH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 7/91 (7%)

Query: 409 LDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI-CIMQSLEKLNLSHNSLS 467
           L  S  +L  ++P+SL +    + + LDLS N L           + +L  L LSHN L+
Sbjct: 23  LSCSKQQLP-NVPQSLPS----YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 468 GLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
            +    F  +  L ++D+S N L  ++    
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLH-TLDEFL 107

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 45/230 (19%)

Query: 73  DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGS 132
              L    ++         L+++  +  + + +  S+   +  L ++  L L  N L   
Sbjct: 23  KANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH-- 76

Query: 133 IPHSLG---NLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLS 189
               +     LTNL  L +  N L +                L    F+         L+
Sbjct: 77  ---DISALKELTNLTYLILTGNQLQS----------------LPNGVFDK--------LT 109

Query: 190 NLATLYLDTNSLSYSIPSELGN-LRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFEN 247
           NL  L L  N L  S+P  + + L +L+ L+L +N+L  S+P  +   L+NLT L+L  N
Sbjct: 110 NLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN 167

Query: 248 SLSGAIPYE-YRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRN 294
            L  ++P   +  L +L  L L  NQ +  +P  +   LTSL+ + L  N
Sbjct: 168 QLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 20/165 (12%)

Query: 20  LKSLSDLELGNNKLSGSIPHSLG---NLTNLATLYIHTNSLSGSIPGEIGNFRFFSD--- 73
           L ++  L LG NKL       +     LTNL  L +  N L  S+P  +  F   ++   
Sbjct: 62  LPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGV--FDKLTNLKE 113

Query: 74  LELSNNKLSGSIPPSLGN-LSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSG 131
           L L  N+L  S+P  + + L+NL  L L  N L  S+P  +   L +L+ L L+ N L  
Sbjct: 114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ- 170

Query: 132 SIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSEN 175
           S+P  +   LT L  L +Y N L +   G    L SL  + L +N
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 65.8 bits (161), Expect = 8e-12
 Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 8/137 (5%)

Query: 19  NLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELS 77
            L +L+ L L  N+L  S+P+ +   LTNL  L +  N L     G        + L L+
Sbjct: 83  ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA 141

Query: 78  NNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPH 135
           +N+L  S+P  +   L+NL  L L  N L  S+P  +   L  L +L+L  N L  S+P 
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPD 198

Query: 136 -SLGNLTNLATLYIYSN 151
                LT+L  ++++ N
Sbjct: 199 GVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 28/206 (13%)

Query: 240 TYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR--GPIPILRNLTSLERVRLDRNYLT 297
              NL + S++ A+      L  +  ++  ++  +    I  L N+  L    L  N L 
Sbjct: 22  IKANLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQYLPNVRYL---ALGGNKLH 76

Query: 298 GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS-S 356
                +     NLTY+ L+ N      +  + +   L  L    N +  ++P  +    +
Sbjct: 77  D--ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT 133

Query: 357 QLGVLDLSSNHIVGEIPI----ELGKLNFFIKLVLAHNQLSGQLSPK--LGSLVQLEHLD 410
            L  L+L+ N +   +P     +L  L    +L L++NQL  Q  P+     L QL+ L 
Sbjct: 134 NLTYLNLAHNQLQ-SLPKGVFDKLTNLT---ELDLSYNQL--QSLPEGVFDKLTQLKDLR 187

Query: 411 LSSNRLSNSIPK----SLGNLELIHL 432
           L  N+L  S+P      L +L+ I L
Sbjct: 188 LYQNQL-KSVPDGVFDRLTSLQYIWL 212

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 41/172 (23%), Positives = 80/172 (46%), Gaps = 23/172 (13%)

Query: 333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLV------ 386
            +  +  + ++I       I +   +  L L  N        +L  ++   +L       
Sbjct: 42  SIDQIIANNSDIKS--VQGIQYLPNVRYLALGGN--------KLHDISALKELTNLTYLI 91

Query: 387 LAHNQLSGQLSPKL-GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREA 445
           L  NQL   L   +   L  L+ L L  N+L  S+P  + + +L +L+ L+L+ N L ++
Sbjct: 92  LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD-KLTNLTYLNLAHNQL-QS 147

Query: 446 IPSQIC-IMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
           +P  +   + +L +L+LS+N L  L    F+K+  L  + +  N+L+ S+P+
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPD 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 67/277 (24%), Positives = 109/277 (39%), Gaps = 52/277 (18%)

Query: 610 IGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           IGKG    V   KLA    +G  +A+K          + Q+ F  EV+ +  + H NIVK
Sbjct: 23  IGKGNFAKV---KLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVK 78

Query: 666 VYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           ++      + L+++ EY      F        +    A             + IV A+ Y
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---------KFRQIVSAVQY 129

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 778
            H      IVHRD+ ++N+LLD +    ++DFG +              G   Y APEL 
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPELF 185

Query: 779 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
               Y      + DV+S GV+   ++ G  P        F   NL    + +L  +   P
Sbjct: 186 QGKKYDGP---EVDVWSLGVILYTLVSGSLP--------FDGQNLKELRERVLRGKYRIP 234

Query: 836 ---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
              S +  + L   + +       NP  R T++++ +
Sbjct: 235 FYMSTDCENLLKRFLVL-------NPIKRGTLEQIMK 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 62/299 (20%), Positives = 109/299 (36%), Gaps = 65/299 (21%)

Query: 610 IGKGGQGSVYM------SKLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIW-H 660
           +G+G  G V         K A+   +AVK     L    T    +  ++E+K L  I  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 90

Query: 661 RNIVKVYGFCLHV-RHLFIVYEYFKMCSL-------------AVILSNDAAAKNLGWTRR 706
            N+V + G C      L ++ E+ K  +L               +   D     L     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS---- 762
           +     +   + ++ +      +HRD++++N+LL  +N   + DFG+A+ +  D      
Sbjct: 151 ICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 763 -------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMS 814
                   W          APE  +    T + DV+SFGVL  E+   G  P        
Sbjct: 208 GDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------- 250

Query: 815 FSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
           +  + ++      L    R+  P      ++   +     C    P  RPT  ++ + L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 305

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 49/228 (21%)

Query: 602 NDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           + F+    IGKG  G V +  K  + ++ A+K  +     E    +    E++ +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 661 RNIVKVYGFCLH-----VRHLFIVYEY------FKMCSLAVILSNDAA----AKNLGWTR 705
             +V      L         +F+V +              V    +       +      
Sbjct: 75  PFLVN-----LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE------ 123

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
                  +V AL Y+ N     I+HRD+   N+LLD     H++DF IA  L  ++   T
Sbjct: 124 -------LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173

Query: 766 ELAGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            +AGT  Y+APE+        Y+  V    D +S GV A E+++G+ P
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 75.3 bits (186), Expect = 7e-15
 Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 74/306 (24%)

Query: 607 EHCIGKGGQGSVYMSKLASGE------IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEI 658
              +G+   G VY   L           +A+K     L  +       EF +E      +
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT----LKDKAEGPLREEFRHEAMLRARL 69

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMC---------------SLAVILSNDAAAKNLGW 703
            H N+V + G     + L +++ Y                    +     +      L  
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSY--CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 704 TRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL------ 757
              ++++  I   + Y+ +      VH+D++++NVL+  +    +SD G+ + +      
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 184

Query: 758 KPDSSN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFIS 811
           K   ++     W          APE     K +   D++S+GV+  EV   G  P     
Sbjct: 185 KLLGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YC 232

Query: 812 SMSFSSLNLNIALDEMLDP--RLPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQK 866
             S      N  + EM+     LP P      V+        + I C +E P  RP  + 
Sbjct: 233 GYS------NQDVVEMIRNRQVLPCPDDCPAWVY-------ALMIECWNEFPSRRPRFKD 279

Query: 867 VCQLLK 872
           +   L+
Sbjct: 280 IHSRLR 285

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 59/299 (19%), Positives = 118/299 (39%), Gaps = 62/299 (20%)

Query: 610 IGKGGQGSVYM------SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRN 662
           +G G  G V         K  +   +AVK            ++  ++E+K L+ +  H N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMN 88

Query: 663 IVKVYGFCLHVRHLFIVYEY---------------FKMCSLAVILSNDAAAKNLGWTRRM 707
           IV + G C       ++ EY                 +CS       +     L     +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 708 NMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-----SS 762
           +    +   ++++ +      +HRD++++N+LL       + DFG+A+ +K D       
Sbjct: 149 SFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 763 N------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSF 815
           N      W          APE  +    T + DV+S+G+   E+   G  P        +
Sbjct: 206 NARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------Y 248

Query: 816 SSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             + ++    +M+    R+ +P  +   ++  I++   +C D +P  RPT +++ QL++
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSP-EHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 303

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 12/140 (8%)

Query: 45  TNLATLYIHTNSLSGSIPGEIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYL 100
             +  + +  N++   IP   G F  +  L    LSNN++S  + P +   L +L +L L
Sbjct: 32  ETITEIRLEQNTIK-VIPP--GAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87

Query: 101 DTNSLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPH-SLGNLTNLATLYIYSNSLSASIL 158
             N ++  +P  L   L SL  L LN N ++  +   +  +L NL  L +Y N L     
Sbjct: 88  YGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAK 145

Query: 159 GKIGNLKSLSNLQLSENNFN 178
           G    L+++  + L++N F 
Sbjct: 146 GTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 33/130 (25%), Positives = 60/130 (46%), Gaps = 8/130 (6%)

Query: 74  LELSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSG 131
           + L  N +   IPP +      L  + L  N +S  +  +    LRSL++L L  N ++ 
Sbjct: 37  IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 132 SIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLS 189
            +P SL   L +L  L + +N ++   +    +L +L+ L L +N    +I   +   L 
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152

Query: 190 NLATLYLDTN 199
            + T++L  N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 5/143 (3%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSN 238
            IP +L     +  + L+ N++    P      + L  + L  N++S  +       L +
Sbjct: 25  EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLT 297
           L  L L+ N ++      +  L  L +LLL  N+     +   ++L +L  + L  N L 
Sbjct: 82  LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141

Query: 298 GNISESFYIYPNLTYIDLSQNNF 320
                +F     +  + L+QN F
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 36/174 (20%), Positives = 69/174 (39%), Gaps = 33/174 (18%)

Query: 77  SNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPH- 135
               L+  IP +L     +  + L+ N++    P      + L  + L+NN +S  +   
Sbjct: 19  RGKGLT-EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74

Query: 136 SLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL-GNLSNLATL 194
           +   L +L +L +Y N ++                          +P SL   L +L  L
Sbjct: 75  AFQGLRSLNSLVLYGNKIT-------------------------ELPKSLFEGLFSLQLL 109

Query: 195 YLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFEN 247
            L+ N ++  +  +   +L +L+ LSL  NKL      +   L  +  ++L +N
Sbjct: 110 LLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 29/128 (22%), Positives = 55/128 (42%), Gaps = 10/128 (7%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPH-SLGNLTNLATLYIHTNSLSGSIPG 63
             N++    P      K L  ++L NN++S  +   +   L +L +L ++ N ++  +P 
Sbjct: 40  EQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPK 97

Query: 64  EIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSELGNLRSL 119
            +  F     L+   L+ NK++  +   +  +L NL  L L  N L          LR++
Sbjct: 98  SL--FEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154

Query: 120 SNLQLNNN 127
             + L  N
Sbjct: 155 QTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 34/155 (21%), Positives = 60/155 (38%), Gaps = 28/155 (18%)

Query: 121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
            ++L  N +    P +      L  + + +N +S                 L+ + F G 
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE----------------LAPDAFQG- 78

Query: 181 IPPSLGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLSGSIPISM-GNLSN 238
                  L +L +L L  N ++  +P  L   L SL  L L  NK++  + +    +L N
Sbjct: 79  -------LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHN 129

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQF 273
           L  L+L++N L       +  L  +  + L  N F
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 27/117 (23%), Positives = 54/117 (46%), Gaps = 7/117 (5%)

Query: 384 KLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFL 442
           ++ L  N +   + P       +L  +DLS+N++S  +        L  L+ L L  N +
Sbjct: 36  EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQ-GLRSLNSLVLYGNKI 92

Query: 443 REAIPSQI-CIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
              +P  +   + SL+ L L+ N ++ L    F+ ++ L  + +  N+L+ +I   T
Sbjct: 93  -TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 35/147 (23%), Positives = 61/147 (41%), Gaps = 16/147 (10%)

Query: 348 VPPEIGHSSQLGVLDLSSNHIVGEIP----IELGKLNFFIKLVLAHNQLSGQLSPKL-GS 402
           +P  +     +  + L  N I   IP        KL     + L++NQ+S +L+P     
Sbjct: 26  IPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRR---IDLSNNQIS-ELAPDAFQG 78

Query: 403 LVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI-CIMQSLEKLNL 461
           L  L  L L  N+++  +PKSL    L  L  L L+ N +   +       + +L  L+L
Sbjct: 79  LRSLNSLVLYGNKIT-ELPKSLFE-GLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSL 135

Query: 462 SHNSLSGLIPSCFEKMNGLLHIDISYN 488
             N L  +    F  +  +  + ++ N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 25/133 (18%), Positives = 47/133 (35%), Gaps = 5/133 (3%)

Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNY 295
             +T + L +N++    P  +    KL  + L +NQ         + L SL  + L  N 
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 296 LTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSINNITGNVPPEIGH 354
           +T      F    +L  + L+ N     +  D +     L+ L    N +   +      
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFS 149

Query: 355 S-SQLGVLDLSSN 366
               +  + L+ N
Sbjct: 150 PLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 5/93 (5%)

Query: 407 EHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQIC-IMQSLEKLNLSHNS 465
             + L  N +    P +    +   L  +DLS N +   +       ++SL  L L  N 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYK--KLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91

Query: 466 LSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
           ++ L  S FE +  L  + ++ N++   +    
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDA 123

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 34/237 (14%)

Query: 587 TFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQ 645
                   E   +  + F  E   G+G  G+V + K   +G  +A+KK       +  F+
Sbjct: 8   LNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ----DPRFR 63

Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRH-------LFIVYEYFKMCSLAVILSNDAAA 698
              L  ++ L  + H NIV++  +   +         L +V EY          +     
Sbjct: 64  NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ 123

Query: 699 KNLGWTRRMNMIKG----IVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGI 753
                     +IK     ++ ++  +H      + HRDI   NVL++  +    + DFG 
Sbjct: 124 VAP----PPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178

Query: 754 AKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 804
           AK L P   N   +   Y Y APEL      YT  V    D++S G + A E++ G+
Sbjct: 179 AKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLGE 229

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 58/381 (15%), Positives = 112/381 (29%), Gaps = 86/381 (22%)

Query: 113 LGNLRSLSNLQLNNNILSG----SIPHSLGNLTNLATLYIYSNSLS---ASILGK-IGNL 164
           +    S+    L  + ++     S+   L    ++  + +  N++    A  L + I + 
Sbjct: 1   MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 165 KSLSNLQLSENNFN----------GSIPPSLGNLSNLATLYLDTNSLSY----SIPSELG 210
           K L   + S+                +  +L     L T+ L  N+        +   L 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 211 NLRSLSNLSLGYNKLS--GSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLL 268
               L +L L  N L       I+   L  L      +N+              L  ++ 
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARA-LQELAVNKKAKNAPP------------LRSIIC 166

Query: 269 GHNQFR--GPIPI---LRNLTSLERVRLDRNYLT-----GNISESFYIYPNLTYIDLSQN 318
           G N+             ++   L  V++ +N +        + E       L  +DL  N
Sbjct: 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 226

Query: 319 NFYGE----ISSDWGRCPKLSTLDFSINNITGNVPPEI------GHSSQLGVLDLSSNHI 368
            F       ++      P L  L  +   ++      +        +  L  L L  N I
Sbjct: 227 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286

Query: 369 VGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN---------S 419
             +    L         V+               +  L  L+L+ NR S           
Sbjct: 287 ELDAVRTLKT-------VIDEK------------MPDLLFLELNGNRFSEEDDVVDEIRE 327

Query: 420 IPKSLGNLELIHLSELDLSRN 440
           +  + G  EL  L +++   +
Sbjct: 328 VFSTRGRGELDELDDMEELTD 348

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 47/306 (15%), Positives = 87/306 (28%), Gaps = 59/306 (19%)

Query: 13  IPSELRNLKSLSDLELGNNKLSG----SIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNF 68
           + + L    S+ ++ L  N +       +  ++ +  +L                     
Sbjct: 24  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83

Query: 69  RFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSN----SIPSELGNLRSLSNLQL 124
           R                  +L     L T+ L  N+        +   L     L +L L
Sbjct: 84  RLLLQ--------------ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129

Query: 125 NNNILS-------------GSIPHSLGNLTNLATLYIYSNSL---SASILGK-IGNLKSL 167
           +NN L               ++     N   L ++    N L   S     K   + + L
Sbjct: 130 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189

Query: 168 SNLQLSENNFN-----GSIPPSLGNLSNLATLYLDTNSLS----YSIPSELGNLRSLSNL 218
             +++ +N          +   L     L  L L  N+ +     ++   L +  +L  L
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249

Query: 219 SLGYNKLS--GSIPIS----MGNLSNLTYLNLFENSLS--GAIPYE---YRNLVKLTILL 267
            L    LS  G+  +           L  L L  N +        +      +  L  L 
Sbjct: 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 309

Query: 268 LGHNQF 273
           L  N+F
Sbjct: 310 LNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 67.0 bits (164), Expect = 9e-12
 Identities = 47/317 (14%), Positives = 103/317 (32%), Gaps = 61/317 (19%)

Query: 89  LGNLSNLATLYLDTNSLSN----SIPSELGNLRSLSNLQLNNNILSG----SIPHSLGNL 140
           +   S +    L  ++++     S+ + L    S+  + L+ N +       +  ++ + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 141 TNLATLYIYSNSLS----------ASILGKIGNLKSLSNLQLSENNFNG----SIPPSLG 186
            +L                       +L  +     L  ++LS+N F       +   L 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 187 NLSNLATLYLDTNSLS-------------YSIPSELGNLRSLSNLSLGYNKLS--GSIPI 231
             + L  LYL  N L               ++  +  N   L ++  G N+L        
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 232 S--MGNLSNLTYLNLFENSL-----SGAIPYEYRNLVKLTILLLGHNQF--RGPIPI--- 279
           +    +   L  + + +N +        +        +L +L L  N F   G   +   
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239

Query: 280 LRNLTSLERVRLDRNYLTGN----ISESFYIYPN--LTYIDLSQNNFYGE-----ISSDW 328
           L++  +L  + L+   L+      + ++F    N  L  + L  N    +      +   
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299

Query: 329 GRCPKLSTLDFSINNIT 345
            + P L  L+ + N  +
Sbjct: 300 EKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 44/309 (14%), Positives = 85/309 (27%), Gaps = 72/309 (23%)

Query: 233 MGNLSNLTYLNLFENSLSG----AIPYEYRNLVKLTILLLGHNQFRGPI------PILRN 282
           M   S +   +L  ++++     ++         +  ++L  N   G          + +
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIAS 58

Query: 283 LTSLERVRLDRNYL----------TGNISESFYIYPNLTYIDLSQNNFYGE----ISSDW 328
              LE       +              + ++    P L  + LS N F       +    
Sbjct: 59  KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118

Query: 329 GRCPKLSTLDFSINNIT-------------GNVPPEIGHSSQLGVLDLSSNHIVGEIPIE 375
            +   L  L    N +                V  +  ++  L  +    N +      E
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178

Query: 376 LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNS-IPKSLGNL--ELIHL 432
             K           ++              L  + +  N +    I   L         L
Sbjct: 179 WAK-------TFQSHR-------------LLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218

Query: 433 SELDLSRNFLR----EAIPSQICIMQSLEKLNLSHNSLSG----LIPSCFEKMN--GLLH 482
             LDL  N        A+   +    +L +L L+   LS      +   F K+   GL  
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278

Query: 483 IDISYNELR 491
           + + YNE+ 
Sbjct: 279 LRLQYNEIE 287

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 44/243 (18%), Positives = 75/243 (30%), Gaps = 39/243 (16%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSG----SIPHSLGNLTNLATLYIHTNSLSGSIPGEIGN 67
            +   L     L  + L +N         +   L   T L  LY+H N L     G    
Sbjct: 85  LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL-----GPQAG 139

Query: 68  FRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSN----SIPSELGNLRSLSNLQ 123
            +    L+               N   L ++    N L N           + R L  ++
Sbjct: 140 AKIARALQELAVNK------KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK 193

Query: 124 LNNNIL-----SGSIPHSLGNLTNLATLYIYSNSLS---ASILGK-IGNLKSLSNLQLSE 174
           +  N +        +   L     L  L +  N+ +   +S L   + +  +L  L L++
Sbjct: 194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253

Query: 175 NNFNG----SIPPSLGNLSN--LATLYLDTNSLSYSIPSELG-----NLRSLSNLSLGYN 223
              +     ++  +   L N  L TL L  N +       L       +  L  L L  N
Sbjct: 254 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313

Query: 224 KLS 226
           + S
Sbjct: 314 RFS 316

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 27/206 (13%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIWHRNI 663
           +G+G  G V   +   +G I+A+KKF        +   + +      E+K L ++ H N+
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V +   C   +  ++V+E+    ++   L  +     L +      +  I++ + + H+ 
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 778
               I+HRDI  +N+L+       + DFG A+ L      + +   T  Y APEL     
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGK 804
            Y   V    DV++ G L  E+  G+
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGE 222

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 49/220 (22%), Positives = 84/220 (38%), Gaps = 33/220 (15%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            DF     +G+G   +V +++  A+    A+K        +         E   ++ + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 661 RNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAA----AKNLGWTRRMNMI 710
              VK+Y        L+    Y       K                 A+           
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----------- 138

Query: 711 KGIVDALSYMH-NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTE 766
             IV AL Y+H       I+HRD+  +N+LL+ +    ++DFG AK L P+S      + 
Sbjct: 139 --IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 191

Query: 767 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIWHRNI 663
           IG+G  G V+  +   +G+I+A+KKF        +     +      E++ L ++ H N+
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
           V +       R L +V+EY    ++   L  D   + +      ++    + A+++ H  
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 778
                +HRD+  +N+L+   +   + DFG A+ L   S  + +   T  Y +PEL     
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGK 804
            Y   V    DV++ G +  E++ G 
Sbjct: 179 QYGPPV----DVWAIGCVFAELLSGV 200

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 65/300 (21%), Positives = 120/300 (40%), Gaps = 67/300 (22%)

Query: 610 IGKGGQGSVYM------SKLASGEII--AVKKFHSPLPGEMTFQ--QEFLNEVKALTEIW 659
           +G+G  G V M       K    E +  AVK     L  + T +   + ++E++ +  I 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 98

Query: 660 -HRNIVKVYGFCLHVRHLFIVYEYFKMCSL-------------AVILSNDAAAKNLGWTR 705
            H+NI+ + G C     L+++ EY    +L                  N    + + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----- 760
            ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+ +        
Sbjct: 159 LVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 761 SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSM 813
           ++N      W          APE  +    T + DV+SFGVL  E+   G  P   I   
Sbjct: 216 TTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-- 264

Query: 814 SFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                     L ++L    R+  P  N  ++L  ++     C    P  RPT +++ + L
Sbjct: 265 -------VEELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 75.6 bits (186), Expect = 3e-14
 Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 24/234 (10%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N F     +GKGG G V   ++ A+G++ A KK       +   +   LNE + L ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 661 RNIVKVYGFCLH-VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           R +V +  +       L +V        L   + +          R +     I   L  
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAEICCGLED 301

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 778
           +H +    IV+RD+  +N+LLD      +SD G+A  +    +      GT GY+APE+ 
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVV 357

Query: 779 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD 829
               YT       D ++ G L  E+I G+ P        F      I  +E+  
Sbjct: 358 KNERYTFSP----DWWALGCLLYEMIAGQSP--------FQQRKKKIKREEVER 399

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 75.2 bits (185), Expect = 4e-14
 Identities = 59/250 (23%), Positives = 101/250 (40%), Gaps = 57/250 (22%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE----FLNEVKALT 656
           + F D   +G+GG G V+  ++ A+G++ A KK    L  +   +++     + E K L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK----LNKKRLKKRKGYQGAMVEKKILA 240

Query: 657 EIWHRNIVKVYGFCLHVR-HLFIVYEY----------FKMCSLAVILSNDAA----AKNL 701
           ++  R IV +  +    +  L +V             + +           A    A+  
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-- 297

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS 761
                      IV  L ++H      I++RD+  +NVLLD +    +SD G+A  LK   
Sbjct: 298 -----------IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

Query: 762 SNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS 817
           +     AGT G++APEL     Y   V    D ++ GV   E+I  + P        F +
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP--------FRA 391

Query: 818 LNLNIALDEM 827
               +   E+
Sbjct: 392 RGEKVENKEL 401

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.5 bits (181), Expect = 6e-14
 Identities = 72/365 (19%), Positives = 136/365 (37%), Gaps = 82/365 (22%)

Query: 560 FKFQRRKNDSQTQQSSPGNSRGLLSVLT----FEGKIIYEEIIRATNDFDDE-------- 607
              +R+   S    SS  ++  L+ + T         +   +       D +        
Sbjct: 24  IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKL 83

Query: 608 ---HCIGKGGQGSVYM------SKLASGEII--AVKKFHSPLPGEMTFQ--QEFLNEVKA 654
                +G+G  G V M       K    E +  AVK     L  + T +   + ++E++ 
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEM 139

Query: 655 LTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSL-------------AVILSNDAAAKN 700
           +  I  H+NI+ + G C     L+++ EY    +L                  N    + 
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
           + +   ++    +   + Y+ +      +HRD++++NVL+   N   ++DFG+A+ +   
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 761 -----SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRD 808
                ++N      W          APE  +    T + DV+SFGVL  E+   G  P  
Sbjct: 257 DYYKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307

Query: 809 FISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQK 866
            I             L ++L    R+  P  N  ++L  ++     C    P  RPT ++
Sbjct: 308 GIP---------VEELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQ 354

Query: 867 VCQLL 871
           + + L
Sbjct: 355 LVEDL 359

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 67/301 (22%)

Query: 610 IGKGGQGSVYM--------SKLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIW 659
           +G+G  G V +         K      +AVK     L  + T +   + ++E++ +  I 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 132

Query: 660 -HRNIVKVYGFCLHVRHLFIVYEYFKMCSL-------------AVILSNDAAAKNLGWTR 705
            H+NI+ + G C     L+++ EY    +L                  +    + L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD----- 760
            ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +        
Sbjct: 193 LVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 761 SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSM 813
           ++N      W          APE  +    T + DV+SFGVL  E+   G  P   +   
Sbjct: 250 TTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 298

Query: 814 SFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL 871
                     L ++L    R+  P  N  ++L  ++     C    P  RPT +++ + L
Sbjct: 299 -------VEELFKLLKEGHRMDKP-SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 347

Query: 872 K 872
            
Sbjct: 348 D 348

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 36/140 (25%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 45  TNLATLYIHTNSLSGSIPGEIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYL 100
              A L ++ N  +  +    G F+    L     SNNK++  I   +    S +  + L
Sbjct: 32  QYTAELRLNNNEFT-VLEAT-GIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILL 88

Query: 101 DTNSLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPH-SLGNLTNLATLYIYSNSLSASIL 158
            +N L  ++  ++   L SL  L L +N ++  + + S   L+++  L +Y N ++    
Sbjct: 89  TSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAP 146

Query: 159 GKIGNLKSLSNLQLSENNFN 178
           G    L SLS L L  N FN
Sbjct: 147 GAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 29/130 (22%), Positives = 56/130 (43%), Gaps = 7/130 (5%)

Query: 74  LELSNNKLSGSIPPS--LGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG 131
           L L+NN+ +  +  +     L  L  +    N +++           ++ + L +N L  
Sbjct: 37  LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94

Query: 132 SIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLS 189
           ++ H +   L +L TL + SN ++         L S+  L L +N    ++ P +   L 
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153

Query: 190 NLATLYLDTN 199
           +L+TL L  N
Sbjct: 154 SLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 8/145 (5%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSE--LGNLRSLSNLSLGYNKLSGSIPISM-GNL 236
            IP  +      A L L+ N  +  + +      L  L  ++   NK++  I        
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGA 80

Query: 237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNY 295
           S +  + L  N L       ++ L  L  L+L  N+           L+S+  + L  N 
Sbjct: 81  SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ 140

Query: 296 LTGNISESFYIYPNLTYIDLSQNNF 320
           +T     +F    +L+ ++L  N F
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 27/131 (20%), Positives = 56/131 (42%), Gaps = 15/131 (11%)

Query: 5   YNNSLYDSIPSE--LRNLKSLSDLELGNNKLSGSIPH-SLGNLTNLATLYIHTNSLSGSI 61
            NN     + +    + L  L  +   NNK++  I   +    + +  + + +N L  ++
Sbjct: 40  NNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NV 96

Query: 62  PGEIGNFRFFSDLE---LSNNKLSGSIPP-SLGNLSNLATLYLDTNSLSNSIPSE-LGNL 116
             ++  F+    L+   L +N+++  +   S   LS++  L L  N ++ ++       L
Sbjct: 97  QHKM--FKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152

Query: 117 RSLSNLQLNNN 127
            SLS L L  N
Sbjct: 153 HSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 29/144 (20%), Positives = 61/144 (42%), Gaps = 9/144 (6%)

Query: 348 VPPEIGHSSQLGVLDLSSNHIVG-EIPIELGKLNFFIKLVLAHNQLSGQLSPK-LGSLVQ 405
           +P  I   +    L L++N     E      KL    K+  ++N+++  +          
Sbjct: 26  IPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 406 LEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICI-MQSLEKLNLSHN 464
           +  + L+SNRL  ++   +    L  L  L L  N +   + +   I + S+  L+L  N
Sbjct: 83  VNEILLTSNRLE-NVQHKMFK-GLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDN 139

Query: 465 SLSGLIPSCFEKMNGLLHIDISYN 488
            ++ + P  F+ ++ L  +++  N
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 21/118 (17%), Positives = 55/118 (46%), Gaps = 8/118 (6%)

Query: 384 KLVLAHNQLSGQLSPK--LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNF 441
           +L L +N+ +  L        L QL  ++ S+N++++    +        ++E+ L+ N 
Sbjct: 36  ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS--GVNEILLTSNR 92

Query: 442 LREAIPSQICI-MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST 498
           L E +  ++   ++SL+ L L  N ++ +    F  ++ +  + +  N++  ++    
Sbjct: 93  L-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.0 bits (181), Expect = 1e-13
 Identities = 38/187 (20%), Positives = 64/187 (34%), Gaps = 27/187 (14%)

Query: 11  DSIPSELRNLKSLSDLELGNN-------------KLSGSIPHSLGNLTNLATLYIH---- 53
             + SEL + K L +LE  N                      +L   + L  +       
Sbjct: 362 TVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421

Query: 54  ----TNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSI 109
                +            +     L L++  L+  +   L  L  +  L L  N L  ++
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-AL 478

Query: 110 PSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSA-SILGKIGNLKSLS 168
           P  L  LR L  LQ ++N L  ++   + NL  L  L + +N L   + +  + +   L 
Sbjct: 479 PPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536

Query: 169 NLQLSEN 175
            L L  N
Sbjct: 537 LLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 73.3 bits (179), Expect = 2e-13
 Identities = 44/280 (15%), Positives = 93/280 (33%), Gaps = 28/280 (10%)

Query: 189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENS 248
            +L    L+     ++         S     L  ++              L    L    
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360

Query: 249 LSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYP 308
            +  +  E  +  +L  L   +      + I+  + +L+ +  ++  L          + 
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCL--LTIILLMRALDPLLYEKETLQY--------FS 409

Query: 309 NLTYIDLSQNNFYGEISSDWGRCPKLS--------TLDFSINNITGNVPPEIGHSSQLGV 360
            L  +D  +  +  ++ S +     +          L  +  ++T  V   +     +  
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTH 467

Query: 361 LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN-S 419
           LDLS N +   +P  L  L     L  + N L   +   + +L +L+ L L +NRL   +
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSA 524

Query: 420 IPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKL 459
             + L +     L  L+L  N L +    Q  + + L  +
Sbjct: 525 AIQPLVSCP--RLVLLNLQGNSLCQEEGIQERLAEMLPSV 562

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.3 bits (161), Expect = 2e-11
 Identities = 39/259 (15%), Positives = 77/259 (29%), Gaps = 23/259 (8%)

Query: 168 SNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG 227
                  +         +   S+     +           +      L    L   K + 
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST- 362

Query: 228 SIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLE 287
            +   + +   L  L          I    R L  L                   L +++
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQY-------FSTLKAVD 415

Query: 288 RVRLD-----RNYLTGNISESFYIYPNLTYIDLSQNNFYGEISS--DWGRCPKLSTLDFS 340
            +R       R+      S     Y ++  + L+  +    ++      +   ++ LD S
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD----LTVLCHLEQLLLVTHLDLS 471

Query: 341 INNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPK- 399
            N +   +PP +     L VL  S N +   +   +  L    +L+L +N+L    + + 
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQP 528

Query: 400 LGSLVQLEHLDLSSNRLSN 418
           L S  +L  L+L  N L  
Sbjct: 529 LVSCPRLVLLNLQGNSLCQ 547

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.9 bits (147), Expect = 1e-09
 Identities = 43/287 (14%), Positives = 87/287 (30%), Gaps = 40/287 (13%)

Query: 235 NLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRN 294
           ++    +++  E  LS           ++  LLL  ++    +             +   
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302

Query: 295 YLTGNISESFYIYPNLTYIDLSQNNFYGEISS---------DWGRCPKLSTLDFSINNIT 345
            L                I    ++    +           D     +L   + S+   T
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362

Query: 346 GNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG----------- 394
             +  E+    +L  L+  +   +  I + +  L+  +         S            
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421

Query: 395 ----------QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE-LIHLSELDLSRNFLR 443
                     + S        +  L L+   L+      L +LE L+ ++ LDLS N LR
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-----VLCHLEQLLLVTHLDLSHNRLR 476

Query: 444 EAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
             +P  +  ++ LE L  S N+L  +       +  L  + +  N L
Sbjct: 477 A-LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRL 520

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.4 bits (143), Expect = 3e-09
 Identities = 41/254 (16%), Positives = 71/254 (27%), Gaps = 38/254 (14%)

Query: 119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
           L    LN+ +   +         +     +  +             + L   +LS     
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC-RDSATDEQLFRCELSVEKST 362

Query: 179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG----------- 227
             +   L +   L  L  +      +I   +  L  L          S            
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY 421

Query: 228 ----------SIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPI 277
                        +     +++  L+L    L+     E   L+ +T L L HN+ R   
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQ--LLLVTHLDLSHNRLRALP 479

Query: 278 PILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW------GRC 331
           P L  L  LE ++   N L  N+       P L  + L  N                  C
Sbjct: 480 PALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL-----QQSAAIQPLVSC 532

Query: 332 PKLSTLDFSINNIT 345
           P+L  L+   N++ 
Sbjct: 533 PRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.7 bits (110), Expect = 3e-05
 Identities = 26/121 (21%), Positives = 40/121 (33%), Gaps = 30/121 (24%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
           +N L  ++P  L  L+ L  L+  +N L  ++   + NL  L  L               
Sbjct: 472 HNRL-RALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELL-------------- 514

Query: 66  GNFRFFSDLELSNNKLSG-SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRS-LSNLQ 123
                     L NN+L   +    L +   L  L L  NSL          L   L ++ 
Sbjct: 515 ----------LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVS 563

Query: 124 L 124
            
Sbjct: 564 S 564

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 58/281 (20%), Positives = 105/281 (37%), Gaps = 59/281 (20%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIWHR--NI 663
           +G GG GSVY    ++    +A+K   K      GE+        EV  L ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 664 VKVYGFCLHVRHLFIVYEY-------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
           +++  +        ++ E        F   +    L  + A       R       +++A
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-------RSF--FWQVLEA 161

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 775
           + + HN     ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT  Y  
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 216

Query: 776 PEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR 831
           PE      Y  +      V+S G+L  +++ G  P +                +E++  +
Sbjct: 217 PEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHD--------------EEIIRGQ 259

Query: 832 LPTP---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           +      S      LI        C+   P  RPT +++  
Sbjct: 260 VFFRQRVSSECQH-LIR------WCLALRPSDRPTFEEIQN 293

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 28/216 (12%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              + +   IG G QG V  +        +A+KK   P     T  +    E+  +  + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 82

Query: 660 HRNIVKVYGFCLHV----------RHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMN 708
           H+NI+ +    L+V          + ++IV E   M  +L  ++        L   R   
Sbjct: 83  HKNIIGL----LNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQ-----MELDHERMSY 131

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA 768
           ++  ++  + ++H+     I+HRD+   N+++  +    + DFG+A+         T   
Sbjct: 132 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 187

Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
            T  Y APE+   M   E  D++S G +  E+IKG 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 56/235 (23%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTE 657
           +DF+    IG+G    V + K+  +G++ A+K   K+     GE++    F  E   L  
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVN 117

Query: 658 IWHRNIVKVYGFCLH-----VRHLFIVYEY-------FKMCSLAVILSNDAA----AKNL 701
              R I +     LH       +L++V EY         +      +  + A    A+  
Sbjct: 118 GDRRWITQ-----LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-- 170

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKP 759
                      IV A+  +H       VHRDI   N+LLD     H+  +DFG    L+ 
Sbjct: 171 -----------IVMAIDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRA 214

Query: 760 DSSNWTELA-GTYGYVAPELAYTMKVTEK-------CDVYSFGVLALEVIKGKHP 806
           D +  + +A GT  Y++PE+   +            CD ++ GV A E+  G+ P
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 43/254 (16%)

Query: 569 SQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEI 628
           +  + +   +   ++ VL  +GK   +  I     + +   IG G  G V+ +KL   + 
Sbjct: 11  NGVKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKLVESDE 66

Query: 629 IAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHRNIVKVYGFCLHVRH------LFIVYE 681
           +A+KK            + F N E++ +  + H N+V +  F            L +V E
Sbjct: 67  VAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118

Query: 682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDALSYMHNDCFPPIVHRDISSKN 737
           Y                + +     M +IK     ++ +L+Y+H+     I HRDI  +N
Sbjct: 119 YVPETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171

Query: 738 VLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVY 791
           +LLD  +    + DFG AK L     N + +   Y Y APEL      YT  +    D++
Sbjct: 172 LLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-YRAPELIFGATNYTTNI----DIW 226

Query: 792 SFG-VLALEVIKGK 804
           S G V+A E+++G+
Sbjct: 227 STGCVMA-ELMQGQ 239

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 56/305 (18%), Positives = 116/305 (38%), Gaps = 70/305 (22%)

Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           IG+G  G V+      +       ++AVK        +M  Q +F  E   + E  + NI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNI 112

Query: 664 VKVYGFCLHVRHLFIVYEY---------------------FKMCSLAVILSNDAAAKNLG 702
           VK+ G C   + + +++EY                                +      L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL----- 757
              ++ + + +   ++Y+    F   VHRD++++N L+       ++DFG+++ +     
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 758 -KPDSSN-----WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDF 809
            K D ++     W           PE + Y  + T + DV+++GV+  E+   G  P   
Sbjct: 230 YKADGNDAIPIRWM---------PPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP--- 276

Query: 810 ISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV 867
                +  +  +  +   +     L  P  N   +L +++     C  + P  RP+   +
Sbjct: 277 -----YYGMA-HEEVIYYVRDGNILACP-ENCPLELYNLMR---LCWSKLPADRPSFCSI 326

Query: 868 CQLLK 872
            ++L+
Sbjct: 327 HRILQ 331

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 5/133 (3%)

Query: 45  TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTN 103
           TN   LY+H N ++   PG   +     +L L +N+L  ++P  +  +L+ L  L L TN
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 104 SLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG 162
            L+  +PS +   L  L  L +  N L+  +P  +  LT+L  L +  N L +   G   
Sbjct: 99  QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156

Query: 163 NLKSLSNLQLSEN 175
            L SL++  L  N
Sbjct: 157 RLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 37/128 (28%), Positives = 66/128 (51%), Gaps = 5/128 (3%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
           L L +N+++   P    +L NL  LY+ +N L     G   +    + L+L  N+L+  +
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VL 103

Query: 86  PPSL-GNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPH-SLGNLTNL 143
           P ++   L +L  L++  N L+  +P  +  L  L++L L+ N L  SIPH +   L++L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSL 161

Query: 144 ATLYIYSN 151
              Y++ N
Sbjct: 162 THAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 17/131 (12%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPG 63
           ++N +    P    +L +L +L LG+N+L  ++P  +  +LT L  L + TN L+  +P 
Sbjct: 48  HDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPS 105

Query: 64  EIGNFRFF------SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE-LGNL 116
            +     F       +L +  NKL+  +P  +  L++L  L LD N L  SIP      L
Sbjct: 106 AV-----FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRL 158

Query: 117 RSLSNLQLNNN 127
            SL++  L  N
Sbjct: 159 SSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 6/129 (4%)

Query: 169 NLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLSG 227
            L L +N      P    +L NL  LYL +N L  ++P  +  +L  L+ L LG N+L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 228 SIPISM-GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTS 285
            +P ++   L +L  L +  N L+  +P     L  LT L L  NQ +  P      L+S
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160

Query: 286 LERVRLDRN 294
           L    L  N
Sbjct: 161 LTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 6/141 (4%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSN 238
           S+P   G  +N   LYL  N ++   P    +L +L  L LG N+L  ++P+ +  +L+ 
Sbjct: 33  SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLT 297
           LT L+L  N L+      +  LV L  L +  N+    +P  +  LT L  + LD+N L 
Sbjct: 90  LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148

Query: 298 GNISESFYIYPNLTYIDLSQN 318
                +F    +LT+  L  N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 44/142 (30%), Positives = 66/142 (46%), Gaps = 7/142 (4%)

Query: 348 VPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL-GSLVQL 406
           VP  I  ++Q  +L L  N I    P     L    +L L  NQL   L   +  SL QL
Sbjct: 34  VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 407 EHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSL 466
             LDL +N+L+  +P ++ +  L+HL EL +  N L   +P  I  +  L  L L  N L
Sbjct: 91  TVLDLGTNQLT-VLPSAVFD-RLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147

Query: 467 SGLIPSCFEKMNGLLHIDISYN 488
             +    F++++ L H  +  N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 35/114 (30%), Positives = 60/114 (52%), Gaps = 6/114 (5%)

Query: 384 KLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLR 443
            L L  NQ++        SL+ L+ L L SN+L  ++P  + +  L  L+ LDL  N L 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD-SLTQLTVLDLGTNQL- 100

Query: 444 EAIPSQIC-IMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
             +PS +   +  L++L +  N L+  +P   E++  L H+ +  N+L+ SIP+
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPH 152

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 59/306 (19%), Positives = 112/306 (36%), Gaps = 74/306 (24%)

Query: 610 IGKGGQGSVYMSKLASGE------IIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIWHR 661
           +G+G  G V  +     +       +AVK     L    +    ++ L+E   L ++ H 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKM----LKENASPSELRDLLSEFNVLKQVNHP 86

Query: 662 NIVKVYGFCLHVRHLFIVYEY---------------------FKMCSLAVILSNDAAAKN 700
           +++K+YG C     L ++ EY                         S      +    + 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
           L     ++    I   + Y+        VHRD++++N+L+    +  +SDFG+++ +  +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 761 -----SSN------WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPR 807
                 S       W          A E L      T + DV+SFGVL  E++  G +P 
Sbjct: 204 DSYVKRSQGRIPVKWM---------AIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP- 252

Query: 808 DFISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQ 865
                +          L  +L    R+  P  N  +++  ++     C  + P+ RP   
Sbjct: 253 --YPGIP------PERLFNLLKTGHRMERP-DNCSEEMYRLML---QCWKQEPDKRPVFA 300

Query: 866 KVCQLL 871
            + + L
Sbjct: 301 DISKDL 306

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.3 bits (175), Expect = 5e-13
 Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 54/233 (23%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTE 657
            DF+    IG+G  G V + KL  + ++ A+K   K+      E      F  E   L  
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVN 130

Query: 658 IWHRNIVKVYGFCLH-----VRHLFIVYEY-------FKMCSLAVILSNDAA----AKNL 701
              + I       LH       +L++V +Y         +      L  + A    A+  
Sbjct: 131 GDSKWITT-----LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE-- 183

Query: 702 GWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKP 759
                      +V A+  +H       VHRDI   N+L+D     H+  +DFG    L  
Sbjct: 184 -----------MVIAIDSVHQLH---YVHRDIKPDNILMD--MNGHIRLADFGSCLKLME 227

Query: 760 DSSNWTELA-GTYGYVAPELAYTMKVTEK-----CDVYSFGVLALEVIKGKHP 806
           D +  + +A GT  Y++PE+   M+  +      CD +S GV   E++ G+ P
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 57/306 (18%), Positives = 112/306 (36%), Gaps = 71/306 (23%)

Query: 610 IGKGGQGSVYM------SKLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIW-H 660
           +G G  G V        SK      +AVK     L  +      +  ++E+K +T++  H
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKM----LKEKADSSEREALMSELKMMTQLGSH 108

Query: 661 RNIVKVYGFCLHVRHLFIVYEY--------------------FKMCSLAVILSNDAAAKN 700
            NIV + G C     +++++EY                             L  +     
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
           L +   +     +   + ++        VHRD++++NVL+       + DFG+A+ +  D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 761 -----SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRD 808
                  N      W          APE  +    T K DV+S+G+L  E+   G +P  
Sbjct: 226 SNYVVRGNARLPVKWM---------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-- 274

Query: 809 FISSMSFSSLNLNIALDEMLDP--RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQK 866
                 +  + ++    +++    ++  P     +++  I++   SC   +   RP+   
Sbjct: 275 ------YPGIPVDANFYKLIQNGFKMDQP-FYATEEIYIIMQ---SCWAFDSRKRPSFPN 324

Query: 867 VCQLLK 872
           +   L 
Sbjct: 325 LTSFLG 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 70.9 bits (174), Expect = 6e-13
 Identities = 50/225 (22%), Positives = 91/225 (40%), Gaps = 41/225 (18%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTE 657
            D++    IG+G  G V + +  ++ ++ A+K        EM  + +   F  E   +  
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF---EMIKRSDSAFFWEERDIMAF 125

Query: 658 IWHRNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDA---AAKNLGWTRRMN 708
                +V+++      R+L++V EY        + S   +    A    A+         
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE--------- 176

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTE 766
               +V AL  +H+      +HRD+   N+LLD     H+  +DFG    +  +     +
Sbjct: 177 ----VVLALDAIHSMG---FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCD 227

Query: 767 LA-GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            A GT  Y++PE+            +CD +S GV   E++ G  P
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.5 bits (173), Expect = 7e-13
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 40/220 (18%)

Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIWHR 661
           + D   IG G  G VY +KL  SGE++A+KK        +   + F N E++ + ++ H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 107

Query: 662 NIVKVYGFCLHVR------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG--- 712
           NIV++  F           +L +V +Y       V      A + L     +  +K    
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMY 163

Query: 713 -IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA-HVSDFGIAKFLKPDSSNWTELAGT 770
            +  +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220

Query: 771 YGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 804
           Y Y APEL      YT  +    DV+S G VLA E++ G+
Sbjct: 221 Y-YRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.3 bits (172), Expect = 9e-13
 Identities = 45/212 (21%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              + +   IG G QG V  +        +A+KK   P     T  +    E+  +  + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 119

Query: 660 HRNIVKVY------GFCLHVRHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKG 712
           H+NI+ +             + +++V E   M  +L  ++        L   R   ++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQ-----MELDHERMSYLLYQ 172

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           ++  + ++H+     I+HRD+   N+++  +    + DFG+A+     S   T    T  
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRY 228

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
           Y APE+   M   E  D++S G +  E+++ K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 68.3 bits (168), Expect = 1e-12
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWHRNIVKV 666
           IG+G  G VY ++   GE  A+KK       E    T     + E+  L E+ H NIVK+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT----IREISILKELKHSNIVKL 65

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDALSYMHN 722
           Y      + L +V+E+     L  +L         G        K     +++ ++Y H+
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDV----CEGGLE--SVTAKSFLLQLLNGIAYCHD 118

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 778
                ++HRD+  +N+L++ E E  ++DFG+A+        +T    T  Y AP++    
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 779 -AYTMKVTEKCDVYSFGVLALEVIKGK 804
             Y+  +    D++S G +  E++ G 
Sbjct: 176 KKYSTTI----DIWSVGCIFAEMVNGT 198

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 38/220 (17%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           + FD    +G G  G V + K   SG   A+K        ++   +  LNE + L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 661 RNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAA----AKNLGWTRRMNMI 710
             +VK+        +L++V EY      F         S   A    A+           
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ----------- 149

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGT 770
             IV    Y+H+     +++RD+  +N+L+D +    V+DFG AK  +     WT L GT
Sbjct: 150 --IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWT-LCGT 201

Query: 771 YGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
              +APE+     Y   V    D ++ GVL  E+  G  P
Sbjct: 202 PEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 70.7 bits (173), Expect = 1e-12
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 43/225 (19%)

Query: 602 NDFDDEHCIGKGGQGSVYMS-KLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 658
           NDF     IG+GG G VY   K  +G++ A+K            +   LNE   L+ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 659 -WHRNIVKVYGFCLHVR-HLFIVYEY-------FKMCSLAVILSNDA---AAKNLGWTRR 706
                IV +  +  H    L  + +        + +    V    D    AA+       
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE------- 300

Query: 707 MNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE 766
                 I+  L +MHN     +V+RD+   N+LLD      +SD G+A        +   
Sbjct: 301 ------IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--A 349

Query: 767 LAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
             GT+GY+APE+     AY        D +S G +  ++++G  P
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 30/207 (14%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWHRNIVKV 666
           +G+G  G VY +K + G I+A+K+       E    T     + E+  L E+ H NIV +
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA----IREISLLKELHHPNIVSL 84

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV----DALSYMHN 722
                  R L +V+E+ +   L  +L         G     + IK  +      +++ H 
Sbjct: 85  IDVIHSERCLTLVFEFMEK-DLKKVLDE----NKTGLQ--DSQIKIYLYQLLRGVAHCHQ 137

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 778
                I+HRD+  +N+L++ +    ++DFG+A+       ++T    T  Y AP++    
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194

Query: 779 -AYTMKVTEKCDVYSFGVLALEVIKGK 804
             Y+  V    D++S G +  E+I GK
Sbjct: 195 KKYSTSV----DIWSIGCIFAEMITGK 217

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 61/298 (20%), Positives = 113/298 (37%), Gaps = 64/298 (21%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVK-------------------KFHSPLPGEMTFQQEFL 649
           IGKG  G V ++         A+K                   +   P PG     +  +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 650 N----EVKALTEIWHRNIVKVYGFCLHV------RHLFIVYEYFKMCSLAVI-----LSN 694
                E+  L ++ H N+VK+      V       HL++V+E      +  +     LS 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136

Query: 695 DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA 754
           D A             + ++  + Y+H      I+HRDI   N+L+  +    ++DFG++
Sbjct: 137 DQARF---------YFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPRDFIS 811
              K   +  +   GT  ++APE     +     +  DV++ GV     + G+ P  F+ 
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMD 242

Query: 812 SMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                 L+  I    +  P  P  + ++ D +  +++        NPESR  + ++  
Sbjct: 243 E-RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK-------NPESRIVVPEIKL 292

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 22/213 (10%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              + D   +G G  G+V  +    +G  +A+KK + P      F +    E++ L  + 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR 82

Query: 660 HRNIVKVY------GFCLHVRHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKG 712
           H N++ +                ++V  +  M   L  ++ ++     LG  R   ++  
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLMKHE----KLGEDRIQFLVYQ 136

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           ++  L Y+H      I+HRD+   N+ ++ + E  + DFG+A   +   S  T    T  
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRW 190

Query: 773 YVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
           Y APE+    M+ T+  D++S G +  E+I GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.8 bits (164), Expect = 5e-12
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G   +VY      +G  +A+K+    L  E       + E+  + E+ H NIV++Y 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTAIREISLMKELKHENIVRLYD 70

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV----DALSYMHNDC 724
                  L +V+E+     L   + +     N      +N++K         L++ H + 
Sbjct: 71  VIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 779
              I+HRD+  +N+L++   +  + DFG+A+      + ++    T  Y AP++      
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGK 804
           Y+  +    D++S G +  E+I GK
Sbjct: 186 YSTSI----DIWSCGCILAEMITGK 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 57/274 (20%), Positives = 100/274 (36%), Gaps = 41/274 (14%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V ++    + E +AVK        +     +   E+     + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72

Query: 669 FCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                   ++  EY      F      + +    A +             ++  + Y+H 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---------FFHQLMAGVVYLHG 123

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPEL- 778
                I HRDI  +N+LLD  +   +SDFG+A   + ++     L    GT  YVAPEL 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELL 179

Query: 779 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
               +     E  DV+S G++   ++ G+ P  +           +    +         
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI 234

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                  L  I+         NP +R T+  + +
Sbjct: 235 DSAPLALLHKILVE-------NPSARITIPDIKK 261

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 60/278 (21%), Positives = 111/278 (39%), Gaps = 53/278 (19%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V + +   +G  +AVK  +      +    +   E++ L    H +I+K+Y 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77

Query: 669 FCLHV----RHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
               V       F+V EY      F        +    A +         + + I+ A+ 
Sbjct: 78  ---QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---------LFQQILSAVD 125

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H      +VHRD+  +NVLLD    A ++DFG++  +       T   G+  Y APE+
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEV 181

Query: 779 ----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
                Y      + D++S GV+   ++ G  P        F   ++     ++       
Sbjct: 182 ISGRLYA---GPEVDIWSCGVILYALLCGTLP--------FDDEHVPTLFKKIRGGVFYI 230

Query: 835 P---SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           P   +R+V   L+ +++V       +P  R T++ + +
Sbjct: 231 PEYLNRSVATLLMHMLQV-------DPLKRATIKDIRE 261

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 66.1 bits (162), Expect = 1e-11
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEF----LNEVKALTEIWHRNIV 664
           +G+G   +VY ++   + +I+A+KK    L      +       L E+K L E+ H NI+
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 665 KVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDALSYM 720
            +     H  ++ +V+++ +   L VI+ +     +L  T   + IK      +  L Y+
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKD----NSLVLT--PSHIKAYMLMTLQGLEYL 128

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 778
           H      I+HRD+   N+LLD      ++DFG+AK     +  +T    T  Y APEL  
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 779 ---AYTMKVTEKCDVYSFG-VLALEVIKGK 804
               Y + V    D+++ G +LA E++   
Sbjct: 186 GARMYGVGV----DMWAVGCILA-ELLLRV 210

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 35/200 (17%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           IG G  G   + +   + E++AVK     +       +    E+     + H NIV+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKY----IERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 669 FCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
             L   HL I+ EY      ++    A   S D A       R     + ++  +SY H+
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA-------RFF--FQQLLSGVSYCHS 134

Query: 723 DCFPPIVHRDISSKNVLLDFENEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 778
                I HRD+  +N LLD  + A    + DFG +K     S   + + GT  Y+APE+ 
Sbjct: 135 MQ---ICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 189

Query: 779 ---AYTMKVTEKCDVYSFGV 795
               Y  K     DV+S GV
Sbjct: 190 LRQEYDGK---IADVWSCGV 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 27/201 (13%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY 667
           +G+G  G V       +    AVK      L      +     E++ L  + H+N++++ 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 668 GFCLHV------RHLFIVYEYFKMCSLAVI-LSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
                V      + +++V EY   C   +  + +    K     +       ++D L Y+
Sbjct: 73  ----DVLYNEEKQKMYMVMEY---CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAP 776
           H+     IVH+DI   N+LL       +S  G+A+ L P +++  +      G+  +  P
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTCRTSQGSPAFQPP 180

Query: 777 ELAYTMKVTE--KCDVYSFGV 795
           E+A  +      K D++S GV
Sbjct: 181 EIANGLDTFSGFKVDIWSAGV 201

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 31/217 (14%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              +     +G G  GSV  +    SGE +A+KK   P      F +    E+  L  + 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ 81

Query: 660 HRNIVKVYGFCLHV----------RHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMN 708
           H N++ +    L V             ++V  +  M   L  I+            +   
Sbjct: 82  HENVIGL----LDVFTPASSLRNFYDFYLVMPF--MQTDLQKIMG-----LKFSEEKIQY 130

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA 768
           ++  ++  L Y+H+     +VHRD+   N+ ++ + E  + DFG+A   +   +  T   
Sbjct: 131 LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYV 184

Query: 769 GTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
            T  Y APE+  + M   +  D++S G +  E++ GK
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G   +VY  K   +  ++A+K+    L  E       + EV  L ++ H NIV ++ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV----DALSYMHNDC 724
                + L +V+EY     L   L       + G    M+ +K  +      L+Y H   
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYL------DDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 779
              ++HRD+  +N+L++   E  ++DFG+A+     +  +     T  Y  P++      
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGK 804
           Y+ ++    D++  G +  E+  G+
Sbjct: 178 YSTQI----DMWGVGCIFYEMATGR 198

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 45/231 (19%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKK--FHSPLPGEMTFQQEFLNEVKALTE 657
            + + D   +G GG G V+ +      + +A+KK     P        +  L E+K +  
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QSVKHALREIKIIRR 64

Query: 658 IWHRNIVKVY--------------GFCLHVRHLFIVYEYFKM-CSLAVILSNDAAAKNLG 702
           + H NIVKV+              G    +  ++IV EY  M   LA +L        L 
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY--METDLANVLE----QGPLL 118

Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDS 761
                  +  ++  L Y+H+     ++HRD+   N+ ++ E+    + DFG+A+ + P  
Sbjct: 119 EEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 762 SN---WTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 804
           S+    +E   T  Y +P L      YT  +    D+++ G +  E++ GK
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 44/212 (20%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIWHRNI 663
           IG+G  G+V+ +K   + EI+A+K+        +    E +      E+  L E+ H+NI
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNI 63

Query: 664 VKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKG----IVDALSY 719
           V+++      + L +V+E+     L     +     N        ++K     ++  L +
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS----CNGDLD--PEIVKSFLFQLLKGLGF 116

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 778
            H+     ++HRD+  +N+L++   E  +++FG+A+        ++    T  Y  P++ 
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 779 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
                Y+  +    D++S G +  E+     P
Sbjct: 174 FGAKLYSTSI----DMWSAGCIFAELANAGRP 201

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 29/230 (12%)

Query: 593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT---FQQEF- 648
           +  E+    + +  +  I  G  G+V     + G  +A+K+  + +    T       F 
Sbjct: 13  LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72

Query: 649 ----LNEVKALTEIWHRNIVKVYGFCLHV-----RHLFIVYEYFKM-CSL-AVILSNDAA 697
               L E++ L    H NI+ +    +H        L++V E   M   L  VI      
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL--MRTDLAQVIHDQRIV 130

Query: 698 AKNLGWTRRMNMIKGIVDALSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK 755
                       +  I+  L  +H        +VHRD+   N+LL   N+  + DF +A+
Sbjct: 131 ISP---QHIQYFMYHILLGLHVLHEAG-----VVHRDLHPGNILLADNNDITICDFNLAR 182

Query: 756 FLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
               D +N T       Y APEL       T+  D++S G +  E+   K
Sbjct: 183 EDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 22/213 (10%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              + +   +G G  GSV  +    +G  +AVKK   P    +   +    E++ L  + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK 86

Query: 660 HRNIVKVY------GFCLHVRHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKG 712
           H N++ +               +++V     M   L  I+      + L       +I  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHL--MGADLNNIVK----CQKLTDDHVQFLIYQ 140

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYG 772
           I+  L Y+H+     I+HRD+   N+ ++ + E  + DFG+A   +  +   T    T  
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRW 194

Query: 773 YVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 804
           Y APE+    M   +  D++S G +  E++ G+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 54/273 (19%), Positives = 105/273 (38%), Gaps = 44/273 (16%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V ++    + + +A+K     L  +         E+  L  + H +I+K+Y 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 669 FCLHVRHLFIVYEY-----FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND 723
                  + +V EY     F        ++ D   +           + I+ A+ Y H  
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRR---------FFQQIICAIEYCHRH 127

Query: 724 CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----A 779
               IVHRD+  +N+LLD      ++DFG++  +   +   T   G+  Y APE+     
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKL 183

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP---S 836
           Y      + DV+S G++   ++ G+ P        F    +     ++       P   S
Sbjct: 184 YA---GPEVDVWSCGIVLYVMLVGRLP--------FDDEFIPNLFKKVNSCVYVMPDFLS 232

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                 +  ++         +P  R T+Q++ +
Sbjct: 233 PGAQSLIRRMIVA-------DPMQRITIQEIRR 258

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 46/208 (22%), Positives = 87/208 (41%), Gaps = 36/208 (17%)

Query: 610 IGKGGQGSVYMSK---LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +G+G  G VY +K       +  A+K+                 E+  L E+ H N++ +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE-----GTGISMSACREIALLRELKHPNVISL 83

Query: 667 YGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN--MIKG----IVDALS 718
               L    R ++++++Y +   L  I+    A+K      ++   M+K     I+D + 
Sbjct: 84  QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAH----VSDFGIAKFLKPDSSNWTELAG---TY 771
           Y+H +    ++HRD+   N+L+  E        ++D G A+          +L     T+
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 772 GYVAPEL-----AYTMKVTEKCDVYSFG 794
            Y APEL      YT  +    D+++ G
Sbjct: 200 WYRAPELLLGARHYTKAI----DIWAIG 223

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 32/200 (16%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V ++    + E +AVK        +     +   E+     + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72

Query: 669 FCLHVRHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                   ++  EY      F      + +    A       +R      ++  + Y+H 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-------QRF--FHQLMAGVVYLHG 123

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPEL- 778
                I HRDI  +N+LLD  +   +SDFG+A   + ++     L    GT  YVAPEL 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELL 179

Query: 779 ---AYTMKVTEKCDVYSFGV 795
               +     E  DV+S G+
Sbjct: 180 KRREFH---AEPVDVWSCGI 196

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 65.7 bits (160), Expect = 4e-11
 Identities = 72/491 (14%), Positives = 152/491 (30%), Gaps = 54/491 (10%)

Query: 12  SIPSELRNLKSL--SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFR 69
            I + LR LKS+    + + +  L         +L  L  L   +   +  +   + + R
Sbjct: 106 EISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL-KLDKCSGFTTDGLLSIVTHCR 164

Query: 70  FFSDLELSNNKLSGSIPPSLG----NLSNLATLYLDTNSLSN----SIPSELGNLRSLSN 121
               L +  +  S      L     + ++L  L       +      + +   N RSL +
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224

Query: 122 LQLNN--NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
           +++ +   +       +  NL       +  +         +   + L  L LS    N 
Sbjct: 225 VKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE 284

Query: 180 SIPPSLGNLSNLATLYL-DTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSN 238
            +P      + +  L L      +    + +    +L  L          + +       
Sbjct: 285 -MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQ 343

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTG 298
           L  L +   +    +  E   + +  ++ L            +    LE + +  + +T 
Sbjct: 344 LKRLRIERGADEQGMEDEEGLVSQRGLIALA-----------QGCQELEYMAVYVSDITN 392

Query: 299 N----ISESFYIYPNLTYIDLSQNNFYGEISSDWG------RCPKLSTLDFSIN--NITG 346
                I        +   + L +     ++  D G       C KL    F +    +T 
Sbjct: 393 ESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD 452

Query: 347 NVPPEIG-HSSQLGVLDLSSNHIVGEIPIELGK-LNFFIKLVLAHNQLSGQ-LSPKLGSL 403
                IG +S  +  + L       E  +E  +      KL +     S + ++  +  L
Sbjct: 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKL 512

Query: 404 VQLEHLDLSSNRLSNSIPKSLG------NLELIHLSELDLSRNFLREAIPSQICIMQSLE 457
             L +L +   R S +    +       N+ELI    +             +I  M+   
Sbjct: 513 PSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQ------QGEIREMEHPA 566

Query: 458 KLNLSHNSLSG 468
            + L++ SL+G
Sbjct: 567 HI-LAYYSLAG 576

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 61.5 bits (149), Expect = 7e-10
 Identities = 62/454 (13%), Positives = 140/454 (30%), Gaps = 58/454 (12%)

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSL----GNLSNLATLYLDTNSLSNS-----IPSELGN 115
           +      +   L      G + P +     NL  L +++     +S+        +   +
Sbjct: 80  LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADD 139

Query: 116 LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSN---SLSASILGKIG-NLKSLSNLQ 171
           L +L  L   +   +  +   + +   + TL +  +         L ++  +  SL  L 
Sbjct: 140 LETL-KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198

Query: 172 LSENNFNGSIPPSL----GNLSNLATLYLDTNSLS--YSIPSELGNLRSLSNLSLGYNKL 225
                F    P  L     N  +L ++ +    +           NL      SL  +  
Sbjct: 199 FYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIG 258

Query: 226 SGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP--IPILRNL 283
                +++     L  L L     +  +P  +    ++  L L +          +++  
Sbjct: 259 MPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKC 317

Query: 284 TSLERVRLDRNYLT----GNISESFYIYPNLTYIDLSQNNFYGEISSDWGR--------- 330
            +LE +   RN +       +++       L  + + +      +  + G          
Sbjct: 318 PNLEVLET-RNVIGDRGLEVLAQYC---KQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373

Query: 331 ---CPKLSTLDFSINNITGNVPPEIGHS----SQLGVLDLSSNHIVGEIPIELGKLNFFI 383
              C +L  +   +++IT      IG          ++ L     + ++P++ G  +  I
Sbjct: 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI 433

Query: 384 KLV----LAHNQLSGQLSPK----LGSL-VQLEHLDLSSNRLSNSIPKSLGNLELIHLSE 434
                   A     G L+      +G     +  + L     S+            +L +
Sbjct: 434 GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSR-GCPNLQK 492

Query: 435 LDLSR-NFLREAIPSQICIMQSLEKLNLSHNSLS 467
           L++    F   AI + +  + SL  L +     S
Sbjct: 493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 6/129 (4%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
           L+L  N L          LT+L  LY+  N L     G        + L LS N+L  S+
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91

Query: 86  PPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSGSIPH-SLGNLTN 142
           P  +   L+ L  L L+TN L  S+P  +   L  L +L+L  N L  S+P      LT+
Sbjct: 92  PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTS 149

Query: 143 LATLYIYSN 151
           L  ++++ N
Sbjct: 150 LQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 46/143 (32%), Positives = 67/143 (46%), Gaps = 8/143 (5%)

Query: 108 SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL 167
           S+P+  G     + L L  N L          LT+L  LY+  N L +   G    L SL
Sbjct: 21  SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78

Query: 168 SNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKL 225
           + L LS N    S+P  +   L+ L  L L+TN L  S+P  +   L  L +L L  N+L
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

Query: 226 SGSIPISM-GNLSNLTYLNLFEN 247
             S+P  +   L++L Y+ L +N
Sbjct: 137 K-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 7/130 (5%)

Query: 169 NLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGN-LRSLSNLSLGYNKLSG 227
            L L  N+           L++L  LYL  N L  S+P+ + N L SL+ L+L  N+L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 228 SIPISM-GNLSNLTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQFRG-PIPILRNLT 284
           S+P  +   L+ L  L L  N L  ++P   +  L +L  L L  NQ +  P  +   LT
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148

Query: 285 SLERVRLDRN 294
           SL+ + L  N
Sbjct: 149 SLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 41/129 (31%), Positives = 63/129 (48%), Gaps = 6/129 (4%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGN-LRSLSNLQLNNNILSGS 132
           L+L  N L          L++L  LYL  N L  S+P+ + N L SL+ L L+ N L  S
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 133 IPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSN 190
           +P+ +   LT L  L + +N L +   G    L  L +L+L +N    S+P      L++
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTS 149

Query: 191 LATLYLDTN 199
           L  ++L  N
Sbjct: 150 LQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 44/132 (33%), Positives = 62/132 (46%), Gaps = 18/132 (13%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGN-LTNLATLYIHTNSLSGSIPG 63
             NSL          L SL+ L LG NKL  S+P+ + N LT+L  L + TN L  S+P 
Sbjct: 36  ETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPN 93

Query: 64  EIGNFRFF------SDLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSE-LGN 115
            +     F       +L L+ N+L  S+P  +   L+ L  L L  N L  S+P      
Sbjct: 94  GV-----FDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDR 146

Query: 116 LRSLSNLQLNNN 127
           L SL  + L++N
Sbjct: 147 LTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 33/116 (28%), Positives = 45/116 (38%), Gaps = 3/116 (2%)

Query: 204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKL 263
           S+P+  G     + L L  N L          L++LT L L  N L       +  L  L
Sbjct: 21  SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78

Query: 264 TILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
           T L L  NQ +  P  +   LT L+ + L+ N L       F     L  + L QN
Sbjct: 79  TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 5/114 (4%)

Query: 384 KLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLR 443
            L L  N L    +     L  L  L L  N+L  S+P  + N +L  L+ L+LS N L 
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFN-KLTSLTYLNLSTNQL- 88

Query: 444 EAIPSQIC-IMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
           +++P+ +   +  L++L L+ N L  L    F+K+  L  + +  N+L+ S+P+
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPD 141

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 64.0 bits (155), Expect = 6e-11
 Identities = 23/102 (22%), Positives = 36/102 (35%), Gaps = 2/102 (1%)

Query: 78  NNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNNILSGSIPHS 136
               +      L    NL  LY++       +    L  L  L NL +  + L    P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 137 LGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
                 L+ L +  N+L +     +  L SL  L LS N  +
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 61.7 bits (149), Expect = 3e-10
 Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 10/107 (9%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIP-HSLGNLTNLATLYIHTNSLSGSI 61
           C  + +L       L   ++L++L + N +    +    L  L  L  L I  + L   +
Sbjct: 15  CTRDGAL--DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FV 71

Query: 62  PGEIGNFRFFSDLE---LSNNKLSGSIPPSLGNLSNLATLYLDTNSL 105
             +   F F   L    LS N L  S+        +L  L L  N L
Sbjct: 72  APDA--FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 21/101 (20%), Positives = 36/101 (35%), Gaps = 2/101 (1%)

Query: 150 SNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLSYSIPSE 208
           +   +   L  +   ++L+ L +        +    L  L  L  L +  + L +  P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 209 LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
                 LS L+L +N L  S+        +L  L L  N L
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 23/126 (18%), Positives = 35/126 (27%), Gaps = 28/126 (22%)

Query: 30  NNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPP-S 88
               +    H L    NL  LY                        + N +    +    
Sbjct: 16  TRDGALDSLHHLPGAENLTELY------------------------IENQQHLQHLELRD 51

Query: 89  LGNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLY 147
           L  L  L  L +  + L   +  +       LS L L+ N L  S+        +L  L 
Sbjct: 52  LRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109

Query: 148 IYSNSL 153
           +  N L
Sbjct: 110 LSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 6e-08
 Identities = 23/116 (19%), Positives = 43/116 (37%), Gaps = 7/116 (6%)

Query: 330 RCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLA 388
                S L  + +    +    +  +  L  L + +   +  + +  L  L     L + 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 389 HNQLSGQLSPK-LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLR 443
            + L   ++P       +L  L+LS N L  S+      ++ + L EL LS N L 
Sbjct: 65  KSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKT--VQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 6e-07
 Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 5/101 (4%)

Query: 223 NKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQFRGPIP--I 279
              +      +    NLT L +        +     R L +L  L +  +  R  +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 280 LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF 320
                 L R+ L  N L  ++S       +L  + LS N  
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 21/119 (17%), Positives = 33/119 (27%), Gaps = 25/119 (21%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSGSIPISMGNLSN 238
                L    NL  LY++       +    L  L  L NL++  + L   +         
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-------- 72

Query: 239 LTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLT 297
                          P  +    +L+ L L  N             SL+ + L  N L 
Sbjct: 73  ---------------PDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 3e-06
 Identities = 16/87 (18%), Positives = 34/87 (39%), Gaps = 4/87 (4%)

Query: 413 SNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQ-ICIMQSLEKLNLSHNSLSGLIP 471
           +   +      L   E  +L+EL +      + +  + +  +  L  L +  + L  + P
Sbjct: 16  TRDGALDSLHHLPGAE--NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 472 SCFEKMNGLLHIDISYNELRGSIPNST 498
             F     L  +++S+N L  S+   T
Sbjct: 74  DAFHFTPRLSRLNLSFNALE-SLSWKT 99

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.4 bits (155), Expect = 8e-11
 Identities = 46/217 (21%), Positives = 90/217 (41%), Gaps = 45/217 (20%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEF-------LNEVKALTEIWHR 661
           +G+G  G VY +    + E +A+K+           + E        + EV  L E+ HR
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVSLLKELQHR 93

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV----DAL 717
           NI+++     H   L +++EY +   L   +       ++     M +IK  +    + +
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVS----MRVIKSFLYQLINGV 145

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAH-----VSDFGIAKFLKPDSSNWTELAGTYG 772
           ++ H+      +HRD+  +N+LL   + +      + DFG+A+        +T    T  
Sbjct: 146 NFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202

Query: 773 YVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 804
           Y  PE+      Y+  V    D++S   +  E++   
Sbjct: 203 YRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 3/103 (2%)

Query: 98  LYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASI 157
           LYLD N  +  +P EL N + L+ + L+NN +S     S  N+T L TL +  N L    
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94

Query: 158 LGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTN 199
                 LKSL  L L  N+ +  +P  +  +LS L+ L +  N
Sbjct: 95  PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 8/105 (7%)

Query: 194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSLSGA 252
           LYLD N  +  +P EL N + L+ + L  N++S ++      N++ L  L L  N L   
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 253 IPYE-YRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRN 294
           IP   +  L  L +L L  N     +P     +L++L  + +  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 36/125 (28%), Positives = 51/125 (40%), Gaps = 29/125 (23%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
             N     +P EL N K L+ ++L NN++S     S  N+T L TL              
Sbjct: 39  DGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI------------- 84

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNL 122
                      LS N+L   IPP     L +L  L L  N +S  +P     +L +LS+L
Sbjct: 85  -----------LSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131

Query: 123 QLNNN 127
            +  N
Sbjct: 132 AIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 56.5 bits (137), Expect = 3e-09
 Identities = 36/131 (27%), Positives = 55/131 (41%), Gaps = 33/131 (25%)

Query: 121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
            L L+ N  +  +P  L N  +L  + + +N +S                 LS  +F+  
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST----------------LSNQSFS-- 75

Query: 181 IPPSLGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLSGSIPISMG---NL 236
                 N++ L TL L  N L   IP      L+SL  LSL  N +S  +P   G   +L
Sbjct: 76  ------NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP--EGAFNDL 125

Query: 237 SNLTYLNLFEN 247
           S L++L +  N
Sbjct: 126 SALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 29/97 (29%), Positives = 42/97 (43%), Gaps = 10/97 (10%)

Query: 348 VPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL-GSLVQL 406
           +P  I        L L  N     +P EL        + L++N++S  LS +   ++ QL
Sbjct: 25  LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 407 EHLDLSSNRLSNSIPK----SLGNLELIHLSELDLSR 439
             L LS NRL   IP      L +L L+ L   D+S 
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV 116

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 42/210 (20%), Positives = 82/210 (39%), Gaps = 36/210 (17%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVY 667
           +G+G    V+ +  + + E + VK            +++   E+K L  +    NI+ + 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGPNIITLA 97

Query: 668 GFCLHVRHLFI---VYEYFKMCSLAVILS--NDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
              +          V+E+        +     D   +          +  I+ AL Y H+
Sbjct: 98  D-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--------MYEILKALDYCHS 148

Query: 723 DCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--- 778
                I+HRD+   NV++D E+ +  + D+G+A+F  P    +     +  +  PEL   
Sbjct: 149 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVD 204

Query: 779 --AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
              Y   +    D++S G +   +I  K P
Sbjct: 205 YQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 51/236 (21%), Positives = 102/236 (43%), Gaps = 53/236 (22%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEF-------LN 650
              + ++    IG+G  G V+ ++   +G+ +A+KK           + E        L 
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKEGFPITALR 65

Query: 651 EVKALTEIWHRNIVKVYG--------FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
           E+K L  + H N+V +          +      +++V+++ +   LA +LSN      + 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN----VLVK 120

Query: 703 WTRRMNMIKGIV----DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF-- 756
           +T  ++ IK ++    + L Y+H +    I+HRD+ + NVL+  +    ++DFG+A+   
Sbjct: 121 FT--LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 175

Query: 757 --LKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 804
                  + +T    T  Y  PEL      Y   +    D++  G ++A E+    
Sbjct: 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 74/493 (15%), Positives = 161/493 (32%), Gaps = 68/493 (13%)

Query: 11  DSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRF 70
            ++      ++S+      +      +P   G         + ++            + +
Sbjct: 59  ATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSS------------YTW 106

Query: 71  FSDLELSNNKLSGSIPPSLG-NLSNLATLYLD-----TNSLSNSIPSELGNLRSLSNLQL 124
             ++ L    ++      +  +  N   L L      +     +I +   NL+ L +L+ 
Sbjct: 107 LEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKEL-DLRE 165

Query: 125 NN--NILSGSIPHSLGNLTNLATLYI--YSNSLSASILGKIG-NLKSLSNLQLSENNFNG 179
           ++  ++    + H     T+L +L I   ++ +S S L ++     +L +L+L+      
Sbjct: 166 SDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225

Query: 180 SIPPSLGNLSNLATLYLD------TNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM 233
            +   L     L  L            +   +   L   + L  LS  ++ +   +P   
Sbjct: 226 KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVY 285

Query: 234 GNLSNLTYLNL-----FENSLSGAIPYEYRNLVKLTILLLGHN-QFRGPIPILRNLTSLE 287
              S LT LNL         L   +        KL  L +    +  G   +      L 
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLL----CQCPKLQRLWVLDYIEDAGLEVLASTCKDLR 341

Query: 288 RVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGN 347
            +R+  +               LT   L        +S     CPKL ++ +    +T  
Sbjct: 342 ELRVFPSEPFVMEPNV-----ALTEQGLVS------VSM---GCPKLESVLYFCRQMTNA 387

Query: 348 VPPEIGHS-SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQ------LSGQLSPK- 399
               I  +   +    L          + L  L+     ++ H +      LSG L+ K 
Sbjct: 388 ALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKV 447

Query: 400 ----LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSR-NFLREAIPSQICIMQ 454
                    ++E L ++    S+     + +     L +L++    F  +A+ +    ++
Sbjct: 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS-GCDSLRKLEIRDCPFGDKALLANASKLE 506

Query: 455 SLEKLNLSHNSLS 467
           ++  L +S  S+S
Sbjct: 507 TMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 40/295 (13%), Positives = 89/295 (30%), Gaps = 26/295 (8%)

Query: 235 NLSNLTYLNLFENSLS----GAIPYEYRNLVKLTILLLGHNQF--RGPIPILRNLTSLER 288
           + + L  + L    ++      I   ++N   L   L     F   G   I     +L+ 
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLV--LSSCEGFSTDGLAAIAATCRNLKE 160

Query: 289 VRLDRNYLTGNISESFYIY----PNLTYIDLSQNNFYGEISSD-----WGRCPKLSTLDF 339
           + L  + +          +     +L  +++S      E+S         RCP L +L  
Sbjct: 161 LDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS--CLASEVSFSALERLVTRCPNLKSLKL 218

Query: 340 SINNITGNVPPEIGHSSQLGVLDLSS------NHIVGEIPIELGKLNFFIKLVLAHNQLS 393
           +       +   +  + QL  L            +   + + L        L    + + 
Sbjct: 219 NRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP 278

Query: 394 GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
             L        +L  L+LS   + +     L   +   L  L +        +       
Sbjct: 279 AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLC-QCPKLQRLWVLDYIEDAGLEVLASTC 337

Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEAL 508
           + L +L +  +    + P+      GL+ + +   +L   +       +A +  +
Sbjct: 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 7/109 (6%)

Query: 74  LELSNNKLSGSIPPS--LGNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILS 130
           L L++N+L   I      G L +L  L L  N L+  I          +  LQL  N + 
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 131 GSIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
             I + +   L  L TL +Y N +S  + G   +L SL++L L+ N FN
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 7/106 (6%)

Query: 98  LYLDTNSLSNSIPSE--LGNLRSLSNLQLNNNILSGSIPHSL-GNLTNLATLYIYSNSLS 154
           L L+ N L   I S+   G L  L  L+L  N L+  I  +     +++  L +  N + 
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 155 ASILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTN 199
                    L  L  L L +N  +  + P S  +L++L +L L +N
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 33/110 (30%), Positives = 45/110 (40%), Gaps = 9/110 (8%)

Query: 169 NLQLSENNFNGSIPPS--LGNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKL 225
            L L++N     I      G L +L  L L  N L+  I          +  L LG NK+
Sbjct: 33  ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 226 SGSIPISM-GNLSNLTYLNLFENSLSGAIPYE-YRNLVKLTILLLGHNQF 273
              I   M   L  L  LNL++N +S  +    + +L  LT L L  N F
Sbjct: 91  K-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 32/108 (29%), Positives = 44/108 (40%), Gaps = 9/108 (8%)

Query: 121 NLQLNNNILSGSIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
            L LN+N L       L G L +L  L +  N L+            +  LQL EN    
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 180 SIPPSL-GNLSNLATLYLDTNSLSYSIPSELG---NLRSLSNLSLGYN 223
            I   +   L  L TL L  N +S  +    G   +L SL++L+L  N
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQIS-CVMP--GSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 13/106 (12%)

Query: 5   YNNSLYDSIPSE--LRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSI 61
            +N L   I S+     L  L  LEL  N+L+  I  +     +++  L +  N +   I
Sbjct: 37  NDNEL-GRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EI 93

Query: 62  PGEIGNFRFFS---DLELSNNKLSGSIPP-SLGNLSNLATLYLDTN 103
                 F        L L +N++S  + P S  +L++L +L L +N
Sbjct: 94  SN--KMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 2/104 (1%)

Query: 217 NLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG 275
            L L  N+L       + G L +L  L L  N L+G  P  +     +  L LG N+ + 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92

Query: 276 -PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
               +   L  L+ + L  N ++  +  SF    +LT ++L+ N
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 31/108 (28%), Positives = 57/108 (52%), Gaps = 7/108 (6%)

Query: 384 KLVLAHNQLSGQLSPK--LGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNF 441
           +L+L  N+L  ++S     G L  L  L+L  N+L+  I  +       H+ EL L  N 
Sbjct: 33  ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFE-GASHIQELQLGENK 89

Query: 442 LREAIPSQICI-MQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
           + + I +++ + +  L+ LNL  N +S ++P  FE +N L  ++++ N
Sbjct: 90  I-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 46/218 (21%), Positives = 90/218 (41%), Gaps = 33/218 (15%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---------- 658
           +G G   +V+++K + +   +A+K        +  + +   +E+K L  +          
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 659 -WHRNIVKVYGFCLH----VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI 713
               +I+K+     H      H+ +V+E      LA+I   +     L + +++   K +
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 140

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH------VSDFGIAKFLKPDSSNWTEL 767
           +  L YMH  C   I+H DI  +NVL++  +         ++D G A +      ++T  
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNS 195

Query: 768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 805
             T  Y +PE+          D++S   L  E+I G  
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 23/153 (15%)

Query: 728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV-----APELAYTM 782
            +HRD++++N+LL  +N   + DFG+A+ +  D      +      +     APE  +  
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDR 270

Query: 783 KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP--RLPTPSRNV 839
             T + DV+SFGVL  E+   G  P        +  + ++      L    R+  P    
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGASP--------YPGVKIDEEFCRRLKEGTRMRAP-DYT 321

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             ++   +     C    P  RPT  ++ + L 
Sbjct: 322 TPEMYQTML---DCWHGEPSQRPTFSELVEHLG 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 31/158 (19%), Positives = 57/158 (36%), Gaps = 24/158 (15%)

Query: 610 IGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-WH 660
           +G+G  G V       + K A+   +AVK     L    T    +  ++E+K L  I  H
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 85

Query: 661 RNIVKVYGFCLHVRH-LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
            N+V + G C      L ++ E+ K  +L+  L           ++R   +        +
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARF 135

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL 757
                +   +  D+  +   +     +  S F   K L
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 50/229 (21%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKK---FHSPLPGEMTFQQEFLNEVKALT 656
              + +   IG+G  G V  +    +   +A+KK   F        T+ Q  L E+K L 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILL 80

Query: 657 EIWHRNIVKVYGFCLHV---------RHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRR 706
              H NI+ +      +         + ++IV +   M   L  +L      ++L     
Sbjct: 81  RFRHENIIGI----NDIIRAPTIEQMKDVYIVQDL--METDLYKLLK----TQHLSNDHI 130

Query: 707 MNMIKGIVDALSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN- 763
              +  I+  L Y+H  N     ++HRD+   N+LL+   +  + DFG+A+   PD  + 
Sbjct: 131 CYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 764 --WTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 804
              TE   T  Y APE+      YT  +    D++S G +LA E++  +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 61.0 bits (149), Expect = 4e-10
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKK--FHSPLPGEMTFQQEFLNEVKAL 655
            AT+ ++    IG G  G+VY ++   SG  +A+K     +   G        + EV  L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 656 TEI---WHRNIVKVYGFCLHVRH-----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRM 707
             +    H N+V++   C   R      + +V+E+     L   L     A   G     
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK---APPPGLP--A 119

Query: 708 NMIKGIV----DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSS 762
             IK ++      L ++H +C   IVHRD+  +N+L+       ++DFG+A+ +      
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--M 174

Query: 763 NWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK 804
             T +  T  Y APE+     Y   V    D++S G +  E+ + K
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 35/173 (20%), Positives = 63/173 (36%), Gaps = 18/173 (10%)

Query: 103 NSLSNSIPSELGNLRSLSNLQLNNNILS-GSIPHSLGNLTNLATLYIYSNSLSASILGKI 161
           +++      +         ++L+  I     +  +L  L     L + +N++      KI
Sbjct: 9   DAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KI 63

Query: 162 GNLKSLSNLQ---LSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNL 218
            +L  + NL+   L  N     I         L  L++  N ++ S+ S +  L +L  L
Sbjct: 64  SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVL 120

Query: 219 SLGYNKLSGSIPIS-MGNLSNLTYLNLFENSLS-----GAIPYEYRNLVKLTI 265
            +  NK++    I  +  L  L  L L  N L           EYR  V   +
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 9/129 (6%)

Query: 25  DLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGS 84
           +L      +   +  +L  L     L + TN++   I   +        L L  N +   
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-K 84

Query: 85  IPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILS--GSIPHSLGNLTN 142
           I         L  L++  N +++   S +  L +L  L ++NN ++  G I   L  L  
Sbjct: 85  IENLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDK 141

Query: 143 LATLYIYSN 151
           L  L +  N
Sbjct: 142 LEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 7/111 (6%)

Query: 13  IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFS 72
           + + L  LK+   L L  N +   I   L  + NL  L +  N +   I           
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 73  DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
           +L +S N+++ S+   +  L NL  LY+  N ++N    E+  L +L  L+
Sbjct: 97  ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAALDKLE 143

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 30/145 (20%), Positives = 55/145 (37%), Gaps = 13/145 (8%)

Query: 361 LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
           L      I  ++   L  L     L L+ N +  ++S  L  +  L  L L  N +    
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLI---- 82

Query: 421 PKSLGNLE--LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIP-SCFEKM 477
            K + NL+     L EL +S N +     S I  + +L  L +S+N ++          +
Sbjct: 83  -KKIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAAL 139

Query: 478 NGLLHIDISYNELRGSIPNSTTFKD 502
           + L  + ++ N L      +    +
Sbjct: 140 DKLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 23/140 (16%), Positives = 46/140 (32%), Gaps = 16/140 (11%)

Query: 218 LSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPI 277
           L      +   +  ++  L    +L L  N++          +  L IL LG N  +   
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLS--GMENLRILSLGRNLIKKIE 86

Query: 278 PILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW------GRC 331
            +     +LE + +  N +  ++        NL  + +S N       ++W         
Sbjct: 87  NLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKI-----TNWGEIDKLAAL 139

Query: 332 PKLSTLDFSINNITGNVPPE 351
            KL  L  + N +  +    
Sbjct: 140 DKLEDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 29/98 (29%), Positives = 41/98 (41%), Gaps = 6/98 (6%)

Query: 17  LRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLEL 76
           L  +++L  L LG N +   I +       L  L+I  N ++ S+ G I        L +
Sbjct: 66  LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYM 122

Query: 77  SNNKLS--GSIPPSLGNLSNLATLYLDTNSLSNSIPSE 112
           SNNK++  G I   L  L  L  L L  N L N     
Sbjct: 123 SNNKITNWGEIDK-LAALDKLEDLLLAGNPLYNDYKEN 159

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 61.3 bits (149), Expect = 7e-10
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 35/202 (17%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G  G V + K   +G  +AVK  +      +    +   E++ L    H +I+K+Y 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY- 82

Query: 669 FCLHV----RHLFIVYEY------FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
               V      +F+V EY      F        L    + +         + + I+  + 
Sbjct: 83  ---QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR---------LFQQILSGVD 130

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y H      +VHRD+  +NVLLD    A ++DFG++  +       T   G+  Y APE+
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEV 186

Query: 779 ----AYTMKVTEKCDVYSFGVL 796
                Y      + D++S GV+
Sbjct: 187 ISGRLYA---GPEVDIWSSGVI 205

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 58.0 bits (141), Expect = 7e-10
 Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 6/105 (5%)

Query: 74  LELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSG 131
           LEL +NKL  S+P  +   L+ L  L L  N +  S+P  +   L  L+ L L+ N L  
Sbjct: 33  LELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89

Query: 132 SIPHSL-GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSEN 175
           S+P+ +   LT L  L + +N L +   G    L SL  + L  N
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 37/117 (31%), Positives = 47/117 (40%), Gaps = 10/117 (8%)

Query: 13  IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFS 72
           IPS    L      EL +NKL          LT L  L +  N +     G        +
Sbjct: 26  IPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79

Query: 73  DLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSE-LGNLRSLSNLQLNNN 127
            L L  NKL  S+P  +   L+ L  L LDTN L  S+P      L SL  + L+ N
Sbjct: 80  ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 5/104 (4%)

Query: 194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSLSGA 252
           L L++N L          L  L+ LSL  N++  S+P  +   L+ LT L L EN L  +
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 253 IPYE-YRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRN 294
           +P   +  L +L  L L  NQ +  P  I   LTSL+++ L  N
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 32/103 (31%), Positives = 43/103 (41%), Gaps = 1/103 (0%)

Query: 217 NLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG- 275
            L L  NKL          L+ LT L+L +N +       +  L KLTIL L  N+ +  
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSL 91

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
           P  +   LT L+ + LD N L       F    +L  I L  N
Sbjct: 92  PNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 33/105 (31%), Positives = 44/105 (41%), Gaps = 4/105 (3%)

Query: 121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
            L+L +N L          LT L  L +  N + +   G    L  L+ L L EN    S
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 181 IPPSL-GNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYN 223
           +P  +   L+ L  L LDTN L  S+P      L SL  + L  N
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 55/235 (23%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKK---FHSPLPGEMTFQQEFLNEVKALT 656
           ++DF  +  +G+G  G V  +    +GEI+A+KK   F  P      F    L E+K L 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILK 64

Query: 657 EIWHRNIVKVYGFCLHV---------RHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRR 706
              H NI+ +     ++           ++I+ E   M   L  ++S     + L     
Sbjct: 65  HFKHENIITI----FNIQRPDSFENFNEVYIIQEL--MQTDLHRVIST----QMLSDDHI 114

Query: 707 MNMIKGIVDALSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
              I   + A+  +H  N     ++HRD+   N+L++   +  V DFG+A+ +   +++ 
Sbjct: 115 QYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 765 TELAGTYG----YV------APEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 804
           +E  G       +V      APE+      Y+  +    DV+S G +  E+   +
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 59.5 bits (145), Expect = 2e-09
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 40/221 (18%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            DF     +G G  G V++ +   +G   A+K     +   +   +   +E   L+ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 661 RNIVKVYGFCLHVRHLFIVYEY------FKMCSLAVILSNDAA----AKNLGWTRRMNMI 710
             I++++G     + +F++ +Y      F +   +    N  A    A+           
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----------- 114

Query: 711 KGIVDALSYMH-NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
             +  AL Y+H  D    I++RD+  +N+LLD      ++DFG AK        +T L G
Sbjct: 115 --VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYT-LCG 165

Query: 770 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+     Y   +    D +SFG+L  E++ G  P
Sbjct: 166 TPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 42/224 (18%), Positives = 71/224 (31%), Gaps = 71/224 (31%)

Query: 598 IRATNDFDD----EHCIGKGGQGSVYM-SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEV 652
           I+     DD       +G G  G V       + E  A+K              +   EV
Sbjct: 10  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREV 61

Query: 653 KALTEIW-HRNIVKVYGFC----LHVRHLFIVYEYFKMCS----LAVILS--------ND 695
           +         +IV++           + L IV E           + I           +
Sbjct: 62  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC---LDGGELFSRIQDRGDQAFTERE 118

Query: 696 AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH---VSDFG 752
           A+           ++K I +A+ Y+H+     I HRD+  +N+L   +       ++DFG
Sbjct: 119 ASE----------IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165

Query: 753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 796
            AK               Y              + CD++S GV+
Sbjct: 166 FAKET---------TGEKYD-------------KSCDMWSLGVI 187

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 38/222 (17%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           N+F+    +GKG  G V + K  A+G   A+K     +          L E + L    H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 661 RNIVKVYGFCLH-VRHLFIVYEY-------FKMCSLAVILSNDA---AAKNLGWTRRMNM 709
             +  +  +       L  V EY       F +    V   + A    A+          
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE---------- 256

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELA 768
              IV AL Y+H++    +V+RD+  +N++LD +    ++DFG+ K  +K  ++  T   
Sbjct: 257 ---IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FC 310

Query: 769 GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           GT  Y+APE+     Y   V    D +  GV+  E++ G+ P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 4e-09
 Identities = 111/590 (18%), Positives = 183/590 (31%), Gaps = 160/590 (27%)

Query: 291 LDRNY--LTGNISESFYIYPNL---TYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNIT 345
           L  NY  L   I       P++    YI+  ++  Y +         K            
Sbjct: 87  LRINYKFLMSPIKTE-QRQPSMMTRMYIE-QRDRLYNDNQ----VFAKY----------- 129

Query: 346 GNVP-PEIGHSSQLGVLDLSSNHIVGEIPIE--LGKLNFFIKLVLAHNQL-SGQLSPKLG 401
            NV   +     +  +L+L     V    I+  LG      K  +A +   S ++  K+ 
Sbjct: 130 -NVSRLQPYLKLRQALLELRPAKNVL---IDGVLG----SGKTWVALDVCLSYKVQCKMD 181

Query: 402 SLVQLEH-LDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQS-LEKL 459
             +     L+L +     ++ + L  L L  +     SR+     I  +I  +Q+ L +L
Sbjct: 182 FKI---FWLNLKNCNSPETVLEMLQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 460 NLSH---NSLSGLI------PSCFEKMNG----LLHIDISYNELRGSIPNSTTFKDAPIE 506
             S    N L  L+         +   N     LL    +  +      ++ T     ++
Sbjct: 238 LKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILL---TTRFKQVTDFLSAATTTHISLD 292

Query: 507 ALQGNKGLYGD-VKGLLSCKALKSNKQALRTIWVVVVFPLLGFVALLISLIGLFFK---- 561
               +  L  D VK LL  K L    Q L    V+   P        +S+I    +    
Sbjct: 293 --HHSMTLTPDEVKSLLL-KYLDCRPQDLPRE-VLTTNPRR------LSIIAESIRDGLA 342

Query: 562 ----FQRRKND--SQTQQSS-----PGNSRGL---LSVLTFEGKIIYE--EIIRATNDFD 605
               ++    D  +   +SS     P   R +   LSV      I      +I       
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402

Query: 606 DEHCIGKGGQGSVYMSKLASGEIIA--VKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           D   +         ++KL    ++    K+    +P       E   +++    + HR+I
Sbjct: 403 DVMVV---------VNKLHKYSLVEKQPKESTISIPS---IYLELKVKLENEYAL-HRSI 449

Query: 664 VKVYGF--CLHVRHLFIVYE--YFKMCS-LAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
           V  Y          L   Y   YF   S +   L      KN+    RM +         
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYF--YSHIGHHL------KNIEHPERMTL--------- 492

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
                 F            V LDF        F   K ++ DS+ W       G +   L
Sbjct: 493 ------FR----------MVFLDF-------RFLEQK-IRHDSTAW----NASGSILNTL 524

Query: 779 A----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL 824
                Y   + +    Y   V A+     K   + I S  ++ L L IAL
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS-KYTDL-LRIAL 572

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 2e-06
 Identities = 67/454 (14%), Positives = 133/454 (29%), Gaps = 128/454 (28%)

Query: 482 HIDISYNELRGS----IPNSTTFKDAPIEALQGNKGLYGDV----KGLLSCKALK----- 528
           H+D    E +      +     F+DA ++          DV    K +LS + +      
Sbjct: 6   HMDFETGEHQYQYKDILS---VFEDAFVDNFDCK-----DVQDMPKSILSKEEIDHIIMS 57

Query: 529 --SNKQALRTIW--------VVVVF------PLLGFVALLI-------SLIGLFFKFQRR 565
             +    LR  W        +V  F          F+   I       S++   +  QR 
Sbjct: 58  KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117

Query: 566 KNDSQTQQSSPGN-SRGLLSVLTFEGKIIYEEIIRATNDFDDEHCI---GKGGQG-SVYM 620
           +  +  Q  +  N SR             Y ++ +A  +      +   G  G G +   
Sbjct: 118 RLYNDNQVFAKYNVSRLQP----------YLKLRQALLELRPAKNVLIDGVLGSGKTW-- 165

Query: 621 SKLASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF 677
             +A  ++    K    +  +   +  +    N  + + E+  +           +   +
Sbjct: 166 --VAL-DVCLSYKVQCKMDFKIFWLNLKNC--NSPETVLEMLQK-------LLYQIDPNW 213

Query: 678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKN 737
                    S  + L   +    L   RR+   K   + L          +V  ++ +  
Sbjct: 214 TSRSDH---SSNIKLRIHSIQAEL---RRLLKSKPYENCL----------LVLLNVQNAK 257

Query: 738 VLLDFENEAHV----SDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKCDVYS 792
               F     +        +  FL   ++    L   +      E      +  K     
Sbjct: 258 AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCR 314

Query: 793 FGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS--RNV-HDKLISIVEV 849
              L  EV+   +P     S+        IA  E +   L T    ++V  DKL +I+E 
Sbjct: 315 PQDLPREVLTT-NP--RRLSI--------IA--ESIRDGLATWDNWKHVNCDKLTTIIES 361

Query: 850 TISCVDEN------------PESRPTMQKVCQLL 871
           +++ ++              P S      +  L+
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 1e-05
 Identities = 70/468 (14%), Positives = 152/468 (32%), Gaps = 101/468 (21%)

Query: 9   LYDSIPSELRNLKSLSDLEL-GNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGN 67
            Y  +   L  L+   ++ + G   + GS     G  T +A     +  +   +  +I  
Sbjct: 136 PYLKLRQALLELRPAKNVLIDG---VLGS-----GK-TWVALDVCLSYKVQCKMDFKI-- 184

Query: 68  FRFFSDLELSNNKLSGSIPPSLGNL-SNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
             F+  L L N     ++   L  L   +   +   +  S++I   + ++++    +L  
Sbjct: 185 --FW--LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA----ELRR 236

Query: 127 NILSGSIPHSLGNLTNLATLYIYSN-SLSASIL------GKIGNLKSLSNLQLSENNFNG 179
            + S    + L  L N+     ++  +LS  IL           L + +   +S ++ + 
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSM 296

Query: 180 SIPP--SLGNLSN--------LATLYLDTNSLSYS-IPSELGNLRSLSN--LSLGYNKLS 226
           ++ P      L          L    L TN    S I   + +  +  +    +  +KL+
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356

Query: 227 GSIPISMGNLSNLTYLNLFENSLS----GA-IPY----------EYRN-------LVKLT 264
             I  S+  L    Y  +F+  LS     A IP              +       L K +
Sbjct: 357 TIIESSLNVLEPAEYRKMFD-RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415

Query: 265 ILLLGHNQFRGPIPIL--------RNLTSL-----ERVRLDRNYLTGNISESF---YIYP 308
           ++     +    IP +         N  +L     +   + + + + ++   +   Y Y 
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS 475

Query: 309 NLTYIDLSQNNFYGEISSDWGRCPKLSTLDFS-----INNITGNVPPEIGHSSQLGVLDL 363
           ++ +  L        ++        +  LDF      I + +          + L  L  
Sbjct: 476 HIGH-HLKNIEHPERMTL----FRMV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF 529

Query: 364 SSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDL 411
              +I    P     +N  +  +    +          +L+  ++ DL
Sbjct: 530 YKPYICDNDPKYERLVNAILDFLPKIEE----------NLICSKYTDL 567

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 55/360 (15%), Positives = 106/360 (29%), Gaps = 77/360 (21%)

Query: 185 LGNLSNLATLYLDTNSLSYSIPSELG-----NLRSLSNLSLGYNKLS--GSIPIS---MG 234
                 + +L L  N+L      EL         S+++L+L  N L    S  +      
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 235 NLSNLTYLNLFENS--------LSGAIPYEYRNLVKLTILLLGHNQF--RGPIPILRNL- 283
             +N+T LNL  N         L   +         +T+L LG N F  +      +   
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLA---AIPFTITVLDLGWNDFSSKSSSEFKQAFS 134

Query: 284 ---TSLERVRLDRNYLTGN----ISESFYIYP-NLTYIDLSQNNFYGE-----ISSDWGR 330
               S+  + L  N L       + +     P N+  ++L  NN   +            
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194

Query: 331 CPKLSTLDFSINNITGNVPPEIG-----HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKL 385
              +++LD S N +      E+        + +  L+L  N + G     L  L      
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL------ 248

Query: 386 VLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL-----ELIHLSELDLSRN 440
                +              L+ + L  + + N   +    L      +  +  +D +  
Sbjct: 249 -KDSLK-------------HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK 294

Query: 441 FLREAIPSQIC-----IMQSLEKLNLSHNSL---SGLIPSCFEKMNG--LLHIDISYNEL 490
            +  +    I      +    +  +L +  L        +  +      L     +   L
Sbjct: 295 EIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 51/316 (16%), Positives = 106/316 (33%), Gaps = 63/316 (19%)

Query: 218 LSLGYNKLSGSIPIS--MGNLSNLTYLNLFENSLS--GAIPYEYRNLVKLTILLLGHNQF 273
           ++       GS P+         +T L+L  N+L            L++           
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSIST-----VELIQA---------- 45

Query: 274 RGPIPILRNLTSLERVRLDRNYLTGN----ISESFYIYP-NLTYIDLSQNNFYGE----I 324
                      S+  + L  N L       + +     P N+T ++LS N    +    +
Sbjct: 46  -----FANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100

Query: 325 SSDWGRCP-KLSTLDFSINNITGNVPPEIGH-----SSQLGVLDLSSNHI----VGEIPI 374
                  P  ++ LD   N+ +     E         + +  L+L  N +      E+  
Sbjct: 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160

Query: 375 ELGKLNFFIK-LVLAHNQLSGQLSPKLGSLV-----QLEHLDLSSNRLSNSIPKSLGNL- 427
            L  +   +  L L  N L+ +   +L   +      +  LDLS+N L       L  + 
Sbjct: 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIF 220

Query: 428 --ELIHLSELDLSRNFLREAIPSQICIM----QSLEKLNLSHNSLSGL-------IPSCF 474
                H+  L+L  N L       + ++    + L+ + L ++ +  +       + + F
Sbjct: 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAF 280

Query: 475 EKMNGLLHIDISYNEL 490
             +  ++ +D +  E+
Sbjct: 281 PNIQKIILVDKNGKEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 41/237 (17%), Positives = 79/237 (33%), Gaps = 53/237 (22%)

Query: 331 CPKLSTLDFSINNITGNVPPEIG-----HSSQLGVLDLSSNHI----VGEIPIELGKLNF 381
              +++LD S+NN+      E+        + +  L+LS N +      E+   L  +  
Sbjct: 21  PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80

Query: 382 FIK-LVLAHNQLSGQLSPKLGSLVQ-----LEHLDLSSNRLSNSIPKSLGNL---ELIHL 432
            +  L L+ N LS + S +L   +      +  LDL  N  S+                +
Sbjct: 81  NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140

Query: 433 SELDLSRNFLREAIPSQICIM-----QSLEKLNLSHNSLS----GLIPSCFEKMN-GLLH 482
           + L+L  N L      ++  +      ++  LNL  N+L+      +      +   +  
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTS 200

Query: 483 IDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALKSNKQALRTIWV 539
           +D+S N L                   G K        L       S    + ++ +
Sbjct: 201 LDLSANLL-------------------GLKS----YAEL--AYIFSSIPNHVVSLNL 232

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 50/280 (17%), Positives = 92/280 (32%), Gaps = 46/280 (16%)

Query: 17  LRNLKSLSDLELGNNKLSGSIPHSLG-----NLTNLATLYIHTNSLSGSIPGEIG----- 66
                 ++ L+L  N L       L         ++ +L +  NSL      E+      
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 67  NFRFFSDLELSNNKLSGSIPPSLGNL-----SNLATLYLDTNSLSNSIPSELGNL----- 116
                + L LS N LS      L          +  L L  N  S+   SE         
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 117 RSLSNLQLNNNILSGSIPHSLGNL-----TNLATLYIYSNSLS---ASILGK--IGNLKS 166
            S+++L L  N L       L  +      N+ +L +  N+L+    + L K       S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 167 LSNLQLSENNFNGSIPPSLG-----NLSNLATLYLDTNSLSYS----IPSELGNLRSLSN 217
           +++L LS N         L        +++ +L L  N L       +     +L+ L  
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257

Query: 218 LSLGYNKLSG-------SIPISMGNLSNLTYLNLFENSLS 250
           + L Y+ +         ++  +  N+  +  ++     + 
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 58.4 bits (140), Expect = 4e-09
 Identities = 28/179 (15%), Positives = 54/179 (30%), Gaps = 29/179 (16%)

Query: 298 GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS-- 355
            ++S      P L  + +   N    +S      P L +L+     +  +V  +I  S  
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 356 SQLGVLDLS--SNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
             L  L L         +  +                      S        L+ L +  
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMN---------------VFRPLFSK--DRFPNLKWLGIVD 261

Query: 414 NRLSNSIPKSLGN-LELIHLSELDLSRNFLR----EAIPSQICIMQSLEKLNLSHNSLS 467
               N + +       L  L  +D+S   L       +   +  ++ L+ +N+ +N LS
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.4 bits (114), Expect = 6e-06
 Identities = 26/179 (14%), Positives = 58/179 (32%), Gaps = 23/179 (12%)

Query: 278 PILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD--WGRCPKLS 335
           P+L  +  L  +++     T N+S      PNL  +++        +  D      P L 
Sbjct: 166 PVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLE 222

Query: 336 TLD--FSINNITGNVPPEI-------GHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLV 386
            L     + +   +    +            L  L +        +     + +   +L 
Sbjct: 223 KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282

Query: 387 ---LAHNQLSG----QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL--ELIHLSELD 436
              ++   L+      L   +  +  L+ +++  N LS+ + K L       I +S+  
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.9 bits (110), Expect = 2e-05
 Identities = 25/155 (16%), Positives = 49/155 (31%), Gaps = 18/155 (11%)

Query: 116 LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG--NLKSLSNLQLS 173
           L ++  L       + ++        NL +L I S  L  S++  I   +L +L  L L 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 174 ENNFNGSIPPSLGNLS---------NLATLYLDTNSLSYSIPSELGN---LRSLSNLSLG 221
               +      +             NL  L +        +         L  L  + + 
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287

Query: 222 YNKLSGS----IPISMGNLSNLTYLNLFENSLSGA 252
              L+      +   +  + +L ++N+  N LS  
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 2e-04
 Identities = 25/183 (13%), Positives = 59/183 (32%), Gaps = 22/183 (12%)

Query: 18  RNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFS--DLE 75
             L ++  L     K + ++        NL +L I +  L  S+  +I      +   L 
Sbjct: 166 PVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLV 225

Query: 76  L---SNNKLSGSIPPSL------GNLSNLATLYLDTNSLSNSIPSELGN---LRSLSNLQ 123
           L     +                    NL  L +      N +         L  L  + 
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285

Query: 124 LNNNILSGS----IPHSLGNLTNLATLYIYSNSLSASILGKI----GNLKSLSNLQLSEN 175
           ++  +L+      +   +  + +L  + +  N LS  +  ++         +S+ Q  ++
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDD 345

Query: 176 NFN 178
           +++
Sbjct: 346 DYS 348

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.0 bits (100), Expect = 3e-04
 Identities = 21/124 (16%), Positives = 46/124 (37%), Gaps = 12/124 (9%)

Query: 379 LNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL- 437
           L+    L     + +  LS        L+ L++ S  L +S+ + +   +L +L +L L 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 438 --SRNFLREAIPSQIC------IMQSLEKLNLSHNSLSGLIPSCF---EKMNGLLHIDIS 486
               ++  +   +            +L+ L +       ++   F   + +  L  +DIS
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287

Query: 487 YNEL 490
              L
Sbjct: 288 AGVL 291

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 38/187 (20%), Positives = 74/187 (39%), Gaps = 52/187 (27%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVK---------KFHSPLPGEMTF-----QQEFLNEVKAL 655
           IG+GG G +Y++ + S E +              + PL  E+ F     + E + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 656 TEIWHRNIVKVYGFCLHV----RHLFIVYE--------YFKMC----SLAVILSNDAAAK 699
            ++ +  + K +G  LH      + F++ +         ++      S   +L       
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL------- 155

Query: 700 NLGWTRRMNMI-KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKF 756
                     +   I+D L Y+H   +   VH DI + N+LL+++N   V   D+G+A  
Sbjct: 156 ---------QLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

Query: 757 LKPDSSN 763
             P+  +
Sbjct: 204 YCPEGVH 210

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 55.7 bits (135), Expect = 3e-08
 Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 41/228 (17%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSK--LASGEIIAVKKFHSPLPGE---MTFQQEFLNEVK 653
           RA   ++    IG+G  G V+ ++     G  +A+K+       E   ++     + EV 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVA 63

Query: 654 ALTEI---WHRNIVKVY-----GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
            L  +    H N+V+++             L +V+E+     L   L         G   
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVP- 118

Query: 706 RMNMIKG----IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPD 760
               IK     ++  L ++H+     +VHRD+  +N+L+    +  ++DFG+A+ +    
Sbjct: 119 -TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ- 173

Query: 761 SSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK 804
               T +  T  Y APE+    +Y   V    D++S G +  E+ + K
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 32/114 (28%), Positives = 45/114 (39%), Gaps = 8/114 (7%)

Query: 18  RNLKSLSDLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLEL 76
           R   ++ +L L N K + G I        NL  L +    L  S+   +        LEL
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLEL 78

Query: 77  SNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ---LNNN 127
           S N++ G +      L NL  L L  N L +   S L  L+ L  L+   L N 
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 31/105 (29%), Positives = 43/105 (40%), Gaps = 4/105 (3%)

Query: 73  DLELSNNKLS-GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG 131
           +L L N K + G I        NL  L L    L  S+ + L  L  L  L+L+ N + G
Sbjct: 28  ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFG 85

Query: 132 SIPHSLGNLTNLATLYIYSNSLSA-SILGKIGNLKSLSNLQLSEN 175
            +      L NL  L +  N L   S L  +  L+ L +L L   
Sbjct: 86  GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 32/111 (28%), Positives = 43/111 (38%), Gaps = 4/111 (3%)

Query: 163 NLKSLSNLQLSENNFN-GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLG 221
              ++  L L     N G I        NL  L L    L  S+ + L  L  L  L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 222 YNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY-RNLVKLTILLLGHN 271
            N++ G + +    L NLT+LNL  N L      E  + L  L  L L + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 27/115 (23%), Positives = 45/115 (39%), Gaps = 6/115 (5%)

Query: 91  NLSNLATLYLDTNSLSN-SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIY 149
             + +  L LD    ++  I        +L  L L N  L  S+  +L  L  L  L + 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79

Query: 150 SNSLSASILGKIGNLKSLSNLQLSENNFN--GSIPPSLGNLSNLATLYLDTNSLS 202
            N +   +      L +L++L LS N      ++ P L  L  L +L L    ++
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 31/107 (28%), Positives = 45/107 (42%), Gaps = 8/107 (7%)

Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE-LGKLNFFIKLVLAHNQLSG 394
            LD   +N  G +         L  L L +  ++    +  L KL    KL L+ N++ G
Sbjct: 30  VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLELSENRIFG 85

Query: 395 QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL-ELIHLSELDLSRN 440
            L      L  L HL+LS N+L +    +L  L +L  L  LDL   
Sbjct: 86  GLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 5/87 (5%)

Query: 405 QLEHLDLSSNRLSNSIPKSLGNLE-LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSH 463
            +  L L + +  ++  K  G     ++L  L L    L     S +  +  L+KL LS 
Sbjct: 25  AVRELVLDNCK--SNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80

Query: 464 NSLSGLIPSCFEKMNGLLHIDISYNEL 490
           N + G +    EK+  L H+++S N+L
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKL 107

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 13/99 (13%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I   L ++ +     I++RD+   NV+LD E    ++DFG+ K  +    +  T   GT 
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTP 506

Query: 772 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y+APE+     Y   V    D ++FGVL  E++ G+ P
Sbjct: 507 DYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 32/184 (17%), Positives = 64/184 (34%), Gaps = 52/184 (28%)

Query: 610 IGKGGQGSVYM---------SKLASGEIIAVK--KFHSPLPGEMTFQQ-----EFLNEVK 653
             +  QG +Y                +  ++K       L  E  F Q       +N+ K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 654 ALTEIWHRNIVKVYGFCLHV-RHLFIVYE--------YFKMC-----SLAVILSNDAAAK 699
            L       I    GF +H  ++ F+V             +      S   +L       
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL------- 162

Query: 700 NLGWTRRMNMI-KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKF 756
                     +   ++DAL ++H + +   VH +++++N+ +D E+++ V  + +G A  
Sbjct: 163 ---------QVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

Query: 757 LKPD 760
             P 
Sbjct: 211 YCPS 214

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 47/251 (18%), Positives = 87/251 (34%), Gaps = 64/251 (25%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           +  +     +G G  G V     + SG+  A+KK        +   +    E+  +  + 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLD 58

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN----------- 708
           H NI+K+     +                  +   +    N   +  +N           
Sbjct: 59  HVNIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 709 ---------MIKGIVDA-------------------LSYMHNDCFPPIVHRDISSKNVLL 740
                    ++K  + +                   + ++H+     I HRDI  +N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174

Query: 741 DFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG 794
           + ++    + DFG AK L P   +   +   + Y APEL      YT  +    D++S G
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIG 229

Query: 795 -VLALEVIKGK 804
            V   E+I GK
Sbjct: 230 CVFG-ELILGK 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 54.5 bits (132), Expect = 6e-08
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           IV AL Y+H+     +V+RDI  +N++LD +    ++DFG+ K  +   ++  T   GT 
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169

Query: 772 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y+APE+     Y   V    D +  GV+  E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 36/178 (20%), Positives = 70/178 (39%), Gaps = 37/178 (20%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVK------KFHSPLPGEMTF-----QQEFLNEVKALTE 657
           IG GG G +Y+       E  A        + + PL  E+ F     +++ + +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 658 IWHRNIVKVYGFCLHV----RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN----- 708
           + +  I   YG  L       + F+V E      L  I                      
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLG-IDLQKISG---------QNGTFKKSTVL 154

Query: 709 MI-KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE--AHVSDFGIAKFLKPDSSN 763
            +   ++D L Y+H + +   VH DI + N+LL ++N    +++D+G++    P+ ++
Sbjct: 155 QLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.6 bits (124), Expect = 7e-08
 Identities = 29/112 (25%), Positives = 45/112 (40%), Gaps = 4/112 (3%)

Query: 18  RNLKSLSDLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLEL 76
           R    + +L L N++ + G +         L  L      L+ SI   +        LEL
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLEL 71

Query: 77  SNNKLSGSIPPSLGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNLQLNNN 127
           S+N++SG +        NL  L L  N + + S    L  L +L +L L N 
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 28/111 (25%), Positives = 42/111 (37%), Gaps = 4/111 (3%)

Query: 91  NLSNLATLYLDTNSLSN-SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIY 149
             S++  L LD +  +   +         L  L   N  L+ SI + L  L  L  L + 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 150 SNSLSASILGKIGNLKSLSNLQLSENNFNG-SIPPSLGNLSNLATLYLDTN 199
            N +S  +        +L++L LS N     S    L  L NL +L L   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.9 bits (117), Expect = 5e-07
 Identities = 26/105 (24%), Positives = 45/105 (42%), Gaps = 4/105 (3%)

Query: 73  DLELSNNKLS-GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG 131
           +L L N++ + G +         L  L      L+ SI + L  L  L  L+L++N +SG
Sbjct: 21  ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSG 78

Query: 132 SIPHSLGNLTNLATLYIYSNSLSA-SILGKIGNLKSLSNLQLSEN 175
            +        NL  L +  N +   S +  +  L++L +L L   
Sbjct: 79  GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 4/111 (3%)

Query: 115 NLRSLSNLQLNNN-ILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLS 173
               +  L L+N+    G +         L  L   +  L+   +  +  L  L  L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72

Query: 174 ENNFNGSIPPSLGNLSNLATLYLDTNSL-SYSIPSELGNLRSLSNLSLGYN 223
           +N  +G +        NL  L L  N +   S    L  L +L +L L   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 9e-06
 Identities = 29/111 (26%), Positives = 42/111 (37%), Gaps = 4/111 (3%)

Query: 163 NLKSLSNLQLSENNFN-GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLG 221
               +  L L  +  N G +         L  L      L+ SI + L  L  L  L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 222 YNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY-RNLVKLTILLLGHN 271
            N++SG + +      NLT+LNL  N +      E  + L  L  L L + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 22/88 (25%), Positives = 41/88 (46%), Gaps = 5/88 (5%)

Query: 405 QLEHLDLSSNRLSNSIPKSLGNLE-LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSH 463
            ++ L L ++R  ++  K  G  +    L  L      L     + +  +  L+KL LS 
Sbjct: 18  DVKELVLDNSR--SNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73

Query: 464 NSLSGLIPSCFEKMNGLLHIDISYNELR 491
           N +SG +    EK   L H+++S N+++
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 26/85 (30%), Positives = 40/85 (47%), Gaps = 5/85 (5%)

Query: 357 QLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRL 416
           +L  L   +  +   I   L KLN   KL L+ N++SG L         L HL+LS N++
Sbjct: 43  ELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

Query: 417 SNSIPKSLGNL-ELIHLSELDLSRN 440
            +    ++  L +L +L  LDL   
Sbjct: 101 KD--LSTIEPLKKLENLKSLDLFNC 123

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 17/101 (16%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAK-FLKPDSSNWTELAG 769
           I  AL Y+H+     IV+RD+  +N+LLD  ++ H+  +DFG+ K  ++ +S+  T   G
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLD--SQGHIVLTDFGLCKENIEHNSTTST-FCG 201

Query: 770 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+     Y   V    D +  G +  E++ G  P
Sbjct: 202 TPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 53.3 bits (129), Expect = 1e-07
 Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 9/97 (9%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAK-FLKPDSSNWTELAG 769
           +  AL ++H+     I++RD+  +N+LLD   E H+  +DFG++K  +  +   ++   G
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYS-FCG 188

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I  AL+Y+H      I++RD+   NVLLD E    ++D+G+ K  L+P  +  T   GT 
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 174

Query: 772 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y+APE+     Y   V    D ++ GVL  E++ G+ P
Sbjct: 175 NYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 53.4 bits (129), Expect = 2e-07
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 17/101 (16%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAK-FLKPDSSNWTELAG 769
           I+  L ++H+     IV+RD+   N+LLD   + H+  +DFG+ K  +  D+   T   G
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNT-FCG 180

Query: 770 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+     Y   V    D +SFGVL  E++ G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 23/113 (20%), Positives = 40/113 (35%), Gaps = 4/113 (3%)

Query: 40  SLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY 99
              N      L +    +   I         F  ++ S+N++   +      L  L TL 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70

Query: 100 LDTNSLSNSIPSELGNLRSLSNLQL-NNNILSGSIPHSLGNLTNLATLYIYSN 151
           ++ N +          L  L+ L L NN+++       L +L +L  L I  N
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 8/116 (6%)

Query: 15  SELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDL 74
           ++  N     +L+L   K+   I +    L     +    N +   + G     R    L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69

Query: 75  ELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ---LNNN 127
            ++NN++          L +L  L L  NSL      +L  L SL +L    +  N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 24/133 (18%), Positives = 50/133 (37%), Gaps = 10/133 (7%)

Query: 360 VLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNS 419
           ++ L++  I  +   +        +L L   ++   +     +L Q + +D S N +   
Sbjct: 1   MVKLTAELI-EQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--- 54

Query: 420 IPKSLGNLE-LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGL-IPSCFEKM 477
             + L     L  L  L ++ N +          +  L +L L++NSL  L        +
Sbjct: 55  --RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112

Query: 478 NGLLHIDISYNEL 490
             L ++ I  N +
Sbjct: 113 KSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 23/113 (20%), Positives = 36/113 (31%), Gaps = 4/113 (3%)

Query: 136 SLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLY 195
              N      L +    +   I      L     +  S+N     +      L  L TL 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70

Query: 196 LDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG-SIPISMGNLSNLTYLNLFEN 247
           ++ N +          L  L+ L L  N L        + +L +LTYL +  N
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 17/97 (17%), Positives = 41/97 (42%), Gaps = 9/97 (9%)

Query: 397 SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL--ELIHLSELDLSRNFLREAIPSQICIMQ 454
           + +  + V+   LDL   ++       + NL   L     +D S N +R+       +++
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLR 64

Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
            L+ L +++N +  +     + +  L  + ++ N L 
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 23/120 (19%), Positives = 37/120 (30%), Gaps = 14/120 (11%)

Query: 277 IPILRNLTSLERVRLDRNYLT--GNISESFYIYPNLTYIDLSQNNFYGEISS--DWGRCP 332
                N      + L    +    N+  +         ID S N    EI     +    
Sbjct: 12  AAQYTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDN----EIRKLDGFPLLR 64

Query: 333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHI--VGEIPIELGKLNFFIKLVLAHN 390
           +L TL  + N I             L  L L++N +  +G++   L  L     L +  N
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 24/122 (19%), Positives = 40/122 (32%), Gaps = 5/122 (4%)

Query: 153 LSASILGKIGNLKSLSNLQ-LS-ENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELG 210
           L+A ++ +     +    + L         I      L     +    N +   +     
Sbjct: 4   LTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFP 61

Query: 211 NLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY-RNLVKLTILLLG 269
            LR L  L +  N++          L +LT L L  NSL      +   +L  LT L + 
Sbjct: 62  LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 121

Query: 270 HN 271
            N
Sbjct: 122 RN 123

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.0 bits (128), Expect = 2e-07
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I+ AL ++H+     I++RD+   NVLLD E    ++DFG+ K  +    +  T   GT 
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTP 188

Query: 772 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y+APE+     Y   V    D ++ GVL  E++ G  P
Sbjct: 189 DYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK-FLKPDSSNWTELAGTY 771
           I  AL+Y+H      I++RD+   NVLLD E    ++D+G+ K  L+P  +  T   GT 
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 217

Query: 772 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
            Y+APE+     Y   V    D ++ GVL  E++ G+ P
Sbjct: 218 NYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 48/245 (19%), Positives = 93/245 (37%), Gaps = 63/245 (25%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           +  +H IG+G  G VY++    + + +A+KK +     ++   +  L E+  L  +    
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDY 86

Query: 663 IVKVYGFCL-----HVRHLFIVYEYFKM-CSL-AVILSN----DAAAKNLGWTRRMNMIK 711
           I+++Y   +         L+IV E       L  +  +     +   K + +    N++ 
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEI--ADSDLKKLFKTPIFLTEEHIKTILY----NLLL 140

Query: 712 GIVDALSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
           G     +++H        I+HRD+   N LL+ +    V DFG+A+ +  +         
Sbjct: 141 G----ENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 770 TY----------------GYV------APEL-----AYTMKVTEKCDVYSFG-VLALEVI 801
                              +V      APEL      YT  +    D++S G + A E++
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFA-ELL 246

Query: 802 KGKHP 806
                
Sbjct: 247 NMLQS 251

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 26/126 (20%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTE-LAG 769
           IV AL ++H      I++RDI  +N+LLD  +  HV  +DFG++K    D +       G
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADETERAYDFCG 222

Query: 770 TYGYVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA 823
           T  Y+AP++       +   V    D +S GVL  E++ G  P        F+      +
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP--------FTVDGEKNS 270

Query: 824 LDEMLD 829
             E+  
Sbjct: 271 QAEISR 276

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 31/83 (37%), Positives = 50/83 (60%), Gaps = 10/83 (12%)

Query: 74  LELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSELG---NLRSLSNLQLNNNIL 129
           L L+NN+++  + P +  +L NL  LY ++N L+ +IP+  G    L  L+ L LN+N L
Sbjct: 38  LWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFDKLTQLTQLDLNDNHL 93

Query: 130 SGSIPH-SLGNLTNLATLYIYSN 151
             SIP  +  NL +L  +Y+Y+N
Sbjct: 94  K-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 5/104 (4%)

Query: 97  TLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSAS 156
            +      L+ S+P+  G       L LNNN ++   P    +L NL  LY  SN L+A 
Sbjct: 16  LVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAI 72

Query: 157 ILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTN 199
             G    L  L+ L L++N+   SIP  +  NL +L  +YL  N
Sbjct: 73  PTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 14/89 (15%)

Query: 166 SLSNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSELG---NLRSLSNLSLG 221
               L L+ N     + P +  +L NL  LY ++N L+ +IP+  G    L  L+ L L 
Sbjct: 34  DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFDKLTQLTQLDLN 89

Query: 222 YNKLSGSIPISMG---NLSNLTYLNLFEN 247
            N L  SIP   G   NL +LT++ L+ N
Sbjct: 90  DNHLK-SIP--RGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 34/119 (28%), Positives = 52/119 (43%), Gaps = 38/119 (31%)

Query: 13  IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFS 72
           IP++ + L       L NN+++   P    +L NL  LY                     
Sbjct: 31  IPTDKQRL------WLNNNQITKLEPGVFDHLVNLQQLY--------------------- 63

Query: 73  DLELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSELG---NLRSLSNLQLNNN 127
               ++NKL+ +IP  +   L+ L  L L+ N L  SIP   G   NL+SL+++ L NN
Sbjct: 64  ---FNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPR--GAFDNLKSLTHIYLYNN 115

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 52.2 bits (126), Expect = 4e-07
 Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 17/101 (16%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAK-FLKPDSSNWTELAG 769
           I   L ++ +     I++RD+   NV+LD  +E H+  +DFG+ K  +    +  T   G
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKT-FCG 183

Query: 770 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+     Y   V    D ++FGVL  E++ G+ P
Sbjct: 184 TPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 51.8 bits (125), Expect = 4e-07
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 9/97 (9%)

Query: 713 IVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAK-FLKPDSSNWTELAG 769
           I  AL ++H      I++RD+  +N++L+  ++ HV  +DFG+ K  +   +   T   G
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHT-FCG 183

Query: 770 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 806
           T  Y+APE+          D +S G L  +++ G  P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 61/240 (25%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHR 661
           ++    +GKG  G V+ S    +GE++AVKK         T  Q    E+  LTE+  H 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHE 69

Query: 662 NIVKVYGFCLHV------RHLFIVYEYFKM-CSL-AVILSNDAAAKNLGWTRRMNMIKGI 713
           NIV +    L+V      R +++V++Y  M   L AVI +N      L    +  ++  +
Sbjct: 70  NIVNL----LNVLRADNDRDVYLVFDY--METDLHAVIRANI-----LEPVHKQYVVYQL 118

Query: 714 VDALSYMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY 771
           +  + Y+H        ++HRD+   N+LL+ E    V+DFG+++           +  + 
Sbjct: 119 IKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 772 ---------------GYV------APEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 804
                           YV      APE+      YT  +    D++S G +L  E++ GK
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG-EILCGK 228

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.2 bits (118), Expect = 6e-07
 Identities = 26/81 (32%), Positives = 45/81 (55%), Gaps = 6/81 (7%)

Query: 74  LELSNNKLSGSIPPSL-GNLSNLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSG 131
           L L +N+++  + P +   L+ L  L LD N L+  +P+ +   L  L+ L LN+N L  
Sbjct: 35  LYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK- 91

Query: 132 SIPH-SLGNLTNLATLYIYSN 151
           SIP  +  NL +L  +++ +N
Sbjct: 92  SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 5/104 (4%)

Query: 97  TLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSAS 156
           T+     SL+ S+P+  G   +   L L +N ++   P     LT L  L + +N L+  
Sbjct: 13  TVDCSGKSLA-SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL 69

Query: 157 ILGKIGNLKSLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTN 199
             G    L  L+ L L++N    SIP  +  NL +L  ++L  N
Sbjct: 70  PAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 10/87 (11%)

Query: 166 SLSNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYN 223
           +   L L +N     + P +   L+ L  L LD N L+  +P+ +   L  L+ LSL  N
Sbjct: 31  TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88

Query: 224 KLSGSIPISMG---NLSNLTYLNLFEN 247
           +L  SIP   G   NL +LT++ L  N
Sbjct: 89  QLK-SIP--RGAFDNLKSLTHIWLLNN 112

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 51.7 bits (124), Expect = 7e-07
 Identities = 52/278 (18%), Positives = 96/278 (34%), Gaps = 76/278 (27%)

Query: 563 QRRKNDSQTQQSSPGNSRGLLSVLTFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSK 622
           Q+     +   SS   +        ++            + ++  H IG G  G V  + 
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQ----------IPDRYEIRHLIGTGSYGHVCEAY 73

Query: 623 -LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVY-----GFCLHVRHL 676
                 ++A+KK       ++   +  L E+  L  + H ++VKV              L
Sbjct: 74  DKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132

Query: 677 FIVYEYFKM-CSL-AVILSN----DAAAKNLGWTRRMNMIKGIVDALSYMH--NDCFPPI 728
           ++V E          +  +     +   K L +    N++ G    + Y+H        I
Sbjct: 133 YVVLEI--ADSDFKKLFRTPVYLTELHIKTLLY----NLLVG----VKYVHSAG-----I 177

Query: 729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTY----------------- 771
           +HRD+   N L++ +    V DFG+A+ +    +  ++L  +                  
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237

Query: 772 ----GYV------APEL-----AYTMKVTEKCDVYSFG 794
               G+V      APEL      YT  +    DV+S G
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIG 271

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 29/208 (13%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR------N 662
           IGKG  G V  +      + +A+K   +    E  F ++   E++ L  +  +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           ++ +        H+ + +E   M    +I  N     +L   R+      I+  L  +H 
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHK 218

Query: 723 DCFPPIVHRDISSKNVLLDFENEAH--VSDFGIAKFLKPDSSNWTELAGTY----GYVAP 776
                I+H D+  +N+LL  +  +   V DFG + +         +   TY     Y AP
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-------HQRVYTYIQSRFYRAP 268

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGK 804
           E+    +     D++S G +  E++ G 
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 39/214 (18%)

Query: 610 IGKGGQGSVYM-SKLASGEIIAVK------KFHSPLPGEMTFQQEFLNEVKALTEIWHR- 661
           IGKG  G V         E +A+K       F           Q    EV+ L  +    
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---------NQA-QIEVRLLELMNKHD 111

Query: 662 -----NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
                 IV +    +   HL +V+E        ++ + +    +L  TR+    + +  A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTA 169

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAH--VSDFGIAKFLKPDSSNWTELAGTY--- 771
           L ++       I+H D+  +N+LL     +   + DFG +  L        +    Y   
Sbjct: 170 LLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-------GQRIYQYIQS 221

Query: 772 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
             Y +PE+   M      D++S G + +E+  G+
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 35/173 (20%), Positives = 63/173 (36%), Gaps = 52/173 (30%)

Query: 607 EHCIGKGGQGSVYMSK-LASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIWH 660
              IG G  G + + K L + E +A+K          L  E  F ++  +          
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD-------- 65

Query: 661 RNIVKVYGFCLHVRHLFIV--------YEYFKMC----SLAVILSNDAAAKNLGWTRRMN 708
             I +VY F    ++  +V         + F +C    SL  +L                
Sbjct: 66  -GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVL---------------- 108

Query: 709 MI-KGIVDALSYMHNDCFPPIVHRDISSKNVLL-----DFENEAHVSDFGIAK 755
           MI   ++  + Y+H+      ++RD+  +N L+       +   H+ DF +AK
Sbjct: 109 MIAIQLISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 31/182 (17%), Positives = 59/182 (32%), Gaps = 56/182 (30%)

Query: 674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDI 733
            H+ +V+E      L  I+ ++     L   +++  I+ ++  L Y+H  C   I+H DI
Sbjct: 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI--IQQVLQGLDYLHTKC--RIIHTDI 173

Query: 734 SSKNVLLDFEN------------------------------------------------- 744
             +N+LL                                                     
Sbjct: 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233

Query: 745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 804
           +  ++D G A ++       TE   T  Y + E+          D++S   +A E+  G 
Sbjct: 234 KVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

Query: 805 HP 806
           + 
Sbjct: 291 YL 292

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 44.9 bits (105), Expect = 6e-05
 Identities = 32/254 (12%), Positives = 64/254 (25%), Gaps = 54/254 (21%)

Query: 598 IRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFH-----SPLPGEMTFQQEFLNEV 652
              T        IG+G  G V+ +  A    +A+K                  +E L E+
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 653 KALTEIW---------HRNIVKVYGFCL----HVRHLFIVYEYF--KMCSLAVILS---- 693
               E+              + +         +   L   ++++     S          
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 694 ----------------NDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKN 737
                                K        +++  +  +L+           HRD+   N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192

Query: 738 VLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK--CDVYSFGV 795
           VLL   +   +      K              + G     + YT+   E+    V+    
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDVS 243

Query: 796 LALEVIKGKHPRDF 809
           +  ++  G     F
Sbjct: 244 MDEDLFTGDGDYQF 257

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 32/170 (18%), Positives = 53/170 (31%), Gaps = 52/170 (30%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKK-----FHSPLPGEMTFQQEFLNEVKALTEIWHRNI 663
           IG+G  G ++    L + + +A+K          L  E    +                I
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---------GI 68

Query: 664 VKVYGFCLHVRHLFIV--------YEYFKMC----SLAVILSNDAAAKNLGWTRRMNMI- 710
             VY F     H  +V         +   +C    S+  +                 M  
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVA----------------MAA 112

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-----ENEAHVSDFGIAK 755
           K ++  +  +H       V+RDI   N L+        N  +V DFG+ K
Sbjct: 113 KQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 34/164 (20%), Positives = 60/164 (36%), Gaps = 42/164 (25%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH-RNIVKVY 667
           IG G  G +Y+   +A+GE +A+K        +    Q    E K    +     I  + 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQ-LHIESKIYKMMQGGVGIPTIR 71

Query: 668 GFCLHVRHLFIV--------YEYFKMC----SLAVILSNDAAAKNLGWTRRMNMI-KGIV 714
                  +  +V         + F  C    SL  +L                ++   ++
Sbjct: 72  WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVL----------------LLADQMI 115

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAK 755
             + Y+H+  F   +HRD+   N L+      N  ++ DFG+AK
Sbjct: 116 SRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 60/415 (14%), Positives = 113/415 (27%), Gaps = 95/415 (22%)

Query: 151 NSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELG 210
            ++ A +   I NL +L N Q  +          L     L  L+      +    +E+ 
Sbjct: 12  RAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV- 70

Query: 211 NLRSLSNLSLGYNKLS--GSIPISMG---NLSNLTYLNLFENSLSGA-IPYEYRNLVKLT 264
            L SL  L+L   +++      ++         L  +NL    L  A +       ++  
Sbjct: 71  -LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129

Query: 265 ILLLGHNQF--RGPIPI----LRNLTSLERVRLDRNYLTGN----ISESFYIYPNLTYID 314
            L L  N         +    L +   +  +RL  N LT      + E      ++T++ 
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLS 189

Query: 315 LSQNNFYGE----ISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVG 370
           L       E    +++   R  +L  L+ + N                  L L+      
Sbjct: 190 LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG-----------DTAALALAR----- 233

Query: 371 EIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG----- 425
                              +               LE L L  N LS+   + L      
Sbjct: 234 ---------------AAREHP-------------SLELLHLYFNELSSEGRQVLRDLGGA 265

Query: 426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDI 485
                 +         + E           L ++  + NS         ++   LL  D+
Sbjct: 266 AEGGARVVVSLTEGTAVSEY------WSVILSEVQRNLNSWDRAR---VQRHLELLLRDL 316

Query: 486 SYNELRGSIPNSTTFKDAPIEALQGNKGLY---------GDVKGLLSCKALKSNK 531
             +           ++ A  + L+    +          G   G  S    +   
Sbjct: 317 EDS----RGATLNPWRKA--QLLRVEGEVRALLEQLGSSGSPSGSWSHPQFEKGA 365

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	873
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.98
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.75
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.74
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.71
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.62
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.59
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.59
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.43
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.43
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.42
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.4
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.38
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.35
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.33
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.22
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.03
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.01
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.96
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.96
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.81
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.51
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.49
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.49
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.35
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.24
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.21
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.02
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.01
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.95
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.87
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.72
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.66
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.64
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.51
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.38
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.1
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.98
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.96
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.91
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.89
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.83
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.71
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.19
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.17
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.02
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.58
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.49
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.33
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.7
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	86.82
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.53
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.79
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	83.68

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.5e-67  Score=632.63  Aligned_cols=518  Identities=31%  Similarity=0.433  Sum_probs=385.7

Q ss_pred             ccCCcccccCCccc-cCCCCCCEEECCCCcccccCCcc---ccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccC
Q 039344            4 IYNNSLYDSIPSEL-RNLKSLSDLELGNNKLSGSIPHS---LGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNN   79 (873)
Q Consensus         4 ~~~n~~~~~~p~~~-~~l~~l~~L~L~~n~l~~~~p~~---~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n   79 (873)
                      +++|.+.+.+|..+ .++++|++|+|++|++++..|..   +.++++|++|++++|++++..|.  ..+++|++|+|++|
T Consensus       133 Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n  210 (768)
T 3rgz_A          133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSN  210 (768)
T ss_dssp             CCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSS
T ss_pred             CcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCC
Confidence            35677777777665 67777777777777777666655   55666666666666666544332  45555555555555


Q ss_pred             CCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccccccccc----------------------ccCccc
Q 039344           80 KLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG----------------------SIPHSL  137 (873)
Q Consensus        80 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~----------------------~~~~~~  137 (873)
                      .+++.+|. |.++++|++|+|++|++++.+|..|.++++|++|++++|.+++                      .+|..+
T Consensus       211 ~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~  289 (768)
T 3rgz_A          211 NFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFL  289 (768)
T ss_dssp             CCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCS
T ss_pred             cCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHH
Confidence            55544444 5555555555555555555555555555555555555555544                      444444


Q ss_pred             cCC-CCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCcc-ccCCCCCcEEeccCCCCcccCCccccCCC-C
Q 039344          138 GNL-TNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS-LGNLSNLATLYLDTNSLSYSIPSELGNLR-S  214 (873)
Q Consensus       138 ~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~  214 (873)
                      ..+ ++|++|+|++|++++..+..|+.+++|++|+|++|++++.+|.. +..+++|++|++++|.+++..|..+..++ +
T Consensus       290 ~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~  369 (768)
T 3rgz_A          290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS  369 (768)
T ss_dssp             CTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTT
T ss_pred             HhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcC
Confidence            332 55555555555554444455555555555555555554444433 55555555555555555544555555444 5


Q ss_pred             CCEEEccCcccCCCcccccCC--CCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc-CCcCCCCCCCCeEEc
Q 039344          215 LSNLSLGYNKLSGSIPISMGN--LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP-IPILRNLTSLERVRL  291 (873)
Q Consensus       215 L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~l~~l~~L~~L~L  291 (873)
                      |++|++++|++++..|..+..  +++|++|++++|.+++..|..+..+++|+.|++++|++.+. +..+..+++|+.|++
T Consensus       370 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  449 (768)
T 3rgz_A          370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL  449 (768)
T ss_dssp             CSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred             CcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEEC
Confidence            555555555555444444444  56777788888887777888888888899999999988864 446888889999999


Q ss_pred             cCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCC
Q 039344          292 DRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGE  371 (873)
Q Consensus       292 ~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~  371 (873)
                      ++|.+++..+..+..+++|++|++++|++++.+|..+..+++|+.|++++|++++.+|..++.+++|++|+|++|++++.
T Consensus       450 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  529 (768)
T 3rgz_A          450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN  529 (768)
T ss_dssp             CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEE
T ss_pred             CCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCc
Confidence            99998888888888889999999999999888888899999999999999999988999999999999999999999888


Q ss_pred             CCccccccccccEEEecCccccCCccccc---------------------------------------------------
Q 039344          372 IPIELGKLNFFIKLVLAHNQLSGQLSPKL---------------------------------------------------  400 (873)
Q Consensus       372 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---------------------------------------------------  400 (873)
                      +|..+..+++|+.|++++|++++.+|..+                                                   
T Consensus       530 ~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  609 (768)
T 3rgz_A          530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST  609 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGG
T ss_pred             CCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccc
Confidence            99999999999999999998887666543                                                   


Q ss_pred             -------------------ccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecc
Q 039344          401 -------------------GSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNL  461 (873)
Q Consensus       401 -------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  461 (873)
                                         ..+.+|+.||||+|+++|.+|.+++++.  +|+.|||++|++++.+|..++.+++|+.|||
T Consensus       610 ~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~--~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdL  687 (768)
T 3rgz_A          610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP--YLFILNLGHNDISGSIPDEVGDLRGLNILDL  687 (768)
T ss_dssp             TCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT--TCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred             ccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc--cCCEEeCcCCccCCCCChHHhCCCCCCEEEC
Confidence                               3356789999999999999999999887  9999999999999999999999999999999


Q ss_pred             cCccccCCCchhhhccCCCcEEecCCCcccccCCCCCcccCCCcccccCCCCcccCccCcccccccc
Q 039344          462 SHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALK  528 (873)
Q Consensus       462 ~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l~g~~~~~~~c~~~~  528 (873)
                      ++|+++|.+|..|..+++|++|||++|+++|.||.+++|..++..+|.||+++||.+..  +|....
T Consensus       688 s~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~--~C~~~~  752 (768)
T 3rgz_A          688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP--RCDPSN  752 (768)
T ss_dssp             CSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC--CCCSCC
T ss_pred             CCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc--CCCCCc
Confidence            99999999999999999999999999999999999999999999999999999998743  786544

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=7.2e-62  Score=587.21  Aligned_cols=510  Identities=32%  Similarity=0.450  Sum_probs=417.5

Q ss_pred             ccCCcccccCCc--cccCCCCCCEEECCCCcccccCCccc-cCCCCCceEEccCCcccccCCCC---ccCCCCCCEEEcc
Q 039344            4 IYNNSLYDSIPS--ELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPGE---IGNFRFFSDLELS   77 (873)
Q Consensus         4 ~~~n~~~~~~p~--~~~~l~~l~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~---~~~l~~L~~L~L~   77 (873)
                      +++|.+++.+|.  .++++++|++|+|++|.+++..|..+ .++++|++|+|++|++++..|..   +.++++|++|+++
T Consensus       107 Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls  186 (768)
T 3rgz_A          107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS  186 (768)
T ss_dssp             CCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECC
T ss_pred             CCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECC
Confidence            578999999999  99999999999999999998888776 89999999999999999888877   8899999999999


Q ss_pred             cCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCcccc
Q 039344           78 NNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASI  157 (873)
Q Consensus        78 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  157 (873)
                      +|.+++..+  +..+++|++|+|++|++++.+|. +.++++|++|++++|.+++..|..|+.+++|++|++++|++.+..
T Consensus       187 ~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~  263 (768)
T 3rgz_A          187 GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI  263 (768)
T ss_dssp             SSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESC
T ss_pred             CCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCcc
Confidence            999997655  48899999999999999987777 999999999999999999999999999999999999999997655


Q ss_pred             ccccCCCCCCCEEEccCCcCccCCCccccCC-CCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccc-cCC
Q 039344          158 LGKIGNLKSLSNLQLSENNFNGSIPPSLGNL-SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPIS-MGN  235 (873)
Q Consensus       158 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~  235 (873)
                      +..  .+++|++|+|++|++++.+|..+... ++|++|++++|.+++..|..|+.+++|++|++++|++.+.+|.. +..
T Consensus       264 ~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~  341 (768)
T 3rgz_A          264 PPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK  341 (768)
T ss_dssp             CCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTT
T ss_pred             Ccc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhc
Confidence            443  67778888888888777777776654 77777777777777777777777777777777777776555543 677


Q ss_pred             CCCccEEecccccCCCCCchhhcCCC-C--------------------------CcEEEccCCcCcC-cCCcCCCCCCCC
Q 039344          236 LSNLTYLNLFENSLSGAIPYEYRNLV-K--------------------------LTILLLGHNQFRG-PIPILRNLTSLE  287 (873)
Q Consensus       236 l~~L~~L~L~~n~l~~~~~~~~~~l~-~--------------------------L~~L~L~~N~l~~-~~~~l~~l~~L~  287 (873)
                      +++|++|++++|++++..|..+..++ +                          |++|++++|++.+ .+..+..+++|+
T Consensus       342 l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~  421 (768)
T 3rgz_A          342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV  421 (768)
T ss_dssp             CTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCC
T ss_pred             CCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCC
Confidence            77777777777777666666555544 4                          5555555555544 233566777788


Q ss_pred             eEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCc
Q 039344          288 RVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH  367 (873)
Q Consensus       288 ~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~  367 (873)
                      +|++++|.+++..+..+..+++|++|++++|.+.+.+|..+..+++|+.|++++|++++.+|..++.+++|++|+|++|+
T Consensus       422 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  501 (768)
T 3rgz_A          422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR  501 (768)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             EEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCc
Confidence            88888888777777777788888888888888887888888888888888888888888888888888888888888888


Q ss_pred             cCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchh-------------------
Q 039344          368 IVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE-------------------  428 (873)
Q Consensus       368 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-------------------  428 (873)
                      +++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|||++|+++|.+|..+....                   
T Consensus       502 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (768)
T 3rgz_A          502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND  581 (768)
T ss_dssp             CCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECC
T ss_pred             cCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccc
Confidence            8888888888888899999999988888888888899999999999998888776543210                   


Q ss_pred             -------------------------------------------------hhhhhcccccCCccCcccchhhhhhccccee
Q 039344          429 -------------------------------------------------LIHLSELDLSRNFLREAIPSQICIMQSLEKL  459 (873)
Q Consensus       429 -------------------------------------------------~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  459 (873)
                                                                       +.+|+.|||++|++++.+|..++.+++|+.|
T Consensus       582 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L  661 (768)
T 3rgz_A          582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL  661 (768)
T ss_dssp             SCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEE
T ss_pred             cccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEE
Confidence                                                             1367889999999999999999999999999


Q ss_pred             cccCccccCCCchhhhccCCCcEEecCCCcccccCCCC-CcccCCCcccccCCCCcccCcc
Q 039344          460 NLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS-TTFKDAPIEALQGNKGLYGDVK  519 (873)
Q Consensus       460 ~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~l~g~~~  519 (873)
                      +|++|+++|.+|..|..+++|+.||||+|+++|.+|.. ..++......+.+|. +.|.+|
T Consensus       662 ~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~-l~g~iP  721 (768)
T 3rgz_A          662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN-LSGPIP  721 (768)
T ss_dssp             ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE-EEEECC
T ss_pred             eCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc-ccccCC
Confidence            99999999999999999999999999999999999975 234445555566653 444443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.4e-57  Score=537.96  Aligned_cols=478  Identities=22%  Similarity=0.224  Sum_probs=420.7

Q ss_pred             cCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccc
Q 039344           12 SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGN   91 (873)
Q Consensus        12 ~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   91 (873)
                      .+|..+.  +.+++|+|++|+|+++.|.+|.++++|++|+|++|+++++.|++|+++++|++|+|++|++++..|.+|.+
T Consensus        26 ~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  103 (606)
T 3t6q_A           26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG  103 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSS
T ss_pred             cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcc
Confidence            5677676  37899999999999888889999999999999999998888889999999999999999998888889999


Q ss_pred             ccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCC--E
Q 039344           92 LSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLS--N  169 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~  169 (873)
                      +++|++|++++|++++..+..|.++++|++|++++|.+++.....+..+++|++|++++|.++.+.+..|+.+++|+  .
T Consensus       104 l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~  183 (606)
T 3t6q_A          104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS  183 (606)
T ss_dssp             CTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEE
T ss_pred             cccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeE
Confidence            99999999999999876678888999999999999998864444555689999999999999888888888888888  8


Q ss_pred             EEccCCcCccCCCccccCC---------------------------------------------------CCCcEEeccC
Q 039344          170 LQLSENNFNGSIPPSLGNL---------------------------------------------------SNLATLYLDT  198 (873)
Q Consensus       170 L~L~~n~i~~~~~~~~~~l---------------------------------------------------~~L~~L~L~~  198 (873)
                      |++++|.+++..|..+...                                                   .+|+.|++++
T Consensus       184 L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~  263 (606)
T 3t6q_A          184 LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK  263 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTT
T ss_pred             EecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeec
Confidence            8999999887766655431                                                   1678899999


Q ss_pred             CCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcC-
Q 039344          199 NSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPI-  277 (873)
Q Consensus       199 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-  277 (873)
                      |.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..+..+++|++|++++|.+.+.. 
T Consensus       264 n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~  342 (606)
T 3t6q_A          264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG  342 (606)
T ss_dssp             CCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCC
T ss_pred             CccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccc
Confidence            9999888888999999999999999998 67788999999999999999999888889999999999999999988633 


Q ss_pred             -CcCCCCCCCCeEEccCccccccc--ccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCcc-cc
Q 039344          278 -PILRNLTSLERVRLDRNYLTGNI--SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPE-IG  353 (873)
Q Consensus       278 -~~l~~l~~L~~L~L~~n~l~~~~--~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~-~~  353 (873)
                       ..+..+++|++|++++|.+++..  +..+..+++|++|++++|.+.+..+..|..+++|+.|++++|++++..+.. ++
T Consensus       343 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  422 (606)
T 3t6q_A          343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ  422 (606)
T ss_dssp             SSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTT
T ss_pred             hhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhh
Confidence             35889999999999999999876  677889999999999999999888999999999999999999998766544 88


Q ss_pred             CCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCC---cccccccccccccccccccccccccCCCcCchhhh
Q 039344          354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQ---LSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELI  430 (873)
Q Consensus       354 ~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~  430 (873)
                      .+++|++|++++|.+++..|..+..+++|++|++++|++++.   .+..+..+++|+.|+|++|++++..|..|+.+.  
T Consensus       423 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~--  500 (606)
T 3t6q_A          423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK--  500 (606)
T ss_dssp             TCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCT--
T ss_pred             CcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhcccc--
Confidence            999999999999999988899999999999999999999863   235688899999999999999988899998876  


Q ss_pred             hhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCC
Q 039344          431 HLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIP  495 (873)
Q Consensus       431 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p  495 (873)
                      +|++|+|++|++++..|..+..+++| .|+|++|++++.+|..|..+++|+.|++++|++.+..+
T Consensus       501 ~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             TCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             CCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            99999999999999999999999999 99999999999999999999999999999999987655

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=4.5e-57  Score=540.83  Aligned_cols=511  Identities=22%  Similarity=0.228  Sum_probs=375.3

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +++|++++..|..|.++++|++|+|++|.+++..|++|.++++|++|+|++|++++..+.+|+++++|++|+|++|++++
T Consensus        32 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~  111 (680)
T 1ziw_A           32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK  111 (680)
T ss_dssp             CCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred             CCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc
Confidence            56788888888888888888888888888888888888888888888888888886555678888888888888888887


Q ss_pred             CCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCcccc--CCCCCcEEEccCCCCcccccccc
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLG--NLTNLATLYIYSNSLSASILGKI  161 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~  161 (873)
                      ..|.+|.++++|++|+|++|.+++..|..+.++++|++|++++|.+++..+..+.  .+++|++|++++|+++++.+..|
T Consensus       112 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~  191 (680)
T 1ziw_A          112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF  191 (680)
T ss_dssp             CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGG
T ss_pred             cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhh
Confidence            7777888888888888888888877777888888888888888888766665544  45778888888887776665554


Q ss_pred             CCC---------------------------CCCCEEEccCCcCccCCCccccCCCC--CcEEeccCCCCcccCCccccCC
Q 039344          162 GNL---------------------------KSLSNLQLSENNFNGSIPPSLGNLSN--LATLYLDTNSLSYSIPSELGNL  212 (873)
Q Consensus       162 ~~l---------------------------~~L~~L~L~~n~i~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~~~~l  212 (873)
                      ..+                           ++|++|++++|.+++..|.+|.+++.  |++|++++|.+++..+..|+.+
T Consensus       192 ~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l  271 (680)
T 1ziw_A          192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL  271 (680)
T ss_dssp             GGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTC
T ss_pred             hhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCc
Confidence            432                           34455555555555555555555433  6666666666665555556666


Q ss_pred             CCCCEEEccCcccCCCccccc---------------------------------CCCCCccEEecccccCCCCCchhhcC
Q 039344          213 RSLSNLSLGYNKLSGSIPISM---------------------------------GNLSNLTYLNLFENSLSGAIPYEYRN  259 (873)
Q Consensus       213 ~~L~~L~L~~N~l~~~~~~~~---------------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~  259 (873)
                      ++|++|++++|++.+..+..+                                 ..+++|++|++++|.+++..+..|.+
T Consensus       272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  351 (680)
T 1ziw_A          272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG  351 (680)
T ss_dssp             TTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTT
T ss_pred             ccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhcc
Confidence            666666666666554444444                                 44555555555556665555555666


Q ss_pred             CCCCcEEEccCCcCcC--c-CCcCCC--CCCCCeEEccCcccccccccccccCCCccEEeccCccccccCC-CCCCCCCC
Q 039344          260 LVKLTILLLGHNQFRG--P-IPILRN--LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEIS-SDWGRCPK  333 (873)
Q Consensus       260 l~~L~~L~L~~N~l~~--~-~~~l~~--l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~~l~~  333 (873)
                      +++|++|++++|.+..  . ...+..  .++|+.|++++|.++++.+..|..+++|++|++++|.+.+.++ ..|..+++
T Consensus       352 l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~  431 (680)
T 1ziw_A          352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN  431 (680)
T ss_dssp             CTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTT
T ss_pred             ccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCccc
Confidence            6666666666665432  1 112222  2456667777777777777777778888888888888876544 56777888


Q ss_pred             CCeeeeccccCCccCCccccCCCCCCEEeccCCccC--CCCCccccccccccEEEecCccccCCcccccccccccccccc
Q 039344          334 LSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIV--GEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDL  411 (873)
Q Consensus       334 L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  411 (873)
                      |+.|++++|++++..+..|..+++|+.|++++|.+.  +.+|..+..+++|+.|++++|++++..+..+..+++|+.|+|
T Consensus       432 L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L  511 (680)
T 1ziw_A          432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL  511 (680)
T ss_dssp             CCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeC
Confidence            888888888887777777888888888888888876  467888889999999999999999877788899999999999


Q ss_pred             cccccccccCC--------CcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEE
Q 039344          412 SSNRLSNSIPK--------SLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHI  483 (873)
Q Consensus       412 s~N~l~~~~~~--------~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l  483 (873)
                      ++|++++..+.        .+.++.  +|+.|+|++|++++..+..|..+++|+.|+|++|+|+++++..|..+++|++|
T Consensus       512 s~N~l~~~~~~~~~~~~~~~~~~l~--~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L  589 (680)
T 1ziw_A          512 QHNNLARLWKHANPGGPIYFLKGLS--HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL  589 (680)
T ss_dssp             CSSCCGGGGSTTSTTSCCCTTTTCT--TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCccccchhhccCCcchhhcCCC--CCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEE
Confidence            99999754322        255554  89999999999997666778999999999999999998888888999999999


Q ss_pred             ecCCCcccccCCCCC--cccCCCcccccCCCCccc
Q 039344          484 DISYNELRGSIPNST--TFKDAPIEALQGNKGLYG  516 (873)
Q Consensus       484 ~ls~N~l~~~~p~~~--~~~~~~~~~~~~n~~l~g  516 (873)
                      +|++|++++..|..-  .++......+.+|+-.|.
T Consensus       590 ~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             ECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             ECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            999999998665432  355666677788876664

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=4.5e-55  Score=523.49  Aligned_cols=491  Identities=25%  Similarity=0.249  Sum_probs=401.8

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +++|.+++..|..|+++++|++|+|++|+++++.+.+|.++++|++|+|++|+++++.|..|+++++|++|+|++|.+++
T Consensus        56 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  135 (680)
T 1ziw_A           56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS  135 (680)
T ss_dssp             CCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccc
Confidence            46788999999999999999999999999987666689999999999999999997777889999999999999999998


Q ss_pred             CCCcccccccccceeeccccccCCCCCcccc--CCcccCcccccccccccccCccccCC---------------------
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSNSIPSELG--NLRSLSNLQLNNNILSGSIPHSLGNL---------------------  140 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l---------------------  140 (873)
                      ..|..|.++++|++|++++|.+++..+..+.  .+++|++|++++|.+++..|..|..+                     
T Consensus       136 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~  215 (680)
T 1ziw_A          136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL  215 (680)
T ss_dssp             CCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHH
T ss_pred             cCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHH
Confidence            8888899999999999999998876666554  45778888888887776555544332                     


Q ss_pred             ------CC--------------------------CcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCC
Q 039344          141 ------TN--------------------------LATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNL  188 (873)
Q Consensus       141 ------~~--------------------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l  188 (873)
                            ++                          |++|++++|++.++.+..|..+++|++|+|++|++++..|..|.++
T Consensus       216 ~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  295 (680)
T 1ziw_A          216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL  295 (680)
T ss_dssp             HHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTC
T ss_pred             HHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCC
Confidence                  22                          5555555555555545555555555555555555555555555555


Q ss_pred             CCCcEEeccCCCCcc-----cCC----ccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCC--CCCchhh
Q 039344          189 SNLATLYLDTNSLSY-----SIP----SELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS--GAIPYEY  257 (873)
Q Consensus       189 ~~L~~L~L~~n~l~~-----~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~  257 (873)
                      ++|++|++++|...+     .+|    ..|..+++|++|++++|++.+..+..|.++++|++|++++|.+.  ......|
T Consensus       296 ~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f  375 (680)
T 1ziw_A          296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF  375 (680)
T ss_dssp             TTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTT
T ss_pred             CCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhh
Confidence            555555555543321     112    25677888999999999999888889999999999999999854  2333445


Q ss_pred             cCC--CCCcEEEccCCcCcCc-CCcCCCCCCCCeEEccCccccc-ccccccccCCCccEEeccCccccccCCCCCCCCCC
Q 039344          258 RNL--VKLTILLLGHNQFRGP-IPILRNLTSLERVRLDRNYLTG-NISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPK  333 (873)
Q Consensus       258 ~~l--~~L~~L~L~~N~l~~~-~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~  333 (873)
                      ..+  ++|+.|++++|++.+. +..+..+++|+.|++++|.+++ +....|..+++|++|++++|++.+..+..|..+++
T Consensus       376 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~  455 (680)
T 1ziw_A          376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS  455 (680)
T ss_dssp             GGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTT
T ss_pred             cccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcc
Confidence            444  6899999999999985 4578999999999999999986 45578999999999999999999999999999999


Q ss_pred             CCeeeeccccCC--ccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcc--------cccccc
Q 039344          334 LSTLDFSINNIT--GNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLS--------PKLGSL  403 (873)
Q Consensus       334 L~~L~l~~N~i~--~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l  403 (873)
                      |+.|++++|.+.  +..|..++.+++|+.|+|++|.|++..+..+..+++|++|++++|++++..+        ..+..+
T Consensus       456 L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l  535 (680)
T 1ziw_A          456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL  535 (680)
T ss_dssp             CCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTC
T ss_pred             cccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCC
Confidence            999999999987  5678899999999999999999998888889999999999999999986422        237889


Q ss_pred             cccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhh-ccCCCcE
Q 039344          404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFE-KMNGLLH  482 (873)
Q Consensus       404 ~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~L~~  482 (873)
                      ++|+.|+|++|+|+...+..|.++.  +|+.|||++|++++..+..|..+++|+.|+|++|+|++.+|..|. .+++|+.
T Consensus       536 ~~L~~L~L~~N~l~~i~~~~~~~l~--~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~  613 (680)
T 1ziw_A          536 SHLHILNLESNGFDEIPVEVFKDLF--ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE  613 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCT--TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSE
T ss_pred             CCCCEEECCCCCCCCCCHHHccccc--CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCE
Confidence            9999999999999855455688876  999999999999998888889999999999999999999999888 8999999


Q ss_pred             EecCCCcccccCCC
Q 039344          483 IDISYNELRGSIPN  496 (873)
Q Consensus       483 l~ls~N~l~~~~p~  496 (873)
                      |++++|+|.+.-+.
T Consensus       614 l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          614 LDMRFNPFDCTCES  627 (680)
T ss_dssp             EECTTCCCCBCCCC
T ss_pred             EEccCCCcccCCcc
Confidence            99999999987654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.9e-55  Score=519.53  Aligned_cols=464  Identities=24%  Similarity=0.245  Sum_probs=427.3

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +++|.|++..|..|.++++|++|+|++|+++++.|++|.++++|++|+|++|++++..|.+|+++++|++|++++|++++
T Consensus        40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  119 (606)
T 3t6q_A           40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS  119 (606)
T ss_dssp             CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred             ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence            57899999999999999999999999999999999999999999999999999998999999999999999999999998


Q ss_pred             CCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCc--EEEccCCCCcccccccc
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLA--TLYIYSNSLSASILGKI  161 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~~~~~~~~  161 (873)
                      ..+..|.++++|++|++++|++++..+..+..+++|++|++++|.+++..+..|+.+++|+  +|++++|.+.++.+..|
T Consensus       120 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~  199 (606)
T 3t6q_A          120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF  199 (606)
T ss_dssp             GGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTT
T ss_pred             CCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHh
Confidence            7788999999999999999999975555666699999999999999988888999999999  99999999998777665


Q ss_pred             CCC---------------------------------------------------CCCCEEEccCCcCccCCCccccCCCC
Q 039344          162 GNL---------------------------------------------------KSLSNLQLSENNFNGSIPPSLGNLSN  190 (873)
Q Consensus       162 ~~l---------------------------------------------------~~L~~L~L~~n~i~~~~~~~~~~l~~  190 (873)
                      ...                                                   .+|+.|++++|.+++..+..|+.+++
T Consensus       200 ~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~  279 (606)
T 3t6q_A          200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG  279 (606)
T ss_dssp             TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTT
T ss_pred             hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccC
Confidence            431                                                   16888999999999888888999999


Q ss_pred             CcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCc-hhhcCCCCCcEEEcc
Q 039344          191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIP-YEYRNLVKLTILLLG  269 (873)
Q Consensus       191 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~  269 (873)
                      |++|++++|.++ .+|..+..+++|++|++++|++++..|..+..+++|++|++++|.+.+..+ ..+..+++|++|+++
T Consensus       280 L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~  358 (606)
T 3t6q_A          280 LQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS  358 (606)
T ss_dssp             CSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECC
T ss_pred             CCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECC
Confidence            999999999999 788889999999999999999998888899999999999999999985554 459999999999999


Q ss_pred             CCcCcCc---CCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCC-CCCCCCCCCeeeeccccCC
Q 039344          270 HNQFRGP---IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISS-DWGRCPKLSTLDFSINNIT  345 (873)
Q Consensus       270 ~N~l~~~---~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~i~  345 (873)
                      +|++.+.   ...+..+++|++|++++|.++++.+..|..+++|++|++++|.+.+..+. .+..+++|+.|++++|.++
T Consensus       359 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~  438 (606)
T 3t6q_A          359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD  438 (606)
T ss_dssp             SSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCB
T ss_pred             CCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccC
Confidence            9999875   45789999999999999999999999999999999999999999877654 4899999999999999999


Q ss_pred             ccCCccccCCCCCCEEeccCCccCCC---CCccccccccccEEEecCccccCCcccccccccccccccccccccccccCC
Q 039344          346 GNVPPEIGHSSQLGVLDLSSNHIVGE---IPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPK  422 (873)
Q Consensus       346 ~~~~~~~~~~~~L~~L~Ls~N~i~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  422 (873)
                      +..|..++.+++|++|+|++|.+++.   .+..+..+++|+.|++++|++++..|..+..+++|+.|+|++|++++..|.
T Consensus       439 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  518 (606)
T 3t6q_A          439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE  518 (606)
T ss_dssp             TTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGG
T ss_pred             CcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChh
Confidence            88899999999999999999999862   346789999999999999999998899999999999999999999999999


Q ss_pred             CcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCc
Q 039344          423 SLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIP  471 (873)
Q Consensus       423 ~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  471 (873)
                      .+..+.  .| .|+|++|++++.+|..+..+++|+.|++++|++++..+
T Consensus       519 ~l~~l~--~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          519 ALSHLK--GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             GGTTCC--SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             HhCccc--cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            999877  88 99999999999999999999999999999999997655

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-55  Score=535.10  Aligned_cols=491  Identities=22%  Similarity=0.244  Sum_probs=366.9

Q ss_pred             CCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCccccc-CCCCccCCCCCCEEEcccCCCCCC
Q 039344            6 NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGS-IPGEIGNFRFFSDLELSNNKLSGS   84 (873)
Q Consensus         6 ~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~   84 (873)
                      .++++.. |. +  .++|++|||++|.|+++.|..|.++++|++|+|++|...+. .|++|+++++|++|+|++|.+++.
T Consensus        13 ~~~L~~v-P~-l--p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~   88 (844)
T 3j0a_A           13 FCNLTQV-PQ-V--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL   88 (844)
T ss_dssp             CCCSSCC-CS-S--CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEE
T ss_pred             CCCCCCC-CC-C--CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCccc
Confidence            4455554 43 3  36788888888888888888888888888888888854434 478888888888888888888877


Q ss_pred             CCcccccccccceeeccccccCCCCCcc--ccCCcccCcccccccccccccC-ccccCCCCCcEEEccCCCCcccccccc
Q 039344           85 IPPSLGNLSNLATLYLDTNSLSNSIPSE--LGNLRSLSNLQLNNNILSGSIP-HSLGNLTNLATLYIYSNSLSASILGKI  161 (873)
Q Consensus        85 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~  161 (873)
                      .|.+|.++++|++|+|++|.+++..|..  |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+
T Consensus        89 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l  168 (844)
T 3j0a_A           89 HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL  168 (844)
T ss_dssp             CTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG
T ss_pred             CHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc
Confidence            7888888888888888888888755554  8888888888888888876544 568888888888888888887777777


Q ss_pred             CCC--CCCCEEEccCCcCccCCCccccCCCC------CcEEeccCCCCcccCCccccC----------------------
Q 039344          162 GNL--KSLSNLQLSENNFNGSIPPSLGNLSN------LATLYLDTNSLSYSIPSELGN----------------------  211 (873)
Q Consensus       162 ~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~------L~~L~L~~n~l~~~~~~~~~~----------------------  211 (873)
                      ..+  ++|+.|+++.|.+.+..+..+..+++      |+.|++++|.+++..+..+..                      
T Consensus       169 ~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~  248 (844)
T 3j0a_A          169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG  248 (844)
T ss_dssp             HHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSS
T ss_pred             ccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccc
Confidence            776  78888888888888777776666555      888888888776544433321                      


Q ss_pred             ----------------CCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcC
Q 039344          212 ----------------LRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG  275 (873)
Q Consensus       212 ----------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (873)
                                      .++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..+..|..+++|++|++++|++.+
T Consensus       249 ~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~  328 (844)
T 3j0a_A          249 FHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE  328 (844)
T ss_dssp             CSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSC
T ss_pred             ccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCc
Confidence                            2578888888888887777788888888888888888888888888888888888888888877


Q ss_pred             c-CCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccC
Q 039344          276 P-IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGH  354 (873)
Q Consensus       276 ~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~  354 (873)
                      . +..+..+++|+.|++++|.++.+.+..|..+++|++|+|++|.+++.     ..+++|+.|++++|+++ .+|..   
T Consensus       329 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---  399 (844)
T 3j0a_A          329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---  399 (844)
T ss_dssp             CCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---
T ss_pred             cCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---
Confidence            4 44788888888888888888888888888888888888888888642     23677888888888877 34432   


Q ss_pred             CCCCCEEeccCCccCCCCC-ccccccccccEEEecCccccCCccc-ccccccccccccccccccc-----cccCCCcCch
Q 039344          355 SSQLGVLDLSSNHIVGEIP-IELGKLNFFIKLVLAHNQLSGQLSP-KLGSLVQLEHLDLSSNRLS-----NSIPKSLGNL  427 (873)
Q Consensus       355 ~~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l  427 (873)
                      ..+++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|.++
T Consensus       400 ~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l  479 (844)
T 3j0a_A          400 NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL  479 (844)
T ss_dssp             CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCB
T ss_pred             ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCc
Confidence            3567777777777764321 2344677777788888877754332 3455677777777777776     3334556655


Q ss_pred             hhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCCCCcccCCCccc
Q 039344          428 ELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEA  507 (873)
Q Consensus       428 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~  507 (873)
                      .  +|+.|+|++|.+++.+|..+..+++|+.|+|++|+|++++|..+.  ++|+.|||++|++++.+|+.  |+......
T Consensus       480 ~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~  553 (844)
T 3j0a_A          480 S--HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLD  553 (844)
T ss_dssp             C--CEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEE
T ss_pred             c--cccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEE
Confidence            4  777777777777777777777777777788887777777666655  67777777777777776653  44555555


Q ss_pred             ccCCCCcc
Q 039344          508 LQGNKGLY  515 (873)
Q Consensus       508 ~~~n~~l~  515 (873)
                      +.+|+-.|
T Consensus       554 l~~Np~~C  561 (844)
T 3j0a_A          554 ITHNKFIC  561 (844)
T ss_dssp             EEEECCCC
T ss_pred             ecCCCccc
Confidence            66666555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.1e-55  Score=521.48  Aligned_cols=476  Identities=21%  Similarity=0.208  Sum_probs=339.0

Q ss_pred             CCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCC
Q 039344            6 NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI   85 (873)
Q Consensus         6 ~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~   85 (873)
                      +++++. +|..+.  +++++|+|++|++++..+.+|.++++|++|+|++|+++++.|.+|+++++|++|+|++|.+++..
T Consensus        20 ~~~l~~-ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~   96 (606)
T 3vq2_A           20 DQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS   96 (606)
T ss_dssp             TSCCSS-CCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCC
T ss_pred             CCCccc-CCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccC
Confidence            445544 555565  68899999999998888888999999999999999998888888899999999999999998877


Q ss_pred             CcccccccccceeeccccccCCCCCccccCCcccCccccccccccc-ccCccccCCCCCcEEEccCCCCccccccccCCC
Q 039344           86 PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG-SIPHSLGNLTNLATLYIYSNSLSASILGKIGNL  164 (873)
Q Consensus        86 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  164 (873)
                      |.+|.++++|++|+|++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|+++++.+..|+.+
T Consensus        97 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  176 (606)
T 3vq2_A           97 PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL  176 (606)
T ss_dssp             TTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHH
T ss_pred             hhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhh
Confidence            8889999999999999999987777888889999999999999875 468889999999999999999888877777766


Q ss_pred             CCCC----EEEccCCcCccCCCccccCCCCCcEEeccCCCCcc-cCCcc-------------------------------
Q 039344          165 KSLS----NLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY-SIPSE-------------------------------  208 (873)
Q Consensus       165 ~~L~----~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~-------------------------------  208 (873)
                      ++|+    +|++++|.+++..+..+... +|+.|++++|.+++ ..|..                               
T Consensus       177 ~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~  255 (606)
T 3vq2_A          177 RENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM  255 (606)
T ss_dssp             HHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGG
T ss_pred             hccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHh
Confidence            6554    78999998886666666554 78888888887641 12222                               


Q ss_pred             -------------------------ccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCC
Q 039344          209 -------------------------LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKL  263 (873)
Q Consensus       209 -------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  263 (873)
                                               +..+++|+.|++++|.+.. .| .+..+++|++|++++|.+. ..| .+ .+++|
T Consensus       256 ~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L  330 (606)
T 3vq2_A          256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLK-QFP-TL-DLPFL  330 (606)
T ss_dssp             TTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCS-SCC-CC-CCSSC
T ss_pred             hhhhhccHhheeccccccccccccccccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCc-ccc-cC-CCCcc
Confidence                                     4455666666666666653 33 5666666666666666663 444 33 66666


Q ss_pred             cEEEccCCcCcCcCCcCCCCCCCCeEEccCccccccc--ccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeecc
Q 039344          264 TILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNI--SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI  341 (873)
Q Consensus       264 ~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~--~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~  341 (873)
                      +.|++++|+..+.. .+..+++|++|++++|.+++..  +..+..+++|++|++++|.+.+ .+..+..+++|+.|++++
T Consensus       331 ~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~  408 (606)
T 3vq2_A          331 KSLTLTMNKGSISF-KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQH  408 (606)
T ss_dssp             CEEEEESCSSCEEC-CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTT
T ss_pred             ceeeccCCcCccch-hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCC
Confidence            66666666544332 4556666777777777666553  4556666677777777776664 346666667777777777


Q ss_pred             ccCCccCC-ccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccC-Ccccccccccccccccccccccccc
Q 039344          342 NNITGNVP-PEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG-QLSPKLGSLVQLEHLDLSSNRLSNS  419 (873)
Q Consensus       342 N~i~~~~~-~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~  419 (873)
                      |++.+..| ..+..+++|++|++++|.+++..|..+..+++|++|++++|++++ .+|..+..+++|+.|+|++|++++.
T Consensus       409 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~  488 (606)
T 3vq2_A          409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI  488 (606)
T ss_dssp             SEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred             CccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCcc
Confidence            76665555 456666677777777777666666666666777777777776665 3566666667777777777777666


Q ss_pred             cCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccC-CCcEEecCCCcccccCC
Q 039344          420 IPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMN-GLLHIDISYNELRGSIP  495 (873)
Q Consensus       420 ~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-~L~~l~ls~N~l~~~~p  495 (873)
                      .|..++.+.  +|++|+|++|++++..|..+..+++|+.|+|++|+|+. +|..+..++ +|++|++++|++.+..+
T Consensus       489 ~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          489 SWGVFDTLH--RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             CTTTTTTCT--TCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             Chhhhcccc--cCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCc
Confidence            666666654  66777777777766666666667777777777777663 444466665 47777777777665444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.7e-55  Score=516.26  Aligned_cols=479  Identities=21%  Similarity=0.232  Sum_probs=420.7

Q ss_pred             CCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc
Q 039344           23 LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        23 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  102 (873)
                      .+.++.++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|.+|.++++|++|+|++
T Consensus        13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~   89 (606)
T 3vq2_A           13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG   89 (606)
T ss_dssp             TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence            468999999998 6777665  8999999999999988888999999999999999999988899999999999999999


Q ss_pred             cccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccc-cccccCCCCCCCEEEccCCcCccCC
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSAS-ILGKIGNLKSLSNLQLSENNFNGSI  181 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~i~~~~  181 (873)
                      |++++..|..|.++++|++|++++|.+++..+..|+.+++|++|++++|++.+. .+..|+++++|++|++++|++++..
T Consensus        90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~  169 (606)
T 3vq2_A           90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT  169 (606)
T ss_dssp             CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred             CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence            999988899999999999999999999977778899999999999999999864 4788999999999999999999888


Q ss_pred             CccccCCCCCc----EEeccCCCCcccCCccccCCCCCCEEEccCcccC-------------------------------
Q 039344          182 PPSLGNLSNLA----TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS-------------------------------  226 (873)
Q Consensus       182 ~~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------------  226 (873)
                      +..++.+++|+    +|++++|.+++..+..+... +|++|++++|.+.                               
T Consensus       170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~  248 (606)
T 3vq2_A          170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE  248 (606)
T ss_dssp             TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred             hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence            88888776655    89999999997666666655 8999999998764                               


Q ss_pred             ---------------------------CCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCc
Q 039344          227 ---------------------------GSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPI  279 (873)
Q Consensus       227 ---------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  279 (873)
                                                 +..|. +..+++|+.|++++|.+.. .| .+..+++|+.|++++|++.. .+.
T Consensus       249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~~-lp~  324 (606)
T 3vq2_A          249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLKQ-FPT  324 (606)
T ss_dssp             CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCSS-CCC
T ss_pred             ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCcc-ccc
Confidence                                       11222 5677899999999999975 44 78889999999999999944 445


Q ss_pred             CCCCCCCCeEEccCcccccccccccccCCCccEEeccCcccccc--CCCCCCCCCCCCeeeeccccCCccCCccccCCCC
Q 039344          280 LRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGE--ISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQ  357 (873)
Q Consensus       280 l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  357 (873)
                      + .+++|++|++++|...+..  .+..+++|++|++++|.+++.  .+..+..+++|+.|++++|.+++ +|..+..+++
T Consensus       325 ~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~  400 (606)
T 3vq2_A          325 L-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEE  400 (606)
T ss_dssp             C-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTT
T ss_pred             C-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCC
Confidence            6 8999999999999544332  677899999999999999876  37888899999999999999985 6688999999


Q ss_pred             CCEEeccCCccCCCCC-ccccccccccEEEecCccccCCccccccccccccccccccccccc-ccCCCcCchhhhhhhcc
Q 039344          358 LGVLDLSSNHIVGEIP-IELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN-SIPKSLGNLELIHLSEL  435 (873)
Q Consensus       358 L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~~~L~~L  435 (873)
                      |+.|++++|.+.+..| ..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|++.+ .+|..++.+.  +|+.|
T Consensus       401 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~--~L~~L  478 (606)
T 3vq2_A          401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT--NLTFL  478 (606)
T ss_dssp             CCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT--TCCEE
T ss_pred             CCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCC--CCCEE
Confidence            9999999999998777 688999999999999999999899999999999999999999997 4799998876  99999


Q ss_pred             cccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCCC-Cccc-CCCcccccCCCC
Q 039344          436 DLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS-TTFK-DAPIEALQGNKG  513 (873)
Q Consensus       436 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~-~~~~-~~~~~~~~~n~~  513 (873)
                      +|++|++++..|..+..+++|+.|+|++|++++.+|..|..+++|++|||++|+++ .+|.. ..++ ......+.+|+-
T Consensus       479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~  557 (606)
T 3vq2_A          479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSV  557 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCC
T ss_pred             ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCc
Confidence            99999999999999999999999999999999999999999999999999999999 56654 2222 244556778765


Q ss_pred             ccc
Q 039344          514 LYG  516 (873)
Q Consensus       514 l~g  516 (873)
                      .|.
T Consensus       558 ~c~  560 (606)
T 3vq2_A          558 ACI  560 (606)
T ss_dssp             CCS
T ss_pred             ccC
Confidence            554

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-54  Score=528.21  Aligned_cols=477  Identities=23%  Similarity=0.217  Sum_probs=421.1

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCccc-ccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLS   82 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~   82 (873)
                      +++|.|++..|.+|+++++|++|+|++|... .+.|++|.++++|++|+|++|.+++..|++|+++++|++|+|++|.++
T Consensus        31 Ls~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~  110 (844)
T 3j0a_A           31 LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS  110 (844)
T ss_dssp             EESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCS
T ss_pred             CCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCC
Confidence            5789999999999999999999999999655 444899999999999999999999999999999999999999999999


Q ss_pred             CCCCcc--cccccccceeeccccccCCCCC-ccccCCcccCcccccccccccccCccccCC--CCCcEEEccCCCCcccc
Q 039344           83 GSIPPS--LGNLSNLATLYLDTNSLSNSIP-SELGNLRSLSNLQLNNNILSGSIPHSLGNL--TNLATLYIYSNSLSASI  157 (873)
Q Consensus        83 ~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~  157 (873)
                      +..|..  |.++++|++|+|++|.+++..+ ..|.++++|++|+|++|.+++..+..|..+  ++|+.|++++|.+.+..
T Consensus       111 ~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~  190 (844)
T 3j0a_A          111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRV  190 (844)
T ss_dssp             SCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCC
T ss_pred             cccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcccccc
Confidence            766654  9999999999999999997654 679999999999999999998889999888  89999999999998877


Q ss_pred             ccccCCCCC------CCEEEccCCcCccCCCcccc------------------------------------C--CCCCcE
Q 039344          158 LGKIGNLKS------LSNLQLSENNFNGSIPPSLG------------------------------------N--LSNLAT  193 (873)
Q Consensus       158 ~~~~~~l~~------L~~L~L~~n~i~~~~~~~~~------------------------------------~--l~~L~~  193 (873)
                      +..+..+.+      |++|++++|.+++..+..+.                                    +  .++|+.
T Consensus       191 ~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~  270 (844)
T 3j0a_A          191 SVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH  270 (844)
T ss_dssp             CCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCE
T ss_pred             ccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccE
Confidence            777766665      99999999988765554332                                    1  268999


Q ss_pred             EeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcC
Q 039344          194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQF  273 (873)
Q Consensus       194 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  273 (873)
                      |++++|.+++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|+.|++++|++
T Consensus       271 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  350 (844)
T 3j0a_A          271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI  350 (844)
T ss_dssp             EECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCC
T ss_pred             EECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCC
Confidence            99999999988899999999999999999999988889999999999999999999999899999999999999999999


Q ss_pred             cCcCC-cCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCC-cc
Q 039344          274 RGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVP-PE  351 (873)
Q Consensus       274 ~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~-~~  351 (873)
                      ....+ .+..+++|+.|+|++|.++++..     +++|+.|++++|+++ .+|..   ..+++.|++++|++++... ..
T Consensus       351 ~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~-----~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~  421 (844)
T 3j0a_A          351 AIIQDQTFKFLEKLQTLDLRDNALTTIHF-----IPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYF  421 (844)
T ss_dssp             CCCCSSCSCSCCCCCEEEEETCCSCCCSS-----CCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHH
T ss_pred             CccChhhhcCCCCCCEEECCCCCCCcccC-----CCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhh
Confidence            88554 68999999999999999986543     789999999999998 44443   4689999999999986432 23


Q ss_pred             ccCCCCCCEEeccCCccCCCCCc-cccccccccEEEecCcccc-----CCcccccccccccccccccccccccccCCCcC
Q 039344          352 IGHSSQLGVLDLSSNHIVGEIPI-ELGKLNFFIKLVLAHNQLS-----GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG  425 (873)
Q Consensus       352 ~~~~~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  425 (873)
                      +..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|..+++|+.|+|++|+|++..|..|.
T Consensus       422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  501 (844)
T 3j0a_A          422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS  501 (844)
T ss_dssp             HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred             hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence            56899999999999999865443 4567899999999999997     34456788999999999999999999999898


Q ss_pred             chhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCC
Q 039344          426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN  496 (873)
Q Consensus       426 ~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~  496 (873)
                      ++.  +|+.|+|++|+|++..+..+.  ++|+.|+|++|+|++.+|..|   .+|+.+++++|++.+..+-
T Consensus       502 ~l~--~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          502 HLT--ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SCC--SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred             chh--hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence            877  999999999999998877776  899999999999999999875   4899999999999986653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-52  Score=488.69  Aligned_cols=476  Identities=24%  Similarity=0.270  Sum_probs=416.4

Q ss_pred             cCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccc
Q 039344           12 SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGN   91 (873)
Q Consensus        12 ~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   91 (873)
                      .+|..+.  +.++.|+|++|+++++.+.+|.++++|++|+|++|+++++.|++|+++++|++|+|++|++++..|.+|.+
T Consensus        21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (570)
T 2z63_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (570)
T ss_dssp             SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence            4666665  57999999999999888999999999999999999999888899999999999999999999888899999


Q ss_pred             ccccceeeccccccCCCCCccccCCcccCccccccccccc-ccCccccCCCCCcEEEccCCCCccccccccCCCCCC---
Q 039344           92 LSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG-SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL---  167 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L---  167 (873)
                      +++|++|++++|+++...+..|.++++|++|++++|.+++ .+|..|+++++|++|++++|+++.+.+..++.+++|   
T Consensus        99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~  178 (570)
T 2z63_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL  178 (570)
T ss_dssp             CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC
T ss_pred             ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchh
Confidence            9999999999999997666679999999999999999986 368999999999999999999999888888888888   


Q ss_pred             -CEEEccCCcCccCCCccccCCCCCcEEeccCCCCcc-cCCccccCCCC-------------------------------
Q 039344          168 -SNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY-SIPSELGNLRS-------------------------------  214 (873)
Q Consensus       168 -~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~-------------------------------  214 (873)
                       +.|++++|.+++..+..+..+ +|+.|++++|.... ..+..+..++.                               
T Consensus       179 ~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l  257 (570)
T 2z63_A          179 NLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL  257 (570)
T ss_dssp             CCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGS
T ss_pred             hhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccccc
Confidence             899999999998888888766 89999999884331 11222222222                               


Q ss_pred             -CCEEEccCc-ccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEcc
Q 039344          215 -LSNLSLGYN-KLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLD  292 (873)
Q Consensus       215 -L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~  292 (873)
                       ++.+++++| .+.+..+..+..+++|++|++++|.++ ..|..+..+ +|+.|++++|.+...+.  ..+++|+.|+++
T Consensus       258 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~--~~l~~L~~L~l~  333 (570)
T 2z63_A          258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPT--LKLKSLKRLTFT  333 (570)
T ss_dssp             EEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCB--CBCSSCCEEEEE
T ss_pred             chhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCc--ccccccCEEeCc
Confidence             455666666 666677888899999999999999998 467778888 99999999999985433  578899999999


Q ss_pred             CcccccccccccccCCCccEEeccCccccccC--CCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCC
Q 039344          293 RNYLTGNISESFYIYPNLTYIDLSQNNFYGEI--SSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVG  370 (873)
Q Consensus       293 ~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~  370 (873)
                      +|.+.+..+.  ..+++|++|++++|.+++..  +..+..+++|+.|++++|.+++..+ .+..+++|++|++++|.+.+
T Consensus       334 ~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~  410 (570)
T 2z63_A          334 SNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQ  410 (570)
T ss_dssp             SCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEES
T ss_pred             CCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCcccc
Confidence            9998865544  67899999999999998654  6778889999999999999986544 49999999999999999987


Q ss_pred             CCC-ccccccccccEEEecCccccCCcccccccccccccccccccccc-cccCCCcCchhhhhhhcccccCCccCcccch
Q 039344          371 EIP-IELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLS-NSIPKSLGNLELIHLSELDLSRNFLREAIPS  448 (873)
Q Consensus       371 ~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~  448 (873)
                      ..| ..+..+++|++|++++|.+++..+..+..+++|+.|+|++|++. +.+|..+..+.  +|++|+|++|++++..|.
T Consensus       411 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~--~L~~L~l~~n~l~~~~~~  488 (570)
T 2z63_A          411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR--NLTFLDLSQCQLEQLSPT  488 (570)
T ss_dssp             CTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT--TCCEEECTTSCCCEECTT
T ss_pred             ccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhccc--CCCEEECCCCccccCChh
Confidence            666 57889999999999999999989999999999999999999997 67999998876  999999999999999899


Q ss_pred             hhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCCCCc
Q 039344          449 QICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTT  499 (873)
Q Consensus       449 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~~~  499 (873)
                      .+..+++|+.|++++|++++.+|..|..+++|++|++++|++++..|....
T Consensus       489 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~  539 (570)
T 2z63_A          489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY  539 (570)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred             hhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHH
Confidence            999999999999999999999999999999999999999999999887543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-52  Score=442.63  Aligned_cols=255  Identities=21%  Similarity=0.356  Sum_probs=209.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      .++++.+.||+|+||+||+|++.      +++.||||+++.....  ...++|.+|+.++++++|||||+++|+|.+.+.
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            44666789999999999999863      5688999999765332  335789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          676 LFIVYEYFKMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      .++|||||++|+|.+++....             ....++|.++.+++.|||+||+|||++   +|+||||||+|||+++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            999999999999999996532             234589999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ++.+||+|||+|+.......  ......||+.|||||++.++.|+.++|||||||++|||+| |+.||.......     
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-----  255 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----  255 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-----
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999987644322  2345679999999999999999999999999999999998 899987544322     


Q ss_pred             hhhhhhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 039344          820 LNIALDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI  873 (873)
Q Consensus       820 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  873 (873)
                         ....+..+. .+.+. .+   +..+.+++.+||+.||++||||+||++.|+.
T Consensus       256 ---~~~~i~~~~~~~~p~-~~---~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          256 ---VVEMIRNRQVLPCPD-DC---PAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             ---HHHHHHTTCCCCCCT-TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---HHHHHHcCCCCCCcc-cc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               122222222 22222 22   2348899999999999999999999999863

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-52  Score=440.87  Aligned_cols=254  Identities=23%  Similarity=0.430  Sum_probs=208.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++..   .....++|.+|++++++++|||||+++|+|.+++.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            56888899999999999999753      4788999999753   23346789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccc----------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC
Q 039344          676 LFIVYEYFKMCSLAVILSNDA----------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE  745 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~  745 (873)
                      .|+|||||++|+|.++++...          ....++|.++..++.||++||+|||++   +|+||||||+|||+++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence            999999999999999997542          234699999999999999999999999   9999999999999999999


Q ss_pred             eEEeccccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhh
Q 039344          746 AHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNI  822 (873)
Q Consensus       746 ~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~  822 (873)
                      +||+|||+|+.........  ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.......        
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------  238 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------  238 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence            9999999998765433321  23468999999999999999999999999999999999 999987544322        


Q ss_pred             hhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+..+..+..+...   +..+.+++.+||+.||++|||++||.+.|+
T Consensus       239 ~~~~i~~~~~~~~p~~~---~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          239 VIECITQGRVLQRPRTC---PQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             HHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            12222222222112222   234889999999999999999999998874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.6e-52  Score=441.83  Aligned_cols=253  Identities=24%  Similarity=0.420  Sum_probs=202.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++..   .....++|.+|++++++++|||||+++|+|.+.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            56777889999999999999864      5789999999753   33446789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccc------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC
Q 039344          676 LFIVYEYFKMCSLAVILSNDA------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE  743 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~  743 (873)
                      .|+|||||++|+|.++++...            ...+++|.++..|+.||+.||+|||++   +|+||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            999999999999999997543            224689999999999999999999999   99999999999999999


Q ss_pred             CCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhh
Q 039344          744 NEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       744 ~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~  820 (873)
                      +.+||+|||+|+.......  ......||+.|||||++.+..++.++|||||||++|||+| |+.||.........    
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----  270 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI----  270 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH----
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH----
Confidence            9999999999987654332  2235679999999999999999999999999999999999 99998754432211    


Q ss_pred             hhhhhhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          821 NIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       821 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ..+..+ +++.+.. +   ...+.+++.+||+.||++||||+||++.|+
T Consensus       271 ----~~i~~g~~~~~p~~-~---~~~~~~li~~cl~~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          271 ----DCITQGRELERPRA-C---PPEVYAIMRGCWQREPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             ----HHHHHTCCCCCCTT-C---CHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred             ----HHHHcCCCCCCccc-c---cHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence                111111 2222221 2   234889999999999999999999999885

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=432.58  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+++.+.++||+|+||+||+|++.  ..||||+++.... .....+.|.+|++++++++|||||+++|+|.+ +..++||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            467888899999999999999876  3599999875433 23346789999999999999999999999864 5689999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |||++|+|.++++...  ..+++.++..|+.|||.||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus       111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            9999999999996543  4599999999999999999999999   9999999999999999999999999999876543


Q ss_pred             C--CCcccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          761 S--SNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       761 ~--~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      .  .......||+.|||||++.+   ++|+.++|||||||++|||+||+.||............   .......+..+..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~---~~~~~~~p~~~~~  262 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---VGRGYASPDLSKL  262 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HHTTCCCCCSTTS
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH---HhcCCCCCCcccc
Confidence            2  23345789999999999864   45899999999999999999999999754432211111   1111222322222


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...   ....+.+++.+||+.||++||||+||++.|+
T Consensus       263 ~~~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          263 YKN---CPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             CTT---SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             ccc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            222   2335889999999999999999999998875

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=472.47  Aligned_cols=459  Identities=22%  Similarity=0.216  Sum_probs=408.5

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +++|++++..|.+|.++++|++|+|++|+++++.|++|.++++|++|+|++|++++..|++|.++++|++|++++|+++.
T Consensus        35 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  114 (570)
T 2z63_A           35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS  114 (570)
T ss_dssp             CCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred             ccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccccccc
Confidence            57899999999999999999999999999998889999999999999999999998888999999999999999999997


Q ss_pred             CCCcccccccccceeeccccccCC-CCCccccCCcccCcccccccccccccCccccCCCCC----cEEEccCCCCccccc
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNL----ATLYIYSNSLSASIL  158 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~  158 (873)
                      ..+..|+++++|++|++++|.+++ .+|..|.++++|++|++++|.+++..+..|+.+++|    +.|++++|.+..+.+
T Consensus       115 l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~  194 (570)
T 2z63_A          115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP  194 (570)
T ss_dssp             STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECT
T ss_pred             CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCH
Confidence            777789999999999999999986 369999999999999999999998888889999999    899999999999888


Q ss_pred             cccCCCCCCCEEEccCCcCcc-------------------------------CCCccccCCC--CCcEEeccCC-CCccc
Q 039344          159 GKIGNLKSLSNLQLSENNFNG-------------------------------SIPPSLGNLS--NLATLYLDTN-SLSYS  204 (873)
Q Consensus       159 ~~~~~l~~L~~L~L~~n~i~~-------------------------------~~~~~~~~l~--~L~~L~L~~n-~l~~~  204 (873)
                      ..|..+ +|++|++++|....                               .....+..+.  .++.++++++ .+.+.
T Consensus       195 ~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~  273 (570)
T 2z63_A          195 GAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD  273 (570)
T ss_dssp             TTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESC
T ss_pred             HHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhh
Confidence            888776 89999999884321                               1112222222  2456667666 66667


Q ss_pred             CCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCC
Q 039344          205 IPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLT  284 (873)
Q Consensus       205 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~  284 (873)
                      .+..+..+++|++|++++|.++ ..|..+..+ +|++|++++|.+.. .|.  ..+++|+.|++++|.+.+..+. ..++
T Consensus       274 ~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~-l~~--~~l~~L~~L~l~~n~~~~~~~~-~~~~  347 (570)
T 2z63_A          274 IIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSE-VDLP  347 (570)
T ss_dssp             STTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSS-CCB--CBCSSCCEEEEESCBSCCBCCC-CBCT
T ss_pred             chhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccc-cCc--ccccccCEEeCcCCcccccccc-ccCC
Confidence            8888999999999999999998 577788888 99999999999984 443  5789999999999998876555 7889


Q ss_pred             CCCeEEccCccccccc--ccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCC-ccccCCCCCCEE
Q 039344          285 SLERVRLDRNYLTGNI--SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVP-PEIGHSSQLGVL  361 (873)
Q Consensus       285 ~L~~L~L~~n~l~~~~--~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~-~~~~~~~~L~~L  361 (873)
                      +|++|++++|.+++..  +..+..+++|++|++++|.+.+..+. +..+++|+.|++++|.+++..+ ..+..+++|++|
T Consensus       348 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  426 (570)
T 2z63_A          348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  426 (570)
T ss_dssp             TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred             CCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence            9999999999999765  56788999999999999999876555 8999999999999999987666 578899999999


Q ss_pred             eccCCccCCCCCccccccccccEEEecCcccc-CCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCC
Q 039344          362 DLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS-GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN  440 (873)
Q Consensus       362 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N  440 (873)
                      ++++|.+.+..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++..|..+..+.  +|++|+|++|
T Consensus       427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n  504 (570)
T 2z63_A          427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS--SLQVLNMASN  504 (570)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT--TCCEEECCSS
T ss_pred             eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhccc--CCCEEeCCCC
Confidence            99999999889999999999999999999998 57889999999999999999999988899999876  9999999999


Q ss_pred             ccCcccchhhhhhcccceecccCccccCCCch
Q 039344          441 FLREAIPSQICIMQSLEKLNLSHNSLSGLIPS  472 (873)
Q Consensus       441 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  472 (873)
                      ++++.++..+..+++|+.|++++|++++..|.
T Consensus       505 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             cCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            99999999999999999999999999988774

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=9.7e-51  Score=473.54  Aligned_cols=477  Identities=22%  Similarity=0.211  Sum_probs=403.7

Q ss_pred             cCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCC
Q 039344            5 YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGS   84 (873)
Q Consensus         5 ~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~   84 (873)
                      ++|.++ .+|..+.  +.|++|+|++|++++..|.+|.++++|++|+|++|++++..|++|.++++|++|+|++|++++.
T Consensus        13 ~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~   89 (549)
T 2z81_A           13 RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSL   89 (549)
T ss_dssp             TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSC
T ss_pred             CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCcc
Confidence            456666 4566665  7899999999999988899999999999999999999988889999999999999999999988


Q ss_pred             CCcccccccccceeeccccccCCC-CCccccCCcccCcccccccc-cccccCccccCCCCCcEEEccCCCCccccccccC
Q 039344           85 IPPSLGNLSNLATLYLDTNSLSNS-IPSELGNLRSLSNLQLNNNI-LSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG  162 (873)
Q Consensus        85 ~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  162 (873)
                      .|.+|+++++|++|++++|++++. .|..|.++++|++|++++|. ++...+..|.++++|++|++++|.+++..+..+.
T Consensus        90 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~  169 (549)
T 2z81_A           90 SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK  169 (549)
T ss_dssp             CHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred             CHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhh
Confidence            788899999999999999999863 57789999999999999998 4534446899999999999999999998899999


Q ss_pred             CCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccC--C-ccccCCCCCCEEEccCcccCCCcc----cccCC
Q 039344          163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSI--P-SELGNLRSLSNLSLGYNKLSGSIP----ISMGN  235 (873)
Q Consensus       163 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~  235 (873)
                      .+++|++|+++.|.+.......+..+++|++|++++|.+++..  + .....+++|+.|++++|++++..+    ..+..
T Consensus       170 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~  249 (549)
T 2z81_A          170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY  249 (549)
T ss_dssp             TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred             ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence            9999999999999987443333467899999999999998642  2 234567899999999999875433    34467


Q ss_pred             CCCccEEecccccCCCCC------chhhcCCCCCcEEEccCCcCcCcCC------cCCCCCCCCeEEccCcccccccccc
Q 039344          236 LSNLTYLNLFENSLSGAI------PYEYRNLVKLTILLLGHNQFRGPIP------ILRNLTSLERVRLDRNYLTGNISES  303 (873)
Q Consensus       236 l~~L~~L~L~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~------~l~~l~~L~~L~L~~n~l~~~~~~~  303 (873)
                      +++|+.|++++|.+.+..      ...+..+.+|+.|++.++.+.....      .+...++|+.|++++|.++.++...
T Consensus       250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~  329 (549)
T 2z81_A          250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF  329 (549)
T ss_dssp             CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHH
T ss_pred             hccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHH
Confidence            789999999999887542      2345678899999999998765211      1234578999999999999877776


Q ss_pred             cccCCCccEEeccCccccccC---CCCCCCCCCCCeeeeccccCCccCC--ccccCCCCCCEEeccCCccCCCCCccccc
Q 039344          304 FYIYPNLTYIDLSQNNFYGEI---SSDWGRCPKLSTLDFSINNITGNVP--PEIGHSSQLGVLDLSSNHIVGEIPIELGK  378 (873)
Q Consensus       304 ~~~~~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~l~~N~i~~~~~--~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~  378 (873)
                      +..+++|++|++++|++.+..   +..+..+++|+.|++++|++++..+  ..++.+++|++|+|++|+++ .+|..+..
T Consensus       330 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  408 (549)
T 2z81_A          330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW  408 (549)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCC
T ss_pred             HhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcc
Confidence            778999999999999998765   3457889999999999999986432  45889999999999999998 68889999


Q ss_pred             cccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccce
Q 039344          379 LNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEK  458 (873)
Q Consensus       379 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  458 (873)
                      +++|++|++++|+++. ++..+  .++|+.|||++|+|++..    ..+.  +|++|+|++|+|+. +|. ...+++|+.
T Consensus       409 ~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~--~L~~L~Ls~N~l~~-ip~-~~~l~~L~~  477 (549)
T 2z81_A          409 PEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLP--RLQELYISRNKLKT-LPD-ASLFPVLLV  477 (549)
T ss_dssp             CTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCT--TCCEEECCSSCCSS-CCC-GGGCTTCCE
T ss_pred             cccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCC--hhcEEECCCCccCc-CCC-cccCccCCE
Confidence            9999999999999985 34333  268999999999998643    3333  89999999999995 555 467899999


Q ss_pred             ecccCccccCCCchhhhccCCCcEEecCCCcccccCCC
Q 039344          459 LNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN  496 (873)
Q Consensus       459 L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~  496 (873)
                      |+|++|++++.+|..|..+++|+.|++++|++.+..|.
T Consensus       478 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             EECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             EecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            99999999999999999999999999999999988774

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.6e-51  Score=432.98  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=210.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..|++.+.||+|+||+||+|+.. +|+.||||++.......   .+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56889999999999999999864 79999999997543322   356889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |||++|+|.+++..    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       151 Ey~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          151 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            99999999999864    3489999999999999999999999   9999999999999999999999999999988766


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      .....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||..........     .+.....+.++...    
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-----~i~~~~~~~~~~~~----  294 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-----MIRDNLPPRLKNLH----  294 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSSCCCCSCGG----
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-----HHHcCCCCCCCccc----
Confidence            666677899999999999999999999999999999999999999987543322111     11111122222211    


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          295 KVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22335889999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-51  Score=439.19  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=204.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            6799999999999999999976 479999999997654332 34578999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |||++|+|.+++.... ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999999996543 23478899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.......        ....+.....+.....  
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~~~~~--  248 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSFPPVSLH--  248 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCCCCTT--
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCCCCCCcc--
Confidence            333456789999999999999999999999999999999999999987543221        1222222232222211  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ....+.+++.+||+.||++|||++|+++
T Consensus       249 -~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          249 -YSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1234889999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.4e-51  Score=426.42  Aligned_cols=248  Identities=21%  Similarity=0.301  Sum_probs=208.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++.+.........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999975 579999999986432222233577999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999643   4599999999999999999999999   9999999999999999999999999999987644


Q ss_pred             C--CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 S--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .  ....+.+||+.|||||++.+..|+.++||||+||++|||+||+.||......        .....+....+..+...
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~p~~~  257 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAKIIKLEYDFPEKF  257 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCCTTC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCccc
Confidence            3  2345678999999999999999999999999999999999999998753322        12222333333333222


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKV  867 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev  867 (873)
                      .    ..+.+++.+|++.||++|||++|+
T Consensus       258 s----~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          258 F----PKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             C----HHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             C----HHHHHHHHHHccCCHhHCcChHHH
Confidence            2    247899999999999999999885

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=434.18  Aligned_cols=249  Identities=24%  Similarity=0.414  Sum_probs=210.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..|++.+.||+|+||+||+|+.. +|+.||||++.......   .+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            56999999999999999999864 79999999997543332   356889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |||++|+|.+++..    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       228 Ey~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          228 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             ECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            99999999999854    3489999999999999999999999   9999999999999999999999999999988766


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      .....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||..........     .+.....+.+.....   
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-----~i~~~~~~~~~~~~~---  372 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-----MIRDNLPPRLKNLHK---  372 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSCCCCCSCTTS---
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-----HHHcCCCCCCccccc---
Confidence            666677899999999999999999999999999999999999999987544322111     111112222222222   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       ....+.+++.+||+.||++|||++|+++
T Consensus       373 -~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          373 -VSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1234789999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.2e-50  Score=414.04  Aligned_cols=248  Identities=21%  Similarity=0.326  Sum_probs=192.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++.+.........+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999976 479999999997654444444677999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+ +|+|.+++...   ..+++.++..++.||+.|++|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 57898888643   4599999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                       ....+.+||+.|||||++.+..+ +.++||||+||++|||+||+.||......        .....+.......+... 
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--------~~~~~i~~~~~~~p~~~-  235 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--------VLFKNISNGVYTLPKFL-  235 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCCTTS-
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC-
Confidence             33456789999999999998876 57999999999999999999998753321        11222222333322221 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+.+++.+||+.||++|||++|+++
T Consensus       236 ---s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          236 ---SPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               224789999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-49  Score=414.56  Aligned_cols=246  Identities=21%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             CCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe----cceeEEE
Q 039344          605 DDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRHLFIV  679 (873)
Q Consensus       605 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv  679 (873)
                      ++.+.||+|+||+||+|+.. +++.||+|++...... ....+.|.+|++++++++|||||+++++|.+    .+..|+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            56678999999999999764 6899999998754332 2335779999999999999999999999875    3568999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeC-CCCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLD-FENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~~  756 (873)
                      ||||++|+|.+++.+.   ..+++..+..++.||+.||+|||++   +  |+||||||+|||++ .+|.+||+|||+|+.
T Consensus       108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            9999999999999653   4589999999999999999999998   6  99999999999998 479999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ..  .....+.+||+.|||||++.+ +|+.++||||+||++|||+||+.||.......       .....+..+..+...
T Consensus       182 ~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~~~~~~~~~  251 (290)
T 3fpq_A          182 KR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKPASF  251 (290)
T ss_dssp             CC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCCGGG
T ss_pred             CC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHHcCCCCCCC
Confidence            43  234456789999999998865 69999999999999999999999986433221       111122222211111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .  ......+.+++.+||+.||++|||++|+++
T Consensus       252 ~--~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          252 D--KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             G--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C--ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  111224789999999999999999999986

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.7e-50  Score=474.96  Aligned_cols=451  Identities=21%  Similarity=0.284  Sum_probs=345.0

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccC-----------CCCCCEEEcccCCCCCCCCcccc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGN-----------FRFFSDLELSNNKLSGSIPPSLG   90 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-----------l~~L~~L~L~~n~l~~~~~~~~~   90 (873)
                      .++.|+|++|++++.+|.+|+++++|++|+|++|.+. ..+..++.           +..|+ +++++|.+.+.+|..+.
T Consensus        82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~~~~~~~~~~~~~l~-l~l~~~~l~~~~~~~~~  159 (636)
T 4eco_A           82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKGISANMSDEQKQKMR-MHYQKTFVDYDPREDFS  159 (636)
T ss_dssp             CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTSBCTTCCHHHHHHHH-THHHHHHTCCCGGGGSC
T ss_pred             CEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccccccCchHHHHHHHH-hhHHHhhhccCchhhHH
Confidence            4566666666666666666666666666666666552 11111110           12233 44444444433333333


Q ss_pred             c-ccccceeeccccccCCCCCccccCCcccCccccc--ccccccccCccccCCCCCcEEEccCCCCccc-----------
Q 039344           91 N-LSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN--NNILSGSIPHSLGNLTNLATLYIYSNSLSAS-----------  156 (873)
Q Consensus        91 ~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------  156 (873)
                      . +.++..+++....+..      .....++.+.+.  .|++++ +|..|+.+++|++|+|++|++++.           
T Consensus       160 ~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~  232 (636)
T 4eco_A          160 DLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS  232 (636)
T ss_dssp             HHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred             HHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccccc
Confidence            1 1222222222222110      111233444443  578887 888899999999999999999874           


Q ss_pred             ------cccccC--CCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCC-Ccc-cCCccccCC------CCCCEEEc
Q 039344          157 ------ILGKIG--NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNS-LSY-SIPSELGNL------RSLSNLSL  220 (873)
Q Consensus       157 ------~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L  220 (873)
                            .|..++  ++++|++|+|++|++.+.+|..|+++++|++|++++|+ +++ .+|..++.+      ++|++|++
T Consensus       233 ~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L  312 (636)
T 4eco_A          233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI  312 (636)
T ss_dssp             HHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEEC
T ss_pred             chhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEEC
Confidence                  677777  89999999999999988899999999999999999998 887 788877776      89999999


Q ss_pred             cCcccCCCccc--ccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCC-CCeEEccCcccc
Q 039344          221 GYNKLSGSIPI--SMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTS-LERVRLDRNYLT  297 (873)
Q Consensus       221 ~~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~-L~~L~L~~n~l~  297 (873)
                      ++|+++ .+|.  .+..+++|++|++++|++++.+| .|..+++|++|++++|++...+..+..+++ |++|++++|.++
T Consensus       313 ~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~  390 (636)
T 4eco_A          313 GYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK  390 (636)
T ss_dssp             CSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS
T ss_pred             CCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc
Confidence            999998 6777  88999999999999999987778 888999999999999999877777888888 999999999998


Q ss_pred             cccccccccC--CCccEEeccCccccccCCCCCC-------CCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCcc
Q 039344          298 GNISESFYIY--PNLTYIDLSQNNFYGEISSDWG-------RCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHI  368 (873)
Q Consensus       298 ~~~~~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i  368 (873)
                      .++ ..+...  ++|++|++++|.+.+..|..+.       .+++|+.|++++|++++..+..+..+++|++|+|++|.+
T Consensus       391 ~lp-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l  469 (636)
T 4eco_A          391 YIP-NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML  469 (636)
T ss_dssp             SCC-SCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCC
T ss_pred             ccc-hhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCC
Confidence            554 455544  4899999999999988888888       788999999999999854444556789999999999999


Q ss_pred             CCCCCccccc-c-------ccccEEEecCccccCCcccccc--cccccccccccccccccccCCCcCchhhhhhhcccc-
Q 039344          369 VGEIPIELGK-L-------NFFIKLVLAHNQLSGQLSPKLG--SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL-  437 (873)
Q Consensus       369 ~~~~~~~~~~-l-------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~L-  437 (873)
                      + .+|..... .       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+.  +|+.|+| 
T Consensus       470 ~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~--~L~~L~Ls  544 (636)
T 4eco_A          470 T-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS--TLKGFGIR  544 (636)
T ss_dssp             S-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCS--SCCEEECC
T ss_pred             C-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCC--CCCEEECC
Confidence            8 56654433 2       28999999999999 5777776  89999999999999987 888888765  9999999 


Q ss_pred             -----cCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccc
Q 039344          438 -----SRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRG  492 (873)
Q Consensus       438 -----s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~  492 (873)
                           ++|++.+.+|..+..+++|+.|+|++|++ +.+|..+.  ++|++|||++|++..
T Consensus       545 ~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             SCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred             CCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence                 56888999999999999999999999999 56677655  899999999998874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-49  Score=428.55  Aligned_cols=264  Identities=22%  Similarity=0.353  Sum_probs=212.1

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeE
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKV  666 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l  666 (873)
                      ..+++...++|++.+.||+|+||+||+|+..      +++.||||+++....  ....++|.+|++++++++ |||||++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445556688999999999999999999754      246899999975432  233578999999999995 5999999


Q ss_pred             EeEEEec-ceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 039344          667 YGFCLHV-RHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRD  732 (873)
Q Consensus       667 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D  732 (873)
                      +|+|.+. +..++|||||++|+|.++++....             ...+++.++..++.|||.||+|||++   +|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999764 568999999999999999975432             24589999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcc
Q 039344          733 ISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF  809 (873)
Q Consensus       733 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~  809 (873)
                      |||+|||+++++.+||+|||+|+.+......  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999977554432  234678999999999999999999999999999999998 9999975


Q ss_pred             cccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          810 ISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ........    ..+.+-  .+++.+...    ...+.+++.+||+.||++|||++||++.|+
T Consensus       291 ~~~~~~~~----~~i~~g--~~~~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          291 VKIDEEFC----RRLKEG--TRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             CCCSHHHH----HHHHHT--CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHH----HHHHcC--CCCCCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            44221111    111111  122222222    224889999999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-49  Score=421.37  Aligned_cols=247  Identities=22%  Similarity=0.277  Sum_probs=200.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.|+..++||+|+||+||+|+. .+|+.||||+++....        ..+|+.+++.++|||||++++++.+++..|+||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5677888999999999999986 4799999999975321        247999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  759 (873)
                      ||+++|+|.+++...   +.+++.++..++.||+.||+|||++   +|+||||||+|||++.+| .+||+|||+|+.+..
T Consensus       130 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             CCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            999999999999643   4599999999999999999999999   999999999999999998 699999999998754


Q ss_pred             CCCC-----ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          760 DSSN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       760 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ....     ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.................. .  ..++ 
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~--~~~~-  279 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-I--REIP-  279 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-G--GGSC-
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-c--hhcC-
Confidence            3321     22357999999999999999999999999999999999999999754432221111111000 0  0011 


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                       .    .....+.+++.+||+.||++|||++|+++.|
T Consensus       280 -~----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l  311 (336)
T 4g3f_A          280 -P----SCAPLTAQAIQEGLRKEPVHRASAMELRRKV  311 (336)
T ss_dssp             -T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -c----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence             1    1123478999999999999999999998875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.3e-49  Score=470.99  Aligned_cols=437  Identities=20%  Similarity=0.256  Sum_probs=265.5

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEc-cCCcccccCCCCc----------------------------------
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYI-HTNSLSGSIPGEI----------------------------------   65 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-~~n~l~~~~p~~~----------------------------------   65 (873)
                      ..++.|+|++|++++.+|++|++|++|++|+| ++|.+++..|-..                                  
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            46899999999999999999999999999999 8888876633221                                  


Q ss_pred             -----------------cCCCCCCEEEccc--CCCCCCCCcccccccccceeeccccccCC-----------------CC
Q 039344           66 -----------------GNFRFFSDLELSN--NKLSGSIPPSLGNLSNLATLYLDTNSLSN-----------------SI  109 (873)
Q Consensus        66 -----------------~~l~~L~~L~L~~--n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~  109 (873)
                                       .....++.+.+..  |++++ +|..|.++++|++|+|++|++++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                             1112223333332  56665 66677777777777777777775                 26


Q ss_pred             Ccccc--CCcccCcccccccccccccCccccCCCCCcEEEccCCC-Ccc-ccccccC-------CCCCCCEEEccCCcCc
Q 039344          110 PSELG--NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNS-LSA-SILGKIG-------NLKSLSNLQLSENNFN  178 (873)
Q Consensus       110 ~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~-------~l~~L~~L~L~~n~i~  178 (873)
                      |..++  ++++|++|+|++|.+.+.+|..|+.+++|++|+|++|+ +++ ..|..+.       .+++|++|+|++|+++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            66655  77777777777777666677777777777777777776 654 3343333       3347777777777776


Q ss_pred             cCCCc--cccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCC-ccEEecccccCCCCCch
Q 039344          179 GSIPP--SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSN-LTYLNLFENSLSGAIPY  255 (873)
Q Consensus       179 ~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~  255 (873)
                       .+|.  .++++++|+.|+|++|.++ .+| .|+.+++|++|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|.
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~  636 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN  636 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence             5565  6677777777777777776 555 6667777777777777776 56666666666 777777777776 4555


Q ss_pred             hhcCCCC--CcEEEccCCcCcCcCCcCC------CCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCC
Q 039344          256 EYRNLVK--LTILLLGHNQFRGPIPILR------NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD  327 (873)
Q Consensus       256 ~~~~l~~--L~~L~L~~N~l~~~~~~l~------~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~  327 (873)
                      .+..+..  |+.|++++|++.+..+.+.      .+++|+.|+|++|.++.++...+..+++|+.|+|++|++. .+|..
T Consensus       637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~  715 (876)
T 4ecn_A          637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN  715 (876)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTT
T ss_pred             hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChH
Confidence            5555433  7777777777766443322      3346666777777666655555556666666666666666 33332


Q ss_pred             CCC--------CCCCCeeeeccccCCccCCcccc--CCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcc
Q 039344          328 WGR--------CPKLSTLDFSINNITGNVPPEIG--HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLS  397 (873)
Q Consensus       328 ~~~--------l~~L~~L~l~~N~i~~~~~~~~~--~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  397 (873)
                      +..        +++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|.|++ +|..+..+++|+.|+|++|+      
T Consensus       716 ~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------  787 (876)
T 4ecn_A          716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------  787 (876)
T ss_dssp             SSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------
T ss_pred             HhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------
Confidence            222        126666666666666 4555554  66666666666666664 56666666666666665532      


Q ss_pred             cccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhcc
Q 039344          398 PKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKM  477 (873)
Q Consensus       398 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  477 (873)
                                  ++++|++.+.+|..+..+.  +|+.|+|++|++ +.+|..+.  ++|+.|+|++|++..+.+..+...
T Consensus       788 ------------~ls~N~l~~~ip~~l~~L~--~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~  850 (876)
T 4ecn_A          788 ------------DAEGNRILRQWPTGITTCP--SLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPY  850 (876)
T ss_dssp             ------------CTTCCBCCCCCCTTGGGCS--SCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHH
T ss_pred             ------------CcccccccccChHHHhcCC--CCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHcccc
Confidence                        2223444444444444333  444444444444 23333332  244444444444444444444443


Q ss_pred             CCCcEEecCCCc
Q 039344          478 NGLLHIDISYNE  489 (873)
Q Consensus       478 ~~L~~l~ls~N~  489 (873)
                      ..+..+.|++|+
T Consensus       851 ~~~~~~~L~~n~  862 (876)
T 4ecn_A          851 IEAGMYVLLYDK  862 (876)
T ss_dssp             HHTTCCEEECCT
T ss_pred             ccchheeecCCC
Confidence            344444444443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=8.1e-49  Score=457.33  Aligned_cols=478  Identities=21%  Similarity=0.207  Sum_probs=401.3

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeec
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYL  100 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  100 (873)
                      +.....|.++++++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|.+|.++++|++|+|
T Consensus         5 ~~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            5 DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             CTTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            34455789999998 6777664  89999999999999888999999999999999999999888899999999999999


Q ss_pred             cccccCCCCCccccCCcccCccccccccccc-ccCccccCCCCCcEEEccCCC-CccccccccCCCCCCCEEEccCCcCc
Q 039344          101 DTNSLSNSIPSELGNLRSLSNLQLNNNILSG-SIPHSLGNLTNLATLYIYSNS-LSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       101 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      ++|++++..|..|.++++|++|++++|.+++ ..|..|+.+++|++|++++|. +..+.+..|.++++|++|++++|.++
T Consensus        82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~  161 (549)
T 2z81_A           82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR  161 (549)
T ss_dssp             TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence            9999998777789999999999999999986 356789999999999999998 66666678999999999999999999


Q ss_pred             cCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCc--c-cccCCCCCccEEecccccCCCCCch
Q 039344          179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSI--P-ISMGNLSNLTYLNLFENSLSGAIPY  255 (873)
Q Consensus       179 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~-~~~~~l~~L~~L~L~~n~l~~~~~~  255 (873)
                      +..|..+..+++|++|++++|.+.......+..+++|++|++++|++++..  + .....+++|+.|++++|.+++..+.
T Consensus       162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  241 (549)
T 2z81_A          162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN  241 (549)
T ss_dssp             EECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH
T ss_pred             ccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH
Confidence            999999999999999999999998443334567999999999999998642  2 2334678999999999998765443


Q ss_pred             h----hcCCCCCcEEEccCCcCcCcC-------CcCCCCCCCCeEEccCccccccc-----ccccccCCCccEEeccCcc
Q 039344          256 E----YRNLVKLTILLLGHNQFRGPI-------PILRNLTSLERVRLDRNYLTGNI-----SESFYIYPNLTYIDLSQNN  319 (873)
Q Consensus       256 ~----~~~l~~L~~L~L~~N~l~~~~-------~~l~~l~~L~~L~L~~n~l~~~~-----~~~~~~~~~L~~L~Ls~N~  319 (873)
                      .    +..+++|+.+++++|.+.+..       ..+..+++|+.|.+.++.+....     ...+...++|+.|++++|.
T Consensus       242 ~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~  321 (549)
T 2z81_A          242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK  321 (549)
T ss_dssp             HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSC
T ss_pred             HHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCc
Confidence            3    466789999999999987632       34577899999999999876532     1224456789999999999


Q ss_pred             ccccCCCCC-CCCCCCCeeeeccccCCccCCc---cccCCCCCCEEeccCCccCCCCC--ccccccccccEEEecCcccc
Q 039344          320 FYGEISSDW-GRCPKLSTLDFSINNITGNVPP---EIGHSSQLGVLDLSSNHIVGEIP--IELGKLNFFIKLVLAHNQLS  393 (873)
Q Consensus       320 l~~~~~~~~-~~l~~L~~L~l~~N~i~~~~~~---~~~~~~~L~~L~Ls~N~i~~~~~--~~~~~l~~L~~L~L~~N~l~  393 (873)
                      +. .+|..+ ..+++|+.|++++|++++..|.   .++.+++|++|+|++|++++..+  ..+..+++|++|++++|+++
T Consensus       322 l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~  400 (549)
T 2z81_A          322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH  400 (549)
T ss_dssp             CC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred             cc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc
Confidence            97 555555 5799999999999999976643   37889999999999999985432  45889999999999999999


Q ss_pred             CCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchh
Q 039344          394 GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC  473 (873)
Q Consensus       394 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  473 (873)
                       .+|..+..+++|+.|+|++|+|+ .+|..+.    .+|+.|||++|++++.+    ..+++|++|+|++|+|+. +|. 
T Consensus       401 -~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~----~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~~-ip~-  468 (549)
T 2z81_A          401 -PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP----QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLKT-LPD-  468 (549)
T ss_dssp             -CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC----TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSS-CCC-
T ss_pred             -cCChhhcccccccEEECCCCCcc-cccchhc----CCceEEECCCCChhhhc----ccCChhcEEECCCCccCc-CCC-
Confidence             57888999999999999999997 4555443    38999999999999754    478999999999999995 555 


Q ss_pred             hhccCCCcEEecCCCcccccCCCC-CcccCCCcccccCCCCc
Q 039344          474 FEKMNGLLHIDISYNELRGSIPNS-TTFKDAPIEALQGNKGL  514 (873)
Q Consensus       474 ~~~~~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~l  514 (873)
                      ...+++|++|||++|++++.+|.. ..++......+.+|+-.
T Consensus       469 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  510 (549)
T 2z81_A          469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD  510 (549)
T ss_dssp             GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBC
T ss_pred             cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCcc
Confidence            467999999999999999877753 34555566667777543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-50  Score=420.76  Aligned_cols=249  Identities=22%  Similarity=0.293  Sum_probs=199.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.+.||+|+||+||+|+..    +++.||+|+++....... ....+.+|++++++++|||||++++++.+++..|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            57999999999999999999752    578999999875432221 1346789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++...   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus       103 ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999999653   4599999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ........+.+||+.|||||++.+..|+.++||||+||++|||+||+.||.......        ....+....++.+..
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~p~~  248 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--------TMTMILKAKLGMPQF  248 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTT
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--------HHHHHHcCCCCCCCc
Confidence            655555567889999999999999999999999999999999999999987543221        222222333333322


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTM-----QKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~  869 (873)
                      .    ...+.+++.+||+.||++|||+     +|+++
T Consensus       249 ~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          249 L----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            2    2247899999999999999984     56653

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=457.76  Aligned_cols=454  Identities=20%  Similarity=0.204  Sum_probs=299.8

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      +.||+++|+++ .+|..+.  ++|++|+|++|++++..|+.|.++++|++|+|++|++++..|.+|.++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            35556666655 3444443  55666666666665544555555666666666666665555555666666666666666


Q ss_pred             ccCCCCCccccCCcccCccccccccccc-ccCccccCCCCCcEEEccCCCCccccccccCCCCCC--CEEEccCCcC--c
Q 039344          104 SLSNSIPSELGNLRSLSNLQLNNNILSG-SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL--SNLQLSENNF--N  178 (873)
Q Consensus       104 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~i--~  178 (873)
                      +++ .+|..  .+++|++|+|++|.+++ ..|..|+.+++|++|++++|++++   ..+..+++|  ++|++++|.+  .
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            655 33333  55566666666666554 245556666666666666665544   234444455  6666666666  4


Q ss_pred             cCCCccccCCC-CCcEEeccCCCCcccCC-ccccCCCCCCEEEccCcc-------cCCCcccccCCCCCccEEecccccC
Q 039344          179 GSIPPSLGNLS-NLATLYLDTNSLSYSIP-SELGNLRSLSNLSLGYNK-------LSGSIPISMGNLSNLTYLNLFENSL  249 (873)
Q Consensus       179 ~~~~~~~~~l~-~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~n~l  249 (873)
                      +..|..+..+. ....+++++|.+.+..+ ..+..+++|+.|++++|.       +.+..+ .+..+++|+.|++++|.+
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l  232 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET  232 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred             ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence            45555555443 23344555555543332 345556666666666665       443333 456666666666666665


Q ss_pred             CCCCchhhc---CCCCCcEEEccCCcCcC-cCCcC-----CCCCCCCeEEccCcccccccccccccC---CCccEEeccC
Q 039344          250 SGAIPYEYR---NLVKLTILLLGHNQFRG-PIPIL-----RNLTSLERVRLDRNYLTGNISESFYIY---PNLTYIDLSQ  317 (873)
Q Consensus       250 ~~~~~~~~~---~l~~L~~L~L~~N~l~~-~~~~l-----~~l~~L~~L~L~~n~l~~~~~~~~~~~---~~L~~L~Ls~  317 (873)
                      ++..+..+.   ..++|++|++++|++.+ .+..+     ..+++|+.+++++|.+ .++...+..+   ++|+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~  311 (520)
T 2z7x_B          233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSG  311 (520)
T ss_dssp             EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEES
T ss_pred             CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCC
Confidence            532221111   13467777777777664 33334     6677777777777777 4443333333   5688888888


Q ss_pred             ccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCC--CCCccccccccccEEEecCccccCC
Q 039344          318 NNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVG--EIPIELGKLNFFIKLVLAHNQLSGQ  395 (873)
Q Consensus       318 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~  395 (873)
                      |.+....  .+..+++|+.|++++|++++..|..++.+++|++|+|++|++++  .+|..+..+++|+.|++++|++++.
T Consensus       312 n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~  389 (520)
T 2z7x_B          312 TRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD  389 (520)
T ss_dssp             SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred             Ccccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence            8875432  12577888888888888888788888888888888888888875  4556788888899999999988874


Q ss_pred             ccc-ccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhh
Q 039344          396 LSP-KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCF  474 (873)
Q Consensus       396 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  474 (873)
                      +|. .+..+++|+.|+|++|++++..|..+.    .+|+.|||++|+++ .+|..+..+++|+.|+|++|+|+++++..|
T Consensus       390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~----~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~  464 (520)
T 2z7x_B          390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP----PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF  464 (520)
T ss_dssp             GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC----TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTT
T ss_pred             cccchhccCccCCEEECcCCCCCcchhhhhc----ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHh
Confidence            454 578889999999999999888877765    38899999999998 577777799999999999999997655569


Q ss_pred             hccCCCcEEecCCCcccccCC
Q 039344          475 EKMNGLLHIDISYNELRGSIP  495 (873)
Q Consensus       475 ~~~~~L~~l~ls~N~l~~~~p  495 (873)
                      ..+++|++|++++|++++..+
T Consensus       465 ~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          465 DRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             TTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCcccEEECcCCCCcccCC
Confidence            999999999999999997654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.3e-49  Score=417.78  Aligned_cols=261  Identities=22%  Similarity=0.301  Sum_probs=199.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc----eeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR----HLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  677 (873)
                      ++|.+.+.||+|+||+||+|++. |+.||||++...    ......+..|+..+.+++|||||+++|+|.+++    ..|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            45778899999999999999985 899999998642    111222344566667889999999999998754    579


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC-----FPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      +||||+++|+|.++++..    .++|+.+.+++.|++.||+|||+++     .++|+||||||+|||++.++.+||+|||
T Consensus        78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999999643    4899999999999999999999762     3589999999999999999999999999


Q ss_pred             cccccCCCCCC----ccccccccccccccccccC------CCCCcchhHHHHHHHHHHHhCCCCCcccccc--hhhh---
Q 039344          753 IAKFLKPDSSN----WTELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSM--SFSS---  817 (873)
Q Consensus       753 ~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~sDv~s~G~il~el~tg~~P~~~~~~~--~~~~---  817 (873)
                      +|+........    ....+||+.|||||++.+.      .++.++|||||||++|||+||+.||......  .+..   
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99877544332    2245799999999998764      4678999999999999999999887543221  1111   


Q ss_pred             --hhhhhh----hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          818 --LNLNIA----LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       818 --~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        ......    .....++.++.... ..+....+.+++.+||+.||++||||+||++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  293 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGG-SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCcccc-chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence              111111    22223333332221 2244556889999999999999999999999874

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.4e-49  Score=468.71  Aligned_cols=431  Identities=17%  Similarity=0.268  Sum_probs=231.4

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCccc------c------cCCccccCCCCCceEEccCCcccccCCCCccCC-C-
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLS------G------SIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNF-R-   69 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~------~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~-   69 (873)
                      +.+|.+.+.+|.+|++++.|+.|+|++|.+.      +      .+|...  +..|+ +++++|.+.+..|..+..+ . 
T Consensus        88 L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~  164 (636)
T 4eco_A           88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKD  164 (636)
T ss_dssp             CTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHH
T ss_pred             ecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHH
Confidence            4689999999999999999999999999872      1      233322  34556 6666666665555544411 1 


Q ss_pred             -----------------CCCEEEc--ccCCCCCCCCcccccccccceeeccccccCCC-----------------CCccc
Q 039344           70 -----------------FFSDLEL--SNNKLSGSIPPSLGNLSNLATLYLDTNSLSNS-----------------IPSEL  113 (873)
Q Consensus        70 -----------------~L~~L~L--~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~~~~~  113 (873)
                                       .++.+.+  .+|++++ +|..|+++++|++|+|++|++++.                 +|..+
T Consensus       165 l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l  243 (636)
T 4eco_A          165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL  243 (636)
T ss_dssp             HHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred             HhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhh
Confidence                             1111111  1344444 455555555555555555555542                 45555


Q ss_pred             c--CCcccCcccccccccccccCccccCCCCCcEEEccCCC-Ccc-ccccccCCC------CCCCEEEccCCcCccCCCc
Q 039344          114 G--NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNS-LSA-SILGKIGNL------KSLSNLQLSENNFNGSIPP  183 (873)
Q Consensus       114 ~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~n~i~~~~~~  183 (873)
                      .  ++++|++|+|++|.+.+.+|..|+++++|++|++++|+ +++ ..|..+..+      ++|++|+|++|+++ .+|.
T Consensus       244 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~  322 (636)
T 4eco_A          244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV  322 (636)
T ss_dssp             CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred             hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence            4  55555555555555555555555555555555555554 444 334434333      55555555555555 4444


Q ss_pred             --cccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCC-ccEEecccccCCCCCchhhcCC
Q 039344          184 --SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSN-LTYLNLFENSLSGAIPYEYRNL  260 (873)
Q Consensus       184 --~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l  260 (873)
                        .++++++|++|++++|.+++.+| .|..+++|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+..+
T Consensus       323 ~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~  399 (636)
T 4eco_A          323 ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK  399 (636)
T ss_dssp             HHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTT
T ss_pred             hhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhc
Confidence              45555555555555555554444 4555555555555555555 44444555555 555555555555 344444433


Q ss_pred             C--CCcEEEccCCcCcCcCC-cCC-------CCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCC
Q 039344          261 V--KLTILLLGHNQFRGPIP-ILR-------NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGR  330 (873)
Q Consensus       261 ~--~L~~L~L~~N~l~~~~~-~l~-------~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~  330 (873)
                      .  +|+.|++++|++.+..+ .+.       .+++|++|++++|.++.++...+..+++|++|+|++|+++...+..+..
T Consensus       400 ~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~  479 (636)
T 4eco_A          400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD  479 (636)
T ss_dssp             CSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEE
T ss_pred             ccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcc
Confidence            2  55555555555554222 233       4455556666666655555555555566666666666665222222222


Q ss_pred             C-------CCCCeeeeccccCCccCCcccc--CCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccc
Q 039344          331 C-------PKLSTLDFSINNITGNVPPEIG--HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLG  401 (873)
Q Consensus       331 l-------~~L~~L~l~~N~i~~~~~~~~~--~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  401 (873)
                      .       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+          
T Consensus       480 ~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~----------  547 (636)
T 4eco_A          480 ENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR----------  547 (636)
T ss_dssp             TTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB----------
T ss_pred             ccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc----------
Confidence            2       25666666666665 4555554  56666666666666664 55566666666666664322          


Q ss_pred             cccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCcccc
Q 039344          402 SLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLS  467 (873)
Q Consensus       402 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  467 (873)
                              ++++|++.+.+|..+..+.  +|+.|+|++|++ +.+|..+.  ++|+.|+|++|++.
T Consensus       548 --------~ls~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          548 --------DAQGNRTLREWPEGITLCP--SLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             --------CTTCCBCCCCCCTTGGGCS--SCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred             --------ccccCcccccChHHHhcCC--CCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence                    2234444455555554443  555555555555 23344333  45555555555554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=451.88  Aligned_cols=450  Identities=21%  Similarity=0.230  Sum_probs=386.2

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +++|+|+ .+|..+.  ++|++|+|++|++++..|++|.++++|++|+|++|++++..|++|+++++|++|+|++|+++ 
T Consensus         7 ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-   82 (520)
T 2z7x_B            7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-   82 (520)
T ss_dssp             CTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-
T ss_pred             cCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-
Confidence            4678898 5788777  89999999999999888899999999999999999999888999999999999999999999 


Q ss_pred             CCCcccccccccceeeccccccCC-CCCccccCCcccCcccccccccccccCccccCCCCC--cEEEccCCCC--ccccc
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNL--ATLYIYSNSL--SASIL  158 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~  158 (873)
                      .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++   ..|..+++|  ++|++++|.+  .+..+
T Consensus        83 ~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~  157 (520)
T 2z7x_B           83 KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDP  157 (520)
T ss_dssp             EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCT
T ss_pred             ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccccccc
Confidence            45555  89999999999999997 478999999999999999999985   467788888  9999999999  77777


Q ss_pred             cccCCCC-CCCEEEccCCcCccCCC-ccccCCCCCcEEeccCCC-------CcccCCccccCCCCCCEEEccCcccCCCc
Q 039344          159 GKIGNLK-SLSNLQLSENNFNGSIP-PSLGNLSNLATLYLDTNS-------LSYSIPSELGNLRSLSNLSLGYNKLSGSI  229 (873)
Q Consensus       159 ~~~~~l~-~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  229 (873)
                      ..+..+. +...+++++|.+.+..+ ..+..+++|+.|++++|.       +.+.++ .+..+++|+.|++++|.+++..
T Consensus       158 ~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~  236 (520)
T 2z7x_B          158 EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNS  236 (520)
T ss_dssp             TTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHH
T ss_pred             ccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHH
Confidence            7777665 34467889999876554 467889999999999997       665555 7889999999999999987532


Q ss_pred             ccccC---CCCCccEEecccccCCCCCchhh-----cCCCCCcEEEccCCcCcCcC-CcCCCC---CCCCeEEccCcccc
Q 039344          230 PISMG---NLSNLTYLNLFENSLSGAIPYEY-----RNLVKLTILLLGHNQFRGPI-PILRNL---TSLERVRLDRNYLT  297 (873)
Q Consensus       230 ~~~~~---~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~-~~l~~l---~~L~~L~L~~n~l~  297 (873)
                      +..+.   ..++|++|++++|++++..|..+     ..+++|+.+++++|.+ ..+ ..+..+   ++|+.|++++|.+.
T Consensus       237 ~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~  315 (520)
T 2z7x_B          237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMV  315 (520)
T ss_dssp             HHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCC
T ss_pred             HHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCccc
Confidence            22111   24699999999999998888888     8999999999999999 322 233333   67999999999987


Q ss_pred             cccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCc--cCCccccCCCCCCEEeccCCccCCCCCc-
Q 039344          298 GNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG--NVPPEIGHSSQLGVLDLSSNHIVGEIPI-  374 (873)
Q Consensus       298 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~--~~~~~~~~~~~L~~L~Ls~N~i~~~~~~-  374 (873)
                      ....  +..+++|++|++++|++++..|..+..+++|+.|++++|++++  .+|..++.+++|++|+|++|.+++.+|. 
T Consensus       316 ~~~~--~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~  393 (520)
T 2z7x_B          316 HMLC--PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG  393 (520)
T ss_dssp             CCCC--CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGC
T ss_pred             cccc--hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccc
Confidence            6542  2678999999999999999899999999999999999999986  5567899999999999999999975665 


Q ss_pred             cccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhc
Q 039344          375 ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ  454 (873)
Q Consensus       375 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~  454 (873)
                      .+..+++|++|++++|++++..|..+.  ++|+.|||++|+|+ .+|..+..+.  +|++|+|++|++++..+..+..++
T Consensus       394 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~--~L~~L~L~~N~l~~l~~~~~~~l~  468 (520)
T 2z7x_B          394 DCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE--ALQELNVASNQLKSVPDGIFDRLT  468 (520)
T ss_dssp             SCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCT--TCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             hhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCC--CCCEEECCCCcCCccCHHHhccCC
Confidence            488899999999999999887776664  79999999999998 8888887655  999999999999975555589999


Q ss_pred             ccceecccCccccCCCc
Q 039344          455 SLEKLNLSHNSLSGLIP  471 (873)
Q Consensus       455 ~L~~L~L~~N~l~~~~~  471 (873)
                      +|+.|++++|++++..+
T Consensus       469 ~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          469 SLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             TCCEEECCSSCBCCCHH
T ss_pred             cccEEECcCCCCcccCC
Confidence            99999999999997654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-47  Score=458.64  Aligned_cols=433  Identities=19%  Similarity=0.220  Sum_probs=372.0

Q ss_pred             ccCCcccccCCccccCCCCCCEEEC-CCCcccccCCccc-----------------------------------------
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLEL-GNNKLSGSIPHSL-----------------------------------------   41 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L-~~n~l~~~~p~~~-----------------------------------------   41 (873)
                      +.+|+|.+.+|.+|++++.|+.|+| ++|.+++..|-.-                                         
T Consensus       330 Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~  409 (876)
T 4ecn_A          330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN  409 (876)
T ss_dssp             CTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred             CccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhh
Confidence            4689999999999999999999999 8998876533210                                         


Q ss_pred             ----------cCCCCCceEEccC--CcccccCCCCccCCCCCCEEEcccCCCCC-----------------CCCcccc--
Q 039344           42 ----------GNLTNLATLYIHT--NSLSGSIPGEIGNFRFFSDLELSNNKLSG-----------------SIPPSLG--   90 (873)
Q Consensus        42 ----------~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~--   90 (873)
                                .....++.+.+..  |++++ +|..|+++++|++|+|++|.+++                 .+|..++  
T Consensus       410 ~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~  488 (876)
T 4ecn_A          410 RNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS  488 (876)
T ss_dssp             TCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGG
T ss_pred             hCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhc
Confidence                      1223445555554  88997 89999999999999999999997                 3888877  


Q ss_pred             cccccceeeccccccCCCCCccccCCcccCcccccccc-ccc-ccCccccCCC-------CCcEEEccCCCCcccccc--
Q 039344           91 NLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNI-LSG-SIPHSLGNLT-------NLATLYIYSNSLSASILG--  159 (873)
Q Consensus        91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~n~l~~~~~~--  159 (873)
                      ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..++.++       +|+.|+|++|+++. .+.  
T Consensus       489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~-ip~~~  567 (876)
T 4ecn_A          489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASA  567 (876)
T ss_dssp             GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB-CCCHH
T ss_pred             cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCc-cCChh
Confidence            99999999999999999999999999999999999998 887 7888777665       99999999999984 455  


Q ss_pred             ccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCC-CCEEEccCcccCCCcccccCCCCC
Q 039344          160 KIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRS-LSNLSLGYNKLSGSIPISMGNLSN  238 (873)
Q Consensus       160 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~  238 (873)
                      .|..+++|++|+|++|+++ .+| .|..+++|+.|+|++|.++ .+|..+..+++ |++|+|++|+++ .+|..+..++.
T Consensus       568 ~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~  643 (876)
T 4ecn_A          568 SLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV  643 (876)
T ss_dssp             HHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS
T ss_pred             hhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcccc
Confidence            8999999999999999999 677 8999999999999999999 78888999999 999999999999 67878777654


Q ss_pred             --ccEEecccccCCCCCchhh---c--CCCCCcEEEccCCcCcCcCCc-CCCCCCCCeEEccCcccccccccccccC---
Q 039344          239 --LTYLNLFENSLSGAIPYEY---R--NLVKLTILLLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNISESFYIY---  307 (873)
Q Consensus       239 --L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~~---  307 (873)
                        |+.|+|++|++.+..|...   .  .+++|+.|++++|++...+.. +..+++|+.|+|++|.++.++...+...   
T Consensus       644 ~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~  723 (876)
T 4ecn_A          644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN  723 (876)
T ss_dssp             SCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSC
T ss_pred             CCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccccc
Confidence              9999999999987665332   2  345899999999999975554 4588999999999999998777666544   


Q ss_pred             ----CCccEEeccCccccccCCCCCC--CCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCcccccccc
Q 039344          308 ----PNLTYIDLSQNNFYGEISSDWG--RCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNF  381 (873)
Q Consensus       308 ----~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~  381 (873)
                          ++|++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..++.+++|+.|+|++|+              
T Consensus       724 l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~--------------  787 (876)
T 4ecn_A          724 YKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR--------------  787 (876)
T ss_dssp             CTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB--------------
T ss_pred             ccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC--------------
Confidence                39999999999999 6788887  89999999999999997 79899999999999999987              


Q ss_pred             ccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecc
Q 039344          382 FIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNL  461 (873)
Q Consensus       382 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  461 (873)
                          ++++|++.+.+|..+..+++|+.|+|++|+| +.+|..+..    +|+.|||++|++....+..++....+..+.|
T Consensus       788 ----~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~----~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L  858 (876)
T 4ecn_A          788 ----DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP----QLYILDIADNPNISIDVTSVCPYIEAGMYVL  858 (876)
T ss_dssp             ----CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCS----SSCEEECCSCTTCEEECGGGHHHHHTTCCEE
T ss_pred             ----CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcC----CCCEEECCCCCCCccChHHccccccchheee
Confidence                5677888888888888888999999999998 688887652    8889999999998888888888888888888


Q ss_pred             cCcccc
Q 039344          462 SHNSLS  467 (873)
Q Consensus       462 ~~N~l~  467 (873)
                      .+|++.
T Consensus       859 ~~n~~~  864 (876)
T 4ecn_A          859 LYDKTQ  864 (876)
T ss_dssp             ECCTTS
T ss_pred             cCCCcc
Confidence            888765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-47  Score=405.51  Aligned_cols=250  Identities=22%  Similarity=0.398  Sum_probs=193.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc------
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR------  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  674 (873)
                      .+|++.+.||+|+||+||+|+.+ +|+.||||+++...  .....+.+.+|++++++++|||||++++++.+.+      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            46899999999999999999764 79999999987542  2334577999999999999999999999987644      


Q ss_pred             ------eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          675 ------HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       675 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                            ..|+||||+++|+|.+++.........++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence                  3699999999999999998765545567777899999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCC------------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhh
Q 039344          749 SDFGIAKFLKPDSSN------------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS  816 (873)
Q Consensus       749 ~Dfg~a~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~  816 (873)
                      +|||+|+........            .++.+||+.|||||++.+..|+.++||||+||++|||++   ||.....    
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----  232 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----  232 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence            999999877543221            234579999999999999999999999999999999996   7653111    


Q ss_pred             hhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          817 SLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         .......+.+...+.   ..........+++.+||+.||++|||+.|+++
T Consensus       233 ---~~~~~~~~~~~~~p~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 ---RVRTLTDVRNLKFPP---LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ---HHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHHhcCCCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               111122222223221   12233345678999999999999999999986

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.9e-46  Score=443.08  Aligned_cols=469  Identities=23%  Similarity=0.238  Sum_probs=356.0

Q ss_pred             cCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccc
Q 039344           12 SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGN   91 (873)
Q Consensus        12 ~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   91 (873)
                      .+|..++  +++++|||++|+|+++.|.+|.++++|++|+|++|+|+++.|++|+++++|++|+|++|+|++..+.+|.+
T Consensus        45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~  122 (635)
T 4g8a_A           45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG  122 (635)
T ss_dssp             SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT
T ss_pred             ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC
Confidence            5677776  58999999999999888899999999999999999999888999999999999999999999888889999


Q ss_pred             ccccceeeccccccCCCCCccccCCcccCccccccccccc-ccCccccCCCCCcEEEccCCCCccccccccCCCCCC---
Q 039344           92 LSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG-SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL---  167 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L---  167 (873)
                      +++|++|+|++|+++++.+..|+++++|++|+|++|.+++ ..|..++.+++|++|++++|+++++.+..|..+.++   
T Consensus       123 L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~  202 (635)
T 4g8a_A          123 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL  202 (635)
T ss_dssp             CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred             CCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhh
Confidence            9999999999999998777889999999999999999975 357889999999999999999999888887765544   


Q ss_pred             -CEEEccCCcCccCCCccccCCCCCcEEeccCCCCcc-cCCccc------------------------------------
Q 039344          168 -SNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY-SIPSEL------------------------------------  209 (873)
Q Consensus       168 -~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~------------------------------------  209 (873)
                       ..++++.|.++...+..+. ...+..+++.+|.... ..+..+                                    
T Consensus       203 ~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l  281 (635)
T 4g8a_A          203 NLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL  281 (635)
T ss_dssp             CCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGS
T ss_pred             hhhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccch
Confidence             4788999999865554443 3345666666654331 111112                                    


Q ss_pred             ---------------------cCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEc
Q 039344          210 ---------------------GNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLL  268 (873)
Q Consensus       210 ---------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  268 (873)
                                           ..+.+++.+++.+|.+...  ..+....+|+.|++.+|.+....+   ..+..|+.+++
T Consensus       282 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l  356 (635)
T 4g8a_A          282 TIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTF  356 (635)
T ss_dssp             EEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEE
T ss_pred             hhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCc---ccchhhhhccc
Confidence                                 2233444555555544422  123344566666666666654333   23456666666


Q ss_pred             cCCcCcCcCCcCCCCCCCCeEEccCcccccc--cccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCc
Q 039344          269 GHNQFRGPIPILRNLTSLERVRLDRNYLTGN--ISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG  346 (873)
Q Consensus       269 ~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~  346 (873)
                      .+|.+.... ....+++|+.|++++|.+...  .+..+..+.+|+.|+++.|.+.. .+..+..+++|+.++++.|+...
T Consensus       357 ~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~  434 (635)
T 4g8a_A          357 TSNKGGNAF-SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ  434 (635)
T ss_dssp             ESCCSCCBC-CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEES
T ss_pred             ccccCCCCc-ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccc
Confidence            666655432 334577888888888877633  34445567778888888887763 45567778888888888777654


Q ss_pred             cCC-ccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccc-cCCcccccccccccccccccccccccccCCCc
Q 039344          347 NVP-PEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQL-SGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSL  424 (873)
Q Consensus       347 ~~~-~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  424 (873)
                      ..+ ..+..+.+++.++++.|.+.+..+..+..++.|+.|++++|.+ .+..|..+..+++|+.|||++|+|++..|..|
T Consensus       435 ~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f  514 (635)
T 4g8a_A          435 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF  514 (635)
T ss_dssp             TTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence            433 4567778888888888888877777788888888888888864 44566778888888888888888887778888


Q ss_pred             CchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhhhcc-CCCcEEecCCCcccc
Q 039344          425 GNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKM-NGLLHIDISYNELRG  492 (873)
Q Consensus       425 ~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-~~L~~l~ls~N~l~~  492 (873)
                      +++.  +|++|+|++|+|++..|..+..+++|+.|+|++|+|++.+|..|..+ ++|++|+|++|+|.+
T Consensus       515 ~~l~--~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          515 NSLS--SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             TTCT--TCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             cCCC--CCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            8766  88888888888888888888888888888888888888888888777 578888888888875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.9e-46  Score=432.35  Aligned_cols=459  Identities=20%  Similarity=0.183  Sum_probs=360.5

Q ss_pred             CCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeec
Q 039344           21 KSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYL  100 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  100 (873)
                      ...+.+++++|+++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|.+|.++++|++|+|
T Consensus        31 ~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  107 (562)
T 3a79_B           31 ELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV  107 (562)
T ss_dssp             --CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence            34578999999998 4776554  78999999999999777788999999999999999999888889999999999999


Q ss_pred             cccccCCCCCccccCCcccCcccccccccccc-cCccccCCCCCcEEEccCCCCccccccccCCCCCC--CEEEccCCcC
Q 039344          101 DTNSLSNSIPSELGNLRSLSNLQLNNNILSGS-IPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSL--SNLQLSENNF  177 (873)
Q Consensus       101 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~i  177 (873)
                      ++|+++ .+|..  .+++|++|+|++|.+++. .|..|+++++|++|++++|+++...   +..+++|  ++|++++|.+
T Consensus       108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~---~~~l~~L~L~~L~L~~n~l  181 (562)
T 3a79_B          108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD---LLPVAHLHLSCILLDLVSY  181 (562)
T ss_dssp             TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT---TGGGTTSCEEEEEEEESSC
T ss_pred             CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc---hhhhhhceeeEEEeecccc
Confidence            999998 56655  789999999999999863 4578999999999999999987643   4444555  9999999998


Q ss_pred             --ccCCCccccCCC-CCcEEeccCCCCcccCCc-cccCCCCCCEEEccCcccC----CCcccccCCCCCccEEecccccC
Q 039344          178 --NGSIPPSLGNLS-NLATLYLDTNSLSYSIPS-ELGNLRSLSNLSLGYNKLS----GSIPISMGNLSNLTYLNLFENSL  249 (873)
Q Consensus       178 --~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~n~l  249 (873)
                        ++..|..+..+. ..-.+++++|.+.+..+. .+..+++|+.|++++|+..    ......+..+++|+.|+++++.+
T Consensus       182 ~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l  261 (562)
T 3a79_B          182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET  261 (562)
T ss_dssp             CCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEE
T ss_pred             cccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcC
Confidence              777787777664 222567888888764443 4667889999999988521    01223466778888888888776


Q ss_pred             CCCCchh---hcCCCCCcEEEccCCcCcCcC-CcC-----CCCCCCCeEEccCccccccccccccc---CCCccEEeccC
Q 039344          250 SGAIPYE---YRNLVKLTILLLGHNQFRGPI-PIL-----RNLTSLERVRLDRNYLTGNISESFYI---YPNLTYIDLSQ  317 (873)
Q Consensus       250 ~~~~~~~---~~~l~~L~~L~L~~N~l~~~~-~~l-----~~l~~L~~L~L~~n~l~~~~~~~~~~---~~~L~~L~Ls~  317 (873)
                      .+.....   .....+|++|++++|++.+.. ..+     ..++.|+.++++.|.+ .++...+..   .++|++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~~  340 (562)
T 3a79_B          262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSISD  340 (562)
T ss_dssp             CHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTCCCSEEEEES
T ss_pred             cHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhhhccCcceEEEccC
Confidence            5321111   123358999999999998633 333     5666666666666666 333232222   36799999999


Q ss_pred             ccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCC--CCccccccccccEEEecCccccCC
Q 039344          318 NNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGE--IPIELGKLNFFIKLVLAHNQLSGQ  395 (873)
Q Consensus       318 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~  395 (873)
                      |.+....  ....+++|+.|++++|++++..|..++.+++|++|+|++|++++.  +|..+..+++|+.|++++|++++.
T Consensus       341 n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~  418 (562)
T 3a79_B          341 TPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH  418 (562)
T ss_dssp             SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSC
T ss_pred             CCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCc
Confidence            9986322  126789999999999999988999999999999999999999863  346788999999999999999984


Q ss_pred             cc-cccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchhh
Q 039344          396 LS-PKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCF  474 (873)
Q Consensus       396 ~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  474 (873)
                      +| ..+..+++|+.|+|++|++++.+|..+.    .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++++..|
T Consensus       419 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~----~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~  493 (562)
T 3a79_B          419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLP----PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVF  493 (562)
T ss_dssp             CSSCCCCCCTTCCEEECCSSCCCGGGGSSCC----TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTST
T ss_pred             cChhhhcCcccCCEEECCCCCCCcchhhhhc----CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHH
Confidence            44 4688999999999999999988887775    38999999999999 466666799999999999999997655559


Q ss_pred             hccCCCcEEecCCCcccccCCC
Q 039344          475 EKMNGLLHIDISYNELRGSIPN  496 (873)
Q Consensus       475 ~~~~~L~~l~ls~N~l~~~~p~  496 (873)
                      ..+++|+.|++++|+|.+..|-
T Consensus       494 ~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          494 DRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             TTCTTCCCEECCSCCBCCCHHH
T ss_pred             hcCCCCCEEEecCCCcCCCcch
Confidence            9999999999999999987654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=400.29  Aligned_cols=260  Identities=22%  Similarity=0.335  Sum_probs=200.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------c
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------R  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  674 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|+++|+.++|||||++++++...      +
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5799999999999999999976 47999999999765332 23356788999999999999999999998643      5


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..|+||||++ |+|.+++...   +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            6899999997 6788888653   4599999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCC----CCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh------
Q 039344          755 KFLKPD----SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA------  823 (873)
Q Consensus       755 ~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~------  823 (873)
                      +.+...    .....+.+||+.|||||++.+. .++.++||||+||++|||++|+.||................      
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            876432    2234567899999999998875 46899999999999999999999997543221111110000      


Q ss_pred             ------------hhhhcCCCCCCCCch-hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 ------------LDEMLDPRLPTPSRN-VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ------------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                  ......+..+.+... .......+.+++.+||+.||++|||++|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        000011111111000 0011235789999999999999999999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3e-45  Score=427.38  Aligned_cols=451  Identities=21%  Similarity=0.206  Sum_probs=372.4

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +++|+|++ +|..+.  ++|++|+|++|++++..|++|.++++|++|+|++|++++..|++|.++++|++|+|++|+++ 
T Consensus        38 ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-  113 (562)
T 3a79_B           38 YSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-  113 (562)
T ss_dssp             CTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-
T ss_pred             cCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-
Confidence            46788886 777775  89999999999999888899999999999999999999988999999999999999999999 


Q ss_pred             CCCcccccccccceeeccccccCCC-CCccccCCcccCcccccccccccccCccccCCCCC--cEEEccCCCC--ccccc
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSNS-IPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNL--ATLYIYSNSL--SASIL  158 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~  158 (873)
                      .+|..  .+++|++|+|++|++++. .|..|.++++|++|++++|.+++.   .+..+++|  ++|++++|.+  ++..+
T Consensus       114 ~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~  188 (562)
T 3a79_B          114 NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGET  188 (562)
T ss_dssp             EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSC
T ss_pred             ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCc
Confidence            56655  899999999999999963 468999999999999999999853   45666666  9999999999  77778


Q ss_pred             cccCCCC-CCCEEEccCCcCccCCCc-cccCCCCCcEEeccCCCCc----ccCCccccCCCCCCEEEccCcccCCCc---
Q 039344          159 GKIGNLK-SLSNLQLSENNFNGSIPP-SLGNLSNLATLYLDTNSLS----YSIPSELGNLRSLSNLSLGYNKLSGSI---  229 (873)
Q Consensus       159 ~~~~~l~-~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~---  229 (873)
                      ..+..+. ..-.++++.|.+.+..+. .+..+++|+.|++++|...    ......+..+++|+.|+++++.+.+..   
T Consensus       189 ~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~  268 (562)
T 3a79_B          189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK  268 (562)
T ss_dssp             CEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHH
T ss_pred             ccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHH
Confidence            8877765 122678899998875554 5667899999999999632    012345788899999999988876321   


Q ss_pred             -ccccCCCCCccEEecccccCCCCCchhh-----cCCCCCcEEEccCCcCcCcCCcCC---CCCCCCeEEccCccccccc
Q 039344          230 -PISMGNLSNLTYLNLFENSLSGAIPYEY-----RNLVKLTILLLGHNQFRGPIPILR---NLTSLERVRLDRNYLTGNI  300 (873)
Q Consensus       230 -~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~l~---~l~~L~~L~L~~n~l~~~~  300 (873)
                       +..+ ..++|++|++++|.+++..|..+     ..+++|+.++++.|.+..+...+.   ...+|++|++++|.+....
T Consensus       269 ~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~  347 (562)
T 3a79_B          269 LFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV  347 (562)
T ss_dssp             HHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC
T ss_pred             HHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc
Confidence             1111 23599999999999998888776     777777777887777721111121   2267999999999987543


Q ss_pred             ccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCcc--CCccccCCCCCCEEeccCCccCCCCCc-ccc
Q 039344          301 SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGN--VPPEIGHSSQLGVLDLSSNHIVGEIPI-ELG  377 (873)
Q Consensus       301 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~--~~~~~~~~~~L~~L~Ls~N~i~~~~~~-~~~  377 (873)
                      .  ...+++|++|++++|.+++..+..+..+++|+.|++++|++++.  +|..++.+++|++|+|++|.+++.+|. .+.
T Consensus       348 ~--~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  425 (562)
T 3a79_B          348 C--PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA  425 (562)
T ss_dssp             C--CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCC
T ss_pred             C--ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhc
Confidence            2  26789999999999999998999999999999999999999863  346789999999999999999985665 588


Q ss_pred             ccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccc
Q 039344          378 KLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLE  457 (873)
Q Consensus       378 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  457 (873)
                      .+++|++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+.  +|++|+|++|++++..+..+..+++|+
T Consensus       426 ~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~--~L~~L~L~~N~l~~l~~~~~~~l~~L~  500 (562)
T 3a79_B          426 WAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQ--ALQELNVASNQLKSVPDGVFDRLTSLQ  500 (562)
T ss_dssp             CCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSC--CCSEEECCSSCCCCCCTTSTTTCTTCC
T ss_pred             CcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCC--CCCEEECCCCCCCCCCHHHHhcCCCCC
Confidence            899999999999999887766554  78999999999998 7888777665  999999999999965555599999999


Q ss_pred             eecccCccccCCCc
Q 039344          458 KLNLSHNSLSGLIP  471 (873)
Q Consensus       458 ~L~L~~N~l~~~~~  471 (873)
                      .|++++|++++..+
T Consensus       501 ~L~l~~N~~~c~c~  514 (562)
T 3a79_B          501 YIWLHDNPWDCTCP  514 (562)
T ss_dssp             CEECCSCCBCCCHH
T ss_pred             EEEecCCCcCCCcc
Confidence            99999999997655

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-44  Score=390.04  Aligned_cols=198  Identities=27%  Similarity=0.353  Sum_probs=171.0

Q ss_pred             HHHhcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe
Q 039344          598 IRATNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH  672 (873)
Q Consensus       598 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  672 (873)
                      ....+.|++.+.||+|+||+||+|+.+    +++.||+|++....     ....+.+|+++++.+ +|||||++++++.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            345678999999999999999999753    57889999986431     135688999999998 69999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEecc
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDF  751 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Df  751 (873)
                      .+..|+||||+++|+|.+++.      .+++.++..++.|++.||+|||++   ||+||||||+|||++.+ +.+||+||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            999999999999999999883      388999999999999999999999   99999999999999877 79999999


Q ss_pred             ccccccCCCCC----------------------------CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHh
Q 039344          752 GIAKFLKPDSS----------------------------NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIK  802 (873)
Q Consensus       752 g~a~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~t  802 (873)
                      |+|+.......                            ...+.+||+.|+|||++.+. .++.++||||+||++|||+|
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99986543221                            12345799999999998875 48999999999999999999


Q ss_pred             CCCCCcc
Q 039344          803 GKHPRDF  809 (873)
Q Consensus       803 g~~P~~~  809 (873)
                      |+.||..
T Consensus       243 G~~Pf~~  249 (361)
T 4f9c_A          243 GRYPFYK  249 (361)
T ss_dssp             TCSSSSC
T ss_pred             CCCCCCC
Confidence            9999853

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.2e-43  Score=416.97  Aligned_cols=455  Identities=20%  Similarity=0.186  Sum_probs=382.2

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG   83 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~   83 (873)
                      +++|+|+...|.+|.++++|++|+|++|+|+++.|++|.++++|++|+|++|+|++..+++|.++++|++|+|++|++++
T Consensus        59 Ls~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~  138 (635)
T 4g8a_A           59 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS  138 (635)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC
T ss_pred             eeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC
Confidence            47899999999999999999999999999998889999999999999999999998888899999999999999999998


Q ss_pred             CCCcccccccccceeeccccccCCC-CCccccCCcccCcccccccccccccCccccCCCCCc----EEEccCCCCccccc
Q 039344           84 SIPPSLGNLSNLATLYLDTNSLSNS-IPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLA----TLYIYSNSLSASIL  158 (873)
Q Consensus        84 ~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~  158 (873)
                      +.+.+|+++++|++|+|++|+++.. .|..+..+++|++|++++|++++..+..|..+.+++    .++++.|.+..+.+
T Consensus       139 l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~  218 (635)
T 4g8a_A          139 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP  218 (635)
T ss_dssp             STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECT
T ss_pred             CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCc
Confidence            8888999999999999999999863 578899999999999999999988888887766544    68889998877665


Q ss_pred             cccCCCCCCCEEEccCCcCcc----------------------------------------------------------C
Q 039344          159 GKIGNLKSLSNLQLSENNFNG----------------------------------------------------------S  180 (873)
Q Consensus       159 ~~~~~l~~L~~L~L~~n~i~~----------------------------------------------------------~  180 (873)
                      ..+..+ .++.+++++|....                                                          .
T Consensus       219 ~~~~~~-~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~  297 (635)
T 4g8a_A          219 GAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDG  297 (635)
T ss_dssp             TTTTTC-EEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEE
T ss_pred             ccccch-hhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccc
Confidence            554332 34445554442210                                                          0


Q ss_pred             CCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCC
Q 039344          181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL  260 (873)
Q Consensus       181 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  260 (873)
                      ....+..+.+++.+.+.++.+...  ..+.....|+.|++.+|.+....+   ..+..|+.+++..|.+...  ..+..+
T Consensus       298 ~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l  370 (635)
T 4g8a_A          298 IIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDL  370 (635)
T ss_dssp             CTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBC
T ss_pred             hhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccc
Confidence            111233345677777777776632  346677899999999999985543   3567899999999988643  345678


Q ss_pred             CCCcEEEccCCcCcCc---CCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccC-CCCCCCCCCCCe
Q 039344          261 VKLTILLLGHNQFRGP---IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEI-SSDWGRCPKLST  336 (873)
Q Consensus       261 ~~L~~L~L~~N~l~~~---~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~  336 (873)
                      ++|+.|++++|.+...   ...+..+.+|+.+++..|.+.... ..+..+++|+.+++++|+..... ...|..+++++.
T Consensus       371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~-~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~  449 (635)
T 4g8a_A          371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMS-SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY  449 (635)
T ss_dssp             TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEEC-SCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCE
T ss_pred             cccccchhhccccccccccccchhhhhhhhhhhcccccccccc-ccccccccccchhhhhcccccccccccccccccccc
Confidence            9999999999998752   224567889999999999987654 45778999999999999887654 456788999999


Q ss_pred             eeeccccCCccCCccccCCCCCCEEeccCCccC-CCCCccccccccccEEEecCccccCCcccccccccccccccccccc
Q 039344          337 LDFSINNITGNVPPEIGHSSQLGVLDLSSNHIV-GEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNR  415 (873)
Q Consensus       337 L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  415 (873)
                      ++++.|.+....+..+..++.|+.|+|++|.+. +..|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+
T Consensus       450 l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~  529 (635)
T 4g8a_A          450 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  529 (635)
T ss_dssp             EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCc
Confidence            999999999888999999999999999999854 4578889999999999999999999889999999999999999999


Q ss_pred             cccccCCCcCchhhhhhhcccccCCccCcccchhhhhh-cccceecccCccccCC
Q 039344          416 LSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM-QSLEKLNLSHNSLSGL  469 (873)
Q Consensus       416 l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~  469 (873)
                      |++..|..|.++.  +|+.|||++|+|++..|..+..+ ++|+.|+|++|+++..
T Consensus       530 l~~l~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          530 FFSLDTFPYKCLN--SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             CCBCCCGGGTTCT--TCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCCCChhHHhCCC--CCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            9988888888876  99999999999999999999988 6899999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.5e-44  Score=406.42  Aligned_cols=251  Identities=22%  Similarity=0.222  Sum_probs=199.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHH---HHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFL---NEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.++||+|+||+||+|+.+ +|+.||+|++.+...........+.   .++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999764 7999999998643211111122333   3456667778999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||++||+|.+++...   +.+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999999653   4599999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ...  ...+.+||+.|||||++.+ ..|+.++|+||+||++|||++|+.||.........     .............+.
T Consensus       343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-----~i~~~i~~~~~~~p~  415 (689)
T 3v5w_A          343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLTMAVELPD  415 (689)
T ss_dssp             SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-----HHHHHHHHCCCCCCT
T ss_pred             CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHhhcCCCCCCCc
Confidence            543  2345789999999999974 57999999999999999999999999753322111     111122222222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                      ..    ...+.+++.+||+.||++|++     ++||++
T Consensus       416 ~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          416 SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             TS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             cC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            22    224789999999999999998     677754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-43  Score=406.49  Aligned_cols=251  Identities=19%  Similarity=0.293  Sum_probs=209.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++....   ....+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6799999999999999999976 479999999987532   233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC--CCeEEeccccccccC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE--NEAHVSDFGIAKFLK  758 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~--~~~kl~Dfg~a~~~~  758 (873)
                      ||+++|+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+.
T Consensus       234 E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          234 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             ECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             eecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999986432  3589999999999999999999999   99999999999999854  899999999999876


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......        .....+.......+...
T Consensus       309 ~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~  379 (573)
T 3uto_A          309 PK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWNMDDSA  379 (573)
T ss_dssp             TT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCCCCCSGG
T ss_pred             CC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCCCCCCccc
Confidence            43 3445678999999999999999999999999999999999999998754332        12222222222222222


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+.+|+.+||+.||++|||++|+++
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2222345789999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.8e-42  Score=392.19  Aligned_cols=392  Identities=22%  Similarity=0.251  Sum_probs=249.0

Q ss_pred             CEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccccccccccc-CccccCCCCCcEEEccC
Q 039344           72 SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI-PHSLGNLTNLATLYIYS  150 (873)
Q Consensus        72 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~  150 (873)
                      +.++.+++.++ .+|. +.  ++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ +..|.++++|++|+|++
T Consensus        13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            45666666666 4444 22  56666666666666555666666666666666666665333 44566666666666666


Q ss_pred             CCCccccccccCCCCCCCEEEccCCcCccCCCcc--ccCCCCCcEEeccCCCCcccCCcc-ccCCCCCCEEEccCcccCC
Q 039344          151 NSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS--LGNLSNLATLYLDTNSLSYSIPSE-LGNLRSLSNLSLGYNKLSG  227 (873)
Q Consensus       151 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~  227 (873)
                      |+++++.+..|.++++|++|+|++|++++..+..  |..+++|++|+|++|.+++..|.. +..+++|++|++++|++++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            6666555556666666666666666665432222  555555555555555555444443 4555555555555555555


Q ss_pred             CcccccCCC--CCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccc
Q 039344          228 SIPISMGNL--SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFY  305 (873)
Q Consensus       228 ~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~  305 (873)
                      ..+..+..+  .+|+.|++++|.+.+..+..+..               .....+..+++|++|++++|.+++..+..+.
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~---------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~  233 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW---------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFF  233 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH---------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHH
T ss_pred             cChhhhhccccccccccccccCcccccchhhccc---------------cccccccccceeeeEecCCCcccccchhhhh
Confidence            444444443  34455555555544332221110               0011233456777777777777766555554


Q ss_pred             cC---CCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccC--CCCCCEEeccCCccCCCCCccccccc
Q 039344          306 IY---PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGH--SSQLGVLDLSSNHIVGEIPIELGKLN  380 (873)
Q Consensus       306 ~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~--~~~L~~L~Ls~N~i~~~~~~~~~~l~  380 (873)
                      ..   ++|+.|++++|.+.+...              ..+.+.+..+..+..  .++|+.|++++|.+++..|..+..++
T Consensus       234 ~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  299 (455)
T 3v47_A          234 DAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT  299 (455)
T ss_dssp             HHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCT
T ss_pred             ccccccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCC
Confidence            43   678888888776653211              111222122222222  35677777777777777777777777


Q ss_pred             cccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceec
Q 039344          381 FFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLN  460 (873)
Q Consensus       381 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  460 (873)
                      +|++|++++|++++..+..+..+++|+.|+|++|++++..|..+..+.  +|++|+|++|++++..|..+..+++|++|+
T Consensus       300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  377 (455)
T 3v47_A          300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD--KLEVLDLSYNHIRALGDQSFLGLPNLKELA  377 (455)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT--TCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc--cCCEEECCCCcccccChhhccccccccEEE
Confidence            777777777777776777777788888888888888776677777665  788888888888887788888888999999


Q ss_pred             ccCccccCCCchhhhccCCCcEEecCCCcccccCCCCC
Q 039344          461 LSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNST  498 (873)
Q Consensus       461 L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~~  498 (873)
                      |++|+|++.++..|..+++|++|++++|++++..|...
T Consensus       378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             CCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            99999998888888889999999999999998888644

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=9.3e-42  Score=384.27  Aligned_cols=413  Identities=25%  Similarity=0.310  Sum_probs=248.3

Q ss_pred             CccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCC-------------CEEEcccCC
Q 039344           14 PSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF-------------SDLELSNNK   80 (873)
Q Consensus        14 p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~   80 (873)
                      |..+ ..+.|++|++++|++ +.+|++|+++++|++|++++|++++.+|..++.+.+|             ++|++++|.
T Consensus         5 p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~   82 (454)
T 1jl5_A            5 PRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG   82 (454)
T ss_dssp             -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred             cccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence            4444 358899999999999 6899999999999999999999999999999998875             888888888


Q ss_pred             CCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccc
Q 039344           81 LSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGK  160 (873)
Q Consensus        81 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  160 (873)
                      +++ +|..   .++|++|++++|.+++ +|..   +++|++|++++|.+++ ++..   .++|++|++++|++++++  .
T Consensus        83 l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~lp--~  148 (454)
T 1jl5_A           83 LSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEKLP--E  148 (454)
T ss_dssp             CSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSSCC--C
T ss_pred             ccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCCCc--c
Confidence            885 4432   3678888888888885 5543   3788888888888874 3321   168888888888888743  5


Q ss_pred             cCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCcc
Q 039344          161 IGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLT  240 (873)
Q Consensus       161 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  240 (873)
                      |+.+++|++|++++|++++ +|..+   .+|++|++++|.+++ +| .++++++|++|++++|++++ .|..   .++|+
T Consensus       149 ~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~  218 (454)
T 1jl5_A          149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLE  218 (454)
T ss_dssp             CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCC
T ss_pred             cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCccc
Confidence            8888888888888888885 44433   478888888888885 45 58888888888888888875 3332   25788


Q ss_pred             EEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccc
Q 039344          241 YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF  320 (873)
Q Consensus       241 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l  320 (873)
                      +|++++|.++ ..| .+..+++|++|++++|++.+.+..   +++|+.|++++|.+++++..    .++|++|++++|++
T Consensus       219 ~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~l~~~----~~~L~~L~ls~N~l  289 (454)
T 1jl5_A          219 SIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTDLPEL----PQSLTFLDVSENIF  289 (454)
T ss_dssp             EEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSCCCCC----CTTCCEEECCSSCC
T ss_pred             EEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccccCcc----cCcCCEEECcCCcc
Confidence            8888888888 445 377888888888888888764432   36788888888888865432    37788888888888


Q ss_pred             cccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCccccc
Q 039344          321 YGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKL  400 (873)
Q Consensus       321 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  400 (873)
                      ++.. .   -.++|+.|++++|++++. +.   ..++|++|++++|++++ +|..   +++|+.|++++|+++. +|.  
T Consensus       290 ~~l~-~---~~~~L~~L~l~~N~l~~i-~~---~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~--  354 (454)
T 1jl5_A          290 SGLS-E---LPPNLYYLNASSNEIRSL-CD---LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE--  354 (454)
T ss_dssp             SEES-C---CCTTCCEEECCSSCCSEE-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--
T ss_pred             Cccc-C---cCCcCCEEECcCCcCCcc-cC---CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc--
Confidence            7522 1   125788888888887742 21   12478888888888874 5543   4677888888888874 444  


Q ss_pred             cccccccccccccccccc--ccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccC--CCchhhhc
Q 039344          401 GSLVQLEHLDLSSNRLSN--SIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSG--LIPSCFEK  476 (873)
Q Consensus       401 ~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~  476 (873)
                       .+++|+.|+|++|++++  .+|.++..+          +.|.+.+.+|..   +++|+.|++++|++++  .+|.    
T Consensus       355 -~l~~L~~L~L~~N~l~~l~~ip~~l~~L----------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~----  416 (454)
T 1jl5_A          355 -LPQNLKQLHVEYNPLREFPDIPESVEDL----------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE----  416 (454)
T ss_dssp             -CCTTCCEEECCSSCCSSCCCCCTTCCEE----------ECCC-------------------------------------
T ss_pred             -hhhhccEEECCCCCCCcCCCChHHHHhh----------hhcccccccccc---cCcCCEEECCCCcCCccccchh----
Confidence             46778888888888876  566665533          345555555542   4678888888888876  4444    


Q ss_pred             cCCCcEEecCCCcccccCCC
Q 039344          477 MNGLLHIDISYNELRGSIPN  496 (873)
Q Consensus       477 ~~~L~~l~ls~N~l~~~~p~  496 (873)
                        .++.|.+.+|.+.+++|.
T Consensus       417 --sl~~L~~~~~~~~~~~~~  434 (454)
T 1jl5_A          417 --SVEDLRMNSERVVDPYEF  434 (454)
T ss_dssp             --------------------
T ss_pred             --hHhheeCcCcccCCcccc
Confidence              345566777777665543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=6.4e-42  Score=389.18  Aligned_cols=389  Identities=19%  Similarity=0.164  Sum_probs=226.7

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCC-CCCcccccccccceeeccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG-SIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~  102 (873)
                      +.++.++++++ .+|. +.  ++|++|+|++|++++..|..|.++++|++|+|++|.+.+ +.+.+|.++++|++|+|++
T Consensus        13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            45667777776 4554 22  667777777777776667777777777777777776653 3355666677777777777


Q ss_pred             cccCCCCCccccCCcccCcccccccccccccCcc--ccCCCCCcEEEccCCCCccccccc-cCCCCCCCEEEccCCcCcc
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHS--LGNLTNLATLYIYSNSLSASILGK-IGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~i~~  179 (873)
                      |++++..|..|.++++|++|+|++|.+++..+..  |..+++|++|+|++|++.++.+.. |..+++|++|++++|.+++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            7766555666666666666666666666433333  666666666666666665554443 5556666666666666655


Q ss_pred             CCCccccCC--CCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhh
Q 039344          180 SIPPSLGNL--SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY  257 (873)
Q Consensus       180 ~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  257 (873)
                      ..+..+..+  .+|+.|++++|.+....+..++.                .....+..+++|++|++++|++++..+..+
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~  232 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRF  232 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred             cChhhhhccccccccccccccCcccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhh
Confidence            555555443  34555555555554322221110                000112244566666666666665555555


Q ss_pred             cCC---CCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCccccccccccccc--CCCccEEeccCccccccCCCCCCCCC
Q 039344          258 RNL---VKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYI--YPNLTYIDLSQNNFYGEISSDWGRCP  332 (873)
Q Consensus       258 ~~l---~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~--~~~L~~L~Ls~N~l~~~~~~~~~~l~  332 (873)
                      ...   .+|+.|++++|.+.+.......             +.......+..  .++|++|++++|.+.+..+..+..++
T Consensus       233 ~~~~~~~~L~~L~l~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  299 (455)
T 3v47_A          233 FDAIAGTKIQSLILSNSYNMGSSFGHTN-------------FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT  299 (455)
T ss_dssp             HHHTTTCCEEEEECTTCTTTSCCTTCCS-------------SCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCT
T ss_pred             hccccccceeeEeeccccccccccchhh-------------hccCcccccccccccCceEEEecCccccccchhhcccCC
Confidence            443   5666666666655442111111             11111111211  24566666666666666666666666


Q ss_pred             CCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCccccccccccccccccc
Q 039344          333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLS  412 (873)
Q Consensus       333 ~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  412 (873)
                      +|+.|++++|++++..|..|+.+++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|+
T Consensus       300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  379 (455)
T 3v47_A          300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD  379 (455)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence            66666666666666556666666666666666666665555666666666666666666666556666666666666666


Q ss_pred             ccccccccCCCcCchhhhhhhcccccCCccCcccc
Q 039344          413 SNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIP  447 (873)
Q Consensus       413 ~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~  447 (873)
                      +|+|++..+..+..+.  +|++|+|++|++++..|
T Consensus       380 ~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          380 TNQLKSVPDGIFDRLT--SLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             SSCCSCCCTTTTTTCT--TCCEEECCSSCBCCCTT
T ss_pred             CCccccCCHhHhccCC--cccEEEccCCCcccCCC
Confidence            6666654444555544  66666666666665544

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-42  Score=372.05  Aligned_cols=264  Identities=28%  Similarity=0.397  Sum_probs=204.5

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      ..++.....+|++.+.||+|+||+||+|+.. |+.||||++..... .....+++.+|++++++++||||+++++++.+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3334445678999999999999999999874 88999999876433 233456799999999999999999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeCCCCCeEEecc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      +..++||||+++++|.+++........+++..++.++.|++.|++|||++   +  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence            99999999999999999997765445589999999999999999999999   8  999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      |+++.............||+.|+|||.+.+..++.++||||+||++|||++|+.||............      ......
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~  257 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV------GFKCKR  257 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------HHSCCC
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcCCC
Confidence            99986655444445678999999999999999999999999999999999999998754322111110      011122


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       258 ~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          258 LEIPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2222211    224889999999999999999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-42  Score=374.87  Aligned_cols=280  Identities=31%  Similarity=0.582  Sum_probs=226.8

Q ss_pred             ccccCHHHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEe
Q 039344          589 EGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG  668 (873)
Q Consensus       589 ~~~~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  668 (873)
                      ...+++.++....++|++.+.||+|+||.||+|+..+|+.||||++........  ...+.+|+++++.++||||+++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEE
Confidence            346778899999999999999999999999999988899999999976433222  236889999999999999999999


Q ss_pred             EEEecceeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeE
Q 039344          669 FCLHVRHLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAH  747 (873)
Q Consensus       669 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k  747 (873)
                      ++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.|++|||+++.++|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999997654 334589999999999999999999998777899999999999999999999


Q ss_pred             EeccccccccCCCCCC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc--------hhhhh
Q 039344          748 VSDFGIAKFLKPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM--------SFSSL  818 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~--------~~~~~  818 (873)
                      |+|||+++........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||+.....        .+...
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999999876544332 33456999999999999989999999999999999999999999632211        00000


Q ss_pred             -hhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          819 -NLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       819 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ........+.+.....  ....+....+.+++.+||+.||++|||++||++.|+
T Consensus       255 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence             0111122222322222  223455677999999999999999999999999985

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-41  Score=362.75  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=209.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||+||+|+. .+|+.||+|++.......   .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            46799999999999999999985 578999999987543222   46789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...    .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999998643    488999999999999999999999   999999999999999999999999999988776


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||...........     ......+....+..  
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~--  241 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-----IATNGTPELQNPEK--  241 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHHCSCCCSCGGG--
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCCCCCCCccc--
Confidence            65556667899999999999999999999999999999999999999875433211111     11111122222211  


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ....+.+++.+||+.||++|||++|+++
T Consensus       242 --~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          242 --LSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              2234789999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.5e-42  Score=371.92  Aligned_cols=272  Identities=30%  Similarity=0.485  Sum_probs=221.3

Q ss_pred             CHHHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe
Q 039344          593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH  672 (873)
Q Consensus       593 ~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  672 (873)
                      .+.++..++++|++.+.||+|+||.||+|+.++|+.||||++.....   ...+.+.+|+.+++.++||||+++++++.+
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            33445567789999999999999999999988899999999875422   235789999999999999999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      .+..++||||+++|+|.+++.... ....+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999987544 233589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh-------hhhh
Q 039344          752 GIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL-------NLNI  822 (873)
Q Consensus       752 g~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~-------~~~~  822 (873)
                      |+++.......  ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....+......       ....
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            99986543222  22345689999999999999999999999999999999999999875433211111       0111


Q ss_pred             hhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......++.....  ...+....+.+++.+||+.||++|||++|+++.|+
T Consensus       264 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          264 QLEQIVDPNLADK--IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CCCSSSSSSCTTC--SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cHHHhcChhhccc--cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1223333333222  22455667999999999999999999999999885

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.5e-41  Score=362.47  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=214.3

Q ss_pred             cccCHHHHHHHhcC----------CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc
Q 039344          590 GKIIYEEIIRATND----------FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI  658 (873)
Q Consensus       590 ~~~~~~e~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l  658 (873)
                      +.++++++..+.+.          |+..+.||+|+||.||+|+.. +|+.||||++......   ..+.+.+|+.+++.+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l   99 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDY   99 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhC
Confidence            45677777777654          666789999999999999876 7999999998754322   246789999999999


Q ss_pred             cCCceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       659 ~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +||||+++++++...+..++||||+++++|.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||
T Consensus       100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  172 (321)
T 2c30_A          100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI  172 (321)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            999999999999999999999999999999999864    2489999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL  818 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~  818 (873)
                      +++.++.+||+|||+++.............||+.|+|||++.+..++.++||||+|+++|||++|+.||.........  
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~--  250 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--  250 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence            999999999999999987765544555678999999999999999999999999999999999999998754322111  


Q ss_pred             hhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          819 NLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ........+......    .....+.+++.+||+.||++|||++|+++
T Consensus       251 ---~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          251 ---KRLRDSPPPKLKNSH----KVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ---HHHHHSSCCCCTTGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHhcCCCCCcCccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               111111122222111    12234889999999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-41  Score=366.03  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=208.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            46799999999999999999986 58999999998754322 23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999998653   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      . .......||+.|+|||++.+..+. .++||||+||++|||++|+.||+......        ....+..+....+...
T Consensus       167 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~p~~~  237 (328)
T 3fe3_A          167 G-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--------LRERVLRGKYRIPFYM  237 (328)
T ss_dssp             S-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTS
T ss_pred             C-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCCC
Confidence            3 344567899999999999888765 78999999999999999999987543221        1222222333333222


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ...+.+++.+||+.||.+|||++|+++
T Consensus       238 ----s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          238 ----STDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                224789999999999999999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-41  Score=366.10  Aligned_cols=250  Identities=23%  Similarity=0.295  Sum_probs=207.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            67899999999999999999865 69999999986532112223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999988643   3589999999999999999999999   9999999999999999999999999999875555


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+...  
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~--  228 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRTL--  228 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTS--
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCCCC--
Confidence            555566789999999999999999999999999999999999999987533221        1112222222222221  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                        ...+.+++.+||+.||++||     +++|+++
T Consensus       229 --s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          229 --SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence              22478999999999999999     8999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.9e-41  Score=359.94  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=207.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|.+.+.||+|+||+||+|+.. +++.||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            367888999999999999999864 6899999988542   334467899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...  ...+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            9999999999999653  24589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCc--------------cccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhh-hhhhhhhh
Q 039344          760 DSSNW--------------TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-SLNLNIAL  824 (873)
Q Consensus       760 ~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~-~~~~~~~~  824 (873)
                      .....              ....||+.|+|||++.+..++.++||||+|+++|||++|..||......... ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  240 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL  240 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence            32211              1457999999999999999999999999999999999999998653322111 11111112


Q ss_pred             hhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....+..+          ..+.+++.+||+.||++|||++++++.|+
T Consensus       241 ~~~~~~~~~----------~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          241 DRYCPPNCP----------PSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             HHTCCTTCC----------TTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCCCCCC----------HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            222122221          13789999999999999999999999875

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.6e-40  Score=374.15  Aligned_cols=404  Identities=26%  Similarity=0.322  Sum_probs=281.4

Q ss_pred             ccCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCC-------------ceEEccCCcccccCCCCccCCCC
Q 039344            4 IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNL-------------ATLYIHTNSLSGSIPGEIGNFRF   70 (873)
Q Consensus         4 ~~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~p~~~~~l~~   70 (873)
                      +++|++ +.+|.+|+++++|++|++++|++++.+|.+++.+++|             ++|++++|+++ .+|..   .++
T Consensus        18 l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~---~~~   92 (454)
T 1jl5_A           18 RHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL---PPH   92 (454)
T ss_dssp             -----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC---CTT
T ss_pred             cccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC---cCC
Confidence            357888 8999999999999999999999999999999999875             99999999999 45552   378


Q ss_pred             CCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccC
Q 039344           71 FSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYS  150 (873)
Q Consensus        71 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  150 (873)
                      |++|++++|.+++ +|..   +++|++|++++|++++ +|..   .++|++|++++|.+++ +| .|+.+++|++|++++
T Consensus        93 L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~  162 (454)
T 1jl5_A           93 LESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN  162 (454)
T ss_dssp             CSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred             CCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence            9999999999996 6644   3789999999999985 3332   2799999999999995 77 599999999999999


Q ss_pred             CCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcc
Q 039344          151 NSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP  230 (873)
Q Consensus       151 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  230 (873)
                      |++++++. .   ..+|++|++++|++++ +| .++++++|++|++++|.+++ +|...   ++|++|++++|+++ .+|
T Consensus       163 N~l~~lp~-~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp  231 (454)
T 1jl5_A          163 NSLKKLPD-L---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP  231 (454)
T ss_dssp             SCCSCCCC-C---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC
T ss_pred             CcCcccCC-C---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc
Confidence            99987432 2   3599999999999996 45 69999999999999999995 44432   58999999999999 566


Q ss_pred             cccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCc
Q 039344          231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNL  310 (873)
Q Consensus       231 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L  310 (873)
                       .+..+++|++|++++|++++. |.   .+++|+.|++++|++.+.+..   .++|++|++++|.++++..    ..++|
T Consensus       232 -~~~~l~~L~~L~l~~N~l~~l-~~---~~~~L~~L~l~~N~l~~l~~~---~~~L~~L~ls~N~l~~l~~----~~~~L  299 (454)
T 1jl5_A          232 -ELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSGLSE----LPPNL  299 (454)
T ss_dssp             -CCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSEESC----CCTTC
T ss_pred             -ccCCCCCCCEEECCCCcCCcc-cc---cccccCEEECCCCcccccCcc---cCcCCEEECcCCccCcccC----cCCcC
Confidence             489999999999999999864 33   248999999999999985443   4899999999999997542    13789


Q ss_pred             cEEeccCccccccCCCCCCCC-CCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecC
Q 039344          311 TYIDLSQNNFYGEISSDWGRC-PKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAH  389 (873)
Q Consensus       311 ~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~  389 (873)
                      ++|++++|++++..     .+ ++|+.|++++|++++ +|..   +++|++|++++|.++ .+|.   .+.+|+.|++++
T Consensus       300 ~~L~l~~N~l~~i~-----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~  366 (454)
T 1jl5_A          300 YYLNASSNEIRSLC-----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEY  366 (454)
T ss_dssp             CEEECCSSCCSEEC-----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred             CEEECcCCcCCccc-----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCC
Confidence            99999999998532     23 589999999999986 5554   589999999999998 5666   478999999999


Q ss_pred             ccccC--CcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCc--ccchhhhhhcccceecccCcc
Q 039344          390 NQLSG--QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLRE--AIPSQICIMQSLEKLNLSHNS  465 (873)
Q Consensus       390 N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~  465 (873)
                      |++++  .+|..+..        |+.|.+.+.+|..+     .+|+.||+++|++++  .+|      ++|+.|.+.+|.
T Consensus       367 N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~~-----~~L~~L~ls~N~l~~~~~iP------~sl~~L~~~~~~  427 (454)
T 1jl5_A          367 NPLREFPDIPESVED--------LRMNSHLAEVPELP-----QNLKQLHVETNPLREFPDIP------ESVEDLRMNSER  427 (454)
T ss_dssp             SCCSSCCCCCTTCCE--------EECCC----------------------------------------------------
T ss_pred             CCCCcCCCChHHHHh--------hhhccccccccccc-----CcCCEEECCCCcCCccccch------hhHhheeCcCcc
Confidence            99998  56655543        34577777777643     378899999999987  444      357788899999


Q ss_pred             ccCCCchhhhcc
Q 039344          466 LSGLIPSCFEKM  477 (873)
Q Consensus       466 l~~~~~~~~~~~  477 (873)
                      +.+..|......
T Consensus       428 ~~~~~~~~~~~~  439 (454)
T 1jl5_A          428 VVDPYEFAHETT  439 (454)
T ss_dssp             ------------
T ss_pred             cCCccccCHHHh
Confidence            988776654433

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.9e-40  Score=354.62  Aligned_cols=276  Identities=30%  Similarity=0.491  Sum_probs=225.9

Q ss_pred             ccccCHHHHHHHhcCCCCC------ceeeecCCeEEEEEEeCCCcEEEEEEccCCCC-CcchhHHHHHHHHHHHHhccCC
Q 039344          589 EGKIIYEEIIRATNDFDDE------HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEIWHR  661 (873)
Q Consensus       589 ~~~~~~~e~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~  661 (873)
                      ...+.+.++..++..|...      +.||+|+||.||+|+. +++.||||++..... ......+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3567889999999998877      8999999999999987 488999999875432 2233467899999999999999


Q ss_pred             ceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC
Q 039344          662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD  741 (873)
Q Consensus       662 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~  741 (873)
                      ||+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.|++|||++   +|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            99999999999999999999999999999997655556799999999999999999999999   999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh
Q 039344          742 FENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN  819 (873)
Q Consensus       742 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~  819 (873)
                      .++.+||+|||+++........  .....|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||+...........
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            9999999999999876543222  234578999999998765 5889999999999999999999999754432111111


Q ss_pred             ------hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          820 ------LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       820 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                            ......+.+++.+....   ......+.+++.+||+.||++|||++++++.|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~  302 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ  302 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSCSCCC---HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             HHHhhhhhhhhhhhccccccccc---hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                  11123344454443332   344556899999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.2e-41  Score=370.68  Aligned_cols=255  Identities=22%  Similarity=0.368  Sum_probs=208.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe--------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL--------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      .++|++.+.||+|+||.||+|+.        .++..||||+++..  ......+.+.+|+.+++.+ +||||++++++|.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            46788999999999999999975        24567999999754  2333457799999999999 8999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +.+..|+||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||++   +|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            99999999999999999999975432             23578999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||........
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999987654332  2233457889999999999999999999999999999999 9999875432211


Q ss_pred             hhhhhhhhhhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .        ..+..+. ...+..    ....+.+++.+||+.||++||++.|+++.|+
T Consensus       315 ~--------~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~  360 (370)
T 2psq_A          315 F--------KLLKEGHRMDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  360 (370)
T ss_dssp             H--------HHHHTTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--------HHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1        1111111 111111    1234889999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.7e-41  Score=370.52  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.++||+|+||+||+|+.+ +++.||+|++++.........+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999865 6889999999765433333345678899999887 89999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|+|..++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999998653   4589999999999999999999999   99999999999999999999999999998755


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhh-hhhhhhhhhhhcCCCCCCCCc
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-SLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||+........ ..........+.......+..
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            4445556678999999999999999999999999999999999999999743321111 111111222233333333322


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~  864 (873)
                      .    ...+.+++.+||+.||++||++
T Consensus       285 ~----s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 L----SVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             S----CHHHHHHHHHHTCSCTTTSTTC
T ss_pred             C----CHHHHHHHHHHhcCCHhHcCCC
Confidence            2    2247899999999999999985

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.6e-41  Score=365.51  Aligned_cols=254  Identities=20%  Similarity=0.262  Sum_probs=209.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCc---chhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+.|++.+.||+|+||.||+|+.. +|+.||+|++.......   ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999865 68999999987643321   12357899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC----CeEEeccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFG  752 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg  752 (873)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999643   3589999999999999999999999   999999999999998877    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||......        .....+.....
T Consensus       165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~~~~~  235 (361)
T 2yab_A          165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITAVSY  235 (361)
T ss_dssp             SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC
T ss_pred             CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCC
Confidence            99876543 3344567999999999999989999999999999999999999998753322        22223333333


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+..........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3222222222345889999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.6e-41  Score=362.70  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=205.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57899999999999999999865 6899999999865444444456788999999988 899999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++...   ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999998643   3589999999999999999999999   999999999999999999999999999987554


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhh-hhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-SLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..........+.......+...
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence            444556678999999999999999999999999999999999999999753221100 0111111222222333222222


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTM  864 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~  864 (873)
                          ...+.+++.+||+.||++||++
T Consensus       243 ----s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 ----SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ----CHHHHHHHHHHhcCCHhHCCCC
Confidence                2247899999999999999995

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6e-41  Score=357.03  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=205.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367999999999999999999754 7899999998765555555567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999998643   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC-Cc
Q 039344          760 DSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP-SR  837 (873)
Q Consensus       760 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  837 (873)
                      ... ......||+.|+|||.+.+..++.++||||+|+++|||+||+.||.........       ...+ ....+.. ..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-------~~~~-~~~~~~~~~~  235 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-------IKHI-QDSVPNVTTD  235 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-------HHHH-SSCCCCHHHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHh-hccCCCcchh
Confidence            322 233457899999999999999999999999999999999999998754322111       1111 1111110 00


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRP-TMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~  872 (873)
                      ...+....+.+++.+||+.||++|| +++++.+.|+
T Consensus       236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            0011223588999999999999998 8888888764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7e-41  Score=374.91  Aligned_cols=255  Identities=19%  Similarity=0.241  Sum_probs=208.4

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            356799999999999999999975 57899999998764322 2335678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC---CCCCeEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD---FENEAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~---~~~~~kl~Dfg~a~  755 (873)
                      ||||+++|+|.+.+...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++   .++.+||+|||+++
T Consensus        88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999988653   3589999999999999999999999   999999999999998   46789999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      .............||+.|+|||++.+..++.++||||+||++|+|++|+.||........        ...+..+....+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--------~~~i~~~~~~~~  233 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--------YQQIKAGAYDFP  233 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHTCCCCC
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--------HHHHHhCCCCCC
Confidence            877665555667899999999999999999999999999999999999999865432211        111222222111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111122335889999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=368.39  Aligned_cols=251  Identities=22%  Similarity=0.337  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|+++..........+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999865 6899999998753222223356688999999988 79999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999998653   4589999999999999999999999   99999999999999999999999999998655


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~  247 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVVYPTWL  247 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTTS
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC
Confidence            4445555678999999999999989999999999999999999999998754322        22222333333333222


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCH------HHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTM------QKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~------~ev~~  869 (873)
                      .    ..+.+++.+||+.||++||++      +|+++
T Consensus       248 ~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          248 H----EDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             C----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1    247899999999999999998      66654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.9e-41  Score=367.68  Aligned_cols=256  Identities=20%  Similarity=0.250  Sum_probs=207.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCC--CCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPL--PGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      +.|++.+.||+|+||+||+|+.. +|+.||||++....  .......+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            56999999999999999999764 78999999985321  1111125779999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC---eEEeccccc
Q 039344          679 VYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIA  754 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~Dfg~a  754 (873)
                      ||||+++++|.+++.... ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999988876543 334589999999999999999999999   9999999999999987654   999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      +.............||+.|+|||++.+..++.++||||+||++|+|++|+.||.....         .....+.......
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~~~~~~  251 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIKGKYKM  251 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHHTCCCC
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHcCCCCC
Confidence            8876554445567899999999999999999999999999999999999999874321         1122222222222


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...........+.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            21111122345889999999999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-41  Score=360.41  Aligned_cols=251  Identities=20%  Similarity=0.270  Sum_probs=208.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+...    ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            467999999999999999999765 6889999998643    22346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC--CCCeEEecccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF--ENEAHVSDFGIAKFL  757 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~  757 (873)
                      |||+++++|.+++....  ..+++.++..++.|++.|++|||++   +|+||||||+||+++.  ++.+||+|||+++..
T Consensus        80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999999986432  3589999999999999999999999   9999999999999997  789999999999877


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......        .....+.......+..
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~  225 (321)
T 1tki_A          155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCHH
T ss_pred             CCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHcCCCCCChh
Confidence            543 3345567999999999999888999999999999999999999998753322        1222222233322222


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22223345889999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=355.81  Aligned_cols=264  Identities=19%  Similarity=0.284  Sum_probs=209.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc--eeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR--HLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  678 (873)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||++......  ...+.+.+|++++++++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            57899999999999999999865 5899999998753222  22577889999999999999999999998765  7899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee----CCCCCeEEeccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL----DFENEAHVSDFGIA  754 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Dfg~a  754 (873)
                      ||||+++++|.+++........+++..++.++.|++.|++|||++   +|+||||||+||++    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999998766555699999999999999999999999   99999999999999    77788999999999


Q ss_pred             cccCCCCCCccccccccccccccccc--------cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAY--------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      +...... ......||+.|+|||++.        +..++.++||||+||++|||++|+.||...................
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            8775443 334567999999999886        5678999999999999999999999997433211111111111100


Q ss_pred             h-----------------cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          827 M-----------------LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       827 ~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .                 ..+..+............+.+++.+||+.||++|||++|+++..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            0                 00122222223345566789999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-40  Score=356.38  Aligned_cols=262  Identities=20%  Similarity=0.303  Sum_probs=202.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||+||+|+..+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            367999999999999999999998899999999975432 2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++ ++.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 7777765432  3589999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh-------------hhh
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA-------------LDE  826 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~-------------~~~  826 (873)
                      ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||................             ...
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence            555566788999999999876 568999999999999999999999997544321111110000             000


Q ss_pred             hcCCCCCCCC--c---hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPS--R---NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~--~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +.+.......  .   ........+.+++.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000000000  0   00011235789999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=360.00  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      ..+|++.+.||+|+||.||+|+..    .+..||||+++...  .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            356888999999999999999874    35569999997542  233457899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999986432  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-C
Q 039344          757 LKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-R  831 (873)
Q Consensus       757 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~  831 (873)
                      ........   ....+|+.|+|||++.+..++.++||||+||++|||++ |+.||........        ...+... .
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------~~~~~~~~~  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--------ISSVEEGYR  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------HHHHHTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--------HHHHHcCCC
Confidence            75443221   22345778999999998999999999999999999999 9999865332211        1111111 1


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.+..    ....+.+++.+||+.||++|||++++++.|+
T Consensus       273 ~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          273 LPAPMG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC----cCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            222211    1234889999999999999999999999885

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-40  Score=363.93  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            467999999999999999999764 6899999999764332 23356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---CeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~Dfg~a~~  756 (873)
                      |||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++   .+||+|||+++.
T Consensus       107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999988643   3589999999999999999999999   999999999999998654   599999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......        ....+.......+.
T Consensus       181 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~  251 (362)
T 2bdw_A          181 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDYPS  251 (362)
T ss_dssp             CTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCT
T ss_pred             ecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCCc
Confidence            6533 33445689999999999999899999999999999999999999987533221        11112222222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++||+++|+++
T Consensus       252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111222345889999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-40  Score=354.10  Aligned_cols=257  Identities=25%  Similarity=0.399  Sum_probs=199.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHh--ccCCceeeEEeEEEec----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE--IWHRNIVKVYGFCLHV----R  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~  674 (873)
                      .++|++.+.||+|+||+||+|+. +|+.||||++...      ..+.+..|.+++..  ++||||+++++++.+.    .
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            46799999999999999999988 5899999998642      23566677777776  7999999999997653    4


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH--------NDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      ..++||||+++|+|.+++..    ..+++..++.++.|++.|++|||        +.   +|+||||||+||+++.++.+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             eeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            58999999999999999954    34899999999999999999999        77   99999999999999999999


Q ss_pred             EEeccccccccCCCCCC----ccccccccccccccccccC------CCCCcchhHHHHHHHHHHHhC----------CCC
Q 039344          747 HVSDFGIAKFLKPDSSN----WTELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKG----------KHP  806 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~sDv~s~G~il~el~tg----------~~P  806 (873)
                      ||+|||+++........    .....||+.|+|||++.+.      .++.++|||||||++|||+||          +.|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            99999999876544332    2234799999999998876      455799999999999999999          777


Q ss_pred             Ccccccchhhhhhh-hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          807 RDFISSMSFSSLNL-NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       807 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      |............. .........+..+.. .........+.+++.+||+.||++|||++|+++.|+
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNR-WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCCChh-hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            65432211111111 111111111222211 112234567999999999999999999999999885

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=358.40  Aligned_cols=253  Identities=20%  Similarity=0.272  Sum_probs=206.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCc---chhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      +.|.+.+.||+|+||.||+|+.. +|+.||+|++.......   ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            56889999999999999999865 68999999987543221   123578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC----CeEEecccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFGI  753 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg~  753 (873)
                      +||||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999998643   4589999999999999999999999   999999999999999887    799999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......        ....+......
T Consensus       165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~  235 (326)
T 2y0a_A          165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNYE  235 (326)
T ss_dssp             CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHTCCC
T ss_pred             CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHhcCCC
Confidence            98775432 3345679999999999998999999999999999999999999986433211        11111111111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+..........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111122335789999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-40  Score=348.05  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||.||+|+..++..||+|++.....    ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            467899999999999999999999888999999975422    2467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++....  ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999986542  3589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 SSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ... .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||+.......        ...+...........
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  229 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--------VLKVSQGHRLYRPHL  229 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCCCCCCTT
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--------HHHHHcCCCCCCCCc
Confidence            221 223446678999999998889999999999999999999 9999875432211        111111111111111


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .   ...+.+++.+||+.||++|||++|+++.|+
T Consensus       230 ~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (268)
T 3sxs_A          230 A---SDTIYQIMYSCWHELPEKRPTFQQLLSSIE  260 (268)
T ss_dssp             S---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred             C---hHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1   124889999999999999999999999885

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-40  Score=349.92  Aligned_cols=252  Identities=23%  Similarity=0.413  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||.||+|+..+++.||+|++.....    ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            367888999999999999999998899999999975422    2467999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++....  ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            9999999999996533  3589999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......        ....+...........
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~  231 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPRL  231 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCTT
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhcCccCCCCCc
Confidence            21 2223456788999999998999999999999999999999 999987533221        1111111111111111


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .   ...+.+++.+||+.||++||+++++++.|+
T Consensus       232 ~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  262 (269)
T 4hcu_A          232 A---STHVYQIMNHCWRERPEDRPAFSRLLRQLA  262 (269)
T ss_dssp             S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C---CHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            1   224889999999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-41  Score=363.16  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=205.3

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEeccee
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  676 (873)
                      ...++|.+.+.||+|+||.||+|+.+ +|+.||+|+++..........+.+..|..+++.+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            44578999999999999999999875 6899999998753211112246678899999887 899999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      |+||||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.+|.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999998643   3589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ............||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+.
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~  239 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNPFYPR  239 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCT
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCCCCCc
Confidence            5544445556789999999999999999999999999999999999999987533221        11111112222221


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQ-KVC  868 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~  868 (873)
                      ..    ...+.+++.+||+.||++||++. +++
T Consensus       240 ~~----s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          240 WL----EKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             TS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             cc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            11    22478999999999999999987 554

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.9e-41  Score=369.48  Aligned_cols=255  Identities=24%  Similarity=0.408  Sum_probs=206.8

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..++|.+.+.||+|+||.||+|+.. +++.||||+++...  .....++|.+|+++++.++||||+++++++.+.+..++
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            3467889999999999999999876 78999999987542  22334678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|+|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999996432  3589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          759 PDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       759 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ......  ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||.........     .....  ..+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-----~~~~~--~~~~~~~  337 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-----EFVEK--GGRLPCP  337 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-----HHHHT--TCCCCCC
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHc--CCCCCCC
Confidence            321111  12235778999999998899999999999999999998 99998754322111     11111  1122222


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .. .   ...+.+++.+||+.||++|||++++++.|+
T Consensus       338 ~~-~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          338 EL-C---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             TT-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC-C---CHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            21 1   224889999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.7e-41  Score=361.21  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|.+.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999986 57899999998643211112235788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+ +|++.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 67888887543   4589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      . .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+......        ....+.......+...
T Consensus       161 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~  231 (336)
T 3h4j_B          161 G-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------LFKKVNSCVYVMPDFL  231 (336)
T ss_dssp             S-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------CBCCCCSSCCCCCTTS
T ss_pred             C-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCCCCCcccC
Confidence            3 33345679999999999988776 789999999999999999999987532211        1111112222222211


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ...+.+++.+||+.||.+|||++|+++
T Consensus       232 ----s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          232 ----SPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ----CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                224789999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.3e-40  Score=365.92  Aligned_cols=253  Identities=23%  Similarity=0.438  Sum_probs=195.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      ..+|++.+.||+|+||.||+|+..    ++..||||+++...  .....++|.+|+.++++++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            357999999999999999999864    57789999997542  233457899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999996542  4589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-C
Q 039344          757 LKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-R  831 (873)
Q Consensus       757 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~  831 (873)
                      ........   ....+++.|+|||++.+..++.++|||||||++||+++ |+.||........        ...+... +
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--------~~~i~~~~~  268 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------IKAVDEGYR  268 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--------HHHHHTTEE
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCC
Confidence            65433221   12335678999999999999999999999999999998 9999864332211        1111111 1


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.+..    ....+.+++.+||+.||++||++++|++.|+
T Consensus       269 ~~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          269 LPPPMD----CPAALYQLMLDCWQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             CCCCTT----CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcc----ccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence            111111    1234889999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-40  Score=359.42  Aligned_cols=263  Identities=24%  Similarity=0.332  Sum_probs=203.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc----ee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR----HL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  676 (873)
                      ..+|++.+.||+|+||+||+|+.. ++.||||++...    ......+.+|+.++++++||||+++++++.+..    ..
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            467999999999999999999887 899999998642    222345667888999999999999999998754    46


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC-------CCCeeeCCCCCCCeeeCCCCCeEEe
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC-------FPPIVHRDISSKNVLLDFENEAHVS  749 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------~~~i~H~Dlk~~Nill~~~~~~kl~  749 (873)
                      ++||||+++|+|.+++...    .+++..+..++.|++.|++|||+..       .++|+||||||+||+++.++.+||+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999999643    4899999999999999999999861       2389999999999999999999999


Q ss_pred             ccccccccCCCCC--Ccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcccccc---hhhhh-
Q 039344          750 DFGIAKFLKPDSS--NWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSM---SFSSL-  818 (873)
Q Consensus       750 Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~---~~~~~-  818 (873)
                      |||+++.......  ......||+.|+|||++.+     ..++.++|||||||++|||+||+.||......   .+... 
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999987654332  2334679999999999886     34567899999999999999999999754321   11100 


Q ss_pred             ----hhhhhhhhhcCCCCCCC-Cc--hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          819 ----NLNIALDEMLDPRLPTP-SR--NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       819 ----~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ................. ..  ........+.+++.+||+.||++|||++|+++.|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  314 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT  314 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                11111111111111111 11  11233456899999999999999999999999885

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.7e-39  Score=365.86  Aligned_cols=356  Identities=30%  Similarity=0.417  Sum_probs=259.5

Q ss_pred             CcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCC
Q 039344            7 NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIP   86 (873)
Q Consensus         7 n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~   86 (873)
                      +++.+.++.  ..++.++.|++++|+++ .+|. +..+++|++|+|++|++++..|  +..+++|++|++++|.+++..+
T Consensus        34 ~~~~~~i~~--~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~  107 (466)
T 1o6v_A           34 TNVTDTVSQ--TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP  107 (466)
T ss_dssp             SSTTSEECH--HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG
T ss_pred             cccccccCh--hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh
Confidence            334444442  34567889999999887 4554 7888999999999999885544  8888999999999998885544


Q ss_pred             cccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCC
Q 039344           87 PSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKS  166 (873)
Q Consensus        87 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  166 (873)
                        +.++++|++|++++|++++. +. +.++++|++|++++|.+++ ++ .+..+++|++|+++ |.+....  .+..+++
T Consensus       108 --~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~  178 (466)
T 1o6v_A          108 --LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTT  178 (466)
T ss_dssp             --GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTT
T ss_pred             --hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCC
Confidence              88889999999999988854 33 8888899999999998884 33 48888888888886 4554433  3788888


Q ss_pred             CCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEeccc
Q 039344          167 LSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE  246 (873)
Q Consensus       167 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  246 (873)
                      |++|++++|.+++.  ..+..+++|++|++++|.+++..+  ++.+++|++|++++|++++.  ..+..+++|++|++++
T Consensus       179 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~  252 (466)
T 1o6v_A          179 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN  252 (466)
T ss_dssp             CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred             CCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCC
Confidence            88888888888754  347778888888888888875544  67788888888888888753  3567778888888888


Q ss_pred             ccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCC
Q 039344          247 NSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISS  326 (873)
Q Consensus       247 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~  326 (873)
                      |.+++..+  +..+++|+.|++++|++.+..+ +..+++|++|++++|.++++.+  +..+++|++|++++|++++..+ 
T Consensus       253 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-  326 (466)
T 1o6v_A          253 NQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-  326 (466)
T ss_dssp             SCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-
T ss_pred             Cccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-
Confidence            88876544  7777788888888887776444 6677777777777777776544  5666777777777777765444 


Q ss_pred             CCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccC
Q 039344          327 DWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG  394 (873)
Q Consensus       327 ~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  394 (873)
                       +..+++|+.|++++|++++.  ..++.+++|+.|++++|++++..|  +..+++|+.|++++|.+++
T Consensus       327 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          327 -VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             -GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             -hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence             55666777777777766643  456666667777777776665554  5666666666666666664

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=353.30  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=198.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCc-----------------------chhHHHHHHHHHHHH
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGE-----------------------MTFQQEFLNEVKALT  656 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~  656 (873)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.......                       ....+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46799999999999999999976 468999999986542211                       112356889999999


Q ss_pred             hccCCceeeEEeEEEe--cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 039344          657 EIWHRNIVKVYGFCLH--VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDIS  734 (873)
Q Consensus       657 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk  734 (873)
                      .++||||+++++++.+  .+..++||||++++++.+++..    ..+++..+..++.|++.||+|||++   +|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            9999999999999986  5688999999999999876532    3589999999999999999999999   99999999


Q ss_pred             CCCeeeCCCCCeEEeccccccccCCCCCCccccccccccccccccccCC---CCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          735 SKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       735 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      |+||+++.++.+||+|||+++.............||+.|+|||.+.+..   ++.++||||+||++|||++|+.||....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999999988765554455678999999999988765   3778999999999999999999987533


Q ss_pred             cchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          812 SMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........    ..  ....+....    ....+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~----~~--~~~~~~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMCLHSKIK----SQ--ALEFPDQPD----IAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHHH----HC--CCCCCSSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHh----cc--cCCCCCccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            221111100    00  111111111    1224889999999999999999999875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.1e-39  Score=365.33  Aligned_cols=360  Identities=20%  Similarity=0.231  Sum_probs=177.7

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccc
Q 039344           13 IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNL   92 (873)
Q Consensus        13 ~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   92 (873)
                      .+..++.+++|++|+|++|++++. | .|..+++|++|+|++|++++. |  ++.+++|++|++++|++++. +  ++++
T Consensus        34 ~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l  105 (457)
T 3bz5_A           34 DTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPL  105 (457)
T ss_dssp             SEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred             cccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCC
Confidence            334444455555555555555432 3 345555555555555555532 2  44444555555555554432 1  4444


Q ss_pred             cccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEc
Q 039344           93 SNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQL  172 (873)
Q Consensus        93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  172 (873)
                      ++|++|++++|++++ +|  +.                        .+++|++|++++|+++++   .++.+++|++|++
T Consensus       106 ~~L~~L~L~~N~l~~-l~--~~------------------------~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l  155 (457)
T 3bz5_A          106 TKLTYLNCDTNKLTK-LD--VS------------------------QNPLLTYLNCARNTLTEI---DVSHNTQLTELDC  155 (457)
T ss_dssp             TTCCEEECCSSCCSC-CC--CT------------------------TCTTCCEEECTTSCCSCC---CCTTCTTCCEEEC
T ss_pred             CcCCEEECCCCcCCe-ec--CC------------------------CCCcCCEEECCCCcccee---ccccCCcCCEEEC
Confidence            444444444444443 22  44                        444444444444444432   1344444444444


Q ss_pred             cCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCC
Q 039344          173 SENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGA  252 (873)
Q Consensus       173 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  252 (873)
                      ++|...+.+  .+..+++|++|++++|.+++ +|  +..+++|++|++++|++++.   .+..+++|++|++++|++++ 
T Consensus       156 ~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-  226 (457)
T 3bz5_A          156 HLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-  226 (457)
T ss_dssp             TTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-
T ss_pred             CCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-
Confidence            444322222  24444455555555555543 22  44455555555555555432   24445555555555555554 


Q ss_pred             CchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCC
Q 039344          253 IPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCP  332 (873)
Q Consensus       253 ~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~  332 (873)
                      +|  +..+++|+.|++++|++++.+  +..+++|+.|++++|.              |+.|++++|.+.+.+|  +..++
T Consensus       227 ip--~~~l~~L~~L~l~~N~l~~~~--~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~  286 (457)
T 3bz5_A          227 ID--VTPLTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCR  286 (457)
T ss_dssp             CC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCT
T ss_pred             cC--ccccCCCCEEEeeCCcCCCcC--HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccc
Confidence            22  445555555555555555432  3344555555554432              3445555665544444  34556


Q ss_pred             CCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCccccccccccccccccc
Q 039344          333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLS  412 (873)
Q Consensus       333 ~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  412 (873)
                      +|+.|++++|...+.+|.   ...+|+.|++++|             ++|++|++++|++++. +  ++.+++|+.||++
T Consensus       287 ~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~  347 (457)
T 3bz5_A          287 KIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCV  347 (457)
T ss_dssp             TCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECC
T ss_pred             cCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECC
Confidence            666666666665544442   2344444444444             3566666666666652 2  5666666666666


Q ss_pred             ccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCchh
Q 039344          413 SNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC  473 (873)
Q Consensus       413 ~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  473 (873)
                      +|+|++     +     ..|..|++++|.+.+.     ..+..|+.+++++|+++|.+|..
T Consensus       348 ~N~l~~-----l-----~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          348 NAHIQD-----F-----SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             SSCCCB-----C-----TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             CCCCCC-----c-----cccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence            666653     1     1445556666666543     23445555666666666555543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=355.05  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=204.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            67899999999999999999865 79999999986532212223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.+|.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999998653   3589999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...  
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~p~~~--  226 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAELRFPPFF--  226 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCCCCCTTS--
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCCCC--
Confidence               23467999999999999999999999999999999999999998643322        11222222222222221  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                        ...+.+++.+|++.||++||     +++|+++
T Consensus       227 --~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          227 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             --CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence              12478999999999999999     8888874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.4e-40  Score=350.44  Aligned_cols=261  Identities=23%  Similarity=0.348  Sum_probs=199.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      ++|++.+.||+|+||+||+|+..+|+.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            468899999999999999999888999999998754322 2224678899999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++ ++.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9985 8888876432  4588999999999999999999999   99999999999999999999999999998776544


Q ss_pred             CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh----------hh--hhc
Q 039344          762 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA----------LD--EML  828 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~----------~~--~~~  828 (873)
                      .......||+.|+|||++.+. .++.++||||+||++|||++|+.||................          ..  ...
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            445556789999999998764 58999999999999999999999997543221111000000          00  000


Q ss_pred             CCCCC----CCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          829 DPRLP----TPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       829 ~~~~~----~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ++...    .+.. ........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11110    0000 00112234789999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.4e-40  Score=359.98  Aligned_cols=252  Identities=21%  Similarity=0.268  Sum_probs=206.7

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      ..++|++.+.||+|+||.||+|+.+ +|+.||+|+++..........+.+..|..+++.+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3478999999999999999999876 5789999998753211222346788999999888 8999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999998643   3589999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ...........||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+..
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~  243 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVAYPKS  243 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTT
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCCCCCCC
Confidence            54444555678999999999999999999999999999999999999998753322        1222222233322222


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                      .    ...+.+++.+||+.||++||+     ++++++
T Consensus       244 ~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          244 M----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             S----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             C----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            2    224789999999999999995     566654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.7e-40  Score=355.49  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=195.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe----CCCcEEEEEEccCCCCC-cchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLPG-EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|+++..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999986    47899999999764321 12234567899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .|+||||+++++|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999998643   3588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      .............||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~~~p  241 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--------TIDKILKCKLNLP  241 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCCC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCC
Confidence            65544444455689999999999999999999999999999999999999987543221        1122222222222


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      ...    ...+.+++.+||+.||++||     +++|+++
T Consensus       242 ~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          242 PYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             TTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            221    22478999999999999999     7778765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.2e-40  Score=355.05  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            367999999999999999999865 7899999998654222  2236688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           84 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            9999999999998643   3489999999999999999999999   999999999999999999999999999986543


Q ss_pred             CC--CCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC-CCC
Q 039344          760 DS--SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL-PTP  835 (873)
Q Consensus       760 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  835 (873)
                      ..  .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.........       ......... ..+
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~  230 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYLNP  230 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-------HHHHHTTCTTSTT
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhcccccCCc
Confidence            22  22345679999999999987775 77899999999999999999999754322110       111111111 111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..   .....+.+++.+||+.||++|||++|+++
T Consensus       231 ~~---~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          231 WK---KIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             GG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc---cCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11   12234789999999999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=361.82  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67899999999999999999765 68899999986432222223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+.+|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.+|.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999998653   3589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                       .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.........     .....+.......+..
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~~p~~  242 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-----EIVHTFETTVVTYPSA  242 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-----HHHHHHHHCCCCCCTT
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-----HHHHHHhhcccCCCCc
Confidence             34456789999999999874   45899999999999999999999999743322111     1111111122222222


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPT-MQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~  869 (873)
                      .    ...+.+++.+||+.||++||+ ++++.+
T Consensus       243 ~----s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          243 W----SQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             S----CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             C----CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            2    224889999999999999998 677654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.7e-40  Score=357.32  Aligned_cols=251  Identities=21%  Similarity=0.381  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....  .....+.+.+|+.++++++||||+++++++.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            357899999999999999999876 79999999997543  2234578999999999999999999999986543     


Q ss_pred             ----------------------------------------------------eeEEEEEeccCCChhhHhcccccccCCC
Q 039344          675 ----------------------------------------------------HLFIVYEYFKMCSLAVILSNDAAAKNLG  702 (873)
Q Consensus       675 ----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~  702 (873)
                                                                          ..++||||+++++|.+++.........+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                3799999999999999998766656677


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC------------Cccccccc
Q 039344          703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS------------NWTELAGT  770 (873)
Q Consensus       703 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~g~  770 (873)
                      +..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.......            ......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            788999999999999999999   999999999999999999999999999987765421            22345799


Q ss_pred             cccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHH
Q 039344          771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVT  850 (873)
Q Consensus       771 ~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  850 (873)
                      +.|+|||++.+..++.++||||+||++|||++|..|+...          ............+   .........+.+++
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~~~~~---~~~~~~~~~~~~li  306 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRNLKFP---LLFTQKYPQEHMMV  306 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHTTCCC---HHHHHHCHHHHHHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhccCCC---cccccCChhHHHHH
Confidence            9999999999999999999999999999999998884311          1111112222222   11223344578999


Q ss_pred             hhcccCCCCCCCCHHHHHH
Q 039344          851 ISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       851 ~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+||+.||++|||++|+++
T Consensus       307 ~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHH
T ss_pred             HHHccCCCCcCCCHHHHhh
Confidence            9999999999999999986

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=6.4e-40  Score=369.62  Aligned_cols=374  Identities=17%  Similarity=0.180  Sum_probs=301.3

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      ++......+......+..++.+++|++|++++|.+++. | .|..+++|++|++++|++++. |  +..+++|++|++++
T Consensus        20 l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~   94 (457)
T 3bz5_A           20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDS   94 (457)
T ss_dssp             HHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCS
T ss_pred             HHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcC
Confidence            44444444445545555677777888888888888753 4 677888888888888888753 3  77888888888888


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCC
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIP  206 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  206 (873)
                      |.+++. +  ++.+++|++|++++|+++++.   ++.+++|++|++++|++++.   .++.+++|++|++++|...+.+ 
T Consensus        95 N~l~~~-~--~~~l~~L~~L~L~~N~l~~l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~-  164 (457)
T 3bz5_A           95 NKLTNL-D--VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL-  164 (457)
T ss_dssp             SCCSCC-C--CTTCTTCCEEECCSSCCSCCC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC-
T ss_pred             CCCcee-e--cCCCCcCCEEECCCCcCCeec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc-
Confidence            888853 3  888999999999999998753   88999999999999999974   3888999999999999654344 


Q ss_pred             ccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCC
Q 039344          207 SELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSL  286 (873)
Q Consensus       207 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L  286 (873)
                       .+..+++|++|++++|++++. |  +..+++|+.|++++|++++.   .+..+++|+.|++++|++++.+  +..+++|
T Consensus       165 -~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L  235 (457)
T 3bz5_A          165 -DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQL  235 (457)
T ss_dssp             -CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTC
T ss_pred             -ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCC
Confidence             488899999999999999863 4  78899999999999999875   4888999999999999999843  7888999


Q ss_pred             CeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCC
Q 039344          287 ERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSN  366 (873)
Q Consensus       287 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N  366 (873)
                      +.|++++|.+++++   +..+++|+.|++++|              +|+.|++++|.+.+.+|  ++.+++|+.|+|++|
T Consensus       236 ~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n  296 (457)
T 3bz5_A          236 TYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHN  296 (457)
T ss_dssp             SEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTC
T ss_pred             CEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCC
Confidence            99999999998865   456788889988776              46788899998776665  577899999999999


Q ss_pred             ccCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCccc
Q 039344          367 HIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAI  446 (873)
Q Consensus       367 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~  446 (873)
                      ...+.+|.   ...+|+.|++++|             ++|+.|+|++|+|++. +  ++.+.  +|+.||+++|++++  
T Consensus       297 ~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~--~L~~L~l~~N~l~~--  353 (457)
T 3bz5_A          297 TQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNT--KLKSLSCVNAHIQD--  353 (457)
T ss_dssp             TTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCT--TCSEEECCSSCCCB--
T ss_pred             cccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCC--cCcEEECCCCCCCC--
Confidence            98777664   3345555555544             6899999999999973 3  77665  99999999999986  


Q ss_pred             chhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCCC
Q 039344          447 PSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS  497 (873)
Q Consensus       447 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~  497 (873)
                            ++.|..|++++|.++|.     ..+..|..+++++|+++|.+|..
T Consensus       354 ------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          354 ------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             ------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             ------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence                  35788899999999986     35677888999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.3e-40  Score=352.03  Aligned_cols=260  Identities=25%  Similarity=0.410  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  673 (873)
                      .++|++.+.||+|+||+||+|+.     .+++.||||++...   .....+.+.+|++++++++||||+++++++...  
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46789999999999999999974     36899999998743   333457899999999999999999999999654  


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...++||||+++++|.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            45899999999999999996543  3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc--------hhhhhhhhh
Q 039344          754 AKFLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM--------SFSSLNLNI  822 (873)
Q Consensus       754 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~--------~~~~~~~~~  822 (873)
                      ++........   .....++..|+|||.+.+..++.++||||+|+++|||+||..||......        .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            9876543321   22345777899999999999999999999999999999999997643211        000001111


Q ss_pred             hhhhhcC-CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLD-PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+.. .+.+.+..    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HHHHHHTTCCCCCCTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhccCcCCCCcC----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            1111111 12222221    1234889999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=362.79  Aligned_cols=255  Identities=22%  Similarity=0.364  Sum_probs=208.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC--------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      .++|.+.+.||+|+||+||+|+..        .+..||||++....  .....+.+.+|+++++.+ +||||+++++++.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            467899999999999999999752        34679999997642  233457799999999999 9999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence            99999999999999999999975432             24589999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987654332  2334567889999999999999999999999999999999 9999875432211


Q ss_pred             hhhhhhhhhhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                              ...+.... ...+...    ...+.+++.+||+.||++|||++|+++.|+
T Consensus       303 --------~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~  348 (382)
T 3tt0_A          303 --------FKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD  348 (382)
T ss_dssp             --------HHHHHTTCCCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --------HHHHHcCCCCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                    11111111 1111111    224889999999999999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-39  Score=347.23  Aligned_cols=261  Identities=20%  Similarity=0.299  Sum_probs=201.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            47889999999999999999865 6899999999765432 334577889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++ +.+.+...  ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~-l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           81 EFCDQD-LKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEE-HHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             ecCCCC-HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            999864 44444322  24589999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccc-hhhhhhhhh-------h---hhhhc
Q 039344          761 SSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSM-SFSSLNLNI-------A---LDEML  828 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~-~~~~~~~~~-------~---~~~~~  828 (873)
                      ........||+.|+|||++.+.. ++.++||||+||++|||++|..||...... .........       .   .....
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence            55556678899999999988766 799999999999999999998885422211 000000000       0   00000


Q ss_pred             C----CCCC---CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          829 D----PRLP---TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       829 ~----~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +    +..+   ............+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0    0000   000000112235789999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-40  Score=360.78  Aligned_cols=258  Identities=20%  Similarity=0.383  Sum_probs=208.9

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH  672 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  672 (873)
                      ...++|++.+.||+|+||.||+|+..      +++.||+|+++...  .....+.+.+|+.+++.++||||+++++++.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            34578999999999999999999864      34889999997543  23345789999999999999999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhccccc---------------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAA---------------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHR  731 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  731 (873)
                      .+..++||||+++++|.+++.....                     ...+++.+++.++.||++|++|||++   +|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            9999999999999999999975321                     24689999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCCeEEeccccccccCCCC--CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCc
Q 039344          732 DISSKNVLLDFENEAHVSDFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRD  808 (873)
Q Consensus       732 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~  808 (873)
                      ||||+||+++.++.+||+|||+++......  .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            999999999999999999999998654322  12234567899999999999999999999999999999999 999987


Q ss_pred             ccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......        ....+.++.........   ...+.+++.+||+.||++||++.++++.|+
T Consensus       279 ~~~~~~--------~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          279 GMAHEE--------VIYYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             TSCHHH--------HHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCChHH--------HHHHHhCCCcCCCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence            533221        11222222222111111   224889999999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-40  Score=365.89  Aligned_cols=264  Identities=22%  Similarity=0.356  Sum_probs=209.7

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeE
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKV  666 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  666 (873)
                      ..++....++|++.+.||+|+||.||+|+.      .+++.||||+++...  .....+.+.+|+++++++ +||||+++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            445555678899999999999999999963      356899999997542  223356799999999999 89999999


Q ss_pred             EeEEEecc-eeEEEEEeccCCChhhHhccccc------------------------------------------------
Q 039344          667 YGFCLHVR-HLFIVYEYFKMCSLAVILSNDAA------------------------------------------------  697 (873)
Q Consensus       667 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------  697 (873)
                      ++++.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998755 48999999999999999976432                                                


Q ss_pred             ---------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCC
Q 039344          698 ---------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       698 ---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                                     ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12288999999999999999999999   999999999999999999999999999987644332


Q ss_pred             --CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          763 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       763 --~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                        ......||+.|+|||++.+..++.++||||+||++|||+| |+.||...........    ..........  +... 
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~-  321 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTRMRA--PDYT-  321 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH----HHHHTCCCCC--CTTC-
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH----HHHcCCCCCC--CCCC-
Confidence              2334568899999999999999999999999999999998 9999875432211111    1111111111  1111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ...+.+++.+||+.||++|||++|+++.|+
T Consensus       322 ---~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          322 ---TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence               124889999999999999999999999885

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-40  Score=347.39  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=193.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCc-chhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE-MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||.||+|+.. |+.||||+++...... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367889999999999999999986 8999999987543322 22357789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC--------CCCeEEecc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF--------ENEAHVSDF  751 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--------~~~~kl~Df  751 (873)
                      |||+++++|.+++..    ..+++..++.++.|++.|++|||++...+|+||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999853    35899999999999999999999992222999999999999986        678999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      |+++.......  ....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||............    ...  ...
T Consensus       161 g~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~--~~~  232 (271)
T 3dtc_A          161 GLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV----AMN--KLA  232 (271)
T ss_dssp             CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----HTS--CCC
T ss_pred             Ccccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh----hcC--CCC
Confidence            99986654322  2457899999999999999999999999999999999999998754322111100    001  111


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.+..    ....+.+++.+||+.||++|||+.|+++.|+
T Consensus       233 ~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          233 LPIPST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence            111111    1234889999999999999999999999885

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.7e-40  Score=358.60  Aligned_cols=247  Identities=22%  Similarity=0.275  Sum_probs=205.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67899999999999999999865 79999999986432222223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999998653   3589999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+..+....+...  
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~--  261 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHF--  261 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTC--
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCCCC--
Confidence               234679999999999999999999999999999999999999987533221        1222222333322222  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                        ...+.+++.+||+.||++||+     ++|+++
T Consensus       262 --~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          262 --SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence              224789999999999999998     888764

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=5.4e-39  Score=365.34  Aligned_cols=347  Identities=30%  Similarity=0.400  Sum_probs=274.5

Q ss_pred             cCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCc
Q 039344           42 GNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN  121 (873)
Q Consensus        42 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (873)
                      ..+++|+.|++++|.++ .+|+ +..+++|++|+|++|.+++..+  +.++++|++|++++|++++..+  +.++++|++
T Consensus        43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            34678999999999988 5564 7888999999999999985544  8889999999999999985444  888999999


Q ss_pred             ccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCC
Q 039344          122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSL  201 (873)
Q Consensus       122 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l  201 (873)
                      |++++|.+++..+  +..+++|++|++++|.+.++.  .+..+++|++|+++ |.+.+.  ..+.++++|++|++++|.+
T Consensus       117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~l  189 (466)
T 1o6v_A          117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKV  189 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred             EECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCcC
Confidence            9999999885433  888999999999999887643  48888999999986 555533  2388888999999999988


Q ss_pred             cccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCC
Q 039344          202 SYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILR  281 (873)
Q Consensus       202 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~  281 (873)
                      +..  ..+..+++|++|++++|++.+..+  +..+++|++|++++|.+++.  ..+..+++|+.|++++|++.+..+ +.
T Consensus       190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~  262 (466)
T 1o6v_A          190 SDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LS  262 (466)
T ss_dssp             CCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GT
T ss_pred             CCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hh
Confidence            743  347888889999999998886654  67788889999988888754  357788888888888888887554 77


Q ss_pred             CCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEE
Q 039344          282 NLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVL  361 (873)
Q Consensus       282 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L  361 (873)
                      .+++|++|++++|.++++.+  +..+++|++|++++|++.+..+  +..+++|+.|++++|++++..|  ++.+++|+.|
T Consensus       263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  336 (466)
T 1o6v_A          263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL  336 (466)
T ss_dssp             TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred             cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence            78888888888888887654  7778888888888888875443  6778888888888888876544  6778888888


Q ss_pred             eccCCccCCCCCccccccccccEEEecCccccCCccccccccccccccccccccccc
Q 039344          362 DLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN  418 (873)
Q Consensus       362 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  418 (873)
                      ++++|.+++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++
T Consensus       337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            8888888754  467778888888888888877655  7777888888888888875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=362.95  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      .++|++.+.||+|+||+||+|+..      +++.||||++....  .......+.+|+.++++++||||+++++++.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            367889999999999999999843      56789999997532  2233567899999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccc----cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---CeE
Q 039344          675 HLFIVYEYFKMCSLAVILSNDA----AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAH  747 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~k  747 (873)
                      ..++||||+++|+|.+++....    ....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999997543    223589999999999999999999999   999999999999999655   499


Q ss_pred             EeccccccccCCCC--CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhh
Q 039344          748 VSDFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIAL  824 (873)
Q Consensus       748 l~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~  824 (873)
                      |+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++ |..||........        .
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--------~  296 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------L  296 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------H
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------H
Confidence            99999997553221  22234567899999999999999999999999999999998 9999875432211        1


Q ss_pred             hhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+............   ...+.+++.+||+.||++||++++|++.|+
T Consensus       297 ~~i~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          297 EFVTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             HHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            112221111111111   224889999999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-40  Score=363.11  Aligned_cols=248  Identities=22%  Similarity=0.275  Sum_probs=196.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHH-HHhccCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA-LTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++++.........+.+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367999999999999999999875 688999999976533333334556777776 577899999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999998653   3588999999999999999999999   99999999999999999999999999998755


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~  262 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPLQLKPNI  262 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHHSCCCCCSSS
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcccCCCCCC
Confidence            4445556678999999999999999999999999999999999999998753322        12222222222222221


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQK  866 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~e  866 (873)
                          ...+.+++.+||+.||++||++.+
T Consensus       263 ----~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          263 ----TNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ----CHHHHHHHHHHcccCHHhCCCCCC
Confidence                124789999999999999999853

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.9e-40  Score=354.25  Aligned_cols=250  Identities=23%  Similarity=0.312  Sum_probs=186.2

Q ss_pred             CceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEEEEecc
Q 039344          607 EHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      .+.||+|+||.||+|+.. +|+.||||++...      ....+.+|+.+++.+. ||||+++++++.+....|+||||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            478999999999999865 6899999998632      2467889999999996 9999999999999999999999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---CeEEeccccccccCCCC
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~  761 (873)
                      +++|.+++...   ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++   .+||+|||+++......
T Consensus        90 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           90 GGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             SCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            99999998653   4589999999999999999999999   999999999999998766   79999999998776655


Q ss_pred             CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHH
Q 039344          762 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHD  841 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  841 (873)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...........+..+....+......
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKGDFSFEGEAWKN  242 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcCCCCCCcccccC
Confidence            55566788999999999999999999999999999999999999987533211 11112223444445555444433334


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          842 KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       842 ~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          243 VSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            4556899999999999999999998864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=362.09  Aligned_cols=259  Identities=21%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      ...++|++.+.||+|+||.||+|+.      .+++.||+|++......  ...+.+.+|+.+++++ +||||+++++++.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3457899999999999999999985      24668999999754322  2246799999999999 8999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc--------------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA--------------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHR  731 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  731 (873)
                      +.+..++||||+++|+|.+++.....                    ...+++..++.++.|++.||+|||++   +|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            99999999999999999999976432                    13478999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCc
Q 039344          732 DISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRD  808 (873)
Q Consensus       732 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~  808 (873)
                      ||||+||+++.++.+||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876544332  234557889999999999999999999999999999998 999987


Q ss_pred             ccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .........    ...........+  ..    ....+.+++.+||+.||++|||+.++++.|+
T Consensus       277 ~~~~~~~~~----~~~~~~~~~~~~--~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          277 GIPVDANFY----KLIQNGFKMDQP--FY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             TCCCSHHHH----HHHHTTCCCCCC--TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCcHHHHH----HHHhcCCCCCCC--CC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            544221111    111111111111  11    1234889999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-40  Score=347.88  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||+||+|+..++..||+|++.....    ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            467889999999999999999999888999999975422    2467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           99 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999996532  4589999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. ......+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||.........     ...........+  ...
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-----~~~~~~~~~~~~--~~~  246 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----EHIAQGLRLYRP--HLA  246 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----HHHHTTCCCCCC--TTC
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-----HHHhcccCCCCC--CcC
Confidence            11 1223456788999999998899999999999999999998 99998754322111     111111111111  111


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ...+.+++.+||+.||++|||++++++.|+
T Consensus       247 ----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          247 ----SEKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             ----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence                124889999999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-40  Score=374.88  Aligned_cols=251  Identities=23%  Similarity=0.294  Sum_probs=197.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999975 47899999998753222222346678999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999998643   358999999999999999999998 8   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||........        ...+.......+...
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--------~~~i~~~~~~~p~~~  372 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------FELILMEEIRFPRTL  372 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCCCCTTS
T ss_pred             CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--------HHHHHhCCCCCCccC
Confidence            555555667899999999999999999999999999999999999999865332211        111222222222221


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                          ...+.+++.+||+.||++||     +++|+++
T Consensus       373 ----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          373 ----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                12478999999999999999     9999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-39  Score=353.95  Aligned_cols=255  Identities=16%  Similarity=0.214  Sum_probs=204.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..+|++.+.||+|+||+||+|+. .+|+.||||++.....     .+.+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            46799999999999999999985 5789999999875422     23578999999999 99999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC-----eEEecccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE-----AHVSDFGI  753 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-----~kl~Dfg~  753 (873)
                      ||||+ +++|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+
T Consensus        83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            99999 89999998754  34699999999999999999999999   9999999999999999887     99999999


Q ss_pred             ccccCCCCCC-------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          754 AKFLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       754 a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      ++.+......       .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............     
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~-----  231 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK-----  231 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH-----
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH-----
Confidence            9876543321       2456799999999999999999999999999999999999999986432211111111     


Q ss_pred             hcCCCCCCCCch-hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          827 MLDPRLPTPSRN-VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       827 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.....+.+... ..... .+.+++.+||+.||.+||+++++.+.|+
T Consensus       232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            000000000000 00011 5889999999999999999999999874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=347.24  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=184.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            36799999999999999999986 57999999998643211222346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++....  ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999986532  4589999999999999999999999   999999999999999999999999999987764


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........|++.|+|||.+.+..++.++||||+|+++|||++|+.||........        ...........+... 
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~-  235 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVVLADYEMPSFL-  235 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCCTTS-
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHhhcccCCcccc-
Confidence            44444456789999999999988899999999999999999999999875332111        111111122112111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+.+++.+||+.||++|||++++++
T Consensus       236 ---~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          236 ---SIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               224789999999999999999999976

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.6e-40  Score=356.52  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=189.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+.|++.+.||+|+||.||+|+.. +++.||||++....     ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            467999999999999999999876 58899999997542     135688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Dfg~a~~  756 (873)
                      |||+++++|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.   ++.+||+|||+++.
T Consensus       127 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999998653   3489999999999999999999999   9999999999999975   88999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .....+.........
T Consensus       201 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~~~~~~~~~  272 (349)
T 2w4o_A          201 VEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRILNCEYYFIS  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHHTTCCCCCT
T ss_pred             cCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHHhCCCccCC
Confidence            6432 23345679999999999999999999999999999999999999986433221       111222222222111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++|||+.|+++
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111122335889999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-40  Score=360.33  Aligned_cols=259  Identities=23%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCC------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLAS------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      ...++|++.+.||+|+||.||+|+...      +..||+|.+....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            345789999999999999999998642      2479999997543  223357799999999999 8999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc-----------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA-----------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL  740 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill  740 (873)
                      +.+..++||||+++|+|.+++.....           ...+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence            99999999999999999999865431           24578999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhh
Q 039344          741 DFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSS  817 (873)
Q Consensus       741 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~  817 (873)
                      +.++.+||+|||+++........  .....+|+.|+|||.+.+..++.++||||+|+++|||+| |..||..........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            99999999999999866443322  223456789999999999999999999999999999998 999987543221111


Q ss_pred             hhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ...........+  ...    ...+.+++.+||+.||.+|||+.|+++.|+
T Consensus       278 ----~~~~~~~~~~~~--~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          278 ----KLVKDGYQMAQP--AFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             ----HHHHHTCCCCCC--TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----HHHhcCCCCCCC--CCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence                111111111111  111    224889999999999999999999999874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-40  Score=368.13  Aligned_cols=264  Identities=21%  Similarity=0.252  Sum_probs=207.3

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH  672 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  672 (873)
                      +.++....++|++.++||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3444555789999999999999999999876 578999999864211111112348899999999999999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      .+..|+||||+++|+|.+++...  ...+++..+..++.||+.|++|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence            99999999999999999999653  24589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          753 IAKFLKPDSSN-WTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       753 ~a~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      +|+........ ....+||+.|+|||++.     ...++.++||||+||++|||++|+.||................ ..
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~  299 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-ER  299 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-cc
Confidence            99876544332 23468999999999987     5668999999999999999999999987544322111111100 01


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPES--RPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  869 (873)
                         ..++.....   ....+.+++.+|+..+|++  ||+++|+++
T Consensus       300 ---~~~p~~~~~---~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          300 ---FQFPTQVTD---VSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ---CCCCSSCCC---SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ---ccCCccccc---CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence               111211111   1224789999999888888  999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-40  Score=357.42  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=198.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH----  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  675 (873)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++..........+.+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999985 5789999999987655555556789999999999999999999999987553    


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .|+||||+++++|.+++...   ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            49999999999999998643   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          756 FLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       756 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ........   .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..........        .......
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--------~~~~~~~  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--------QHVREDP  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--------HHHHCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--------HHhcCCC
Confidence            76543222   234568999999999999999999999999999999999999987543321111        1111111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+..........+.+++.+||+.||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            1110000112235889999999999999998777654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=358.50  Aligned_cols=252  Identities=17%  Similarity=0.262  Sum_probs=205.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999765 68999999987532   22346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC--CCCeEEecccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF--ENEAHVSDFGIAKFL  757 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~  757 (873)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+||+++.  ++.+||+|||+++..
T Consensus       127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999986432  3589999999999999999999999   9999999999999984  467999999999877


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........        ..+.......+..
T Consensus       202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--------~~i~~~~~~~~~~  272 (387)
T 1kob_A          202 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL--------QNVKRCDWEFDED  272 (387)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--------HHHHHCCCCCCSS
T ss_pred             CCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH--------HHHHhCCCCCCcc
Confidence            543 2334567999999999999999999999999999999999999998754332111        1111111111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........+.+++.+||+.||++|||++|+++
T Consensus       273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            11112234889999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.4e-40  Score=368.37  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=207.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            67899999999999999999865 79999999986432222223567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999998643   4589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                       .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.....        .....+.++....+....
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~s  240 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDGIFYTPQYLN  240 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTTCCCCCTTCC
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCcCCCccCC
Confidence             33445689999999999988776 68999999999999999999998753322        112223333333222211


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ..+.+++.+||+.||++|||++|+++
T Consensus       241 ----~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          241 ----PSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                24789999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.1e-40  Score=356.51  Aligned_cols=251  Identities=20%  Similarity=0.256  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++.....       ...+|++++.++ +||||+++++++.+.+..|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            467999999999999999999765 689999999975432       234688888888 79999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-C---CeEEeccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-N---EAHVSDFGIA  754 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~---~~kl~Dfg~a  754 (873)
                      ||||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||++..+ +   .+||+|||++
T Consensus        94 v~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            99999999999998654   3589999999999999999999999   99999999999998543 3   4999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      +.............||+.|+|||++.+..++.++||||+||++|||++|+.||........     ......+..+....
T Consensus       168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~~~~~  242 (342)
T 2qr7_A          168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EEILARIGSGKFSL  242 (342)
T ss_dssp             EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HHHHHHHHHCCCCC
T ss_pred             ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HHHHHHHccCCccc
Confidence            9876655555667899999999999888899999999999999999999999975322111     11122222222222


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +..........+.+++.+||+.||++||+++++++
T Consensus       243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            21111122335889999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-39  Score=348.82  Aligned_cols=263  Identities=19%  Similarity=0.337  Sum_probs=191.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||+||+|+.. +|+.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            467999999999999999999764 6899999998754322  2236788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccc---cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      |||++ ++|.+++....   ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99998 58988886432   223588999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------h---hh
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------A---LD  825 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~---~~  825 (873)
                      ............||+.|+|||++.+ ..++.++||||+||++|||++|+.||...............       .   ..
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            7655455556689999999999876 46899999999999999999999999754322111110000       0   00


Q ss_pred             hh--cCCCCCCC-CchhH---------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EM--LDPRLPTP-SRNVH---------DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~--~~~~~~~~-~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..  ..+..... .....         .....+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00  00000000 00000         11235889999999999999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.6e-41  Score=371.30  Aligned_cols=259  Identities=20%  Similarity=0.257  Sum_probs=205.2

Q ss_pred             HHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          596 EIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       596 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ++....++|++.+.||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999865 68899999986421111111244789999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..|+||||+++|+|.+++...    .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999998542    489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC-CccccccccccccccccccCC----CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcC
Q 039344          755 KFLKPDSS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLD  829 (873)
Q Consensus       755 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  829 (873)
                      +....... .....+||+.|+|||++.+..    ++.++||||+||++|||++|+.||...............    ...
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----~~~  291 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH----KNS  291 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH----HHH
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc----ccc
Confidence            87654432 233568999999999988665    788999999999999999999998754322111111110    001


Q ss_pred             CCCCCCCchhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 039344          830 PRLPTPSRNVHDKLISIVEVTISCVDENPES--RPTMQKVCQ  869 (873)
Q Consensus       830 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~  869 (873)
                      ..++.....    ...+.+++.+|++.+|++  ||+++|+++
T Consensus       292 ~~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          292 LTFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CCCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ccCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            112211111    224789999999999988  999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9e-40  Score=352.11  Aligned_cols=256  Identities=23%  Similarity=0.379  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ..+|.+.+.||+|+||.||+|+.      .+++.||+|+++...  .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            46788999999999999999975      345889999997542  2334577999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhccccc---------------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAA---------------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDI  733 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl  733 (873)
                      ..++||||+++++|.+++.....                     ...+++.+++.++.|++.|++|||++   +|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence            99999999999999999975432                     13478999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCccc
Q 039344          734 SSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI  810 (873)
Q Consensus       734 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~  810 (873)
                      ||+||+++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876544332  223456788999999999899999999999999999999 99998754


Q ss_pred             ccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          811 SSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ........     .........  +..    ....+.+++.+||+.||++||+++|+++.|+
T Consensus       257 ~~~~~~~~-----~~~~~~~~~--~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          257 PPERLFNL-----LKTGHRMER--PDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLE  307 (314)
T ss_dssp             CGGGHHHH-----HHTTCCCCC--CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHH-----hhcCCcCCC--Ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            43221111     111111111  111    1234889999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.9e-40  Score=351.99  Aligned_cols=257  Identities=23%  Similarity=0.373  Sum_probs=208.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      .++|++.+.||+|+||.||+|+.      .+++.||+|+++...  .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            46789999999999999999974      357889999997542  223357799999999999 999999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhccccc---------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAA---------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +..++||||+++|+|.+++.....               ...+++..++.++.|++.|++|||++   +|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            999999999999999999975432               22489999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|||+| |+.||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            9999999999999999877654332  223457789999999999999999999999999999999 9999875432211


Q ss_pred             hhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..    ...........+  ..    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       257 ~~----~~~~~~~~~~~~--~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  303 (313)
T 1t46_A          257 FY----KMIKEGFRMLSP--EH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (313)
T ss_dssp             HH----HHHHHTCCCCCC--TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH----HHhccCCCCCCc--cc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            11    111111111111  11    1234889999999999999999999999885

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.7e-40  Score=371.83  Aligned_cols=254  Identities=23%  Similarity=0.404  Sum_probs=207.4

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ...++|++.+.||+|+||.||+|+..++..||||+++...    ...+.|.+|+.+++.++||||+++++++. .+..++
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            3457788999999999999999999889999999997532    22578999999999999999999999986 667899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            999999999999997543 23588999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          759 PDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       759 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... ......+++.|+|||++....++.++|||||||++|||+| |+.||..........     .+...  .+.+.+.
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~-----~i~~~--~~~~~~~  408 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-----ALERG--YRMPRPE  408 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-----HHHHT--CCCCCCT
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcC--CCCCCCC
Confidence            3211 1123346788999999998999999999999999999999 999987543322111     11111  1222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .    ....+.+++.+||+.||++|||+++|++.|+
T Consensus       409 ~----~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~  440 (454)
T 1qcf_A          409 N----CPEELYNIMMRCWKNRPEERPTFEYIQSVLD  440 (454)
T ss_dssp             T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            1    1234889999999999999999999999885

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-39  Score=366.57  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=202.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-eeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-HLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. |+.||||+++...     ..+.|.+|+.++++++||||+++++++.+.+ ..++|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            467888999999999999999887 7899999997542     2477999999999999999999999987765 78999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++.... ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       266 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            99999999999997543 23478999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCc
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSR  837 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  837 (873)
                      .   .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||.........        ..+..+ +++.+..
T Consensus       342 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~--------~~i~~~~~~~~p~~  410 (450)
T 1k9a_A          342 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--------PRVEKGYKMDAPDG  410 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH--------HHHHTTCCCCCCTT
T ss_pred             c---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------HHHHcCCCCCCCCc
Confidence            2   223467889999999999999999999999999999998 99998754432211        111111 2222221


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ....+.+++.+||+.||++|||+.++++.|+
T Consensus       411 ----~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          411 ----CPPAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                1234889999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2e-39  Score=345.76  Aligned_cols=251  Identities=22%  Similarity=0.327  Sum_probs=209.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367889999999999999999875 5889999998765444444567889999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||.++....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999987543   3589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.......        ....+.......+... 
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~-  238 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEYSIPKHI-  238 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCTTS-
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhccCCCcccc-
Confidence            5555556679999999999999889999999999999999999999987533211        1112222222222221 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+.+++.+||+.||++|||++|+++
T Consensus       239 ---~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          239 ---NPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               124789999999999999999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-39  Score=355.25  Aligned_cols=248  Identities=27%  Similarity=0.409  Sum_probs=200.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..|+..+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999985 579999999997654444444577999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+. |++.+++...  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9998 5777776432  24589999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          761 SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                          ....||+.|+|||++.   ...++.++|||||||++|||++|+.||...........     ......+...  ..
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-----~~~~~~~~~~--~~  276 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNESPALQ--SG  276 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCC--CT
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----HHhcCCCCCC--CC
Confidence                3457999999999884   56789999999999999999999999865432211111     0111111111  11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .   ....+.+++.+||+.||++|||++++++
T Consensus       277 ~---~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          277 H---WSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             T---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C---CCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            1   1224789999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-39  Score=360.21  Aligned_cols=264  Identities=18%  Similarity=0.274  Sum_probs=204.0

Q ss_pred             hcCCCCCceeeec--CCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          601 TNDFDDEHCIGKG--GQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ..+|++.+.||+|  +||+||+|+.. +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            4679999999999  99999999875 7999999999754322 234577889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||.+...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999875432 3489999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCC-------CCcccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhc
Q 039344          758 KPDS-------SNWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       758 ~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      ....       .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||...................+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            3221       11223478999999999987  57899999999999999999999999754432211111111000000


Q ss_pred             CCCC---------------------------C-------CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          829 DPRL---------------------------P-------TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       829 ~~~~---------------------------~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +...                           +       ............+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000                           0       000001112345889999999999999999999975

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-39  Score=352.59  Aligned_cols=257  Identities=22%  Similarity=0.356  Sum_probs=191.6

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeCCC----cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLASG----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ..++|++.+.||+|+||.||+|+....    ..||||+++...... ...+.+.+|++++++++||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            346799999999999999999986533    279999997543222 335789999999999999999999999987665


Q ss_pred             e------EEEEEeccCCChhhHhcccccc---cCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          676 L------FIVYEYFKMCSLAVILSNDAAA---KNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       676 ~------~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      .      ++||||+++++|.+++......   ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            4      9999999999999998654322   2589999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~  823 (873)
                      ||+|||+++.......  ......+++.|+|||.+.+..++.++||||+||++|||++ |+.||.........       
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------  249 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-------  249 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-------
Confidence            9999999987654332  1223456788999999999999999999999999999999 99998754432211       


Q ss_pred             hhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ..+.... ...+..    ....+.+++.+||+.||++|||+.++++.|+
T Consensus       250 -~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          250 -NYLIGGNRLKQPPE----CMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             -HHHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHhcCCCCCCCCc----cCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             1111111 111211    1234889999999999999999999998874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-39  Score=348.25  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=197.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999986 57899999999764444445567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          680 YEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||+++++|.+++.... ....+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999986532 234589999999999999999999999   99999999999999999999999999998766


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ..........|++.|+|||.+.+..++.++||||||+++|||++|+.||.......      ......+.....+.... 
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~-  260 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPLPS-  260 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHHHHHTTCSCCCCT-
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHHHhhcccCCCCcc-
Confidence            54444445678999999999999999999999999999999999999986432110      01111111111111110 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ......+.+++.+||+.||++|||++++++.|+
T Consensus       261 -~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~  293 (310)
T 2wqm_A          261 -DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK  293 (310)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence             011224889999999999999999999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-39  Score=349.53  Aligned_cols=254  Identities=19%  Similarity=0.263  Sum_probs=207.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcc---hhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEM---TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356899999999999999999865 689999999875433221   1357899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC----CeEEeccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFG  752 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg  752 (873)
                      ++||||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999998653   3588999999999999999999999   999999999999999888    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      +++..... .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......        .....+.....
T Consensus       165 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~  235 (321)
T 2a2a_A          165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSVSY  235 (321)
T ss_dssp             TCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC
T ss_pred             cceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhccc
Confidence            99876543 2334567999999999999999999999999999999999999998643321        11122222222


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+..........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            2211111122335889999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=348.47  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=196.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      ++|++.+.||+|+||+||+|+.. ++.||+|++...     ...+.+.+|++++++++||||+++++++.  +..++|||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e   79 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME   79 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence            57888999999999999999886 789999998642     23578999999999999999999999886  34799999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC-eEEeccccccccCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE-AHVSDFGIAKFLKPD  760 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~  760 (873)
                      |+++++|.+++........+++..++.++.|+++|++|||+....+|+||||||+||+++.++. +||+|||+++.....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999986655456889999999999999999999932129999999999999998886 799999999765432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .....||+.|+|||.+.+..++.++||||||+++|||++|+.||+........      ..........+.....  
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~--  228 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR------IMWAVHNGTRPPLIKN--  228 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH------HHHHHHTTCCCCCBTT--
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH------HHHHHhcCCCCCcccc--
Confidence               23456899999999999999999999999999999999999998754322110      0001111111111111  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ....+.+++.+||+.||++|||++++++.|+
T Consensus       229 -~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          229 -LPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -cCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence             1224789999999999999999999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.6e-39  Score=353.10  Aligned_cols=252  Identities=22%  Similarity=0.282  Sum_probs=193.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            467999999999999999999875 7899999999754322    25688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC--eEEecccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE--AHVSDFGIAKFL  757 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~--~kl~Dfg~a~~~  757 (873)
                      |||+++|+|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.  +||+|||+++..
T Consensus        95 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           95 MEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            9999999999998543   3589999999999999999999999   9999999999999988775  999999999754


Q ss_pred             CCCCCCccccccccccccccccccCCCCCc-chhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEK-CDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||..........    .....+.......+.
T Consensus       169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~  243 (361)
T 3uc3_A          169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR----KTIQRILSVKYSIPD  243 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH----HHHHHHHTTCCCCCT
T ss_pred             ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH----HHHHHHhcCCCCCCC
Confidence            332 22344679999999999988887655 899999999999999999997544321111    112222222222111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..  .....+.+++.+||+.||++|||++|+++
T Consensus       244 ~~--~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          244 DI--RISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             TS--CCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cC--CCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            10  01224789999999999999999999975

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.3e-39  Score=344.02  Aligned_cols=257  Identities=17%  Similarity=0.197  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.....     .+.+.+|+..++.+ +|+|++++++++.+....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            46799999999999999999985 5799999999865422     24577899999999 89999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC-----eEEecccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE-----AHVSDFGI  753 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-----~kl~Dfg~  753 (873)
                      ||||+ +++|.+++...  ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.     +||+|||+
T Consensus        84 v~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            99999 89999999653  23589999999999999999999999   9999999999999988776     99999999


Q ss_pred             ccccCCCCC-------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          754 AKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       754 a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      ++.......       ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||............... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~  236 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-GEK  236 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH-HHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH-Hhh
Confidence            987754432       134567999999999999999999999999999999999999999864322111110000 000


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......+   .........+.+++.+||+.||++||++++|++.|+
T Consensus       237 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          237 KQSTPLR---ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HHHSCHH---HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             ccCccHH---HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            0000000   000011235889999999999999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-39  Score=356.47  Aligned_cols=261  Identities=23%  Similarity=0.281  Sum_probs=202.6

Q ss_pred             HHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCC--CcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          598 IRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLP--GEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       598 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ....++|++.+.||+|+||.||+|+. .+++.||+|++.....  ......+.+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34567899999999999999999976 4688999999864311  12233578999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhccccc-------------------------------------ccCCChHHHHHHHHHHHHHH
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAA-------------------------------------AKNLGWTRRMNMIKGIVDAL  717 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------~~~~~~~~~~~i~~~i~~~l  717 (873)
                      ..++||||+++|+|.+++.....                                     ...+++..++.++.|++.|+
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999999999999853111                                     11235677889999999999


Q ss_pred             HHHHhCCCCCeeeCCCCCCCeeeCCCC--CeEEeccccccccCCCCC----Ccccccccccccccccccc--CCCCCcch
Q 039344          718 SYMHNDCFPPIVHRDISSKNVLLDFEN--EAHVSDFGIAKFLKPDSS----NWTELAGTYGYVAPELAYT--MKVTEKCD  789 (873)
Q Consensus       718 ~~LH~~~~~~i~H~Dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~sD  789 (873)
                      +|||++   +|+||||||+||+++.++  .+||+|||+++.+.....    ......||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999   999999999999998777  899999999986543221    2345679999999999875  67889999


Q ss_pred             hHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          790 VYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       790 v~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      |||+||++|||++|+.||.......        ....+.......+..........+.+++.+||+.||++||++.|+++
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDAD--------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999999987543221        12222222222222222222345889999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.6e-39  Score=343.05  Aligned_cols=253  Identities=20%  Similarity=0.291  Sum_probs=205.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            468999999999999999999764 6899999998754332 23356788999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC---eEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~Dfg~a~~  756 (873)
                      |||++++++.+.+...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.   +||+|||.+..
T Consensus        84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999998888543   4589999999999999999999999   9999999999999987665   99999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||..........        .+.......+.
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~~~~  228 (284)
T 3kk8_A          158 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA--------QIKAGAYDYPS  228 (284)
T ss_dssp             CCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHTCCCCCT
T ss_pred             cccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH--------HHHhccccCCc
Confidence            6543 33345679999999999999999999999999999999999999986543221111        11111111111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111112234889999999999999999999976

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-39  Score=352.18  Aligned_cols=252  Identities=23%  Similarity=0.430  Sum_probs=197.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      ++|++.+.||+|+||+||+|+.. +|+    .||+|.++....  ....+.+.+|+.++++++||||++++++|.+.. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            67899999999999999999854 444    368888764322  223578999999999999999999999998754 7


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++|+||+.+|+|.+++....  ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            88999999999999986543  4589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .......  .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||+........     ......  ...+
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~--~~~~  239 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----SILEKG--ERLP  239 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHHTT--CCCC
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-----HHHHcC--CCCC
Confidence            7544332  233456889999999999999999999999999999999 99998754332211     111111  1122


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+...    ...+.+++.+||+.||++||++.++++.|+
T Consensus       240 ~~~~~----~~~~~~li~~~l~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          240 QPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCTTB----CHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             CCccC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            22211    224889999999999999999999998874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.3e-39  Score=351.87  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=205.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe--------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL--------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      .++|++.+.||+|+||.||+|+.        .+++.||+|++....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            47899999999999999999976        356789999997542  233457799999999999 8999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +.+..++||||+++++|.+++.....             ...+++..++.++.|++.|++|||++   +|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence            99999999999999999999976432             23488999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+||+|||+++........  .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||........
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            9999999999999999876543321  223456789999999998889999999999999999999 9999875432211


Q ss_pred             hhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...     .........  +..    ....+.+++.+||+.||++||+++|+++.|+
T Consensus       269 ~~~-----~~~~~~~~~--~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  314 (334)
T 2pvf_A          269 FKL-----LKEGHRMDK--PAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  314 (334)
T ss_dssp             HHH-----HHHTCCCCC--CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH-----HhcCCCCCC--Ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            111     111111111  111    1224889999999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=348.36  Aligned_cols=261  Identities=21%  Similarity=0.341  Sum_probs=199.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            57899999999999999999875 589999999875432 2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++++++.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999999887543   3489999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------------hhhh
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------------ALDE  826 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------------~~~~  826 (873)
                      ........||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...............             ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            555566789999999999876 56799999999999999999999999754432111100000             0000


Q ss_pred             hcCCCCCCCCch------hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPSRN------VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......+.+...      .......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            001111111000      0112335789999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-39  Score=343.55  Aligned_cols=252  Identities=22%  Similarity=0.378  Sum_probs=193.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .++|++.+.||+|+||.||+|+..    .+..||+|++....  .....+.+.+|+.++++++||||+++++++. .+..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            467889999999999999999764    24579999987542  2334577999999999999999999999984 5678


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999986432  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC-CC
Q 039344          757 LKPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR-LP  833 (873)
Q Consensus       757 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~  833 (873)
                      ...... ......+++.|+|||.+.+..++.++||||+|+++|||++ |..||........        ...+.... .+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--------~~~i~~~~~~~  237 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------IGRIENGERLP  237 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCCC
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--------HHHHHcCCCCC
Confidence            654322 2233456789999999998899999999999999999997 9999875433211        11111111 11


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+..    ....+.+++.+||+.||++|||+.|+++.|+
T Consensus       238 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          238 MPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1111    1234889999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-39  Score=348.84  Aligned_cols=257  Identities=22%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999865 7889999999765444444567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999998643   3589999999999999999999999   999999999999999999999999999986654


Q ss_pred             CC-CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DS-SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.........     ....    ...+.+...
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~----~~~~~~~~~  257 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-----AHIN----QAIPRPSTV  257 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-----HHHH----SCCCCGGGT
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-----HHhc----cCCCCcccc
Confidence            32 2233567899999999999999999999999999999999999998753321110     0011    111100000


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRP-TMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~  872 (873)
                      .......+.+++.+||+.||++|| +++++++.|+
T Consensus       258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence            011122488999999999999999 9999998874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6e-40  Score=354.76  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=209.8

Q ss_pred             HHHHHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeE
Q 039344          596 EIIRATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGF  669 (873)
Q Consensus       596 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  669 (873)
                      ++....++|++.+.||+|+||.||+|+..      +++.||+|++....  .......+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            33445678999999999999999999754      47889999997542  22335678999999999999999999999


Q ss_pred             EEecceeEEEEEeccCCChhhHhccccc-------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          670 CLHVRHLFIVYEYFKMCSLAVILSNDAA-------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       670 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                      +.+.+..++||||+++++|.+++.....       ...+++..++.++.|++.|++|||++   +|+||||||+||+++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence            9999999999999999999999875432       13568999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLN  819 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~  819 (873)
                      ++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......     
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  248 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----  248 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-----
Confidence            999999999999866433221  223456889999999999999999999999999999999 899986533221     


Q ss_pred             hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          820 LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+...........   ....+.+++.+||+.||++|||+.|+++.|+
T Consensus       249 ---~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~  295 (322)
T 1p4o_A          249 ---VLRFVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIK  295 (322)
T ss_dssp             ---HHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             ---HHHHHHcCCcCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence               1112222222111111   1224889999999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=356.80  Aligned_cols=247  Identities=22%  Similarity=0.284  Sum_probs=196.9

Q ss_pred             CCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          606 DEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       606 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      ..+.||+|+||.||+|+. .+|+.||+|+++...   ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            357899999999999976 468999999987532   2335789999999999999999999999999999999999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee--CCCCCeEEeccccccccCCCCC
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL--DFENEAHVSDFGIAKFLKPDSS  762 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~  762 (873)
                      +++|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+||++  +.++.+||+|||+++...... 
T Consensus       170 ~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          170 GGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             TCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            999998886432  3589999999999999999999999   99999999999999  567899999999998775432 


Q ss_pred             CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHH
Q 039344          763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDK  842 (873)
Q Consensus       763 ~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  842 (873)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......        ....+.......+.......
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~  315 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--------TLNNILACRWDLEDEEFQDI  315 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCSCSGGGTTS
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccCCCChhhhccC
Confidence            3344579999999999998889999999999999999999999987543221        11222222222222111222


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          843 LISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       843 ~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+.+++.+||+.||++|||++|+++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            345889999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.1e-39  Score=355.43  Aligned_cols=251  Identities=21%  Similarity=0.264  Sum_probs=191.1

Q ss_pred             cCCCCC-ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe----cc
Q 039344          602 NDFDDE-HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH----VR  674 (873)
Q Consensus       602 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~  674 (873)
                      ++|.+. +.||+|+||+||+|+.. +|+.||||++...        ..+.+|++++.+. +||||+++++++..    .+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            456665 68999999999999765 6899999998631        4567888887544 89999999999876    56


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CCCeEEecc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAHVSDF  751 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Df  751 (873)
                      ..|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            7899999999999999997543 24589999999999999999999999   9999999999999998   789999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      |+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..............    .+..+.
T Consensus       209 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~  283 (400)
T 1nxk_A          209 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQ  283 (400)
T ss_dssp             TTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTC
T ss_pred             ccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCc
Confidence            999876533 233456789999999999999999999999999999999999999975443221111111    111111


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+..........+.+++.+||+.||++|||++|+++
T Consensus       284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111111112234889999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-39  Score=372.37  Aligned_cols=254  Identities=25%  Similarity=0.394  Sum_probs=208.0

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ...+|++.+.||+|+||.||+|+.. +++.||||+++....    ..++|.+|+.++++++||||++++++|.+.+..++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3467888999999999999999876 488999999975422    25789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|+|.+++.... ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999999997533 24589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          759 PDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       759 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.........     ..+...  .+...+.
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-----~~~~~~--~~~~~~~  442 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----ELLEKD--YRMERPE  442 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----HHHHTT--CCCCCCT
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHcC--CCCCCCC
Confidence            4322 1223446788999999999999999999999999999999 99998754322111     111111  1112121


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .    ....+.+++.+||+.||++|||++++++.|+
T Consensus       443 ~----~~~~l~~li~~cl~~dP~~RPs~~el~~~L~  474 (495)
T 1opk_A          443 G----CPEKVYELMRACWQWNPSDRPSFAEIHQAFE  474 (495)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            1    1234889999999999999999999999885

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-39  Score=351.75  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=209.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|.+.+.||+|+||.||+++.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467899999999999999999865 5789999998765444444567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999987543   4589999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........|++.|+|||.+.+..++.++||||+|+++|||++|+.||........        ...+.......+... 
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~~-  264 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRIKKNEYSIPKHI-  264 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHHTCCCCCTTS-
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH--------HHHHhcCCCCCCccC-
Confidence            55555567799999999999998999999999999999999999999875332111        111111122212111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+.+++.+||+.||++||+++|+++
T Consensus       265 ---~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          265 ---NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               124789999999999999999999876

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.3e-39  Score=345.64  Aligned_cols=260  Identities=22%  Similarity=0.398  Sum_probs=204.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--c
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--R  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  674 (873)
                      ..|++.+.||+|+||.||+|++     .+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            5588899999999999999983     46899999999754322  2357899999999999999999999999876  6


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||+++++|.+++....  ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            6899999999999999985433  4589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc-------hhhhhhhhhhh
Q 039344          755 KFLKPDSS---NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-------SFSSLNLNIAL  824 (873)
Q Consensus       755 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-------~~~~~~~~~~~  824 (873)
                      +.......   ......||..|+|||.+.+..++.++||||+|+++|||+||+.|+......       ...........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87765443   223456788899999999999999999999999999999999996532110       00011111111


Q ss_pred             hhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          825 DEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       825 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+... +.+.+..    ....+.+++.+||+.||++|||++++++.|+
T Consensus       254 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          254 NTLKEGKRLPCPPN----CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             HHHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhccCCCCCCCC----CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            111111 1222211    1234889999999999999999999999885

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=359.93  Aligned_cols=266  Identities=19%  Similarity=0.292  Sum_probs=209.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc--eeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR--HLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~  677 (873)
                      .++|.+.+.||+|+||+||+|+.. +|+.||||++.....  ....+.+.+|++++++++||||+++++++.+..  ..+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            357899999999999999999865 589999999875322  222577889999999999999999999998755  779


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee----CCCCCeEEecccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL----DFENEAHVSDFGI  753 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Dfg~  753 (873)
                      +||||+++|+|.+++........+++..++.++.|++.|++|||++   +|+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999998766555599999999999999999999999   99999999999999    7777899999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc--------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT--------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ++...... ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||..................
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            98765432 3345679999999998865        56788999999999999999999998743321110000000000


Q ss_pred             hh-----------------cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          826 EM-----------------LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       826 ~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..                 ..+..+............+.+++.+||+.||++||+++|+++.++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence            00                 001122222223455667889999999999999999999988763

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-39  Score=367.57  Aligned_cols=252  Identities=26%  Similarity=0.436  Sum_probs=201.7

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..++|++.+.||+|+||.||+|+..++..||||+++....    ..++|.+|+.++++++||||+++++++.+ +..++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            3467888999999999999999998888899999975422    24689999999999999999999999876 678999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++.... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999999999996532 24589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCC
Q 039344          760 DSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPS  836 (873)
Q Consensus       760 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  836 (873)
                      ... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||........        ...+..+ +.+.+.
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------~~~i~~~~~~~~~~  404 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------LDQVERGYRMPCPP  404 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------HHHHHTTCCCCCCT
T ss_pred             CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCCCCC
Confidence            322 2223456789999999999999999999999999999999 9999875432211        1111111 222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .    ....+.+++.+||+.||++|||++++++.|+
T Consensus       405 ~----~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~  436 (452)
T 1fmk_A          405 E----CPESLHDLMCQCWRKEPEERPTFEYLQAFLE  436 (452)
T ss_dssp             T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1    1234889999999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-39  Score=343.82  Aligned_cols=249  Identities=26%  Similarity=0.438  Sum_probs=200.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999765 6779999998643222222356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||++++++.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999998643   3589999999999999999999999   999999999999999999999999999865433


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .  ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||........        ...+.......+... 
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~-  230 (279)
T 3fdn_A          162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRVEFTFPDFV-  230 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHHTCCCCCTTS-
T ss_pred             c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--------HHHHHhCCCCCCCcC-
Confidence            2  23446789999999999999999999999999999999999999874332211        111111122212111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+.+++.+||+.||++|||++|+++
T Consensus       231 ---~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          231 ---TEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               124789999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3e-39  Score=341.25  Aligned_cols=250  Identities=20%  Similarity=0.311  Sum_probs=204.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|... +++.||+|++.......   .+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            456899999999999999999765 57789999987543322   57799999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~~  756 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||++   +.++.+||+|||++..
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           85 MELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            9999999999988643   3589999999999999999999999   99999999999999   7888999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......||+.|+|||.+.+. ++.++||||+|+++|||++|+.||.......        ....+.......+.
T Consensus       159 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  228 (277)
T 3f3z_A          159 FKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------VMLKIREGTFTFPE  228 (277)
T ss_dssp             CCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCH
T ss_pred             ccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCCc
Confidence            6543 333456799999999988654 8999999999999999999999987533221        11222222222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            211122345889999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.7e-39  Score=340.43  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=201.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchh----HHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTF----QQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      .++|++.+.||+|+||+||+|+. .+++.||+|++..........    .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            36799999999999999999986 478999999987654333221    167899999999999999999999986654 


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeCCCCC-----eEE
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLDFENE-----AHV  748 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~-----~kl  748 (873)
                       ++||||+++++|.+++....  ..+++..++.++.|++.|++|||++   +  |+||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             79999999999988886543  4589999999999999999999999   8  999999999999998876     999


Q ss_pred             eccccccccCCCCCCccccccccccccccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          749 SDFGIAKFLKPDSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       749 ~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      +|||+++....   ......||+.|+|||.+.  ...++.++||||+||++|||++|+.||..........  .......
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~  245 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREE  245 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHS
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhcc
Confidence            99999975432   344567999999999984  4557889999999999999999999987543221100  0011111


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+..+.  .    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       246 ~~~~~~~~--~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          246 GLRPTIPE--D----CPPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             CCCCCCCT--T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCc--c----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            11112211  1    1234889999999999999999999999885

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-39  Score=341.01  Aligned_cols=252  Identities=23%  Similarity=0.403  Sum_probs=206.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||.||+|+..+++.||+|++.....    ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            367888999999999999999998899999999975432    2467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            9999999999986532  4588999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......        ....+...........
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~~  229 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPRL  229 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCTT
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--------HHHHHhcCCcCCCCcc
Confidence            11 1223456788999999998899999999999999999999 899987533221        1111111111111111


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+.+++.+||+.||++||+++++++.|+
T Consensus       230 ---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          230 ---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence               1224889999999999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=345.31  Aligned_cols=246  Identities=22%  Similarity=0.265  Sum_probs=193.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ++|++.++||+|+||+||+|+.. +|+.||||++......... ...+..|+..+.++ +||||++++++|.+.+..++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            57999999999999999999876 7999999998765443332 34555666666555 899999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+ ++++.+++...  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 57888887543  24599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....           ...+.....+.  ...
T Consensus       210 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~~~--~~~  274 (311)
T 3p1a_A          210 AG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPP--EFT  274 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCCCH--HHH
T ss_pred             CC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCCCc--ccc
Confidence            32 3344569999999998876 789999999999999999999776542211           11111111110  111


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......+.+++.+||+.||++|||++|+++
T Consensus       275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            112335889999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-39  Score=341.67  Aligned_cols=251  Identities=19%  Similarity=0.288  Sum_probs=203.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  678 (873)
                      .++|++.+.||+|+||.||+|+.. |+.||||+++..... ....+.+.+|+.+++.++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            367889999999999999999986 889999999765322 23356799999999999999999999999876  77899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ||||+++|+|.+++.... ...+++..++.++.|++.|++|||++   +  |+||||||+||+++.++.++++|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            999999999999997543 23589999999999999999999998   7  99999999999999999999999998764


Q ss_pred             cCCCCCCccccccccccccccccccCCCCC---cchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ...     ....||+.|+|||.+.+..++.   ++||||+|+++|||++|+.||..........    ........+..+
T Consensus       163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~  233 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM----KVALEGLRPTIP  233 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH----HHHHSCCCCCCC
T ss_pred             ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH----HHHhcCCCCCCC
Confidence            332     2346899999999998765544   7999999999999999999987543221111    111111112221


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .  .    ....+.+++.+||+.||++|||++++++.|+
T Consensus       234 ~--~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~  266 (271)
T 3kmu_A          234 P--G----ISPHVSKLMKICMNEDPAKRPKFDMIVPILE  266 (271)
T ss_dssp             T--T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C--C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1  1    1224889999999999999999999999885

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-40  Score=361.63  Aligned_cols=262  Identities=23%  Similarity=0.249  Sum_probs=205.0

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      .+.....++|++.+.||+|+||+||+|+.+ +|+.||+|++++.........+.+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344445688999999999999999999875 7999999998642111111224478999999999999999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      +..|+||||+++|+|.+++....  ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999996432  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC-ccccccccccccccccc-------cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          754 AKFLKPDSSN-WTELAGTYGYVAPELAY-------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       754 a~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ++........ ....+||+.|+|||++.       +..++.++||||+||++|||++|+.||............... ..
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~  287 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY-KE  287 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH-HH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cc
Confidence            9877554332 23468999999999987       356899999999999999999999998754332211111110 00


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCC---CCHHHHHH
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESR---PTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~~  869 (873)
                      .   ..++....   .....+.+++.+||. +|++|   |+++|+++
T Consensus       288 ~---~~~p~~~~---~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 H---LSLPLVDE---GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             H---CCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             C---cCCCcccc---CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            1   11111001   112347899999999 99998   68999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.1e-39  Score=340.65  Aligned_cols=253  Identities=20%  Similarity=0.293  Sum_probs=203.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCc---chhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++.......   ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56889999999999999999876 68999999987543221   123578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC----CeEEecccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFGI  753 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg~  753 (873)
                      +||||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++    .+||+|||.
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999998643   4589999999999999999999999   999999999999999887    799999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ++...... ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.......        ....+......
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~  229 (283)
T 3bhy_A          159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--------TLTNISAVNYD  229 (283)
T ss_dssp             CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCC
T ss_pred             ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--------HHHHhHhcccC
Confidence            98765432 3344578999999999999999999999999999999999999987533211        11112122221


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+..........+.+++.+||+.||++||+++|+++
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            111111122335889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.7e-39  Score=368.02  Aligned_cols=257  Identities=23%  Similarity=0.295  Sum_probs=208.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999875 69999999986432222223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      ||+++|+|.+++.... ....+++..+..++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986543 234689999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||.........    ......+.......+... 
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~~~~~p~~~-  416 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQAVTYPDKF-  416 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHCCCCCCTTS-
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhcccCCCccc-
Confidence            544445568999999999999999999999999999999999999999754321110    111122222222222221 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTM-----QKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~  869 (873)
                         ...+.+++.+||+.||++||++     +++++
T Consensus       417 ---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          417 ---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               2247899999999999999965     56653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=350.35  Aligned_cols=246  Identities=20%  Similarity=0.284  Sum_probs=203.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcc-----hhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEM-----TFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++........     ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            346799999999999999999975 5789999999876532211     1234577899999999999999999999999


Q ss_pred             ceeEEEEEeccCC-ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          674 RHLFIVYEYFKMC-SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       674 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      +..++||||+.+| ++.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 999988654   3489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      +++...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....              .....
T Consensus       176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~~  240 (335)
T 3dls_A          176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEAA  240 (335)
T ss_dssp             TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTTC
T ss_pred             cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhhc
Confidence            998765443 3345679999999999988877 7899999999999999999999864221              11111


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                      ...+...    ...+.+++.+||+.||++|||++++++.
T Consensus       241 ~~~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          241 IHPPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             cCCCccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112111    1248899999999999999999999873

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-39  Score=344.50  Aligned_cols=257  Identities=24%  Similarity=0.345  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cceeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  677 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+  ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            367899999999999999999865 7899999999754332 2345779999999999999999999998854  56889


Q ss_pred             EEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCC-----eeeCCCCCCCeeeCCCCCeEEecc
Q 039344          678 IVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPP-----IVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      +||||+++++|.+++.... ....+++..++.++.|++.|++|||+.   +     |+||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            9999999999999997543 234589999999999999999999998   7     999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      |.++.............|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.........        ..+..+.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~i~~~~  232 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA--------GKIREGK  232 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------HHHHHTC
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH--------HHHhhcc
Confidence            99987655433344567899999999999989999999999999999999999998754322111        1111111


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.....   ....+.+++.+||+.||++||+++|+++.+.
T Consensus       233 ~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          233 FRRIPYR---YSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             cccCCcc---cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            1111111   1224889999999999999999999998653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-39  Score=350.33  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=198.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcE----EEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEI----IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      ++|++.+.||+|+||+||+|+.. +++.    ||+|.+......  ...+.+.+|+.+++.++||||+++++++. .+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            67889999999999999999754 4544    788887543221  12356778999999999999999999986 5668


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            99999999999999986542  4589999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ......  ......+++.|+|||.+.+..++.++||||+||++|||+| |+.||...........     ....  ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----~~~~--~~~~  237 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-----LEKG--ERLA  237 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-----HHTT--CBCC
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-----HHcC--CCCC
Confidence            754432  2345567889999999999999999999999999999999 9999875433221111     1111  1111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+...    ...+.+++.+||+.||++||+++++++.|+
T Consensus       238 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          238 QPQIC----TIDVYMVMVKCWMIDENIRPTFKELANEFT  272 (325)
T ss_dssp             CCTTB----CTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred             CCCcC----cHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111    113778999999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.3e-39  Score=367.75  Aligned_cols=256  Identities=22%  Similarity=0.254  Sum_probs=206.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999865 7999999998643211222246688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++.... ...+++..+..++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986543 23489999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||..........    .....+.......+... 
T Consensus       339 ~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~----~i~~~i~~~~~~~p~~~-  412 (576)
T 2acx_A          339 G-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVKEVPEEYSERF-  412 (576)
T ss_dssp             T-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH----HHHHHHHHCCCCCCTTS-
T ss_pred             C-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH----HHHHHhhcccccCCccC-
Confidence            3 23345689999999999999899999999999999999999999997543211100    01111111111111111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                         ...+.+++.+||+.||++||     +++|+++
T Consensus       413 ---s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          413 ---SPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence               22478999999999999999     7888875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=351.33  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=196.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC--CceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l  678 (873)
                      .+.|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.+++.++|  |||+++++++.+....++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            467999999999999999999988899999999875432 23345778999999999976  999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||| +.+++|.+++...   ..+++.++..++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++...
T Consensus        87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 5678999998653   4589999999999999999999999   999999999999997 6889999999998765


Q ss_pred             CCCC--Ccccccccccccccccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          759 PDSS--NWTELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       759 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ....  ......||+.|+|||++.+           ..++.++||||+||++|||++|+.||......       .....
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~  231 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH  231 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHHHH
Confidence            4432  2235679999999999865           67889999999999999999999998643221       01111


Q ss_pred             hhcCCCCC--CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLDPRLP--TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...++...  .+...    ...+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          232 AIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcCCcccCCcccC----CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            22222211  11111    124789999999999999999999976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.2e-39  Score=353.90  Aligned_cols=266  Identities=21%  Similarity=0.274  Sum_probs=206.0

Q ss_pred             cCHHHHHHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-----CCceee
Q 039344          592 IIYEEIIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-----HRNIVK  665 (873)
Q Consensus       592 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~  665 (873)
                      +.+.+.....++|.+.+.||+|+||+||+|+. .+++.||||++..    .....+.+..|+.+++.+.     ||||++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34444445568899999999999999999986 4789999999863    2233567788999999996     999999


Q ss_pred             EEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---
Q 039344          666 VYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---  742 (873)
Q Consensus       666 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---  742 (873)
                      +++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+||+++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence            999999999999999999 8999999875432 3489999999999999999999999   9999999999999975   


Q ss_pred             ----------------------CCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHH
Q 039344          743 ----------------------ENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV  800 (873)
Q Consensus       743 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el  800 (873)
                                            ++.+||+|||+|+.....   .....||+.|+|||++.+..++.++||||+||++|||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                  789999999999865432   2346789999999999999999999999999999999


Q ss_pred             HhCCCCCcccccchhhhhhhh-------hh--------hhhhcC-----CCCCCCCchhHH--------------HHHHH
Q 039344          801 IKGKHPRDFISSMSFSSLNLN-------IA--------LDEMLD-----PRLPTPSRNVHD--------------KLISI  846 (873)
Q Consensus       801 ~tg~~P~~~~~~~~~~~~~~~-------~~--------~~~~~~-----~~~~~~~~~~~~--------------~~~~l  846 (873)
                      ++|+.||..............       ..        .....+     ..++........              ....+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999999975432211000000       00        000000     001111100000              01357


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHH
Q 039344          847 VEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       847 ~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+++.+||+.||++|||++|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            79999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.5e-39  Score=339.04  Aligned_cols=251  Identities=22%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||.||+|+..+++.||+|++.....    ..+.+.+|+++++.++||||+++++++. .+..++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence            467889999999999999999998888999999875422    2477999999999999999999999986 45689999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++.... ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999999986532 23589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC-CCCCCc
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR-LPTPSR  837 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  837 (873)
                      .. ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||........        ...+.... ...+..
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  234 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRMVRPDN  234 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------HHHHHTTCCCCCCTT
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--------HHHHhcccCCCCccc
Confidence            22 1223456788999999998889999999999999999999 9999875332211        11111111 111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ....+.+++.+||+.||++|||++++++.|+
T Consensus       235 ----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----ccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                1234889999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.4e-39  Score=344.31  Aligned_cols=257  Identities=24%  Similarity=0.397  Sum_probs=203.2

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec--ce
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV--RH  675 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  675 (873)
                      .|++.+.||+|+||+||++.+.     +|+.||||++....  .....+.+.+|+++++.++||||+++++++.+.  ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            3488999999999999998642     68899999997542  233457799999999999999999999999874  67


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+++++|.+++...    .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            89999999999999998643    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccch-------hhhhhhhhhhh
Q 039344          756 FLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-------FSSLNLNIALD  825 (873)
Q Consensus       756 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-------~~~~~~~~~~~  825 (873)
                      ........   .....+++.|+|||.+.+..++.++||||+|+++|||+||+.||.......       ...........
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            77654322   234567888999999999889999999999999999999999987432110       00001111111


Q ss_pred             hhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          826 EMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       826 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..... ..+.+..    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       263 ~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          263 LLERGERLPRPDK----CPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             HHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcccCCCCCcc----ccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111 1111111    1234889999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=337.67  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.....||+|+||.||+|+. .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            3455556999999999999985 5688999999875422   23577999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-CCCeEEeccccccccCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-ENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~  759 (873)
                      ||+++++|.+++.........++..+..++.|++.|++|||++   +|+||||||+||+++. ++.+||+|||.++....
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999997654444577889999999999999999999   9999999999999987 89999999999987765


Q ss_pred             CCCCccccccccccccccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      .........|++.|+|||.+.+..  ++.++||||||+++|||++|+.||..........  .. .......+..+.  .
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~-~~~~~~~~~~~~--~  250 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM--FK-VGMFKVHPEIPE--S  250 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--HH-HHHHCCCCCCCT--T
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--Hh-hccccccccccc--c
Confidence            444444567899999999987654  7889999999999999999999986433221100  00 001111122221  1


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ....+.+++.+||+.||++||+++++++
T Consensus       251 ----~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          251 ----MSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1224789999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-39  Score=340.42  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++......  ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            56889999999999999999764 6899999998764322  22578999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccc
Q 039344          681 EYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAKF  756 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~~  756 (873)
                      ||+++++|.+++.... ....+++..+..++.|++.|++|||++   +|+||||||+||++   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999999886542 335689999999999999999999999   99999999999999   4567899999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......|++.|+|||.+. +.++.++||||+|+++|||++|+.||............      ....+......
T Consensus       177 ~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~------~~~~~~~~~~~  248 (285)
T 3is5_A          177 FKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------TYKEPNYAVEC  248 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCCC--
T ss_pred             cCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh------ccCCccccccc
Confidence            6543 2334567899999999875 56889999999999999999999998754322111110      11111111111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..   ....+.+++.+||+.||++|||++|+++
T Consensus       249 ~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          249 RP---LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             Cc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10   1224789999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.6e-39  Score=340.66  Aligned_cols=257  Identities=24%  Similarity=0.404  Sum_probs=193.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ..+|++.+.||+|+||+||+|+..  ..||+|+++..... ....+.+.+|+.+++.++||||+++++++ .....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            467999999999999999999875  35999998765332 33457799999999999999999999975 456689999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++....  ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999986443  4589999999999999999999999   9999999999999999999999999999865432


Q ss_pred             --CCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          761 --SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       761 --~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                        ........||+.|+|||.+.   +..++.++||||+|+++|||++|+.||...........   ........+.....
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~  250 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE---MVGRGSLSPDLSKV  250 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH---HHHHTSCCCCTTSS
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH---HhcccccCcchhhc
Confidence              22234567899999999986   56688899999999999999999999875443211111   11111111211111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..   .....+.+++.+||+.||++|||++++++.|+
T Consensus       251 ~~---~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  284 (289)
T 3og7_A          251 RS---NCPKRMKRLMAECLKKKRDERPSFPRILAEIE  284 (289)
T ss_dssp             CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cc---cCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            11   12235889999999999999999999999885

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-39  Score=343.51  Aligned_cols=264  Identities=23%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCC--cchhHHHHHHHHHHHHhcc---CCceeeEEeEEEec
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIW---HRNIVKVYGFCLHV  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  673 (873)
                      ..++|++.+.||+|+||+||+|+. .+|+.||+|++......  .......+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999985 57899999998643221  1112346677888777765   99999999999875


Q ss_pred             c-----eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          674 R-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       674 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                      .     ..++||||+. ++|.+++..... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999998 599998875442 3489999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhh---h
Q 039344          749 SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL---D  825 (873)
Q Consensus       749 ~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~---~  825 (873)
                      +|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.................   .
T Consensus       162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            999999876543 334556889999999999999999999999999999999999999975443211111110000   0


Q ss_pred             -----------hhcCCCCCCCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 -----------EMLDPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 -----------~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                 ....+..+.+. ....+....+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                       00000000000 000112235789999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-39  Score=346.38  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=208.5

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ...+|++.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            4577999999999999999999876 5889999998743    2235789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++++|.+++.... ...+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        87 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999996533 24589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          759 PDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       759 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||..........     .........  .+.
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-----~~~~~~~~~--~~~  235 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKDYRME--RPE  235 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----HHHTTCCCC--CCT
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHhccCCCC--CCC
Confidence            4432 2233456788999999999999999999999999999999 999987543221111     111111111  111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .    ....+.+++.+||+.||++|||++++++.|+
T Consensus       236 ~----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          236 G----CPEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence            1    1234889999999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.9e-39  Score=351.64  Aligned_cols=261  Identities=22%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCc-----chhHHHHHHHHHHHHhc-cCCceeeE
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGE-----MTFQQEFLNEVKALTEI-WHRNIVKV  666 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l-~h~niv~l  666 (873)
                      +.......++|++.+.||+|+||.||+|+.. +|+.||||++.......     ....+.+.+|+.+++.+ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            4444455678999999999999999999875 79999999987543211     12245688999999999 79999999


Q ss_pred             EeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       667 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                      ++++...+..++||||+++++|.+++...   ..+++..+..++.||+.|++|||+.   ||+||||||+||+++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            99999999999999999999999998643   4589999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCcccccccccccccccccc------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~  820 (873)
                      ||+|||++...... .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||........     
T Consensus       240 kl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-----  313 (365)
T 2y7j_A          240 RLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-----  313 (365)
T ss_dssp             EECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----
T ss_pred             EEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence            99999999877643 33445689999999998863      3578899999999999999999999865332211     


Q ss_pred             hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ...+..................+.+++.+||+.||++|||++|+++
T Consensus       314 ---~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 ---LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               1111112221111111112335889999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.4e-39  Score=354.65  Aligned_cols=261  Identities=19%  Similarity=0.268  Sum_probs=198.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC------CcEEEEEEccCCCCCcch--------hHHHHHHHHHHHHhccCCceeeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS------GEIIAVKKFHSPLPGEMT--------FQQEFLNEVKALTEIWHRNIVKV  666 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l  666 (873)
                      ..+|++.+.||+|+||.||+|+...      ++.||||++.........        ....+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999998754      478999998654211000        01123445556667789999999


Q ss_pred             EeEEEec----ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-
Q 039344          667 YGFCLHV----RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-  741 (873)
Q Consensus       667 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-  741 (873)
                      ++++...    ...++||||+ +++|.+++...  ...+++..++.++.||+.||+|||++   +|+||||||+||+++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            9999875    4589999999 99999998653  24599999999999999999999999   999999999999999 


Q ss_pred             -CCCCeEEeccccccccCCCCCC-------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc
Q 039344          742 -FENEAHVSDFGIAKFLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM  813 (873)
Q Consensus       742 -~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~  813 (873)
                       .++.+||+|||+++.+......       .....||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999876543221       13345999999999999999999999999999999999999999853221


Q ss_pred             -hhh---hhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          814 -SFS---SLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       814 -~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ...   ..........+.++.++...     ....+.+++..||+.||++||+++++++.|+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAAN-----APGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTC-----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhccccc-----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence             111   11111112222222211110     1224889999999999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-38  Score=340.12  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            35689999999999999999975 47899999999755332  2357899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999999854    3589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........|++.|+|||.+.+..++.++||||||+++|+|++|+.||..........     .......+..+.  .. 
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~--~~-  243 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-----LIPKNNPPTLEG--NY-  243 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSCCCCCCS--SC-
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-----HhhcCCCCCCcc--cc-
Confidence            5444456679999999999999999999999999999999999999987543221111     111111111111  11 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                         ...+.+++.+||+.||++|||++|+++.
T Consensus       244 ---~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          244 ---SKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ---CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ---CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               2248899999999999999999999763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-39  Score=354.78  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=191.3

Q ss_pred             CCCCCceeeecCCeEEEEEEeC--CC--cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cceeE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA--SG--EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VRHLF  677 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  677 (873)
                      .|.+.+.||+|+||+||+|+..  ++  ..||+|.+...  ......+.|.+|+.++++++||||+++++++.+ .+..+
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            4667789999999999999753  22  36899998753  233346789999999999999999999999764 45789


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++....  ..+++..+..++.||++|++|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999996533  3578999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCC----CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          758 KPDSS----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       758 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .....    ......+++.|+|||.+.+..++.++|||||||++|||+| |..||...........        +.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~--------~~~~~~  314 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------LLQGRR  314 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH--------HHTTCC
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH--------HHcCCC
Confidence            43321    1233457789999999999999999999999999999999 6777765433222111        111111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .......   ...+.+++.+||+.||++||+++|+++.|+
T Consensus       315 ~~~p~~~---~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          315 LLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111111   224889999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.9e-39  Score=368.32  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356899999999999999999865 7999999998765444344467899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~~  756 (873)
                      |||+.+++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||++   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999988654   3589999999999999999999999   99999999999999   5678999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.......        ....+..+....+.
T Consensus       179 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~  248 (484)
T 3nyv_A          179 FEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILKKVEKGKYTFEL  248 (484)
T ss_dssp             BCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCS
T ss_pred             cccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCCC
Confidence            7543 33455679999999999866 68999999999999999999999987543321        12222222322222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            222223345889999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=346.16  Aligned_cols=252  Identities=26%  Similarity=0.449  Sum_probs=197.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCC-----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLAS-----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+|++.+.||+|+||.||+|+...     +..||+|+++...  .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            567778999999999999997542     2459999997543  233356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++...  ...+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            9999999999999998643  24589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-C
Q 039344          757 LKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-R  831 (873)
Q Consensus       757 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~  831 (873)
                      .......   .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......        ....+.+. +
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~  268 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------VMKAINDGFR  268 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCC
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHCCCc
Confidence            6543221   123345788999999998899999999999999999999 999986433211        11122222 1


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.+..    ....+.+++.+||+.||++||+++++++.|+
T Consensus       269 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          269 LPTPMD----CPSAIYQLMMQCWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             CCCCTT----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            222221    1234889999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=345.44  Aligned_cols=263  Identities=25%  Similarity=0.387  Sum_probs=198.6

Q ss_pred             HHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc--cCCceeeEEeEEEec--
Q 039344          598 IRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI--WHRNIVKVYGFCLHV--  673 (873)
Q Consensus       598 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~--  673 (873)
                      ....++|++.+.||+|+||.||+|+.. |+.||||++...      ....+..|.+++...  +||||+++++++.+.  
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            344578999999999999999999887 899999998532      134455666665554  899999999999887  


Q ss_pred             --ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCCeeeCCCCCe
Q 039344          674 --RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC-----FPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       674 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                        ...++||||+++|+|.+++...    .+++..++.++.|++.|++|||+++     .++|+||||||+||+++.++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence              6889999999999999999543    4899999999999999999999762     2389999999999999999999


Q ss_pred             EEeccccccccCCCCCCc----cccccccccccccccccCCCCCc------chhHHHHHHHHHHHhC----------CCC
Q 039344          747 HVSDFGIAKFLKPDSSNW----TELAGTYGYVAPELAYTMKVTEK------CDVYSFGVLALEVIKG----------KHP  806 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~------sDv~s~G~il~el~tg----------~~P  806 (873)
                      ||+|||+++.........    ....||+.|+|||++.+.....+      +|||||||++|||+||          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999998765433321    24579999999999987766655      9999999999999999          555


Q ss_pred             Ccccccchhhhhhh-hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          807 RDFISSMSFSSLNL-NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       807 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      |............. .........+..+.. ....+....+.+++.+||+.||++|||+.|+++.|+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNR-WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HhhhcCCCCchhhhHHHHhhhccCcccccc-chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence            44322111100011 111111112222211 112245567999999999999999999999999885

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.6e-39  Score=348.04  Aligned_cols=262  Identities=19%  Similarity=0.285  Sum_probs=204.3

Q ss_pred             HHHHHHHhcCCCCC-ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEE
Q 039344          594 YEEIIRATNDFDDE-HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFC  670 (873)
Q Consensus       594 ~~e~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  670 (873)
                      ++......+.|.+. +.||+|+||.||+|+.. +|+.||+|++....... .....+.+|+.+++.+ +||||+++++++
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            33344555667776 89999999999999765 68999999987643332 3357899999999999 579999999999


Q ss_pred             EecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CCCeE
Q 039344          671 LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAH  747 (873)
Q Consensus       671 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~k  747 (873)
                      .+.+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence            99999999999999999999986532 34589999999999999999999999   9999999999999998   78999


Q ss_pred             EeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhh
Q 039344          748 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      |+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...........     ....
T Consensus       175 L~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----i~~~  248 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-----ISQV  248 (327)
T ss_dssp             ECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHT
T ss_pred             EeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----HHhc
Confidence            99999998765432 33446799999999999999999999999999999999999999875432211111     1111


Q ss_pred             cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ....+..........+.+++.+||+.||++|||++++++
T Consensus       249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 ---NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ---CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence               111111111112234789999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.5e-39  Score=344.77  Aligned_cols=259  Identities=18%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             cCCCCC-ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          602 NDFDDE-HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       602 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      +.|.+. +.||+|+||+||+|+. .+++.||||++.....   ...+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            567774 7899999999999985 4799999999975422   2357789999999985 79999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC---eEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~Dfg~a~  755 (873)
                      ||||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.   +||+|||+++
T Consensus        89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            99999999999998653   3589999999999999999999999   9999999999999998876   9999999997


Q ss_pred             ccCCCCC-------Ccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCcccccc--hhhh----
Q 039344          756 FLKPDSS-------NWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSM--SFSS----  817 (873)
Q Consensus       756 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~--~~~~----  817 (873)
                      .......       ......||+.|+|||++.+     ..++.++||||+||++|||++|+.||......  .|..    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6543211       1224568999999999875     55889999999999999999999999754321  1110    


Q ss_pred             -hhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          818 -LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       818 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                       .........+.......+..........+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             0011122223333333222111122345889999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=350.65  Aligned_cols=260  Identities=19%  Similarity=0.256  Sum_probs=196.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcch--------hHHHHHHHHHHHHhccCCceeeEEe
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMT--------FQQEFLNEVKALTEIWHRNIVKVYG  668 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~  668 (873)
                      .++|.+.+.||+|+||.||+|+..    ++..||+|++.........        ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999875    5788999998754221100        1134678888899999999999999


Q ss_pred             EEEe----cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          669 FCLH----VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       669 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      ++.+    ....++||||+ +++|.+++....   .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9988    67899999999 999999986543   589999999999999999999999   999999999999999887


Q ss_pred             --CeEEeccccccccCCCCC-------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchh
Q 039344          745 --EAHVSDFGIAKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSF  815 (873)
Q Consensus       745 --~~kl~Dfg~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~  815 (873)
                        .+||+|||+++.+.....       ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999987643221       12455799999999999999999999999999999999999999964221111


Q ss_pred             hhhhhhhhhhhhcC----CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLD----PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..............    ...+. .    .....+.+++.+||+.||++||++++|++.|+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  324 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAPS-G----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILN  324 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSCT-T----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred             HHHHHHHhhcccccHHHHhhccc-c----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            00000000000000    00000 0    11224889999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-38  Score=353.15  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=197.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc--CCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW--HRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.+++.++  ||||+++++++...+..|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            56999999999999999999988899999999875433 2334578999999999996  59999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      || +.+++|.+++...   ..+++.++..++.||+.||+|||++   +|+||||||+||+++ ++.+||+|||+++....
T Consensus       135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 6778999998654   3588999999999999999999999   999999999999996 68999999999987654


Q ss_pred             CCC--Ccccccccccccccccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          760 DSS--NWTELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       760 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      ...  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......       ......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~~  279 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHA  279 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHHH
Confidence            332  2245679999999999865           36889999999999999999999998643211       011222


Q ss_pred             hcCCCCC--CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLP--TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +.++...  .+...    ...+.+++.+||+.||++|||++|+++
T Consensus       280 ~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          280 IIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCccccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            2222221  11111    124789999999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-38  Score=360.60  Aligned_cols=258  Identities=20%  Similarity=0.292  Sum_probs=195.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  673 (873)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            467999999999999999999754 689999999975422 233457789999999999999999999999654      


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...|+||||++++ +.+.+.     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            3579999999865 544443     2388999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh------------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN------------  821 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~------------  821 (873)
                      |+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..............            
T Consensus       211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9876543 334557899999999999999999999999999999999999999976432211100000            


Q ss_pred             --hhhhhhcCCC----------------CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 --IALDEMLDPR----------------LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 --~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ..........                .+............+.+++.+||+.||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0011111111                01111111222456899999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8e-39  Score=339.26  Aligned_cols=248  Identities=23%  Similarity=0.397  Sum_probs=204.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            67899999999999999999865 67899999986432112223467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999998653   3589999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||+.......        ...+.......+...  
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~~--  235 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--------HRRIVNVDLKFPPFL--  235 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHTTCCCCCTTS--
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--------HHHHhccccCCCCcC--
Confidence              23346789999999999999999999999999999999999999875332211        112222222222211  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ...+.+++.+||+.||++||+++++++
T Consensus       236 --~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          236 --SDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              224789999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.8e-39  Score=346.80  Aligned_cols=264  Identities=22%  Similarity=0.361  Sum_probs=209.6

Q ss_pred             HHHHHHHhcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeE
Q 039344          594 YEEIIRATNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKV  666 (873)
Q Consensus       594 ~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  666 (873)
                      ..+.....++|++.+.||+|+||+||+|+.      .+++.||||+++...  .....+.+.+|+.+++++ +||||+++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            444445568899999999999999999974      356899999997543  223356799999999999 79999999


Q ss_pred             EeEEEecc-eeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 039344          667 YGFCLHVR-HLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRD  732 (873)
Q Consensus       667 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D  732 (873)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..++.++.|++.|++|||++   +|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99998754 58999999999999999976442             12378899999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcc
Q 039344          733 ISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF  809 (873)
Q Consensus       733 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~  809 (873)
                      |||+||+++.++.+||+|||+++........  .....||+.|+|||.+.+..++.++||||+|+++|||+| |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876544332  234567889999999999999999999999999999998 9999875


Q ss_pred             cccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          810 ISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ........    .......  ....+...    ...+.+++.+||+.||++|||++|+++.|+
T Consensus       254 ~~~~~~~~----~~~~~~~--~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          254 VKIDEEFC----RRLKEGT--RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             CCCSHHHH----HHHHHTC--CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cchhHHHH----HHhccCc--cCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            43221110    0111111  11111111    224889999999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=348.74  Aligned_cols=260  Identities=16%  Similarity=0.255  Sum_probs=192.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|.+.+.||+|+||+||+|+.. +++.||+|++........  ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            57889999999999999999875 789999999875422111  123557999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++ +++.+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             ECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9998 5888887643  24589999999999999999999999   9999999999999999999999999999876655


Q ss_pred             CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh----------------hh
Q 039344          761 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN----------------IA  823 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~----------------~~  823 (873)
                      ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............                ..
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            555556688999999999876 5689999999999999999999999975432211110000                00


Q ss_pred             hhhhcCCCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 LDEMLDPRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......+......  .........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000001110000  000011235789999999999999999999976

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=337.45  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=203.0

Q ss_pred             cCCCCCc-eeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEH-CIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|.+.+ .||+|+||.||+|...   +++.||+|+++...  .....+.+.+|+++++.++||||+++++++ +.+..+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            4555555 8999999999999753   67889999997642  333467899999999999999999999999 556789


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++++|.+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            999999999999998643  24589999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          758 KPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       758 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ......   .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..........     .......+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-----~i~~~~~~~~-  234 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGKRMEC-  234 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-----HHHTTCCCCC-
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-----HHhcCCcCCC-
Confidence            544332   123456889999999988889999999999999999998 999987543321111     1111111111 


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       +..    ....+.+++.+||+.||++||++.++++.|+
T Consensus       235 -~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          235 -PPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             -CTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCC----cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             111    1234889999999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-38  Score=341.99  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++......   ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            467899999999999999999865 7999999999754222   235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee---CCCCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~~  756 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||+++.
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           85 MQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             ECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            9999999999988543   3589999999999999999999999   99999999999999   7788999999999975


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ...  .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||........        ...+.......+.
T Consensus       159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~i~~~~~~~~~  228 (304)
T 2jam_A          159 EQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--------FEKIKEGYYEFES  228 (304)
T ss_dssp             CCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHCCCCCCT
T ss_pred             cCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHcCCCCCCc
Confidence            432  223445789999999999999999999999999999999999999864332111        1111111111111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++||+++|+++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111112235889999999999999999999976

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=348.03  Aligned_cols=266  Identities=21%  Similarity=0.300  Sum_probs=199.0

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCc--chhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGE--MTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ....+|++.+.||+|+||.||+|+.. +|+.||||++.......  ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999865 68999999987543221  1112468899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+++ ++.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 7887775432  4588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh-------hhhh
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA-------LDEM  827 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~-------~~~~  827 (873)
                      .............||+.|+|||.+.+. .++.++||||+||++|||++|..||................       ....
T Consensus       161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            876555555667899999999998764 47899999999999999999999987544321111111100       0000


Q ss_pred             ------cC-CCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 039344          828 ------LD-PRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQL  870 (873)
Q Consensus       828 ------~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  870 (873)
                            .. ...+...  .........+.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                  00 0000000  0001112458899999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-38  Score=343.42  Aligned_cols=259  Identities=22%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      ...++|.+.+.||+|+||.||+|+..    +++.||+|+++..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            34577888999999999999999754    3458999998754332 233567999999999999999999999998755


Q ss_pred             -----eeEEEEEeccCCChhhHhcccc---cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          675 -----HLFIVYEYFKMCSLAVILSNDA---AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       675 -----~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                           ..++||||+++++|.+++....   ....+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence                 3599999999999999985332   334689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~  823 (873)
                      ||+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.........       
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------  259 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-------  259 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-------
Confidence            9999999987654322  1233457889999999999999999999999999999999 88998754432211       


Q ss_pred             hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ..+...........   ....+.+++.+||+.||++|||+.++++.|+
T Consensus       260 -~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          260 -DYLLHGHRLKQPED---CLDELYEIMYSCWRTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             -HHHHTTCCCCCBTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHcCCCCCCCcc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             11111111111111   1234889999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7e-39  Score=340.95  Aligned_cols=253  Identities=24%  Similarity=0.373  Sum_probs=201.1

Q ss_pred             hcCCCCCc-eeeecCCeEEEEEEe---CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEH-CIGKGGQGSVYMSKL---ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      ..+|.+.+ .||+|+||.||+|..   .+++.||||+++.... .....+++.+|+.+++.++||||+++++++ +.+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            45677777 999999999999954   3468899999976432 233467899999999999999999999999 56778


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++...   ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            9999999999999999653   3489999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          757 LKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       757 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ........   ....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.........     ........+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~  241 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-----AMLEKGERMGC  241 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTCCCCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-----HHHHcCCCCCC
Confidence            75543322   22346788999999988889999999999999999999 99998754322111     11111111111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        +..    ....+.+++.+||+.||++||++.++++.|+
T Consensus       242 --~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          242 --PAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             --CTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             --CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence              111    1234889999999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8e-39  Score=346.48  Aligned_cols=262  Identities=17%  Similarity=0.280  Sum_probs=192.9

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ...++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3457899999999999999999975 47899999999754322 223466789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-----CCCCeEEeccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-----FENEAHVSDFG  752 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-----~~~~~kl~Dfg  752 (873)
                      +||||++ ++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++     .++.+||+|||
T Consensus       110 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            9999998 5898888644   3489999999999999999999999   999999999999994     44569999999


Q ss_pred             cccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh--------
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA--------  823 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~--------  823 (873)
                      +++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||................        
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            998776555555666789999999998875 48999999999999999999999997544321111100000        


Q ss_pred             -----hhhhcCCCCCC-CCchhHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 -----LDEMLDPRLPT-PSRNVHD-----KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 -----~~~~~~~~~~~-~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                           ...+. ...+. .......     ....+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                 00000 00000 0000000     1235789999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-38  Score=338.22  Aligned_cols=258  Identities=18%  Similarity=0.241  Sum_probs=197.9

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEE-EecceeE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFC-LHVRHLF  677 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~  677 (873)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++......     +.+.+|+.+++.++|++++..++++ .+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            457899999999999999999985 57899999987643222     3478899999999888777666665 5677889


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee---CCCCCeEEeccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIA  754 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a  754 (873)
                      +||||+ +++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            999999 899999986432  3589999999999999999999999   99999999999999   78899999999999


Q ss_pred             cccCCCCC-------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhh
Q 039344          755 KFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       755 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      +.......       ......||+.|+|||.+.+..++.++||||+||++|||++|+.||....................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            87654432       12346789999999999999999999999999999999999999976443211111111100111


Q ss_pred             cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          828 LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+. .   .........+.+++.+||+.||++|||++++++.|+
T Consensus       236 ~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          236 STPI-E---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HSCH-H---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             cchh-h---hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            0000 0   000001234889999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.9e-39  Score=341.94  Aligned_cols=247  Identities=20%  Similarity=0.394  Sum_probs=198.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CC-------cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SG-------EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH  672 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  672 (873)
                      .++|.+.+.||+|+||+||+|+.. ++       ..||+|++...   .....+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            367889999999999999999754 23       46999998643   22345789999999999999999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC-------
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE-------  745 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-------  745 (873)
                      .+..++||||+++++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.       
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            999999999999999999997543  3489999999999999999999999   9999999999999998887       


Q ss_pred             -eEEeccccccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCC-Ccccccchhhhhhhhh
Q 039344          746 -AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNI  822 (873)
Q Consensus       746 -~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P-~~~~~~~~~~~~~~~~  822 (873)
                       +||+|||+++....    .....|++.|+|||.+.+ ..++.++||||+|+++|||++|..| |........     ..
T Consensus       159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----~~  229 (289)
T 4fvq_A          159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-----LQ  229 (289)
T ss_dssp             EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HH
T ss_pred             eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-----HH
Confidence             99999999975432    233567899999999987 6789999999999999999996554 432221110     00


Q ss_pred             hhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....  ....+...      ...+.+++.+||+.||++|||++|+++.|+
T Consensus       230 ~~~~--~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  271 (289)
T 4fvq_A          230 FYED--RHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLN  271 (289)
T ss_dssp             HHHT--TCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             Hhhc--cCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            0110  11111111      113789999999999999999999999885

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-38  Score=344.90  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=206.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEE--ec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCL--HV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~  673 (873)
                      .++|++.+.||+|+||.||+|+.     .+++.||||++...   .....+.+.+|++++++++||||+++++++.  +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            36789999999999999999983     46889999998753   2333567999999999999999999999987  45


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...++||||+++++|.+++....  ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            66899999999999999996533  3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhh-------hhhhhhh
Q 039344          754 AKFLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFS-------SLNLNIA  823 (873)
Q Consensus       754 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~-------~~~~~~~  823 (873)
                      ++........   .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.........       .......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            9877544321   23346788899999999988999999999999999999999998643221000       0000111


Q ss_pred             hhhhcCCC-CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPR-LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ........ .+.+..    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       254 ~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          254 LELLEEGQRLPAPPA----CPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             HHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhhcccCCCCCCc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111111 111111    1234889999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.6e-39  Score=337.20  Aligned_cols=250  Identities=21%  Similarity=0.342  Sum_probs=196.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+..++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999875 7999999998643222223356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998653   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      . .......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||+.......        ...+.......+...
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  234 (276)
T 2h6d_A          164 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--------FKKIRGGVFYIPEYL  234 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCCCCTTS
T ss_pred             C-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--------HHHhhcCcccCchhc
Confidence            3 22344578999999999987765 5899999999999999999999875332111        111111121112111


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                          ...+.+++.+||+.||++|||++|+++
T Consensus       235 ----~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          235 ----NRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                124789999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-38  Score=338.04  Aligned_cols=257  Identities=18%  Similarity=0.246  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEE-EecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFC-LHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l  678 (873)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.....     .+.+.+|+.+++.++|++++..++++ .+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            46899999999999999999986 6799999999865422     24588999999999888766666655 56678899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee---CCCCCeEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~  755 (873)
                      ||||+ +++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||++   +.++.+||+|||+++
T Consensus        83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            99999 899999986332  4589999999999999999999999   99999999999999   478899999999998


Q ss_pred             ccCCCCCC-------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhc
Q 039344          756 FLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       756 ~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      ........       .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.....................
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            76654321       23567899999999999999999999999999999999999999854322111111000000000


Q ss_pred             CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       829 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+. +   .........+.+++.+||+.||++|||++++++.|+
T Consensus       237 ~~~-~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          237 TPI-E---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             SCH-H---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             Cch-H---HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence            000 0   000011234889999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=344.01  Aligned_cols=253  Identities=24%  Similarity=0.437  Sum_probs=196.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcE----EEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEI----IAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ..+|++.+.||+|+||+||+|+.. +++.    ||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            367999999999999999999854 4544    57777764322  233578999999999999999999999998755 


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++|+||+.+|++.+++....  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            789999999999999986543  4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          756 FLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       756 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ........  .....+|+.|+|||.+.+..++.++||||+||++|||++ |+.||+..........     ...  ....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-----~~~--~~~~  238 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GERL  238 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHT--TCCC
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHc--CCCC
Confidence            76543322  233456788999999999999999999999999999999 9999875443221111     111  1112


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+...    ...+.+++.+||+.||++||++.|+++.|+
T Consensus       239 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~  274 (327)
T 3lzb_A          239 PQPPIC----TIDVYMIMRKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            222221    224889999999999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-38  Score=336.54  Aligned_cols=253  Identities=22%  Similarity=0.366  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .++|.+.+.||+|+||.||+|+...    +..||+|++....  .....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            4678999999999999999997542    3469999987542  23345789999999999999999999999865 456


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++...  ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        88 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            8999999999999998643  24589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          757 LKPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       757 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ...... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...........     ....  ...+.
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-----~~~~--~~~~~  235 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-----LEKG--DRLPK  235 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-----HHHT--CCCCC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-----HhcC--CCCCC
Confidence            654322 2234457889999999998899999999999999999998 9999874333221111     1111  11111


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +...    ...+.+++.+||+.||++||++.|+++.|+
T Consensus       236 ~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          236 PDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence            1111    224889999999999999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-38  Score=332.99  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            367899999999999999999865 7899999998654222  2357889999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||.+.....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           84 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999999998643   3589999999999999999999999   999999999999999999999999999986543


Q ss_pred             CC--CCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC-CCC
Q 039344          760 DS--SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL-PTP  835 (873)
Q Consensus       760 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  835 (873)
                      ..  .......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||+........       ...+..... ...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~  230 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYLNP  230 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-------HHHHHTTCTTSTT
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHhhhcccccCc
Confidence            22  22345678999999999987765 77899999999999999999999754322110       011111111 111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..   .....+.+++.+||+.||++|||++|+++
T Consensus       231 ~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 WK---KIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             GG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hh---hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            11   11234789999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-38  Score=355.95  Aligned_cols=256  Identities=20%  Similarity=0.276  Sum_probs=192.9

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCC-----cchhHHHHHHHHHHHHhccCCceeeEEeEEEe
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPG-----EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH  672 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  672 (873)
                      ...++|.+.+.||+|+||+||+|.. .+++.||||++......     .......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            3457899999999999999999976 46899999998643211     1111235889999999999999999999985 


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---CeEEe
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---EAHVS  749 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~  749 (873)
                      .+..++||||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            45579999999999999988643   4589999999999999999999999   999999999999997654   59999


Q ss_pred             ccccccccCCCCCCcccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          750 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       750 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      |||+++..... .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||........       ....
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~~  356 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LKDQ  356 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-------HHHH
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-------HHHH
Confidence            99999876533 33445679999999999864   5678899999999999999999999874332111       1111


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +..................+.+++.+||+.||++|||++|+++
T Consensus       357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1222222221111122345889999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=371.25  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=197.5

Q ss_pred             CCCCc-eeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          604 FDDEH-CIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       604 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      +.+.+ .||+|+||.||+|...   ++..||||+++....  ....++|.+|+++++.++|||||+++++|.+ +..++|
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            33344 7999999999999763   466799999976432  2336789999999999999999999999976 568999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++...  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9999999999999653  34589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCC
Q 039344          760 DSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPT  834 (873)
Q Consensus       760 ~~~~~---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  834 (873)
                      .....   ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.........        ..+..+ +...
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~--------~~i~~~~~~~~  560 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM--------AFIEQGKRMEC  560 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH--------HHHHTTCCCCC
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--------HHHHcCCCCCC
Confidence            33222   22345688999999999999999999999999999998 99998754432211        111111 1222


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +..    ....+.+++.+||+.||++||++++|++.|+
T Consensus       561 p~~----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          561 PPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             CTT----CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             CCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            221    1234889999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-38  Score=364.01  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=203.9

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCc----------chhHHHHHHHHHHHHhccCCceeeEEe
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGE----------MTFQQEFLNEVKALTEIWHRNIVKVYG  668 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~l~~  668 (873)
                      ..++|.+.+.||+|+||+||+|+.. +++.||+|++.......          ....+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999865 68899999987543221          123577999999999999999999999


Q ss_pred             EEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---C
Q 039344          669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---E  745 (873)
Q Consensus       669 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~  745 (873)
                      ++.+.+..++||||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999888543   4589999999999999999999999   999999999999999876   6


Q ss_pred             eEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          746 AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       746 ~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      +||+|||+++..... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||......        ....
T Consensus       188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIK  257 (504)
T ss_dssp             EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred             EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHH
Confidence            999999999876543 3344567999999999976 46899999999999999999999998753322        1222


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+..+....+..........+.+++.+||+.||.+|||++|+++
T Consensus       258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            22223332222211222345889999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-38  Score=364.38  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++....... ...+.+.+|++++++++||||+++++++.+....|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            367999999999999999999865 78999999986432111 1257789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC---CCCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD---FENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~---~~~~~kl~Dfg~a~~  756 (873)
                      |||+++++|.+.+...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999888543   3589999999999999999999999   999999999999995   456799999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.......        ....+..+......
T Consensus       174 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~  243 (486)
T 3mwu_A          174 FQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAFDL  243 (486)
T ss_dssp             BCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCSCS
T ss_pred             CCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCC
Confidence            6543 33445679999999999875 58999999999999999999999987543221        12222222222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            222223345889999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=338.16  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=201.9

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  .   .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--D---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--C---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--H---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3577999999999999999999865 58999999987532  1   3678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++++|.+++...  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++...
T Consensus       102 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999998532  34589999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ..........|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.........     ........+....+.. 
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~-  250 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-----FMIPTNPPPTFRKPEL-  250 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCSSGGG-
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCCcccCCccc-
Confidence            5544455567999999999999999999999999999999999999998754322111     0111111112211111 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ....+.+++.+||+.||++|||+.++++
T Consensus       251 ---~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          251 ---WSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               1234889999999999999999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-38  Score=339.13  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=199.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  675 (873)
                      ...|++.+.||+|+||+||+|+..+    +..||+|.+...  ......+.+.+|+.++++++||||+++++++.+ .+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3568888999999999999997542    236899998753  233345779999999999999999999999754 567


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+++++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            899999999999999996532  4588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC----CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          756 FLKPDSS----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       756 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      .......    ......+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||.........        ......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~--------~~~~~~  248 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--------VYLLQG  248 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH--------HHHHTT
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH--------HHHhcC
Confidence            6644321    2234567889999999999999999999999999999999 55565543322211        111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .........   ...+.+++.+||+.||++|||++|+++.|+
T Consensus       249 ~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          249 RRLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             CCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111111   124889999999999999999999999885

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-38  Score=345.39  Aligned_cols=262  Identities=21%  Similarity=0.367  Sum_probs=199.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            367899999999999999999875 58999999986543 2333456688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||++++++.++....   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          103 FEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999998876433   3489999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh----------------hh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL----------------NI  822 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~----------------~~  822 (873)
                      .........|++.|+|||.+.+. .++.++||||+||++|||++|+.||.............                ..
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            55555567899999999998875 68999999999999999999999997544321110000                00


Q ss_pred             hhhhhcCCCCCCCCch---hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          823 ALDEMLDPRLPTPSRN---VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+........   .......+.+++.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0011111111111100   0112345889999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.9e-38  Score=343.67  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=204.9

Q ss_pred             HHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHh--ccCCceeeEEeEEEecc
Q 039344          597 IIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE--IWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       597 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~  674 (873)
                      .....++|.+.+.||+|+||.||+|+.. |+.||||++...      ..+.+.+|+++++.  ++||||+++++++....
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            3445678999999999999999999885 899999998632      24677889999887  68999999999998775


Q ss_pred             ----eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCeeeCC
Q 039344          675 ----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH--------NDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       675 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dlk~~Nill~~  742 (873)
                          ..++||||+++|+|.+++...    .+++.+++.++.|++.|++|||        +.   +|+||||||+||+++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK  182 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence                789999999999999999642    4899999999999999999999        77   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCC----ccccccccccccccccccC------CCCCcchhHHHHHHHHHHHhC---------
Q 039344          743 ENEAHVSDFGIAKFLKPDSSN----WTELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKG---------  803 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~sDv~s~G~il~el~tg---------  803 (873)
                      ++.+||+|||+++........    .....||+.|+|||.+.+.      .++.++|||||||++|||+||         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999876554332    2345789999999998765      234689999999999999999         


Q ss_pred             -CCCCcccccchhh-hhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          804 -KHPRDFISSMSFS-SLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       804 -~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ..||......... .............+.++... ...+....+.+++.+||+.||++|||+++|++.|+
T Consensus       263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccCccccCcCcccHHHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence             6676543221110 01111111222222222111 11244557899999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.2e-39  Score=370.01  Aligned_cols=252  Identities=26%  Similarity=0.436  Sum_probs=206.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..++|++.+.||+|+||.||+|+..++..||||+++....    ..++|.+|++++++++||||+++++++.+ +..++|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            4567888999999999999999998888899999975422    24689999999999999999999999876 678999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++.... ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999996532 24589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCC
Q 039344          760 DSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPS  836 (873)
Q Consensus       760 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  836 (873)
                      ... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||........        ...+... +.+.+.
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--------~~~i~~~~~~~~~~  487 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------LDQVERGYRMPCPP  487 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--------HHHHHTTCCCCCCT
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCCCCC
Confidence            211 1123456788999999999999999999999999999999 9999875432211        1111111 222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .    ....+.+++.+||+.||++|||+++|++.|+
T Consensus       488 ~----~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  519 (535)
T 2h8h_A          488 E----CPESLHDLMCQCWRKEPEERPTFEYLQAFLE  519 (535)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1    1234889999999999999999999999885

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.7e-38  Score=336.12  Aligned_cols=247  Identities=22%  Similarity=0.317  Sum_probs=199.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++....... ....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            467999999999999999999875 79999999997653333 2357788999999999 99999999999999999999


Q ss_pred             EEEeccCCChhhHhccccc-ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-------------
Q 039344          679 VYEYFKMCSLAVILSNDAA-AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-------------  744 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-------------  744 (873)
                      ||||+++++|.+++..... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++             
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999975432 24589999999999999999999999   999999999999998544             


Q ss_pred             ------CeEEeccccccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhh
Q 039344          745 ------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS  817 (873)
Q Consensus       745 ------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~  817 (873)
                            .+||+|||.++......    ...||+.|+|||.+.+. .++.++||||+||++|||++|..|+.....     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-----  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred             ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence                  79999999998765432    24589999999998766 566899999999999999999987542211     


Q ss_pred             hhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            ...+.....+......   ...+.+++.+||+.||++|||++|+++
T Consensus       237 ------~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ------WHEIRQGRLPRIPQVL---SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------HHHHHTTCCCCCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHcCCCCCCCccc---CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                  1111122221111111   224889999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3e-39  Score=356.80  Aligned_cols=245  Identities=13%  Similarity=0.112  Sum_probs=191.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHH---HHHhccCCceeeEE-------eE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK---ALTEIWHRNIVKVY-------GF  669 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~l~-------~~  669 (873)
                      .++|.+.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999985 569999999997554444445678999995   55555899999998       77


Q ss_pred             EEecc-----------------eeEEEEEeccCCChhhHhccccc----ccCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039344          670 CLHVR-----------------HLFIVYEYFKMCSLAVILSNDAA----AKNLGWTRRMNMIKGIVDALSYMHNDCFPPI  728 (873)
Q Consensus       670 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  728 (873)
                      +.+.+                 ..|+||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            66553                 278999999 5899999975431    11233588889999999999999999   99


Q ss_pred             eeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCccccccccccccccccccC-----------CCCCcchhHHHHHHH
Q 039344          729 VHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-----------KVTEKCDVYSFGVLA  797 (873)
Q Consensus       729 ~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~sDv~s~G~il  797 (873)
                      +||||||+|||++.++.+||+|||+|+...   .......| +.|+|||++.+.           .++.++|||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999999998643   23345567 999999999887           899999999999999


Q ss_pred             HHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          798 LEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       798 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      |||++|+.||........        ...+.... +.       ....+.+++.+||+.||++|||+.|+++
T Consensus       304 ~elltg~~Pf~~~~~~~~--------~~~~~~~~-~~-------~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          304 YWIWCADLPITKDAALGG--------SEWIFRSC-KN-------IPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHSSCCC------CC--------SGGGGSSC-CC-------CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHCCCCCcccccccc--------hhhhhhhc-cC-------CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999864332211        11111111 11       1124789999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-38  Score=363.34  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=199.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+.|++.+.||+|+||+||+|+.. +++.||+|++........ ....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356999999999999999999865 789999999876432222 246789999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a~~  756 (873)
                      |||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +|+||||||+||+++..   +.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999888543   3589999999999999999999999   99999999999999764   4599999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.......        ....+..+......
T Consensus       189 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~  258 (494)
T 3lij_A          189 FENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--------ILRKVEKGKYTFDS  258 (494)
T ss_dssp             CBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCS
T ss_pred             CCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCc
Confidence            6543 2344567999999999876 569999999999999999999999987543321        12222222222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            222222345889999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-38  Score=375.77  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=209.2

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++..........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999865 6889999998743211122246688899999887 7999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999998654   3589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ...........||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+..
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~  564 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPKS  564 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSCCCCCTT
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCcc
Confidence            5555556677899999999999999999999999999999999999999875332        22233344444433332


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTM-----QKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~  869 (873)
                      .    ...+.+++.+||+.||++||++     +||++
T Consensus       565 ~----s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          565 M----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             S----CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             C----CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            2    2247899999999999999997     66653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=353.68  Aligned_cols=320  Identities=22%  Similarity=0.245  Sum_probs=187.6

Q ss_pred             ceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccccc
Q 039344           48 ATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNN  127 (873)
Q Consensus        48 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  127 (873)
                      +.++.++++++ .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            34555555555 4444432  34555555555555444555555555555555555555444444555555555555555


Q ss_pred             ccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCc
Q 039344          128 ILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPS  207 (873)
Q Consensus       128 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  207 (873)
                      .++                        .+.+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+++..+.
T Consensus        91 ~l~------------------------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  146 (477)
T 2id5_A           91 RLK------------------------LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR  146 (477)
T ss_dssp             CCC------------------------SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred             cCC------------------------ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh
Confidence            444                        44444444444455555555554444444455555555555555555544444


Q ss_pred             cccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcC-cCCcCCCCCCC
Q 039344          208 ELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSL  286 (873)
Q Consensus       208 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~l~~l~~L  286 (873)
                      .|.++++|++|++++|++++..+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+ ..+......+|
T Consensus       147 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L  226 (477)
T 2id5_A          147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL  226 (477)
T ss_dssp             SSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred             hccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence            55555555555555555554444445555555555555555555555555555666666666555443 22233334467


Q ss_pred             CeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCC
Q 039344          287 ERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSN  366 (873)
Q Consensus       287 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N  366 (873)
                      ++|++++|.++.++...|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|
T Consensus       227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (477)
T 2id5_A          227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN  306 (477)
T ss_dssp             SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred             cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence            77777777777666666777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             ccCCCCCccccccccccEEEecCccccC
Q 039344          367 HIVGEIPIELGKLNFFIKLVLAHNQLSG  394 (873)
Q Consensus       367 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~  394 (873)
                      .|++..+..+..+++|+.|++++|.+..
T Consensus       307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          307 QLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             CCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             cCceeCHhHcCCCcccCEEEccCCCccC
Confidence            7775555556666666677777666654

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=355.81  Aligned_cols=318  Identities=22%  Similarity=0.212  Sum_probs=208.3

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      +.++.++++++ .+|..+.  +++++|+|++|++++..|..|.++++|++|+|++|.+++..|.+|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            46777777776 5665543  57777777777777777777777777777777777777777777777777888888777


Q ss_pred             ccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCc
Q 039344          104 SLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP  183 (873)
Q Consensus       104 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~  183 (873)
                      +++...+..|.++++|++|+|++|.+++..+..|..+++|++|++++|.+..+.+..|.++++|++|+|++|++++..+.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            77765555677777777777777777766677777777777777777777777777777777777777777777766556


Q ss_pred             cccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCC
Q 039344          184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKL  263 (873)
Q Consensus       184 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  263 (873)
                      .|..+++|+.|++++|.+++..+..|..+++|++|++++|...+..+.......+|++|++++|+++...+..|..+++|
T Consensus       171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  250 (477)
T 2id5_A          171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL  250 (477)
T ss_dssp             HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred             HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence            67777777777777777776666677777777777777776655555555555567777777777765554556666666


Q ss_pred             cEEEccCCcCcCcCC-cCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccc
Q 039344          264 TILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN  342 (873)
Q Consensus       264 ~~L~L~~N~l~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  342 (873)
                      +.|+|++|++.+..+ .+..+++|++|+|++|.++++.+..|..+++|++|+|++|++++..+..|..+++|+.|++++|
T Consensus       251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  330 (477)
T 2id5_A          251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN  330 (477)
T ss_dssp             CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred             CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence            666666666554222 3444444444444444444444444444444444444444444333333333444444444444


Q ss_pred             cC
Q 039344          343 NI  344 (873)
Q Consensus       343 ~i  344 (873)
                      .+
T Consensus       331 ~l  332 (477)
T 2id5_A          331 PL  332 (477)
T ss_dssp             CE
T ss_pred             Cc
Confidence            33

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-38  Score=344.34  Aligned_cols=256  Identities=24%  Similarity=0.347  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      .++|++.+.||+|+||.||+|+.      .+++.||||++....  .......+.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            46799999999999999999973      357789999997432  2334567899999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhHhccccc----ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeE
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAA----AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAH  747 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~k  747 (873)
                      ..++||||+++++|.+++.....    ...+++..++.++.|++.|++|||++   +|+||||||+||+++.+   ..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999975432    23488999999999999999999999   99999999999999954   4699


Q ss_pred             EeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhh
Q 039344          748 VSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIAL  824 (873)
Q Consensus       748 l~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~  824 (873)
                      |+|||+++.......  ......|++.|+|||.+.+..++.++||||+|+++|||+| |+.||.......        ..
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------VL  255 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--------HH
Confidence            999999976543322  2234567899999999999999999999999999999998 999987433221        11


Q ss_pred             hhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+...........   ....+.+++.+||+.||++||+++++++.|+
T Consensus       256 ~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          256 EFVTSGGRMDPPKN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            11111111111111   1224889999999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=341.78  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=195.9

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe----
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH----  672 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----  672 (873)
                      ...++|++.+.||+|+||.||+|+. .+|+.||+|++.....    ..+.+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3467899999999999999999986 4789999999875322    236788999999999 89999999999987    


Q ss_pred             --cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 039344          673 --VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD  750 (873)
Q Consensus       673 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D  750 (873)
                        .+..++||||+++++|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence              467899999999999999997543 34589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ||++..............|++.|+|||++.     +..++.++||||+||++|+|++|+.||..........     ...
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~  247 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIP  247 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHH
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-----Hhh
Confidence            999987654433444567999999999987     5668899999999999999999999986543221110     011


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+.... ...    ...+.+++.+||+.||++||+++++++
T Consensus       248 ~~~~~~~~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          248 RNPAPRLKS-KKW----SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HSCCCCCSC-SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCccccCCc-ccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111111 111    224889999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-38  Score=336.44  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=195.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-ceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-RHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|+.. |+.||||+++...     ..+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            467899999999999999999886 8899999987432     247799999999999999999999997654 478999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++.... ...+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            99999999999986543 22378999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCc
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSR  837 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  837 (873)
                      .   .....+++.|+|||.+.+..++.++||||+|+++|||+| |+.||........        ...+... ....+..
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  238 (278)
T 1byg_A          170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------VPRVEKGYKMDAPDG  238 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--------HHHHTTTCCCCCCTT
T ss_pred             c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHhcCCCCCCccc
Confidence            2   223467889999999999999999999999999999998 9999875432211        1111111 1111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ....+.+++.+||+.||++||++.|+++.|+
T Consensus       239 ----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  269 (278)
T 1byg_A          239 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  269 (278)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence                1234889999999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.1e-39  Score=352.23  Aligned_cols=257  Identities=9%  Similarity=0.026  Sum_probs=185.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc--cCCceeeEE-------eEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI--WHRNIVKVY-------GFC  670 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~  670 (873)
                      ..+|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999864 7899999999876544444566788886666555  599988755       555


Q ss_pred             Eec-----------------ceeEEEEEeccCCChhhHhcccccccCCChHHH------HHHHHHHHHHHHHHHhCCCCC
Q 039344          671 LHV-----------------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRR------MNMIKGIVDALSYMHNDCFPP  727 (873)
Q Consensus       671 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~  727 (873)
                      ...                 ...|+||||++ |+|.+++....  ..+++..+      ..++.||+.||+|||++   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            433                 34799999999 89999997643  23456666      78889999999999999   9


Q ss_pred             eeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCC
Q 039344          728 IVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKH  805 (873)
Q Consensus       728 i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~  805 (873)
                      |+||||||+|||++.++.+||+|||+|+....   ......+|+.|+|||++.+  ..++.++||||+||++|||++|+.
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999986542   2224567799999999987  678999999999999999999999


Q ss_pred             CCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          806 PRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       806 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ||............ ..............+.  .......+.+++.+||+.||++|||++++++
T Consensus       292 Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWK-RPSLRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCC-BCCTTSCCCCSCCCTT--SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchh-hhhhhhccccccchhh--ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99754322110000 0000011111111110  0112234889999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=345.36  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=195.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHH--HHhccCCceeeEEeEEEe-----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA--LTEIWHRNIVKVYGFCLH-----V  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~  673 (873)
                      .++|++.+.||+|+||.||+|+. +++.||||++...      ..+.+..|.++  +..++||||+++++++..     .
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            46799999999999999999987 4899999998632      13444555555  445799999999987653     2


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCeeeCCCCCeE
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC------FPPIVHRDISSKNVLLDFENEAH  747 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~Dlk~~Nill~~~~~~k  747 (873)
                      ...++||||+++|+|.+++....    .++..+..++.|++.||+|||+..      .++|+||||||+||+++.++.+|
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            35789999999999999985432    588999999999999999999873      23899999999999999999999


Q ss_pred             EeccccccccCCCC--------CCcccccccccccccccccc-------CCCCCcchhHHHHHHHHHHHhCCCCCccccc
Q 039344          748 VSDFGIAKFLKPDS--------SNWTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIKGKHPRDFISS  812 (873)
Q Consensus       748 l~Dfg~a~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~  812 (873)
                      |+|||+++.+....        .......||+.|+|||++.+       ..++.++|||||||++|||++|+.||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998765321        12234579999999999876       4567789999999999999999877643221


Q ss_pred             ch-hhh-------------hhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          813 MS-FSS-------------LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       813 ~~-~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .. +..             ............+.++............+.+++.+||+.||++|||++|+++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            10 000             0000011111223333322222334556999999999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-38  Score=353.67  Aligned_cols=203  Identities=27%  Similarity=0.424  Sum_probs=164.1

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecc--e
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVR--H  675 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  675 (873)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.+++.+. ||||+++++++...+  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            457899999999999999999975 47899999998754332 234567889999999997 999999999997544  6


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .|+||||++ ++|..++..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 588888754    3588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCC---------------------CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          756 FLKPD---------------------SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       756 ~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      .....                     .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            65431                     112344689999999999876 678999999999999999999999997544

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-38  Score=343.64  Aligned_cols=253  Identities=23%  Similarity=0.386  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcE--EEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEI--IAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.+.||+|+||.||+|+.. +|..  ||+|.+.....  ....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            67899999999999999999764 5664  49998875322  22346789999999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccc-------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          678 IVYEYFKMCSLAVILSNDA-------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      +||||+++++|.+++....             ....+++.+++.++.|++.|++|||++   +|+||||||+||+++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence            9999999999999997643             234689999999999999999999999   999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~  823 (873)
                      .+||+|||+++..... .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||........        
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--------  250 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------  250 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--------
Confidence            9999999999754322 12233456889999999998889999999999999999998 9999875432211        


Q ss_pred             hhhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+... ....+..    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       251 ~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  296 (327)
T 1fvr_A          251 YEKLPQGYRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLN  296 (327)
T ss_dssp             HHHGGGTCCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1111111 1111111    1234889999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-38  Score=336.00  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=198.4

Q ss_pred             CCCCCceeeecCCeEEEEEEeC-C---CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee-E
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLA-S---GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL-F  677 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~  677 (873)
                      .|...+.||+|+||+||+|+.. +   +..||+|++...  ......+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            4566789999999999999753 2   237999998753  2333467899999999999999999999999876654 9


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+.+++|.+++...  ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            999999999999999653  24588999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCC----CCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC-CcccccchhhhhhhhhhhhhhcCC-C
Q 039344          758 KPDS----SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSFSSLNLNIALDEMLDP-R  831 (873)
Q Consensus       758 ~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P-~~~~~~~~~~~~~~~~~~~~~~~~-~  831 (873)
                      ....    .......+++.|+|||.+.+..++.++||||+|+++|+|++|..| |.........        ..+... .
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~--------~~~~~~~~  246 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT--------HFLAQGRR  246 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH--------HHHHTTCC
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH--------HHhhcCCC
Confidence            4321    222345678899999999999999999999999999999996655 4322221111        111111 1


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.+...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       247 ~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  283 (298)
T 3pls_A          247 LPQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVE  283 (298)
T ss_dssp             CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1111111    224889999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=340.64  Aligned_cols=257  Identities=21%  Similarity=0.340  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe----cce
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRH  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~  675 (873)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++...   .....+.+.+|+++++.++||||+++++++..    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            46799999999999999999986 57999999998642   23345779999999999999999999999973    447


Q ss_pred             eEEEEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      .++||||+++++|.+++.... ....+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            899999999999999987532 235689999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCC---------ccccccccccccccccccCC---CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh
Q 039344          755 KFLKPDSSN---------WTELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI  822 (873)
Q Consensus       755 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~  822 (873)
                      +........         .....||+.|+|||.+.+..   ++.++||||||+++|||++|+.||+......   .....
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~  258 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVAL  258 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhH
Confidence            765422111         12345799999999987554   6889999999999999999999986421110   00000


Q ss_pred             hhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....  ....+....    ....+.+++.+||+.||++||+++++++.|+
T Consensus       259 ~~~~--~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          259 AVQN--QLSIPQSPR----HSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             HHHC--C--CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             Hhhc--cCCCCcccc----CCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            1111  111111111    1234889999999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-38  Score=346.29  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=195.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      ..+|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            46799999999999999999986 4799999999976433 2334577899999999999999999999997653     


Q ss_pred             -eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                       ..|+||||+ +++|.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence             469999999 7899998864    3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-----------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-----------  821 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-----------  821 (873)
                      ++....   ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..............           
T Consensus       175 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          175 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            987543   2344678999999999877 6789999999999999999999999975443211110000           


Q ss_pred             --------hhhhhhcCCCCCCC-CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 --------IALDEMLDPRLPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 --------~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                              ...... ....... ..........+.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          252 RLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             TCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhhhHHHHHHHHhC-CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                    000000 0000000 0000111234789999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-38  Score=333.63  Aligned_cols=245  Identities=23%  Similarity=0.368  Sum_probs=202.8

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe------
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH------  672 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  672 (873)
                      ...+|++.+.||+|+||.||+|+.. +|+.||+|++....       +.+.+|+++++.++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3467999999999999999999875 79999999987531       346789999999999999999999865      


Q ss_pred             ----------cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC
Q 039344          673 ----------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF  742 (873)
Q Consensus       673 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~  742 (873)
                                ....++||||+++++|.+++.... ...+++..++.++.|++.|++|||++   +|+||||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                      455899999999999999996543 34589999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh
Q 039344          743 ENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI  822 (873)
Q Consensus       743 ~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~  822 (873)
                      ++.+||+|||+++...... ......|++.|+|||.+.+..++.++||||+|+++|||++|..|+....          .
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~  226 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------K  226 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------H
T ss_pred             CCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------H
Confidence            9999999999998775443 2334578999999999999999999999999999999999999964211          1


Q ss_pred             hhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .......+..+...      ...+.+++.+||+.||++|||+.|+++.|+
T Consensus       227 ~~~~~~~~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          227 FFTDLRDGIISDIF------DKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             HHHHHHTTCCCTTS------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhcccccccC------CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11122222222111      123789999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=348.49  Aligned_cols=247  Identities=15%  Similarity=0.129  Sum_probs=200.3

Q ss_pred             HhcCCCCCceeeecCCeEEEEEE------eCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc---CCceeeEEeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSK------LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW---HRNIVKVYGFC  670 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~  670 (873)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||+|++...      ...++..|+++++.++   |+||+++++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            34679999999999999999993      457899999998743      1457788888888886   99999999999


Q ss_pred             EecceeEEEEEeccCCChhhHhcccc--cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC------
Q 039344          671 LHVRHLFIVYEYFKMCSLAVILSNDA--AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF------  742 (873)
Q Consensus       671 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~------  742 (873)
                      ...+..++||||+++|+|.+++....  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence            99999999999999999999997532  235699999999999999999999999   9999999999999998      


Q ss_pred             -----CCCeEEeccccccccCC--CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchh
Q 039344          743 -----ENEAHVSDFGIAKFLKP--DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSF  815 (873)
Q Consensus       743 -----~~~~kl~Dfg~a~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~  815 (873)
                           ++.+||+|||+|+.+..  .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......+
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 89999999999976542  22344567899999999999999999999999999999999999999864322111


Q ss_pred             hhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHh
Q 039344          816 SSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESR-PTMQKVCQLL  871 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ev~~~L  871 (873)
                      .           ....+....  .   ...+.+++..|++.+|.+| |+++++.+.|
T Consensus       294 ~-----------~~~~~~~~~--~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          294 K-----------PEGLFRRLP--H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             E-----------ECSCCTTCS--S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             e-----------echhccccC--c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence            0           111111111  1   2247788999999999998 6777777665

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.8e-38  Score=343.40  Aligned_cols=260  Identities=21%  Similarity=0.328  Sum_probs=198.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--------
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--------  672 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  672 (873)
                      .+|++.+.||+|+||+||+|+. .+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            6799999999999999999987 578999999987553322 224678899999999999999999999987        


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      .+..++||||+++ ++.+.+....  ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            3468999999985 6666664332  3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCC----CCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhh
Q 039344          753 IAKFLKPD----SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       753 ~a~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      +++.+...    ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||............... ....
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~  248 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL-CGSI  248 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCC
Confidence            99876532    223345678999999998876 45799999999999999999999998754322111100000 0000


Q ss_pred             cCC--------------C-CCCCCchhHHH------HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LDP--------------R-LPTPSRNVHDK------LISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~~--------------~-~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...              . .........+.      ...+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000              0 00000001111      234789999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.6e-38  Score=338.68  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=197.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+.|++.+.||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            467999999999999999999875 589999999875422   2357889999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||++++++.+++...  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        95 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999988643  24589999999999999999999999   999999999999999999999999999864322


Q ss_pred             CCCCcccccccccccccccc-----ccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          760 DSSNWTELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      .........|++.|+|||.+     .+..++.++||||+|+++|+|++|+.||...........     ......+....
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~  244 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-----IAKSDPPTLLT  244 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCSS
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-----HhccCCcccCC
Confidence            21222345789999999988     366788999999999999999999999875432211110     11111111111


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +..    ....+.+++.+||+.||++|||++++++
T Consensus       245 ~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          245 PSK----WSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             GGG----SCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccc----cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111    1234889999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-38  Score=357.90  Aligned_cols=195  Identities=24%  Similarity=0.382  Sum_probs=154.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----R  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  674 (873)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...     .
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            367999999999999999999754 789999999875432 333457799999999999999999999999543     5


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..|+||||+. ++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            6899999985 6888887543   4589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC---------------------------CCcccccccccccccccc-ccCCCCCcchhHHHHHHHHHHHhC
Q 039344          755 KFLKPDS---------------------------SNWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKG  803 (873)
Q Consensus       755 ~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDv~s~G~il~el~tg  803 (873)
                      +......                           ......+||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            8765322                           123456789999999976 456799999999999999999993

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.7e-38  Score=335.95  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=205.3

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCc------chhHHHHHHHHHHHHhcc-CCceeeEEeEEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGE------MTFQQEFLNEVKALTEIW-HRNIVKVYGFCL  671 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  671 (873)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++.......      ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999875 68999999987543211      123456889999999995 999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecc
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDF  751 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df  751 (873)
                      +.+..++||||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999998643   4589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      |+++..... .......|++.|+|||++.      ...++.++||||+|+++|||++|+.||........        ..
T Consensus       169 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~  239 (298)
T 1phk_A          169 GFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--------LR  239 (298)
T ss_dssp             TTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HH
T ss_pred             cchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--------HH
Confidence            999876543 2334567899999999875      45678899999999999999999999865332211        11


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .+.......+..........+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11111111111111122345889999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=346.28  Aligned_cols=258  Identities=16%  Similarity=0.206  Sum_probs=200.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC---------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceee------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS---------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK------  665 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------  665 (873)
                      .++|++.+.||+|+||.||+|+...         ++.||+|++...        +.+.+|++++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            3679999999999999999998763         789999998643        35789999999999999988      


Q ss_pred             ---------EEeEEEe-cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 039344          666 ---------VYGFCLH-VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISS  735 (873)
Q Consensus       666 ---------l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~  735 (873)
                               +++++.. .+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++   +|+||||||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp  187 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA  187 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence                     6778876 67889999999 999999997542 35699999999999999999999999   999999999


Q ss_pred             CCeeeCCCC--CeEEeccccccccCCCCC-------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 039344          736 KNVLLDFEN--EAHVSDFGIAKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP  806 (873)
Q Consensus       736 ~Nill~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P  806 (873)
                      +||+++.++  .+||+|||+++.+.....       ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  899999999987653322       12345799999999999999999999999999999999999999


Q ss_pred             CcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          807 RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      |..................... ..+.............+.+++.+||+.||++||+++++++.|+
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence            8754311100000000001100 1110000000011234889999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.5e-38  Score=368.94  Aligned_cols=246  Identities=24%  Similarity=0.386  Sum_probs=195.3

Q ss_pred             ceeeecCCeEEEEEEe---CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKGGQGSVYMSKL---ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      +.||+|+||.||+|.+   .+++.||||+++.... .....+++.+|++++++++|||||++++++.+ +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999964   3567899999975422 22346789999999999999999999999964 55889999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC-
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-  763 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  763 (873)
                      +|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.+...... 
T Consensus       453 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          453 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999999543   4589999999999999999999999   9999999999999999999999999999877544322 


Q ss_pred             --ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          764 --WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       764 --~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........     ..+....  +...+..   
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----~~i~~~~--~~~~p~~---  596 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-----AMLEKGE--RMGCPAG---  596 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTC--CCCCCTT---
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHcCC--CCCCCCC---
Confidence              223456788999999999999999999999999999998 99998754332111     1111111  1111211   


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                       ....+.+++.+||+.||++||++++|++.|+
T Consensus       597 -~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          597 -CPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             -CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence             1234889999999999999999999999885

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.4e-38  Score=332.88  Aligned_cols=249  Identities=21%  Similarity=0.308  Sum_probs=198.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe----ccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  676 (873)
                      ..|.+.+.||+|+||.||+|.. .++..||+|++...... ....+.+.+|+.+++.++||||+++++++..    ....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            4477788999999999999976 46889999998754322 2345779999999999999999999999876    3568


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeC-CCCCeEEecccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLD-FENEAHVSDFGI  753 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~-~~~~~kl~Dfg~  753 (873)
                      ++||||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +  |+||||||+||+++ .++.+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            9999999999999999643   4589999999999999999999999   7  99999999999998 789999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ++....  .......|++.|+|||.+. +.++.++||||+|+++|+|++|+.||........       ....+.....+
T Consensus       179 ~~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~  248 (290)
T 1t4h_A          179 ATLKRA--SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKP  248 (290)
T ss_dssp             GGGCCT--TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCC
T ss_pred             cccccc--cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-------HHHHHhccCCc
Confidence            975443  2334567999999999876 4589999999999999999999999875332211       11111111111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...  .......+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ASF--DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGG--GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccc--CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            110  0111124889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=340.79  Aligned_cols=260  Identities=25%  Similarity=0.407  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-----CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  674 (873)
                      .++|++.+.||+|+||.||+|+.     .+|+.||||++...   .....+.+.+|++++++++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            35688899999999999999983     46899999998753   2334578999999999999999999999987644 


Q ss_pred             -eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                       ..++||||+++++|.+++....  ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence             6899999999999999996543  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchh--------hhhhhhh
Q 039344          754 AKFLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSF--------SSLNLNI  822 (873)
Q Consensus       754 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~--------~~~~~~~  822 (873)
                      ++........   .....++..|+|||.+.+..++.++||||+|+++|||+||..||........        .......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9877554332   1234567789999999988899999999999999999999999763211000        0000001


Q ss_pred             hhhhhcC-CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLD-PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+.. .+.+.+..    ....+.+++.+||+.||++|||+.|+++.|+
T Consensus       272 ~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~el~~~L~  318 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRVD  318 (326)
T ss_dssp             HHHHHHTTCCCCCCTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111111 12222221    1234889999999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-37  Score=343.35  Aligned_cols=258  Identities=21%  Similarity=0.303  Sum_probs=192.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            367999999999999999999754 689999999975432 2334567889999999999999999999997654     


Q ss_pred             -eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                       ..++||||+++ ++.+.+.     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence             78999999985 6777664     2488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh------------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN------------  821 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~------------  821 (873)
                      ++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..............            
T Consensus       174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9866432 233456789999999999999999999999999999999999999975432211000000            


Q ss_pred             --hhhhhhc--CCC--------------CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 --IALDEML--DPR--------------LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 --~~~~~~~--~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        .......  .+.              .+............+.+++.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence              0000000  000              01111112233456899999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.8e-38  Score=351.80  Aligned_cols=200  Identities=23%  Similarity=0.382  Sum_probs=168.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----R  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  674 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            468999999999999999999764 688999999976433 333457899999999999999999999999766     5


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..|+||||++ ++|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6899999987 5898888543   4589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC----------------------Ccccccccccccccccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCc
Q 039344          755 KFLKPDSS----------------------NWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRD  808 (873)
Q Consensus       755 ~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~sDv~s~G~il~el~tg~~P~~  808 (873)
                      +.......                      .....+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            87654321                      23567899999999986 56669999999999999999998766654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-38  Score=337.22  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=195.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC--CCc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA--SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .++|++.+.||+|+||+||+|+..  +++  .||+|+++..........+.+.+|+.+++.++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999753  333  68999987654444455678999999999999999999999998755 8


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999986542  4589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcC--C
Q 039344          757 LKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD--P  830 (873)
Q Consensus       757 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~--~  830 (873)
                      .......   .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......        ....+..  .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGE  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHccCC
Confidence            7554332   223457788999999998889999999999999999999 999987543221        1111111  1


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+.+..    ....+.+++.+||+.||++|||+.++++.|+
T Consensus       243 ~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          243 RLPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            1221111    1234889999999999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.7e-38  Score=345.43  Aligned_cols=258  Identities=21%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            357899999999999999999865 78999999987642  233457799999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||+++....
T Consensus       110 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999998653   35899999999999999999999832  899999999999999999999999999975532


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh--------------------
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN--------------------  819 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~--------------------  819 (873)
                      .  ......||+.|+|||++.+..++.++||||+||++|||++|+.||............                    
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            2  223457899999999999999999999999999999999999999753321110000                    


Q ss_pred             --------------hhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          820 --------------LNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       820 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                    .....+.......+....  ......+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCT--TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCc--ccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                          000011111111111000  011234889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-38  Score=346.56  Aligned_cols=255  Identities=21%  Similarity=0.296  Sum_probs=201.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEe----CCCcEEEEEEccCCCC-CcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  675 (873)
                      ++|++.+.||+|+||.||+|+.    .+|+.||||+++.... ......+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6799999999999999999987    4789999999864321 1112235577899999999 69999999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+++++|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999998643   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          756 FLKPDSS-NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       756 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ....... ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........    ..........
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~----~~~~~~~~~~  283 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE----ISRRILKSEP  283 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH----HHHHHHHCCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH----HHHHHhccCC
Confidence            6543222 23346799999999998853  478899999999999999999999875332211111    1111111122


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRP-----TMQKVCQL  870 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  870 (873)
                      +.+...    ...+.+++.+||+.||++||     +++|+++.
T Consensus       284 ~~~~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          284 PYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCCccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            222111    22478999999999999999     99999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.7e-38  Score=346.06  Aligned_cols=258  Identities=21%  Similarity=0.258  Sum_probs=195.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH-----  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  675 (873)
                      ..+|++.+.||+|+||+||+|+...+..||+|++......       ..+|+++++.++||||+++++++...+.     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            3569999999999999999999877777999988653222       2369999999999999999999965443     


Q ss_pred             -eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-CCCCeEEecccc
Q 039344          676 -LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-FENEAHVSDFGI  753 (873)
Q Consensus       676 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Dfg~  753 (873)
                       .++||||++++.+............+++..+..++.|++.||+|||++   +|+||||||+||+++ .++.+||+|||+
T Consensus       112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence             789999999765554443333445689999999999999999999999   999999999999999 789999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-----------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-----------  821 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-----------  821 (873)
                      |+....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..............           
T Consensus       189 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          189 AKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            987654332 3346789999999998765 589999999999999999999999976443211110000           


Q ss_pred             hhhhhhcCCCCCCCCc-hh-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 IALDEMLDPRLPTPSR-NV-----HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ~~~~~~~~~~~~~~~~-~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..........++.... ..     ......+.+++.+||+.||++|||+.|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            0001111111111000 00     012235889999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4e-38  Score=340.26  Aligned_cols=254  Identities=22%  Similarity=0.284  Sum_probs=196.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCC-----cchhHHHHHHHHHHHHhccCCceeeEEeEEEecc
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPG-----EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  674 (873)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++......     .......+.+|+++++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999764 6889999998654211     1122345889999999999999999999987655


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC---eEEecc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSDF  751 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~Df  751 (873)
                       .++||||+++++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence             89999999999999988643   4589999999999999999999999   9999999999999987665   999999


Q ss_pred             ccccccCCCCCCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhc
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      |+++..... .......||+.|+|||++.   ...++.++||||+||++|+|++|+.||.........       ...+.
T Consensus       162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~  233 (322)
T 2ycf_A          162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------KDQIT  233 (322)
T ss_dssp             TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-------HHHHH
T ss_pred             ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-------HHHHH
Confidence            999876432 2234457899999999874   466889999999999999999999998753322110       01111


Q ss_pred             CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       829 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .................+.+++.+||+.||++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11111111111112345889999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-38  Score=340.65  Aligned_cols=264  Identities=23%  Similarity=0.385  Sum_probs=186.1

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++.....  ....+++.+|+.+++.++||||+++++++...+..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            4457899999999999999999975 4689999999865422  223467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccc-----cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          678 IVYEYFKMCSLAVILSNDA-----AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      +||||+++++|.+++....     ....+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            9999999999999986421     234589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC-----Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          753 IAKFLKPDSS-----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       753 ~a~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      +++.......     ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||...................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            9986643321     1234578999999999876 568999999999999999999999987544322111111000000


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ... ..... .........+.+++.+||+.||++||+++|+++
T Consensus       247 ~~~-~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          247 LET-GVQDK-EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TTC-------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccc-ccccc-hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000 00000 000011234789999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5e-38  Score=345.54  Aligned_cols=271  Identities=21%  Similarity=0.296  Sum_probs=200.2

Q ss_pred             cCHHHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCc--------chhHHHHHHHHHHHHhccCCce
Q 039344          592 IIYEEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGE--------MTFQQEFLNEVKALTEIWHRNI  663 (873)
Q Consensus       592 ~~~~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni  663 (873)
                      ...+++.....+|++.+.||+|+||.||+|...+|+.||||++.......        ....+.+.+|+.+++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34567778889999999999999999999998889999999986543321        1224779999999999999999


Q ss_pred             eeEEeEEEe-----cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          664 VKVYGFCLH-----VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       664 v~l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +++++++..     ....++||||++ |++.+++...  ...+++..+..++.|++.|++|||++   +|+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            999999954     236899999998 5777777543  24589999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS  817 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~  817 (873)
                      +++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             EECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999754433 23344678999999999877 678999999999999999999999997543221111


Q ss_pred             hhhh---------------hhhhhhcCCCCC-CCCch----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          818 LNLN---------------IALDEMLDPRLP-TPSRN----VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       818 ~~~~---------------~~~~~~~~~~~~-~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....               ....+....... .+...    .......+.+++.+||+.||++|||++|+++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            0000               000011111110 00000    0111235889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-38  Score=344.01  Aligned_cols=255  Identities=20%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcc--------------hhHHHHHHHHHHHHhccCCceeeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEM--------------TFQQEFLNEVKALTEIWHRNIVKV  666 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l  666 (873)
                      .++|++.+.||+|+||.||+|+. +|+.||+|++........              ...+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999998 899999999864322111              112789999999999999999999


Q ss_pred             EeEEEecceeEEEEEeccCCChhhH------hcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCee
Q 039344          667 YGFCLHVRHLFIVYEYFKMCSLAVI------LSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVL  739 (873)
Q Consensus       667 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nil  739 (873)
                      ++++.+.+..++||||+++++|.++      +... ....+++..++.++.|++.|++|||+ .   +|+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      4432 13568999999999999999999999 8   9999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCCCccccccccccccccccccC-CCCC-cchhHHHHHHHHHHHhCCCCCcccccchhhh
Q 039344          740 LDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTE-KCDVYSFGVLALEVIKGKHPRDFISSMSFSS  817 (873)
Q Consensus       740 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~sDv~s~G~il~el~tg~~P~~~~~~~~~~~  817 (873)
                      ++.++.+||+|||.++.....  ......|++.|+|||.+.+. .++. ++||||+|+++|||++|+.||......    
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999999876443  34456789999999999877 5665 999999999999999999998754331    


Q ss_pred             hhhhhhhhhhcCCCCCCCCc---------------hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          818 LNLNIALDEMLDPRLPTPSR---------------NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       818 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ......+.......+..               ........+.+++.+||+.||++|||++|+++
T Consensus       259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               01111111111111100               00112235889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=339.35  Aligned_cols=251  Identities=21%  Similarity=0.294  Sum_probs=185.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEE-------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCL-------  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------  671 (873)
                      ..+|++.+.||+|+||.||+|+.. +|+.||+|++...   .....+.+.+|+.+++++. ||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            357999999999999999999864 7899999998543   2334577899999999995 999999999994       


Q ss_pred             -ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeCCCCCeEE
Q 039344          672 -HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       672 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl  748 (873)
                       .....++||||+. |+|.+++........+++..++.++.|++.|++|||+.   +  |+||||||+||+++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence             3445899999997 78888886644455699999999999999999999999   8  999999999999999999999


Q ss_pred             eccccccccCCCCCCc------------ccccccccccccccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc
Q 039344          749 SDFGIAKFLKPDSSNW------------TELAGTYGYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM  813 (873)
Q Consensus       749 ~Dfg~a~~~~~~~~~~------------~~~~g~~~y~aPE~~---~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~  813 (873)
                      +|||+++.........            ....||+.|+|||++   .+..++.++||||+||++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432211            134589999999998   5667889999999999999999999998643322


Q ss_pred             hhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          814 SFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..        .......  +.....    ...+.+++.+||+.||++|||++|+++.|+
T Consensus       260 ~~--------~~~~~~~--~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 RI--------VNGKYSI--PPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------------CCC--CTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             Hh--------hcCcccC--Cccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11        1111111  111111    113778999999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.8e-38  Score=331.70  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=203.8

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            34568999999999999999999875 78999999986543222 23577999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeEEeccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSDFGIA  754 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a  754 (873)
                      +||||+++++|.+++...   ..+++..+..++.|++.|++|||++   +++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999998888543   3589999999999999999999999   99999999999999764   46999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      +...... ......|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||........        ...+..+....
T Consensus       172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~  241 (287)
T 2wei_A          172 TCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--------LKRVETGKYAF  241 (287)
T ss_dssp             GTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCCC
T ss_pred             eeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHcCCCCC
Confidence            8765432 2334568999999998865 489999999999999999999999875432211        11111122221


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...........+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11111122335889999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.6e-38  Score=333.37  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=185.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|+++..... ....+.+.++...++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            46799999999999999999986 57899999999754322 22233445555567888999999999999999999999


Q ss_pred             EEeccCCChhhHhccc-ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          680 YEYFKMCSLAVILSND-AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||++ |++.+++... .....+++..+..++.|++.|++|||+++  +|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99998 4877776542 23356899999999999999999999853  89999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCC
Q 039344          759 PDSSNWTELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT  834 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  834 (873)
                      ... ......||+.|+|||.+    .+..++.++||||+|+++|||++|+.||+......      ..............
T Consensus       162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~  234 (290)
T 3fme_A          162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEPSPQL  234 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSCCCCC
T ss_pred             ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccCCCCc
Confidence            432 22335789999999996    55678899999999999999999999987432210      00001111111111


Q ss_pred             CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +...   ....+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          235 PADK---FSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CTTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccc---CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111   1234889999999999999999999976

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=332.34  Aligned_cols=252  Identities=19%  Similarity=0.289  Sum_probs=197.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCC-cchhHHHHHHHHHHHHhccCCceeeEEeEEE--eccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPG-EMTFQQEFLNEVKALTEIWHRNIVKVYGFCL--HVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  676 (873)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999864 6889999998643211 1123577999999999999999999999984  45678


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||++++ +.+++.... ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||.+..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999977 666665432 34689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC--CCccccccccccccccccccCC--CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          757 LKPDS--SNWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       757 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .....  .......|++.|+|||++.+..  ++.++||||+|+++|||++|+.||........        ...+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~i~~~~~  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL--------FENIGKGSY  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--------HHHHhcCCC
Confidence            65322  2233567899999999987644  37799999999999999999999875332211        111112222


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+...    ...+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222221    224789999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.4e-37  Score=348.95  Aligned_cols=257  Identities=18%  Similarity=0.268  Sum_probs=201.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC-CceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH-RNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.++||+|+||.||+|+. .+++.||||++......     +++..|+++++.++| ++++.+..++.+.+..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            46899999999999999999985 57999999987654322     347889999999976 666677777778888999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee---CCCCCeEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL---DFENEAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~  755 (873)
                      ||||+ +++|.+++...  ...+++..++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus        81 vme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            99999 89999998643  24599999999999999999999999   99999999999999   688999999999998


Q ss_pred             ccCCCCCC-------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhc
Q 039344          756 FLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       756 ~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      .+......       .....||+.|+|||++.+..++.++|||||||++|||++|+.||...................+ 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-
Confidence            77654322       1256799999999999999999999999999999999999999986443211111111000000 


Q ss_pred             CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       829 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....   .........+.+++.+||+.||++||++++|++.|+
T Consensus       234 ~~~~~---~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          234 ATSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             HSCHH---HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cccHH---HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            00000   000011235889999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.8e-38  Score=344.51  Aligned_cols=257  Identities=20%  Similarity=0.317  Sum_probs=182.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  673 (873)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            46899999999999999999975 5789999999976432 223457788999999999999999999999754      


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      ...|+|+|++ +++|.+++..    ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999998 6888888754    3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hh--
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IA--  823 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~--  823 (873)
                      ++.....   .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............       ..  
T Consensus       179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865432   344678999999999877 6789999999999999999999999975443211111000       00  


Q ss_pred             ------hhhhcC--CCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 ------LDEMLD--PRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ------~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            ...+..  +..+...  .........+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                  000000  0000000  000011234789999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-37  Score=341.31  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----R  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  674 (873)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|++...  ......+.+.+|++++++++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            467999999999999999999764 7889999999753  2233457789999999999999999999999764     3


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||++ ++|.+++..    ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence            6899999998 588888754    3489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh---------
Q 039344          755 KFLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN---------  821 (873)
Q Consensus       755 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~---------  821 (873)
                      +.......   ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............         
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            87654322   2244689999999998654 4589999999999999999999999975443221111100         


Q ss_pred             ----------hhhhhhcCCCCCCCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 ----------IALDEMLDPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ----------~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                .......... ..+. .........+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhhHHHHHHhcCCcc-CCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                      0000000000 0000 000111235889999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=338.51  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=198.4

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ...++|++.+.||+|+||.||+|+...  .||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            345789999999999999999998863  48999987543222 223557789999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++ ++.+||+|||+++...
T Consensus       107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            999999999999996543  4589999999999999999999999   999999999999998 7899999999987653


Q ss_pred             CC-----CCCcccccccccccccccccc---------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhh
Q 039344          759 PD-----SSNWTELAGTYGYVAPELAYT---------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL  824 (873)
Q Consensus       759 ~~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~  824 (873)
                      ..     ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||...........     .
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~  255 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-----M  255 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-----H
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----h
Confidence            21     122334568999999999864         4578899999999999999999999875432211111     1


Q ss_pred             hhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....+......     ....+.+++.+||+.||++|||++++++.|+
T Consensus       256 ~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  298 (319)
T 2y4i_B          256 GTGMKPNLSQIG-----MGKEISDILLFCWAFEQEERPTFTKLMDMLE  298 (319)
T ss_dssp             HTTCCCCCCCSS-----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred             ccCCCCCCCcCC-----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            111111111110     1123789999999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-37  Score=331.13  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=191.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-------  672 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  672 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++..    .....+.+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            467899999999999999999864 799999999853    22345778999999999999999999999865       


Q ss_pred             ------cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCe
Q 039344          673 ------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEA  746 (873)
Q Consensus       673 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~  746 (873)
                            .+..++||||+++++|.+++....  ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence                  457899999999999999997533  3477889999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCC--------------CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          747 HVSDFGIAKFLKPDS--------------SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      ||+|||+++......              .......|++.|+|||.+.+. .++.++||||+||++|||++   ||....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            999999998764321              122345689999999998764 68999999999999999998   443111


Q ss_pred             cchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          812 SMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .       .......+.......+..........+.+++.+||+.||++|||++++++
T Consensus       233 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 E-------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H-------HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h-------HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0       01111111111111111111122234789999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.8e-37  Score=334.00  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=197.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEe--cceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLH--VRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~  677 (873)
                      ++|++.+.||+|+||+||+|+. .+++.||+|++...      ..+.+.+|+.+++.++ ||||+++++++.+  ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            6789999999999999999975 57899999998632      1467899999999996 9999999999987  66789


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEeccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKF  756 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~  756 (873)
                      +||||++++++.+++.      .+++..+..++.|++.|++|||++   +|+||||||+||+++.++ .+||+|||+++.
T Consensus       110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            9999999999998873      378899999999999999999999   999999999999999777 899999999987


Q ss_pred             cCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccc-hh-h---hhhhhhh-------
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-SF-S---SLNLNIA-------  823 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-~~-~---~~~~~~~-------  823 (873)
                      ..... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .. .   .......       
T Consensus       181 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          181 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            65433 3345678999999999877 66899999999999999999999998532211 00 0   0000000       


Q ss_pred             --------hhhhcCCCCCCC------CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 --------LDEMLDPRLPTP------SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 --------~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                              ............      ..........+.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    000000000000      0000112345889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-37  Score=344.82  Aligned_cols=258  Identities=18%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc--------CCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW--------HRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~  671 (873)
                      .++|++.+.||+|+||+||+|+. .+++.||||++...    ....+.+.+|+.+++.++        |+||+++++++.
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            36799999999999999999975 46889999998642    234577899999999996        888999999998


Q ss_pred             ----ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC---
Q 039344          672 ----HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN---  744 (873)
Q Consensus       672 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---  744 (873)
                          +....++||||+. +++.+++.... ...+++..++.++.||+.||+|||+++  +|+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVLG-HHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEeccC-ccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence                4567899999995 55555554322 245899999999999999999999964  899999999999999876   


Q ss_pred             ----------------------------------------------CeEEeccccccccCCCCCCccccccccccccccc
Q 039344          745 ----------------------------------------------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL  778 (873)
Q Consensus       745 ----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~  778 (873)
                                                                    .+||+|||+++.....   .....||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence                                                          7999999999876533   334578999999999


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh-hhhhhhh------------------cCCC-----CCC
Q 039344          779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL-NIALDEM------------------LDPR-----LPT  834 (873)
Q Consensus       779 ~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~-~~~~~~~------------------~~~~-----~~~  834 (873)
                      +.+..++.++||||+||++|||++|+.||.......+..... .....+.                  ....     ...
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999997543221110000 0000000                  0000     000


Q ss_pred             ------------CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          835 ------------PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       835 ------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                  ...........+.+++.+||+.||++|||++|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                        00112344567899999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-37  Score=347.04  Aligned_cols=199  Identities=19%  Similarity=0.298  Sum_probs=173.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc------cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI------WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~  673 (873)
                      ..+|++.+.||+|+||+||+|+.. +++.||||+++..    ....+.+.+|+.+++.+      +|+||+++++++...
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            457999999999999999999764 6899999998742    23356788899988887      467999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC--eEEecc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE--AHVSDF  751 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~--~kl~Df  751 (873)
                      +..++||||+. +++.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.  +||+||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            99999999997 688888865432 3489999999999999999999999   9999999999999999987  999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      |+|+.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999765432   334678999999999999999999999999999999999999997544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-37  Score=343.07  Aligned_cols=259  Identities=22%  Similarity=0.261  Sum_probs=194.2

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec----
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV----  673 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  673 (873)
                      ....+|++.+.||+|+||+||+|+. .+|+.||+|++......       ..+|+.+++.++||||+++++++...    
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            4567899999999999999999975 57999999998654222       23799999999999999999998543    


Q ss_pred             ----------------------------------ceeEEEEEeccCCChhhHhccc-ccccCCChHHHHHHHHHHHHHHH
Q 039344          674 ----------------------------------RHLFIVYEYFKMCSLAVILSND-AAAKNLGWTRRMNMIKGIVDALS  718 (873)
Q Consensus       674 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~  718 (873)
                                                        ...++||||++ ++|.+.+... .....+++..+..++.|++.||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              34889999999 5777666532 23456899999999999999999


Q ss_pred             HHHhCCCCCeeeCCCCCCCeeeC-CCCCeEEeccccccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHH
Q 039344          719 YMHNDCFPPIVHRDISSKNVLLD-FENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVL  796 (873)
Q Consensus       719 ~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~i  796 (873)
                      |||+.   +|+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||.+.+. .++.++||||+||+
T Consensus       156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999   999999999999998 68899999999998765443 23345789999999998775 48999999999999


Q ss_pred             HHHHHhCCCCCcccccchhhhhhhh-------hhhhhh----cCCCCCCCC-chh-----HHHHHHHHHHHhhcccCCCC
Q 039344          797 ALEVIKGKHPRDFISSMSFSSLNLN-------IALDEM----LDPRLPTPS-RNV-----HDKLISIVEVTISCVDENPE  859 (873)
Q Consensus       797 l~el~tg~~P~~~~~~~~~~~~~~~-------~~~~~~----~~~~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~  859 (873)
                      +|||++|+.||..............       .....+    ....++... ...     ......+.+++.+||+.||+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999986443211111100       000000    000111000 000     01123488999999999999


Q ss_pred             CCCCHHHHHH
Q 039344          860 SRPTMQKVCQ  869 (873)
Q Consensus       860 ~RPs~~ev~~  869 (873)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-37  Score=340.60  Aligned_cols=256  Identities=20%  Similarity=0.318  Sum_probs=195.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee---
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL---  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  676 (873)
                      .++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            467899999999999999999754 689999999976533 233457789999999999999999999999876654   


Q ss_pred             ---EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          677 ---FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       677 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                         ++||||+. +++.+++.     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999998 67877763     2389999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-----------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-----------  821 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-----------  821 (873)
                      ++.....   .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............           
T Consensus       191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            9865432   334678999999999887 6789999999999999999999999975432211111000           


Q ss_pred             --------hhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 --------IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                              ........................+.+++.+||+.||++|||++|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                    000010000000000000112345889999999999999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-37  Score=335.46  Aligned_cols=264  Identities=21%  Similarity=0.346  Sum_probs=199.6

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEe--CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc---cCCceeeEEeEEE--
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKL--ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---WHRNIVKVYGFCL--  671 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--  671 (873)
                      ++.++|++.+.||+|+||.||+|+.  .+|+.||+|+++....... ....+.+|+.+++.+   +||||+++++++.  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            3457899999999999999999987  4688999999864322211 123456777777766   8999999999997  


Q ss_pred             ---ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEE
Q 039344          672 ---HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV  748 (873)
Q Consensus       672 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl  748 (873)
                         .....++||||++ |+|.+++..... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence               5667899999998 699998865432 3489999999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh----h
Q 039344          749 SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA----L  824 (873)
Q Consensus       749 ~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~----~  824 (873)
                      +|||+++..... .......|++.|+|||++.+..++.++||||+|+++|||++|+.||................    .
T Consensus       162 ~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          162 ADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             ecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            999999865432 23344678999999999999999999999999999999999999997544321111110000    0


Q ss_pred             hh----------hcCCCCCCC-CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 DE----------MLDPRLPTP-SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~~----------~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..          ........+ ..........+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00          000000000 0000112234789999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.4e-37  Score=343.64  Aligned_cols=256  Identities=25%  Similarity=0.312  Sum_probs=191.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------c
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------R  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  674 (873)
                      .+|++.+.||+|+||.||+|+.. +|+.||||++.....       .+.+|+++++.++||||+++++++...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            46888999999999999999875 699999999865322       223799999999999999999998642      2


Q ss_pred             eeEEEEEeccCCChhhHhcc-cccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEeccc
Q 039344          675 HLFIVYEYFKMCSLAVILSN-DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFG  752 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg  752 (873)
                      ..++||||+++ ++.+.+.. ......+++..+..++.||++||+|||++   +|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            36799999986 55554432 22345689999999999999999999999   99999999999999966 568999999


Q ss_pred             cccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------hhh
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------IAL  824 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~~~  824 (873)
                      +++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..............       ..+
T Consensus       203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9987654332 3346789999999998765 689999999999999999999999976443211111000       001


Q ss_pred             hhh----cCCCCCCCC--chh----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 DEM----LDPRLPTPS--RNV----HDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~~~----~~~~~~~~~--~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+    .+..++...  .+.    ......+.+++.+||+.||++||++.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            111    011111100  000    011235889999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.5e-37  Score=333.62  Aligned_cols=256  Identities=20%  Similarity=0.302  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe--CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc------eeeEEeEEEe
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL--ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN------IVKVYGFCLH  672 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  672 (873)
                      .++|++.+.||+|+||+||+|..  .+|+.||||+++..    ....+.+.+|+.+++.++|++      ++++++++.+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            36799999999999999999976  36889999998642    234577889999999997765      9999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC----------
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF----------  742 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~----------  742 (873)
                      .+..++||||+ ++++.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.          
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999 7899998865432 3588999999999999999999999   9999999999999987          


Q ss_pred             ---------CCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc
Q 039344          743 ---------ENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM  813 (873)
Q Consensus       743 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~  813 (873)
                               ++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                     668999999999865432   23467899999999999999999999999999999999999999754322


Q ss_pred             hhhhhhhhh-------h--------------------------hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCC
Q 039344          814 SFSSLNLNI-------A--------------------------LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPES  860 (873)
Q Consensus       814 ~~~~~~~~~-------~--------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  860 (873)
                      .........       .                          ......+ ..............+.+++.+||+.||++
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            110000000       0                          0000000 00000001123456889999999999999


Q ss_pred             CCCHHHHHH
Q 039344          861 RPTMQKVCQ  869 (873)
Q Consensus       861 RPs~~ev~~  869 (873)
                      |||++|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.7e-38  Score=348.57  Aligned_cols=198  Identities=21%  Similarity=0.368  Sum_probs=153.8

Q ss_pred             CCCC-CceeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--ccee
Q 039344          603 DFDD-EHCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHL  676 (873)
Q Consensus       603 ~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  676 (873)
                      .|++ .++||+|+||+||+|+..   +++.||+|++.....     .+.+.+|+.+++.++||||+++++++..  ....
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3555 568999999999999865   578999999975321     2568899999999999999999999964  6789


Q ss_pred             EEEEEeccCCChhhHhcccc------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee----CCCCCe
Q 039344          677 FIVYEYFKMCSLAVILSNDA------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL----DFENEA  746 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~  746 (873)
                      ++||||+++ ++.+++....      ....+++..++.++.||+.||+|||++   +|+||||||+||++    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999984 7777664322      122489999999999999999999999   99999999999999    677899


Q ss_pred             EEeccccccccCCCC---CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcc
Q 039344          747 HVSDFGIAKFLKPDS---SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF  809 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~  809 (873)
                      ||+|||+|+......   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            999999998765432   223456789999999998874 589999999999999999999999964

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.9e-37  Score=339.27  Aligned_cols=266  Identities=20%  Similarity=0.219  Sum_probs=189.0

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV  673 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  673 (873)
                      .+.....++|++.+.||+|+||.||+|+.. +|+.||||++......    ...+.+|+..++.++||||+++++++...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            445667789999999999999999999874 6899999998653222    24566788888999999999999999764


Q ss_pred             ce-------eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCCeeeCC-C
Q 039344          674 RH-------LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH--NDCFPPIVHRDISSKNVLLDF-E  743 (873)
Q Consensus       674 ~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~Dlk~~Nill~~-~  743 (873)
                      +.       .++||||++++..............+++..+..++.|++.|++|||  +.   +|+||||||+||+++. +
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence            43       7899999996543333322233456889999999999999999999  88   9999999999999997 8


Q ss_pred             CCeEEeccccccccCCCCCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-
Q 039344          744 NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-  821 (873)
Q Consensus       744 ~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-  821 (873)
                      +.+||+|||+++...... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.............. 
T Consensus       169 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             TEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            999999999998765433 233457899999999987654 89999999999999999999999976443211111100 


Q ss_pred             ------hhhhhhcCCCCC-------CCCch-------hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 ------IALDEMLDPRLP-------TPSRN-------VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ------~~~~~~~~~~~~-------~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            .....+ ++...       ....+       .......+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          248 LGCPSREVLRKL-NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCCCCHHHHHHH-CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCHHHHHhc-ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000 00000       00000       0012345889999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.2e-37  Score=333.00  Aligned_cols=251  Identities=20%  Similarity=0.258  Sum_probs=171.4

Q ss_pred             hcCCCCC-ceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHH-HHHHhccCCceeeEEeEEEe----c
Q 039344          601 TNDFDDE-HCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEV-KALTEIWHRNIVKVYGFCLH----V  673 (873)
Q Consensus       601 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~----~  673 (873)
                      .++|.+. +.||+|+||+||+|+.. +|+.||||++...        ....+|+ ..++.++||||+++++++..    .
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            4678885 46999999999999876 7999999998642        1222333 33566689999999999986    4


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC---CCeEEec
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE---NEAHVSD  750 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~D  750 (873)
                      ...++||||+++|+|.+++.... ...+++.+++.++.|++.|++|||++   +|+||||||+||+++.+   +.+||+|
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            56899999999999999997543 24589999999999999999999999   99999999999999864   4599999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      ||+++.....  ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.............    ..+...
T Consensus       175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~  248 (336)
T 3fhr_A          175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----RRIRLG  248 (336)
T ss_dssp             CTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----Hhhhcc
Confidence            9999866532  2334678999999999988889999999999999999999999987543221111100    011111


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+..........+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111111112234889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.3e-37  Score=330.13  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=196.1

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc--CCceeeEEeEEEeccee
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW--HRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~  676 (873)
                      ...++|++.+.||+|+||.||+|+..+++.||||++...... ....+.+.+|+.++++++  ||||+++++++.+.+..
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            345779999999999999999999888999999998754322 334577899999999996  59999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||| +.+++|.+++...   ..+++..+..++.|++.|++|||++   +|+||||||+||+++ ++.+||+|||+++.
T Consensus       104 ~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecccccc
Confidence            99999 6678999998653   3589999999999999999999999   999999999999996 48999999999987


Q ss_pred             cCCCCCC--cccccccccccccccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh
Q 039344          757 LKPDSSN--WTELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       757 ~~~~~~~--~~~~~g~~~y~aPE~~~~-----------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~  823 (873)
                      .......  .....|++.|+|||.+.+           ..++.++||||+|+++|||++|+.||.......       ..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------~~  248 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SK  248 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HH
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------HH
Confidence            6543321  234578999999999875           467889999999999999999999986432210       11


Q ss_pred             hhhhcCCCC--CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 LDEMLDPRL--PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....++..  ..+...    ...+.+++.+||+.||++||+++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          249 LHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhcccccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            112222211  111111    124789999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.9e-37  Score=337.29  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=197.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----R  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  674 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++...  ........+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            467999999999999999999865 6899999999643  2333456788999999999999999999998764     6


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..++||||++ ++|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            7899999998 588888754    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC----------cccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh--
Q 039344          755 KFLKPDSSN----------WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN--  821 (873)
Q Consensus       755 ~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~--  821 (873)
                      +........          .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  239 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII  239 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            876533211          223578999999998764 6789999999999999999999999975432111000000  


Q ss_pred             --------------hhhhhhcC--CCCCCCC--chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 --------------IALDEMLD--PRLPTPS--RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 --------------~~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                    ....+...  +..+...  .........+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                          00000000  0000000  000112335789999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.7e-37  Score=335.10  Aligned_cols=256  Identities=19%  Similarity=0.315  Sum_probs=194.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH----  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  675 (873)
                      ..+|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            367889999999999999999864 799999999976432 23345778999999999999999999999987653    


Q ss_pred             --eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          676 --LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       676 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                        .++||||++ +++.+++.     ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence              499999998 57877763     2489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-----------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-----------  821 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-----------  821 (873)
                      ++.....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..............           
T Consensus       173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865432   334578999999999877 6789999999999999999999999975442211100000           


Q ss_pred             --------hhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 --------IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                              .....+..................+.+++.+||+.||++|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    000000000000000000112335889999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.3e-37  Score=361.08  Aligned_cols=254  Identities=22%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC----CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH  675 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  675 (873)
                      ..++|++.+.||+|+||.||+|+..    .+..||+|+++...  .....+.+.+|+.+++.++||||+++++++. .+.
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3467888899999999999999764    25679999987532  2334578999999999999999999999985 456


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            899999999999999996432  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          756 FLKPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       756 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........     +...  .+.+
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-----i~~~--~~~~  612 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----IENG--ERLP  612 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----HHHT--CCCC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----HHcC--CCCC
Confidence            7654322 2223456789999999998999999999999999999997 9999875433221111     1111  1111


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+..    ....+.+++.+||+.||++|||+.++++.|+
T Consensus       613 ~~~~----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          613 MPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1211    1234889999999999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=332.84  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=191.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEE--------
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCL--------  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------  671 (873)
                      ..+|++.+.||+|+||.||+|+.. +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            467899999999999999999876 5899999998643   2334578899999999999999999999884        


Q ss_pred             ------ecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-CCC
Q 039344          672 ------HVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-FEN  744 (873)
Q Consensus       672 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~  744 (873)
                            +....++||||++ |+|.+++..    ..+++..+..++.|++.|++|||++   +|+||||||+||+++ .++
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                  3467899999998 689998854    3488999999999999999999999   999999999999997 567


Q ss_pred             CeEEeccccccccCCCC---CCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDS---SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL  820 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~  820 (873)
                      .+||+|||+++......   .......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||.............
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999998765322   12334567899999998765 678999999999999999999999997544321111000


Q ss_pred             hh-------hhhh------------hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 NI-------ALDE------------MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ~~-------~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..       ...+            ...+..+ ...........+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKP-LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCC-HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCC-hhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00       0000            0000000 00000112345889999999999999999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.6e-36  Score=332.69  Aligned_cols=202  Identities=22%  Similarity=0.293  Sum_probs=171.4

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CC-----ceeeEEeEEEe
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HR-----NIVKVYGFCLH  672 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~  672 (873)
                      ..++|++.+.||+|+||+||+|+.. +++.||||+++..    .....++..|+.+++.++ |+     +|+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3578999999999999999999765 6889999998742    233567788999988884 55     49999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC--CCCCeEEec
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD--FENEAHVSD  750 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--~~~~~kl~D  750 (873)
                      .+..++||||++ ++|.+++..... ..+++..+..++.|++.|++|||++ ..+|+||||||+||+++  .++.+||+|
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999997 599988865432 3489999999999999999999952 11899999999999995  467899999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccc
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS  811 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~  811 (873)
                      ||+++.....   .....||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus       205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999876532   334678999999999999999999999999999999999999998543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.6e-37  Score=332.80  Aligned_cols=256  Identities=24%  Similarity=0.329  Sum_probs=177.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHH-HHHhccCCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....  .....++..|+. +++.++||||+++++++.+.+..++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            367899999999999999999874 789999999975422  223455666666 6777799999999999999999999


Q ss_pred             EEEeccCCChhhHhcccc--cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          679 VYEYFKMCSLAVILSNDA--AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ||||+++ ++.+++....  ....+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            9999985 7777765321  2356899999999999999999999953  799999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      ..... ......|++.|+|||.+    .+..++.++||||||+++|||++|+.||......       ............
T Consensus       176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~  247 (327)
T 3aln_A          176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVVKGDP  247 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred             ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHhcCCC
Confidence            65432 22334789999999998    4566899999999999999999999998743211       001111111111


Q ss_pred             CC-CCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PT-PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +. +..........+.+++.+||+.||++||+++++++
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            10 00000111234889999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-36  Score=341.32  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=186.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.|...+.||+|+||+||.+...+|+.||||++...      ..+.+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            345556889999999998877778999999998642      235678999999887 8999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccC----CChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-------------
Q 039344          681 EYFKMCSLAVILSNDAAAKN----LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-------------  743 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-------------  743 (873)
                      ||+. |+|.+++........    .++..++.++.||+.||+|||++   +|+||||||+||+++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence            9996 699999976442111    13445678999999999999999   99999999999999754             


Q ss_pred             CCeEEeccccccccCCCCCC----cccccccccccccccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCcccc
Q 039344          744 NEAHVSDFGIAKFLKPDSSN----WTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFIS  811 (873)
Q Consensus       744 ~~~kl~Dfg~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~sDv~s~G~il~el~t-g~~P~~~~~  811 (873)
                      +.+||+|||+++........    .....||+.|+|||++.+       ..++.++||||+||++|||+| |+.||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            47999999999887654322    234579999999999875       568999999999999999999 999986432


Q ss_pred             cchhhhhhhhhhhhhhcC-CCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          812 SMSFSSLNLNIALDEMLD-PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...      ......... +....  .........+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~------~~i~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRE------SNIIRGIFSLDEMKC--LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THH------HHHHHTCCCCCCCTT--CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH------HHHhcCCCCcccccc--cccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            111      011111111 11111  111234456889999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.5e-37  Score=332.25  Aligned_cols=244  Identities=20%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcc---hhHHHHHHHHHHHHhcc--CCceeeEEeEEEec
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEM---TFQQEFLNEVKALTEIW--HRNIVKVYGFCLHV  673 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~  673 (873)
                      ...+|++.+.||+|+||.||+|+. .+++.||||++........   ...+.+.+|+.+++.++  ||||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            457799999999999999999975 5789999999875432221   11245678999999996  59999999999999


Q ss_pred             ceeEEEEEeccC-CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-CCCCeEEecc
Q 039344          674 RHLFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-FENEAHVSDF  751 (873)
Q Consensus       674 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Df  751 (873)
                      +..++|||++.+ ++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++ .++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 8999998643   4589999999999999999999999   999999999999999 7889999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP  830 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  830 (873)
                      |+++.....  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......              ...
T Consensus       195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------------~~~  258 (320)
T 3a99_A          195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------IRG  258 (320)
T ss_dssp             TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------------HHC
T ss_pred             ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------------hcc
Confidence            999876532  3344679999999999887766 67899999999999999999998642210              001


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+...    ...+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          259 QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111111    124789999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-36  Score=334.38  Aligned_cols=258  Identities=19%  Similarity=0.299  Sum_probs=196.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-----------CCceeeEEe
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-----------HRNIVKVYG  668 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~  668 (873)
                      ..+|.+.+.||+|+||+||+|+. .+++.||||++..    .....+.+.+|+.++++++           ||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            36799999999999999999986 5789999999863    2233567889999999886           899999999


Q ss_pred             EEEecc----eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC---
Q 039344          669 FCLHVR----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD---  741 (873)
Q Consensus       669 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~---  741 (873)
                      ++...+    ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++  +|+||||||+||+++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            998654    789999999 8999999865432 34899999999999999999999953  899999999999995   


Q ss_pred             ---CCCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhh
Q 039344          742 ---FENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSL  818 (873)
Q Consensus       742 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~  818 (873)
                         ..+.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......+...
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               3447999999999876532   3345789999999999999999999999999999999999999975432111000


Q ss_pred             hh-hhhhhhh------------------cCCC-----CCC------------CCchhHHHHHHHHHHHhhcccCCCCCCC
Q 039344          819 NL-NIALDEM------------------LDPR-----LPT------------PSRNVHDKLISIVEVTISCVDENPESRP  862 (873)
Q Consensus       819 ~~-~~~~~~~------------------~~~~-----~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RP  862 (873)
                      .. .....+.                  ....     ...            ...........+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            00 0000000                  0000     000            0001134456789999999999999999


Q ss_pred             CHHHHHH
Q 039344          863 TMQKVCQ  869 (873)
Q Consensus       863 s~~ev~~  869 (873)
                      |++|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=337.36  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=186.5

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ..+|...++||+|+||+||.....+|+.||||++.....      ..+.+|+.+++.+ +||||+++++++.+....|+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            356888899999999997766666799999999864321      2356899999999 799999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-----CCeEEeccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-----NEAHVSDFGIA  754 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-----~~~kl~Dfg~a  754 (873)
                      |||+. |+|.+++....  ...++..+..++.||+.||+|||+.   +|+||||||+||+++.+     ..+||+|||+|
T Consensus        97 ~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            99997 59999986543  2355567789999999999999999   99999999999999532     35889999999


Q ss_pred             cccCCCC---CCccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhh
Q 039344          755 KFLKPDS---SNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       755 ~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      +......   .......||+.|+|||++.   ...++.++||||+||++|||++ |..||.......     ....... 
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~~~~~~~-  244 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----ANILLGA-  244 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----HHHHTTC-
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----HHHHhcc-
Confidence            8765432   2234567999999999987   4567889999999999999999 999985322111     0000111 


Q ss_pred             cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+.   ......+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          245 CSLDCLHPE---KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCTTSCTT---CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCccccCcc---ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            011111111   122334789999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5e-36  Score=328.88  Aligned_cols=257  Identities=18%  Similarity=0.262  Sum_probs=196.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CC-cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc------eeeEEeEEEe
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SG-EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN------IVKVYGFCLH  672 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  672 (873)
                      .++|++.+.||+|+||+||+|... ++ +.||+|+++..    ....+.+.+|+.+++.++|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            368999999999999999999864 34 68999998642    233567889999999998776      9999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee------------
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL------------  740 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill------------  740 (873)
                      .+..++||||+ ++++.+++.... ...+++..+..++.||+.||+|||++   +|+||||||+||++            
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            99999999999 456666664432 23589999999999999999999999   99999999999999            


Q ss_pred             -------CCCCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc
Q 039344          741 -------DFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM  813 (873)
Q Consensus       741 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~  813 (873)
                             +.++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   56789999999999865432   23467999999999999999999999999999999999999999754322


Q ss_pred             hhhhhhhhh-------hhhhh------cCCC--CCCC-----------------CchhHHHHHHHHHHHhhcccCCCCCC
Q 039344          814 SFSSLNLNI-------ALDEM------LDPR--LPTP-----------------SRNVHDKLISIVEVTISCVDENPESR  861 (873)
Q Consensus       814 ~~~~~~~~~-------~~~~~------~~~~--~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~R  861 (873)
                      .........       .....      ....  +...                 ..........+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            110000000       00000      0000  0000                 00001223468899999999999999


Q ss_pred             CCHHHHHH
Q 039344          862 PTMQKVCQ  869 (873)
Q Consensus       862 Ps~~ev~~  869 (873)
                      ||++|+++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=327.48  Aligned_cols=247  Identities=21%  Similarity=0.323  Sum_probs=191.3

Q ss_pred             HHHHhcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcc---hhHHHHHHHHHHHHhc----cCCceeeEEe
Q 039344          597 IIRATNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEM---TFQQEFLNEVKALTEI----WHRNIVKVYG  668 (873)
Q Consensus       597 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~niv~l~~  668 (873)
                      .....++|++.+.||+|+||.||+|+. .+|+.||||++........   .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999976 4788999999975432211   1123466799999998    8999999999


Q ss_pred             EEEecceeEEEEEe-ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC-CCCCe
Q 039344          669 FCLHVRHLFIVYEY-FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD-FENEA  746 (873)
Q Consensus       669 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~  746 (873)
                      ++.+.+..++|||| +.+++|.+++...   ..+++..++.++.|++.|++|||++   +|+||||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            99999999999999 7899999998653   3589999999999999999999999   999999999999999 88999


Q ss_pred             EEeccccccccCCCCCCccccccccccccccccccCCCC-CcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhh
Q 039344          747 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD  825 (873)
Q Consensus       747 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~  825 (873)
                      ||+|||+++.....  ......|++.|+|||++.+..+. .++||||+|+++|||++|+.||.....          .. 
T Consensus       180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~-  246 (312)
T 2iwi_A          180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------IL-  246 (312)
T ss_dssp             EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HH-
T ss_pred             EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------Hh-
Confidence            99999999876543  33456789999999998877664 589999999999999999999864211          00 


Q ss_pred             hhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ......+...    ...+.+++.+||+.||++|||++|+++
T Consensus       247 ---~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 ---EAELHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---HTCCCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---hhccCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1111111111    224789999999999999999999987

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.2e-35  Score=327.87  Aligned_cols=310  Identities=18%  Similarity=0.148  Sum_probs=238.8

Q ss_pred             CCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccccccccee
Q 039344           19 NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATL   98 (873)
Q Consensus        19 ~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L   98 (873)
                      .+++++.|++++|.++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            35788999999999986666668889999999999999997777889999999999999999998888888999999999


Q ss_pred             eccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCc
Q 039344           99 YLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus        99 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      +|++|+++...+..|.++++|++|++++|.+++..+..|..+++|++|++++|+++.+.   +..+++|+.|++++|.++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccccc
Confidence            99999998555555788999999999999998777778888999999999999887653   556788888999988887


Q ss_pred             cCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhc
Q 039344          179 GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYR  258 (873)
Q Consensus       179 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  258 (873)
                      +.     ...++|++|++++|.++.. |..  ..++|++|++++|++++.  ..+..+++|++|++++|.+++..|..|.
T Consensus       200 ~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~  269 (390)
T 3o6n_A          200 TL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV  269 (390)
T ss_dssp             EE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             cc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence            43     3345788888888888844 332  246788888888888753  4677888888888888888877788888


Q ss_pred             CCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeee
Q 039344          259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD  338 (873)
Q Consensus       259 ~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  338 (873)
                      .+++|+.|++++|++.+.+..+..+++|++|++++|.+++++. .+..+++|++|++++|+++...   +..+++|+.|+
T Consensus       270 ~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~  345 (390)
T 3o6n_A          270 KMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVER-NQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLT  345 (390)
T ss_dssp             TCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCCCCGG-GHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEE
T ss_pred             ccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcceecCc-cccccCcCCEEECCCCccceeC---chhhccCCEEE
Confidence            8888888888888887765556667777777777777765432 3455666666666666665331   44455555555


Q ss_pred             eccccCC
Q 039344          339 FSINNIT  345 (873)
Q Consensus       339 l~~N~i~  345 (873)
                      +++|.+.
T Consensus       346 l~~N~~~  352 (390)
T 3o6n_A          346 LSHNDWD  352 (390)
T ss_dssp             CCSSCEE
T ss_pred             cCCCCcc
Confidence            5555554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.9e-37  Score=352.76  Aligned_cols=261  Identities=24%  Similarity=0.276  Sum_probs=200.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe------c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH------V  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~  673 (873)
                      .++|++.+.||+|+||.||+|.. .+|+.||||+++...  .....+.+.+|++++++++||||+++++++..      .
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            36799999999999999999976 468999999987542  23345779999999999999999999999765      6


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC---eEEec
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE---AHVSD  750 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~D  750 (873)
                      +..++||||+++|+|.+++........+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence            67899999999999999998765555689999999999999999999999   9999999999999997775   99999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccc-hhhhhhhhh-----hh
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-SFSSLNLNI-----AL  824 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~-~~~~~~~~~-----~~  824 (873)
                      ||.++...... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .|.......     ..
T Consensus       168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99998765433 334568999999999999999999999999999999999999998643211 111110000     00


Q ss_pred             hhhc------CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 039344          825 DEML------DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKV  867 (873)
Q Consensus       825 ~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  867 (873)
                      .+..      ....+.+..........+.+++.+||+.||++|||++|+
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            0001      111122222222344568999999999999999999764

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.1e-35  Score=327.90  Aligned_cols=334  Identities=21%  Similarity=0.187  Sum_probs=176.3

Q ss_pred             CcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEe
Q 039344          116 LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLY  195 (873)
Q Consensus       116 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  195 (873)
                      +++++.|++++|.++...+..|..+++|++|++++|.++.+.+..|..+++|++|+|++|.+++..|..|.++++|++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            45566666666666533333455566666666666666555555566666666666666666555555555555555555


Q ss_pred             ccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcC
Q 039344          196 LDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG  275 (873)
Q Consensus       196 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (873)
                      +++|.++...+..|..+++|++|++++|++++..+..+..+++|++|++++|++++.   .+..+++|            
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L------------  188 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSL------------  188 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTC------------
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cccccccc------------
Confidence            555555533333345555555555555555544444455555555555555555432   12333344            


Q ss_pred             cCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCC
Q 039344          276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHS  355 (873)
Q Consensus       276 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~  355 (873)
                                 +.|++++|.++++     ...+.|++|++++|.+......   ..++|+.|++++|++++.  ..++.+
T Consensus       189 -----------~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l  247 (390)
T 3o6n_A          189 -----------FHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNY  247 (390)
T ss_dssp             -----------SEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGC
T ss_pred             -----------ceeeccccccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCC
Confidence                       4444444443321     1123444455555544432111   123455555555555432  344445


Q ss_pred             CCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcc
Q 039344          356 SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSEL  435 (873)
Q Consensus       356 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L  435 (873)
                      ++|++|+|++|.+++..|..                        +..+++|+.|+|++|++++ +|..+..++  +|+.|
T Consensus       248 ~~L~~L~Ls~n~l~~~~~~~------------------------~~~l~~L~~L~L~~n~l~~-~~~~~~~l~--~L~~L  300 (390)
T 3o6n_A          248 PGLVEVDLSYNELEKIMYHP------------------------FVKMQRLERLYISNNRLVA-LNLYGQPIP--TLKVL  300 (390)
T ss_dssp             TTCSEEECCSSCCCEEESGG------------------------GTTCSSCCEEECCSSCCCE-EECSSSCCT--TCCEE
T ss_pred             CCccEEECCCCcCCCcChhH------------------------ccccccCCEEECCCCcCcc-cCcccCCCC--CCCEE
Confidence            55555555555554433444                        4444444444444444432 233333332  55666


Q ss_pred             cccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCCCCcccCCCcccccCCCCcc
Q 039344          436 DLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLY  515 (873)
Q Consensus       436 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l~  515 (873)
                      +|++|++++ +|..+..+++|+.|+|++|+++...   +..+++|++|++++|++.+.-.. ..+...+...+.++...|
T Consensus       301 ~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c  375 (390)
T 3o6n_A          301 DLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHC  375 (390)
T ss_dssp             ECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCC
T ss_pred             ECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCcee
Confidence            666666653 4555667778888888888877653   55677888888888888764221 223344444556666666


Q ss_pred             cC
Q 039344          516 GD  517 (873)
Q Consensus       516 g~  517 (873)
                      ..
T Consensus       376 ~~  377 (390)
T 3o6n_A          376 KI  377 (390)
T ss_dssp             CT
T ss_pred             cc
Confidence            53

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=325.00  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=178.4

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++...... ....+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            367888999999999999999875 7899999999754322 22233445555568888999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||+ ++.+..+....  ...+++..+..++.|++.|++|||+ .   +|+||||||+||+++.++.+||+|||+++...
T Consensus       103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 45555554321  3458999999999999999999998 6   89999999999999999999999999997665


Q ss_pred             CCCCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          759 PDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ... ......|++.|+|||.+.     ...++.++||||+|+++|||++|+.||.......   ..... ......+..+
T Consensus       177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~-~~~~~~~~~~  251 (318)
T 2dyl_A          177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---EVLTK-VLQEEPPLLP  251 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHH-HHHSCCCCCC
T ss_pred             CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---HHHHH-HhccCCCCCC
Confidence            432 233457899999999984     4568899999999999999999999987432210   00000 0011111122


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....    ....+.+++.+||+.||++||+++++++
T Consensus       252 ~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          252 GHMG----FSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             SSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCC----CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1111    1224889999999999999999999875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=3e-35  Score=344.71  Aligned_cols=335  Identities=21%  Similarity=0.178  Sum_probs=176.3

Q ss_pred             cccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEec
Q 039344          117 RSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYL  196 (873)
Q Consensus       117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L  196 (873)
                      .+++.|++++|.++...+..|..+++|++|+|++|.++++.+..|..+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  130 (597)
T 3oja_B           51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  130 (597)
T ss_dssp             CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence            44555555555555333333445555555555555555444445555555555555555555444444444455555555


Q ss_pred             cCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc
Q 039344          197 DTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP  276 (873)
Q Consensus       197 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  276 (873)
                      ++|.++...+..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|.++                        +.
T Consensus       131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------~~  186 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------------------HV  186 (597)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS------------------------BC
T ss_pred             eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC------------------------Cc
Confidence            555444333333444444444444444444444444444444444444444443                        32


Q ss_pred             CCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCC
Q 039344          277 IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSS  356 (873)
Q Consensus       277 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~  356 (873)
                        .+..+++|+.|++++|.++++     ...+.|+.|++++|.+....+..   .++|+.|+|++|.+++  +..++.++
T Consensus       187 --~~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~  254 (597)
T 3oja_B          187 --DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYP  254 (597)
T ss_dssp             --CGGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCT
T ss_pred             --ChhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCC
Confidence              122334444444444444321     12234444555555444222211   1344555555554442  23344444


Q ss_pred             CCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhccc
Q 039344          357 QLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELD  436 (873)
Q Consensus       357 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~  436 (873)
                      +|+.|+|++|.++                        +..|..+..+++|+.|+|++|++++ +|..+..++  +|+.|+
T Consensus       255 ~L~~L~Ls~N~l~------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~--~L~~L~  307 (597)
T 3oja_B          255 GLVEVDLSYNELE------------------------KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP--TLKVLD  307 (597)
T ss_dssp             TCSEEECCSSCCC------------------------EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCT--TCCEEE
T ss_pred             CCCEEECCCCccC------------------------CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCC--CCcEEE
Confidence            4444444444444                        4444445555555555555555543 344443333  666777


Q ss_pred             ccCCccCcccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCCCCcccCCCcccccCCCCccc
Q 039344          437 LSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYG  516 (873)
Q Consensus       437 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l~g  516 (873)
                      |++|.++ .+|..+..+++|+.|+|++|++++..   +..+++|+.|+|++|+|.+..+. ..+.......+.++...|+
T Consensus       308 Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~  382 (597)
T 3oja_B          308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCK  382 (597)
T ss_dssp             CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCC
T ss_pred             CCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCC
Confidence            7777766 35666778888889999999888664   55678899999999999876432 2355556666788888888


Q ss_pred             Ccc
Q 039344          517 DVK  519 (873)
Q Consensus       517 ~~~  519 (873)
                      .+.
T Consensus       383 ~~~  385 (597)
T 3oja_B          383 IDY  385 (597)
T ss_dssp             TTC
T ss_pred             cch
Confidence            643

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6.4e-35  Score=318.80  Aligned_cols=306  Identities=27%  Similarity=0.384  Sum_probs=161.6

Q ss_pred             cCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccce
Q 039344           18 RNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLAT   97 (873)
Q Consensus        18 ~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~   97 (873)
                      ..+++|++|++++|+++ .+|. |..+++|++|++++|++++. +. +..+++|++|++++|.++. + .+|..+++|++
T Consensus        41 ~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~  114 (347)
T 4fmz_A           41 EELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLRE  114 (347)
T ss_dssp             HHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSE
T ss_pred             hhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCE
Confidence            34455555555555554 2222 55555555555555555532 22 5555555555555555553 2 23555555555


Q ss_pred             eeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcC
Q 039344           98 LYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNF  177 (873)
Q Consensus        98 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i  177 (873)
                      |++++|++++. +. +..+++|++|++++|..... +..+..+++|++|++++|.+....+                   
T Consensus       115 L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~-------------------  172 (347)
T 4fmz_A          115 LYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP-------------------  172 (347)
T ss_dssp             EECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG-------------------
T ss_pred             EECcCCcccCc-hh-hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh-------------------
Confidence            55555555422 22 44455555555555533322 2224444455555555444443322                   


Q ss_pred             ccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhh
Q 039344          178 NGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEY  257 (873)
Q Consensus       178 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  257 (873)
                             +..+++|++|++++|.+++..+  +..+++|+.|++++|++.+..+  +..+++|++|++++|++++..+  +
T Consensus       173 -------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~  239 (347)
T 4fmz_A          173 -------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--L  239 (347)
T ss_dssp             -------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred             -------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--h
Confidence                   4444455555555555542221  4445555555555555543322  4455555555555555554332  5


Q ss_pred             cCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCee
Q 039344          258 RNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTL  337 (873)
Q Consensus       258 ~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  337 (873)
                      ..+++|++|++++|.+... +.+..+++|++|++++|.++++  ..+..+++|++|++++|.+++..+..+..+++|+.|
T Consensus       240 ~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  316 (347)
T 4fmz_A          240 ANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL  316 (347)
T ss_dssp             TTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred             hcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence            5555555555555555543 3455556666666666666654  345566667777777777766666666667777777


Q ss_pred             eeccccCCccCCccccCCCCCCEEeccCCccC
Q 039344          338 DFSINNITGNVPPEIGHSSQLGVLDLSSNHIV  369 (873)
Q Consensus       338 ~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~  369 (873)
                      ++++|++++..|  ++.+++|++|++++|.|+
T Consensus       317 ~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          317 FLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             ECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EccCCccccccC--hhhhhccceeehhhhccc
Confidence            777777765444  666777777777777764

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6.7e-35  Score=318.65  Aligned_cols=306  Identities=26%  Similarity=0.401  Sum_probs=249.8

Q ss_pred             cCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcE
Q 039344           66 GNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLAT  145 (873)
Q Consensus        66 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  145 (873)
                      ..+++|++|++++|.+.. ++ .+..+++|++|++++|++++. +. +.++++|++|++++|.++. ++ .|..+++|++
T Consensus        41 ~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~  114 (347)
T 4fmz_A           41 EELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE  114 (347)
T ss_dssp             HHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred             hhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence            455666666666666663 33 366667777777777777643 33 6777777777777777763 33 5778888888


Q ss_pred             EEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCccc
Q 039344          146 LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL  225 (873)
Q Consensus       146 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  225 (873)
                      |++++|.+..+.+  +..+++|++|++++|..... +..+..+++|++|++++|.+....+  +..+++|++|++++|++
T Consensus       115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l  189 (347)
T 4fmz_A          115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI  189 (347)
T ss_dssp             EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred             EECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence            8888888876544  78888888899988865533 3448899999999999999985443  88999999999999999


Q ss_pred             CCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccc
Q 039344          226 SGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFY  305 (873)
Q Consensus       226 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~  305 (873)
                      .+..+  +..+++|++|++++|.+++..+  +..+++|++|++++|++....+ +..+++|++|++++|.++++  ..+.
T Consensus       190 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~  262 (347)
T 4fmz_A          190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVK  262 (347)
T ss_dssp             CCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGT
T ss_pred             ccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHh
Confidence            86544  8899999999999999987655  8899999999999999997655 88999999999999999986  4688


Q ss_pred             cCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEE
Q 039344          306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKL  385 (873)
Q Consensus       306 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L  385 (873)
                      .+++|++|++++|.+++.  ..+..+++|+.|++++|++++..+..++.+++|++|+|++|.+++..|  +..+++|++|
T Consensus       263 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  338 (347)
T 4fmz_A          263 DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA  338 (347)
T ss_dssp             TCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEE
T ss_pred             cCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhcccee
Confidence            999999999999999864  468889999999999999998888999999999999999999997666  8899999999


Q ss_pred             EecCcccc
Q 039344          386 VLAHNQLS  393 (873)
Q Consensus       386 ~L~~N~l~  393 (873)
                      ++++|.|+
T Consensus       339 ~l~~N~i~  346 (347)
T 4fmz_A          339 DFANQVIK  346 (347)
T ss_dssp             SSSCC---
T ss_pred             ehhhhccc
Confidence            99999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-35  Score=314.41  Aligned_cols=230  Identities=11%  Similarity=0.043  Sum_probs=183.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+..++.++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999875 58999999998765555555678999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++++|.+++...     ....++.+++.|++.||+|||++   +|+||||||+||+++.++.+||+++|        
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            999999999998532     35567889999999999999999   99999999999999999999998554        


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                                  |++       .++.++||||+||++|||+||+.||.............     ...............
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  230 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-----RDTAGQPIEPADIDR  230 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-----BCTTSCBCCHHHHCT
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-----HHhccCCCChhhccc
Confidence                        333       26789999999999999999999998544321000000     000111111000001


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....+.+++.+||+.||++| |++|+++.|+
T Consensus       231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~  261 (286)
T 3uqc_A          231 DIPFQISAVAARSVQGDGGIR-SASTLLNLMQ  261 (286)
T ss_dssp             TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence            122358899999999999999 9999999874

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2e-34  Score=337.67  Aligned_cols=288  Identities=18%  Similarity=0.152  Sum_probs=215.9

Q ss_pred             CCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           20 LKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        20 l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      +.+++.|++++|.++.+.+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            46788888888888877777788888899999999988887788888888899999998888888888888888888888


Q ss_pred             ccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc
Q 039344          100 LDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  179 (873)
                      |++|.++...+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.++++.   +..+++|+.|++++|.+++
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence            8888888665566788888888888888888777778888888888888888887653   4556788888888888764


Q ss_pred             CCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcC
Q 039344          180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRN  259 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  259 (873)
                      .     ...++|+.|++++|.++...+ .+  .++|+.|+|++|.+++  +..+..+++|++|+|++|.+++..|..|..
T Consensus       207 l-----~~~~~L~~L~ls~n~l~~~~~-~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  276 (597)
T 3oja_B          207 L-----AIPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK  276 (597)
T ss_dssp             E-----ECCTTCSEEECCSSCCCEEEC-SC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred             c-----cCCchhheeeccCCccccccc-cc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcC
Confidence            2     334578888888888874332 22  2578888888888775  356777778888888888877777777777


Q ss_pred             CCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCcccc
Q 039344          260 LVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFY  321 (873)
Q Consensus       260 l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~  321 (873)
                      +++|+.|+|++|.+.+.+..+..+++|+.|+|++|.++.++ ..+..+++|++|+|++|.+.
T Consensus       277 l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~~i~-~~~~~l~~L~~L~L~~N~l~  337 (597)
T 3oja_B          277 MQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVE-RNQPQFDRLENLYLDHNSIV  337 (597)
T ss_dssp             CSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCCCCG-GGHHHHTTCSEEECCSSCCC
T ss_pred             ccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCCccC-cccccCCCCCEEECCCCCCC
Confidence            77777777777777765555555666666666666665432 23344555555555555554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-34  Score=309.09  Aligned_cols=230  Identities=20%  Similarity=0.268  Sum_probs=178.7

Q ss_pred             cCCCCC-ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHH-HhccCCceeeEEeEEEe----cc
Q 039344          602 NDFDDE-HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIWHRNIVKVYGFCLH----VR  674 (873)
Q Consensus       602 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~  674 (873)
                      ++|.+. +.||+|+||.||+|.. .+++.||+|++..        ...+.+|+.++ +..+||||+++++++..    ..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            557666 7899999999999976 5789999999863        14577888887 55589999999999987    67


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CCCeEEecc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAHVSDF  751 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Df  751 (873)
                      ..++||||+++++|.+++.... ...+++..++.++.|++.|++|||++   +|+||||||+||+++.   ++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            8899999999999999997543 23589999999999999999999999   9999999999999998   788999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      |+++...                      +..++.++||||+||++|||++|+.||...........    ....+....
T Consensus       165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----~~~~~~~~~  218 (299)
T 3m2w_A          165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTRIRMGQ  218 (299)
T ss_dssp             TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----SCCSSCTTC
T ss_pred             ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----HHHHHhhcc
Confidence            9987533                      23467789999999999999999999864332211000    011111112


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+..........+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            22121111122345889999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7e-35  Score=346.24  Aligned_cols=236  Identities=25%  Similarity=0.354  Sum_probs=190.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC--CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecce---
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA--SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRH---  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  675 (873)
                      .++|++.+.||+|+||+||+|+..  +|+.||||++...  ......+.+.+|+.++++++||||+++++++.+.+.   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            368999999999999999999875  6899999998753  233445678999999999999999999999987665   


Q ss_pred             --eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          676 --LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       676 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                        .|+||||+++++|.+++..     .+++.+++.++.||+.||+|||++   +|+||||||+||+++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence              7999999999999887643     589999999999999999999999   99999999999999975 999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ++.....    ....||+.|+|||++.+.. +.++|||||||++|+|++|..||......                 ..+
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~~  285 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GLP  285 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SCC
T ss_pred             chhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------ccc
Confidence            9876543    3457999999999987654 88999999999999999999886531110                 001


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPT-MQKVCQL  870 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~  870 (873)
                      .. .........+.+++.+||+.||++||+ ++++.+.
T Consensus       286 ~~-~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~  322 (681)
T 2pzi_A          286 ED-DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ  322 (681)
T ss_dssp             TT-CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             cc-ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence            11 111122345889999999999999996 4445443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.2e-33  Score=306.25  Aligned_cols=287  Identities=23%  Similarity=0.243  Sum_probs=196.3

Q ss_pred             CCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccc
Q 039344           46 NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN  125 (873)
Q Consensus        46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  125 (873)
                      +++.+++++|.++ .+|..+.  ++|++|+|++|.+++..+.+|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            5677777777776 5565553  567777777777776666677777777777777777776666777777777777777


Q ss_pred             ccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc--CCCccccCCCCCcEEeccCCCCcc
Q 039344          126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG--SIPPSLGNLSNLATLYLDTNSLSY  203 (873)
Q Consensus       126 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~n~l~~  203 (873)
                      +|.++ .+|..+.  ++|++|++++|+++.+.+..|..+++|++|++++|.++.  ..+..+..+ +|++|++++|.++.
T Consensus       111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~  186 (332)
T 2ft3_A          111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG  186 (332)
T ss_dssp             SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred             CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence            77776 4454443  677777777777777766677777777777777777753  556666666 77888888887774


Q ss_pred             cCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCC
Q 039344          204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL  283 (873)
Q Consensus       204 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l  283 (873)
                       +|..+.  ++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|++...+..+..+
T Consensus       187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l  263 (332)
T 2ft3_A          187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDL  263 (332)
T ss_dssp             -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGC
T ss_pred             -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcC
Confidence             444443  67788888888887776677778888888888888888777777777888888888888777665567777


Q ss_pred             CCCCeEEccCccccccccccccc------CCCccEEeccCcccc--ccCCCCCCCCCCCCeeeeccc
Q 039344          284 TSLERVRLDRNYLTGNISESFYI------YPNLTYIDLSQNNFY--GEISSDWGRCPKLSTLDFSIN  342 (873)
Q Consensus       284 ~~L~~L~L~~n~l~~~~~~~~~~------~~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~l~~N  342 (873)
                      ++|++|++++|.+++++...|..      .+.|+.|++++|.+.  +..+..|..+++|+.|++++|
T Consensus       264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred             ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence            77777777777777666655543      234555555555554  334444445555555555544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-35  Score=328.11  Aligned_cols=244  Identities=14%  Similarity=0.116  Sum_probs=180.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC-Ccee---------------
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH-RNIV---------------  664 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv---------------  664 (873)
                      ..|...+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.+++.++| +|..               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4577789999999999999984 5799999999885433333335779999999999976 2211               


Q ss_pred             e------EEeEEEe-----cceeEEEEEeccCCChhhHhccc----ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCee
Q 039344          665 K------VYGFCLH-----VRHLFIVYEYFKMCSLAVILSND----AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV  729 (873)
Q Consensus       665 ~------l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~  729 (873)
                      .      +..++..     ....+++|+++ +++|.+++...    .....+++..++.++.|+++||+|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            1      1111111     12356677754 58898888421    1234477889999999999999999999   999


Q ss_pred             eCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcccccccccccccccc----------ccCCCCCcchhHHHHHHHHH
Q 039344          730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA----------YTMKVTEKCDVYSFGVLALE  799 (873)
Q Consensus       730 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~sDv~s~G~il~e  799 (873)
                      ||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++          .+..++.++|||||||++||
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999999999999999999999865432   344577 999999998          55568889999999999999


Q ss_pred             HHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          800 VIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       800 l~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      |++|+.||........        ...........        ...+.+++.+||+.||++||++.++++
T Consensus       310 lltg~~Pf~~~~~~~~--------~~~~~~~~~~~--------~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          310 IWCADLPNTDDAALGG--------SEWIFRSCKNI--------PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHSSCCCCTTGGGSC--------SGGGGSSCCCC--------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHCCCCCCCcchhhh--------HHHHHhhcccC--------CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999875432211        11122211111        124889999999999999999888764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.1e-35  Score=315.85  Aligned_cols=245  Identities=15%  Similarity=0.131  Sum_probs=187.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCC-----cchhHHHHHHHHHHHHhcc---------CCceeeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG-----EMTFQQEFLNEVKALTEIW---------HRNIVKV  666 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~niv~l  666 (873)
                      .++|++.+.||+|+||+||+|+. +|+.||||++......     .....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            36688999999999999999988 5899999999765321     2233577899999999886         7777777


Q ss_pred             EeEEE-----------------e-------------cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHH
Q 039344          667 YGFCL-----------------H-------------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA  716 (873)
Q Consensus       667 ~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~  716 (873)
                      .+++.                 +             .+..|+||||+++|++.+.+.+    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            76643                 2             6789999999999976666633    348999999999999999


Q ss_pred             HHHHH-hCCCCCeeeCCCCCCCeeeCCCC--------------------CeEEeccccccccCCCCCCcccccccccccc
Q 039344          717 LSYMH-NDCFPPIVHRDISSKNVLLDFEN--------------------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVA  775 (873)
Q Consensus       717 l~~LH-~~~~~~i~H~Dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~a  775 (873)
                      |+||| ++   +|+||||||+|||++.++                    .+||+|||+|+.....     ...||+.|+|
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999 88   999999999999999887                    8999999999876532     3479999999


Q ss_pred             ccccccCCCCCcchhHHHHHH-HHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcc
Q 039344          776 PELAYTMKVTEKCDVYSFGVL-ALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCV  854 (873)
Q Consensus       776 PE~~~~~~~~~~sDv~s~G~i-l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  854 (873)
                      ||++.+.. +.++||||+|++ .+++++|..||...   .|.............. ...............+.+++.+||
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---LWLHYLTDKMLKQMTF-KTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---HHHHHHHHHHHHTCCC-SSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---hhhhHHHHhhhhhhcc-CcccchhhhhhcCHHHHHHHHHHh
Confidence            99998766 889999998776 77889999997421   1111111111111111 111222233455667999999999


Q ss_pred             cCCCCCCCCHHHHH
Q 039344          855 DENPESRPTMQKVC  868 (873)
Q Consensus       855 ~~dP~~RPs~~ev~  868 (873)
                      +.|     |++|++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            976     999988

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.8e-33  Score=301.45  Aligned_cols=288  Identities=22%  Similarity=0.233  Sum_probs=172.2

Q ss_pred             CCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccc
Q 039344           46 NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN  125 (873)
Q Consensus        46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  125 (873)
                      +++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            5666666666666 4554443  456666666666665555566666666666666666665556666666666666666


Q ss_pred             ccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc--CCCccccCCCCCcEEeccCCCCcc
Q 039344          126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG--SIPPSLGNLSNLATLYLDTNSLSY  203 (873)
Q Consensus       126 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~n~l~~  203 (873)
                      +|.++ .+|..+.  ++|++|++++|+++.+.+..|.++++|++|++++|.++.  ..+..+.++++|++|++++|.++.
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  185 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  185 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence            66666 3444333  566666666666666666666666666666666666643  455566666666666666666663


Q ss_pred             cCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCC
Q 039344          204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL  283 (873)
Q Consensus       204 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l  283 (873)
                       +|..+.  ++|++|++++|++++..+..+..+++|++|++++|.+++..+..+..+++|++|++++|++...+..+..+
T Consensus       186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l  262 (330)
T 1xku_A          186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH  262 (330)
T ss_dssp             -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTC
T ss_pred             -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccC
Confidence             333332  56677777777766555666666677777777777766666666666677777777777666555556666


Q ss_pred             CCCCeEEccCcccccccccccccC------CCccEEeccCccccc--cCCCCCCCCCCCCeeeeccc
Q 039344          284 TSLERVRLDRNYLTGNISESFYIY------PNLTYIDLSQNNFYG--EISSDWGRCPKLSTLDFSIN  342 (873)
Q Consensus       284 ~~L~~L~L~~n~l~~~~~~~~~~~------~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N  342 (873)
                      ++|++|++++|.+++++...|...      +.++.|++++|.+..  ..|..|..+++++.++|++|
T Consensus       263 ~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence            666666666666666655555322      344444444444431  22333333444444444433

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.5e-32  Score=297.54  Aligned_cols=287  Identities=21%  Similarity=0.258  Sum_probs=151.2

Q ss_pred             cCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccC
Q 039344          119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT  198 (873)
Q Consensus       119 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~  198 (873)
                      ++.++++++.++ .+|..+.  ++|+.|++++|.++++.+..|.++++|++|+|++|.+++..|..|..+++|++|++++
T Consensus        33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            444444444444 2333322  3444555555555444444455555555555555555544444555555555555555


Q ss_pred             CCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCC--CCchhhcCCCCCcEEEccCCcCcCc
Q 039344          199 NSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG--AIPYEYRNLVKLTILLLGHNQFRGP  276 (873)
Q Consensus       199 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~  276 (873)
                      |.++ .+|..+.  ++|++|++++|++++..+..+.++++|++|++++|.++.  ..+..+..+++|++|++++|++...
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l  186 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI  186 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence            5554 2332222  455555555555554444445555555555555555532  4445555666666666666665543


Q ss_pred             CCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCC
Q 039344          277 IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSS  356 (873)
Q Consensus       277 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~  356 (873)
                      +..+.  ++|++|++++|.++++.+..|..+++|++|+|++|.+++..+..+..+++|+.|++++|+++ .+|..+..++
T Consensus       187 ~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~  263 (330)
T 1xku_A          187 PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK  263 (330)
T ss_dssp             CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred             Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC
Confidence            33222  56666666666666665666666666666666666666555556666666666666666666 4555666666


Q ss_pred             CCCEEeccCCccCCCCCccccc------cccccEEEecCccccC--Cccccccccccccccccccc
Q 039344          357 QLGVLDLSSNHIVGEIPIELGK------LNFFIKLVLAHNQLSG--QLSPKLGSLVQLEHLDLSSN  414 (873)
Q Consensus       357 ~L~~L~Ls~N~i~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N  414 (873)
                      +|++|+|++|.|++..+..+..      ...++.|++++|.+..  ..|..|..+.+++.++|++|
T Consensus       264 ~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             CcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence            6666666666666544444432      2344455555554432  33344444555555555554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=9.5e-33  Score=299.27  Aligned_cols=289  Identities=22%  Similarity=0.297  Sum_probs=120.4

Q ss_pred             ccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEcc
Q 039344           94 NLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLS  173 (873)
Q Consensus        94 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  173 (873)
                      +|+.++++++.++ .+|..+.  ++|++|++++|.+++..+..|..+++|++|++++|+++.+.+..|..+++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            4555555555554 3333332  344444554444443334444444444444444444444444444444444444444


Q ss_pred             CCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCC
Q 039344          174 ENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAI  253 (873)
Q Consensus       174 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  253 (873)
                      +|+++. +|..+.  ++|++|++++|.++...+..|..+++|++|++++|.++.                      .+..
T Consensus       111 ~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~  165 (332)
T 2ft3_A          111 KNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN----------------------SGFE  165 (332)
T ss_dssp             SSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG----------------------GGSC
T ss_pred             CCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc----------------------CCCC
Confidence            444442 222221  344444444444443333333444444444444444321                      0122


Q ss_pred             chhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCC
Q 039344          254 PYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPK  333 (873)
Q Consensus       254 ~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~  333 (873)
                      +..+..+ +|+.|++++|++++.+..+.  ++|++|++++|.++++.+..|..+++|++|++++|++.+..+..+..+++
T Consensus       166 ~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  242 (332)
T 2ft3_A          166 PGAFDGL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT  242 (332)
T ss_dssp             TTSSCSC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTT
T ss_pred             cccccCC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCC
Confidence            3333333 33333333333333222111  34444444444444444444444444444444444444444444444444


Q ss_pred             CCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccc------cccccEEEecCcccc--CCcccccccccc
Q 039344          334 LSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGK------LNFFIKLVLAHNQLS--GQLSPKLGSLVQ  405 (873)
Q Consensus       334 L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~------l~~L~~L~L~~N~l~--~~~~~~~~~l~~  405 (873)
                      |+.|++++|+++ .+|..+..+++|+.|++++|.|++..+..+..      ...|+.|++++|.+.  +..+..+..+++
T Consensus       243 L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~  321 (332)
T 2ft3_A          243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD  321 (332)
T ss_dssp             CCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCC
T ss_pred             CCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccch
Confidence            444444444444 34444444444444444444444333333322      123444444444443  233344444444


Q ss_pred             ccccccccc
Q 039344          406 LEHLDLSSN  414 (873)
Q Consensus       406 L~~L~Ls~N  414 (873)
                      |+.|+|++|
T Consensus       322 L~~l~l~~n  330 (332)
T 2ft3_A          322 RLAIQFGNY  330 (332)
T ss_dssp             STTEEC---
T ss_pred             hhhhhcccc
Confidence            444444444

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=8.3e-37  Score=347.71  Aligned_cols=158  Identities=23%  Similarity=0.257  Sum_probs=71.7

Q ss_pred             CCCCEEEcccCCCCCCCCcc-cccccccceeeccccccCC----CCCccccCCcccCcccccccccccccCccc-cCCC-
Q 039344           69 RFFSDLELSNNKLSGSIPPS-LGNLSNLATLYLDTNSLSN----SIPSELGNLRSLSNLQLNNNILSGSIPHSL-GNLT-  141 (873)
Q Consensus        69 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~-  141 (873)
                      ++|++|+|++|+++...... +..+++|++|+|++|+++.    .++..+..+++|++|+|++|.++...+..+ ..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            34556666666655322222 4555566666666665552    123444455555555555555543222222 2233 


Q ss_pred             ---CCcEEEccCCCCcc----ccccccCCCCCCCEEEccCCcCccCCCccc-----cCCCCCcEEeccCCCCcccC----
Q 039344          142 ---NLATLYIYSNSLSA----SILGKIGNLKSLSNLQLSENNFNGSIPPSL-----GNLSNLATLYLDTNSLSYSI----  205 (873)
Q Consensus       142 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~----  205 (873)
                         +|++|+|++|+++.    ..+..+..+++|++|+|++|.+++..+..+     ...++|++|++++|.++...    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               35555555555542    123444455555555555555443222111     11234555555555444322    


Q ss_pred             CccccCCCCCCEEEccCcccC
Q 039344          206 PSELGNLRSLSNLSLGYNKLS  226 (873)
Q Consensus       206 ~~~~~~l~~L~~L~L~~N~l~  226 (873)
                      +..+..+++|++|++++|.++
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~  183 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDIN  183 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHhhCCCCCEEECcCCCcc
Confidence            223333444444444444443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3e-33  Score=299.90  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=161.2

Q ss_pred             CCccEEecccccCCC--CCchhhcCCCCCcEEEccC-CcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEE
Q 039344          237 SNLTYLNLFENSLSG--AIPYEYRNLVKLTILLLGH-NQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYI  313 (873)
Q Consensus       237 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L  313 (873)
                      .+++.|+|++|.+++  ..|..+.++++|++|++++ |.+.+                       ..+..|..+++|++|
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~-----------------------~~p~~l~~l~~L~~L  106 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG-----------------------PIPPAIAKLTQLHYL  106 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEES-----------------------CCCGGGGGCTTCSEE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccc-----------------------cCChhHhcCCCCCEE
Confidence            467777777777776  5666666666666666663 55554                       333334444444444


Q ss_pred             eccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccc-cccEEEecCccc
Q 039344          314 DLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLN-FFIKLVLAHNQL  392 (873)
Q Consensus       314 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~-~L~~L~L~~N~l  392 (873)
                      +|++|.+++..|..|..+++|++|++++|.+++.+|..++.+++|++|+|++|.+++.+|..+..+. +|+.|++++|++
T Consensus       107 ~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l  186 (313)
T 1ogq_A          107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL  186 (313)
T ss_dssp             EEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred             ECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence            4444444444444444555555555555555544555555555555555555555545555555554 555555555555


Q ss_pred             cCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCch
Q 039344          393 SGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS  472 (873)
Q Consensus       393 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  472 (873)
                      ++..|..+..+. |+.|+|++|++++..|..+..+.  +|+.|+|++|.+++.+|. +..+++|++|+|++|++++.+|.
T Consensus       187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~  262 (313)
T 1ogq_A          187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK--NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ  262 (313)
T ss_dssp             EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTS--CCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCG
T ss_pred             eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCC--CCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCCh
Confidence            555555555554 66666666666555555555544  666666666666654444 56677888888888888888888


Q ss_pred             hhhccCCCcEEecCCCcccccCCCCCcccCCCcccccCCCCcccCcc
Q 039344          473 CFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVK  519 (873)
Q Consensus       473 ~~~~~~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l~g~~~  519 (873)
                      .|..+++|++|+|++|+++|.+|....++......+.+|+.+||.+.
T Consensus       263 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             HHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence            88888888888888888888888887777777788888888888654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=2e-36  Score=344.65  Aligned_cols=158  Identities=22%  Similarity=0.249  Sum_probs=83.1

Q ss_pred             CCCCEEECCCCcccccCCcc-ccCCCCCceEEccCCcccc----cCCCCccCCCCCCEEEcccCCCCCCCCcccc-ccc-
Q 039344           21 KSLSDLELGNNKLSGSIPHS-LGNLTNLATLYIHTNSLSG----SIPGEIGNFRFFSDLELSNNKLSGSIPPSLG-NLS-   93 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~-   93 (873)
                      +.|++|||++|+++...... |..+++|++|+|++|+++.    .++..+..+++|++|+|++|.++...+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            34667777777776443332 6667777777777777663    2355566666777777777766543332222 233 


Q ss_pred             ---ccceeeccccccCC----CCCccccCCcccCcccccccccccccCcccc-----CCCCCcEEEccCCCCcccc----
Q 039344           94 ---NLATLYLDTNSLSN----SIPSELGNLRSLSNLQLNNNILSGSIPHSLG-----NLTNLATLYIYSNSLSASI----  157 (873)
Q Consensus        94 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~----  157 (873)
                         +|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+.     ..++|++|++++|+++...    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               46666666666552    2345555555555555555555433222221     1334555555555554322    


Q ss_pred             ccccCCCCCCCEEEccCCcCc
Q 039344          158 LGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       158 ~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      +..+..+++|++|++++|.++
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~  183 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDIN  183 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHhhCCCCCEEECcCCCcc
Confidence            222333444444444444443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.98  E-value=1e-32  Score=295.74  Aligned_cols=249  Identities=28%  Similarity=0.456  Sum_probs=185.6

Q ss_pred             CCCceEEccCCcccc--cCCCCccCCCCCCEEEccc-CCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCc
Q 039344           45 TNLATLYIHTNSLSG--SIPGEIGNFRFFSDLELSN-NKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN  121 (873)
Q Consensus        45 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (873)
                      .++++|+|++|.+++  .+|..|.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|.++++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            467777777777776  6777777777777777774 7777777777777777777777777777677777777777777


Q ss_pred             ccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCC-CCCEEEccCCcCccCCCccccCCCCCcEEeccCCC
Q 039344          122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLK-SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNS  200 (873)
Q Consensus       122 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~  200 (873)
                      |+|++|.+++.+|..|..+++|++|++++|++++..+..+..++ +|++|+|++|++++..|..+..++ |++|++++|.
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            77777777777777777777777777777777766666777776 777777777777777777777776 7777777777


Q ss_pred             CcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcC
Q 039344          201 LSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPIL  280 (873)
Q Consensus       201 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l  280 (873)
                      +++..|..|..+++|++|+|++|++++..+. +..+++|++|+|++|++++..|..+..+++|+.|++++|++++..+..
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            7777777777777788888888877755444 667777888888888777777777777777777777777777665555


Q ss_pred             CCCCCCCeEEccCcc
Q 039344          281 RNLTSLERVRLDRNY  295 (873)
Q Consensus       281 ~~l~~L~~L~L~~n~  295 (873)
                      ..+++|+.|++++|.
T Consensus       288 ~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          288 GNLQRFDVSAYANNK  302 (313)
T ss_dssp             TTGGGSCGGGTCSSS
T ss_pred             ccccccChHHhcCCC
Confidence            666677777776665

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=1.6e-32  Score=322.93  Aligned_cols=393  Identities=13%  Similarity=0.071  Sum_probs=206.4

Q ss_pred             cccccceeeccccccCCCCCccccC-Cc-ccCcccccccc-ccc-ccCccccCCCCCcEEEccCCCCcccc----ccccC
Q 039344           91 NLSNLATLYLDTNSLSNSIPSELGN-LR-SLSNLQLNNNI-LSG-SIPHSLGNLTNLATLYIYSNSLSASI----LGKIG  162 (873)
Q Consensus        91 ~l~~L~~L~L~~n~l~~~~~~~~~~-l~-~L~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~  162 (873)
                      .+++|++|+|++|.+++..+..+.. ++ +|++|+|++|. ++. .++.....+++|++|+|++|.+++..    ...+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            3444445555444444333333332 22 25555554443 110 01111224455555555555443321    11233


Q ss_pred             CCCCCCEEEccCCcCccC----CCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccC---CCcccccCC
Q 039344          163 NLKSLSNLQLSENNFNGS----IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS---GSIPISMGN  235 (873)
Q Consensus       163 ~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~  235 (873)
                      .+++|++|++++|.+++.    ++..+..+++|++|++++|.+.+ .+..+..+++|++|+++.+...   ...+..+..
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~  268 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF  268 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence            445555555555555421    22233345555555555555553 4445555566666665542221   122234455


Q ss_pred             CCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc--CCcCCCCCCCCeEEccCcccccc-cccccccCCCccE
Q 039344          236 LSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP--IPILRNLTSLERVRLDRNYLTGN-ISESFYIYPNLTY  312 (873)
Q Consensus       236 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~~~~L~~  312 (873)
                      +++|+.|+++++... ..|..+..+++|++|++++|.+...  ...+..+++|++|+++ +.+++. ....+..+++|++
T Consensus       269 ~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~  346 (592)
T 3ogk_B          269 PRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKR  346 (592)
T ss_dssp             CTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCE
T ss_pred             cccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCE
Confidence            566666666654322 3455555666666666666665431  1224556666666666 333322 2223345666777


Q ss_pred             EeccC-----------ccccccCCCC-CCCCCCCCeeeeccccCCccCCccccC-CCCCCEEecc----CCccCCC----
Q 039344          313 IDLSQ-----------NNFYGEISSD-WGRCPKLSTLDFSINNITGNVPPEIGH-SSQLGVLDLS----SNHIVGE----  371 (873)
Q Consensus       313 L~Ls~-----------N~l~~~~~~~-~~~l~~L~~L~l~~N~i~~~~~~~~~~-~~~L~~L~Ls----~N~i~~~----  371 (873)
                      |++++           |.+++..... ...+++|+.|+++.|++++..+..++. +++|+.|+++    .|.+++.    
T Consensus       347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~  426 (592)
T 3ogk_B          347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN  426 (592)
T ss_dssp             EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred             EEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence            77772           4444322111 234677777777777776655555554 6777777775    5666643    


Q ss_pred             -CCccccccccccEEEecCc--cccCCcccccc-cccccccccccccccccc-cCCCcCchhhhhhhcccccCCccCcc-
Q 039344          372 -IPIELGKLNFFIKLVLAHN--QLSGQLSPKLG-SLVQLEHLDLSSNRLSNS-IPKSLGNLELIHLSELDLSRNFLREA-  445 (873)
Q Consensus       372 -~~~~~~~l~~L~~L~L~~N--~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~~~L~~L~Ls~N~l~~~-  445 (873)
                       ++..+.++++|+.|++++|  .+++..+..+. .+++|+.|+|++|++++. ++..+..+.  +|++|+|++|.+++. 
T Consensus       427 ~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~--~L~~L~l~~n~l~~~~  504 (592)
T 3ogk_B          427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP--NLQKLEMRGCCFSERA  504 (592)
T ss_dssp             HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCT--TCCEEEEESCCCBHHH
T ss_pred             HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCc--ccCeeeccCCCCcHHH
Confidence             2223556777777777643  35544444443 367788888888877642 233334433  777888888887654 


Q ss_pred             cchhhhhhcccceecccCccccCCCchhh-hccCCCcEEecCCC
Q 039344          446 IPSQICIMQSLEKLNLSHNSLSGLIPSCF-EKMNGLLHIDISYN  488 (873)
Q Consensus       446 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~~L~~l~ls~N  488 (873)
                      ++..+..+++|++|+|++|+++..-...+ ..++.+....+..+
T Consensus       505 ~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          505 IAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             HHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             HHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            33444567888888888888876544333 34566665555443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.5e-30  Score=282.74  Aligned_cols=283  Identities=19%  Similarity=0.181  Sum_probs=167.0

Q ss_pred             CCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEE
Q 039344          187 NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTIL  266 (873)
Q Consensus       187 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  266 (873)
                      .++.....++++|.++ .+|..+.  ++|++|++++|++++..+..+.++++|++|++++|++++..+..|.++++|++|
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            3445556777777777 4554443  467777777777775555566777777777777777766666666666666666


Q ss_pred             EccCCcCcCcCCc-CCCCCCCCeEEccCcccccccc-cccccCCCccEEeccCc-cccccCCCCCCCCCCCCeeeecccc
Q 039344          267 LLGHNQFRGPIPI-LRNLTSLERVRLDRNYLTGNIS-ESFYIYPNLTYIDLSQN-NFYGEISSDWGRCPKLSTLDFSINN  343 (873)
Q Consensus       267 ~L~~N~l~~~~~~-l~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~  343 (873)
                      ++++|++++.++. +..+++|++|++++|.+++++. ..|..+++|++|++++| .+.+..+..|..+++|+.|++++|+
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~  185 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD  185 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence            6666666653332 4555555555555555554444 34445555555555555 2443344444445555555555555


Q ss_pred             CCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCCC
Q 039344          344 ITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKS  423 (873)
Q Consensus       344 i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  423 (873)
                      +++..|..+                        ..+++|++|++++|+++......+..+++|+.|+|++|++++..+..
T Consensus       186 l~~~~~~~l------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~  241 (353)
T 2z80_A          186 LQSYEPKSL------------------------KSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE  241 (353)
T ss_dssp             CCEECTTTT------------------------TTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-
T ss_pred             cCccCHHHH------------------------hccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccc
Confidence            544444444                        44444555555555444322222333455555555555555433332


Q ss_pred             cCchh-hhhhhcccccCCccCc----ccchhhhhhcccceecccCccccCCCchhhhccCCCcEEecCCCcccccCCC
Q 039344          424 LGNLE-LIHLSELDLSRNFLRE----AIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN  496 (873)
Q Consensus       424 ~~~l~-~~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~~~~p~  496 (873)
                      +.... ...++.++|++|.+++    .+|..+..+++|+.|+|++|+++.+++..|..+++|++|+|++|++.+..|.
T Consensus       242 l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          242 LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             -----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             cccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            22111 1134445555555544    4677888999999999999999976666679999999999999999987764

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=5.2e-33  Score=326.98  Aligned_cols=402  Identities=17%  Similarity=0.114  Sum_probs=176.8

Q ss_pred             CCccccCCCCCCEEECCCCccc---ccCCcccc------------CCCCCceEEccCCcccccCCCCccCC--CCCCEEE
Q 039344           13 IPSELRNLKSLSDLELGNNKLS---GSIPHSLG------------NLTNLATLYIHTNSLSGSIPGEIGNF--RFFSDLE   75 (873)
Q Consensus        13 ~p~~~~~l~~l~~L~L~~n~l~---~~~p~~~~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~   75 (873)
                      ++..+..+++|++|+|+++.-.   +.+|..+.            .+++|++|+|++|.+++..+..+...  .+|++|+
T Consensus        65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~  144 (592)
T 3ogk_B           65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK  144 (592)
T ss_dssp             HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred             hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence            3344455666666666654321   22222222            45566666666665554444444332  2266666


Q ss_pred             cccCC-CCC-CCCcccccccccceeeccccccCCC----CCccccCCcccCccccccccccc----ccCccccCCCCCcE
Q 039344           76 LSNNK-LSG-SIPPSLGNLSNLATLYLDTNSLSNS----IPSELGNLRSLSNLQLNNNILSG----SIPHSLGNLTNLAT  145 (873)
Q Consensus        76 L~~n~-l~~-~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~  145 (873)
                      |++|. ++. .++.....+++|++|+|++|.+++.    ++..+..+++|++|++++|.+++    .++..+..+++|++
T Consensus       145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~  224 (592)
T 3ogk_B          145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS  224 (592)
T ss_dssp             EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred             CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence            65554 110 0111122455566666665555433    22233445555555555555541    22233344555555


Q ss_pred             EEccCCCCccccccccCCCCCCCEEEccCCcCc---cCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccC
Q 039344          146 LYIYSNSLSASILGKIGNLKSLSNLQLSENNFN---GSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGY  222 (873)
Q Consensus       146 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  222 (873)
                      |++++|.+.++ +..+..+++|++|+++.....   ...+..+..+++|+.|+++++... ..|..+..+++|++|+|++
T Consensus       225 L~L~~~~~~~l-~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~  302 (592)
T 3ogk_B          225 VKVGDFEILEL-VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLY  302 (592)
T ss_dssp             EECSSCBGGGG-HHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETT
T ss_pred             EeccCccHHHH-HHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCC
Confidence            55555555442 344555555555555532221   112233444555555555554332 3444445555555555555


Q ss_pred             cccCCCcc-cccCCCCCccEEecccccCC-CCCchhhcCCCCCcEEEccC-----------CcCcC--cCCcCCCCCCCC
Q 039344          223 NKLSGSIP-ISMGNLSNLTYLNLFENSLS-GAIPYEYRNLVKLTILLLGH-----------NQFRG--PIPILRNLTSLE  287 (873)
Q Consensus       223 N~l~~~~~-~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~-----------N~l~~--~~~~l~~l~~L~  287 (873)
                      |.+++... ..+..+++|++|+++ +.+. ...+..+..+++|++|++++           |.++.  .......+++|+
T Consensus       303 ~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  381 (592)
T 3ogk_B          303 ALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELE  381 (592)
T ss_dssp             CCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCS
T ss_pred             CcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCe
Confidence            55432211 123445555555555 2222 11222233445555555552           33332  111123345555


Q ss_pred             eEEccCccccccccccccc-CCCccEEecc----Ccccccc-----CCCCCCCCCCCCeeeecccc--CCccCCcccc-C
Q 039344          288 RVRLDRNYLTGNISESFYI-YPNLTYIDLS----QNNFYGE-----ISSDWGRCPKLSTLDFSINN--ITGNVPPEIG-H  354 (873)
Q Consensus       288 ~L~L~~n~l~~~~~~~~~~-~~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~l~~N~--i~~~~~~~~~-~  354 (873)
                      +|+++.|.+++.....+.. +++|+.|+++    .|.+++.     ++..+..+++|+.|++++|.  +++..+..++ .
T Consensus       382 ~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~  461 (592)
T 3ogk_B          382 YMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQY  461 (592)
T ss_dssp             EEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHS
T ss_pred             EEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHh
Confidence            5555555554433333332 4455555553    3334321     11113334455555554322  3333222222 2


Q ss_pred             CCCCCEEeccCCccCCC-CCccccccccccEEEecCccccCCc-ccccccccccccccccccccc
Q 039344          355 SSQLGVLDLSSNHIVGE-IPIELGKLNFFIKLVLAHNQLSGQL-SPKLGSLVQLEHLDLSSNRLS  417 (873)
Q Consensus       355 ~~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  417 (873)
                      +++|++|+|++|.+++. ++..+..+++|++|++++|.+++.. +.....+++|+.|+|++|+++
T Consensus       462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it  526 (592)
T 3ogk_B          462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS  526 (592)
T ss_dssp             CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred             CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence            44455555555554431 1222334445555555555544321 122233444555555555544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=9.9e-30  Score=272.28  Aligned_cols=280  Identities=22%  Similarity=0.244  Sum_probs=134.7

Q ss_pred             CEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCc--ccccCCCCCccEEecc
Q 039344          168 SNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSI--PISMGNLSNLTYLNLF  245 (873)
Q Consensus       168 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~  245 (873)
                      +.++.+++.++ .+|..+.  ++|++|++++|.++...+..|.++++|++|+|++|+++...  +..+..+++|++|+++
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            34555555555 2333222  35555555555555333334555555555555555554221  2333344555555555


Q ss_pred             cccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccc-cccccCCCccEEeccCccccccC
Q 039344          246 ENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNIS-ESFYIYPNLTYIDLSQNNFYGEI  324 (873)
Q Consensus       246 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~~  324 (873)
                      +|.++. .+..+..+++|++|++++|++.+                       +.. ..+..+++|++|++++|.+.+..
T Consensus        87 ~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~-----------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~  142 (306)
T 2z66_A           87 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ-----------------------MSEFSVFLSLRNLIYLDISHTHTRVAF  142 (306)
T ss_dssp             SCSEEE-EEEEEETCTTCCEEECTTSEEES-----------------------STTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred             CCcccc-ChhhcCCCCCCCEEECCCCcccc-----------------------cccchhhhhccCCCEEECCCCcCCccc
Confidence            555542 33334444555555555554444                       332 33444444444444444444444


Q ss_pred             CCCCCCCCCCCeeeeccccCCc-cCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccc
Q 039344          325 SSDWGRCPKLSTLDFSINNITG-NVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSL  403 (873)
Q Consensus       325 ~~~~~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  403 (873)
                      +..+..+++|+.|++++|.+++ ..|..++.+++|++|+|++|.+++..|..+..+++|++|++++|++++..+..+..+
T Consensus       143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  222 (306)
T 2z66_A          143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL  222 (306)
T ss_dssp             TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred             hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence            4444444555555555554443 344444445555555555555544444444455555555555555544444445555


Q ss_pred             cccccccccccccccccCCCcCchhhhhhhcccccCCccCccc--chhhhhhcccceecccCccccCCCchhhh
Q 039344          404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAI--PSQICIMQSLEKLNLSHNSLSGLIPSCFE  475 (873)
Q Consensus       404 ~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  475 (873)
                      ++|+.|||++|++.+..|..+..+. .+|++|+|++|++++..  ......+...+.+....+.+....|..+.
T Consensus       223 ~~L~~L~L~~N~l~~~~~~~~~~~~-~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~  295 (306)
T 2z66_A          223 NSLQVLDYSLNHIMTSKKQELQHFP-SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ  295 (306)
T ss_dssp             TTCCEEECTTSCCCBCSSSSCCCCC-TTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred             ccCCEeECCCCCCcccCHHHHHhhh-ccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence            5555555555555555555444431 14555555555554321  11123344455555555555555555544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=6.7e-30  Score=273.62  Aligned_cols=247  Identities=23%  Similarity=0.284  Sum_probs=137.8

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCC--CCcccccccccceeecc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGS--IPPSLGNLSNLATLYLD  101 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~  101 (873)
                      +.++.++++++ .+|..+.  ++|++|+|++|+++...++.|.++++|++|+|++|.++..  .+..+..+++|++|+|+
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            45666666665 4454333  4666666666666644444456666666666666666522  14445556666666666


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccC-ccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc-
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP-HSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG-  179 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-  179 (873)
                      +|.++ .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+....+..|..+++|++|++++|.+++ 
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            66665 345555566666666666666654332 345555666666666666555555555555566666666665554 


Q ss_pred             CCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcC
Q 039344          180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRN  259 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  259 (873)
                      ..|..+..+++|++|++++|.+++..|..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  245 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH  245 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred             cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence            34555555555555555555555544555555555555555555555444444555555555555555555555544444


Q ss_pred             CC-CCcEEEccCCcCc
Q 039344          260 LV-KLTILLLGHNQFR  274 (873)
Q Consensus       260 l~-~L~~L~L~~N~l~  274 (873)
                      ++ +|++|++++|++.
T Consensus       246 ~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          246 FPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             CCTTCCEEECTTCCEE
T ss_pred             hhccCCEEEccCCCee
Confidence            42 4555555555444

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=2.2e-30  Score=283.18  Aligned_cols=279  Identities=20%  Similarity=0.208  Sum_probs=127.0

Q ss_pred             CCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccc
Q 039344           45 TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL  124 (873)
Q Consensus        45 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (873)
                      +.....++++|.++ .+|..+.  ++|++|++++|.+++..+..|.++++|++|++++|++++..|..|.++++|++|++
T Consensus        31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (353)
T 2z80_A           31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL  107 (353)
T ss_dssp             CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence            33333444444444 3333332  24444444444444333334444444444444444444433444444444444444


Q ss_pred             cccccccccCccccCCCCCcEEEccCCCCccccc-cccCCCCCCCEEEccCC-cCccCCCccccCCCCCcEEeccCCCCc
Q 039344          125 NNNILSGSIPHSLGNLTNLATLYIYSNSLSASIL-GKIGNLKSLSNLQLSEN-NFNGSIPPSLGNLSNLATLYLDTNSLS  202 (873)
Q Consensus       125 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~n~l~  202 (873)
                      ++|.+++..+..|..+++|++|++++|+++.+.. ..|..+++|++|++++| .++...+..|.++++|++|++++|.++
T Consensus       108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~  187 (353)
T 2z80_A          108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ  187 (353)
T ss_dssp             CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence            4444443222234444444444444444443333 33444444444444444 233333444444444444444444444


Q ss_pred             ccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCC
Q 039344          203 YSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRN  282 (873)
Q Consensus       203 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~  282 (873)
                      +..|..+..+++|++|++++|+++...+..+..+++|++|++++|.+++..+..+.                    ....
T Consensus       188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~--------------------~~~~  247 (353)
T 2z80_A          188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS--------------------TGET  247 (353)
T ss_dssp             EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--------------------------C
T ss_pred             ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc--------------------cccc
Confidence            44444444444444444444444422222222344444444444444433222111                    1112


Q ss_pred             CCCCCeEEccCcccccc----cccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCc
Q 039344          283 LTSLERVRLDRNYLTGN----ISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG  346 (873)
Q Consensus       283 l~~L~~L~L~~n~l~~~----~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~  346 (873)
                      .+.++.++++++.+++.    .+..+..+++|++|++++|+++...+..|..+++|+.|++++|.+.+
T Consensus       248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~  315 (353)
T 2z80_A          248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  315 (353)
T ss_dssp             CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence            23344444444444431    23445566677777777777764433445667777777777777664

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.3e-28  Score=278.67  Aligned_cols=247  Identities=23%  Similarity=0.258  Sum_probs=145.8

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      ...++.+++.++ .+|..+.  +++++|+|++|.+++..+..|.++++|++|+|++|+++++.+..|.++++|++|+|++
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            345555555555 4444443  4556666666666555555566666666666666666555555556666666666666


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccC-CcCccCCCccccCCCCCcEEeccCCCCcccC
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE-NNFNGSIPPSLGNLSNLATLYLDTNSLSYSI  205 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~  205 (873)
                      |.++...+..|..+++|++|+|++|+++.+.+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|.+++ .
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~  211 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M  211 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence            666544444555566666666666666555555566666666666665 33443334455566666666666666653 2


Q ss_pred             CccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCC-cCCCCC
Q 039344          206 PSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLT  284 (873)
Q Consensus       206 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~  284 (873)
                      | .+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+++..++ .+..++
T Consensus       212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  290 (452)
T 3zyi_A          212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR  290 (452)
T ss_dssp             C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred             c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence            2 35556666666666666665556666666666666666666666666666666666666666666665333 455666


Q ss_pred             CCCeEEccCccccc
Q 039344          285 SLERVRLDRNYLTG  298 (873)
Q Consensus       285 ~L~~L~L~~n~l~~  298 (873)
                      +|+.|+|++|.+..
T Consensus       291 ~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          291 YLVELHLHHNPWNC  304 (452)
T ss_dssp             TCCEEECCSSCEEC
T ss_pred             CCCEEEccCCCcCC
Confidence            66667776666653

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=1.7e-28  Score=276.67  Aligned_cols=246  Identities=25%  Similarity=0.278  Sum_probs=145.0

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      ...++.+++.++ .+|..+.  ++++.|+|++|+++...+..|.++++|++|+|++|+++.+.+..|.++++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            445555555555 4454443  4555666666666555555566666666666666666555555556666666666666


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCC-cCccCCCccccCCCCCcEEeccCCCCcccC
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSEN-NFNGSIPPSLGNLSNLATLYLDTNSLSYSI  205 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~  205 (873)
                      |+++...+..|..+++|++|+|++|+++.+.+..|..+++|++|+|++| .+....+..|.++++|++|+|++|.++ .+
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~  200 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI  200 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence            6665444445566666666666666665555555666666666666653 333333445556666666666666665 23


Q ss_pred             CccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCC-cCCCCC
Q 039344          206 PSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLT  284 (873)
Q Consensus       206 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~  284 (873)
                      | .+..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+++..++ .+..++
T Consensus       201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  279 (440)
T 3zyj_A          201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH  279 (440)
T ss_dssp             C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred             c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence            3 35556666666666666665556666666666666666666666666666666666666666666665333 455666


Q ss_pred             CCCeEEccCcccc
Q 039344          285 SLERVRLDRNYLT  297 (873)
Q Consensus       285 ~L~~L~L~~n~l~  297 (873)
                      +|+.|+|++|.+.
T Consensus       280 ~L~~L~L~~Np~~  292 (440)
T 3zyj_A          280 HLERIHLHHNPWN  292 (440)
T ss_dssp             TCCEEECCSSCEE
T ss_pred             CCCEEEcCCCCcc
Confidence            6666666666665

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.9e-29  Score=265.63  Aligned_cols=224  Identities=25%  Similarity=0.291  Sum_probs=116.1

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      +.++.++++++ .+|..+  .++|++|+|++|.+++..++.|..+++|++|+|++|.+++..|.+|.++++|++|++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            45555555555 344333  245555666665555544455555555555555555555444555555555555555555


Q ss_pred             c-cCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCC
Q 039344          104 S-LSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP  182 (873)
Q Consensus       104 ~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~  182 (873)
                      + ++...|..|..+++|++|++++|.++                        .+.+..|..+++|++|++++|++++..+
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~  146 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ------------------------ELGPGLFRGLAALQYLYLQDNALQALPD  146 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCC------------------------EECHhHhhCCcCCCEEECCCCcccccCH
Confidence            4 44333444444444444444444444                        4444444444444444444444444334


Q ss_pred             ccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCC
Q 039344          183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVK  262 (873)
Q Consensus       183 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  262 (873)
                      ..|..+++|++|++++|.++...+..|..+++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++
T Consensus       147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  226 (285)
T 1ozn_A          147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (285)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence            44444555555555555554433444555555555555555555444555555555555555555555544455555555


Q ss_pred             CcEEEccCCcCc
Q 039344          263 LTILLLGHNQFR  274 (873)
Q Consensus       263 L~~L~L~~N~l~  274 (873)
                      |+.|++++|++.
T Consensus       227 L~~L~l~~N~~~  238 (285)
T 1ozn_A          227 LQYLRLNDNPWV  238 (285)
T ss_dssp             CCEEECCSSCEE
T ss_pred             cCEEeccCCCcc
Confidence            555555555554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.4e-28  Score=276.48  Aligned_cols=250  Identities=23%  Similarity=0.233  Sum_probs=223.9

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      ....++.++++++ .+|..+.  ++|++|+|++|+++++.|..|.++++|++|+|++|.++++.+.+|.++++|++|+|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            3568899999998 6776655  789999999999998889999999999999999999998888999999999999999


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccC-CCCccccccccCCCCCCCEEEccCCcCccC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYS-NSLSASILGKIGNLKSLSNLQLSENNFNGS  180 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  180 (873)
                      +|+++...+..|.++++|++|+|++|.++...+..|..+++|++|++++ |.+..+....|.++++|++|+|++|++++.
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            9999977777799999999999999999977777899999999999998 677777777899999999999999999854


Q ss_pred             CCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCC
Q 039344          181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL  260 (873)
Q Consensus       181 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  260 (873)
                       | .+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+
T Consensus       212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence             3 58889999999999999998889999999999999999999998888899999999999999999998888889999


Q ss_pred             CCCcEEEccCCcCcCc
Q 039344          261 VKLTILLLGHNQFRGP  276 (873)
Q Consensus       261 ~~L~~L~L~~N~l~~~  276 (873)
                      ++|+.|+|++|.+.-.
T Consensus       290 ~~L~~L~L~~Np~~Cd  305 (452)
T 3zyi_A          290 RYLVELHLHHNPWNCD  305 (452)
T ss_dssp             TTCCEEECCSSCEECS
T ss_pred             cCCCEEEccCCCcCCC
Confidence            9999999999988653

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.6e-28  Score=275.16  Aligned_cols=249  Identities=25%  Similarity=0.258  Sum_probs=223.1

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      ..+.++.++++++ .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|.++.+.+.+|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            4578899999998 6777665  789999999999998888999999999999999999998888899999999999999


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccC-CCCccccccccCCCCCCCEEEccCCcCccC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYS-NSLSASILGKIGNLKSLSNLQLSENNFNGS  180 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  180 (873)
                      +|+++...+..|.++++|++|+|++|.++...+..|..+++|++|+|++ |.+..+....|.++++|++|+|++|+++..
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  200 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI  200 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence            9999977777899999999999999999977777899999999999998 567777777899999999999999999844


Q ss_pred             CCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCC
Q 039344          181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL  260 (873)
Q Consensus       181 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  260 (873)
                       | .+..+++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++...+..|..+
T Consensus       201 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          201 -P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             -C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             -c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence             4 48889999999999999998889999999999999999999998888899999999999999999998888889999


Q ss_pred             CCCcEEEccCCcCcC
Q 039344          261 VKLTILLLGHNQFRG  275 (873)
Q Consensus       261 ~~L~~L~L~~N~l~~  275 (873)
                      ++|+.|+|++|.+.-
T Consensus       279 ~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          279 HHLERIHLHHNPWNC  293 (440)
T ss_dssp             TTCCEEECCSSCEEC
T ss_pred             cCCCEEEcCCCCccC
Confidence            999999999999864

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.8e-28  Score=258.01  Aligned_cols=268  Identities=22%  Similarity=0.215  Sum_probs=145.2

Q ss_pred             cEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCc
Q 039344          144 ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYN  223 (873)
Q Consensus       144 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  223 (873)
                      ++++++++.++.++..   ..++|++|+|++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|
T Consensus        14 ~~~~c~~~~l~~ip~~---~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPVG---IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCSSCCTT---CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcccCCcC---CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            5666777666654332   2356777777777776666666666777777777777776655666666667777777766


Q ss_pred             c-cCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCC-cCCCCCCCCeEEccCcccccccc
Q 039344          224 K-LSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNIS  301 (873)
Q Consensus       224 ~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~L~~n~l~~~~~  301 (873)
                      + ++...+..+..+++|++|++++|.+++..+..|..+++|++|++++|++....+ .+..+++|++|++++|.+++++.
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  170 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence            5 655555666666666666666666665555556666666666666665554332 24444444444444444444443


Q ss_pred             cccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCcccccccc
Q 039344          302 ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNF  381 (873)
Q Consensus       302 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~  381 (873)
                      ..                        |..+++|+.|++++|++++..|..++.+++|+.|+|++|.+++..+..+..+++
T Consensus       171 ~~------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  226 (285)
T 1ozn_A          171 RA------------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (285)
T ss_dssp             TT------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             HH------------------------hcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence            33                        444444444444444444444444444444444444444444333333444444


Q ss_pred             ccEEEecCccccCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccC
Q 039344          382 FIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSR  439 (873)
Q Consensus       382 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~  439 (873)
                      |+.|++++|.+....+. ......++.+..+.|.+....|..+.+..+..++..++++
T Consensus       227 L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~  283 (285)
T 1ozn_A          227 LQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG  283 (285)
T ss_dssp             CCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCC
T ss_pred             cCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhcc
Confidence            44444444444432111 0112334555566666666666665554433444444443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=2.5e-28  Score=263.10  Aligned_cols=235  Identities=21%  Similarity=0.298  Sum_probs=138.5

Q ss_pred             CCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           20 LKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        20 l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      .+.++.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..|.++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            356777777777776 56666777777777777777777 66777777777777777777777 5666777777777777


Q ss_pred             ccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc
Q 039344          100 LDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  179 (873)
                      |++|++.+.+|..+...               ..+..|.++++|++|+|++|+++. .+..+..+++|++|+|++|++++
T Consensus       157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~~-lp~~l~~l~~L~~L~L~~N~l~~  220 (328)
T 4fcg_A          157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA  220 (328)
T ss_dssp             EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCCC-CCGGGGGCTTCCEEEEESSCCCC
T ss_pred             CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcCc-chHhhcCCCCCCEEEccCCCCCc
Confidence            77766666666655430               001112334555555555555542 23334455555555555555552


Q ss_pred             CCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcC
Q 039344          180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRN  259 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  259 (873)
                       +|..+..+++|++|++++|.+.+..|..+..+++|++|+|++|.+.+..|..+..+++|++|+|++|.+.+.+|..+.+
T Consensus       221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~  299 (328)
T 4fcg_A          221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ  299 (328)
T ss_dssp             -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred             -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence             3334555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCCCcEEEccCCcCc
Q 039344          260 LVKLTILLLGHNQFR  274 (873)
Q Consensus       260 l~~L~~L~L~~N~l~  274 (873)
                      +++|+.+++..+.+.
T Consensus       300 L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          300 LPANCIILVPPHLQA  314 (328)
T ss_dssp             SCTTCEEECCGGGSC
T ss_pred             ccCceEEeCCHHHHH
Confidence            566666655555443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=9.9e-28  Score=258.45  Aligned_cols=237  Identities=20%  Similarity=0.265  Sum_probs=198.6

Q ss_pred             CCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccc
Q 039344           44 LTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ  123 (873)
Q Consensus        44 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (873)
                      .+++++|+|++|+++ .+|..+..+++|++|+|++|.++ .+|..|.++++|++|+|++|+++ .+|..+.++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            467788888888887 66777777888888888888887 67777788888888888888877 6677777788888888


Q ss_pred             ccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcc
Q 039344          124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY  203 (873)
Q Consensus       124 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~  203 (873)
                      |++|++.+.+|..+...               ...+.|.++++|++|+|++|+++ .+|..+..+++|++|+|++|.+++
T Consensus       157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~  220 (328)
T 4fcg_A          157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA  220 (328)
T ss_dssp             EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred             CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence            88777766677655431               11234677999999999999999 788889999999999999999994


Q ss_pred             cCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc-CCcCCC
Q 039344          204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP-IPILRN  282 (873)
Q Consensus       204 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~l~~  282 (873)
                       +|..+..+++|++|+|++|.+.+..|..+..+++|++|+|++|.+.+..|..+..+++|+.|++++|++.+. +..+..
T Consensus       221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~  299 (328)
T 4fcg_A          221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ  299 (328)
T ss_dssp             -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred             -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence             666799999999999999999999999999999999999999999999999999999999999999998884 457999


Q ss_pred             CCCCCeEEccCccccccc
Q 039344          283 LTSLERVRLDRNYLTGNI  300 (873)
Q Consensus       283 l~~L~~L~L~~n~l~~~~  300 (873)
                      +++|+.+++..+.+....
T Consensus       300 L~~L~~l~l~~~~~~~l~  317 (328)
T 4fcg_A          300 LPANCIILVPPHLQAQLD  317 (328)
T ss_dssp             SCTTCEEECCGGGSCC--
T ss_pred             ccCceEEeCCHHHHHHHh
Confidence            999999999988776543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=3.2e-29  Score=268.67  Aligned_cols=251  Identities=20%  Similarity=0.187  Sum_probs=125.0

Q ss_pred             cCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCccc-ccCCCCcc-------CCCCCCEEEcccCCCCCCCCccc
Q 039344           18 RNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLS-GSIPGEIG-------NFRFFSDLELSNNKLSGSIPPSL   89 (873)
Q Consensus        18 ~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~L~~L~L~~n~l~~~~~~~~   89 (873)
                      +..++|++|++++|.+  .+|..+...  |++|+|++|+++ ..+|..+.       ++++|++|+|++|++++..|..+
T Consensus        40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  115 (312)
T 1wwl_A           40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL  115 (312)
T ss_dssp             EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred             ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence            4445566666666666  455544433  666666666663 23444443       45666666666666665555554


Q ss_pred             --ccccccceeeccccccCCCCCccccCC-----cccCcccccccccccccCccccCCCCCcEEEccCCCCccc--cccc
Q 039344           90 --GNLSNLATLYLDTNSLSNSIPSELGNL-----RSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSAS--ILGK  160 (873)
Q Consensus        90 --~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~  160 (873)
                        ..+++|++|+|++|++++. |..+..+     ++|++|+|++|.+++..+..|+.+++|++|++++|++.+.  .+..
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA  194 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred             HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence              5566666666666666544 5555544     5555555555555544445555555555555555554332  1111


Q ss_pred             --cCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcc-cccCCCC
Q 039344          161 --IGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP-ISMGNLS  237 (873)
Q Consensus       161 --~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~  237 (873)
                        +..+++|++|+|++|++++..                     ......+..+++|++|++++|++++..| ..+..++
T Consensus       195 ~~~~~l~~L~~L~L~~N~l~~~~---------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~  253 (312)
T 1wwl_A          195 LCPLKFPTLQVLALRNAGMETPS---------------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS  253 (312)
T ss_dssp             SCTTSCTTCCEEECTTSCCCCHH---------------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred             HHhccCCCCCEEECCCCcCcchH---------------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence              244555555555555554210                     1111222344444444444444443332 2233344


Q ss_pred             CccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCccccc
Q 039344          238 NLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTG  298 (873)
Q Consensus       238 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~  298 (873)
                      +|++|+|++|+++ .+|..+.  ++|++|++++|++++.+ .+..+++|++|++++|.+++
T Consensus       254 ~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p-~~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          254 QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNP-SPDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCC-CTTTSCEEEEEECTTCTTTC
T ss_pred             CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCCh-hHhhCCCCCEEeccCCCCCC
Confidence            5555555555554 2333332  45555555555555442 25555555555555555543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=7.2e-27  Score=270.56  Aligned_cols=87  Identities=24%  Similarity=0.215  Sum_probs=44.3

Q ss_pred             CCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEe
Q 039344          308 PNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVL  387 (873)
Q Consensus       308 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L  387 (873)
                      ++|++|+|++|.+++ +|   ..+++|+.|++++|+|+. +|.   .+++|+.|+|++|.|+ .+|..+..+++|+.|+|
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            334444444444442 22   223455555555555552 333   3455666666666665 45555666666666666


Q ss_pred             cCccccCCcccccccc
Q 039344          388 AHNQLSGQLSPKLGSL  403 (873)
Q Consensus       388 ~~N~l~~~~~~~~~~l  403 (873)
                      ++|.+++..|..+..+
T Consensus       292 ~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          292 EGNPLSERTLQALREI  307 (622)
T ss_dssp             CSCCCCHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHhc
Confidence            6666665555444433

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=3e-29  Score=269.55  Aligned_cols=257  Identities=21%  Similarity=0.188  Sum_probs=141.3

Q ss_pred             cceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccC
Q 039344           95 LATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE  174 (873)
Q Consensus        95 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  174 (873)
                      ++.++++.+.+.......+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+  |..+++|++|+|++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            3344555555543333444555566666666666665555566666666666666666654433  66666666666666


Q ss_pred             CcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCc
Q 039344          175 NNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIP  254 (873)
Q Consensus       175 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  254 (873)
                      |++++..     ..++|++|++++|.+++..+.   .+++|++|++++|++++..+..+..+++|++|++++|.+++..+
T Consensus        90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  161 (317)
T 3o53_A           90 NYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF  161 (317)
T ss_dssp             SEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred             Ccccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence            6665322     225666666666666644332   24566777777777766556666667777777777777766555


Q ss_pred             hhhc-CCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCC
Q 039344          255 YEYR-NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPK  333 (873)
Q Consensus       255 ~~~~-~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~  333 (873)
                      ..+. .+++|++|++++|+++.... ...+++|++|++++|.++++++. +..+++|++|+|++|+++ .+|..+..+++
T Consensus       162 ~~~~~~l~~L~~L~L~~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~  238 (317)
T 3o53_A          162 AELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQN  238 (317)
T ss_dssp             GGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred             HHHhhccCcCCEEECCCCcCccccc-ccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcCCC
Confidence            5543 56666666666666655422 22355555555555555544333 444455555555555544 23333444444


Q ss_pred             CCeeeeccccCC-ccCCccccCCCCCCEEecc
Q 039344          334 LSTLDFSINNIT-GNVPPEIGHSSQLGVLDLS  364 (873)
Q Consensus       334 L~~L~l~~N~i~-~~~~~~~~~~~~L~~L~Ls  364 (873)
                      |+.|++++|.+. +..|..++.+++|+.|+++
T Consensus       239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             CCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            444444444444 3333333444444444443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.7e-29  Score=290.93  Aligned_cols=187  Identities=19%  Similarity=0.125  Sum_probs=133.1

Q ss_pred             eeecCCeEEEEEE-eCCCcEEEEEEccCCCCCc-------chhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeEEEE
Q 039344          610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGE-------MTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       610 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .+.|+.|.+..++ .-.|+.+|+|.+.......       ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666666553 3358999999997542211       12346799999999999 7999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||++|++|.+.+....   +++..   +|+.||+.||+|+|++   |||||||||+|||++.+|.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999996543   35543   5889999999999999   9999999999999999999999999999987766


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP  806 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P  806 (873)
                      .....+.+||+.|||||++.+. +..++|+||+|++.+++.++..|
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            6666778899999999998764 67789999999998887665544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=4.7e-29  Score=267.97  Aligned_cols=256  Identities=23%  Similarity=0.225  Sum_probs=156.4

Q ss_pred             EEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccccccc
Q 039344           50 LYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNIL  129 (873)
Q Consensus        50 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  129 (873)
                      ++++++.+....+..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+  +..+++|++|++++|.+
T Consensus        15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l   92 (317)
T 3o53_A           15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV   92 (317)
T ss_dssp             ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred             eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence            3444444443333333444455555555555554444455555555555555555543322  55555566666666555


Q ss_pred             ccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccc
Q 039344          130 SGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSEL  209 (873)
Q Consensus       130 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  209 (873)
                      ++. +    ..++|++|++++|+++++.+..   +++|++|++++|++++..+..+..+++|++|++++|.+++..+..+
T Consensus        93 ~~l-~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  164 (317)
T 3o53_A           93 QEL-L----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL  164 (317)
T ss_dssp             EEE-E----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGG
T ss_pred             ccc-c----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHH
Confidence            521 1    2256666666666666554433   4566777777777766656666667777777777777775555555


Q ss_pred             -cCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCe
Q 039344          210 -GNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLER  288 (873)
Q Consensus       210 -~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~  288 (873)
                       ..+++|++|+|++|+|++. + ....+++|++|+|++|++++..+ .+..+++|+.|++++|+++..+..+..+++|+.
T Consensus       165 ~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~  241 (317)
T 3o53_A          165 AASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEH  241 (317)
T ss_dssp             GGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCE
T ss_pred             hhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccchhhHhhcCCCCCE
Confidence             3567777777777777643 2 22346777777777777775433 477777777777777777766666777777777


Q ss_pred             EEccCcccc-cccccccccCCCccEEeccCc
Q 039344          289 VRLDRNYLT-GNISESFYIYPNLTYIDLSQN  318 (873)
Q Consensus       289 L~L~~n~l~-~~~~~~~~~~~~L~~L~Ls~N  318 (873)
                      |++++|.++ +..+..+..+++|+.|+++++
T Consensus       242 L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~  272 (317)
T 3o53_A          242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV  272 (317)
T ss_dssp             EECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             EEccCCCccCcCHHHHHhccccceEEECCCc
Confidence            777777777 455556666777777777733

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1e-26  Score=269.33  Aligned_cols=127  Identities=23%  Similarity=0.269  Sum_probs=86.2

Q ss_pred             CCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEec
Q 039344          284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL  363 (873)
Q Consensus       284 ~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~L  363 (873)
                      ++|+.|++++|.+++++.    .+++|+.|++++|.++. +|.   .+++|+.|++++|+|++ +|   ..+++|+.|+|
T Consensus       181 ~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~L  248 (622)
T 3g06_A          181 SGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMV  248 (622)
T ss_dssp             TTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEEC
T ss_pred             CCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEEC
Confidence            444444444444443322    12556666666666653 332   24678888888888875 44   45578888888


Q ss_pred             cCCccCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCCCcCch
Q 039344          364 SSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL  427 (873)
Q Consensus       364 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  427 (873)
                      ++|.|+ .+|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+++..|..+..+
T Consensus       249 s~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          249 SGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             CSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             CCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence            888887 4555   5677888888888888 567778888888888888888887766655543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.6e-28  Score=263.10  Aligned_cols=204  Identities=18%  Similarity=0.171  Sum_probs=103.7

Q ss_pred             cccccccceeeccccccCCCCCccccCCcccCcccccccccc-cccCcccc-------CCCCCcEEEccCCCCccccccc
Q 039344           89 LGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILS-GSIPHSLG-------NLTNLATLYIYSNSLSASILGK  160 (873)
Q Consensus        89 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~  160 (873)
                      ++..++|+.|++++|.+  .+|..+...  |+.|+|++|.++ ..+|..+.       .+++|++|+|++|++++..+..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            34455566666666665  345444432  566666666653 23333333       4555555555555555444443


Q ss_pred             c--CCCCCCCEEEccCCcCccCCCccccCC-----CCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCC--ccc
Q 039344          161 I--GNLKSLSNLQLSENNFNGSIPPSLGNL-----SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGS--IPI  231 (873)
Q Consensus       161 ~--~~l~~L~~L~L~~n~i~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~  231 (873)
                      +  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|.+++..+..|+.+++|++|++++|++.+.  .+.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            3  5555555555555555544 4444444     5555555555555554445555555555555555554432  111


Q ss_pred             c--cCCCCCccEEecccccCCCC---CchhhcCCCCCcEEEccCCcCcCcC--CcCCCCCCCCeEEccCcccc
Q 039344          232 S--MGNLSNLTYLNLFENSLSGA---IPYEYRNLVKLTILLLGHNQFRGPI--PILRNLTSLERVRLDRNYLT  297 (873)
Q Consensus       232 ~--~~~l~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~--~~l~~l~~L~~L~L~~n~l~  297 (873)
                      .  +..+++|++|++++|++++.   ....+..+++|++|++++|++.+..  +.+..+++|++|+|++|.|+
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK  266 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence            2  24555566666666655521   1122345555555555555555532  23333444444444444444

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.95  E-value=7.9e-31  Score=308.55  Aligned_cols=442  Identities=15%  Similarity=0.131  Sum_probs=193.7

Q ss_pred             EEECCCCcccccCCccccCCCCCceEEccCCcccc---cCCCC------------ccCCCCCCEEEcccCCCCCCCCccc
Q 039344           25 DLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSG---SIPGE------------IGNFRFFSDLELSNNKLSGSIPPSL   89 (873)
Q Consensus        25 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~---~~p~~------------~~~l~~L~~L~L~~n~l~~~~~~~~   89 (873)
                      .+++.++... ..+..+..+++|++|++++|....   ..|..            +..+++|++|+|++|.+++..+..+
T Consensus        47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l  125 (594)
T 2p1m_B           47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI  125 (594)
T ss_dssp             EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred             EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence            4455444332 222345556666677666654221   11111            1234556666666665554444444


Q ss_pred             c-cccccceeecccc-ccCCC-CCccccCCcccCcccccccccccccCcccc----CCCCCcEEEccCCC--Ccccc-cc
Q 039344           90 G-NLSNLATLYLDTN-SLSNS-IPSELGNLRSLSNLQLNNNILSGSIPHSLG----NLTNLATLYIYSNS--LSASI-LG  159 (873)
Q Consensus        90 ~-~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~n~--l~~~~-~~  159 (873)
                      . .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++|++++|.  +.... ..
T Consensus       126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~  205 (594)
T 2p1m_B          126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALER  205 (594)
T ss_dssp             HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHH
T ss_pred             HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHH
Confidence            3 4556666666555 33321 223333555666666666555443332222    34456666665554  21100 11


Q ss_pred             ccCCCCCCCEEEccCC-cCccCCCccccCCCCCcEEeccCCC-------CcccCCccccCCCCCCEE-EccCcccCCCcc
Q 039344          160 KIGNLKSLSNLQLSEN-NFNGSIPPSLGNLSNLATLYLDTNS-------LSYSIPSELGNLRSLSNL-SLGYNKLSGSIP  230 (873)
Q Consensus       160 ~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~  230 (873)
                      .+..+++|++|+|++| .+.+ ++..+..+++|++|+++.+.       +.+ .+..+.++++|+.| .+.+.... ..+
T Consensus       206 l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~  282 (594)
T 2p1m_B          206 LVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLP  282 (594)
T ss_dssp             HHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGG
T ss_pred             HHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHH
Confidence            1123455555555555 2222 34444455555555543332       221 22234455555555 22222111 122


Q ss_pred             cccCCCCCccEEecccccCCCCCc-hhhcCCCCCcEEEccCCcCcC-cCC-cCCCCCCCCeEEccCcccccccccccccC
Q 039344          231 ISMGNLSNLTYLNLFENSLSGAIP-YEYRNLVKLTILLLGHNQFRG-PIP-ILRNLTSLERVRLDRNYLTGNISESFYIY  307 (873)
Q Consensus       231 ~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~~  307 (873)
                      ..+..+++|++|++++|.+++... ..+..+++|+.|++++| +.. ... ....+++|++|+++++.-.+         
T Consensus       283 ~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g---------  352 (594)
T 2p1m_B          283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV---------  352 (594)
T ss_dssp             GGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC---------
T ss_pred             HHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc---------
Confidence            222234455555555554432111 11234444444444444 211 111 11123444444442210000         


Q ss_pred             CCccEEeccCccccccCCCCCC-CCCCCCeeeeccccCCccCCcccc-CCCCCCEEecc--C----CccCCCC-----Cc
Q 039344          308 PNLTYIDLSQNNFYGEISSDWG-RCPKLSTLDFSINNITGNVPPEIG-HSSQLGVLDLS--S----NHIVGEI-----PI  374 (873)
Q Consensus       308 ~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~N~i~~~~~~~~~-~~~~L~~L~Ls--~----N~i~~~~-----~~  374 (873)
                            ..+.+.+++.....+. .+++|+.|+++.|++++..+..+. .+++|+.|+|+  +    |.+++..     +.
T Consensus       353 ------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~  426 (594)
T 2p1m_B          353 ------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGA  426 (594)
T ss_dssp             ------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHH
T ss_pred             ------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHH
Confidence                  0011222221111111 244555555555555443333332 34555555555  2    3333111     11


Q ss_pred             cccccccccEEEecCccccCCccccccc-ccccccccccccccccccCCCc-CchhhhhhhcccccCCccCcccch-hhh
Q 039344          375 ELGKLNFFIKLVLAHNQLSGQLSPKLGS-LVQLEHLDLSSNRLSNSIPKSL-GNLELIHLSELDLSRNFLREAIPS-QIC  451 (873)
Q Consensus       375 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~~~L~~L~Ls~N~l~~~~~~-~~~  451 (873)
                      .+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..  .++|++|+|++|.+++.... .+.
T Consensus       427 l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~--~~~L~~L~L~~n~~~~~~~~~~~~  503 (594)
T 2p1m_B          427 IVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG--CDSLRKLEIRDCPFGDKALLANAS  503 (594)
T ss_dssp             HHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHH--CTTCCEEEEESCSCCHHHHHHTGG
T ss_pred             HHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhc--CCCcCEEECcCCCCcHHHHHHHHH
Confidence            133445566666654 444433333333 5566666666666654333322 22  23566666666666544333 233


Q ss_pred             hhcccceecccCccccCCCchhh-hccCCCcEEecCCCc
Q 039344          452 IMQSLEKLNLSHNSLSGLIPSCF-EKMNGLLHIDISYNE  489 (873)
Q Consensus       452 ~l~~L~~L~L~~N~l~~~~~~~~-~~~~~L~~l~ls~N~  489 (873)
                      .+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus       504 ~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          504 KLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             GGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred             hCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence            46777777777777754333334 456777666665553

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=4.9e-30  Score=301.77  Aligned_cols=372  Identities=13%  Similarity=0.113  Sum_probs=217.3

Q ss_pred             CCcccCcccccccccccccCcccc-CCCCCcEEEccCC-CCccc-cccccCCCCCCCEEEccCCcCccCCCcccc----C
Q 039344          115 NLRSLSNLQLNNNILSGSIPHSLG-NLTNLATLYIYSN-SLSAS-ILGKIGNLKSLSNLQLSENNFNGSIPPSLG----N  187 (873)
Q Consensus       115 ~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~----~  187 (873)
                      .+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. .+..+..+++|++|+|++|.+++..+..+.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            344555555555554443333333 3455555555555 33221 111222455555555555554433322222    3


Q ss_pred             CCCCcEEeccCCC--Ccc-cCCccccCCCCCCEEEccCc-ccCCCcccccCCCCCccEEecccc-------cCCCCCchh
Q 039344          188 LSNLATLYLDTNS--LSY-SIPSELGNLRSLSNLSLGYN-KLSGSIPISMGNLSNLTYLNLFEN-------SLSGAIPYE  256 (873)
Q Consensus       188 l~~L~~L~L~~n~--l~~-~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~n-------~l~~~~~~~  256 (873)
                      +++|++|++++|.  ++. ..+..+..+++|++|++++| .+.+ .+..+..+++|+.|+++.+       .+.+ .+..
T Consensus       183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~  260 (594)
T 2p1m_B          183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVA  260 (594)
T ss_dssp             CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHH
T ss_pred             CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHH
Confidence            4455555555554  110 01111233456666666655 3332 4444455556666654333       2222 2235


Q ss_pred             hcCCCCCcEE-EccCCcCcCcCCcCCCCCCCCeEEccCcccccccc-cccccCCCccEEeccCccccccC-CCCCCCCCC
Q 039344          257 YRNLVKLTIL-LLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNIS-ESFYIYPNLTYIDLSQNNFYGEI-SSDWGRCPK  333 (873)
Q Consensus       257 ~~~l~~L~~L-~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~~-~~~~~~l~~  333 (873)
                      +.++++|+.| .+.+.........+..+++|++|++++|.+++... ..+..+++|++|++++| +.+.. +.....+++
T Consensus       261 l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~  339 (594)
T 2p1m_B          261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD  339 (594)
T ss_dssp             HHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT
T ss_pred             HhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC
Confidence            5666666666 33333222222233356677777777777554322 22446677777777776 43222 112224677


Q ss_pred             CCeeeec---------cccCCccCCcccc-CCCCCCEEeccCCccCCCCCcccc-ccccccEEEec--C----ccccCCc
Q 039344          334 LSTLDFS---------INNITGNVPPEIG-HSSQLGVLDLSSNHIVGEIPIELG-KLNFFIKLVLA--H----NQLSGQL  396 (873)
Q Consensus       334 L~~L~l~---------~N~i~~~~~~~~~-~~~~L~~L~Ls~N~i~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~  396 (873)
                      |+.|+++         .+.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+++  +    |.+++..
T Consensus       340 L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~  419 (594)
T 2p1m_B          340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP  419 (594)
T ss_dssp             CCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCC
T ss_pred             CCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCc
Confidence            8888773         3456544333343 489999999999999876665555 58899999999  4    5666322


Q ss_pred             -----ccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhh-hhhcccceecccCccccCCC
Q 039344          397 -----SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQI-CIMQSLEKLNLSHNSLSGLI  470 (873)
Q Consensus       397 -----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~  470 (873)
                           +..+..+++|+.|+|++ .+++..+..+.. ...+|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..
T Consensus       420 ~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~-~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~  497 (594)
T 2p1m_B          420 LDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT-YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKA  497 (594)
T ss_dssp             THHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH-HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHH
T ss_pred             hhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHH-hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHH
Confidence                 22356788999999988 676554444443 13489999999999988766666 67899999999999997554


Q ss_pred             ch-hhhccCCCcEEecCCCccc
Q 039344          471 PS-CFEKMNGLLHIDISYNELR  491 (873)
Q Consensus       471 ~~-~~~~~~~L~~l~ls~N~l~  491 (873)
                      .. ....+++|++|++++|+++
T Consensus       498 ~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          498 LLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             HHHTGGGGGGSSEEEEESSCCB
T ss_pred             HHHHHHhCCCCCEEeeeCCCCC
Confidence            44 3456899999999999884

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=2e-27  Score=270.07  Aligned_cols=233  Identities=21%  Similarity=0.231  Sum_probs=135.6

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      +|+.|+|++|++++..|.+|..+++|++|+|++|.+++..|  |..+++|++|+|++|.+++..     ..++|++|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence            67777777777776666677777777777777777765444  666677777777777666322     22566666666


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccC-CCCCCCEEEccCCcCccC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIG-NLKSLSNLQLSENNFNGS  180 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~  180 (873)
                      +|.+++..+.   .+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..+..+. .+++|++|+|++|.+++.
T Consensus       108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            6666644332   245566666666666655566666666666666666666665555554 566666666666666544


Q ss_pred             CCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCC-CCCchhhcC
Q 039344          181 IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS-GAIPYEYRN  259 (873)
Q Consensus       181 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~  259 (873)
                      .  .+..+++|++|+|++|.+++.. ..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +..|..+..
T Consensus       185 ~--~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~  260 (487)
T 3oja_A          185 K--GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK  260 (487)
T ss_dssp             E--CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred             c--ccccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence            2  2234556666666666665432 235555556666666655552 3444555555555555555554 333333444


Q ss_pred             CCCCcEEEc
Q 039344          260 LVKLTILLL  268 (873)
Q Consensus       260 l~~L~~L~L  268 (873)
                      ++.|+.+++
T Consensus       261 l~~L~~l~~  269 (487)
T 3oja_A          261 NQRVQTVAK  269 (487)
T ss_dssp             CHHHHHHHH
T ss_pred             CCCCcEEec
Confidence            444443333

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=4.8e-27  Score=266.98  Aligned_cols=236  Identities=24%  Similarity=0.244  Sum_probs=150.1

Q ss_pred             CCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEE
Q 039344           68 FRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLY  147 (873)
Q Consensus        68 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  147 (873)
                      +++|++|+|++|.+++..|.+|..+++|++|+|++|.+++..|  |..+++|++|+|++|.+++..     ..++|++|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~  105 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLH  105 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEE
Confidence            3456666666666665555666666666666666666664333  666666666666666666322     226677777


Q ss_pred             ccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCcccc-CCCCCCEEEccCcccC
Q 039344          148 IYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELG-NLRSLSNLSLGYNKLS  226 (873)
Q Consensus       148 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~  226 (873)
                      +++|.++++.+.   .+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|.|+
T Consensus       106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            777777665543   345677777777777766666777777777777777777766666664 6777777777777776


Q ss_pred             CCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccc-cccccccc
Q 039344          227 GSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLT-GNISESFY  305 (873)
Q Consensus       227 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~  305 (873)
                      +..  ....+++|++|+|++|.+++..+ .+..+++|+.|++++|.+.+.++.+..+++|+.|++++|.+. +..+..+.
T Consensus       183 ~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~  259 (487)
T 3oja_A          183 DVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (487)
T ss_dssp             EEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred             ccc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence            442  23346777777777777775444 366777777777777777765555666666666666666665 23333344


Q ss_pred             cCCCccEEecc
Q 039344          306 IYPNLTYIDLS  316 (873)
Q Consensus       306 ~~~~L~~L~Ls  316 (873)
                      .++.|+.++++
T Consensus       260 ~l~~L~~l~~~  270 (487)
T 3oja_A          260 KNQRVQTVAKQ  270 (487)
T ss_dssp             TCHHHHHHHHH
T ss_pred             hCCCCcEEecc
Confidence            44444444443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.8e-25  Score=235.16  Aligned_cols=206  Identities=24%  Similarity=0.245  Sum_probs=113.7

Q ss_pred             CCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEcc
Q 039344           70 FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIY  149 (873)
Q Consensus        70 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  149 (873)
                      +|++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            34444444444443333344444444444444444443333444444555555555555544444455555555555555


Q ss_pred             CCCCccccccccCCCCCCCEEEccCCcCccC-CCccccCCCCCcEEeccCCCCcccCCccccCCCCCC----EEEccCcc
Q 039344          150 SNSLSASILGKIGNLKSLSNLQLSENNFNGS-IPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLS----NLSLGYNK  224 (873)
Q Consensus       150 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~N~  224 (873)
                      +|.+..+.+..+..+++|++|++++|.+++. +|..+..+++|++|++++|.+++..+..+..+++|+    +|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            5555554444555555666666666665543 355666666666666666666655555555444444    66777777


Q ss_pred             cCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc
Q 039344          225 LSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP  276 (873)
Q Consensus       225 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  276 (873)
                      +++..+..+. ..+|++|++++|++++..+..|..+++|+.|++++|++...
T Consensus       189 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          189 MNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             CCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred             ccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence            7644443333 33677777777777766555666677777777777766643

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.6e-25  Score=235.54  Aligned_cols=211  Identities=26%  Similarity=0.300  Sum_probs=132.6

Q ss_pred             CCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccc
Q 039344           13 IPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNL   92 (873)
Q Consensus        13 ~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   92 (873)
                      +|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++
T Consensus        22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   99 (276)
T 2z62_A           22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL   99 (276)
T ss_dssp             CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred             cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC
Confidence            444444  457777777777776666677777777777777777776666667777777777777777776666667777


Q ss_pred             cccceeeccccccCCCCCccccCCcccCcccccccccccc-cCccccCCCCCcEEEccCCCCccccccccCCCCCCC---
Q 039344           93 SNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGS-IPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLS---  168 (873)
Q Consensus        93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~---  168 (873)
                      ++|++|++++|++++..+..+..+++|++|++++|.+++. +|..|..+++|++|++++|+++++.+..|..+++|+   
T Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~  179 (276)
T 2z62_A          100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN  179 (276)
T ss_dssp             TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred             ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccc
Confidence            7777777777777655555666667777777777766642 466666666666666666666665555555554444   


Q ss_pred             -EEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccC
Q 039344          169 -NLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS  226 (873)
Q Consensus       169 -~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  226 (873)
                       +|++++|.+++..+..+.. .+|++|++++|.+++..+..|..+++|++|++++|++.
T Consensus       180 l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  237 (276)
T 2z62_A          180 LSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  237 (276)
T ss_dssp             EEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred             eeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence             5666666665444333332 25555555555555444444455555555555555554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=1.8e-24  Score=226.49  Aligned_cols=201  Identities=26%  Similarity=0.300  Sum_probs=107.0

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      .+.+++++++++ .+|..+.  ++|++|+|++|+++...+.+|.++++|++|+|++|+++...+..|.++++|++|+|++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            344444444444 3333332  3444444444444444444444455555555555554433333344455555555555


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCC
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIP  206 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  206 (873)
                      |.+++..+..|..+++|++|++++|+++.+.+..|..+++|++|+|++|.+++..+..|..+++|++|++++|.++...+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            55554444445555555555555555555555555555555555555555554444455556666666666666655545


Q ss_pred             ccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCC
Q 039344          207 SELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS  250 (873)
Q Consensus       207 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  250 (873)
                      ..|..+++|++|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            55666666666666666666555555666666666666666654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=2.3e-24  Score=225.77  Aligned_cols=201  Identities=28%  Similarity=0.349  Sum_probs=96.1

Q ss_pred             CCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccC
Q 039344           71 FSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYS  150 (873)
Q Consensus        71 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  150 (873)
                      .+.+++++++++ .+|..+.  ++|++|+|++|+++...+..|.++++|++|+|++|.++...+..|..+++|++|++++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            444555555544 2333332  3445555555555443334444555555555555555433333344455555555555


Q ss_pred             CCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcc
Q 039344          151 NSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP  230 (873)
Q Consensus       151 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  230 (873)
                      |+++.+.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.++...+..|..+++|++|+|++|+++...+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            55544444444445555555555555544444444445555555555555544333344445555555555555544444


Q ss_pred             cccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCc
Q 039344          231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFR  274 (873)
Q Consensus       231 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  274 (873)
                      ..|..+++|++|+|++|++++..+..|..+++|+.|++++|++.
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            44444455555555555554444444444455555555555443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=3.1e-24  Score=226.68  Aligned_cols=202  Identities=26%  Similarity=0.279  Sum_probs=112.1

Q ss_pred             ccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccc
Q 039344           17 LRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLA   96 (873)
Q Consensus        17 ~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~   96 (873)
                      ++++++++.+++++|+++ .+|..+.  +++++|+|++|++++..|..|..+++|++|+|++|.+++..+  ...+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence            556666777777777776 4454443  566777777777766666666666777777777766664322  24556666


Q ss_pred             eeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCc
Q 039344           97 TLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENN  176 (873)
Q Consensus        97 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  176 (873)
                      +|+|++|+++ .+|..+.++++|++|++++|++++..+..|..+++|++|+|++|+++.+.+..|..+++|++|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            6666666665 445555555555555555555554444455555555555555555555544445555555555555555


Q ss_pred             CccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCccc
Q 039344          177 FNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKL  225 (873)
Q Consensus       177 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  225 (873)
                      ++...+..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|.+
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence            55443344444445555555555444 3333333444444444444444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.3e-25  Score=257.28  Aligned_cols=187  Identities=15%  Similarity=0.172  Sum_probs=147.5

Q ss_pred             CCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcch-----hHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          605 DDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMT-----FQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       605 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ...+.||+|+||+||+|+.. ++.+++|+..........     ..+.+.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            34578999999999999554 788899886543222111     134589999999999999999777777777888999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++++|.+++..           +..++.|+++|++|||++   +|+||||||+||+++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999864           458999999999999999   9999999999999998  999999999998754


Q ss_pred             CCCC-------cccccccccccccccccc--CCCCCcchhHHHHHHHHHHHhCCCCCc
Q 039344          760 DSSN-------WTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRD  808 (873)
Q Consensus       760 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~sDv~s~G~il~el~tg~~P~~  808 (873)
                      ....       .....||+.|||||++..  ..|+..+|+||...-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            3221       135679999999999886  557888999999999988888877753

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.1e-24  Score=228.44  Aligned_cols=226  Identities=23%  Similarity=0.270  Sum_probs=141.3

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      .+..+++.++.+...  ..+..+++|++|++++|.++ .++ .+..+++|++|++++|.+++.  ..+..+++|++|+|+
T Consensus        20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~   93 (272)
T 3rfs_A           20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT   93 (272)
T ss_dssp             HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred             HHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence            344555666655533  23455666667777766666 332 356666666666666666642  356666666666666


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI  181 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  181 (873)
                      +|++++..+..|.++++|++|++++|.+++..+..|+.+++|++|++++|+++++.+..|..+++|++|++++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  173 (272)
T 3rfs_A           94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP  173 (272)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence            66666555555666666666666666666555555666666666666666666666666666666666666666666555


Q ss_pred             CccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCC
Q 039344          182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNL  260 (873)
Q Consensus       182 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  260 (873)
                      +..+..+++|++|++++|.+++..+..+..+++|++|++++|.+.+       .+++|++|++..|.+++.+|..++.+
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCccccc
Confidence            5556666666666666666666555556666666666666666552       24456666666666666666555444

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=4.1e-24  Score=225.72  Aligned_cols=204  Identities=26%  Similarity=0.288  Sum_probs=134.8

Q ss_pred             cccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCccc
Q 039344           40 SLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL  119 (873)
Q Consensus        40 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  119 (873)
                      .+.++++++++++++|.++ .+|..+.  +++++|+|++|.+++..+..|.++++|++|+|++|++++..+ . ..+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTC
T ss_pred             cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcC
Confidence            3667777888888888887 5565554  577788888888776667777777777777777777774322 2 566777


Q ss_pred             CcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCC
Q 039344          120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTN  199 (873)
Q Consensus       120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n  199 (873)
                      ++|+|++|.++ .+|..+..+++|++|++++|+++.+.+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus        80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            77777777776 55666666777777777777776666666666666666666666666555555666666666666666


Q ss_pred             CCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCC
Q 039344          200 SLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS  250 (873)
Q Consensus       200 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  250 (873)
                      +++...+..|..+++|++|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus       159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            666544445556666666666666665 34444444555555555555554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.4e-24  Score=227.59  Aligned_cols=221  Identities=24%  Similarity=0.301  Sum_probs=196.8

Q ss_pred             CCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCC
Q 039344            6 NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI   85 (873)
Q Consensus         6 ~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~   85 (873)
                      .+.+.+.  ..+..+++|++|++++|.++ .. ..+..+++|++|+|++|++++ + ..+..+++|++|+|++|.+++..
T Consensus        28 ~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~  101 (272)
T 3rfs_A           28 KKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLP  101 (272)
T ss_dssp             CSCTTSE--ECHHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCC
T ss_pred             Ccccccc--cccccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccC
Confidence            3444444  33567889999999999998 33 358999999999999999995 3 47899999999999999999888


Q ss_pred             CcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCC
Q 039344           86 PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLK  165 (873)
Q Consensus        86 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  165 (873)
                      +..|.++++|++|++++|++++..+..|.++++|++|++++|.+++..+..|..+++|++|++++|+++++.+..|..++
T Consensus       102 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  181 (272)
T 3rfs_A          102 NGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLT  181 (272)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             hhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCc
Confidence            88899999999999999999987788899999999999999999977777889999999999999999998888899999


Q ss_pred             CCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCc
Q 039344          166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL  239 (873)
Q Consensus       166 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  239 (873)
                      +|++|+|++|++++..+..+..+++|++|++++|.+.+       .+++|+.|++..|.+++.+|..++.+...
T Consensus       182 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~~~  248 (272)
T 3rfs_A          182 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAPD  248 (272)
T ss_dssp             TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred             cCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccCCC
Confidence            99999999999998888889999999999999998874       35689999999999999999888776543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=6.5e-24  Score=218.05  Aligned_cols=196  Identities=20%  Similarity=0.206  Sum_probs=122.9

Q ss_pred             CCceEEccCCcccccCCCCccCCCCCCEEEcccCC-CCCCCCcccccccccceeeccc-cccCCCCCccccCCcccCccc
Q 039344           46 NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNK-LSGSIPPSLGNLSNLATLYLDT-NSLSNSIPSELGNLRSLSNLQ  123 (873)
Q Consensus        46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~  123 (873)
                      +|++|++++|+++++.+.+|.++++|++|++++|+ ++.+.+.+|.++++|++|++++ |+++...+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            56666666666665555556666666666666664 5544555666666666666665 666654455566666666666


Q ss_pred             ccccccccccCccccCCCCCc---EEEccCC-CCccccccccCCCCCCC-EEEccCCcCccCCCccccCCCCCcEEeccC
Q 039344          124 LNNNILSGSIPHSLGNLTNLA---TLYIYSN-SLSASILGKIGNLKSLS-NLQLSENNFNGSIPPSLGNLSNLATLYLDT  198 (873)
Q Consensus       124 L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~  198 (873)
                      +++|.+++ +|. |..+++|+   +|++++| .++.+.+..|.++++|+ +|++++|+++...+..|.. ++|++|++++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            66666663 444 55666665   6777766 66666666666677777 7777777776444444444 6777777777


Q ss_pred             CC-CcccCCccccCC-CCCCEEEccCcccCCCcccccCCCCCccEEecccc
Q 039344          199 NS-LSYSIPSELGNL-RSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFEN  247 (873)
Q Consensus       199 n~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  247 (873)
                      |+ ++...+..|..+ ++|++|++++|+++...+.   .+++|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            74 765556667777 7777777777777643332   4567777777665

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=8.3e-24  Score=217.24  Aligned_cols=196  Identities=22%  Similarity=0.278  Sum_probs=96.6

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCc-ccccCCCCccCCCCCCEEEccc-CCCCCCCCcccccccccceee
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNS-LSGSIPGEIGNFRFFSDLELSN-NKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      +|++|+|++|+++++.+.+|.++++|++|++++|+ ++++.+.+|.++++|++|++++ |+++...+.+|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            45555555555554444455555555555555554 5444444555555555555554 555544444555555555555


Q ss_pred             ccccccCCCCCccccCCcccC---ccccccc-ccccccCccccCCCCCc-EEEccCCCCccccccccCCCCCCCEEEccC
Q 039344          100 LDTNSLSNSIPSELGNLRSLS---NLQLNNN-ILSGSIPHSLGNLTNLA-TLYIYSNSLSASILGKIGNLKSLSNLQLSE  174 (873)
Q Consensus       100 L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  174 (873)
                      +++|++++ +|. |..+++|+   +|++++| .+++..+..|..+++|+ +|++++|+++.+....|.. ++|++|+|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            55555553 333 44444444   5555555 55443344455555555 5555555555444444443 4555555555


Q ss_pred             Cc-CccCCCccccCC-CCCcEEeccCCCCcccCCccccCCCCCCEEEccCc
Q 039344          175 NN-FNGSIPPSLGNL-SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYN  223 (873)
Q Consensus       175 n~-i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  223 (873)
                      |+ ++...+..|..+ ++|+.|++++|.++.. |..  .+++|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence            52 544444445555 5555555555555422 221  3444555554443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=2.6e-25  Score=243.51  Aligned_cols=251  Identities=18%  Similarity=0.211  Sum_probs=119.4

Q ss_pred             cCCcccccCCccccCCCCCCEEECCCCcccccCC----ccccCCC-CCceEEccCCcccccCCCCccCC-----CCCCEE
Q 039344            5 YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIP----HSLGNLT-NLATLYIHTNSLSGSIPGEIGNF-----RFFSDL   74 (873)
Q Consensus         5 ~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L   74 (873)
                      ++|++++.+|..+...++|++|+|++|++++..+    +.|..++ +|++|+|++|++++..+..+..+     ++|++|
T Consensus         6 s~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L   85 (362)
T 3goz_A            6 TLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSL   85 (362)
T ss_dssp             CCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEE
T ss_pred             ccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEE
Confidence            4455555555555544455555555555554444    4555555 55555555555554444444433     555555


Q ss_pred             EcccCCCCCCCCcccccc-----cccceeeccccccCCCCCccccCCcccCcccccccccccccCccccC-CCCCcEEEc
Q 039344           75 ELSNNKLSGSIPPSLGNL-----SNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGN-LTNLATLYI  148 (873)
Q Consensus        75 ~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L  148 (873)
                      +|++|.+++..+..+...     ++|++|+|++|+++...+..+..                    .+.. .++|++|+|
T Consensus        86 ~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~--------------------~l~~~~~~L~~L~L  145 (362)
T 3goz_A           86 NLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ--------------------AFSNLPASITSLNL  145 (362)
T ss_dssp             ECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH--------------------HHTTSCTTCCEEEC
T ss_pred             ECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH--------------------HHHhCCCceeEEEc
Confidence            555555554443332222     45555555555554333322221                    1111 134555555


Q ss_pred             cCCCCccccccc----cCCCC-CCCEEEccCCcCccCCCccc----cCC-CCCcEEeccCCCCccc----CCccccC-CC
Q 039344          149 YSNSLSASILGK----IGNLK-SLSNLQLSENNFNGSIPPSL----GNL-SNLATLYLDTNSLSYS----IPSELGN-LR  213 (873)
Q Consensus       149 ~~n~l~~~~~~~----~~~l~-~L~~L~L~~n~i~~~~~~~~----~~l-~~L~~L~L~~n~l~~~----~~~~~~~-l~  213 (873)
                      ++|.++......    +..++ +|++|+|++|++++..+..+    ..+ ++|++|+|++|.++..    ++..+.. .+
T Consensus       146 s~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~  225 (362)
T 3goz_A          146 RGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN  225 (362)
T ss_dssp             TTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCT
T ss_pred             cCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCC
Confidence            555444322211    22232 45555555555544333222    222 3555555555555532    2223333 23


Q ss_pred             CCCEEEccCcccCCCcc----cccCCCCCccEEecccccCCCCCc-------hhhcCCCCCcEEEccCCcCcC
Q 039344          214 SLSNLSLGYNKLSGSIP----ISMGNLSNLTYLNLFENSLSGAIP-------YEYRNLVKLTILLLGHNQFRG  275 (873)
Q Consensus       214 ~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~-------~~~~~l~~L~~L~L~~N~l~~  275 (873)
                      +|++|+|++|+|++..+    ..+..+++|++|+|++|.+....+       ..+..+++|+.|++++|++..
T Consensus       226 ~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~  298 (362)
T 3goz_A          226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP  298 (362)
T ss_dssp             TCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred             CceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence            56666666666554332    223445566666666665433322       234455666666666666654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=5.7e-25  Score=240.84  Aligned_cols=249  Identities=21%  Similarity=0.221  Sum_probs=168.6

Q ss_pred             EccCCcccccCCCCccCCCCCCEEEcccCCCCCCCC----ccccccc-ccceeeccccccCCCCCccccCC-----cccC
Q 039344           51 YIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIP----PSLGNLS-NLATLYLDTNSLSNSIPSELGNL-----RSLS  120 (873)
Q Consensus        51 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L~  120 (873)
                      .|+.|.+++.+|..+...++|++|+|++|.+++..+    .+|..++ +|++|+|++|+++...+..+..+     ++|+
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            344444444444444444444444444444443333    4444454 55555555555554444444443     6666


Q ss_pred             cccccccccccccCcc----ccCC-CCCcEEEccCCCCcccccccc----CC-CCCCCEEEccCCcCccCCCc----ccc
Q 039344          121 NLQLNNNILSGSIPHS----LGNL-TNLATLYIYSNSLSASILGKI----GN-LKSLSNLQLSENNFNGSIPP----SLG  186 (873)
Q Consensus       121 ~L~L~~n~l~~~~~~~----~~~l-~~L~~L~L~~n~l~~~~~~~~----~~-l~~L~~L~L~~n~i~~~~~~----~~~  186 (873)
                      +|+|++|.+++..+..    +..+ ++|++|+|++|+++......+    .. .++|++|+|++|.+++....    .+.
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~  163 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA  163 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence            6666666666544443    3334 788888888888877665543    34 36999999999999864433    345


Q ss_pred             CCC-CCcEEeccCCCCcccCCccc----cCC-CCCCEEEccCcccCCC----cccccCC-CCCccEEecccccCCCCCc-
Q 039344          187 NLS-NLATLYLDTNSLSYSIPSEL----GNL-RSLSNLSLGYNKLSGS----IPISMGN-LSNLTYLNLFENSLSGAIP-  254 (873)
Q Consensus       187 ~l~-~L~~L~L~~n~l~~~~~~~~----~~l-~~L~~L~L~~N~l~~~----~~~~~~~-l~~L~~L~L~~n~l~~~~~-  254 (873)
                      .++ +|++|+|++|.+++..+..+    ..+ ++|++|+|++|+|++.    ++..+.. .++|++|+|++|.+++..+ 
T Consensus       164 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  243 (362)
T 3goz_A          164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE  243 (362)
T ss_dssp             TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred             cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence            555 99999999999997666544    455 6999999999999864    3334444 4699999999999997665 


Q ss_pred             ---hhhcCCCCCcEEEccCCcCcC--------cCCcCCCCCCCCeEEccCcccccc
Q 039344          255 ---YEYRNLVKLTILLLGHNQFRG--------PIPILRNLTSLERVRLDRNYLTGN  299 (873)
Q Consensus       255 ---~~~~~l~~L~~L~L~~N~l~~--------~~~~l~~l~~L~~L~L~~n~l~~~  299 (873)
                         ..+..+++|+.|++++|.+..        ....+..+++|+.|++++|.+...
T Consensus       244 ~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             HHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             HHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence               335678999999999999443        334677899999999999999865

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.3e-23  Score=224.77  Aligned_cols=225  Identities=19%  Similarity=0.214  Sum_probs=175.6

Q ss_pred             CCCceEEccCCcccccC-CC--CccCCCCCCEEEcccCCCCCCCCccc--ccccccceeeccccccCCCCC----ccccC
Q 039344           45 TNLATLYIHTNSLSGSI-PG--EIGNFRFFSDLELSNNKLSGSIPPSL--GNLSNLATLYLDTNSLSNSIP----SELGN  115 (873)
Q Consensus        45 ~~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~  115 (873)
                      ..++.|.+.++.++... ..  .+..+++|++|++++|.+++..|..+  ..+++|++|+|++|++++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            35788888887776211 10  11234669999999999988888888  889999999999999986544    34567


Q ss_pred             CcccCcccccccccccccCccccCCCCCcEEEccCCCCcc---cc-ccccCCCCCCCEEEccCCcCccCCCc----cccC
Q 039344          116 LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSA---SI-LGKIGNLKSLSNLQLSENNFNGSIPP----SLGN  187 (873)
Q Consensus       116 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~-~~~~~~l~~L~~L~L~~n~i~~~~~~----~~~~  187 (873)
                      +++|++|+|++|.+++..+..|+.+++|++|+|++|++.+   +. ...+..+++|++|+|++|+++.. +.    .+..
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhc
Confidence            8899999999999987777889999999999999998754   22 22346788999999999998732 22    3567


Q ss_pred             CCCCcEEeccCCCCcccCCccccCC---CCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCc
Q 039344          188 LSNLATLYLDTNSLSYSIPSELGNL---RSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLT  264 (873)
Q Consensus       188 l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  264 (873)
                      +++|++|+|++|.+++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|++|+|++|++++. |. +..+++|+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            8899999999999997777777766   69999999999998 5566554  7999999999999865 33 67889999


Q ss_pred             EEEccCCcCcC
Q 039344          265 ILLLGHNQFRG  275 (873)
Q Consensus       265 ~L~L~~N~l~~  275 (873)
                      .|++++|+++.
T Consensus       298 ~L~L~~N~l~~  308 (310)
T 4glp_A          298 NLTLDGNPFLV  308 (310)
T ss_dssp             CEECSSTTTSC
T ss_pred             EEECcCCCCCC
Confidence            99999998864

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=6.1e-25  Score=243.17  Aligned_cols=247  Identities=19%  Similarity=0.190  Sum_probs=132.4

Q ss_pred             CCCCcccccCCccccCCCCCceEEccCCcccccC----CCCccCCCCCCEEEcccCCCC---CCCCccc-------cccc
Q 039344           28 LGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSI----PGEIGNFRFFSDLELSNNKLS---GSIPPSL-------GNLS   93 (873)
Q Consensus        28 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~L~~n~l~---~~~~~~~-------~~l~   93 (873)
                      +....+. .++..+..+++|++|+|++|+++...    +..+..+++|++|+|++|.+.   +.+|..+       ..++
T Consensus        16 l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~   94 (386)
T 2ca6_A           16 ITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCP   94 (386)
T ss_dssp             CCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCT
T ss_pred             CCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCC
Confidence            3333443 45666677777777777777777543    334566777777777775433   3334333       4566


Q ss_pred             ccceeeccccccCC----CCCccccCCcccCcccccccccccccCcccc----CC---------CCCcEEEccCCCCccc
Q 039344           94 NLATLYLDTNSLSN----SIPSELGNLRSLSNLQLNNNILSGSIPHSLG----NL---------TNLATLYIYSNSLSAS  156 (873)
Q Consensus        94 ~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l---------~~L~~L~L~~n~l~~~  156 (873)
                      +|++|+|++|+++.    .+|..+..+++|++|+|++|.++...+..+.    .+         ++|++|+|++|+++..
T Consensus        95 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~  174 (386)
T 2ca6_A           95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG  174 (386)
T ss_dssp             TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred             cccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcH
Confidence            66666666666664    2455566666666666666666533332222    22         5666666666666521


Q ss_pred             c-c---cccCCCCCCCEEEccCCcCcc-----CCCccccCCCCCcEEeccCCCCc----ccCCccccCCCCCCEEEccCc
Q 039344          157 I-L---GKIGNLKSLSNLQLSENNFNG-----SIPPSLGNLSNLATLYLDTNSLS----YSIPSELGNLRSLSNLSLGYN  223 (873)
Q Consensus       157 ~-~---~~~~~l~~L~~L~L~~n~i~~-----~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~N  223 (873)
                      . +   ..+..+++|++|+|++|.++.     ..+..+..+++|++|+|++|.++    ..+|..+..+++|++|+|++|
T Consensus       175 ~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n  254 (386)
T 2ca6_A          175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC  254 (386)
T ss_dssp             GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTC
T ss_pred             HHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCC
Confidence            1 1   234455566666666666552     12224555556666666666653    234445555555666666655


Q ss_pred             ccCCC----ccccc--CCCCCccEEecccccCCC----CCchhh-cCCCCCcEEEccCCcCcC
Q 039344          224 KLSGS----IPISM--GNLSNLTYLNLFENSLSG----AIPYEY-RNLVKLTILLLGHNQFRG  275 (873)
Q Consensus       224 ~l~~~----~~~~~--~~l~~L~~L~L~~n~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~  275 (873)
                      +|++.    ++..+  ..+++|++|+|++|.++.    .+|..+ .++++|+.|++++|++++
T Consensus       255 ~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             CCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             CCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence            55533    22233  224555555555555554    233333 334555555555554443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=1.6e-24  Score=239.75  Aligned_cols=243  Identities=19%  Similarity=0.164  Sum_probs=110.7

Q ss_pred             CccccCCCCCcEEEccCCCCcccccc----ccCCCCCCCEEEccCCcC---ccCCCccc-------cCCCCCcEEeccCC
Q 039344          134 PHSLGNLTNLATLYIYSNSLSASILG----KIGNLKSLSNLQLSENNF---NGSIPPSL-------GNLSNLATLYLDTN  199 (873)
Q Consensus       134 ~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~L~~n~i---~~~~~~~~-------~~l~~L~~L~L~~n  199 (873)
                      +..+..+++|++|+|++|.++...+.    .+..+++|++|+|++|.+   ++.+|..+       ..+++|++|+|++|
T Consensus        25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n  104 (386)
T 2ca6_A           25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  104 (386)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCC
Confidence            33444444444444444444433221    233445555555555322   22223222       44555555555555


Q ss_pred             CCcc----cCCccccCCCCCCEEEccCcccCCCcccccCC----C---------CCccEEecccccCCC-CCc---hhhc
Q 039344          200 SLSY----SIPSELGNLRSLSNLSLGYNKLSGSIPISMGN----L---------SNLTYLNLFENSLSG-AIP---YEYR  258 (873)
Q Consensus       200 ~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~L~~n~l~~-~~~---~~~~  258 (873)
                      .++.    .++..+..+++|++|+|++|.++...+..+..    +         ++|++|+|++|+++. ..+   ..+.
T Consensus       105 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~  184 (386)
T 2ca6_A          105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ  184 (386)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH
Confidence            5553    23444555555555555555554322222221    2         555555555555541 222   2344


Q ss_pred             CCCCCcEEEccCCcCcC-----cCC-cCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCC
Q 039344          259 NLVKLTILLLGHNQFRG-----PIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCP  332 (873)
Q Consensus       259 ~l~~L~~L~L~~N~l~~-----~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~  332 (873)
                      .+++|++|++++|++..     ..+ .+..+++|+.|+|++|.++....                    ..++..+..++
T Consensus       185 ~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~--------------------~~l~~~l~~~~  244 (386)
T 2ca6_A          185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS--------------------SALAIALKSWP  244 (386)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH--------------------HHHHHHGGGCT
T ss_pred             hCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHH--------------------HHHHHHHccCC
Confidence            45555555555555541     111 34444444444444444431000                    22333444445


Q ss_pred             CCCeeeeccccCCcc----CCcccc--CCCCCCEEeccCCccCC----CCCccc-cccccccEEEecCccccCCc
Q 039344          333 KLSTLDFSINNITGN----VPPEIG--HSSQLGVLDLSSNHIVG----EIPIEL-GKLNFFIKLVLAHNQLSGQL  396 (873)
Q Consensus       333 ~L~~L~l~~N~i~~~----~~~~~~--~~~~L~~L~Ls~N~i~~----~~~~~~-~~l~~L~~L~L~~N~l~~~~  396 (873)
                      +|+.|+|++|.|++.    ++..+.  .+++|+.|+|++|.|++    .+|..+ .++++|+.|++++|.+++..
T Consensus       245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            555555555555433    233332  25555555555555554    244444 33555566666666555433

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.4e-22  Score=216.15  Aligned_cols=210  Identities=27%  Similarity=0.443  Sum_probs=141.6

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      ..+.+..+.++...+  +..+++|++|++++|.++ .+| .+..+++|++|+|++|.+++..+  +..+++|++|+|++|
T Consensus        22 ~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n   95 (308)
T 1h6u_A           22 IKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN   95 (308)
T ss_dssp             HHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred             HHHHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCC
Confidence            334455555553322  445667777777777776 344 46667777777777777764333  677777777777777


Q ss_pred             ccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCc
Q 039344          104 SLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP  183 (873)
Q Consensus       104 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~  183 (873)
                      ++++ + ..+..+++|++|++++|.+++ ++ .+..+++|++|++++|+++++.+  +..+++|++|+|++|++++..+ 
T Consensus        96 ~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-  168 (308)
T 1h6u_A           96 PLKN-V-SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-  168 (308)
T ss_dssp             CCSC-C-GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred             cCCC-c-hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-
Confidence            7764 2 356677777777777777764 33 27777777777777777766544  6777777777777777775432 


Q ss_pred             cccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCC
Q 039344          184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG  251 (873)
Q Consensus       184 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  251 (873)
                       +..+++|+.|++++|.+++..+  +..+++|++|++++|++++..  .+..+++|++|++++|++++
T Consensus       169 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             -GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             -hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence             7777777788887777774433  677778888888888877544  36777888888888888764

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=4.9e-22  Score=205.56  Aligned_cols=177  Identities=27%  Similarity=0.322  Sum_probs=84.1

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      .++++++++.++ .+|..+.  ++++.|+|++|.+++..+.+|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            444555555555 3443333  3455555555555544444455555555555555555544444444444444444444


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCC
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIP  206 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  206 (873)
                      |.+++..+..|..+++|++|+|++|+++.+.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+
T Consensus        93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A           93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            44443334444444555555555555544444444444445555555554444333344444444444444444443333


Q ss_pred             ccccCCCCCCEEEccCcccC
Q 039344          207 SELGNLRSLSNLSLGYNKLS  226 (873)
Q Consensus       207 ~~~~~l~~L~~L~L~~N~l~  226 (873)
                      ..|..+++|++|+|++|++.
T Consensus       173 ~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             TTTTTCTTCCEEECCSCCBC
T ss_pred             HHHhCCCCCCEEEeeCCcee
Confidence            34444444444444444443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=3.8e-22  Score=206.37  Aligned_cols=180  Identities=23%  Similarity=0.291  Sum_probs=163.6

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      ..+++++++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            4678999999998 6776665  689999999999998888899999999999999999998888889999999999999


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI  181 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  181 (873)
                      +|+++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|++++..
T Consensus        92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  171 (251)
T 3m19_A           92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP  171 (251)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence            99999877788999999999999999999777777899999999999999999988888999999999999999999888


Q ss_pred             CccccCCCCCcEEeccCCCCccc
Q 039344          182 PPSLGNLSNLATLYLDTNSLSYS  204 (873)
Q Consensus       182 ~~~~~~l~~L~~L~L~~n~l~~~  204 (873)
                      +..|..+++|+.|++++|.+...
T Consensus       172 ~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          172 HGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHHhCCCCCCEEEeeCCceeCC
Confidence            88899999999999999999854

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=3.4e-24  Score=232.60  Aligned_cols=250  Identities=17%  Similarity=0.205  Sum_probs=170.1

Q ss_pred             ccEEecccccCCCCCchhhcCC--CCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccc-cccccccCCCccEEec
Q 039344          239 LTYLNLFENSLSGAIPYEYRNL--VKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGN-ISESFYIYPNLTYIDL  315 (873)
Q Consensus       239 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~~~~L~~L~L  315 (873)
                      ++.+++++|.+.   +..+..+  ++++.|++++|.+.+..+.+..+++|++|++++|.+++. .+..+..+++|++|+|
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L  125 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL  125 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeC
Confidence            455566655544   3444444  566666666666666555555667777777777776654 4455667777777777


Q ss_pred             cCccccccCCCCCCCCCCCCeeeeccc-cCCcc-CCccccCCCCCCEEeccCC-ccCCC-CCccccccc-cccEEEecCc
Q 039344          316 SQNNFYGEISSDWGRCPKLSTLDFSIN-NITGN-VPPEIGHSSQLGVLDLSSN-HIVGE-IPIELGKLN-FFIKLVLAHN  390 (873)
Q Consensus       316 s~N~l~~~~~~~~~~l~~L~~L~l~~N-~i~~~-~~~~~~~~~~L~~L~Ls~N-~i~~~-~~~~~~~l~-~L~~L~L~~N  390 (873)
                      ++|.+++..+..+..+++|+.|++++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|++|++++|
T Consensus       126 ~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          126 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             cCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            777777666666777777777887777 56642 4555677778888888888 77643 455667777 7888888887


Q ss_pred             --ccc-CCcccccccccccccccccccc-cccccCCCcCchhhhhhhcccccCCc-cCcccchhhhhhcccceecccCcc
Q 039344          391 --QLS-GQLSPKLGSLVQLEHLDLSSNR-LSNSIPKSLGNLELIHLSELDLSRNF-LREAIPSQICIMQSLEKLNLSHNS  465 (873)
Q Consensus       391 --~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~  465 (873)
                        .++ +.++..+..+++|+.|+|++|. +++..+..+..+.  +|++|++++|. ++......+..+++|+.|++++| 
T Consensus       206 ~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~--~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-  282 (336)
T 2ast_B          206 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN--YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-  282 (336)
T ss_dssp             GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT--TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred             cccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC--CCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence              444 3455566777888888888888 6666666776654  88888888884 43333346778889999999988 


Q ss_pred             ccCCCchhhhcc-CCCcEEecCCCcccccCCCC
Q 039344          466 LSGLIPSCFEKM-NGLLHIDISYNELRGSIPNS  497 (873)
Q Consensus       466 l~~~~~~~~~~~-~~L~~l~ls~N~l~~~~p~~  497 (873)
                      ++.   ..+..+ ..+..|++++|.+++..|+.
T Consensus       283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          283 VPD---GTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence            432   334444 33677778999998877764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=1.2e-22  Score=217.36  Aligned_cols=226  Identities=18%  Similarity=0.198  Sum_probs=189.2

Q ss_pred             CCCCEEECCCCcccccC-C--ccccCCCCCceEEccCCcccccCCCCc--cCCCCCCEEEcccCCCCCCCC----ccccc
Q 039344           21 KSLSDLELGNNKLSGSI-P--HSLGNLTNLATLYIHTNSLSGSIPGEI--GNFRFFSDLELSNNKLSGSIP----PSLGN   91 (873)
Q Consensus        21 ~~l~~L~L~~n~l~~~~-p--~~~~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~   91 (873)
                      ..++.|.+.++.++... .  ..+..+++|++|++++|++++..|..+  ..+++|++|+|++|.+++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            35889999998876221 1  123345779999999999999999988  999999999999999997555    44567


Q ss_pred             ccccceeeccccccCCCCCccccCCcccCcccccccccccc--c--CccccCCCCCcEEEccCCCCcccccc---ccCCC
Q 039344           92 LSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGS--I--PHSLGNLTNLATLYIYSNSLSASILG---KIGNL  164 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~l  164 (873)
                      +++|++|+|++|++.+..+..|.++++|++|+|++|++.+.  .  +..+..+++|++|+|++|+++.+...   .+..+
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l  223 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG  223 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence            99999999999999988889999999999999999998642  2  23457899999999999999754332   35788


Q ss_pred             CCCCEEEccCCcCccCCCccccCC---CCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccE
Q 039344          165 KSLSNLQLSENNFNGSIPPSLGNL---SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY  241 (873)
Q Consensus       165 ~~L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  241 (873)
                      ++|++|+|++|++++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|++|+|++|+|++. |. +..+++|+.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~  298 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN  298 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence            999999999999998878777776   69999999999999 5676664  8999999999999964 43 688999999


Q ss_pred             EecccccCCC
Q 039344          242 LNLFENSLSG  251 (873)
Q Consensus       242 L~L~~n~l~~  251 (873)
                      |+|++|+++.
T Consensus       299 L~L~~N~l~~  308 (310)
T 4glp_A          299 LTLDGNPFLV  308 (310)
T ss_dssp             EECSSTTTSC
T ss_pred             EECcCCCCCC
Confidence            9999999974

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=3.7e-24  Score=232.32  Aligned_cols=221  Identities=20%  Similarity=0.247  Sum_probs=124.5

Q ss_pred             CCEEECCCCcccccCCccccCC--CCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCC-CCcccccccccceee
Q 039344           23 LSDLELGNNKLSGSIPHSLGNL--TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGS-IPPSLGNLSNLATLY   99 (873)
Q Consensus        23 l~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~   99 (873)
                      ++.|++++|++.   |..+..+  ++++.|++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            566777776665   3445555  6677777777766644443 44566666666666666543 455566666666666


Q ss_pred             ccccccCCCCCccccCCcccCccccccc-ccccc-cCccccCCCCCcEEEccCC-CCccc-cccccCCCC-CCCEEEccC
Q 039344          100 LDTNSLSNSIPSELGNLRSLSNLQLNNN-ILSGS-IPHSLGNLTNLATLYIYSN-SLSAS-ILGKIGNLK-SLSNLQLSE  174 (873)
Q Consensus       100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~L~~  174 (873)
                      |++|++++..+..+..+++|++|+|++| .+++. ++..+..+++|++|++++| .+++. .+..+..++ +|++|++++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            6666666555556666666666666666 45432 4444556666666666666 55532 233455555 666666666


Q ss_pred             C--cCc-cCCCccccCCCCCcEEeccCCC-CcccCCccccCCCCCCEEEccCcc-cCCCcccccCCCCCccEEecccc
Q 039344          175 N--NFN-GSIPPSLGNLSNLATLYLDTNS-LSYSIPSELGNLRSLSNLSLGYNK-LSGSIPISMGNLSNLTYLNLFEN  247 (873)
Q Consensus       175 n--~i~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~n  247 (873)
                      |  .++ ..++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+..+++|++|++++|
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence            6  333 2233444455566666666665 444444455555556666665553 22111123445555555555555

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=3.5e-22  Score=213.12  Aligned_cols=37  Identities=22%  Similarity=0.266  Sum_probs=15.4

Q ss_pred             CCCCCEEEcccCCCCCCCCcccccccccceeeccccccC
Q 039344           68 FRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLS  106 (873)
Q Consensus        68 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  106 (873)
                      +++|++|++++|.++. ++ .+..+++|++|+|++|+++
T Consensus        40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~   76 (308)
T 1h6u_A           40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT   76 (308)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC
T ss_pred             cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCC
Confidence            3444444444444442 22 3444444444444444443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=4.8e-22  Score=216.42  Aligned_cols=239  Identities=19%  Similarity=0.174  Sum_probs=107.2

Q ss_pred             eEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCC-ccccCCcccCc-ccccc
Q 039344           49 TLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIP-SELGNLRSLSN-LQLNN  126 (873)
Q Consensus        49 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~-L~L~~  126 (873)
                      +++.++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++|++ +.++.
T Consensus        13 ~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            3444444444 3443331  344455555555543333444555555555555554433222 23444444433 33334


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccC-CcCccCCCccccCCC-CCcEEeccCCCCccc
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE-NNFNGSIPPSLGNLS-NLATLYLDTNSLSYS  204 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~  204 (873)
                      |+++...|..|..+++|++|++++|++..+.+..+....++..|++.+ +++....+..|..+. .++.|+|++|+|+.+
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i  169 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  169 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence            444444444445555555555555555444444444444444444433 334433334444432 355555555555532


Q ss_pred             CCccccCCCCCCEEEcc-CcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCC
Q 039344          205 IPSELGNLRSLSNLSLG-YNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL  283 (873)
Q Consensus       205 ~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l  283 (873)
                      .+..| ...+|++|+++ +|.++.+.+..|.++++|++|+|++|+|+.+.+..|   .+|+.|.+.++.--...|.+..+
T Consensus       170 ~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP~l~~l  245 (350)
T 4ay9_X          170 HNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLPTLEKL  245 (350)
T ss_dssp             CTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCCCTTTC
T ss_pred             Chhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCCCchhC
Confidence            22222 33445555554 244443333445555555555555555554433332   23333333333222233345555


Q ss_pred             CCCCeEEccCc
Q 039344          284 TSLERVRLDRN  294 (873)
Q Consensus       284 ~~L~~L~L~~n  294 (873)
                      ++|+.+++.++
T Consensus       246 ~~L~~l~l~~~  256 (350)
T 4ay9_X          246 VALMEASLTYP  256 (350)
T ss_dssp             CSCCEEECSCH
T ss_pred             cChhhCcCCCC
Confidence            55555555443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=4.6e-22  Score=216.53  Aligned_cols=203  Identities=19%  Similarity=0.187  Sum_probs=123.5

Q ss_pred             CcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCC-CccccCCCCCcE-Eecc
Q 039344          120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI-PPSLGNLSNLAT-LYLD  197 (873)
Q Consensus       120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~-L~L~  197 (873)
                      ++++.++++++ .+|..+  .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+ +.+|.+++++++ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            34555666666 455544  256777777777777666667777777777777777764433 345666666554 4555


Q ss_pred             CCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEeccc-ccCCCCCchhhcCCC-CCcEEEccCCcCcC
Q 039344          198 TNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFE-NSLSGAIPYEYRNLV-KLTILLLGHNQFRG  275 (873)
Q Consensus       198 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~  275 (873)
                      +|+++.+.|..|..+++|++|++++|+|+...+..+....++..|++.+ |.+..+.+..|..+. .++.|++++|+++.
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~  168 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE  168 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence            6777766667777777777777777777765555566666667777654 456555555555553 46666666666665


Q ss_pred             cCCcCCCCCCCCeEEccC-cccccccccccccCCCccEEeccCccccccCC
Q 039344          276 PIPILRNLTSLERVRLDR-NYLTGNISESFYIYPNLTYIDLSQNNFYGEIS  325 (873)
Q Consensus       276 ~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~  325 (873)
                      ..+.....++|++|++.+ |.++.++...|..+++|++|||++|+|+...+
T Consensus       169 i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~  219 (350)
T 4ay9_X          169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS  219 (350)
T ss_dssp             ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred             CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence            444433445555665543 45555555555555555555555555554333

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.5e-22  Score=212.28  Aligned_cols=154  Identities=17%  Similarity=0.100  Sum_probs=122.1

Q ss_pred             HHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcc---------------hhHHHHHHHHHHHHhccC
Q 039344          596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEM---------------TFQQEFLNEVKALTEIWH  660 (873)
Q Consensus       596 e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h  660 (873)
                      .+......|.+.+.||+|+||.||+|+..+|+.||+|+++.......               .....+.+|+.++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34445566778899999999999999888899999999864322110               12466899999999998 


Q ss_pred             CceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeee
Q 039344          661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLL  740 (873)
Q Consensus       661 ~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill  740 (873)
                       | +++.+++. .+..++||||+++++|.+ +..         .....++.|++.|++|||+.   +|+||||||+||++
T Consensus       163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl  226 (282)
T 1zar_A          163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  226 (282)
T ss_dssp             -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence             4 66666554 356799999999999987 421         23457999999999999999   99999999999999


Q ss_pred             CCCCCeEEeccccccccCCCCCCccccccccccccccccc
Q 039344          741 DFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY  780 (873)
Q Consensus       741 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~  780 (873)
                      + ++.+||+|||+|+.             +..|+|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            9 99999999999963             33478899864

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=1e-20  Score=189.60  Aligned_cols=178  Identities=25%  Similarity=0.284  Sum_probs=93.4

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      +.++.++++++ .+|..+  .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            45566666665 344333  245666666666666544455556666666666666666444445555566666666666


Q ss_pred             ccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCc
Q 039344          104 SLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP  183 (873)
Q Consensus       104 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~  183 (873)
                      ++++..+..|.++++|++|++++|.+++..+..|..+++|++|++++|+++++.+..|..+++|++|++++|.+.+    
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----  162 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----  162 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence            5554444445555555555555555554444445555555555555555554444445555555555555554331    


Q ss_pred             cccCCCCCcEEeccCCCCcccCCccccC
Q 039344          184 SLGNLSNLATLYLDTNSLSYSIPSELGN  211 (873)
Q Consensus       184 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~  211 (873)
                         .+++|+.|+++.|.+++.+|..++.
T Consensus       163 ---~~~~l~~L~~~~n~~~g~ip~~~~~  187 (208)
T 2o6s_A          163 ---TCPGIRYLSEWINKHSGVVRNSAGS  187 (208)
T ss_dssp             ---CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred             ---CCCCHHHHHHHHHhCCceeeccCcc
Confidence               2234444444444444444444443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=2.1e-20  Score=187.34  Aligned_cols=177  Identities=26%  Similarity=0.303  Sum_probs=93.2

Q ss_pred             ceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccccc
Q 039344           48 ATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNN  127 (873)
Q Consensus        48 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  127 (873)
                      +.++++++.++ .+|..+  .++|++|++++|++++..+..|..+++|++|++++|+++...+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            45666666666 444433  245666666666666555555666666666666666666444444555555556655555


Q ss_pred             ccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCc
Q 039344          128 ILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPS  207 (873)
Q Consensus       128 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  207 (873)
                      .+++..+..|..+++|++|++++|+++.+.+..|..+++|++|+|++|++++..+..+..+++|++|++++|.+.+    
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----  162 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----  162 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence            5554444445555555555555555555444445555555555555555554444444444455555555443331    


Q ss_pred             cccCCCCCCEEEccCcccCCCcccccC
Q 039344          208 ELGNLRSLSNLSLGYNKLSGSIPISMG  234 (873)
Q Consensus       208 ~~~~l~~L~~L~L~~N~l~~~~~~~~~  234 (873)
                         .+++|++|+++.|++++.+|..++
T Consensus       163 ---~~~~l~~L~~~~n~~~g~ip~~~~  186 (208)
T 2o6s_A          163 ---TCPGIRYLSEWINKHSGVVRNSAG  186 (208)
T ss_dssp             ---CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred             ---CCCCHHHHHHHHHhCCceeeccCc
Confidence               223444444444444444444433

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=3.9e-21  Score=219.73  Aligned_cols=183  Identities=27%  Similarity=0.314  Sum_probs=91.1

Q ss_pred             CCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccc
Q 039344           46 NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN  125 (873)
Q Consensus        46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  125 (873)
                      +|++|+|++|++++ +|..+.  ++|++|+|++|.++ .+|   ..+++|++|+|++|++++ +|. +.+  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            66666666666663 444442  55666666666666 344   334566666666666664 444 433  56666666


Q ss_pred             ccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccC
Q 039344          126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSI  205 (873)
Q Consensus       126 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~  205 (873)
                      +|.+++ +|.   .+++|+.|+|++|++++++.    .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|.|+ .+
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            666553 333   34555555555555554322    34455555555555553 333 33  45555555555555 33


Q ss_pred             CccccCCCCC-------CEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchh
Q 039344          206 PSELGNLRSL-------SNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYE  256 (873)
Q Consensus       206 ~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  256 (873)
                      |. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..
T Consensus       196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~  249 (571)
T 3cvr_A          196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES  249 (571)
T ss_dssp             CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred             hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence            33 322  33       44444444444 23333333444444444444444433333

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=3.9e-20  Score=195.38  Aligned_cols=186  Identities=28%  Similarity=0.452  Sum_probs=85.4

Q ss_pred             EEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccc
Q 039344           25 DLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNS  104 (873)
Q Consensus        25 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  104 (873)
                      .+.+..+.++...+  +..+++|++|++++|.++ .++ .+..+++|++|+|++|++++..+  +..+++|++|++++|+
T Consensus        28 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~  101 (291)
T 1h6t_A           28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK  101 (291)
T ss_dssp             HHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence            33444444442222  334555555555555555 222 24555555555555555553322  5555555555555555


Q ss_pred             cCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCcc
Q 039344          105 LSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS  184 (873)
Q Consensus       105 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  184 (873)
                      +++ + ..+..+++|++|++++|.+++.  ..+..+++|+.|++++|+++++  ..+..+++|++|++++|++++..+  
T Consensus       102 l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--  173 (291)
T 1h6t_A          102 VKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--  173 (291)
T ss_dssp             CCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred             CCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--
Confidence            542 1 2244455555555555555421  2344445555555555544433  234444444444444444443222  


Q ss_pred             ccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccC
Q 039344          185 LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS  226 (873)
Q Consensus       185 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  226 (873)
                      +..+++|++|++++|.++. ++ .+..+++|+.|++++|++.
T Consensus       174 l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence            4444444444444444442 11 2444444444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.81  E-value=7.7e-20  Score=209.01  Aligned_cols=188  Identities=28%  Similarity=0.363  Sum_probs=161.0

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      +|+.|+|++|+|++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|++++ +|. |.+  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            89999999999996 776553  89999999999999 677   457999999999999996 666 765  99999999


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI  181 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  181 (873)
                      +|++++ +|.   .+++|++|+|++|.|++ +|.   .+++|++|+|++|++++++.  |.  ++|+.|+|++|+|+ .+
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCCCCC-ch
Confidence            999996 666   68999999999999995 665   57899999999999998554  65  89999999999999 55


Q ss_pred             CccccCCCCC-------cEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCC
Q 039344          182 PPSLGNLSNL-------ATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLS  237 (873)
Q Consensus       182 ~~~~~~l~~L-------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  237 (873)
                      |. +..  +|       +.|+|++|.|+ .+|..+..+++|+.|+|++|++++..|..+..++
T Consensus       196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            55 554  77       99999999999 5788788899999999999999988887776544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=5.6e-20  Score=194.15  Aligned_cols=171  Identities=27%  Similarity=0.367  Sum_probs=80.4

Q ss_pred             cCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCE
Q 039344          138 GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSN  217 (873)
Q Consensus       138 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  217 (873)
                      ..+++|+.|++++|.+..+  ..+..+++|++|+|++|++++..+  +..+++|++|++++|.+++ ++ .+..+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence            3444455555555554433  124444555555555555543322  4445555555555555542 11 2455555555


Q ss_pred             EEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccc
Q 039344          218 LSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLT  297 (873)
Q Consensus       218 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~  297 (873)
                      |++++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++.+..+ +..+++|+.|++++|.++
T Consensus       117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred             EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCC
Confidence            55555555432  2344455555555555555433  334445555555555555544332 444444555555444444


Q ss_pred             cccccccccCCCccEEeccCcccc
Q 039344          298 GNISESFYIYPNLTYIDLSQNNFY  321 (873)
Q Consensus       298 ~~~~~~~~~~~~L~~L~Ls~N~l~  321 (873)
                      ++.  .+..+++|+.|++++|++.
T Consensus       192 ~l~--~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          192 DLR--ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             BCG--GGTTCTTCSEEEEEEEEEE
T ss_pred             CCh--hhccCCCCCEEECcCCccc
Confidence            332  2344444444444444443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=1.1e-19  Score=210.20  Aligned_cols=192  Identities=27%  Similarity=0.377  Sum_probs=106.0

Q ss_pred             ccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEE
Q 039344           92 LSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQ  171 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  171 (873)
                      +.++..+.+..+.+....  .+..+++|+.|++++|.+.. ++ .|..+++|+.|+|++|++.++.+  +..+++|+.|+
T Consensus        20 l~~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             HHHHHHHhccCCCccccc--chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            344555555555555322  24456666666666666652 33 36666666666666666665444  56666666666


Q ss_pred             ccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCC
Q 039344          172 LSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG  251 (873)
Q Consensus       172 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  251 (873)
                      |++|.+++.  +.+..+++|+.|+|++|.++..  ..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+++
T Consensus        94 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~  167 (605)
T 1m9s_A           94 LDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  167 (605)
T ss_dssp             CCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred             CcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence            666666532  2455666666666666666532  2355566666666666666543  345555555555555555554


Q ss_pred             CCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCccccc
Q 039344          252 AIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTG  298 (873)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~  298 (873)
                      ..|  +..+++|+.|+|++|++.+. +.+..+++|+.|+|++|.+++
T Consensus       168 ~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          168 IVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred             chh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcC
Confidence            433  55555555555555555443 234444444444444444443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=1.7e-19  Score=208.58  Aligned_cols=199  Identities=24%  Similarity=0.323  Sum_probs=163.3

Q ss_pred             CcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEe
Q 039344          116 LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLY  195 (873)
Q Consensus       116 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  195 (873)
                      +.++..+.++.+.+....+  +..+++|+.|++++|.+..+.  .+..+++|+.|+|++|.+++..+  +..+++|+.|+
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            4567778888888875433  678899999999999998753  58889999999999999986544  88999999999


Q ss_pred             ccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcC
Q 039344          196 LDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG  275 (873)
Q Consensus       196 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (873)
                      |++|.+++ ++ .+..+++|++|+|++|+|.+.  ..+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|++.+
T Consensus        94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~  167 (605)
T 1m9s_A           94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  167 (605)
T ss_dssp             CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred             CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence            99999984 33 688999999999999999854  4588899999999999999865  578889999999999999887


Q ss_pred             cCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCC
Q 039344          276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWG  329 (873)
Q Consensus       276 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  329 (873)
                      ..+ +..+++|+.|+|++|.|+++  ..+..+++|+.|+|++|.+.+.....+.
T Consensus       168 ~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~  218 (605)
T 1m9s_A          168 IVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS  218 (605)
T ss_dssp             CGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred             chh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence            655 88888899999999988876  3577888888888888888754444333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=8.4e-20  Score=199.47  Aligned_cols=176  Identities=24%  Similarity=0.276  Sum_probs=100.7

Q ss_pred             ceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccc-cccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           48 ATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLG-NLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        48 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      +.+++++++++ .+|..+.  +.+++|+|++|+|++..+..|. ++++|++|+|++|+|+.+.+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            34555555555 3444332  2355555555555544444454 555555555555555544445555555555555555


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccc---cCCCCCcEEeccCCCCcc
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSL---GNLSNLATLYLDTNSLSY  203 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~---~~l~~L~~L~L~~n~l~~  203 (873)
                      |+|+...+..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+...+..|   ..+++|+.|+|++|.|+.
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            55554444555666666666666666665555666666666666666666664443444   446677777777777765


Q ss_pred             cCCccccCCCC--CCEEEccCcccC
Q 039344          204 SIPSELGNLRS--LSNLSLGYNKLS  226 (873)
Q Consensus       204 ~~~~~~~~l~~--L~~L~L~~N~l~  226 (873)
                      ..+..+..++.  ++.|+|++|.+.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             cCHHHhhhccHhhcceEEecCCCcc
Confidence            44455666665  367777777776

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=3e-19  Score=180.14  Aligned_cols=152  Identities=25%  Similarity=0.390  Sum_probs=87.2

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      +.+++++++++ .+|..+.  ++|++|+|++|+++++.+..|..+++|++|+|++|++++..|.+|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            45666666665 4454443  55666666666666555556666666666666666666555666666666666666666


Q ss_pred             ccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCc
Q 039344          104 SLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       104 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      +++.+.+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|+++.+.+..|..+++|++|+|++|.+.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            666444444555555555555555555544555555555555555555555554444555555555555555443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=4.4e-19  Score=178.93  Aligned_cols=152  Identities=26%  Similarity=0.357  Sum_probs=81.9

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCC-CCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP-GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  102 (873)
                      +.+++++|+++ .+|..+.  +.+++|+|++|++++..| +.|..+++|++|+|++|+++++.+.+|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            35666666665 3454443  344566666666664433 3455566666666666666555555555555555555555


Q ss_pred             cccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCc
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      |++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+++++.+..|..+++|++|+|++|.+.
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            5555444444555555555555555555444455555555555555555555444444444445555555444443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.79  E-value=1.7e-19  Score=197.12  Aligned_cols=177  Identities=27%  Similarity=0.228  Sum_probs=140.4

Q ss_pred             CEEEcccCCCCCCCCcccccccccceeeccccccCCCCCcccc-CCcccCcccccccccccccCccccCCCCCcEEEccC
Q 039344           72 SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELG-NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYS  150 (873)
Q Consensus        72 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  150 (873)
                      +.++++++.++ .+|..+.  ..++.|+|++|+|++..+..|. ++++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            57888888888 5666555  4578888888888876677776 888888888888888876677788888888888888


Q ss_pred             CCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccc---cCCCCCCEEEccCcccCC
Q 039344          151 NSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSEL---GNLRSLSNLSLGYNKLSG  227 (873)
Q Consensus       151 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~N~l~~  227 (873)
                      |+++.+.+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|.++...+..|   ..+++|+.|+|++|+|+.
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            88888877788888888888888888887778888888888888888888886555555   568888888888888886


Q ss_pred             CcccccCCCCC--ccEEecccccCCC
Q 039344          228 SIPISMGNLSN--LTYLNLFENSLSG  251 (873)
Q Consensus       228 ~~~~~~~~l~~--L~~L~L~~n~l~~  251 (873)
                      ..+..+..++.  ++.|+|++|.+..
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             cCHHHhhhccHhhcceEEecCCCccC
Confidence            66666777776  4788888888764

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=5.1e-19  Score=178.45  Aligned_cols=133  Identities=24%  Similarity=0.342  Sum_probs=74.1

Q ss_pred             ccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEcc
Q 039344           94 NLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLS  173 (873)
Q Consensus        94 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  173 (873)
                      +|+.|+|++|+|+.+.+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+|+.+.+..|.++++|++|+|+
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~  112 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN  112 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence            44444444444443333444444555555555555544445555555555555555555555555555555566666666


Q ss_pred             CCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccC
Q 039344          174 ENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS  226 (873)
Q Consensus       174 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  226 (873)
                      +|+|++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+.
T Consensus       113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            66665555555666666666666666666555555666666666666666654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=8.1e-19  Score=176.97  Aligned_cols=133  Identities=23%  Similarity=0.253  Sum_probs=74.5

Q ss_pred             cceeeccccccCCCCC-ccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEcc
Q 039344           95 LATLYLDTNSLSNSIP-SELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLS  173 (873)
Q Consensus        95 L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  173 (873)
                      +++|+|++|++++..+ ..|.++++|++|+|++|.+++..+..|..+++|++|+|++|+++.+.+..|..+++|++|+|+
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  113 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR  113 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence            3444444444443322 234445555555555555554444455555555555555555555555555556666666666


Q ss_pred             CCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCC
Q 039344          174 ENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG  227 (873)
Q Consensus       174 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  227 (873)
                      +|+|++..|..|..+++|++|+|++|.+++..|..|..+++|++|+|++|.+..
T Consensus       114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A          114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            666665555566666666666666666665556666666666666666666653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=1.9e-18  Score=175.52  Aligned_cols=152  Identities=26%  Similarity=0.364  Sum_probs=93.9

Q ss_pred             CCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc
Q 039344           23 LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        23 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  102 (873)
                      -+.++.++++++ .+|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|+++.+.+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            345666666665 4554433  6666666666666666666666666666666666666655555566666666666666


Q ss_pred             cccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCc
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      |++++..+..|..+++|++|+|++|.++ .+|..+..+++|+.|+|++|+++.+.+..|..+++|+.|+|++|.+.
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            6666555555566666666666666666 45555666666666666666666555555555555666666555554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=4.1e-20  Score=192.01  Aligned_cols=169  Identities=24%  Similarity=0.365  Sum_probs=83.7

Q ss_pred             CCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           20 LKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        20 l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      +.++..+++++|.+++..  .+..+++|++|++++|+++ .+| .+..+++|++|+|++|++++..+  +..+++|++|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            344555555555555322  3555555555555555555 333 45555555555555555553322  55555555555


Q ss_pred             ccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc
Q 039344          100 LDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  179 (873)
                      |++|++++ +|..                         .. ++|++|++++|+++++  ..+..+++|++|+|++|++++
T Consensus        92 L~~N~l~~-l~~~-------------------------~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A           92 VNRNRLKN-LNGI-------------------------PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             CCSSCCSC-CTTC-------------------------CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB
T ss_pred             CCCCccCC-cCcc-------------------------cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC
Confidence            55555553 2211                         11 4444444444444432  134445555555555555543


Q ss_pred             CCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCC
Q 039344          180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG  227 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  227 (873)
                      .  +.+..+++|++|++++|.+++.  ..+..+++|+.|++++|++..
T Consensus       143 ~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          143 I--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             C--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             C--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence            3  2344555555555555555533  345555555555555555553

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=1.2e-20  Score=217.23  Aligned_cols=108  Identities=25%  Similarity=0.287  Sum_probs=68.7

Q ss_pred             CCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecc
Q 039344          166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLF  245 (873)
Q Consensus       166 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  245 (873)
                      .|+.|+|++|.|++ +|. ++.+++|+.|+|++|.|+ .+|..|+.+++|++|+|++|+|++ +| .+..+++|++|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            36666666666664 343 666666666666666666 556666666666666666666664 34 56666666666666


Q ss_pred             cccCCCCC-chhhcCCCCCcEEEccCCcCcCcCC
Q 039344          246 ENSLSGAI-PYEYRNLVKLTILLLGHNQFRGPIP  278 (873)
Q Consensus       246 ~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~  278 (873)
                      +|+|++.. |..+..+++|+.|+|++|++++.++
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            66666554 6666666666666666666665443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=4.6e-19  Score=191.07  Aligned_cols=287  Identities=13%  Similarity=0.077  Sum_probs=127.0

Q ss_pred             ccccceeeccccccCCCCCccccC-CcccCcccccccccc--cccCccccCCCCCcEEEccCCCCccccccccCC-----
Q 039344           92 LSNLATLYLDTNSLSNSIPSELGN-LRSLSNLQLNNNILS--GSIPHSLGNLTNLATLYIYSNSLSASILGKIGN-----  163 (873)
Q Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-----  163 (873)
                      +.+++.|.++++ +....-..+.. +++|+.|||++|++.  .....   .++.+..+.+..|.   ++..+|.+     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~---I~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANF---VPAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccc---cCHHHhccccccc
Confidence            556667766653 22111122222 555666666666665  11111   12223444444442   33444555     


Q ss_pred             ---CCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcc----cCCCcccccCCC
Q 039344          164 ---LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNK----LSGSIPISMGNL  236 (873)
Q Consensus       164 ---l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l  236 (873)
                         +++|+.|+|.+ .++.+.+.+|.++++|+.+++++|.+..+.+.+|.++.++..+.+..+.    .......+|.++
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~  175 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG  175 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence               55555555555 5554445555555555555555555554555555555444444444321    111222333334


Q ss_pred             CCcc-EEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEec
Q 039344          237 SNLT-YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDL  315 (873)
Q Consensus       237 ~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~L  315 (873)
                      .+|+ .+++....-   .+..+.                   ..-....+++.+.+.++-...........+++|+.|+|
T Consensus       176 ~~L~~~i~~~~~~~---l~~~~~-------------------~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L  233 (329)
T 3sb4_A          176 EPLETTIQVGAMGK---LEDEIM-------------------KAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDI  233 (329)
T ss_dssp             CCCEEEEEECTTCC---HHHHHH-------------------HTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEEC
T ss_pred             cccceeEEecCCCc---HHHHHh-------------------hcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEEC
Confidence            4443 232222110   010000                   00011223333333332111111111112445555555


Q ss_pred             cCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCC-EEeccCCccCCCCCccccccccccEEEecCccccC
Q 039344          316 SQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLG-VLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG  394 (873)
Q Consensus       316 s~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~-~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  394 (873)
                      ++|+++.....+|..+++|+.|+|.+| ++.+.+.+|.++.+|+ .+++.+ .++...+.+|.++.+|+.+++++|+++.
T Consensus       234 ~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~  311 (329)
T 3sb4_A          234 SKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITT  311 (329)
T ss_dssp             TTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCE
T ss_pred             CCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCc
Confidence            555555555555555555555555554 4444445555555555 555555 4443344455555555555555555554


Q ss_pred             Cccccccccccccccc
Q 039344          395 QLSPKLGSLVQLEHLD  410 (873)
Q Consensus       395 ~~~~~~~~l~~L~~L~  410 (873)
                      ..+.+|.++++|+.++
T Consensus       312 I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          312 LGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECTTTTCTTCCCCEEE
T ss_pred             cchhhhcCCcchhhhc
Confidence            4445555555555543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=9e-21  Score=218.14  Aligned_cols=203  Identities=22%  Similarity=0.221  Sum_probs=147.5

Q ss_pred             CCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCC-------------CCCCCCcccccccccceee-ccccccCCC
Q 039344           43 NLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNK-------------LSGSIPPSLGNLSNLATLY-LDTNSLSNS  108 (873)
Q Consensus        43 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-------------l~~~~~~~~~~l~~L~~L~-L~~n~l~~~  108 (873)
                      .+++|+.|+|++|+++ .+|..++++++|+.|++++|.             ..+..|..++.+++|+.|+ ++.|.+   
T Consensus       347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~---  422 (567)
T 1dce_A          347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL---  422 (567)
T ss_dssp             TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH---
T ss_pred             cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc---
Confidence            3444555555555554 445455555555555544432             3334555556666666665 444433   


Q ss_pred             CCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCC
Q 039344          109 IPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNL  188 (873)
Q Consensus       109 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l  188 (873)
                              .+|+.+.+++|.++...+      ..|+.|+|++|.+++++ . |+.+++|+.|+|++|.|+ .+|..++.+
T Consensus       423 --------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp-~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l  485 (567)
T 1dce_A          423 --------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLC-H-LEQLLLVTHLDLSHNRLR-ALPPALAAL  485 (567)
T ss_dssp             --------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCC-C-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred             --------chhhhhhhhcccccccCc------cCceEEEecCCCCCCCc-C-ccccccCcEeecCccccc-ccchhhhcC
Confidence                    345555666666663222      25899999999998854 3 999999999999999999 778899999


Q ss_pred             CCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCc-ccccCCCCCccEEecccccCCCCCchh---hcCCCCCc
Q 039344          189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSI-PISMGNLSNLTYLNLFENSLSGAIPYE---YRNLVKLT  264 (873)
Q Consensus       189 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~l~~L~  264 (873)
                      ++|+.|+|++|.+++ +| .++.+++|++|+|++|+|++.. |..+..+++|+.|+|++|.+++..+..   +..+++|+
T Consensus       486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~  563 (567)
T 1dce_A          486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS  563 (567)
T ss_dssp             TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred             CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence            999999999999995 56 7999999999999999999776 899999999999999999998765532   44578888


Q ss_pred             EEEc
Q 039344          265 ILLL  268 (873)
Q Consensus       265 ~L~L  268 (873)
                      .|++
T Consensus       564 ~L~l  567 (567)
T 1dce_A          564 SILT  567 (567)
T ss_dssp             EEEC
T ss_pred             ccCC
Confidence            8764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=9.1e-19  Score=173.55  Aligned_cols=154  Identities=16%  Similarity=0.271  Sum_probs=104.6

Q ss_pred             ccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccC
Q 039344           41 LGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS  120 (873)
Q Consensus        41 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  120 (873)
                      ...+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..+..+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            355667777777777776 445 4666777777777777555  223666777777777777777765666777777777


Q ss_pred             cccccccccccccCccccCCCCCcEEEccCCC-CccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCC
Q 039344          121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNS-LSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTN  199 (873)
Q Consensus       121 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n  199 (873)
                      +|++++|.+++..+..|+.+++|++|++++|. ++.+.  .+..+++|++|++++|.+++. + .+..+++|++|++++|
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence            77777777776566677777777777777776 65542  567777777777777777753 2 5677777777777777


Q ss_pred             CCc
Q 039344          200 SLS  202 (873)
Q Consensus       200 ~l~  202 (873)
                      ++.
T Consensus       192 ~i~  194 (197)
T 4ezg_A          192 TIG  194 (197)
T ss_dssp             ---
T ss_pred             ccC
Confidence            765

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.76  E-value=2e-17  Score=181.85  Aligned_cols=266  Identities=12%  Similarity=0.088  Sum_probs=199.5

Q ss_pred             CCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           20 LKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        20 l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      ...++.+.+-+ +++.+.+.+|.++ +|+.+.+.++ ++.+...+|.+. +|+.+.+.+ .++.+.+.+|.++++|+.++
T Consensus       112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            35677777764 4666777788875 6888888776 666777777774 688888875 66667777888888888888


Q ss_pred             ccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCcc
Q 039344          100 LDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG  179 (873)
Q Consensus       100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  179 (873)
                      +..|+++.+...+|. ..+|+.+.|.++ ++.+...+|.++++|+.+++..| +..+...+|.+ .+|+.+.+ .+.++.
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~  261 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN  261 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence            888888865555666 578888888744 66566677888888888888764 66777777877 67888888 455665


Q ss_pred             CCCccccCCCCCcEEeccCCCCc-----ccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCc
Q 039344          180 SIPPSLGNLSNLATLYLDTNSLS-----YSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIP  254 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  254 (873)
                      +...+|.++++|+.+++.+|.+.     .+.+.+|.+|++|+.+.|.+ .++.+...+|.++++|+.++|..| ++.+..
T Consensus       262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~  339 (401)
T 4fdw_A          262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINF  339 (401)
T ss_dssp             ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred             EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence            66778888888888888877765     46677888888888888884 476677778888888888888655 776778


Q ss_pred             hhhcCCCCCcEEEccCCcCcCcC-CcCCCCC-CCCeEEccCccccc
Q 039344          255 YEYRNLVKLTILLLGHNQFRGPI-PILRNLT-SLERVRLDRNYLTG  298 (873)
Q Consensus       255 ~~~~~l~~L~~L~L~~N~l~~~~-~~l~~l~-~L~~L~L~~n~l~~  298 (873)
                      .+|.++ +|+.+++++|.+.... ..|.+++ +++.|++..+.+..
T Consensus       340 ~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~  384 (401)
T 4fdw_A          340 SAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK  384 (401)
T ss_dssp             TSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred             HhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence            888888 8888888888776633 3566664 78888888877653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.76  E-value=7.3e-18  Score=171.20  Aligned_cols=133  Identities=29%  Similarity=0.383  Sum_probs=60.6

Q ss_pred             cccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEec
Q 039344          117 RSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYL  196 (873)
Q Consensus       117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L  196 (873)
                      ++|++|+|++|.+++..|..|..+++|++|+|++|+++.+.+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            34444444444444433444444444444444444444444444444444444444444444433344444444444444


Q ss_pred             cCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCC
Q 039344          197 DTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS  250 (873)
Q Consensus       197 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  250 (873)
                      ++|.++ .+|..+..+++|++|+|++|+|+...+..+..+++|+.|+|++|.+.
T Consensus       120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            444444 33444444444444444444444333334444444444444444443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=1e-18  Score=181.42  Aligned_cols=169  Identities=22%  Similarity=0.267  Sum_probs=81.5

Q ss_pred             cccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEec
Q 039344          117 RSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYL  196 (873)
Q Consensus       117 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L  196 (873)
                      .++..+++++|.+++ ++ .+..+++|++|++++|.++.+.  .+..+++|++|+|++|++++..+  +..+++|++|++
T Consensus        19 ~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L   92 (263)
T 1xeu_A           19 ANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV   92 (263)
T ss_dssp             HHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred             HHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence            344444444444442 22 3444444445555444444322  34444445555555554443322  444445555555


Q ss_pred             cCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc
Q 039344          197 DTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP  276 (873)
Q Consensus       197 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  276 (873)
                      ++|++++ ++. +.. ++|++|++++|+|++.  ..+..+++|++|++++|++++. + .+..+++|+.|++++|++.+.
T Consensus        93 ~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A           93 NRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             CSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            5555442 221 111 4555555555555532  1345555555555555555543 1 455555555555555555544


Q ss_pred             CCcCCCCCCCCeEEccCcccccc
Q 039344          277 IPILRNLTSLERVRLDRNYLTGN  299 (873)
Q Consensus       277 ~~~l~~l~~L~~L~L~~n~l~~~  299 (873)
                       ..+..+++|+.|++++|.++..
T Consensus       166 -~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          166 -GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -HHhccCCCCCEEeCCCCcccCC
Confidence             4455555666666666655544

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.76  E-value=1.5e-18  Score=186.98  Aligned_cols=259  Identities=14%  Similarity=0.060  Sum_probs=140.7

Q ss_pred             CCCCCEEECCCCccc--ccCCccccCCCCCceEEccCCcccccCCCCccC--------CCCCCEEEcccCCCCCCCCccc
Q 039344           20 LKSLSDLELGNNKLS--GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGN--------FRFFSDLELSNNKLSGSIPPSL   89 (873)
Q Consensus        20 l~~l~~L~L~~n~l~--~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~--------l~~L~~L~L~~n~l~~~~~~~~   89 (873)
                      +++|+.|||++|+|.  ...+..+   +.++.+.+..|.   +.+.+|.+        +++|+.|+|.+ .++.+.+.+|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred             hccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence            778999999999998  3333332   335555555553   34566667        88888888888 7776777788


Q ss_pred             ccccccceeeccccccCCCCCccccCCcccCccccccccc----ccccCccccCCCCCc-EEEccCCCCcccccccc---
Q 039344           90 GNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNIL----SGSIPHSLGNLTNLA-TLYIYSNSLSASILGKI---  161 (873)
Q Consensus        90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l----~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~---  161 (873)
                      .++++|+.|++.+|.+..+.+.+|.++.++..+.+..+..    .......|..+..|+ .+.+....-  +....+   
T Consensus       121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~--l~~~~~~~~  198 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGK--LEDEIMKAG  198 (329)
T ss_dssp             TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCC--HHHHHHHTT
T ss_pred             hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCc--HHHHHhhcc
Confidence            8888888888888887767777787777777776655322    223344566666666 444432211  111111   


Q ss_pred             CCCCCCCEEEccCCcCccCCCccc-cCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCcc
Q 039344          162 GNLKSLSNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLT  240 (873)
Q Consensus       162 ~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  240 (873)
                      ....+++.+.+.++-.. .....+ ..+++|+.++|++|.++.+.+.+|.+|++|++|+|.+| ++.+.+.+|.++++|+
T Consensus       199 ~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~  276 (329)
T 3sb4_A          199 LQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA  276 (329)
T ss_dssp             CCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             cCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence            12233444444333111 000111 12445555555555555444444555555555555554 4434444555555555


Q ss_pred             -EEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc-CCcCCCCCCCCeEE
Q 039344          241 -YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP-IPILRNLTSLERVR  290 (873)
Q Consensus       241 -~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~l~~l~~L~~L~  290 (873)
                       .+++.+ .++.+.+.+|.++++|+.+++++|++... ..+|.++++|+.++
T Consensus       277 ~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          277 GTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence             555554 44444445555555555555555555442 22455555555544

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=3.2e-18  Score=177.14  Aligned_cols=142  Identities=16%  Similarity=0.156  Sum_probs=109.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcE--EEEEEccCCCCCc---------------------chhHHHHHHHHHHHH
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEI--IAVKKFHSPLPGE---------------------MTFQQEFLNEVKALT  656 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~e~~~l~  656 (873)
                      ..-|++.+.||+|+||.||+|.. .+|+.  ||||+++......                     ......+.+|+..++
T Consensus        46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            33467789999999999999987 67999  9999876432110                     011236889999999


Q ss_pred             hccCCce--eeEEeEEEecceeEEEEEeccC-C----ChhhHhcccccccCCChHHHHHHHHHHHHHHHHHH-hCCCCCe
Q 039344          657 EIWHRNI--VKVYGFCLHVRHLFIVYEYFKM-C----SLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH-NDCFPPI  728 (873)
Q Consensus       657 ~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i  728 (873)
                      .++|+++  +.++++    +..++||||+.+ |    ++.++...      .++..+..++.|++.|++||| +.   +|
T Consensus       126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---gi  192 (258)
T 1zth_A          126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---EL  192 (258)
T ss_dssp             HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CE
T ss_pred             HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CE
Confidence            9988864  444443    357899999953 3    56555321      235567889999999999999 88   99


Q ss_pred             eeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          729 VHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       729 ~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||||+|||++.  .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999999998  9999999999754

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.75  E-value=5.5e-17  Score=179.42  Aligned_cols=332  Identities=11%  Similarity=0.042  Sum_probs=162.3

Q ss_pred             cCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccC
Q 039344           60 SIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGN  139 (873)
Q Consensus        60 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  139 (873)
                      +...+|.++.+|+.+.+..+ ++.+...+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+ +......+|.+
T Consensus        62 Ig~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~  138 (394)
T 4fs7_A           62 IGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG  138 (394)
T ss_dssp             ECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred             hHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence            33334444444444444322 33333444444444444444322 33233334444444444444332 22133334444


Q ss_pred             CCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEE
Q 039344          140 LTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLS  219 (873)
Q Consensus       140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  219 (873)
                      +..++.....  .+..+...+|.++++|+.+.+..+.. ......|.++.+|+.+.+..+ ++.+...+|.++..|+.+.
T Consensus       139 ~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~  214 (394)
T 4fs7_A          139 CDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME  214 (394)
T ss_dssp             CCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred             ccccccccCc--cccccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence            3322222111  12223344455555555555543322 233444555555555555444 3334444555555555555


Q ss_pred             ccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccc
Q 039344          220 LGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGN  299 (873)
Q Consensus       220 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~  299 (873)
                      +..+... . ........+|+.+.+..+ ++.+....|..+..|+.+.+..+........+..+..++.+....+.   +
T Consensus       215 ~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~---i  288 (394)
T 4fs7_A          215 FPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVI---V  288 (394)
T ss_dssp             CCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSE---E
T ss_pred             cCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCcee---e
Confidence            5444322 1 122223345555555432 23244445555666666666555444444455556666665555443   2


Q ss_pred             cccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCcccccc
Q 039344          300 ISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKL  379 (873)
Q Consensus       300 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l  379 (873)
                      ....|....+|+.+.+.++ +..+...+|..+.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++.....+|.++
T Consensus       289 ~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C  365 (394)
T 4fs7_A          289 PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGC  365 (394)
T ss_dssp             CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTC
T ss_pred             ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCC
Confidence            3445666666666666544 44455666666667777766533 55555566666777777777655 544445566677


Q ss_pred             ccccEEEecCccccCCcccccccccccccc
Q 039344          380 NFFIKLVLAHNQLSGQLSPKLGSLVQLEHL  409 (873)
Q Consensus       380 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  409 (873)
                      .+|+.+++..+ ++ ....+|.++.+|+.+
T Consensus       366 ~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          366 INLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             CCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            77777777654 22 123456666666653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.75  E-value=2.6e-18  Score=170.29  Aligned_cols=155  Identities=19%  Similarity=0.272  Sum_probs=128.8

Q ss_pred             ccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCc
Q 039344           65 IGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLA  144 (873)
Q Consensus        65 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  144 (873)
                      ...+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|.+++..+..|+.+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            367788999999999998 455 6888999999999999776  345788899999999999999877788899999999


Q ss_pred             EEEccCCCCccccccccCCCCCCCEEEccCCc-CccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCc
Q 039344          145 TLYIYSNSLSASILGKIGNLKSLSNLQLSENN-FNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYN  223 (873)
Q Consensus       145 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  223 (873)
                      +|++++|++++..+..+..+++|++|++++|. ++. ++ .+..+++|++|++++|.+++ .+ .+..+++|++|++++|
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence            99999999988778888999999999999998 664 34 68889999999999999985 33 6888999999999999


Q ss_pred             ccCC
Q 039344          224 KLSG  227 (873)
Q Consensus       224 ~l~~  227 (873)
                      +|.+
T Consensus       192 ~i~~  195 (197)
T 4ezg_A          192 TIGG  195 (197)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            8863

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.74  E-value=5.8e-17  Score=178.22  Aligned_cols=263  Identities=11%  Similarity=0.124  Sum_probs=140.6

Q ss_pred             CCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEc
Q 039344           69 RFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYI  148 (873)
Q Consensus        69 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  148 (873)
                      ..++.+.+.+ .++.+...+|.++ +|+.+.+..+ ++.+...+|.++ +|+.+.+.+ .++.....+|.++++|+.+++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            3444444443 2333444455543 4555555443 443444445442 455555543 344344445555555555555


Q ss_pred             cCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCC
Q 039344          149 YSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGS  228 (873)
Q Consensus       149 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  228 (873)
                      ++|.+..+...+|. +.+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. +.++.+
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I  262 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNI  262 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEE
T ss_pred             CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEE
Confidence            55555555555554 345555555532 44444455555555555555543 33344445554 455555552 334434


Q ss_pred             cccccCCCCCccEEecccccCC-----CCCchhhcCCCCCcEEEccCCcCcC-cCCcCCCCCCCCeEEccCccccccccc
Q 039344          229 IPISMGNLSNLTYLNLFENSLS-----GAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISE  302 (873)
Q Consensus       229 ~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~  302 (873)
                      ...+|.++++|+.+++.+|.+.     .+.+.+|.++++|+.+++.++ +.. ...+|.++++|+.+.|..| ++.+...
T Consensus       263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~~-i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~  340 (401)
T 4fdw_A          263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPES-IRILGQGLLGGNRKVTQLTIPAN-VTQINFS  340 (401)
T ss_dssp             CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred             ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCCc-eEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence            4455555555555555555443     345556666666666666633 333 3345666666666666443 5566666


Q ss_pred             ccccCCCccEEeccCccccccCCCCCCCCC-CCCeeeeccccC
Q 039344          303 SFYIYPNLTYIDLSQNNFYGEISSDWGRCP-KLSTLDFSINNI  344 (873)
Q Consensus       303 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~i  344 (873)
                      +|..+ +|+.|++++|.+.......|..++ +++.|.+..+.+
T Consensus       341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             SSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             hCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            77776 777777777776666666666663 567777766654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.74  E-value=5e-17  Score=179.78  Aligned_cols=336  Identities=10%  Similarity=0.033  Sum_probs=262.7

Q ss_pred             cccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCc
Q 039344           32 KLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPS  111 (873)
Q Consensus        32 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  111 (873)
                      .++.+...+|.++.+|+.+.|.+ .++.+...+|.++.+|+.+++.++ ++.+...+|.++.+|+.+.+..+ +..+...
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            46778888999999999999975 477677889999999999999865 66577889999999999887654 5546667


Q ss_pred             cccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCC
Q 039344          112 ELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNL  191 (873)
Q Consensus       112 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L  191 (873)
                      +|.++..++.......  ......+|.++++|+.+.+..+ +..+...+|.++.+|+.+++..| ++.+...+|.++..|
T Consensus       135 aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L  210 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL  210 (394)
T ss_dssp             TTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred             eeecccccccccCccc--cccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence            7887765444433332  2244567999999999999765 45677888999999999999876 555667788899999


Q ss_pred             cEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCC
Q 039344          192 ATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHN  271 (873)
Q Consensus       192 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  271 (873)
                      +.+.+..+... . ...+....+|+.+.+..+. +.+....+.++..|+.+.+..+... +....|..+..++.+....+
T Consensus       211 ~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~  286 (394)
T 4fs7_A          211 ENMEFPNSLYY-L-GDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV  286 (394)
T ss_dssp             CBCCCCTTCCE-E-CTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred             ceeecCCCceE-e-ehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence            99988877654 2 3344456789999887653 3355677888999999999877554 67778899999999988776


Q ss_pred             cCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCcc
Q 039344          272 QFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPE  351 (873)
Q Consensus       272 ~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~  351 (873)
                      .+.  ...+..+.+|+.+.+.++ ++.+...+|..+.+|+.+++.++ ++.....+|..|++|+.+++..+ ++.+...+
T Consensus       287 ~i~--~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a  361 (394)
T 4fs7_A          287 IVP--EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANA  361 (394)
T ss_dssp             EEC--TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             eec--cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHH
Confidence            543  346788899999999765 77788899999999999999754 77778899999999999999876 77777889


Q ss_pred             ccCCCCCCEEeccCCccCCCCCccccccccccEE
Q 039344          352 IGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKL  385 (873)
Q Consensus       352 ~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L  385 (873)
                      |.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus       362 F~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          362 FQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             BTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             hhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            999999999999765 33 345678888887764

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.74  E-value=9.9e-19  Score=207.64  Aligned_cols=229  Identities=23%  Similarity=0.225  Sum_probs=120.1

Q ss_pred             CCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEecc
Q 039344          237 SNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLS  316 (873)
Q Consensus       237 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls  316 (873)
                      +.++.|+|.+|.+... +.     ..|+.++|+.|.+.+             +++..|.+. +.+..|..++.|+.|+|+
T Consensus       173 ~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls  232 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLS  232 (727)
T ss_dssp             ---------------------------------------------------------------------CCCCCCEEECT
T ss_pred             CccceEEeeCCCCCcc-hh-----hHhhcCccCcccccC-------------cccccccee-cChhhhccCCCCcEEECC
Confidence            4566777777776642 21     234445555554432             233445444 556677788888888888


Q ss_pred             CccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCc
Q 039344          317 QNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQL  396 (873)
Q Consensus       317 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  396 (873)
                      +|.+. .++..+..+++|+.|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..+..+.+|+.|+|++|.|+ .+
T Consensus       233 ~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~l  308 (727)
T 4b8c_D          233 NLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TL  308 (727)
T ss_dssp             TSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CC
T ss_pred             CCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-cc
Confidence            88887 56666668889999999999988 78888888999999999999988 77888889999999999999887 56


Q ss_pred             ccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCc--------cccC
Q 039344          397 SPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN--------SLSG  468 (873)
Q Consensus       397 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N--------~l~~  468 (873)
                      |..|+.+++|+.|+|++|.|++.+|..+..+.. .+..|+|++|.+++.+|.      .|+.|++++|        .|++
T Consensus       309 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~  381 (727)
T 4b8c_D          309 PWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV-TGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQ  381 (727)
T ss_dssp             CSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH-HHHHHHHHHCCCCCCCCC------C---------------------
T ss_pred             ChhhhcCCCccEEeCCCCccCCCChHHHhhcch-hhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccc
Confidence            777889999999999999998888887766532 334578899999887775      4566677777        5555


Q ss_pred             CCchhhhccCCCcEEecCCCcccccCCC
Q 039344          469 LIPSCFEKMNGLLHIDISYNELRGSIPN  496 (873)
Q Consensus       469 ~~~~~~~~~~~L~~l~ls~N~l~~~~p~  496 (873)
                      ..+..+..+..+....+++|-+.+....
T Consensus       382 ~~~~~~~~l~~~~~~~ls~Nil~~~~~~  409 (727)
T 4b8c_D          382 STEHLATDLAKRTFTVLSYNTLCQHYAT  409 (727)
T ss_dssp             --------------------CCCGGGCC
T ss_pred             cccchhhcccccceeeeeccccccccCc
Confidence            5666666777778888888887754433

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.71  E-value=3.8e-18  Score=202.64  Aligned_cols=223  Identities=20%  Similarity=0.156  Sum_probs=111.0

Q ss_pred             CCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEcc
Q 039344          213 RSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLD  292 (873)
Q Consensus       213 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~  292 (873)
                      +.++.|+|.+|.+... +.     ..|+.++|+.|.|.+              +++..|.+......+..+++|+.|+|+
T Consensus       173 ~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~~~~~~~~~l~~L~~L~Ls  232 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSIDE--------------DDDIENRMVMPKDSKYDDQLWHALDLS  232 (727)
T ss_dssp             ---------------------------------------------------------------------CCCCCCEEECT
T ss_pred             CccceEEeeCCCCCcc-hh-----hHhhcCccCcccccC--------------ccccccceecChhhhccCCCCcEEECC
Confidence            5688899999998852 32     345666677766553              244455555555566777777777777


Q ss_pred             CcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCC
Q 039344          293 RNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEI  372 (873)
Q Consensus       293 ~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~  372 (873)
                      +|.+..++...+ .+++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+
T Consensus       233 ~n~l~~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~l  308 (727)
T 4b8c_D          233 NLQIFNISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TL  308 (727)
T ss_dssp             TSCCSCCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CC
T ss_pred             CCCCCCCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-cc
Confidence            777775554443 7788888888888887 67777888888888888888888 67888888888888888888887 67


Q ss_pred             CccccccccccEEEecCccccCCcccccccccc-cccccccccccccccCCCcCchhhhhhhcccccCC--------ccC
Q 039344          373 PIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQ-LEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN--------FLR  443 (873)
Q Consensus       373 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N--------~l~  443 (873)
                      |..+..+.+|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..+.        .|++++|        .+.
T Consensus       309 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~--------~l~l~~n~~~~~~~~~l~  380 (727)
T 4b8c_D          309 PWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR--------FIEINTDGEPQREYDSLQ  380 (727)
T ss_dssp             CSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------------
T ss_pred             ChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc--------eeEeecccccccccCCcc
Confidence            777888888888888888888877777765432 34588999999888887554        4455555        455


Q ss_pred             cccchhhhhhcccceecccCcccc
Q 039344          444 EAIPSQICIMQSLEKLNLSHNSLS  467 (873)
Q Consensus       444 ~~~~~~~~~l~~L~~L~L~~N~l~  467 (873)
                      +..+..+..+..++...++.|-+.
T Consensus       381 ~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          381 QSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ---------------------CCC
T ss_pred             ccccchhhcccccceeeeeccccc
Confidence            555555666777778888888775

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=9.1e-18  Score=165.38  Aligned_cols=131  Identities=24%  Similarity=0.331  Sum_probs=78.1

Q ss_pred             CeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCc-cccccccccEEEecCccccCCcccccccccccccccccc
Q 039344          335 STLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI-ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS  413 (873)
Q Consensus       335 ~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  413 (873)
                      +.+++++|+++ .+|..+..  +|++|+|++|.|++..+. .+..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56777777775 45554432  667777777777644443 356666666666666666665566666666666666666


Q ss_pred             cccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCC
Q 039344          414 NRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLI  470 (873)
Q Consensus       414 N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  470 (873)
                      |+|++..+..|..+.  +|++|+|++|+|++..|..+..+++|+.|+|++|++++..
T Consensus        88 N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A           88 NKIKEISNKMFLGLH--QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCCEECSSSSTTCT--TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CcCCccCHHHhcCCC--CCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            666655555555543  5555555555555555555555555555555555555443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=1.4e-16  Score=153.32  Aligned_cols=131  Identities=25%  Similarity=0.270  Sum_probs=64.3

Q ss_pred             CCCCEEECCCCccc-ccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           21 KSLSDLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        21 ~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      ++|++|+|++|+++ +.+|..|..+++|++|+|++|++++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            45555555555555 44555555555555555555555533  4455555555555555555544444444455555555


Q ss_pred             ccccccCCCC-CccccCCcccCcccccccccccccC---ccccCCCCCcEEEccCCCC
Q 039344          100 LDTNSLSNSI-PSELGNLRSLSNLQLNNNILSGSIP---HSLGNLTNLATLYIYSNSL  153 (873)
Q Consensus       100 L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~n~l  153 (873)
                      |++|++++.. +..+..+++|++|++++|.+++..+   ..|..+++|++|++++|.+
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~  159 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED  159 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence            5555554321 1344444444444444444442222   2344444444444444443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.65  E-value=6.4e-16  Score=152.10  Aligned_cols=109  Identities=24%  Similarity=0.265  Sum_probs=53.1

Q ss_pred             CCCeEEccCccccccccc-ccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEec
Q 039344          285 SLERVRLDRNYLTGNISE-SFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL  363 (873)
Q Consensus       285 ~L~~L~L~~n~l~~~~~~-~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~L  363 (873)
                      +|++|++++|.++++.+. .|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|+.+++|++|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            444444444444444332 2444455555555555555444455555555555555555555444444445555555555


Q ss_pred             cCCccCCCCCccccccccccEEEecCcccc
Q 039344          364 SSNHIVGEIPIELGKLNFFIKLVLAHNQLS  393 (873)
Q Consensus       364 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  393 (873)
                      ++|+|++..|..+..+++|+.|+|++|.++
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence            555554444444444444444444444444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=3.7e-16  Score=150.41  Aligned_cols=131  Identities=24%  Similarity=0.222  Sum_probs=56.2

Q ss_pred             CCCEEEcccCCCC-CCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEc
Q 039344           70 FFSDLELSNNKLS-GSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYI  148 (873)
Q Consensus        70 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  148 (873)
                      +|++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+++.+|..+..+++|++|++
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            3444444444443 23333344444444444444444422  33444444444444444444333443444444444444


Q ss_pred             cCCCCccccc-cccCCCCCCCEEEccCCcCccCCC---ccccCCCCCcEEeccCCCCc
Q 039344          149 YSNSLSASIL-GKIGNLKSLSNLQLSENNFNGSIP---PSLGNLSNLATLYLDTNSLS  202 (873)
Q Consensus       149 ~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~---~~~~~l~~L~~L~L~~n~l~  202 (873)
                      ++|+++++.. ..+..+++|++|++++|.+++..+   ..+..+++|++|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            4444443321 344444444444444444443322   23444444444444444444

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=2.8e-16  Score=168.02  Aligned_cols=144  Identities=10%  Similarity=0.134  Sum_probs=103.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCC------cc-----hhHH--------HHHHHHHHHHhccCC
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG------EM-----TFQQ--------EFLNEVKALTEIWHR  661 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~-----~~~~--------~~~~e~~~l~~l~h~  661 (873)
                      ..-|++.++||+|+||.||+|...+|+.||||+++.....      ..     ....        ....|...+.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            3448889999999999999999999999999987642110      00     0001        123466667777655


Q ss_pred             ceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC
Q 039344          662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD  741 (873)
Q Consensus       662 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~  741 (873)
                      ++.-..-+..  ...++||||++++++..+..         ......++.|++.++.|||+.   |||||||||.|||++
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence            5432222211  23479999999988865532         223456889999999999999   999999999999999


Q ss_pred             CCCC----------eEEeccccccccC
Q 039344          742 FENE----------AHVSDFGIAKFLK  758 (873)
Q Consensus       742 ~~~~----------~kl~Dfg~a~~~~  758 (873)
                      +++.          +.|+||+-+....
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCcccccccccceEEEEeCCcccCC
Confidence            8773          8999999886543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.63  E-value=9e-16  Score=150.98  Aligned_cols=108  Identities=26%  Similarity=0.370  Sum_probs=53.3

Q ss_pred             CCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEcc
Q 039344           70 FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIY  149 (873)
Q Consensus        70 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  149 (873)
                      +|++|+|++|.++ .+|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus        32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            3444444444444 333444444444444444444444444444444444444444455444444445555555555555


Q ss_pred             CCCCccccccccCCCCCCCEEEccCCcCc
Q 039344          150 SNSLSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       150 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      +|+++.+.+..|..+++|+.|+|++|.+.
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            55555544445555555555555555554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.63  E-value=1.4e-15  Score=149.69  Aligned_cols=125  Identities=29%  Similarity=0.447  Sum_probs=59.4

Q ss_pred             EEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccc
Q 039344           25 DLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNS  104 (873)
Q Consensus        25 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  104 (873)
                      .+++++|+++ .+|..+.  ++|++|+|++|+++ .+|..|..+++|++|+|++|.|++..+.+|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4445555544 3333322  34455555555554 344444445555555555555544444445555555555555555


Q ss_pred             cCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCC
Q 039344          105 LSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSL  153 (873)
Q Consensus       105 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  153 (873)
                      ++++.|..|.++++|++|+|++|.++...+..|..+++|+.|+|++|.+
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence            5444444444455555555555555433333444445555555555444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.62  E-value=2.6e-16  Score=148.12  Aligned_cols=126  Identities=22%  Similarity=0.269  Sum_probs=61.7

Q ss_pred             CCCCEEECCCCccc-ccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceee
Q 039344           21 KSLSDLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY   99 (873)
Q Consensus        21 ~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   99 (873)
                      ++|++|++++|+++ +.+|..|..+++|++|++++|++++.  ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34555555555555 44555555555555555555555533  4455555555555555555544444444455555555


Q ss_pred             ccccccCCC-CCccccCCcccCcccccccccccccC---ccccCCCCCcEEEc
Q 039344          100 LDTNSLSNS-IPSELGNLRSLSNLQLNNNILSGSIP---HSLGNLTNLATLYI  148 (873)
Q Consensus       100 L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L  148 (873)
                      +++|++++. .+..+..+++|++|++++|.+++..+   ..+..+++|+.|++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l  147 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG  147 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence            555555431 12344444444444444444443222   23444444444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.62  E-value=3.9e-16  Score=146.89  Aligned_cols=127  Identities=20%  Similarity=0.245  Sum_probs=81.1

Q ss_pred             CCCceEEccCCccc-ccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccc
Q 039344           45 TNLATLYIHTNSLS-GSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ  123 (873)
Q Consensus        45 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (873)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            66777777777776 56666777777777777777777744  5666677777777777777655566566666666666


Q ss_pred             ccccccccc-cCccccCCCCCcEEEccCCCCccccc---cccCCCCCCCEEEcc
Q 039344          124 LNNNILSGS-IPHSLGNLTNLATLYIYSNSLSASIL---GKIGNLKSLSNLQLS  173 (873)
Q Consensus       124 L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~  173 (873)
                      +++|.+++. .+..+..+++|++|++++|.+++..+   ..+..+++|++|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666642 22555666666666666666655443   345555555555554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.62  E-value=3.3e-14  Score=157.07  Aligned_cols=319  Identities=10%  Similarity=0.120  Sum_probs=173.7

Q ss_pred             CCCccCCC-CCCEEEcccCCCCCCCCcccccccccceeeccccc---cCCCCCccccCCcccCcccccccccccccCccc
Q 039344           62 PGEIGNFR-FFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNS---LSNSIPSELGNLRSLSNLQLNNNILSGSIPHSL  137 (873)
Q Consensus        62 p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  137 (873)
                      ..+|.+.. .|+.+.+..+ ++.+...+|.++++|+.+.+..|.   ++.+...+|.++.+|+.+.+.++ ++.....+|
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF  133 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF  133 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred             HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence            33444432 2444444432 333444444444445544444432   33333444555555555554433 222333445


Q ss_pred             cCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCE
Q 039344          138 GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSN  217 (873)
Q Consensus       138 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  217 (873)
                      ..+.+|+.+.+..+ +..+...+|..+.+|+.+.+..+ ++.+...+|.. ..|+.+.+..+... ....+|..+.++..
T Consensus       134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~  209 (394)
T 4gt6_A          134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALST  209 (394)
T ss_dssp             TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCE
T ss_pred             hhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccce
Confidence            55555555555432 33444455555555555555433 22233333432 34555555444332 44445555555555


Q ss_pred             EEccCcccCCCccc-------------ccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCC
Q 039344          218 LSLGYNKLSGSIPI-------------SMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLT  284 (873)
Q Consensus       218 L~L~~N~l~~~~~~-------------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~  284 (873)
                      .....+........             .+.....+..+.+. +.++.+...+|.++..|+.+.+.++.......+|.+++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~  288 (394)
T 4gt6_A          210 ITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCP  288 (394)
T ss_dssp             EEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCEECTTTTTTCT
T ss_pred             ecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccceecCccccccc
Confidence            55444433211100             11122233344433 23444556778888888888887776655566788888


Q ss_pred             CCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEecc
Q 039344          285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS  364 (873)
Q Consensus       285 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls  364 (873)
                      +|+.+.+. +.++.+...+|.++.+|+.+++..+ ++.+...+|..|.+|+.+.+..+ ++.+...+|.++++|+.+++.
T Consensus       289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~  365 (394)
T 4gt6_A          289 ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYS  365 (394)
T ss_dssp             TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEES
T ss_pred             ccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEEC
Confidence            88888885 5577788888888888888888754 66677788888888998888654 666667788888899999888


Q ss_pred             CCccCCCCCccccccccccEEEecCcccc
Q 039344          365 SNHIVGEIPIELGKLNFFIKLVLAHNQLS  393 (873)
Q Consensus       365 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  393 (873)
                      +|....   ..+....+|+.+.+..|.+.
T Consensus       366 ~~~~~~---~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          366 GSRSQW---NAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             SCHHHH---HTCBCCCCC-----------
T ss_pred             Cceeeh---hhhhccCCCCEEEeCCCCEE
Confidence            876541   35666777888877766543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.61  E-value=5e-14  Score=155.65  Aligned_cols=322  Identities=12%  Similarity=0.106  Sum_probs=137.8

Q ss_pred             ccccCCccccCCC-CCceEEccCCcccccCCCCccCCCCCCEEEcccCC---CCCCCCcccccccccceeeccccccCCC
Q 039344           33 LSGSIPHSLGNLT-NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNK---LSGSIPPSLGNLSNLATLYLDTNSLSNS  108 (873)
Q Consensus        33 l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~L~~n~l~~~  108 (873)
                      ++.+...+|.+++ .|+.+.+-++ ++.+...+|.++.+|+.+.+.+|.   ++.+...+|.++.+|+.+.+..+ ++.+
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I  128 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI  128 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence            3334444555543 3555555432 444445555555555555555442   33344445555555555544332 3323


Q ss_pred             CCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCC
Q 039344          109 IPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNL  188 (873)
Q Consensus       109 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l  188 (873)
                      ...+|.++.+|+.+.+..+. .......|..+.+|+.+.+..+ +..+...+|.. .+|+.+.+..+-.. ....+|..+
T Consensus       129 ~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c  204 (394)
T 4gt6_A          129 DSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSEC  204 (394)
T ss_dssp             CTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTC
T ss_pred             hhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhc
Confidence            34445555555555554332 2233344555555555555433 33344444433 34555555433222 333445555


Q ss_pred             CCCcEEeccCCCCcccCCcc-------------ccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCch
Q 039344          189 SNLATLYLDTNSLSYSIPSE-------------LGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPY  255 (873)
Q Consensus       189 ~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  255 (873)
                      ..++......+.........             +.....+..+.+..+ ++.+...+|.++.+|+.+.+..+... +...
T Consensus       205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~-v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~  282 (394)
T 4gt6_A          205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNG-VARIETHAFDSCAYLASVKMPDSVVS-IGTG  282 (394)
T ss_dssp             TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTT-EEEECTTTTTTCSSCCEEECCTTCCE-ECTT
T ss_pred             cccceecccccccccccceeecccccccccccccccccccceEEcCCc-ceEcccceeeecccccEEecccccce-ecCc
Confidence            55555544443332111000             011122233333221 22233344555555555555433322 4444


Q ss_pred             hhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCC
Q 039344          256 EYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS  335 (873)
Q Consensus       256 ~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  335 (873)
                      +|.++.+|+.+.+..+--.-...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.....+|..|++|+
T Consensus       283 aF~~c~~L~~i~l~~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~  360 (394)
T 4gt6_A          283 AFMNCPALQDIEFSSRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALN  360 (394)
T ss_dssp             TTTTCTTCCEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCC
T ss_pred             ccccccccccccCCCcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCC
Confidence            455555555555542221112334555555555555432 44444555555555555555432 4434445555555555


Q ss_pred             eeeeccccCCccCCccccCCCCCCEEeccCCc
Q 039344          336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNH  367 (873)
Q Consensus       336 ~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~  367 (873)
                      .+++.++....   ..+..+..|+.+.+..|.
T Consensus       361 ~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~  389 (394)
T 4gt6_A          361 NIEYSGSRSQW---NAISTDSGLQNLPVAPGS  389 (394)
T ss_dssp             EEEESSCHHHH---HTCBCCCCC---------
T ss_pred             EEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence            55555543321   234444455555544443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.59  E-value=6.8e-15  Score=142.81  Aligned_cols=39  Identities=31%  Similarity=0.347  Sum_probs=14.3

Q ss_pred             cCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCc
Q 039344          138 GNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENN  176 (873)
Q Consensus       138 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  176 (873)
                      ..+++|++|++++|+++.+.+..|..+++|++|+|++|.
T Consensus        97 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (177)
T 2o6r_A           97 DKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  135 (177)
T ss_dssp             TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             hCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCC
Confidence            333333333333333333333333333333333333333

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.59  E-value=6.2e-15  Score=143.11  Aligned_cols=131  Identities=22%  Similarity=0.347  Sum_probs=108.7

Q ss_pred             CCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc
Q 039344           23 LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        23 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  102 (873)
                      .+.+++++|+++ .+|..+.  ++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            467888999887 5555443  6889999999999877777788889999999999999877777788899999999999


Q ss_pred             cccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccc
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSAS  156 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  156 (873)
                      |++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|.+...
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            999877777788889999999999999866666678889999999999988753

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.56  E-value=2.3e-15  Score=145.98  Aligned_cols=109  Identities=22%  Similarity=0.236  Sum_probs=46.1

Q ss_pred             cCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccce
Q 039344           18 RNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLAT   97 (873)
Q Consensus        18 ~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~   97 (873)
                      .+..+|++|+|++|+++. +|......++|++|+|++|++++.  ..|..+++|++|+|++|++++..+..|..+++|++
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            334445555555555442 232212122445555555544432  34444444444444444444332233344444444


Q ss_pred             eeccccccCCCCCc--cccCCcccCcccccccccc
Q 039344           98 LYLDTNSLSNSIPS--ELGNLRSLSNLQLNNNILS  130 (873)
Q Consensus        98 L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~  130 (873)
                      |+|++|+++ .+|.  .+..+++|++|++++|.++
T Consensus        93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence            444444443 2222  3344444444444444443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=1.2e-16  Score=158.26  Aligned_cols=151  Identities=21%  Similarity=0.255  Sum_probs=107.4

Q ss_pred             CCCCeeeeccccCCccCCc------cccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCcccccccccc
Q 039344          332 PKLSTLDFSINNITGNVPP------EIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQ  405 (873)
Q Consensus       332 ~~L~~L~l~~N~i~~~~~~------~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  405 (873)
                      ..++.++++.|.+++..|.      .++.+++|++|+|++|.+++ +| .+..+++|+.|++++|.++ .+|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            3445555555555544444      67777777788887777774 55 7777777888888888777 45666666778


Q ss_pred             cccccccccccccccCCCcCchhhhhhhcccccCCccCcccc-hhhhhhcccceecccCccccCCCch----------hh
Q 039344          406 LEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIP-SQICIMQSLEKLNLSHNSLSGLIPS----------CF  474 (873)
Q Consensus       406 L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----------~~  474 (873)
                      |+.|+|++|++++ +| .+..+.  +|+.|+|++|++++..+ ..+..+++|+.|++++|++++.+|.          .+
T Consensus        95 L~~L~L~~N~l~~-l~-~~~~l~--~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~  170 (198)
T 1ds9_A           95 LEELWISYNQIAS-LS-GIEKLV--NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV  170 (198)
T ss_dssp             CSEEEEEEEECCC-HH-HHHHHH--HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred             CCEEECcCCcCCc-CC-ccccCC--CCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence            8888888888874 34 354443  78888888888876443 5677888899999999988877665          37


Q ss_pred             hccCCCcEEecCCCccc
Q 039344          475 EKMNGLLHIDISYNELR  491 (873)
Q Consensus       475 ~~~~~L~~l~ls~N~l~  491 (873)
                      ..+++|+.||  +|+++
T Consensus       171 ~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          171 KRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHCSSCSEEC--CGGGT
T ss_pred             HhCCCcEEEC--CcccC
Confidence            8888999887  66665

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.55  E-value=4.7e-15  Score=143.79  Aligned_cols=137  Identities=19%  Similarity=0.212  Sum_probs=117.8

Q ss_pred             CccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCc
Q 039344           38 PHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLR  117 (873)
Q Consensus        38 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  117 (873)
                      ...|..+.+|++|++++|+++ .+|......++|++|+|++|.+++.  ..|..+++|++|+|++|++++..+..|..++
T Consensus        12 ~~~~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   88 (176)
T 1a9n_A           12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP   88 (176)
T ss_dssp             SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             HHhcCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence            345788999999999999999 5565444444999999999999965  6899999999999999999966556679999


Q ss_pred             ccCcccccccccccccCc--cccCCCCCcEEEccCCCCcccccc---ccCCCCCCCEEEccCCcCc
Q 039344          118 SLSNLQLNNNILSGSIPH--SLGNLTNLATLYIYSNSLSASILG---KIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       118 ~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~n~i~  178 (873)
                      +|++|++++|.++ .+|.  .+..+++|+.|++++|.+..+...   .+..+++|++|+++.|.+.
T Consensus        89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            9999999999997 5665  899999999999999999865443   4889999999999999876

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=9.4e-17  Score=159.11  Aligned_cols=134  Identities=23%  Similarity=0.314  Sum_probs=72.4

Q ss_pred             ccCCCCCCEEECCCCcccccCCc------cccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccc
Q 039344           17 LRNLKSLSDLELGNNKLSGSIPH------SLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLG   90 (873)
Q Consensus        17 ~~~l~~l~~L~L~~n~l~~~~p~------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~   90 (873)
                      +.....++.++++.+.+++..|.      .|..+++|++|+|++|++++ +| .+..+++|++|++++|.++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            34445566666666666655554      56666666666666666653 44 5555556666666666555 3444555


Q ss_pred             cccccceeeccccccCCCCCccccCCcccCcccccccccccccC-ccccCCCCCcEEEccCCCCcc
Q 039344           91 NLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP-HSLGNLTNLATLYIYSNSLSA  155 (873)
Q Consensus        91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~  155 (873)
                      .+++|++|++++|++++ +| .+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.+
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~  154 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence            55555555555555553 22 35555555555555555553211 244555555555555555543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.43  E-value=3.4e-13  Score=129.52  Aligned_cols=105  Identities=26%  Similarity=0.390  Sum_probs=69.5

Q ss_pred             CCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc
Q 039344           23 LSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        23 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  102 (873)
                      .+.|++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            356777777776 4555443  6677777777777766666677777777777777777765566666667777777777


Q ss_pred             cccCCCCCccccCCcccCcccccccccc
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILS  130 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~  130 (873)
                      |+|++..+..|..+++|++|+|++|.+.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            7766555555666666666666666665

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.43  E-value=1.1e-11  Score=136.02  Aligned_cols=304  Identities=11%  Similarity=0.073  Sum_probs=168.8

Q ss_pred             ccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcc
Q 039344           39 HSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRS  118 (873)
Q Consensus        39 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  118 (873)
                      +||....+|+.+.+.+ .++.+...+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+.. .++.+...+|.+. +
T Consensus        40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~  114 (379)
T 4h09_A           40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-D  114 (379)
T ss_dssp             TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-C
T ss_pred             cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-C
Confidence            4566666777777764 455566667777777777777644 554666677765 566666643 3443444555553 6


Q ss_pred             cCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccC------------CCcccc
Q 039344          119 LSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS------------IPPSLG  186 (873)
Q Consensus       119 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~------------~~~~~~  186 (873)
                      |+.+.+.++-.. .....|... +|+.+.+.. .+..+...+|..+.+++.+.+..+.....            ....+.
T Consensus       115 L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (379)
T 4h09_A          115 LDDFEFPGATTE-IGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYP  191 (379)
T ss_dssp             CSEEECCTTCCE-ECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECC
T ss_pred             cccccCCCcccc-ccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecccc
Confidence            777777654322 334455543 455555543 34455666677777777776665443211            112233


Q ss_pred             CCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEE
Q 039344          187 NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTIL  266 (873)
Q Consensus       187 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  266 (873)
                      ....+..+.+..+.-. .....+..+.+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+...+|.++.+|+.+
T Consensus       192 ~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i  268 (379)
T 4h09_A          192 AAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTL  268 (379)
T ss_dssp             TTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEE
T ss_pred             ccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccc
Confidence            4444555554443322 44445556666666666544 22244455666666666666554 444555566666666666


Q ss_pred             EccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCc
Q 039344          267 LLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG  346 (873)
Q Consensus       267 ~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~  346 (873)
                      .+..+--.....+|.++++|+.+.+.++.++.+...+|.++.+|+.++|..+ ++.+...+|..|++|+.+.+..+ ++.
T Consensus       269 ~l~~~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~  346 (379)
T 4h09_A          269 NFYAKVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITL  346 (379)
T ss_dssp             EECCCCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCE
T ss_pred             cccccceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCE
Confidence            6654422223345566666666666666666566666666666666666433 44455555666666666655433 443


Q ss_pred             cCCccccCC
Q 039344          347 NVPPEIGHS  355 (873)
Q Consensus       347 ~~~~~~~~~  355 (873)
                      +...+|.++
T Consensus       347 I~~~aF~~c  355 (379)
T 4h09_A          347 IESGAFEGS  355 (379)
T ss_dssp             ECTTTTTTS
T ss_pred             EchhHhhCC
Confidence            444444443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.42  E-value=3.8e-13  Score=129.61  Aligned_cols=104  Identities=25%  Similarity=0.379  Sum_probs=68.3

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            56777777775 5555443  66777777777777666666777777777777777776555555666667777777777


Q ss_pred             ccCCCCCccccCCcccCcccccccccc
Q 039344          104 SLSNSIPSELGNLRSLSNLQLNNNILS  130 (873)
Q Consensus       104 ~l~~~~~~~~~~l~~L~~L~L~~n~l~  130 (873)
                      +|++..+..|..+++|++|+|++|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            666544445666666666666666665

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=4.3e-13  Score=128.83  Aligned_cols=104  Identities=27%  Similarity=0.341  Sum_probs=51.1

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      .++|++++|.++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            345555555555 3444332  4555555555555544455555555555555555555544344444444444444444


Q ss_pred             cccccccCccccCCCCCcEEEccCCCC
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSL  153 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l  153 (873)
                      |+|++..+..|..+++|++|+|++|.+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~  114 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPW  114 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCC
Confidence            444433333344444444444444444

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.40  E-value=7.8e-13  Score=127.42  Aligned_cols=104  Identities=28%  Similarity=0.421  Sum_probs=53.1

Q ss_pred             ceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccccc
Q 039344           48 ATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNN  127 (873)
Q Consensus        48 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  127 (873)
                      +.+++++|+++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45666666665 4454443  55555555555555555555555555555555555555433333444555555555555


Q ss_pred             ccccccCccccCCCCCcEEEccCCCCc
Q 039344          128 ILSGSIPHSLGNLTNLATLYIYSNSLS  154 (873)
Q Consensus       128 ~l~~~~~~~~~~l~~L~~L~L~~n~l~  154 (873)
                      +|++..+..|..+++|++|+|++|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            554333333444444444444444443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.38  E-value=3.8e-11  Score=131.85  Aligned_cols=305  Identities=10%  Similarity=0.076  Sum_probs=228.9

Q ss_pred             cccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCccccccccc
Q 039344           16 ELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNL   95 (873)
Q Consensus        16 ~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L   95 (873)
                      ++..-.+|+.+.+.. .++.+...+|.+|.+|+.+.|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|... +|
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL  115 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence            344556788888864 688788899999999999999765 776788889887 6888888754 554667778764 79


Q ss_pred             ceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCcc------------ccccccCC
Q 039344           96 ATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSA------------SILGKIGN  163 (873)
Q Consensus        96 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------~~~~~~~~  163 (873)
                      +.+.+..+ +..+...+|.+. +|+.+.+..+ ++......|..+.+++.+.+..+....            .....+..
T Consensus       116 ~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (379)
T 4h09_A          116 DDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA  192 (379)
T ss_dssp             SEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred             ccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence            99999765 343555566654 5777666544 343556778888899888877654321            12233555


Q ss_pred             CCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEe
Q 039344          164 LKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN  243 (873)
Q Consensus       164 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  243 (873)
                      ...+..+.+...... .....+..+.+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+...+|.++.+|+.+.
T Consensus       193 ~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~  269 (379)
T 4h09_A          193 AKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLN  269 (379)
T ss_dssp             TCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEE
T ss_pred             cccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccc
Confidence            666777766554433 45567778889999998765 44467778899999999999876 5556677889999999999


Q ss_pred             cccccCCCCCchhhcCCCCCcEEEccCCcCcC-cCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccc
Q 039344          244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRG-PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG  322 (873)
Q Consensus       244 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~  322 (873)
                      +..+ +..+...+|.++.+|+.+.+.++.++. ...+|.++.+|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.
T Consensus       270 l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~  346 (379)
T 4h09_A          270 FYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITL  346 (379)
T ss_dssp             ECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCE
T ss_pred             cccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCE
Confidence            9654 666777889999999999999888876 4558999999999999755 78888999999999999999765 666


Q ss_pred             cCCCCCCCCCCC
Q 039344          323 EISSDWGRCPKL  334 (873)
Q Consensus       323 ~~~~~~~~l~~L  334 (873)
                      +...+|..+..+
T Consensus       347 I~~~aF~~c~~~  358 (379)
T 4h09_A          347 IESGAFEGSSIT  358 (379)
T ss_dssp             ECTTTTTTSSCC
T ss_pred             EchhHhhCCCCC
Confidence            777888776533

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.35  E-value=7.3e-15  Score=159.85  Aligned_cols=15  Identities=20%  Similarity=0.096  Sum_probs=9.0

Q ss_pred             CCCcEEEccCCcCcC
Q 039344          261 VKLTILLLGHNQFRG  275 (873)
Q Consensus       261 ~~L~~L~L~~N~l~~  275 (873)
                      ++|+.|+|++|.++.
T Consensus        72 ~~L~~L~Ls~n~l~~   86 (372)
T 3un9_A           72 SSLRQLNLAGVRMTP   86 (372)
T ss_dssp             TTCCEEECTTSCCCH
T ss_pred             hhCCEEEecCCCCCH
Confidence            456666666666553

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.33  E-value=1.4e-14  Score=157.51  Aligned_cols=62  Identities=19%  Similarity=0.080  Sum_probs=29.1

Q ss_pred             CCCCEEEccCcccCCCcccccCC-----CCCccEEecccccCCCCCchhhc-CCCCCcEEEccCCcCc
Q 039344          213 RSLSNLSLGYNKLSGSIPISMGN-----LSNLTYLNLFENSLSGAIPYEYR-NLVKLTILLLGHNQFR  274 (873)
Q Consensus       213 ~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~  274 (873)
                      ++|++|+|++|.|+......+..     .++|++|+|++|.++......+. .+++|+.|+|++|.++
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~  139 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG  139 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence            45666666666665332222221     24566666666655432222221 2344445555554443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.22  E-value=4e-11  Score=124.31  Aligned_cols=145  Identities=12%  Similarity=0.041  Sum_probs=113.7

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  677 (873)
                      ..-..|++....+.|+.+.||++... |+.+++|+........   ...+.+|+.+++.+. +..++++++++.+.+..|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            34467888888899999999999865 6889999986422111   235789999999984 678889999999988999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC---------------------------------  724 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------  724 (873)
                      +||||++|.++.+.+.        +......++.+++++++.||+..                                 
T Consensus        87 lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999999876631        12234578889999999999810                                 


Q ss_pred             -----------------------CCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          725 -----------------------FPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       725 -----------------------~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                                             .+.++|||+++.||+++.++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   0358999999999999876566799998774

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.22  E-value=2.3e-11  Score=131.90  Aligned_cols=103  Identities=24%  Similarity=0.286  Sum_probs=71.7

Q ss_pred             EEECCCC-cccccCCccccCCCCCceEEccC-CcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccc
Q 039344           25 DLELGNN-KLSGSIPHSLGNLTNLATLYIHT-NSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        25 ~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  102 (873)
                      .++++++ +|+ .+|. |..+++|++|+|++ |+|+++.++.|.++++|++|+|++|+|+++.|.+|.+|++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4566766 666 4566 77777777777775 777766666777777777777777777776677777777777777777


Q ss_pred             cccCCCCCccccCCcccCcccccccccc
Q 039344          103 NSLSNSIPSELGNLRSLSNLQLNNNILS  130 (873)
Q Consensus       103 n~l~~~~~~~~~~l~~L~~L~L~~n~l~  130 (873)
                      |+|++..+..|..++ |++|+|.+|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            777755555555554 777777777766

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.18  E-value=2.8e-11  Score=131.14  Aligned_cols=103  Identities=22%  Similarity=0.234  Sum_probs=66.3

Q ss_pred             eEEccCC-cccccCCCCccCCCCCCEEEccc-CCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           49 TLYIHTN-SLSGSIPGEIGNFRFFSDLELSN-NKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        49 ~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      .++++++ +++ .+|. |..+.+|++|+|++ |.|+++.+.+|.+|++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4566665 666 4555 66666666666664 666665556666666666666666666666666666666666666666


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCc
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLS  154 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~  154 (873)
                      |+|++..+..|..++ |+.|+|.+|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            666654444555444 666666666664

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.03  E-value=3.5e-10  Score=117.16  Aligned_cols=136  Identities=15%  Similarity=0.090  Sum_probs=100.5

Q ss_pred             CCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc--eeeEEeEEEecceeEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~  680 (873)
                      .+.+....+.|..+.||++...+|+.+++|......      ...+.+|+.+++.+.+.+  +++++++....+..++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            344433334566799999988778889999976431      135778999999986544  567899888888899999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC------------------------------------  724 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  724 (873)
                      ||++|.++.  ...      .   ....++.++++.++.||+..                                    
T Consensus        95 e~i~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999998874  211      1   12356778888888888752                                    


Q ss_pred             -------------------CCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          725 -------------------FPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       725 -------------------~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                                         .+.++|||++|.||+++.++.+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                               0129999999999999877667799999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.01  E-value=1.5e-10  Score=124.71  Aligned_cols=114  Identities=16%  Similarity=0.088  Sum_probs=60.0

Q ss_pred             hhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccc--cCCCccEEeccC--cccccc-----CC
Q 039344          255 YEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFY--IYPNLTYIDLSQ--NNFYGE-----IS  325 (873)
Q Consensus       255 ~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~--~~~~L~~L~Ls~--N~l~~~-----~~  325 (873)
                      ..+..+++|+.|++++|.-.... .+ .+++|++|+|..|.++......+.  .+|+|+.|+|+.  |...+.     +.
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l~l~-~~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~  243 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNLSIG-KK-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR  243 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTCBCC-SC-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred             HHHhcCCCCcEEEEeCCCCceec-cc-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence            44566677777777766311122 23 267788888887777654433343  567788777753  221111     00


Q ss_pred             CCC--CCCCCCCeeeeccccCCccCCcccc---CCCCCCEEeccCCccCC
Q 039344          326 SDW--GRCPKLSTLDFSINNITGNVPPEIG---HSSQLGVLDLSSNHIVG  370 (873)
Q Consensus       326 ~~~--~~l~~L~~L~l~~N~i~~~~~~~~~---~~~~L~~L~Ls~N~i~~  370 (873)
                      ..+  ..+++|+.|+|++|.+.+..+..+.   .+++|++|+|+.|.|++
T Consensus       244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence            111  2356666666666665543322222   24455555555555543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.96  E-value=2e-09  Score=117.09  Aligned_cols=143  Identities=13%  Similarity=0.182  Sum_probs=107.5

Q ss_pred             CCceeeecCCeEEEEEEeCCCcEEEEEEcc--CCCCCcchhHHHHHHHHHHHHhcc--CCceeeEEeEEEec---ceeEE
Q 039344          606 DEHCIGKGGQGSVYMSKLASGEIIAVKKFH--SPLPGEMTFQQEFLNEVKALTEIW--HRNIVKVYGFCLHV---RHLFI  678 (873)
Q Consensus       606 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~l  678 (873)
                      ..+.++.|.++.||+.+..+ ..+++|+..  ....  ......+.+|+.+++.+.  +..++++++++.+.   +..++
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            35678999999999998774 578888875  2211  111356788999999996  45688999998876   45899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC----------------------------------  724 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  724 (873)
                      ||||++|..+.+..     ...++..++..++.++++.++.||+..                                  
T Consensus       119 vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            99999988774321     123677888899999999999999731                                  


Q ss_pred             ---------------------CCCeeeCCCCCCCeeeCCCCC--eEEeccccccc
Q 039344          725 ---------------------FPPIVHRDISSKNVLLDFENE--AHVSDFGIAKF  756 (873)
Q Consensus       725 ---------------------~~~i~H~Dlk~~Nill~~~~~--~kl~Dfg~a~~  756 (873)
                                           .+.++|||+++.||+++.++.  +.|.||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 147999999999999998763  68999999874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.96  E-value=2.2e-10  Score=123.36  Aligned_cols=59  Identities=24%  Similarity=0.245  Sum_probs=33.7

Q ss_pred             ccccCCCCCCEEEccCcc-cCCCcccccCCCCCccEEecccccCCCCCchhhc--CCCCCcEEEcc
Q 039344          207 SELGNLRSLSNLSLGYNK-LSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYR--NLVKLTILLLG  269 (873)
Q Consensus       207 ~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~  269 (873)
                      ..+..+++|+.|+|++|. +. . +. + .+++|+.|+|..|.+.......+.  .+++|+.|+|+
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l~-l-~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~  227 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNLS-I-GK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY  227 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTCB-C-CS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred             HHHhcCCCCcEEEEeCCCCce-e-cc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence            345566777777776662 22 1 21 2 266777777777766543333333  56777777764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.81  E-value=2.3e-09  Score=113.52  Aligned_cols=185  Identities=23%  Similarity=0.247  Sum_probs=124.0

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCc--eeeEEeEEEecc---eeEEEE
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRN--IVKVYGFCLHVR---HLFIVY  680 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~  680 (873)
                      .+.++.|.+..||+..    +.+++|+....     .....+.+|+.+++.+ .+..  +.+++.+.....   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4679999999999873    56888885421     2356788999999988 3333  455655544333   358999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC------------------------------------  724 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  724 (873)
                      |+++|.++.+...     ..++.+++..++.++++.++.||+..                                    
T Consensus        96 ~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           96 TKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             ECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             cccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            9999988764321     23677778888889999988888621                                    


Q ss_pred             -------------------CCCeeeCCCCCCCeeeCC--CCCeEEeccccccccCCCCCCccccc------c--------
Q 039344          725 -------------------FPPIVHRDISSKNVLLDF--ENEAHVSDFGIAKFLKPDSSNWTELA------G--------  769 (873)
Q Consensus       725 -------------------~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~------g--------  769 (873)
                                         .+.++|+|+++.||+++.  ++.+.++||+.+....+. .......      +        
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHH
Confidence                               135799999999999998  456789999998754321 1110000      0        


Q ss_pred             -cccccc-ccccccCCCCCcchhHHHHHHHHHHHhCCCCCc
Q 039344          770 -TYGYVA-PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD  808 (873)
Q Consensus       770 -~~~y~a-PE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~  808 (873)
                       ..++.. |+....  .....+.|++|.++|.+.+|+.||.
T Consensus       250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence             001111 222111  1123689999999999999998853

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.49  E-value=1.5e-08  Score=98.35  Aligned_cols=65  Identities=11%  Similarity=0.156  Sum_probs=28.1

Q ss_pred             CCCCCCCeEEccCcccccccc----cccccCCCccEEeccCcccccc----CCCCCCCCCCCCeeee--ccccCC
Q 039344          281 RNLTSLERVRLDRNYLTGNIS----ESFYIYPNLTYIDLSQNNFYGE----ISSDWGRCPKLSTLDF--SINNIT  345 (873)
Q Consensus       281 ~~l~~L~~L~L~~n~l~~~~~----~~~~~~~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l--~~N~i~  345 (873)
                      ...++|++|+|++|.|++...    ..+...+.|++|+|++|.|++.    +...+...++|++|+|  ++|.|+
T Consensus        62 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A           62 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence            334445555555555443222    2222334455555555554432    1223333444555555  444444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.49  E-value=6.2e-09  Score=101.00  Aligned_cols=113  Identities=15%  Similarity=0.140  Sum_probs=52.7

Q ss_pred             ccCCCccEEeccCc-ccccc----CCCCCCCCCCCCeeeeccccCCccC----CccccCCCCCCEEeccCCccCCC----
Q 039344          305 YIYPNLTYIDLSQN-NFYGE----ISSDWGRCPKLSTLDFSINNITGNV----PPEIGHSSQLGVLDLSSNHIVGE----  371 (873)
Q Consensus       305 ~~~~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~~----~~~~~~~~~L~~L~Ls~N~i~~~----  371 (873)
                      ...+.|++|+|++| .+...    +...+...++|++|+|++|+|.+..    ...+...++|++|+|++|.|++.    
T Consensus        33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~  112 (185)
T 1io0_A           33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA  112 (185)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence            33444445555544 44321    1222334455566666666554322    22333445566666666666532    


Q ss_pred             CCccccccccccEEEe--cCccccCCcc----cccccccccccccccccccc
Q 039344          372 IPIELGKLNFFIKLVL--AHNQLSGQLS----PKLGSLVQLEHLDLSSNRLS  417 (873)
Q Consensus       372 ~~~~~~~l~~L~~L~L--~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~  417 (873)
                      +...+.....|++|+|  ++|.|+....    ..+...++|++|+|++|.+.
T Consensus       113 l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          113 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            2233344445555555  4455543222    22333355555555555553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.37  E-value=4.8e-08  Score=99.36  Aligned_cols=79  Identities=30%  Similarity=0.399  Sum_probs=38.3

Q ss_pred             ccccccccccccccccc--ccCCCcCchhhhhhhcccccCCccCcccchhhhhhc--ccceecccCccccCCCc------
Q 039344          402 SLVQLEHLDLSSNRLSN--SIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ--SLEKLNLSHNSLSGLIP------  471 (873)
Q Consensus       402 ~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~------  471 (873)
                      .+++|+.|+||+|+|++  .+|..+..+.  +|+.|+|++|+|++.  ..+..+.  +|++|+|++|++++.+|      
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~--~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~  243 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAP--NLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYI  243 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHST--TCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHH
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCC--CCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHH
Confidence            34455555555555553  2233333322  555555555555542  2223333  56666666666655444      


Q ss_pred             -hhhhccCCCcEEe
Q 039344          472 -SCFEKMNGLLHID  484 (873)
Q Consensus       472 -~~~~~~~~L~~l~  484 (873)
                       ..+..+++|+.||
T Consensus       244 ~~il~~~P~L~~LD  257 (267)
T 3rw6_A          244 SAIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHHCTTCCEES
T ss_pred             HHHHHHCcccCeEC
Confidence             1245566666554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.35  E-value=2.9e-06  Score=87.88  Aligned_cols=135  Identities=13%  Similarity=0.094  Sum_probs=99.6

Q ss_pred             ceeeecCCe-EEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKGGQG-SVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      +.+..|..| .||+.... ++..+++|+-..      ....++.+|...++.+. +--+.++++++.+.+..++|||+++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            356667666 68988765 466788998542      12467889999999884 4447889999999999999999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC----------------------------------------  724 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  724 (873)
                      |.++.+....       .......++.++++.++.||+..                                        
T Consensus       104 G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          104 GKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             SEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            9887765422       12234456667777777777531                                        


Q ss_pred             ---------------CCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          725 ---------------FPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       725 ---------------~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                                     .+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           0237899999999999987777899999875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.28  E-value=7.1e-08  Score=98.15  Aligned_cols=40  Identities=33%  Similarity=0.368  Sum_probs=20.1

Q ss_pred             CCCCCCEEEcccCCCCCC--CCcccccccccceeeccccccC
Q 039344           67 NFRFFSDLELSNNKLSGS--IPPSLGNLSNLATLYLDTNSLS  106 (873)
Q Consensus        67 ~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~  106 (873)
                      ++++|+.|+|++|+|++.  +|..+..+++|+.|+|++|+|+
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~  209 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  209 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence            345555555555555541  2234444555555555555554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.21  E-value=9e-06  Score=85.62  Aligned_cols=137  Identities=15%  Similarity=0.115  Sum_probs=95.4

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCC---ceeeEEeEEE-ecceeEEEEEe
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR---NIVKVYGFCL-HVRHLFIVYEY  682 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~  682 (873)
                      .+.++.|....||+.    |+.+++|+...     ......+.+|+.+++.+.+.   .+.+++.++. ..+..++||||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            456889999999998    56788888431     12346789999999999642   4677777775 34567899999


Q ss_pred             ccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 039344          683 FKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND---------------------------------------  723 (873)
Q Consensus       683 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  723 (873)
                      ++|.++.+...     ..++..++..++.++++.++.||+.                                       
T Consensus        95 i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           95 VQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             cCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            99988765311     1134444455555555555555542                                       


Q ss_pred             ------------------CCCCeeeCCCCCCCeeeCC---CCC-eEEecccccccc
Q 039344          724 ------------------CFPPIVHRDISSKNVLLDF---ENE-AHVSDFGIAKFL  757 (873)
Q Consensus       724 ------------------~~~~i~H~Dlk~~Nill~~---~~~-~kl~Dfg~a~~~  757 (873)
                                        ..+.++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              1235699999999999997   455 489999988643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.02  E-value=8.2e-06  Score=88.22  Aligned_cols=83  Identities=5%  Similarity=-0.043  Sum_probs=56.3

Q ss_pred             cee-eecCCeEEEEEEeC-------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-C--CceeeEEeEEEec---
Q 039344          608 HCI-GKGGQGSVYMSKLA-------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-H--RNIVKVYGFCLHV---  673 (873)
Q Consensus       608 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---  673 (873)
                      +.| +.|....+|+....       +++.+++|+..............+.+|+.+++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88889999998754       26678888865321000000134678888888884 3  3577888888665   


Q ss_pred             ceeEEEEEeccCCChhh
Q 039344          674 RHLFIVYEYFKMCSLAV  690 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~  690 (873)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.01  E-value=7.3e-07  Score=83.87  Aligned_cols=83  Identities=10%  Similarity=0.156  Sum_probs=41.6

Q ss_pred             CCceEEccCCcccccCCCCccCCCCCCEEEcccCC-CCCCCCcccccc----cccceeeccccc-cCCCCCccccCCccc
Q 039344           46 NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNK-LSGSIPPSLGNL----SNLATLYLDTNS-LSNSIPSELGNLRSL  119 (873)
Q Consensus        46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~L  119 (873)
                      +|++|+|++|.++..--..+.++++|++|+|++|. ++...-..+..+    ++|++|+|++|. |+..--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555554444444555555555555553 443222233332    246666666653 553323344556666


Q ss_pred             Ccccccccc
Q 039344          120 SNLQLNNNI  128 (873)
Q Consensus       120 ~~L~L~~n~  128 (873)
                      ++|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.95  E-value=1.7e-06  Score=81.32  Aligned_cols=83  Identities=16%  Similarity=0.099  Sum_probs=42.1

Q ss_pred             CCCeeeeccccCCccCCccccCCCCCCEEeccCCc-cCCCCCcccccc----ccccEEEecCc-cccCCccccccccccc
Q 039344          333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH-IVGEIPIELGKL----NFFIKLVLAHN-QLSGQLSPKLGSLVQL  406 (873)
Q Consensus       333 ~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~-i~~~~~~~~~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~L  406 (873)
                      +|+.||+++|.|++..-..+..+++|+.|+|++|. |++..-..+..+    ++|++|+|++| ++++..-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555554444444555555555555553 443333333332    24555555555 3554444445556666


Q ss_pred             ccccccccc
Q 039344          407 EHLDLSSNR  415 (873)
Q Consensus       407 ~~L~Ls~N~  415 (873)
                      ++|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666554

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.87  E-value=5.9e-05  Score=80.92  Aligned_cols=140  Identities=19%  Similarity=0.290  Sum_probs=81.0

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC--CceeeEEe------EEEecceeEEE
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIVKVYG------FCLHVRHLFIV  679 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv  679 (873)
                      +.++.|..+.||+....+| .+++|+....       ...+..|+.+++.+..  -.+++++.      +....+..+++
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            4466678899999987755 4889988641       1334456666665531  13344443      22346678999


Q ss_pred             EEeccCCChh--------------hHhccccc----c-------cCCChHHH----------------------------
Q 039344          680 YEYFKMCSLA--------------VILSNDAA----A-------KNLGWTRR----------------------------  706 (873)
Q Consensus       680 ~e~~~~~~L~--------------~~l~~~~~----~-------~~~~~~~~----------------------------  706 (873)
                      |||++|..+.              ..+|....    .       ....|...                            
T Consensus       110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  189 (346)
T 2q83_A          110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL  189 (346)
T ss_dssp             EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred             EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence            9999986542              01111100    0       00122211                            


Q ss_pred             ---HHHHHHHHHHHHHHHh----------CCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          707 ---MNMIKGIVDALSYMHN----------DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       707 ---~~i~~~i~~~l~~LH~----------~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                         ..+..++..++++|+.          ...+.++|||+.+.||+++.++.+.++||+.+.
T Consensus       190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence               0111234445666653          012489999999999999888899999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.75  E-value=8.5e-05  Score=81.44  Aligned_cols=78  Identities=17%  Similarity=0.056  Sum_probs=50.2

Q ss_pred             CceeeecCCeEEEEEEeC-CCcEEEEEEccCCCC--Cc--chhHHHHHHHHHHHHhccC--C-ceeeEEeEEEecceeEE
Q 039344          607 EHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLP--GE--MTFQQEFLNEVKALTEIWH--R-NIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l  678 (873)
                      .+.+|.|.++.||+++.. +++.++||.......  ..  ......+..|.++++.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 468899998653211  00  0112456778888888742  3 45566654  3455689


Q ss_pred             EEEeccCC
Q 039344          679 VYEYFKMC  686 (873)
Q Consensus       679 v~e~~~~~  686 (873)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.72  E-value=0.00018  Score=75.23  Aligned_cols=138  Identities=16%  Similarity=0.179  Sum_probs=92.2

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc---CCceeeEEeEEEecceeEEEEEec
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW---HRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      .+.++.|....+|+.... +..+++|+....      ....+..|+..++.+.   ...++++++++...+..++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            467899999999999874 677888986532      2467889999999884   367889999998888899999999


Q ss_pred             cCCChhh-----------Hhccccc----c---------------cCCChHHHH---HHHH----------------HHH
Q 039344          684 KMCSLAV-----------ILSNDAA----A---------------KNLGWTRRM---NMIK----------------GIV  714 (873)
Q Consensus       684 ~~~~L~~-----------~l~~~~~----~---------------~~~~~~~~~---~i~~----------------~i~  714 (873)
                      ++.....           .+|....    +               ..-+|....   ++..                .++
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9876421           1121111    0               011344321   1111                111


Q ss_pred             -HHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          715 -DALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       715 -~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                       .....|.. ...+.++|+|+.+.|++++.++ +.|.||+
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             11223422 2246899999999999999887 8899984

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.66  E-value=1.1e-05  Score=77.41  Aligned_cols=42  Identities=14%  Similarity=0.212  Sum_probs=18.8

Q ss_pred             CCCCCCCCeEEccCccccccccc----ccccCCCccEEeccCcccc
Q 039344          280 LRNLTSLERVRLDRNYLTGNISE----SFYIYPNLTYIDLSQNNFY  321 (873)
Q Consensus       280 l~~l~~L~~L~L~~n~l~~~~~~----~~~~~~~L~~L~Ls~N~l~  321 (873)
                      +...+.|+.|+|++|.|++....    .+...+.|++|+|++|.|+
T Consensus        66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            33344455555555555433222    2223344555555555554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.64  E-value=4.3e-06  Score=80.19  Aligned_cols=64  Identities=16%  Similarity=0.209  Sum_probs=29.7

Q ss_pred             CCCccEEeccCc-ccccc----CCCCCCCCCCCCeeeeccccCCccCCc----cccCCCCCCEEeccCCccCC
Q 039344          307 YPNLTYIDLSQN-NFYGE----ISSDWGRCPKLSTLDFSINNITGNVPP----EIGHSSQLGVLDLSSNHIVG  370 (873)
Q Consensus       307 ~~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~~~~----~~~~~~~L~~L~Ls~N~i~~  370 (873)
                      .+.|++|+|++| +|...    +..++...+.|+.|+|++|.|.+....    .+...+.|++|+|++|.|++
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            344455555443 44321    223333444555555555555433222    22344556666666666553

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.51  E-value=0.00046  Score=71.79  Aligned_cols=81  Identities=17%  Similarity=0.167  Sum_probs=58.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-C--CceeeEEeEEEecceeE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-H--RNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~  677 (873)
                      ..+....+.+|.|..+.||+.+..+|+.|++|+........   ...|..|+..|+.+. .  --+++++++.    ..+
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~   86 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT   86 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence            34555678899999999999999999999999875432221   245788999999884 2  2355666553    347


Q ss_pred             EEEEeccCCCh
Q 039344          678 IVYEYFKMCSL  688 (873)
Q Consensus       678 lv~e~~~~~~L  688 (873)
                      +||||++++..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            89999886643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.38  E-value=0.00097  Score=73.48  Aligned_cols=76  Identities=12%  Similarity=0.110  Sum_probs=48.0

Q ss_pred             CCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcccccc--ccccccccccccC---CCCCcchhHHHHHHHHHH
Q 039344          726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG--TYGYVAPELAYTM---KVTEKCDVYSFGVLALEV  800 (873)
Q Consensus       726 ~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~sDv~s~G~il~el  800 (873)
                      +.++|||+++.||+++.++ ++++||+.+....+. ........  ...|.+|+.....   ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999999876 999999988743321 11111111  1346676654321   112235556778888877


Q ss_pred             HhC
Q 039344          801 IKG  803 (873)
Q Consensus       801 ~tg  803 (873)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.10  E-value=0.0014  Score=69.69  Aligned_cols=142  Identities=15%  Similarity=0.090  Sum_probs=74.2

Q ss_pred             ceeeecCCeE-EEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC--CceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKGGQGS-VYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      +.++.|+... +|+....+|+.+++|.......      .++..|+.+++.+..  -.+++++.+..+.+  +++||++.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence            4565565554 6677665467777776543211      223456677766632  23567777754433  68999988


Q ss_pred             CCChhhHhccccc---------------------c--cCCChHHHH-------H-------------HHHHHHHHHHHHH
Q 039344          685 MCSLAVILSNDAA---------------------A--KNLGWTRRM-------N-------------MIKGIVDALSYMH  721 (873)
Q Consensus       685 ~~~L~~~l~~~~~---------------------~--~~~~~~~~~-------~-------------i~~~i~~~l~~LH  721 (873)
                      +..+.+++.....                     .  ..++.....       .             ....+...++.+.
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            7666544321110                     0  001111000       0             0011122223331


Q ss_pred             h---CCCCCeeeCCCCCCCeeeCCC----CCeEEecccccccc
Q 039344          722 N---DCFPPIVHRDISSKNVLLDFE----NEAHVSDFGIAKFL  757 (873)
Q Consensus       722 ~---~~~~~i~H~Dlk~~Nill~~~----~~~kl~Dfg~a~~~  757 (873)
                      .   ...+.++|||+.+.||+++.+    +.+.|+||+.+...
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1   123479999999999999875    67999999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.98  E-value=0.0016  Score=71.71  Aligned_cols=73  Identities=18%  Similarity=0.302  Sum_probs=50.6

Q ss_pred             CceeeecCCeEEEEEEeCC--------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce-eeEEeEEEecceeE
Q 039344          607 EHCIGKGGQGSVYMSKLAS--------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI-VKVYGFCLHVRHLF  677 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~  677 (873)
                      .+.|+.|....+|+....+        ++.+++|+...+  ..   ...+..|..+++.+...++ +++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            3568889999999998753        578999998532  11   1455679999888853333 677776542    3


Q ss_pred             EEEEeccCCCh
Q 039344          678 IVYEYFKMCSL  688 (873)
Q Consensus       678 lv~e~~~~~~L  688 (873)
                      +|+||++|.++
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999986444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.96  E-value=0.0065  Score=64.24  Aligned_cols=142  Identities=13%  Similarity=0.148  Sum_probs=82.8

Q ss_pred             ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc--eeeEEeE-----EEecceeEEEE
Q 039344          608 HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IVKVYGF-----CLHVRHLFIVY  680 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~  680 (873)
                      ..++ |....||+....+|+.+++|.......    ....+..|..+++.+....  +++++..     ....+..+++|
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            4566 888899998877787899999863211    1356777888888774222  4455543     22345668899


Q ss_pred             EeccCCChhh-----H---------hccccc------ccCCChHHH----HH---------------HHHHHHHHHHHHH
Q 039344          681 EYFKMCSLAV-----I---------LSNDAA------AKNLGWTRR----MN---------------MIKGIVDALSYMH  721 (873)
Q Consensus       681 e~~~~~~L~~-----~---------l~~~~~------~~~~~~~~~----~~---------------i~~~i~~~l~~LH  721 (873)
                      |+++|..+..     .         +|....      ....++...    ..               +...+.+.++.+.
T Consensus       107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~  186 (328)
T 1zyl_A          107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT  186 (328)
T ss_dssp             ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence            9998754320     0         111000      001121110    00               1111112233332


Q ss_pred             hC----CCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          722 ND----CFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       722 ~~----~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ..    ....++|||+++.||+++ + .+.++||+.+..
T Consensus       187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            21    223688999999999999 5 899999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.92  E-value=0.0068  Score=63.89  Aligned_cols=158  Identities=13%  Similarity=0.157  Sum_probs=88.4

Q ss_pred             cCHHHHHHHhcCCCCC-----ceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc--ee
Q 039344          592 IIYEEIIRATNDFDDE-----HCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN--IV  664 (873)
Q Consensus       592 ~~~~e~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  664 (873)
                      ++.+++......|...     +.++.|....+|+....+| .+++|......  .   .+.+..|+.+++.+....  ++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCC
Confidence            4455555555566652     3466788899999987766 57788876421  1   134567788877774222  34


Q ss_pred             eEEeE------EEecceeEEEEEeccCCChhh--------------Hhccccc--ccC----C---ChHHHHH-------
Q 039344          665 KVYGF------CLHVRHLFIVYEYFKMCSLAV--------------ILSNDAA--AKN----L---GWTRRMN-------  708 (873)
Q Consensus       665 ~l~~~------~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~~--~~~----~---~~~~~~~-------  708 (873)
                      +++..      ....+..+++|+|++|..+..              .+|....  ...    .   .|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            44421      123456789999999865321              0111100  000    0   1221100       


Q ss_pred             -----HHHHHHHHHHHHHhC----CCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          709 -----MIKGIVDALSYMHND----CFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       709 -----i~~~i~~~l~~LH~~----~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                           +...+.+.+++++..    ...+++|+|+.+.||+++.++.+.++||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 011244455555532    12478999999999999977666899999775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.91  E-value=0.0031  Score=65.88  Aligned_cols=71  Identities=13%  Similarity=-0.031  Sum_probs=45.1

Q ss_pred             CceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce-eeEEeEEEecceeEEEEEec-c
Q 039344          607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI-VKVYGFCLHVRHLFIVYEYF-K  684 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~  684 (873)
                      .+.|+.|....+|+.     +.+++|+........    ....+|+.+++.+....+ .++++++  .+.-++++||+ +
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            678999999999999     568888876431111    112467777777743233 4666543  33457899999 6


Q ss_pred             CCCh
Q 039344          685 MCSL  688 (873)
Q Consensus       685 ~~~L  688 (873)
                      +.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            5544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.89  E-value=0.00076  Score=60.36  Aligned_cols=37  Identities=24%  Similarity=0.370  Sum_probs=24.5

Q ss_pred             ccceecccCccccCCCchhhhccCCCcEEecCCCccc
Q 039344          455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR  491 (873)
Q Consensus       455 ~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~ls~N~l~  491 (873)
                      +|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4666666666666666666666666667777766664

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.83  E-value=0.0036  Score=67.28  Aligned_cols=141  Identities=16%  Similarity=0.164  Sum_probs=83.2

Q ss_pred             ceeeecCCeEEEEEEeC--------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEE
Q 039344          608 HCIGKGGQGSVYMSKLA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  678 (873)
                      +.+..|....+|+....        +++.+++|+.....    .....+.+|..+++.+. +.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            56777888999999875        25789999863311    11355678999998884 3334677776643    38


Q ss_pred             EEEeccCCChhhH-h----------------cccc--cccCCC--hHHHHHHHHHHHH-------------------HHH
Q 039344          679 VYEYFKMCSLAVI-L----------------SNDA--AAKNLG--WTRRMNMIKGIVD-------------------ALS  718 (873)
Q Consensus       679 v~e~~~~~~L~~~-l----------------~~~~--~~~~~~--~~~~~~i~~~i~~-------------------~l~  718 (873)
                      ||||++|.++..- +                |...  ..+...  +.++.++..++..                   .++
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998665311 0                1110  111122  3444445443322                   223


Q ss_pred             HH----HhC-CCCCeeeCCCCCCCeeeCCC----CCeEEeccccccc
Q 039344          719 YM----HND-CFPPIVHRDISSKNVLLDFE----NEAHVSDFGIAKF  756 (873)
Q Consensus       719 ~L----H~~-~~~~i~H~Dlk~~Nill~~~----~~~kl~Dfg~a~~  756 (873)
                      +|    ... ....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33    221 12368899999999999876    6899999998863

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.71  E-value=0.0017  Score=58.00  Aligned_cols=57  Identities=19%  Similarity=0.342  Sum_probs=40.1

Q ss_pred             CEEECCCCccc-ccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCC
Q 039344           24 SDLELGNNKLS-GSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLS   82 (873)
Q Consensus        24 ~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~   82 (873)
                      ..++-++++++ ..+|..+.  ++|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            36777777775 34554433  46778888888888666677777788888888887765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.45  E-value=0.014  Score=64.45  Aligned_cols=74  Identities=18%  Similarity=0.140  Sum_probs=48.1

Q ss_pred             CceeeecCCeEEEEEEeCC-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce-eeEEeEEEecceeEEEEEecc
Q 039344          607 EHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI-VKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  684 (873)
                      .+.|+.|....+|+....+ ++.+++|+.........    +..+|..+++.+...++ +++++++.  +  ..||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i----dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII----NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS----CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc----CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            3578889999999998875 47888988754221111    12478888888854444 57777763  2  35999998


Q ss_pred             CCCh
Q 039344          685 MCSL  688 (873)
Q Consensus       685 ~~~L  688 (873)
                      |.++
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.19  E-value=0.013  Score=62.31  Aligned_cols=32  Identities=25%  Similarity=0.320  Sum_probs=28.2

Q ss_pred             CCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          726 PPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       726 ~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      ..++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47899999999999998889999999887643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.17  E-value=0.007  Score=65.23  Aligned_cols=73  Identities=8%  Similarity=0.011  Sum_probs=44.4

Q ss_pred             ceeeecCCeEEEEEEeCC---------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc-eeeEEeEEEecceeE
Q 039344          608 HCIGKGGQGSVYMSKLAS---------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN-IVKVYGFCLHVRHLF  677 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~  677 (873)
                      +.++.|....+|+....+         ++.+++|+.......    ..+...|..+++.+...+ ++++++..  .  -+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            567888889999998654         267888887542111    112357888888875333 45676554  2  36


Q ss_pred             EEEEeccCCCh
Q 039344          678 IVYEYFKMCSL  688 (873)
Q Consensus       678 lv~e~~~~~~L  688 (873)
                      +||||++|..+
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.02  E-value=0.024  Score=54.47  Aligned_cols=103  Identities=17%  Similarity=0.105  Sum_probs=66.6

Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCcc
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT  765 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  765 (873)
                      -+|.++|...  +.+++++++|.++.|.+.++.-.-.+.  .-..+=+.|..|++..+|.|.+.+ +.+.          
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            4788888643  467999999999999999988763211  111233456889999999998764 1111          


Q ss_pred             ccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 039344          766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP  806 (873)
Q Consensus       766 ~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P  806 (873)
                        .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1123467888753 3456788999999999998865555

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.49  E-value=0.082  Score=57.47  Aligned_cols=73  Identities=8%  Similarity=-0.026  Sum_probs=47.9

Q ss_pred             ceeeecCCeEEEEEEeCC--------CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEE
Q 039344          608 HCIGKGGQGSVYMSKLAS--------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  678 (873)
                      +.+..|....+|+....+        ++.+++|+.......-    -+..+|..+++.+. +.-..++++.+.    -+.
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~----idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~  147 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF----YDSKVELDVFRYLSNINIAPNIIADFP----EGR  147 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC----CCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh----cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence            567778899999998763        5788998865421111    12347888888874 333456665432    378


Q ss_pred             EEEeccCCCh
Q 039344          679 VYEYFKMCSL  688 (873)
Q Consensus       679 v~e~~~~~~L  688 (873)
                      ||||++|.++
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.33  E-value=0.61  Score=50.42  Aligned_cols=29  Identities=24%  Similarity=0.447  Sum_probs=24.6

Q ss_pred             eeeCCCCCCCeee------CCCCCeEEeccccccc
Q 039344          728 IVHRDISSKNVLL------DFENEAHVSDFGIAKF  756 (873)
Q Consensus       728 i~H~Dlk~~Nill------~~~~~~kl~Dfg~a~~  756 (873)
                      ++|+|+.+.||++      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4456799999998863

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.70  E-value=0.77  Score=44.08  Aligned_cols=116  Identities=9%  Similarity=0.098  Sum_probs=81.3

Q ss_pred             cCCceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       659 ~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      .||+.++. .+-.+.+.+.+.|+.-+.+  ..+    ..-...+...+++++.+|+...++++++     +|--+.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f----~~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPF----DNIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTS--EEG----GGGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCccc--CCH----HHHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence            58888866 4556667666666654422  222    1123478889999999999999877766     7889999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCc
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD  808 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~  808 (873)
                      +++.++.+++.-.|+...+                 +|.     ..++..=.-.+=+++..++++++.|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999877754332                 222     11222233456688889999999986

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=86.82  E-value=0.44  Score=32.49  Aligned_cols=24  Identities=21%  Similarity=0.321  Sum_probs=11.1

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhccc
Q 039344          544 PLLGFVALLISLIGLFFKFQRRKN  567 (873)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~~~~  567 (873)
                      .+.|++++++++++++++++||+.
T Consensus        17 VVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           17 MVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             hhHHHHHHHHHHHHHHHHhhhhHh
Confidence            333344444444444555554444

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.53  E-value=0.49  Score=32.16  Aligned_cols=23  Identities=17%  Similarity=0.206  Sum_probs=10.3

Q ss_pred             HHHHHHHHHHHHHHhhhhhcccc
Q 039344          546 LGFVALLISLIGLFFKFQRRKND  568 (873)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~~~  568 (873)
                      .|+++++++++.++++++||+.+
T Consensus        18 gGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           18 GGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHhhhhhhh
Confidence            33444444444444444444433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.79  E-value=2.1  Score=41.18  Aligned_cols=115  Identities=10%  Similarity=0.077  Sum_probs=79.8

Q ss_pred             cCCceeeEEeEEEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCCC
Q 039344          659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS-YMHNDCFPPIVHRDISSKN  737 (873)
Q Consensus       659 ~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~Dlk~~N  737 (873)
                      .||+.  -..+-.+++.+.+.++.-+++.-...+      ...+...+++++.+|+.... +++++     +|--+.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence            57887  444446677777777765444222222      34788899999999999888 77765     788899999


Q ss_pred             eeeCCCCCeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCc
Q 039344          738 VLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD  808 (873)
Q Consensus       738 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~  808 (873)
                      +++|.++.+++.-.|+-..                 ++|..     .++..=.-.+=+++..++.+++.|+
T Consensus       115 L~f~~~~~p~i~hRGi~~~-----------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKES-----------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTT-----------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCccc-----------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999987765432                 33332     1111223356678888888888876

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=83.68  E-value=0.81  Score=31.05  Aligned_cols=25  Identities=12%  Similarity=0.288  Sum_probs=10.9

Q ss_pred             ehHHHHHHHHHHHHHHHHhhhhhcc
Q 039344          542 VFPLLGFVALLISLIGLFFKFQRRK  566 (873)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~  566 (873)
                      +..++|+++++++.++++++.|||+
T Consensus        15 a~~vVGvll~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           15 ISAVVGILLVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhheehhh
Confidence            3444454444444444444444443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	873
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-51
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-22
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-12
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.004
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	9e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 9e-57
 Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 22/282 (7%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           EI            IG G  G+VY  K      +AVK  +   P      Q F NEV  L
Sbjct: 4   EIPD--GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTP-QQLQAFKNEVGVL 58

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
            +  H NI+   G+      L IV ++ +  SL   L            + +++ +    
Sbjct: 59  RKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQ 115

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGY 773
            + Y+H      I+HRD+ S N+ L  +    + DFG+A      S +  + +L+G+  +
Sbjct: 116 GMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 774 VAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
           +APE+         + + DVY+FG++  E++ G+ P    S+++     + +     L P
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSP 229

Query: 831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            L     N    +  ++     C+ +  + RP   ++   ++
Sbjct: 230 DLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 67/273 (24%), Positives = 119/273 (43%), Gaps = 18/273 (6%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           D++  + IG G  G     +  + G+I+  K+       E   +Q  ++EV  L E+ H 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63

Query: 662 NIVKVYGFCLHV--RHLFIVYEYFKMCSLA-VILSNDAAAKNLGWTRRMNMIKGIVDALS 718
           NIV+ Y   +      L+IV EY +   LA VI       + L     + ++  +  AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 719 YMH--NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
             H  +D    ++HRD+   NV LD +    + DFG+A+ L  D+S      GT  Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 777 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
           E    M   EK D++S G L  E+     P        F++ +      ++ + +     
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPP--------FTAFSQKELAGKIREGKFRRIP 235

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
               D+L  I+      ++     RP+++++ +
Sbjct: 236 YRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 55/272 (20%), Positives = 106/272 (38%), Gaps = 20/272 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
                   +G G  G V+M        +AVK               FL E   + ++ H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQHQ 68

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            +V++Y        ++I+ EY +  SL   L   +  K L   + ++M   I + ++++ 
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW-TELAGTYGYVAPELAY 780
                  +HRD+ + N+L+       ++DFG+A+ ++ +             + APE   
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
               T K DV+SFG+L  E++             +  +     +  +          N  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP-------YPGMTNPEVIQNLERGYRMVRPDNCP 236

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           ++L  ++     C  E PE RPT   +  +L+
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLE 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 7e-53
 Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 21/269 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            DF+    +GKG  G+VY+++   S  I+A+K        +   + +   EV+  + + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            NI+++YG+      ++++ EY  + ++   L            R    I  + +ALSY 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     ++HRDI  +N+LL    E  ++DFG +      SS  T L GT  Y+ PE+  
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIE 177

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
                EK D++S GVL  E + GK P        F +         +       P   V 
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP--------FEANTYQETYKRISRVEFTFPD-FVT 228

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQ 869
           +    ++      +  NP  RP +++V +
Sbjct: 229 EGARDLIS---RLLKHNPSQRPMLREVLE 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-52
 Identities = 54/272 (19%), Positives = 115/272 (42%), Gaps = 20/272 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           ++      IG G  G V++    + + +A+K            +++F+ E + + ++ H 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSHP 60

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            +V++YG CL    + +V+E+ +   L+  L              + M   + + ++Y+ 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLE 118

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE-LAGTYGYVAPELAY 780
                 ++HRD++++N L+       VSDFG+ +F+  D    +        + +PE+  
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
             + + K DV+SFGVL  EV              + + + +  ++++         R   
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI-------PYENRSNSEVVEDISTGFRLYKPRLAS 228

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             +  I+     C  E PE RP   ++ + L 
Sbjct: 229 THVYQIMN---HCWKERPEDRPAFSRLLRQLA 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (461), Expect = 6e-52
 Identities = 63/298 (21%), Positives = 123/298 (41%), Gaps = 37/298 (12%)

Query: 594 YEEIIRATNDFDDE---------HCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPG 640
           +E+   A  +F  E           IG G  G V    L         +A+K   S    
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 641 EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN 700
           +   +++FL+E   + +  H N++ + G       + I+ E+ +  SL   L  +     
Sbjct: 69  KQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQ 124

Query: 701 LGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD 760
               + + M++GI   + Y+ +      VHRD++++N+L++      VSDFG+++FL+ D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 761 SSNWTELA-----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMS 814
           +S+ T  +         + APE     K T   DV+S+G++  EV+  G+ P        
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 233

Query: 815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +  +     ++ +       P  +    L  ++     C  ++   RP   ++   L 
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML---DCWQKDRNHRPKFGQIVNTLD 288

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-51
 Identities = 60/273 (21%), Positives = 112/273 (41%), Gaps = 22/273 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            D      +G G  G V   K      +A+K            + EF+ E K +  + H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLSHE 59

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
            +V++YG C   R +FI+ EY     L   L            + + M K + +A+ Y+ 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGTYGYVAPELAY 780
                  +HRD++++N L++ +    VSDFG+++++  D  ++         +  PE+  
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 781 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
             K + K D+++FGVL  E+   GK P        +     +   + +            
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMP--------YERFTNSETAEHIAQGLRLYRPHLA 226

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            +K+ +I+    SC  E  + RPT + +   + 
Sbjct: 227 SEKVYTIMY---SCWHEKADERPTFKILLSNIL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-51
 Identities = 60/303 (19%), Positives = 114/303 (37%), Gaps = 42/303 (13%)

Query: 600 ATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
             +DF+    +G G  G V+      SG ++A K  H  L  +   + + + E++ L E 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHEC 61

Query: 659 WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
               IV  YG       + I  E+    SL  +L     A  +       +   ++  L+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLT 118

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           Y+       I+HRD+   N+L++   E  + DFG++  L    +      GT  Y++PE 
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHP------------------------------RD 808
                 + + D++S G+  +E+  G++P                                
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 809 FISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQK 866
              S         +A+ E+LD  +  P   +   + S    +    C+ +NP  R  +++
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 867 VCQ 869
           +  
Sbjct: 295 LMV 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 5e-51
 Identities = 65/272 (23%), Positives = 110/272 (40%), Gaps = 24/272 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            +      IGKG  G V +     G  +AVK   +         Q FL E   +T++ H 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60

Query: 662 NIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           N+V++ G  +  +  L+IV EY    SL   L        LG    +     + +A+ Y+
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
                   VHRD++++NVL+  +N A VSDFG+ K     SS          + APE   
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
             K + K DV+SFG+L  E+              +  + L   +  +             
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVVPRVEKGYKMDAPDGCP 226

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             +  +++   +C   +   RP+  ++ + L+
Sbjct: 227 PAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-50
 Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 22/278 (7%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           EI R       E  +G+G  G V+M        +A+K             + FL E + +
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFLQEAQVM 66

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
            ++ H  +V++Y        ++IV EY    SL   L  +   K L   + ++M   I  
Sbjct: 67  KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIAS 124

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD-SSNWTELAGTYGYV 774
            ++Y+        VHRD+ + N+L+       V+DFG+A+ ++ +  +          + 
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPT 834
           APE A   + T K DV+SFG+L  E+              +  +     LD++       
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMVNREVLDQVERGYRMP 234

Query: 835 PSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                 + L  ++     C  + PE RPT + +   L+
Sbjct: 235 CPPECPESLHDLMC---QCWRKEPEERPTFEYLQAFLE 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 4e-50
 Identities = 57/274 (20%), Positives = 112/274 (40%), Gaps = 26/274 (9%)

Query: 606 DEHCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           ++  +G G  G+V           + +AVK   +    +   + E L E   + ++ +  
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPY 69

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
           IV++ G C       +V E  ++  L   L  +   +++     + ++  +   + Y+  
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLE- 124

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW---TELAGTYGYVAPELA 779
                 VHRD++++NVLL  ++ A +SDFG++K L+ D + +   T       + APE  
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 780 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
              K + K DV+SFGVL  E    G+ P        +  +  +     +           
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP--------YRGMKGSEVTAMLEKGERMGCPAG 234

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              ++  ++     C   + E+RP    V   L+
Sbjct: 235 CPREMYDLMN---LCWTYDVENRPGFAAVELRLR 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 7e-50
 Identities = 57/272 (20%), Positives = 113/272 (41%), Gaps = 25/272 (9%)

Query: 604 FDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           FD E  IG+G   +VY      +   +A  +       + + +Q F  E + L  + H N
Sbjct: 13  FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69

Query: 663 IVKVYGFCLHV----RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
           IV+ Y          + + +V E     +L   L      K +      +  + I+  L 
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQ 126

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           ++H    PPI+HRD+   N+ +        + D G+A   +   +    + GT  ++APE
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPE 183

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
           + Y  K  E  DVY+FG+  LE+   ++P  +    + + +   +        +  +  +
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRV----TSGVKPASFDK 236

Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
               ++  I+E    C+ +N + R +++ +  
Sbjct: 237 VAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-49
 Identities = 65/285 (22%), Positives = 129/285 (45%), Gaps = 26/285 (9%)

Query: 594 YEEIIRATN---DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFL 649
           YE + R  N    ++    +G G  G VY ++   +  + A K   +    E+   ++++
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYM 57

Query: 650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNM 709
            E+  L    H NIVK+     +  +L+I+ E+    ++  ++      + L  ++   +
Sbjct: 58  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVV 115

Query: 710 IKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAG 769
            K  +DAL+Y+H+     I+HRD+ + N+L   + +  ++DFG++              G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172

Query: 770 TYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL 824
           T  ++APE+             K DV+S G+  +E+ + + P   ++ M    + L IA 
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAK 229

Query: 825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            E   P L  PSR         ++    C+++N ++R T  ++ Q
Sbjct: 230 SE--PPTLAQPSR-WSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 2e-49
 Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 26/271 (9%)

Query: 604 FDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN 662
           F D   IG G  G+VY ++ + + E++A+KK            Q+ + EV+ L ++ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 663 IVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
            ++  G  L     ++V EY    +  ++  +    K L       +  G +  L+Y+H+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS 133

Query: 723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 782
                ++HRD+ + N+LL       + DFG A  + P +S      GT  ++APE+   M
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 186

Query: 783 ---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML-DPRLPTPSRN 838
              +   K DV+S G+  +E+ + K P          ++N   AL  +  +      S +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP--------LFNMNAMSALYHIAQNESPALQSGH 238

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             +   + V+   SC+ + P+ RPT + + +
Sbjct: 239 WSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (440), Expect = 4e-49
 Identities = 52/300 (17%), Positives = 115/300 (38%), Gaps = 44/300 (14%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 655
           N+ +    IG+G  G V+ ++           ++AVK        +M  Q +F  E   +
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70

Query: 656 TEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN--------------------- 694
            E  + NIVK+ G C   + + +++EY     L   L +                     
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 695 DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA 754
                 L    ++ + + +   ++Y+        VHRD++++N L+       ++DFG++
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 755 KFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 812
           + +            A    ++ PE  +  + T + DV+++GV+  E+            
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP----- 242

Query: 813 MSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             +  +     +  + D  +     N   +L +++     C  + P  RP+   + ++L+
Sbjct: 243 --YYGMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 297

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 5e-49
 Identities = 57/286 (19%), Positives = 111/286 (38%), Gaps = 27/286 (9%)

Query: 595 EEIIRATNDFD-DEHCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLN 650
           +++    ++    +  +G G  GSV             +A+K        E    +E + 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 58

Query: 651 EVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
           E + + ++ +  IV++ G C     L +V E      L   L      + +  +    ++
Sbjct: 59  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELL 115

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE---L 767
             +   + Y+        VHRD++++NVLL   + A +SDFG++K L  D S +T     
Sbjct: 116 HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 768 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDE 826
                + APE     K + + DV+S+GV   E +  G+ P        +  +     +  
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--------YKKMKGPEVMAF 224

Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +   +          +L +++     C     E RP    V Q ++
Sbjct: 225 IEQGKRMECPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMR 267

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-48
 Identities = 62/270 (22%), Positives = 128/270 (47%), Gaps = 20/270 (7%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              +     IG+G  G+VY +  +A+G+ +A+++ +     +   ++  +NE+  + E  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           + NIV      L    L++V EY    SL  +++       +   +   + +  + AL +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEF 131

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H++    ++HRDI S N+LL  +    ++DFG    + P+ S  + + GT  ++APE+ 
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
                  K D++S G++A+E+I+G+ P  +++     +L L         P L  P   +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGT---PELQNPE-KL 242

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                  +     C+D + E R + +++ Q
Sbjct: 243 SAIFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (434), Expect = 2e-48
 Identities = 59/273 (21%), Positives = 111/273 (40%), Gaps = 20/273 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            D   +H +G G  G VY          +AVK        +    +EFL E   + EI H
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKH 72

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+V++ G C      +I+ E+    +L   L  +   + +     + M   I  A+ Y+
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN-WTELAGTYGYVAPELA 779
                   +HRD++++N L+   +   V+DFG+++ +  D+            + APE  
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
              K + K DV++FGVL  E+              +  ++L+   + +            
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLSQVYELLEKDYRMERPEGC 241

Query: 840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            +K+  ++    +C   NP  RP+  ++ Q  +
Sbjct: 242 PEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 271

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 9e-48
 Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 21/272 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            D+D    +G+G  G V ++    + E +AVK     +   +   +    E+     + H
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
            N+VK YG        ++  EY     L   +  D     +           ++  + Y+
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYL 119

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPEL 778
           H      I HRDI  +N+LLD  +   +SDFG+A   + ++      ++ GT  YVAPEL
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 779 AYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
               +   E  DV+S G++   ++ G+ P D  S             D         P +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKKTYLNPWK 230

Query: 838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            +    ++++      + ENP +R T+  + +
Sbjct: 231 KIDSAPLALLH---KILVENPSARITIPDIKK 259

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 1e-47
 Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 40/296 (13%)

Query: 607 EHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKV 666
           +  IGKG  G V+  K   GE +AVK F S    E ++ +E   E+     + H NI+  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 62

Query: 667 YGFC----LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN 722
                        L++V +Y +  SL   L+       +     + +       L+++H 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 118

Query: 723 DCF-----PPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW----TELAGTYGY 773
           +       P I HRD+ SKN+L+       ++D G+A      +           GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 774 VAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN------ 821
           +APE+          +  ++ D+Y+ G++  E+ +                +L       
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 822 -----IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                +  ++ L P +P   ++  + L  + ++   C   N  +R T  ++ + L 
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQS-CEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 57/279 (20%), Positives = 111/279 (39%), Gaps = 25/279 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGE-----IIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
           +    +  IG G  G VY   L +        +A+K   +    +   + +FL E   + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64

Query: 657 EIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDA 716
           +  H NI+++ G     + + I+ EY +  +L   L            + + M++GI   
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAG 122

Query: 717 LSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW---TELAGTYGY 773
           + Y+ N      VHRD++++N+L++      VSDFG+++ L+ D       +       +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
            APE     K T   DV+SFG++  EV+             +  L+ +  +  + D    
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------YWELSNHEVMKAINDGFRL 232

Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
               +    +  ++     C  +    RP    +  +L 
Sbjct: 233 PTPMDCPSAIYQLMM---QCWQQERARRPKFADIVSILD 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-47
 Identities = 57/308 (18%), Positives = 119/308 (38%), Gaps = 49/308 (15%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFL 649
           E  R   + +    +G G  G V       +SK      +AVK        + + ++  +
Sbjct: 33  EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALM 88

Query: 650 NEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-------------- 694
           +E+K +T++  H NIV + G C     +++++EY     L   L +              
Sbjct: 89  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 695 ------DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHV 748
                 +     L +   +     +   + ++        VHRD++++NVL+       +
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 205

Query: 749 SDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKH 805
            DFG+A+ +  DS+            ++APE  +    T K DV+S+G+L  E+   G +
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

Query: 806 PRDFISSMSFSSLNLNIALDEMLDPRL-PTPSRNVHDKLISIVEVTISCVDENPESRPTM 864
           P        +  + ++    +++             +++  I++   SC   +   RP+ 
Sbjct: 266 P--------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSF 314

Query: 865 QKVCQLLK 872
             +   L 
Sbjct: 315 PNLTSFLG 322

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 28/281 (9%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
            D      +G G  G V   +          +AVK     +  +     +F+ EV A+  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 658 IWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
           + HRN++++YG  L    + +V E   + SL   L       +            + + +
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 124

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW---TELAGTYGYV 774
            Y+ +      +HRD++++N+LL   +   + DFG+ + L  +  ++         + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEML--DPR 831
           APE   T   +   D + FGV   E+   G+ P        +  LN +  L ++     R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGER 233

Query: 832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           LP P  +    + +++     C    PE RPT   +   L 
Sbjct: 234 LPRPE-DCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 21/278 (7%)

Query: 599 RATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 657
           +   DF     +G+G   +V +++ LA+    A+K        +         E   ++ 
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 658 IWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
           + H   VK+Y        L+    Y K   L   +       +   T        IV AL
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSAL 121

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVA 775
            Y+H      I+HRD+  +N+LL+ +    ++DFG AK L P+S         GT  YV+
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
           PEL       +  D+++ G +  +++ G  P        F + N  +   +++      P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP--------FRAGNEYLIFQKIIKLEYDFP 230

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLKI 873
                 K   +VE     +  +   R   +++     +
Sbjct: 231 E-KFFPKARDLVE---KLLVLDATKRLGCEEMEGYGPL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 8e-46
 Identities = 53/288 (18%), Positives = 112/288 (38%), Gaps = 33/288 (11%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 658
           ND   +  IG+G  G V  +++         A+K+       +    ++F  E++ L ++
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67

Query: 659 W-HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-------------DAAAKNLGWT 704
             H NI+ + G C H  +L++  EY    +L   L               ++ A  L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
           + ++    +   + Y+        +HRD++++N+L+     A ++DFG+++  +      
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIAL 824
                   ++A E       T   DV+S+GVL  E++             +  +      
Sbjct: 185 M-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------PYCGMTCAELY 236

Query: 825 DEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +++          N  D++  ++     C  E P  RP+  ++   L 
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLN 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 26/272 (9%)

Query: 610 IGKGGQGSVYMSKLA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVK 665
           IG+G  G VY   L          AVK  +     ++    +FL E   + +  H N++ 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 666 VYGFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC 724
           + G CL       +V  Y K   L   + N+     +       +          M    
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA-----KGMKFLA 147

Query: 725 FPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS----SNWTELAGTYGYVAPELAY 780
               VHRD++++N +LD +    V+DFG+A+ +         N T       ++A E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
           T K T K DV+SFGVL  E++    P        +  +N       +L  R         
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 841 DKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           D L  ++     C     E RP+  ++   + 
Sbjct: 261 DPLYEVML---KCWHPKAEMRPSFSELVSRIS 289

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 4e-45
 Identities = 59/302 (19%), Positives = 120/302 (39%), Gaps = 42/302 (13%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFL 649
           E  R  N       +G G  G V       + K  +   +AVK         +T ++  +
Sbjct: 19  EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALM 74

Query: 650 NEVKALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSN-------------- 694
           +E+K L+ +  H NIV + G C       ++ EY     L   L                
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 695 -DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI 753
            +     L     ++    +   ++++ +      +HRD++++N+LL       + DFG+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191

Query: 754 AKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 811
           A+ +K DS+            ++APE  +    T + DV+S+G+   E+           
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---- 247

Query: 812 SMSFSSLNLNIALDEMLDPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQL 870
              +  + ++    +M+       S  +   ++  I++   +C D +P  RPT +++ QL
Sbjct: 248 ---YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQL 301

Query: 871 LK 872
           ++
Sbjct: 302 IE 303

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  163 bits (414), Expect = 5e-45
 Identities = 50/271 (18%), Positives = 107/271 (39%), Gaps = 20/271 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           + +D    +G G  G V+     A+G   A K   +P     + ++    E++ ++ + H
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRH 82

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             +V ++        + ++YE+     L   +++      +     +  ++ +   L +M
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           H +     VH D+  +N++   +    +   DFG+   L P  S      GT  + APE+
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEV 196

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN 838
           A    V    D++S GVL+  ++ G  P  F       +L    + D  +D         
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAF---SG 251

Query: 839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           + +     +      +  +P +R T+ +  +
Sbjct: 252 ISEDGKDFIR---KLLLADPNTRMTIHQALE 279

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-44
 Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 27/283 (9%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNE 651
           EI R     +   CIG+G  G V+     S       +A+K   +      + +++FL E
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQE 58

Query: 652 VKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIK 711
              + +  H +IVK+ G       ++I+ E   +  L   L       +L     +    
Sbjct: 59  ALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAY 115

Query: 712 GIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS-NWTELAGT 770
            +  AL+Y+ +      VHRDI+++NVL+   +   + DFG++++++  +    ++    
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172

Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSFSSLNLNIALDEMLD 829
             ++APE     + T   DV+ FGV   E++  G  P   + +        N        
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------G 225

Query: 830 PRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
            RLP P  N    L S++     C   +P  RP   ++   L 
Sbjct: 226 ERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 1e-43
 Identities = 57/292 (19%), Positives = 112/292 (38%), Gaps = 32/292 (10%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFL 649
           E+ R          +G+G  G VY      + K      +A+K  +      M  + EFL
Sbjct: 16  EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 71

Query: 650 NEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-------SNDAAAKNLG 702
           NE   + E    ++V++ G     +   ++ E      L   L       +N+       
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
            ++ + M   I D ++Y++       VHRD++++N ++  +    + DFG+ + +     
Sbjct: 132 LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 763 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL 820
                +      +++PE       T   DV+SFGV+  E+              +  L+ 
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGLSN 241

Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
              L  +++  L     N  D L  ++     C   NP+ RP+  ++   +K
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-43
 Identities = 59/284 (20%), Positives = 114/284 (40%), Gaps = 26/284 (9%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVYMSK-LASGE----IIAVKKFHSPLPGEMTFQQEFLN 650
            I++ T +F     +G G  G+VY    +  GE     +A+K+       +    +E L+
Sbjct: 4   RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60

Query: 651 EVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMI 710
           E   +  + + ++ ++ G CL      I       C L  +  +     N+G    +N  
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWC 117

Query: 711 KGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW--TELA 768
             I   ++Y+       +VHRD++++NVL+       ++DFG+AK L  +   +      
Sbjct: 118 VQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML 828
               ++A E       T + DV+S+GV   E++           +  S ++  +   E  
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGE-- 230

Query: 829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
             RLP P       +  I+     C   + +SRP  +++     
Sbjct: 231 --RLPQPP-ICTIDVYMIMV---KCWMIDADSRPKFRELIIEFS 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (401), Expect = 3e-43
 Identities = 50/274 (18%), Positives = 107/274 (39%), Gaps = 26/274 (9%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           + +D    +G G  G V+     A+G +   K  ++P P +   +    NE+  + ++ H
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHH 85

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             ++ ++        + ++ E+     L   ++ +     +     +N ++   + L +M
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHM 143

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPEL 778
           H      IVH DI  +N++ + +  + V   DFG+A  L PD         T  + APE+
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEI 199

Query: 779 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR- 837
                V    D+++ GVL   ++ G  P        F+  +    L  +           
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP--------FAGEDDLETLQNVKRCDWEFDEDA 251

Query: 838 --NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             +V  +    ++   + + + P  R T+    +
Sbjct: 252 FSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 9e-43
 Identities = 57/266 (21%), Positives = 103/266 (38%), Gaps = 20/266 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW- 659
            DF     +GKG  G V++++   + +  A+K     +       +  + E + L+  W 
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H  +  ++       +LF V EY     L   + +         +R       I+  L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H+     IV+RD+   N+LLD +    ++DFG+ K      +      GT  Y+APE+ 
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
              K     D +SFGVL  E++ G+ P        F   +       +       P R +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP--------FHGQDEEELFHSIRMDNPFYP-RWL 226

Query: 840 HDKLISIVEVTISCVDENPESRPTMQ 865
             +   ++          PE R  ++
Sbjct: 227 EKEAKDLLV---KLFVREPEKRLGVR 249

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 68/283 (24%), Positives = 125/283 (44%), Gaps = 24/283 (8%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
           ++ ++    +G GG   V++++ L     +AVK   + L  + +F   F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 660 HRNIVKVYGFCLHVRH----LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           H  IV VY             +IV EY    +L  I+  +     +   R + +I     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTE---LAGTYG 772
           AL++ H      I+HRD+   N+++   N   V DFGIA+ +    ++ T+   + GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 773 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           Y++PE A    V  + DVYS G +  EV+ G+ P    +  S  S+      ++ + P  
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSA 236

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRP-TMQKVCQ-LLKI 873
                 +   L ++V      + +NPE+R  T  ++   L+++
Sbjct: 237 RHE--GLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 9e-42
 Identities = 56/263 (21%), Positives = 110/263 (41%), Gaps = 22/263 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
            DF     +G G  G V++ +   +G   A+K     +   +   +   +E   L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             I++++G     + +F++ +Y +   L  +L      +             +  AL Y+
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     I++RD+  +N+LLD      ++DFG AK++         L GT  Y+APE+  
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVS 174

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
           T    +  D +SFG+L  E++ G  P        F   N     +++L+  L  P    +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP--------FYDSNTMKTYEKILNAELRFPP-FFN 225

Query: 841 DKLISIVEVTISCVDENPESRPT 863
           + +  ++      +  +   R  
Sbjct: 226 EDVKDLLS---RLITRDLSQRLG 245

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 57/273 (20%), Positives = 110/273 (40%), Gaps = 21/273 (7%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
            + +D    +G G    V +++   + +++A+K            +    NE+  L +I 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KKALEGKEGSMENEIAVLHKIK 65

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NIV +        HL+++ +      L   +                +I  ++DA+ Y
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKY 122

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 779
           +H+        +  +     LD +++  +SDFG++K   P S   T   GT GYVAPE+ 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVL 181

Query: 780 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR-- 837
                ++  D +S GV+A  ++ G  P        F   N     +++L       S   
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPP--------FYDENDAKLFEQILKAEYEFDSPYW 233

Query: 838 -NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
            ++ D     +      ++++PE R T ++  Q
Sbjct: 234 DDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-41
 Identities = 54/295 (18%), Positives = 112/295 (37%), Gaps = 39/295 (13%)

Query: 602 NDFDDEHCIGKGGQGSVYM--------SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 653
           +       +G+G  G V +         K      +AVK   S    +     + ++E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70

Query: 654 ALTEIW-HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVIL-------------SNDAAAK 699
            +  I  H+NI+ + G C     L+++ EY    +L   L              +    +
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 700 NLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP 759
            L     ++    +   + Y+ +      +HRD++++NVL+  +N   ++DFG+A+ +  
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 760 DSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSS 817
                          ++APE  +    T + DV+SFGVL  E+              +  
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------PYPG 240

Query: 818 LNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           + +      + +        N  ++L  ++     C    P  RPT +++ + L 
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 55/289 (19%), Positives = 112/289 (38%), Gaps = 31/289 (10%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
             +     IG+G  G VY ++   GE  A+KK       E       + E+  L E+ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NIVK+Y      + L +V+E+       ++   +     L      + +  +++ ++Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH 117

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAY 780
           +     ++HRD+  +N+L++ E E  ++DFG+A+        +T    T  Y AP+ L  
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS--------------------FSSLNL 820
           + K +   D++S G +  E++ G      +S                             
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           +            +  + + +  I ++      +  +P  R T ++  +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-41
 Identities = 50/266 (18%), Positives = 106/266 (39%), Gaps = 27/266 (10%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G+G  G V+     +S +    K        + T Q     E+  L    HRNI+ ++ 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 669 FCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPI 728
               +  L +++E+     +   ++    A  L     ++ +  + +AL ++H+     I
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNI 123

Query: 729 VHRDISSKNVLLDFENEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 786
            H DI  +N++      + +   +FG A+ LKP  +    L     Y APE+     V+ 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVST 182

Query: 787 KCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS---RNVHDKL 843
             D++S G L   ++ G +P        F +      ++ +++          + +  + 
Sbjct: 183 ATDMWSLGTLVYVLLSGINP--------FLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 844 ISIVEVTISCVDENPESRPTMQKVCQ 869
           +  V+     + +  +SR T  +  Q
Sbjct: 235 MDFVD---RLLVKERKSRMTASEALQ 257

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 54/276 (19%), Positives = 110/276 (39%), Gaps = 23/276 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTE 657
           + +D    +G G    V   +  ++G   A K   K  +        +++   EV  L E
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 658 IWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
           I H N++ ++    +   + ++ E      L       A  ++L        +K I++ +
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGV 126

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEA----HVSDFGIAKFLKPDSSNWTELAGTYGY 773
            Y+H+     I H D+  +N++L   N       + DFG+A  +   +  +  + GT  +
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182

Query: 774 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
           VAPE+     +  + D++S GV+   ++ G  P  F+      +L    A++   +    
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYF 240

Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
               N        +      + ++P+ R T+Q   Q
Sbjct: 241 ---SNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 5e-40
 Identities = 47/287 (16%), Positives = 100/287 (34%), Gaps = 27/287 (9%)

Query: 598 IRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
           +R  N +     IG G  G +Y+   +A+GE +A+K          T   +   E K   
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57

Query: 657 EIWHRNIVKVYGFCLHVR-HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
            +     +    +C     +  +V E        +        +       + +   ++ 
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114

Query: 716 ALSYMHNDCFPPIVHRDISSKNVL---LDFENEAHVSDFGIAKFLKPDSSN-------WT 765
            + Y+H+      +HRD+   N L       N  ++ DFG+AK  +   ++         
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALD 825
            L GT  Y +      ++ + + D+ S G + +    G  P   + + +       I+  
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231

Query: 826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
           +M  P +    +    +  + +     C     + +P    + QL +
Sbjct: 232 KMSTP-IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (369), Expect = 8e-40
 Identities = 56/284 (19%), Positives = 114/284 (40%), Gaps = 35/284 (12%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMT------FQQEFLNEVKAL 655
           +++ +  +G+G    V       + +  AVK       G  +       ++  L EV  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 656 TEI-WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIV 714
            ++  H NI+++          F+V++  K   L   L+       L       +++ ++
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120

Query: 715 DALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           + +  +H      IVHRD+  +N+LLD +    ++DFG +  L P      E+ GT  Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176

Query: 775 APELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML 828
           APE+             ++ D++S GV+   ++ G  P        F      + L  ++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--------FWHRKQMLMLRMIM 228

Query: 829 --DPRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             + +  +P   +  D +  +V      +   P+ R T ++   
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 58/283 (20%), Positives = 110/283 (38%), Gaps = 32/283 (11%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEM--TFQQEFLNEVKALTEIWHRNIVKV 666
           +G+G   +VY ++   + +I+A+KK       E      +  L E+K L E+ H NI+ +
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 667 YGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFP 726
                H  ++ +V+++ +     +I  N      L  +     +   +  L Y+H     
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 727 PIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-T 785
            I+HRD+   N+LLD      ++DFG+AK     +  +T    T  Y APEL +  ++  
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 786 EKCDVYSFGVLALEVIKGKHPRDFISSM-------------------SFSSLNLNIALDE 826
              D+++ G +  E++         S +                      SL   +    
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
                L        D L+ +++        NP +R T  +  +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (372), Expect = 3e-39
 Identities = 57/270 (21%), Positives = 98/270 (36%), Gaps = 22/270 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEV---KALTE 657
           NDF     IG+GG G VY  +   +G++ A+K            +   LNE      ++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 658 IWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
                IV +         L  + +      L   LS                   I+  L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
            +MHN     +V+RD+   N+LLD      +SD G+A        + +   GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175

Query: 778 -LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS 836
            L   +      D +S G +  ++++G  P     +     ++        L   +  P 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TLTMAVELPD 230

Query: 837 RNVHDKLISIVEVTISCVDENPESRPTMQK 866
            +   +L S++E     +  +   R     
Sbjct: 231 -SFSPELRSLLE---GLLQRDVNRRLGCLG 256

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-38
 Identities = 61/266 (22%), Positives = 105/266 (39%), Gaps = 19/266 (7%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           NDFD    +GKG  G V + +  A+G   A+K     +          + E + L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             +  +         L  V EY     L   LS +   +     R       IV AL Y+
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYL 121

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     +V+RDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE+  
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
                   D +  GV+  E++ G+ P        F + +     + +L   +  P R + 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP--------FYNQDHERLFELILMEEIRFP-RTLS 229

Query: 841 DKLISIVEVTISCVDENPESRPTMQK 866
            +  S++      + ++P+ R     
Sbjct: 230 PEAKSLLA---GLLKKDPKQRLGGGP 252

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 9e-38
 Identities = 52/289 (17%), Positives = 110/289 (38%), Gaps = 31/289 (10%)

Query: 603 DFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
           +F     IG+G  G VY ++   +GE++A+KK       E       + E+  L E+ H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61

Query: 662 NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMH 721
           NIVK+         L++V+E+        + ++      +      + +  ++  L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH 119

Query: 722 NDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAY 780
           +     ++HRD+  +N+L++ E    ++DFG+A+        +T    T  Y APE L  
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS--------------------FSSLNL 820
               +   D++S G +  E++  +      S +                      S  + 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 821 NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             +  +            + +   S++      +  +P  R + +    
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 42/277 (15%), Positives = 93/277 (33%), Gaps = 29/277 (10%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN-IVKVY 667
           IG+G  G ++    L + + +A+K          +   +  +E +    +     I  VY
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 668 GFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP 727
            F     H  +V +        ++       +           K ++  +  +H      
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 728 IVHRDISSKNVLLD-----FENEAHVSDFGIAKFLKPDSSN-------WTELAGTYGYVA 775
           +V+RDI   N L+        N  +V DFG+ KF +   +           L+GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 776 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP 835
                  + + + D+ + G + +  ++G  P   + + +       I   +   P L   
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LREL 240

Query: 836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK 872
                ++    +       +   ++ P    +  L  
Sbjct: 241 CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 7e-37
 Identities = 60/302 (19%), Positives = 113/302 (37%), Gaps = 43/302 (14%)

Query: 596 EIIRATNDFDDEHCIGKGGQGSVY------MSKLASGEIIAVKKFHSPLPGEMTFQQEFL 649
           E  R  +       +G+G  G V       + K A+   +AVK             +  +
Sbjct: 9   EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALM 64

Query: 650 NEVKALTEIWHR-NIVKVYGFCLHV-RHLFIVYEYFKMCSLAVILSN------------- 694
           +E+K L  I H  N+V + G C      L ++ E+ K  +L+  L +             
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 695 DAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA 754
           D     L     +     +   + ++ +      +HRD++++N+LL  +N   + DFG+A
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181

Query: 755 KFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 812
           + +  D       +      ++APE  +    T + DV+SFGVL  E+            
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------ 235

Query: 813 MSFSSLNLNIALDEML--DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQL 870
             +  + ++      L    R+  P      ++   +     C    P  RPT  ++ + 
Sbjct: 236 -PYPGVKIDEEFCRRLKEGTRMRAPD-YTTPEMYQTML---DCWHGEPSQRPTFSELVEH 290

Query: 871 LK 872
           L 
Sbjct: 291 LG 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-36
 Identities = 53/276 (19%), Positives = 106/276 (38%), Gaps = 33/276 (11%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPL---PGEMTFQQEFLNEVKALTE 657
           + +     +G GG GSVY    ++    +A+K          GE+        EV  L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 658 I--WHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           +      ++++  +        ++ E  +          +     L      +    +++
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLE 121

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYV 774
           A+ + HN     ++HRDI  +N+L+D    E  + DFG    LK   + +T+  GT  Y 
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYS 176

Query: 775 APE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP 833
            PE + Y         V+S G+L  +++ G  P +                +E++  ++ 
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVF 222

Query: 834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
              R V  +   ++     C+   P  RPT +++  
Sbjct: 223 FRQR-VSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-35
 Identities = 61/292 (20%), Positives = 107/292 (36%), Gaps = 35/292 (11%)

Query: 603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHR 661
            + D   IG G  G VY +KL  SGE++A+KK           ++    E++ + ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHC 73

Query: 662 NIVKVYGFCLHV------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
           NIV++  F           +L +V +Y       V      A + L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAH-VSDFGIAKFLKPDSSNWTELAGTYGYV 774
           +L+Y+H+     I HRDI  +N+LLD +     + DFG AK L     N + +   Y   
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 775 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI------------ 822
              +      T   DV+S G +  E++ G+      S +      + +            
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 823 ---ALDEMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQ 869
                +         P   V         + +    ++  P +R T  + C 
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 1e-35
 Identities = 56/296 (18%), Positives = 112/296 (37%), Gaps = 32/296 (10%)

Query: 599 RATNDFDDEHCIGKGGQGSVYM--SKLASGEIIAVKKFHSPLPGEMTFQQEFLNEV---K 653
           RA   ++    IG+G  G V+        G  +A+K+      GE       + EV   +
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLR 62

Query: 654 ALTEIWHRNIVKVYGFCLHVR-----HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
            L    H N+V+++  C   R      L +V+E+        +         +      +
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKD 120

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELA 768
           M+  ++  L ++H+     +VHRD+  +N+L+    +  ++DFG+A+      +  + + 
Sbjct: 121 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VV 176

Query: 769 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSMSFSSLNLNIALD 825
            T  Y APE+          D++S G +  E+ + K        +  +      + +  +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 826 EMLDPRLPTPSRNVHDKLISIVEVTISCVDE------------NPESRPTMQKVCQ 869
           E     +  P +  H K    +E  ++ +DE            NP  R +      
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 4e-35
 Identities = 58/273 (21%), Positives = 102/273 (37%), Gaps = 28/273 (10%)

Query: 607 EHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIV 664
              +G G  G V       + E  A+K              +   EV+         +IV
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 68

Query: 665 KVYGFCLHV----RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           ++     ++    + L IV E      L   +  D   +         ++K I +A+ Y+
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 721 HNDCFPPIVHRDISSKNVLLDFENE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 777
           H+     I HRD+  +N+L   +       ++DFG AK     +S  T    T  YVAPE
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPE 183

Query: 778 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR 837
           +    K  + CD++S GV+   ++ G  P  F S+   +          M     P P  
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 838 -NVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
             V +++  ++    + +   P  R T+ +   
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 4e-35
 Identities = 55/262 (20%), Positives = 101/262 (38%), Gaps = 22/262 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
           + FD    +G G  G V + K   SG   A+K        ++   +  LNE + L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
             +VK+        +L++V EY     +   L                    IV    Y+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYL 157

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
           H+     +++RD+  +N+L+D +    V+DFG AK           L GT   +APE+  
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIIL 211

Query: 781 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH 840
           +    +  D ++ GVL  E+  G  P        F +       ++++  ++  PS +  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP--------FFADQPIQIYEKIVSGKVRFPS-HFS 262

Query: 841 DKLISIVEVTISCVDENPESRP 862
             L  ++    + +  +   R 
Sbjct: 263 SDLKDLLR---NLLQVDLTKRF 281

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 4e-35
 Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 35/296 (11%)

Query: 601 TNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW 659
              + +   IG+G  G V  +    +   +A+KK         T+ Q  L E+K L    
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFR 64

Query: 660 HRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSY 719
           H NI+ +           +   Y     +   L      ++L        +  I+  L Y
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 720 MHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAP 776
           +H+     ++HRD+   N+LL+   +  + DFG+A+   PD  +    TE   T  Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 777 ELAYT-MKVTEKCDVYSFGVLALEVIKGKHP----------------------RDFISSM 813
           E+       T+  D++S G +  E++  +                         D    +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 814 SFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ 869
           +  + N  ++L             N   K + +++     +  NP  R  +++   
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 6e-34
 Identities = 52/288 (18%), Positives = 112/288 (38%), Gaps = 27/288 (9%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH 660
             ++    IG+G  G+V+ +K   + EI+A+K+       E       L E+  L E+ H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60

Query: 661 RNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYM 720
           +NIV+++      + L +V+E+          S +      G      +   +   L  +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114

Query: 721 HNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 780
                  ++HRD+  +N+L++   E  +++FG+A+        ++    T  Y  P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 781 TMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV 839
             K+ +   D++S G +  E+     P    + +      +   L    + + P+ ++  
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 840 HDKLISIVEVTIS------------------CVDENPESRPTMQKVCQ 869
             K   +   T S                   +  NP  R + ++  Q
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 23/274 (8%)

Query: 602 NDFDDEHCIGKGGQGSVYMSKLA----SGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALT 656
            +F+    +G G  G V++ +      +G++ A+K    + +  +    +    E + L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 657 EIWHR-NIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVD 715
            I     +V ++        L ++ +Y     L   LS     +          +  IV 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140

Query: 716 ALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT-ELAGTYGYV 774
           AL ++H      I++RDI  +N+LLD      ++DFG++K    D +    +  GT  Y+
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 775 APELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL 832
           AP++         +  D +S GVL  E++ G  P  F      +S           +P  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255

Query: 833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQK 866
           P   + +      +++     + ++P+ R     
Sbjct: 256 P---QEMSALAKDLIQ---RLLMKDPKKRLGCGP 283

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 6e-32
 Identities = 54/308 (17%), Positives = 110/308 (35%), Gaps = 45/308 (14%)

Query: 598 IRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 656
               + ++    IG+G  G V+ ++   +G+ +A+KK       E  F    L E+K L 
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQ 64

Query: 657 EIWHRNIVKVYGFCLHV--------RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMN 708
            + H N+V +   C             +++V+++ +     ++ +          +    
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKR 121

Query: 709 MIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS----NW 764
           +++ +++ L Y+H      I+HRD+ + NVL+  +    ++DFG+A+      +     +
Sbjct: 122 VMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 765 TELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA 823
           T    T  Y  PEL    +      D++  G +  E+           +     L L   
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQ 236

Query: 824 LDEMLDPR----------------LPTPSRNVHDKLISIVEVTI------SCVDENPESR 861
           L   + P                 +    R V D+L + V            +  +P  R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296

Query: 862 PTMQKVCQ 869
                   
Sbjct: 297 IDSDDALN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-31
 Identities = 52/309 (16%), Positives = 110/309 (35%), Gaps = 47/309 (15%)

Query: 594 YEEIIRATNDFDD----EHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEF 648
            +E+ +   +          +G G  G+V  +    +G  +A+KK + P   E+ F +  
Sbjct: 6   RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRA 64

Query: 649 LNEVKALTEIWHRNIVKVYGFCLH------VRHLFIVYEYFKMCSLAVILSNDAAAKNLG 702
             E++ L  + H N++ +                ++V  +       ++       + LG
Sbjct: 65  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLG 119

Query: 703 WTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS 762
             R   ++  ++  L Y+H        HRD+   N+ ++ + E  + DFG+A+    DS 
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ--ADSE 174

Query: 763 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM--------- 813
               +   +      +   M+ T+  D++S G +  E+I GK        +         
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234

Query: 814 -------------SFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPES 860
                        S  + N    L E+      +   N     ++++E     +  + E 
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQ 291

Query: 861 RPTMQKVCQ 869
           R T  +   
Sbjct: 292 RVTAGEALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (298), Expect = 7e-30
 Identities = 53/300 (17%), Positives = 108/300 (36%), Gaps = 48/300 (16%)

Query: 602 NDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-W 659
           +D+     +G+G    V+ +  + + E + VK            +++   E+K L  +  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88

Query: 660 HRNIVKVYGFCLHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDAL 717
             NI+ +         R   +V+E+        +       + L        +  I+ AL
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKAL 142

Query: 718 SYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 776
            Y H+     I+HRD+   NV++D E+ +  + D+G+A+F  P    +     +  +  P
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 198

Query: 777 ELAYTMK-VTEKCDVYSFGVLALEVIKGKHP-----------------------RDFISS 812
           EL    +      D++S G +   +I  K P                        D+I  
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 813 MSFS-SLNLNIALDEMLDPRLPTPSRNVHDKLIS--IVEVTISCVDENPESRPTMQKVCQ 869
            +       N  L      R      + +  L+S   ++     +  + +SR T ++  +
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-29
 Identities = 52/304 (17%), Positives = 106/304 (34%), Gaps = 27/304 (8%)

Query: 587 TFEGKIIYEEIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQ 645
           TF  + + + I      + +   +G G  GSV  +    +G  +AVKK   P    +   
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HA 61

Query: 646 QEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFKMCSLAVILSNDAAAKN-LGWT 704
           +    E++ L  + H N++ +       R L    + + +  L     N+      L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121

Query: 705 RRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW 764
               +I  I+  L Y+H+       HRD+   N+ ++ + E  + DFG+A+    D    
Sbjct: 122 HVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEMT 176

Query: 765 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-- 822
             +A  +      +   M   +  D++S G +  E++ G+        +    L L +  
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236

Query: 823 -------------ALDEMLDPRLPTPSRNVHDKLISIVEVTI----SCVDENPESRPTMQ 865
                        +    +      P  N  +  I    + +      +  + + R T  
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

Query: 866 KVCQ 869
           +   
Sbjct: 297 QALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 5e-29
 Identities = 51/314 (16%), Positives = 105/314 (33%), Gaps = 48/314 (15%)

Query: 593 IYEEIIRATNDFDDEHCIGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNE 651
           + +        + +   IG G QG V  +        +A+KK   P   + T  +    E
Sbjct: 8   VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRE 66

Query: 652 VKALTEIWHRNIVKVYGFCLH------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTR 705
           +  +  + H+NI+ +             + +++V E        VI         L   R
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHER 120

Query: 706 RMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNWT 765
              ++  ++  + ++H+      +HRD+   N+++  +    + DFG+A+     S   T
Sbjct: 121 MSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMT 176

Query: 766 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------------------- 806
               T  Y APE+   M   E  D++S G +  E+++ K                     
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 807 --RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTIS---------CVD 855
              +F+  +  +  N      +      P    +      S      +          + 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 856 ENPESRPTMQKVCQ 869
            +P  R ++    Q
Sbjct: 297 IDPAKRISVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 2e-23
 Identities = 50/245 (20%), Positives = 99/245 (40%), Gaps = 27/245 (11%)

Query: 610 IGKGGQGSVYMSK-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYG 668
           +G G   +V+++K + +   +A+K     + G+  + +   +E+K L  +   +  K   
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKI----VRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 669 FCLH---------------VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGI 713
              +                 H+ +V+E      LA+I   +     L + +++   K +
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 134

Query: 714 VDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKFLKPDSS--NWTELAGT 770
           +  L YMH  C   I+H DI  +NVL++  +   ++    IA          ++T    T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 771 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP 830
             Y +PE+          D++S   L  E+I G    +     S++  + +IA    L  
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 831 RLPTP 835
            LP+ 
Sbjct: 253 ELPSY 257

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 99.3 bits (246), Expect = 3e-23
 Identities = 63/273 (23%), Positives = 102/273 (37%), Gaps = 12/273 (4%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           L+L NNK++        NL NL TL L  N +S   P     L  L  L L+ N L    
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELP 95

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLAT 193
                 L  L         +  S+   +  +  +  L  +    +G    +   +  L+ 
Sbjct: 96  EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSY 154

Query: 194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAI 253
           + +   +++ +IP   G   SL+ L L  NK++     S+  L+NL  L L  NS+S   
Sbjct: 155 IRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211

Query: 254 PYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYI------Y 307
                N   L  L L +N+       L +   ++ V L  N ++   S  F         
Sbjct: 212 NGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271

Query: 308 PNLTYIDLSQNNF-YGEISSDWGRC-PKLSTLD 338
            + + + L  N   Y EI     RC    + + 
Sbjct: 272 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 97.8 bits (242), Expect = 7e-23
 Identities = 48/279 (17%), Positives = 90/279 (32%), Gaps = 10/279 (3%)

Query: 165 KSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNK 224
              + L L  N           NL NL TL L  N +S   P     L  L  L L  N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 225 LSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLT 284
           L          L  L         +  ++      ++ + +               + + 
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNI 344
            L  +R+    +T   +    + P+LT + L  N      ++       L+ L  S N+I
Sbjct: 151 KLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

Query: 345 TGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSG------QLSP 398
           +      + ++  L  L L++N +V ++P  L    +   + L +N +S           
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266

Query: 399 KLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDL 437
                     + L SN +     +      +   + + L
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 96.3 bits (238), Expect = 2e-22
 Identities = 61/288 (21%), Positives = 103/288 (35%), Gaps = 12/288 (4%)

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
            +P  L    + A L L  N ++     +  NL++L  L L  NK+S   P +   L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 240 TYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGN 299
             L L +N L        + L +L +      + R  +    N   +  +  +    +G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 300 ISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLG 359
            + +F     L+YI ++  N     +   G  P L+ L    N IT      +   + L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 360 VLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLS-- 417
            L LS N I       L       +L L +N+L             ++ + L +N +S  
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL-ADHKYIQVVYLHNNNISAI 257

Query: 418 --NSIPKSLGNLELIHLSELDLSRNFLR--EAIPSQICIMQSLEKLNL 461
             N       N +    S + L  N ++  E  PS    +     + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 94.3 bits (233), Expect = 1e-21
 Identities = 67/289 (23%), Positives = 104/289 (35%), Gaps = 16/289 (5%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
            +P +L      + L+L NNK++        NL NL TL +  N +S   PG        
Sbjct: 24  KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 72  SDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSG 131
             L LS N+L          L  L     +   +  S+ + L  +  +  L  N    SG
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140

Query: 132 SIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNL 191
               +   +  L+ + I   +++       G   SL+ L L  N        SL  L+NL
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTI---PQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197

Query: 192 ATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSG 251
           A L L  NS+S      L N   L  L L  NKL   +P  + +   +  + L  N++S 
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

Query: 252 ------AIPYEYRNLVKLTILLLGHNQ---FRGPIPILRNLTSLERVRL 291
                   P         + + L  N    +       R +     V+L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.4 bits (215), Expect = 3e-19
 Identities = 57/255 (22%), Positives = 112/255 (43%), Gaps = 15/255 (5%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
           + NN + +    + +NLK+L  L L NNK+S   P +   L  L  LY+  N L   +P 
Sbjct: 38  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 96

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT--NSLSNSIPSELGNLRSLSN 121
           ++   +   +L +  N+++         L+ +  + L T     S         ++ LS 
Sbjct: 97  KM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154

Query: 122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI 181
           +++ +  ++ +IP  L    +L  L++  N ++      +  L +L+ L LS N+ +   
Sbjct: 155 IRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211

Query: 182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSG------SIPISMGN 235
             SL N  +L  L+L+ N L   +P  L + + +  + L  N +S         P     
Sbjct: 212 NGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 270

Query: 236 LSNLTYLNLFENSLS 250
            ++ + ++LF N + 
Sbjct: 271 KASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 75.1 bits (183), Expect = 4e-15
 Identities = 44/223 (19%), Positives = 84/223 (37%), Gaps = 6/223 (2%)

Query: 306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
           + P+   +DL  N        D+     L TL    N I+   P       +L  L LS 
Sbjct: 29  LPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88

Query: 366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
           N +     +         +L +  N+++         L Q+  ++L +N L +S  ++  
Sbjct: 89  NQLKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145

Query: 426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDI 485
              +  LS + ++   +   IP  +    SL +L+L  N ++ +  +  + +N L  + +
Sbjct: 146 FQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202

Query: 486 SYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCKALK 528
           S+N +      S        E    N  L     GL   K ++
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.5 bits (179), Expect = 1e-14
 Identities = 39/207 (18%), Positives = 75/207 (36%), Gaps = 6/207 (2%)

Query: 284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINN 343
                + L  N +T      F    NL  + L  N         +    KL  L  S N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 344 ITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSL 403
           +            +L V +     +   +   L      ++L     + SG  +     +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSH 463
            +L ++ ++   ++ +IP+ L       L+EL L  N + +   + +  + +L KL LS 
Sbjct: 150 KKLSYIRIADTNIT-TIPQGL----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 464 NSLSGLIPSCFEKMNGLLHIDISYNEL 490
           NS+S +          L  + ++ N+L
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKL 231

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.8 bits (133), Expect = 8e-09
 Identities = 33/178 (18%), Positives = 69/178 (38%), Gaps = 12/178 (6%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
                          + +K LS + + +  ++ +IP  L    +L  L++  N ++    
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDA 188

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
             +      + L LS N +S     SL N  +L  L+L+ N L   +P  L + + +  +
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVV 247

Query: 123 QLNNNILSG------SIPHSLGNLTNLATLYIYSNSLSASIL--GKIGNLKSLSNLQL 172
            L+NN +S         P       + + + ++SN +    +       +   + +QL
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.4 bits (106), Expect = 1e-05
 Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 5/88 (5%)

Query: 405 QLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN 464
            L  +  S   L   +PK L        + LDL  N + E        +++L  L L +N
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPP----DTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65

Query: 465 SLSGLIPSCFEKMNGLLHIDISYNELRG 492
            +S + P  F  +  L  + +S N+L+ 
Sbjct: 66  KISKISPGAFAPLVKLERLYLSKNQLKE 93

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (237), Expect = 2e-22
 Identities = 65/265 (24%), Positives = 102/265 (38%), Gaps = 7/265 (2%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
           ++P  +    +   + L  N++S     S     NL  L++H+N L+             
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 72  SDLELSNNKLSGSI-PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILS 130
             L+LS+N    S+ P +   L  L TL+LD   L    P     L +L  L L +N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 131 GSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSN 190
                +  +L NL  L+++ N +S+        L SL  L L +N      P +  +L  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           L TLYL  N+LS      L  LR+L  L L  N             + L       + + 
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVP 261

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRG 275
            ++P          +  L  N  +G
Sbjct: 262 CSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (227), Expect = 4e-21
 Identities = 60/250 (24%), Positives = 95/250 (38%), Gaps = 4/250 (1%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           + L  N++S     S     NL  L+L +N L+    +    L  L  L L++N    S+
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 134 -PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLA 192
            P +   L  L TL++    L     G    L +L  L L +N        +  +L NL 
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGA 252
            L+L  N +S         L SL  L L  N+++   P +  +L  L  L LF N+LS  
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216

Query: 253 IPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTY 312
                  L  L  L L  N +            L++ R   + +  ++ +          
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDL 273

Query: 313 IDLSQNNFYG 322
             L+ N+  G
Sbjct: 274 KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (205), Expect = 4e-18
 Identities = 58/278 (20%), Positives = 88/278 (31%), Gaps = 11/278 (3%)

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGA 252
           T       L  ++P  +    +   + L  N++S     S     NLT L L  N L+  
Sbjct: 15  TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 253 IPYEYRNLVKLTILLLGHNQFRGPIP--ILRNLTSLERVRLDRNYLTGNISESFYIYPNL 310
               +  L  L  L L  N     +       L  L  + LDR  L       F     L
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 311 TYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVG 370
            Y+ L  N         +     L+ L    N I+            L  L L  N +  
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 371 EIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELI 430
             P     L   + L L  N LS   +  L  L  L++L L+ N                
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL---WA 248

Query: 431 HLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSG 468
            L +   S + +  ++P +   +   +   L+ N L G
Sbjct: 249 WLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (167), Expect = 3e-13
 Identities = 51/253 (20%), Positives = 82/253 (32%), Gaps = 8/253 (3%)

Query: 263 LTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFY 321
              + L  N+         R   +L  + L  N L    + +F     L  +DLS N   
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 322 GEISSDW-GRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLN 380
             +         +L TL      +    P      + L  L L  N +          L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 381 FFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRN 440
               L L  N++S         L  L+ L L  NR+++  P +  +L  +    L L  N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM--TLYLFAN 211

Query: 441 FLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS--- 497
            L       +  +++L+ L L+ N       +       L     S +E+  S+P     
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270

Query: 498 TTFKDAPIEALQG 510
              K      LQG
Sbjct: 271 RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (166), Expect = 4e-13
 Identities = 45/200 (22%), Positives = 63/200 (31%), Gaps = 4/200 (2%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
              N  L    P+    L  L  L L    L    P     L  L  LY+  N+L     
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
               +    + L L  N++S     +   L +L  L L  N +++  P    +L  L  L
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
            L  N LS     +L  L  L  L +  N               L   + S +    S+P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP 265

Query: 183 PSLGNLSNLATLYLDTNSLS 202
             L          L  N L 
Sbjct: 266 QRLAGRD---LKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.5 bits (111), Expect = 3e-06
 Identities = 32/163 (19%), Positives = 55/163 (33%), Gaps = 6/163 (3%)

Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKL-NFFIKLVLAHNQLSG 394
           T       +   VP  I  +SQ   + L  N I            N  I  + ++     
Sbjct: 15  TTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 395 QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
             +   G  +  +     + +L +  P +   L    L  L L R  L+E  P     + 
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL--GRLHTLHLDRCGLQELGPGLFRGLA 129

Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPNS 497
           +L+ L L  N+L  L    F  +  L H+ +  N +      +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 97.4 bits (241), Expect = 4e-22
 Identities = 61/386 (15%), Positives = 120/386 (31%), Gaps = 34/386 (8%)

Query: 115 NLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSE 174
            L       L    ++ ++  +  +L  + TL      + +  +  +  L +L+ +  S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75

Query: 175 NNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMG 234
           N      P  L NL+ L  + ++ N ++   P       +   L          +     
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 235 NLSNLTYLNLFENSLSGAIPYEYRN------------LVKLTILLLGHNQFRGPIPILRN 282
                   N   +  + +     +             L  LT L            I   
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN 342
                   L       +      I  NL  + L+ N      +        L+ LD + N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANN 251

Query: 343 NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGS 402
            I+      +   ++L  L L +N I    P+            L  N+   +    + +
Sbjct: 252 QISN--LAPLSGLTKLTELKLGANQISNISPLA----GLTALTNLELNENQLEDISPISN 305

Query: 403 LVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLS 462
           L  L +L L  N +S+  P S     L  L  L  + N + +   S +  + ++  L+  
Sbjct: 306 LKNLTYLTLYFNNISDISPVS----SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 463 HNSLSGLIPSCFEKMNGLLHIDISYN 488
           HN +S L P     +  +  + ++  
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 96.6 bits (239), Expect = 7e-22
 Identities = 75/380 (19%), Positives = 139/380 (36%), Gaps = 36/380 (9%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
             L    ++ ++  +  +L  + TL  D   + +     +  L +L+ +  +NN L+   
Sbjct: 27  TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDIT 82

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG------- 186
           P  L NLT L  + + +N ++           +   L  ++      +            
Sbjct: 83  P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140

Query: 187 --NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLS----LGYNKLSGSIPISMGNLSNLT 240
              +S+++ L   T+    S  +++ +L+ L+NL+    L  +    S    +  L+NL 
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200

Query: 241 YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNI 300
            L    N +S   P        L  L L  NQ +  I  L +LT+L  + L  N ++   
Sbjct: 201 SLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLA 257

Query: 301 SESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGV 360
                    LT + L  N                      +N         I +   L  
Sbjct: 258 --PLSGLTKLTELKLGANQISNISPLAGLTALTN----LELNENQLEDISPISNLKNLTY 311

Query: 361 LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
           L L  N+I    P+    L    +L  A+N++S      L +L  +  L    N++S+  
Sbjct: 312 LTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367

Query: 421 PKSLGNLELIHLSELDLSRN 440
           P  L NL    +++L L+  
Sbjct: 368 P--LANLT--RITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 96.2 bits (238), Expect = 9e-22
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 16/206 (7%)

Query: 42  GNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD 101
             LTNL +L    N +S   P  I       +L L+ N+L      +L +L+NL  L L 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKI 161
            N +SN  P  L  L  L+ L+L  N +S   P  L  LT L  L +  N L       I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS--PI 303

Query: 162 GNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLG 221
            NLK+L+ L L  NN +   P  + +L+ L  L+   N +S    S L NL +++ LS G
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVSSLANLTNINWLSAG 359

Query: 222 YNKLSGSIPISMGNLSNLTYLNLFEN 247
           +N++S   P+   NL+ +T L L + 
Sbjct: 360 HNQISDLTPL--ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 92.0 bits (227), Expect = 2e-20
 Identities = 83/387 (21%), Positives = 144/387 (37%), Gaps = 38/387 (9%)

Query: 43  NLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT 102
            L       +   +++ ++     +    + L+     +  SI   +  L+NL  +    
Sbjct: 20  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75

Query: 103 NSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASI----- 157
           N L++  P  L NL  L ++ +NNN ++   P +        TL+    +    +     
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 158 ----------LGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPS 207
                     +  I  L  L++LQ        +    L NL+ L  L + +N    S  S
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDIS 191

Query: 208 ELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILL 267
            L  L +L +L    N++S   P  +G L+NL  L+L  N L         +L  LT L 
Sbjct: 192 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 268 LGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD 327
           L +NQ     P L  LT L  ++L  N ++     +         ++ +Q        S 
Sbjct: 248 LANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI----SP 302

Query: 328 WGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVL 387
                 L+ L    NNI+      +   ++L  L  ++N +       L  L     L  
Sbjct: 303 ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 388 AHNQLSGQLSPKLGSLVQLEHLDLSSN 414
            HNQ+S      L +L ++  L L+  
Sbjct: 359 GHNQISD--LTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.8 bits (224), Expect = 6e-20
 Identities = 66/365 (18%), Positives = 125/365 (34%), Gaps = 48/365 (13%)

Query: 163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGY 222
            L       L + N   ++  +  +L  + TL  D   +  SI   +  L +L+ ++   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 223 NKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP---- 278
           N+L+   P+   NL+ L  + +  N ++   P      +    L         P+     
Sbjct: 76  NQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 279 ----------ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDW 328
                     I           L +      +++   +    T   L  ++      S  
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 329 GRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLA 388
            +   L +L  + N I+   P  I  +  L  L L+ N +       L  L     L LA
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 389 HNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIP------------------KSLGNLELI 430
           +NQ+S      L  L +L  L L +N++SN  P                         L 
Sbjct: 250 NNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 431 HLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNEL 490
           +L+ L L  N + +  P  +  +  L++L  ++N +S    S    +  +  +   +N++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363

Query: 491 RGSIP 495
               P
Sbjct: 364 SDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.1 bits (222), Expect = 9e-20
 Identities = 87/389 (22%), Positives = 152/389 (39%), Gaps = 36/389 (9%)

Query: 4   IYNNSLYDSIP-SELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIP 62
           +   ++ D++  ++L  + +L    LG   + G     +  L NL  +    N L+   P
Sbjct: 29  LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 83

Query: 63  GEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL 122
             + N     D+ ++NN+++   P +        TL+ +  +  + +             
Sbjct: 84  --LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK------------ 129

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN-GSI 181
            L N        +++ +++ L+ L         + +  +  L +L+ L+  + + N  S 
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189

Query: 182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTY 241
              L  L+NL +L    N +S   P  +    +L  LSL  N+L      ++ +L+NLT 
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTD 245

Query: 242 LNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNIS 301
           L+L  N +S   P     L KLT L LG NQ     P L  LT+L  + L+ N       
Sbjct: 246 LDLANNQISNLAPLS--GLTKLTELKLGANQISNISP-LAGLTALTNLELNENQ--LEDI 300

Query: 302 ESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVL 361
                  NLTY+ L  NN             KL  L F+ N ++      + + + +  L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356

Query: 362 DLSSNHIVGEIPIELGKLNFFIKLVLAHN 390
               N I    P  L  L    +L L   
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.9 bits (204), Expect = 1e-18
 Identities = 27/187 (14%), Positives = 53/187 (28%), Gaps = 35/187 (18%)

Query: 610 IGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQ-------EFLNEVKALTEIWHRN 662
           +G+G + +V+           VK            ++        F            R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 663 IVKVYGFC----LHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALS 718
           + K+ G             ++ E                   +       ++  I++ ++
Sbjct: 68  LQKLQGLAVPKVYAWEGNAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVA 117

Query: 719 YMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK---------FLKPDSSNWTE-LA 768
             ++     IVH D+S  NVL+  E    + DF  +           L+ D  N     +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 769 GTYGYVA 775
            TY    
Sbjct: 174 RTYRTEK 180

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 85.6 bits (210), Expect = 1e-18
 Identities = 59/262 (22%), Positives = 98/262 (37%), Gaps = 7/262 (2%)

Query: 259 NLVKLTILLLGHNQFRGPIPI---LRNLTSLERVRLDRNY-LTGNISESFYIYPNLTYID 314
              ++  L L       P PI   L NL  L  + +     L G I  +      L Y+ 
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 315 LSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI 374
           ++  N  G I     +   L TLDFS N ++G +PP I     L  +    N I G IP 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 375 ELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSE 434
             G    F KL  +      +L+ K+       +L       +     +         ++
Sbjct: 168 SYG---SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 435 LDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSI 494
                         ++ + ++L  L+L +N + G +P    ++  L  +++S+N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 495 PNSTTFKDAPIEALQGNKGLYG 516
           P     +   + A   NK L G
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 84.4 bits (207), Expect = 3e-18
 Identities = 66/264 (25%), Positives = 107/264 (40%), Gaps = 4/264 (1%)

Query: 114 GNLRSLSNLQLNNNILSG--SIPHSLGNLTNLATLYIYSN-SLSASILGKIGNLKSLSNL 170
                ++NL L+   L     IP SL NL  L  LYI    +L   I   I  L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 171 QLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIP 230
            ++  N +G+IP  L  +  L TL    N+LS ++P  + +L +L  ++   N++SG+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 231 ISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVR 290
            S G+ S L        +            + L  + L  N   G   +L       +  
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 291 LDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPP 350
                          +  NL  +DL  N  YG +     +   L +L+ S NN+ G + P
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-P 285

Query: 351 EIGHSSQLGVLDLSSNHIVGEIPI 374
           + G+  +  V   ++N  +   P+
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.5 bits (202), Expect = 1e-17
 Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 7/261 (2%)

Query: 23  LSDLELGNNKLSG--SIPHSLGNLTNLATLYIHTN-SLSGSIPGEIGNFRFFSDLELSNN 79
           +++L+L    L     IP SL NL  L  LYI    +L G IP  I        L +++ 
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 80  KLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGN 139
            +SG+IP  L  +  L TL    N+LS ++P  + +L +L  +  + N +SG+IP S G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 140 LTNLAT-LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT 198
            + L T + I  N L+  I     NL               +      + +         
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 199 NSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYR 258
           +         L    +  +L    N++ G++P  +  L  L  LN+  N+L G IP +  
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG 288

Query: 259 NLVKLTILLLGHNQFRGPIPI 279
           NL +  +    +N+     P+
Sbjct: 289 NLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.6 bits (197), Expect = 6e-17
 Identities = 64/263 (24%), Positives = 101/263 (38%), Gaps = 4/263 (1%)

Query: 162 GNLKSLSNLQLSENNFNG--SIPPSLGNLSNLATLYLDTN-SLSYSIPSELGNLRSLSNL 218
                ++NL LS  N      IP SL NL  L  LY+    +L   IP  +  L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 219 SLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP 278
            + +  +SG+IP  +  +  L  L+   N+LSG +P    +L  L  +    N+  G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 279 ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLD 338
                 S     +  +                        N     +S      K +   
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 339 FSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSP 398
               N       ++G S  L  LDL +N I G +P  L +L F   L ++ N L G++ P
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-P 285

Query: 399 KLGSLVQLEHLDLSSNRLSNSIP 421
           + G+L + +    ++N+     P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 73.2 bits (178), Expect = 1e-14
 Identities = 74/251 (29%), Positives = 112/251 (44%), Gaps = 5/251 (1%)

Query: 6   NNSLYDSIPSELRNLKSLSDLEL-GNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
           N      IPS L NL  L+ L + G N L G IP ++  LT L  LYI   ++SG+IP  
Sbjct: 61  NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL-SNLQ 123
           +   +    L+ S N LSG++PPS+ +L NL  +  D N +S +IP   G+   L +++ 
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           ++ N L+G IP +  NL         S ++       +      +       N       
Sbjct: 181 ISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            +G   NL  L L  N +  ++P  L  L+ L +L++ +N L G IP   GNL       
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSA 297

Query: 244 LFENSLSGAIP 254
              N      P
Sbjct: 298 YANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.9 bits (172), Expect = 9e-14
 Identities = 66/247 (26%), Positives = 92/247 (37%), Gaps = 26/247 (10%)

Query: 74  LELSNNKLSG--SIPPSLGNLSNLATLYLDTN-SLSNSIPSELGNLRSLSNLQLNNNILS 130
           L+LS   L     IP SL NL  L  LY+    +L   IP  +  L  L  L + +  +S
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 131 GSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSN 190
           G+IP  L  +  L TL    N+LS ++   I +L +L  +    N  +G+IP S G+ S 
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 191 LATLYLDT-NSLSYSIPSELGNLRSLSNLSL----------------------GYNKLSG 227
           L T    + N L+  IP    NL                                     
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 228 SIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLE 287
                +G   NL  L+L  N + G +P     L  L  L +  N   G IP   NL   +
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294

Query: 288 RVRLDRN 294
                 N
Sbjct: 295 VSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.7 bits (148), Expect = 9e-11
 Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 2/62 (3%)

Query: 28  LGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNK-LSGSIP 86
           L NN++ G++P  L  L  L +L +  N+L G IP + GN + F     +NNK L GS  
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309

Query: 87  PS 88
           P+
Sbjct: 310 PA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 4/182 (2%)

Query: 2   PCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHT-NSLSGS 60
                N+L  ++P  + +L +L  +    N++SG+IP S G+ + L T    + N L+G 
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189

Query: 61  IPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS 120
           IP    N          N     +      + +          +       ++G  ++L+
Sbjct: 190 IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT--QKIHLAKNSLAFDLGKVGLSKNLN 247

Query: 121 NLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS 180
            L L NN + G++P  L  L  L +L +  N+L   I  + GNL+       + N     
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCG 306

Query: 181 IP 182
            P
Sbjct: 307 SP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.3 bits (134), Expect = 5e-09
 Identities = 19/62 (30%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 1   LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGS 60
              + NN +Y ++P  L  LK L  L +  N L G IP   GNL          N     
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306

Query: 61  IP 62
            P
Sbjct: 307 SP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.1 bits (131), Expect = 1e-08
 Identities = 58/225 (25%), Positives = 85/225 (37%), Gaps = 24/225 (10%)

Query: 5   YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
             N+L   IP  +  L  L  L + +  +SG+IP  L  +  L TL    N+LSG++P  
Sbjct: 85  GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDT-NSLSNSIPSELGNLRSLSNLQ 123
           I +      +    N++SG+IP S G+ S L T    + N L+  IP    NL       
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204

Query: 124 LNN----------------------NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKI 161
             N                                +G   NL  L + +N +  ++   +
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL 264

Query: 162 GNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIP 206
             LK L +L +S NN  G I P  GNL          N      P
Sbjct: 265 TQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 3/98 (3%)

Query: 401 GSLVQLEHLDLSSNRLSN--SIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEK 458
               ++ +LDLS   L     IP SL NL  ++   +    N +   IP  I  +  L  
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP-IPPAIAKLTQLHY 105

Query: 459 LNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
           L ++H ++SG IP    ++  L+ +D SYN L G++P 
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.9 bits (159), Expect = 2e-12
 Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 6/209 (2%)

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
            +  +++   +  D  +L+ ++P +L   +  + L L  N L      ++   + LT LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 244 LFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES 303
           L  +            L  L  L L HNQ +    + + L +L  + +  N LT     +
Sbjct: 62  L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL 363
                 L  + L  N             PKL  L  + NN+T      +     L  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 364 SSNHIVGEIPIELGKLNFFIKLVLAHNQL 392
             N +   IP      +      L  N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 46/212 (21%), Positives = 75/212 (35%), Gaps = 11/212 (5%)

Query: 40  SLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLY 99
            +  + +   +     +L+ ++P ++   +  + L LS N L      +L   + L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 100 LDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSL--GNLTNLATLYIYSNSLSASI 157
                L  +  ++L    +L  L   +   +      L    L  L  L +  N L++  
Sbjct: 62  -----LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116

Query: 158 LGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSN 217
           LG +  L  L  L L  N      P  L     L  L L  N+L+      L  L +L  
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176

Query: 218 LSLGYNKLSGSIPISMGNLSNLTYLNLFENSL 249
           L L  N L  +IP        L +  L  N  
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.6 bits (135), Expect = 3e-09
 Identities = 45/198 (22%), Positives = 70/198 (35%), Gaps = 11/198 (5%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
             +L  ++P +L   K  + L L  N L      +L   T L  L      L  +   ++
Sbjct: 19  KRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN-----LDRAELTKL 70

Query: 66  GNFRFFSDLELSNNKLSGS--IPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
                   L   +   +    +P     L  L  L +  N L++     L  L  L  L 
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           L  N L    P  L     L  L + +N+L+    G +  L++L  L L EN+   +IP 
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 184 SLGNLSNLATLYLDTNSL 201
                  L   +L  N  
Sbjct: 190 GFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 9e-07
 Identities = 45/216 (20%), Positives = 80/216 (37%), Gaps = 9/216 (4%)

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS 335
           PI  +  + S   V  D+  LT  +     +  + T + LS+N  Y    +      +L+
Sbjct: 2   PICEVSKVASHLEVNCDKRNLT-ALPPD--LPKDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQ 395
            L+     +T         +  +      S++ +  +P+    L     L ++ N+L+  
Sbjct: 59  QLNLDRAELTKLQVD---GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 396 LSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQS 455
               L  L +L+ L L  N L    P  L     +      L+ N L E     +  +++
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL--SLANNNLTELPAGLLNGLEN 173

Query: 456 LEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
           L+ L L  NSL   IP  F   + L    +  N   
Sbjct: 174 LDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 15/57 (26%), Positives = 23/57 (40%), Gaps = 1/57 (1%)

Query: 1   LPCIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSL 57
              + NN+L +     L  L++L  L L  N L  +IP        L   ++H N  
Sbjct: 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 65.2 bits (157), Expect = 8e-12
 Identities = 50/328 (15%), Positives = 95/328 (28%), Gaps = 28/328 (8%)

Query: 165 KSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNL------ 218
           +    L+L+    + S+P    +L    +L    NSL+  +P    +L+SL         
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 219 ------SLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQ 272
                  L Y  +S +    +  L N ++L + +   +              I    +  
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 273 FRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCP 332
              P        +      +      ++  S         I                   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQL 392
                       +        +          S   +         L+     +   N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 393 SGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICI 452
           S ++         LE L++S+N+L   +P     LE      L  S N L E +P    +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE-----RLIASFNHLAE-VPE---L 322

Query: 453 MQSLEKLNLSHNSLSGLIPSCFEKMNGL 480
            Q+L++L++ +N L    P   E +  L
Sbjct: 323 PQNLKQLHVEYNPLREF-PDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.1 bits (128), Expect = 3e-08
 Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 12/97 (12%)

Query: 30  NNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSL 89
            N  S  I        +L  L +  N L   +P           L  S N L+  +P   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELP 323

Query: 90  GNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
            NL     L+++ N L    P       S+ +L++N+
Sbjct: 324 QNLK---QLHVEYNPLR-EFPDIPE---SVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.5 bits (124), Expect = 9e-08
 Identities = 24/97 (24%), Positives = 35/97 (36%), Gaps = 10/97 (10%)

Query: 147 YIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIP 206
             Y N+ S  I        SL  L +S N     +P     L     L    N L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVP 320

Query: 207 SELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLN 243
               NL+ L    + YN L    P    ++ +L  +N
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)

Query: 51  YIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIP 110
             + N+ S  I           +L +SNNKL   +P     L     L    N L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVP 320

Query: 111 SELGNLRSLSNLQLNNNILSGSIPHSLGNLTNL 143
               NL+ L    +  N L    P    ++ +L
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 2e-06
 Identities = 57/319 (17%), Positives = 95/319 (29%), Gaps = 24/319 (7%)

Query: 189 SNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENS 248
                L L+   LS S+P    +L S   L    N L+  +P    +L +L   N    +
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 249 LSGAIP----YEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESF 304
           LS   P        N     +  L ++ F   I +  N                  +   
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 305 YIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS 364
              P L  +      +    S        LS       N      PE+ +   L  +   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 365 SNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSL 424
           +N +     +        ++     +      S     + +     LS    +     + 
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 425 GNLE------LIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMN 478
            N           L EL++S N L E +P+       LE+L  S N L+ +         
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAEVPEL----PQ 324

Query: 479 GLLHIDISYNELRGSIPNS 497
            L  + + YN LR   P+ 
Sbjct: 325 NLKQLHVEYNPLR-EFPDI 342

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.9 bits (112), Expect = 3e-06
 Identities = 19/93 (20%), Positives = 31/93 (33%), Gaps = 9/93 (9%)

Query: 123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIP 182
               N  S  I        +L  L + +N L   +      L+ L     S N+    +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP 320

Query: 183 PSLGNLSNLATLYLDTNSLSYSIPSELGNLRSL 215
               NL     L+++ N L    P    ++  L
Sbjct: 321 ELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 3e-05
 Identities = 27/129 (20%), Positives = 38/129 (29%), Gaps = 34/129 (26%)

Query: 303 SFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLD 362
            F     L       N    EI S     P L  L+ S N +   +P        L  L 
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLI 310

Query: 363 LSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN--SI 420
            S NH+  E+P                                L+ L +  N L     I
Sbjct: 311 ASFNHL-AEVPELPQN---------------------------LKQLHVEYNPLREFPDI 342

Query: 421 PKSLGNLEL 429
           P+S+ +L +
Sbjct: 343 PESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 10/69 (14%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSG--SI 61
           + NN L   +P+    L+ L       N L+  +P    NL     L++  N L     I
Sbjct: 291 VSNNKL-IELPALPPRLERLI---ASFNHLA-EVPELPQNLK---QLHVEYNPLREFPDI 342

Query: 62  PGEIGNFRF 70
           P  + + R 
Sbjct: 343 PESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 21/62 (33%), Positives = 29/62 (46%), Gaps = 5/62 (8%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
           LEL+N  LS S+P    +L    +L    NSL+  +P    +L+SL     N   LS   
Sbjct: 43  LELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 97

Query: 134 PH 135
           P 
Sbjct: 98  PL 99

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.2 bits (152), Expect = 3e-11
 Identities = 52/291 (17%), Positives = 98/291 (33%), Gaps = 23/291 (7%)

Query: 145 TLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY- 203
           TL +   +L   + G++ +   ++  +   +  +  +         +  + L  + +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61

Query: 204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKL 263
           ++   L     L NLSL   +LS  I  ++   SNL  LNL   S               
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG-------------- 107

Query: 264 TILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGE 323
                           L  L           ++   ++        L      +N    +
Sbjct: 108 -FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166

Query: 324 ISSDWGRCPKLSTLDFSIN-NITGNVPPEIGHSSQLGVLDLSS-NHIVGEIPIELGKLNF 381
           +S+   RCP L  LD S +  +  +   E    + L  L LS    I+ E  +ELG++  
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 382 FIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHL 432
              L +      G L   L     L HL ++ +  +     ++GN +   +
Sbjct: 227 LKTLQVFGIVPDGTL-QLLKE--ALPHLQINCSHFTTIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 2e-08
 Identities = 46/280 (16%), Positives = 87/280 (31%), Gaps = 15/280 (5%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG-S 84
           L+L    L   +   L +   +       + +   +      FR    ++LSN+ +   +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEVST 62

Query: 85  IPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL--QLNNNILSGSIPHSLGNLTN 142
           +   L   S L  L L+   LS+ I + L    +L  L     +     ++   L + + 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 143 LATLYIY-----SNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLD 197
           L  L +      +       +  +    +  NL     N   S   +L            
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 198 TNSLSYS--IPSELGNLRSLSNLSLGY-NKLSGSIPISMGNLSNLTYLNLFENSLSGAIP 254
           ++S+        E   L  L +LSL     +     + +G +  L  L +F     G + 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 255 YEYRNLVKLTILLLGHNQFRGPIPILRNLTSL--ERVRLD 292
                L  L I          P    +    +   + RL 
Sbjct: 243 LLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRLT 282

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 22/104 (21%), Positives = 45/104 (43%), Gaps = 3/104 (2%)

Query: 361 LDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSI 420
           LDL+  ++  ++   L      I      + +   L  +  S  +++H+DLS++ +  S 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGV-IAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVST 62

Query: 421 PKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHN 464
              + + +   L  L L    L + I + +    +L +LNLS  
Sbjct: 63  LHGILS-QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 3e-06
 Identities = 37/284 (13%), Positives = 78/284 (27%), Gaps = 25/284 (8%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL-NNNILSGS 132
           L+L+   L   +   L +   +       + +   +       R + ++ L N+ I   +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 133 IPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNL--QLSENNFNGSIPPSLGNLSN 190
           +   L   + L  L +    LS  I+  +    +L  L           ++   L + S 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 191 LATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS 250
           L                   NL    + +  + +++ +         NL+          
Sbjct: 123 LDE----------------LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166

Query: 251 GAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDR-NYLTGNISESFYIYPN 309
            +        +    L                L  L+ + L R   +           P 
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 310 LTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIG 353
           L  + +      G +       P    L  + ++ T    P IG
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 9e-06
 Identities = 31/271 (11%), Positives = 75/271 (27%), Gaps = 13/271 (4%)

Query: 240 TYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGN 299
             L+L   +L   +         +       +    P+    +   ++ + L  + +  +
Sbjct: 3   QTLDLTGKNLHPDVT-GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 300 -ISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQL 358
            +         L  + L        I +   +   L  L+ S  +       +   SS  
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 359 GVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSN 418
            + +L+ +         +      +   +    LSG       S +        +    +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 419 SIPKSLGNLELIH-------LSELDLSR-NFLREAIPSQICIMQSLEKLNLSHNSLSGLI 470
                +   +          L  L LSR   +      ++  + +L+ L +      G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 471 PSCFEKMNGLLHIDISYNELRGSIPNSTTFK 501
               E    L H+ I+ +        +   K
Sbjct: 242 QLLKE---ALPHLQINCSHFTTIARPTIGNK 269

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 54.1 bits (128), Expect = 3e-08
 Identities = 39/329 (11%), Positives = 87/329 (26%), Gaps = 31/329 (9%)

Query: 165 KSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSY----SIPSELGNLRSLSNLSL 220
           KSL    ++  +   S+   L    ++  + L  N++       +   + + + L     
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 221 GYN---KLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPI 277
                 ++   IP ++  L          +++  +         +  I  L  +     +
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 278 PILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEIS-----SDWGRCP 332
            +  N    +        L                  +   N     S       +    
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 333 KLSTLDFSINNITGNVPPEIGHSSQLGVLDL---------SSNHIVGEIPIELGKLNFFI 383
            L T+    N I       +         +L          ++     + I L       
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 384 KLVLAHNQLSGQLSPKLG------SLVQLEHLDLSSNRLSNSIPKSLGNLE---LIHLSE 434
           +L L    LS + +  +         + L+ L L  N +     ++L  +    +  L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 435 LDLSRNFLREAIPSQICIMQSLEKLNLSH 463
           L+L+ N   E       I +         
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 40/345 (11%), Positives = 93/345 (26%), Gaps = 34/345 (9%)

Query: 71  FSDLELSNNKLSG----SIPPSLGNLSNLATLYLDTNSLSN----SIPSELGNLRSLSNL 122
                L  + ++     S+   L    ++  + L  N++       +   + + + L   
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 123 QLNNN---ILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
           + ++     +   IP +L  L          +++  S        +      LS++    
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 180 SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
            +      L   A   +       ++  +  N   L ++  G N+L              
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184

Query: 240 TYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGN 299
             L      +   I  E    + L  L          +                +  +  
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF----------THLGSSA 234

Query: 300 ISESFYIYPNLTYIDLSQNNFYGEISSDWGRC------PKLSTLDFSINNITGNVPPEIG 353
           ++ +   +PNL  + L+        ++             L TL    N I  +    + 
Sbjct: 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294

Query: 354 HS-----SQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS 393
                    L  L+L+ N    E    + ++           +L 
Sbjct: 295 TVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFST-RGRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 5e-04
 Identities = 42/326 (12%), Positives = 79/326 (24%), Gaps = 59/326 (18%)

Query: 214 SLSNLSLGYNKLSG----SIPISMGNLSNLTYLNLFENSLSG----AIPYEYRNLVKLTI 265
           S+   SL  + ++     S+   +    ++  + L  N++       +     +   L I
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 266 LLLGHNQFRGPIPIL-----------RNLTSLERVRLDRNYLTGNISESFYIYPNLTYID 314
                         +                L  VRL  N       E    + +     
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 315 LSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPI 374
                    +    G     +  + ++N    N PP          L+  S     +   
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 375 ELGKLNFFIKLVLAHNQLSGQLSPKLG------------------------------SLV 404
               L+    +         +     G                              S  
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 405 QLEHLDLSSNRLSN----SIPKSLGNLELIHLSELDLSRNFLREAIPSQICI-----MQS 455
            L  L L+   LS     ++  +   LE I L  L L  N +       +       M  
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 456 LEKLNLSHNSLSGLIPSCFEKMNGLL 481
           L  L L+ N  S       +++  + 
Sbjct: 304 LLFLELNGNRFSEE-DDVVDEIREVF 328

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 5e-08
 Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 18/226 (7%)

Query: 19  NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSN 78
            L +   +  G + ++ ++  +  +L  + TL      ++ +I G +        LEL +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 79  NKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLG 138
           N+++      L NL+ +  L L  N L N             +L          +     
Sbjct: 73  NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL-- 128

Query: 139 NLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT 198
                 +           I          +   LS  N   S    L NLS L TL  D 
Sbjct: 129 ------SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 199 NSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNL 244
           N +S   P  L +L +L  + L  N++S   P++  N SNL  + L
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.6 bits (122), Expect = 9e-08
 Identities = 33/224 (14%), Positives = 70/224 (31%), Gaps = 16/224 (7%)

Query: 211 NLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGH 270
            L +   ++ G + ++ ++  +  +L  +T L+ F   ++     +Y  L  L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQY--LNNLIGLELKD 72

Query: 271 NQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGR 330
           NQ     P            L +                +  +   +             
Sbjct: 73  NQITDLAP---------LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 331 CPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHN 390
                +    +      +      +    +  LS  +        L  L+    L    N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 391 QLSGQLSPKLGSLVQLEHLDLSSNRLSNSIP-KSLGNLELIHLS 433
           ++S      L SL  L  + L +N++S+  P  +  NL ++ L+
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 5e-07
 Identities = 37/218 (16%), Positives = 70/218 (32%), Gaps = 22/218 (10%)

Query: 67  NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN 126
                  +    + ++ ++  +  +L  + TL      ++      +  L +L  L+L +
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG 186
           N ++   P           L        ++I G               +    +   +L 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 187 NLSNLATL--------------YLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPIS 232
            L                    YL   +   S  + L NL  L+ L    NK+S   P+ 
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL- 191

Query: 233 MGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGH 270
             +L NL  ++L  N +S   P    N   L I+ L +
Sbjct: 192 -ASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 9e-07
 Identities = 31/229 (13%), Positives = 69/229 (30%), Gaps = 19/229 (8%)

Query: 235 NLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRN 294
            L+N   +   +++++  +     +L  +T L          I  ++ L +L  + L  N
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDN 73

Query: 295 YLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGH 354
            +T               +  +       I+          T     +         +  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 355 SSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSN 414
                         + +I              L+           L +L +L  L    N
Sbjct: 134 L----------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 415 RLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSH 463
           ++S+  P  L +L   +L E+ L  N + +  P  +    +L  + L++
Sbjct: 184 KISDISP--LASLP--NLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 2e-06
 Identities = 42/227 (18%), Positives = 75/227 (33%), Gaps = 17/227 (7%)

Query: 163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGY 222
            L +   +   ++N   ++  +  +L  + TL      ++ +I   +  L +L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72

Query: 223 NKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRN 282
           N+++      + NL+ +T L L  N L           +K   L         P+  L N
Sbjct: 73  NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN 342
           L  L             I+    +        LS  N      +      KL+TL    N
Sbjct: 131 LQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 343 NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAH 389
            I+      +     L  + L +N I    P  L   +    + L +
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 4e-05
 Identities = 28/228 (12%), Positives = 67/228 (29%), Gaps = 19/228 (8%)

Query: 259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
            L     +  G +     +    +L  +  +      +T    E      NL  ++L  N
Sbjct: 17  ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73

Query: 319 NFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGK 378
                             L  +       +       +        ++         L  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 379 LNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLS 438
           L   +  +   + L+G  + +  S+   +  DL+                L  L+ L   
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLA------------NLSKLTTLKAD 181

Query: 439 RNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDIS 486
            N + +  P  +  + +L +++L +N +S + P      + L  + ++
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 41/217 (18%), Positives = 77/217 (35%), Gaps = 18/217 (8%)

Query: 4   IYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPG 63
              +++ D++     +L  ++ L      ++ +I   +  L NL  L +  N        
Sbjct: 26  AGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN-------- 73

Query: 64  EIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQ 123
           +I +     +L           P    +           +  S  I          +   
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 124 LNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPP 183
           L  ++   +    L  LTNL  L I +  +S      + NL  L+ L+  +N  +   P 
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISP- 190

Query: 184 SLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL 220
            L +L NL  ++L  N +S   P  L N  +L  ++L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 21/76 (27%), Positives = 35/76 (46%), Gaps = 4/76 (5%)

Query: 51  YIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIP 110
           Y+   +   S    + N    + L+  +NK+S   P  L +L NL  ++L  N +S+  P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

Query: 111 SELGNLRSLSNLQLNN 126
             L N  +L  + L N
Sbjct: 213 --LANTSNLFIVTLTN 226

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.9 bits (123), Expect = 6e-08
 Identities = 38/223 (17%), Positives = 80/223 (35%), Gaps = 21/223 (9%)

Query: 220 LGYNKLSGSIPISM----GNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG 275
           LG   ++   PI         +     NL + S++ A+      L  +  ++  ++  + 
Sbjct: 3   LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS 335
              I + L ++ ++ L+ N LT     +        ++D ++      +           
Sbjct: 61  VQGI-QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS--- 116

Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQ 395
               S+ +   +    + H  QL  L L +N I     +            L+       
Sbjct: 117 ---LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS----RLTKLDTLSLEDNQIS 169

Query: 396 LSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLS 438
               L  L +L++L LS N +S+   ++L  L+  +L  L+L 
Sbjct: 170 DIVPLAGLTKLQNLYLSKNHISD--LRALAGLK--NLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 6e-07
 Identities = 30/218 (13%), Positives = 67/218 (30%), Gaps = 21/218 (9%)

Query: 202 SYSIPSELG------NLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPY 255
           + ++P+ +               +L    ++ ++  +   L+++  +    + +      
Sbjct: 7   TITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGI 64

Query: 256 EYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDL 315
           +   L  +T L L  N+        + L +L+ +             S            
Sbjct: 65  Q--YLPNVTKLFLNGNKLTDI----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLS 118

Query: 316 SQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIE 375
            ++N   +I+         S    +       V   +     L + D   + I     + 
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VP 173

Query: 376 LGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
           L  L     L L+ N +S      L  L  L+ L+L S
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 1e-06
 Identities = 34/207 (16%), Positives = 68/207 (32%), Gaps = 28/207 (13%)

Query: 60  SIPGEIG------NFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSEL 113
           ++P  I        F       L    ++ ++  +   L+++  +  + + + +     +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64

Query: 114 GNLRSLSNLQLNNNILSG---------------SIPHSLGNLTNLATLYIYSNSLSASIL 158
             L +++ L LN N L+                         +      + S SL  + +
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124

Query: 159 GKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNL 218
             I  L  L  L+      N     ++ +           ++    I   L  L  L NL
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNL 183

Query: 219 SLGYNKLSGSIPISMGNLSNLTYLNLF 245
            L  N +S  +  ++  L NL  L LF
Sbjct: 184 YLSKNHIS-DLR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 5e-05
 Identities = 32/202 (15%), Positives = 63/202 (31%), Gaps = 16/202 (7%)

Query: 19  NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSN 78
                    L    ++ ++  +   L ++  +  + + +       I      + L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 79  NKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLG 138
           NKL+         L+NL  L       +                    +         + 
Sbjct: 78  NKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN----GISDIN 128

Query: 139 NLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT 198
            L +L  L       +      + +  +  +    E+N    I P L  L+ L  LYL  
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSK 187

Query: 199 NSLSYSIPSELGNLRSLSNLSL 220
           N +S  + + L  L++L  L L
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 35/227 (15%), Positives = 64/227 (28%), Gaps = 39/227 (17%)

Query: 139 NLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDT 198
                    +   S++ ++      L S+  +  + ++        +  L N+  L+L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 199 NSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYR 258
           N L+                              +  L+NL  L       +        
Sbjct: 78  NKLT-----------------------------DIKPLANLKNLGWLFLDENKVKDLSSL 108

Query: 259 NLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQN 318
             +K    L   +     I  L +L  LE + L  N +T     S     +         
Sbjct: 109 KDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LE 164

Query: 319 NFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
           +             KL  L  S N+I+      +     L VL+L S
Sbjct: 165 DNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 1e-06
 Identities = 19/75 (25%), Positives = 31/75 (41%), Gaps = 5/75 (6%)

Query: 404 VQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLRE----AIPSQICIMQSLEKL 459
           + ++ LD+    LS++    L  L L     + L    L E     I S + +  +L +L
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPL-LQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 460 NLSHNSLSGLIPSCF 474
           NL  N L  +   C 
Sbjct: 61  NLRSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 1e-06
 Identities = 16/91 (17%), Positives = 38/91 (41%), Gaps = 5/91 (5%)

Query: 94  NLATLYLDTNSLSNSIPSEL-GNLRSLSNLQLNNNILSG----SIPHSLGNLTNLATLYI 148
           ++ +L +    LS++  +EL   L+    ++L++  L+      I  +L     LA L +
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 149 YSNSLSASILGKIGNLKSLSNLQLSENNFNG 179
            SN L    +  +       + ++ + +   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 21/113 (18%), Positives = 41/113 (36%), Gaps = 8/113 (7%)

Query: 384 KLVLAHNQLS-GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL--ELIHLSELDLSRN 440
            L +   +LS  + +  L  L Q + + L    L+ +  K + +       L+EL+L  N
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65

Query: 441 FLREAIPSQICIM-----QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYN 488
            L +     +          ++KL+L +  L+G            L      +
Sbjct: 66  ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 118

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 5/91 (5%)

Query: 142 NLATLYIYSNSLSASILGKI-GNLKSLSNLQLSENNFNG----SIPPSLGNLSNLATLYL 196
           ++ +L I    LS +   ++   L+    ++L +          I  +L     LA L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 197 DTNSLSYSIPSELGNLRSLSNLSLGYNKLSG 227
            +N L       +       +  +    L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 20/109 (18%), Positives = 32/109 (29%), Gaps = 8/109 (7%)

Query: 355 SSQLGVLDLSSNHIVGEIPIEL-GKLNFFIKLVLAHNQLSGQ----LSPKLGSLVQLEHL 409
           S  +  LD+    +      EL   L     + L    L+      +S  L     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 410 DLSSNRLSNSIPKSLGNL---ELIHLSELDLSRNFLREAIPSQICIMQS 455
           +L SN L +     +          + +L L    L  A    +     
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 109

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 8e-06
 Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 5/95 (5%)

Query: 46  NLATLYIHTNSLSGSIPGEI-GNFRFFSDLELSNNKLSG----SIPPSLGNLSNLATLYL 100
           ++ +L I    LS +   E+    +    + L +  L+      I  +L     LA L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 101 DTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPH 135
            +N L +     +       + ++    L      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 10/89 (11%)

Query: 166 SLSNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSY----SIPSELGNLRSLSNLSL 220
            + +L +     + +    L   L     + LD   L+      I S L    +L+ L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 221 GYNKLSGSIPISMG-----NLSNLTYLNL 244
             N+L       +          +  L+L
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 9/92 (9%), Positives = 24/92 (26%), Gaps = 5/92 (5%)

Query: 309 NLTYIDLSQNNFYGE-ISSDWGRCPKLSTLDFSINNITGNVPPEIG----HSSQLGVLDL 363
           ++  +D+          +       +   +      +T     +I      +  L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 364 SSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQ 395
            SN +       + +        +    L   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 10/90 (11%)

Query: 385 LVLAHNQLSGQ----LSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNL---ELIHLSELDL 437
           L LA   +S      L+  L +   L  LDLS+N L ++    L          L +L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 438 SRNFLREAIPSQICIMQSLEKLNLSHNSLS 467
              +  E +  ++   Q+LEK   S   +S
Sbjct: 434 YDIYWSEEMEDRL---QALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 13/73 (17%), Positives = 29/73 (39%), Gaps = 5/73 (6%)

Query: 430 IHLSELDLSRNFLREAIPSQIC-IMQSLEKLNLSHNSLSG----LIPSCFEKMNGLLHID 484
           + +  LD+    L +A  +++  ++Q  + + L    L+      I S       L  ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 485 ISYNELRGSIPNS 497
           +  NEL     + 
Sbjct: 62  LRSNELGDVGVHC 74

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 13/85 (15%), Positives = 24/85 (28%), Gaps = 9/85 (10%)

Query: 304 FYIYPNLTYIDLSQNNFYGE----ISSDWGRCPKLSTLDFSINNITGNVPPEIG-----H 354
                 L  + L+  +        +++       L  LD S N +      ++       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 355 SSQLGVLDLSSNHIVGEIPIELGKL 379
              L  L L   +   E+   L  L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 13/93 (13%)

Query: 187 NLSNLATLYLDTNSLS----YSIPSELGNLRSLSNLSLGYNKLSGSIPISMG-----NLS 237
             S L  L+L    +S     S+ + L    SL  L L  N L  +  + +         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 238 NLTYLNLFENSLSGAIPYEYRNLVK----LTIL 266
            L  L L++   S  +    + L K    L ++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 6e-05
 Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 10/94 (10%)

Query: 190 NLATLYLDTNSLSYSIPSEL-GNLRSLSNLSLGYNKLSG----SIPISMGNLSNLTYLNL 244
           ++ +L +    LS +  +EL   L+    + L    L+      I  ++     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 245 FENSLSGAIPYE-----YRNLVKLTILLLGHNQF 273
             N L     +           K+  L L +   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 17/108 (15%), Positives = 31/108 (28%), Gaps = 23/108 (21%)

Query: 325 SSDWGRCPKLSTLDFSINNITGNVPPEIG----HSSQLGVLDLSSNHIVGEIPIELGKLN 380
                    L  L  +  +++ +    +      +  L  LDLS+N +     ++L +  
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-- 419

Query: 381 FFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLE 428
                 +                  LE L L     S  +   L  LE
Sbjct: 420 -----SVRQPGCL------------LEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 17/76 (22%), Positives = 28/76 (36%), Gaps = 9/76 (11%)

Query: 74  LELSNNKLSG----SIPPSLGNLSNLATLYLDTNSLSNSIPSELG-----NLRSLSNLQL 124
           L L++  +S     S+  +L    +L  L L  N L ++   +L          L  L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 125 NNNILSGSIPHSLGNL 140
            +   S  +   L  L
Sbjct: 434 YDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 15/83 (18%), Positives = 30/83 (36%), Gaps = 9/83 (10%)

Query: 115 NLRSLSNLQLNNNILSG----SIPHSLGNLTNLATLYIYSNSLSASILGKIG-----NLK 165
               L  L L +  +S     S+  +L    +L  L + +N L  + + ++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 166 SLSNLQLSENNFNGSIPPSLGNL 188
            L  L L +  ++  +   L  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 16/85 (18%), Positives = 28/85 (32%), Gaps = 5/85 (5%)

Query: 4  IYNNSLYDSIPSEL-RNLKSLSDLELGNNKLSG----SIPHSLGNLTNLATLYIHTNSLS 58
          I    L D+  +EL   L+    + L +  L+      I  +L     LA L + +N L 
Sbjct: 9  IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 59 GSIPGEIGNFRFFSDLELSNNKLSG 83
                +         ++    L  
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 17/94 (18%), Positives = 30/94 (31%), Gaps = 11/94 (11%)

Query: 261 VKLTILLLGHNQF--RGPIPILRNLTSLERVRLDRNYLTG----NISESFYIYPNLTYID 314
           + +  L +   +        +L  L   + VRLD   LT     +IS +  + P L  ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 315 LSQNNFYGEISSDWGR-----CPKLSTLDFSINN 343
           L  N           +       K+  L      
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 28/126 (22%), Positives = 51/126 (40%), Gaps = 10/126 (7%)

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGA 252
            L+L    L+  +   L  L  +++L L +N+L    P ++  L  L  L   +N+L   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 253 IPYEYRNLVKLTILLLGHNQFRG--PIPILRNLTSLERVRLDRNYLT---GNISESFYIY 307
                   ++   LLL +N+ +    I  L +   L  + L  N L    G       + 
Sbjct: 59  DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 308 PNLTYI 313
           P+++ I
Sbjct: 117 PSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 29/120 (24%), Positives = 44/120 (36%), Gaps = 7/120 (5%)

Query: 97  TLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSAS 156
            L+L    L+  +   L  L  +++L L++N L    P +L  L  L  L    N+    
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56

Query: 157 ILGKIGNLKSLSNLQLSENNFNG-SIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSL 215
            +  + NL  L  L L  N     +    L +   L  L L  NSL          L  +
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.6 bits (102), Expect = 1e-05
 Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 8/109 (7%)

Query: 385 LVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLRE 444
           L LAH  L+      L  L+ + HLDLS NRL    P +L  L  + + +   +      
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--- 56

Query: 445 AIPSQICIMQSLEKLNLSHNSLSGL-IPSCFEKMNGLLHIDISYNELRG 492
                +  +  L++L L +N L              L+ +++  N L  
Sbjct: 57  -NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.4 bits (99), Expect = 2e-05
 Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 5/107 (4%)

Query: 241 YLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNI 300
            L+L    L+  +      L+ +T L L HN+ R   P L  L  LE ++   N      
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA--LEN 57

Query: 301 SESFYIYPNLTYIDLSQNNF-YGEISSDWGRCPKLSTLDFSINNITG 346
            +     P L  + L  N             CP+L  L+   N++  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 4e-05
 Identities = 25/127 (19%), Positives = 41/127 (32%), Gaps = 12/127 (9%)

Query: 26  LELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI 85
           L L +  L+  +   L  L  +  L +  N L    P             L  +  +   
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNALEN 57

Query: 86  PPSLGNLSNLATLYLDTNSLSN-SIPSELGNLRSLSNLQLNNNILSG------SIPHSLG 138
              + NL  L  L L  N L   +    L +   L  L L  N L         +   L 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 139 NLTNLAT 145
           +++++ T
Sbjct: 118 SVSSILT 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 9e-05
 Identities = 24/104 (23%), Positives = 35/104 (33%), Gaps = 26/104 (25%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL--------- 124
           L L++  L+  +   L  L  +  L L  N L  ++P  L  LR L  LQ          
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD 59

Query: 125 --------------NNNILSGSIPHSLGNLTNLATLYIYSNSLS 154
                         NN +   +    L +   L  L +  NSL 
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 1e-04
 Identities = 29/126 (23%), Positives = 49/126 (38%), Gaps = 8/126 (6%)

Query: 336 TLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQ 395
            L  +  ++T  V   +     +  LDLS N +    P  L  L     L  + N L   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 396 LSPKLGSLVQLEHLDLSSNRLSN-SIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
                 +L +L+ L L +NRL   +  + L +     L  L+L  N L +    Q  + +
Sbjct: 59  DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCP--RLVLLNLQGNSLCQEEGIQERLAE 114

Query: 455 SLEKLN 460
            L  ++
Sbjct: 115 MLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 23/107 (21%), Positives = 43/107 (40%), Gaps = 6/107 (5%)

Query: 312 YIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGE 371
            + L+  +    +     +   ++ LD S N +    PP +     L VL   ++    E
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNALE 56

Query: 372 IPIELGKLNFFIKLVLAHNQLSGQLSPK-LGSLVQLEHLDLSSNRLS 417
               +  L    +L+L +N+L    + + L S  +L  L+L  N L 
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.7 bits (104), Expect = 1e-05
 Identities = 33/195 (16%), Positives = 67/195 (34%), Gaps = 14/195 (7%)

Query: 235 NLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRN 294
            L+      L + +++  +     +L ++T L       +  I  +  L +L ++    N
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNN 72

Query: 295 YLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGH 354
            LT               ++ +Q      +++           +   +         +  
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 355 SSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSN 414
                   L  +         L  L    +L  + NQ++      L +L  LE LD+SSN
Sbjct: 133 --------LELSSNTISDISALSGLTSLQQLNFSSNQVTD--LKPLANLTTLERLDISSN 182

Query: 415 RLSN-SIPKSLGNLE 428
           ++S+ S+   L NLE
Sbjct: 183 KVSDISVLAKLTNLE 197

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 6e-04
 Identities = 38/199 (19%), Positives = 67/199 (33%), Gaps = 15/199 (7%)

Query: 163 NLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGY 222
            L       L + N   ++  S  +L  + TL  D   +  SI   +  L +L+ ++   
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 223 NKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRN 282
           N+L+      +  L NLT L     + +          +     L   N     I  L+N
Sbjct: 72  NQLTD-----ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126

Query: 283 LTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSIN 342
           LT+L R+ L  N ++   + S              ++              L  LD S N
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLN----FSSNQVTDLKPLANLTTLERLDISSN 182

Query: 343 NITGNVPPEIGHSSQLGVL 361
            ++      +   + L  L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 30/190 (15%), Positives = 60/190 (31%), Gaps = 20/190 (10%)

Query: 19  NLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSN 78
            L       LG   ++ ++  +  +L  + TL      +  SI G +      + +  SN
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 79  NKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLG 138
           N+L+   P           +  +  +    + +               +I       +L 
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 139 NLTNLATL--------------YIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS 184
            L   +                 +  +S   + L  + NL +L  L +S N  +      
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 185 LGNLSNLATL 194
           L  L+NL +L
Sbjct: 190 LAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 28/183 (15%), Positives = 56/183 (30%), Gaps = 20/183 (10%)

Query: 74  LELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSI 133
             L    ++ ++  S  +L  + TL  D   + +     +  L +L+ +  +NN L+   
Sbjct: 23  TVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDIT 78

Query: 134 PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLAT 193
           P           +     +    +                 +        +L  L   + 
Sbjct: 79  PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138

Query: 194 L--------------YLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
                           L+ +S   +    L NL +L  L +  NK+S      +  L+NL
Sbjct: 139 TISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNL 196

Query: 240 TYL 242
             L
Sbjct: 197 ESL 199

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.4 bits (103), Expect = 1e-05
 Identities = 37/174 (21%), Positives = 64/174 (36%), Gaps = 8/174 (4%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSL-GNLTNLATLYIHTNSLSGSIPGE 64
              L   IP ++      ++L L +N+L       L G L +L  L +  N L+G  P  
Sbjct: 17  GRGL-KEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL 124
                   +L+L  NK+          L  L TL L  N +S  +P    +L SL++L L
Sbjct: 74  FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133

Query: 125 NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN 178
            +N  + +   +      L    +   +           ++ +    L  + F 
Sbjct: 134 ASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA---PSKVRDVQIKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 37/177 (20%), Positives = 65/177 (36%), Gaps = 9/177 (5%)

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISM-GNLSNLTYLNLFENSLSG 251
           T+      L   IP ++      + L L  N+L       + G L +L  L L  N L+G
Sbjct: 12  TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 252 AIPYEYRNLVKLTILLLGHNQFRGPIP-ILRNLTSLERVRLDRNYLTGNISESFYIYPNL 310
             P  +     +  L LG N+ +     +   L  L+ + L  N ++  +  SF    +L
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 311 TYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH 367
           T ++L+ N F       W     L     +        P ++     + + DL  + 
Sbjct: 129 TSLNLASNPFNCNCHLAWFAE-WLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSE 181

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.6 bits (93), Expect = 3e-04
 Identities = 37/156 (23%), Positives = 57/156 (36%), Gaps = 4/156 (2%)

Query: 166 SLSNLQLSENNFNGSIPPSL-GNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNK 224
             + L L++N         L G L +L  L L  N L+   P+       +  L LG NK
Sbjct: 30  HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89

Query: 225 LSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLT 284
           +          L  L  LNL++N +S  +P  + +L  LT L L  N F     +     
Sbjct: 90  IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE 149

Query: 285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNF 320
            L +  L+                ++   DL  + F
Sbjct: 150 WLRKKSLNGGAARCGAPSKVR---DVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.8 bits (91), Expect = 5e-04
 Identities = 30/193 (15%), Positives = 57/193 (29%), Gaps = 29/193 (15%)

Query: 306 IYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSS 365
           I  + T + L+ N      S                 N    + P     +         
Sbjct: 27  IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86

Query: 366 NHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLG 425
            + + EI  ++                          L QL+ L+L  N++S  +P S  
Sbjct: 87  ENKIKEISNKM-----------------------FLGLHQLKTLNLYDNQISCVMPGSFE 123

Query: 426 NLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDI 485
           +L  +         +             + L K +L+  +     PS   K+  +   D+
Sbjct: 124 HLNSLTSLN---LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDL 177

Query: 486 SYNELRGSIPNST 498
            ++E + S  NS 
Sbjct: 178 PHSEFKCSSENSE 190

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 29/121 (23%), Positives = 44/121 (36%), Gaps = 5/121 (4%)

Query: 354 HSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSS 413
           +      LDL       +    L   N  + L    +  +  L     ++ +L  L+LS+
Sbjct: 20  YDGSQQALDLKGLRSDPD----LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSN 74

Query: 414 NRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC 473
           NRL      S    +  +L  L+LS N L+            LE+L L  NSLS      
Sbjct: 75  NRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134

Query: 474 F 474
            
Sbjct: 135 S 135

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (97), Expect = 7e-05
 Identities = 28/156 (17%), Positives = 45/156 (28%), Gaps = 21/156 (13%)

Query: 161 IGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSL 220
           +      S   L          P L   +    L   ++  + ++     N+  L +L+L
Sbjct: 16  MSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNL 72

Query: 221 GYNKLSG--SIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIP 278
             N+L     +   +    NL  LNL  N L      +    +KL  L L  N       
Sbjct: 73  SNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

Query: 279 ILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYID 314
                                IS     +P L  +D
Sbjct: 133 DQST----------------YISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 1e-04
 Identities = 29/149 (19%), Positives = 57/149 (38%), Gaps = 8/149 (5%)

Query: 362 DLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLS--NS 419
           +L    +  ++ + + K     +  L    L  +  P L +      L+  S+  +    
Sbjct: 3   ELKPEQV-EQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRI 59

Query: 420 IPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSCFEKMNG 479
           I +++  L  ++LS   L R    + + S +    +L+ LNLS N L         K   
Sbjct: 60  IEENIPELLSLNLSNNRLYRL---DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116

Query: 480 LLHIDISYNELRGSIPNSTTFKDAPIEAL 508
           L  + +  N L  +  + +T+  A  E  
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERF 145

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 7e-04
 Identities = 24/134 (17%), Positives = 41/134 (30%), Gaps = 5/134 (3%)

Query: 12  SIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFF 71
            +   +      S   L    L       L        L   ++  + ++     N    
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67

Query: 72  SDLELSNNKLSG--SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNIL 129
             L LSNN+L     +   +    NL  L L  N L +    +      L  L L+ N L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 130 SGSIPHSLGNLTNL 143
           S +       ++ +
Sbjct: 128 SDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (88), Expect = 0.001
 Identities = 19/91 (20%), Positives = 33/91 (36%), Gaps = 2/91 (2%)

Query: 7   NSLYDSIPSELRNLKSLSDLELGNNKLSG--SIPHSLGNLTNLATLYIHTNSLSGSIPGE 64
           +S+  ++     N+  L  L L NN+L     +   +    NL  L +  N L      +
Sbjct: 51  SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD 110

Query: 65  IGNFRFFSDLELSNNKLSGSIPPSLGNLSNL 95
                   +L L  N LS +       +S +
Sbjct: 111 KIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (84), Expect = 0.004
 Identities = 21/135 (15%), Positives = 40/135 (29%), Gaps = 4/135 (2%)

Query: 253 IPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTY 312
           +          +   L     R   P L        +    +     +       P L  
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLS 69

Query: 313 IDLSQNNFYG--EISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVG 370
           ++LS N  Y   ++SS   + P L  L+ S N +      +     +L  L L  N +  
Sbjct: 70  LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129

Query: 371 EIPIELGKLNFFIKL 385
               +   ++   + 
Sbjct: 130 TFRDQSTYISAIRER 144

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (97), Expect = 5e-05
 Identities = 29/143 (20%), Positives = 45/143 (31%), Gaps = 5/143 (3%)

Query: 3   CIYNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIP-HSLGNLTNLATLYIHTNSLSGSI 61
           C  + +L       L   ++L++L + N +    +    L  L  L  L I  + L    
Sbjct: 15  CTRDGAL--DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72

Query: 62  PGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLS-NSIPSELGNLRSLS 120
           P         S L LS N L  S+        +L  L L  N L  +     L       
Sbjct: 73  PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131

Query: 121 NLQLNNNILSGSIPHSLGNLTNL 143
              +    L       L ++ N 
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 9e-04
 Identities = 29/155 (18%), Positives = 42/155 (27%), Gaps = 4/155 (2%)

Query: 87  PSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP-HSLGNLTNLAT 145
           P        + L    +         L    +L+ L + N      +    L  L  L  
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 146 LYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSI 205
           L I  + L             LS L LS N    S+        +L  L L  N L  S 
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119

Query: 206 -PSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNL 239
               L          +   KL       + ++ N 
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 21/146 (14%), Positives = 46/146 (31%), Gaps = 4/146 (2%)

Query: 284 TSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSD-WGRCPKLSTLDFSIN 342
                +R  R+    +         NLT + +        +         +L  L    +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 343 NITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPK-LG 401
            +    P     + +L  L+LS N +   +  +  +     +LVL+ N L    + + L 
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125

Query: 402 SLVQLEHLDLSSNRLSNSIPKSLGNL 427
              +     +   +L       L ++
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHM 151

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 35/223 (15%), Positives = 61/223 (27%), Gaps = 8/223 (3%)

Query: 276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLS 335
           P  + RN   L   R     L      +F  + +L  I++SQN+    I +D        
Sbjct: 24  PSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 336 T--LDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLS 393
                   NN+    P    +   L  L +S+  I     +        + L +  N   
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 394 GQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIM 453
             +       +  E + L  N+       +                N L E         
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 454 QSLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELRGSIPN 496
                L++S   +  L     E +  L        +    +P 
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 8e-05
 Identities = 33/230 (14%), Positives = 62/230 (26%), Gaps = 10/230 (4%)

Query: 214 SLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQF 273
           S        +K++  IP  +    N   L      L       +     L  + +  N  
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 274 RGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYG-----EISSDW 328
              I         +   +        +  +   + NL  +     +  G     ++    
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 329 GRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLA 388
                L  +  +IN  T      +G S +  +L L+ N I                 +  
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 389 HNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLS 438
           +N L    +           LD+S  R+ +     L NL+   L      
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK--KLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 29/228 (12%), Positives = 71/228 (31%), Gaps = 8/228 (3%)

Query: 193 TLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGA 252
                 + ++  IPS+L   R+   L     KL      +     +L  + + +N +   
Sbjct: 12  VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68

Query: 253 IPYEYRNLVKLTILLL---GHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPN 309
           I  +  + +     +     +N         +NL +L+ + +    +             
Sbjct: 69  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128

Query: 310 LTYIDLSQ--NNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNH 367
              +D+    N    E +S  G   +   L  + N I          +    +    +N+
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188

Query: 368 IVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNR 415
           +           +  + L ++  ++    S  L +L +L      + +
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 30/223 (13%), Positives = 58/223 (26%), Gaps = 7/223 (3%)

Query: 6   NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEI 65
            + +   IPS+L   ++  +L     KL      +     +L  + I  N +   I  ++
Sbjct: 17  ESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73

Query: 66  GNFRFFSDLEL----SNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSN 121
            +             +N                   +          +       + L +
Sbjct: 74  FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 133

Query: 122 LQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI 181
           +Q N NI +      +G       L++  N +           +         NN     
Sbjct: 134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELP 193

Query: 182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNK 224
                  S    L +    +       L NL+ L   S    K
Sbjct: 194 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 2e-04
 Identities = 13/83 (15%), Positives = 30/83 (36%), Gaps = 4/83 (4%)

Query: 415 RLS-NSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPSC 473
           +L+   I ++      +   ELDL    +   I +    +   + ++ S N +  L    
Sbjct: 2   KLTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DG 58

Query: 474 FEKMNGLLHIDISYNELRGSIPN 496
           F  +  L  + ++ N +      
Sbjct: 59  FPLLRRLKTLLVNNNRICRIGEG 81

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.002
 Identities = 16/97 (16%), Positives = 40/97 (41%), Gaps = 5/97 (5%)

Query: 395 QLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQ 454
           + + +  + V+   LDL   ++   I      L+      +D S N +R        +++
Sbjct: 9   EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLD--QFDAIDFSDNEIR--KLDGFPLLR 63

Query: 455 SLEKLNLSHNSLSGLIPSCFEKMNGLLHIDISYNELR 491
            L+ L +++N +  +     + +  L  + ++ N L 
Sbjct: 64  RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.002
 Identities = 25/146 (17%), Positives = 39/146 (26%), Gaps = 8/146 (5%)

Query: 102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKI 161
           T  L         N      L L    +   I +    L     +    N +    L   
Sbjct: 4   TAELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59

Query: 162 GNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLS----YSIPSELGNLRSLSN 217
             L+ L  L ++ N            L +L  L L  NSL         + L +L  L  
Sbjct: 60  PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119

Query: 218 LSLGYNKLSGSIPISMGNLSNLTYLN 243
           L              +  +  +  L+
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVLD 145

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 41/189 (21%), Positives = 62/189 (32%), Gaps = 23/189 (12%)

Query: 158 LGKIGNLKSLSNLQLSENNFNGSIPP------SLGNLSNLATLYLDTNSLSYSIPSELGN 211
           +      KS+   +  +   +G IPP      +L  L     L L TN++   I S L  
Sbjct: 11  IRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSG 68

Query: 212 LRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHN 271
           + +L  LSLG N     I         L  L +  N ++     E    +++  +     
Sbjct: 69  MENLRILSLGRNL-IKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKI 127

Query: 272 QFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRC 331
              G I  L  L  LE + L  N L  +  E+         +                R 
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV--------------VKRL 173

Query: 332 PKLSTLDFS 340
           P L  LD  
Sbjct: 174 PNLKKLDGM 182

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	873
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.8
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.72
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.71
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.56
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.4
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.38
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.3
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.26
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.54
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.54
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.43
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.02
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.75
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.73
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.52
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.16
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.94
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.34
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.33

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=410.29  Aligned_cols=248  Identities=26%  Similarity=0.438  Sum_probs=208.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++......+....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56899999999999999999875 68999999986432222333577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999998643   3589999999999999999999999   9999999999999999999999999999866532


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                        ......||+.|||||++.+..++.++||||+||++|||++|+.||......        .....+.......+...  
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~--  227 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVEFTFPDFV--  227 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCTTS--
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCccC--
Confidence              334568999999999999999999999999999999999999998753322        12222333333333221  


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ...+.+++.+||+.||++|||++|+++
T Consensus       228 --s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         228 --TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              224789999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=410.07  Aligned_cols=249  Identities=24%  Similarity=0.416  Sum_probs=208.7

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......   ..+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4699999999999999999975 57999999998754322   2477999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++..    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        97 Ey~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             ECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            99999999988753    3489999999999999999999999   9999999999999999999999999999988766


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||.............     ....+.+..+.    
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~----  240 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-----TNGTPELQNPE----  240 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-----HHCSCCCSSGG----
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH-----hCCCCCCCCcc----
Confidence            556667789999999999999999999999999999999999999987543321111111     11111222111    


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12234889999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=411.58  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||+||+|+.+  ..||||+++...... ...+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            467999999999999999999875  359999997553332 346789999999999999999999999754 5689999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++....  ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            9999999999996543  3589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC--Ccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          761 SS--NWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       761 ~~--~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ..  ......||+.|||||++.+   ..++.++|||||||++|||+||+.||.............   ......+.....
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~---~~~~~~p~~~~~  234 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV---GRGYLSPDLSKV  234 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---HHTSCCCCGGGS
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH---hcCCCCCcchhc
Confidence            22  3345689999999999864   357899999999999999999999997544322111111   111112222111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..   .....+.+++.+||+.||++|||++|+++.|+
T Consensus       235 ~~---~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         235 RS---NCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            11   12235889999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=411.29  Aligned_cols=251  Identities=24%  Similarity=0.423  Sum_probs=196.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      ++|++.+.||+|+||+||+|+..+++.||||+++....    ..++|.+|++++++++|||||+++|+|.+++..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            57888999999999999999999899999999875322    24789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|+|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||+|+......
T Consensus        81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            999999999986543  4588999999999999999999999   99999999999999999999999999998775443


Q ss_pred             CC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          762 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       762 ~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .. .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||..........     .+....  +...+. ..
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~-----~i~~~~--~~~~p~-~~  227 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----DISTGF--RLYKPR-LA  227 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH-----HHHHTC--CCCCCT-TS
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHhcC--CCCCcc-cc
Confidence            32 2345789999999999999999999999999999999995 55544322211111     111111  111111 11


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ...+.+++.+||+.||++||||+||++.|+
T Consensus       228 ---~~~l~~li~~cl~~~p~~Rps~~~il~~L~  257 (263)
T d1sm2a_         228 ---STHVYQIMNHCWKERPEDRPAFSRLLRQLA  257 (263)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence               224889999999999999999999999885

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=413.14  Aligned_cols=256  Identities=24%  Similarity=0.346  Sum_probs=196.0

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--cceeEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--VRHLFI  678 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  678 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++...... ....+.+.+|++++++++|||||++++++.+  .+..|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            6799999999999999999976 47999999999765433 2335779999999999999999999999865  456899


Q ss_pred             EEEeccCCChhhHhcccc-cccCCChHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDA-AAKNLGWTRRMNMIKGIVDALSYMHNDC--FPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||+|||++.  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999986543 3456999999999999999999999861  1149999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      .............||+.|||||++.+..++.++||||+||++|||+||+.||........        ...+..+..+..
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--------~~~i~~~~~~~~  234 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--------AGKIREGKFRRI  234 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHTCCCCC
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH--------HHHHHcCCCCCC
Confidence            877655555667899999999999999999999999999999999999999875332211        111222222211


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      +..   ....+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~---~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 PYR---YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Ccc---cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            111   1224889999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=407.89  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......  ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            5799999999999999999986 47999999998754322  22467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++.++..++.||+.|++|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        83 Ey~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          83 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            999999999998643   3599999999999999999999999   9999999999999999999999999999876533


Q ss_pred             C--CCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCC
Q 039344          761 S--SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPS  836 (873)
Q Consensus       761 ~--~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  836 (873)
                      .  ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.........       ....... ....+.
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~~~~~~~~~~~~~  229 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYLNPW  229 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-------HHHHHTTCTTSTTG
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-------HHHHhcCCCCCCcc
Confidence            2  23455789999999999988876 57899999999999999999999753322110       0111111 111111


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..   ....+.+++.+||+.||++|||++|+++
T Consensus       230 ~~---~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 KK---IDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GG---SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc---CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11   1234778999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=412.07  Aligned_cols=253  Identities=21%  Similarity=0.343  Sum_probs=204.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||+||+|+.++++.||||+++....    ..++|.+|++++++++|||||+++|++.+ +..++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            467888999999999999999999889999999975322    24679999999999999999999998854 5679999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++.... ...+++..+.+++.||++|++|||++   +|+||||||+||++++++.+||+|||+|+.....
T Consensus        87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999999876543 34589999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .. ......||+.|+|||++.++.++.++|||||||++|||+||..|+......       ......+..+..+..+...
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCTTC
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCcccC
Confidence            32 233467899999999999999999999999999999999966654322211       1111122222111111111


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ...+.+++.+||+.||++||||+||++.|+
T Consensus       236 ---~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         236 ---PEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence               224889999999999999999999998874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=400.40  Aligned_cols=249  Identities=24%  Similarity=0.429  Sum_probs=209.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      ++|++.++||+|+||+||+|+.++++.||||+++....    ..++|.+|+.++++++||||++++|+|.+++..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            68999999999999999999999888999999975422    24789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|++..++....  ..+++..+.+++.|+++|++|||++   +|+||||||+||+++.++.+||+|||+|+......
T Consensus        80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             ccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            999999998875443  4588999999999999999999999   99999999999999999999999999998765443


Q ss_pred             C-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCch
Q 039344          762 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRN  838 (873)
Q Consensus       762 ~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  838 (873)
                      . ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||........        ...+..+ +.+.+. .
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--------~~~i~~~~~~~~p~-~  225 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------AEHIAQGLRLYRPH-L  225 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------HHHHHTTCCCCCCT-T
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--------HHHHHhCCCCCCcc-c
Confidence            3 2334678999999999999999999999999999999998 8999875443221        1112122 222222 1


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .   ...+.+++.+||+.||++|||++|+++.|
T Consensus       226 ~---~~~l~~li~~cl~~dP~~RPt~~eil~~L  255 (258)
T d1k2pa_         226 A---SEKVYTIMYSCWHEKADERPTFKILLSNI  255 (258)
T ss_dssp             C---CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             c---cHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence            1   23488999999999999999999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-48  Score=411.55  Aligned_cols=252  Identities=25%  Similarity=0.441  Sum_probs=194.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CC---cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      .+|++.+.||+|+||+||+|+.+ +|   ..||||++....  .....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45667789999999999999864 23   358999886543  2334578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++....  ..+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            9999999999999886533  3589999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCCc-----cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcC-C
Q 039344          758 KPDSSNW-----TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLD-P  830 (873)
Q Consensus       758 ~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~  830 (873)
                      .......     ....||+.|||||.+.++.++.++|||||||++|||+| |+.||.......        ....+.. .
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------~~~~i~~~~  250 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQDY  250 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCC
Confidence            5433221     22457899999999999999999999999999999998 899987543221        1111212 2


Q ss_pred             CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          831 RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       831 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      +.+.+..    ....+.+++.+||+.||++|||++||++.|+
T Consensus       251 ~~~~~~~----~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         251 RLPPPMD----CPSALHQLMLDCWQKDRNHRPKFGQIVNTLD  288 (299)
T ss_dssp             CCCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCCcc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            2222222    2234889999999999999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-49  Score=414.16  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=207.4

Q ss_pred             HhcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEE
Q 039344          600 ATNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       600 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  678 (873)
                      ..++|++.+.||+|+||+||+|+.. +|+.||||+++....    ..++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3467888999999999999999875 688999999875322    25779999999999999999999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      ||||+++|++.+++.... ...+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence            999999999999986543 34689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCC-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          759 PDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       759 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||....+...    ....+..-.  +.+.+..
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----~~~~i~~~~--~~~~~~~  240 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDY--RMERPEG  240 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTC--CCCCCTT
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----HHHHHhcCC--CCCCCcc
Confidence            44332 2344578999999999999999999999999999999998777543222110    011111111  1122211


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                          ....+.+++.+||+.||++|||++||++.|+
T Consensus       241 ----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         241 ----CPEKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                1234889999999999999999999998874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=407.79  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=204.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      +.|++.+.||+|+||+||+|+. .+|+.||||++.....   ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            4688999999999999999986 4789999999875432   22467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...  ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 Ey~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          89 EFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             ecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999999999987543  24589999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CCCccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          761 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ........||+.|+|||++.     +..|+.++||||+||++|||+||+.||............     .....+.+..+
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~  238 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-----AKSEPPTLAQP  238 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-----HHSCCCCCSSG
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH-----HcCCCCCCCcc
Confidence            33344578999999999984     456889999999999999999999998754432211111     01011122211


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .    .....+.+++.+||+.||++|||++|+++
T Consensus       239 ~----~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         239 S----RWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             G----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1    12235889999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=404.25  Aligned_cols=252  Identities=22%  Similarity=0.307  Sum_probs=203.9

Q ss_pred             cCCCCCce-eeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHC-IGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|.+.+. ||+|+||+||+|..+   ++..||||+++...  .....++|.+|++++++++|||||+++|+|.+ +..|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            45666664 999999999999753   45579999997542  33346789999999999999999999999865 5679


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999875433  4589999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          758 KPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       758 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ......   .....||+.|+|||++.++.++.++|||||||++|||+| |+.||........        ...+..+..+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--------~~~i~~~~~~  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------MAFIEQGKRM  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--------HHHHHTTCCC
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCC
Confidence            654332   234568899999999999999999999999999999998 9999875433221        1112222211


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..+...   +..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       232 ~~p~~~---~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         232 ECPPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             CCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            111112   234889999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=408.43  Aligned_cols=249  Identities=21%  Similarity=0.300  Sum_probs=204.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999986 479999999986432222223567999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   +.+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999988643   4599999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          761 SS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       761 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||+||+.||......        .....+....+..+...
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~  233 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------LIFQKIIKLEYDFPEKF  233 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTCCCCCTTC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--------HHHHHHHcCCCCCCccC
Confidence            22  334568999999999999999999999999999999999999998753322        11222333333333222


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVC  868 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  868 (873)
                      .    ..+.+++.+||+.||++|||++|+.
T Consensus       234 s----~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         234 F----PKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             C----HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             C----HHHHHHHHHHccCCHhHCcCHHHHc
Confidence            2    2478999999999999999999863

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=401.38  Aligned_cols=254  Identities=23%  Similarity=0.377  Sum_probs=197.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCC-----cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASG-----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+|+..++||+|+||+||+|.+++.     ..||||++.....  .....+|.+|+.++++++|||||+++|++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            5688889999999999999976532     3699999875432  23356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+.++++.+++....  ..+++.++..++.||+.|++|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            99999999999998875433  4589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      .......   .....||+.|+|||++.++.++.++|||||||++|||++|..|+......       ......+.++..+
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~  232 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRL  232 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCCC
Confidence            6543322   22356899999999999999999999999999999999976664422211       1112222222221


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .....   ....+.+++.+||+.||++||||.||++.|+
T Consensus       233 ~~~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         233 PTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             CCCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCchh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence            11111   2234889999999999999999999998874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-48  Score=407.15  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=202.3

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      .|+..+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            488899999999999999975 5789999999976544444456779999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|++..++...   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            99999997766432   4589999999999999999999999   9999999999999999999999999999865432 


Q ss_pred             CCcccccccccccccccccc---CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCC-CCCc
Q 039344          762 SNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLP-TPSR  837 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~---~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  837 (873)
                         ....||+.|||||++.+   +.|+.++||||+||++|||++|+.||........        ...+.....+ ....
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--------~~~i~~~~~~~~~~~  237 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPALQSG  237 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHSCCCCCSCT
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhCCCCCCCCC
Confidence               34579999999999864   4589999999999999999999999864332211        1111111111 1111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .   ....+.+++.+||+.||++|||++|+++
T Consensus       238 ~---~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         238 H---WSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             T---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C---CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1   1234889999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=399.24  Aligned_cols=245  Identities=24%  Similarity=0.392  Sum_probs=196.7

Q ss_pred             ceeeecCCeEEEEEEeC---CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEecc
Q 039344          608 HCIGKGGQGSVYMSKLA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYFK  684 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  684 (873)
                      ++||+|+||+||+|.++   +++.||||+++.... +....++|.+|++++++++|||||+++|+|.+ +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            57999999999999754   356899999975432 33446789999999999999999999999965 45789999999


Q ss_pred             CCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCCc
Q 039344          685 MCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSNW  764 (873)
Q Consensus       685 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  764 (873)
                      +|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+|++|||+|+.........
T Consensus        91 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999998643   4589999999999999999999999   99999999999999999999999999998775543322


Q ss_pred             ---cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCchh
Q 039344          765 ---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRNV  839 (873)
Q Consensus       765 ---~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  839 (873)
                         ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||........        ...+..+ +++.+.. .
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--------~~~i~~~~~~~~p~~-~  235 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------TAMLEKGERMGCPAG-C  235 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------HHHHHTTCCCCCCTT-C
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--------HHHHHcCCCCCCCcc-c
Confidence               23568999999999999999999999999999999998 8999875432211        1111121 2222222 1


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         +..+.+++.+||+.||++|||+++|.+.|+
T Consensus       236 ---~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         236 ---PREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             ---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence               234889999999999999999999988764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-48  Score=407.26  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=191.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .+.|++.+.||+|+||+||+|+.. +|+.||||++.......  ..+.+.+|+.+++.++|||||++++++.+++..|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            466999999999999999999864 78999999997543322  235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC---CCCCeEEeccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD---FENEAHVSDFGIAKF  756 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~---~~~~~kl~Dfg~a~~  756 (873)
                      |||+++|+|.+++...   ..+++.++..++.||+.|++|||++   +|+||||||+||++.   +++.+||+|||+|+.
T Consensus        86 mE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999999653   4599999999999999999999999   999999999999995   578999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      .... ......+||+.|||||++.+..++.++||||+||++|||++|+.||......        .....+.......+.
T Consensus       160 ~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~  230 (307)
T d1a06a_         160 EDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEYEFDS  230 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCCCCCT
T ss_pred             ccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCCCCCC
Confidence            6543 3334568999999999999999999999999999999999999998753322        112222222222221


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .........+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111122335889999999999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=393.68  Aligned_cols=247  Identities=21%  Similarity=0.321  Sum_probs=197.3

Q ss_pred             CCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe----cceeEE
Q 039344          604 FDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH----VRHLFI  678 (873)
Q Consensus       604 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  678 (873)
                      |+..+.||+|+||+||+|+.. +++.||+|++...... ....+.|.+|++++++++|||||++++++.+    ....|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            355678999999999999865 6889999998754322 2335679999999999999999999999875    356899


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCCeeeC-CCCCeEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPP--IVHRDISSKNVLLD-FENEAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~  755 (873)
                      ||||+++|+|.+++...   ..+++..+..++.||+.|++|||++   +  |+||||||+|||++ +++.+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            99999999999998643   4589999999999999999999998   6  99999999999996 57899999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCC
Q 039344          756 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTP  835 (873)
Q Consensus       756 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  835 (873)
                      ....  .......||+.|||||++.+ .++.++||||+||++|||++|+.||.......       .....+..+..+..
T Consensus       164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~~~~  233 (270)
T d1t4ha_         164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKPAS  233 (270)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCCGG
T ss_pred             eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHHcCCCCcc
Confidence            6443  33456789999999998865 59999999999999999999999986433221       11112222211111


Q ss_pred             CchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          836 SRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       836 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .  .......+.+++.+||+.||++|||++|+++
T Consensus       234 ~--~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 F--DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             G--GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c--CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0  1111234789999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=407.44  Aligned_cols=257  Identities=21%  Similarity=0.361  Sum_probs=204.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC-C-----cEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS-G-----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      .++|++.+.||+|+||+||+|+... +     ..||||++......  ...+.+.+|+.++.++ +|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3678999999999999999997642 2     36999998754322  2246789999999998 899999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhccccc--------------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAA--------------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDI  733 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl  733 (873)
                      +..++||||+++|+|.+++.....                    ...+++..++.++.||+.||+|||++   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            999999999999999999965431                    23589999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCeEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCccc
Q 039344          734 SSKNVLLDFENEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI  810 (873)
Q Consensus       734 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~  810 (873)
                      ||+||+++.++.+||+|||+|+........  .....||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876554432  234568999999999999999999999999999999998 89998754


Q ss_pred             ccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          811 SSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ......    ...+..-.  +++.+.. .   ...+.+++.+||+.||++|||++||++.|.
T Consensus       271 ~~~~~~----~~~~~~~~--~~~~p~~-~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDANF----YKLIQNGF--KMDQPFY-A---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSHHH----HHHHHTTC--CCCCCTT-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHH----HHHHhcCC--CCCCCCc-C---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            432111    11111111  1222211 1   234889999999999999999999999884

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=398.47  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=199.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      .++|++.+.||+|+||+||+|+.++++.||||+++....    ..+.|.+|+.++++++|||||+++|+|. .+..++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence            367999999999999999999998888999999975422    2477999999999999999999999985 45679999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|++..++..... ..++|.+++.++.||+.|++|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        91 Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            99999999988876432 4589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCC-CCCCCCch
Q 039344          761 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDP-RLPTPSRN  838 (873)
Q Consensus       761 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  838 (873)
                      .. ......||+.|+|||++.++.++.++|||||||++|||+||+.|+......       .+....+... +.+.+.. 
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~~~-  238 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCPPE-  238 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCTT-
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCCcc-
Confidence            32 334467899999999999999999999999999999999976665432211       1111111111 1222221 


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ....+.+++.+||+.||++||++++|+++|+
T Consensus       239 ---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  269 (285)
T d1fmka3         239 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLE  269 (285)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---cCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence               1234889999999999999999999998874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=409.92  Aligned_cols=257  Identities=21%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|+++....  ....+.+.+|+.++++++|||||+++++|.+++..|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            47899999999999999999986 4789999999976432  23357899999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLK  758 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  758 (873)
                      |||+++|+|.+++.+.   ..+++..+..++.|++.|++|||+ +   +|+||||||+|||++.+|.+||+|||+|+...
T Consensus        83 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            9999999999999653   358999999999999999999997 5   89999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh------------------
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL------------------  820 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~------------------  820 (873)
                      ..  ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.............                  
T Consensus       157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            32  2335689999999999999999999999999999999999999997533211000000                  


Q ss_pred             ----------------hhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 ----------------NIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                                      ............+....  ......+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                            00000001111000000  001234789999999999999999999976

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-47  Score=399.13  Aligned_cols=254  Identities=20%  Similarity=0.270  Sum_probs=209.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCC---cchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPG---EMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+.|++.+.||+|+||+||+|+. .+|+.||||++......   .....+.+.+|+.++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999986 57999999998654222   222367899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC----CeEEeccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN----EAHVSDFG  752 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg  752 (873)
                      |+||||+++|+|.+++...   ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999998653   3599999999999999999999999   999999999999999877    49999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          753 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       753 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      +|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.....
T Consensus       163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~  233 (293)
T d1jksa_         163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAVNY  233 (293)
T ss_dssp             TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTCC
T ss_pred             hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCC
Confidence            99877543 3344568999999999999999999999999999999999999998753322        12222223332


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+..........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2222211222345889999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=403.65  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=210.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999986 579999999987532222223577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++...   ..+++..++.++.||+.|++|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999998654   3589999999999999999999999   9999999999999999999999999999987665


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                      .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.......        ....+....+..+.... 
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------~~~~i~~~~~~~p~~~s-  229 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRTLS-  229 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTSC-
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--------HHHHHhcCCCCCCccCC-
Confidence            566667889999999999999999999999999999999999999987543221        12222223333332222 


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                         ..+.+++.+||++||++||+     ++|+++
T Consensus       230 ---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         230 ---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               24789999999999999995     788765

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.5e-47  Score=406.17  Aligned_cols=251  Identities=19%  Similarity=0.299  Sum_probs=208.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999986 47999999999754   2233577899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC--CCCeEEeccccccccC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF--ENEAHVSDFGIAKFLK  758 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~  758 (873)
                      ||+++|+|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+|+...
T Consensus       103 E~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         103 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999986432  3589999999999999999999999   9999999999999964  5789999999998776


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. .......||+.|||||++.+..++.++||||+||++|||++|+.||.......        ....+.......+...
T Consensus       178 ~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         178 PK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             TT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCSCCGG
T ss_pred             cc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCccc
Confidence            43 33455789999999999999999999999999999999999999987533221        1222222222222222


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2222345889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-46  Score=403.25  Aligned_cols=251  Identities=18%  Similarity=0.280  Sum_probs=207.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999986 579999999987542   223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeC--CCCCeEEeccccccccC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLD--FENEAHVSDFGIAKFLK  758 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~  758 (873)
                      ||+++|+|.+++...  ...+++.+++.++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       106 E~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         106 EFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             ECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence            999999998877543  24589999999999999999999999   999999999999998  57899999999999876


Q ss_pred             CCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCch
Q 039344          759 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRN  838 (873)
Q Consensus       759 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  838 (873)
                      .. .......||+.|+|||++.+..++.++||||+||++|||+||+.||.......        ....+.......+...
T Consensus       181 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~  251 (352)
T d1koba_         181 PD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDEDA  251 (352)
T ss_dssp             TT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCCCCSST
T ss_pred             CC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCccc
Confidence            54 33455789999999999999999999999999999999999999987543221        1122222222111111


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          839 VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       839 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1122334789999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-47  Score=399.81  Aligned_cols=260  Identities=20%  Similarity=0.366  Sum_probs=209.5

Q ss_pred             HHHHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEE
Q 039344          597 IIRATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFC  670 (873)
Q Consensus       597 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  670 (873)
                      ++...++|++.+.||+|+||+||+|+.+      +++.||||+++...  .....++|.+|++++++++||||++++++|
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            3334578999999999999999999864      45789999987543  233457899999999999999999999999


Q ss_pred             EecceeEEEEEeccCCChhhHhcccc---------------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCee
Q 039344          671 LHVRHLFIVYEYFKMCSLAVILSNDA---------------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIV  729 (873)
Q Consensus       671 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~  729 (873)
                      .+.+..++||||+++|+|.+++....                     ....+++..++.++.|++.|++|||++   +|+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            99999999999999999999985422                     123478999999999999999999999   999


Q ss_pred             eCCCCCCCeeeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCC-CC
Q 039344          730 HRDISSKNVLLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HP  806 (873)
Q Consensus       730 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~-~P  806 (873)
                      ||||||+|||++.++.+||+|||+|+.......  ......|++.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999999999987644322  223567889999999999999999999999999999999986 56


Q ss_pred             CcccccchhhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          807 RDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      |.......        ....+.++..+..+...   +..+.+++.+||+.||++||||.||+++|+
T Consensus       243 ~~~~~~~e--------~~~~v~~~~~~~~p~~~---~~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         243 YYGMAHEE--------VIYYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             TTTSCHHH--------HHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCHHH--------HHHHHHcCCCCCCCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            65433222        22223333332222221   234889999999999999999999999885

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-47  Score=388.39  Aligned_cols=247  Identities=28%  Similarity=0.415  Sum_probs=195.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  680 (873)
                      ++|++.+.||+|+||.||+|+.+ |+.||||+++...     ..+.|.+|++++++++||||++++|+|.+ .+..++||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            56888899999999999999986 8899999997531     24779999999999999999999999965 46689999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|+|.+++.... ...+++..+++++.||+.|++|||+.   +|+||||||+||+++.++.+|++|||+++.....
T Consensus        81 ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999996543 23489999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                         .....+++.|+|||++.++.++.++|||||||++|||+| |+.||...........     +.....+..+  ... 
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-----i~~~~~~~~~--~~~-  225 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAP--DGC-  225 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-----HTTTCCCCCC--TTC-
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcCCCCCCC--ccC-
Confidence               334567899999999999999999999999999999998 7888764332221111     1111122222  111 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                         ...+.+++.+||+.||++||||++++++|+
T Consensus       226 ---~~~~~~li~~cl~~dP~~Rps~~~l~~~L~  255 (262)
T d1byga_         226 ---PPAVYEVMKNCWHLDAAMRPSFLQLREQLE  255 (262)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence               234789999999999999999999999885

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-46  Score=395.57  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=205.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..........+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5689999999999999999986 579999999986432222233577999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+++|++..++...   ..+++..+..++.||+.|++|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999999999888644   3478889999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .....||+.|||||++.+..++.++||||+||++|||+||+.||.......        ....+.......+.... 
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~s-  225 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAELRFPPFFN-  225 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCCCCCCTTSC-
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--------HHHHHHcCCCCCCCCCC-
Confidence               335689999999999999999999999999999999999999987533221        12222222332222211 


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                         ..+.+++.+||+.||.+||     |++++++
T Consensus       226 ---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         226 ---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               2478999999999999996     8998875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=390.57  Aligned_cols=253  Identities=24%  Similarity=0.403  Sum_probs=195.6

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC--CC--cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA--SG--EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.+.||+|+||+||+|+..  ++  ..||||++...........++|.+|+.++++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            67899999999999999999753  22  3689999976655555556789999999999999999999999965 4678


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|++.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999998876543  4599999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCC---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCC--C
Q 039344          758 KPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDP--R  831 (873)
Q Consensus       758 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~  831 (873)
                      ......   .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||.......        ....+...  +
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~i~~~~~~  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGER  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------HHHHHHhCCCC
Confidence            654432   223457889999999999999999999999999999998 899986543222        11222111  2


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ++.+..    ....+.+++.+||+.||++|||++||.+.|+
T Consensus       234 ~~~~~~----~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         234 LPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            222221    1234889999999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.3e-46  Score=384.63  Aligned_cols=253  Identities=22%  Similarity=0.341  Sum_probs=206.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcc------hhHHHHHHHHHHHHhcc-CCceeeEEeEEEec
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEM------TFQQEFLNEVKALTEIW-HRNIVKVYGFCLHV  673 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  673 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++........      ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6799999999999999999986 5799999999876543321      12346889999999996 99999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                      +..|+||||+++|+|.+++...   ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999643   4599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc------CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhh
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEM  827 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  827 (873)
                      |+...... ......||+.|+|||.+.+      ..++.++||||+||++|||+||+.||.......        ....+
T Consensus       157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--------~~~~i  227 (277)
T d1phka_         157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMI  227 (277)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH
T ss_pred             eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--------HHHHH
Confidence            98876543 3455789999999998863      346889999999999999999999987543221        11112


Q ss_pred             cCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          828 LDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       828 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+.......+..+.+++.+||++||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            222211111111122345889999999999999999999976

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.5e-46  Score=390.00  Aligned_cols=257  Identities=26%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc----e
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR----H  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  675 (873)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.....+....+.|.+|+++++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999975 579999999998765555555678999999999999999999999998654    4


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .|+||||+++++|.+++...   +.+++.++..++.||+.|++|||++   +|+||||||+||+++.++.++++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            79999999999999887543   4589999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCC---CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          756 FLKPDSS---NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       756 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .......   ......||+.|+|||++.+..++.++||||+||++|||+||+.||.........        ...+....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------~~~~~~~~  231 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--------YQHVREDP  231 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--------HHHHHCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH--------HHHHhcCC
Confidence            6543322   334567999999999999999999999999999999999999999754332111        11111111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHh
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRP-TMQKVCQLL  871 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L  871 (873)
                      ..+.......+..+.+++.+||+.||++|| |++++.+.|
T Consensus       232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l  271 (277)
T d1o6ya_         232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  271 (277)
T ss_dssp             CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence            111111111223588999999999999999 899988776

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=388.03  Aligned_cols=252  Identities=22%  Similarity=0.384  Sum_probs=194.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeCC----CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .++|++.+.||+|+||+||+|+...    +..||||+++..  ......+.|.+|++++++++|||||+++|++. .+..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            4678999999999999999997642    456889988643  23344578999999999999999999999995 4678


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++||||+++|++.+++....  ..+++..++.++.||++|++|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence            99999999999998875432  4589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCC-CC
Q 039344          757 LKPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPR-LP  833 (873)
Q Consensus       757 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~  833 (873)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||+| |..||........        ...+..+. .+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--------~~~i~~~~~~~  229 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------IGRIENGERLP  229 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCCC
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCCCC
Confidence            654333 2344568999999999999999999999999999999998 8999875443221        11122222 22


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+.. .   ...+.+++.+||+.||++|||++||++.|+
T Consensus       230 ~~~~-~---~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         230 MPPN-C---PPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             CCTT-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC-C---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            2221 1   234889999999999999999999998874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=393.42  Aligned_cols=251  Identities=24%  Similarity=0.452  Sum_probs=198.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCc----EEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEeccee
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHL  676 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  676 (873)
                      .+|++.++||+|+||+||+|+.. +|+    .||+|+++....  ....++|.+|++++++++|||||+++|+|.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            56999999999999999999764 444    589998875422  23367899999999999999999999999865 56


Q ss_pred             EEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          677 FIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       677 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ++++||+.+|++.+++...  ...+++..+++++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             eEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence            7889999999998887654  34589999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchhhhhhhhhhhhhhcCCCCC
Q 039344          757 LKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSFSSLNLNIALDEMLDPRLP  833 (873)
Q Consensus       757 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  833 (873)
                      ........  ....||+.|+|||++.++.++.++|||||||++|||+| |+.||+.........     .+..  ..+++
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-----~i~~--~~~~~  233 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEK--GERLP  233 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-----HHHH--TCCCC
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHc--CCCCC
Confidence            76544332  34568999999999999999999999999999999998 889987544322111     1111  11222


Q ss_pred             CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          834 TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       834 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .+...    ...+.+++.+||+.||++|||+.|+++.|
T Consensus       234 ~p~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         234 QPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             CCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCccc----CHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            22221    23488999999999999999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=394.98  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=204.8

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHH-hccCCceeeEEeEEEecceeEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT-EIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++++.........+.+..|+.++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999764 79999999986432111222456677777665 67999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCC
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKP  759 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  759 (873)
                      |||+++|+|.+++...   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999999643   3589999999999999999999999   999999999999999999999999999997766


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchh
Q 039344          760 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNV  839 (873)
Q Consensus       760 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  839 (873)
                      .........||+.|+|||++.+..++.++||||+||++|||+||+.||........        ...+.......+... 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--------~~~i~~~~~~~p~~~-  226 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--------FHSIRMDNPFYPRWL-  226 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCCCCTTS-
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--------HHHHHcCCCCCCccC-
Confidence            66666677899999999999999999999999999999999999999875432211        111111222222211 


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 039344          840 HDKLISIVEVTISCVDENPESRPTMQ-KVC  868 (873)
Q Consensus       840 ~~~~~~l~~li~~cl~~dP~~RPs~~-ev~  868 (873)
                         ...+.+++.+||+.||++||++. +++
T Consensus       227 ---s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         227 ---EKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ---CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence               22478999999999999999985 664

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=390.23  Aligned_cols=251  Identities=20%  Similarity=0.269  Sum_probs=207.9

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIV  679 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  679 (873)
                      .++|++.+.||+|+||+||+|... +|+.||||+++...    .....+.+|+++++.++|||||++++++.+.+..|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999764 78999999997532    2245688999999999999999999999999999999


Q ss_pred             EEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC--CCeEEecccccccc
Q 039344          680 YEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE--NEAHVSDFGIAKFL  757 (873)
Q Consensus       680 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~--~~~kl~Dfg~a~~~  757 (873)
                      |||+++|+|.+++....  ..+++.++..++.||+.|++|||++   +|+||||||+|||++.+  +.+||+|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999986542  3589999999999999999999999   99999999999999855  47999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ... .......+++.|+|||...+..++.++||||+||++|||++|+.||......        .....+.......+..
T Consensus       155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCHH
T ss_pred             ccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCChh
Confidence            543 3344567899999999999999999999999999999999999998753322        2223333333333222


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........+.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            21222345889999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-45  Score=395.81  Aligned_cols=247  Identities=22%  Similarity=0.277  Sum_probs=206.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.+++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999986 479999999986432222233567899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+.+|++..++...   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999998644   3589999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCchhH
Q 039344          761 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSRNVH  840 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  840 (873)
                         .....||+.|||||++.+..++.++||||+||++|||+||+.||.......        ....+.......+.... 
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~s-  262 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHFS-  262 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTCC-
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--------HHHHHhcCCCCCCccCC-
Confidence               334689999999999999999999999999999999999999987543221        12222222332222222 


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          841 DKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       841 ~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                         ..+.+++.+||+.||.+|+     |++|+++
T Consensus       263 ---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         263 ---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               2478999999999999994     8999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-45  Score=385.23  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=198.2

Q ss_pred             CceeeecCCeEEEEEEeCCC----cEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe-cceeEEEEE
Q 039344          607 EHCIGKGGQGSVYMSKLASG----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH-VRHLFIVYE  681 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  681 (873)
                      .++||+|+||+||+|++.++    ..||||+++..  ......++|.+|++++++++||||++++|++.+ ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            46899999999999986532    36899998743  233446789999999999999999999999876 468899999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+++|++.+++....  ...++..+..++.|++.|+.|+|+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999999986543  3477889999999999999999999   99999999999999999999999999998765433


Q ss_pred             CC----ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCCc
Q 039344          762 SN----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPSR  837 (873)
Q Consensus       762 ~~----~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  837 (873)
                      ..    .....||+.|+|||.+.+..++.++||||||+++|||+||+.||.......       .....+..+..+..+.
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPE  257 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCCT
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCCCCCcc
Confidence            22    234568999999999999999999999999999999999888865322110       1111112222111111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          838 NVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       838 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ..   ...+.+++.+||+.||++||+|.||++.|+
T Consensus       258 ~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         258 YC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            22   224889999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=389.25  Aligned_cols=251  Identities=21%  Similarity=0.264  Sum_probs=201.5

Q ss_pred             cCCCCC-ceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEe----cc
Q 039344          602 NDFDDE-HCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLH----VR  674 (873)
Q Consensus       602 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~  674 (873)
                      ++|.+. +.||+|+||+||+|+. .+|+.||||+++..        ..+.+|++++.++ +|||||++++++.+    ..
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            578876 4699999999999976 57999999998632        5577899987655 89999999999976    46


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CCCeEEecc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAHVSDF  751 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Df  751 (873)
                      ..|+|||||++|+|.+++.... ...+++.++..++.||+.|++|||++   +|+||||||+||+++.   ++.+||+||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            7899999999999999997532 24589999999999999999999999   9999999999999986   457999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCC
Q 039344          752 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPR  831 (873)
Q Consensus       752 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  831 (873)
                      |+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||..........    .....+....
T Consensus       159 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~~~i~~~~  233 (335)
T d2ozaa1         159 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQ  233 (335)
T ss_dssp             TTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS
T ss_pred             ceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHHHHHhcCC
Confidence            9998776543 3445789999999999999999999999999999999999999997543321111    1111222233


Q ss_pred             CCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          832 LPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       832 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ...+..........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            33333333344556899999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=387.70  Aligned_cols=259  Identities=22%  Similarity=0.348  Sum_probs=196.5

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      ...++|++.+.||+|+||+||+|+..      +++.||||+++....  ....+.+.+|+..+.++ +|+||+++++++.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            33478999999999999999999753      356899999875432  23356788888888887 7899999999987


Q ss_pred             ec-ceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 039344          672 HV-RHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKN  737 (873)
Q Consensus       672 ~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~N  737 (873)
                      +. ...++||||+++|+|.+++.....             ...+++.++..++.||+.||+|||++   +|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence            64 468999999999999999965432             23588999999999999999999999   99999999999


Q ss_pred             eeeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCC-CCCcccccch
Q 039344          738 VLLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSMS  814 (873)
Q Consensus       738 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~-~P~~~~~~~~  814 (873)
                      ||++.++.+||+|||+|+.......  ......||+.|+|||++.+..++.++|||||||++|||+||. .||.......
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654433  234567999999999999999999999999999999999975 5776433221


Q ss_pred             hhhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          815 FSSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...    ..+.+...+..  +...    ...+.+++.+||+.||++|||++|+++.|+
T Consensus       245 ~~~----~~~~~~~~~~~--~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         245 EFC----RRLKEGTRMRA--PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             HHH----HHHHHTCCCCC--CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH----HHHhcCCCCCC--CccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            111    11111112222  2111    224889999999999999999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.3e-45  Score=395.47  Aligned_cols=251  Identities=22%  Similarity=0.238  Sum_probs=198.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHH---HHHHHhccCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNE---VKALTEIWHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.............+.+|   +.+++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999865 799999999854221111112334444   56667778999999999999999999


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFL  757 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~  757 (873)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999998654   4588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCCCCCC
Q 039344          758 KPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRLPTPS  836 (873)
Q Consensus       758 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  836 (873)
                      ...  ......||+.|+|||++.. ..++.++||||+||++|||+||+.||.........     .............+.
T Consensus       158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~  230 (364)
T d1omwa3         158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLTMAVELPD  230 (364)
T ss_dssp             SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-----HHHHHSSSCCCCCCS
T ss_pred             CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcccCCCCCCC
Confidence            543  2344689999999999875 56899999999999999999999999754322111     111122222222222


Q ss_pred             chhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 039344          837 RNVHDKLISIVEVTISCVDENPESRPT-----MQKVCQ  869 (873)
Q Consensus       837 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  869 (873)
                      ..    ...+.+++.+||+.||++|||     ++|+++
T Consensus       231 ~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         231 SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            22    224789999999999999999     688764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=389.47  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=200.9

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCc--EEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEecceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHVRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  677 (873)
                      ++|++.++||+|+||+||+|+.+ +|.  .||||++......  ...++|.+|+++++++ +|||||+++|+|.+.+..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            67888999999999999999765 444  4778887543222  2356799999999999 7999999999999999999


Q ss_pred             EEEEeccCCChhhHhccc-------------ccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC
Q 039344          678 IVYEYFKMCSLAVILSND-------------AAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN  744 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~  744 (873)
                      +||||+++|+|.++++..             .....+++.++..++.||+.|++|+|++   +|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence            999999999999999754             2345689999999999999999999999   999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC-CCcccccchhhhhhhhhh
Q 039344          745 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH-PRDFISSMSFSSLNLNIA  823 (873)
Q Consensus       745 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~-P~~~~~~~~~~~~~~~~~  823 (873)
                      .+||+|||+|+....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.......        .
T Consensus       165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------~  235 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------L  235 (309)
T ss_dssp             CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------H
T ss_pred             ceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------H
Confidence            999999999986543322 234568999999999999999999999999999999999764 665433221        1


Q ss_pred             hhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          824 LDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ...+..+..+..+...   ...+.+++.+||+.||++||||+||++.|+
T Consensus       236 ~~~i~~~~~~~~~~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         236 YEKLPQGYRLEKPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLN  281 (309)
T ss_dssp             HHHGGGTCCCCCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2222222111111111   224889999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=385.68  Aligned_cols=255  Identities=22%  Similarity=0.367  Sum_probs=203.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC--------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCL  671 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  671 (873)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++....  .....++.+|+..+.++ +|||||+++++|.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            367888999999999999999753        234799999976432  23457899999999988 8999999999999


Q ss_pred             ecceeEEEEEeccCCChhhHhccccc-------------ccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          672 HVRHLFIVYEYFKMCSLAVILSNDAA-------------AKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       672 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +++..++||||+++|++.+++.....             ...+++.+++.++.||+.||+|||++   +|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence            99999999999999999999965432             24589999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCC--CccccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      |++.++.+||+|||+++.......  ......|++.|+|||.+.++.++.++|||||||++|||++ |+.||....... 
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence            999999999999999987754332  2334678999999999999999999999999999999998 688876433221 


Q ss_pred             hhhhhhhhhhhhcCC-CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDP-RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                             ....+.++ +++.+.. .   ...+.+++.+||+.||++|||++||++.|+
T Consensus       246 -------~~~~i~~~~~~~~p~~-~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~  292 (299)
T d1fgka_         246 -------LFKLLKEGHRMDKPSN-C---TNELYMMMRDCWHAVPSQRPTFKQLVEDLD  292 (299)
T ss_dssp             -------HHHHHHTTCCCCCCSS-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHcCCCCCCCcc-c---hHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence                   11112122 2222221 1   234889999999999999999999999884

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-45  Score=384.62  Aligned_cols=259  Identities=22%  Similarity=0.343  Sum_probs=197.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHH--HHHHHHhccCCceeeEEeEEEecc----e
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLN--EVKALTEIWHRNIVKVYGFCLHVR----H  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~~~----~  675 (873)
                      ++|...+.||+|+||.||+|+.. |+.||||+++..    .  .+++..  |+..++.++|||||+++|+|.+.+    .
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~----~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----E--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG----G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc----c--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            56778899999999999999875 899999998632    1  233444  455566789999999999998754    5


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCCeeeCCCCCeEEec
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDC-----FPPIVHRDISSKNVLLDFENEAHVSD  750 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlk~~Nill~~~~~~kl~D  750 (873)
                      .|+||||+++|+|.+++++.    .++|..+.+++.|++.|++|+|+..     .++|+||||||+|||++.++.+||+|
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            79999999999999999653    4899999999999999999999731     23999999999999999999999999


Q ss_pred             cccccccCCCCC----CccccccccccccccccccCC------CCCcchhHHHHHHHHHHHhCCCCCcccccch--h---
Q 039344          751 FGIAKFLKPDSS----NWTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSMS--F---  815 (873)
Q Consensus       751 fg~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~sDv~s~G~il~el~tg~~P~~~~~~~~--~---  815 (873)
                      ||+++.......    ......||+.|+|||++.+..      ++.++|||||||++|||+||..||.......  +   
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            999987754432    233567999999999987643      5778999999999999999998875433111  0   


Q ss_pred             --hhhhhh----hhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 --SSLNLN----IALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 --~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                        ......    .......++.++.... ..+....+.+++.+||+.||++|||+.||++.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             ccccchHHHHHHHHhccccCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence              011111    1122222333322211 2234556889999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-45  Score=386.48  Aligned_cols=258  Identities=21%  Similarity=0.316  Sum_probs=209.7

Q ss_pred             HHhcCCCCCceeeecCCeEEEEEEeC------CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe
Q 039344          599 RATNDFDDEHCIGKGGQGSVYMSKLA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH  672 (873)
Q Consensus       599 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  672 (873)
                      ...++|++.+.||+|+||+||+|...      +++.||||+++...  .......|.+|++++++++|||||+++|+|..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            33478889999999999999999753      35789999997542  33335679999999999999999999999999


Q ss_pred             cceeEEEEEeccCCChhhHhcccc-------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCC
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDA-------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENE  745 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~  745 (873)
                      .+..++||||+++|++.+++....       ....+++..+.+++.|+++||+|||++   +|+||||||+|||+++++.
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            999999999999999999986432       112468899999999999999999999   9999999999999999999


Q ss_pred             eEEeccccccccCCCCCC--ccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCC-CCCcccccchhhhhhhhh
Q 039344          746 AHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSMSFSSLNLNI  822 (873)
Q Consensus       746 ~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~-~P~~~~~~~~~~~~~~~~  822 (873)
                      +||+|||+|+........  .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.....        ..
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~~  243 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQ  243 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence            999999999876544332  23446899999999999999999999999999999999985 66653322        22


Q ss_pred             hhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          823 ALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      ....+.++..+......   ...+.+++.+||+.||++|||+++|++.|+
T Consensus       244 ~~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~  290 (308)
T d1p4oa_         244 VLRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIK  290 (308)
T ss_dssp             HHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             HHHHHHhCCCCCCcccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            23333333333222222   234889999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=386.57  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=206.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe------CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc-cCCceeeEEeEEEec
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-WHRNIVKVYGFCLHV  673 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  673 (873)
                      .++|++.+.||+|+||.||+|+.      .+++.||||+++...  ......+|.+|+.+++++ +|||||+++|+|.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            36788899999999999999975      356789999997543  233456799999999999 699999999999999


Q ss_pred             ceeEEEEEeccCCChhhHhcccc---------------cccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDA---------------AAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNV  738 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni  738 (873)
                      +..++||||+++|++.+++....               ....+++..+..++.||++|++|||++   +++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            99999999999999999986543               223588999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEeccccccccCCCCCCc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCcccccchh
Q 039344          739 LLDFENEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSF  815 (873)
Q Consensus       739 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~t-g~~P~~~~~~~~~  815 (873)
                      +++.++.+|++|||.++.........  ....||+.|+|||++.++.++.++|||||||++|||+| |.+||........
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999999776543322  34578999999999999999999999999999999999 5555543332211


Q ss_pred             hhhhhhhhhhhhcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          816 SSLNLNIALDEMLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .    ...+..-..+..+  ..    ....+.+++.+||+.||++||||++|+++|+
T Consensus       257 ~----~~~i~~~~~~~~~--~~----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         257 F----YKMIKEGFRMLSP--EH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             H----HHHHHHTCCCCCC--TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H----HHHHhcCCCCCCc--cc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1    1111111222221  11    1234889999999999999999999999885

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-45  Score=385.57  Aligned_cols=257  Identities=21%  Similarity=0.264  Sum_probs=196.7

Q ss_pred             CceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcc--hhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEEec
Q 039344          607 EHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEM--TFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYEYF  683 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  683 (873)
                      .++||+|+||+||+|+. .+|+.||||+++.......  ...+.+.+|+.++++++|||||++++++.+.+..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            47899999999999986 4699999999875432211  12356889999999999999999999999999999999999


Q ss_pred             cCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCCCC
Q 039344          684 KMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDSSN  763 (873)
Q Consensus       684 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  763 (873)
                      .++++..+...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            98887766543   34589999999999999999999999   9999999999999999999999999999887766555


Q ss_pred             ccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------hhhhh-------c
Q 039344          764 WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------ALDEM-------L  828 (873)
Q Consensus       764 ~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~~~~~-------~  828 (873)
                      ....+||+.|+|||++.+. .++.++||||+||++|||+||+.||...............       .....       .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            5667899999999988754 5799999999999999999999999754432111110000       00000       0


Q ss_pred             CCCCCCCCc--hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          829 DPRLPTPSR--NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       829 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ....+....  ........+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000000000  00011235889999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=379.80  Aligned_cols=262  Identities=21%  Similarity=0.325  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            5799999999999999999986 57999999999754322 222467899999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      ||+.++.+......  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.|+.....
T Consensus        81 e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99986655433322  234589999999999999999999999   9999999999999999999999999999887766


Q ss_pred             CCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh-------h---hhhhhcC
Q 039344          761 SSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN-------I---ALDEMLD  829 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~-------~---~~~~~~~  829 (873)
                      ........||+.|+|||.+.... ++.++||||+||++|+|++|+.||..............       .   ......+
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence            66666678999999999877665 47899999999999999999999975432211000000       0   0000000


Q ss_pred             --CCCCCC-Cch----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          830 --PRLPTP-SRN----VHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       830 --~~~~~~-~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                        ...+.. ...    .......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              000000 000    0111235789999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-44  Score=377.28  Aligned_cols=261  Identities=21%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             cCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVYE  681 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  681 (873)
                      ++|++.++||+|+||+||+|+.++|+.||||+++..... ....+.+.+|+.++++++|||||++++++.+.+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            578999999999999999999999999999999765322 2235789999999999999999999999999999999999


Q ss_pred             eccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCCC
Q 039344          682 YFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPDS  761 (873)
Q Consensus       682 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  761 (873)
                      |+.++.+..+....   +.+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.|.......
T Consensus        81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            99988777776433   4599999999999999999999999   99999999999999999999999999998876555


Q ss_pred             CCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh----------------hhh
Q 039344          762 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN----------------IAL  824 (873)
Q Consensus       762 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~----------------~~~  824 (873)
                      .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||..............                ...
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            555566789999999998764 468999999999999999999999975432111000000                000


Q ss_pred             hhhcCCCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          825 DEMLDPRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       825 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ........+.+.. ........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000000 00111235789999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=375.11  Aligned_cols=242  Identities=20%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcc---hhHHHHHHHHHHHHhcc--CCceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEM---TFQQEFLNEVKALTEIW--HRNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  675 (873)
                      .+|++.+.||+|+||+||+|+. .+|+.||||++........   .....+.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999986 4799999999875432221   11234678999999996  8999999999999999


Q ss_pred             eEEEEEeccC-CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCC-CCeEEecccc
Q 039344          676 LFIVYEYFKM-CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFE-NEAHVSDFGI  753 (873)
Q Consensus       676 ~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~  753 (873)
                      .++||||+.+ +++.+++...   ..+++.++..++.|++.|++|||++   +|+||||||+||+++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 5777776543   4589999999999999999999999   99999999999999865 7999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      |+....  ...+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....              +.....
T Consensus       158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~~  221 (273)
T d1xwsa_         158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQV  221 (273)
T ss_dssp             CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCCC
T ss_pred             ceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhhccc
Confidence            986543  33456789999999999987765 5679999999999999999999864221              111111


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ..+...    +..+.+++.+||+.||++|||++|+++
T Consensus       222 ~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111111    124789999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=374.90  Aligned_cols=262  Identities=20%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CC-CcEEEEEEccCCCCCcchhHHHHHHHHHHHHhc---cCCceeeEEeEEEe---
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-AS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---WHRNIVKVYGFCLH---  672 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---  672 (873)
                      .++|++.+.||+|+||+||+|+. ++ ++.||||+++....... ....+.+|+.+++.+   +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47899999999999999999986 34 67799999865422221 123456777777666   79999999999864   


Q ss_pred             --cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEec
Q 039344          673 --VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSD  750 (873)
Q Consensus       673 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D  750 (873)
                        ....+++|||+.++.+......  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence              3468999999998877655432  234589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh-------h
Q 039344          751 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI-------A  823 (873)
Q Consensus       751 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~-------~  823 (873)
                      ||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...............       .
T Consensus       160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            9999765432 3345678999999999999999999999999999999999999999754322111110000       0


Q ss_pred             h-------hhhcCCCCCCCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 L-------DEMLDPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ~-------~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .       ..........+. .........+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0       000000000000 000111234788999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-42  Score=369.01  Aligned_cols=257  Identities=25%  Similarity=0.281  Sum_probs=194.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec------c
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV------R  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  674 (873)
                      .+|+..++||+|+||+||+|+.. +|+.||||++.....       .+.+|++++++++||||++++++|...      .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            36888899999999999999864 799999999975422       123799999999999999999998643      3


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEecccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGI  753 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~  753 (873)
                      ..++||||++++..............+++.+++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            4789999999776555544334455699999999999999999999999   999999999999999876 899999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-----------hh
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-----------LN  821 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-----------~~  821 (873)
                      ++...... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||............           ..
T Consensus       170 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         170 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hhhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            98775443 3345689999999998765 46899999999999999999999999754322111000           00


Q ss_pred             hhhhhhcCCCCCCCC------chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 IALDEMLDPRLPTPS------RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .......+..++...      .........+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000111111111000      000111234789999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=360.93  Aligned_cols=261  Identities=19%  Similarity=0.300  Sum_probs=195.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe--------
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH--------  672 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  672 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......+ ...+.+.+|+.++++++||||+++++++..        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            6799999999999999999986 579999999987553332 234678899999999999999999999865        


Q ss_pred             cceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccc
Q 039344          673 VRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFG  752 (873)
Q Consensus       673 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg  752 (873)
                      .+..|+||||++++.+..+...   ...++...++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            3457999999998877655432   34588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC----CccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhh----
Q 039344          753 IAKFLKPDSS----NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIA----  823 (873)
Q Consensus       753 ~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~----  823 (873)
                      +++.......    ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....+...........    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9987654322    22345799999999998765 68999999999999999999999997544322111111100    


Q ss_pred             ---hhhhcC-------CCCCCCCchhHH------HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          824 ---LDEMLD-------PRLPTPSRNVHD------KLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       824 ---~~~~~~-------~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ......       ...........+      ....+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence               000000       000000111111      1224678999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=366.60  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=195.1

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc----e
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR----H  675 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  675 (873)
                      +.+|++.+.||+|+||+||+|+. .+|+.||||++....  .....+.+.+|++++++++||||+++++++....    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            45699999999999999999975 589999999997532  3334577899999999999999999999997643    2


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .+++++|+.+|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        85 ~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            3555667789999999854    3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---Ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhh---------
Q 039344          756 FLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNI---------  822 (873)
Q Consensus       756 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~---------  822 (873)
                      .......   .....+||+.|+|||.+.. ..++.++||||+||++|||++|+.||...............         
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            7644322   2345679999999999854 55788999999999999999999999754321111000000         


Q ss_pred             -------hhhhh--cCCCCCCCCc-hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          823 -------ALDEM--LDPRLPTPSR-NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       823 -------~~~~~--~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                             .....  .......+.. ........+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   00000  0000000000 00011234789999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=356.58  Aligned_cols=261  Identities=19%  Similarity=0.272  Sum_probs=205.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecceeEEEE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVRHLFIVY  680 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  680 (873)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            5789999999999999999986 5789999999976543 3344678999999999999999999999999999999999


Q ss_pred             EeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccccccCCC
Q 039344          681 EYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKFLKPD  760 (873)
Q Consensus       681 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  760 (873)
                      |++.++++..++...   +.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.|+.....
T Consensus        81 ~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999999988877543   4588999999999999999999999   9999999999999999999999999999987766


Q ss_pred             CCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccch-hhhhhhh-------------hhhh
Q 039344          761 SSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMS-FSSLNLN-------------IALD  825 (873)
Q Consensus       761 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-~~~~~~~-------------~~~~  825 (873)
                      ........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....+.. .......             ....
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            65555667889999999987665 6899999999999999999999974322210 0000000             0000


Q ss_pred             hhcC-CCC---CCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          826 EMLD-PRL---PTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       826 ~~~~-~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      .... +..   .............+.+++.+|++.||++||||+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000 000   0000011112234789999999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-41  Score=356.56  Aligned_cols=257  Identities=18%  Similarity=0.244  Sum_probs=192.2

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCc-eeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRN-IVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++......     +++..|+++++.++|++ |+.+.+++.+.+..++
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            35799999999999999999976 57899999998754222     35788999999997666 5555566677888999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC---CCCeEEecccccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF---ENEAHVSDFGIAK  755 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Dfg~a~  755 (873)
                      ||||+. +++...+..  ....+++..+..++.|++.|++|||++   +|+||||||+||+++.   +..+|++|||+|+
T Consensus        81 vme~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          81 VMELLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEECCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            999996 455554432  234589999999999999999999999   9999999999999864   4579999999999


Q ss_pred             ccCCCCC-------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhc
Q 039344          756 FLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEML  828 (873)
Q Consensus       756 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  828 (873)
                      .+.....       ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            8754332       123467999999999999999999999999999999999999999754432111111110000000


Q ss_pred             CCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 039344          829 DPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLLK  872 (873)
Q Consensus       829 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  872 (873)
                      .+ .+   ......+..+.+++.+||+.+|++||+++++.+.|+
T Consensus       235 ~~-~~---~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         235 TP-IE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             SC-HH---HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             CC-hh---HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            00 00   000011234889999999999999999999887764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=365.48  Aligned_cols=257  Identities=20%  Similarity=0.293  Sum_probs=192.3

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEecc-----
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHVR-----  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  674 (873)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+++++.++|||||+++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            36799999999999999999986 4799999999976433 3334577899999999999999999999997654     


Q ss_pred             -eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccc
Q 039344          675 -HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGI  753 (873)
Q Consensus       675 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~  753 (873)
                       .+|+||||+ ++++..+...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence             469999999 4667766542    3599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhh------------
Q 039344          754 AKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNL------------  820 (873)
Q Consensus       754 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~------------  820 (873)
                      |+....   ..+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.............            
T Consensus       168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             eeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            987653   33456899999999998764 56899999999999999999999997543211100000            


Q ss_pred             ------hhhhhhhcCCCCCCCC-chhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 ------NIALDEMLDPRLPTPS-RNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ------~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                            ................ .........+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  0000000000000000 000111224779999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=361.58  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=201.3

Q ss_pred             cCCCCCceeeecCCeEEEEEEe----CCCcEEEEEEccCCCC-CcchhHHHHHHHHHHHHhccC-CceeeEEeEEEecce
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEIWH-RNIVKVYGFCLHVRH  675 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  675 (873)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||+++.... .+....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6699999999999999999974    2588999999865321 122234668899999999966 899999999999999


Q ss_pred             eEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          676 LFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       676 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .++||||+.+|+|.+++....   .++...+..++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999986543   477889999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccC--CCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhhhcCCCC
Q 039344          756 FLKPDSS-NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDEMLDPRL  832 (873)
Q Consensus       756 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  832 (873)
                      .+..... ......|++.|+|||.+.+.  .++.++||||+||++|||+||+.||..............    .......
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~----~~~~~~~  253 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR----RILKSEP  253 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----HHHHCCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hcccCCC
Confidence            7644322 33456799999999998765  468899999999999999999999976543321111111    1112222


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 039344          833 PTPSRNVHDKLISIVEVTISCVDENPESRP-----TMQKVCQ  869 (873)
Q Consensus       833 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  869 (873)
                      +.+...    ...+.+++.+||++||++||     |++|+++
T Consensus       254 ~~~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 PYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCcccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            222222    23488999999999999999     4788875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-40  Score=349.35  Aligned_cols=256  Identities=17%  Similarity=0.196  Sum_probs=198.6

Q ss_pred             hcCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEE
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  678 (873)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++......     ..+.+|++.++.+. |+|++.+++++.+....++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            467999999999999999999864 7899999988643221     34678888999885 5899999999999999999


Q ss_pred             EEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCC-----CCCeEEecccc
Q 039344          679 VYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDF-----ENEAHVSDFGI  753 (873)
Q Consensus       679 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-----~~~~kl~Dfg~  753 (873)
                      ||||+ +++|.+++....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.     ++.+||+|||+
T Consensus        79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            99998 588888875432  4589999999999999999999999   9999999999999975     56899999999


Q ss_pred             ccccCCCCC-------CccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhhhhhhh
Q 039344          754 AKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLNIALDE  826 (873)
Q Consensus       754 a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~  826 (873)
                      |+.+.....       ......||+.|||||.+.+..++.++||||+||++|||+||+.||...................
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            987654321       2234679999999999999999999999999999999999999997544321111100000000


Q ss_pred             hcCCCCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 039344          827 MLDPRLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQLL  871 (873)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  871 (873)
                      .. ...   .......+..+.+++..||+.+|++||+++.+.+.|
T Consensus       233 ~~-~~~---~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l  273 (293)
T d1csna_         233 QS-TPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF  273 (293)
T ss_dssp             HH-SCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred             CC-CCh---HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            00 000   000001112488899999999999999998887765

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=358.79  Aligned_cols=257  Identities=20%  Similarity=0.280  Sum_probs=191.4

Q ss_pred             cCCCCCceeeecCCeEEEEEEeC-CCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEe------cc
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKLA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLH------VR  674 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  674 (873)
                      ++|++.++||+|+||+||+|+.. +|+.||||++...... ....+.+.+|+.+++.++|||||++++++..      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            57999999999999999999865 7999999999765433 3345678999999999999999999999964      36


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..|+||||+.++.+..+.      ..+++..++.++.||+.|++|||++   ||+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            789999999876655442      3488999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh--------------h
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN--------------L  820 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~--------------~  820 (873)
                      +..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||............              .
T Consensus       167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            865533 3344567899999999999999999999999999999999999999643311100000              0


Q ss_pred             hhhhhhhcCC----------------CCCCCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 NIALDEMLDP----------------RLPTPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                      ......+...                ..+............+.+|+.+|++.||++||||+|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000000                111112223344567899999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-40  Score=354.43  Aligned_cols=252  Identities=20%  Similarity=0.271  Sum_probs=195.1

Q ss_pred             cCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEe--cceeE
Q 039344          602 NDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLH--VRHLF  677 (873)
Q Consensus       602 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~  677 (873)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++..      ..+.+.+|+++++.++ ||||+++++++..  ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            5799999999999999999986 57999999998642      1467889999999995 9999999999975  35689


Q ss_pred             EEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCC-CeEEeccccccc
Q 039344          678 IVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFEN-EAHVSDFGIAKF  756 (873)
Q Consensus       678 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~  756 (873)
                      +||||+.+++|..+.      +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|+.
T Consensus       109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence            999999999987663      3489999999999999999999999   999999999999998765 699999999987


Q ss_pred             cCCCCCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccch-hhhhhh--------------
Q 039344          757 LKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMS-FSSLNL--------------  820 (873)
Q Consensus       757 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~-~~~~~~--------------  820 (873)
                      ..... ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||....+.. ......              
T Consensus       180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             ccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            76443 344567899999999987654 7999999999999999999999986433210 000000              


Q ss_pred             -----hhhhhhhcCCCCC------CCCchhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          821 -----NIALDEMLDPRLP------TPSRNVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       821 -----~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                           .............      ............+.+++.+|++.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0000001000000      000001112235789999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-40  Score=355.28  Aligned_cols=258  Identities=19%  Similarity=0.278  Sum_probs=194.8

Q ss_pred             hcCCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCceeeEEeEEEec-----c
Q 039344          601 TNDFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIVKVYGFCLHV-----R  674 (873)
Q Consensus       601 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  674 (873)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|++++++++|||||++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            46799999999999999999975 57999999999865332 23356789999999999999999999998643     3


Q ss_pred             eeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEeccccc
Q 039344          675 HLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVSDFGIA  754 (873)
Q Consensus       675 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a  754 (873)
                      ..+++++|+.+|+|.+++..    +.+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+|++|||.|
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            45677888899999999854    3499999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhhhh------------
Q 039344          755 KFLKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLNLN------------  821 (873)
Q Consensus       755 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~~~------------  821 (873)
                      ....   .......|++.|+|||...+.. ++.++||||+||++|+|++|+.||..............            
T Consensus       169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            7553   2334567899999999877654 68899999999999999999999975432211100000            


Q ss_pred             ---hhhhhhcC--CCCCCCCc--hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 039344          822 ---IALDEMLD--PRLPTPSR--NVHDKLISIVEVTISCVDENPESRPTMQKVCQ  869 (873)
Q Consensus       822 ---~~~~~~~~--~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  869 (873)
                         ........  ...+....  ........+.+++.+|++.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence               00000000  01110000  00111234789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.7e-36  Score=324.75  Aligned_cols=257  Identities=18%  Similarity=0.253  Sum_probs=189.7

Q ss_pred             CCCCCceeeecCCeEEEEEEe-CCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-----------CCceeeEEeEE
Q 039344          603 DFDDEHCIGKGGQGSVYMSKL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-----------HRNIVKVYGFC  670 (873)
Q Consensus       603 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~  670 (873)
                      +|++.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.+++.++           |+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            489999999999999999986 57999999999743    223467788999888875           57899999998


Q ss_pred             Eec--ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCC--
Q 039344          671 LHV--RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENE--  745 (873)
Q Consensus       671 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~--  745 (873)
                      ...  ...+++++++..+..............+++..+..++.||+.|++|||+ .   +|+||||||+|||++.++.  
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence            654  4567777776665544444344445668899999999999999999998 6   9999999999999987653  


Q ss_pred             ----eEEeccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCcccccchhhhhh-h
Q 039344          746 ----AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSFSSLN-L  820 (873)
Q Consensus       746 ----~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il~el~tg~~P~~~~~~~~~~~~~-~  820 (873)
                          ++++|||.|+.....   .....||+.|+|||++.+..++.++||||+||++++|++|+.||............ .
T Consensus       167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence                999999999865432   23467999999999999999999999999999999999999998743321100000 0


Q ss_pred             ------------h------hhhhhhcCC-----CCCC------------CCchhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 039344          821 ------------N------IALDEMLDP-----RLPT------------PSRNVHDKLISIVEVTISCVDENPESRPTMQ  865 (873)
Q Consensus       821 ------------~------~~~~~~~~~-----~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  865 (873)
                                  .      .......+.     ....            ...........+.+++.+|++.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence                        0      000000000     0000            0111234455789999999999999999999


Q ss_pred             HHHH
Q 039344          866 KVCQ  869 (873)
Q Consensus       866 ev~~  869 (873)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9986

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=3.1e-29  Score=275.22  Aligned_cols=356  Identities=26%  Similarity=0.332  Sum_probs=184.5

Q ss_pred             ECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccC
Q 039344           27 ELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLS  106 (873)
Q Consensus        27 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  106 (873)
                      .+..+++++.+..  ..+.+|++|++++|.|+. + +.+..+++|++|+|++|+|++..  .|.++++|++|++++|+++
T Consensus        28 ~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~  101 (384)
T d2omza2          28 VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA  101 (384)
T ss_dssp             HTTCSSTTSEECH--HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             HhCCCCCCCccCH--HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence            4444555443332  344556666666666652 2 23555566666666666665322  2555666666666666665


Q ss_pred             CCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCcccc
Q 039344          107 NSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLG  186 (873)
Q Consensus       107 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~  186 (873)
                      +..  .++++++|+.|++++|.+++..+  ......+..+....|.+.......................     ...+.
T Consensus       102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  172 (384)
T d2omza2         102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLA  172 (384)
T ss_dssp             CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGT
T ss_pred             ccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhhhc
Confidence            321  25555666666666555553222  2333445555555555443332222222111111111111     12233


Q ss_pred             CCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEE
Q 039344          187 NLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTIL  266 (873)
Q Consensus       187 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  266 (873)
                      ..+.........|...  ....+..+++++.+++++|.+++..+  +..+++|++|++++|.++..  ..+..+++|+.|
T Consensus       173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  246 (384)
T d2omza2         173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDL  246 (384)
T ss_dssp             TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             cccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchh
Confidence            3344444444444443  23345555666666666666654433  34455666666666666532  245556666666


Q ss_pred             EccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCc
Q 039344          267 LLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITG  346 (873)
Q Consensus       267 ~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~  346 (873)
                      ++++|++++.. .+..+++|++|++++|.++++.  .+..++.++.+++++|.+.+  ...+..+++++.|++++|++++
T Consensus       247 ~l~~n~l~~~~-~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~  321 (384)
T d2omza2         247 DLANNQISNLA-PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD  321 (384)
T ss_dssp             ECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSC
T ss_pred             ccccCccCCCC-cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCC
Confidence            66666665433 2555566666666666665443  24455566666666666643  2235555666666666666654


Q ss_pred             cCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCccccCCccccccccccccccccccc
Q 039344          347 NVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSN  414 (873)
Q Consensus       347 ~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  414 (873)
                      ..  .+..+++|+.|++++|+|++ ++ .+..+++|++|++++|++++..|  +..+++|+.|+|++|
T Consensus       322 l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         322 IS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             Cc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            32  25566666666666666653 22 45566666666666666665332  556666666666665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=9.5e-29  Score=271.34  Aligned_cols=354  Identities=28%  Similarity=0.358  Sum_probs=274.0

Q ss_pred             CCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCC
Q 039344            6 NNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI   85 (873)
Q Consensus         6 ~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~   85 (873)
                      .+++++.++.  ..+.+|++|++++|+|+. + +.+..+++|++|+|++|+|++. | .++++++|++|++++|++.+..
T Consensus        31 ~~~~~~~~~~--~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~  104 (384)
T d2omza2          31 KTNVTDTVSQ--TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT  104 (384)
T ss_dssp             CSSTTSEECH--HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG
T ss_pred             CCCCCCccCH--HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc
Confidence            3455555543  567789999999999984 3 3588999999999999999954 4 3999999999999999998543


Q ss_pred             CcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCC
Q 039344           86 PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLK  165 (873)
Q Consensus        86 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  165 (873)
                        .+..+++|+.|++++|.+++..  .......+..+....|.+....+..................     ...+....
T Consensus       105 --~l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  175 (384)
T d2omza2         105 --PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLT  175 (384)
T ss_dssp             --GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCT
T ss_pred             --cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccch-----hhhhcccc
Confidence              4899999999999999998533  34455788888888888875444333333333333332222     23355566


Q ss_pred             CCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecc
Q 039344          166 SLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLF  245 (873)
Q Consensus       166 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  245 (873)
                      .........|...  ....+..+++++.+++++|.+++..|  +..+++|++|++++|+++..  ..+..+++|+.|+++
T Consensus       176 ~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~  249 (384)
T d2omza2         176 TLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA  249 (384)
T ss_dssp             TCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred             ccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccc
Confidence            6677777777664  34567788899999999999886543  56678899999999998853  357788999999999


Q ss_pred             cccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCC
Q 039344          246 ENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEIS  325 (873)
Q Consensus       246 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~  325 (873)
                      +|.+++..+  +..+++|+.|++++|++.+.. .+..++.++.+.+++|.++++  ..+..+++++.|++++|++++.. 
T Consensus       250 ~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~-  323 (384)
T d2omza2         250 NNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS-  323 (384)
T ss_dssp             SSCCCCCGG--GTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG-
T ss_pred             cCccCCCCc--ccccccCCEeeccCcccCCCC-ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc-
Confidence            999886543  778889999999999988644 477788899999999998864  34778899999999999998643 


Q ss_pred             CCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccccEEEecCcc
Q 039344          326 SDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFIKLVLAHNQ  391 (873)
Q Consensus       326 ~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~  391 (873)
                       .+..+++|+.|++++|+|++ + ..++.+++|++|++++|+|++..|  +.++++|+.|+|++|.
T Consensus       324 -~l~~l~~L~~L~L~~n~l~~-l-~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         324 -PVSSLTKLQRLFFANNKVSD-V-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             -GGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             -ccccCCCCCEEECCCCCCCC-C-hhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence             37889999999999999984 3 368899999999999999986554  7889999999999883

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=8.4e-30  Score=271.08  Aligned_cols=258  Identities=26%  Similarity=0.465  Sum_probs=159.7

Q ss_pred             CccEEecccccCCCC--CchhhcCCCCCcEEEccC-CcCcCc-CCcCCCCCCCCeEEccCcccccccccccccCCCccEE
Q 039344          238 NLTYLNLFENSLSGA--IPYEYRNLVKLTILLLGH-NQFRGP-IPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYI  313 (873)
Q Consensus       238 ~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~-N~l~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L  313 (873)
                      +++.|+|++|.+.+.  +|..+.++++|++|+|++ |++.+. ++.+.++++|++|+|++|.+.+..+..+..++.|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            566777777766652  456666666666666654 555542 2245555555555555555555444444444445555


Q ss_pred             eccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCccccccccc-cEEEecCccc
Q 039344          314 DLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFF-IKLVLAHNQL  392 (873)
Q Consensus       314 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L-~~L~L~~N~l  392 (873)
                      ++++|.+.                        +.+|..++.++.|+.+++++|.+.+.+|..+..+..+ +.+++++|++
T Consensus       131 ~l~~N~~~------------------------~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l  186 (313)
T d1ogqa_         131 DFSYNALS------------------------GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL  186 (313)
T ss_dssp             ECCSSEEE------------------------SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred             cccccccc------------------------ccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence            55555444                        4444445555555555555555544445444444443 4455555555


Q ss_pred             cCCcccccccccccccccccccccccccCCCcCchhhhhhhcccccCCccCcccchhhhhhcccceecccCccccCCCch
Q 039344          393 SGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGNLELIHLSELDLSRNFLREAIPSQICIMQSLEKLNLSHNSLSGLIPS  472 (873)
Q Consensus       393 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  472 (873)
                      ++..+..+..+..+ .+++++|.+.+.+|..+..+.  +|+.+++++|.+++.+| .+..+++|+.|+|++|+++|.+|.
T Consensus       187 ~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~--~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~  262 (313)
T d1ogqa_         187 TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDK--NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQ  262 (313)
T ss_dssp             EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTS--CCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCG
T ss_pred             cccccccccccccc-ccccccccccccccccccccc--ccccccccccccccccc-ccccccccccccCccCeecccCCh
Confidence            55555555444333 466666666666666655544  66666666666665443 466677888888888888888888


Q ss_pred             hhhccCCCcEEecCCCcccccCCCCCcccCCCcccccCCCCcccCccCccccc
Q 039344          473 CFEKMNGLLHIDISYNELRGSIPNSTTFKDAPIEALQGNKGLYGDVKGLLSCK  525 (873)
Q Consensus       473 ~~~~~~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l~g~~~~~~~c~  525 (873)
                      .|..+++|++|||++|+++|.+|+...+..+....+.+|+.+||.|  +++|+
T Consensus       263 ~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p--lp~c~  313 (313)
T d1ogqa_         263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP--LPACT  313 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT--SSCCC
T ss_pred             HHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC--CCCCC
Confidence            8888888888888888888888887777777778888888888865  34663

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.95  E-value=1.3e-28  Score=261.69  Aligned_cols=248  Identities=28%  Similarity=0.447  Sum_probs=180.8

Q ss_pred             ccceeeccccccCC--CCCccccCCcccCcccccc-cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEE
Q 039344           94 NLATLYLDTNSLSN--SIPSELGNLRSLSNLQLNN-NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNL  170 (873)
Q Consensus        94 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  170 (873)
                      +++.|+|++|.+.+  .+|.++.++++|++|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            45556666665554  3566677777777777765 56666677777777777777777777777777777777777788


Q ss_pred             EccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCC-CEEEccCcccCCCcccccCCCCCccEEecccccC
Q 039344          171 QLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSL-SNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL  249 (873)
Q Consensus       171 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l  249 (873)
                      ++++|.+.+.+|..+.+++.|+.+++++|.+++.+|..+..+..+ +.+++++|++++..+..+..+.. ..++++.+..
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            888887777777788888888888888888877777777777665 77888888887777766666544 4688888888


Q ss_pred             CCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCC
Q 039344          250 SGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWG  329 (873)
Q Consensus       250 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  329 (873)
                      .+..|..+..+++|+.+++++|.+.+.++.+..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++.+|. +.
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-ST
T ss_pred             cccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cc
Confidence            77778777888888888888888877666677777777777777777766666677777777777777777766663 45


Q ss_pred             CCCCCCeeeecccc
Q 039344          330 RCPKLSTLDFSINN  343 (873)
Q Consensus       330 ~l~~L~~L~l~~N~  343 (873)
                      ++++|+.+++++|+
T Consensus       289 ~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         289 NLQRFDVSAYANNK  302 (313)
T ss_dssp             TGGGSCGGGTCSSS
T ss_pred             cCCCCCHHHhCCCc
Confidence            66667777776665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=1.6e-26  Score=244.55  Aligned_cols=250  Identities=25%  Similarity=0.294  Sum_probs=162.9

Q ss_pred             CCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCccccc
Q 039344           46 NLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLN  125 (873)
Q Consensus        46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  125 (873)
                      .+++++-++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4566677777777 5565553  567777777777775555567777777777777777776666667777777777777


Q ss_pred             ccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCc--cCCCccccCCCCCcEEeccCCCCcc
Q 039344          126 NNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN--GSIPPSLGNLSNLATLYLDTNSLSY  203 (873)
Q Consensus       126 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~n~l~~  203 (873)
                      +|+++ .+|..+  ...|..|++.+|.+..+....+.....+..++...|...  ...+..+..+++|+.+++++|.++ 
T Consensus        88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-  163 (305)
T d1xkua_          88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-  163 (305)
T ss_dssp             SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence            77776 344332  246677777777777666666666667777777766543  223445666667777777777766 


Q ss_pred             cCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCC
Q 039344          204 SIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNL  283 (873)
Q Consensus       204 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l  283 (873)
                      .+|..+  +++|++|++++|.+....+..+.+++.+++|++++|.+.+..+..+.++++|++|+|++|+++..+..+..+
T Consensus       164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l  241 (305)
T d1xkua_         164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH  241 (305)
T ss_dssp             SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTC
T ss_pred             ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccc
Confidence            333322  456777777777766666666666777777777777776666666666777777777777666655556666


Q ss_pred             CCCCeEEccCccccccccccc
Q 039344          284 TSLERVRLDRNYLTGNISESF  304 (873)
Q Consensus       284 ~~L~~L~L~~n~l~~~~~~~~  304 (873)
                      ++|++|+|++|+|+.+....|
T Consensus       242 ~~L~~L~Ls~N~i~~i~~~~f  262 (305)
T d1xkua_         242 KYIQVVYLHNNNISAIGSNDF  262 (305)
T ss_dssp             SSCCEEECCSSCCCCCCTTSS
T ss_pred             cCCCEEECCCCccCccChhhc
Confidence            666666666666665544443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=3.9e-26  Score=241.59  Aligned_cols=241  Identities=27%  Similarity=0.342  Sum_probs=162.0

Q ss_pred             CcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCC
Q 039344            7 NSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIP   86 (873)
Q Consensus         7 n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~   86 (873)
                      ++++ ++|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|.+|.++++|++|++++|+++ .+|
T Consensus        20 ~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~   95 (305)
T d1xkua_          20 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP   95 (305)
T ss_dssp             SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCC
T ss_pred             CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCc
Confidence            3455 4455664  56788888888887555567788888888888888888666777778888888888888777 344


Q ss_pred             cccccccccceeeccccccCCCCCccccCCcccCcccccccccc--cccCccccCCCCCcEEEccCCCCccccccccCCC
Q 039344           87 PSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILS--GSIPHSLGNLTNLATLYIYSNSLSASILGKIGNL  164 (873)
Q Consensus        87 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  164 (873)
                      ..+.  ..++.|++..|.+....+..+.....++.++...|...  ...+..|..+++|+.+++++|.+..+...   .+
T Consensus        96 ~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~---~~  170 (305)
T d1xkua_          96 EKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG---LP  170 (305)
T ss_dssp             SSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS---CC
T ss_pred             cchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc---cC
Confidence            4332  46777777777777655555666667777777666543  23344566777777777777776654332   24


Q ss_pred             CCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEec
Q 039344          165 KSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNL  244 (873)
Q Consensus       165 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  244 (873)
                      ++|++|++++|.++...+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.++.++++|++|+|
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  249 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence            56777777777776666666777777777777777777666666677777777777777776 34556666777777777


Q ss_pred             ccccCCCCCchhh
Q 039344          245 FENSLSGAIPYEY  257 (873)
Q Consensus       245 ~~n~l~~~~~~~~  257 (873)
                      ++|+|+.+....|
T Consensus       250 s~N~i~~i~~~~f  262 (305)
T d1xkua_         250 HNNNISAIGSNDF  262 (305)
T ss_dssp             CSSCCCCCCTTSS
T ss_pred             CCCccCccChhhc
Confidence            7777665444333

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.5e-26  Score=238.99  Aligned_cols=205  Identities=27%  Similarity=0.310  Sum_probs=113.4

Q ss_pred             CCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccc-cccccccccCccccCCCCCcEEEcc
Q 039344           71 FSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL-NNNILSGSIPHSLGNLTNLATLYIY  149 (873)
Q Consensus        71 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L-~~n~l~~~~~~~~~~l~~L~~L~L~  149 (873)
                      +++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+.++..++.++. ..|.++...+..|+++++|++|+++
T Consensus        34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~  113 (284)
T d1ozna_          34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD  113 (284)
T ss_dssp             CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence            444444444444333344444444444444444444444444444444444433 2333443344455555555555555


Q ss_pred             CCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCc
Q 039344          150 SNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSI  229 (873)
Q Consensus       150 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  229 (873)
                      +|.+..+....+..+++|+.+++++|+++++.+..|..+++|+.|++++|.++...+..|.++++|+++++++|++++..
T Consensus       114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~  193 (284)
T d1ozna_         114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH  193 (284)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence            55555555555555555666666666665555555555566666666666666555556666666666666666666555


Q ss_pred             ccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcC
Q 039344          230 PISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG  275 (873)
Q Consensus       230 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (873)
                      |..|..+++|++|++++|++.+..+..|..+++|++|++++|++..
T Consensus       194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            6666666666666666666666666666666666666666666553

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.7e-25  Score=230.36  Aligned_cols=255  Identities=22%  Similarity=0.204  Sum_probs=126.3

Q ss_pred             EEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEcc-Cc
Q 039344          145 TLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLG-YN  223 (873)
Q Consensus       145 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~N  223 (873)
                      .++.+++.++.++.. +.  +++++|+|++|+|+...+.+|.++++|++|++++|.+..+.+..+..++.+..+... .|
T Consensus        15 ~v~c~~~~L~~iP~~-ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          15 TTSCPQQGLQAVPVG-IP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EEECCSSCCSSCCTT-CC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEEcCCCCCCccCCC-CC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            345555555544322 21  345666666666665555556666666666666666655555555555555555443 34


Q ss_pred             ccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccc
Q 039344          224 KLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISES  303 (873)
Q Consensus       224 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  303 (873)
                      .++...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|+++                       +++...
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-----------------------~i~~~~  148 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-----------------------ALPDDT  148 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-----------------------CCCTTT
T ss_pred             ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-----------------------ccChhH
Confidence            444444455555555555555555554444444444444444444444444                       444444


Q ss_pred             cccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEeccCCccCCCCCcccccccccc
Q 039344          304 FYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLSSNHIVGEIPIELGKLNFFI  383 (873)
Q Consensus       304 ~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~  383 (873)
                      |..+++|++|++++|++....+..|..+++|+.+++++|++++..|..|+.+++|++|++++|.+.+..+..+..+.+|+
T Consensus       149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~  228 (284)
T d1ozna_         149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ  228 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred             hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence            44444444555555554444444445555555555555555544455555555555555555555544444444444455


Q ss_pred             EEEecCccccCCcccccccccccccccccccccccccCCCcCc
Q 039344          384 KLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPKSLGN  426 (873)
Q Consensus       384 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  426 (873)
                      +|++++|.+...-+ ...-...++.+....+.+..+.|..+.+
T Consensus       229 ~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g  270 (284)
T d1ozna_         229 YLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG  270 (284)
T ss_dssp             EEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred             EEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC
Confidence            55555554443211 0011123445555555555555555443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.8e-23  Score=214.21  Aligned_cols=197  Identities=27%  Similarity=0.287  Sum_probs=94.6

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNN  126 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  126 (873)
                      +.+.+.+++.++ .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+. +| .++.+++|++|+|++
T Consensus        12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~   86 (266)
T d1p9ag_          12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSH   86 (266)
T ss_dssp             CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCS
T ss_pred             CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccc
Confidence            333444444444 3333332  234444444444443333444444444444444444442 11 223444445555555


Q ss_pred             cccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCC
Q 039344          127 NILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIP  206 (873)
Q Consensus       127 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  206 (873)
                      |+++ ..+..+..+++|+.|++++|.+..+....+..+.++++|++++|.++...+..+..+++|+.|++++|++++..+
T Consensus        87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~  165 (266)
T d1p9ag_          87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA  165 (266)
T ss_dssp             SCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred             cccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence            5444 234444555555555555555555445555555555555555555554444444555555555555555554444


Q ss_pred             ccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCC
Q 039344          207 SELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLS  250 (873)
Q Consensus       207 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  250 (873)
                      ..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       166 ~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            44555555555555555555 34444444555555555555443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.6e-23  Score=212.56  Aligned_cols=202  Identities=26%  Similarity=0.285  Sum_probs=173.4

Q ss_pred             cCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccce
Q 039344           18 RNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLAT   97 (873)
Q Consensus        18 ~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~   97 (873)
                      .....+.+.+.++++|+ .+|+.+.  +++++|+|++|+|+++.+++|.++++|++|+|++|+|+. ++ .+..+++|++
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence            45566777899999998 5676654  578999999999987777888999999999999999884 33 4677899999


Q ss_pred             eeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcC
Q 039344           98 LYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNF  177 (873)
Q Consensus        98 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i  177 (873)
                      |+|++|+++ ..+..+.++++|+.|++++|.+....+..+..+.++++|++++|.+..+.+..+..+++|+.|++++|++
T Consensus        82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l  160 (266)
T d1p9ag_          82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (266)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence            999999998 5677888899999999999999877778888999999999999999988888889999999999999999


Q ss_pred             ccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccC
Q 039344          178 NGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLS  226 (873)
Q Consensus       178 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  226 (873)
                      ++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            9888888999999999999999999 67777888999999999999876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=1.3e-22  Score=197.50  Aligned_cols=172  Identities=17%  Similarity=0.127  Sum_probs=122.3

Q ss_pred             CCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCC-----------c----chhHHHHHHHHHHHHhccCCceeeEEeE
Q 039344          605 DDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPG-----------E----MTFQQEFLNEVKALTEIWHRNIVKVYGF  669 (873)
Q Consensus       605 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~----~~~~~~~~~e~~~l~~l~h~niv~l~~~  669 (873)
                      .+.++||+|+||+||+|+..+|+.||||+++.....           .    ......+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            457899999999999999889999999987642111           0    0112335678888999999999988866


Q ss_pred             EEecceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeeeCCCCCeEEe
Q 039344          670 CLHVRHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCFPPIVHRDISSKNVLLDFENEAHVS  749 (873)
Q Consensus       670 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~  749 (873)
                      .    ..+++|||+++....          .++......++.|+++|++|||++   +|+||||||+|||++++ .++++
T Consensus        83 ~----~~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            3    237999999875543          245556678999999999999999   99999999999999965 58999


Q ss_pred             ccccccccCCCCCCccccccccccccccccccCCCCCcchhHHHHHHH
Q 039344          750 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA  797 (873)
Q Consensus       750 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDv~s~G~il  797 (873)
                      |||.|+....+... .....+... -.| +..++|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~-~~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR-EILERDVRN-IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH-HHHHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH-HHHHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence            99999765432111 000000000 011 2245688899999976443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.87  E-value=8.4e-20  Score=196.59  Aligned_cols=299  Identities=27%  Similarity=0.336  Sum_probs=173.3

Q ss_pred             CCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecc
Q 039344           22 SLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLD  101 (873)
Q Consensus        22 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  101 (873)
                      ++++|||++|+++ .+|+.   .++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++. ++. +.  +.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~-lp--~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD-LP--PLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS-CC--TTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhh-hc--ccccccccc
Confidence            5888999999887 56753   467888899998888 667654   578888888888873 332 11  358888888


Q ss_pred             ccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCC
Q 039344          102 TNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSI  181 (873)
Q Consensus       102 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  181 (873)
                      +|.+. .+|. +..+++|++|++++|.+.. .+..   ...+..+.+..+....  ...+..++.++.|++++|.+... 
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~-  177 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKL-  177 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSC-
T ss_pred             ccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhccccccc--cccccccccceeccccccccccc-
Confidence            88887 4453 5678888888888888763 3332   3556677776665533  44566777788888888877632 


Q ss_pred             CccccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCC
Q 039344          182 PPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLV  261 (873)
Q Consensus       182 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  261 (873)
                      +..   ....+.+...++.+. ..+ .+..++.|+.+++++|.... .+   ....++..+.+..|.+....    ....
T Consensus       178 ~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~~~----~~~~  244 (353)
T d1jl5a_         178 PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTDLP----ELPQ  244 (353)
T ss_dssp             CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSCCC----CCCT
T ss_pred             ccc---ccccccccccccccc-ccc-cccccccccccccccccccc-cc---cccccccccccccccccccc----cccc
Confidence            211   234456666666655 333 35667777777777777653 22   23345666777766665321    1234


Q ss_pred             CCcEEEccCCcCcCcCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeecc
Q 039344          262 KLTILLLGHNQFRGPIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSI  341 (873)
Q Consensus       262 ~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~  341 (873)
                      .+...++..+.+.+....   .......++..+.+.++.    ..+++|++|+|++|++. .+|.   .+++|+.|++++
T Consensus       245 ~l~~~~~~~~~~~~l~~l---~~~~~~~~~~~~~~~~~~----~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~  313 (353)
T d1jl5a_         245 SLTFLDVSENIFSGLSEL---PPNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASF  313 (353)
T ss_dssp             TCCEEECCSSCCSEESCC---CTTCCEEECCSSCCSEEC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred             cccccccccccccccccc---cchhcccccccCcccccc----ccCCCCCEEECCCCccC-cccc---ccCCCCEEECCC
Confidence            555556555554432111   122334444444444321    22345555555555554 2222   133445555555


Q ss_pred             ccCCccCCccccCCCCCCEEeccCCccC
Q 039344          342 NNITGNVPPEIGHSSQLGVLDLSSNHIV  369 (873)
Q Consensus       342 N~i~~~~~~~~~~~~~L~~L~Ls~N~i~  369 (873)
                      |+|+ .+|..   +.+|++|+|++|+|+
T Consensus       314 N~L~-~l~~~---~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         314 NHLA-EVPEL---PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             SCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred             CcCC-ccccc---cCCCCEEECcCCcCC
Confidence            5544 23321   234444444444444

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=2.1e-19  Score=193.35  Aligned_cols=304  Identities=27%  Similarity=0.320  Sum_probs=160.7

Q ss_pred             CCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccc
Q 039344           45 TNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQL  124 (873)
Q Consensus        45 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (873)
                      .++++|+|++|.++ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++. +++.   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence            36778888888887 56653   357788888888887 556543   467777788877773 3321   135777777


Q ss_pred             cccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCccc
Q 039344          125 NNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYS  204 (873)
Q Consensus       125 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~  204 (873)
                      ++|.+. .+|. ++.+++|+.|++++|.+....    .....+..+.+..+...  ....+..++.++.+++++|.... 
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~----~~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~-  176 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP----DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-  176 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-
T ss_pred             cccccc-cccc-hhhhccceeeccccccccccc----cccccccchhhcccccc--ccccccccccceecccccccccc-
Confidence            777776 3443 566777777777777665422    22345566666655543  22345556666666666666652 


Q ss_pred             CCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCC
Q 039344          205 IPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLT  284 (873)
Q Consensus       205 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~  284 (873)
                      .+..   ....+.+...++.+. ..+ .+..++.|+.+++++|..... +   ....++..+.+.+|.+......   ..
T Consensus       177 ~~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~~~~~---~~  244 (353)
T d1jl5a_         177 LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTDLPEL---PQ  244 (353)
T ss_dssp             CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSCCCCC---CT
T ss_pred             cccc---ccccccccccccccc-ccc-ccccccccccccccccccccc-c---cccccccccccccccccccccc---cc
Confidence            2211   123345555555544 222 244556666666666655422 1   1234455555555555432221   22


Q ss_pred             CCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEecc
Q 039344          285 SLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDLS  364 (873)
Q Consensus       285 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~Ls  364 (873)
                      ++..+++..+.+.++..    ..                        ......++..|.+.+.    ...+++|++|+|+
T Consensus       245 ~l~~~~~~~~~~~~l~~----l~------------------------~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls  292 (353)
T d1jl5a_         245 SLTFLDVSENIFSGLSE----LP------------------------PNLYYLNASSNEIRSL----CDLPPSLEELNVS  292 (353)
T ss_dssp             TCCEEECCSSCCSEESC----CC------------------------TTCCEEECCSSCCSEE----CCCCTTCCEEECC
T ss_pred             ccccccccccccccccc----cc------------------------chhcccccccCccccc----cccCCCCCEEECC
Confidence            33333433333322110    01                        1223344444443321    1223455555665


Q ss_pred             CCccCCCCCccccccccccEEEecCccccCCcccccccccccccccccccccccccCC
Q 039344          365 SNHIVGEIPIELGKLNFFIKLVLAHNQLSGQLSPKLGSLVQLEHLDLSSNRLSNSIPK  422 (873)
Q Consensus       365 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  422 (873)
                      +|+|+ .+|..   +++|+.|+|++|+|+. +|+.   +.+|++|+|++|+|+ .+|.
T Consensus       293 ~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         293 NNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             SSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             CCccC-ccccc---cCCCCEEECCCCcCCc-cccc---cCCCCEEECcCCcCC-CCCc
Confidence            55555 34432   3455556666666653 3322   345666777777765 4444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=4.3e-23  Score=231.40  Aligned_cols=109  Identities=23%  Similarity=0.259  Sum_probs=50.1

Q ss_pred             CCCEEEcccCCCCCCC-CcccccccccceeeccccccCC----CCCccccCCcccCccccccccccccc----CccccC-
Q 039344           70 FFSDLELSNNKLSGSI-PPSLGNLSNLATLYLDTNSLSN----SIPSELGNLRSLSNLQLNNNILSGSI----PHSLGN-  139 (873)
Q Consensus        70 ~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~-  139 (873)
                      +|+.||+++|++++.. ...+..++++++|+|++|.++.    .++..+..+++|++|+|++|.|+...    ...+.. 
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            3556666666665321 2234445556666666665542    12233445555555555555554211    111111 


Q ss_pred             CCCCcEEEccCCCCcccc----ccccCCCCCCCEEEccCCcCc
Q 039344          140 LTNLATLYIYSNSLSASI----LGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       140 l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      ..+|++|+|++|++++..    +..+..+++|++|+|++|.+.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            124555555555554322    223344455555555555543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=3.3e-22  Score=224.03  Aligned_cols=379  Identities=20%  Similarity=0.138  Sum_probs=177.7

Q ss_pred             ccceeeccccccCCCC-CccccCCcccCccccccccccc----ccCccccCCCCCcEEEccCCCCcccccccc----C-C
Q 039344           94 NLATLYLDTNSLSNSI-PSELGNLRSLSNLQLNNNILSG----SIPHSLGNLTNLATLYIYSNSLSASILGKI----G-N  163 (873)
Q Consensus        94 ~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~-~  163 (873)
                      +|+.||+++|++++.. ...+..+++++.|+|++|.++.    .++..+..+++|++|+|++|.|+......+    . .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5667777777776421 2334556666666666666652    223345566666666666666643221111    1 1


Q ss_pred             CCCCCEEEccCCcCccC----CCccccCCCCCcEEeccCCCCcccCCcccc-----CCCCCCEEEccCcccCCCcccccC
Q 039344          164 LKSLSNLQLSENNFNGS----IPPSLGNLSNLATLYLDTNSLSYSIPSELG-----NLRSLSNLSLGYNKLSGSIPISMG  234 (873)
Q Consensus       164 l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~  234 (873)
                      ..+|++|+|++|++++.    ++..+..+++|++|++++|.++......+.     .......+......+.......  
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~--  160 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP--  160 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH--
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcc--
Confidence            23466666666655432    223344455555555555555422111111     1112222222222221100000  


Q ss_pred             CCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCc-----CCcC-CCCCCCCeEEccCcccccccc----ccc
Q 039344          235 NLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGP-----IPIL-RNLTSLERVRLDRNYLTGNIS----ESF  304 (873)
Q Consensus       235 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-----~~~l-~~l~~L~~L~L~~n~l~~~~~----~~~  304 (873)
                                        ....+.....++.++++++.....     ...+ ........+.+.++.+.....    ..+
T Consensus       161 ------------------~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l  222 (460)
T d1z7xw1         161 ------------------LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV  222 (460)
T ss_dssp             ------------------HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred             ------------------cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccc
Confidence                              001122234444444444443210     0000 111233444444444432211    122


Q ss_pred             ccCCCccEEeccCccccc-----cCCCCCCCCCCCCeeeeccccCCcc----CCccccCCCCCCEEeccCCccCCCCCcc
Q 039344          305 YIYPNLTYIDLSQNNFYG-----EISSDWGRCPKLSTLDFSINNITGN----VPPEIGHSSQLGVLDLSSNHIVGEIPIE  375 (873)
Q Consensus       305 ~~~~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~l~~N~i~~~----~~~~~~~~~~L~~L~Ls~N~i~~~~~~~  375 (873)
                      ...+.++.+++++|.+..     ...........++.|++++|.+...    ....+...+.++.+++++|.+++.....
T Consensus       223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~  302 (460)
T d1z7xw1         223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL  302 (460)
T ss_dssp             HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred             cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence            334555566666555432     1122233345566666666665432    1122344556666666666664322221


Q ss_pred             c-----cccccccEEEecCccccCCccccc----ccccccccccccccccccccCCCcCc-h--hhhhhhcccccCCccC
Q 039344          376 L-----GKLNFFIKLVLAHNQLSGQLSPKL----GSLVQLEHLDLSSNRLSNSIPKSLGN-L--ELIHLSELDLSRNFLR  443 (873)
Q Consensus       376 ~-----~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~-l--~~~~L~~L~Ls~N~l~  443 (873)
                      +     .....|+.+++++|.++......+    ....+|++|||++|+|++.....+.. +  ....|+.|+|++|.|+
T Consensus       303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~  382 (460)
T d1z7xw1         303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  382 (460)
T ss_dssp             HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence            1     123456666666666654433333    23446777777777775432222110 0  0124677777777776


Q ss_pred             cc----cchhhhhhcccceecccCccccCCCchhh----h-ccCCCcEEecCCCcccc
Q 039344          444 EA----IPSQICIMQSLEKLNLSHNSLSGLIPSCF----E-KMNGLLHIDISYNELRG  492 (873)
Q Consensus       444 ~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~-~~~~L~~l~ls~N~l~~  492 (873)
                      +.    ++..+...++|++|+|++|+|+......|    . ....|+.|++++|.+..
T Consensus       383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            53    23344556778888888887764333322    1 23357888888777653

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.9e-19  Score=181.25  Aligned_cols=217  Identities=18%  Similarity=0.160  Sum_probs=117.8

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCC-CCcccccccccceeeccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGS-IPPSLGNLSNLATLYLDT  102 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~  102 (873)
                      +.++.++++++ .+|+.+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+... .+.+|.+++++++|.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            34555555555 4444332  3566666666666644445566666666666666655432 344556666666665543


Q ss_pred             -cccCCCCCccccCCcccCcccccccccccccC-ccccCCCCCcEEEccCCCCccccccccCCCC-CCCEEEccCCcCcc
Q 039344          103 -NSLSNSIPSELGNLRSLSNLQLNNNILSGSIP-HSLGNLTNLATLYIYSNSLSASILGKIGNLK-SLSNLQLSENNFNG  179 (873)
Q Consensus       103 -n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~  179 (873)
                       |++....+..|.++++|++|++++|.+....+ ..+..+..+..+..+++.+..+....|.+++ .++.|++++|+++.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~  167 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE  167 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred             cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence             45554555556666666666666666553222 1233445555555555566655555555543 46666666666664


Q ss_pred             CCCccccCCCCCcEE-eccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEec
Q 039344          180 SIPPSLGNLSNLATL-YLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNL  244 (873)
Q Consensus       180 ~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  244 (873)
                      ..+..+. .++++.+ ++++|.++.+.+..|.++++|++|+|++|+|+...+..|.++++|+++++
T Consensus       168 i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         168 IHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             ECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             ccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            4333332 3333333 45556666444445666666666666666666444445555555555554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=3.6e-19  Score=178.41  Aligned_cols=126  Identities=23%  Similarity=0.371  Sum_probs=51.3

Q ss_pred             cCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcE
Q 039344          114 GNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLAT  193 (873)
Q Consensus       114 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~  193 (873)
                      +.+.+|++|++.+|.|+. + +.+..+++|++|++++|++.++.+  +..+++|+++++++|.++..  ..+.++++|+.
T Consensus        38 ~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~  111 (227)
T d1h6ua2          38 ADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT  111 (227)
T ss_dssp             HHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred             HHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccc
Confidence            334444444444444442 2 124444444444444444443221  44444444444444444321  22334444444


Q ss_pred             EeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccC
Q 039344          194 LYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSL  249 (873)
Q Consensus       194 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l  249 (873)
                      ++++++...+.  ..+...+.+..+.++.+.+...  ..+..+++|++|++++|.+
T Consensus       112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~  163 (227)
T d1h6ua2         112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV  163 (227)
T ss_dssp             EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred             ccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccc
Confidence            44444443311  1233334444444444444321  1233334444444444443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2.3e-19  Score=182.01  Aligned_cols=217  Identities=19%  Similarity=0.177  Sum_probs=134.1

Q ss_pred             CceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCC-CCccccCCcccCccccc
Q 039344           47 LATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNS-IPSELGNLRSLSNLQLN  125 (873)
Q Consensus        47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~  125 (873)
                      .+.++.++..++ .+|+.+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+... .+..|.++++++++.+.
T Consensus        10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            367788888888 6666553  5788888888888866666788888888888888877653 34567777777777765


Q ss_pred             c-cccccccCccccCCCCCcEEEccCCCCcccccc-ccCCCCCCCEEEccCCcCccCCCccccCCC-CCcEEeccCCCCc
Q 039344          126 N-NILSGSIPHSLGNLTNLATLYIYSNSLSASILG-KIGNLKSLSNLQLSENNFNGSIPPSLGNLS-NLATLYLDTNSLS  202 (873)
Q Consensus       126 ~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~  202 (873)
                      . |.+....+..|.++++|++|++++|.+...... .+..++.+..+..+++.+....+..|.+++ .++.|++++|+++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence            3 556656666777777777777777777643322 223344455555566666655555555543 5666666666666


Q ss_pred             ccCCccccCCCCCCEE-EccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEE
Q 039344          203 YSIPSELGNLRSLSNL-SLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILL  267 (873)
Q Consensus       203 ~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  267 (873)
                      .+.+..+. ..++.++ .+++|+|+.+.+..|.++++|++|+|++|+|+...+..|.++++|+.++
T Consensus       167 ~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~  231 (242)
T d1xwdc1         167 EIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS  231 (242)
T ss_dssp             EECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred             cccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCc
Confidence            43333333 3333333 4555666644444556666666666666666654444455544444443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=8.5e-19  Score=175.64  Aligned_cols=208  Identities=22%  Similarity=0.329  Sum_probs=135.7

Q ss_pred             CcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEe
Q 039344          116 LRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLY  195 (873)
Q Consensus       116 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  195 (873)
                      +.++..++++.+++++..  .++.+.+|+.|++.+|.|+.+  ..+..+++|++|++++|++++..  .+..+++|++++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~   91 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELE   91 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--cccccccccccc
Confidence            344555677777777543  467788899999999988765  34788888999999988887543  377888888888


Q ss_pred             ccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcC
Q 039344          196 LDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRG  275 (873)
Q Consensus       196 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (873)
                      +++|.++. + ..+..+++|++++++++...+.  ..+...+.++.+.++++.+...  ..+..+++|+.|++++|.+..
T Consensus        92 ~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~  165 (227)
T d1h6ua2          92 LSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD  165 (227)
T ss_dssp             CCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred             cccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccccc
Confidence            88888873 3 3577788888888888877643  2355667777777777776533  235566677777777776654


Q ss_pred             cCCcCCCCCCCCeEEccCcccccccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeec
Q 039344          276 PIPILRNLTSLERVRLDRNYLTGNISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFS  340 (873)
Q Consensus       276 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  340 (873)
                      .. .+.++++|++|++++|+++++.  .+..+++|++|+|++|++++..  .+..+++|+.|+++
T Consensus       166 ~~-~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         166 LT-PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             CG-GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred             ch-hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence            22 2555566666666666655432  2445555555555555554322  14444555555544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3.2e-18  Score=168.70  Aligned_cols=182  Identities=27%  Similarity=0.448  Sum_probs=126.6

Q ss_pred             EEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccc
Q 039344           25 DLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNS  104 (873)
Q Consensus        25 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  104 (873)
                      ...+.++.+++.++.  ..+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..  .+..+++|++|++++|+
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~  101 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK  101 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence            345666666644443  346677777777777773 33 3667777777777777777432  35677778888887777


Q ss_pred             cCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCcc
Q 039344          105 LSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS  184 (873)
Q Consensus       105 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  184 (873)
                      +++ +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.+++  ...+..+++|+++++++|++++. + .
T Consensus       102 i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~  173 (210)
T d1h6ta2         102 VKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-P  173 (210)
T ss_dssp             CCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-G
T ss_pred             ccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-c
Confidence            773 33 47777788888888777762 2 357777888888888887765  33466777888888888888753 2 3


Q ss_pred             ccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccC
Q 039344          185 LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGY  222 (873)
Q Consensus       185 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  222 (873)
                      ++++++|++|+|++|.++. ++ .+.++++|++|+|++
T Consensus       174 l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            7778888888888888874 33 477888888888763

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=6.9e-19  Score=172.07  Aligned_cols=178  Identities=28%  Similarity=0.461  Sum_probs=81.9

Q ss_pred             EEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccc
Q 039344           25 DLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNS  104 (873)
Q Consensus        25 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  104 (873)
                      .+.++.+.+++..+  ...++++++|++++|.++ .++ .+..+++|++|++++|++++..+  +.++++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            34455555543322  234455555555555555 222 24445555555555555543221  4455555555555554


Q ss_pred             cCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCcc
Q 039344          105 LSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPS  184 (873)
Q Consensus       105 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  184 (873)
                      +.. ++ .+.++++|+.|++++|.+.                        ..  ..+..+++|+.|++++|++...  +.
T Consensus        96 ~~~-~~-~l~~l~~L~~L~l~~~~~~------------------------~~--~~~~~l~~L~~L~l~~n~l~~~--~~  145 (199)
T d2omxa2          96 IAD-IT-PLANLTNLTGLTLFNNQIT------------------------DI--DPLKNLTNLNRLELSSNTISDI--SA  145 (199)
T ss_dssp             CCC-CG-GGTTCTTCSEEECCSSCCC------------------------CC--GGGTTCTTCSEEECCSSCCCCC--GG
T ss_pred             ccc-cc-ccccccccccccccccccc------------------------cc--cccchhhhhHHhhhhhhhhccc--cc
Confidence            442 11 2444444444444444443                        32  1234444444555554444321  23


Q ss_pred             ccCCCCCcEEeccCCCCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEE
Q 039344          185 LGNLSNLATLYLDTNSLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYL  242 (873)
Q Consensus       185 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  242 (873)
                      +..+++|+.|++++|.+++. + .++++++|++|++++|+|++. + .++.+++|++|
T Consensus       146 l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         146 LSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             ccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            44445555555555555422 1 245555555555555555532 1 24445555543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=1.5e-17  Score=163.95  Aligned_cols=145  Identities=31%  Similarity=0.414  Sum_probs=58.5

Q ss_pred             ccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCcccCCccccCCCCCC
Q 039344          137 LGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYSIPSELGNLRSLS  216 (873)
Q Consensus       137 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  216 (873)
                      +..+++|++|+|++|+++++.  .++.+++|++|++++|++++. + .+..+++|+.|++++|.+..  ...+..+++++
T Consensus        64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~  137 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLE  137 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCC
T ss_pred             HhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc-c-cccccccccccccccccccc--ccccccccccc
Confidence            333444444444444443322  133344444444444444321 1 23344444444444444431  11234444444


Q ss_pred             EEEccCcccCCCcccccCCCCCccEEecccccCCCCCchhhcCCCCCcEEEccCCcCcCcCCcCCCCCCCCeEEcc
Q 039344          217 NLSLGYNKLSGSIPISMGNLSNLTYLNLFENSLSGAIPYEYRNLVKLTILLLGHNQFRGPIPILRNLTSLERVRLD  292 (873)
Q Consensus       217 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~  292 (873)
                      .+++++|.+++.  ..+..+++|+++++++|++++..  .+.++++|++|++++|+++.. +.+.++++|++|+|+
T Consensus       138 ~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         138 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELF  208 (210)
T ss_dssp             EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEE
T ss_pred             cccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEcc
Confidence            444444444321  12333444444444444444321  144444444444444444432 234444444444443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=1.2e-17  Score=163.20  Aligned_cols=174  Identities=29%  Similarity=0.456  Sum_probs=137.5

Q ss_pred             cCCcccccCCccccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCC
Q 039344            5 YNNSLYDSIPSELRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGS   84 (873)
Q Consensus         5 ~~n~~~~~~p~~~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~   84 (873)
                      ..+++++.++.  ..+.++++|++++|+++. ++ .+..+++|++|++++|++++..|  ++++++|++|++++|.+.. 
T Consensus        26 ~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-   98 (199)
T d2omxa2          26 GKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-   98 (199)
T ss_dssp             TCSSTTSEECH--HHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred             CCCCCCCccCH--HHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-
Confidence            45666665543  467889999999999984 43 48899999999999999995443  8999999999999999984 


Q ss_pred             CCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCC
Q 039344           85 IPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNL  164 (873)
Q Consensus        85 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  164 (873)
                      ++ .+.++++|+.|++++|.+...  ..+..+++|+.|++++|.+.. ++ .+..+++|++|++++|+++++.  .++++
T Consensus        99 ~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l  171 (199)
T d2omxa2          99 IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANL  171 (199)
T ss_dssp             CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTC
T ss_pred             cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCC
Confidence            33 589999999999999998743  457888999999999998873 33 5778888888888888887643  47778


Q ss_pred             CCCCEEEccCCcCccCCCccccCCCCCcEE
Q 039344          165 KSLSNLQLSENNFNGSIPPSLGNLSNLATL  194 (873)
Q Consensus       165 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L  194 (873)
                      ++|++|++++|++++.  +.++++++|++|
T Consensus       172 ~~L~~L~ls~N~i~~i--~~l~~L~~L~~L  199 (199)
T d2omxa2         172 TTLERLDISSNKVSDI--SVLAKLTNLESL  199 (199)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             CCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence            8888888888887743  346667777665

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.72  E-value=3.1e-18  Score=166.29  Aligned_cols=126  Identities=29%  Similarity=0.416  Sum_probs=53.0

Q ss_pred             eEEccCCcccccCCCCccCCCCCCEEEcccCCCCC-CCCcccccccccceeeccccccCCCCCccccCCcccCccccccc
Q 039344           49 TLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSG-SIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNN  127 (873)
Q Consensus        49 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  127 (873)
                      +++.++++++ .+|..+.  +++++|+|++|+|+. ..+..|.++++|++|+|++|++....+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            4455555555 3443332  344444444444432 22333444444444444444444433444444444444444444


Q ss_pred             ccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcC
Q 039344          128 ILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNF  177 (873)
Q Consensus       128 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i  177 (873)
                      +|+...+.+|.++++|++|+|++|+|+.+.++.|..+++|++|+|++|.+
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~  138 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF  138 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence            44433333344444444444444444433333333333333333333333

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.71  E-value=2e-17  Score=160.54  Aligned_cols=107  Identities=23%  Similarity=0.256  Sum_probs=43.7

Q ss_pred             CCCeEEccCccccc-ccccccccCCCccEEeccCccccccCCCCCCCCCCCCeeeeccccCCccCCccccCCCCCCEEec
Q 039344          285 SLERVRLDRNYLTG-NISESFYIYPNLTYIDLSQNNFYGEISSDWGRCPKLSTLDFSINNITGNVPPEIGHSSQLGVLDL  363 (873)
Q Consensus       285 ~L~~L~L~~n~l~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~L  363 (873)
                      ++++|+|++|.|+. +....|..+++|++|+|++|.+....+..|..+++|+.|+|++|+|+...+.+|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            33444444444432 22333344444444444444444444444444444444444444444333334444444444444


Q ss_pred             cCCccCCCCCccccccccccEEEecCcc
Q 039344          364 SSNHIVGEIPIELGKLNFFIKLVLAHNQ  391 (873)
Q Consensus       364 s~N~i~~~~~~~~~~l~~L~~L~L~~N~  391 (873)
                      ++|+|++..+..|..+++|++|+|++|.
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~  137 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNP  137 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred             CCccccccCHHHhcCCcccccccccccc
Confidence            4444443333333333333333333333

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=2.1e-15  Score=140.78  Aligned_cols=127  Identities=20%  Similarity=0.219  Sum_probs=72.9

Q ss_pred             ccCCCCCCEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccc
Q 039344           17 LRNLKSLSDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLA   96 (873)
Q Consensus        17 ~~~l~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~   96 (873)
                      +.+..++++|+|++|+|+ .+|..+..+++|++|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            455556666777777766 345555666667777777776663 32 356666666666666666644444455566666


Q ss_pred             eeeccccccCCCCC-ccccCCcccCcccccccccccccCc----cccCCCCCcEEE
Q 039344           97 TLYLDTNSLSNSIP-SELGNLRSLSNLQLNNNILSGSIPH----SLGNLTNLATLY  147 (873)
Q Consensus        97 ~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~  147 (873)
                      +|++++|+++.... ..+..+++|++|++++|.++. .|.    .++.+++|+.||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            66666666653211 245555556666666655542 221    344455555544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=3.4e-16  Score=161.76  Aligned_cols=126  Identities=20%  Similarity=0.186  Sum_probs=62.0

Q ss_pred             cEEEccCCCCccccccccCCCCCCCEEEccCCcCccCCCccccCCCCCcEEeccCCCCccc-CCccccCCCCCCEEEccC
Q 039344          144 ATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGSIPPSLGNLSNLATLYLDTNSLSYS-IPSELGNLRSLSNLSLGY  222 (873)
Q Consensus       144 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~  222 (873)
                      ++||++++.+.......+.. ..+..+.++...+.... .......+|++|++++|.++.. ....+..+++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            36677776664222111111 13445555555544222 2222334666666666665532 233455666666666666


Q ss_pred             cccCCCcccccCCCCCccEEecccc-cCCCCC-chhhcCCCCCcEEEccCC
Q 039344          223 NKLSGSIPISMGNLSNLTYLNLFEN-SLSGAI-PYEYRNLVKLTILLLGHN  271 (873)
Q Consensus       223 N~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~-~~~~~~l~~L~~L~L~~N  271 (873)
                      |.+++..+..++.+++|++|+++++ .++... ...+.++++|++|+++++
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c  131 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC  131 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence            6665544555555666666666653 333211 111234455555555553

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=9.6e-16  Score=158.33  Aligned_cols=126  Identities=20%  Similarity=0.134  Sum_probs=75.1

Q ss_pred             CcccccccccccccCccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCccC-CCccccCCCCCcEEeccC
Q 039344          120 SNLQLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFNGS-IPPSLGNLSNLATLYLDT  198 (873)
Q Consensus       120 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~  198 (873)
                      +.|||+++.+.......+.. ..+..+.++...+..... ......+|++|+|+++.++.. +...+..+++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            35777777664222111111 234555666555443222 233445788888888777643 234466777888888888


Q ss_pred             CCCcccCCccccCCCCCCEEEccCc-ccCCCcc-cccCCCCCccEEecccc
Q 039344          199 NSLSYSIPSELGNLRSLSNLSLGYN-KLSGSIP-ISMGNLSNLTYLNLFEN  247 (873)
Q Consensus       199 n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~-~~~~~l~~L~~L~L~~n  247 (873)
                      |.+++..+..++.+++|++|+++++ .+++..- ....++++|++|+++++
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c  131 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC  131 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence            8777666667777788888888774 4543211 12345678888888775

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.55  E-value=2.8e-16  Score=167.95  Aligned_cols=93  Identities=18%  Similarity=0.159  Sum_probs=45.2

Q ss_pred             CCccccCCCCCceEEccCCccccc----CCCCccCCCCCCEEEcccCCCCCCC----------Ccccccccccceeeccc
Q 039344           37 IPHSLGNLTNLATLYIHTNSLSGS----IPGEIGNFRFFSDLELSNNKLSGSI----------PPSLGNLSNLATLYLDT  102 (873)
Q Consensus        37 ~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~----------~~~~~~l~~L~~L~L~~  102 (873)
                      +...+.....|++|+|++|.+...    +...+...++|+.|+++++......          ...+..+++|++|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            334455566666666666666422    2334455566666666655443111          11233345555555555


Q ss_pred             cccCCC----CCccccCCcccCccccccccc
Q 039344          103 NSLSNS----IPSELGNLRSLSNLQLNNNIL  129 (873)
Q Consensus       103 n~l~~~----~~~~~~~l~~L~~L~L~~n~l  129 (873)
                      |.+...    +...+...++|++|++++|.+
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l  133 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL  133 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred             cccccccccchhhhhcccccchheecccccc
Confidence            555432    122233345555555555544

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2e-15  Score=140.98  Aligned_cols=128  Identities=21%  Similarity=0.206  Sum_probs=74.4

Q ss_pred             ccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccC
Q 039344           41 LGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLS  120 (873)
Q Consensus        41 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  120 (873)
                      |.++.+|++|+|++|+|+ .++..+..+++|++|+|++|.|+..  ..|..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            566667777777777777 4455556667777777777777633  2466666677777777766644444455566666


Q ss_pred             cccccccccccccC-ccccCCCCCcEEEccCCCCcccc---ccccCCCCCCCEEE
Q 039344          121 NLQLNNNILSGSIP-HSLGNLTNLATLYIYSNSLSASI---LGKIGNLKSLSNLQ  171 (873)
Q Consensus       121 ~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~  171 (873)
                      +|++++|+++.... ..+..+++|++|++++|.+....   ...++.+++|++||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            66666666653211 24555555555555555554322   11234444555444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.54  E-value=3.9e-16  Score=166.73  Aligned_cols=38  Identities=26%  Similarity=0.228  Sum_probs=17.7

Q ss_pred             CCCCEEeccCCccCCCC----Ccccc-ccccccEEEecCcccc
Q 039344          356 SQLGVLDLSSNHIVGEI----PIELG-KLNFFIKLVLAHNQLS  393 (873)
Q Consensus       356 ~~L~~L~Ls~N~i~~~~----~~~~~-~l~~L~~L~L~~N~l~  393 (873)
                      ..|++|++++|.|+...    ...+. +.++|+.|+|++|++.
T Consensus       273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            34555555555554321    11221 3445555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=1.3e-14  Score=128.58  Aligned_cols=102  Identities=27%  Similarity=0.356  Sum_probs=63.5

Q ss_pred             CEEECCCCcccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           24 SDLELGNNKLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        24 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      +.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|+.+++|++|++++|.|+. +| .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            45677777776 333 3666777777777777776 555566666777777777777663 33 3666666666666666


Q ss_pred             ccCCCC-CccccCCcccCcccccccccc
Q 039344          104 SLSNSI-PSELGNLRSLSNLQLNNNILS  130 (873)
Q Consensus       104 ~l~~~~-~~~~~~l~~L~~L~L~~n~l~  130 (873)
                      +|+... ...+..+++|++|++++|.++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            666332 134555666666666666654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=1.3e-14  Score=128.56  Aligned_cols=101  Identities=29%  Similarity=0.395  Sum_probs=49.6

Q ss_pred             EEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcccccccccccccCccccCCCCCcEEEccCCC
Q 039344           73 DLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIPHSLGNLTNLATLYIYSNS  152 (873)
Q Consensus        73 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  152 (873)
                      +|+|++|+++ .++ .+..+++|++|++++|+|+ .+|+.|..+++|++|++++|.|+. +| .++.+++|++|++++|+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            4444444444 222 2444555555555555554 334444455555555555555542 22 25555555555555555


Q ss_pred             Ccccc-ccccCCCCCCCEEEccCCcCc
Q 039344          153 LSASI-LGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       153 l~~~~-~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      |+.+. ...+..+++|+.|++++|.++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            55433 234555555555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.40  E-value=5e-15  Score=143.38  Aligned_cols=126  Identities=21%  Similarity=0.297  Sum_probs=63.1

Q ss_pred             CCEEECCCC--cccccCCccccCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeec
Q 039344           23 LSDLELGNN--KLSGSIPHSLGNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYL  100 (873)
Q Consensus        23 l~~L~L~~n--~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  100 (873)
                      ++.++++++  .++ ..|.+|..+++|++|+|++|+|+ .++ .+..+++|++|+|++|.|+ .++..+..+++|++|++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence            344455433  232 34455566666666666666665 232 3555555666666655555 33433344445555555


Q ss_pred             cccccCCCCCccccCCcccCcccccccccccccC-ccccCCCCCcEEEccCCCCc
Q 039344          101 DTNSLSNSIPSELGNLRSLSNLQLNNNILSGSIP-HSLGNLTNLATLYIYSNSLS  154 (873)
Q Consensus       101 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~  154 (873)
                      ++|+++. + +.+..+++|++|++++|+++.... ..|..+++|+.|+|++|++.
T Consensus       101 ~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         101 SYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            5555552 1 234455555555555555542211 23445555555555555443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.38  E-value=7.9e-15  Score=141.93  Aligned_cols=130  Identities=23%  Similarity=0.345  Sum_probs=91.9

Q ss_pred             CCCceEEccCC--cccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeeccccccCCCCCccccCCcccCcc
Q 039344           45 TNLATLYIHTN--SLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL  122 (873)
Q Consensus        45 ~~L~~L~L~~n--~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (873)
                      ..++.++++++  .++ .++..+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+|+ .+|..+..+++|++|
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L   98 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL   98 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred             cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccc
Confidence            34555666553  343 455667778888888888888874 33 5778888888888888887 456556666778888


Q ss_pred             cccccccccccCccccCCCCCcEEEccCCCCccccc-cccCCCCCCCEEEccCCcCccC
Q 039344          123 QLNNNILSGSIPHSLGNLTNLATLYIYSNSLSASIL-GKIGNLKSLSNLQLSENNFNGS  180 (873)
Q Consensus       123 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~  180 (873)
                      ++++|.++. + ..+..+++|+.|++++|+|+.+.. ..+..+++|++|+|++|.+...
T Consensus        99 ~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_          99 WISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             ECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             ccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence            888888874 3 347777888888888888876532 4577777888888888777543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=1.6e-12  Score=119.99  Aligned_cols=81  Identities=21%  Similarity=0.235  Sum_probs=35.0

Q ss_pred             EEECCCCcccccCCccccCCCCCceEEccCC-cccccCCCCccCCCCCCEEEcccCCCCCCCCcccccccccceeecccc
Q 039344           25 DLELGNNKLSGSIPHSLGNLTNLATLYIHTN-SLSGSIPGEIGNFRFFSDLELSNNKLSGSIPPSLGNLSNLATLYLDTN  103 (873)
Q Consensus        25 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  103 (873)
                      .++.++++++ ..|..+..+++|++|++++| .++.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3444444444 33444444444444444333 244333344444444444444444444333444444444444444444


Q ss_pred             ccC
Q 039344          104 SLS  106 (873)
Q Consensus       104 ~l~  106 (873)
                      +|+
T Consensus        91 ~l~   93 (156)
T d2ifga3          91 ALE   93 (156)
T ss_dssp             CCS
T ss_pred             CCc
Confidence            444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=8.3e-12  Score=115.13  Aligned_cols=105  Identities=25%  Similarity=0.219  Sum_probs=48.0

Q ss_pred             CCEEEccCCcCccCCCccccCCCCCcEEeccCC-CCcccCCccccCCCCCCEEEccCcccCCCcccccCCCCCccEEecc
Q 039344          167 LSNLQLSENNFNGSIPPSLGNLSNLATLYLDTN-SLSYSIPSELGNLRSLSNLSLGYNKLSGSIPISMGNLSNLTYLNLF  245 (873)
Q Consensus       167 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  245 (873)
                      .+.++.+++.+. ..|..+..+++|++|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            344555555544 23344444455555555433 2444344444555555555555555544444444444455555555


Q ss_pred             cccCCCCCchhhcCCCCCcEEEccCCcC
Q 039344          246 ENSLSGAIPYEYRNLVKLTILLLGHNQF  273 (873)
Q Consensus       246 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l  273 (873)
                      +|+|+.+.+..|..+ +|+.|+|++|.+
T Consensus        89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~  115 (156)
T d2ifga3          89 FNALESLSWKTVQGL-SLQELVLSGNPL  115 (156)
T ss_dssp             SSCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred             CCCCcccChhhhccc-cccccccCCCcc
Confidence            555443333333322 344444444443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=3.7e-09  Score=97.68  Aligned_cols=69  Identities=23%  Similarity=0.123  Sum_probs=33.2

Q ss_pred             CccccCCcccCccccccccccccc--CccccCCCCCcEEEccCCCCccccccccCCCCCCCEEEccCCcCc
Q 039344          110 PSELGNLRSLSNLQLNNNILSGSI--PHSLGNLTNLATLYIYSNSLSASILGKIGNLKSLSNLQLSENNFN  178 (873)
Q Consensus       110 ~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  178 (873)
                      +..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|.|+.+..-.+....+|+.|++++|.+.
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            333444555555555555555321  233444555555555555555443322223334555555555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=3.2e-09  Score=98.18  Aligned_cols=88  Identities=23%  Similarity=0.110  Sum_probs=37.9

Q ss_pred             cCCCCCceEEccCCcccccCCCCccCCCCCCEEEcccCCCCCCC--CcccccccccceeeccccccCCCCCccccCCccc
Q 039344           42 GNLTNLATLYIHTNSLSGSIPGEIGNFRFFSDLELSNNKLSGSI--PPSLGNLSNLATLYLDTNSLSNSIPSELGNLRSL  119 (873)
Q Consensus        42 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  119 (873)
                      ..+..+..|....+... .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+.+..+|
T Consensus        39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L  117 (162)
T d1koha1          39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL  117 (162)
T ss_dssp             TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred             hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccc
Confidence            33344444444444333 33333344555555555555555321  1233444555555555555543222122223344


Q ss_pred             Ccccccccccc
Q 039344          120 SNLQLNNNILS  130 (873)
Q Consensus       120 ~~L~L~~n~l~  130 (873)
                      ++|++++|.+.
T Consensus       118 ~~L~L~~Npl~  128 (162)
T d1koha1         118 EELWLDGNSLS  128 (162)
T ss_dssp             SSCCCTTSTTS
T ss_pred             ceeecCCCCcC
Confidence            44444444444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.43  E-value=5.4e-07  Score=90.41  Aligned_cols=149  Identities=13%  Similarity=0.064  Sum_probs=103.1

Q ss_pred             HHHHHHhcCCCCCceeeecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEec
Q 039344          595 EEIIRATNDFDDEHCIGKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHV  673 (873)
Q Consensus       595 ~e~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  673 (873)
                      .|+...-+.|+..+..+.++.+.||+.... ++.+++|+........   ...+.+|...+..+. +--+.+++.++.++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            345555567776665544555789998755 5667788875432222   234678888888773 44467888998888


Q ss_pred             ceeEEEEEeccCCChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhCCC----------------------------
Q 039344          674 RHLFIVYEYFKMCSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHNDCF----------------------------  725 (873)
Q Consensus       674 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~----------------------------  725 (873)
                      +..++||++++|.++.+....        ......++.++++.++.||+...                            
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CceEEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            999999999999887654321        12233456667777777775310                            


Q ss_pred             ----------------------------CCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          726 ----------------------------PPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       726 ----------------------------~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                                                  +.++|+|+.+.||++++++.+.|.||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                        237899999999999987777899999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.02  E-value=8.4e-06  Score=80.95  Aligned_cols=130  Identities=15%  Similarity=0.080  Sum_probs=87.8

Q ss_pred             eeeecCC-eEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccC--CceeeEEeEEEecceeEEEEEeccC
Q 039344          609 CIGKGGQ-GSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWH--RNIVKVYGFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       609 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  685 (873)
                      .+..|.. +.||+....++..+++|.......      ..+..|+..++.+..  -.+.++++++.+.+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            4455554 678999988888899998654321      346678888877743  3467888888888889999999988


Q ss_pred             CChhhHhcccccccCCChHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 039344          686 CSLAVILSNDAAAKNLGWTRRMNMIKGIVDALSYMHND------------------------------------------  723 (873)
Q Consensus       686 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  723 (873)
                      .++.+..        ..   ....+.++++.++-||+.                                          
T Consensus        91 ~~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (255)
T d1nd4a_          91 QDLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  159 (255)
T ss_dssp             EETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             ccccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence            6653321        01   111223334444444431                                          


Q ss_pred             ---------C----CCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          724 ---------C----FPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       724 ---------~----~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                               .    .+.++|+|+.|.||+++.+..+.|+||+.+.
T Consensus       160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                     0    1247999999999999987777899999775

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.75  E-value=4.5e-06  Score=76.78  Aligned_cols=37  Identities=11%  Similarity=0.096  Sum_probs=15.3

Q ss_pred             CCCccEEeccCcccccc----CCCCCCCCCCCCeeeecccc
Q 039344          307 YPNLTYIDLSQNNFYGE----ISSDWGRCPKLSTLDFSINN  343 (873)
Q Consensus       307 ~~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~  343 (873)
                      .+.|++|+|++|.++..    +..++...++|+.|++++|.
T Consensus        71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~  111 (167)
T d1pgva_          71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR  111 (167)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCc
Confidence            34444444444444322    11223334445555554443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.73  E-value=6.9e-06  Score=75.47  Aligned_cols=37  Identities=14%  Similarity=0.043  Sum_probs=15.9

Q ss_pred             CCCCcEEEccCCcCcC-----cCCcCCCCCCCCeEEccCccc
Q 039344          260 LVKLTILLLGHNQFRG-----PIPILRNLTSLERVRLDRNYL  296 (873)
Q Consensus       260 l~~L~~L~L~~N~l~~-----~~~~l~~l~~L~~L~L~~n~l  296 (873)
                      .+.|++|+|++|.+..     ...++...++|++|++++|.+
T Consensus        71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred             cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence            3444444444444432     112233444455555544443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.52  E-value=0.00024  Score=74.77  Aligned_cols=79  Identities=15%  Similarity=0.015  Sum_probs=48.8

Q ss_pred             CceeeecCCeEEEEEEeCC-CcEEEEEEccCC----CCCcchhHHHHHHHHHHHHhcc-C--CceeeEEeEEEecceeEE
Q 039344          607 EHCIGKGGQGSVYMSKLAS-GEIIAVKKFHSP----LPGEMTFQQEFLNEVKALTEIW-H--RNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       607 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  678 (873)
                      .+.||.|....||+....+ ++.|+||.-...    .............|.+.++.+. +  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999998654 678889864321    1111111233456888887763 2  356667665  4556689


Q ss_pred             EEEeccCCC
Q 039344          679 VYEYFKMCS  687 (873)
Q Consensus       679 v~e~~~~~~  687 (873)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999987654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.16  E-value=1e-05  Score=74.27  Aligned_cols=117  Identities=18%  Similarity=0.137  Sum_probs=53.6

Q ss_pred             ccCCCCCCEEECCC-Ccccc----cCCccccCCCCCceEEccCCccccc----CCCCccCCCCCCEEEcccCCCCCCCCc
Q 039344           17 LRNLKSLSDLELGN-NKLSG----SIPHSLGNLTNLATLYIHTNSLSGS----IPGEIGNFRFFSDLELSNNKLSGSIPP   87 (873)
Q Consensus        17 ~~~l~~l~~L~L~~-n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~   87 (873)
                      ..+.+.|++|+|++ +.++.    .+-.++...++|++|+|++|.++..    +...+...++++.+++++|.+......
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            34445666666665 33431    1223344555666666666655422    112233334445555544444311100


Q ss_pred             ccccccccceeeccccccCCCCCccccCCcccCcc--ccccccccc----ccCccccCCCCCcEEEccCCCC
Q 039344           88 SLGNLSNLATLYLDTNSLSNSIPSELGNLRSLSNL--QLNNNILSG----SIPHSLGNLTNLATLYIYSNSL  153 (873)
Q Consensus        88 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L--~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l  153 (873)
                                          .+...+...++|+.+  ++++|.+..    .+.+.+...++|+.|+++.+..
T Consensus        93 --------------------~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          93 --------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             --------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             --------------------HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence                                122334444555543  333444432    2333455566777777766543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.16  E-value=3.8e-05  Score=70.34  Aligned_cols=86  Identities=10%  Similarity=0.147  Sum_probs=35.8

Q ss_pred             CCCCCCCeEEccCcccccccc----cccccCCCccEEeccCcccccc----CCCCCCCCCCCCeeee--ccccCCcc---
Q 039344          281 RNLTSLERVRLDRNYLTGNIS----ESFYIYPNLTYIDLSQNNFYGE----ISSDWGRCPKLSTLDF--SINNITGN---  347 (873)
Q Consensus       281 ~~l~~L~~L~L~~n~l~~~~~----~~~~~~~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l--~~N~i~~~---  347 (873)
                      ...++|++|++++|.++....    ..+...+.++.+++++|.++..    +...+...++|+.++|  ++|.+...   
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~  122 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM  122 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred             hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence            344445555555554443221    2233344555555555554322    1223334445554333  33444321   


Q ss_pred             -CCccccCCCCCCEEeccCC
Q 039344          348 -VPPEIGHSSQLGVLDLSSN  366 (873)
Q Consensus       348 -~~~~~~~~~~L~~L~Ls~N  366 (873)
                       +...+...++|+.|+++.+
T Consensus       123 ~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_         123 EIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHHHHHHHCSSCCEEECCCS
T ss_pred             HHHHHHHhCCCcCEEeCcCC
Confidence             2223334455555555444

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.94  E-value=0.0016  Score=66.37  Aligned_cols=138  Identities=13%  Similarity=0.113  Sum_probs=79.4

Q ss_pred             cCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCcee--eEE-----eEEEecceeEEEEEeccC
Q 039344          613 GGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNIV--KVY-----GFCLHVRHLFIVYEYFKM  685 (873)
Q Consensus       613 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~-----~~~~~~~~~~lv~e~~~~  685 (873)
                      +..-.||+++..+|+.|++|+.+...    ...+++..|...+..+....+.  ..+     ......+..+.++++++|
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            33458999999999999999986431    1246788899888888533322  111     122345667889999876


Q ss_pred             CChhh----Hh----------cc----cc--cccCCC-------------------hHHHHHHHHHHHHHHHHHHh----
Q 039344          686 CSLAV----IL----------SN----DA--AAKNLG-------------------WTRRMNMIKGIVDALSYMHN----  722 (873)
Q Consensus       686 ~~L~~----~l----------~~----~~--~~~~~~-------------------~~~~~~i~~~i~~~l~~LH~----  722 (873)
                      ..+..    ..          +.    ..  .....+                   ...+..+...+.+.++.+..    
T Consensus       109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~  188 (325)
T d1zyla1         109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  188 (325)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence            43310    00          00    00  000111                   11111222223333333322    


Q ss_pred             CCCCCeeeCCCCCCCeeeCCCCCeEEeccccccc
Q 039344          723 DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAKF  756 (873)
Q Consensus       723 ~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~  756 (873)
                      ....+++|+|+.+.||+++. + ..++||+-+..
T Consensus       189 ~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         189 DFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             cCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            22347899999999999974 3 45899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.34  E-value=0.0099  Score=59.91  Aligned_cols=158  Identities=11%  Similarity=0.057  Sum_probs=84.6

Q ss_pred             cCHHHHHHHhcCCCCCcee-----eecCCeEEEEEEeCCCcEEEEEEccCCCCCcchhHHHHHHHHHHHHhccCCce--e
Q 039344          592 IIYEEIIRATNDFDDEHCI-----GKGGQGSVYMSKLASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIWHRNI--V  664 (873)
Q Consensus       592 ~~~~e~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v  664 (873)
                      ++.+|+.....+|.+++..     ..|.--+.|+.+..+|+ +++|++.....     .+++..|++.+..+...++  +
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC-----HHHHHHHHHHHHhhhhcccccc
Confidence            4567788888889886543     35666788999888665 78898864311     1345567777777743332  2


Q ss_pred             eEEe------EEEecceeEEEEEeccCCChhhHh--------------cc----cc--ccc------------------C
Q 039344          665 KVYG------FCLHVRHLFIVYEYFKMCSLAVIL--------------SN----DA--AAK------------------N  700 (873)
Q Consensus       665 ~l~~------~~~~~~~~~lv~e~~~~~~L~~~l--------------~~----~~--~~~------------------~  700 (873)
                      ..+.      +....+..+.++.+..+......-              +.    ..  ...                  .
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            1111      112234456666665543221100              00    00  000                  0


Q ss_pred             CChHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeeeCCCCCeEEecccccc
Q 039344          701 LGWTRRMNMIKGIVDALSYMHN-DCFPPIVHRDISSKNVLLDFENEAHVSDFGIAK  755 (873)
Q Consensus       701 ~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~  755 (873)
                      .........+..+...+...+. ....|++|+|+.+.||+++.+...-|.||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0011112222222333333222 123489999999999999988878899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.33  E-value=0.0061  Score=63.72  Aligned_cols=72  Identities=17%  Similarity=0.240  Sum_probs=49.2

Q ss_pred             ceeeecCCeEEEEEEeCCC--------cEEEEEEccCCCCCcchhHHHHHHHHHHHHhcc-CCceeeEEeEEEecceeEE
Q 039344          608 HCIGKGGQGSVYMSKLASG--------EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIW-HRNIVKVYGFCLHVRHLFI  678 (873)
Q Consensus       608 ~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  678 (873)
                      +.|+.|-.-.+|++..+++        +.|.+++....  ..   .....+|..+++.+. +.=.+++++++.+    ++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            5788899999999986543        45777776421  11   234568888888884 4334578887753    68


Q ss_pred             EEEeccCCCh
Q 039344          679 VYEYFKMCSL  688 (873)
Q Consensus       679 v~e~~~~~~L  688 (873)
                      |+||++|.++
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987544